PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Reddy, GR; Subramanian, H; Birk, A; Milde, M; Nikolaev, VO; Bunemann, M				Reddy, Gopireddy Raghavender; Subramanian, Hariharan; Birk, Alexandra; Milde, Markus; Nikolaev, Viacheslav O.; Buenemann, Moritz			Adenylyl cyclases 5 and 6 underlie PIP3-dependent regulation	FASEB JOURNAL			English	Article						cAMP; GPCR; PI3K; G alpha(i); FRET	G-PROTEIN; CA2+ CURRENT; REBOUND STIMULATION; ION CHANNELS; VENTRICULAR MYOCYTES; SMOOTH-MUSCLE; CAMP; ACETYLCHOLINE; GAMMA; RECEPTORS	Many different neurotransmitters and hormones control intracellular signaling by regulating the production of the second messenger cAMP. The function of the broadly expressed adenylyl cyclases (ACs) 5 and 6 is regulated by either stimulatory or inhibitory G proteins. By analyzing a well-known rebound stimulation phenomenon after withdrawal of G(i) protein in atrial myocytes, we discovered that AC5 and -6 are tightly regulated by the second messenger PIP3. By monitoring cAMP levels in real time by means of Forster resonance energy transfer (FRET)-based biosensors, we reproduced the rebound stimulation in a heterologous expression system specifically for AC5 or -6. Strikingly, this cAMP rebound stimulation was completely blocked by the PI3K inhibitor wortmannin, both in atrial myocytes and in transfected human embryonic kidney cells. Similar effects were observed by heterologous expression of the PIP3 phosphatase and tensin homolog (PTEN). However, general kinase inhibitors or inhibitors of Akt had no effect, suggesting a PIP3-dependent mechanism. These findings demonstrate the existence of a novel general pathway for regulation of AC5 and -6 activity via PIP3 that leads to pronounced alterations of cytosolic cAMP levels.- Reddy, G. R., Subramanian, H., Birk, A., Milde, M., Nikolaev, V. O., Bunemann, M. Adenylyl cyclases 5 and 6 underlie PIP3-dependent regulation.	[Reddy, Gopireddy Raghavender; Birk, Alexandra; Buenemann, Moritz] Univ Marburg, Fac Pharm, D-35032 Marburg, Germany; [Subramanian, Hariharan; Nikolaev, Viacheslav O.] Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [Milde, Markus] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany	Philipps University Marburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen	Bunemann, M (corresponding author), Univ Marburg, Karl von Frisch Str 1, D-35032 Marburg, Germany.	moritz.buenemann@staff.uni-marburg.de	Nikolaev, Vyacheslav/AAT-7746-2020	Buenemann, Moritz/0000-0002-2259-4378	Deutsche Forschungsgemeinschaft [SFB593]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Drs. Dominik Oliver, Jin Zhang, and Kazuhiro Aoki for providing FRET- and PIP<INF>3</INF>-dependent translocation biosensors. This work was funded in part by Deutsche Forschungsgemeinschaft SFB593. The authors declare no conflicts of interest.	BANACH K, 1993, PFLUG ARCH EUR J PHY, V423, P245, DOI 10.1007/BF00374402; Belevych AE, 2000, J PHYSIOL-LONDON, V528, P279, DOI 10.1111/j.1469-7793.2000.00279.x; Belevych AE, 2001, J PHYSIOL-LONDON, V536, P677, DOI 10.1111/j.1469-7793.2001.00677.x; Bett GCL, 2002, J PHYSIOL-LONDON, V542, P107, DOI 10.1113/jphysiol.2002.017335; Bodmann EL, 2014, BIOCHEM J, V458, P131, DOI 10.1042/BJ20130782; Brady JD, 2006, P NATL ACAD SCI USA, V103, P15635, DOI 10.1073/pnas.0603344103; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; DEIGHTON NM, 1990, N-S ARCH PHARMACOL, V341, P14; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gottle M, 2009, J PHARMACOL EXP THER, V329, P1156, DOI 10.1124/jpet.109.150953; Gregg CJ, 2010, ANESTH ANALG, V111, P870, DOI 10.1213/ANE.0b013e3181ee8312; HARTZELL HC, 1988, PROG BIOPHYS MOL BIO, V52, P165, DOI 10.1016/0079-6107(88)90014-4; Harvey RD, 2003, BRIT J PHARMACOL, V139, P1074, DOI 10.1038/sj.bjp.0705338; Hu CL, 2009, AM J PHYSIOL-HEART C, V297, pH1776, DOI 10.1152/ajpheart.00050.2009; Jungmichel S, 2014, CELL REP, V6, P578, DOI 10.1016/j.celrep.2013.12.038; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mattick P, 2007, J PHYSIOL-LONDON, V582, P1195, DOI 10.1113/jphysiol.2007.133439; Milde M, 2013, BIOCHEM J, V454, P515, DOI 10.1042/BJ20130554; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Murthy KS, 1998, MOL PHARMACOL, V54, P122, DOI 10.1124/mol.54.1.122; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; ONO K, 1994, JPN J PHYSIOL, V44, pS193; OSAKA T, 1993, AM J PHYSIOL, V264, pH1916; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pavan B, 2009, DRUG DISCOV TODAY, V14, P982, DOI 10.1016/j.drudis.2009.07.007; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Song YJ, 1998, J CARDIOVASC ELECTR, V9, P718, DOI 10.1111/j.1540-8167.1998.tb00959.x; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; Viard P, 1999, FASEB J, V13, P685, DOI 10.1096/fasebj.13.6.685; von Hayn K, 2010, AM J PHYSIOL-CELL PH, V298, pC324, DOI 10.1152/ajpcell.00197.2009; Wang YG, 1998, J GEN PHYSIOL, V111, P113, DOI 10.1085/jgp.111.1.113; WANG YG, 1995, CIRC RES, V76, P634, DOI 10.1161/01.RES.76.4.634; Wang YG, 1996, CIRC RES, V79, P109, DOI 10.1161/01.RES.79.1.109; Wang YX, 1999, J BIOL CHEM, V274, P13859, DOI 10.1074/jbc.274.20.13859; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Zakharov SI, 1997, J PHYSIOL-LONDON, V499, P105, DOI 10.1113/jphysiol.1997.sp021914; Zindel D, 2015, MOL PHARMACOL, V87, P349, DOI 10.1124/mol.114.095422	50	3	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3458	3471		10.1096/fj.14-268466	http://dx.doi.org/10.1096/fj.14-268466			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25931510				2022-12-26	WOS:000358796900032
J	Monteil, A; Chausson, P; Boutourlinsky, K; Mezghrani, A; Huc-Brandt, S; Blesneac, I; Bidaud, I; Lemmers, C; Leresche, N; Lambert, RC; Lory, P				Monteil, Arnaud; Chausson, Patrick; Boutourlinsky, Katia; Mezghrani, Alexandre; Huc-Brandt, Sylvaine; Blesneac, Iulia; Bidaud, Isabelle; Lemmers, Celine; Leresche, Nathalie; Lambert, Regis C.; Lory, Philippe			Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; neuroblastoma; neuron; patch clamp; Western blot; Cav3; 2; HEK-293T cell line; T-type calcium channels; Sindbis virus; thalamic neurons	PLASMA-MEMBRANE EXPRESSION; CA2+ CHANNELS; SURFACE EXPRESSION; ABSENCE EPILEPSY; NEURONS; MUTATIONS; ALPHA(1G); RAT	Background: Novel strategies are needed to characterize the properties of T-type (Cav3) calcium channel isoforms. Results: The I-II loop of the Cav3.2 protein potently inhibits both recombinant and neuronal Cav3.1 and Cav3.2 channels. Conclusion: This I-II loop region can be used to selectively silence Cav3.1/Cav3.2 channels. Significance: This study reveals a new approach to differentiate among the activity of native Cav3 channels. Voltage-dependent calcium channels (Cav) of the T-type family (Cav3.1, Cav3.2, and Cav3.3) are activated by low threshold membrane depolarization and contribute greatly to neuronal network excitability. Enhanced T-type channel activity, especially Cav3.2, contributes to disease states, including absence epilepsy. Interestingly, the intracellular loop connecting domains I and II (I-II loop) of Cav3.2 channels is implicated in the control of both surface expression and channel gating, indicating that this I-II loop plays an important regulatory role in T-type current. Here we describe that co-expression of this I-II loop or its proximal region (1-Cav3.2; Ser(423)-Pro(542)) together with recombinant full-length Cav3.2 channel inhibited T-type current without affecting channel expression and membrane incorporation. Similar T-type current inhibition was obtained in NG 108-15 neuroblastoma cells that constitutively express Cav3.2 channels. Of interest, 1-Cav3.2 inhibited both Cav3.2 and Cav3.1 but not Cav3.3 currents. Efficacy of 1-Cav3.2 to inhibit native T-type channels was assessed in thalamic neurons using viral transduction. We describe that T-type current was significantly inhibited in the ventrobasal neurons that express Cav3.1, whereas in nucleus reticularis thalami neurons that express Cav3.2 and Cav3.3 channels, only the fast inactivating T-type current (Cav3.2 component) was significantly inhibited. Altogether, these data describe a new strategy to differentially inhibit Cav3 isoforms of the T-type calcium channels.	[Monteil, Arnaud; Mezghrani, Alexandre; Huc-Brandt, Sylvaine; Blesneac, Iulia; Bidaud, Isabelle; Lemmers, Celine; Lory, Philippe] Univ Montpellier, Inst Genom Fonct, Dept Physiol, CNRS,UMR 5203, F-34094 Montpellier, France; [Monteil, Arnaud; Mezghrani, Alexandre; Huc-Brandt, Sylvaine; Blesneac, Iulia; Bidaud, Isabelle; Lemmers, Celine; Lory, Philippe] INSERM, U1191, F-34094 Montpellier, France; [Monteil, Arnaud; Lemmers, Celine] INSERM, US009, CNRS, Plateforme Vectorol,UMS 3426, F-34094 Montpellier, France; [Monteil, Arnaud; Mezghrani, Alexandre; Huc-Brandt, Sylvaine; Blesneac, Iulia; Bidaud, Isabelle; Lemmers, Celine; Lory, Philippe] LabEx Ion Channel Sci & Therapeut, F-34094 Montpellier, France; [Chausson, Patrick; Boutourlinsky, Katia; Leresche, Nathalie; Lambert, Regis C.] Univ Paris 06, Univ Sorbonne, UM 119, NPS, F-75005 Paris, France; [Chausson, Patrick; Boutourlinsky, Katia; Leresche, Nathalie; Lambert, Regis C.] CNRS, UMR 8246, NPS, F-75005 Paris, France; [Chausson, Patrick; Boutourlinsky, Katia; Leresche, Nathalie; Lambert, Regis C.] INSERM, NPS, U1130, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lory, P (corresponding author), Inst Genom Fonct, 141 Rue Cardonille, F-34094 Montpellier 5, France.	philippe.lory@igf.cnrs.fr	Monteil, Arnaud/G-3113-2012; Brandt, Sylvaine/AAJ-1277-2021	Monteil, Arnaud/0000-0003-1632-7318; Brandt, Sylvaine/0000-0002-5582-4643; BIDAUD, Isabelle/0000-0002-1812-1447; Leresche, Nathalie/0000-0001-6705-9769; LORY, philippe/0000-0002-1638-7604	Agence Nationale de la Recherche [ANR-10-BLAN-1601, ANR-09-MNPS-035]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grants ANR-10-BLAN-1601 (to P. L.) and ANR-09-MNPS-035 grants (to P. L., R. C. L., and N. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Astori S, 2013, J NEUROSCI, V33, P624, DOI 10.1523/JNEUROSCI.3185-12.2013; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Bidaud I, 2011, BIOCHIMIE, V93, P2080, DOI 10.1016/j.biochi.2011.05.015; Cain SM, 2010, CHANNELS, V4, P475, DOI 10.4161/chan.4.6.14106; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Ernst WL, 2009, J NEUROSCI, V29, P1615, DOI 10.1523/JNEUROSCI.2081-08.2009; Francois A, 2014, PFLUG ARCH EUR J PHY, V466, P707, DOI 10.1007/s00424-014-1484-4; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Lambert RC, 2014, PFLUG ARCH EUR J PHY, V466, P415, DOI 10.1007/s00424-013-1353-6; Leresche N, 1998, J NEUROSCI, V18, P4842; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Shcheglovitov A, 2008, FEBS LETT, V582, P3765, DOI 10.1016/j.febslet.2008.10.013; Talley EM, 1999, J NEUROSCI, V19, P1895; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Zamponi GW, 2010, PFLUG ARCH EUR J PHY, V460, P395, DOI 10.1007/s00424-009-0772-x	22	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16168	16176		10.1074/jbc.M114.634261	http://dx.doi.org/10.1074/jbc.M114.634261			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25931121	hybrid, Green Published			2022-12-26	WOS:000356930100021
J	Arcanjo, AF; LaRocque-de-Freitas, IF; Rocha, JDB; Zamith, D; Costa-da-Silva, AC; Nunes, MP; Mesquita-Santos, FP; Morrot, A; Filardy, AA; Mariano, M; Bandeira-Melo, C; DosReis, GA; Decote-Ricardo, D; Freire-de-Lima, CG				Arcanjo, Angelica F.; LaRocque-de-Freitas, Isabel F.; Rocha, Juliana Dutra B.; Zamith, Daniel; Costa-da-Silva, Ana Caroline; Nunes, Marise Pinheiro; Mesquita-Santos, Fabio P.; Morrot, Alexandre; Filardy, Alessandra A.; Mariano, Mario; Bandeira-Melo, Christianne; DosReis, George A.; Decote-Ricardo, Debora; Freire-de-Lima, Celio Geraldo			The PGE(2)/IL-10 Axis Determines Susceptibility of B-1 Cell-Derived Phagocytes (B-1CDP) to Leishmania major Infection	PLOS ONE			English	Article							BIPHENOTYPIC B/MACROPHAGE CELLS; B-CELLS; LIPID DROPLETS; MONONUCLEAR PHAGOCYTE; APOPTOTIC CELLS; IMMUNE-RESPONSE; T-CELLS; EXPRESSION; PARASITE; MACROPHAGES	B-1 cells can be differentiated from B-2 cells because they are predominantly located in the peritoneal and pleural cavities and have distinct phenotypic patterns and activation properties. A mononuclear phagocyte derived from B-1 cells (B-1CDP) has been described. As the B-1CDP cells migrate to inflammatory/infectious sites and exhibit phagocytic capacity, the microbicidal ability of these cells was investigated using the Leishmania major infection model in vitro. The data obtained in this study demonstrate that B-1CDP cells are more susceptible to infection than peritoneal macrophages, since B-1CDP cells have a higher number of intracellular amastigotes forms and consequently release a larger number of promastigotes. Exacerbated infection by Leishmania major required lipid bodies/PGE(2) and IL-10 by B-1CDP cells. Both infection and the production of IL-10 were decreased when PGE(2) production was blocked by NSAIDs. The involvement of IL-10 in this mechanism was confirmed, since B-1CDP cells from IL-10 KO mice are more competent to control Leishmania major infection than cells from wild type mice. These findings further characterize the B-1CDP cells as an important mononuclear phagocyte that plays a previously unrecognized role in host responses to Leishmania major infection, most likely via PGE(2)-driven production of IL-10.	[Arcanjo, Angelica F.; LaRocque-de-Freitas, Isabel F.; Rocha, Juliana Dutra B.; Zamith, Daniel; Costa-da-Silva, Ana Caroline; Mesquita-Santos, Fabio P.; Filardy, Alessandra A.; Bandeira-Melo, Christianne; DosReis, George A.; Freire-de-Lima, Celio Geraldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [LaRocque-de-Freitas, Isabel F.; Decote-Ricardo, Debora] Univ Fed Rural Rio de Janeiro, Dept Vet, Rio De Janeiro, Brazil; [Nunes, Marise Pinheiro] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Morrot, Alexandre] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21941 Rio De Janeiro, Brazil; [Mariano, Mario] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP)	Decote-Ricardo, D (corresponding author), Univ Fed Rural Rio de Janeiro, Dept Vet, Rio De Janeiro, Brazil.	decotericardo@ufrrj.br; celio@biof.ufrj.br	Mariano, Mario/L-2557-2015; Filardy, Alessandra/AAH-6034-2020; Zamith-Miranda, Daniel/E-8877-2013; de Melo, Christianne Bandeira/B-7724-2009; Decote-Ricardo, Debora/O-6480-2019; Bandeira-Melo, Christianne/X-5619-2019; de Lima, Celio Geraldo Freire/A-9057-2012	Filardy, Alessandra/0000-0003-4098-3235; Zamith-Miranda, Daniel/0000-0001-7532-2432; de Melo, Christianne Bandeira/0000-0003-3305-3865; Bandeira-Melo, Christianne/0000-0003-3305-3865; Costa da silva, Ana Caroline/0000-0002-2729-5836; DosReis, George/0000-0002-8924-4727	Brazilian National Research Council (CNPq); Rio de Janeiro State Science Foundation (FAPERJ)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Brazilian National Research Council (CNPq) and Rio de Janeiro State Science Foundation (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; ARIASNEGRETE S, 1995, BIOCHEM BIOPH RES CO, V208, P582, DOI 10.1006/bbrc.1995.1378; Askenase PW, 1999, INT ARCH ALLERGY IMM, V118, P145, DOI 10.1159/000024052; Babai B, 1999, CLIN EXP IMMUNOL, V117, P123; Bandeira-Melo C, 2011, METHODS MOL BIOL, V717, P277, DOI 10.1007/978-1-61779-024-9_16; Barbeiro DF, 2011, IMMUNOBIOLOGY, V216, P302, DOI 10.1016/j.imbio.2010.08.002; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; Bonamin LV, EVID BASED COMPLEMEN; Borrello MA, 1999, J IMMUNOL, V163, P3605; Bozza PT, 2007, PHARMACOL THERAPEUT, V113, P30, DOI 10.1016/j.pharmthera.2006.06.006; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Charron AJ, 2002, J CELL SCI, V115, P3049; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cruz-Leal Y, 2014, INT IMMUNOL, V26, P427, DOI 10.1093/intimm/dxu042; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Fujimoto T, 2004, SEIKAGAKU, V76, P578; Ghosn EEB, 2006, J LEUKOCYTE BIOL, V80, P36, DOI 10.1189/jlb.1005603; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gomes NA, 2000, INT IMMUNOL, V12, P1227, DOI 10.1093/intimm/12.9.1227; Graf BA, 1999, EUR J IMMUNOL, V29, P3793, DOI 10.1002/(SICI)1521-4141(199911)29:11<3793::AID-IMMU3793>3.0.CO;2-3; GREENSPAN P, 1985, J LIPID RES, V26, P781; HARDY RR, 1987, EUR J IMMUNOL, V17, P1769, DOI 10.1002/eji.1830171214; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HOERAUF A, 1994, INT IMMUNOL, V6, P1117, DOI 10.1093/intimm/6.8.1117; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Joss A, 2000, EUR J IMMUNOL, V30, P1683, DOI 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Katoh S, 1990, Dev Immunol, V1, P113, DOI 10.1155/1990/28760; KIPPS TJ, 1989, ADV IMMUNOL, V47, P117, DOI 10.1016/S0065-2776(08)60663-X; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Lopes JD, 2009, AN ACAD BRAS CIENC, V81, P489, DOI 10.1590/S0001-37652009000300013; Laurindo MFL, 2013, IMMUNOBIOLOGY, V218, P609, DOI 10.1016/j.imbio.2012.07.032; Luna-Gomes T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090582; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; Melo RCN, 2003, CELL BIOL INT, V27, P853, DOI 10.1016/S1065-6995(03)00173-2; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MURAKAMI K, 1994, VIROLOGY, V202, P458, DOI 10.1006/viro.1994.1362; MURAKAMI Y, 1995, IMMUNOLOGY, V86, P238; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Padigel UM, 2003, J IMMUNOL, V171, P3705, DOI 10.4049/jimmunol.171.7.3705; Palos MC, 2012, INFLAMM RES, V61, P1187, DOI 10.1007/s00011-012-0514-y; PENNELL CA, 1988, J IMMUNOL, V141, P2788; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pinheiro RO, 2009, MICROBES INFECT, V11, P181, DOI 10.1016/j.micinf.2008.11.006; Popi AF, 2009, IMMUNOBIOLOGY, V214, P664, DOI 10.1016/j.imbio.2008.12.007; Popi AF, 2009, IMMUNOLOGY, V126, P114, DOI 10.1111/j.1365-2567.2008.02883.x; Popi AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034570; Pugliese LS, 2012, IMMUNOBIOLOGY, V217, P336, DOI 10.1016/j.imbio.2011.07.014; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; RENZ H, 1988, J IMMUNOL, V141, P2388; Santos-Lima EC, 2001, EUR J IMMUNOL, V31, P634, DOI 10.1002/1521-4141(200102)31:2&lt;634::AID-IMMU634&gt;3.0.CO;2-H; SCHANDENE L, 1994, J IMMUNOL, V152, P4368; SPENCKER T, 1995, BIOCHEM BIOPH RES CO, V216, P540, DOI 10.1006/bbrc.1995.2656; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Takeshita H, 1998, INT IMMUNOL, V10, P435, DOI 10.1093/intimm/10.4.435; Thies FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062805; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415	70	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124888	10.1371/journal.pone.0124888	http://dx.doi.org/10.1371/journal.pone.0124888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933287	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100062
J	Bukowska-Osko, I; Pawelczyk, A; Perlejewski, K; Kubisa, N; Cortes, KC; Rosinska, M; Ploski, R; Fic, M; Kazmierczak, J; Popiel, M; Zabek, P; Horban, A; Radkowski, M; Laskus, T				Bukowska-Osko, Iwona; Pawelczyk, Agnieszka; Perlejewski, Karol; Kubisa, Natalia; Cortes, Kamila Caraballo; Rosinska, Magdalena; Ploski, Rafal; Fic, Maria; Kazmierczak, Justyna; Popiel, Marta; Zabek, Piotr; Horban, Andrzej; Radkowski, Marek; Laskus, Tomasz			Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin	PLOS ONE			English	Article							CHRONICALLY INFECTED PATIENTS; QUASI-SPECIES HETEROGENEITY; VIRAL BREAKTHROUGH; HIV; EVOLUTION; THERAPY; MORTALITY; PERSISTENCE; MUTATIONS; DEATH	Association between hepatitis C virus (HCV) quasispecies and treatment outcome among patients with chronic hepatitis C has been the subject of many studies. However, these studies focused mainly on viral variable regions (E1 and E2) and usually did not include human immunodeficiency virus (HIV)-positive patients. The aim of the present study was to analyze heterogeneity of the 5'untranslated region (5'UTR) in HCV/HIV coinfected patients treated with interferon and ribavirin. The HCV 5'UTR was amplified from serum and peripheral blood mononuclear cells (PBMC) samples in 37 HCV/HIV coinfected patients treated for chronic hepatitis C. Samples were collected right before treatment, and at 2, 4, 6, 8, 12, 20, 24, 36, 44, 48, 60, and 72 weeks. Heterogeneity of the 5'UTR was analyzed by single strand conformational polymorphism (SSCP), cloning and sequencing. Sustained virological response (SVR) was achieved in 46% of analyzed HCV/HIV co-infected patients. Stable SSCP band pattern was observed in 22 patients (62.9%) and SVR rate among these patients was 23%. Decline in the number of bands and/or shift in band positions were found in 6 patients (17.1%), 5 (83%) of whom achieved SVR (p=0.009). A novel viral genotype was identified in all but one of these patients. In 5 of these 6 patients a new genotype was dominant. 5'UTR heterogeneity may correlate with interferon and ribavirin treatment outcome. In the analyzed group of HCV/HIV coinfected patients, viral quasispecies stability during treatment favored viral persistence, whereas decrease in the number of variants and/or emergence of new variants was associated with SVR. Among injection drug users (IDU) patients, a new genotype may become dominant during treatment, probably due to the presence of mixed infections with various strains, which have different susceptibility to treatment.	[Bukowska-Osko, Iwona; Pawelczyk, Agnieszka; Perlejewski, Karol; Kubisa, Natalia; Cortes, Kamila Caraballo; Fic, Maria; Kazmierczak, Justyna; Popiel, Marta; Radkowski, Marek; Laskus, Tomasz] Med Univ Warsaw, Dept Immunopathol, Warsaw, Poland; [Rosinska, Magdalena] Natl Inst Hyg, Dept Epidemiol, PL-00791 Warsaw, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Zabek, Piotr; Horban, Andrzej] Hosp Infect Dis, Warsaw, Poland	Medical University of Warsaw; National Institute of Hygiene (NIH); Medical University of Warsaw	Bukowska-Osko, I (corresponding author), Med Univ Warsaw, Dept Immunopathol, Warsaw, Poland.	ibukowska@wum.edu.pl	Caraballo Cortes, Kamila/W-2011-2018; Rosińska, Magdalena/Q-2068-2018; Perlejewski, Karol/V-3854-2018; Cortés, Kamila Caraballo/ABB-9291-2020; Pawełczyk, Agnieszka/M-4934-2018; Bukowska-Ośko, Iwona/V-3859-2018; Rosińska, Magdalena/K-5857-2019; Radkowski, Marek/V-3860-2018	Caraballo Cortes, Kamila/0000-0002-7924-7852; Rosińska, Magdalena/0000-0002-6256-7809; Perlejewski, Karol/0000-0002-3782-6442; Cortés, Kamila Caraballo/0000-0002-7924-7852; Pawełczyk, Agnieszka/0000-0001-9336-8258; Bukowska-Ośko, Iwona/0000-0002-0216-7184; Rosińska, Magdalena/0000-0002-6256-7809; Radkowski, Marek/0000-0003-1808-679X; Ploski, Rafal/0000-0001-6286-5526				Ananthakrishnan AN, 2010, J VIRAL HEPATITIS, V17, P720, DOI 10.1111/j.1365-2893.2009.01232.x; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Bolcic F, 2012, ARCH VIROL, V157, P703, DOI 10.1007/s00705-012-1230-1; Booth JCL, 1998, HEPATOLOGY, V27, P223, DOI 10.1002/hep.510270134; Bukowska-Osko I, 2014, J VIRAL HEPATITIS, V21, P551, DOI 10.1111/jvh.12182; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; El Awady MK, 2009, WORLD J GASTROENTERO, V15, P1480, DOI 10.3748/wjg.15.1480; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; Feliu A, 2004, LIVER TRANSPLANT, V10, P1131, DOI 10.1002/lt.20206; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Gallegos-Orozco JF, 2006, J VIRAL HEPATITIS, V13, P489, DOI 10.1111/j.1365-2893.2006.00724.x; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Katano Y, 2007, HEPATO-GASTROENTEROL, V54, P854; Khaliq S, 2014, ARCH VIROL, V159, P1, DOI 10.1007/s00705-013-1780-x; Lara J, 2012, ANTIVIR THER, V17, P1471, DOI 10.3851/IMP2478; Laskus T, 2004, GASTROENTEROLOGY, V127, P764, DOI 10.1053/j.gastro.2004.06.005; Laskus T, 1996, VIROLOGY, V220, P171, DOI 10.1006/viro.1996.0297; Laskus T, 2000, J VIROL, V74, P1014, DOI 10.1128/JVI.74.2.1014-1017.2000; Laskus T, 2001, J VIROL, V75, P2059, DOI 10.1128/JVI.75.5.2059-2066.2001; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Moreau I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-78; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Ni YH, 1999, J MED VIROL, V58, P132, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;132::AID-JMV6&gt;3.0.CO;2-V; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Quesnel-Vallieres M, 2008, J CLIN VIROL, V43, P236, DOI 10.1016/j.jcv.2008.06.019; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; Rockstroh JK, 2004, LANCET INFECT DIS, V4, P437, DOI 10.1016/S1473-3099(04)01059-X; Sherman KE, 2010, J INFECT DIS, V201, P712, DOI 10.1086/650490; Soler M, 2002, VIROLOGY, V298, P160, DOI 10.1006/viro.2002.1494; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Toyoda H, 1997, J HEPATOL, V26, P975, DOI 10.1016/S0168-8278(97)80105-5; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; Vuillermoz I, 2004, J MED VIROL, V74, P41, DOI 10.1002/jmv.20144; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Xu ZK, 2008, J VIROL, V82, P9417, DOI 10.1128/JVI.00896-08; Zekri ARN, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-16	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125604	10.1371/journal.pone.0125604	http://dx.doi.org/10.1371/journal.pone.0125604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932941	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100121
J	Jia, GQ; Liu, XT; Schnable, JC; Niu, ZG; Wang, CF; Li, YH; Wang, SJ; Wang, SY; Liu, JR; Guo, EH; Zhi, H; Diao, XM				Jia, Guanqing; Liu, Xiaotong; Schnable, James C.; Niu, Zhengang; Wang, Chunfang; Li, Yuhui; Wang, Shujun; Wang, Suying; Liu, Jinrong; Guo, Erhu; Zhi, Hui; Diao, Xianmin			Microsatellite Variations of Elite Setaria Varieties Released during Last Six Decades in China	PLOS ONE			English	Article							FOXTAIL MILLET; POPULATION-STRUCTURE; GENETIC DIVERSITY; AGRONOMIC TRAITS; ASSOCIATION; ITALICA; L.; DOMESTICATION; SEQUENCE; ENVIRONMENT	Crop improvement is a multifaceted micro-evolutionary process, involving changes in breeding approaches, planting configurations and consumption preferences of human beings. Recent research has started to identify the specific genes or genomic regions correlate to improved agronomic traits, however, an apparent blank between the genetic structure of crop elite varieties and their improving histories in diverse modern breeding programs is still in existence. Foxtail millet (Setaria italica) was one of the earliest cereal crops to be domesticated and served as a staple crop for early civilizations in China, where it is still widely grown today. In the present trial, a panel of foxtail millet elite varieties, which were released in the last sixty years in different geographical regions of China, was characterized using microsatellite markers (SSRs). A clear separation of two subpopulations corresponding to the two eco-geographical regions of foxtail millet production in China was identified by the dataset, which also indicated that in more recently released elite varieties, large quantities of accessions have been transferred from spring-sowing to summer-sowing ecotypes, likely as a result of breeding response to planting configurations. An association mapping study was conducted to identify loci controlling traits of major agronomic interest. Furthermore, selective sweeps involved in improvement of foxtail millet were identified as multi-diverse minor effect loci controlling different agronomic traits during the long-term improvement of elite varieties. Our results highlight the effect of transition of planting configuration and breeding preference on genetic evolvement of crop species.	[Jia, Guanqing; Liu, Xiaotong; Schnable, James C.; Niu, Zhengang; Wang, Chunfang; Zhi, Hui; Diao, Xianmin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Li, Yuhui; Guo, Erhu] Shanxi Acad Agr Sci, Inst Millet Crops, Changzhi, Shanxi, Peoples R China; [Wang, Shujun; Wang, Suying; Liu, Jinrong] Anyang Acad Agr Sci, Inst Millet Crops, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University	Diao, XM (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	diaoxianmin@caas.cn		Schnable, James/0000-0001-6739-5527; Liu, Xiaotong/0000-0002-9256-297X	Key Technologies R&D Program of China during the 12th Five-Year Plan period [2011BAD06B01-2, 2014BAD07B01]; National High Technology Research and Development Program of China (863 Program) [2013AA102603]; National Natural Science Foundation of China [31171560, 31301328]; Fundamental Research Funds of ICS-CAAS [2013007]; Beijing Natural Science Foundation [6142019]; China Agricultural Research System [CARS07-12.5-A02]; Agricultural Science and Technology Innovation Program of CAAS	Key Technologies R&D Program of China during the 12th Five-Year Plan period; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of ICS-CAAS; Beijing Natural Science Foundation(Beijing Natural Science Foundation); China Agricultural Research System; Agricultural Science and Technology Innovation Program of CAAS	This work was supported by the Key Technologies R&D Program of China during the 12th Five-Year Plan period (2011BAD06B01-2, 2014BAD07B01), National High Technology Research and Development Program of China (863 Program) (2013AA102603), the National Natural Science Foundation of China (31171560, 31301328), Fundamental Research Funds of ICS-CAAS (Grant to Guanqing Jia, 2013007), Beijing Natural Science Foundation (6142019), China Agricultural Research System (CARS07-12.5-A02) and The Agricultural Science and Technology Innovation Program of CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MOL TECHNIQUES TAXON; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Diao X, 2011, INDUSTRIAL PRODUCTIO, P20; Diao XM, 2014, FRONT AGRIC SCI ENG, V1, P16, DOI 10.15302/J-FASE-2014011; Doust AN, 2005, GENETICS, V169, P1659, DOI 10.1534/genetics.104.035543; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Doust AN, 2014, P NATL ACAD SCI USA, V111, P6178, DOI 10.1073/pnas.1308940110; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fu YB, 2003, CROP SCI, V43, P1989, DOI 10.2135/cropsci2003.1989; Fu YB, 2010, MOL ECOL RESOUR, V10, P389, DOI 10.1111/j.1755-0998.2009.02752.x; Gupta S, 2014, PLANT CELL REP, V33, P881, DOI 10.1007/s00299-014-1564-0; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jia GQ, 2013, J EXP BOT, V64, P3645, DOI 10.1093/jxb/ert198; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Karki S, 2013, RICE, V6, DOI 10.1186/1939-8433-6-28; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu ZL, 2011, CROP SCI, V51, P1655, DOI 10.2135/cropsci2010.11.0643; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mauro-Herrera M, 2013, G3-GENES GENOM GENET, V3, P283, DOI 10.1534/g3.112.005207; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Pritchard JK, 2000, GENETICS, V155, P945; Qie LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101868; Vetriventhan M, 2012, PLANT GENET RESOUR-C, V10, P214, DOI 10.1017/S1479262112000287; Wang CF, 2012, G3-GENES GENOM GENET, V2, P769, DOI 10.1534/g3.112.002907; Wang T, 1996, SCI AGR SINCA, V29, P96; Xin LJ, 2009, CHINESE GEOGR SCI, V19, P97, DOI 10.1007/s11769-009-0103-x; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; [朱会义 ZHU Huiyi], 2007, [自然资源学报, Journal of Natural Resources], V22, P907	42	10	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125688	10.1371/journal.pone.0125688	http://dx.doi.org/10.1371/journal.pone.0125688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932649	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100127
J	Lu, Z; Cao, SB; Zhou, HB; Hua, L; Zhang, SS; Cao, JY				Lu, Zheng; Cao, Shengbo; Zhou, Hongbo; Hua, Ling; Zhang, Shishuo; Cao, Jiyue			Mechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721	PLOS ONE			English	Article							NF-KAPPA-B; BCL-2 FAMILY-MEMBERS; INDUCED APOPTOSIS; CANCER-CELLS; TRANSCRIPTION FACTORS; KINASE ACTIVATION; IN-VITRO; P53; MITOCHONDRIA; DEATH	Arctigenin (ARG) has been previously reported to exert high biological activities including anti-inflammatory, antiviral and anticancer. In this study, the anti-tumor mechanism of ARG towards human hepatocellular carcinoma (HCC) was firstly investigated. We demonstrated that ARG could induce apoptosis in Hep G2 and SMMC7721 cells but not in normal hepatic cells, and its apoptotic effect on Hep G2 was stronger than that on SMMC7721. Furthermore, the following study showed that ARG treatment led to a loss in the mitochondrial out membrane potential, up-regulation of Bax, down-regulation of Bcl-2, a release of cytochrome c, caspase-9 and caspase-3 activation and a cleavage of poly (ADP-ribose) polymerase in both Hep G2 and SMMC7721 cells, suggesting ARG-induced apoptosis was associated with the mitochondria mediated pathway. Moreover, the activation of caspase-8 and the increased expression levels of Fas/FasL and TNF-alpha revealed that the Fas/FasL-related pathway was also involved in this process. Additionally, ARG induced apoptosis was accompanied by a deactivation of PI3K/p-Akt pathway, an accumulation of p53 protein and an inhibition of NF-kappa B nuclear translocation especially in Hep G2 cells, which might be the reason that Hep G2 was more sensitive than SMMC7721 cells to ARG treatment.	[Lu, Zheng; Cao, Shengbo; Zhou, Hongbo; Zhang, Shishuo; Cao, Jiyue] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Hua, Ling] Southwest Univ, Dept Vet Med, Chongqing, Peoples R China	Huazhong Agricultural University; Southwest University - China	Cao, JY (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China.	caojiyue@mail.hzau.edu.cn						Ahmad N, 2000, ARCH BIOCHEM BIOPHYS, V376, P338, DOI 10.1006/abbi.2000.1742; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chao X, 2010, BIOMED PHARMACOTHER, V64, P600, DOI 10.1016/j.biopha.2010.08.008; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cho MK, 2004, INT IMMUNOPHARMACOL, V4, P1419, DOI 10.1016/j.intimp.2004.06.011; Colgate EC, 2007, CANCER LETT, V246, P201, DOI 10.1016/j.canlet.2006.02.015; Cosentino K, 2014, CHEM PHYS LIPIDS, V181, P62, DOI 10.1016/j.chemphyslip.2014.04.001; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Dai Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-392; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gu Y, 2012, BIOCHEM PHARMACOL, V84, P468, DOI 10.1016/j.bcp.2012.06.002; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsieh CJ, 2014, FREE RADICAL BIO MED, V67, P159, DOI 10.1016/j.freeradbiomed.2013.10.004; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong JB, 2011, INT IMMUNOPHARMACOL, V11, P1573, DOI 10.1016/j.intimp.2011.05.016; Jeong SJ, 2008, VIROLOGY, V370, P264, DOI 10.1016/j.virol.2007.09.003; Kalra N, 2007, LIFE SCI, V80, P2137, DOI 10.1016/j.lfs.2007.04.009; Kim JY, 2010, J CELL PHYSIOL, V224, P33, DOI 10.1002/jcp.22085; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li X, 2010, CANCER LETT, V293, P109, DOI 10.1016/j.canlet.2010.01.002; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Makin G, 2000, CELL TISSUE RES, V301, P143, DOI 10.1007/s004419900160; Marsoni S, 2004, ANN ONCOL, V15, P229, DOI 10.1093/annonc/mdh931; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Moritani S, 1996, BIOL PHARM BULL, V19, P1515, DOI 10.1248/bpb.19.1515; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Penolazzi L, 2003, BIOCHEM PHARMACOL, V66, P1189, DOI 10.1016/S0006-2952(03)00470-2; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Sun Y, 2013, CHEM-BIOL INTERACT, V201, P1, DOI 10.1016/j.cbi.2012.11.005; Susanti S, 2013, PHYTOMEDICINE, V21, P39, DOI 10.1016/j.phymed.2013.08.003; Swarup V, 2008, J ANTIMICROB CHEMOTH, V61, P679, DOI 10.1093/jac/dkm503; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Umehara K, 1996, CHEM PHARM BULL, V44, P2300, DOI 10.1248/cpb.44.2300; Wahl C, 2003, INT J MED MICROBIOL, V293, P377, DOI 10.1078/1438-4221-00274; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XD, 2001, GENE DEV, V15, P2922; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao F, 2009, J ETHNOPHARMACOL, V122, P457, DOI 10.1016/j.jep.2009.01.038	63	27	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125727	10.1371/journal.pone.0125727	http://dx.doi.org/10.1371/journal.pone.0125727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933104	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100130
J	Ometto, L; Li, MA; Bresadola, L; Barbaro, E; Neteler, M; Varotto, C				Ometto, Lino; Li, Mingai; Bresadola, Luisa; Barbaro, Enrico; Neteler, Markus; Varotto, Claudio			Demographic History, Population Structure, and Local Adaptation in Alpine Populations of Cardamine impatiens and Cardamine resedifolia	PLOS ONE			English	Article							FREEZING TOLERANCE; CLINAL VARIATION; SELECTION; PLANT; SOFTWARE; DIFFERENTIATION; ASSOCIATION; DIVERGENCE; EVOLUTION; ENVIRONMENTS	Species evolution depends on numerous and distinct forces, including demography and natural selection. For example, local adaptation and population structure affect the evolutionary history of species living along environmental clines. This is particularly relevant in plants, which are often characterized by limited dispersal ability and the need to respond to abiotic and biotic stress factors specific to the local environment. Here we study the demographic history and the possible existence of local adaptation in two related species of Brassicaceae, Cardamine impatiens and Cardamine resedifolia, which occupy separate habitats along the elevation gradient. Previous genome-wide analyses revealed the occurrence of distinct selective pressures in the two species, with genes involved in cold response evolving particularly fast in C. resedifolia. In this study we surveyed patterns of molecular evolution and genetic variability in a set of 19 genes, including neutral and candidate genes involved in cold response, across 10 populations each of C. resedifolia and C. impatiens from the Italian Alps (Trentino). We inferred the population structure and demographic history of the two species, and tested the occurrence of signatures of local adaptation in these genes. The results indicate that, despite a slightly higher population differentiation in C. resedifolia than in C. impatiens, both species are only weakly structured and that populations sampled at high altitude experience less gene flow than low-altitude ones. None of the genes showed signatures of positive selection, suggesting that they do not seemto play relevant roles in the current evolutionary processes of adaptation to alpine environments of these species.	[Ometto, Lino; Li, Mingai; Bresadola, Luisa; Barbaro, Enrico; Neteler, Markus; Varotto, Claudio] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, I-38010 San Michele All Adige, TN, Italy	Fondazione Edmund Mach	Varotto, C (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, Via E Mach 1, I-38010 San Michele All Adige, TN, Italy.	claudio.varotto@fmach.it	Neteler, Markus/C-6328-2008; Bresadola, Luisa/D-8976-2019; Ometto, Lino/C-3609-2008	Neteler, Markus/0000-0003-1916-1966; Ometto, Lino/0000-0002-2679-625X; Varotto, Claudio/0000-0001-5018-087X; Barbaro, Enrico/0000-0003-1809-4394; Li, Mingai/0000-0003-2074-1546	Autonomous Province of Trento (Italy), under the ACE-SAP project [23]; ACE-SAP project; Edmund Mach Foundation	Autonomous Province of Trento (Italy), under the ACE-SAP project; ACE-SAP project; Edmund Mach Foundation	To carry out this work CV received funding by the Autonomous Province of Trento (Italy), under the ACE-SAP project (regulation number 23, June 12th 2008, of the Servizio istruzione e formazione del secondo grado, Universita e ricerca [former Servizio Universita e Ricerca Scientifica]; (http://www.uniricerca.provincia.tn.it/)). The postdoc position of LO was funded by the ACE-SAP project. ML, EB, MN and CV positions were funded through core funding of the Edmund Mach Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschimann D, 2004, FLORA ALPINA; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Becker U, 2008, OIKOS, V117, P1865, DOI 10.1111/j.0030-1299.2008.16939.x; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; Bernhardsson C, 2012, MOL ECOL, V21, P2197, DOI 10.1111/j.1365-294X.2012.05524.x; Bierne N, 2010, EVOLUTION, V64, P3254, DOI 10.1111/j.1558-5646.2010.01050.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cullings KW, 1992, MOL ECOL, V1, P233, DOI 10.1111/j.1365-294X.1992.tb00182.x; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond A. J., 2010, GENEIOUS V5 3; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Falush D, 2003, GENETICS, V164, P1567; Fior S, 2013, NEW PHYTOL, V198, P579, DOI 10.1111/nph.12163; Fischer MC, 2013, MOL ECOL; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Freedman AH, 2010, MOL ECOL, V19, P3773, DOI 10.1111/j.1365-294X.2010.04684.x; Gardner KM, 2006, MOL ECOL, V15, P1321, DOI 10.1111/j.1365-294X.2005.02835.x; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Hendry AP, 2004, EVOLUTION, V58, P2319; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Keller I, 2011, MOL ECOL, V20, P1888, DOI 10.1111/j.1365-294X.2011.05067.x; Keller SR, 2011, GENETICS, V188, P941, DOI 10.1534/genetics.111.128041; KIMATA M, 1983, BOT MAG TOKYO, V96, P299, DOI 10.1007/BF02488175; Kronholm I, 2012, EVOLUTION, V66, P2287, DOI 10.1111/j.1558-5646.2012.01590.x; Leuenberger C, 2010, GENETICS, V184, P243, DOI 10.1534/genetics.109.109058; Li HP, 2011, MOL BIOL EVOL, V28, P365, DOI 10.1093/molbev/msq211; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lihova J, 2009, J BIOGEOGR, V36, P104, DOI 10.1111/j.1365-2699.2008.01998.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Neteler M, 2010, REMOTE SENS-BASEL, V2, P333, DOI 10.3390/rs1020333; Ometto L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-7; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2001, GENETICS, V158, P1147; Roze D, 2003, GENETICS, V165, P2153; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; St Onge KR, 2011, MOL ECOL, V20, P3306, DOI 10.1111/j.1365-294X.2011.05189.x; Steyaert Sam M. J. G., 2009, Ekologia (Bratislava), V28, P191, DOI 10.4149/ekol_2009_02_191; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Vittoz P, 2009, BASIC APPL ECOL, V10, P508, DOI 10.1016/j.baae.2009.02.001; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Whitlock MC, 2003, GENETICS, V164, P767; Whitlock MC, 1997, GENETICS, V146, P427; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wright S, 1931, GENETICS, V16, P0097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhen Y, 2008, MOL BIOL EVOL, V25, P2547, DOI 10.1093/molbev/msn196; Zhen Y, 2008, NEW PHYTOL, V177, P419, DOI 10.1111/j.1469-8137.2007.02262.x	73	7	7	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125199	10.1371/journal.pone.0125199	http://dx.doi.org/10.1371/journal.pone.0125199			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933225	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100090
J	Sporndly-Nees, E; Ekstedt, E; Magnusson, U; Fakhrzadeh, A; Hendriks, CLL; Holm, L				Sporndly-Nees, Ellinor; Ekstedt, Elisabeth; Magnusson, Ulf; Fakhrzadeh, Azadeh; Hendriks, Cris L. Luengo; Holm, Lena			Effect of Pre-Fixation Delay and Freezing on Mink Testicular Endpoints for Environmental Research	PLOS ONE			English	Article							BLACK-TAILED DEER; KODIAK ISLAND; TESTIS; RAT; CONTAMINANTS; CHEMICALS; EXPOSURE; WILDLIFE; GATA-4; SIZE	There is growing interest in using wild animals to monitor the real-life cocktail effect of environmental chemicals on male reproduction. However, practical difficulties, such as long distances to the laboratory, generally prolong the time between euthanisation and specimen handling. For instance, tissue fixation is often performed on frozen material or on material where deterioration has started, which may affect tissue morphology. This study examined the effect of pre-fixation delay and freezing on mink testicular endpoints in order to determine robust endpoints in suboptimally handled specimens. Sexually mature farmed mink (n=30) selected at culling were divided into six groups and subjected to different time intervals between euthanisation and fixation or freezing: 0 hours (fixed immediately post mortem), 6 hours, 18 hours, 30 hours, 42 hours, or frozen 6 hours post mortem and thawed overnight. Unaffected endpoints when pre-fixation storage was extended to 30 hours included: area and diameter of the seminiferous tubules, length and weight of the testes, and acrosomes marked with Gata-4. Epithelial height, Sertoli cells marked with Gata-4 and cell morphology were affected endpoints after 6 hours of storage. Freezing the tissue prior to fixation severely altered cell morphology and reduced testicular weight, tubular diameter and area. Morphological changes seen after 6 hours included shredded germ cells and excess cytoplasm in seminiferous tubular lumen, chromatin rearrangements and increased germ cell death. Extended delay before fixation and freezing affected many endpoints in the mink testicular tissue. Some of these endpoints may mimic chemically induced effects, which is important to consider when evaluating specimens from wild animals for environmental toxicity.	[Sporndly-Nees, Ellinor; Ekstedt, Elisabeth; Holm, Lena] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Magnusson, Ulf] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden; [Fakhrzadeh, Azadeh; Hendriks, Cris L. Luengo] Uppsala Univ, Ctr Image Anal, Dept Informat Technol, Div Visual Informat & Interact, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University	Sporndly-Nees, E (corresponding author), Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	Ellinor.Sporndly-Nees@slu.se	Fakhrzadeh, Azadeh/ABF-3485-2021; Luengo Hendriks, Cris L./B-1097-2008	Magnusson, Ulf/0000-0002-7087-6820; Luengo Hendriks, Cris L./0000-0002-8279-1760				Alam MS, 2010, REPRODUCTION, V139, P427, DOI 10.1530/REP-09-0226; [Anonymous], 2012, NAT METHODS, V9, P627, DOI 10.1038/nmeth.2102; Bailey SA, 2004, TOXICOL PATHOL, V32, P448, DOI 10.1080/01926230490465874; Barrett W A, 1997, Med Image Anal, V1, P331, DOI 10.1016/S1361-8415(97)85005-0; Basu N, 2007, ENVIRON RES, V103, P130, DOI 10.1016/j.envres.2006.04.005; Bellingham M, 2012, INT J ANDROL, V35, P317, DOI 10.1111/j.1365-2605.2011.01234.x; Bergman A., 2013, STATE SCI ENDOCRINE, DOI DOI 10.1016/J; Berndtson WE, 2011, J ANDROL, V32, P2, DOI 10.2164/jandrol.109.008870; Berndtson WE, 2010, J ANDROL, V31, P607, DOI 10.2164/jandrol.110.010116; Berndtson WE, 2010, J ANDROL, V31, P593, DOI 10.2164/jandrol.109.008920; Bryant BH, 2007, TOXICOL PATHOL, V35, P665, DOI 10.1080/01926230701459994; Bubenik GA, 2002, Z JAGDWISS, V48, P234, DOI 10.1007/BF02189694; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chodorowski A, 2005, PROC SPIE, V5747, P1589, DOI 10.1117/12.594944; Creasy DM, 2003, BIRTH DEFECTS RES B, V68, P408, DOI 10.1002/bdrb.10041; Creasy DM, 1997, TOXICOL PATHOL, V25, P119, DOI 10.1177/019262339702500201; Creasy DM, 2001, TOXICOL PATHOL, V29, P64, DOI 10.1080/019262301301418865; Dallinga JW, 2002, HUM REPROD, V17, P1973, DOI 10.1093/humrep/17.8.1973; Falcao AX, 1998, GRAPH MODEL IM PROC, V60, P233, DOI 10.1006/gmip.1998.0475; Fox GA, 2001, ENVIRON HEALTH PERSP, V109, P853, DOI 10.2307/3454647; Hildreth E, 1980, P ROY SOC LONDON, V207, P182; Jimenez-Severiano H, 2005, J ANIM SCI, V83, P2111; Karadzic R, 2010, ROM J LEG MED, V18, P247, DOI 10.4323/rjlm.2010.247; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Ketola I, 2002, EUR J ENDOCRINOL, V147, P397, DOI 10.1530/eje.0.1470397; KIHLSTROM JE, 1992, AMBIO, V21, P563; Lanning LL, 2002, TOXICOL PATHOL, V30, P507, DOI 10.1080/01926230290105695; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; LEE HC, 1991, IEEE T SIGNAL PROCES, V39, P1181, DOI 10.1109/78.80971; Mathur PP, 2011, ASIAN J ANDROL, V13, P585, DOI 10.1038/aja.2011.40; McClusky LM, 2009, J MOL HISTOL, V40, P287, DOI 10.1007/s10735-009-9240-3; McCoard SA, 2001, BIOL REPROD, V64, P689, DOI 10.1095/biolreprod64.2.689; PELLETIER RM, 1986, AM J ANAT, V175, P91, DOI 10.1002/aja.1001750109; Persson S., 2012, ACTA VET SCAND S1, V54, pS9, DOI DOI 10.1186/1751-0147-54-S1-S9; Petrelli G, 2001, EUR J EPIDEMIOL, V17, P675, DOI 10.1023/A:1015511625099; Predes FD, 2010, INT J EXP PATHOL, V91, P125, DOI 10.1111/j.1365-2613.2009.00692.x; Ramos-Vara JA, 2009, VET PATHOL, V46, P893, DOI 10.1354/vp.08-VP-0287-R-BC; Regulation (EC) No 1069/ 2009 of the European Parliament and of the Council, 2009, OFFICIAL J EUROPEAN; Ryokkynen A, 2005, TOXICOL APPL PHARM, V202, P132, DOI 10.1016/j.taap.2004.06.012; Saradha B, 2006, ENVIRON TOXICOL PHAR, V21, P34, DOI 10.1016/j.etap.2005.06.004; Scudamore C. L., 2011, Comparative Clinical Pathology, V20, P95, DOI 10.1007/s00580-010-1149-4; Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Sonne C, 2006, ENVIRON SCI TECHNOL, V40, P5668, DOI 10.1021/es060836n; Toman R, 2012, J ENVIRON SCI HEAL A, V47, P1272, DOI 10.1080/10934529.2012.672130; Tomita Yukari, 2004, Leg Med (Tokyo), V6, P25, DOI 10.1016/j.legalmed.2003.09.001; Veeramachaneni DNR, 2006, ENVIRON HEALTH PERSP, V114, P51, DOI 10.1289/ehp.8052; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176	48	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125139	10.1371/journal.pone.0125139	http://dx.doi.org/10.1371/journal.pone.0125139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933113	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100081
J	Stoel, M; Pool, J; de Vries-Idema, J; Zaaraoui-Boutahar, F; Bijl, M; Andeweg, AC; Wilschut, J; Huckriede, A				Stoel, Maaike; Pool, Judith; de Vries-Idema, Jacqueline; Zaaraoui-Boutahar, Fatiha; Bijl, Maarten; Andeweg, Arno C.; Wilschut, Jan; Huckriede, Anke			Innate Responses Induced by Whole Inactivated Virus or Subunit Influenza Vaccines in Cultured Dendritic Cells Correlate with Immune Responses In Vivo	PLOS ONE			English	Article							SYSTEMS BIOLOGY; IMMUNOGENICITY; ANTIGENICITY; VACCINATION; IFN	Vaccine development involves time-consuming and expensive evaluation of candidate vaccines in animal models. As mediators of both innate and adaptive immune responses dendritic cells (DCs) are considered to be highly important for vaccine performance. Here we evaluated how far the response of DCs to a vaccine in vitro is in line with the immune response the vaccine evokes in vivo. To this end, we investigated the response of murine bone marrow-derived DCs to whole inactivated virus (WIV) and subunit (SU) influenza vaccine preparations. These vaccine preparations were chosen because they differ in the immune response they evoke in mice with WIV being superior to SU vaccine through induction of higher virus-neutralizing antibody titers and a more favorable Th1-skewed response phenotype. Stimulation of DCs with WIV, but not SU vaccine, resulted in a cytokine response that was comparable to that of DCs stimulated with live virus. Similarly, the gene expression profiles of DCs treated with WIV or live virus were similar and differed from that of SU vaccine-treated DCs. More specifically, exposure of DCs to WIV resulted in differential expression of genes in known antiviral pathways, whereas SU vaccine did not. The stronger antiviral and more Th1-related response of DCs to WIV as compared to SU vaccine correlates well with the superior immune response found in mice. These results indicate that in vitro stimulation of DCs with novel vaccine candidates combined with the assessment of multiple parameters, including gene signatures, may be a valuable tool for the selection of vaccine candidates.	[Stoel, Maaike; Pool, Judith; de Vries-Idema, Jacqueline; Wilschut, Jan; Huckriede, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Zaaraoui-Boutahar, Fatiha; Bijl, Maarten; Andeweg, Arno C.] Erasmus Univ, Dept Virosci, Rotterdam, Netherlands	University of Groningen; Erasmus University Rotterdam	Huckriede, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	a.l.w.huckriede@umcg.nl	Huckriede, Anke/P-3558-2019	Huckriede, Anke/0000-0002-2646-5143	VIRGO consortium - Netherlands Genomics Initiative; Dutch Government [FES0908]	VIRGO consortium - Netherlands Genomics Initiative; Dutch Government	This study was financially supported by the VIRGO consortium, which is funded by the Netherlands Genomics Initiative and by the Dutch Government (FES0908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKOVIC ES, 1987, ANTIVIR RES, V8, P151, DOI 10.1016/0166-3542(87)90068-4; BERNSTEIN DI, 1982, PEDIATRICS, V69, P404; Budimir N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063163; Budimir N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030898; Chang WLW, 2007, J IMMUNOL, V178, P1457, DOI 10.4049/jimmunol.178.3.1457; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; FAZEKAS G, 1994, EUR J IMMUNOL, V24, P3063, DOI 10.1002/eji.1830241222; Geeraedts F, 2011, ADV EXP MED BIOL, V780, P161, DOI 10.1007/978-1-4419-5632-3_13; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057; Halbroth BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103392; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Hovden AO, 2005, SCAND J IMMUNOL, V62, P36, DOI 10.1111/j.1365-3083.2005.01633.x; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; KARK JD, 1981, MED MICROBIOL IMMUN, V170, P55, DOI 10.1007/BF02123797; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plotkin SA, 2011, NAT REV MICROBIOL, V9, P889, DOI 10.1038/nrmicro2668; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Wilschut JC, 2006, VACCINATION CORNERST, P150	37	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125228	10.1371/journal.pone.0125228	http://dx.doi.org/10.1371/journal.pone.0125228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933037	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100094
J	Brindle, NR; Joyce, JA; Rostker, F; Lawlor, ER; Swigart-Brown, L; Evan, G; Hanahan, D; Shchors, K				Brindle, Nicola R.; Joyce, Johanna A.; Rostker, Fanya; Lawlor, Elizabeth R.; Swigart-Brown, Lamorna; Evan, Gerard; Hanahan, Douglas; Shchors, Ksenya			Deficiency for the Cysteine Protease Cathepsin L Impairs Myc-Induced Tumorigenesis in a Mouse Model of Pancreatic Neuroendocrine Cancer	PLOS ONE			English	Article							C-MYC; ANGIOGENIC SWITCH; INDUCED APOPTOSIS; GENE-EXPRESSION; HUMAN-MELANOMA; IN-VITRO; AUTOPHAGY; CELLS; ACTIVATION; INHIBITION	Motivated by the recent implication of cysteine protease cathepsin L as a potential target for anti-cancer drug development, we used a conditional MycER(TAM); Bcl-x(L) model of pancreatic neuroendocrine tumorigenesis (PNET) to assess the role of cathepsin L in Myc-induced tumor progression. By employing a cysteine cathepsin activity probe in vivo and in vitro, we first established that cathepsin activity increases during the initial stages of MycER(TAM); Bcl-x(L) tumor development. Among the cathepsin family members investigated, only cathepsin L was predominately produced by beta-tumor cells in neoplastic pancreata and, consistent with this, cathepsin L mRNA expression was rapidly upregulated following Myc activation in the beta cell compartment. By contrast, cathepsins B, S and C were highly enriched in tumor-infiltrating leukocytes. Genetic deletion of cathepsin L had no discernible effect on the initiation of neoplastic growth or concordant angiogenesis. However, the tumors that developed in the cathepsin L-deficient background were markedly reduced in size relative to their typical wild-type counterparts, indicative of a role for cathepsin L in enabling expansive tumor growth. Thus, genetic blockade of cathepsin L activity is inferred to retard Myc-driven tumor growth, encouraging the potential utility of pharmacological inhibitors of cysteine cathepsins in treating late stage tumors.	[Brindle, Nicola R.; Hanahan, Douglas; Shchors, Ksenya] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland; [Joyce, Johanna A.; Rostker, Fanya; Lawlor, Elizabeth R.; Swigart-Brown, Lamorna; Evan, Gerard; Shchors, Ksenya] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Joyce, Johanna A.; Rostker, Fanya; Lawlor, Elizabeth R.; Swigart-Brown, Lamorna; Evan, Gerard; Shchors, Ksenya] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center	Shchors, K (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.	ksenya.shchors@epfl.ch			National Cancer Institute (NCI); European Research Council (ERC); Ecole polytechnique federale de Lausanne (EPFL); NCI; National Institute of Health (NIH) [CA106039]; Cancer Research UK [19013, 12077] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [F32CA106039] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Research Council (ERC)(European Research Council (ERC)); Ecole polytechnique federale de Lausanne (EPFL); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Cancer Institute (NCI), The European Research Council (ERC) and by core support from The Ecole polytechnique federale de Lausanne (EPFL) to D.H NCI to GE, F32-CA106039 National Institute of Health (NIH) to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Berdowska I, 2004, CLIN CHIM ACTA, V342, P41, DOI 10.1016/j.cccn.2003.12.016; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Berquin IM, 1996, ADV EXP MED BIOL, V389, P281; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; EMMERTBUCK MR, 1994, AM J PATHOL, V145, P1285; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lah TT, 1998, BIOL CHEM, V379, P125; Lankelma JM, 2010, LIFE SCI, V86, P225, DOI 10.1016/j.lfs.2009.11.016; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Levicar N, 2003, CANCER GENE THER, V10, P141, DOI 10.1038/sj.cgt.7700546; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mahmood DFD, 2011, J BIOL CHEM, V286, P28858, DOI 10.1074/jbc.M111.273292; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Matarrese P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-207; Meara JP, 1996, J MED CHEM, V39, P3357, DOI 10.1021/jm950445b; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; PAVELIC K, 1995, J PATHOL, V177, P395, DOI 10.1002/path.1711770410; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Rebbaa A, 2009, ANTICANCER RES, V29, P4473; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Shchors K, 2013, ONCOGENE, V32, P502, DOI 10.1038/onc.2012.60; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Stypmann J, 2002, P NATL ACAD SCI USA, V99, P6234, DOI 10.1073/pnas.092637699; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tsuneoka M, 2003, CELL STRUCT FUNCT, V28, P195; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Turk V, 2002, ADV ENZYME REGUL, V42, P285, DOI 10.1016/S0065-2571(01)00034-6; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015	54	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0120348	10.1371/journal.pone.0120348	http://dx.doi.org/10.1371/journal.pone.0120348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927437	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100003
J	Domenech, M; Damian, D; Ardanuy, C; Linares, J; Fenoll, A; Garcia, E				Domenech, Mirian; Damian, Diana; Ardanuy, Carmen; Linares, Josefina; Fenoll, Asuncion; Garcia, Ernesto			Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; STAPHYLOCOCCUS-AUREUS; COLONIZATION; CHILDREN	Background Since the use of pneumococcal conjugate vaccines PCV7 and PCV13 in children became widespread, invasive pneumococcal disease (IPD) has dramatically decreased. Nevertheless, there has been a rise in incidence of Streptococcus pneumoniae non-vaccine serotypes (NVT) colonising the human nasopharynx. Nasopharyngeal colonisation, an essential step in the development of S. pneumoniae-induced IPD, is associated with biofilm formation. Although the capsule is the main pneumococcal virulence factor, the formation of pneumococcal biofilms might, in fact, be limited by the presence of capsular polysaccharide (CPS). Methodology/Principal Findings We used clinical isolates of 16 emerging, non-PCV13 serotypes as well as isogenic transformants of the same serotypes. The biofilm formation capacity of isogenic transformants expressing CPSs from NVT was evaluated in vitro to ascertain whether this trait can be used to predict the emergence of NVT. Fourteen out of 16 NVT analysed were not good biofilm formers, presumably because of the presence of CPS. In contrast, serotypes 11A and 35B formed >= 45% of the biofilm produced by the non-encapsulated M11 strain. Conclusions/Significance This study suggest that emerging, NVT serotypes 11A and 35B deserve a close surveillance.	[Domenech, Mirian; Damian, Diana; Garcia, Ernesto] CSIC, Ctr Invest Biol, Madrid, Spain; [Domenech, Mirian; Ardanuy, Carmen; Linares, Josefina; Garcia, Ernesto] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Ardanuy, Carmen; Linares, Josefina] Univ Barcelona, Hosp Univ Bellvitge, Fdn Privada, Inst Invest Biomed Bellvitge, Barcelona, Spain; [Fenoll, Asuncion] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Domenech, M (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	mirid@cib.csic.es	Ardanuy, Carmen/C-4463-2015; Liñares, Josefina/N-9450-2014; Domenech, Mirian/G-2561-2018	Domenech, Mirian/0000-0002-0942-8180; Ardanuy, Carmen/0000-0003-0225-607X; Partearroyo Lacaba, Olvido/0000-0002-1692-4481	Ministerio de Economia y Competi-tividad [SAF2012-39444-C02-01/02, PI11/0763]	Ministerio de Economia y Competi-tividad(Spanish Government)	This work was supported by grants from the Ministerio de Economia y Competi-tividad (SAF2012-39444-C02-01/02 and PI11/0763). CIBER de Enfermedades Respiratorias (CIBERES) is an initiative of Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardanuy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043619; Auranen K, 2013, VACCINE, V32, P153, DOI 10.1016/j.vaccine.2013.08.061; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brady AM, 2014, J INFECT DIS, V210, P1155, DOI 10.1093/infdis/jiu195; Calix JJ, 2014, J CLIN MICROBIOL, V52, P758, DOI 10.1128/JCM.02695-13; Camilli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076309; Charalambous BM, 2012, CURR OPIN PULM MED, V18, P222, DOI 10.1097/MCP.0b013e328352103b; Chiba N, 2014, EMERG INFECT DIS, V20, P1132, DOI 10.3201/eid2007.131485; Crook DW, 2004, PNEUMOCCOCUS, P136; del Amo E, 2014, EUR J CLIN MICROBIOL; Domenech A, 2014, ANTIMICROB AGENTS CH, V58, P2393, DOI 10.1128/AAC.02669-13; Domenech M, 2014, ENVIRON MICROBIOL, V16, P1193, DOI 10.1111/1462-2920.12370; Domenech M, 2012, MICROB BIOTECHNOL, V5, P455, DOI 10.1111/j.1751-7915.2011.00294.x; Domenech M, 2009, ENVIRON MICROBIOL, V11, P2542, DOI 10.1111/j.1462-2920.2009.01979.x; Feldman Charles, 2014, F1000Prime Rep, V6, P82, DOI 10.12703/P6-82; Goldblatt D, 2013, VACCINE, V32, P146, DOI 10.1016/j.vaccine.2013.06.040; Grabenstein JD, 2012, CLIN MICROBIOL INFEC, V18, P15, DOI 10.1111/j.1469-0691.2012.03943.x; Grau I, 2014, INT J INFECT DIS, V25, P59, DOI 10.1016/j.ijid.2013.12.013; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hausdorff WP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-4; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Li Y, 2013, INFECT IMMUN, V81, P4519, DOI 10.1128/IAI.00724-13; Marks LR, 2013, MBIO, V4, DOI 10.1128/mBio.00438-13; Marks LR, 2012, MBIO, V3, DOI 10.1128/mBio.00200-12; Martin JM, 2014, PEDIATR INFECT DIS J, V33, pE286, DOI 10.1097/INF.0000000000000445; McElligott M, 2014, VACCINE, V32, P3495, DOI 10.1016/j.vaccine.2014.04.047; Mendes RE, 2014, ANTIMICROB AGENTS CH, V58, P4923, DOI 10.1128/AAC.02976-14; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Munoz R, 1999, J BACTERIOL, V181, P6214; Nunes MC, 2015, VACCINE, V33, P628, DOI 10.1016/j.vaccine.2014.12.023; Nzenze SA, 2014, VACCINE, V32, P5520, DOI 10.1016/j.vaccine.2014.06.091; Richter SS, 2014, ANTIMICROB AGENTS CH, V58, P6484, DOI 10.1128/AAC.03344-14; Saha S, 2015, VACCINE, V33, P713, DOI 10.1016/j.vaccine.2014.11.040; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Skinner JM, 2011, VACCINE, V29, P8870, DOI 10.1016/j.vaccine.2011.09.078; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Vernatter J, 2013, CURR OPIN INFECT DIS, V26, P277, DOI 10.1097/QCO.0b013e3283608419; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P12	47	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125636	10.1371/journal.pone.0125636	http://dx.doi.org/10.1371/journal.pone.0125636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927917	Green Published, gold			2022-12-26	WOS:000353713100108
J	Gao, XJJ; Clandinin, TR; Luo, LQ				Gao, Xiaojing J.; Clandinin, Thomas R.; Luo, Liqun			Extremely Sparse Olfactory Inputs Are Sufficient to Mediate Innate Aversion in Drosophila	PLOS ONE			English	Article							ODOR DISCRIMINATION; CHEMOSENSORY RECEPTORS; GENE-EXPRESSION; NEURONS; ORGANIZATION; RESPONSES; SYSTEM; ATTRACTION; POPULATION; CHEMOTAXIS	Innate attraction and aversion to odorants are observed throughout the animal kingdom, but how olfactory circuits encode such valences is not well understood, despite extensive anatomical and functional knowledge. In Drosophila melanogaster, similar to 50 types of olfactory receptor neurons (ORNs) each express a unique receptor gene, and relay information to a cognate type of projection neurons (PNs). To examine the extent to which the population activity of ORNs is required for olfactory behavior, we developed a genetic strategy to block all ORN outputs, and then to restore output in specific types. Unlike attraction, aversion was unaffected by simultaneous silencing of many ORNs, and even single ORN types previously shown to convey neutral valence sufficed to mediate aversion. Thus, aversion may rely on specific activity patterns in individual ORNs rather than the number or identity of activated ORNs. ORN activity is relayed into the brain by downstream circuits, with excitatory PNs (ePN) representing a major output. We found that silencing the majority of ePNs did not affect aversion, even when ePNs directly downstream of single restored ORN types were silenced. Our data demonstrate the robustness of olfactory aversion, and suggest that its circuit mechanism is qualitatively different from attraction.	[Gao, Xiaojing J.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Gao, Xiaojing J.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Clandinin, Thomas R.; Luo, Liqun] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Gao, XJJ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	xjgao@stanford.edu	Gao, Xiaojing/K-2376-2016	Gao, Xiaojing/0000-0002-3094-1456; Luo, Liqun/0000-0001-5467-9264	Enlight Foundation Interdisciplinary Fellowship; NIH [R01-DC005982, R01-EY022638]; NATIONAL EYE INSTITUTE [R01EY022638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	Enlight Foundation Interdisciplinary Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	XJG is supported by an Enlight Foundation Interdisciplinary Fellowship. LL is an investigator of the Howard Hughes Medical Institute. This study was also supported by NIH grants R01-DC005982 (LL) and R01-EY022638 (TRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; DasGupta S, 2008, CURR BIOL, V18, P1668, DOI 10.1016/j.cub.2008.08.071; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Faucher CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056361; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fraenkel GS, 1961, ORIENTATION ANIMALS; Gao XJJ, 2013, CURR BIOL, V23, P1163, DOI 10.1016/j.cub.2013.05.008; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joo WJ, 2013, NEURON, V78, P673, DOI 10.1016/j.neuron.2013.03.022; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Liang L, 2013, NEURON, V79, P917, DOI 10.1016/j.neuron.2013.06.014; Lin HH, 2013, SCIENCE, V340, P1338, DOI 10.1126/science.1236693; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Newsome TP, 2000, DEVELOPMENT, V127, P851; Parnas M, 2013, NEURON, V79, P932, DOI 10.1016/j.neuron.2013.08.006; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Smear M, 2013, NAT NEUROSCI, V16, P1687, DOI 10.1038/nn.3519; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336	50	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125986	10.1371/journal.pone.0125986	http://dx.doi.org/10.1371/journal.pone.0125986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927233	gold, Green Submitted, Green Published			2022-12-26	WOS:000353713100121
J	Landgraf, D; Long, J; Der-Avakian, A; Streets, M; Welsh, DK				Landgraf, Dominic; Long, Jaimie; Der-Avakian, Andre; Streets, Margo; Welsh, David K.			Dissociation of Learned Helplessness and Fear Conditioning in Mice: A Mouse Model of Depression	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; TAIL SUSPENSION TEST; ANIMAL-MODELS; STRESSOR CONTROLLABILITY; UNCONTROLLABLE STRESS; REVEALS PERSISTENT; EXPOSURE; CLOCK; RATS; INTERFERENCE	The state of being helpless is regarded as a central aspect of depression, and therefore the learned helplessness paradigm in rodents is commonly used as an animal model of depression. The term 'learned helplessness' refers to a deficit in escaping from an aversive situation after an animal is exposed to uncontrollable stress specifically, with a control/comparison group having been exposed to an equivalent amount of controllable stress. A key feature of learned helplessness is the transferability of helplessness to different situations, a phenomenon called 'trans-situationality'. However, most studies in mice use learned helplessness protocols in which training and testing occur in the same environment and with the same type of stressor. Consequently, failures to escape may reflect conditioned fear of a particular environment, not a general change of the helpless state of an animal. For mice, there is no established learned helplessness protocol that includes the trans-situationality feature. Here we describe a simple and reliable learned helplessness protocol for mice, in which training and testing are carried out in different environments and with different types of stressors. We show that with our protocol approximately 50% of mice develop learned helplessness that is not attributable to fear conditioning.	[Landgraf, Dominic; Long, Jaimie; Welsh, David K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Landgraf, Dominic; Long, Jaimie; Welsh, David K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Landgraf, Dominic; Long, Jaimie; Welsh, David K.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA; [Der-Avakian, Andre] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Streets, Margo] Univ Calif San Diego, Anim Phenotyping Core, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Welsh, DK (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.	welshdk@ucsd.edu	Der-Avakian, Andre/AAI-7734-2020; Der-Avakian, Andre/Q-5201-2018	Landgraf, Dominic/0000-0002-1328-1871	U.S. Department of Veterans Affairs [1I01BX001146]; NARSAD	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NARSAD(NARSAD)	This research was funded by the U.S. Department of Veterans Affairs, Grant number: 1I01BX001146, URL: http://www.va.gov/ and the NARSAD Young Investigator Award to David K. Welsh, URL: https://bbrfoundation.org/yi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Anisman H., 2001, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.11S0810CSIL.; Azzinnari D, 2014, NEUROPHARMACOLOGY, V85, P328, DOI 10.1016/j.neuropharm.2014.05.039; Baratta MV, 2007, NEUROSCIENCE, V146, P1495, DOI 10.1016/j.neuroscience.2007.03.042; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Chourbaji S, 2005, BRAIN RES PROTOC, V16, P70, DOI 10.1016/j.brainresprot.2005.09.002; Chourbaji S, 2005, BEHAV BRAIN RES, V164, P100, DOI 10.1016/j.bbr.2005.06.003; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Drugan RC, 1997, BRAIN RES PROTOC, V2, P69, DOI 10.1016/S1385-299X(97)00031-7; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Grahn RE, 2000, BEHAV BRAIN RES, V112, P33, DOI 10.1016/S0166-4328(00)00161-3; Greenwood BN, 2010, BEHAV BRAIN RES, V211, P71, DOI 10.1016/j.bbr.2010.03.012; Landgraf D, 2014, BEHAV NEUROSCI, V128, P344, DOI 10.1037/a0036029; Maier SF, 2001, BIOL PSYCHIAT, V49, P763, DOI 10.1016/S0006-3223(00)01095-7; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Maier SF, 1998, COGNITIVE THER RES, V22, P595, DOI 10.1023/A:1018794104325; MAIER SF, 1995, BEHAV NEUROSCI, V109, P404, DOI 10.1037/0735-7044.109.3.404; Maier SF, 2015, NEUROBIOL STRESS, V1, P12, DOI 10.1016/j.ynstr.2014.09.003; Ohl F, 2005, HANDB EXP PHARM, V169, P35; Pryce CR, 2012, NEUROPHARMACOLOGY, V62, P358, DOI 10.1016/j.neuropharm.2011.08.012; Radulovic J, 1998, BEHAV BRAIN RES, V95, P179, DOI 10.1016/S0166-4328(98)00039-4; RAPS CS, 1982, J ABNORM PSYCHOL, V91, P102, DOI 10.1037/0021-843X.91.2.102; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; SELIGMAN ME, 1968, J ABNORM PSYCHOL, V73, P256, DOI 10.1037/h0025831; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; SHANKS N, 1988, BEHAV NEUROSCI, V102, P894, DOI 10.1037/0735-7044.102.6.894; Shumake J, 2005, BEHAV BRAIN RES, V164, P222, DOI 10.1016/j.bbr.2005.06.016; Steru L, 1985, PSYCHOPHARMACOLOGY B, V853, P367; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Vollmayr B, 2004, BEHAV BRAIN RES, V150, P217, DOI 10.1016/S0166-4328(03)00259-6; Vollmayr B, 2013, CELL TISSUE RES, V354, P171, DOI 10.1007/s00441-013-1654-2; WEISS JM, 1968, J COMP PHYSIOL PSYCH, V65, P251, DOI 10.1037/h0025562; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young JW, 2011, BRIT J PHARMACOL, V164, P1263, DOI 10.1111/j.1476-5381.2011.01318.x	38	31	32	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125892	10.1371/journal.pone.0125892	http://dx.doi.org/10.1371/journal.pone.0125892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928892	gold, Green Published			2022-12-26	WOS:000353713100120
J	Metzler, MA; Venkatesh, SG; Lakshmanan, J; Carenbauer, AL; Perez, SM; Andres, SA; Appana, S; Brock, GN; Wittliff, JL; Darling, DS				Metzler, Melissa A.; Venkatesh, Srirangapatnam G.; Lakshmanan, Jaganathan; Carenbauer, Anne L.; Perez, Sara M.; Andres, Sarah A.; Appana, Savitri; Brock, Guy N.; Wittliff, James L.; Darling, Douglas S.			A Systems Biology Approach Identifies a Regulatory Network in Parotid Acinar Cell Terminal Differentiation	PLOS ONE			English	Article							RADIATION-INDUCED XEROSTOMIA; UNFOLDED PROTEIN RESPONSE; ACTIVATED-RECEPTOR-GAMMA; SECRETORY PROTEIN; SALIVARY-GLANDS; STROMAL CELLS; NECK-CANCER; EXPRESSION; XBP1; MIST1	Objective The transcription factor networks that drive parotid salivary gland progenitor cells to terminally differentiate, remain largely unknown and are vital to understanding the regeneration process. Methodology A systems biology approach was taken to measure mRNA and microRNA expression in vivo across acinar cell terminal differentiation in the rat parotid salivary gland. Laser capture microdissection (LCM) was used to specifically isolate acinar cell RNA at times spanning the month-long period of parotid differentiation. Results Clustering of microarray measurements suggests that expression occurs in four stages. mRNA expression patterns suggest a novel role for Pparg which is transiently increased during mid postnatal differentiation in concert with several target gene mRNAs. 79 microRNAs are significantly differentially expressed across time. Profiles of statistically significant changes of mRNA expression, combined with reciprocal correlations of microRNAs and their target mRNAs, suggest a putative network involving Klf4, a differentiation inhibiting transcription factor, which decreases as several targeting microRNAs increase late in differentiation. The network suggests a molecular switch (involving Prdm1, Sox11, Pax5, miR-200a, and miR-30a) progressively decreases repression of Xbp1 gene transcription, in concert with decreased translational repression by miR-214. The transcription factor Xbp1 mRNA is initially low, increases progressively, and may be maintained by a positive feedback loop with Atf6. Transfection studies show that Xbp1Mist1 promoter. In addition, Xbp1 and Mist1 each activate the parotid secretory protein (Psp) gene, which encodes an abundant salivary protein, and is a marker of terminal differentiation. Conclusion This study identifies novel expression patterns of Pparg, Klf4, and Sox11 during parotid acinar cell differentiation, as well as numerous differentially expressed microRNAs. Network analysis identifies a novel stemness arm, a genetic switch involving transcription factors and microRNAs, and transition to an Xbp1 driven differentiation network. This proposed network suggests key regulatory interactions in parotid gland terminal differentiation.	[Metzler, Melissa A.; Venkatesh, Srirangapatnam G.; Lakshmanan, Jaganathan; Carenbauer, Anne L.; Perez, Sara M.; Darling, Douglas S.] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Metzler, Melissa A.; Andres, Sarah A.; Wittliff, James L.; Darling, Douglas S.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Metzler, Melissa A.; Venkatesh, Srirangapatnam G.; Andres, Sarah A.; Wittliff, James L.; Darling, Douglas S.] Univ Louisville, Inst Mol Div & Drug Design, Louisville, KY 40292 USA; [Appana, Savitri; Brock, Guy N.] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Metzler, MA (corresponding author), Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA.	melissa.metzler@louisville.edu	Darling, Douglas S/D-4573-2009	Darling, Douglas/0000-0002-9039-1169; brock, guy/0000-0001-5317-079X	National Institute of Dental and Craniofacial Research [R01DE019243, F31DE022679]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE022679, R01DE019243] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by R01DE019243 National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/) to DSD, and F31DE022679 National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/) to MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolhosseini M, 2012, MOL CELL BIOCHEM, V359, P1, DOI 10.1007/s11010-011-0991-2; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Andres SA, 2011, ENDOCRINE, V40, P212, DOI 10.1007/s12020-011-9522-x; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Vegliante MC, 2013, BLOOD, V121, P2175, DOI 10.1182/blood-2012-06-438937; Chambers MS, 2004, HEAD NECK-J SCI SPEC, V26, P796, DOI 10.1002/hed.20045; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P986, DOI 10.1016/j.biocel.2003.12.002; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Evans RL, 2000, J BIOL CHEM, V275, P26720; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gadi J, 2013, J BIOL CHEM, V288, P25400, DOI 10.1074/jbc.M112.413377; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guchelaar HJ, 1997, SUPPORT CARE CANCER, V5, P281, DOI 10.1007/s005200050075; Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61, DOI 10.14219/jada.archive.2003.0018; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1061, DOI 10.1007/s00520-010-0837-6; Johnson CL, 2004, MECH DEVELOP, V121, P261, DOI 10.1016/j.mod.2004.01.003; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Lai JK, 2012, J CELL SCI, V125, P4853, DOI 10.1242/jcs.108910; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lemercier C, 2000, GENE, V242, P209, DOI 10.1016/S0378-1119(99)00523-5; Lemercier C, 1997, DEV BIOL, V182, P101, DOI 10.1006/dbio.1996.8454; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; Lombaert IMA, 2013, STEM CELL REP, V1, P604, DOI 10.1016/j.stemcr.2013.10.013; MIKKELSEN TR, 1992, NUCLEIC ACIDS RES, V20, P2249, DOI 10.1093/nar/20.9.2249; Mills JC, 2012, BIOESSAYS, V34, P10, DOI 10.1002/bies.201100089; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Mukunyadzi P, 2003, MODERN PATHOL, V16, P1218, DOI 10.1097/01.MP.0000096042.70559.7E; Musselmann K, 2011, J DENT RES, V90, P1078, DOI 10.1177/0022034511413131; Nanduri LSY, 2013, RADIOTHER ONCOL, V108, P458, DOI 10.1016/j.radonc.2013.05.020; Nanduri LSY, 2011, RADIOTHER ONCOL, V99, P367, DOI 10.1016/j.radonc.2011.05.085; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nguyen HV, 2000, J PHYSIOL-LONDON, V523, P139, DOI 10.1111/j.1469-7793.2000.t01-2-00139.x; Oh S, 2011, BIOINFORMATICS, V27, P78, DOI 10.1093/bioinformatics/btq613; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Quissell DO, 1998, IN VITRO CELL DEV-AN, V34, P58; Quissell DO, 1998, EUR J MORPHOL, V36, P50; Rebustini IT, 2012, DEVELOPMENT, V139, P191, DOI 10.1242/dev.070151; REDMAN RS, 1971, DEV BIOL, V25, P248, DOI 10.1016/0012-1606(71)90030-3; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sivakumar S, 1998, ANAT REC, V252, P485; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Venkatesh SG, 2011, J DENT RES, V90, P1085, DOI 10.1177/0022034511410699; Warner DR, 2014, MICRORNA EXPRESSION; Wei W, 2011, MOL CELL BIOL, V31, P4692, DOI 10.1128/MCB.05979-11; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wittliff JL, 2010, TECHNIQUES CONFOCAL, P463; Wu HC, 2013, J CELL BIOCHEM, V114, P1969, DOI 10.1002/jcb.24534; Xu GS, 2012, BLOOD, V119, P4205, DOI 10.1182/blood-2011-05-353300; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298	68	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125153	10.1371/journal.pone.0125153	http://dx.doi.org/10.1371/journal.pone.0125153			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928148	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100071
J	Thach, DT; Fisher, J; Hanieh, S; Tran, T; Simpson, JA; Tran, H; Biggs, BA				Thach Duc Tran; Fisher, Jane; Hanieh, Sarah; Tran, Tuan; Simpson, Julie Anne; Tran, Ha; Biggs, Beverley-Ann			Antenatal Iron Supplementation Regimens for Pregnant Women in Rural Vietnam and Subsequent Haemoglobin Concentration and Anaemia among Their Infants	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; DEFICIENCY	Background Little evidence about the effects of antenatal iron supplementation on infant anaemia is available. The aim was to compare effects on six-month-old infants' Haemoglobin (Hb) concentration and anaemia of daily iron-folic acid (IFA), twice-weekly IFA with or without other micronutrients (MMN) and usual antenatal care in rural Vietnam. Methods and Findings Secondary data analysis from: a prospective population-based observational study (OS) which examined effects of antenatal psychosocial factors, anaemia and iron deficiency on infant development and health; and a three-arm cluster randomised trial (CRT) of different antenatal iron supplementation regimens. In the OS 497 women (<20 weeks gestation) from 50 randomly-selected communes participated, and in the CRT 1,258 pregnant women (<16 weeks gestation) in 104 communes were allocated randomly to trial arms. The main outcome was six-month-old infant Hb concentration. Baseline data included women's socio-demographic characteristics, reproductive health, Hb and serum ferritin. Mean differences in infant Hb and odds ratios of infant anaemia between CRT arms and OS were calculated by multivariable regression models, controlling for baseline differences and clustering, using robust standard errors. Infant anaemia prevalence was 68.6% in the OS, 47.2% daily IFA, 53.5% weekly IFA, and 50.3% MMN conditions. After adjustment, mean infant haemoglobin levels in daily IFA (mean difference = 0.95 g/dL; 95% CI 0.7-11.18); weekly IFA (0.91; 95% CI 0.69-1.12) and MMN (1.04; 95% CI 0.8-1.27) were higher than in the OS. After adjustment there were lower odds ratios of anaemia among infants in the daily IFA (OR = 0.31; 95% CI 0.22-0.43), weekly IFA (0.38; 95% CI 0.26-0.54) and MMN (0.33; 95% CI 0.23-0.48) groups than in the OS. Conclusions Infant anaemia is a public health problem in Vietnam and other resource-constrained countries. All supplementation regimens could have clinically significant benefits for Hb and reduce anaemia risk among six-month-old infants. Universal provision of free intermittent iron supplements is warranted.	[Thach Duc Tran; Tran, Tuan; Tran, Ha] Res & Training Ctr Community Dev, Hanoi, Vietnam; [Thach Duc Tran; Fisher, Jane] Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Unit, Melbourne, Vic 3004, Australia; [Hanieh, Sarah; Biggs, Beverley-Ann] Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Melbourne, Vic 3050, Australia; [Simpson, Julie Anne] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Thach, DT (corresponding author), Res & Training Ctr Community Dev, Hanoi, Vietnam.	indthach@yahoo.com	TRAN, THACH DUC/H-7734-2014; Mireku, Michael/D-5262-2016; Fisher, Jane/I-1569-2014	TRAN, THACH DUC/0000-0002-4686-8601; Tran, Tuan/0000-0002-4947-9169; Fisher, Jane/0000-0002-1959-6807	Australian Research Council [DP0986594]; National Health and Medical Research Council of Australia [628751]; Monash University; Jean Hailes Professorial Fellowship	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Jean Hailes Professorial Fellowship	The Observational study was funded by Australian Research Council Discovery Project Grant DP0986594. This Trial was funded through a grant from the National Health and Medical Research Council of Australia (Grant number 628751). JF is supported by a Professorial Fellowship from Monash University and the Jean Hailes Professorial Fellowship. TDT is supported by a Bridging Postdoctoral Research Fellowship from Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2006, PUBLIC HEALTH NUTR, V9, P443, DOI 10.1079/PHN2005851; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Black RE, 2008, LANCET, V371, P17, DOI DOI 10.1016/S0140-6736(08)60052-5.PUBMED:18183655; Fisher J, 2013, INT HEALTH, V5, P29, DOI 10.1093/inthealth/ihs012; Fisher J, 2010, B WORLD HEALTH ORGAN, V88, P737, DOI 10.2471/BLT.09.067066; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Hanieh S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001470; Kawai K, 2011, B WORLD HEALTH ORGAN, V89, P402, DOI 10.2471/BLT.10.083758; Khan NC, 2007, ASIA PAC J CLIN NUTR, V16, P152; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lu WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088496; Minister of Health, 2001, VIETN NAT NUTR STRAT; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009997; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Preziosi P, 1997, AM J CLIN NUTR, V66, P1178, DOI 10.1093/ajcn/66.5.1178; Szajewska H, 2010, AM J CLIN NUTR, V91, P1684, DOI 10.3945/ajcn.2010.29191; Tran TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078162; Tran TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074876; Tran TD, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-8; Trinh Lieu Thi Thuy, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P927; Unicef/UNU/WHO, 1999, UNICEF UNU WHO WORKS; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2011, GUID INT IR FOL AC S	23	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125740	10.1371/journal.pone.0125740	http://dx.doi.org/10.1371/journal.pone.0125740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928545	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100116
J	Wen, HC; Chuu, CP; Chen, CY; Shiah, SG; Kung, HJ; King, KL; Su, LC; Chang, SC; Chang, CH				Wen, Hui-Chin; Chuu, Chih-Pin; Chen, Chen-Yu; Shiah, Shine-Gwo; Kung, Hsing-Jien; King, Kuang-Liang; Su, Liang-Chen; Chang, Shi-Chuan; Chang, Chung-Ho			Elevation of Soluble Guanylate Cyclase Suppresses Proliferation and Survival of Human Breast Cancer Cells	PLOS ONE			English	Article							OXIDE SYNTHASE ACTIVITY; NITRIC-OXIDE; BRADYKININ RECEPTORS; EXPRESSION; EPIGENETICS; INHIBITOR; APOPTOSIS	Nitric oxide (NO) is an essential signaling molecule in biological systems. Soluble guanylate cyclase (sGC), composing of alpha 1 and beta 1 subunit, is the receptor for NO. Using radioimmunoassay, we discovered that activation of sGC by treatment with bradykinin or sodium nitroprusside (SNP) is impaired in MCF-7 and MDA-MB-231 breast cancer cells as compared to normal breast epithelial 184A1 cells. The 184A1 cells expressed both sGC alpha 1 and sGC beta 1 mRNAs. However, levels of sGC beta 1 mRNAs were relatively lower in MCF-7 cells while both mRNA of sGC subunits were absent in MDA-MB-231 cells. Treatment with DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) increased mRNA levels of both sGC alpha 1 and sGC beta 1 in MDA-MB-231 cells but only sGC beta 1 mRNAs in MCF-7 cells. The 5-aza-dC treatment increased the SNP-induced cGMP production in MCF-7 and MDA-MB-231, but not in 184A1 cells. Bisulfite sequencing revealed that the promoter of sGCa1 in MDA-MB-231 cells and promoter of sGC beta 1 in MCF-7 cells were methylated. Promoter hypermethylation of sGC alpha 1 and sGC beta 1 was found in 1 out of 10 breast cancer patients. Over-expression of both sGC subunits in MDA-MB-231 cells induced apoptosis and growth inhibition in vitro as well as reduced tumor incidence and tumor growth rate of MDA-MB-231 xenografts in nude mice. Elevation of sGC reduced protein abundance of Bcl-2, Bcl-xL, Cdc2, Cdc25A, Cyclin B1, Cyclin D1, Cdk6, c-Myc, and Skp2 while increased protein expression of p53. Our study demonstrated that down-regulation of sGC, partially due to promoter methylation, provides growth and survival advantage in human breast cancer cells.	[Wen, Hui-Chin; Chuu, Chih-Pin; Chen, Chen-Yu; Su, Liang-Chen; Chang, Chung-Ho] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan; [Shiah, Shine-Gwo] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan; [Kung, Hsing-Jien] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan; [King, Kuang-Liang] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Chang, Shi-Chuan] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Chang, Shi-Chuan] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Chang, Chung-Ho] China Med Univ, Grad Inst Basic Med Sci, PhD Program Aging, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan	Chang, SC (corresponding author), Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan.	scchang@vghtpe.gov.tw; changch@nhri.org.tw	Chuu, Chih-Pin/N-6697-2019		National Health Research Institutes, Taiwan [CS-103-PP-03, CA-103-SP-01]; National Science Council, Taiwan [NSC 95-2314-B-309-007-MY3, NSC 95-2314-B-309-003-MY3]; Ministry of Science and Technology, Taiwan [MOST 103-2325-B-400-001]; Micro-Western Array core facility, sequencing core facility, and cell sorting core facility of National Health Research Institutes; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Micro-Western Array core facility, sequencing core facility, and cell sorting core facility of National Health Research Institutes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by CS-103-PP-03 and CA-103-SP-01 (National Health Research Institutes, Taiwan) and NSC 95-2314-B-309-007-MY3 and NSC 95-2314-B-309-003-MY3 (National Science Council, Taiwan) for CHC; MOST 103-2325-B-400-001 (Ministry of Science and Technology, Taiwan) in Taiwan for CPC. The authors are thankful for the support from the Micro-Western Array core facility, sequencing core facility, and cell sorting core facility of National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Blaukat A, 2003, ANDROLOGIA, V35, P17, DOI 10.1046/j.1439-0272.2003.00533.x; BRAUGHLER JM, 1979, P NATL ACAD SCI USA, V76, P219, DOI 10.1073/pnas.76.1.219; Cai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095974; Chen ZJ, 2004, HYPERTENSION, V44, P963, DOI 10.1161/01.HYP.0000145859.94894.23; Chen ZJ, 2002, CANCER LETT, V177, P181, DOI 10.1016/S0304-3835(01)00788-1; Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Conran N, 2004, BRIT J HAEMATOL, V124, P547, DOI 10.1111/j.1365-2141.2004.04810.x; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Girault I, 2003, CLIN CANCER RES, V9, P4415; Guh JH, 1998, MOL PHARMACOL, V53, P467, DOI 10.1124/mol.53.3.467; Hall JM, 1997, GEN PHARMACOL, V28, P1, DOI 10.1016/S0306-3623(96)00174-7; Haramis G, 2008, BRIT J PHARMACOL, V155, P804, DOI 10.1038/bjp.2008.312; Hinshelwood RA, 2008, J MOL MED, V86, P1315, DOI 10.1007/s00109-008-0386-3; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; Jeannin JF, 2008, NITRIC OXIDE-BIOL CH, V19, P158, DOI 10.1016/j.niox.2008.04.024; Jovanovic J, 2010, MOL ONCOL, V4, P242, DOI 10.1016/j.molonc.2010.04.002; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Mujoo K, 2010, NITRIC OXIDE-BIOL CH, V22, P43, DOI 10.1016/j.niox.2009.11.007; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Olson SY, 2008, NITRIC OXIDE-BIOL CH, V19, P170, DOI 10.1016/j.niox.2008.04.005; Parrella P, 2010, BREAST CARE, V5, P66, DOI 10.1159/000309138; Pervin S, 2008, NITRIC OXIDE-BIOL CH, V19, P103, DOI 10.1016/j.niox.2008.04.016; Pervin S, 2010, CURR PHARM DESIGN, V16, P451, DOI 10.2174/138161210790232130; Regoli D, 1996, REGUL PEPTIDES, V65, P83, DOI 10.1016/0167-0115(96)00076-6; Sen S, 2013, FREE RADICAL BIO MED, V57, P210, DOI 10.1016/j.freeradbiomed.2012.10.545; THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274; Tse GMK, 2005, J CLIN PATHOL, V58, P600, DOI 10.1136/jcp.2004.023028; Vakkala M, 2000, CLIN CANCER RES, V6, P2408; Vetter M, 2003, HYPERTENSION, V41, P1136, DOI 10.1161/01.HYP.0000068201.48340.3B; Walter U, 1989, REV PHYSIOL BIOCH P, V113, P41; Yang CM, 1999, CELL SIGNAL, V11, P853, DOI 10.1016/S0898-6568(99)00056-X; Yang SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058100	42	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125518	10.1371/journal.pone.0125518	http://dx.doi.org/10.1371/journal.pone.0125518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928539	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100096
J	Zhang, XW; Qu, YY; Ma, Q; Zhang, ZJ; Li, DX; Wang, JW; Shen, WL; Shen, E; Zhou, JT				Zhang, Xuwang; Qu, Yuanyuan; Ma, Qiao; Zhang, Zhaojing; Li, Duanxing; Wang, Jingwei; Shen, Wenli; Shen, E.; Zhou, Jiti			Illumina MiSeq Sequencing Reveals Diverse Microbial Communities of Activated Sludge Systems Stimulated by Different Aromatics for Indigo Biosynthesis from Indole	PLOS ONE			English	Article							BACTERIAL DIVERSITY; NAPHTHALENE DIOXYGENASE; RIBOSOMAL-RNA; WATER; GENES; WASTE; DEGRADATION; DERIVATIVES; EXPRESSION; DYESTUFFS	Indole, as a typical N-heteroaromatic compound existed in coking wastewater, can be used for bio-indigo production. The microbial production of indigo from indole has been widely reported during the last decades using culture-dependent methods, but few studies have been carried out by microbial communities. Herein, three activated sludge systems stimulated by different aromatics, i.e. naphthalene plus indole (G1), phenol plus indole (G2) and indole only (G3), were constructed for indigo production from indole. During the operation, G1 produced the highest indigo yield in the early stage, but it switched to G3 in the late stage. Based on LC-MS analysis, indigo was the major product in G1 and G3, while the purple product 2-(7-oxo-1H-indol-6(7H)-ylidene) indolin-3-one was dominant in G2. Illumina MiSeq sequencing of 16S rRNA gene amplicons was applied to analyze the microbial community structure and composition. Detrended correspondence analysis (DCA) and dissimilarity tests showed that the overall community structures of three groups changed significantly during the operation (P<0.05). Nevertheless, the bacteria assigned to phylum Proteobacteria, family Comamonadaceae, and genera Diaphorobacter, Comamonas and Aquamicrobium were commonly shared dominant populations. Pearson correlations were calculated to discern the relationship between microbial communities and indigo yields. The typical indigo-producing populations Comamonas and Pseudomonas showed no positive correlations with indigo yields, while there emerged many other genera that exhibited positive relationships, such as Aquamicrobium, Truepera and Pusillimonas, which had not been reported for indigo production previously. The present study should provide new insights into indigo bio-production by microbial communities from indole.	[Zhang, Xuwang; Qu, Yuanyuan; Ma, Qiao; Zhang, Zhaojing; Li, Duanxing; Wang, Jingwei; Shen, Wenli; Shen, E.; Zhou, Jiti] Dalian Univ Technol, Sch Environm Sci & Technol, Key Lab Ind Ecol & Environm Engn, Minist Educ, Dalian, Peoples R China	Dalian University of Technology	Qu, YY (corresponding author), Dalian Univ Technol, Sch Environm Sci & Technol, Key Lab Ind Ecol & Environm Engn, Minist Educ, Dalian, Peoples R China.	qyy@dlut.edu.cn	Zhang, Xuwang/L-7097-2019; ma, qiao/AAK-2605-2021; Ma, Qiao/L-1317-2015	Ma, Qiao/0000-0003-0614-2192	National Natural Science Foundation of China [21176040]; Program for New Century Excellent Talents in University [NCET-13-0077]; Fundamental Research Funds for the Central Universities [DUT14YQ107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (No. 21176040), the Program for New Century Excellent Talents in University (No. NCET-13-0077), and the Fundamental Research Funds for the Central Universities (No. DUT14YQ107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalid T, 2012, CRIT REV ENV SCI TEC, V42, P1631, DOI 10.1080/10643389.2011.569872; Albuquerque L, 2005, FEMS MICROBIOL LETT, V247, P161, DOI 10.1016/j.femsle.2005.05.002; Allen CCR, 1997, APPL ENVIRON MICROB, V63, P151, DOI 10.1128/AEM.63.1.151-155.1997; BLACK JA, 1983, FUND APPL TOXICOL, V3, P353, DOI 10.1016/S0272-0590(83)80004-9; Cao BY, 2011, J BACTERIOL, V193, P4021, DOI 10.1128/JB.05242-11; Chang YC, 2013, APPL BIOCHEM BIOTECH, V170, P381, DOI 10.1007/s12010-013-0191-5; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Dedysh SN, 2005, J BACTERIOL, V187, P3884, DOI 10.1128/JB.187.11.3884-3888.2005; Doukyu N, 2002, APPL MICROBIOL BIOT, V58, P543, DOI 10.1007/s00253-001-0919-y; Doukyu N, 1998, BIOSCI BIOTECH BIOCH, V62, P1075, DOI 10.1271/bbb.62.1075; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; Fetzner S, 1998, APPL MICROBIOL BIOT, V49, P237, DOI 10.1007/s002530051164; Gillam EMJ, 1999, BIOCHEM BIOPH RES CO, V265, P469, DOI 10.1006/bbrc.1999.1702; Gillam EMJ, 2001, IUBMB LIFE, V52, P271, DOI 10.1080/152165401317291110; Kim JY, 2005, LETT APPL MICROBIOL, V41, P163, DOI 10.1111/j.1472-765X.2005.01734.x; Kim JY, 2003, LETT APPL MICROBIOL, V36, P343, DOI 10.1046/j.1472-765X.2003.01279.x; Kleerebezem R, 2007, CURR OPIN BIOTECH, V18, P207, DOI 10.1016/j.copbio.2007.05.001; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang B, 2014, WATER RES, V54, P137, DOI 10.1016/j.watres.2014.01.052; Ma JX, 2013, WATER RES, V47, P859, DOI 10.1016/j.watres.2012.11.013; Ma Q, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00102-15; Ma Q, 2015, BIORESOURCE TECHNOL, V179, P436, DOI 10.1016/j.biortech.2014.12.041; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marshall CW, 2013, CURR OPIN BIOTECH, V24, P391, DOI 10.1016/j.copbio.2013.03.016; McClay K, 2005, APPL ENVIRON MICROB, V71, P5476, DOI 10.1128/AEM.71.9.5476-5483.2005; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; O'Connor KE, 1998, BIOTECHNOL LETT, V20, P219, DOI 10.1023/A:1005361415496; OConnor KE, 1997, APPL ENVIRON MICROB, V63, P4287, DOI 10.1128/AEM.63.11.4287-4291.1997; Padoley KV, 2008, BIORESOURCE TECHNOL, V99, P4029, DOI 10.1016/j.biortech.2007.01.047; Pathak H, 2010, APPL BIOCHEM BIOTECH, V160, P1616, DOI 10.1007/s12010-009-8638-4; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Qu YY, 2012, BIOTECHNOL LETT, V34, P353, DOI 10.1007/s10529-011-0778-2; Qu YY, 2010, BIORESOURCE TECHNOL, V101, P4527, DOI 10.1016/j.biortech.2010.01.033; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Singh D, 2013, BIODEGRADATION, V24, P645, DOI 10.1007/s10532-012-9612-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093422; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Wu JF, 2006, APPL ENVIRON MICROB, V72, P1759, DOI 10.1128/AEM.72.3.1759-1765.2006; Zhang T, 2009, WATER RES, V43, P5209, DOI 10.1016/j.watres.2009.08.054; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang XW, 2013, PROCESS BIOCHEM, V48, P581, DOI 10.1016/j.procbio.2013.02.008; Zhou JZ, 2014, P NATL ACAD SCI USA, V111, pE836, DOI 10.1073/pnas.1324044111; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00584-12	48	32	38	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125732	10.1371/journal.pone.0125732	http://dx.doi.org/10.1371/journal.pone.0125732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928424	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100115
J	Brugger, A; Morton, TA; Dessai, S				Bruegger, Adrian; Morton, Thomas A.; Dessai, Suraje			Hand in Hand: Public Endorsement of Climate Change Mitigation and Adaptation	PLOS ONE			English	Article							RISK PERCEPTIONS; CHANGE POLICY; WILLINGNESS; MOTIVATION; ATTITUDES; BELIEFS; SUPPORT; ACT	This research investigated how an individual's endorsements of mitigation and adaptation relate to each other, and how well each of these can be accounted for by relevant social psychological factors. Based on survey data from two European convenience samples (N = 616/309) we found that public endorsements of mitigation and adaptation are strongly associated: Someone who is willing to reduce greenhouse gas emissions (mitigation) is also willing to prepare for climate change impacts (adaptation). Moreover, people endorsed the two response strategies for similar reasons: People who believe that climate change is real and dangerous, who have positive attitudes about protecting the environment and the climate, and who perceive climate change as a risk, are willing to respond to climate change. Furthermore, distinguishing between (spatially) proximal and distant risk perceptions suggested that the idea of portraying climate change as a proximal (i.e., local) threat might indeed be effective in promoting personal actions. However, to gain endorsement of broader societal initiatives such as policy support, it seems advisable to turn to the distant risks of climate change. The notion that "localising" climate change might not be the panacea for engaging people in this domain is discussed in regard to previous theory and research.	[Bruegger, Adrian] Univ Bern, Fac Business Econ & Social Sci, Bern, Switzerland; [Bruegger, Adrian; Morton, Thomas A.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Dessai, Suraje] Univ Leeds, Sustainabil Res Inst, Leeds, W Yorkshire, England; [Dessai, Suraje] Univ Leeds, ESRC Ctr Climate Change Econ & Policy, Sch Earth & Environm, Leeds, W Yorkshire, England; [Dessai, Suraje] Univ Lisbon, Fac Sci, Climate Change Impacts Adaptat & Mitigat Res Grp, P-1699 Lisbon, Portugal	University of Bern; University of Exeter; University of Leeds; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Leeds; Universidade de Lisboa	Brugger, A (corresponding author), Univ Bern, Fac Business Econ & Social Sci, Bern, Switzerland.	adrian.bruegger@imu.unibe.ch	Brügger, Adrian/E-4252-2014; Dessai, Suraje/D-4219-2009	Brügger, Adrian/0000-0003-0026-3153; Dessai, Suraje/0000-0002-7879-9364; /0000-0002-7577-7047	Social Psychology Division of the Otto-von-Guericke University at Magdeburg, Germany; Climate Change and Sustainable Futures theme at the University of Exeter; European Research Council under the 7th Framework Programme/ERC Grant [284369]; UK Economic and Social Research Council (ESRC); Economic and Social Research Council [ES/K006576/1] Funding Source: researchfish; ESRC [ES/K006576/1] Funding Source: UKRI	Social Psychology Division of the Otto-von-Guericke University at Magdeburg, Germany; Climate Change and Sustainable Futures theme at the University of Exeter; European Research Council under the 7th Framework Programme/ERC Grant; UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study conducted in Switzerland was partly supported by the Social Psychology Division of the Otto-von-Guericke University at Magdeburg, Germany. Adrian Brugger was supported by a doctoral fellowship from the Climate Change and Sustainable Futures theme at the University of Exeter. Suraje Dessai is supported by the European Research Council under the 7th Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 284369 and by the UK Economic and Social Research Council (ESRC) for the Centre for Climate Change Economics and Policy (CCCEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger W. N., 2001, Journal of International Development, V13, P921, DOI 10.1002/jid.833; [Anonymous], 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; [Anonymous], 2006, RECIEL REV EUROPEAN, DOI [10.1111/j.1467-9388.2006.00501.x, DOI 10.1111/J.1467-9388.2006.00501.X, DOI 10.1177/0306312715620061]; Arbuckle JG, 2013, CLIMATIC CHANGE, V117, P943, DOI 10.1007/s10584-013-0707-6; Barnett J, 2010, WIRES CLIM CHANGE, V1, P314, DOI 10.1002/wcc.28; Bichard E, 2012, CLIMATIC CHANGE, V112, P633, DOI 10.1007/s10584-011-0257-8; Blennow K, 2009, GLOBAL ENVIRON CHANG, V19, P100, DOI 10.1016/j.gloenvcha.2008.10.003; Brody S, 2012, CLIM POLICY, V12, P1, DOI 10.1080/14693062.2011.579261; Brugger A, 2011, EUR PSYCHOL, V16, P324, DOI 10.1027/1016-9040/a000032; Bubeck P, 2012, RISK ANAL, V32, P1481, DOI 10.1111/j.1539-6924.2011.01783.x; City of London Corporation, 2007, RISING TO THE CHALLE; CRED, 2009, THE PSYCHOLOGY OF CL; Devine-Wright P, 2013, GLOBAL ENVIRON CHANG, V23, P61, DOI 10.1016/j.gloenvcha.2012.08.003; Dietz T, 2007, RURAL SOCIOL, V72, P185, DOI 10.1526/003601107781170026; Esham M, 2013, MITIG ADAPT STRAT GL, V18, P535, DOI 10.1007/s11027-012-9374-6; Field C. B., 2014, CONTRIBUTION OF WORK; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; Gardner GT, 2008, ENVIRONMENT, V50, P12, DOI 10.3200/ENVT.50.5.12-25; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Haden V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052882; Hayward SF, 2006, ACCLIMATIZING HOW TO; IPCC, 2014, WORKING GROUP III CO; IPCC (Intergovernmental Panel on Climate Change), 2007, CONTRIBUTION WORKING, P793; Kaiser FG, 2004, PERS INDIV DIFFER, V36, P1531, DOI 10.1016/j.paid.2003.06.003; Kim HY, 2009, J CONSUM RES, V35, P877, DOI 10.1086/593700; Klein RJT, 2005, ENVIRON SCI POLICY, V8, P579, DOI 10.1016/j.envsci.2005.06.010; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Lindell MK, 2000, ENVIRON BEHAV, V32, P461, DOI 10.1177/00139160021972621; Lorenzoni I, 2007, GLOBAL ENVIRON CHANG, V17, P445, DOI 10.1016/j.gloenvcha.2007.01.004; Marx SM, 2007, GLOBAL ENVIRON CHANG, V17, P47, DOI 10.1016/j.gloenvcha.2006.10.004; McCrann T, 2011, THE AUSTRALIAN BUSIN; Monbiot G, 2006, NEW INT MAG; Monckton C, 2010, WAS THE WARMEST YEAR; Nilsson A, 2004, J ENVIRON PSYCHOL, V24, P267, DOI 10.1016/j.jenvp.2004.06.002; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; Olausson U, 2009, PUBLIC UNDERST SCI, V18, P421, DOI 10.1177/0963662507081242; Prillwitz J, 2011, J TRANSP GEOGR, V19, P1590, DOI 10.1016/j.jtrangeo.2011.06.011; Semenza JC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-46; Shwom R, 2008, CLIMATIC CHANGE, V90, P343, DOI 10.1007/s10584-008-9428-7; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Smith N, 2012, RISK ANAL, V32, P1021, DOI 10.1111/j.1539-6924.2012.01801.x; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Tobler C, 2012, J ENVIRON PSYCHOL, V32, P197, DOI 10.1016/j.jenvp.2012.02.001; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Tucker CM, 2010, GLOBAL ENVIRON CHANG, V20, P23, DOI 10.1016/j.gloenvcha.2009.07.006; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003; Whitmarsh L, 2009, PUBLIC UNDERST SCI, V18, P401, DOI 10.1177/0963662506073088	52	33	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124843	10.1371/journal.pone.0124843	http://dx.doi.org/10.1371/journal.pone.0124843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25922938	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600106
J	Herrera, MS; Kuhn, WR; Lorenzo-Carballa, MO; Harding, KM; Ankrom, N; Sherratt, TN; Hoffmann, J; Van Gossum, H; Ware, JL; Cordero-Rivera, A; Beatty, CD				Herrera, Melissa Sanchez; Kuhn, William R.; Olalla Lorenzo-Carballa, Maria; Harding, Kathleen M.; Ankrom, Nikole; Sherratt, Thomas N.; Hoffmann, Joachim; Van Gossum, Hans; Ware, Jessica L.; Cordero-Rivera, Adolfo; Beatty, Christopher D.			Mixed Signals? Morphological and Molecular Evidence Suggest a Color Polymorphism in Some Neotropical Polythore Damselflies	PLOS ONE			English	Article							SEXUALLY SELECTED TRAIT; PARASITE RESISTANCE; PREMATING ISOLATION; NEURAL-NETWORKS; GENE FLOW; SELECTION; HYBRIDIZATION; SPECIATION; EXPRESSION; ORNAMENT	The study of color polymorphisms (CP) has provided profound insights into the maintenance of genetic variation in natural populations. We here offer the first evidence for an elaborate wing polymorphism in the Neotropical damselfly genus Polythore, which consists of 21 described species, distributed along the eastern slopes of the Andes in South America. These damselflies display highly complex wing colors and patterning, incorporating black, white, yellow, and orange in multiple wing bands. Wing colors, along with some components of the male genitalia, have been the primary characters used in species description; few other morphological traits vary within the group, and so there are few useful diagnostic characters. Previous research has indicated the possibility of a cryptic species existing in P. procera in Colombia, despite there being no significant differences in wing color and pattern between the populations of the two putative species. Here we analyze the complexity and diversity of wing color patterns of individuals from five described Polythore species in the Central Amazon Basin of Peru using a novel suite of morphological analyses to quantify wing color and pattern: geometric morphometrics, chromaticity analysis, and Gabor wavelet transformation. We then test whether these color patterns are good predictors of species by recovering the phylogenetic relationships among the 5 species using the barcode gene (COI). Our results suggest that, while highly distinct and discrete wing patterns exist in Polythore, these "wingforms" do not represent monophyletic clades in the recovered topology. The wingforms identified as P. victoria and P. ornata are both involved in a polymorphism with P. neopicta; also, cryptic speciation may have taking place among individuals with the P. victoria wingform. Only P. aurora and P. spateri represent monophyletic species with a single wingform in our molecular phylogeny. We discuss the implications of this polymorphism, and the potential evolutionary mechanisms that could maintain it.	[Herrera, Melissa Sanchez; Kuhn, William R.; Ware, Jessica L.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Olalla Lorenzo-Carballa, Maria; Harding, Kathleen M.; Cordero-Rivera, Adolfo; Beatty, Christopher D.] Univ Vigo, Dept Ecol & Biol Anim, Grp Ecol Evolut & Conservac, Galiza, Spain; [Olalla Lorenzo-Carballa, Maria] Univ Liverpool, Inst Integrat Biol, Dept Evolut Ecol & Behav, Liverpool L69 3BX, Merseyside, England; [Ankrom, Nikole; Beatty, Christopher D.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Sherratt, Thomas N.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Hoffmann, Joachim] ALAUDA Arbeitsgemeinschaft Landschaftsokol Unters, Hamburg, Germany; [Van Gossum, Hans] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium	Rutgers State University Newark; Rutgers State University New Brunswick; Universidade de Vigo; University of Liverpool; Santa Clara University; Carleton University; University of Antwerp	Beatty, CD (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Grp Ecol Evolut & Conservac, Galiza, Spain.	cbeatty@scu.edu	Beatty, Christopher/ABE-6438-2020; Lorenzo-Carballa, M. Olalla/B-2624-2017; Sanchez-Herrera, Melissa/AAL-3270-2021; Cordero-Rivera, Adolfo/K-4182-2014	Beatty, Christopher/0000-0003-2641-0000; Lorenzo-Carballa, M. Olalla/0000-0003-4570-2594; Sanchez-Herrera, Melissa/0000-0001-5144-4996; Cordero-Rivera, Adolfo/0000-0002-5087-3550; Ware, Jessica/0000-0002-4066-7681; Kuhn, William/0000-0002-5506-6379	Spanish Ministry of Science and Innovation [PCI2006-A7-0639, CGL2008-02799]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding was provided by grants from the Spanish Ministry of Science and Innovation with competences in Science to CDB (Grant PCI2006-A7-0639) and ACR (Grant CGL2008-02799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beccaloni George W., 1997, Tropical Lepidoptera, V8, P103; BICK G H, 1985, Odonatologica, V14, P1; BICK G H, 1986, Odonatologica, V15, P245; Brower AVZ, 2011, GENETICA, V139, P589, DOI 10.1007/s10709-010-9530-4; Brower AVZ, 1996, ZOOL J LINN SOC-LOND, V116, P317; CAIN AJ, 1954, GENETICS, V39, P89; Chapman RF, 1998, THE INSECTS STRUCTUR; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Corbet PS, 1999, DRAGONFLIES BEHAVIOU; Cordoba-Aguilar A, 2002, ANIM BEHAV, V63, P759, DOI 10.1006/anbe.2001.1974; Cordoba-Aguilar A, 2008, DRAGONFLIES AND DAMS; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DAUGMAN JG, 1980, VISION RES, V20, P847, DOI 10.1016/0042-6989(80)90065-6; DAUGMAN JG, 1988, IEEE T ACOUST SPEECH, V36, P1169, DOI 10.1109/29.1644; Davison A, 2000, P ROY SOC B-BIOL SCI, V267, P1399, DOI 10.1098/rspb.2000.1156; de Marmels J., 1982, Advances in Odonatology, V1, P39; Doyle J. J., 1987, PHYTOCHEM B, P11; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feder JL, 2012, PHILOS T R SOC B, V367, P461, DOI 10.1098/rstb.2011.0256; Fitzstephens DM, 2000, ANIM BEHAV, V60, P851, DOI 10.1006/anbe.2000.1548; Ford E. B., 1940, P493; Franks DW, 2009, EVOLUTION, V63, P2697, DOI 10.1111/j.1558-5646.2009.00748.x; Garrison RW, 2010, DAMSELFLY GENERA OF; GILLESPIE AR, 1987, REMOTE SENS ENVIRON, V22, P343, DOI 10.1016/0034-4257(87)90088-5; Goloboff P, 2008, CLADISTICS, V24, P91; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Grether GF, 1997, P ROY SOC B-BIOL SCI, V264, P207, DOI 10.1098/rspb.1997.0029; Grether GF, 1996, EVOLUTION, V50, P1939, DOI 10.1111/j.1558-5646.1996.tb03581.x; Grether GF, 1996, EVOLUTION, V50, P1949, DOI 10.1111/j.1558-5646.1996.tb03582.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hassall C, 2014, PEERJ, V2, DOI 10.7717/peerj.438; Hill RI, 2012, BIOL J LINN SOC, V106, P540, DOI 10.1111/j.1095-8312.2012.01874.x; Honkavaara J, 2011, J EVOLUTION BIOL, V24, P139, DOI 10.1111/j.1420-9101.2010.02146.x; Hooper RE, 1999, PHYSIOL ENTOMOL, V24, P364, DOI 10.1046/j.1365-3032.1999.00152.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Joop G, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-19; Joron M, 2006, HEREDITY, V97, P157, DOI 10.1038/sj.hdy.6800873; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; LEES DR, 1975, J ANIM ECOL, V44, P67, DOI 10.2307/3852; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOUTON J.A., 1996, MANU BIODIVERSITY SE, P431; Maddison WP, 2011, MESQUITE A MODULAR S; MALLET J, 1989, PROC R SOC SER B-BIO, V236, P163, DOI 10.1098/rspb.1989.0019; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Mullen SP, 2014, ANNU REV ENTOMOL, V59, P339, DOI 10.1146/annurev-ento-120710-100621; Lorenzo-Carballa MO, 2014, INT J ODONATOL, V17, P149, DOI 10.1080/13887890.2014.951696; Polly P. D., 2014, GEOMETRIC MORPHOMETR; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Rambaut A, 2014, FIGTREE V 1 4 1 A TR; Rambaut A., 2014, TRACER V1 6; RIEK EF, 1984, CAN J ZOOL, V62, P1150, DOI 10.1139/z84-166; ROBERTSON HM, 1982, EVOLUTION, V36, P243, DOI 10.1111/j.1558-5646.1982.tb05037.x; Rohlf F. J., 2005, TPSDIG DIGITIZE LAND; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Russell KN, 2007, SYST ASSOC SPEC VOL, V74, P131; Salazar C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-132; Herrera MS, 2010, MOL PHYLOGENET EVOL, V57, P912, DOI 10.1016/j.ympev.2010.08.016; Sanchez-Herrera M, 2010, INT J ODONATOL, V13, P27, DOI 10.1080/13887890.2010.9748358; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Sonnentag O, 2012, AGR FOREST METEOROL, V152, P159, DOI 10.1016/j.agrformet.2011.09.009; Sukumaran J., 2008, SUMTREES SUMMARIZATI; Svensson EI, 2004, AM NAT, V163, P726, DOI 10.1086/383592; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; Svensson EI, 2006, EVOLUTION, V60, P1242; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tynkkynen K, 2008, ANIM BEHAV, V75, P1431, DOI 10.1016/j.anbehav.2007.09.017; Tynkkynen Katja, 2008, P139; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Weldon TP, 1996, PATTERN RECOGN, V29, P2005, DOI 10.1016/S0031-3203(96)00047-7; Wellenreuther M, 2010, BIOL J LINN SOC, V100, P506, DOI 10.1111/j.1095-8312.2010.01464.x; Wellenreuther M, 2010, EVOLUTION, V64, P242, DOI 10.1111/j.1558-5646.2009.00815.x; WOEBBECKE DM, 1995, T ASAE, V38, P259, DOI 10.13031/2013.27838; Wolfram Research, 2010, MATHEMATICA EDITION; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zwickl DJ., 2006, THESIS	87	7	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125074	10.1371/journal.pone.0125074	http://dx.doi.org/10.1371/journal.pone.0125074			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923455	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600122
J	Meeus, I; Parmentier, L; Billiet, A; Maebe, K; Van Nieuwerburgh, F; Deforce, D; Wackers, F; Vandamme, P; Smagghe, G				Meeus, Ivan; Parmentier, Laurian; Billiet, Annelies; Maebe, Kevin; Van Nieuwerburgh, Filip; Deforce, Dieter; Wackers, Felix; Vandamme, Peter; Smagghe, Guy			16S rRNA Amplicon Sequencing Demonstrates that Indoor-Reared Bumblebees (Bombus terrestris) Harbor a Core Subset of Bacteria Normally Associated with the Wild Host	PLOS ONE			English	Article							GUT MICROBIOTA; DIGESTIVE-TRACT; SP NOV.; BEES; DIVERSITY; PATTERNS; DECLINES; HONEYBEE; BIFIDOBACTERIA; CONSERVATION	A MiSeq multiplexed 16S rRNA amplicon sequencing of the gut microbiota of wild and indoor-reared Bombus terrestris (bumblebees) confirmed the presence of a core set of bacteria, which consisted of Neisseriaceae (Snodgrassella), Orbaceae (Gilliamella), Lactobacillaceae (Lactobacillus), and Bifidobacteriaceae (Bifidobacterium). In wild B. terrestris we detected several non-core bacteria having a more variable prevalence. Although Enterobacteriaceae are unreported by non next-generation sequencing studies, it can become a dominant gut resident. Furthermore the presence of some non-core lactobacilli were associated with the relative abundance of bifidobacteria. This association was not observed in indoor-reared bumblebees lacking the non-core bacteria, but having a more standardized microbiota compared to their wild counterparts. The impact of the bottleneck microbiota of indoor-reared bumblebees when they are used in the field for pollination purpose is discussed.	[Meeus, Ivan; Parmentier, Laurian; Billiet, Annelies; Maebe, Kevin; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Wackers, Felix] Biobest NV, B-2260 Westerlo, Belgium; [Vandamme, Peter] Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Meeus, I (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, Coupure Links 653, B-9000 Ghent, Belgium.	ivan.meeus@ugent.be; guy.smagghe@UGent.be	Smagghe, Guy/AAE-8914-2019; Vandamme, Peter AR/B-7967-2009; Vandamme, Peter/ABG-3431-2021; Van Nieuwerburgh, Filip/H-9697-2015	Smagghe, Guy/0000-0001-8334-3313; Vandamme, Peter AR/0000-0002-5581-7937; Vandamme, Peter/0000-0002-5581-7937; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Maebe, Kevin/0000-0002-3741-2143	Fund for Scientific Research-Flanders (FWO-Vlaanderen); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT, Brussels, Belgium); Biobest NV	Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT, Brussels, Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Biobest NV	This study was supported by the Fund for Scientific Research-Flanders (FWO-Vlaanderen; www.fwo.be) and the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT, Brussels, Belgium, www.iwt.be). Biobest NV provided support in the form of salary for author FW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cariveau PD, 2014, ISME J, P1, DOI [10.1038/ismej.2014.99, DOI 10.1038/ISMEJ.2014.99]; Demirci M, 2013, FOLIA MICROBIOL, V58, P201, DOI 10.1007/s12223-012-0199-1; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engel P, 2013, INT J SYST EVOL MICR, V63, P3646, DOI 10.1099/ijs.0.049569-0; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Hamdi C, 2011, J APPL ENTOMOL, V135, P524, DOI 10.1111/j.1439-0418.2010.01609.x; Killer J, 2011, INT J SYST EVOL MICR, V61, P1315, DOI 10.1099/ijs.0.022525-0; Killer J, 2010, ANAEROBE, V16, P165, DOI 10.1016/j.anaerobe.2009.07.007; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Maebe K, 2014, APIDOLOGIE, V45, P189, DOI 10.1007/s13592-013-0237-2; Maebe K, 2013, APIDOLOGIE, V44, P188, DOI 10.1007/s13592-012-0170-9; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Meeus I, 2013, APIDOLOGIE, V44, P708, DOI 10.1007/s13592-013-0222-9; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Mulder CPH, 2004, OIKOS, V107, P50, DOI 10.1111/j.0030-1299.2004.13110.x; Murray TE, 2013, BIOL CONSERV, V159, P269, DOI 10.1016/j.biocon.2012.10.021; Newton ILG, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-12, DOI 10.1186/1471-2180-12-12]; Parmentier L, 2014, ENVIRON MONIT ASSESS, V186, P2357, DOI 10.1007/s10661-013-3543-2; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Podgwaite JD, 2013, J ENTOMOL SCI, V48, P128; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pridal P, 1997, ACTA UNIV AGRIC ET S, V8, P59; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Vasanthakumar A, 2006, ENVIRON ENTOMOL, V35, P1710, DOI 10.1603/0046-225X(2006)35[1710:COGBIL]2.0.CO;2; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Ventura M, 2012, TRENDS MICROBIOL, V20, P467, DOI 10.1016/j.tim.2012.07.002; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2008, AUSTRAL ECOL, V33, P290, DOI 10.1111/j.1442-9993.2007.01816.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Warton DI, 2005, ENVIRONMETRICS, V16, P275, DOI 10.1002/env.702; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1	50	32	33	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125152	10.1371/journal.pone.0125152	http://dx.doi.org/10.1371/journal.pone.0125152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923917	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600129
J	Garcia, NW; Pfennig, KS; Burmeister, SS				Garcia, Nicholas W.; Pfennig, Karin S.; Burmeister, Sabrina S.			Leptin Manipulation Reduces Appetite and Causes a Switch in Mating Preference in the Plains Spadefoot Toad (Spea bombifrons)	PLOS ONE			English	Article							MATE CHOICE; WEIGHT; ADIPOSITY; OBESE; GROWTH	Condition- or context-dependent mate choice occurs when females modify their mate preferences depending on their internal or external environment. While the ecological and evolutionary factors that favor the evolution of such plasticity are emerging, relatively little is known of the mechanisms underlying such choice. Here we evaluated whether leptin, a protein hormone involved in the regulation of appetite, might affect the expression of conditiondependent mate choice decisions. To do so, we administered leptin to spadefoot toads, Spea bombifrons, which exhibit condition-dependent mate choice for males of their own species versus congeneric males of S. multiplicata. In particular, poor-condition S. bombifrons are more likely than are good-condition S. bombifrons to prefer S. multiplicata males, but only in environments where hybridization between the two species is beneficial. We found that our leptin treatment reduced appetite in S. bombifrons adults, as was expected from leptin's known effects on appetite. However, although we predicted that leptin would reduce female preferences for heterospecific males, we found the opposite. In particular, our leptin treatment generated a consistent, repeatable preference for heterospecifics in an environment where females generally prefer conspecifics regardless of condition. These results indicate that leptin has the potential to affect female mate choice, but that it might do so in non-intuitive ways.	[Garcia, Nicholas W.; Pfennig, Karin S.; Burmeister, Sabrina S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Burmeister, Sabrina S.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Burmeister, SS (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	sburmeister@unc.edu		Burmeister, Sabrina/0000-0001-5612-692X	New Innovator Award from the Office of the Director of the National Institutes of Health [1 DP2 OD004436-01]; University of North Carolina Research Council Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004436] Funding Source: NIH RePORTER	New Innovator Award from the Office of the Director of the National Institutes of Health; University of North Carolina Research Council Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported by a New Innovator Award from the Office of the Director of the National Institutes of Health (1 DP2 OD004436-01) to KSP and by a University of North Carolina Research Council Award to SSB. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bragg AN, 1965, GNOMES NIGHT SPADEFO; Caprio M, 2001, TRENDS ENDOCRIN MET, V12, P65, DOI 10.1016/S1043-2760(00)00352-0; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Crespi EJ, 2006, P NATL ACAD SCI USA, V103, P10092, DOI 10.1073/pnas.0507519103; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Drazen DL, 2001, ENDOCRINOLOGY, V142, P2768, DOI 10.1210/en.142.7.2768; French SS, 2011, INTEGR COMP BIOL, V51, P505, DOI 10.1093/icb/icr019; Froiland E, 2012, GEN COMP ENDOCR, V178, P330, DOI 10.1016/j.ygcen.2012.06.017; Gorissen M, 2012, GEN COMP ENDOCR, V178, P75, DOI 10.1016/j.ygcen.2012.04.004; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kronfeld-Schor N, 2000, AM J PHYSIOL-REG I, V279, pR1277, DOI 10.1152/ajpregu.2000.279.4.R1277; Londraville RL, 2014, GEN COMP ENDOCR, V203, P146, DOI 10.1016/j.ygcen.2014.02.002; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Nieminen P, 2002, J BIOL RHYTHM, V17, P155, DOI 10.1177/074873002129002447; Oomura Y, 2006, PEPTIDES, V27, P2738, DOI 10.1016/j.peptides.2006.07.001; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pfennig KS, 2000, BEHAV ECOL, V11, P220, DOI 10.1093/beheco/11.2.220; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Spanovich S, 2006, COMP BIOCHEM PHYS B, V143, P507, DOI 10.1016/j.cbpb.2006.01.001; Sprent J, 2012, GEN COMP ENDOCR, V178, P372, DOI 10.1016/j.ygcen.2012.06.021; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X	24	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125981	10.1371/journal.pone.0125981	http://dx.doi.org/10.1371/journal.pone.0125981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919309	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659400091
J	Park, MS				Park, Min-Sun			Molecular Dynamics Simulations of the Human Glucose Transporter GLUT1	PLOS ONE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; FREE-ENERGY DIFFERENCES; DEFICIENCY SYNDROME; CRYSTAL-STRUCTURE; BRAIN; MECHANISM; RESIDUES; MUTATION; BINDING; FAMILY	Glucose transporters (GLUTs) provide a pathway for glucose transport across membranes. Human GLUTs are implicated in devastating diseases such as heart disease, hyper- and hypo-glycemia, type 2 diabetes and caner. The human GLUT1 has been recently crystalized in the inward-facing open conformation. However, there is no other structural information for other conformations. The X-ray structures of E. coli Xylose permease (XylE), a glucose transporter homolog, are available in multiple conformations with and without the substrates D-xylose and D-glucose. XylE has high sequence homology to human GLUT1 and key residues in the sugar-binding pocket are conserved. Here we construct a homology model for human GLUT1 based on the available XylE crystal structure in the partially occluded outward-facing conformation. A long unbiased all atom molecular dynamics simulation starting from the model can capture a new fully opened outward-facing conformation. Our investigation of molecular interactions at the interface between the transmembrane (TM) domains and the intracellular helices (ICH) domain in the outward- and inward-facing conformation supports that the ICH domain likely stabilizes the outward-facing conformation in GLUT1. Furthermore, inducing a conformational transition, our simulations manifest a global asymmetric rocker switch motion and detailed molecular interactions between the substrate and residues through the water-filled selective pore along a pathway from the extracellular to the intracellular side. The results presented here are consistent with previously published biochemical, mutagenesis and functional studies. Together, this study shed light on the structure and functional relationships of GLUT1 in multiple conformational states.	Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Park, MS (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA.	parkm10@janelia.hhmi.org			Howard Hughes Medical Institute (HHMI)	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ASANO T, 1991, J BIOL CHEM, V266, P24632; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; Brockmann K, 2001, ANN NEUROL, V50, P476, DOI 10.1002/ana.1222; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Doege H, 1998, BIOCHEM J, V329, P289, DOI 10.1042/bj3290289; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Hruz PW, 1999, J BIOL CHEM, V274, P36176, DOI 10.1074/jbc.274.51.36176; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; INUKAI K, 1994, BIOCHEM J, V302, P355, DOI 10.1042/bj3020355; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Jojart B, 2007, J COMPUT CHEM, V28, P2051, DOI 10.1002/jcc.20748; Klepper J, 2002, EUR J PEDIATR, V161, P295, DOI 10.1007/s00431-002-0939-3; Klepper J, 1999, NEUROCHEM RES, V24, P587, DOI 10.1023/A:1022544131826; Klepper J, 2001, FEBS LETT, V498, P104, DOI 10.1016/S0014-5793(01)02463-2; Klepper J, 2001, HUM MOL GENET, V10, P63, DOI 10.1093/hmg/10.1.63; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LAM VMS, 1980, J BACTERIOL, V143, P396, DOI 10.1128/JB.143.1.396-402.1980; Lee HS, 2006, BIOCHEM BIOPH RES CO, V342, P702, DOI 10.1016/j.bbrc.2006.01.184; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; Liu YF, 2013, STAT INTERFACE, V6, P1; LOIKE JD, 1993, J GEN PHYSIOL, V102, P897, DOI 10.1085/jgp.102.5.897; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MORI H, 1994, J BIOL CHEM, V269, P11578; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; MURAOKA A, 1995, BIOCHEM J, V311, P699, DOI 10.1042/bj3110699; Olsowski A, 2000, BIOCHEMISTRY-US, V39, P2469, DOI 10.1021/bi992160x; Overweg-Plandsoen WCG, 2003, J INHERIT METAB DIS, V26, P559, DOI 10.1023/A:1025999914822; Pantano S, 2007, PROTEINS, V66, P930, DOI 10.1002/prot.21239; Pascual JM, 2002, ANN NEUROL, V52, P458, DOI 10.1002/ana.10311; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Roux B, 2004, STRUCTURE, V12, P1343, DOI 10.1016/j.str.2004.06.013; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider SA, 2009, MOVEMENT DISORD, V24, P1684, DOI 10.1002/mds.22507; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tikhonova IG, 2013, BIOCHEMISTRY-US, V52, P5593, DOI 10.1021/bi400499n; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; Wang D, 2008, PEDIATR RES, V64, P538, DOI 10.1203/PDR.0b013e318184d2b5; WILLEJORGENSEN P, 1983, ARCH SURG-CHICAGO, V118, P926; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Ytreberg FM, 2004, J COMPUT CHEM, V25, P1749, DOI 10.1002/jcc.20103; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528	64	34	36	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125361	10.1371/journal.pone.0125361	http://dx.doi.org/10.1371/journal.pone.0125361			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919356	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659400081
J	Bernard, LP; Zhang, HY				Bernard, Laura P.; Zhang, Huaye			MARK/Par1 Kinase Is Activated Downstream of NMDA Receptors through a PKA-Dependent Mechanism	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOLOGY; SYNAPTIC PLASTICITY; PROTEIN-KINASE; PHOSPHORYLATION; POLARITY; PSD-95; LKB1; NEURONS; SYNAPTOGENESIS	The Par1 kinases, also known as microtubule affinity-regulating kinases (MARKs), are important for the establishment of cell polarity from worms to mammals. Dysregulation of these kinases has been implicated in autism, Alzheimer's disease and cancer. Despite their important function in health and disease, it has been unclear how the activity of MARK/Par1 is regulated by signals from cell surface receptors. Here we show that MARK/Par1 is activated downstream of NMDA receptors in primary hippocampal neurons. Further, we show that this activation is dependent on protein kinase A (PKA), through the phosphorylation of Ser431 of Par4/LKB1, the major upstream kinase of MARK/Par1. Together, our data reveal a novel mechanism by which MARK/Par1 is activated at the neuronal synapse.	[Bernard, Laura P.; Zhang, Huaye] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, HY (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	huaye.zhang@rutgers.edu			National Institutes of Health grant [NS065183]; Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065183] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS065183 and startup funds from the Rutgers Robert Wood Johnson Medical School to H.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Colgan LA, 2013, ANN REV PHYSL; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hayashi K, 2011, J NEUROSCI, V31, P12094, DOI 10.1523/JNEUROSCI.0751-11.2011; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hou HL, 2013, J CELL BIOL, V203, P521, DOI 10.1083/jcb.201303035; Hu XD, 2011, J NEUROSCI, V31, P15597, DOI 10.1523/JNEUROSCI.2445-11.2011; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Merriam EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027688; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Repetto D, 2014, J NEUROSCI, V34, P1542, DOI 10.1523/JNEUROSCI.2341-13.2014; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Stein V, 2003, J NEUROSCI, V23, P5503; Sun M, 2013, JOVE-J VIS EXP, DOI 10.3791/50808; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Wang JW, 2007, J NEUROSCI, V27, P574, DOI 10.1523/JNEUROSCI.5094-06.2007; Wu Q, 2012, J BIOL CHEM, V287, P30781, DOI 10.1074/jbc.M112.351452; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yu WD, 2012, HUM MOL GENET, V21, P1384, DOI 10.1093/hmg/ddr576; Zhu D, 2002, AMINO ACIDS, V23, P11, DOI 10.1007/s00726-001-0103-9; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	46	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124816	10.1371/journal.pone.0124816	http://dx.doi.org/10.1371/journal.pone.0124816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932647	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100057
J	Du, HW; Shi, LL; Chen, P; Yang, WK; Xun, YP; Yang, CH; Zhao, LQ; Zhou, YB; Chen, GY				Du, Hongwu; Shi, Lili; Chen, Peng; Yang, Weikang; Xun, Yiping; Yang, Chunhe; Zhao, Lanqing; Zhou, Yabin; Chen, Guangyu			Prohibitin Is Involved in Patients with IgG4 Related Disease	PLOS ONE			English	Article							IGG4-RELATED SYSTEMIC-DISEASE; AUTOIMMUNE PANCREATITIS; TUBULOINTERSTITIAL NEPHRITIS; SCLEROSING PANCREATITIS; IDENTIFICATION; AUTOANTIBODIES; FIBROSIS; ANTIBODY	Objective IgG4-related disease (IgG4-RD) is a chronic systemic disease involved in many organs and tissues. As only limited autoantigens have been found since the beginning of this century, the aim of this study was to reveal new candidate autoantigens of IgG4-RD. Methods Multiple cell lines including HT-29, EA.hy926, HEK 293 and HepG2 were used to test the binding ability of circulating autoantibodies from IgG4-RD sera. The amino-acid sequence was then analyzed by matrix-assisted laser desorption/ionization time-of-flight tandem (MALDI-TOF/TOF) mass spectrometry. After the cloning and expression of recombinant putative autoantigen in a bacterial expression system, the corresponding immuno assay was set up and utilized to observe the prevalence of serum autoantibodies in a large set of confirmed clinical samples. Results One positive autoantigen was identified as prohibitin. ELISA analysis showed that a majority of patients with IgG4-RD have antibodies against prohibitin. Anti-prohibitin antibodies were present in the sera of patients with definite autoimmune pancreatitis (25/34; 73.5%), Mikulicz's disease (8/15; 53.3%), retroperitoneal fibrosis (6/11; 54.5%), other probable IgG4-RD (26/29; 89.7%) and Sjogren's syndrome (4/30; 13.3%) but not in apparently healthy donors (1/70; 1.4%). Conclusions An association between prohibitin and patients with some IgG4-RD was observed, although the results were quite heterogeneous among different individuals within autoimmune pancreatitis, Mikulicz's disease and retroperitoneal fibrosis.	[Du, Hongwu; Shi, Lili; Chen, Peng; Yang, Weikang; Xun, Yiping; Yang, Chunhe; Zhao, Lanqing; Zhou, Yabin] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Lab 112, Beijing 100083, Peoples R China; [Chen, Guangyu] ImmunoHunt Corp, Beijing, Peoples R China	University of Science & Technology Beijing	Du, HW (corresponding author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Lab 112, Beijing 100083, Peoples R China.	hongwudu@ustb.edu.cn		Xun, Yiping/0000-0001-6367-8407	Fundamental Research Funds for the Central Universities, Program for New Century Excellent Talents in University; National Natural Science Foundation of China [21105113, 31371203]	Fundamental Research Funds for the Central Universities, Program for New Century Excellent Talents in University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities, Program for New Century Excellent Talents in University and the National Natural Science Foundation of China (No. 21105113; No. 31371203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ImmunoHunt Corporation provided support in the form of a salary for author GYC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 2006, PANCREAS, V33, P20, DOI 10.1097/01.mpa.0000226881.48204.fd; Cornell LD, 2007, AM J SURG PATHOL, V31, P1586, DOI 10.1097/PAS.0b013e318059b87c; Deshpande V, 2006, AM J SURG PATHOL, V30, P1537, DOI 10.1097/01.pas.0000213331.09864.2c; Du HW, 2013, BIOANALYSIS, V5, P2269, DOI 10.4155/bio.13.195; Endo T, 2009, DIABETES, V58, P732, DOI 10.2337/db08-0493; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Gill J, 2009, HUM PATHOL, V40, P881, DOI 10.1016/j.humpath.2008.10.020; Guma M, 2012, BEST PRACT RES CL RH, V26, P425, DOI 10.1016/j.berh.2012.07.001; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Homma M, 1985, SCAND J RHEUMATOL, V61, P26; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Masaki Y, 2011, J CLIN EXP HEMATOP, V51, P13, DOI 10.3960/jslrt.51.13; Mikulicz JV, 1938, MODERN CLASSICS, P165; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nishi H, 2007, NEPHROL DIAL TRANSPL, V22, P1273, DOI 10.1093/ndt/gfl672; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Okazaki K, 2011, CLIN REV ALLERG IMMU, V41, P126, DOI 10.1007/s12016-010-8214-2; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Saeki T, 2010, KIDNEY INT, V78, P1016, DOI 10.1038/ki.2010.271; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Stone JH, 2012, SEMIN DIAGN PATHOL, V29, P177, DOI 10.1053/j.semdp.2012.08.002; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Wallace ZS, 2012, SURV OPHTHALMOL, V57, P26, DOI 10.1016/j.survophthal.2011.07.004; Xun YP, 2014, BIOCHEM BIOPH RES CO, V451, P389, DOI 10.1016/j.bbrc.2014.07.126; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Zen Y, 2005, HUM PATHOL, V36, P710, DOI 10.1016/j.humpath.2005.05.011; Zen Y, 2011, CURR OPIN RHEUMATOL, V23, P114, DOI 10.1097/BOR.0b013e3283412f4a; Zhou TB, 2012, NEPHROLOGY, V17, P189, DOI 10.1111/j.1440-1797.2011.01522.x	33	44	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125331	10.1371/journal.pone.0125331	http://dx.doi.org/10.1371/journal.pone.0125331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932630	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100099
J	Pasdar, EA; Smits, M; Stapelberg, M; Bajzikova, M; Stantic, M; Goodwin, J; Yan, B; Stursa, J; Kovarova, J; Sachaphibulkij, K; Bezawork-Geleta, A; Sobol, M; Filimonenko, A; Tomasetti, M; Zobalova, R; Hozak, P; Dong, LF; Neuzil, J				Pasdar, Elham Alizadeh; Smits, Michael; Stapelberg, Michael; Bajzikova, Martina; Stantic, Marina; Goodwin, Jacob; Yan, Bing; Stursa, Jan; Kovarova, Jaromira; Sachaphibulkij, Karishma; Bezawork-Geleta, Ayenachew; Sobol, Margaryta; Filimonenko, Anatoly; Tomasetti, Marco; Zobalova, Renata; Hozak, Pavel; Dong, Lan-Feng; Neuzil, Jiri			Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; EMBRYONIC STEM-CELLS; ALPHA-TOCOPHERYL SUCCINATE; DRUG-RESISTANCE; SELF-RENEWAL; BRAIN-TUMORS; CANCER; MITOCHONDRIAL; CD24; DIFFERENTIATION	Malignant mesothelioma (MM) is an aggressive type of tumour causing high mortality. One reason for this paradigm may be the existence of a subpopulation of tumour-initiating cells (TICs) that endow MM with drug resistance and recurrence. The objective of this study was to identify and characterise a TIC subpopulation in MM cells, using spheroid cultures, mesospheres, as a model of MM TICs. Mesospheres, typified by the stemness markers CD24, ABCG2 and OCT4, initiated tumours in immunodeficient mice more efficiently than adherent cells. CD24 knock-down cells lost the sphere-forming capacity and featured lower tumorigenicity. Upon serial transplantation, mesospheres were gradually more efficiently tumrigenic with increased level of stem cell markers. We also show that mesospheres feature mitochondrial and metabolic properties similar to those of normal and cancer stem cells. Finally, we show that mesothelioma-initiating cells are highly susceptible to mitochondrially targeted vitamin E succinate. This study documents that mesospheres can be used as a plausible model of mesothelioma-initiating cells and that they can be utilised in the search for efficient agents against MM.	[Pasdar, Elham Alizadeh; Smits, Michael; Stapelberg, Michael; Stantic, Marina; Goodwin, Jacob; Yan, Bing; Sachaphibulkij, Karishma; Bezawork-Geleta, Ayenachew; Zobalova, Renata; Dong, Lan-Feng; Neuzil, Jiri] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia; [Bajzikova, Martina; Kovarova, Jaromira; Zobalova, Renata; Neuzil, Jiri] Acad Sci Czech Republic, Inst Biotechnol, Prague, Czech Republic; [Stursa, Jan] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Sobol, Margaryta; Filimonenko, Anatoly; Hozak, Pavel] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic; [Tomasetti, Marco] Polytech Univ Marche, Dept Mol & Clin Sci, Ancona, Italy	Griffith University; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University Hospital Hradec Kralove; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Marche Polytechnic University	Neuzil, J (corresponding author), Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia.	j.neuzil@griffith.edu.au	Stursa, Jan/J-4255-2014; Bajzikova, Martina/H-4781-2014; DONG, LANFENG/S-8805-2019; Hozak, Pavel/AAB-5359-2021; Kovarova, Jaromira/H-4812-2014; Neuzil, Jiri/H-7204-2014	Hozak, Pavel/0000-0003-1901-1394; Neuzil, Jiri/0000-0002-2478-2460; Bezawork-Geleta, Ayenachew/0000-0001-5404-5093; Stantic, Marina/0000-0002-2800-5538; Dong, Lanfeng/0000-0002-9857-6352; Zobalova, Renata/0000-0002-9097-4700; Bezawork-Geleta, Ayenachew/0000-0003-2739-8023; Goodwin, Jacob/0000-0002-3834-3071	Australian Research Council; Cancer Council Queensland; European Regional Development Fund (the BIOCEV project) [CZ.1.05/1.1.00/02.0109]; Douglas Francis Green PhD Scholarship; Griffith University Research Fellowship	Australian Research Council(Australian Research Council); Cancer Council Queensland(Cancer Council Queensland); European Regional Development Fund (the BIOCEV project); Douglas Francis Green PhD Scholarship; Griffith University Research Fellowship	The work was supported in part by grants from the Australian Research Council, Cancer Council Queensland, and the European Regional Development Fund (the BIOCEV project, CZ.1.05/1.1.00/02.0109) to JN. EAP was supported by the Douglas Francis Green PhD Scholarship provided by the Queensland Asbestos-Related Disease Society. LFD was supported by the Griffith University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Baas P, 2002, SEMIN ONCOL, V29, P62, DOI 10.1053/sonc.2002.30231; Barrientos A., 2009, CURR PROTOC HUM GENE, V19, P13, DOI DOI 10.1002/0471142905.HG1903S63; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Carbone M, 1997, NAT MED, V3, P908, DOI 10.1038/nm0897-908; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Cortes-Dericks L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-304; Cortes-Dericks L, 2010, INT J ONCOL, V37, P437, DOI 10.3892/ijo_00000692; Deguen B, 1998, INT J CANCER, V77, P554, DOI 10.1002/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Gordon GJ, 2005, CLIN CANCER RES, V11, P4406, DOI 10.1158/1078-0432.CCR-04-2181; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Herrick SE, 2007, INT J ARTIF ORGANS, V30, P527, DOI 10.1177/039139880703000611; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Jackaman C, 2003, J IMMUNOL, V171, P5051, DOI 10.4049/jimmunol.171.10.5051; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kao SCH, 2011, PATHOLOGY, V43, P128, DOI 10.1097/PAT.0b013e328342016c; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Kovarova J, 2014, REDOX REP, V19, P16, DOI 10.1179/1351000213Y.0000000064; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Lu LW, 2000, EUR J IMMUNOL, V30, P2686, DOI 10.1002/1521-4141(200009)30:9<2686::AID-IMMU2686>3.0.CO;2-F; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Neuzil J, 2001, FASEB J, V15, P403, DOI 10.1096/fj.00-0251com; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Prigione A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027352; Ramos-Mejia V, 2012, STEM CELLS DEV, V21, P1145, DOI 10.1089/scd.2011.0248; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rice J, 2011, INT J HEALTH SERV, V41, P239, DOI 10.2190/HS.41.2.d; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2923, DOI 10.1089/ars.2011.4192; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Sagiv E, 2008, CANCER RES, V68, P2803, DOI 10.1158/0008-5472.CAN-07-6463; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith SC, 2006, CANCER RES, V66, P1917, DOI 10.1158/0008-5472.CAN-05-3855; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Stapelberg M, 2014, FREE RADICAL BIO MED, V67, P41, DOI 10.1016/j.freeradbiomed.2013.10.003; Steele JPC, 2005, ANN ONCOL, V16, P345, DOI 10.1093/annonc/mdi094; TASWELL C, 1981, J IMMUNOL, V126, P1614; Tomasetti M, 2004, INT J CANCER, V109, P641, DOI 10.1002/ijc.20062; Tomasetti Marco, 2009, Curr Mol Pharmacol, V2, P190; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zucali PA, 2011, CANCER TREAT REV, V37, P543, DOI 10.1016/j.ctrv.2011.01.001	65	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0119549	10.1371/journal.pone.0119549	http://dx.doi.org/10.1371/journal.pone.0119549			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932953	Green Published, gold			2022-12-26	WOS:000353887100002
J	Van Handel, MM; Branson, BM				Van Handel, Michelle M.; Branson, Bernard M.			Monitoring HIV Testing in the United States: Consequences of Methodology Changes to National Surveys	PLOS ONE			English	Article								Objective In 2011, the National Health Interview Survey (NHIS), an in-person household interview, revised the human immunodeficiency virus (HIV) section of the survey and the Behavioral Risk Factor Surveillance System (BRFSS), a telephone-based survey, added cellphone numbers to its sampling frame. We sought to determine how these changes might affect assessment of HIV testing trends. Methods We used linear regression with pairwise contrasts with 2003-2013 data from NHIS and BRFSS to compare percentages of persons aged 18-64 years who reported HIV testing in landline versus cellphone-only households before and after 2011, when NHIS revised its in-person questionnaire and BRFSS added cellphone numbers to its telephone-based sample. Results In NHIS, the percentage of persons in cellphone-only households increased 13-fold from 2003 to 2013. The percentage ever tested for HIV was 6%-10% higher among persons in cellphone-only than landline households. The percentage ever tested for HIV increased significantly from 40.2% in 2003 to 45.0% in 2010, but was significantly lower in 2011 (40.6%) and 2012 (39.7%). In BRFSS, the percentage ever tested decreased significantly from 45.9% in 2003 to 40.2% in 2010, but increased to 42.9% in 2011 and 43.5% in 2013. Conclusions HIV testing estimates were lower after NHIS questionnaire changes but higher after BRFSS methodology changes. Data before and after 2011 are not comparable, complicating assessment of trends.	[Van Handel, Michelle M.; Branson, Bernard M.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Van Handel, MM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	ioq4@cdc.gov						Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], OMB STAND GUID STAT; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], HIV TESTING US BASEL; [Anonymous], FEDCASIC WASH DC MAR; [Anonymous], 2011, WIRELESS SUBSTITUTIO; [Anonymous], 2013 NHIS QUEST SAMP; [Anonymous], QUEST ORD; [Anonymous], 2011 NAT HIV INT SUR; [Anonymous], QUESTIONS ANSWERS AT; [Anonymous], BRFSS 2013 SUMM DAT; Blumberg SJ, 2006, AM J PUBLIC HEALTH, V96, P926, DOI 10.2105/AJPH.2004.057885; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1110; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Gundersen DA, 2014, AM J EPIDEMIOL, V179, P39, DOI 10.1093/aje/kwt226; Hu SS, 2011, AM J EPIDEMIOL, V173, P703, DOI 10.1093/aje/kwq442; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Peytchev A, 2013, PUBLIC OPIN QUART, V77, P283, DOI 10.1093/poq/nft003; Pierannunzi Carol, 2012, Morbidity and Mortality Weekly Report, V61, P410; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Viall Abigail H., 2011, Morbidity and Mortality Weekly Report, V60, P805	22	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125637	10.1371/journal.pone.0125637	http://dx.doi.org/10.1371/journal.pone.0125637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25927983	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100109
J	Wang, WP; Liu, JL; Zhao, BZ; Zhang, JB; Li, XP; Yan, YF				Wang Weipeng; Liu Jianli; Zhao Bingzi; Zhang Jiabao; Li Xiaopeng; Yan Yifan			Critical Evaluation of Particle Size Distribution Models Using Soil Data Obtained with a Laser Diffraction Method	PLOS ONE			English	Article							WATER-RETENTION CURVE; HYDRAULIC CONDUCTIVITY; PIPETTE-METHOD; PARAMETERS; TEXTURE; PERFORMANCE; FRACTIONS; EQUATION	Mathematical descriptions of classical particle size distribution (PSD) data are often used to estimate soil hydraulic properties. Laser diffraction methods (LDM) now provide more detailed PSD measurements, but deriving a function to characterize the entire range of particle sizes is a major challenge. The aim of this study was to compare the performance of eighteen PSD functions for fitting LDM data sets from a wide range of soil textures. These models include five lognormal models, five logistic models, four van Genuchten models, two Fredlund models, a logarithmic model, and an Andersson model. The fits were evaluated using Akaike's information criterion (AIC), adjusted R-2, and root-mean-square error (RMSE). The results indicated that the Fredlund models (FRED3 and FRED4) had the best performance for most of the soils studied, followed by one logistic growth function extension model (MLOG3) and three lognormal models (ONLG3, ORLG3, and SHCA3). The performance of most PSD models was better for soils with higher silt content and poorer for soils with higher clay and sand content. The FRED4 model best described the PSD of clay, silty clay, clay loam, silty clay loam, silty loam, loam, and sandy loam, whereas FRED3, MLOG3, ONLG3, ORLG3, and SHCA3 showed better performance for most soils studied.	[Wang Weipeng; Liu Jianli; Zhao Bingzi; Zhang Jiabao; Li Xiaopeng; Yan Yifan] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Wang Weipeng; Yan Yifan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, JL (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	Jlliu@issas.ac.cn			National Basic Research Program of China (973 Program) [2011CB100506]; National Natural Science Foundation of China [41171179]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Basic Research Program of China (973 Program No. 2011CB100506)-LJL; National Natural Science Foundation of China (Contract No. 41171179)-LJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 1990, 26 MINERALJORDENS MU, P7; Arriaga FJ, 2006, SOIL SCI, V171, P663, DOI 10.1097/01.ss.0000228056.92839.88; Bah AR, 2009, SOIL SCI SOC AM J, V73, P1101, DOI 10.2136/sssaj2007.0433; Bittelli M, 1999, SOIL SCI SOC AM J, V63, P782, DOI 10.2136/sssaj1999.634782x; BUCHAN GD, 1993, SOIL SCI SOC AM J, V57, P901, DOI 10.2136/sssaj1993.03615995005700040004x; BUCHAN GD, 1989, SOIL SCI, V147, P155, DOI 10.1097/00010694-198903000-00001; Buurman P, 2001, GEOL MIJNBOUW-N J G, V80, P49, DOI 10.1017/S0016774600022319; CARRERA J, 1986, WATER RESOUR RES, V22, P199, DOI 10.1029/WR022i002p00199; Eshel G, 2004, SOIL SCI SOC AM J, V68, P736, DOI 10.2136/sssaj2004.0736; Filgueira RR, 2006, GEODERMA, V134, P327, DOI 10.1016/j.geoderma.2006.03.008; Fredlund MD, 2000, CAN GEOTECH J, V65, P638; Gee G.W., 1986, AGRONOMY MONOGROPH, V9, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; GEE GW, 1979, SOIL SCI SOC AM J, V43, P1004, DOI 10.2136/sssaj1979.03615995004300050038x; Hajnos M, 2006, GEODERMA, V135, P307, DOI 10.1016/j.geoderma.2006.01.010; HAVERKAMP R, 1986, SOIL SCI, V142, P325, DOI 10.1097/00010694-198612000-00001; Hwang SI, 2006, GEODERMA, V133, P421, DOI 10.1016/j.geoderma.2005.08.006; Hwang SI, 2004, GEODERMA, V123, P363, DOI 10.1016/j.geoderma.2004.03.003; Hwang SI, 2002, SOIL SCI SOC AM J, V66, P1143, DOI 10.2136/sssaj2002.1143; Jaky J., 1944, SOIL MECH; Jauhiainen M, 2004, RELATIONSHIPS PARTIC, P165; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Miller BA, 2012, SOIL SCI SOC AM J, V76, P1719, DOI 10.2136/sssaj2011.0303; Minasny B, 1999, GEODERMA, V93, P225, DOI 10.1016/S0016-7061(99)00061-0; Nemes A, 1999, GEODERMA, V90, P187, DOI 10.1016/S0016-7061(99)00014-2; Pieri L, 2006, GEODERMA, V135, P118, DOI 10.1016/j.geoderma.2005.11.009; Press WH, 1992, NMNERICAL RECIPES FO, V77; Rousseva SS, 1997, EUR J SOIL SCI, V48, P749, DOI 10.1046/j.1365-2389.1997.00113.x; Ryzak M, 2011, J PLANT NUTR SOIL SC, V174, P624, DOI 10.1002/jpln.201000255; SHIOZAWA S, 1991, SOIL SCI, V152, P427, DOI 10.1097/00010694-199112000-00004; Shiozawa s, 1992, INT J ROCK MECH MIN, V29, P211; Skaggs TH, 2001, SOIL SCI SOC AM J, V65, P1038, DOI 10.2136/sssaj2001.6541038x; Slawinski C., 2006, International Agrophysics, V20, P55; Smettem KRJ, 1996, AUST J SOIL RES, V34, P695, DOI 10.1071/SR9960695; THORNLEY JHM, 1990, ANN BOT-LONDON, V66, P309, DOI 10.1093/oxfordjournals.aob.a088029; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; WALKER PH, 1986, SOIL SCI SOC AM J, V50, P394, DOI 10.2136/sssaj1986.03615995005000020028x; Wang WP, 2013, SOIL SCI, V178, P194, DOI 10.1097/SS.0b013e31829908be; Zhuang J, 2001, SOIL SCI, V166, P308, DOI 10.1097/00010694-200105000-00002	38	15	15	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125048	10.1371/journal.pone.0125048	http://dx.doi.org/10.1371/journal.pone.0125048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927441	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100063
J	Kartsev, NN; Fursova, NK; Pachkunov, DM; Bannov, VA; Eruslanov, BV; Svetoch, EA; Dyatlov, IA				Kartsev, Nikolay N.; Fursova, Nadezhda K.; Pachkunov, Dmitry M.; Bannov, Vasiliy A.; Eruslanov, Boris V.; Svetoch, Edward A.; Dyatlov, Ivan A.			Molecular Characterization of Enterotoxin-Producing Escherichia coli Collected in 2011-2012, Russia	PLOS ONE			English	Article							MULTIPLEX PCR; GENES; SEROGROUPS; RESISTANCE; DIARRHEA; O45	Enterotoxin-producing Escherichia coli (ETEC) are one of themain causative agents of diarrhea in children especially in developing countries and travel diarrhoea in adults. Pathogenic properties of ETEC associated with their ability to produce a heat-stable (ST) and/or heat-labile (LT) enterotoxins, as well as adhesins providing bacterial adhesion to intestinal epithelial cells. This study presents the molecular characterization of the ETEC isolates collected from the Central and Far-Eastern regions of Russia in 2011-2012. It was shown that all ETEC under study (n=18) had the heat-labile enterotoxin-coding operon elt, and had no the genes of the heat-stable enterotoxin operon est. DNA sequencing revealed two types of nucleotide exchanges in the eltB gene coding subunit B of LT in isolates collected from Cherepovets city (Central region, Russia) and Vladivostok city (Far-East region, Russia). Only one ETEC strain carried genes cfaA, cfaB, cfaC and cfaD coding adhesion factor CFA/I. Expression of LT in four ETEC isolates in the agglutination reaction was detected using a latex test-system. The isolates were assigned to serogroups O142 (n = 6), O6 (n = 4), O25 (n = 5), O26 (n = 2), and O115 (n = 1). Genotyping showed that they belonged to an earlier described sequence-type ST4 (n = 3) as well as to 11 novel sequence-types ST1043, ST1312, ST3697, ST3707, ST3708, ST3709, ST3710, ST3755, ST3756, ST3757 and ST4509. The ETEC isolates displayed different levels of antimicrobial resistance. Eight isolates were resistant to only one drug, three isolates-to two drugs, one isolate-to three drugs, two isolates-to four antibacterials, and only one isolate to each of the five, six and ten antibacterials simultaneously. Genetic determinants of the resistance to beta-lactams and other classes of antibacterials on the ETEC genomes were identified. There are blaTEM (n = 10), bla(CTX-M-15) (n = 1), class 1 integron (n = 3) carrying resistance cassettes to aminoglycosides and sulphonamides dfrA17-aadA5 and dfrA12-orfF-aadA2. One isolate ETE-C_Ef-6 was found to be amultidrug-resistant (MDR) pathogen that carried both the beta-lactamase gene and class 1 integron. These data suggest the circulation of ETEC in Russia. Further investigations are necessary to study the spread of the revealed ETEC sequence types (STs) and serotypes. Their role in the etiology of diarrhea should be also estimated.	[Kartsev, Nikolay N.; Fursova, Nadezhda K.; Bannov, Vasiliy A.; Eruslanov, Boris V.; Svetoch, Edward A.; Dyatlov, Ivan A.] State Res Ctr Appl Microbiol & Biotechnol, Dept Mol Microbiol, Obolensk, Russia; [Pachkunov, Dmitry M.] Volga State Technol Univ, Dept Innovat Res, Yoshkar Ola, Russia		Kartsev, NN (corresponding author), State Res Ctr Appl Microbiol & Biotechnol, Dept Mol Microbiol, Obolensk, Russia.	karcev.nikolay@mail.ru	Kartsev, Nikolay/G-5910-2017; Fursova, Nadezhda K/K-1133-2017	Fursova, Nadezhda K/0000-0001-6053-2621; Kartsev, Nikolay/0000-0002-2006-9131	Rospotrebnadzor [037, 039]	Rospotrebnadzor	Grant 037, Rospotrebnadzor, Grant 039, Rospotrebnadzor.	Ansaruzzaman M, 2007, J MED MICROBIOL, V56, P217, DOI 10.1099/jmm.0.46473-0; Belaia YA, 2005, MODERN SCI TECH, V10, P35; Clarke SC, 2001, DIAGN MICR INFEC DIS, V41, P93, DOI 10.1016/S0732-8893(01)00303-0; DebRoy C, 2005, APPL ENVIRON MICROB, V71, P4919, DOI 10.1128/AEM.71.8.4919-4924.2005; Del Canto F, 2011, J CLIN MICROBIOL, V49, P3198, DOI 10.1128/JCM.02473-10; Dupont HL, 2009, ALIMENT PHARM THER, V30, P187, DOI 10.1111/j.1365-2036.2009.04028.x; Egorova SA, 2011, INFEKTSIYA IMMUN, V1, P181; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB.187.18.6509-6516.2005; Jian Zhang, 2008, TENCON 2008 - 2008 IEEE Region 10 Conference, DOI 10.1109/TENCON.2008.4766399; Jobling MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029898; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Kim JS, 2014, J MICROBIOL BIOTECHN, V24, P421, DOI 10.4014/jmb.1401.01023; Konishi N, 2011, J CLIN MICROBIOL, V49, P3348, DOI 10.1128/JCM.02576-10; Li D, 2010, J MICROBIOL METH, V82, P71, DOI 10.1016/j.mimet.2010.04.008; MANIATIS T, 1982, MOL CLONING LAB MANU; MUNDELL DH, 1976, INFECT IMMUN, V14, P383, DOI 10.1128/IAI.14.2.383-388.1976; Nada RA, 2011, J CLIN MICROBIOL, V49, P1403, DOI 10.1128/JCM.02006-10; Paddock Z, 2012, VET MICROBIOL, V156, P381, DOI 10.1016/j.vetmic.2011.11.017; Paredes-Paredes M, 2011, J TRAVEL MED, V18, P121, DOI 10.1111/j.1708-8305.2010.00488.x; Pazhani GP, 2011, INDIAN J MED RES, V134, P214; Pryamchuk S. D., 2010, Antibiotiki i Khimioterapiya, V55, P3; Rajkhowa S, 2009, J APPL MICROBIOL, V106, P455, DOI 10.1111/j.1365-2672.2008.04013.x; Rodas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018313; Shahrokhi N, 2011, J INFECT DEV COUNTR, V5, P248; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turner SM, 2006, FEMS MICROBIOL LETT, V263, P10, DOI 10.1111/j.1574-6968.2006.00401.x; Walker RI, 2015, VACCINE, V33, P954, DOI 10.1016/j.vaccine.2014.11.049; Wang QA, 2010, MOL CELL PROBE, V24, P286, DOI 10.1016/j.mcp.2010.06.002; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Zimmer M, 2003, AVIAN DIS, V47, P101, DOI 10.1637/0005-2086(2003)047[0101:DOCJSI]2.0.CO;2	31	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123357	10.1371/journal.pone.0123357	http://dx.doi.org/10.1371/journal.pone.0123357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923803	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600044
J	Meng, XK; Zhang, YX; Bao, HB; Liu, ZW				Meng, Xiangkun; Zhang, Yixi; Bao, Haibo; Liu, Zewen			Sequence Analysis of Insecticide Action and Detoxification-Related Genes in the Insect Pest Natural Enemy Pardosa pseudoannulata	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; PYRETHROID RESISTANCE; NEONICOTINOID INSECTICIDES; IMIDACLOPRID RESISTANCE; DROSOPHILA-MELANOGASTER; CYTOCHROME-P450 GENES; EUROPEAN POPULATIONS; POINT MUTATION; IDENTIFICATION; SENSITIVITY	The pond wolf spider Pardosa pseudoannulata, an important natural predatory enemy of rice planthoppers, is found widely distributed in paddy fields. However, data on the genes involved in insecticide action, detoxification, and response are very limited for P. pseudoannulata, which inhibits the development and appropriate use of selective insecticides to control insect pests on rice. We used transcriptome construction from adult spider cephalothoraxes to analyze and manually identify genes enconding metabolic enzymes and target receptors related to insecticide action and detoxification, including 90 cytochrome P450s, 14 glutathione S-transferases (GSTs), 17 acetylcholinesterases (AChEs), 17 nicotinic acetylcholine receptors (nAChRs), and 17 gamma-aminobutyric acid (GABA) receptors, as well as 12 glutamate-gated chloride channel (GluCl) unigenes. Sequence alignment and phylogenetic analysis revealed the different subclassifications of P450s and GSTs, some important sequence diversities in nAChRs and GABA receptors, polymorphism in AChEs, and high similarities in GluCls. For P450s in P. pseudoannulata, the number of unigenes belonging to the CYP2 clade was much higher than that in CYP3 and CYP4 clades. The results differed from insects in which most P450 genes were in CYP3 and CYP4 clades. For GSTs, most unigenes belonged to the delta and sigma classes, and no epsilon GST class gene was found, which differed from the findings for insects and acarina. Our results will be useful for studies on insecticide action, selectivity, and detoxification in the spider and other related animals, and the sequence differences in target genes between the spider and insects will provide important information for the design of selective insecticides.	[Meng, Xiangkun; Zhang, Yixi; Bao, Haibo; Liu, Zewen] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing 210095, Jiangsu, Peoples R China; [Bao, Haibo] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing 210014, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Liu, ZW (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing 210095, Jiangsu, Peoples R China.	liuzewen@njau.edu.cn			National High Technology Research and Development Program of China (Program 863) [2011AA10A207, 2012AA101502]; National Natural Science Foundation of China [31322045, 31130045, 31171869]; Jiangsu Science Program for Distinguished Young Scholars [BK20130028]; National Key Technology Research and Development Program [2012BAD19B01]	National High Technology Research and Development Program of China (Program 863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Science Program for Distinguished Young Scholars; National Key Technology Research and Development Program(National Key Technology R&D Program)	This work was supported by the National High Technology Research and Development Program of China (Program 863: 2011AA10A207 and 2012AA101502), ZWL; the National Natural Science Foundation of China (31322045, 31130045, and 31171869), ZWL; the Jiangsu Science Program for Distinguished Young Scholars (BK20130028), ZWL; and the National Key Technology Research and Development Program (2012BAD19B01), ZWL (http://www.most.gov.cn/; http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Deng HM, 2009, J INSECT PHYSIOL, V55, P1174, DOI 10.1016/j.jinsphys.2009.08.017; Ding ZP, 2013, INSECT BIOCHEM MOLEC, V43, P1021, DOI 10.1016/j.ibmb.2013.08.005; Domingues LN, 2013, VET PARASITOL, V198, P172, DOI 10.1016/j.vetpar.2013.08.023; Feng LF, 2014, AQUAT TOXICOL, V149, P126, DOI 10.1016/j.aquatox.2014.02.004; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han H, 2014, CROP PROT, V65, P57, DOI 10.1016/j.cropro.2014.06.026; Huang HS, 1998, INSECT BIOCHEM MOLEC, V28, P651, DOI 10.1016/S0965-1748(98)00049-6; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kehoe J, 2009, J MOL EVOL, V69, P125, DOI 10.1007/s00239-009-9256-z; Kim JI, 2012, J ASIA-PAC ENTOMOL, V15, P401, DOI 10.1016/j.aspen.2012.02.008; Kita T, 2014, INSECT BIOCHEM MOLEC, V45, P1, DOI 10.1016/j.ibmb.2013.11.004; Kwon DH, 2010, INSECT MOL BIOL, V19, P583, DOI 10.1111/j.1365-2583.2010.01017.x; Kwon DH, 2012, PESTIC BIOCHEM PHYS, V103, P94, DOI 10.1016/j.pestbp.2012.04.003; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Liu ZW, 2008, AFR J BIOTECHNOL, V7, P4935; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Lou YG, 2014, BIOL CONTROL, V68, P103, DOI 10.1016/j.biocontrol.2013.09.018; Malekmohammadi M, 2012, PESTIC BIOCHEM PHYS, V104, P150, DOI 10.1016/j.pestbp.2012.06.004; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Meng XK, 2015, NEUROSCI LETT, V584, P123, DOI 10.1016/j.neulet.2014.10.013; Nakao T, 2010, PESTIC BIOCHEM PHYS, V97, P262, DOI 10.1016/j.pestbp.2010.03.006; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Pavlidi N, 2012, PESTIC BIOCHEM PHYS, V104, P132, DOI 10.1016/j.pestbp.2012.07.003; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Pekar S, 2012, PEST MANAG SCI, V68, P1438, DOI 10.1002/ps.3397; Pridgeon JW, 2003, GENE, V314, P157, DOI 10.1016/S0378-1119(03)00725-X; Puinean AM, 2013, J NEUROCHEM, V124, P590, DOI 10.1111/jnc.12029; Puinean AM, 2013, PEST MANAG SCI, V69, P195, DOI 10.1002/ps.3300; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rasool Akhtar, 2014, Insect Biochemistry and Molecular Biology, V53, P54, DOI 10.1016/j.ibmb.2014.07.006; Riga M, 2014, INSECT BIOCHEM MOLEC, V46, P43, DOI 10.1016/j.ibmb.2014.01.006; Shi XG, 2012, J FOOD AGRIC ENVIRON, V10, P1227; Song F, 2009, INSECT BIOCHEM MOLEC, V39, P833, DOI 10.1016/j.ibmb.2009.09.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang Liang-De, 2014, Chinese Journal of Applied Entomology, V51, P13, DOI 10.7679/j.issn.2095-1353.2014.002; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Villatte F, 2000, PESTIC BIOCHEM PHYS, V67, P95, DOI 10.1006/pest.2000.2478; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Wei DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080046; Wondji CS, 2011, INSECT BIOCHEM MOLEC, V41, P484, DOI 10.1016/j.ibmb.2011.03.012; Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094779; Yang X, 2013, PESTIC BIOCHEM PHYS, V107, P343, DOI 10.1016/j.pestbp.2013.10.002; Zhai Qihui, 1995, Acta Entomologica Sinica, V38, P493; Zhang YX, 2014, INSECT BIOCHEM MOLEC, V46, P25, DOI 10.1016/j.ibmb.2014.01.004; Zheng Y, 2003, INSECT BIOCHEM MOLEC, V33, P595, DOI 10.1016/S0965-1748(03)00038-9; Zimmer CT, 2014, INSECT BIOCHEM MOLEC, V45, P18, DOI 10.1016/j.ibmb.2013.11.008; Zimmer CT, 2011, PESTIC BIOCHEM PHYS, V100, P264, DOI 10.1016/j.pestbp.2011.04.011	57	21	20	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125242	10.1371/journal.pone.0125242	http://dx.doi.org/10.1371/journal.pone.0125242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923714	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600138
J	Pukazhenthi, BS; Nagashima, J; Travis, AJ; Costa, GM; Escobar, EN; Franca, LR; Wildt, DE				Pukazhenthi, Budhan S.; Nagashima, Jennifer; Travis, Alexander J.; Costa, Guilherme M.; Escobar, Enrique N.; Franca, Luiz R.; Wildt, David E.			Slow Freezing, but Not Vitrification Supports Complete Spermatogenesis in Cryopreserved, Neonatal Sheep Testicular Xenografts	PLOS ONE			English	Article							TESTIS TISSUE; RECIPIENT MICE; SPERMATOGONIAL SURVIVAL; GENETIC MATERIAL; GONADAL TISSUES; MOUSE TESTES; SPERM; PORCINE; CELLS; TRANSPLANTATION	The ability to spur growth of early stage gametic cells recovered from neonates could lead to significant advances in rescuing the genomes of rare genotypes or endangered species that die unexpectedly. The purpose of this study was to determine, for the first time, the ability of two substantially different cryopreservation approaches, slow freezing versus vitrification, to preserve testicular tissue of the neonatal sheep and subsequently allow initiation of spermatogenesis post-xenografting. Testis tissue from four lambs (3-5 wk old) was processed and then untreated or subjected to slow freezing or vitrification. Tissue pieces (fresh, n = 214; slow freezing, then thawing, n = 196; vitrification, then warming, n = 139) were placed subcutaneously under the dorsal skin of SCID mice and then grafts recovered and evaluated 17 wk later. Grafts from fresh and slow frozen tissue contained the most advanced stages of spermatogenesis, including normal tubule architecture with elongating spermatids in similar to 1% (fresh) and similar to 10% (slow frozen) of tubules. Fewer than 2% of seminiferous tubules advanced to the primary spermatocyte stage in xenografts derived from vitrified tissue. Results demonstrate that slow freezing of neonatal lamb testes was far superior to vitrification in preserving cellular integrity and function after xenografting, including allowing similar to 10% of tubules to retain the capacity to resume spermatogenesis and yield mature spermatozoa. Although a first for any ruminant species, findings also illustrate the importance of preemptive studies that examine cryo-sensitivity of testicular tissue before attempting this type of male fertility preservation on a large scale.	[Pukazhenthi, Budhan S.; Nagashima, Jennifer; Wildt, David E.] Ctr Species Survival, Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Nagashima, Jennifer; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Travis, Alexander J.] Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA; [Costa, Guilherme M.] Univ Fed Minas Gerais, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil; [Escobar, Enrique N.] Univ Maryland Eastern Shore, Dept Agr Food & Resource Sci, Sch Agr & Nat Sci, Princess Anne, MD USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Cornell University; Cornell University; Universidade Federal de Minas Gerais; University System of Maryland; University of Maryland Eastern Shore	Pukazhenthi, BS (corresponding author), Ctr Species Survival, Smithsonian Conservat Biol Inst, Natl Zool Pk, Front Royal, VA 22630 USA.	pukazhenthib@si.edu	Mattos Jardim Costa, Guilherme/A-7369-2016; DE FRANCA, LUIZ/AAA-6923-2021	Mattos Jardim Costa, Guilherme/0000-0002-2907-7760; Pukazhenthi, Budhan/0000-0003-4657-2023; Nagashima, Jennifer/0000-0001-6189-0914	Sichel Endowment Fund	Sichel Endowment Fund	This study was supported with funding from the Sichel Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2012, ANIM REPROD SCI, V135, P47, DOI 10.1016/j.anireprosci.2012.09.007; Abbasi S, 2011, THERIOGENOLOGY, V76, P607, DOI 10.1016/j.theriogenology.2011.03.011; Abbasi S, 2010, REPROD FERT DEVELOP, V22, P1279, DOI 10.1071/RD10084; Abrishami M, 2010, THERIOGENOLOGY, V73, P86, DOI 10.1016/j.theriogenology.2009.08.004; Campos PHA, 2014, REPRODUCTION, V147, P291, DOI 10.1530/REP-13-0581; Arregui L, 2008, REPRODUCTION, V136, P85, DOI 10.1530/REP-07-0433; Arregui L, 2008, ANIM REPROD SCI, V106, P65, DOI 10.1016/j.anireprosci.2007.03.026; Arregui L, 2014, REPROD FERT DEVELOP, V26, P817, DOI 10.1071/RD12411; Baert Y, 2012, FERTIL STERIL, V97, P1152, DOI 10.1016/j.fertnstert.2012.02.010; Caires KC, 2008, REPROD DOMEST ANIM, V43, P280, DOI 10.1111/j.1439-0531.2008.01175.x; Comizzoli P, 2012, THERIOGENOLOGY, V78, P1666, DOI 10.1016/j.theriogenology.2012.04.008; Comizzoli P, 2014, ADV EXP MED BIOL, V753, P331, DOI 10.1007/978-1-4939-0820-2_14; Comizzoli P, 2014, REPROD FERT DEVELOP, V26, P91, DOI 10.1071/RD13259; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; Frederickx V, 2004, HUM REPROD, V19, P948, DOI 10.1093/humrep/deh154; Gao D, 2000, ILAR J, V41, P187; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; Goossens E, 2008, FERTIL STERIL, V89, P725, DOI 10.1016/j.fertnstert.2007.03.044; Gourdon JC, 2011, COMPARATIVE MED, V61, P145; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; Honaramooz A, 2004, BIOL REPROD, V70, P1500, DOI 10.1095/biolreprod.103.025536; Honaramooz A., 2005, REPROD FERT DEVELOP, V17, P247, DOI [10.1071/RDV17N2AB193, DOI 10.1071/RDV17N2AB193]; Honaramooz A, 2008, REPROD FERT DEVELOP, V20, P802, DOI 10.1071/RD08093; IUCN, IUCN RED LIST THREAT; Jahnukainen K, 2007, HUM REPROD, V22, P1060, DOI 10.1093/humrep/del471; Kagawa N, 2009, REPROD BIOMED ONLINE, V18, P568, DOI 10.1016/S1472-6483(10)60136-8; Kaneko H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070989; Kaneko H, 2012, THERIOGENOLOGY, V78, P898, DOI 10.1016/j.theriogenology.2012.04.004; Keros V, 2005, HUM REPROD, V20, P1676, DOI 10.1093/humrep/deh797; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Kikuchi K, 2011, ANIM SCI J, V82, P495, DOI 10.1111/j.1740-0929.2011.00919.x; Kim Y, 2007, REPROD FERT DEVELOP, V19, P869, DOI 10.1071/RD07056; Kvist K, 2006, HUM REPROD, V21, P484, DOI 10.1093/humrep/dei331; Lees C. M., 2009, International Zoo Yearbook, V43, P6, DOI 10.1111/j.1748-1090.2008.00066.x; Leibo SP, 2002, THERIOGENOLOGY, V57, P303, DOI 10.1016/S0093-691X(01)00673-2; Leus K.L., 2011, WAZA MAGAZINE, V12, P11; Milazzo JP, 2008, HUM REPROD, V23, P17, DOI 10.1093/humrep/dem355; Mota PC, 2012, THERIOGENOLOGY, V77, P299, DOI 10.1016/j.theriogenology.2011.07.042; Nakai M, 2010, REPRODUCTION, V139, P331, DOI 10.1530/REP-09-0509; Oatley OM, 2004, BIOL REPROD, V71, P494, DOI 10.1095/biolreprod.104.027953; Petrie A., 2012, ADDRA GAZELLE NANGER, P1; Piltz J., 2012, SABLE ANTELOPE HIPPO, P1; Poels J, 2012, THERIOGENOLOGY, V77, P1008, DOI 10.1016/j.theriogenology.2011.10.015; Poels J, 2013, HUM REPROD, V28, P578, DOI 10.1093/humrep/des455; Pope CE, 2000, THERIOGENOLOGY, V53, P163, DOI 10.1016/S0093-691X(99)00249-6; Pothana L, 2015, THERIOGENOLOGY, V83, P625, DOI 10.1016/j.theriogenology.2014.10.028; Pukazhenthi B, 2006, REPROD FERT DEVELOP, V18, P77, DOI 10.1071/RD05117; Pukazhenthi Budhan, 2007, P433; Rathi R, 2005, REPRODUCTION, V130, P923, DOI 10.1530/rep.1.00912; Rathi R, 2006, REPRODUCTION, V131, P1091, DOI 10.1530/rep.1.01101; Rodriguez-Sosa Jose R, 2013, Methods Mol Biol, V927, P489; Rodriguez-Sosa JR, 2012, REPRODUCTION, V144, P37, DOI 10.1530/REP-12-0020; Rodriguez-Sosa JR, 2009, REPRODUCTION, V138, P187, DOI 10.1530/REP-09-0012; Rohrs M, 1990, GRZIMEKS ENCY MAMMAL, V4, P440; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Sato Y, 2010, HUM REPROD, V25, P1113, DOI 10.1093/humrep/deq001; Schlatt S, 2002, REPRODUCTION, V124, P339, DOI 10.1530/rep.0.1240339; Schlatt S, 2003, BIOL REPROD, V68, P2331, DOI 10.1095/biolreprod.102.014894; Schlatt S, 2009, PEDIATR BLOOD CANCER, V53, P274, DOI 10.1002/pbc.22002; Shinohara T, 2002, HUM REPROD, V17, P3039, DOI 10.1093/humrep/17.12.3039; Snedaker AK, 2004, J ANDROL, V25, P926; Song Y, 2007, POULTRY SCI, V86, P1390, DOI 10.1093/ps/86.7.1390; Thuwanut P, 2013, CRYOBIOLOGY, V67, P244, DOI 10.1016/j.cryobiol.2013.07.002; Van Saen D, 2013, REPROD BIOMED ONLINE, V26, P286, DOI 10.1016/j.rbmo.2012.11.013; Wildt DE, 2013, CONNECT MAGAZINE AUG, P10; Wowk B, 2010, CRYOBIOLOGY, V60, P11, DOI 10.1016/j.cryobiol.2009.05.007; Wyns C, 2008, HUM REPROD, V23, P2402, DOI 10.1093/humrep/den272; Wyns C, 2007, HUM REPROD, V22, P1603, DOI 10.1093/humrep/dem062; Yildiz C, 2013, CRYOBIOLOGY, V67, P70, DOI 10.1016/j.cryobiol.2013.05.004; Zeng W, 2009, REPROD FERT DEVELOP, V21, P489, DOI 10.1071/RD08235; Zeng WX, 2006, J ANDROL, V27, P527, DOI 10.2164/jandrol.05143	72	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123957	10.1371/journal.pone.0123957	http://dx.doi.org/10.1371/journal.pone.0123957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923660	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600064
J	Ruggiero, MA; Gordon, DP; Orrell, TM; Bailly, N; Bourgoin, T; Brusca, RC; Cavalier-Smith, T; Guiry, MD; Kirk, PM				Ruggiero, Michael A.; Gordon, Dennis P.; Orrell, Thomas M.; Bailly, Nicolas; Bourgoin, Thierry; Brusca, Richard C.; Cavalier-Smith, Thomas; Guiry, Michael D.; Kirk, Paul M.			A Higher Level Classification of All Living Organisms	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY HISTORY; ANIMAL BIODIVERSITY; ACANTHOCEPHALA; PHYLOGENOMICS; DIVERSITY; TREE; GNATHOSTOMULIDA; PLATYHELMINTHES; MICROGNATHOZOA	We present a consensus classification of life to embrace the more than 1.6 million species already provided by more than 3,000 taxonomists' expert opinions in a unified and coherent, hierarchically ranked system known as the Catalogue of Life (CoL). The intent of this collaborative effort is to provide a hierarchical classification serving not only the needs of the CoL's database providers but also the diverse public-domain user community, most of whom are familiar with the Linnaean conceptual system of ordering taxon relationships. This classification is neither phylogenetic nor evolutionary but instead represents a consensus view that accommodates taxonomic choices and practical compromises among diverse expert opinions, public usages, and conflicting evidence about the boundaries between taxa and the ranks of major taxa, including kingdoms. Certain key issues, some not fully resolved, are addressed in particular. Beyond its immediate use as a management tool for the CoL and ITIS (Integrated Taxonomic Information System), it is immediately valuable as a reference for taxonomic and biodiversity research, as a tool for societal communication, and as a classificatory "backbone" for biodiversity databases, museum collections, libraries, and textbooks. Such a modern comprehensive hierarchy has not previously existed at this level of specificity.	[Ruggiero, Michael A.; Orrell, Thomas M.] Smithsonian Inst, Natl Museum Nat Hist, Integrated Taxon Informat Syst, Washington, DC 20560 USA; [Gordon, Dennis P.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Bailly, Nicolas] WorldFish FIN, Los Banos, Philippines; [Bourgoin, Thierry] Univ Paris 04, Inst Systemat, UMR 7205 MNHN CNRS UPMC EPHE, Evolut,Biodiversite ISYEB,Museum Natl Hist Nat, F-75005 Paris, France; [Brusca, Richard C.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Cavalier-Smith, Thomas] Univ Oxford, Dept Zool, Oxford, England; [Guiry, Michael D.] Natl Univ Ireland, Ryan Inst, AlgaeBase Fdn & Irish Seaweed Res Grp, Galway, Ireland; [Kirk, Paul M.] Royal Bot Gardens, Mycol Sect, London, England	Smithsonian Institution; Smithsonian National Museum of Natural History; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; CGIAR; Worldfish; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Arizona; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Royal Botanic Gardens, Kew	Ruggiero, MA (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Integrated Taxon Informat Syst, Washington, DC 20560 USA.	ruggierm@si.edu	Bourgoin, Thierry/L-5146-2019; Orrell, Thomas/R-9460-2017; Bailly, Nicolas/AID-4444-2022; Brusca, Richard/S-1673-2019	Bourgoin, Thierry/0000-0001-9277-2478; Orrell, Thomas/0000-0003-1038-3028; 	Natural Environment Research Council [NE/C510975/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Adrianov AV, 1995, ZOOSYST ROSS, V3, P181; Alrichs WH, 1995, THESIS GEORGE AUGUST; Alrichs WH, 1977, ZOOMORPHOLOGY, V117, P41; [Anonymous], 2013, LPSN LIST PROKARYOTI; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BREMER K, 1985, Cladistics, V1, P369, DOI 10.1111/j.1096-0031.1985.tb00434.x; Brusca RC, 2003, INVERTEBRATES; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Burki F, 2009, GENOME BIOL EVOL, V1, P231, DOI 10.1093/gbe/evp022; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2000, THE MYCOTA A, VVII; Cavalier-Smith T, 1993, ORIGIN PLATIDS SYMBI; Cavalier-Smith T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016006; Cavalier-Smith T, 2014, MOL PHYLOGENET EVOL, V81, P71, DOI 10.1016/j.ympev.2014.08.012; Cavalier-Smith T, 2013, EUR J PROTISTOL, V49, P115, DOI 10.1016/j.ejop.2012.06.001; Cavalier-Smith T, 2010, PHILOS T R SOC B, V365, P111, DOI 10.1098/rstb.2009.0161; CAVALIERSMITH T, 1981, BIOSYSTEMS, V14, P461, DOI 10.1016/0303-2647(81)90050-2; Chapman A, 2009, NUMBERS LIVING SPECI, P1; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; David J, 2012, ZOOKEYS, P67, DOI 10.3897/zookeys.192.3347; De Smet WH, 2002, J ZOOL, V258, P381, DOI 10.1017/S095283690200153X; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Egger B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005502; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/BF02338837; Garrity GM, 2007, TAXONOMIC OUTLINE BA; Gazave E, 2012, HYDROBIOLOGIA, V687, P3, DOI 10.1007/s10750-011-0842-x; Gazi M, 2012, PARASITOL INT, V61, P307, DOI 10.1016/j.parint.2011.12.001; Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x; Giribet G, 2002, MOL SYSTEMATICS EVOL; Giribet G, 2007, ZOOTAXA, P61, DOI 10.11646/zootaxa.1668.1.8; Gordon D., 2009, NZ INVENTORY BIODIVE, V1; Gordon DP, 2010, NZ INVENTORY BIODIVE, V2; Gordon DP, 2012, NZ INVENTORY BIODIVE; Gruhl A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-10; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hennig W., 1966, P263; Hooper JNA, 2002, SYSTEMA PORIFERA GUI; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; JEFFREY C, 1971, Kew Bulletin, V25, P291, DOI 10.2307/4103226; Jenner RA, 2004, CONTRIB ZOOL, V73, P3, DOI 10.1163/18759866-0730102001; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; Kristensen RM, 2000, J MORPHOL, V246, P1; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Lemburg Christian, 1995, Microfauna Marina, V10, P7; Linnaeus C, 1753, SPECIES PLATARUM EXH; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Mabberley D. J., 2008, MABBERLEYS PLANT BOO; Mallatt J, 2002, MOL BIOL EVOL, V19, P289, DOI 10.1093/oxfordjournals.molbev.a004082; Mallatt J, 2007, MOL PHYLOGENET EVOL, V43, P1005, DOI 10.1016/j.ympev.2006.11.023; Mallatt J, 2010, MOL PHYLOGENET EVOL, V55, P1, DOI 10.1016/j.ympev.2009.09.028; Margulis L, 2001, 5 KINGDOMS ILLUSTRAT; Mayr E, 2002, J ZOOL SYST EVOL RES, V40, P169, DOI 10.1046/j.1439-0469.2002.00211.x; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; Monks S, 2001, SYST PARASITOL, V48, P81, DOI 10.1023/A:1006400207434; Monks Scott, 2011, Zootaxa, V3148, P234; Neuhaus B, 2002, INTEGR COMP BIOL, V42, P619, DOI 10.1093/icb/42.3.619; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Nielsen C, 2008, EVOL DEV, V10, P241, DOI 10.1111/j.1525-142X.2008.00231.x; Paps J, 2009, P ROY SOC B-BIOL SCI, V276, P1245, DOI 10.1098/rspb.2008.1574; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Parker SP, 1982, SYNOPSIS CLASSIFICAT; Parker SP, 1982, SYNOPSIS CLASSIFICAT, V2; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; RIEGER RM, 1995, INVERTEBR BIOL, V114, P186, DOI 10.2307/3226891; Riutort M, 2012, INT J DEV BIOL, V56, P5, DOI 10.1387/ijdb.113441mr; Roskov Y., 2014, SPECIES 2000 ITIS CA; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY; Schmidt-Lebuhn AN, 2014, CLADISTICS, V30, P229, DOI 10.1111/cla.12037; Segers H, 1998, J ZOOL, V244, P201, DOI 10.1111/j.1469-7998.1998.tb00025.x; Segers Hendrik, 2011, Zootaxa, V3148, P231; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Sorensen MV, 2003, J MORPHOL, V255, P131, DOI 10.1002/jmor.10038; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Stech M, 2008, NOVA HEDWIGIA, V86, P1, DOI 10.1127/0029-5035/2008/0086-0001; Stevens PF, 2014, ANGIOSPERM HYLOGENY; Stuessy TF, 2014, CLADISTICS, V30, P291, DOI 10.1111/cla.12038; Tyler S, 2014, TURBELLARIAN TAXONOM; Tyler Seth, 2011, Zootaxa, V3148, P24; Vences M, 2013, ZOOTAXA, V3636, P201, DOI 10.11646/zootaxa.3636.2.1; Villarreal JC, 2010, PHYTOTAXA, V9, P150; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Zhang KY, 2008, ENTOMOL SCI, V11, P269, DOI 10.1111/j.1479-8298.2008.00271.x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhang ZQ, 2013, ZOOTAXA, V3703, P5; Zrzavy J, 1998, CLADISTICS, V14, P249, DOI 10.1111/j.1096-0031.1998.tb00338.x	99	74	81	3	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0119248	10.1371/journal.pone.0119248	http://dx.doi.org/10.1371/journal.pone.0119248			60	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923521	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600003
J	Wingate, LT; Coleman, MS; Posey, DL; Zhou, WG; Olson, CK; Maskery, B; Cetron, MS; Painter, JA				Wingate, La'Marcus T.; Coleman, Margaret S.; Posey, Drew L.; Zhou, Weigong; Olson, Christine K.; Maskery, Brian; Cetron, Martin S.; Painter, John A.			Cost-Effectiveness of Screening and Treating Foreign-Born Students for Tuberculosis before Entering the United States	PLOS ONE			English	Article							US-BOUND IMMIGRANTS; PULMONARY TUBERCULOSIS; FOLLOW-UP; TB; PREVALENCE; INFECTION; COUNTRIES; SYSTEM; IMPACT	Introduction The Centers for Disease Control and Prevention is considering implementation of overseas medical screening of student-visa applicants to reduce the numbers of active tuberculosis cases entering the United States. Objective To evaluate the costs, cases averted, and cost-effectiveness of screening for, and treating, tuberculosis in United States-bound students from countries with varying tuberculosis prevalence. Methods Costs and benefits were evaluated from two perspectives, combined and United States only. The combined perspective totaled overseas and United States costs and benefits from a societal perspective. The United States only perspective was a domestic measure of costs and benefits. A decision tree was developed to determine the cost-effectiveness of tuberculosis screening and treatment from the combined perspective. Results From the United States only perspective, overseas screening programs of Chinese and Indian students would prevent the importation of 157 tuberculosis cases annually, and result in $2.7 million in savings. From the combined perspective, screening programs for Chinese students would cost more than $2.8 million annually and screening programs for Indian students nearly $440,000 annually. From the combined perspective, the incremental cost for each tuberculosis case averted by screening Chinese and Indian students was $22,187 and $15,063, respectively. Implementing screening programs for German students would prevent no cases in most years, and would result in increased costs both overseas and in the United States. The domestic costs would occur because public health departments would need to follow up on students identified overseas as having an elevated risk of tuberculosis. Conclusions Tuberculosis screening and treatment programs for students seeking long term visas to attend United States schools would reduce the number of tuberculosis cases imported. Implementing screening in high-incidence countries could save the United States millions of dollars annually; however there would be increased costs incurred overseas for students and their families.	[Wingate, La'Marcus T.; Coleman, Margaret S.; Posey, Drew L.; Zhou, Weigong; Olson, Christine K.; Maskery, Brian; Cetron, Martin S.; Painter, John A.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Wingate, LT (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.	latewing@gmail.com						Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Agency for Healthcare Research and Quality, HCUPN TOOL ID TRACK; Alvarez GG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-3; Ananthakrishnan R, 2012, LUNG INDIA, V29, P221, DOI 10.4103/0970-2113.99103; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 1996, COST EFFECTIVENESS H; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Bhat J, 2009, INT J EPIDEMIOL, V38, P1026, DOI 10.1093/ije/dyp222; Board of Governors of the Federal Reserve System, FORE EXCH RAT; Bureau of Labor Statistics, CONS PRIC IND ALL RU; Bureau of Labor Statistics, 2011, OCC EMPL WAG MAY 201; Burman WJ, 1997, CHEST, V112, P63, DOI 10.1378/chest.112.1.63; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Centers for Disease Control and Prevention, DIV GLOB MIGR QUAR; Centers for Disease Control and Prevention, TUB SCREEN TREATM TE; Centers for Disease Control and Prevention, ONL TUB INF SYST; Centers for Disease Control and Prevention, CLIN HLTH SYST RES B; Centers for Medicare and Medicaid Services, OV MED PHYS SCHED; Centers for Medicare and Medicaid Services, CLIN LAB FEE SCHED; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Claassens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058689; Coleman MS, 2014, TRAVEL MED INFECT DI, V12, P63, DOI 10.1016/j.tmaid.2013.10.016; Columbia University, REF RAT WITHDR; Department of Homeland Security, 2012, YB IMM STAT 2012 REF; Department of Transportation Federal Highway Administration, SUMM TRAV TRENDS NAT; Diel R, 2012, EUR RESPIR J, V40, P143, DOI 10.1183/09031936.00204611; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Emory University, WITHD; Energy Information Administration, 1949, MOT VEH MIL FUEL CON; Energy Information Administration, 2013, MONTL EN REV JUL 201; Erkens C, 2008, EUR RESPIR J, V32, P153, DOI 10.1183/09031936.00137907; Global Alliance for TB Drug Development, AN GLOB TB DRUG MARK; Grieco EM, LENGTH VISIT NONIMIG; Haddix AC, 2003, PREVENTION EFFECTIVE; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Institute of International Education, PERC EUR HIGH EC 3 C; Institute of International Education, NEW INT STUD ENR 200; Institute of International Education, INT STUD TOT PLAC EO; Khachetourians N., 2012, 5 REASONS WHY US IS; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; Kowada A, 2012, MOL DIAGN THER, V16, P181, DOI 10.2165/11633610-000000000-00000; Landefeld JS, 2008, J ECON PERSPECT, V22, P193, DOI 10.1257/jep.22.2.193; Lee D, 2013, MMWR SURVEILL SUMM, V62, P1; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Liu YC, 2009, NEW ENGL J MED, V360, P2406, DOI 10.1056/NEJMoa0809497; Meng QY, 2004, INT J HEALTH PLAN M, V19, pS45, DOI 10.1002/hpm.774; Miramontes R, 2013, MMWR-MORBID MORTAL W, V62, P201; Monger R., 2012, US LEGAL PERMANENT R; Monger R., 2011, NONIMMIGRANT ADM US; National Center for Education Statistics, AV GRAD 1 PROF TUIT; National Center for Education Statistics, 2011, AV UND TUIT FEES ROO; New York University, FALL SPRING UND REF; Okada K, 2012, INT J TUBERC LUNG D, V16, P1619, DOI 10.5588/ijtld.12.0201; Organisation for Economic and Co-operation and Development, CONS PRIC; Oxlade O, 2007, INT J TUBERC LUNG D, V11, P16; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Porco TC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-157; Posey DL, 2014, MMWR-MORBID MORTAL W, V63, P234; Purdue University, TUIT REF; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Shepardson D, 2013, INT J TUBERC LUNG D, V17, P1531, DOI 10.5588/ijtld.13.0423; Tadesse T, 2013, INT J TUBERC LUNG D, V17, P630, DOI 10.5588/ijtld.12.0449; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Tempera J., 2013, US TODAY; Texas A& M University, TUIT FEE SCHED; The Pennsylvania State University, TUIT ADJ POL; The World Bank, HOUS FIN CONS EXP ET; World Bank, GDP PER CAP PPP; World Health Organization, GLOB TUB REP 2013; World Health Organziation, COUNTR SPEC UN COSTS; Yang XY, 2008, INT J INFECT DIS, V12, P534, DOI 10.1016/j.ijid.2008.02.011	73	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124116	10.1371/journal.pone.0124116	http://dx.doi.org/10.1371/journal.pone.0124116			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25924009	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600069
J	Ikegami, T; Inatsugi, T; Kojima, I; Umemura, M; Hagiwara, H; Machida, M; Asai, K				Ikegami, Tsutomu; Inatsugi, Toyohiro; Kojima, Isao; Umemura, Myco; Hagiwara, Hiroko; Machida, Masayuki; Asai, Kiyoshi			Hybrid De Novo Genome Assembly Using MiSeq and SOLiD Short Read Data	PLOS ONE			English	Article							SEQUENCE DATA; GENERATION; ALIGNMENT; ORYZAE	A hybrid de novo assembly pipeline was constructed to utilize both MiSeq and SOLiD short read data in combination in the assembly. The short read data were converted to a standard format of the pipeline, and were supplied to the pipeline components such as ABySS and SOAPdenovo. The assembly pipeline proceeded through several stages, and either MiSeq paired-end data, SOLiD mate-paired data, or both of them could be specified as input data at each stage separately. The pipeline was examined on the filamentous fungus Aspergillus oryzae RIB40, by aligning the assembly results against the reference sequences. Using both the MiSeq and the SOLiD data in the hybrid assembly, the alignment length was improved by a factor of 3 to 8, compared with the assemblies using either one of the data types. The number of the reproduced gene cluster regions encoding secondary metabolite biosyntheses (SMB) was also improved by the hybrid assemblies. These results imply that the MiSeq data with long read length are essential to construct accurate nucleotide sequences, while the SOLiD mate-paired reads with long insertion length enhance long-range arrangements of the sequences. The pipeline was also tested on the actinomycete Streptomyces avermitilis MA-4680, whose gene is known to have high-GC content. Although the quality of the SOLiD reads was too low to perform any meaningful assemblies by themselves, the alignment length to the reference was improved by a factor of 2, compared with the assembly using only the MiSeq data.	[Ikegami, Tsutomu; Kojima, Isao] Natl Inst Adv Ind Sci & Technol, Informat Technol Res Inst, Tsukuba, Ibaraki, Japan; [Inatsugi, Toyohiro] Cift Corp, Tsukuba, Ibaraki, Japan; [Umemura, Myco; Hagiwara, Hiroko; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Ikegami, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Informat Technol Res Inst, Tsukuba, Ibaraki, Japan.	t-ikegami@aist.go.jp	Asai, Kiyoshi/AAT-8344-2020; Umemura, Maiko/M-4092-2018; IKEGAMI, TSUTOMU/N-3452-2016; Kojima, Isao/M-2845-2018	Asai, Kiyoshi/0000-0003-0909-4982; Umemura, Maiko/0000-0001-8730-1380; IKEGAMI, TSUTOMU/0000-0003-2977-6390; Kojima, Isao/0000-0001-5505-889X	Cift Corporation	Cift Corporation	Cift Corporation provided support in the form of a salary for author T. Inatsugi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2009, NOVO ERROR CORRECTIO; [Anonymous], 2012, SOLID SYSTEM XSQ TOO; [Anonymous], 2010, APPL BIOSYSTEMS SOLI; [Anonymous], 2011, MATE PAIRED LIB PREP; Arnaud MB, 2013, ASPERGILLUS GENOME D; Breu H., 2010, THEORETICAL UNDERSTA; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Denisov G, 2008, BIOINFORMATICS, V24, P1035, DOI 10.1093/bioinformatics/btn074; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Extensible Sequence (XSQ), 2011, FIL FORM SPEC 1 0 1; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Fujii T, 2015, GENOME ANNOUNCEMENTS, V3, DOI [10.1128/genomeA.00014-15, DOI 10.1128/GEN0MEA.00014-15]; Genome Project of Streptmyces avermitilis, 2013, VERS 11022 090102 CH; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Massingham T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-145; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Oka T, 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.01162-13, DOI 10.1128/GEN0MEA.01162-13]; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Takeda I, 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.00071-14, DOI 10.1128/GEN0MEA.00071-14]; Umemura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063673; Wang J., 2009, GENOME RES; Yu J, 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.00635-14, DOI 10.1128/GEN0MEA.00635-14]; Zhao G, 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.00548-14, DOI 10.1128/GEN0MEA.00548-14]	34	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0126289	10.1371/journal.pone.0126289	http://dx.doi.org/10.1371/journal.pone.0126289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919614	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400094
J	Lou, YT; Chen, CW; Fan, YC; Chang, WC; Lu, CY; Wu, IC; Hsu, WH; Huang, CW; Wang, JY				Lou, Yun-Ting; Chen, Chao-Wen; Fan, Yun-Ching; Chang, Wei-Chiao; Lu, Chien-Yu; Wu, I-Chen; Hsu, Wen-Hung; Huang, Ching-Wen; Wang, Jaw-Yuan			LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy	PLOS ONE			English	Article							COLORECTAL-CANCER; DNA METHYLATION; VASCULAR INVASION; HYPOMETHYLATION; SURVEILLANCE; PHENOTYPE; PROGNOSIS; EVENTS; BLOOD; AGE	Background Methylation levels of long interspersed nucleotide elements (LINE-1) are representative of genome-wide methylation status and crucial in maintaining genomic stability and expression. Their prognostic impact on colon cancer patients receiving adjuvant chemotherapy has not been well established. We evaluated the association between LINE-1 methylation status and clinicopathologic features and postoperative oncological outcomes in stage III colon cancer patients. Materials and Methods 129 UICC stage III colon cancer patients who had received radical resection and FOLFOX adjuvant chemotherapy were enrolled. Global methylation was estimated by analyzing tumor LINE-1 methylation status using bisulfite-polymerase chain reaction (PCR) and pyrosequencing assay. Demographics, clinicopathological data, and postoperative outcomes were recorded by trained abstractors. Outcome measurements included postoperative recurrence and disease-free survival. Univariate, multivariate, and survival analyses were conducted to identify prognostic factors of oncological outcomes. Results The LINE-1 methylation of all 129 patients was measured on a 0-100 scale (mean 63.3; median 63.7, standard deviation 7.1), LINE-1 hypomethylation was more common in patients aged 65 years and above (61.7%+/- 7.6% vs. 64.6 +/- 6.4, p=0.019) and those with post-therapeutic recurrence (61.7 +/- 7.4 vs 64.3 +/- 6.7, p=0.041). Considering risk adjustment, LINE-1 hypomethylation was found to be an independent risk factor of post-therapeutic recurrence (Adjusted OR=14.1, p=0.012). Kaplan-Meier analysis indicated that patients in the low methylation group had shorter period of disease free survival (p=0.01). In a stratified analysis that included 48 patients with post-therapeutic recurrence, it was found that those who experienced shorter period of disease free survival (<= 6 months) appeared to have lower LINE-1 methylation levels than patients who reported of recurrence after 6 months (56.68 +/- 15.75 vs. 63.55 +/- 7.57, p=0.041) Conclusion There was a significantly greater risk of early postoperative recurrence and a shorter period of disease-free survival in Stage III colon cancer patients exhibiting LINE-1 hypomethylation status after being treated with radical resection and FOLFOX chemotherapy.	[Lou, Yun-Ting; Fan, Yun-Ching; Chang, Wei-Chiao; Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Grad Inst Genom Med, Kaohsiung, Taiwan; [Lou, Yun-Ting] I Shou Univ, E DA Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Chen, Chao-Wen; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Emergency Med, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chang, Wei-Chiao; Wang, Jaw-Yuan] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Lu, Chien-Yu; Wu, I-Chen; Hsu, Wen-Hung] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Internal Med, Kaohsiung, Taiwan; [Lu, Chien-Yu; Wu, I-Chen; Hsu, Wen-Hung; Wang, Jaw-Yuan] Kaohsiung Med Univ, Div Gastroenterol, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Ching-Wen; Wang, Jaw-Yuan] Kaohsiung Med Univ, Dept Surg, Kaohsiung Med Univ Hosp, Div Gastrointestinal & Gen Surg, Kaohsiung, Taiwan; [Huang, Ching-Wen; Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Wang, JY (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Genom Med, Kaohsiung, Taiwan.	cy614112@ms14.hinet.net	Jaw-Yuan, Wang/AFS-8845-2022	Jaw-Yuan, Wang/0000-0002-7705-2621; Chen, Chao Wen/0000-0002-8405-342X; Chang, Wei-Chiao/0000-0002-8573-5924	Kaohsiung Medical University Research Foundation [KMU-1M-30]; Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University [KMU-TP103C03, KMU-TP103H11]; Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	Kaohsiung Medical University Research Foundation; Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University; Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	Funding: This study was supported by Kaohsiung Medical University Research Foundation (KMU-1M-30), Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University (KMU-TP103C03, KMU-TP103H11), and the Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan. CWC and JYW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Antelo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045357; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Baca B, 2011, DIS COLON RECTUM, V54, P1036, DOI 10.1007/DCR.0b013e31820db364; Banaz-Yasar F, 2012, DNA CELL BIOL, V31, P1458, DOI 10.1089/dna.2012.1676; Betge J, 2011, ACTA GASTRO-ENT BELG, V74, P516; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bosch LJW, 2011, CLIN COLORECTAL CANC, V10, P8, DOI 10.3816/CCC.2011.n.002; Brennan K, 2012, CANCER PREV RES, V5, P1345, DOI 10.1158/1940-6207.CAPR-12-0316; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Desch CE, 2005, J CLIN ONCOL, V23, P8512, DOI 10.1200/JCO.2005.04.0063; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Hahn MA, 2010, MUTAT RES-FUND MOL M, V693, P77, DOI 10.1016/j.mrfmmm.2009.10.005; Heyn H, 2013, EXPERT REV MOL DIAGN, V13, P473, DOI [10.1586/ERM.13.36, 10.1586/erm.13.36]; Horii J, 2008, CLIN BIOCHEM, V41, P1440, DOI 10.1016/j.clinbiochem.2008.08.089; Hur K, 2014, GUT, V63, P635, DOI 10.1136/gutjnl-2012-304219; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawakami K, 2011, CANCER SCI, V102, P166, DOI 10.1111/j.1349-7006.2010.01776.x; Khare Sharad, 2012, Methods Mol Biol, V863, P177, DOI 10.1007/978-1-61779-612-8_10; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Kozak KR, 2008, J SURG ONCOL, V98, P161, DOI 10.1002/jso.21107; Lara E, 2011, EPIGENETIC ASPECTS OF CHRONIC DISEASES, P21, DOI 10.1007/978-1-84882-644-1_2; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Nelson RL, 1997, CANCER-AM CANCER SOC, V80, P193, DOI 10.1002/(SICI)1097-0142(19970715)80:2<193::AID-CNCR4>3.0.CO;2-V; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Piyathilake CJ, 2011, NUTRITION, V27, P513, DOI 10.1016/j.nut.2010.08.018; Rodic N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003402; Rosati G, 2010, WORLD J GASTROENTERO, V16, P1427, DOI 10.3748/wjg.v16.i12.1427; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Schweiger MR, 2013, BRIEF FUNCT GENOMICS, V12, P411, DOI 10.1093/bfgp/elt024; Sunami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018884; Tournier B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-12; Tsai HL, 2008, J SURG ONCOL, V97, P383, DOI 10.1002/jso.20942; Tsai HL, 2013, INT J COLORECTAL DIS, V28, P415, DOI 10.1007/s00384-012-1570-z; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; Wangsri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045292; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378	45	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123973	10.1371/journal.pone.0123973	http://dx.doi.org/10.1371/journal.pone.0123973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919688	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400040
J	Silver, MJ; Corbin, KD; Hellenthal, G; da Costa, KA; Dominguez-Salas, P; Moore, SE; Owen, J; Prentice, AM; Hennig, BJ; Zeisel, SH				Silver, Matt J.; Corbin, Karen D.; Hellenthal, Garrett; da Costa, Kerry-Ann; Dominguez-Salas, Paula; Moore, Sophie E.; Owen, Jennifer; Prentice, Andrew M.; Hennig, Branwen J.; Zeisel, Steven H.			Evidence for negative selection of gene variants that increase dependence on dietary choline in a Gambian cohort	FASEB JOURNAL			English	Article						diet and selection; adequate intake levels; phosphatidylethanolamine-N-methyltransferase; choline dehydrogenase; methylenetetrahydrofolate dehydrogenase	DNA METHYLATION; BETAINE; GENOME; FOLATE; RISK; POLYMORPHISMS; REQUIREMENT; DEFICIENCY; METABOLISM; NUTRITION	Choline is an essential nutrient, and the amount needed in the diet is modulated by several factors. Given geographical differences in dietary choline intake and disparate frequencies of single-nucleotide polymorphisms (SNPs) in choline metabolism genes between ethnic groups, we tested the hypothesis that 3 SNPs that increase dependence on dietary choline would be under negative selection pressure in settings where choline intake is low: choline dehydrogenase (CHDH) rs12676, methylenetetrahydrofolate reductase 1 (MTHFD1) rs2236225, and phosphatidylethanolamine-N-methyltransferase (PEMT) rs12325817. Evidence of negative selection was assessed in 2 populations: one in The Gambia, West Africa, where there is historic evidence of a choline-poor diet, and the other in the United States, with a comparatively choline-rich diet. We used 2 independent methods, and confirmation of our hypothesis was sought via a comparison with SNP data from the Maasai, an East African population with a genetic background similar to that of Gambians but with a traditional diet that is higher in choline. Our results show that frequencies of SNPs known to increase dependence on dietary choline are significantly reduced in the low-choline setting of The Gambia. Our findings suggest that adequate intake levels of choline may have to be reevaluated in different ethnic groups and highlight a possible approach for identifying novel functional SNPs under the influence of dietary selective pressure.	[Silver, Matt J.; Dominguez-Salas, Paula; Prentice, Andrew M.; Hennig, Branwen J.] Univ London London Sch Hyg & Trop Med, Med Res Council, Int Nutr Grp, London WC1E 7HT, England; [Silver, Matt J.; Dominguez-Salas, Paula; Prentice, Andrew M.; Hennig, Branwen J.] MRC Unit, Banjul, Gambia; [Corbin, Karen D.; Owen, Jennifer; Zeisel, Steven H.] Inst Nutr Res, Kannapolis, NC 28081 USA; [Corbin, Karen D.; Zeisel, Steven H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA; [Hellenthal, Garrett] UCL, Genet Inst, London WC1E 6BT, England; [da Costa, Kerry-Ann] Toxicol Serv Inc, Chapel Hill, NC USA; [Moore, Sophie E.] Med Res Council Human Nutr Res, Maternal & Child Nutr Grp, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Zeisel, SH (corresponding author), Inst Nutr Res, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	Prentice, Andrew/AAG-1961-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Corbin, Karen/0000-0003-2065-0003; Hennig, Branwen J./0000-0003-4127-8386; Silver, Matt/0000-0002-3852-9677; Moore, Sophie/0000-0003-1650-3238	Wellcome Trust Grant [WT086369MA]; U.K. Medical Research Council [MC-A760-5QX00]; United Kingdom Department for the International Development (DFID) under MRC/DFID Concordat agreement; Bill and Melinda Gates Foundation; U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [DK56350]; Wellcome Trust [098386/Z/12/Z]; Royal Society [098386/Z/12/Z]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1005/1, MC_U123292700, MC_EX_MR/M01424X/1] Funding Source: researchfish; MRC [MC_U123292700, MC_EX_MR/M01424X/1, MC_UP_1005/1] Funding Source: UKRI	Wellcome Trust Grant(Wellcome Trust); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Kingdom Department for the International Development (DFID) under MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the women from Kiang West, The Gambia, for their participation; their laboratory technicians, field assistants, nurses, data entry clerks, and other staff at MRC Keneba, The Gambia, and A. J. Fulford, Ph.D., for support in data management; Joseph Galanko, Ph.D., for assistance with data organization; the research subjects in the North Carolina clinical cohorts for participating; Leslie Fischer for clinical study management; and Catherine Walker for a critical reading of the manuscript. The Gambian studies that provided data for the analyses were supported by Wellcome Trust Grant WT086369MA (to B.J.H.), U.K. Medical Research Council core funding Grant MC-A760-5QX00 to the International Nutrition Group, and the United Kingdom Department for the International Development (DFID) under the MRC/DFID Concordat agreement. Work completed by Dr. Zeisel's research team was supported by grants from the Bill and Melinda Gates Foundation and Grant DK56350 from the U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases. G.H. is jointly funded by Grant 098386/Z/12/Z from the Wellcome Trust and by a Sir Henry Dale Fellowship from the Royal Society. B.J.H. and S.H.Z. share senior authorship of this article.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2013, USDA NAT NUTR DAT ST; Babbitt CC, 2011, P ROY SOC B-BIOL SCI, V278, P961, DOI 10.1098/rspb.2010.2433; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Buchman AL, 2009, GASTROENTEROLOGY, V137, pS119, DOI 10.1053/j.gastro.2009.08.010; Carroll N, 2009, HUM GENET, V125, P247, DOI 10.1007/s00439-008-0616-3; Cho E, 2006, AM J CLIN NUTR, V83, P905, DOI 10.1093/ajcn/83.4.905; Corbin KD, 2013, FASEB J, V27, P1674, DOI 10.1096/fj.12-219097; Corbin KD, 2012, PROG MOL BIOL TRANSL, V108, P159, DOI 10.1016/B978-0-12-398397-8.00007-1; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; da Costa KA, 2014, FASEB J, V28, P2970, DOI 10.1096/fj.14-249557; Dalmeijer GW, 2008, EUR J CLIN NUTR, V62, P386, DOI 10.1038/sj.ejcn.1602725; Detopoulou P, 2008, AM J CLIN NUTR, V87, P424, DOI 10.1093/ajcn/87.2.424; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Dyson LK, 2000, FOOD REV, V21, P2; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fay JC, 2000, GENETICS, V155, P1405; Field MS, 2013, J NUTR, V143, P41, DOI 10.3945/jn.112.169821; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Fischer LM, 2010, AM J CLIN NUTR, V92, P1113, DOI 10.3945/ajcn.2010.30064; Fischer LM, 2010, AM J CLIN NUTR, V92, P336, DOI 10.3945/ajcn.2010.29459; Gillespie J. H., 2004, POPULATION GENETICS; Horne DW, 2003, J NUTR, V133, P476, DOI 10.1093/jn/133.2.476; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; HUDSON GJ, 1995, BRIT J NUTR, V73, P551, DOI 10.1079/BJN19950058; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and Its Panel on Folate Other B Vitamins and Choline, 1998, DIETARY REFERENCE IN, V1, P390; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Ivanov A, 2009, J AM DIET ASSOC, V109, P313, DOI 10.1016/j.jada.2008.10.046; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Johnson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036047; Knoll N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-141; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Lachance J, 2013, ANNU REV ECOL EVOL S, V44, P123, DOI 10.1146/annurev-ecolsys-110512-135833; Marsters Kate Ferguson, 2000, TRAVELS INTERIOR DIS; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mehedint MG, 2010, P NATL ACAD SCI USA, V107, P12834, DOI 10.1073/pnas.0914328107; Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107; Murphy P. K., 1981, OXFORD S FODO COOKER, P290; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Oiye S., 2009, Indigenous peoples' food systems: the many dimensions of culture, diversity and environment for nutrition and health, P231; Patin E, 2008, TRENDS ECOL EVOL, V23, P56, DOI 10.1016/j.tree.2007.11.002; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; POMFRET EA, 1990, J NUTR BIOCHEM, V1, P533, DOI 10.1016/0955-2863(90)90039-N; Resseguie ME, 2011, J BIOL CHEM, V286, P1649, DOI 10.1074/jbc.M110.106922; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097; Schlebusch CM, 2013, EUR J HUM GENET, V21, P550, DOI 10.1038/ejhg.2012.199; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; TAJIMA F, 1989, GENETICS, V123, P585; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wagh K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044751; Wallace TC, 2014, J AM COLL NUTR, V33, P94, DOI 10.1080/07315724.2013.846806; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weichselbaum E., 2009, 6 I FODO RES; Yonemori KM, 2013, J NUTR, V143, P894, DOI 10.3945/jn.112.171132; Zeisel SH, 2013, INT J WOMENS HEALTH, V5, P193, DOI 10.2147/IJWH.S36610; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x; Zeng FF, 2014, BRIT J CANCER, V110, P808, DOI 10.1038/bjc.2013.686; Zhang CX, 2013, CANCER SCI, V104, P250, DOI 10.1111/cas.12064	68	14	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3426	3435		10.1096/fj.15-271056	http://dx.doi.org/10.1096/fj.15-271056			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25921832	Green Published, Green Accepted			2022-12-26	WOS:000358796900029
J	Li, HX; Liu, CX; Zhang, HB; Xu, WF; Liu, JH; Chen, Y; Li, TX; Li, B; Wu, ZQ; Xia, TL				Li, Huixin; Liu, Chunxiao; Zhang, Haibin; Xu, Wenfeng; Liu, Jianhua; Chen, Yong; Li, Tangxuan; Li, Bin; Wu, Zhenquan; Xia, Taolin			The Use of Unidirectional Barbed Suture for Urethrovesical Anastomosis during Robot-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis of Efficacy and Safety	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VESICOURETHRAL ANASTOMOSIS; POSTERIOR RECONSTRUCTION; STANDARD MONOFILAMENT; POLYGLYCONATE SUTURE; TIME; IMPACT	Background Unidirectional barbed suture (UBS) has been widely used for surgery in recent years, especially for urethrovesical anastomosis (UVA) during robot-assisted radical prostatectomy (RARP). However, the efficacy and safety comparing it with conventional non-barbed suture (CS) for UVA is still controversial. Aims The objective of this study is to assess the current evidence regarding the efficacy and safety of UBS compared with CS for UVA during RARP. Methods We comprehensively searched PubMed, Embase, The Cochrane Library, SinoMed (Chinese) and other databases on Oct. 9, 2014 to conduct a systematic review and meta-analysis of all randomized controlled trials (RCTs) and other comparative studies evaluating these two types of suture. The outcome measures included anastomosis time operative time, posterior reconstruction (PR) time, postoperative leakage (PL) rate and continence rates at different time points (4-6 weeks, 3 months, 6-12 months) after surgery. Secondary outcomes included estimated blood loss (EBL) and length of catheterization (LOC). Results Three RCTs and six observational studies including 786 cases were identified. Meta-analysis of extractable data showed that use of UBS could significantly reduce anastomosis time (weighted mean difference [WMD]:-3.98min; 95% confidence interval [CI], -6.02 -1.95; p = 0.0001), operative time (WMD:-10.06min; 95% CI, -15.45--4.67; p = 0.0003) and PR time (WMD:-0.93min; 95% CI, -1.52--0.34; p = 0.002). No significant difference was found in PL rate, EBL, LOC, or continence rates at 4-6 weeks, 3 months and 6-12 months after surgery. Conclusions Our meta-analysis indicates that UBS appears to be safe and efficient as CS for UVA during RARP with not only shorter anastomosis time, operative time, PR time, but also equivalent PL rate, EBL, LOC, and continence rates at 4-6 weeks, 3 months and 6-12 months after surgery. For the inherent limitations of the eligible studies, future more persuasive RCTs are needed to confirm and update our findings.	[Li, Huixin; Zhang, Haibin; Xu, Wenfeng; Liu, Jianhua; Chen, Yong; Li, Tangxuan; Li, Bin; Wu, Zhenquan; Xia, Taolin] Sun Yat Sen Univ, Foshan Affiliated Hosp, Peoples Hosp Foshan 1, Dept Urol, Foshan, Guangdong, Peoples R China; [Li, Huixin; Liu, Chunxiao] Southern Med Univ, Dept Urol, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China	Li, HX (corresponding author), Sun Yat Sen Univ, Foshan Affiliated Hosp, Peoples Hosp Foshan 1, Dept Urol, Foshan, Guangdong, Peoples R China.	HuixinLi116@gmail.com	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762				Coelho RF, 2010, EUR UROL, V57, P945, DOI 10.1016/j.eururo.2010.02.001; Coughlin G, 2008, BJU INT, V102, P1482, DOI 10.1111/j.1464-410X.2008.08090.x; Desai D, 2013, BJU INT, V111, P62; Hemal AK, 2012, INT UROL NEPHROL, V44, P125, DOI 10.1007/s11255-011-9967-0; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hu JC, 2006, J UROLOGY, V175, P541, DOI 10.1016/S0022-5347(05)00156-4; Escudero JUJ, 2012, ARCH ESP UROL, V65, P752; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Manganiello M, 2012, INT BRAZ J UROL, V38, P89, DOI 10.1590/S1677-55382012000100013; Massoud W, 2013, UROLOGY, V82, P90, DOI 10.1016/j.urology.2013.02.002; Menon M, 2002, UROLOGY, V60, P864, DOI 10.1016/S0090-4295(02)01881-2; Menon M, 2003, J UROLOGY, V169, P2289, DOI 10.1097/01.ju.0000067464.53313.dd; Phillips B.C., 2009, LEVELS EVIDENCE GRAD; Polland AR, 2011, J ENDOUROL, V25, P1493, DOI 10.1089/end.2010.0668; Rocco F, 2006, J UROLOGY, V175, P2201, DOI 10.1016/S0022-5347(06)00262-X; Sammon J, 2011, UROLOGY, V78, P572, DOI 10.1016/j.urology.2011.03.069; Shalhav AL, 2006, UROLOGY, V68, P508, DOI 10.1016/j.urology.2006.03.071; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su LM, 2011, CAMPBELL WALSH UROLO, V103, P2841; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Tewari AK, 2010, J ENDOUROL, V24, P1645, DOI 10.1089/end.2010.0316; Van Velthoven RF, 2003, UROLOGY, V61, P699, DOI 10.1016/S0090-4295(02)02543-8; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Williams SB, 2010, EUR UROL, V58, P875, DOI 10.1016/j.eururo.2010.07.021; Zorn KC, 2012, BJU INT, V109, P1526, DOI 10.1111/j.1464-410X.2011.10763.x	26	42	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131167	10.1371/journal.pone.0131167	http://dx.doi.org/10.1371/journal.pone.0131167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	25928635	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400037
J	Long, WT; Panwar, P; Witkowska, K; Wong, K; O'Neill, D; Chen, XZ; Lemieux, MJ; Cheeseman, CI				Long, Wentong; Panwar, Pankaj; Witkowska, Kate; Wong, Kenneth; O'Neill, Debbie; Chen, Xing-Zhen; Lemieux, M. Joanne; Cheeseman, Chris I.			Critical Roles of Two Hydrophobic Residues within Human Glucose Transporter 9 (hSLC2A9) in Substrate Selectivity and Urate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; URIC-ACID; EXOFACIAL VESTIBULE; KINETIC-PARAMETERS; ESCHERICHIA-COLI; BINDING-SITE; GLUT-FAMILY; MECHANISM; FRUCTOSE; DETERMINANT	High blood urate levels (hyperuricemia) have been found to be a significant risk factor for cardiovascular diseases and inflammatory arthritis, such as hypertension and gout. Human glucose transporter 9 (hSLC2A9) is an essential protein that mainly regulates urate/hexose homeostasis in human kidney and liver. hSLC2A9 is a high affinity-low capacity hexose transporter and a high capacity urate transporter. Our previous studies identified a single hydrophobic residue in trans-membrane domain 7 of class II glucose transporters as a determinant of fructose transport. A mutation of isoleucine 335 to valine (I355V) in hSLC2A9 can reduce fructose transport while not affecting glucose fluxes. This current study demonstrates that the I335V mutant transports urate similarly to the wild type hSLC2A9; however, Ile-335 is necessary for urate/fructose trans-acceleration exchange to occur. Furthermore, Trp-110 is a critical site for urate transport. Two structural models of the class II glucose transporters, hSLC2A9 and hSLC2A5, based on the crystal structure of hSLC2A1 (GLUT1), reveal that Ile-335 (or the homologous Ile-296 in hSLC2A5) is a key component for protein conformational changes when the protein translocates substrates. The hSLC2A9 model also predicted that Trp-110 is a crucial site that could directly interact with urate during transport. Together, these studies confirm that hSLC2A9 transports both urate and fructose, but it interacts with them in different ways. Therefore, this study advances our understanding of how hSLC2A9 mediates urate and fructose transport, providing further information for developing pharmacological agents to treat hyperuricemia and related diseases, such as gout, hypertension, and diabetes.	[Long, Wentong; Wong, Kenneth; O'Neill, Debbie; Chen, Xing-Zhen; Cheeseman, Chris I.] Univ Alberta, Fac Med & Dent, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Panwar, Pankaj; Lemieux, M. Joanne] Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Witkowska, Kate] QMUL, John Vane Sci Ctr, William Harvey Res Ctr, Dept Clin Pharmacol, London EC16BQ, England	University of Alberta; University of Alberta	Cheeseman, CI (corresponding author), Univ Alberta, Fac Med & Dent, Dept Physiol, Edmonton, AB T6G 2H7, Canada.	chris.cheeseman@ualberta.ca		Lemieux, Joanne/0000-0003-4745-9153; Long, Wentong/0000-0003-4650-8064	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Bo S, 2001, EUR J CLIN INVEST, V31, P318, DOI 10.1046/j.1365-2362.2001.00812.x; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; Carruthers A, 2009, AM J PHYSIOL-ENDOC M, V297, pE836, DOI 10.1152/ajpendo.00496.2009; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Cheeseman C, 2009, CURR OPIN NEPHROL HY, V18, P428, DOI 10.1097/MNH.0b013e32832ee3de; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Dietvorst J, 2010, YEAST, V27, P131, DOI 10.1002/yea.1737; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Hill WG, 2005, AM J PHYSIOL-RENAL, V289, pF217, DOI 10.1152/ajprenal.00022.2005; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; Jayaraj V, 2009, BIOINFORMATION, V3, P409, DOI 10.6026/97320630003409; Johnson RJ, 2010, J AM SOC NEPHROL, V21, P2036, DOI 10.1681/ASN.2010050506; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; KATAGIRI H, 1991, J BIOL CHEM, V266, P7769; KATAGIRI H, 1993, BIOCHEM J, V291, P861, DOI 10.1042/bj2910861; KAYANO T, 1990, J BIOL CHEM, V265, P13276; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084996; Komala MG, 2013, CURR OPIN NEPHROL HY, V22, P113, DOI 10.1097/MNH.0b013e32835a17ae; Komoda F, 2004, PEDIATR NEPHROL, V19, P728, DOI 10.1007/s00467-004-1424-1; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Maher F, 1996, BIOCHEM J, V315, P827, DOI 10.1042/bj3150827; Manolescu A, 2005, J BIOL CHEM, V280, P42978, DOI 10.1074/jbc.M508678200; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Mueckler M, 1997, J BIOL CHEM, V272, P30141, DOI 10.1074/jbc.272.48.30141; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Puig JG, 1999, J HYPERTENS, V17, P869, DOI 10.1097/00004872-199917070-00001; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Stein W. D., 1986, TRANSPORT DIFFUSION, P31; STEIN WD, 1972, ANN NY ACAD SCI, V195, P412, DOI 10.1111/j.1749-6632.1972.tb54823.x; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Sweet IR, 1997, DIABETOLOGIA, V40, P112, DOI 10.1007/s001250050652; TAYLOR LP, 1981, BIOCHIM BIOPHYS ACTA, V642, P325, DOI 10.1016/0005-2736(81)90449-1; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; Wang Q, 2013, J BIOL CHEM, V288, P264, DOI 10.1074/jbc.M112.396408; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Witkowska K, 2012, AM J PHYSIOL-RENAL, V303, pF527, DOI 10.1152/ajprenal.00134.2012; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	53	12	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15292	15303		10.1074/jbc.M114.611178	http://dx.doi.org/10.1074/jbc.M114.611178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922070	Green Published, hybrid			2022-12-26	WOS:000356177300040
J	Akie, TE; Liu, LJ; Nam, M; Lei, S; Cooper, MP				Akie, Thomas E.; Liu, Lijun; Nam, Minwoo; Lei, Shi; Cooper, Marcus P.			OXPHOS-Mediated Induction of NAD(+) Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							HEPATIC INSULIN-RESISTANCE; PROTEIN-KINASE-C; MITOCHONDRIAL ABNORMALITIES; OXIDASE DEFICIENCY; RESPIRATORY-CHAIN; PPAR-ALPHA; STEATOHEPATITIS; ACTIVATION; HOMEOSTASIS; STEATOSIS	OXPHOS is believed to play an important role in non-alcoholic fatty liver disease (NAFLD), however, precise mechanisms whereby OXPHOS influences lipid homeostasis are incompletely understood. We previously reported that ectopic expression of LRPPRC, a protein that increases cristae density and OXPHOS, promoted fatty acid oxidation in cultured primary hepatocytes. To determine the biological significance of that observation and define underlying mechanisms, we have ectopically expressed LRPPRC in mouse liver in the setting of NAFLD. Interestingly, ectopic expression of LRPPRC in mouse liver completely interdicted NAFLD, including inflammation. Consistent with mitigation of NAFLD, two markers of hepatic insulin resistance-ROS and PKC epsilon activity-were both modestly reduced. As reported by others, improvement of NAFLD was associated with improved whole-body insulin sensitivity. Regarding hepatic lipid homeostasis, the ratio of NAD(+) to NADH was dramatically increased in mouse liver replete with LRPPRC. Pharmacological activators and inhibitors of the cellular respiration respectively increased and decreased the [NAD(+)]/[NADH] ratio, indicating respiration-mediated control of the [NAD(+)]/[NADH] ratio. Supporting a prominent role for NAD(+), increasing the concentration of NAD(+) stimulated complete oxidation of fatty acids. Importantly, NAD(+) rescued impaired fatty acid oxidation in hepatocytes deficient for either OXPHOS or SIRT3. These data are consistent with a model whereby augmented hepatic OXPHOS increases NAD(+), which in turn promotes complete oxidation of fatty acids and protects against NAFLD.	[Akie, Thomas E.; Liu, Lijun; Nam, Minwoo; Lei, Shi; Cooper, Marcus P.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Cooper, MP (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01605 USA.	marcus.cooper@umassmed.edu			National Institute of Diabetes and Digestive and Kidney Disease grant [5R01DK089185]; Diabetes Endocrinology Research Center Pilot (DERC); Feasibility Program at the University of Massachusetts Medical School; University of Massachusetts Medical School DERC [DK32520]; Diabetes Research Center grant [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089185, P30DK032520] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease grant; Diabetes Endocrinology Research Center Pilot (DERC); Feasibility Program at the University of Massachusetts Medical School; University of Massachusetts Medical School DERC; Diabetes Research Center grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Disease grant 5R01DK089185 (to M.P. Cooper) and the Diabetes Endocrinology Research Center Pilot (DERC) and Feasibility Program at the University of Massachusetts Medical School (to M.P. Cooper). M.P. Cooper is a member of the University of Massachusetts Medical School DERC (DK32520), and core resources supported by Diabetes Research Center grant DK32520 were also used.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bellafante E, 2013, HEPATOLOGY, V57, P1343, DOI 10.1002/hep.26222; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, J HEPATOL, V31, P430, DOI 10.1016/S0168-8278(99)80033-6; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Eaton S, 1996, BIOCHEM J, V319, P633, DOI 10.1042/bj3190633; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Ganji SH, 2014, AM J PHYSIOL-GASTR L, V306, pG320, DOI 10.1152/ajpgi.00181.2013; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lelliott CJ, 2007, ARTERIOSCL THROM VAS, V27, P2707, DOI 10.1161/ATVBAHA.107.155739; Liu LJ, 2014, J CLIN INVEST, V124, P768, DOI 10.1172/JCI69413; Liu LJ, 2011, J BIOL CHEM, V286, P41253, DOI 10.1074/jbc.M111.276121; MERANTE F, 1993, AM J HUM GENET, V53, P481; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORIN C, 1993, AM J HUM GENET, V53, P488; Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Sondheimer N, 2010, BIOCHEMISTRY-US, V49, P7467, DOI 10.1021/bi1008479; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001	47	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125617	10.1371/journal.pone.0125617	http://dx.doi.org/10.1371/journal.pone.0125617			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933096	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100123
J	Drazic, A; Kutzner, E; Winter, J; Eisenreich, W				Drazic, Adrian; Kutzner, Erika; Winter, Jeannette; Eisenreich, Wolfgang			Metabolic Response of Escherichia coli upon Treatment with Hypochlorite at Sub-Lethal Concentrations	PLOS ONE			English	Article							REDOX-REGULATED CHAPERONE; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; METHIONINE OXIDATION; ACID; PROTEIN; DAMAGE; MODEL; IDENTIFICATION; NEUTROPHILS	Hypochlorite is a reactive oxygen species that is worldwide as an antibacterial disinfectant. Hypochlorite exposure is known to cause oxidative damage to DNA and proteins. As a response to these effects, the metabolite profiles of organisms treated with sub-lethal doses of hypochlorite are assumed to be severely modified; however, the nature of these changes is hardly understood. Therefore, using nuclear magnetic resonance spectroscopy and gas chromatography-coupled mass spectrometry, we analyzed the time-dependent impact of hypochlorite exposure with a sub-lethal concentration (50 mu M) on the metabolite profile of the Escherichia coli strain MG1655. Principle component analysis clearly distinguished between the metabolite profiles of bacteria treated for 0, 5,10, 20, 40, or 60 min. Major changes in the relative amounts of fatty acids, acetic acid, and formic acid occurred within the first 5 min. Comparative gas chromatography-coupled mass spectrometry analyses revealed that the amounts of free methionine and alanine were significantly decreased in the treated cells, demonstrating their susceptibility to hypochlorite exposure. The concentrations of succinate, urea, orotic acid, 2-aminobutyric acid, and 2-hydroxybutyric acid were also severely affected, indicating general changes in the metabolic network by hypochlorite. However, most metabolite levels relaxed to the reference values of untreated cells after 4060 min, reflecting the capability of E. coli to rapidly adapt to environmental stress factors such as the presence of sub-lethal oxidant levels.	[Drazic, Adrian; Winter, Jeannette] Tech Univ Munich, Lehrstuhl Biotechnol, CiPSM, Garching, Germany; [Kutzner, Erika; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, Garching, Germany	Technical University of Munich; Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, Lehrstuhl Biotechnol, CiPSM, Lichtenbergstr 4, Garching, Germany.	winter.jeannette@gmail.com; wolfgang.eisenreich@ch.tum.de	Drazic, Adrian/AAC-6120-2019; Eisenreich, Wolfgang/A-1258-2013	Drazic, Adrian/0000-0001-9263-5502; Eisenreich, Wolfgang/0000-0002-9832-8279	Deutsche Forschungsgemeinschaft [DR 998/2-1, SPP 1316, EI 384/6]; Elitenetzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern	Adrian Drazic thanks the Deutsche Forschungsgemeinschaft (DR 998/2-1) and the Elitenetzwerk Bayern for funding. Wolfgang Eisenreich and Erika Kutzner thank the Deutsche Forschungsgemeinschaft (SPP 1316; EI 384/6) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 2005, PROTEOMICS, V5, P3684, DOI 10.1002/pmic.200401218; CANDEIAS LP, 1994, FREE RADICAL RES, V20, P241, DOI 10.3109/10715769409147520; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chesney JA, 1996, J BACTERIOL, V178, P2131, DOI 10.1128/jb.178.7.2131-2135.1996; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Deng KP, 2011, APPL ENVIRON MICROB, V77, P3952, DOI 10.1128/AEM.02420-10; Drazic A, 2014, BBA-PROTEINS PROTEOM, V1844, P1367, DOI 10.1016/j.bbapap.2014.01.001; Drazic A, 2014, J BIOL CHEM, V289, P977, DOI 10.1074/jbc.M113.521401; Drazic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075683; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Dukan S, 1997, APPL ENVIRON MICROB, V63, P4204, DOI 10.1128/AEM.63.11.4204-4209.1997; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; Grosser N, 2004, BIOCHEM BIOPH RES CO, V314, P351, DOI 10.1016/j.bbrc.2003.12.089; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hazen SL, 1998, J BIOL CHEM, V273, P4997, DOI 10.1074/jbc.273.9.4997; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kirkpatrick C, 2001, J BACTERIOL, V183, P6466, DOI 10.1128/JB.183.21.6466-6477.2001; Kumar A, 2012, CURR SCI INDIA, V102, P288; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leonhartsberger S, 2002, J MOL MICROB BIOTECH, V4, P269; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Mermod M, 2012, BIOMETALS, V25, P33, DOI 10.1007/s10534-011-9510-x; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Morales EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-63; Pan TWM, 1996, PROG NUCL MAGN RESON, V28, P161, DOI DOI 10.1016/0079-6565(95)01017-3; Parker BW, 2013, J BIOL CHEM, V288, P32574, DOI 10.1074/jbc.M113.503516; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Roos D, 2002, SCIENCE, V296, P669, DOI 10.1126/science.1071271; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; Shen T, 2013, MOL BIOSYST, V9, P121, DOI 10.1039/c2mb25285f; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Tkachenko A G, 2001, Mikrobiologiia, V70, P487; Valdivia-Gonzalez M, 2012, BIOMETALS, V25, P451, DOI 10.1007/s10534-012-9518-x; VANDENBERG J, 1994, METHOD ENZYMOL, V233, P639; VISSERS MCM, 1994, FREE RADICAL BIO MED, V16, P703, DOI 10.1016/0891-5849(94)90185-6; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; WILLETTS NS, 1967, BIOCHEM J, V103, P453, DOI 10.1042/bj1030453; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Yuan W, 2009, J BIOL CHEM, V284, P26908, DOI 10.1074/jbc.M109.005496	50	19	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125823	10.1371/journal.pone.0125823	http://dx.doi.org/10.1371/journal.pone.0125823			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932918	Green Published, gold			2022-12-26	WOS:000353887100135
J	Bhat, A; Greulich, MM; Martins, EP				Bhat, Anuradha; Greulich, Melissa M.; Martins, Emilia P.			Behavioral Plasticity in Response to Environmental Manipulation among Zebrafish (Danio rerio) Populations	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; SOCIAL-ENVIRONMENT; HABITAT STABILITY; EVOLUTION; PREDATOR; INFORMATION; AGGRESSION; EXPERIENCE; MONOPOLIZATION; RECOGNITION	Plastic responses can have adaptive significance for organisms occurring in unpredictable environments, migratory species and organisms occupying novel environments. Zebrafish (Danio rerio) occur in a wide range of habitats and environments that fluctuate frequently across seasons and habitats. We expect wild populations of fish to be behaviorally more flexible than fish reared in conventional laboratory and hatchery environments. We measured three behavioral traits among 2 wild (U and PN) and 1 laboratory bred (SH) zebrafish populations in four environments differing in water flow and vegetation regimes. We found that the degree of plasticity varied with the type of behavior and also among populations. In general, vegetation increased aggression and water flow decreased latency to feed after a disturbance, but the patterns were population dependent. For example, while wild U fish fed more readily after a disturbance in vegetated and/or flowing habitats, fish from the wild PN population and lab-reared SH strain showed little variation in foraging across different environmental conditions. Zebrafish from all the three populations were more aggressive when tested in an arena with vegetation. In contrast, while there was an inter-population difference in shoaling distances, variation in shoaling distance across environmental conditions within populations was not significant. These results suggest that both foraging and aggression in zebrafish are more plastic and influenced by immediate context than is shoaling distance, which may have a stronger genetic basis. Our findings point to different underlying mechanisms influencing the expression of these traits and warrants further investigations.	[Bhat, Anuradha; Greulich, Melissa M.; Martins, Emilia P.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Bhat, Anuradha; Greulich, Melissa M.; Martins, Emilia P.] Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN USA; [Bhat, Anuradha] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur, India	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indian Institute of Science Education & Research (IISER) - Kolkata	Bhat, A (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	anuradhabhat@iiserkol.ac.in		Martins, Emilia/0000-0002-8952-3240	National Science Foundation [IOB-0543491, IOS-1257562]; Summer Research Experience for Undergraduates program in Animal Behavior at Indiana University - National Science Foundation [0453403]; Division Of Environmental Biology [1257562] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Summer Research Experience for Undergraduates program in Animal Behavior at Indiana University - National Science Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by funds from National Science Foundation award to EPM (IOB-0543491 and IOS-1257562) and the Summer Research Experience for Undergraduates program in Animal Behavior at Indiana University (funded by National Science Foundation Grant number 0453403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Ariyomo TO, 2013, BEHAV GENET, V43, P161, DOI 10.1007/s10519-013-9585-y; Asbury DA, 2007, EVOL ECOL RES, V9, P801; Barman R.P., 1991, Records of the Zoological Survey of India Occasional Paper, V137, P1; Basquill SP, 1998, CAN J ZOOL, V76, P770, DOI 10.1139/cjz-76-4-770; Bhat A, 2003, ENVIRON BIOL FISH, V68, P25, DOI 10.1023/A:1026017119070; Brown C, 1999, ETHOLOGY, V105, P491, DOI 10.1046/j.1439-0310.1999.00442.x; Brown C, 2003, J FISH BIOL, V63, P187, DOI 10.1111/j.1095-8649.2003.00208.x; Brown C, 2001, J FISH BIOL, V59, P471, DOI [10.1006/jfbi.2001.1689, 10.1111/j.1095-8649.2001.tb02354.x]; Brydges NM, 2008, ANIM BEHAV, V75, P935, DOI 10.1016/j.anbehav.2007.08.005; Chipps SR, 2004, OECOLOGIA, V138, P32, DOI 10.1007/s00442-003-1396-z; CHIVERS DP, 1995, ETHOLOGY, V99, P286; Engeszer RE, 2007, ANIM BEHAV, V74, P1269, DOI 10.1016/j.anbehav.2007.01.032; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Foster SA, 1999, TRENDS ECOL EVOL, V14, P190, DOI 10.1016/S0169-5347(98)01577-8; Hamilton IM, 2002, CAN J ZOOL, V80, P2164, DOI 10.1139/Z02-199; Hazlett B.A., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P317; Jarvi T., 1993, NORDIC J FRESHWATER, V68, P63; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Ketterson ED, 1999, AM NAT, V154, pS4, DOI 10.1086/303280; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; MAGURRAN AE, 1988, ETHOLOGY, V78, P153; Marks C, 2005, COPEIA, P901, DOI 10.1643/0045-8511(2005)005[0901:DEACAI]2.0.CO;2; McClure MM, 2006, J FISH BIOL, V69, P553, DOI 10.1111/j.1095-8649.2006.01125.x; Moretz JA, 2007, ENVIRON BIOL FISH, V80, P91, DOI 10.1007/s10641-006-9122-4; Moretz JA, 2007, BEHAV ECOL, V18, P556, DOI 10.1093/beheco/arm011; Norton WHJ, 2011, J NEUROSCI, V31, P13796, DOI 10.1523/JNEUROSCI.2892-11.2011; Odling-Smee L, 2003, ANIM BEHAV, V65, P701, DOI 10.1006/anbe.2003.2082; Parrish JD, 2000, STUD AVIAN BIOL-SER, P53; Pitcher T.J., 1986, P294; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Rehage JS, 2005, BEHAV ECOL SOCIOBIOL, V57, P256, DOI 10.1007/s00265-004-0850-1; Salvanes AGV, 2005, BEHAV ECOL SOCIOBIOL, V59, P250, DOI 10.1007/s00265-005-0031-x; Salvanes AGV, 2007, ANIM BEHAV, V74, P805, DOI 10.1016/j.anbehav.2007.02.007; Salvanes AGV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1331; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih Andrew, 2004, P112; Spence R, 2006, J FISH BIOL, V69, P1435, DOI 10.1111/j.1095-8649.2006.01206.x; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; SPSS, 2006, SPSS US MAN REL 11 5; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Sundstrom LF, 2001, ANIM BEHAV, V61, P249, DOI 10.1006/anbe.2000.1593; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341	50	45	46	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125097	10.1371/journal.pone.0125097	http://dx.doi.org/10.1371/journal.pone.0125097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927838	gold, Green Submitted, Green Published			2022-12-26	WOS:000353713100067
J	Bullard, KM; Ali, MK; Imperatore, G; Geiss, LS; Saydah, SH; Albu, JB; Cowie, CC; Sohler, N; Albright, A; Gregg, EW				Bullard, Kai McKeever; Ali, Mohammed K.; Imperatore, Giuseppina; Geiss, Linda S.; Saydah, Sharon H.; Albu, Jeanine B.; Cowie, Catherine C.; Sohler, Nancy; Albright, Ann; Gregg, Edward W.			Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007-2012	PLOS ONE			English	Article							COST-EFFECTIVENESS; CONTROLLED-TRIAL; NATIONAL-HEALTH; SECULAR CHANGES; UNITED-STATES; FOLLOW-UP; PREVENTION; PREVALENCE; ADULTS; RISK	Background Screening guidelines are used to help identify prediabetes and diabetes before implementing evidence-based prevention and treatment interventions. We examined screening practices benchmarking against two US guidelines, and the capacity of each guideline to identify dysglycemia. Methods Using 2007-2012 National Health and Nutrition Examination Surveys, we analyzed nationally-representative, cross-sectional data from 5,813 fasting non-pregnant adults aged >= 20 years without self-reported diabetes. We examined proportions of adults eligible for diagnostic glucose testing and those who self-reported receiving testing in the past three years, as recommended by the American Diabetes Association (ADA) and the US Preventive Services Task Force (USPSTF-2008) guidelines. For each screening guideline, we also assessed sensitivity, specificity, and positive (PPV) and negative predictive values in identifying dysglycemia (defined as fasting plasma glucose >= 100 mg/dl or hemoglobin A1c >= 5.7%). Results In 2007-2012, 73.0% and 23.7% of US adults without diagnosed diabetes met ADA and USPSTF-2008 criteria for screening, respectively; and 91.5% had at least one major risk factor for diabetes. Of those ADA- or USPSTF-eligible adults, about 51% reported being tested within the past three years. Eligible individuals not tested were more likely to be lower educated, poorer, uninsured, or have no usual place of care compared to tested eligible adults. Among adults with >= 1 major risk factor, 45.7% reported being tested, and dysglycemia yields (i.e., PPV) ranged from 45.8% (high-risk ethnicity) to 72.6% (self-reported prediabetes). ADA criteria and having any risk factor were more sensitive than the USPSTF-2008 guideline (88.8-97.7% vs. 31.0%) but less specific (13.5-39.7% vs. 82.1%) in recommending glucose testing, resulting in lower PPVs (47.7-54.4% vs. 58.4%). Conclusion Diverging recommendations and variable performance of different guidelines may be impeding national diabetes prevention and treatment efforts. Efforts to align screening recommendations may result in earlier identification of adults at high risk for prediabetes and diabetes.	[Bullard, Kai McKeever; Ali, Mohammed K.; Imperatore, Giuseppina; Geiss, Linda S.; Saydah, Sharon H.; Albright, Ann; Gregg, Edward W.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA; [Albu, Jeanine B.] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Dept Med, New York, NY USA; [Cowie, Catherine C.] NIH, NIDDK, Bethesda, MD 20892 USA; [Sohler, Nancy] CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA	Centers for Disease Control & Prevention - USA; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education	Bullard, KM (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA.	kbullard@cdc.gov	Ali, Mohammed K/N-9833-2013	Gregg, Edward/0000-0003-2381-6822; Ali, Mohammed/0000-0001-7266-2503	NIDDK NIH HHS [P60 DK020541, P30 DK020541] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bullard KM, 2013, DIABETES CARE, V36, P2286, DOI 10.2337/dc12-2563; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Casagrande SS, 2013, AM J PREV MED, V45, P167, DOI 10.1016/j.amepre.2013.02.026; Centers for Disease Control, 2020, NATL DIABETES STAT R; Centers for Disease Control and Prevention [Internet]. Hyattsville: National Center for Health Statistics (NCHS), HYATTSV NAT CTR HLTH; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Chung S, 2014, AM J PREV MED, V47, P375, DOI 10.1016/j.amepre.2014.05.012; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Echouffo-Tcheugui JB, 2011, EPIDEMIOL REV, V33, P63, DOI 10.1093/epirev/mxq020; Engelgau MM, 2012, LANCET, V380, P1716, DOI 10.1016/S0140-6736(12)61682-1; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Glumer C, 2006, DIABETOLOGIA, V49, P1536, DOI 10.1007/s00125-006-0248-x; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Li YF, 2013, MMWR-MORBID MORTAL W, V62, P209; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; National Institute for Health and Care Excellence, 2013, NICE GUID, pPH38; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Ratner RE, 2011, DIABETES CARE, V34, P1054, DOI 10.2337/dc10-1987; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sheehy AM, 2010, MAYO CLIN PROC, V85, P27, DOI 10.4065/mcp.2009.0289; U.S. Preventive Services Task Force [Internet]. Rockville: USPSTF Program Office, TOP UPD PROGR ABN GL; Wilson JMG, 1968, PRINCIPLES PRACTICE; World Health Organization, 2006, DEF DIAGN DIAB MELL	34	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125249	10.1371/journal.pone.0125249	http://dx.doi.org/10.1371/journal.pone.0125249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928306	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100073
J	Donohoe, OH; Henshilwood, K; Way, K; Hakimjavadi, R; Stone, DM; Walls, D				Donohoe, Owen H.; Henshilwood, Kathy; Way, Keith; Hakimjavadi, Roya; Stone, David M.; Walls, Dermot			Identification and Characterization of Cyprinid Herpesvirus-3 (CyHV-3) Encoded MicroRNAs	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; KOI HERPESVIRUS; SMALL RNAS; COMMON CARP; CANONICAL MICRORNAS; EVOLUTIONARY FLUX; OFFSET RNAS; TINY RNAS; EXPRESSION; DISEASE	MicroRNAs (miRNAs) are a class of small non-coding RNAs involved in post-transcriptional gene regulation. Some viruses encode their own miRNAs and these are increasingly being recognized as important modulators of viral and host gene expression. Cyprinid herpesvirus 3 (CyHV-3) is a highly pathogenic agent that causes acute mass mortalities in carp (Cyprinus carpio carpio) and koi (Cyprinus carpio koi) worldwide. Here, bioinformatic analyses of the CyHV-3 genome suggested the presence of non-conserved precursor miRNA (pre-miRNA) genes. Deep sequencing of small RNA fractions prepared from in vitro CyHV-3 infections led to the identification of potential miRNAs and miRNA-offset RNAs (moRNAs) derived from some bioinformatically predicted pre-miRNAs. DNA microarray hybridization analysis, Northern blotting and stem-loop RT-qPCR were then used to definitively confirm that CyHV-3 expresses two pre-miRNAs during infection in vitro. The evidence also suggested the presence of an additional four high-probability and two putative viral pre-miRNAs. MiRNAs from the two confirmed pre-miRNAs were also detected in gill tissue from CyHV-3-infected carp. We also present evidence that one confirmed miRNA can regulate the expression of a putative CyHV-3-encoded dUTPase. Candidate homologues of some CyHV-3 pre-miRNAs were identified in CyHV-1 and CyHV-2. This is the first report of miRNA and moRNA genes encoded by members of the Alloherpesviridae family, a group distantly related to the Herpesviridae family. The discovery of these novel CyHV-3 genes may help further our understanding of the biology of this economically important virus and their encoded miRNAs may have potential as biomarkers for the diagnosis of latent CyHV-3.	[Donohoe, Owen H.; Henshilwood, Kathy] Inst Marine, Oranmore, Co Galway, Ireland; [Donohoe, Owen H.; Hakimjavadi, Roya; Walls, Dermot] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Donohoe, Owen H.; Hakimjavadi, Roya; Walls, Dermot] Dublin City Univ, Natl Ctr Sensor Res, Dublin 9, Ireland; [Way, Keith; Stone, David M.] Nothe, Cefas, Weymouth, Dorset, England	Marine Institute Ireland; Dublin City University; Dublin City University; Centre for Environment Fisheries & Aquaculture Science	Walls, D (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland.	dermot.walls@dcu.ie		Donohoe, Owen/0000-0002-1068-5248; Walls, Dermot/0000-0002-2244-2294	Marine Institute Research Fellowship programme; Defra; Programme for Research in Third Level Institutions (PRTLI) Cycle 5 [The Bioanalysis and Therapeutics (BioAT) programme at DCU].; European Regional Development Fund (ERDF), European Union Structural Funds Programme;  [FC1193];  [FC1202]	Marine Institute Research Fellowship programme; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Programme for Research in Third Level Institutions (PRTLI) Cycle 5 [The Bioanalysis and Therapeutics (BioAT) programme at DCU].; European Regional Development Fund (ERDF), European Union Structural Funds Programme; ; 	This work was supported by the Marine Institute Research Fellowship programme (https://www.marine.ie; OHD), Defra (https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs; research contracts FC1193 and FC1202; KW), the Programme for Research in Third Level Institutions (PRTLI) (http://www.hea.ie/en/prtli,official; RH, DW) Cycle 5 [The Bioanalysis and Therapeutics (BioAT) programme at DCU]. The PRTLI is co-funded through the European Regional Development Fund (ERDF), part of the European Union Structural Funds Programme 2007-2013 (http://eustructuralfunds.gov.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S29; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Amen MA, 2011, J VIROL, V85, P7296, DOI 10.1128/JVI.00505-11; Aoki T, 2007, J VIROL, V81, P5058, DOI 10.1128/JVI.00146-07; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Berezikov E, 2010, NAT GENET, V42, P6, DOI 10.1038/ng0110-6; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bortoluzzi S, 2012, BLOOD, V119, pE120, DOI 10.1182/blood-2011-07-368001; Bortoluzzi S, 2011, TRENDS MOL MED, V17, P473, DOI 10.1016/j.molmed.2011.05.005; Buck AH, 2007, J VIROL, V81, P13761, DOI 10.1128/JVI.01290-07; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Campion EM, 2014, J VIROL, V88, P5001, DOI 10.1128/JVI.03642-13; Cazalla D, 2011, MOL CELL, V43, P982, DOI 10.1016/j.molcel.2011.07.025; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CJ, 2011, J VIROL, V85, P4487, DOI 10.1128/JVI.02557-10; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cui C, 2006, J VIROL, V80, P5499, DOI 10.1128/JVI.00200-06; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Davison AJ, 2013, J VIROL, V87, P2908, DOI 10.1128/JVI.03206-12; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Eide KE, 2011, J VIROL, V85, P4954, DOI 10.1128/JVI.01384-10; Engelsma MY, 2013, DIS AQUAT ORGAN, V107, P113, DOI 10.3354/dao02666; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gilad O, 2004, DIS AQUAT ORGAN, V60, P179, DOI 10.3354/dao060179; Glaunsinger BA, 2006, ADV VIRUS RES, V66, P337, DOI 10.1016/S0065-3527(06)66007-7; Gotesman M, 2013, DIS AQUAT ORGAN, V105, P163, DOI 10.3354/dao02614; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Gu Shuo, 2010, Silence, V1, P11, DOI 10.1186/1758-907X-1-11; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Haenen OLM, 2004, B EUR ASSOC FISH PAT, V24, P293; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hanson L, 2011, VIRUSES-BASEL, V3, P2160, DOI 10.3390/v3112160; Hedrick RP, 2000, J AQUAT ANIM HEALTH, V12, P44, DOI [10.1577/1548-8667(2000)012<0044:AHAWMM>2.0.CO;2, 10.1577/1548-8667(2000)012&lt;0044:AHAWMM&gt;2.0.CO;2]; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ilouze M, 2006, MICROBIOL MOL BIOL R, V70, P147, DOI 10.1128/MMBR.70.1.147-156.2006; Ilouze M, 2012, VIRUS RES, V169, P98, DOI 10.1016/j.virusres.2012.07.015; Ilouze M, 2011, ECOL RES, V26, P885, DOI 10.1007/s11284-010-0694-2; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Liao IC, 2009, ASIA PAC J CLIN NUTR, V18, P564; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin HR, 2011, P NATL ACAD SCI USA, V108, P5148, DOI 10.1073/pnas.1102033108; Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Lu J, 2010, NAT GENET, V42, P9, DOI 10.1038/ng0110-9; Meshesha Mesfin K, 2012, Open Virol J, V6, P38, DOI 10.2174/1874357901206010038; Michel B, 2010, J GEN VIROL, V91, P452, DOI 10.1099/vir.0.015198-0; Michel B, 2010, EMERG INFECT DIS, V16, P1835, DOI 10.3201/eid1612.100593; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Neukirch M, 1999, BULL EUR ASSN FISH P, V19, P221; Nozawa M, 2010, GENOME BIOL EVOL, V2, P180, DOI 10.1093/gbe/evq009; Pearson H, 2004, NATURE, V427, P577, DOI 10.1038/427577a; Penades JR, 2013, CURR OPIN MICROBIOL, V16, P163, DOI 10.1016/j.mib.2013.02.005; Perelberg A, 2003, ISR J AQUACULT-BAMID, V55, P5; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pokorova D, 2005, VET MED-CZECH, V50, P139, DOI 10.17221/5607-VETMED; Pratt ZL, 2009, VIROLOGY, V386, P387, DOI 10.1016/j.virol.2009.01.006; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rakus K, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-85; Reed AN, 2014, J VIROL, V88, P9297, DOI 10.1128/JVI.00990-14; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; sourceforge.net, 2013, MICRORNA DISCOVERY B; St-Hilaire S, 2005, DIS AQUAT ORGAN, V67, P15, DOI 10.3354/dao067015; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Sullivan CS, 2007, METHOD ENZYMOL, V427, P3, DOI 10.1016/S0076-6879(07)27001-6; Taft RJ, 2010, NAT STRUCT MOL BIOL, V17, P1030, DOI 10.1038/nsmb.1841; Takane K, 2011, JPN J INFECT DIS, V64, P357; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Umbach JL, 2010, VIROLOGY, V405, P592, DOI 10.1016/j.virol.2010.06.036; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Umbach JL, 2009, J VIROL, V83, P10677, DOI 10.1128/JVI.01185-09; Waltzek TB, 2005, J GEN VIROL, V86, P1659, DOI 10.1099/vir.0.80982-0; Waltzek TB, 2009, DIS AQUAT ORGAN, V84, P179, DOI 10.3354/dao02023; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Xu JR, 2013, J VIROL METHODS, V187, P372, DOI 10.1016/j.jviromet.2012.11.015; Yao YX, 2008, J VIROL, V82, P4007, DOI 10.1128/JVI.02659-07; Yao YX, 2007, J VIROL, V81, P7164, DOI 10.1128/JVI.00112-07; Yao YX, 2012, J GEN VIROL, V93, P1530, DOI 10.1099/vir.0.040634-0; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zhu JY, 2010, J VIROL, V84, P10266, DOI 10.1128/JVI.01119-10	130	18	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125434	10.1371/journal.pone.0125434	http://dx.doi.org/10.1371/journal.pone.0125434			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928140	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100091
J	Liu, YP; Zhu, PT; Wang, YY; Wei, ZH; Tao, L; Zhu, ZJ; Sheng, XB; Wang, SL; Ruan, JS; Liu, ZG; Cao, YZ; Shan, YL; Sun, LH; Wang, AY; Chen, WX; Lu, Y				Liu, Yuping; Zhu, Pingting; Wang, Yingyu; Wei, Zhonghong; Tao, Li; Zhu, Zhijie; Sheng, Xiaobo; Wang, Siliang; Ruan, Junshan; Liu, Zhaoguo; Cao, Yuzhu; Shan, Yunlong; Sun, Lihua; Wang, Aiyun; Chen, Wenxing; Lu, Yin			Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-kappa B and ERK/MAPK Signaling Pathways	PLOS ONE			English	Article							CELL-CYCLE ARREST; MATRIX METALLOPROTEINASES; APOPTOSIS INDUCTION; EXPRESSION; PROLIFERATION; STRATEGIES; MIGRATION; MMP-9; MAPK	Background Migration and invasion are two crucial steps of tumor metastasis. Blockage of these steps may be an effective strategy to reduce the risk. The objective of the present study was to investigate the effects of diallyl trisulfide (DATS), a natural organosulfuric compound with most sulfur atoms found in garlic, on migration and invasion in triple negative breast cancer (TNBC) cells. Molecular mechanisms underlying the anticancer effects of DATS were further investigated. Methods and Results MDA-MB-231 cells and HS 578t breast cancer cells were treated with different concentrations of DATS. DATS obviously suppressed the migration and invasion of two cell lines and changed the morphological. Moreover, DATS inhibited the mRNA/protein/enzymes activities of MMP2/9 via attenuating the NF-kappa B pathway. DATS also inhibited ERK/MAPK rather than p38 and JNK. Conclusion DATS inhibits MMP2/9 activity and the metastasis of TNBC cells, and emerges as a potential anti-cancer agent. The inhibitory effects are associated with down-regulation of the transcriptional activities of NF-kappa B and ERK/MAPK signaling pathways.	[Liu, Yuping; Zhu, Pingting; Wang, Yingyu; Wei, Zhonghong; Tao, Li; Zhu, Zhijie; Sheng, Xiaobo; Wang, Siliang; Ruan, Junshan; Liu, Zhaoguo; Cao, Yuzhu; Shan, Yunlong; Sun, Lihua; Wang, Aiyun; Chen, Wenxing; Lu, Yin] Nanjing Univ Chinese Med, Sch Pharm, Nanjing 210023, Jiangsu, Peoples R China; [Zhu, Pingting] Yangzhou Univ, Coll Med, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Aiyun; Chen, Wenxing; Lu, Yin] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Tradit Chinese Med, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Yangzhou University; Nanjing University of Chinese Medicine	Lu, Y (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Nanjing 210023, Jiangsu, Peoples R China.	profyinlu@163.com	Tao, Li/AAF-4654-2021; Chen, Wenxing/GSI-9910-2022	Chen, Wenxing/0000-0003-4571-7622	National Natural Science Foundation of China [81173174, 81403260, 81202655]; National Key Technology Research & Development Program [2008BAI51B02]; Ph.D. Programs Foundation of Ministry of Education of China [20113237110008]; Chinese Postdoctoral Science Foundation [2014M551639]; Postdoctoral Science Foundation of Jiangsu province [1401138C]; Doctoral Innovation Project of Jiangsu Province [KYLX_0977]; Jiangsu College graduate research and innovation projects [KYLX_0977, CXZZ13_0627]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research & Development Program; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Jiangsu province(China Postdoctoral Science Foundation); Doctoral Innovation Project of Jiangsu Province; Jiangsu College graduate research and innovation projects	This work was supported by the National Natural Science Foundation of China (No. 81173174, 81403260 and 81202655); The National Key Technology Research & Development Program (No. 2008BAI51B02); Ph.D. Programs Foundation of Ministry of Education of China (No. 20113237110008); Chinese Postdoctoral Science Foundation (2014M551639); Postdoctoral Science Foundation of Jiangsu province (1401138C); Doctoral Innovation Project of Jiangsu Province (KYLX_0977); Jiangsu College graduate research and innovation projects (No. KYLX_0977; CXZZ13_0627). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antosiewicz J, 2006, CANCER RES, V66, P5379, DOI 10.1158/0008-5472.CAN-06-0356; Arslan C, 2009, EXPERT OPIN PHARMACO, V10, P2081, DOI 10.1517/14656560903117309; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; Calvo-Gomez O, 2004, J CHROMATOGR A, V1036, P91, DOI 10.1016/j.chroma.2004.02.072; Chandra-Kuntal K, 2013, BREAST CANCER RES TR, V138, P69, DOI 10.1007/s10549-013-2440-2; Chandra-Kuntal K, 2010, CANCER PREV RES, V3, P1473, DOI 10.1158/1940-6207.CAPR-10-0123; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Ferlay J, 2012, GLOBOCAN 2012 ESTIMA; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Galeone C, 2009, PUBLIC HEALTH NUTR, V12, P1576, DOI 10.1017/S1368980008003820; Garg P, 2010, CANCER RES, V70, P792, DOI 10.1158/0008-5472.CAN-09-3166; Gershtein ES, 2010, B EXP BIOL MED+, V150, P71, DOI 10.1007/s10517-010-1072-3; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Hadler-Olsen E, 2013, TUMOR BIOL, V34, P2041, DOI 10.1007/s13277-013-0842-8; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Hong BH, 2013, MOL NUTR FOOD RES, V57, P886, DOI 10.1002/mnfr.201200715; Hosono T, 2005, J BIOL CHEM, V280, P41487, DOI 10.1074/jbc.M507127200; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Jakubikova J, 2006, NEOPLASMA, V53, P191; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lai KC, 2013, ENVIRON TOXICOL, V28, P479, DOI 10.1002/tox.20737; Levi F, 1999, BRIT J CANCER, V79, P1283, DOI 10.1038/sj.bjc.6690206; Li WJ, 2012, ACTA BIOCH BIOPH SIN, V44, P577, DOI 10.1093/abbs/gms033; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Malki A, 2009, CANCER BIOL THER, V8, P2174, DOI 10.4161/cbt.8.22.9882; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Nkrumah-Elie YM, 2012, FOOD CHEM TOXICOL, V50, P2524, DOI 10.1016/j.fct.2012.04.010; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Reddy KB, 1999, INT J CANCER, V82, P268, DOI 10.1002/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.3.CO;2-W; Shin DY, 2014, ENVIRON TOXICOL PHAR, V37, P74, DOI 10.1016/j.etap.2013.11.002; Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b; Tsubura A, 2011, ANTI-CANCER AGENT ME, V11, P249, DOI 10.2174/187152011795347441; Uekita T, 2014, MOL CANCER RES IN PR; Wu XJ, 2009, ENVIRON MOL MUTAGEN, V50, P266, DOI 10.1002/em.20467; Xin JW, 2009, TRIGGERS PATHWAYS AN, V50, P266; Yi L, 2013, FOOD CHEM TOXICOL, V57, P362, DOI 10.1016/j.fct.2013.04.001	38	51	54	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123781	10.1371/journal.pone.0123781	http://dx.doi.org/10.1371/journal.pone.0123781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927362	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100022
J	Lo, K; Cheung, C; Lee, A; Tam, WWS; Keung, V				Lo, Kenneth; Cheung, Calvin; Lee, Albert; Tam, Wilson W. S.; Keung, Vera			Associations between Parental Feeding Styles and Childhood Eating Habits: A Survey of Hong Kong Pre-School Children	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; FOOD-CONSUMPTION; FRUIT; BEHAVIOR; RISK; VALIDATION	Childhood obesity is a global public health issue, including in the Chinese setting, and its prevalence has increased dramatically throughout the last decade. Since the origins of childhood obesity may lie in the pre-school period, factors relating to very young children's food consumption should be investigated. Parental influence, including feeding style, is the major determinant of childhood dietary behaviour through altering food provision and social environment. However, the applicability of previous research on parental feeding styles was limited by small sample size. To evaluate the influence of parental feeding styles on children's dietary patterns, a cross-sectional study was conducted among 4553 pre-schoolers in Hong Kong. Information was obtained about dietary intake and how regularly they had breakfast, using previous health surveillance surveys taken among primary school students. Parental feeding styles were assessed by a validated Parental Feeding Style Questionnaire and categorized into 'instrumental feeding', 'emotional feeding', 'prompting and encouragement to eat' and 'control over eating'. Multivariable analysis was performed, adjusted for demographic information. Instrumental and/or emotional feeding was found to relate to inadequate consumption of fruit, vegetables and breakfast, and positively correlated with intake of high-energy-density food. Encouragement on eating was associated with more frequent consumption of fruits, vegetables, dairy products and breakfast. Control over eating correlated with more frequent consumption of fruits, vegetables and breakfast, and less consumption of dairy products and high-energy-density food. The present study has provided evidence on the associations between parental feeding styles and dietary patterns of Hong Kong pre-school children from a reasonably large population. Parents should avoid instrumental and emotional feeding, and implement control and encouragement to promote healthy food intake. Longitudinal studies and interventions on parental feeding style are required to confirm the research findings.	[Lo, Kenneth; Lee, Albert] Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Cheung, Calvin; Keung, Vera] Chinese Univ Hong Kong, Ctr Hlth Educ & Hlth Promot, Hong Kong, Hong Kong, Peoples R China; [Tam, Wilson W. S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Alice Lee Ctr Nursing Studies, Singapore 117548, Singapore	Chinese University of Hong Kong; Chinese University of Hong Kong; National University of Singapore	Lee, A (corresponding author), Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	alee@cuhk.edu.hk	Lo, Kenneth/ABB-6248-2020; TAM, Wilson W.S./H-5890-2019; Tam, Wilson/K-1664-2019	Lo, Kenneth/0000-0003-4624-2737; TAM, Wilson W.S./0000-0003-0641-3060; 	Pfizer for Nutrition Education for Kindergartens	Pfizer for Nutrition Education for Kindergartens	This study was supported by a sponsorship from Pfizer for Nutrition Education for Kindergartens. No grant number and URL are available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch LL, 2001, PEDIATR CLIN N AM, V48, P893, DOI 10.1016/S0031-3955(05)70347-3; Blissett J, 2011, APPETITE, V57, P826, DOI 10.1016/j.appet.2011.05.318; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Chen HY, 2010, J CLIN NURS, V19, P234, DOI 10.1111/j.1365-2702.2009.02896.x; Deparment of Health, 2012, BACKGR STARTSMART SC; Department of Health, 2011, 3 6 YEARS OLD FOOD P; Department of Health, 2011, NUTR GUID CHILDR AG; Elwood PC, 2010, LIPIDS, V45, P925, DOI 10.1007/s11745-010-3412-5; Faith MS, 2004, OBES RES, V12, P1711, DOI 10.1038/oby.2004.212; Hennessy E, 2012, J ACAD NUTR DIET, V112, P142, DOI 10.1016/j.jada.2011.08.030; Hubbs-Tait L, 2008, J AM DIET ASSOC, V108, P1154, DOI 10.1016/j.jada.2008.04.008; Hughes SO, 2007, J DEV BEHAV PEDIATR, V28, P100, DOI 10.1097/01.DBP.0000267561.34199.a9; Hurley KM, 2011, J NUTR, V141, P495, DOI 10.3945/jn.110.130047; Jansen E, 2012, EARLY CHILD DEV CARE, V182, P967, DOI 10.1080/03004430.2012.678593; Lazarte CE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-61; Lee A, 2004, PUBLIC HEALTH, V118, P88, DOI 10.1016/S0033-3506(03)00174-4; Lee A, 2013, PUBLIC HEALTH, V127, P182, DOI 10.1016/j.puhe.2012.11.001; Loth KA, 2013, APPETITE, V60, P140, DOI 10.1016/j.appet.2012.09.019; Moens E, 2007, J PEDIATR PSYCHOL, V32, P52, DOI 10.1093/jpepsy/jsl011; Monge-Rojas R, 2010, APPETITE, V55, P253, DOI 10.1016/j.appet.2010.06.010; NEWMAN J, 1992, J EXP CHILD PSYCHOL, V53, P200, DOI 10.1016/0022-0965(92)90049-C; O'Connor TM, 2010, PUBLIC HEALTH NUTR, V13, P91, DOI 10.1017/S1368980009005916; Ogden J, 2006, APPETITE, V47, P100, DOI 10.1016/j.appet.2006.03.330; Patrick H, 2005, APPETITE, V44, P243, DOI 10.1016/j.appet.2002.07.001; Pearson N, 2009, PUBLIC HEALTH NUTR, V12, P267, DOI 10.1017/S1368980008002589; Sleddens EFC, 2010, APPETITE, V54, P30, DOI 10.1016/j.appet.2009.09.002; Smith KJ, 2010, AM J CLIN NUTR, V92, P1316, DOI 10.3945/ajcn.2010.30101; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053069; Tam W, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1194; Vaughn AE, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-61; Wardle J, 2002, OBES RES, V10, P453, DOI 10.1038/oby.2002.63	31	30	33	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124753	10.1371/journal.pone.0124753	http://dx.doi.org/10.1371/journal.pone.0124753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25927836	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100047
J	Manning, J; Reynolds, G; Saygin, ZM; Hofmann, SG; Pollack, M; Gabrieli, JDE; Whitfield-Gabrieli, S				Manning, Joshua; Reynolds, Gretchen; Saygin, Zeynep M.; Hofmann, Stefan G.; Pollack, Mark; Gabrieli, John D. E.; Whitfield-Gabrieli, Susan			Altered Resting-State Functional Connectivity of the Frontal-Striatal Reward System in Social Anxiety Disorder	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; ANTERIOR CINGULATE; HUMAN BRAIN; FMRI; ANTICIPATION; ADOLESCENTS; VALUATION; NETWORKS	We investigated differences in the intrinsic functional brain organization (functional connectivity) of the human reward system between healthy control participants and patients with social anxiety disorder. Functional connectivity was measured in the resting-state via functional magnetic resonance imaging (fMRI). 53 patients with social anxiety disorder and 33 healthy control participants underwent a 6-minute resting-state fMRI scan. Functional connectivity of the reward system was analyzed by calculating whole-brain temporal correlations with a bilateral nucleus accumbens seed and a ventromedial prefrontal cortex seed. Patients with social anxiety disorder, relative to the control group, had (1) decreased functional connectivity between the nucleus accumbens seed and other regions associated with reward, including ventromedial prefrontal cortex; (2) decreased functional connectivity between the ventromedial prefrontal cortex seed and lateral prefrontal regions, including the anterior and dorsolateral prefrontal cortices; and (3) increased functional connectivity between both the nucleus accumbens seed and the ventromedial prefrontal cortex seed with more posterior brain regions, including anterior cingulate cortex. Social anxiety disorder appears to be associated with widespread differences in the functional connectivity of the reward system, including markedly decreased functional connectivity between reward regions and between reward regions and lateral prefrontal cortices, and markedly increased functional connectivity between reward regions and posterior brain regions.	[Manning, Joshua; Saygin, Zeynep M.; Gabrieli, John D. E.; Whitfield-Gabrieli, Susan] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Reynolds, Gretchen; Gabrieli, John D. E.; Whitfield-Gabrieli, Susan] MIT, Poitras Ctr Affect Disorders Res, Cambridge, MA 02139 USA; [Manning, Joshua; Saygin, Zeynep M.; Gabrieli, John D. E.; Whitfield-Gabrieli, Susan] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Reynolds, Gretchen; Hofmann, Stefan G.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Pollack, Mark] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston University; Rush University	Manning, J (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	joshuam@mit.edu	Hofmann, Stefan G/B-8769-2014; Gabrieli, John/AAJ-2869-2020; Saygin, Zeynep M./AAV-4951-2020	Hofmann, Stefan G/0000-0002-3548-9681; 	National Institutes of Health from the National Institute of Mental Health [R01MH078308, R01MH075889]; Poitras Center for Affective Disorder Research at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology, Cambridge, MA; Massachusetts Institute of Technology, Cambridge, MA; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078308, R01MH075889] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Mental Health; Poitras Center for Affective Disorder Research at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology, Cambridge, MA; Massachusetts Institute of Technology, Cambridge, MA; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	SGH and MP were funded by National Institutes of Health grants R01MH078308 and R01MH075889 from the National Institute of Mental Health. The study was funded by the Poitras Center for Affective Disorder Research at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology, Cambridge, MA. JM was funded by the Janet and Sheldon Razin Fellowship at the Massachusetts Institute of Technology, Cambridge, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2008, STAT PARAMETRIC MAPP; Bar-Haim Y, 2009, PSYCHOL SCI, V20, P1009, DOI 10.1111/j.1467-9280.2009.02401.x; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; Bruhl AB, 2011, BRAIN RES, V1378, P72, DOI 10.1016/j.brainres.2010.12.084; Cauda F, 2011, J COGNITIVE NEUROSCI, V23, P2864, DOI 10.1162/jocn.2011.21624; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; Guyer AE, 2006, J NEUROSCI, V26, P6399, DOI 10.1523/JNEUROSCI.0666-06.2006; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Helfinstein SM, 2011, NEUROPSYCHOLOGIA, V49, P479, DOI 10.1016/j.neuropsychologia.2010.12.015; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Liao W, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015283, DOI 10.1371/JOURNAL.PONE.0015283]; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Phan KL, 2009, BIOL PSYCHIAT, V66, P691, DOI 10.1016/j.biopsych.2009.02.028; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sladky R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050050; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Triantafyllou C, 2011, NEUROIMAGE, V55, P597, DOI 10.1016/j.neuroimage.2010.11.084; Turner SM, 1989, SOCIAL PHOBIA ANXIET; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Wechsler D., 1981, WAIS R MANUAL WECHSL	38	28	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125286	10.1371/journal.pone.0125286	http://dx.doi.org/10.1371/journal.pone.0125286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928647	Green Published, gold			2022-12-26	WOS:000353713100077
J	Pacilli, A; Lamacchia, O; Fontana, A; Copetti, M; Cignarelli, M; Trischitta, V; De Cosmo, S				Pacilli, Antonio; Lamacchia, Olga; Fontana, Andrea; Copetti, Massimiliano; Cignarelli, Mauro; Trischitta, Vincenzo; De Cosmo, Salvatore			Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							GLUCOSE CONTROL; BLOOD-PRESSURE; FOLLOW-UP; METAANALYSIS; CHOLESTEROL; PEOPLE; DISEASE; EVENTS; COMPLICATIONS; PREVENTION	Background To investigate prospectively the relationship between target values of glycated hemoglobin, blood pressure and LDL-cholesterol, as considered in a combined fashion, and all-cause mortality in patients with type 2 diabetes mellitus. Methods Two cohorts of patients with type 2 diabetes mellitus, the Gargano Mortality Study (n=810) and the Foggia Mortality Study (n=929), were investigated. A weighted target risk score was built as a weight linear combination of the recommended targets reached by each patient. Results In the Gargano Mortality Study and in the Foggia Mortality Study (mean follow up=7.4 and 5.5 years, respectively), 161 (19.9%) and 220 (23.7%) patients died, with an age and sex adjusted annual incidence rate of 2.1 and 2.8 per 100 person-years, respectively. In both study samples the weighted target risk score tended to be linearly associated with all-cause mortality (HR for one point increment=1.30, 95% CI: 1.11-1.53, p=0.001, and HR=1.08, 95% CI: 0.95-1.24, p=0.243, respectively). When the two cohorts were pooled and analyzed together, a clear association between weighted target risk score and all-cause mortality was observed (HR for one point increment=1.17, 95% CI: 1.05-1.30, p=0.004). This counter-intuitive association was no longer observable in a model including age, sex, body mass index, smoking habit, estimated glomerular filtration rate, albuminuria and anti-diabetic, anti-hypertensive and anti-dyslipidemic treatment as covariates (HR for one point increment=0.99, 95% CI: 0.87-1.12, p=0.852). Conclusions In a real life clinical set of patients with type 2 diabetes mellitus, the combination of recommended target values of established cardiovascular risk factors is not associated with allcause mortality.	[Pacilli, Antonio; De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Unit Internal Med, San Giovanni Rotondo, Italy; [Lamacchia, Olga; Cignarelli, Mauro] Univ Foggia, Dept Surg & Med Sci, Unit Endocrinol & Metab Dis, Foggia, FG, Italy; [Fontana, Andrea; Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Foggia; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome	De Cosmo, S (corresponding author), IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Unit Internal Med, San Giovanni Rotondo, Italy.	sdecosm@tin.it	COPETTI, MASSIMILIANO/K-3186-2016; De Cosmo, Salvatore/J-7420-2016; Fontana, Andrea/J-8584-2016; TRISCHITTA, Vincenzo/K-1487-2016	COPETTI, MASSIMILIANO/0000-0002-7960-5947; De Cosmo, Salvatore/0000-0001-8787-8286; Fontana, Andrea/0000-0002-6660-5315; TRISCHITTA, Vincenzo/0000-0003-1174-127X	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Support was provided by the Italian Ministry of Health grants RF2009 (SDC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Bryg R J, 1999, Curr Hypertens Rep, V1, P337, DOI 10.1007/s11906-999-0043-4; Chiang HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109501; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; De Cosmo S, 2013, DIABETES CARE, V36, P2830, DOI 10.2337/dc12-1906; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Goldman N, 2006, J GERONTOL A-BIOL, V61, P1070, DOI 10.1093/gerona/61.10.1070; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; ISO H, 1994, J CLIN EPIDEMIOL, V47, P961, DOI 10.1016/0895-4356(94)90110-4; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lithovius R, 2015, ACTA DIABETOL, V52, P31, DOI 10.1007/s00592-014-0595-x; Nicholas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068008; Olkin I, 1998, BIOMETRICS, V54, P317, DOI 10.2307/2534018; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Ronnback M, 2006, HYPERTENSION, V47, P168, DOI 10.1161/01.HYP.0000199667.30253.b7; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Vamos EP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5567; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124536	10.1371/journal.pone.0124536	http://dx.doi.org/10.1371/journal.pone.0124536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928715	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100038
J	Sivanandhan, G; Dev, GK; Theboral, J; Selvaraj, N; Ganapathi, A; Manickavasagam, M				Sivanandhan, Ganeshan; Dev, Gnajothi Kapil; Theboral, Jeevaraj; Selvaraj, Natesan; Ganapathi, Andy; Manickavasagam, Markandan			Sonication, Vacuum Infiltration and Thiol Compounds Enhance the Agrobacterium-Mediated Transformation Frequency of Withania somnifera (L.) Dunal	PLOS ONE			English	Article							WITHANOLIDES PRODUCTION; ROOT CULTURES; GENE; CLONING; REGENERATION; EXPRESSION; EFFICIENCY; WITHAFERIN; SELECTION; CITRUS	In the present study, we have established a stable transformation protocol via Agrobacterium tumafacines for the pharmaceutically important Withania somnifera. Six day-old nodal explants were used for 3 day co-cultivation with Agrobacterium tumefaciens strain LBA4404 harbouring the vector pCAMIBA2301. Among the different injury treatments, sonication, vacuum infiltration and their combination treatments tested, a vacuum infiltration for 10 min followed by sonication for 10 sec with A. tumefaciens led to a higher transient GUS expression (84% explants expressing GUS at regenerating sites). In order to improve gene integration, thiol compounds were added to co-cultivation medium. A combined treatment of L-Cys at 100 mg/l, STS at 125 mg/l, DTT at 75 mg/l resulted in a higher GUS expression (90%) in the nodal explants. After 3 days of co-cultivation, the explants were subjected to three selection cycles with increasing concentrations of kanamycin [100 to 115 mg/l]. The integration and expression of gusA gene in T0 and T1 transgenic plants were confirmed by polymerase chain reaction (PCR), and Southern blott analysis. These transformed plants (T0 and T1) were fertile and morphologically normal. From the present investigation, we have achieved a higher transformation efficiency of (10%). Withanolides (withanolide A, withanolide B, withanone and withaferin A) contents of transformed plants (T0 and T1) were marginally higher than control plants.	[Sivanandhan, Ganeshan; Dev, Gnajothi Kapil; Theboral, Jeevaraj; Ganapathi, Andy; Manickavasagam, Markandan] Bharathidasan Univ, Sch Biotechnol, Dept Biotechnol & Genet Engn, Plant Mol Biol Lab, Tiruchirappalli 620024, Tamil Nadu, India; [Selvaraj, Natesan] Periyar EVR Coll Autonomous, Dept Bot, Plant Tissue Culture Lab, Tiruchirappalli 620023, Tamil Nadu, India; [Sivanandhan, Ganeshan] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Hort, Mol Genet & Genom Lab, Taejon 305764, South Korea	Bharathidasan University; Chungnam National University	Sivanandhan, G (corresponding author), Bharathidasan Univ, Sch Biotechnol, Dept Biotechnol & Genet Engn, Plant Mol Biol Lab, Tiruchirappalli 620024, Tamil Nadu, India.	gsivabdu@gmail.com; manickbiotech@gmail.com		, G Kapildev/0000-0001-5448-4838	Council of Scientific and Industrial Research (CSIR) [38(1180/08/EMR-II)]; University Grants Commissions (UGC), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commissions (UGC), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by Council of Scientific and Industrial Research (CSIR) [38(1180/08/EMR-II)]. Prof. A. Ganapathi is thankful to the University Grants Commissions (UGC), Government of India, for the award of UGC-BSR (Basic Scientific Research Fellowship). The first author thankfully acknowledges the Council of Scientific and Industrial Research (CSIR), Government of India, for the award of CSIR-SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Altern Med Rev, V9, P211; Bakshi S, 2011, PLANT CELL REP, V30, P2281, DOI 10.1007/s00299-011-1133-8; Beranova M, 2008, PLANT CELL TISS ORG, V94, P253, DOI 10.1007/s11240-007-9335-z; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Bond JE, 1998, PLANT CELL REP, V18, P229, DOI 10.1007/s002990050562; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; De Clercq J, 2002, PLANT CELL REP, V21, P333, DOI 10.1007/s00299-002-0518-0; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dutta I, 2013, PLANT CELL TISS ORG, V112, P289, DOI 10.1007/s11240-012-0236-4; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; Franklin G, 2007, PLANT SCI, V172, P1193, DOI 10.1016/j.plantsci.2007.02.017; GOLDBERG JB, 1984, J BACTERIOL, V158, P1115, DOI 10.1128/JB.158.3.1115-1121.1984; Gupta P, 2013, PROTOPLASMA, V250, P285, DOI 10.1007/s00709-012-0410-x; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; JEFFERSON RA, 1987, EMBO J, V6, P3901; Joubert P, 2002, PLANT SCI, V162, P733, DOI 10.1016/S0168-9452(02)00012-2; Kole C, 2009, COMPENDIUM TRANSGENI, P115, DOI DOI 10.1002/9781405181099.K0307; Kothari SK, 2003, J HORTIC SCI BIOTECH, V78, P422, DOI 10.1080/14620316.2003.11511642; Liu ZC, 2005, MOL BREEDING, V16, P189, DOI 10.1007/s11032-005-6616-2; Mehrotra M, 2011, PLANT CELL REP, V30, P1603, DOI 10.1007/s00299-011-1071-5; Mirjalili HM, 2009, ENG LIFE SCI, V9, P197, DOI 10.1002/elsc.200800081; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Olhoft PM, 2003, PLANTA, V216, P723, DOI 10.1007/s00425-002-0922-2; Olhoft PM, 2001, PLANT CELL REP, V20, P706, DOI 10.1007/s002990100379; Olhoft PM, 2001, PLANT CELL REP, V20, P731, DOI 10.1007/s002990100388; Padmanabhan P, 2009, PLANT CELL REP, V28, P31, DOI 10.1007/s00299-008-0618-6; Pandey V, 2010, PLANT CELL REP, V29, P133, DOI 10.1007/s00299-009-0805-0; Park BJ, 2005, PLANT CELL REP, V24, P494, DOI 10.1007/s00299-005-0973-5; Pathak MR, 2008, PLANT CELL TISS ORG, V93, P65, DOI 10.1007/s11240-008-9344-6; de Oliveira MLP, 2009, PLANT CELL REP, V28, P387, DOI 10.1007/s00299-008-0646-2; Rajesh M, 2013, PLANT CELL TISS ORG, V114, P71, DOI 10.1007/s11240-013-0307-1; Ray S, 1999, PLANT SCI, V146, P1, DOI 10.1016/S0168-9452(99)00077-1; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; Sharma M, 2011, PLANT CELL TISS ORG, V105, P93, DOI 10.1007/s11240-010-9846-x; Shilpa KS, 2010, PLANT CELL TISS ORG, V103, P387, DOI 10.1007/s11240-010-9792-7; Simoh S, 2009, J PLANT PHYSIOL, V166, P1005, DOI 10.1016/j.jplph.2008.11.015; Sivanandhan G, 2012, IND CROP PROD, V37, P124, DOI 10.1016/j.indcrop.2011.11.022; Sivanandhan G, 2013, PROTOPLASMA, V250, P885, DOI 10.1007/s00709-012-0471-x; Sivanandhan G, 2013, PLANT CELL TISS ORG, V114, P121, DOI 10.1007/s11240-013-0297-z; Sivanandhan G, 2013, ACTA PHYSIOL PLANT, V35, P715, DOI 10.1007/s11738-012-1112-x; Sivanandhan G, 2012, NAT PROD COMMUN, V7, P1271; Sivanandhan G, 2012, APPL BIOCHEM BIOTECH, V168, P681, DOI 10.1007/s12010-012-9809-2; Sivanandhan G, 2011, ACTA PHYSIOL PLANT, V33, P2279, DOI 10.1007/s11738-011-0768-y; Sonia, 2007, PLANT CELL REP, V26, P187, DOI 10.1007/s00299-006-0224-4; Tang W, 2001, PLANTA, V213, P981, DOI 10.1007/s004250100566; Trick HN, 1997, TRANSGENIC RES, V6, P329, DOI 10.1023/A:1018470930944; Vasil IK, 1999, MOL IMPROVEMENT CERE, P43, DOI 10.1007/978-94-011-4802-3_4; Vergauwe A, 1996, PLANT CELL REP, V15, P929, DOI 10.1007/BF00231590; Yasmeen A, 2009, PLANT MOL BIOL REP, V27, P20, DOI 10.1007/s11105-008-0044-5; Zeng P, 2004, PLANT CELL REP, V22, P478, DOI 10.1007/s00299-003-0712-8	52	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124693	10.1371/journal.pone.0124693	http://dx.doi.org/10.1371/journal.pone.0124693			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927703	gold, Green Submitted, Green Published			2022-12-26	WOS:000353713100046
J	Uphoff, CC; Lange, S; Denkmann, SA; Garritsen, HSP; Drexler, HG				Uphoff, Cord C.; Lange, Sandra; Denkmann, Sabine A.; Garritsen, Henk S. P.; Drexler, Hans G.			Prevalence and Characterization of Murine Leukemia Virus Contamination in Human Cell Lines	PLOS ONE			English	Article							IDENTIFICATION; RETROVIRUSES; INACTIVATION; COMPLEMENT	Contaminations of cell cultures with microbiological organisms are well documented and can be managed in cell culture laboratories applying reliable detection, elimination and prevention strategies. However, the presence of viral contaminations in cell cultures is still a matter of debate and cannot be determined with general detection methods. In the present study we screened 577 human cell lines for the presence of murine leukemia viruses (MLV). Nineteen cell lines were found to be contaminated with MLV, including 22RV1 which is contaminated with the xenotropic murine leukemia virus-related virus variant of MLV. Of these, 17 cell lines were shown to produce active retroviruses determined by product enhanced reverse transcriptase PCR assay for reverse transcriptase activity. The contaminated cell lines derive from various solid tumor types as well as from leukemia and lymphoma types. A contamination of primary human cells from healthy volunteers could not be substantiated. Sequence analyses of 17 MLV PCR products and five complete MLV genomes of different infected cell lines revealed at least three groups of related MLV genotypes. The viruses harvested from the supernatants of infected cell cultures were infectious to uninfected cell cultures. In the course of the study we found that contamination of human genomic DNA preparations with murine DNA can lead to false-positive results. Presumably, xeno-transplantations of the human tumor cells into immune-deficient mice to determine the tumorigenicity of the cells are mainly responsible for the MLV contaminations. Furthermore, the use of murine feeder layer cells during the establishment of human cell lines and a cross-contamination with MLV from infected cultures might be sources of infection. A screening of cell cultures for MLV contamination is recommended given a contamination rate of 3.3%.	[Uphoff, Cord C.; Lange, Sandra; Denkmann, Sabine A.; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Garritsen, Henk S. P.] Municipal Hosp, Inst Clin Transfus Med, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Uphoff, CC (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	cup@dsmz.de						ALTORKI N, 1993, CANCER-AM CANCER SOC, V72, P649, DOI 10.1002/1097-0142(19930801)72:3<649::AID-CNCR2820720305>3.0.CO;2-L; BARBEY S, 1990, INT J CANCER, V45, P546, DOI 10.1002/ijc.2910450329; BEPLER G, 1987, J CANCER RES CLIN, V113, P31, DOI 10.1007/BF00389964; Camps J, 2006, LEUKEMIA RES, V30, P923, DOI 10.1016/j.leukres.2005.11.013; CHAMPELOVIER P, 1994, LEUKEMIA RES, V18, P903, DOI 10.1016/0145-2126(94)90102-3; Chang A, 1997, J VIROL METHODS, V65, P45, DOI 10.1016/S0166-0934(96)02168-4; Cmarik JL, 2011, VIRUSES-BASEL, V3, P2442, DOI 10.3390/v3122442; Deichmann M, 2005, ARCH DERMATOL RES, V296, P345, DOI 10.1007/s00403-004-0501-4; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Drexler HG, 2006, LEUKEMIA RES, V30, P911, DOI 10.1016/j.leukres.2006.02.015; Drexler HG, 2015, DSMZ CATALOGUE HUMAN; Hempel HA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00156; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Kakisi OK, 2013, TRANSFUSION MED, V23, P142, DOI 10.1111/tme.12049; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; Lee YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055669; Malmsten A, 1998, J VIROL METHODS, V75, P9, DOI 10.1016/S0166-0934(98)00091-3; MCALLISTER RM, 1972, NATURE-NEW BIOL, V235, P3, DOI 10.1038/newbio235003a0; Miller AD, 1997, J VIROL, V71, P4531, DOI 10.1128/JVI.71.6.4531-4535.1997; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Rabson A. B., 1997, P205; Raisch KP, 2003, VIROLOGY, V308, P83, DOI 10.1016/S0042-6822(02)00074-0; Rein A, 2011, ADV VIROL, V2011, DOI 10.1155/2011/403419; SALTMAN DL, 1988, BLOOD, V72, P2026, DOI 10.1182/blood.V72.6.2026.2026; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; SHERWIN SA, 1978, INT J CANCER, V21, P6, DOI 10.1002/ijc.2910210103; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Stang A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-86; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; TAKEUCHI Y, 1994, J VIROL, V68, P8001, DOI 10.1128/JVI.68.12.8001-8007.1994; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uphoff C C, 2001, Hum Cell, V14, P244; Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79; Uphoff CC, 2010, ENCY IND BIOTECHNOLO, P3611; Uphoff CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/904767; WELSH RM, 1975, NATURE, V257, P612, DOI 10.1038/257612a0; WELSH RM, 1977, J IMMUNOL, V118, P348; Zhang YA, 2011, CANCER BIOL THER, V12, P617, DOI 10.4161/cbt.12.7.15955; Zheng HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029050	43	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125622	10.1371/journal.pone.0125622	http://dx.doi.org/10.1371/journal.pone.0125622			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927683	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100106
J	Velaga, S; Ukena, SN; Dringenberg, U; Alter, C; Pardo, J; Kershaw, O; Franzke, A				Velaga, Sarvari; Ukena, Sya N.; Dringenberg, Ulrike; Alter, Christina; Pardo, Julian; Kershaw, Olivia; Franzke, Anke			Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease	PLOS ONE			English	Article							DEATH; TRANSPLANTATION; PERFORIN; SUPPRESSION; PROTECTS; PATHWAY; ROLES	In our previous work we could identify defects in human regulatory T cells (Tregs) likely favoring the development of graft-versus-host disease (GvHD) following allogeneic stem cell transplantation (SCT). Treg transcriptome analyses comparing GvHD and immune tolerant patients uncovered regulated gene transcripts highly relevant for Treg cell function. Moreover, granzyme A (GZMA) also showed a significant lower expression at the protein level in Tregs of GvHD patients. GZMA induces cytolysis in a perforin-dependent, FAS-FASL independent manner and represents a cell-contact dependent mechanism for Tregs to control immune responses. We therefore analyzed the functional role of GZMA in a murine standard model for GvHD. For this purpose, adoptively transferred CD4(+)CD25(+) Tregs from gzmA(-/-) mice were analyzed in comparison to their wild type counterparts for their capability to prevent murine GvHD. GzmA(-/-) Tregs home efficiently to secondary lymphoid organs and do not show phenotypic alterations with respect to activation and migration properties to inflammatory sites. Whereas gzmA(-/-) Tregs are highly suppressive in vitro, Tregs require GZMA to rescue hosts from murine GvHD, especially regarding gastrointestinal target organ damage. We herewith identify GZMA as critical effector molecule of human Treg function for gastrointestinal immune response in an experimental GvHD model.	[Velaga, Sarvari; Ukena, Sya N.; Dringenberg, Ulrike; Alter, Christina; Franzke, Anke] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Pardo, Julian] Biomed Res Ctr Aragon CIBA, Immune Effector Cells Grp ICE, Zaragoza, Spain; [Kershaw, Olivia] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany	Hannover Medical School; Free University of Berlin	Franzke, A (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	franzke.anke@mh-hannover.de	Franzke, Anke/AAE-7883-2021; Pardo, Julian/K-6764-2014	Pardo, Julian/0000-0003-0154-0730	German Jose Carreras leukemia foundation [DJCLS F12/05]; ARAID foundation; Ministerio de Economia y Competitividad [SAF2011-25390]; Fondo Social Europeo	German Jose Carreras leukemia foundation; ARAID foundation; Ministerio de Economia y Competitividad(Spanish Government); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported by the German Jose Carreras leukemia foundation (grant DJCLS F12/05). JP was supported by ARAID foundation, grant SAF2011-25390 from Ministerio de Economia y Competitividad and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Arias MA, 2014, CELL REP, V8, P419, DOI 10.1016/j.celrep.2014.06.012; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Cai SF, 2010, BLOOD, V115, P1669, DOI 10.1182/blood-2009-07-233676; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Gondek DC, 2008, J IMMUNOL, V181, P4752, DOI 10.4049/jimmunol.181.7.4752; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; Martelli MF, 2014, BLOOD, V124, P638, DOI 10.1182/blood-2014-03-564401; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2009, MICROBES INFECT, V11, P452, DOI 10.1016/j.micinf.2009.02.004; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Susanto O, 2013, CELL DEATH DIFFER, V20, P1183, DOI 10.1038/cdd.2013.59; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Ukena SN, 2011, EXP HEMATOL, V39, P1152, DOI 10.1016/j.exphem.2011.08.010; Ukena SN, 2011, BLOOD, V118, pE82, DOI 10.1182/blood-2011-05-352708	24	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124927	10.1371/journal.pone.0124927	http://dx.doi.org/10.1371/journal.pone.0124927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928296	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100053
J	Andani, ME; Tinazzi, M; Corsi, N; Fiorio, M				Andani, Mehran Emadi; Tinazzi, Michele; Corsi, Nicole; Fiorio, Mirta			Modulation of Inhibitory Corticospinal Circuits Induced by a Nocebo Procedure in Motor Performance	PLOS ONE			English	Article							MAGNETIC BRAIN-STIMULATION; TASK-DEPENDENT MODULATION; PLACEBO-INDUCED CHANGES; SILENT PERIOD; INTRACORTICAL INHIBITION; CORTICAL INHIBITION; COIL ORIENTATION; HEALTHY HUMANS; SPINAL-CORD; FATIGUE	As recently demonstrated, a placebo procedure in motor performance increases force production and changes the excitability of the corticospinal system, by enhancing the amplitude of the motor evoked potentials (MEP) and reducing the duration of the cortical silent period (CSP). However, it is not clear whether these neurophysiological changes are related to the behavioural outcome (increased force) or to a general effect of expectation. To clarify this, we investigated the nocebo effect, in which the induced expectation decreases force production. Two groups of healthy volunteers (experimental and control) performed a motor task by pressing a piston with the right index finger. To induce a nocebo effect in the experimental group, low frequency transcutaneous electrical nerve stimulation (TENS) was applied over the index finger with instructions of its detrimental effects on force. To condition the subjects, the visual feedback on their force level was surreptitiously reduced after TENS. Results showed that the experimental group reduced the force, felt weaker and expected a worse performance than the control group, who was not suggested about TENS. By applying transcranial magnetic stimulation over the primary motor cortex, we found that while MEP amplitude remained stable throughout the procedure in both groups, the CSP duration was shorter in the experimental group after the nocebo procedure. The CSP reduction resembled previous findings on the placebo effect, suggesting that expectation of change in performance diminishes the inhibitory activation of the primary motor cortex, independently of the behavioural outcome.	[Andani, Mehran Emadi; Tinazzi, Michele; Corsi, Nicole; Fiorio, Mirta] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Andani, Mehran Emadi] Univ Isfahan, Dept Biomed Engn, Esfahan, Iran	University of Verona; University of Isfahan	Fiorio, M (corresponding author), Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	mirta.fiorio@univr.it	Corsi, Nicole/L-5001-2019; TINAZZI, Michele/J-7134-2018	TINAZZI, Michele/0000-0002-2370-7063; Corsi, Nicole/0000-0002-9577-2753; Fiorio, Mirta/0000-0002-6356-0211; EMADI ANDANI, Mehran/0000-0001-8238-9969				Alaerts K, 2010, EUR J NEUROSCI, V31, P1144, DOI 10.1111/j.1460-9568.2010.07124.x; Amanzio M, 2013, HUM BRAIN MAPP, V34, P738, DOI 10.1002/hbm.21471; Beedie CJ, 2007, INT J SPORT NUTR EXE, V17, P259, DOI 10.1123/ijsnem.17.3.259; Beedie CJ, 2009, SPORTS MED, V39, P313, DOI 10.2165/00007256-200939040-00004; Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Butler JE, 2012, CLIN NEUROPHYSIOL, V123, P1409, DOI 10.1016/j.clinph.2011.11.034; CANTELLO R, 1992, NEUROLOGY, V42, P1951; Christie A, 2014, AGE, V36, P749, DOI 10.1007/s11357-013-9577-0; Colloca L, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0419-2; Conte A, 2007, EXP BRAIN RES, V182, P109, DOI 10.1007/s00221-007-0975-3; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Crupi D, 2013, J MOTOR BEHAV, V45, P127, DOI 10.1080/00222895.2012.760514; de la Fuente-Fernandez R, 2004, BIOL PSYCHIAT, V56, P67, DOI 10.1016/j.biopsych.2003.11.019; Djaldetti R, 1996, NEUROLOGY, V46, P632, DOI 10.1212/WNL.46.3.632; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Fiorio M, 2014, J NEUROSCI, V34, P3993, DOI 10.1523/JNEUROSCI.3931-13.2014; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Geuter S, 2013, J NEUROSCI, V33, P13784, DOI 10.1523/JNEUROSCI.2191-13.2013; Hess A, 1999, EXP BRAIN RES, V124, P321, DOI 10.1007/s002210050629; Hilty L, 2011, EXP PHYSIOL, V96, P505, DOI 10.1113/expphysiol.2010.056226; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Kidgell DJ, 2010, HUM MOVEMENT SCI, V29, P631, DOI 10.1016/j.humov.2010.01.004; Klein PA, 2012, J NEUROSCI, V32, P18124, DOI 10.1523/JNEUROSCI.1701-12.2012; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Krummenacher P, 2010, PAIN, V148, P368, DOI 10.1016/j.pain.2009.09.033; Lutz K, 2012, NEUROPSYCHOLOGIA, V50, P1739, DOI 10.1016/j.neuropsychologia.2012.03.030; Mathis J, 1998, ELECTROMYOGR MOTOR C, V109, P426, DOI 10.1016/S0924-980X(98)00042-3; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Pollo A, 2008, EUR J NEUROSCI, V28, P379, DOI 10.1111/j.1460-9568.2008.06344.x; Pollo A, 2012, EUR J APPL PHYSIOL, V112, P3893, DOI 10.1007/s00421-012-2333-9; Robbins DW, 2010, J STRENGTH COND RES, V24, P2996, DOI 10.1519/JSC.0b013e3181f67474; Rosler K. M., 2008, OXFORD HDB TRANSCRAN, P77; Saisanen L, 2008, J NEUROSCI METH, V169, P231, DOI 10.1016/j.jneumeth.2007.12.005; Schutz-Bosbach S, 2009, J COGNITIVE NEUROSCI, V21, P1215, DOI 10.1162/jocn.2009.21068; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Surakka J, 2005, BIOL SPORT, V22, P301; Tinazzi M, 2003, EXP BRAIN RES, V150, P222, DOI 10.1007/s00221-003-1448-y; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Werhahn KJ, 2007, J CLIN NEUROPHYSIOL, V24, P419, DOI 10.1097/WNP.0b013e3181379a69; Wolters A, 2008, OXFORD HDB TRANSCRAN, P91; Yu RJ, 2014, HUM BRAIN MAPP, V35, P4583, DOI 10.1002/hbm.22496	49	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125223	10.1371/journal.pone.0125223	http://dx.doi.org/10.1371/journal.pone.0125223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923533	Green Submitted, gold, Green Published			2022-12-26	WOS:000353711600135
J	Brameyer, S; Heermann, R				Brameyer, Sophie; Heermann, Ralf			Specificity of Signal-Binding via Non-AHL LuxR-Type Receptors	PLOS ONE			English	Article							ESCHERICHIA-COLI; QUORUM; PROTEIN; TRAR; AUTOINDUCER	Quorum sensing is a typical communication system among Gram-negative bacteria used to control group-coordinated behavior via small diffusible molecules dependent on cell number. The key components of a quorum sensing system are a LuxI-type synthase, producing acyl-homoserine lactones (AHLs) as signaling molecules, and a LuxR-type receptor that detects AHLs to control expression of specific target genes. Six conserved amino acids are present in the signal-binding domain of AHL-sensing LuxR-type proteins, which are important for ligand-binding and -specificity as well as shaping the ligand-binding pocket. However, many proteobacteria possess LuxR-type regulators without a cognate LuxI synthase, referred to as LuxR solos. The two LuxR solos PluR and PauR from Photorhabdus luminescens and Photorhabdus asymbiotica, respectively, do not sense AHLs. Instead PluR and PauR sense alpha-pyrones and dialkylresorcinols, respectively, and are part of cell-cell communication systems contributing to the overall virulence of these Photorhabdus species. However, PluR and PauR both harbor substitutions in the conserved amino acid motif compared to that in AHL sensors, which appeared to be important for binding the corresponding signaling molecules. Here we analyze the role of the conserved amino acids in the signal-binding domain of these two non-AHL LuxR-type receptors for their role in signal perception. Our studies reveal that the conserved amino acid motif alone is essential but not solely responsible for ligand-binding.	[Brameyer, Sophie; Heermann, Ralf] Univ Munich, Biozentrum, Bereich Mikrobiol, Martinsried, Germany	University of Munich	Heermann, R (corresponding author), Univ Munich, Biozentrum, Bereich Mikrobiol, Martinsried, Germany.	heermann@lmu.de	Heermann, Ralf/E-1793-2013; Heermann, Ralf/CAF-8609-2022	Heermann, Ralf/0000-0003-0631-6156; Brameyer, Sophie/0000-0002-6779-2343	Deutsche Forschungsgemeinschaft [HE5247/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (www.dfg.de) under grant number HE5247/4-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Brachmann AO, 2013, NAT CHEM BIOL, V9, P573, DOI [10.1038/NCHEMBIO.1295, 10.1038/nchembio.1295]; Brameyer S, 2015, P NATL ACAD SCI USA, V112, P572, DOI 10.1073/pnas.1417685112; Brameyer S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00166; Chugani S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00152; Churchill MEA, 2011, CHEM REV, V111, P68, DOI 10.1021/cr1000817; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Gonzalez JF, 2013, TRENDS PLANT SCI, V18, P167, DOI 10.1016/j.tplants.2012.09.007; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Kim T, 2014, ACTA CRYSTALLOGR D, V70, P694, DOI 10.1107/S1399004713032355; Koch B, 2005, MICROBIOL-SGM, V151, P3589, DOI 10.1099/mic.0.27954-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Luo ZQ, 2003, J BIOL CHEM, V278, P13173, DOI 10.1074/jbc.M210035200; Nasser W, 2007, ANAL BIOANAL CHEM, V387, P381, DOI 10.1007/s00216-006-0702-0; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Sambrook J., 2001, MOL CLONING LAB MANU; SHADEL GS, 1990, J BACTERIOL, V172, P3980, DOI 10.1128/jb.172.7.3980-3987.1990; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Trott AE, 2001, J BACTERIOL, V183, P387, DOI 10.1128/JB.183.1.387-392.2001; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WEBER K, 1969, J BIOL CHEM, V244, P4406; Welch M, 2000, EMBO J, V19, P631, DOI 10.1093/emboj/19.4.631; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	26	20	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124093	10.1371/journal.pone.0124093	http://dx.doi.org/10.1371/journal.pone.0124093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923884	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600068
J	Gu, FF; Hou, Q; Yang, HH; Zhu, YQ; Guo, XK; Ni, YX; Han, LZ				Gu, Fei-Fei; Hou, Qi; Yang, Hai-Hui; Zhu, Yue-Qiu; Guo, Xiao-Kui; Ni, Yu-Xing; Han, Li-Zhong			Characterization of Staphylococcus aureus Isolated from Non-Native Patients with Skin and Soft Tissue Infections in Shanghai	PLOS ONE			English	Article							OUTBREAK; MRSA; USA300; MANAGEMENT; STRAINS	Background Staphylococcus aureus is one predominant cause of skin and soft-tissue infections (SSTIs), but little information exists regarding the characterization of S. aureus from non-native patients with SSTIs in China. Methods In this study, we enrolled 52 non-native patients with S. aureus SSTIs, and 65 native control patients with S. aureus SSTIs in Shanghai. 52 and 65 S. aureus isolates were collected from both groups, respectively. S. aureus isolates were characterized by antimicrobial susceptibility testing, toxin gene detection, and molecular typing with sequence type, spa type, agr group and SCCmec type. Results Methicillin-resistant S. aureus (MRSA) was detected in 8 non-native patients and 14 native patients with SSTIs. Overall, antimicrobial susceptibilities of S. aureus isolated from non-native patients were found higher than those from native patients. CC59 (ST338 and ST59) was found in a total of 14 isolates (4 from non-native patients; 10 from native patients), 9 of which were carrying lukS/F-PV (3 from non-native patients; 6 from native patients). ST7 was found in 12 isolates and all 12 isolates were found in native patients. The livestock-associated clone ST398 was found in 11 isolates (6 from non-native patients; 5 from native patients), and 5 ST398 lukS/F-PV-positive methicillin-susceptible S. aureus (MSSA) were all discovered among non-native patients. The molecular epidemiology of S. aureus isolated from non-native patients was quite different from those from native patients. lukS/F-PV was more frequent in isolates originating from non-native patients with SSTIs compared to native patients (31 vs. 7, P < 0.0001). Conclusions CC59 was the most common clonal complex among patients with SSTIs in Shanghai. The other most common sequence types were ST7 and Livestock ST398. The molecular epidemiology of S. aureus isolated from non-native patients was quite different from those from native patients. S. aureus isolated from non-native patients was more likely to carry lukS/F-PV.	[Gu, Fei-Fei; Ni, Yu-Xing; Han, Li-Zhong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China; [Hou, Qi; Zhu, Yue-Qiu] Shanghai United Family Hosp, Lab, Shanghai, Peoples R China; [Yang, Hai-Hui] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Clin Lab, Shanghai 200030, Peoples R China; [Guo, Xiao-Kui] Shanghai Jiao Tong Univ, Sch Med, Dept Microbiol & Parasitol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Han, LZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China.	hanlizhong1107@163.com		Guo, Xiao-Kui/0000-0002-1595-9965	National Natural Science Foundation of China [81472010]; Research Special Fund for Public Welfare Industry of Health [201002021]; Scientific Research Program of Science and Technology Commission of Shanghai Municipality [14140900602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Special Fund for Public Welfare Industry of Health; Scientific Research Program of Science and Technology Commission of Shanghai Municipality	This study was supported by the National Natural Science Foundation of China (No. 81472010), Research Special Fund for Public Welfare Industry of Health (No. 201002021) and Scientific Research Program of Science and Technology Commission of Shanghai Municipality (No. 14140900602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud O, 2014, EUR J CLIN MICROBIOL, V33, P1757, DOI 10.1007/s10096-014-2127-6; Borgundvaag B, 2013, CAN J EMERG MED, V15, P141, DOI 10.2310/8000.2013.130798; Bourigault C, 2014, PLOS CURRENTS, V6; Chen X, 2012, BURNS, V38, P738, DOI 10.1016/j.burns.2011.12.023; Chen XZ, 2009, ACTA AGR JIANGXI, V9, P008, DOI DOI 10.1371/J0URNAL.P0NE.0072811; Cockerill III FR, 2013, M100S23 WAYN, V33; Dryden MS, 2010, J ANTIMICROB CHEMOTH, V65, piii35, DOI 10.1093/jac/dkq302; Dryden MS, 2009, INT J ANTIMICROB AG, V34, pS2, DOI 10.1016/S0924-8579(09)70541-2; Gould IM, 2009, INT J ANTIMICROB AG, V34, pS8, DOI 10.1016/S0924-8579(09)70542-4; Grant D, 2013, ANN ACAD MED SINGAP, V42, P575; Han LZ, 2010, EMERG INFECT DIS, V16, P731, DOI 10.3201/eid1604.081324; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Ito Teruyo, 2014, Methods Mol Biol, V1085, P131, DOI 10.1007/978-1-62703-664-1_8; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kaltsas A, 2011, J CLIN MICROBIOL, V49, P2992, DOI 10.1128/JCM.00704-11; Lee H, 2014, J HOSP INFECT, V87, P145, DOI 10.1016/j.jhin.2014.04.003; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Li TS, 2012, OTHER TITL APPL MATH, V126, P1; Maeda T, 2012, J INFECT CHEMOTHER, V18, P906, DOI 10.1007/s10156-012-0506-4; Merritt C, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-26; NeVille-Swensen M, 2011, J PEDIATR HEALTH CAR, V25, P308, DOI 10.1016/j.pedhc.2010.05.005; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Qiao YH, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0582-4; Sanchini A, 2013, J HOSP INFECT, V83, P36, DOI 10.1016/j.jhin.2012.09.017; Shore AC, 2014, J CLIN MICROBIOL, V52, P859, DOI 10.1128/JCM.02799-13; Tattevin P, 2012, CLIN INFECT DIS, V55, P781, DOI 10.1093/cid/cis527; Udo EE, 2003, J ANTIMICROB CHEMOTH, V51, P1283, DOI 10.1093/jac/dkg188; Verkade E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100823; Waldenburger S, 2014, J DTSCH DERMATOL GES, V12, P59, DOI 10.1111/ddg.12228; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577; Zheng BW, 2015, BRAZ J INFECT DIS, V19, P85, DOI 10.1016/j.bjid.2014.07.006	32	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123557	10.1371/journal.pone.0123557	http://dx.doi.org/10.1371/journal.pone.0123557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923531	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600051
J	Johnson, SS; Chevrette, MG; Ehlmann, BL; Benison, KC				Johnson, Sarah Stewart; Chevrette, Marc Gerard; Ehlmann, Bethany L.; Benison, Kathleen Counter			Insights from the Metagenome of an Acid Salt Lake: The Role of Biology in an Extreme Depositional Environment	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MICROBIAL COMMUNITIES; SALINE LAKES; REFLECTANCE SPECTROSCOPY; HALOMONAS-ELONGATA; WESTERN-AUSTRALIA; MINE DRAINAGE; GEN. NOV.; MERIDIANI; ALIGNMENT	The extremely acidic brine lakes of the Yilgarn Craton of Western Australia are home to some of the most biologically challenging waters on Earth. In this study, we employed meta-genomic shotgun sequencing to generate a microbial profile of the depositional environment associated with the sulfur-rich sediments of one such lake. Of the 1.5 M high-quality reads generated, 0.25 M were mapped to protein features, which in turn provide new insights into the metabolic function of this community. In particular, 45 diverse genes associated with sulfur metabolism were identified, the majority of which were linked to either the conversion of sulfate to adenylylsulfate and the subsequent production of sulfide from sulfite or the oxidation of sulfide, elemental sulfur, and thiosulfate via the sulfur oxidation (Sox) system. This is the first metagenomic study of an acidic, hypersaline depositional environment, and we present evidence for a surprisingly high level of microbial diversity. Our findings also illuminate the possibility that we may be meaningfully underestimating the effects of biology on the chemistry of these sulfur-rich sediments, thereby influencing our understanding of past geobiological conditions that may have been present on Earth as well as early Mars.	[Johnson, Sarah Stewart] Georgetown Univ, Sci Technol & Int Affairs, Washington, DC 20057 USA; [Chevrette, Marc Gerard] Harvard Univ Extens, Grad Program Biotechnol & Bioengn, Cambridge, MA USA; [Ehlmann, Bethany L.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Ehlmann, Bethany L.] CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA; [Benison, Kathleen Counter] W Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA	Georgetown University; California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); West Virginia University	Johnson, SS (corresponding author), Georgetown Univ, Sci Technol & Int Affairs, Washington, DC 20057 USA.	sarah.johnson@georgetown.edu	Chevrette, Marc G/N-7895-2016	Chevrette, Marc G/0000-0002-7209-0717	William F. Milton Fund	William F. Milton Fund	This research was supported by a William F. Milton Fund grant to SSJ (http://www.faculty.harvard.edu/scholarship-and-research/grants-enabling-research/william-f-milton-fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anand RR, 2002, AUST J EARTH SCI, V49, P3, DOI 10.1046/j.1440-0952.2002.00912.x; Arahal DR, 2001, INT J SYST EVOL MICR, V51, P1443, DOI 10.1099/00207713-51-4-1443; Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Beer KD, 2014, APPL ENVIRON MICROB, V80, P1821, DOI 10.1128/AEM.03280-13; Beller HR, 2006, J BACTERIOL, V188, P1473, DOI 10.1128/JB.188.4.1473-1488.2006; Benison KC, 2008, ASTROBIOLOGY, V8, P807, DOI 10.1089/ast.2006.0034; Benison KC, 2008, PALAIOS, V23, P571, DOI 10.2110/palo.2008.S05; Benison KC, 2007, J SEDIMENT RES, V77, P366, DOI 10.2110/jsr.2007.038; Benison KC, 2006, ICARUS, V183, P225, DOI 10.1016/j.icarus.2006.02.018; Benison KC, 2013, CHEM GEOL, V351, P154, DOI 10.1016/j.chemgeo.2013.05.018; Benison KC, 1998, NATURE, V392, P911, DOI 10.1038/31917; Benison KC, 2003, ASTROBIOLOGY, V3, P609, DOI 10.1089/153110703322610690; Benison KC, 2001, SEDIMENTOLOGY, V48, P165, DOI 10.1046/j.1365-3091.2001.00362.x; Benison KC, 2014, GEOLOGY, P1; Benison KC, 2000, J SEDIMENTARY RES, V70; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Bond PL, 2000, APPL ENVIRON MICROB, V66, P4962, DOI 10.1128/AEM.66.11.4962-4971.2000; Bowen BB, 2009, APPL GEOCHEM, V24, P268, DOI 10.1016/j.apgeochem.2008.11.013; BURNS RG, 1987, J GEOPHYS RES-SOLID, V92, pE570, DOI 10.1029/JB092iB04p0E570; Canovas D, 1997, J BIOL CHEM, V272, P25794, DOI 10.1074/jbc.272.41.25794; Challacombe JF, 2013, STAND GENOMIC SCI, V8, P206, DOI 10.4056/sigs.3677284; Chen XG, 2004, LETT APPL MICROBIOL, V39, P495, DOI 10.1111/j.1472-765X.2004.01615.x; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; Clark DP, 2009, BROCK BIOL MICROORGA, P34; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Espana JS, 2005, APPL GEOCHEM, V20, P1320, DOI 10.1016/j.apgeochem.2005.01.011; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Hallberg KB, 2011, EXTREMOPHILES, V15, P271, DOI 10.1007/s00792-011-0359-2; Hawley ER, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01212-13; Jimenez DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052069; Leon MJ, 2014, APPL ENVIRON MICROB, V80, P3850, DOI 10.1128/AEM.00430-14; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kimura S, 2006, BIODEGRADATION, V17, P57, DOI 10.1007/s10532-005-3050-4; Koren S, 2011, BIOINFORMATICS, V27, P2964, DOI 10.1093/bioinformatics/btr520; Kuever J, 2005, BERGEYS MANUAL SYSTE, V2, P988; Kunin V, 2008, MOL SYSTEMS BIOL, V4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lay CY, 2013, APPL ENVIRON MICROB, V79, P3637, DOI 10.1128/AEM.00153-13; Liu B, 2011, GENOME BIOL, V12, P10, DOI 10.1186/1465-6906-12-S1-P11; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/btt688, 10.1093/bioinformatics/bts690]; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Minegishi H, 2010, INT J SYST EVOL MICR, V60, P2513, DOI 10.1099/ijs.0.013722-0; Mormile MR, 2009, ASTROBIOLOGY, V9, P919, DOI 10.1089/ast.2008.0293; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Mwirichia R, 2011, CURR MICROBIOL, V62, P209, DOI 10.1007/s00284-010-9692-4; Nancucheo I, 2012, MICROB BIOTECHNOL, V5, P34, DOI 10.1111/j.1751-7915.2011.00285.x; Norlund KLI, 2010, CHEM GEOL, V275, P235, DOI 10.1016/j.chemgeo.2010.05.014; O'Connor K, 2003, APPL ENVIRON MICROB, V69, P6334, DOI 10.1128/AEM.69.10.6334-6336.2003; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Oren Aharon, 2010, Lakes & Reservoirs Research and Management, V15, P215, DOI 10.1111/j.1440-1770.2010.00435.x; Pastor JM, 2013, J BIOL CHEM, V288, P17769, DOI 10.1074/jbc.M113.470567; Ramana CV, 2009, J GEN APPL MICROBIOL, V55, P301, DOI 10.2323/jgam.55.301; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Roach L, 2007, LUNAR AND PLANETARY; Sanchez-Andrea I, 2015, EXTREMOPHILES, V19, P39, DOI 10.1007/s00792-014-0701-6; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Squyres SW, 2012, SCIENCE, V336, P570, DOI 10.1126/science.1220476; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Stewart FJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00134; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tindall BJ, 2009, STAND GENOMIC SCI, V1, P270, DOI 10.4056/sigs.42644; Treangen TJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r2; Treangen TJ, 2009, IEEE ACM T COMPUT BI, V6, P180, DOI 10.1109/TCBB.2009.9; Vargas Carmen, 2008, Saline Syst, V4, P14, DOI 10.1186/1746-1448-4-14; Wiggli M, 1999, J MICROBIOL METH, V34, P173, DOI 10.1016/S0167-7012(98)00085-2; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yin HQ, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-179	78	34	36	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122869	10.1371/journal.pone.0122869	http://dx.doi.org/10.1371/journal.pone.0122869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923206	Green Accepted, gold, Green Published			2022-12-26	WOS:000353711600024
J	Nersisyan, L; Arakelyan, A				Nersisyan, Lilit; Arakelyan, Arsen			Computel: Computation of Mean Telomere Length from Whole-Genome Next-Generation Sequencing Data	PLOS ONE			English	Article							GENE-EXPRESSION; DNA; ALIGNMENT; DISEASE; CANCER; LONG; END	Telomeres are the ends of eukaryotic chromosomes, consisting of consecutive short repeats that protect chromosome ends from degradation. Telomeres shorten with each cell division, leading to replicative cell senescence. Deregulation of telomere length homeostasis is associated with the development of various age-related diseases and cancers. A number of experimental techniques exist for telomere length measurement; however, until recently, the absence of tools for extracting telomere lengths from high-throughput sequencing data has significantly obscured the association of telomere length with molecular processes in normal and diseased conditions. We have developed Computel, a program in R for computing mean telomere length from whole-genome next-generation sequencing data. Computel is open source, and is freely available at https://github.com/lilit-nersisyan/computel. It utilizes a short-read alignment-based approach and integrates various popular tools for sequencing data analysis. We validated it with synthetic and experimental data, and compared its performance with the previously available software. The results have shown that Computel outperforms existing software in accuracy, independence of results from sequencing conditions, stability against inherent sequencing errors, and better ability to distinguish pure telomeric sequences from interstitial telomeric repeats. By providing a highly reliable methodology for determining telomere lengths from whole-genome sequencing data, Computel should help to elucidate the role of telomeres in cellular health and disease.	[Nersisyan, Lilit; Arakelyan, Arsen] Natl Acad Sci Republ Armenia, Inst Mol Biol, Grp Bioinformat, Yerevan, Armenia	National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA	Arakelyan, A (corresponding author), Natl Acad Sci Republ Armenia, Inst Mol Biol, Grp Bioinformat, Yerevan, Armenia.	aarakelyan@sci.am		Arakelyan, Arsen/0000-0002-6851-1056; Nersisyan, Lilit/0000-0001-8525-420X				Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Azzalin CM, 2001, CHROMOSOMA, V110, P75, DOI 10.1007/s004120100135; Balistreri CR, 2012, REJUV RES, V15, P170, DOI 10.1089/rej.2011.1273; Beirne C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108964; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Castle JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-244; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Ding ZH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku181; Guan JZ, 2015, MOL CELL BIOCHEM, V400, P183, DOI 10.1007/s11010-014-2274-1; Hernandez-Caballero E, 2009, BMB REP, V42, P747, DOI 10.5483/BMBRep.2009.42.11.747; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Ishizuka T, 2013, J AM CHEM SOC, V135, P14, DOI 10.1021/ja308481c; Khan S, 2012, CARDIOVASC J AFR, V23, P563, DOI 10.5830/CVJA-2012-056; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Monaghan P, 2010, ANN NY ACAD SCI, V1206, P130, DOI 10.1111/j.1749-6632.2010.05705.x; Montpetit AJ, 2014, NURS RES, V63, P289, DOI 10.1097/NNR.0000000000000037; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; Parker M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r113; Pereira B, 2013, CURR OPIN ONCOL, V25, P93, DOI 10.1097/CCO.0b013e32835b6358; Riethman H, 2004, GENOME RES, V14, P18, DOI 10.1101/gr.1245004; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Zakian VA, 2012, EXP CELL RES, V318, P1456, DOI 10.1016/j.yexcr.2012.02.015	34	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125201	10.1371/journal.pone.0125201	http://dx.doi.org/10.1371/journal.pone.0125201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923330	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600133
J	Segers, JL; Broders, HG				Segers, Jordi L.; Broders, Hugh G.			Carbon (delta C-13) and Nitrogen (delta N-15) Stable Isotope Signatures in Bat Fur Indicate Swarming Sites Have Catchment Areas for Bats from Different Summering Areas	PLOS ONE			English	Article							LONG-EARED BAT; MIGRATORY CONNECTIVITY; MYOTIS-SEPTENTRIONALIS; GENETIC CONNECTIVITY; DIETARY NICHE; NOVA-SCOTIA; BROWN BATS; BODY-SIZE; POPULATION; MOVEMENTS	Migratory patterns of bats are not well understood and traditional methods to study this, like capture-mark-recapture, may not provide enough detail unless there are many records. Stable isotope profiles of many animal species have been used to make inferences about migration. Each year Myotis lucifugus and M. septentrionalis migrate from summering roosts to swarming caves and mines in the fall, but the pattern of movement between them is not well understood. In this study, fur delta C-13 and delta N-15 values of 305 M. lucifugus and 200 M. septentrionalis were analyzed to make inferences about migration patterns between summering areas and swarming sites in Nova Scotia, Canada. We expected that there would be greater variability in delta C-13 and delta N-15 among individuals at swarming sites because it was believed that these sites are used by individuals originating from many summering areas. There was extensive overlap in the standard ellipse area, corrected for small sample sizes (SEA(c)), of bats at swarming sites and much less overlap in SEA(c) among groups sampled at summering areas. Meaningful inference could not be made on M. septentrionalis because their low variation in SEA(c) may have been the result of sampling only 3 summering areas. However, for M. lucifugus, swarming sites had larger SEA(c) than summering areas and predictive discriminant analysis assigned swarming bats to multiple summering areas, supporting the contention that swarming bats are mixed aggregations of bats from several summering areas. Together, these data support the contention that swarming sites have catchment areas for bats from multiple summering areas and it is likely that the catchment areas for swarming sites overlap. These data suggest that delta C-13 and delta N-15 profiling of bat fur offer some potential to make inferences about regional migration in bats.	[Segers, Jordi L.; Broders, Hugh G.] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Saint Marys University - Canada	Broders, HG (corresponding author), St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada.	hugh.broders@smu.ca		Broders, Hugh/0000-0002-6151-8079	Saint Mary's University; NSERC; Nova Scotia Power Inc.; Shearwind Inc.; Eon Wind Electric	Saint Mary's University; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Power Inc.; Shearwind Inc.; Eon Wind Electric	This work was supported by the Saint Mary's University (http://www.smu.ca/) to JLS and HGB, NSERC (http://www.nserc-crsng.gc.ca/index_eng.asp) to HGB, Nova Scotia Power Inc., (https://www.nspower.ca/en/home/default.aspx) to HGB, Shearwind Inc., (http://www.shearwind.com/) to HGB and Eon Wind Electric, (http://www.eonwind.com/) to HGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041195; Arnold BD, 2007, AM MIDL NAT, V157, P374, DOI 10.1674/0003-0031(2007)157[374:PSASDI]2.0.CO;2; Baerwald EF, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00380.1; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Blem C.R., 1980, P175; Boulet M, 2007, MOL ECOL, V16, P4223, DOI 10.1111/j.1365-294X.2007.03476.x; Broders HG, 2004, J MAMMAL, V85, P273, DOI 10.1644/BWG-102; Broders HG, 2014, ACTA CHIROPTEROL, V16, P315, DOI 10.3161/150811014X687279; Burns LE, 2014, ECOL EVOL, V4, P4130, DOI 10.1002/ece3.1266; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; CONSTANTINE D. G., 1957, JOUR MAMMAL, V38, P461, DOI 10.2307/1376398; Constantine D. G., 1958, Journal of Mammalogy, V39, P344, DOI 10.2307/1376143; Coulton DW, 2010, WATERBIRDS, V33, P10, DOI 10.1675/063.033.0102; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Cryan PM, 2014, ECOL APPL, V24, P602, DOI 10.1890/13-0752.1; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Davis DS, 1996, NATURAL HIST NOVA SC, V2; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; Elewa AMT, 2010, MIGRATION ORGANISMS; FAURE PA, 1993, J EXP BIOL, V178, P173; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Fleming TH, 2003, BAT ECOLOGY, P156; Forman R.T.T., 1986, LANDSCAPE ECOL; Fraser EE, 2013, CAN J ZOOL, V91, P533, DOI 10.1139/cjz-2013-0072; Fraser EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031419; Fry B., 2006, STABLE ISOTOPE ECOLO; Gomez-Diaz E, 2007, ECOL APPL, V17, P1484, DOI 10.1890/06-1232.1; Griffin D. R., 1936, Journal of Mammalogy, V17, P235, DOI 10.2307/1374420; Harrod C, 2005, OECOLOGIA, V144, P673, DOI 10.1007/s00442-005-0161-x; HEATON THE, 1986, CHEM GEOL, V59, P87, DOI [10.1016/0168-9622(86)90059-X, 10.1016/0009-2541(86)90046-X]; Hebert CE, 2001, ENVIRON SCI TECHNOL, V35, P3482, DOI 10.1021/es001970p; Hellberg ME, 2002, B MAR SCI, V70, P273; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jardine T D, 2003, CAN MANUSCR REP FISH, P39; Kellman LM, 2003, AGR ECOSYST ENVIRON, V95, P87, DOI 10.1016/S0167-8809(02)00168-8; Kelly JF, 2005, ECOL APPL, V15, P1487, DOI 10.1890/04-1704; Knick ST, 2013, OECOLOGIA, V2013, P1; Knox Jones J., 1967, Transactions of the Kansas Academy of Science, V70, P184; KOHL DH, 1971, SCIENCE, V174, P1331, DOI 10.1126/science.174.4016.1331; Krouse HR, 1988, STABLE ISOTOPES ECOL; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Litvin SY, 2004, CAN J FISH AQUAT SCI, V61, P1851, DOI 10.1139/F04-121; Lovette IJ, 2004, CONSERV BIOL, V18, P156, DOI 10.1111/j.1523-1739.2004.00239.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Moore Frank R., 1995, P121; Moseley M, 2007, INT J SPELEOL, V36, P1, DOI 10.5038/1827-806X.36.1.1; Nagorsen DW, 1993, BATS BRIT COLUMBIA R; Norquay KJO, 2013, J MAMMAL, V94, P506, DOI 10.1644/12-MAMM-A-065.1; Owen SF, 2002, ROOST TREE SELECTION; Pain DJ, 2004, OECOLOGIA, V138, P168, DOI 10.1007/s00442-003-1416-z; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Randall J, 2014, ACTA CHIROPTEROL, V16, P109, DOI 10.3161/150811014X683327; Ratcliffe JM, 2003, ANIM BEHAV, V66, P847, DOI 10.1006/anbe.2003.2297; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Robinson Scott K., 1994, Bird Conservation International, V4, P233; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rundel PW, 1989, ECOL STUD, V68; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Tiunov MP, 2007, ACTA CHIROPTEROL, V9, P538, DOI 10.3161/1733-5329(2007)9[538:SMIMPC]2.0.CO;2; UCHIDA SEINOSUKE, 1932, BIRD BANDING, V3, P1; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Zazzo A, 2011, RAPID COMMUN MASS SP, V25, P2371, DOI 10.1002/rcm.5131	76	10	10	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125755	10.1371/journal.pone.0125755	http://dx.doi.org/10.1371/journal.pone.0125755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923696	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600161
J	Taylor, AW; Shi, ZM; Montgomerie, A; Dal Grande, E; Campostrini, S				Taylor, Anne W.; Shi, Zumin; Montgomerie, Alicia; Dal Grande, Eleonora; Campostrini, Stefano			The Use of a Chronic Disease and Risk Factor Surveillance System to Determine the Age, Period and Cohort Effects on the Prevalence of Obesity and Diabetes in South Australian Adults-2003-2013	PLOS ONE			English	Article							BODY-MASS INDEX; UNITED-STATES; BIRTH COHORT; OVERWEIGHT; PREVENTION; MORTALITY; EPIDEMIC; ADULTS; TRENDS	Background Age, period and cohort (APC) analyses, using representative, population-based descriptive data, provide additional understanding behind increased prevalence rates. Methods Data on obesity and diabetes from the South Australian (SA) monthly chronic disease and risk factor surveillance system from July 2002 to December 2013 (n = 59,025) were used. Age was the self-reported age of the respondent at the time of the interview. Period was the year of the interview and cohort was age subtracted from the survey year. Cohort years were 1905 to 1995. All variables were treated as continuous. The age-sex standardised prevalence for obesity and diabetes was calculated using the Australia 2011 census. The APC models were constructed with "apcfit" in Stata. Results The age-sex standardised prevalence of obesity and diabetes increased in 2002-2013 from 18.6% to 24.1% and from 6.2% to 7.9%. The peak age for obesity was approximately 70 years with a steady increasing rate from 20 to 70 years of age. The peak age for diabetes was approximately 80 years. There were strong cohort effects and no period effects for both obesity and diabetes. The magnitude of the cohort effect is much more pronounced for obesity than for diabetes. Conclusion The APC analyses showed a higher than expected peak age for both obesity and diabetes, strong cohort effects with an acceleration of risk after 1960s for obesity and after 1940s for diabetes, and no period effects. By simultaneously considering the effects of age, period and cohort we have provided additional evidence for effective public health interventions.	[Taylor, Anne W.; Shi, Zumin; Montgomerie, Alicia; Dal Grande, Eleonora] Univ Adelaide, Populat Res & Outcome Studies, Discipline Med, Adelaide, SA 5005, Australia; [Taylor, Anne W.; Campostrini, Stefano] Ca Foscari Univ, Venice, Italy	University of Adelaide; Universita Ca Foscari Venezia	Taylor, AW (corresponding author), Univ Adelaide, Populat Res & Outcome Studies, Discipline Med, Adelaide, SA 5005, Australia.	Anne.Taylor@adelaide.edu.au	Taylor, Anne w/F-5708-2010; Shi, Zumin/A-1093-2009	Taylor, Anne w/0000-0002-4422-7974; Shi, Zumin/0000-0002-3099-3299; Dal Grande, Eleonora/0000-0002-5919-3893; Campostrini, Stefano/0000-0002-7113-4458				Allman-Farinelli MA, 2008, EUR J CLIN NUTR, V62, P898, DOI 10.1038/sj.ejcn.1602769; Allman-Farinelli MA, 2009, BRIT J NUTR, V101, P609, DOI 10.1017/S0007114508019879; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Australian Institute of Health and Welfare, 2011, AUSTR I HLTH WELF DI; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Chrisopoulos S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-381; Dal Grande E, 2005, AUST NZ J PUBL HEAL, V29, P343, DOI 10.1111/j.1467-842X.2005.tb00205.x; de Koning L, 2011, INT J EPIDEMIOL, V40, P996, DOI 10.1093/ije/dyr053; Diouf I, 2010, EPIDEMIOLOGY, V21, P360, DOI 10.1097/EDE.0b013e3181d5bff5; Harkonen JT, 2011, ALCOHOL ALCOHOLISM, V46, P349, DOI 10.1093/alcalc/agr025; Hart CL, 2007, DIABETIC MED, V24, P73, DOI 10.1111/j.1464-5491.2007.02016.x; Hussain A, 2007, DIABETES RES CLIN PR, V76, P317, DOI 10.1016/j.diabres.2006.09.020; Jiang T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-889; Keyes KM, 2010, SOC SCI MED, V70, P1100, DOI 10.1016/j.socscimed.2009.12.018; Kwon JW, 2008, DIABETES CARE, V31, P255, DOI 10.2337/dc07-0531; Lee JM, 2010, INT J OBESITY, V34, P614, DOI 10.1038/ijo.2009.235; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Popkin BM, 1998, NUTR REV, V56, P106; Population Research and Outcome Studies South Australian Monitoring and Surveillance System (SAMSS) technical report, 2004, 104 SA DEP HLTH; Reither EN, 2009, SOC SCI MED, V69, P1439, DOI 10.1016/j.socscimed.2009.08.040; Robinson WR, 2012, INT J OBESITY, P1; Rogers RG, 2003, J BIOSOC SCI, V35, P107, DOI 10.1017/S002193200300107X; Rutherford MJ, 2010, STATA J, V10, P606, DOI 10.1177/1536867X1101000405; Simpson RW, 2003, DIABETES RES CLIN PR, V59, P165, DOI 10.1016/S0168-8227(02)00275-9; Smith HL, 2008, SOCIOL METHOD RES, V36, P287, DOI 10.1177/0049124107310636; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; Tu YK, 2012, EPIDEMIOLOGY, V23, P583, DOI 10.1097/EDE.0b013e31824d57a9; Tu YK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019401; World Health Organization(WHO), BMI CLASS	31	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125233	10.1371/journal.pone.0125233	http://dx.doi.org/10.1371/journal.pone.0125233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923664	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600136
J	Eriksson, EM; Liegler, T; Keh, CE; Karlsson, AC; Holditch, SJ; Pilcher, CD; Loeb, L; Nixon, DF; Hecht, FM				Eriksson, Emily M.; Liegler, Teri; Keh, Chris E.; Karlsson, Annika C.; Holditch, Sara J.; Pilcher, Christopher D.; Loeb, Lisa; Nixon, Douglas F.; Hecht, Frederick M.			Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LYMPHOCYTE ESCAPE; VIRAL ESCAPE; INFECTION; EVOLUTION; REVERSION; SELECTION; VARIANTS; GAG; MUTATIONS	CD8(+) T cells are important for HIV-1 virus control, but are also a major contributing factor that drives HIV-1 virus sequence evolution. Although HIV-1 cytotoxic T cell (CTL) escape mutations are a common aspect during HIV-1 infection, less is known about the importance of T cell pressure in reversing HIV-1 virus back to a consensus sequences. In this study we aimed to assess the frequency with which reversion of transmitted mutations in T cell epitopes were associated with T cell responses to the mutation. This study included 14 HIV-1 transmission pairs consisting of a 'source' (virus-donor) and a 'recipient' (newly infected individual). Non-consensus B sequence amino acids (mutations) in T cell epitopes in HIV-1 gag regions p17, p24, p2 and p7 were identified in each pair and transmission of mutations to the recipient was verified with population viral sequencing. Longitudinal analyses of the recipient's viral sequence were used to identify whether reversion of mutations back to the consensus B sequence occurred. Autologous 12-mer peptides overlapping by 11 were synthesized, representing the sequence region surrounding each reversion and longitudinal analysis of T cell responses to source-derived mutated and reverted epitopes were assessed. We demonstrated that mutations in the source were frequently transmitted to the new host and on an average 17 percent of mutated epitopes reverted to consensus sequence in the recipient. T cell responses to these mutated epitopes were detected in 7 of the 14 recipients in whom reversion occurred. Overall, these findings indicate that transmitted non-consensus B epitopes are frequently immunogenic in HLA-mismatched recipients and new T cell pressures to T cell escape mutations following transmission play a significant role in maintaining consensus HIV-1 sequences.	[Eriksson, Emily M.; Keh, Chris E.; Holditch, Sara J.; Nixon, Douglas F.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Expt Med,San Francisco Posit Hlth Program, San Francisco, CA USA; [Liegler, Teri; Pilcher, Christopher D.; Loeb, Lisa; Hecht, Frederick M.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco Posit Hlth Program, San Francisco, CA USA; [Karlsson, Annika C.] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Karolinska Institutet	Eriksson, EM (corresponding author), Walter & Eliza Hall Inst Med Sci, Melbourne, Vic, Australia.	eriksson@wehi.edu.au	Karlsson, Annika/R-2255-2016; Nixon, Douglas/AAU-5734-2020	Karlsson, Annika/0000-0002-2028-8393; Nixon, Douglas/0000-0002-2801-1786; Hecht, Frederick/0000-0002-5782-1171; Loeb Stanga, Lisa/0000-0001-7471-5381; Eriksson, Emily/0000-0002-7851-973X	NIH from National Institute of Allergy and Infectious Diseases [P01 AI071713]; American-Scandinavian Foundation; National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI27763]; T32 Training in HIV Translational Research [AI060530]; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, T32AI060530, P01AI071713] Funding Source: NIH RePORTER	NIH from National Institute of Allergy and Infectious Diseases; American-Scandinavian Foundation; National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USAUniversity of California System); T32 Training in HIV Translational Research; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This study was supported by NIH Program Project Grant P01 AI071713 from the National Institute of Allergy and Infectious Diseases. E.M.E was supported by a fellowship from the American-Scandinavian Foundation and a grant from the National Institutes of Health, University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30 AI27763. C.E.K. was supported by T32 Training in HIV Translational Research [PI: Diane Havlir, grant number AI060530]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brander C, 1998, J CLIN INVEST, V101, P2559, DOI 10.1172/JCI2405; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Christie NM, 2009, VIROLOGY, V388, P137, DOI 10.1016/j.virol.2009.03.003; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Feeney ME, 2005, J IMMUNOL, V174, P7524, DOI 10.4049/jimmunol.174.12.7524; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Furutsuki T, 2004, J VIROL, V78, P8437, DOI 10.1128/JVI.78.16.8437-8445.2004; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Keane NM, 2012, IMMUNOL CELL BIOL, V90, P224, DOI 10.1038/icb.2011.34; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Lopez M, 2006, AIDS RES HUM RETROV, V22, P884, DOI 10.1089/aid.2006.22.884; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Milicic A, 2005, J VIROL, V79, P13953, DOI 10.1128/JVI.79.22.13953-13962.2005; Navis M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002422; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Ryland EG, 2010, J VIROL, V84, P12437, DOI 10.1128/JVI.01617-10; Schneidewind A, 2009, J VIROL, V83, P8616, DOI 10.1128/JVI.00730-09; Willberg CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010249	32	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0120787	10.1371/journal.pone.0120787	http://dx.doi.org/10.1371/journal.pone.0120787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919393	Green Published, gold			2022-12-26	WOS:000353659400004
J	Xu, HM; Wang, HS; Xu, QQ; Lv, L; Yin, CH; Liu, XL; Du, HW; Yan, H				Xu, Huimin; Wang, Huasheng; Xu, Qianqian; Lv, Le; Yin, Chunhua; Liu, Xiaolu; Du, Hongwu; Yan, Hai			Pathway for Biodegrading Microcystin-YR by Sphingopyxis sp USTB-05	PLOS ONE			English	Article							CYANOBACTERIAL HEPATOTOXIN; DEGRADING BACTERIUM; ENZYMATIC PATHWAY; FRESH-WATERS; LR; LAKE; DEGRADATION; RR; SEDIMENTS; EXTRACTS	Harmful cyanobacterial blooms in waters have become a global environmental problem, this mainly due to the production and release of various microalgal toxins, in which microcystins (MCs) are distributed widely. Here, we focused on the study of a typical form of microcystins called microcystin-YR (MC-YR). It was found that initial 14.8 mg/L of MC-YR could be completely eliminated within 10 hr by the crude enzymes (CEs) of Sphingopyxis sp. USTB-05, a promising bacterial strain we isolated and identified in our previous study. During the enzymatic biodegradation of MC-YR with time course, the peaks of two intermediate and two final products were observed on the profiles of HPLC at the wavelengths of 238 nm and 230 nm, respectively. Based on the analysis of m/z ratios of MC-YR and its four products by LC-MS/MS, we suggested that at least four enzymes were involved in the biodegradation of MC-YR by Sphingopyxis sp. USTB-05. The first enzyme microcystinase converted cyclic MC-YR to linear MC-YR as the first product. Then the second enzyme serine protease was found to cleave the target peptide bond between alanine (Ala) and tyrosine (Tyr) of linearized MC-YR, producing a tetrapeptide and a tripeptide as second products, which were Adda-Glu-Mdha-Ala and Tyr-Masp-Arg, respectively. Next, the third enzyme peptidase converted the tetrapeptide of Adda-Glu-Mdha-Ala to Adda. And the fourth enzyme cleaved the tripeptide of Tyr-Masp-Arg to produce Tyr and dipeptide (Masp-Arg), which has never been reported. These findings will help us better understand the biodegradation pathway of MC-YR by Sphingopyxis sp. USTB-05.	[Xu, Huimin; Wang, Huasheng; Xu, Qianqian; Lv, Le; Yin, Chunhua; Liu, Xiaolu; Du, Hongwu; Yan, Hai] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China	University of Science & Technology Beijing	Yan, H (corresponding author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China.	haiyan@ustb.edu.cn	liu, xiaolu/AAC-6908-2020		National Natural Science Foundation of China [21177009]; Specifical Foundation of Doctoral Program, Ministry of Education, P.R. China [20120006110001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specifical Foundation of Doctoral Program, Ministry of Education, P.R. China	This work was supported by the National Natural Science Foundation of China (No. 21177009) and the Specifical Foundation of Doctoral Program, Ministry of Education, P.R. China (No. 20120006110001).	Bourne DG, 2006, WATER RES, V40, P1294, DOI 10.1016/j.watres.2006.01.022; Chen XG, 2010, WATER RES, V44, P1884, DOI 10.1016/j.watres.2009.11.025; Cousins IT, 1996, WATER RES, V30, P481, DOI 10.1016/0043-1354(95)00189-1; Ding XS, 2006, TOXICON, V48, P973, DOI 10.1016/j.toxicon.2006.07.039; Edwards C, 2008, CHEMOSPHERE, V73, P1315, DOI 10.1016/j.chemosphere.2008.07.015; Eleuterio L, 2010, TOXICON, V55, P1434, DOI 10.1016/j.toxicon.2010.02.020; Harada K, 2004, TOXICON, V44, P107, DOI 10.1016/j.toxicon.2004.04.003; Ho L, 2007, WATER RES, V41, P4685, DOI 10.1016/j.watres.2007.06.057; Holst T, 2003, WATER RES, V37, P4748, DOI 10.1016/S0043-1354(03)00413-5; JONES GJ, 1994, WATER RES, V28, P871, DOI 10.1016/0043-1354(94)90093-0; Kujbida P, 2008, TOXICON, V51, P1274, DOI 10.1016/j.toxicon.2008.02.013; Lahti K, 1997, WATER RES, V31, P1005, DOI 10.1016/S0043-1354(96)00353-3; Lemes GAF, 2008, ECOTOX ENVIRON SAFE, V69, P358, DOI 10.1016/j.ecoenv.2007.03.013; Morgan M, 2014, J GREAT LAKES RES, V40, P215, DOI [10.1016/j.jglr.2013.12.012, DOI 10.1016/J.JGLR.2013.12.012]; Park HD, 2001, ENVIRON TOXICOL, V16, P337, DOI 10.1002/tox.1041; Pouria S, 1998, LANCET, V352, P111, DOI [10.1016/S0140-6736(97)12285-1, DOI 10.1016/S0140-6736(97)12285-1]; Puerto M, 2009, TOXICON, V54, P161, DOI 10.1016/j.toxicon.2009.03.030; Saito T, 2003, FEMS MICROBIOL LETT, V229, P271, DOI 10.1016/S0378-1097(03)00847-4; Shimizu K, 2012, J BIOSCI BIOENG, V114, P630, DOI 10.1016/j.jbiosc.2012.07.004; Smith EA, 2014, HARMFUL ALGAE, V35, P38, DOI 10.1016/j.hal.2014.03.008; Takenaka S, 1997, CHEMOSPHERE, V34, P749, DOI 10.1016/S0045-6535(97)00002-7; Vareli K, 2013, MAR DRUGS, V11, P2751, DOI 10.3390/md11082751; Vasconcelos VM, 2007, TOXICON, V50, P740, DOI 10.1016/j.toxicon.2007.06.010; Vasconcelos VM, 1996, WATER RES, V30, P2377, DOI 10.1016/0043-1354(96)00152-2; Wang JF, 2010, CHINESE J CHEM ENG, V18, P108, DOI 10.1016/S1004-9541(08)60330-4; Xiao CB, 2011, FRONT ENVIRON SCI EN, V5, P526, DOI 10.1007/s11783-010-0261-7; Yan H, 2012, J ENVIRON SCI-CHINA, V24, P1816, DOI 10.1016/S1001-0742(11)61016-4; Yan H, 2012, CHEMOSPHERE, V87, P12, DOI 10.1016/j.chemosphere.2011.11.030; Yang F, 2014, BIODEGRADATION, V25, P447, DOI 10.1007/s10532-013-9673-y	29	83	85	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124425	10.1371/journal.pone.0124425	http://dx.doi.org/10.1371/journal.pone.0124425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919632	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659400050
J	Teasley, DC; Parajuli, S; Nguyen, M; Moore, HR; Alspach, E; Lock, YJ; Honaker, Y; Saharia, A; Piwnica-Worms, H; Stewart, SA				Teasley, Daniel C.; Parajuli, Shankar; Mai Nguyen; Moore, Hayley R.; Alspach, Elise; Lock, Ying Jie; Honaker, Yuchi; Saharia, Abhishek; Piwnica-Worms, Helen; Stewart, Sheila A.			Flap Endonuclease 1 Limits Telomere Fragility on the Leading Strand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; REPLICATION FORK PROGRESSION; DNA-REPLICATION; MAMMALIAN TELOMERES; TRANSCRIPTION; BINDING; RECOMBINATION; MAINTENANCE; STABILITY; HELICASE	The existence of redundant replication and repair systems that ensure genome stability underscores the importance of faithful DNA replication. Nowhere is this complexity more evident than in challenging DNA templates, including highly repetitive or transcribed sequences. Here, we demonstrate that flap endonuclease 1 (FEN1), a canonical lagging strand DNA replication protein, is required for normal, complete leading strand replication at telomeres. We find that the loss of FEN1 nuclease activity, but not DNA repair activities, results in leading strand-specific telomere fragility. Furthermore, we show that FEN1 depletion-induced telomere fragility is increased by RNA polymerase II inhibition and is rescued by ectopic RNase H1 expression. These data suggest that FEN1 limits leading strand-specific telomere fragility by processing RNA: DNA hybrid/flap intermediates that arise from co-directional collisions occurring between the replisome and RNA polymerase. Our data reveal the first molecular mechanism for leading strand-specific telomere fragility and the first known role for FEN1 in leading strand DNA replication. Because FEN1 mutations have been identified in human cancers, our findings raise the possibility that unresolved RNA: DNA hybrid structures contribute to the genomic instability associated with cancer.	[Teasley, Daniel C.; Parajuli, Shankar; Mai Nguyen; Moore, Hayley R.; Alspach, Elise; Lock, Ying Jie; Honaker, Yuchi; Saharia, Abhishek; Piwnica-Worms, Helen; Stewart, Sheila A.] Washington Univ, Sch Med, Canc Environm Inst, Depts Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, Helen; Stewart, Sheila A.] Washington Univ, Sch Med, Canc Environm Inst, Dept Med, St Louis, MO 63110 USA; [Teasley, Daniel C.; Parajuli, Shankar; Mai Nguyen; Moore, Hayley R.; Alspach, Elise; Stewart, Sheila A.] Washington Univ, Sch Med, Canc Environm Inst, Dept Integrating Communicat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Stewart, SA (corresponding author), Washington Univ, Sch Med, Canc Environm Inst, Depts Cell Biol & Physiol, St Louis, MO 63110 USA.	sheila.stewart@wustl.edu	Regan, Clinton/E-6250-2012	Alspach, Elise/0000-0002-2740-9768	National Institutes of Health [GM95924]; NRSA [GM007067]; Siteman Cancer Center at Barnes-Jewish Hospital; Washington University School of Medicine; NATIONAL CANCER INSTITUTE [T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067, R01GM095924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siteman Cancer Center at Barnes-Jewish Hospital; Washington University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM95924 (to S. A. S.) and Training Grant GM007067 from NRSA (to D. C. T. and E. A.). This work was also supported by the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine (to S. P. and H. R. M.).	Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Bah A, 2012, NUCLEIC ACIDS RES, V40, P2995, DOI 10.1093/nar/gkr1153; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Burrow AA, 2010, NUCLEIC ACIDS RES, V38, P2865, DOI 10.1093/nar/gkp1245; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Chawla R, 2011, EMBO J, V30, P4047, DOI 10.1038/emboj.2011.280; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Popuri V, 2014, NUCLEIC ACIDS RES, V42, P5671, DOI 10.1093/nar/gku200; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Saharia A, 2010, J BIOL CHEM, V285, P27057, DOI 10.1074/jbc.M110.112276; SAMBROOK J, 1989, MOL CLONING LABORATO, pCH7; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Sordet O, 2010, CELL CYCLE, V9, P274, DOI 10.4161/cc.9.2.10506; d'Alcontres MS, 2014, CELL CYCLE, V13, P1463, DOI 10.4161/cc.28419; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Vallabhaneni H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003639; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313	53	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15133	15145		10.1074/jbc.M115.647388	http://dx.doi.org/10.1074/jbc.M115.647388			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922071	hybrid, Green Published			2022-12-26	WOS:000356177300028
J	Bandera, A; Gori, A; Sabbatini, F; Madeddu, G; Bonora, S; Libertone, R; Mastroianni, C; Bonfanti, P; Monforte, AD; Cozzi-Lepri, A				Bandera, Alessandra; Gori, Andrea; Sabbatini, Francesca; Madeddu, Giordano; Bonora, Stefano; Libertone, Raffaella; Mastroianni, Claudio; Bonfanti, Paolo; Monforte, Antonella d'Arminio; Cozzi-Lepri, Alessandro		Icona Fdn Study Grp	Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; RISK-FACTOR; CYSTATIN C; ASSOCIATION; CREATININE; EVENTS; INSUFFICIENCY	Whilst renal dysfunction, especially mild impairment (60<eGFR<90ml/min), has been often described in HIV-infected population, its potential contribution to HIV evolution and risk of cerebro-cardiovascular disease (CCVD) has not been clarified. Data from HIV-1 infected patients enrolled in the Italian Cohort of Antiretroviral-Naive (Icona) Foundation Study collected between January 2000 and February 2014 with at least two creatinine values available. eGFR (CKD-epl) and renal dysfunction defined using a priori cut-offs of 60 (severely impaired) and 90 ml/min/1.73m(2) (mildly impaired). Characteristics of patients were described after stratification in these groups and compared using chi-square test (categorical variables) or Kruskal Wallis test comparing median values. Follow-up accrued from baseline up to the date of the CCVD or AIDS related events or death or last available visit. Kaplan Meier curves were used to estimate the cumulative probability of occurrence of the events over time. Adjusted analysis was performed using a proportional hazards Cox regression model. We included 7,385 patients, observed for a median follow-up of 43 months (interquartile range [IQR]: 21-93 months). Over this time, 130 cerebro-cardiovascular events (including 11 deaths due to CCVD) and 311 AIDS-related events (including 45 deaths) were observed. The rate of CCVD events among patients with eGFR >90, 60-89, <60 ml/min, was 2.91 (95% CI 2.30-3.67), 4.63 (95% CI 3.51-6.11) and 11.9 (95% CI 6.19-22.85) per 1,000 PYFU respectively, with an unadjusted hazard ratio (HR) of 4.14 (95% CI 2.07-8.29) for patients with eGFR < 60 ml/min and 1.58 (95% CI 1.10-2.27) for eGFR 60-89 compared to those with eGFR >= 90. Of note, these estimates are adjusted for traditional cardiovascular risk factors (e.g. smoking, diabetes, hypertension, dyslipidemia). Incidence of AIDS-related events was 9.51 (95% CI 8.35-10.83), 6.04 (95% CI 4.74-7.71) and 25.0 (95% CI 15.96-39.22) per 1,000 PYFU, among patients with eGFR >90, 60-89, <60 ml/min, respectively, with an unadjusted HR of 2.49 (95% CI 1.56-3.97) for patients with eGFR <60 ml/min and 0.68 (95% CI 0.52-0.90) for eGFR 60-89. The risk of AIDS events was significantly lower in mild renal dysfunction group even after adjustment for HIV-related characteristics. Our data confirm that impaired renal function is an important risk marker for CCVD events in the HIV-population; importantly, even those with mild renal impairment (90<eGFR<60) seem to be at increased risk of cerebro-cardiovascular morbidity and mortality.	[Bandera, Alessandra; Gori, Andrea; Sabbatini, Francesca] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy; [Madeddu, Giordano] Univ Sassari, Dept Infect Dis, I-07100 Sassari, Italy; [Bonora, Stefano] Univ Turin, Amedeo di Savoia Hosp, Dept Infect Dis, Turin, Italy; [Libertone, Raffaella] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Mastroianni, Claudio] Univ La Sapienza, Dept Infect & Trop Dis, Latina, Italy; [Bonfanti, Paolo] Alessandro Manzoni Hosp, Infect Dis Unit, Lecce, Italy; [Monforte, Antonella d'Arminio] Univ Milan, San Paolo Hosp, Clin Infect Dis & Trop Med, Milan, Italy; [Cozzi-Lepri, Alessandro] UCL, London, England	San Gerardo Hospital; University of Milano-Bicocca; University of Sassari; University of Turin; IRCCS Lazzaro Spallanzani; Sapienza University Rome; San Paolo-Polo Universitaria Hospital; University of Milan; University of London; University College London	Bandera, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy.	alessandra.bandera@unimib.it	bonora, stefano/AAC-2993-2019; Cingolani, antonella/J-8921-2018; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; MASTROIANNI, Claudio Maria/O-9741-2019; MADEDDU, Giordano/AAP-4342-2020; perno, carlo federico/O-1544-2016; Castagna, Antonella/K-3280-2018; Ursini, Tamara/AAB-3891-2019; Di Biagio, Antonio/J-4901-2019; Bonfanti, Paolo/AAK-9800-2020; Rusconi, Stefano/H-9263-2012; Bandera, Alessandra/AAC-6081-2022; nicastri, emanuele/K-7780-2016; Antinori, Andrea/K-7125-2016; Ippolito, Giuseppe/J-7207-2017; QUIROS ROLDAN, Maria Eugenia/K-7586-2015; TINCATI, CAMILLA/K-4501-2018; De Luca, Andrea/G-8810-2011; MARCHETTI, GIULIA CARLA/K-4384-2018; Balotta, Claudia/L-7295-2017; LAZZARIN, Adriano/K-3607-2018; GALLI, MASSIMO/L-7282-2017	bonora, stefano/0000-0002-7537-3341; Cingolani, antonella/0000-0002-3793-2755; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; MADEDDU, Giordano/0000-0001-6099-2273; Castagna, Antonella/0000-0002-8338-9714; Ursini, Tamara/0000-0002-6012-0667; Di Biagio, Antonio/0000-0003-1436-5089; Bonfanti, Paolo/0000-0001-7289-8823; Rusconi, Stefano/0000-0002-0375-9990; nicastri, emanuele/0000-0002-5606-8712; Antinori, Andrea/0000-0003-2121-4684; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; QUIROS ROLDAN, Maria Eugenia/0000-0003-1452-9100; BORGIA, Guglielmo/0000-0002-1281-1041; Ammassari, Adriana/0000-0002-0284-0340; TINCATI, CAMILLA/0000-0002-3083-2962; De Luca, Andrea/0000-0002-9561-9193; SANTORO, Carmen Rita/0000-0001-7806-8548; Segala, Daniela/0000-0001-6133-0386; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; Castelli, Francesco/0000-0001-9161-7804; Gianotti, Nicola/0000-0002-7182-5080; COSTANTINI, ANDREA/0000-0003-1588-7030; Guaraldi, Giovanni/0000-0002-5724-3914; Cinque, Paola/0000-0003-2448-5957; PERNO, CARLO FEDERICO/0000-0002-0825-5388; LAPADULA, Giuseppe/0000-0002-9976-8102; Bandera, Alessandra/0000-0003-1626-0328; PUZZOLANTE, CINZIA/0000-0002-1179-1341; Balotta, Claudia/0000-0002-1107-9119; BANDERA, ALESSANDRA/0000-0001-9440-4601; Vanino, Elisa/0000-0003-3510-1429; ANGARANO, Gioacchino/0000-0003-3207-7523; Andreoni, Massimo/0000-0002-3205-9758; Ippolito, Giuseppe/0000-0002-1076-2979; LAZZARIN, Adriano/0000-0003-2551-7754; CAUDA, Roberto/0000-0002-1498-4229; Girardi, Enrico/0000-0001-8182-5896; GALLI, MASSIMO/0000-0001-8887-6215; Puoti, Massimo/0000-0003-3278-7138; d'Arminio Monforte, Antonella/0000-0003-0073-1789; Galli, Laura/0000-0001-8046-0290; Capobianchi, Maria Rosaria/0000-0003-3465-0071; MONNO, Laura/0000-0002-2713-4258; Tebano, Gianpiero/0000-0003-1891-4823	AbbVie; Briston Myers-Squibb; Gilead; Jannsen; Merck Sharp Dohme; ViiV Italy	AbbVie(AbbVie); Briston Myers-Squibb; Gilead(Gilead Sciences); Jannsen; Merck Sharp Dohme(Merck & Company); ViiV Italy	ICONA Foundation Study is sponsored by unrestricted grants from AbbVie, Briston Myers-Squibb, Gilead, Jannsen, Merck Sharp & Dohme, ViiV Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi AI, 2010, CIRCULATION, V121, P651, DOI 10.1161/CIRCULATIONAHA.109.898585; Fernando SK, 2008, AM J MED SCI, V335, P89, DOI 10.1097/MAJ.0b013e31812e6b34; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V32, P203, DOI 10.1097/00126334-200302010-00013; Gupta SK, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-31; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Ho JE, 2012, AIDS, V26, P1115, DOI 10.1097/QAD.0b013e328352ce54; Inker LA, 2012, JAIDS-J ACQ IMM DEF, V61, P302, DOI 10.1097/QAI.0b013e31826a6c4f; Kottgen A, 2007, J AM SOC NEPHROL, V18, P1307, DOI 10.1681/ASN.2006101159; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Lucas GM, 2014, HIV MED, V15, P116, DOI 10.1111/hiv.12087; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Sorli ML, 2008, JAIDS-J ACQ IMM DEF, V48, P506, DOI 10.1097/QAI.0b013e31817bbecb; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Szczech LA, 2004, CLIN INFECT DIS, V39, P1199, DOI 10.1086/424013; Tordato F, 2011, HIV MED, V12, P4, DOI 10.1111/j.1468-1293.2010.00855.x; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4	21	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124252	10.1371/journal.pone.0124252	http://dx.doi.org/10.1371/journal.pone.0124252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933346	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100034
J	Berendes, D; Levy, K; Knee, J; Handzel, T; Hill, VR				Berendes, David; Levy, Karen; Knee, Jackie; Handzel, Thomas; Hill, Vincent R.			Ascaris and Escherichia coli Inactivation in an Ecological Sanitation System in Port-au-Prince, Haiti	PLOS ONE			English	Article							FECAL SLUDGE; EGGS; SURVIVAL; SUUM; COMPOST; EFFICIENCY; URINE; FECES	The goal of this study was to evaluate the microbial die-off in a latrine waste composting system in Port-au-Prince, Haiti. Temperature data and samples were collected from compost aged 0 - 12+ months. Samples collected from compost bin centers and corners at two depths were assessed for moisture content, E. coli concentration, and Ascaris spp. viability. Center temperatures in compost bins were all above 58 degrees C, while corner temperatures were 10 - 20 degrees C lower. Moisture content was 67 +/- 10% in all except the oldest compost. A 4-log reduction in E. coli was observed over the first sixteen weeks of composting at both locations and depths, after which E. coli was undetectable (LOD: 142 MPN g(-1) dry weight). In new compost, 10.4% and 8.3% of Ascaris eggs were viable and fully embryonated, respectively. Percent viability dropped to zero in samples older than six weeks. These findings indicate that the Haitian EcoSan composting process was effective in inactivating E. coliand Ascaris spp. in latrine waste within sixteen weeks. This study is one of the first to document efficacy of an ecological sanitation system under field conditions and provides insight into composting methods and monitoring for other international settings.	[Berendes, David; Levy, Karen] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Berendes, David; Handzel, Thomas] Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Div Global Hlth Protect, Atlanta, GA USA; [Hill, Vincent R.] Ctr Dis Control & Prevent, Environm Microbiol Lab, Waterborne Dis Prevent Branch, Div Food Waterborne & Environm Dis, Atlanta, GA 30329 USA	Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hill, VR (corresponding author), Ctr Dis Control & Prevent, Environm Microbiol Lab, Waterborne Dis Prevent Branch, Div Food Waterborne & Environm Dis, Atlanta, GA 30329 USA.	veh2@cdc.gov	Knee, Jackie/AAB-4434-2021	Knee, Jackie/0000-0002-0834-8488	Emergency Response and Recovery Branch in the Division of Global Health Protection; Environmental Microbiology Laboratory of the Waterborne Disease Prevention Branch in the Division of Food, Waterborne, and Environmental Diseases at the Centers for Disease Control and Prevention	Emergency Response and Recovery Branch in the Division of Global Health Protection; Environmental Microbiology Laboratory of the Waterborne Disease Prevention Branch in the Division of Food, Waterborne, and Environmental Diseases at the Centers for Disease Control and Prevention	Materials, salaries, travel, and logistics for this work were supported by funds from the Emergency Response and Recovery Branch in the Division of Global Health Protection and the Environmental Microbiology Laboratory of the Waterborne Disease Prevention Branch in the Division of Food, Waterborne, and Environmental Diseases at the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, STANDARD METHODS EXA; Bowman DD, 2003, WATER RES, V37, P2063, DOI 10.1016/S0043-1354(02)00597-3; Buckley CA, 2008, RES UD VIDP URINE DI; Butkus MA, 2011, APPL ENVIRON MICROB, V77, P363, DOI 10.1128/AEM.01675-10; Chien BT, BIOL STUDY RETENTION; Corrales LF, 2006, TROP MED INT HEALTH, V11, P1821, DOI 10.1111/j.1365-3156.2006.01737.x; Decrey L, 2011, WATER RES, V45, P4960, DOI 10.1016/j.watres.2011.06.042; DINEPA, 2013, GUID TECHN FIL TRAIT; Eccles JP, 2004, J APPL MICROBIOL, V96, P375, DOI 10.1046/j.1365-2672.2004.02165.x; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Endale YT, 2012, WASTE MANAGE RES, V30, P750, DOI 10.1177/0734242X11432190; Esrey SA, 2001, WATER SCI TECHNOL, V43, P177; Fidjeland J, 2013, WATER RES, V47, P6014, DOI 10.1016/j.watres.2013.07.024; Ghiglietti R., 1995, Parassitologia (Rome), V37, P229; Gong CM, 2005, J ENVIRON SCI-CHINA, V17, P770; Green W, 2005, WATER SCI TECHNOL, V51, P29, DOI 10.2166/wst.2005.0348; Jensen PKM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-57; Kato S, 2003, INT J ENVIRON HEAL R, V13, P169, DOI 10.1080/0960312031000098071; Kone D, 2007, WATER RES, V41, P4397, DOI 10.1016/j.watres.2007.06.024; Langergraber G, 2005, ENVIRON INT, V31, P433, DOI 10.1016/j.envint.2004.08.006; Magri ME, 2013, APPL ENVIRON MICROB, V79, P2156, DOI 10.1128/AEM.03920-12; McKinley JW, 2012, APPL ENVIRON MICROB, V78, P5133, DOI 10.1128/AEM.00631-12; Mehl J, 2011, J WATER HEALTH, V9, P187, DOI 10.2166/wh.2010.138; Moe CL, 2003, 2 INT S EC SAN; Muirhead RW, 2004, LETT APPL MICROBIOL, V39, P383, DOI 10.1111/j.1472-765X.2004.01604.x; Nordin A, 2009, APPL ENVIRON MICROB, V75, P662, DOI 10.1128/AEM.01250-08; PEASEY A, 2000, HLTH ASPECTS DRY SAN; Pecson BM, 2007, WATER RES, V41, P2893, DOI 10.1016/j.watres.2007.03.040; Pourcher AM, 2005, J APPL MICROBIOL, V99, P528, DOI 10.1111/j.1365-2672.2005.02642.x; Preneta N, 2013, J WATER SANIT HYG DE, V3, P649, DOI 10.2166/washdev.2013.145; Redlinger T, 2001, APPL ENVIRON MICROB, V67, P4036, DOI 10.1128/AEM.67.9.4036-4040.2001; Schonning C, 2004, GUIDELINES SAFE USE; Stenstrom TA, REDUCTION EFFICIENCY; Szabova E, 2010, WASTE MANAGE, V30, P426, DOI 10.1016/j.wasman.2009.09.035; Tonner-Klank L, 2007, WASTE MANAGE, V27, P1144, DOI 10.1016/j.wasman.2006.04.021; UNICEF and WHO, 2012, PROGR DRINKING WATER; US EPA, 1999, BIOS GEN US DISP US; USEPA, 1995, BIOS MAN HDB 1C; USEPA, 1999, ENVIRONMENTAL REGULA; WHO, 2006, WHO GUID SAF US WAST	40	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125336	10.1371/journal.pone.0125336	http://dx.doi.org/10.1371/journal.pone.0125336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932948	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100100
J	Cooley, LF; Martin, RK; Zellner, HB; Irani, AM; Uram-Tuculescu, C; El Shikh, ME; Conrad, DH				Cooley, Lauren Folgosa; Martin, Rebecca K.; Zellner, Hannah B.; Irani, Anne-Marie; Uram-Tuculescu, Cora; El Shikh, Mohey Eldin; Conrad, Daniel H.			Increased B Cell ADAM10 in Allergic Patients and Th2 Prone Mice	PLOS ONE			English	Article							TNF-ALPHA; DISINTEGRIN; CD23; FORM	ADAM10, as the sheddase of the low affinity IgE receptor (CD23), promotes IgE production and thus is a unique target for attenuating allergic disease. Herein, we describe that B cell levels of ADAM10, specifically, are increased in allergic patients and Th2 prone WT mouse strains (Balb/c and A/J). While T cell help augments ADAM10 expression, Balb WT B cells exhibit increased ADAM10 in the naive state and even more dramatically increased ADAM10 after anti-CD40/IL4 stimulation compared C57 (Th1 prone) WT B cells. Furthermore, ADAM17 and TNF are reduced in allergic patients and Th2 prone mouse strains (Balb/c and A/J) compared to Th1 prone controls. To further understand this regulation, ADAM17 and TNF were studied in C57Bl/6 and Balb/c mice deficient in ADAM10. C57-ADAM10(B-/-) were more adept at increasing ADAM17 levels and thus TNF cleavage resulting in excess follicular TNF levels and abnormal secondary lymphoid tissue architecture not noted in Balb-ADAM10(B-/-). Moreover, the level of B cell ADAM10 as well as Th context is critical for determining IgE production potential. Using a murine house dust mite airway hypersensitivity model, we describe that high B cell ADAM10 level in a Th2 context (Balb/c WT) is optimal for disease induction including bronchoconstriction, goblet cell metaplasia, mucus, inflammatory cellular infiltration, and IgE production. Balb/c mice deficient in B cell ADAM10 have attenuated lung and airway symptoms compared to Balb WT and are actually most similar to C57 WT (Th1 prone). C57-ADAM10(B-/-) have even further reduced symptomology. Taken together, it is critical to consider both innate B cell levels of ADAM10 and ADAM17 as well as Th context when determining host susceptibility to allergic disease. High B cell ADAM10 and low ADAM17 levels would help diagnostically in predicting Th2 disease susceptibility; and, we provide support for the use ADAM10 inhibitors in treating Th2 disease.	[Cooley, Lauren Folgosa] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA 23298 USA; [Cooley, Lauren Folgosa; Martin, Rebecca K.; Zellner, Hannah B.; Conrad, Daniel H.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Irani, Anne-Marie] Virginia Commonwealth Univ, Dept Pediat, Div Allergy & Immunol, Richmond, VA 23298 USA; [Uram-Tuculescu, Cora] Virginia Commonwealth Univ, Dept Pathol, Div Anat Pathol, Richmond, VA 23298 USA; [El Shikh, Mohey Eldin] Queen Mary Univ London, William Harvey Res Inst, Expt Med & Rheumatol, London, England	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of London; Queen Mary University London	Conrad, DH (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	dconrad@vcu.edu		Martin, Rebecca/0000-0001-9948-5463; El Shikh, Mohey Eldin/0000-0003-4395-0375	NIAID/NIH [R01 AI018697-33A1S1, RO1AI18697]; American Asthma Foundation AAF [11-0094]; VCU School of Medicine; Massey Cancer Center Core [P30 CA16059]; NIH-NINDS center core grant [5P30N5S047463]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093857] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Asthma Foundation AAF; VCU School of Medicine; Massey Cancer Center Core; NIH-NINDS center core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grant RO1AI18697 from NIAID/NIH, R01 AI018697-33A1S1 NIAID/NIH, American Asthma Foundation 11-0094 AAF, and a bridge grant from the VCU School of Medicine. Flow cytometry support from the Massey Cancer Center Core P30 CA16059 is also acknowledged. Microscopy was performed at the VCU Department of Neurobiology and Anatomy Facility, supported in part with funding from NIH-NINDS center core grant 5P30N5S047463.	Chaimowitz NS, 2011, J IMMUNOL, V187, P5114, DOI 10.4049/jimmunol.1102172; Conrad DH, 2007, CURR ALLERGY ASTHM R, V7, P331, DOI 10.1007/s11882-007-0050-y; Di Lorenzo G, 1999, ALLERGY ASTHMA PROC, V20, P119, DOI 10.2500/108854199778612590; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Folgosa L, 2013, J IMMUNOL, V191, P5951, DOI 10.4049/jimmunol.1302042; Frasca D, 2012, J IMMUNOL, V188, P279, DOI 10.4049/jimmunol.1003964; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; Hirota JA, 2010, CLIN EXP ALLERGY, V40, P820, DOI 10.1111/j.1365-2222.2010.03458.x; Johansson SGO, 2004, EXPERT REV MOL DIAGN, V4, P273, DOI 10.1586/14737159.4.3.273; Kawakami M, 2012, CELL IMMUNOL, V275, P24, DOI 10.1016/j.cellimm.2012.03.009; Kelly AE, 1998, J IMMUNOL, V161, P6696; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Mathews JA, 2011, ALLERGY, V66, P1193, DOI 10.1111/j.1398-9995.2011.02614.x; Norton SK, 2012, J ALLERGY CLIN IMMUN, V130, P761, DOI 10.1016/j.jaci.2012.04.023; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Sahu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011348; Tumanov AV, 2010, BLOOD, V116, P3456, DOI 10.1182/blood-2009-10-249177; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; Walsh GM, 2009, CURR MED CHEM, V16, P4774, DOI 10.2174/092986709789909639; Walsh GM, 2009, CURR OPIN MOL THER, V11, P329; WATANABE N, 1989, INFECT IMMUN, V57, P1405, DOI 10.1128/IAI.57.5.1405-1408.1989; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399	24	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124331	10.1371/journal.pone.0124331	http://dx.doi.org/10.1371/journal.pone.0124331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933166	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100040
J	Sanderson, M; Lipworth, L; Shen-Miller, D; Nechuta, S; Beeghly-Fadiel, A; Shrubsole, MJ; Zheng, W				Sanderson, Maureen; Lipworth, Loren; Shen-Miller, David; Nechuta, Sarah; Beeghly-Fadiel, Alicia; Shrubsole, Martha J.; Zheng, Wei			Energy-Related Indicators and Breast Cancer Risk among White and Black Women	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; BODY-MASS INDEX; RECREATIONAL PHYSICAL-ACTIVITY; HORMONE-RECEPTOR STATUS; MULTIETHNIC POPULATION; WEIGHT CHANGE; COHORT; SIZE; PREMENOPAUSAL; OBESITY	Energy-related indicators, including physical activity, energy intake, body mass index (BMI) and adult weight change, have been linked to breast cancer risk. Very few studies of these associations have been conducted among black women, therefore we used the Nashville Breast Health Study (NBHS) to determine whether similar effects were seen in black and white women. The NBHS is a population-based case-control study of breast cancer among women age 25 to 75 years conducted between 2001 and 2010 in and around the Nashville Metropolitan area. Telephone interviews and self-administered food frequency questionnaires were completed with 2,614 incident breast cancer cases ascertained through hospitals and the statewide cancer registry, and 2,306 controls selected using random digit dialing. Among premenopausal white and black women, there was little effect of adult exercise or other energy-related indicators on breast cancer risk, regardless of tumor estrogen receptor (ER) status. The beneficial effect of adult exercise on postmenopausal breast cancer appeared to be comparable between white and black women (highest tertile relative to none -white odds ratio [OR] 0.8, 95% confidence interval [CI] 0.6-1.0, p for trend=0.05; black OR 0.7, 95% CI 0.4-1.1, p for trend=0.07); however, among black women the reduction was limited to those with ER-positive disease. White and black women should be encouraged to engage in more physical activity to reduce their risk of postmenopausal breast cancer.	[Sanderson, Maureen] Meharry Med Coll, Dept Family & Community Med, Nashville, TN 37208 USA; [Lipworth, Loren; Nechuta, Sarah; Beeghly-Fadiel, Alicia; Shrubsole, Martha J.; Zheng, Wei] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med,Sch Med, Nashville, TN 37235 USA; [Shen-Miller, David] Tennessee State Univ, Dept Psychol, Nashville, TN 37203 USA	Meharry Medical College; Vanderbilt University; Tennessee State University	Sanderson, M (corresponding author), Meharry Med Coll, Dept Family & Community Med, Nashville, TN 37208 USA.	msanderson@mmc.edu	Shrubsole, Martha J/K-5052-2015; zhang, weihua/GXV-1334-2022; Zheng, Wei/O-3351-2013; Nechuta, Sarah/AAG-4025-2020	Shrubsole, Martha J/0000-0002-5591-7575; Zheng, Wei/0000-0003-1226-070X; Nechuta, Sarah/0000-0003-2773-6678	US National Cancer Institute [R01CA100374, U54CA163069]; Ingram Professorship funds; Vanderbilt-Ingram Cancer Center [P30CA68485]; NATIONAL CANCER INSTITUTE [R01CA100374, P30CA068485, U54CA163072, U54CA163069, U54CA163066] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ingram Professorship funds; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by research grants (R01CA100374, U54CA163069) from the US National Cancer Institute, as well as Ingram Professorship funds. The survey for this study was conducted by the Survey Research Shared Resource, which is supported in part by the Vanderbilt-Ingram Cancer Center (P30CA68485).	Adams-Campbell LL, 2001, J NATL MED ASSOC, V93, P267; AdamsCampbell LL, 1996, OBES RES, V4, P451, DOI 10.1002/j.1550-8528.1996.tb00253.x; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Amadou A, 2013, OBES REV, V14, P665, DOI 10.1111/obr.12028; BARNESJOSIAH D, 1995, CANCER CAUSE CONTROL, V6, P112, DOI 10.1007/BF00052771; Bernstein L, 2005, JNCI-J NATL CANCER I, V97, P1671, DOI 10.1093/jnci/dji374; Berstad P, 2010, CANCER EPIDEM BIOMAR, V19, P1532, DOI 10.1158/1055-9965.EPI-10-0025; Brinton LA, 1997, INT J CANCER, V73, P349, DOI 10.1002/(SICI)1097-0215(19971104)73:3<349::AID-IJC8>3.0.CO;2-#; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Cleary MP, 1997, P SOC EXP BIOL MED, V216, P28, DOI 10.3181/00379727-216-44153B; Cohen SS, 2013, CANCER PREV RES, V6, P566, DOI 10.1158/1940-6207.CAPR-13-0045; Cui Y, 2014, CLIN CANCER RES, V20, P1169, DOI 10.1158/1078-0432.CCR-13-2094; Emaus MJ, 2014, INT J CANCER, V135, P2887, DOI 10.1002/ijc.28926; Friedenreich CM, 2004, EXERC SPORT SCI REV, V32, P180; Gilliland FD, 2001, AM J EPIDEMIOL, V154, P442, DOI 10.1093/aje/154.5.442; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hall IJ, 2005, AM J EPIDEMIOL, V161, P40, DOI 10.1093/aje/kwh331; Hall IJ, 2000, AM J EPIDEMIOL, V151, P754, DOI 10.1093/oxfordjournals.aje.a010275; Han XS, 2014, INT J CANCER, V135, P2900, DOI 10.1002/ijc.28930; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Hildebrand JS, 2013, CANCER EPIDEM BIOMAR, V22, P1906, DOI 10.1158/1055-9965.EPI-13-0407; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; John EM, 2003, CANCER EPIDEM BIOMAR, V12, P1143; John EM, 2011, AM J EPIDEMIOL, V173, P201, DOI 10.1093/aje/kwq345; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Mayberry Robert M., 1994, Annals of Epidemiology, V4, P205, DOI 10.1016/1047-2797(94)90098-1; McCullough LE, 2012, CANCER-AM CANCER SOC, V118, P4860, DOI 10.1002/cncr.27433; McTiernan A, 2003, JAMA-J AM MED ASSOC, V290, P1331, DOI 10.1001/jama.290.10.1331; McTiernan A, 2005, ONCOLOGY-NY, V19, P871; Michels KB, 2012, INT J CANCER, V130, P902, DOI 10.1002/ijc.26069; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Munsell MF, 2014, EPIDEMIOL REV, V36, P114, DOI 10.1093/epirev/mxt010; Silvera SAN, 2006, BREAST CANCER RES TR, V97, P97, DOI 10.1007/s10549-005-9098-3; Palmer JR, 2007, CANCER EPIDEM BIOMAR, V16, P1795, DOI 10.1158/1055-9965.EPI-07-0336; Patel AV, 2003, CANCER CAUSE CONTROL, V14, P519, DOI 10.1023/A:1024895613663; Ratnasinghe LD, 2010, NUTR CANCER, V62, P425, DOI 10.1080/01635580903441295; SCHATZKIN A, 1987, J NATL CANCER I, V78, P213; Sheppard VB, 2011, ETHNIC DIS, V21, P406; Shin A, 2007, INT J CANCER, V121, P136, DOI 10.1002/ijc.22664; Shin A, 2009, BREAST CANCER RES TR, V113, P153, DOI 10.1007/s10549-008-9903-x; Steindorf K, 2013, INT J CANCER, V132, P1667, DOI 10.1002/ijc.27778; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Sue LY, 2009, CANCER EPIDEM BIOMAR, V18, P2842, DOI 10.1158/1055-9965.EPI-09-0087; Suzuki R, 2010, CANCER CAUSE CONTROL, V21, P1787, DOI 10.1007/s10552-010-9605-7; Tehard B, 2006, CANCER EPIDEM BIOMAR, V15, P57, DOI 10.1158/1055-9965.EPI-05-0603; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; Zhang FF, 2013, BREAST CANCER RES TR, V137, P541, DOI 10.1007/s10549-012-2342-8; Zhu KM, 2005, ANN EPIDEMIOL, V15, P123, DOI 10.1016/j.annepidem.2004.05.011	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125058	10.1371/journal.pone.0125058	http://dx.doi.org/10.1371/journal.pone.0125058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927530	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100064
J	Bartz, KK; Ford, MJ; Beechie, TJ; Fresh, KL; Pess, GR; Kennedy, RE; Rowse, ML; Sheer, M				Bartz, Krista K.; Ford, Michael J.; Beechie, Timothy J.; Fresh, Kurt L.; Pess, George R.; Kennedy, Robert E.; Rowse, Melinda L.; Sheer, Mindi			Trends in Developed Land Cover Adjacent to Habitat for Threatened Salmon in Puget Sound, Washington, USA	PLOS ONE			English	Article							FOREST DISTURBANCE; UNITED-STATES; RIVER; PATTERNS; STREAMS; VARIABILITY; NORTHWEST; EXTENT; AREA	For widely distributed species at risk, such as Pacific salmon (Oncorhynchus spp.), habitat monitoring is both essential and challenging. Only recently have widespread monitoring programs been implemented for salmon habitat in the Pacific Northwest. Remote sensing data, such as Landsat images, are therefore a useful way to evaluate trends prior to the advent of species-specific habitat monitoring programs. We used annual (1986-2008) land cover maps created from Landsat images via automated algorithms (LandTrendr) to evaluate trends in developed (50-100% impervious) land cover in areas adjacent to five types of habitat utilized by Chinook salmon (O. tshawytscha) in the Puget Sound region of Washington State, U.S.A. For the region as a whole, we found significant increases in developed land cover adjacent to each of the habitat types evaluated (nearshore, estuary, mainstem channel, tributary channel, and floodplain), but the increases were small (<1% total increase from 1986 to 2008). For each habitat type, the increasing trend changed during the time series. In nearshore, mainstem, and floodplain areas, the rate of increase in developed land cover slowed in the latter portion of the time series, while the opposite occurred in estuary and tributary areas. Watersheds that were already highly developed in 1986 tended to have higher rates of development than initially less developed watersheds. Overall, our results suggest that developed land cover in areas adjacent to Puget Sound salmon habitat has increased only slightly since 1986 and that the rate of change has slowed near some key habitat types, although this has occurred within the context of a degraded baseline condition.	[Bartz, Krista K.; Ford, Michael J.; Rowse, Melinda L.; Sheer, Mindi] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Beechie, Timothy J.; Fresh, Kurt L.; Pess, George R.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Seattle, WA 98112 USA; [Kennedy, Robert E.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Ford, MJ (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA.	mike.ford@noaa.gov			National Marine Fisheries Service	National Marine Fisheries Service	This work was funded by the National Marine Fisheries Service.	Al-Chokhachy R, 2011, T AM FISH SOC, V140, P399, DOI 10.1080/00028487.2011.567865; Alberti M, 2007, LANDSCAPE URBAN PLAN, V80, P345, DOI 10.1016/j.landurbplan.2006.08.001; Anchor QEA LLC, 2009, FIN GEOSP METH US PS; Anlauf KJ, 2011, AQUAT CONSERV, V21, P704, DOI 10.1002/aqc.1221; Anlauf KJ, 2011, T AM FISH SOC, V140, P52, DOI 10.1080/00028487.2010.550496; Bagan H, 2014, ENVIRON RES LETT, V9; Beamer E, 1998, JUVENILE SALMOID USE; Beechie T, 2013, RIVER RES APPL, V29, P939, DOI 10.1002/rra.2590; Beechie T., 1994, North American Journal of Fisheries Management, V14, P797, DOI 10.1577/1548-8675(1994)014<0797:ECSRHA>2.3.CO;2; Beechie TJ, 2006, CAN J FISH AQUAT SCI, V63, P1242, DOI 10.1139/F06-015; Beechie TJ, 2001, WATER SCI APPL, V4, P37; Beechie TJ, 2003, NMFSNWFSC58 NOAA; Booth DB, 1997, J AM WATER RESOUR AS, V33, P1077, DOI 10.1111/j.1752-1688.1997.tb04126.x; Booth DB, 2002, J AM WATER RESOUR AS, V38, P835, DOI 10.1111/j.1752-1688.2002.tb01000.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campbell SP, 2002, ECOL APPL, V12, P674, DOI 10.1890/1051-0761(2002)012[0674:AAOMEI]2.0.CO;2; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; FEMAT (Forest Ecosystem Management Assessment Team), 1993, FOR EC MAN EC EC SOC; Ford M, 2011, NOAATMNWFSC113 US DE; Fullerton AH, 2006, LANDSCAPE ECOL, V21, P1347, DOI 10.1007/s10980-006-0017-8; Gregory S, 1997, PACIFIC SALMON THEIR; Groot C., 1991, PACIFIC SALMON LIFE; Hohensinner S, 2004, RIVER RES APPL, V20, P25, DOI 10.1002/rra.719; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; HUDSON DJ, 1966, J AM STAT ASSOC, V61, P1097, DOI 10.2307/2283203; Jones KB, 2010, LANDSCAPE ECOL, V25, P1261, DOI 10.1007/s10980-010-9510-1; Judge M, 2011, 2011 IMPLEMENTATON S; Katz SL, 2007, RESTOR ECOL, V15, P494, DOI 10.1111/j.1526-100X.2007.00245.x; Kennedy RE, 2011, DEV YEARLY MAPS LAND; Kennedy RE, 2012, REMOTE SENS ENVIRON, V122, P117, DOI 10.1016/j.rse.2011.09.024; Kennedy RE, 2010, REMOTE SENS ENVIRON, V114, P2897, DOI 10.1016/j.rse.2010.07.008; Konrad C, GEOSPATIAL IN PRESS; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; Morley SA, 2002, CONSERV BIOL, V16, P1498, DOI 10.1046/j.1523-1739.2002.01067.x; Muggeo V.M., 2008, R NEWS, V8, P20; Myers JM, 1998, NMFSNWFSC35; Nagendra H, 2013, ECOL INDIC, V33, P45, DOI 10.1016/j.ecolind.2012.09.014; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; NMFS, 2014, SALM STEELH SURV FCR; NOAA Fisheries Service, 2011, 2011 REP C PAC COAST; Pess GR, 2002, CAN J FISH AQUAT SCI, V59, P613, DOI 10.1139/F02-035; PFMC, 2014, REV 2013 OC SALM FIS; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Quinn Thomas P., 2005, P1; Sexton JO, 2013, REMOTE SENS ENVIRON, V129, P42, DOI 10.1016/j.rse.2012.10.025; Shared Strategy Development Committee, 2007, PUGET SOUND SALM REC, V1; Simenstad CA, 2011, 201101 US ARM CORPS; Sleeter BM, 2013, GLOBAL ENVIRON CHANG, V23, P733, DOI 10.1016/j.gloenvcha.2013.03.006; State of Washington, 2013, FORCAST STATE POPULA; State of Washington, 2014, MED HOUS INC EST COU; Treaty Indian Tribes in Western Washington, 2011, TREAT RIGHTS RISK ON; United States Geological Survey (USGS), 2009, GET NHD DAT; US Census Bureau, 1995, HIST POP COUNTS 1900; Washington State Department of Natural Resources (WDNR), 2006, WASH STAT WAT BODY H	56	11	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124415	10.1371/journal.pone.0124415	http://dx.doi.org/10.1371/journal.pone.0124415			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923327	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600085
J	Hao, W; Wang, SJ; Liu, HJ; Zhou, BR; Wang, XW; Jiang, TB				Hao, Wei; Wang, Shengji; Liu, Huajing; Zhou, Boru; Wang, Xinwang; Jiang, Tingbo			Development of SSR Markers and Genetic Diversity in White Birch (Betula platyphylla)	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISMS; MICROSATELLITE MARKERS; LINKAGE MAP; DNA MARKERS; IDENTIFICATION; BARLEY; LOCI; L.	In order to study genetic diversity of white birch (Betula platyphylla), 544 primer pairs were designed based on the genome-wide Solexa sequences. Among them, 215 primer pairs showed polymorphism between five genotypes and 111 primer pairs that presented clear visible bands in genotyping 41 white birch plants that were collected from 6 different geographical regions. A total of 717 alleles were obtained at 111 loci with a range of 2 to 12 alleles per locus. The results of statistic analysis showed that polymorphic frequency of the alleles ranged from 17% to 100% with a mean of 55.85%; polymorphism information content (PIC) of the loci was from 0.09 to 0.58 with a mean of 0.30; and gene diversity between the tested genotypes was from 0.01 to 0.66 with a mean of 0.36. The results also indicated that major allele frequency ranged from 0.39 to 1.00 with an mean of 0.75; expected heterozygosity from 0.22 to 0.54 with a mean of 0.46; observed heterozygosity from 0.02 to 0.95 with a mean of 0.26; Nei's index from 0.21 to 0.54 with a mean of 0.46; and Shannon's Information from 0.26 to 0.87 with a mean of 0.66. The 41 white birch genotypes at the 111 selected SSR loci showed low to moderate similarity (0.025-0.610), indicating complicated genetic diversity among the white birch collections. The UPGMA-based clustering analysis of the allelic constitution of 41 white birch genotypes at 111 SSR loci suggested that the six different geographical regions can be further separated into four clusters at a similarity coefficient of 0.22. Genotypes from Huanren and Liangshui provenances were grouped into Cluster I, genotypes from Xiaobeihu and Qingyuan provenances into Cluster II, genotypes from Finland provenance into Cluster III, and genotypes from Maoershan into Cluster IV. The information provided in this study could help for genetic improvement and germplasm conservation, evaluation and utilization in white birch tree breeding program.	[Hao, Wei; Wang, Shengji; Liu, Huajing; Zhou, Boru; Wang, Xinwang; Jiang, Tingbo] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China; [Liu, Huajing] Northeast Forestry Univ, Coll Resources & Environm Sci, Harbin, Peoples R China; [Wang, Xinwang] Texas A&M Syst, Texas A&M AgriLife Res & Extens Ctr, Dallas, TX USA	Northeast Forestry University - China; Northeast Forestry University - China; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Wang, XW (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China.	xw-wang@tamu.edu; tbjiang@yahoo.com		Wang, Shengji/0000-0001-9914-7800	National High-Tech Research and Development Program of China [2011AA100202, 2013AA102701]; Innovation Project of State Key Laboratory of Tree Genetics and Breeding, Northeast Forestry University	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Innovation Project of State Key Laboratory of Tree Genetics and Breeding, Northeast Forestry University	This work was supported by National High-Tech Research and Development Program of China (2011AA100202, 2013AA102701) and The Innovation Project of State Key Laboratory of Tree Genetics and Breeding, Northeast Forestry University.	Birren B., 1987, NONMAMMALIAN GENOMIC, P75; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Feingold S, 2005, THEOR APPL GENET, V111, P456, DOI 10.1007/s00122-005-2028-2; Guo Y, 2012, GENET RESOUR CROP EV, V59, P1543, DOI 10.1007/s10722-011-9783-5; Jiang TB, 2011, MOL BREEDING, V27, P347, DOI 10.1007/s11032-010-9436-y; Kostova A, 2006, J CROP IMPROV, V16, P37, DOI 10.1300/J411v16n01_03; Kulju KKM, 2004, MOL ECOL NOTES, V4, P471, DOI 10.1111/j.1471-8286.2004.00704.x; Li JW., 2011, CHINA VEGETABLES, V20, P1; LI P, 1995, CHEM IND FOR PROD, V15, P13; Liu ZW, 1996, THEOR APPL GENET, V93, P869, DOI 10.1007/BF00224088; Lu Yong-quan, 2011, Journal of Forestry Research (Harbin), V22, P201, DOI 10.1007/s11676-011-0150-3; Ogyu K, 2003, MOL ECOL NOTES, V3, P268, DOI 10.1046/j.1471-8286.2003.00419.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pekkinen M, 2005, GENOME, V48, P619, DOI 10.1139/G05-031; Perez F, 2005, MAR BIOTECHNOL, V7, P554, DOI 10.1007/s10126-004-5099-1; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Truong C, 2005, MOL ECOL NOTES, V5, P96, DOI 10.1111/j.1471-8286.2004.00848.x; [屠德鹏 TU Depeng], 2011, [草业科学, Pratacultural Science], V28, P746; Tu M, 2007, BIOCHEM GENET, V45, P789, DOI 10.1007/s10528-007-9118-6; Wang QiuYu, 2007, Scientia Silvae Sinicae, V43, P37; Wang YanMin, 2008, Scientia Silvae Sinicae, V44, P78; Weng Y, 2007, INSECT MOL BIOL, V16, P613, DOI 10.1111/j.1365-2583.2007.00757.x; Wu B, 2002, MOL ECOL NOTES, V2, P413, DOI 10.1046/j.1471-8286.2002.00260.x; [许靖诗 Xu Jingshi], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P80	27	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125235	10.1371/journal.pone.0125235	http://dx.doi.org/10.1371/journal.pone.0125235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923698	Green Published, gold			2022-12-26	WOS:000353711600137
J	Lim, FL; Hashim, Z; Than, LTL; Said, SM; Hashim, JH; Norback, D				Lim, Fang Lee; Hashim, Zailina; Than, Leslie Thian Lung; Said, Salmiah Md; Hashim, Jamal Hisham; Norback, Dan			Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust	PLOS ONE			English	Article							SICK BUILDING SYNDROME; RESPIRATORY SYMPTOMS; RISK-FACTORS; BRONCHIAL HYPERRESPONSIVENESS; COMMON AEROALLERGENS; INDOOR ALLERGENS; ADULT-POPULATION; LUNG-FUNCTION; PREVALENCE; SENSITIZATION	A prevalence study was conducted among office workers in Malaysia (N= 695). The aim of this study was to examine associations between asthma, airway symptoms, rhinitis and house dust mites (HDM) and cat allergy and HDM levels in office dust. Medical data was collected by a questionnaire. Skin prick tests were performed for HDM allergens (Dermatophagoides pteronyssinus, Dermatophagoides farinae) and cat allergen Felis domesticus. Indoor temperature and relative air humidity (RH) were measured in the offices and vacuumed dust samples were analyzed for HDM allergens. The prevalence of D. pteronyssinus, D. farinae and cat allergy were 50.3%, 49.0% and 25.5% respectively. Totally 9.6% had doctor-diagnosed asthma, 15.5% had current wheeze and 53.0% had current rhinitis. The Der p 1 (from D. pteronyssinus) and Der f 1 (from D. farinae) allergens levels in dust were 556 ng/g and 658 ng/g respectively. Statistical analysis was conducted by multilevel logistic regression, adjusting for age, gender, current smoking, HDM or cat allergy, home dampness and recent indoor painting at home. Office workers with HDM allergy had more wheeze (p= 0.035), any airway symptoms (p= 0.032), doctor-diagnosed asthma (p= 0.005), current asthma (p= 0.007), current rhinitis (p= 0.021) and rhinoconjuctivitis (p< 0.001). Cat allergy was associated with wheeze (p= 0.021), wheeze when not having a cold (p= 0.033), any airway symptoms (p= 0.034), doctor-diagnosed asthma (p= 0.010), current asthma (p= 0.020) and nasal allergy medication (p= 0.042). Der f 1 level in dust was associated with daytime breathlessness (p= 0.033) especially among those with HDM allergy. Der f 1 levels were correlated with indoor temperature (p< 0.001) and inversely correlated with RH (p<0.001). In conclusion, HDM and cat allergies were common and independently associated with asthma, airway symptoms and rhinitis. Der f 1 allergen can be a risk factor for daytime breathlessness.	[Lim, Fang Lee; Hashim, Zailina] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Environm & Occupat Hlth, Serdang 43400, Selangor, Malaysia; [Than, Leslie Thian Lung] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Serdang 43400, Selangor, Malaysia; [Said, Salmiah Md] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang 43400, Selangor, Malaysia; [Hashim, Jamal Hisham] UN Univ, Int Inst Global Hlth UNU IIGH, Kuala Lumpur, Malaysia; [Hashim, Jamal Hisham] Natl Univ Malaysia, Dept Community Hlth, Kuala Lumpur, Malaysia; [Norback, Dan] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Univ Hosp, Uppsala, Sweden	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Uppsala University; Uppsala University Hospital	Hashim, Z (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Environm & Occupat Hlth, Serdang 43400, Selangor, Malaysia.	zailina@upm.edu.my	Md. Said, Salmiah/ABE-6447-2021	Norback, Dan/0000-0002-5174-6668; Lim, Fang Lee/0000-0002-8253-2662; Than, Leslie/0000-0001-6956-4638; Md. Said, Salmiah/0000-0001-5865-2499	Universiti Putra Malaysia (UPM) for Research University Grant Scheme (RUGS) [9199671]; Swedish Research Council (VR) [2013-6762]	Universiti Putra Malaysia (UPM) for Research University Grant Scheme (RUGS); Swedish Research Council (VR)(Swedish Research Council)	This study was supported by grants from the Universiti Putra Malaysia (UPM) for Research University Grant Scheme (RUGS, grant number: 9199671) and the Swedish Research Council (VR) (grant number: 2013-6762). The funders supported the project financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Akpinar-Elci M, 2008, INDOOR AIR, V18, P125, DOI 10.1111/j.1600-0668.2007.00514.x; Andiappan AK, 2014, ALLERGY, V69, P501, DOI 10.1111/all.12364; Anto JM, 2010, ALLERGY, V65, P1021, DOI 10.1111/j.1398-9995.2009.02301.x; Arbes SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1139, DOI 10.1016/j.jaci.2007.07.056; Arbes SJ, 2004, J ALLERGY CLIN IMMUN, V114, P111, DOI 10.1016/j.jaci.2004.04.036; ARLIAN LG, 1992, EXP APPL ACAROL, V16, P15, DOI 10.1007/BF01201490; Arlian LG, 2003, IMMUNOL ALLERGY CLIN, V23, P443, DOI 10.1016/S0889-8561(03)00005-5; Asha'ari Z A, 2011, Med J Malaysia, V66, P202; Asha'ari ZA, 2010, ANN ACAD MED SINGAP, V39, P619; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Australasian Society of Clinical Immunology and Allergy, 2006, SKIN PRICK TESTING F; Bakolis I, 2015, INDOOR AIR, V25, P235, DOI 10.1111/ina.12137; Bjorksten B, 2008, PEDIAT ALLERG IMM-UK, V19, P110, DOI 10.1111/j.1399-3038.2007.00601.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brunetto B, 2009, ANN I SUPER SANITA, V45, P415; Brunetto B, 2009, ANN I SUPER SANITA, V45, P409; Burney P, 1997, J ALLERGY CLIN IMMUN, V99, P314, DOI 10.1016/S0091-6749(97)70048-4; Chew FT, 1999, ALLERGY, V54, P1150, DOI 10.1034/j.1398-9995.1999.00050.x; Chew GL, 2009, INDOOR AIR, V19, P193, DOI 10.1111/j.1600-0668.2008.00578.x; Cox-Ganser JM, 2005, ENVIRON HEALTH PERSP, V113, P485, DOI 10.1289/ehp.7559; Custovic A, 2002, ANN ALLERG ASTHMA IM, V88, P432, DOI 10.1016/S1081-1206(10)62378-2; Custovic A, 2012, J INVEST ALLERG CLIN, V22, P393; Daengsuwan T, 2003, ASIAN PAC J ALLERGY, V21, P199; Dejsomritrutai W, 2006, CHEST, V129, P602, DOI 10.1378/chest.129.3.602; Gehring U, 2001, EUR RESPIR J, V18, P555, DOI 10.1183/09031936.01.00096801; HO TM, 1995, ASIAN PAC J ALLERGY, V13, P11; Lam HT, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-6; Hoang TL, 2011, RESP MED, V105, P177, DOI 10.1016/j.rmed.2010.10.001; Jaakkola JJK, 2006, AM J EPIDEMIOL, V164, P742, DOI 10.1093/aje/kwj249; Jaakkola MS, 2006, J ALLERGY CLIN IMMUN, V117, P642, DOI 10.1016/j.jaci.2005.11.003; Jacquet A, 2013, ISRN ALLERGY, V2013, DOI [10.1155/2013/735031, DOI 10.1155/2013/735031]; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Jarvis D, 2007, J ALLERGY CLIN IMMUN, V119, P697, DOI 10.1016/j.jaci.2006.10.042; John AB, 1996, ASIAN PAC J ALLERGY, V14, P9; Katelaris CH, 2011, AM J RHINOL ALLERGY, V25, pS3, DOI [10.2500/ajra.2011.25.3674, 10.2500/ajr.2011.25.3674]; Kim JS, 2008, J ALLERGY CLIN IMMUN, V122, P929, DOI 10.1016/j.jaci.2008.08.009; Konishi E, 1999, EXP APPL ACAROL, V23, P41, DOI 10.1023/A:1006121401348; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lal A, 2011, INDIAN J OTOLARYNGOL, V63, P132, DOI 10.1007/s12070-010-0064-y; Langley SJ, 2005, THORAX, V60, P17, DOI 10.1136/thx.2004.027839; Leynaert N, 2004, J ALLERGY CLIN IMMUN, V113, P86, DOI 10.1016/j.jaci.2003.10.010; Li CS, 1997, ARCH ENVIRON HEALTH, V52, P68, DOI 10.1080/00039899709603803; Li J, 2013, CLIN EXP ALLERGY, V43, P1171, DOI 10.1111/cea.12157; Li J, 2009, ALLERGY, V64, P1083, DOI 10.1111/j.1398-9995.2009.01967.x; Liam CK, 2002, RESPIROLOGY, V7, P345, DOI 10.1046/j.1440-1843.2002.00409.x; Lowe LA, 2004, ARCH PEDIAT ADOL MED, V158, P996, DOI 10.1001/archpedi.158.10.996; Lu YX, 2013, SOC PSYCH PSYCH EPID, V48, P1273, DOI 10.1007/s00127-013-0655-5; Macher JM, 2005, INDOOR AIR, V15, P82, DOI 10.1111/j.1600-0668.2005.00347.x; Mariana A, 2000, Southeast Asian J Trop Med Public Health, V31, P712; Menzies D, 1998, J ALLERGY CLIN IMMUN, V101, P38, DOI 10.1016/S0091-6749(98)70191-5; Milian Evelyn, 2004, P R Health Sci J, V23, P47; Nadchatram M., 2005, Tropical Biomedicine, V22, P23; Nam HS, 2008, KOREAN J PARASITOL, V46, P187, DOI 10.3347/kjp.2008.46.3.187; Neal JS, 2002, ANN ALLERG ASTHMA IM, V88, P410, DOI 10.1016/S1081-1206(10)62373-3; Nishihara N, 2014, BUILD ENVIRON, V71, P153, DOI 10.1016/j.buildenv.2013.09.018; Norbaeck D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088303; Olivieri M, 2012, J ALLERGY CLIN IMMUN, V129, P420, DOI 10.1016/j.jaci.2011.10.044; Ooi PL, 1998, OCCUP ENVIRON MED, V55, P188, DOI 10.1136/oem.55.3.188; Park JH, 2006, INDOOR AIR, V16, P192, DOI 10.1111/j.1600-0668.2005.00415.x; Perfetti L, 2004, SCI TOTAL ENVIRON, V328, P15, DOI 10.1016/j.scitotenv.2004.01.028; Prasarnphanich T, 2005, PEDIAT ALLERG IMM-UK, V16, P402, DOI 10.1111/j.1399-3038.2005.00297.x; Prester Ljerka, 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P413, DOI 10.2478/v10004-007-0034-2; Pumhirun P, 1997, ASIAN PAC J ALLERGY, V15, P183; Ramos JDA, 2007, PHILIPP J SCI, V136, P139; Raukas-Kivioja A, 2007, INT ARCH ALLERGY IMM, V142, P247, DOI 10.1159/000097027; Repace JL, 1982, ENVIRON INT, V8, P21; Sakashita M, 2010, INT ARCH ALLERGY IMM, V151, P255, DOI 10.1159/000242363; Samiah Yasmin A., 2013, AM J RES COMMUN, V1, P18; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Simpson A, 2001, CLIN EXP ALLERGY, V31, P803, DOI 10.1046/j.1365-2222.2001.01110.x; Simpson BM, 2001, CLIN EXP ALLERGY, V31, P391, DOI 10.1046/j.1365-2222.2001.01050.x; SKOV P, 1987, ENVIRON INT, V13, P339, DOI 10.1016/0160-4120(87)90190-5; Song WJ, 2014, ASIA PAC ALLERGY, V4, P3, DOI [10.5415/apallergy.2014.4.1.3, 10.5415/apallergy.2014.4.2.75]; Sonomjamts M, 2014, ASIA PAC ALLERGY, V4, P25, DOI 10.5415/apallergy.2014.4.1.25; Stevens W, 2011, CLIN EXP ALLERGY, V41, P1587, DOI 10.1111/j.1365-2222.2011.03832.x; Svanes C, 1999, J ALLERGY CLIN IMMUN, V103, P415, DOI 10.1016/S0091-6749(99)70465-3; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Uthaisangsook S, 2007, ASIAN PAC J ALLERGY, V25, P127; Uthaisangsook S, 2010, ASIAN PAC J ALLERGY, V28, P23; van der Heide S, 1998, ALLERGY, V53, P104, DOI 10.1111/j.1398-9995.1998.tb05009.x; Vidal C, 2004, ALLERGY, V59, P401, DOI 10.1111/j.1398-9995.2003.00430.x; Wan GH, 1999, ARCH ENVIRON HEALTH, V54, P58, DOI 10.1080/00039899909602238; Wang JY, 2013, ALLERGY ASTHMA IMMUN, V5, P68, DOI 10.4168/aair.2013.5.2.68; Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044; Wickens K, 2004, PEDIAT ALLERG IMM-UK, V15, P55, DOI 10.1046/j.0905-6157.2003.00100.x; Wyon DP, 2004, INDOOR AIR, V14, P92, DOI 10.1111/j.1600-0668.2004.00278.x; Yao MS, 2009, AEROBIOLOGIA, V25, P183, DOI 10.1007/s10453-009-9123-9; Yong SB, 2013, J MICROBIOL IMMUNOL, V46, P295, DOI 10.1016/j.jmii.2012.07.002; Yuen Anthony P. W., 2007, Hong Kong Medical Journal, V13, P131; Zhang X, 2011, SCI TOTAL ENVIRON, V409, P5253, DOI 10.1016/j.scitotenv.2011.08.059; Zhao ZH, 2006, INDOOR AIR, V16, P404, DOI 10.1111/j.1600-0668.2006.00433.x; Zhao ZH, 2008, PEDIAT ALLERG IMM-UK, V19, P455, DOI 10.1111/j.1399-3038.2007.00664.x; Zock JP, 2006, J ALLERGY CLIN IMMUN, V118, P682, DOI 10.1016/j.jaci.2006.04.060	94	36	39	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124905	10.1371/journal.pone.0124905	http://dx.doi.org/10.1371/journal.pone.0124905			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923543	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000353711600111
J	Liu, QN; Trudeau, MC				Liu, Qiang-ni; Trudeau, Matthew C.			Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							LONG-QT SYNDROME; GENE POTASSIUM CHANNELS; C-TERMINAL REGION; CARDIAC-ARRHYTHMIA; I-KR; DEACTIVATION; MUTATIONS; RECTIFIER; FAMILY	Human Ether a go-go Related Gene potassium channels form the rapid component of the delayed-rectifier (I-Kr) current in the heart. The N-terminal 'eag' domain, which is composed of a Per-Arnt-Sim (PAS) domain and a short PAS-cap region, is a critical regulator of hERG channel function. In previous studies, we showed that isolated eag (i-eag) domains rescued the dysfunction of long QT type-2 associated mutant hERG R56Q channels, by substituting for defective eag domains, when the channels were expressed in Xenopus oocytes or HEK 293 cells. Here, our goal was to determine whether the rescue of hERG R56Q channels by i-eag domains could be translated into the environment of cardiac myocytes. We expressed hERG R56Q channels in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and measured electrical properties of the cells with whole-cell patch-clamp recordings. We found that, like in non-myocyte cells, hERG R56Q had defective, fast closing (deactivation) kinetics when expressed in hiPSC-CMs. We report here that i-eag domains slowed the deactivation kinetics of hERG R56Q channels in hiPSC-CMs. hERG R56Q channels prolonged the AP of hiPSCs, and the AP was shortened by co-expression of i-eag domains and hERG R56Q channels. We measured robust Forster Resonance Energy Transfer (FRET) between i-eag domains tagged with Cyan fluorescent protein (CFP) and hERG R56Q channels tagged with Citrine fluorescent proteins (Citrine), indicating their close proximity at the cell membrane in live iPSC-CMs. Together, functional regulation and FRET spectroscopy measurements indicated that i-eag domains interacted directly with hERG R56Q channels in hiPSC-CMs. These results mean that the regulatory role of i-eag domains is conserved in the cellular environment of human cardiomyocytes, indicating that i-eag domains may be useful as a biological therapeutic.	[Liu, Qiang-ni; Trudeau, Matthew C.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Trudeau, MC (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	mtrudeau@som.umaryland.edu			NIH NHLBI [R01 HL083121]; Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083121] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH NHLBI R01 HL083121 (http://www.nhlbi.nih.gov/) and the Maryland Stem Cell Research Fund (http://www.mscrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brelidze TI, 2010, PLOS ONE, DOI [10. 1371/ journal. pone. 0012523, DOI 10.1371/J0URNAL.P0NE.0012523]; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Clancy CE, 2001, CARDIOVASC RES, V50, P301, DOI 10.1016/S0008-6363(00)00293-5; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Germanguz I, 2011, J CELL MOL MED, V15, P38, DOI 10.1111/j.1582-4934.2009.00996.x; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Honda M, 2011, J PHARMACOL SCI, V117, P149, DOI 10.1254/jphs.11038FP; Jost N, 2009, BASIC RES CARDIOL, V104, P33, DOI 10.1007/s00395-008-0730-3; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Marques-Carvalho MJ, 2012, ACTA CRYSTALLOGR F, V68, P337, DOI [10.1107/S1744309112004216, 10.1107/S1744309112004216337]; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438	24	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123951	10.1371/journal.pone.0123951	http://dx.doi.org/10.1371/journal.pone.0123951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923442	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600062
J	Parrott, ML; Ward, SJ; Temple-Smith, PD; Selwood, L				Parrott, Marissa L.; Ward, Simon J.; Temple-Smith, Peter D.; Selwood, Lynne			Females Choose Mates Based on Genetic Relatedness in a Small Dasyurid Marsupial, the Agile Antechinus (Antechinus agilis)	PLOS ONE			English	Article							INCREASE OFFSPRING HETEROZYGOSITY; MULTIPLE PATERNITY; SEXUAL SELECTION; SPERM COMPETITION; FIELD POPULATION; MATING-BEHAVIOR; CHOICE; SUCCESS; COMPATIBILITY; EVOLUTION	Females in a variety of taxa mate with more than one male during a single oestrus and exhibit mate preferences for genetically compatible males, but the influence of female mate choice on siring success is not clearly understood. Whether females choose to mate with more than one male or endure forced copulations is also often unknown. Here, we examined the effects of genetic relatedness on female mate choice and siring success in a small semelparous carnivorous marsupial, the agile antechinus (Antechinus agilis), during two consecutive breeding seasons. Experimental trials were conducted in captivity over periods of 72 hours using interconnected enclosures in which female antechinus could choose to access any of four separated males, but males were only able to access females that entered their quarters. Females had access to two genetically similar and two genetically dissimilar males simultaneously and all behavioural interactions were observed and scored from continuous video recordings. Genetic similarity between mates and paternity of young was determined by microsatellite analyses. Some females chose to enter and mate with more than one male during a single oestrus period. Although females investigated all males, they spent significantly more time visiting, and mated more times with, genetically dissimilar males. Males that were genetically dissimilar to the female sired 88% of subsequent offspring. Whilst males mated readily with most females, they rejected the advances of some receptive females, indicating a previously unexpected level of male mate choice. The results show that genetic relatedness between mates has a significant influence on mate choice, breeding and siring success in the agile antechinus.	[Parrott, Marissa L.; Ward, Simon J.; Temple-Smith, Peter D.; Selwood, Lynne] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Ward, Simon J.] NT Dept Nat Resources Environm Arts & Sport, Biodivers Conservat Div, Palmerston, NT, Australia; [Temple-Smith, Peter D.] Monash Univ, Dept Obstet & Gynaecol, Southern Clin Sch, Clayton, Vic 3168, Australia; [Parrott, Marissa L.; Temple-Smith, Peter D.] Zoos Victoria, Wildlife Conservat & Sci, Parkville, Vic, Australia	University of Melbourne; Monash University	Parrott, ML (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	mparrott@zoo.org.au		, Peter/0000-0002-4754-369X	Melbourne Research PhD Scholarship; Holsworth Wildlife Research Endowment and Winifred Violet Scott Estate; Loftus-Hills Memorial Fund Award; David Hay Postgraduate Writing-up Award	Melbourne Research PhD Scholarship; Holsworth Wildlife Research Endowment and Winifred Violet Scott Estate; Loftus-Hills Memorial Fund Award; David Hay Postgraduate Writing-up Award	This research was funded by a Melbourne Research PhD Scholarship, grants from the Holsworth Wildlife Research Endowment and Winifred Violet Scott Estate, a Loftus-Hills Memorial Fund Award and David Hay Postgraduate Writing-up Award to M. Parrott. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Arnqvist G, 1988, OIKOS, V54, P248; Aslin H.J., 1982, P22; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Charpentier MJE, 2010, ANIM BEHAV, V80, P101, DOI 10.1016/j.anbehav.2010.04.005; Consuegra S, 2008, P ROY SOC B-BIOL SCI, V275, P1397, DOI 10.1098/rspb.2008.0066; Craig AS, 2002, CAN J ZOOL, V80, P745, DOI 10.1139/Z02-050; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Gibson RM, 1991, BEHAV ECOL, V2, P165, DOI 10.1093/beheco/2.2.165; Hill CE, 2010, AUK, V127, P300, DOI 10.1525/auk.2009.09055; HILL GE, 1993, EVOLUTION, V47, P1515, DOI 10.1111/j.1558-5646.1993.tb02172.x; Hoogland JL, 1998, ANIM BEHAV, V55, P351, DOI 10.1006/anbe.1997.0575; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jennions MD, 1997, TRENDS ECOL EVOL, V12, P251, DOI 10.1016/S0169-5347(97)01128-2; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Jones TM, 1998, P ROY SOC B-BIOL SCI, V265, P1651, DOI 10.1098/rspb.1998.0484; KELLER L, 1995, ADV STUD BEHAV, V24, P291, DOI 10.1016/S0065-3454(08)60397-6; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kraaijeveld-Smit FJL, 2003, MOL ECOL, V12, P475, DOI 10.1046/j.1365-294X.2003.01745.x; Kraaijeveld-Smit FJL, 2002, J EVOLUTION BIOL, V15, P100, DOI 10.1046/j.1420-9101.2002.00367.x; Kraaijeveld-Smit FJL, 2002, BEHAV ECOL SOCIOBIOL, V52, P84, DOI 10.1007/s00265-002-0485-z; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; LAZENBYCOHEN KA, 1988, BEHAV ECOL SOCIOBIOL, V22, P195, DOI 10.1007/BF00300569; LOMAN J, 1988, OIKOS, V52, P69, DOI 10.2307/3565983; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; MARLOW B. J., 1961, AUSTRALIAN JOUR ZOOL, V9, P203, DOI 10.1071/ZO9610203; Mays HL, 2008, GENETICA, V134, P147, DOI 10.1007/s10709-007-9219-5; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; Meister B, 2012, AMPHIBIA-REPTILIA, V33, P308, DOI 10.1163/156853812X634053; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Noble DWA, 2013, BEHAV ECOL, V24, P1128, DOI 10.1093/beheco/art040; Nolan PM, 2010, ETHOLOGY, V116, P635, DOI 10.1111/j.1439-0310.2010.01775.x; Nordeide JT, 2007, AQUAC RES, V38, P1, DOI 10.1111/j.1365-2109.2006.01635.x; OLSSON M, 1994, NATURE, V369, P528, DOI 10.1038/369528b0; Orrell KS, 2002, ANIM BEHAV, V63, P1091, DOI 10.1006/anbe.2002.3013; Parker GA, 1970, BIOL REV, V45, P526, DOI DOI 10.1111/J.1469-185X.1970.TB01176.X; Parrott ML, 2007, WILDLIFE RES, V34, P437, DOI 10.1071/WR07071; Parrott ML, 2007, BEHAV ECOL SOCIOBIOL, V61, P1075, DOI 10.1007/s00265-006-0340-8; Parrott ML, 2006, AUST J ZOOL, V54, P319, DOI 10.1071/ZO06030; Parrott ML, 2005, AUST J ZOOL, V53, P79, DOI 10.1071/ZO04025; Pitcher TE, 2003, P ROY SOC B-BIOL SCI, V270, P1623, DOI 10.1098/rspb.2002.2280; Puurtinen M, 2009, AM NAT, V174, P741, DOI 10.1086/606024; Ryan KK, 2003, ANIM BEHAV, V65, P379, DOI 10.1006/anbe.2003.2040; Ryan KK, 2001, BEHAV ECOL SOCIOBIOL, V50, P436; SCOTT MP, 1985, BEHAV ECOL SOCIOBIOL, V17, P29, DOI 10.1007/BF00299424; Selwood L., 1982, P31; SELWOOD L, 1987, J REPROD FERTIL, V79, P495; SELWOOD L, 1985, Australian Mammalogy, V8, P91; Shimmin GA, 2000, J ZOOL, V252, P343, DOI 10.1017/S095283690000008X; Shimmin GA, 1999, BIOL REPROD, V60, P1353, DOI 10.1095/biolreprod60.6.1353; Shimmin GA, 2002, J ZOOL, V258, P39, DOI 10.1017/S0952836902001188; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; Stapleton MK, 2007, BEHAV ECOL SOCIOBIOL, V61, P1725, DOI 10.1007/s00265-007-0404-4; STOCKLEY P, 1993, P ROY SOC B-BIOL SCI, V254, P173, DOI 10.1098/rspb.1993.0143; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; *SYSTAT, 2004, SYSTAT WIND STAT VER; TAGGART DA, 1990, J REPROD FERTIL, V88, P81; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; WOOD D H, 1970, Australian Journal of Zoology, V18, P185, DOI 10.1071/ZO9700185; WOOLLEY P., 1966, SYMP ZOOL SOC LONDON, V15, P281; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	67	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122381	10.1371/journal.pone.0122381	http://dx.doi.org/10.1371/journal.pone.0122381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923325	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600013
J	Umbers, KDL; Byatt, LJ; Hill, NJ; Bartolini, RJ; Hose, GC; Herberstein, ME; Power, ML				Umbers, Kate D. L.; Byatt, Lachlan J.; Hill, Nichola J.; Bartolini, Remo J.; Hose, Grant C.; Herberstein, Marie E.; Power, Michelle L.			Prevalence and Molecular Identification of Nematode and Dipteran Parasites in an Australian Alpine Grasshopper (Kosciuscola tristis)	PLOS ONE			English	Article							BODY-SIZE; SEX-DIFFERENCES; HOST; INFECTIONS; MERMITHIDAE; ORTHOPTERA; INSECT; COLOR; HYMENOPTERA; POPULATIONS	In alpine Australia, Orthoptera are abundant, dominant herbivores, important prey species, and hosts for parasites and parasitoids. Despite the central role of orthopterans in alpine ecosystems, the impact of parasites on orthopteran populations is under-explored. In this study we describe the relationship between parasite prevalence and host sex, body size and year of collection. We accessed an existing, preserved collection of 640 Kosciuscola tristis collected from across its range between 2007 and 2011. Upon dissection we collected juvenile parasites and used molecular tools to identify them to three families (Nematoda; Mermithidae, and Arthropoda: Diptera: Tachinidae and Sarcophagidae). The prevalence of nematodes ranged from 3.5% to 25.0% and dipterans from 2.4% to 20.0%. Contrary to predictions, we found no associations between parasite prevalence and grasshopper sex or size. Although there was an association between prevalence of both nematodes and dipterans with year of collection, this is likely driven by a small sample size in the first year. Our results provide a foundation for future studies into parasite prevalence within the alpine environment and the abiotic factors that might influence these associations.	[Umbers, Kate D. L.; Byatt, Lachlan J.; Hill, Nichola J.; Bartolini, Remo J.; Hose, Grant C.; Herberstein, Marie E.; Power, Michelle L.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Umbers, Kate D. L.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Umbers, Kate D. L.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia; [Umbers, Kate D. L.] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia	Macquarie University; University of Wollongong; University of Western Australia; Western Sydney University	Umbers, KDL (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	kate_umbers@uow.edu.au	; Herberstein, Marie/D-2042-2011	/0000-0003-3213-6693; Power, Michelle/0000-0003-3160-4301; Herberstein, Marie/0000-0001-5071-2952; Hose, Grant/0000-0003-2106-5543	Australia & Pacific Science Foundation; Macquarie University; Australian Biological Resources Study	Australia & Pacific Science Foundation; Macquarie University; Australian Biological Resources Study	Funding: This project was funded by the Australia & Pacific Science Foundation, Macquarie University and the Australian Biological Resources Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Attard LM, 2008, J ZOO WILDLIFE MED, V39, P488, DOI 10.1638/2007-0179.1; BAKER G L, 1988, Revue de Nematologie, V11, P343; BAKER G L, 1986, Revue de Nematologie, V9, P125; Baker GL, 1998, AUST J ENTOMOL, V37, P80, DOI 10.1111/j.1440-6055.1998.tb01549.x; Baker GL, 1990, P 5 INT C INV PATH M; BLACKITH R. E., 1967, AUST J ZOOL, V15, P745, DOI 10.1071/ZO9670745; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; CANTRELL BK, 1980, J AUST ENTOMOL SOC, V19, P217; Civantos E, 2005, BIOL J LINN SOC, V85, P373, DOI 10.1111/j.1095-8312.2005.00494.x; Clift A., 1998, Journal of Orthoptera Research, V7, P77; Crane AL, 2011, ANIM BEHAV, V82, P817, DOI 10.1016/j.anbehav.2011.07.015; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Gray DA, 2000, CAN J ZOOL, V78, P140, DOI 10.1139/cjz-78-1-140; Green K., 1994, WILDLIFE AUSTR SNOW; Hall MD, 2012, P ROY SOC B-BIOL SCI, V279, P3176, DOI 10.1098/rspb.2012.0509; Hechinger RF, 2013, AM NAT, V182, P234, DOI 10.1086/670820; Hecker KR, 2002, CAN J ZOOL, V80, P162, DOI 10.1139/Z01-213; Huth-Schwarz A, 2012, J INVERTEBR PATHOL, V110, P48, DOI 10.1016/j.jip.2012.02.003; KEY KHL, 1954, AUST J ZOOL, V2, P309, DOI 10.1071/ZO9540309; Khokhlova IS, 2011, ANIM BEHAV, V81, P275, DOI 10.1016/j.anbehav.2010.10.018; KUKAL O, 1987, CAN J ZOOL, V65, P156, DOI 10.1139/z87-022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laws AN, 2012, B ENTOMOL RES, V102, P123, DOI 10.1017/S0007485311000472; Laws AN, 2009, CAN ENTOMOL, V141, P415, DOI 10.4039/n09-027; Lindsey E, 2009, ECOL ENTOMOL, V34, P551, DOI 10.1111/j.1365-2311.2009.01107.x; Lott MJ, 2012, EXP PARASITOL, V132, P185, DOI 10.1016/j.exppara.2012.06.013; Martin P, 2010, AQUAT ECOL, V44, P431, DOI 10.1007/s10452-009-9301-4; Miura K, 2014, APPL ENTOMOL ZOOL, V49, P171, DOI 10.1007/s13355-013-0236-9; Mongkolkiti S, 1997, J NEMATOL, V3, P356; Poinar GO, 2007, SYST PARASITOL, V68, P115, DOI 10.1007/s11230-007-9102-x; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Poulin R, 2002, ANIM BEHAV, V63, P269, DOI 10.1006/anbe.2001.1938; Rehn JAG, 1957, FAMILY ACRIDIDAE SUB; Rentz D. C. F., 1996, GRASSHOPPER COUNTRY; Sato T, 2008, CAN J ZOOL, V86, P231, DOI 10.1139/Z07-135; Sheridan LAD, 2000, OIKOS, V88, P327, DOI 10.1034/j.1600-0706.2000.880211.x; Slatyer RA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0204-1; STEINHAUS EA, 1958, ECOLOGY, V39, P503, DOI 10.2307/1931761; Sternberg ED, 2013, AM NAT, V182, pE235, DOI 10.1086/673442; Tatarnic NJ, 2013, INVERTEBR SYST, V27, P307, DOI 10.1071/IS12072; Umbers KDL, 2013, J INSECT PHYSIOL, V59, P81, DOI 10.1016/j.jinsphys.2012.10.016; Umbers KDL, 2013, BEHAV ECOL SOCIOBIOL, V67, P439, DOI 10.1007/s00265-012-1464-7; Umbers KDL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049600; Umbers KDL, 2011, J INSECT PHYSIOL, V57, P1198, DOI 10.1016/j.jinsphys.2011.05.010; Vance SA, 1996, P ROY SOC B-BIOL SCI, V263, P907, DOI 10.1098/rspb.1996.0134; Vance SA, 1996, CAN J ZOOL, V74, P1907, DOI 10.1139/z96-215; Ward Darren F., 1998, Journal of Orthoptera Research, V7, P99; Webster JM, 1984, PLANT INSECT NEMATOD; Wedekind C, 1998, OIKOS, V81, P458, DOI 10.2307/3546767; WHITE EG, 1991, NEW ZEAL J ECOL, V15, P139; Yang RC, 2012, EXP PARASITOL, V132, P216, DOI 10.1016/j.exppara.2012.07.003; Yeates GW, 2009, NEW ZEAL J ZOOL, V36, P35, DOI 10.1080/03014220909510137; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]; ZUK M, 1988, EVOLUTION, V42, P969, DOI 10.1111/j.1558-5646.1988.tb02515.x	56	6	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121685	10.1371/journal.pone.0121685	http://dx.doi.org/10.1371/journal.pone.0121685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919745	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400008
J	Murphy, SF; Schaeffer, AJ; Done, J; Wong, L; Bell-Cohn, A; Roman, K; Cashy, J; Ohlhausen, M; Thumbikat, P				Murphy, Stephen F.; Schaeffer, Anthony J.; Done, Joseph; Wong, Larry; Bell-Cohn, Ashlee; Roman, Kenny; Cashy, John; Ohlhausen, Michelle; Thumbikat, Praveen			IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP)	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; PERIPHERAL-NERVE INJURY; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; NEUROPATHIC PAIN; GRO-ALPHA; NEUTROPHIL INFILTRATION; MAST-CELLS; TH17 CELLS; IFN-GAMMA	Chronic pelvic pain syndrome (CPPS) is the most common form of prostatitis, accounting for 90-95% of all diagnoses. It is a complex multi-symptom syndrome with unknown etiology and limited effective treatments. Previous investigations highlight roles for inflammatory mediators in disease progression by correlating levels of cytokines and chemokines with patient reported symptom scores. It is hypothesized that alteration of adaptive immune mechanisms results in autoimmunity and subsequent development of pain. Mouse models of CPPS have been developed to delineate these immune mechanisms driving pain in humans. Using the experimental autoimmune prostatitis (EAP) in C57BL/6 mice model of CPPS we examined the role of CD4+T-cell subsets in the development and maintenance of prostate pain, by tactile allodynia behavioral testing and flow cytometry. In tandem with increased CD4+IL17A+ T-cells upon EAP induction, prophylactic treatment with an anti-IL17 antibody one-day prior to EAP induction prevented the onset of pelvic pain. Therapeutic blockade of IL17 did not reverse pain symptoms indicating that IL17 is essential for development but not maintenance of chronic pain in EAP. Furthermore we identified a cytokine, IL7, to be associated with increased symptom severity in CPPS patients and is increased in patient prostatic secretions and the prostates of EAP mice. IL7 is fundamental to development of IL17 producing cells and plays a role in maturation of auto-reactive T-cells, it is also associated with autoimmune disorders including multiple sclerosis and type-1 diabetes. More recently a growing body of research has pointed to IL17's role in development of neuropathic and chronic pain. This report presents novel data on the role of CD4+IL17+ T-cells in development and maintenance of pain in EAP and CPPS.	[Murphy, Stephen F.; Schaeffer, Anthony J.; Done, Joseph; Wong, Larry; Bell-Cohn, Ashlee; Roman, Kenny; Cashy, John; Ohlhausen, Michelle; Thumbikat, Praveen] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Thumbikat, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	thumbikat@northwestern.edu	Thumbikat, Praveen/AAQ-1782-2021	Thumbikat, Praveen/0000-0002-5454-4172; Roman, Kenny/0000-0002-8302-0829	National Institute Of Diabetes And Digestive And Kidney Diseases [R01DK083609, K01DK079019, R01DK094898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083609, K01DK079019, R01DK094898] Funding Source: NIH RePORTER	National Institute Of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by award number R01DK083609, K01DK079019 and R01DK094898 from the National Institute Of Diabetes And Digestive And Kidney Diseases. No author states a conflict of interest.	Arend WP, 2000, ANN RHEUM DIS, V59, P60, DOI 10.1136/ard.59.suppl_1.i60; Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Benwell RK, 2010, CLIN IMMUNOL, V134, P178, DOI 10.1016/j.clim.2009.09.013; Bikker A, 2012, RHEUMATOLOGY, V51, P996, DOI 10.1093/rheumatology/ker448; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Cha L, 2014, J IMMUNOL; Day YJ, 2014, PAIN, V155, P1293, DOI 10.1016/j.pain.2014.04.004; Desireddi NV, 2008, J UROLOGY, V179, P1857, DOI 10.1016/j.juro.2008.01.028; Done JD, 2012, J UROLOGY, V187, P1473, DOI 10.1016/j.juro.2011.11.116; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Grigorian A, 2012, ANN NY ACAD SCI, V1253, P49, DOI 10.1111/j.1749-6632.2011.06391.x; Haas J, 2011, EUR J IMMUNOL, V41, P845, DOI 10.1002/eji.201041139; Hedelin HH, 2009, SCAND J UROL NEPHROL, V43, P373, DOI 10.3109/00365590903164514; Heninger AK, 2012, J IMMUNOL, V189, P5649, DOI 10.4049/jimmunol.1201286; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Iolyeva M, 2013, BLOOD, V122, P2271, DOI 10.1182/blood-2013-01-478073; Kim CF, 2011, J PAIN, V12, P370, DOI 10.1016/j.jpain.2010.08.003; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Kreft KL, 2012, GENES IMMUN, V13, P587, DOI 10.1038/gene.2012.34; Kuriya G, 2013, DIABETOLOGIA, V56, P1773, DOI 10.1007/s00125-013-2935-8; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Lenz M, 2013, PAIN, V154, P2142, DOI 10.1016/j.pain.2013.06.039; Liu HP, 2013, EUR J IMMUNOL, V43, P1716, DOI 10.1002/eji.201242889; Magri V, 2010, J UROLOGY, V184, P2339, DOI 10.1016/j.juro.2010.08.025; Mahal Brandon A, 2011, Curr Urol Rep, V12, P297, DOI 10.1007/s11934-011-0196-y; McNamee KE, 2011, PAIN, V152, P1838, DOI 10.1016/j.pain.2011.03.035; Meng XZ, 2013, PAIN, V154, P294, DOI 10.1016/j.pain.2012.10.022; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Miller CN, 2013, INT IMMUNOL, V25, P471, DOI 10.1093/intimm/dxt012; Morrison PJ, 2013, MUCOSAL IMMUNOL, V6, P1143, DOI 10.1038/mi.2013.11; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Murphy SF, 2014, NAT REV UROL, V11, P259, DOI 10.1038/nrurol.2014.63; Myles IA, 2013, NAT IMMUNOL, V14, P804, DOI 10.1038/ni.2637; Niu YZ, 2014, J HUAZHONG U SCI-MED, V34, P591, DOI 10.1007/s11596-014-1321-1; Noma N, 2011, NEUROSCI LETT, V493, P86, DOI 10.1016/j.neulet.2011.01.079; Penaranda C, 2012, P NATL ACAD SCI USA, V109, P12668, DOI 10.1073/pnas.1203692109; Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004; Pontari M, 2013, CURR OPIN UROL, V23, P565, DOI 10.1097/MOU.0b013e3283656a55; Quick ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060987; Quick ML, 2012, AM J PHYSIOL-REG I, V303, pR580, DOI 10.1152/ajpregu.00240.2012; Rivero VE, 1998, J AUTOIMMUN, V11, P603, DOI 10.1006/jaut.1998.0248; Roman K, 2014, PAIN; Rudick CN, 2008, AM J PHYSIOL-REG I, V294, pR1268, DOI 10.1152/ajpregu.00836.2007; Rudick CN, 2011, INFECT IMMUN, V79, P628, DOI 10.1128/IAI.00910-10; Samplaski MK, 2012, J UROLOGY, V188, P1788, DOI 10.1016/j.juro.2012.07.036; Sayed BA, 2011, J IMMUNOL, V186, P3294, DOI 10.4049/jimmunol.1003574; Schiff MH, 2000, ANN RHEUM DIS, V59, P103, DOI 10.1136/ard.59.suppl_1.i103; Schuh CD, 2014, PAIN, V155, P545, DOI 10.1016/j.pain.2013.12.006; Shoskes DA, 2010, UROLOGY, V75, P1249, DOI 10.1016/j.urology.2010.01.021; Shoskes DA, 2009, UROLOGY, V73, P538, DOI 10.1016/j.urology.2008.09.074; Singh R.P., 2014, AUTOIMMUN REV; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Tang JH, 1997, J IMMUNOL, V159, P117; THEYER G, 1992, LAB INVEST, V66, P96; Tran CN, 2014, CAN J UROL, V21, P7195; Wagenlehner FME, 2013, WORLD J UROL, V31, P711, DOI 10.1007/s00345-013-1055-x; Webster KE, 2014, MUCOSAL IMMUNOL, V7, P1058, DOI 10.1038/mi.2013.122; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x; Younas M, 2013, J IMMUNOL, V191, P3161, DOI 10.4049/jimmunol.1203547; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zuvich RL, 2010, HUM GENET, V127, P525, DOI 10.1007/s00439-010-0789-4	64	17	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125623	10.1371/journal.pone.0125623	http://dx.doi.org/10.1371/journal.pone.0125623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933188	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100124
J	da Silva, IM; Hill, N; Shimadzu, H; Soares, AMVM; Dornelas, M				da Silva, Isabel Marques; Hill, Nick; Shimadzu, Hideyasu; Soares, Amadeu M. V. M.; Dornelas, Maria			Spillover Effects of a Community-Managed Marine Reserve	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; PROTECTED AREAS; REEF FISH; LONG-TERM; CORAL; POPULATIONS; RECOVERY; BOUNDARIES; ABUNDANCE; BENEFITS	The value of no-take marine reserves as fisheries-management tools is controversial, particularly in high-poverty areas where human populations depend heavily on fish as a source of protein. Spillover, the net export of adult fish, is one mechanism by which no-take marine reserves may have a positive influence on adjacent fisheries. Spillover can contribute to poverty alleviation, although its effect is modulated by the number of fishermen and fishing intensity. In this study, we quantify the effects of a community-managed marine reserve in a high poverty area of Northern Mozambique. For this purpose, underwater visual censuses of reef fish were undertaken at three different times: 3 years before (2003), at the time of establishment (2006) and 6 years after the marine reserve establishment (2012). The survey locations were chosen inside, outside and on the border of the marine reserve. Benthic cover composition was quantified at the same sites in 2006 and 2012. After the reserve establishment, fish sizes were also estimated. Regression tree models show that the distance from the border and the time after reserve establishment were the variables with the strongest effect on fish abundance. The extent and direction of the spillover depends on trophic group and fish size. Poisson Generalized Linear Models show that, prior to the reserve establishment, the survey sites did not differ but, after 6 years, the abundance of all fish inside the reserve has increased and caused spillover of herbivorous fish. Spillover was detected 1 km beyond the limit of the reserve for small herbivorous fishes. Six years after the establishment of a community-managed reserve, the fish assemblages have changed dramatically inside the reserve, and spillover is benefitting fish assemblages outside the reserve.	[da Silva, Isabel Marques] Univ Lurio, Dept Zool, Pemba, Mozambique; [da Silva, Isabel Marques; Soares, Amadeu M. V. M.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Hill, Nick] Zool Soc London, Conservat Programmes, London, England; [Shimadzu, Hideyasu; Dornelas, Maria] Univ St Andrews, Sch Biol, Ctr Biol Divers, St Andrews, Fife, Scotland; [Shimadzu, Hideyasu; Dornelas, Maria] Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Soares, Amadeu M. V. M.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro; Zoological Society of London; University of St Andrews; University of St Andrews; Universidade de Aveiro	da Silva, IM (corresponding author), Univ Lurio, Dept Zool, Pemba, Mozambique.	fish.isabel@gmail.com	Soares, Amadeu/A-8304-2008; Shimadzu, Hideyasu/E-5649-2010; Dornelas, Maria/E-3595-2010	Soares, Amadeu/0000-0003-0879-9470; Shimadzu, Hideyasu/0000-0003-0919-8829; Dornelas, Maria/0000-0003-2077-7055; Hill, Nicholas Anthony Owen/0000-0002-5921-0091; Marques da Silva, Isabel/0000-0002-5510-7636	FCT(Fundacao para Ciencia e Tecnologia) [SFRH/BD/51413/ 2011]; WWF Mozambique; Zoological Society of London; Vamizi lodge and Ideia Wild; ERC project BIOTIME; Scottish Funding Council (MASTS) [HR09011]; Fundacao Calouste Gulbenkian; Oceanario de Lisboa	FCT(Fundacao para Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); WWF Mozambique; Zoological Society of London; Vamizi lodge and Ideia Wild; ERC project BIOTIME; Scottish Funding Council (MASTS); Fundacao Calouste Gulbenkian(European Commission); Oceanario de Lisboa	MS is grateful to FCT(Fundacao para Ciencia e Tecnologia), for supporting this work through a Doctoral scholarship (SFRH/BD/51413/ 2011). We thank WWF Mozambique, the Zoological Society of London, Martin Andersson, Vamizi lodge and Ideia Wild for supporting this work. MD and HS thank the ERC project BIOTIME for support. MD is grateful for support from the Scottish Funding Council (MASTS - grant reference HR09011). IMS and AS thank Fundacao Calouste Gulbenkian and Oceanario de Lisboa for support given through the 2010 Galardao Gulbenkian/Oceanario de Lisboa to the project "Conhecer para Preservar a Biodiversidade Marinha de Pemba (Cabo Delgado, Mocambique)-Ordenacao Socio-Ambiental para a Sustentabilidade"	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Abesamis RA, 2006, AQUAT CONSERV, V16, P349, DOI 10.1002/aqc.730; Adams VM, 2011, BIOL CONSERV, V144, P350, DOI 10.1016/j.biocon.2010.09.012; Ashworth JS, 2005, BIOL CONSERV, V121, P333, DOI 10.1016/j.biocon.2004.05.006; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bertzk B, 2012, PROTECTED PLANET REP; Birkeland C, 2004, BIOSCIENCE, V54, P1021, DOI 10.1641/0006-3568(2004)054[1021:RDTCR]2.0.CO;2; BOHNSACK JA, 1993, OCEANUS, V36, P63; Burke L., 2011, REEFS RISK REVISITED; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Cinner J, 2005, ECOL SOC, V10; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cressey D, 2011, NATURE, V480, P166, DOI 10.1038/480166a; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; De'ath G, 2006, MVPART MULTIVARIATE; Dulvy NK, 2013, AQUAT CONSERV, V23, P357, DOI 10.1002/aqc.2358; English S., 1997, SURVEY MANUAL TROPIC; Fenner Douglas, 2012, Diversity, V4, P105, DOI 10.3390/d4010105; Foale S., 2004, ASIA PAC VIEWP, V45, P373; Forcada A, 2009, MAR ECOL PROG SER, V379, P197, DOI 10.3354/meps07892; Fox J., 2009, CAR COMPANION APPL R; Froese R., 2000, FISHBASE CONCEPTS DE; Gell F. R., 2002, FISHERY EFFECTS MARI, DOI 10.1016/s1386-5056(02)00038-2; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hastings A, 2003, ECOLOGICAL APLICATIO, V13, P565; Hilborn R, 2013, P NATL ACAD SCI USA, V110, P9187, DOI 10.1073/pnas.1308962110; Hill Nicholas A. O., 2009, Western Indian Ocean Journal of Marine Science, V8, P113; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; *ISRS, 2004, 1 ISRS; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Jennings S, 2000, REV FISH BIOL FISHER, V10, P209, DOI 10.1023/A:1016619102955; Jones PJS, 2001, REV FISH BIOL FISHER, V11, P197, DOI 10.1023/A:1020327007975; Kellner JB, 2007, FISHING LINE NEAR MA; Klein CJ, 2008, CONSERV LETT, V1, P44, DOI 10.1111/j.1755-263X.2008.00005.x; legendre P, 2012, PRACTICALS USING R S; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Lubchenco J, 2003, ECOL APPL, V13, pS3; McCay BJ, 2011, CONSERV BIOL, V25, P1130, DOI 10.1111/j.1523-1739.2011.01771.x; McClanahan TR, 2011, AQUAT CONSERV, V21, P658, DOI 10.1002/aqc.1225; McClanahan T.R., 1997, P1533; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; McClanahan TR, 2001, ECOL APPL, V11, P559, DOI 10.2307/3060909; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; McClanahan TR, 1996, CONSERV BIOL, V10, P1187, DOI 10.1046/j.1523-1739.1996.10041187.x; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; McClanahan TR, 2007, ECOLOGICAL APLICATIO, V17, P1044; McClanahan TR, 2009, MARINE ECOLOGICAL PR, V396; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Obura D, 2009, RESILIENCE ASSESSMEN; Oksanen J., 2005, VEGAN R FUNCTIONS VE; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Roberts C.M., 2001, CONSERV PRACT, V2, P10, DOI [DOI 10.1111/J.1526-4629.2001.TB00012.X, 10.1111/j.1526-4629.2001.tb00012.x]; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2000, B MAR SCI, V66, P581; Rosendo S, 2011, OCEAN COAST MANAGE, V54, P55, DOI 10.1016/j.ocecoaman.2010.10.009; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Samoilys MA, 1997, MANUAL ASSESSING FIS; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Sanchirico J.N., 2000, MARINE PROTECTED ARE; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Team RDC, 2019, R LANG ENV STAT COMP; Willis TJ, 2003, ENV CONSERVATION, V30; Wiomsa, 2011, MIGR FISH FISH W IND; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	83	29	29	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0111774	10.1371/journal.pone.0111774	http://dx.doi.org/10.1371/journal.pone.0111774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927235	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100001
J	Ejarque-Ortiz, A; Sola, C; Martinez-Barriocanal, A; Schwartz, S; Martin, M; Peluffo, H; Sayos, J				Ejarque-Ortiz, Aroa; Sola, Carme; Martinez-Barriocanal, Agueda; Schwartz, Simo, Jr.; Martin, Margarita; Peluffo, Hugo; Sayos, Joan			The Receptor CMRF35-Like Molecule-1 (CLM-1) Enhances the Production of LPS-Induced Pro-Inflammatory Mediators during Microglial Activation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEGATIVE REGULATION; CELLS; ASSOCIATION; EXPRESSION; SIGNALS; BINDING; FAMILY; SENSOR	CMRF35-like molecule-1 (CLM-1) belongs to a receptor family mainly expressed in myeloid cells that include activating and inhibitory receptors. CLM-1 contains two ITIMs and a single immunoreceptor tyrosine-based switch motif (ITSM), although also displays a binding site for p85 alpha regulatory subunit of PI3K. By using murine primary microglial cultures, we show the presence of all CLM members in microglial cells and characterize the expression of CLM-1 both in basal conditions and during microglial activation. The TLR4 agonist lipopolysaccharide (LPS) and the TLR3 agonist polyinosinic-polycytidylic acid (Poly I:C) induce an increase in microglial CLM-1 mRNA levels in vitro, whereas the TLR2/6 heterodimer agonist peptidoglycan (PGN) produces a marked decrease. In this study we also describe a new soluble isoform of CLM-1 that is detected at mRNA and protein levels in basal conditions in primary microglial cultures. Interestingly, CLM-1 engagement enhances the transcription of the pro-inflammatory mediators TNF alpha, COX-2 and NOS-2 in microglial cells challenged with LPS. These results reveal that CLM-1 can acts as a co-activating receptor and suggest that this receptor could play a key role in the regulation of microglial activation.	[Ejarque-Ortiz, Aroa; Martinez-Barriocanal, Agueda; Sayos, Joan] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, CIBBIM Nanomed Program, Immunobiol Grp,Inst Recerca VHIR, E-08193 Barcelona, Spain; [Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Drug Delivery & Targeting Grp, CIBBIM Nanomed Program,Inst Recerca VHIR, E-08193 Barcelona, Spain; [Ejarque-Ortiz, Aroa; Martinez-Barriocanal, Agueda; Schwartz, Simo, Jr.; Sayos, Joan] Inst Salud Carlos III, Networking Res Ctr Bioengn Biomat & Nanomed CIBBE, Barcelona, Spain; [Sola, Carme] Inst Invest Biomed August Pi & Sunyer IDIBAPS, CSIC, Inst Invest Biomed Barcelona, Dept Cerebral Ischemia & Neurodegenerat, Barcelona, Spain; [Martin, Margarita] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Fac Med, Biochem Unit, Barcelona 7, Spain; [Peluffo, Hugo] Inst Pasteur Montevideo, Neurodegenerat Lab, Montevideo, Uruguay; [Peluffo, Hugo] UDELAR, Fac Med, Dept Histol & Embryol, Montevideo, Uruguay	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay	Ejarque-Ortiz, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, CIBBIM Nanomed Program, Immunobiol Grp,Inst Recerca VHIR, E-08193 Barcelona, Spain.	aroa.ejarque@vhir.org; joan.sayos@vhir.org	Sayos, Joan/B-6119-2009; Martinez, Agueda/AAB-7186-2019; Schwartz, Simo/H-7776-2012; Peluffo, Hugo/AER-6323-2022; Andorra, Margarita Martin/H-2025-2015	Sayos, Joan/0000-0002-4664-3461; Martinez, Agueda/0000-0002-8809-160X; Peluffo, Hugo/0000-0001-6111-8668; Andorra, Margarita Martin/0000-0002-9245-4899; Schwartz, Simo/0000-0001-8297-7971; Sola, Carme/0000-0002-4012-816X	Fondo de Investigaciones Sanitarias [PI1100045]; Fundacio "La Marato de Tv3" [110532, 110533]; Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR); Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR) [2009 SGR 493]; Agencia Nacional de Investigacion e Innovacion (ANII); PEDECIBA; FOCEM (MERCOSUR Structural Convergence Fund) [COF 03/1111]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacio "La Marato de Tv3"; Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR); Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Agencia Nacional de Investigacion e Innovacion (ANII); PEDECIBA; FOCEM (MERCOSUR Structural Convergence Fund)	This work was supported by grants from Fondo de Investigaciones Sanitarias (PI1100045), Fundacio "La Marato de Tv3" (110532 and 110533), Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR), Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR) (2009 SGR 493), Agencia Nacional de Investigacion e Innovacion (ANII), PEDECIBA, and FOCEM (MERCOSUR Structural Convergence Fund), COF 03/1111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Choi S-C, 2011, J IMMUNOL; Chung D, 1950, J IMMUNOLOGY; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Martinez-Barriocanal A, 2006, J IMMUNOL, V177, P2819, DOI 10.4049/jimmunol.177.5.2819; Moshkovits I, 2014, MUCOSAL IMMUNOL, V7, P292, DOI 10.1038/mi.2013.47; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Peluffo H, 2012, BRAIN PATHOL, V22, P318, DOI 10.1111/j.1750-3639.2011.00537.x; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Shi LY, 2006, BLOOD, V108, P2678, DOI 10.1182/blood-2006-04-015404; Shik D, 2014, ALLERGY, V69, P719, DOI 10.1111/all.12388; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tian L, 2014, NAT COMMUN, P5; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010; Xi H, 2010, J EXP MED, V207, P7, DOI 10.1084/jem.20091508	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123928	10.1371/journal.pone.0123928	http://dx.doi.org/10.1371/journal.pone.0123928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927603	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100025
J	Li, H; Yu, BQ; Li, JF; Su, LP; Yan, M; Zhang, J; Li, C; Zhu, ZG; Liu, BY				Li, Hao; Yu, Beiqin; Li, Jianfang; Su, Liping; Yan, Min; Zhang, Jun; Li, Chen; Zhu, Zhenggang; Liu, Bingya			Characterization of Differentially Expressed Genes Involved in Pathways Associated with Gastric Cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; CELL-PROLIFERATION; DOWN-REGULATION; UP-REGULATION; TUMORIGENESIS; CONTRIBUTES; METASTASIS; INVASION; RECEPTOR; MARKER	To explore the patterns of gene expression in gastric cancer, a total of 26 paired gastric cancer and noncancerous tissues from patients were enrolled for gene expression microarray analyses. Limma methods were applied to analyze the data, and genes were considered to be significantly differentially expressed if the False Discovery Rate (FDR) value was < 0.01, P-value was < 0.01 and the fold change (FC) was >2. Subsequently, Gene Ontology (GO) categories were used to analyze the main functions of the differentially expressed genes. According to the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, we found pathways significantly associated with the differential genes. Gene-Act network and co-expression network were built respectively based on the relationships among the genes, proteins and compounds in the database. 2371 mRNAs and 350 lncRNAs considered as significantly differentially expressed genes were selected for the further analysis. The GO categories, pathway analyses and the Gene-Act network showed a consistent result that up-regulated genes were responsible for tumorigenesis, migration, angiogenesis and microenvironment formation, while down-regulated genes were involved in metabolism. These results of this study provide some novel findings on coding RNAs, lncRNAs, pathways and the co-expression network in gastric cancer which will be useful to guide further investigation and target therapy for this disease.	[Li, Hao; Yu, Beiqin; Li, Jianfang; Su, Liping; Yan, Min; Zhang, Jun; Li, Chen; Zhu, Zhenggang; Liu, Bingya] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Surg, Shanghai Key Lab Gastr Neoplasms,Ruijin Hosp, Shanghai 200025, Peoples R China; [Li, Hao; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Oncol, Shanghai 200025, Peoples R China; [Yan, Min; Li, Chen; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Surg, Shanghai Key Lab Gastr Neoplasms,Ruijin Hosp, Shanghai 200025, Peoples R China.	byliu@sjtu.edu.cn	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81172324, 91229106, 81272749, 81372231]; Science and Technology Commission of Shanghai Municipality [13ZR1425600]; Key Projects in the National Science & Technology Pillar Program of China [2014BAI09B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Projects in the National Science & Technology Pillar Program of China	This work was supported by grants for analysis from the National Natural Science Foundation of China [No. 81172324, No. 91229106, No. 81272749, and No. 81372231], Science and Technology Commission of Shanghai Municipality [No. 13ZR1425600], and Key Projects in the National Science & Technology Pillar Program of China (No. 2014BAI09B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Azim HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062451; Behrends S, 2000, BIOCHEM BIOPH RES CO, V271, P64, DOI 10.1006/bbrc.2000.2596; Cao W, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/480534; Cao XY, 2012, WORLD J GASTROENTERO, V18, P7357, DOI 10.3748/wjg.v18.i48.7357; Choi EH, 2009, CLIN CHIM ACTA, V406, P45, DOI 10.1016/j.cca.2009.05.008; Cui JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017819; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Czekierdowski A, 2008, J PHYSIOL PHARMACOL, V59, P53; Dai J, 2014, TUMOR BIOL, V35, P4199, DOI 10.1007/s13277-013-1550-0; Dong R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/317853; Eftang LL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-586; Fahlbusch FB, 2013, PLACENTA, V34, P1027, DOI 10.1016/j.placenta.2013.08.005; Fino KK, 2012, AM J PHYSIOL-GASTR L, V302, pG1244, DOI 10.1152/ajpgi.00460.2011; Fukuda Michiko N, 2012, Front Biosci (Elite Ed), V4, P342; Gorski DH, 2003, J SURG RES, V111, P91, DOI 10.1016/S0022-4804(03)00042-8; Gu XX, 2014, TUMOR BIOL, V35, P2167, DOI 10.1007/s13277-013-1287-9; Guo GJ, 2014, FEBS LETT, V588, P1780, DOI 10.1016/j.febslet.2014.03.038; Hartl D, 2009, J IMMUNOL, V182, P5098, DOI 10.4049/jimmunol.0803446; Huang J, 2014, INT J ONCOL, V44, P1293, DOI 10.3892/ijo.2014.2298; Huang XH, 2008, J CANCER RES CLIN, V134, P705, DOI 10.1007/s00432-007-0342-6; International Agency for Research on Cancer (IARC), GLOBOCAN2012 DATABSE; Jung SH, 2010, GASTRIC CANCER, V13, P123, DOI 10.1007/s10120-010-0550-7; Junnila S, 2010, GENE CHROMOSOME CANC, V49, P28, DOI 10.1002/gcc.20715; Kim O, 2014, J CELL PHYSIOL, V229, P762, DOI 10.1002/jcp.24496; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Leir SH, 2011, EXP CELL RES, V317, P2408, DOI 10.1016/j.yexcr.2011.07.021; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Li H, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-110; Liu CH, 2001, BIOCHEM BIOPH RES CO, V288, P129, DOI 10.1006/bbrc.2001.5737; Lorenzi T, 2013, INT J CANCER, V133, P2650, DOI 10.1002/ijc.28280; Luo ZY, 2011, J CANCER RES CLIN, V137, P1713, DOI 10.1007/s00432-011-1042-9; Thang NM, 2013, REPROD SCI, V20, P1184, DOI 10.1177/1933719113477485; Nookaew I, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-41; Ohlsson L, 2012, BRIT J CANCER, V107, P150, DOI 10.1038/bjc.2012.220; Okano M, 2013, ONCOL REP, V30, P2903, DOI 10.3892/or.2013.2761; Okugawa T, 2012, DIGEST DIS SCI, V57, P1562, DOI 10.1007/s10620-012-2043-5; Oshima T, 2014, ANTICANCER RES, V34, P2303; Planque C, 2010, CLIN CHEM, V56, P987, DOI 10.1373/clinchem.2009.138917; Praml C, 2003, ONCOGENE, V22, P4765, DOI 10.1038/sj.onc.1206684; Qu Y, 2014, INT J ONCOL, V44, P1512, DOI 10.3892/ijo.2014.2328; Qu Y, 2013, EUR J CANCER, V49, P3718, DOI 10.1016/j.ejca.2013.07.011; Rizzato C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073100; Sanchez C, 2012, MOL CELL ENDOCRINOL, V349, P170, DOI 10.1016/j.mce.2011.10.010; Sato T, 2013, J SURG ONCOL, V108, P364, DOI 10.1002/jso.23425; Schubert T, 2012, INT J MOL MED, V30, P1133, DOI 10.3892/ijmm.2012.1098; Seiz L, 2012, BIOL CHEM, V393, P391, DOI 10.1515/hsz-2011-0264; Sha SM, 2013, DIGEST LIVER DIS, V45, P422, DOI 10.1016/j.dld.2012.12.004; Shibutani M, 2013, ANTICANCER RES, V33, P3301; Sun M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/s13277-013-1142-z; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Vainionpaa N, 2007, LAB INVEST, V87, P780, DOI 10.1038/labinvest.3700592; Vallon M, 2010, EXP CELL RES, V316, P412, DOI 10.1016/j.yexcr.2009.10.013; Wang RF, 2013, EXP MOL PATHOL, V95, P350, DOI 10.1016/j.yexmp.2013.10.008; Wang YF, 2013, TUMOR BIOL, V34, P1685, DOI 10.1007/s13277-013-0703-5; Wei M, 2010, MOL CANCER THER, V9, P1764, DOI 10.1158/1535-7163.MCT-09-1162; Xiao JW, 2012, ASIAN PAC J CANCER P, V13, P5897, DOI 10.7314/APJCP.2012.13.11.5897; Yan J, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0879-6; Yoshida T, 2014, INT J CANCER, V134, P1445, DOI 10.1002/ijc.28470; Zhang YQ, 2014, ACTA BIOCH BIOPH SIN, V46, P283, DOI 10.1093/abbs/gmu001	61	42	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125013	10.1371/journal.pone.0125013	http://dx.doi.org/10.1371/journal.pone.0125013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928635	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100057
J	Matsuzaki, S; Hiratsuka, T; Taniguchi, M; Shingaki, K; Kubo, T; Kiya, K; Fujiwara, T; Kanazawa, S; Kanematsu, R; Maeda, T; Takamura, H; Yamada, K; Miyoshi, K; Hosokawa, K; Tohyama, M; Katayama, T				Matsuzaki, Shinsuke; Hiratsuka, Toru; Taniguchi, Manabu; Shingaki, Kenta; Kubo, Tateki; Kiya, Koichiro; Fujiwara, Toshihiro; Kanazawa, Shigeyuki; Kanematsu, Ryutaro; Maeda, Tameyasu; Takamura, Hironori; Yamada, Kohe; Miyoshi, Ko; Hosokawa, Ko; Tohyama, Masaya; Katayama, Taiichi			Physiological ER Stress Mediates the Differentiation of Fibroblasts	PLOS ONE			English	Article							PLASMA-CELL DIFFERENTIATION; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR; GRANULATION-TISSUE; TRANSDUCER OASIS; CONTRACTION; APOPTOSIS; ALPHA; BETA; MYOFIBROBLASTS	Recently, accumulating reports have suggested the importance of endoplasmic reticulum (ER) stress signaling in the differentiation of several tissues and cells, including myoblasts and osteoblasts. Secretory cells are easily subjected to ER stress during maturation of their secreted proteins. Skin fibroblasts produce and release several proteins, such as collagens, matrix metalloproteinases (MMPs), the tissue inhibitors of metalloproteinases (TIMPs) and glycosaminoglycans (GAGs), and the production of these proteins is increased at wound sites. Differentiation of fibroblasts into myofibroblasts is one of the key factors for wound healing and that TGF-beta can induce fibroblast differentiation into myofibroblasts, which express a-smooth muscle actin. Well-differentiated myofibroblasts show increased production of collagen and TGF-beta, and bring about wound healing. In this study, we examined the effects of ER stress signaling on the differentiation of fibroblasts, which is required for wound healing, using constitutively ER stress-activated primary cultured fibroblasts. The cells expressed positive a-smooth muscle actin signals without TGF-beta stimulation compared with control fibroblasts. Gel-contraction assays suggested that ER stress-treated primary fibroblasts caused stronger shrinkage of collagen gels than control cells. These results suggest that ER stress signaling could accelerate the differentiation of fibroblasts to myofibroblasts at injured sites. The present findings may provide important insights for developing therapies to improve wound healing.	[Matsuzaki, Shinsuke; Hiratsuka, Toru; Taniguchi, Manabu; Shingaki, Kenta; Maeda, Tameyasu; Tohyama, Masaya] Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka, Japan; [Matsuzaki, Shinsuke; Kanematsu, Ryutaro; Takamura, Hironori; Yamada, Kohe; Miyoshi, Ko; Tohyama, Masaya; Katayama, Taiichi] Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan; [Matsuzaki, Shinsuke; Takamura, Hironori; Yamada, Kohe; Miyoshi, Ko] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Shingaki, Kenta] Noevir Co Ltd, Dept Res & Dev, Higashiomi, Shiga, Japan; [Kubo, Tateki; Kiya, Koichiro; Fujiwara, Toshihiro; Kanazawa, Shigeyuki; Hosokawa, Ko] Osaka Univ, Grad Sch Med, Dept Plast Surg, Suita, Osaka, Japan; [Yamada, Kohe] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Tohyama, Masaya] Kinki Univ, Res Inst Tradit Oriental Med, Div Mol Brain Sci, Sayama, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Hamamatsu University School of Medicine; Kindai University (Kinki University)	Matsuzaki, S (corresponding author), Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka, Japan.	matsuzaki@ugscd.osaka-u.ac.jp		Hiratsuka, Toru/0000-0002-5359-2690	Program for Creating Future Wisdom, Osaka University [60403193, 23790224]; Cosmetology Research Foundation; Osaka University Graduate School of Medicine; Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [S2603]	Program for Creating Future Wisdom, Osaka University; Cosmetology Research Foundation; Osaka University Graduate School of Medicine; Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers	This work was supported by Grant-in-Aid for Young Scientists (B) #60403193 https://kaken.nii.ac.jp/d/p/21790181.ja.html, Grant-in-Aid for Young Scientists (B) #23790224 https://kaken.nii.ac.jp/d/p/23790224.ja.html, The Program for Creating Future Wisdom, Osaka University, selected in 2014. http://www.osaka-u.ac.jp/en/news/topics/2014/07/20140717_01, Project MEET, Osaka University Graduate School of Medicine http://www.dmi.med.osaka-u.ac.jp/meet/index.html, and Cosmetology Research Foundation http://www.cosmetology.or.jp/.Noevir Co., Ltd., provided partial support in the form of a salary for author SK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (Grant No. S2603). The specific roles of the authors are articulated in the 'author contributions' section.	Asada R, 2012, J BIOL CHEM, V287, P8144, DOI 10.1074/jbc.M111.332593; Butler PD, 2011, J SURG RES, V167, P151, DOI 10.1016/j.jss.2009.04.036; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; DANS MJ, 1994, J INVEST DERMATOL, V102, P118, DOI 10.1111/1523-1747.ep12371743; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1992, EXP CELL RES, V201, P64, DOI 10.1016/0014-4827(92)90348-C; GABBIANI G, 1972, AM J PATHOL, V66, P131; GABBIANI G, 1972, J EXP MED, V135, P719, DOI 10.1084/jem.135.4.719; Garner Warren L., 1995, Wound Repair and Regeneration, V3, P185, DOI 10.1046/j.1524-475X.1995.30210.x; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Ladin Daniel A., 1995, Wound Repair and Regeneration, V3, P6, DOI 10.1046/j.1524-475X.1995.30106.x; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Modarressi A, 2010, J INVEST DERMATOL, V130, P2818, DOI 10.1038/jid.2010.224; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Moulin V, 1998, EXP CELL RES, V238, P283, DOI 10.1006/excr.1997.3827; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Murray CJ, 1992, WOUNDHEALING BIOCH C, P500; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; RUDOLPH R, 1992, WOUND HEALING BIOCH, P96; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Tanaka K, 2013, BIOCHEM BIOPH RES CO, V438, P463, DOI 10.1016/j.bbrc.2013.07.126; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vedrenne N, 2012, PATHOL BIOL, V60, P20, DOI 10.1016/j.patbio.2011.10.002	37	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123578	10.1371/journal.pone.0123578	http://dx.doi.org/10.1371/journal.pone.0123578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928708	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100018
J	Qian, L; Zhang, Y; Zheng, L; Shang, YQ; Gao, JH; Liu, YJ				Qian, Long; Zhang, Yi; Zheng, Li; Shang, Yuqing; Gao, Jia-Hong; Liu, Yijun			Frequency Dependent Topological Patterns of Resting-State Brain Networks	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; FUNCTIONAL CONNECTIVITY; PARCELLATION; ORGANIZATION; SPECIFICITY; GRAPHS	The topological organization underlying brain networks has been extensively investigated using resting-state fMRI, focusing on the low frequency band from 0.01 to 0.1 Hz. However, the frequency specificities regarding the corresponding brain networks remain largely unclear. In the current study, a data-driven method named complementary ensemble empirical mode decomposition (CEEMD) was introduced to separate the time series of each voxel into several intrinsic oscillation rhythms with distinct frequency bands. Our data indicated that the whole brain BOLD signals could be automatically divided into five specific frequency bands. After applying the CEEMD method, the topological patterns of these five temporally correlated networks were analyzed. The results showed that global topological properties, including the network weighted degree, network efficiency, mean characteristic path length and clustering coefficient, were observed to be most prominent in the ultra-low frequency bands from 0 to 0.015 Hz. Moreover, the saliency of small-world architecture demonstrated frequency-density dependency. Compared to the empirical mode decomposition method (EMD), CEEMD could effectively eliminate the mode-mixing effects. Additionally, the robustness of CEEMD was validated by the similar results derived from a split-half analysis and a conventional frequency division method using the rectangular window band-pass filter. Our findings suggest that CEEMD is a more effective method for extracting the intrinsic oscillation rhythms embedded in the BOLD signals than EMD. The application of CEEMD in fMRI data analysis will provide in-depth insight in investigations of frequency specific topological patterns of the dynamic brain networks.	[Qian, Long; Zheng, Li; Liu, Yijun] Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China; [Zhang, Yi] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Shang, Yuqing] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Gao, Jia-Hong] Peking Univ, Ctr MRI Res, Beijing 100871, Peoples R China	Peking University; Xidian University; National University of Singapore; Peking University	Liu, YJ (corresponding author), Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China.	yjliufl@gmail.com	Zhang, Yi/J-7496-2017	Zhang, Yi/0000-0003-0859-9735; Qian, Long/0000-0002-9707-1096	National Natural Science Foundation of China [81470816, 81271549, 61431013, 61131003, 81201081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China under Grant Nos. 81470816, 81271549, 61431013, 61131003, 81201081.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chen L, 2015, NEUROIMAGE, V104, P452, DOI 10.1016/j.neuroimage.2014.10.027; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Hayasaka S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00880; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Itahashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094115; Kalcher K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093375; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maggioni E, 2014, J NEUROSCI METH, V228, P86, DOI 10.1016/j.jneumeth.2014.03.004; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Song XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086818; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Xie HB, 2006, COMPUT METH PROG BIO, V82, P114, DOI 10.1016/j.cmpb.2006.02.009; Yeh JR, 2010, ADV DATA SCI ADAPT, V2, P135, DOI 10.1142/S1793536910000422; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	50	32	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124681	10.1371/journal.pone.0124681	http://dx.doi.org/10.1371/journal.pone.0124681			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927525	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100044
J	Skurikhin, EG; Pershina, OV; Reztsova, AM; Ermakova, NN; Khmelevskaya, ES; Krupin, VA; Stepanova, IE; Artamonov, AV; Bekarev, AA; Madonov, PG; Dygai, AM				Skurikhin, Evgenii Germanovich; Pershina, Olga Victorovna; Reztsova, Alena Mikhaylovna; Ermakova, Natalia Nikolaevna; Khmelevskaya, Ekaterina Sergeevna; Krupin, Vycheslav Andreevich; Stepanova, Inna Ernestovna; Artamonov, Andrew Vladimirovich; Bekarev, Andrew Alexandrovich; Madonov, Pavel Gennadjevich; Dygai, Alexander Mikhaylovich			Modulation of Bleomycin-Induced Lung Fibrosis by Pegylated Hyaluronidase and Dopamine Receptor Antagonist in Mice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HEMATOPOIETIC STEM-CELL; BETA-ADRENERGIC RECEPTORS; PROGENITOR CELLS; BACTERIAL-INFECTION; COLLAGEN; MODEL; DIFFERENTIATION; PATHOGENESIS; PROGRESS	Hyaluronidases are groups of enzymes that degrade hyaluronic acid (HA). To stop enzymatic hydrolysis we modified testicular hyaluronidase (HYAL) by activated polyethylene oxide with the help of electron-beam synthesis. As a result we received pegylated hyaluronidase (pegHYAL). Spiperone is a selective D-2 dopamine receptor antagonist. It was demonstrated on the model of a single bleomycin damage of alveolar epithelium that during the inflammatory phase monotherapy by pegHYAL or spiperone reduced the populations of hematopoietic stem /progenitor cells in the lung parenchyma. PegHYAL also reduced the levels of transforming growth factor (TGF)-beta, interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha in the serum and lungs, while spiperone reduced the level of the serum IL-1 beta. Polytherapy by spiperone and pegHYAL caused the increase of the quantity of hematopoietic stem/progenitor cells in the lungs. Such an influx of blood cell precursors was observed on the background of considerable fall level of TGF-beta and the increase level of TNF-alpha in the serum and lungs. These results show pegHYAL reduced the bleomycin-induced fibrosis reaction (production and accumulation of collagen) in the lung parenchyma. This effect was observed at a single and repetitive bleomycin damage of alveolar epithelium, the antifibrotic activity of pegHYAL surpassing the activity of testicular HYAL. The antifibrotic effect of pegHYAL is enhanced by an additional instillation of spiperone. Therapy by pegHYAL causes the flow of CD31(-)CD34(-)CD45(-)CD44(+)CD73(+)CD90(+)CD106(+)-cells into the fibrous lungs. These cells are incapable of differentiating into fibroblast cells. Spiperone instillation separately or together with pegHYAL reduced the MSC-like cells considerably. These data enable us to assume, that pegHYAL is a new and promising instrument both for preventive and therapy of toxic pneumofibrosis. The blockage of D-2 dopamine receptors with the following change of hyaluronan matrix can be considered as a new strategy in treatment of pneumofibrosis.	[Skurikhin, Evgenii Germanovich; Pershina, Olga Victorovna; Reztsova, Alena Mikhaylovna; Ermakova, Natalia Nikolaevna; Khmelevskaya, Ekaterina Sergeevna; Krupin, Vycheslav Andreevich; Stepanova, Inna Ernestovna; Dygai, Alexander Mikhaylovich] Res Inst Pharmacol & Regenerat Med, Dept Pathophysiol & Regenerat Med, Tomsk, Russia; [Artamonov, Andrew Vladimirovich; Bekarev, Andrew Alexandrovich; Madonov, Pavel Gennadjevich] Ltd Liabil Co Sci Future Management, Novosibirsk, Russia	Russian Academy of Sciences; Tomsk National Research Medical Center; E. D. Goldberg Research Institute of Pharmacology & Regenerative Medicine	Pershina, OV (corresponding author), Res Inst Pharmacol & Regenerat Med, Dept Pathophysiol & Regenerat Med, Tomsk, Russia.	ovpershina@gmail.com	Khmelevskaya, Ekaterina S/J-3886-2017; Krupin, Viacheslav/N-7125-2016; Skurikhin, Evgenii Germanovich/H-4038-2017; Pershina, Olga Viktorovna/C-6782-2017; Ermakova, Natalia/J-3865-2017; Dygai, Alexander Mikhailovich/A-4528-2015; Stepanova, Inna/AAZ-4710-2021; Madonov, Pavel G./A-7692-2019	Khmelevskaya, Ekaterina S/0000-0003-1776-4149; Krupin, Viacheslav/0000-0001-8263-7184; Skurikhin, Evgenii Germanovich/0000-0001-7445-4767; Pershina, Olga Viktorovna/0000-0002-0468-0272; Ermakova, Natalia/0000-0002-6268-2938; Dygai, Alexander Mikhailovich/0000-0001-6286-5315; Stepanova, Inna/0000-0001-6497-3117; Madonov, Pavel G./0000-0002-1093-8938	Scientific Future Management	Scientific Future Management	The authors received no specific funding for this work. Scientific Future Management provided support in the form of salaries for authors AVA, AAB and PGM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Amenta F., 2002, Italian Journal of Anatomy and Embryology, V107, P145; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Banks DE, 2003, INTERSTITIAL LUNG DI, P402; Baumgartner KB, 2000, AM J EPIDEMIOL, V152, P307, DOI 10.1093/aje/152.4.307; BERG RA, 1981, J CLIN INVEST, V67, P1457, DOI 10.1172/JCI110175; Bitencourt CS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-3; BOSINGSCHNEIDER R, 1976, CELL IMMUNOL, V27, P121, DOI 10.1016/0008-8749(76)90160-X; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; BROWN JE, 1977, J CLIN INVEST, V60, P70, DOI 10.1172/JCI108771; Bruzzone P, 2002, PULM PHARMACOL THER, V15, P393, DOI 10.1006/pupt.2002.0368; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Christophis C, 2011, BIOPHYS J, V101, P585, DOI 10.1016/j.bpj.2011.05.045; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; De Luca K, 2009, LEUKEMIA, V23, P2063, DOI 10.1038/leu.2009.155; Delpech B, 1997, J INTERN MED, V242, P41, DOI 10.1046/j.1365-2796.1997.00172.x; Denham JW, 2002, RADIOTHER ONCOL, V63, P129, DOI 10.1016/S0167-8140(02)00060-9; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; DEPELCHIN A, 1981, IMMUNOL LETT, V3, P207, DOI 10.1016/0165-2478(81)90076-6; Dygai AM, 2011, B EXP BIOL MED+, V152, P173, DOI 10.1007/s10517-011-1480-z; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Fabre A, 2008, EUR RESPIR J, V32, P426, DOI 10.1183/09031936.00126907; Fipula D, 2008, ADV DRUG DELIVER REV, V60, P29, DOI 10.1016/j.addr.2007.02.001; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GIRI SN, 1987, EXP LUNG RES, V13, P401, DOI 10.3109/01902148709069601; Gustafson T, 2007, RESP MED, V101, P2207, DOI 10.1016/j.rmed.2007.02.027; Hall NR, 1981, PSYCHONEUROIMMUNOLOG, P521; Hinds KD, 2005, PROTEIN CONJUGATION, P119; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Hubbard R, 2000, LANCET, V355, P466; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Jha AK, 2011, BIOMATERIALS, V32, P2466, DOI 10.1016/j.biomaterials.2010.12.024; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jun D, 2011, STEM CELLS, V29, P725, DOI 10.1002/stem.604; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Khandare J, 2006, PROG POLYM SCI, V31, P359, DOI 10.1016/j.progpolymsci.2005.09.004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; KOBAYASHI Y, 1995, J VASC RES, V32, P200, DOI 10.1159/000159094; Kolb-Maurer A, 2004, FEMS IMMUNOL MED MIC, V40, P147, DOI 10.1016/S0928-8244(03)00305-5; LANDMANN RMA, 1984, J RECEPTOR RES, V4, P37, DOI 10.3109/10799898409042538; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Loebinger MR, 2008, CLIN SCI, V114, P99, DOI 10.1042/CS20070073; Mahendran S, 2012, QJM-INT J MED, V105, P929, DOI 10.1093/qjmed/hcs076; Malavia NK, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-27; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; MILES K, 1984, INT J IMMUNOPHARMACO, V6, P171, DOI 10.1016/0192-0561(84)90014-6; MLADENOVIC J, 1984, BRIT J HAEMATOL, V56, P323; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; MORLEY A, 1971, P SOC EXP BIOL MED, V138, P57; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 1998, EXP LUNG RES, V24, P721, DOI 10.3109/01902149809099592; Pinheiro GA, 2008, INT J OCCUP ENV HEAL, V14, P117, DOI 10.1179/oeh.2008.14.2.117; PRATT RM, 1975, DEV BIOL, V44, P298, DOI 10.1016/0012-1606(75)90400-5; PRENTO P, 1993, HISTOCHEMISTRY, V99, P163, DOI 10.1007/BF00571877; Ratajczak MZ, 2008, CURR OPIN HEMATOL, V15, P293, DOI 10.1097/MOH.0b013e328302c7ca; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Singh M, 2010, ASIAN PAC J CANCER P, V11, P257; Siniscalco Dario, 2008, Ther Adv Respir Dis, V2, P173, DOI 10.1177/1753465808092340; Skurikhin EG, 2013, OPEN C P J, V4, P31, DOI [10.2174/2210289201304010031, DOI 10.2174/2210289201304010031]; Skurikhin EG, 2014, J STEM CELL RES THER, V4, P210, DOI [10.4172/2157-7633.1000210, DOI 10.4172/2157-7633.1000210]; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Steele M, 2003, INTERSTITIAL LUNG DI, P418; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; TOOLE BP, 1971, DEV BIOL, V26, P28, DOI 10.1016/0012-1606(71)90104-7; Tzilas V, 2009, AM J MED SCI, V338, P481, DOI 10.1097/MAJ.0b013e3181ad5984; USUKI J, 1995, PATHOL INT, V45, P552, DOI 10.1111/j.1440-1827.1995.tb03503.x; VANFURTH R, 1980, REV INFECT DIS, V2, P104; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; WEINSTOCK JV, 1989, J IMMUNOL, V142, P3256; Weissman DN, 2003, INTERSTITIAL LUNG DI, P387; Wenzel SE, 2002, J IMMUNOL, V169, P4613, DOI 10.4049/jimmunol.169.8.4613; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Xynos A, 2010, STEM CELLS, V28, P965, DOI 10.1002/stem.418; ZAHNISER NR, 1989, CLIN PHARMACOL THER, V45, P469, DOI 10.1038/clpt.1989.60; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	95	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125065	10.1371/journal.pone.0125065	http://dx.doi.org/10.1371/journal.pone.0125065			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927611	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100065
J	Kandalepas, D; Blum, MJ; Van Bael, SA				Kandalepas, Demetra; Blum, Michael J.; Van Bael, Sunshine A.			Shifts in Symbiotic Endophyte Communities of a Foundational Salt Marsh Grass following Oil Exposure from the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							TROPICAL FUNGAL ENDOPHYTES; BACILLUS-PUMILUS; BIODIVERSITY LOSS; DIVERSITY; MICROORGANISMS; EVOLUTION; PLANTS; STRESS; GROWTH; COLONIZATION	Symbiotic associations can be disrupted by disturbance or by changing environmental conditions. Endophytes are fungal and bacterial symbionts of plants that can affect performance. As in more widely known symbioses, acute or chronic stressor exposure might trigger disassociation of endophytes from host plants. We tested this hypothesis by examining the effects of oil exposure following the Deepwater Horizon (DWH) oil spill on endophyte diversity and abundance in Spartina alterniflora - the foundational plant in northern Gulf coast salt marshes affected by the spill. We compared bacterial and fungal endophytes isolated from plants in reference areas to isolates from plants collected in areas with residual oil that has persisted for more than three years after the DWH spill. DNA sequence-based estimates showed that oil exposure shifted endophyte diversity and community structure. Plants from oiled areas exhibited near total loss of leaf fungal endophytes. Root fungal endophytes exhibited a more modest decline and little change was observed in endophytic bacterial diversity or abundance, though a shift towards hydrocarbon metabolizers was found in plants from oiled sites. These results show that plant-endophyte symbioses can be disrupted by stressor exposure, and indicate that symbiont community disassembly in marsh plants is an enduring outcome of the DWH spill.	[Kandalepas, Demetra; Blum, Michael J.; Van Bael, Sunshine A.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Kandalepas, Demetra; Blum, Michael J.] Tulane Univ, Tulane Xavier Ctr Bioenvironm Res, New Orleans, LA 70118 USA	Tulane University; Tulane University; Xavier University of Louisiana	Van Bael, SA (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	svanbael@tulane.edu	Van Bael, Sunshine/M-5370-2019; Van Bael, Sunshine/K-1930-2019	Van Bael, Sunshine/0000-0001-7317-3533; 	Tulane University; Gulf of Mexico Research Initiative; Tulane-Xavier Center for Bioenvironmental Research; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	Tulane University; Gulf of Mexico Research Initiative; Tulane-Xavier Center for Bioenvironmental Research; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding for this study was provided from Tulane University to SAV, the Gulf of Mexico Research Initiative to MJB from research funds provided to Louisiana State University and from the Tulane-Xavier Center for Bioenvironmental Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2014, PLANT PHYSIOL BIOCH, V80, P160, DOI 10.1016/j.plaphy.2014.04.003; Alonso-Gutierrez J, 2009, APPL ENVIRON MICROB, V75, P3407, DOI 10.1128/AEM.01776-08; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Bharti N, 2013, WORLD J MICROB BIOT, V29, P379, DOI 10.1007/s11274-012-1192-1; Bik HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038550; Blum MJ, 2014, OIL SPILL REMEDIATION: COLLOID CHEMISTRY-BASED PRINCIPLES AND SOLUTIONS, P59; Cappello S, 2007, MICROBIOL RES, V162, P185, DOI 10.1016/j.micres.2006.05.010; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2015, PRIMER V7 USER MANUA; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Deivanai Subramanian, 2014, J Nat Sci Biol Med, V5, P437, DOI 10.4103/0976-9668.136233; Estrada C, 2013, NEW PHYTOL, V198, P241, DOI 10.1111/nph.12140; FRAVEL DR, 1988, ANNU REV PHYTOPATHOL, V26, P75, DOI 10.1146/annurev.py.26.090188.000451; Friesen ML, 2011, ANNU REV ECOL EVOL S, V42, P23, DOI 10.1146/annurev-ecolsys-102710-145039; GOREAU TJ, 1994, AMBIO, V23, P176; Harvey PJ, 2002, ENVIRON SCI POLLUT R, V9, P29, DOI 10.1007/BF02987315; Hassen AI, 2010, WORLD J MICROB BIOT, V26, P1837, DOI 10.1007/s11274-010-0365-z; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hernandez JP, 2009, EUR J SOIL BIOL, V45, P88, DOI 10.1016/j.ejsobi.2008.08.004; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hubbard M, 2014, J APPL MICROBIOL, V116, P109, DOI 10.1111/jam.12311; Hubbell S.P., 2001, MG POP BIOL, V32; JOHNSON ND, 1987, OECOLOGIA, V74, P425, DOI 10.1007/BF00378940; Joye SB, 2014, BIOSCIENCE, V64, P766, DOI 10.1093/biosci/biu121; Kandalepas D, 2012, THESIS LOUISIANA STA; Kandalepas D, 2010, WETLANDS, V30, P189, DOI 10.1007/s13157-010-0017-y; Khan S, 2013, CHEMOSPHERE, V90, P1317, DOI 10.1016/j.chemosphere.2012.09.045; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Lamendella R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00130; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lin QX, 2012, ENVIRON SCI TECHNOL, V46, P3737, DOI 10.1021/es203552p; Manousaki E, 2011, INT J PHYTOREMEDIAT, V13, P959, DOI 10.1080/15226514.2010.532241; Marks K, 2013, THESIS GEORGIA I TEC; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mejia LC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00479; Mohammed Y, 2015, GULF MEX OIL SPILL E; Morris JT, 2013, WETLANDS, V33, P975, DOI 10.1007/s13157-013-0480-3; Morris J. T., 2014, PERSPECTIVES RESTORA, P111; Mugerwa TTM, 2013, FUNGAL ECOL, V6, P70, DOI 10.1016/j.funeco.2012.08.004; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Nielsen P, 1997, FEMS MICROBIOL ECOL, V22, P183, DOI 10.1016/S0168-6496(96)00089-X; Nyman JA, 2014, ESTUAR COAST, V37, P1490, DOI 10.1007/s12237-013-9747-4; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Rillig MC, 2014, OECOLOGIA, V174, P263, DOI 10.1007/s00442-013-2759-8; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Rudgers J. A., 2012, TRAIT MEDIATED INDIR, P391; Rudgers JA, 2010, J APPL ECOL, V47, P468, DOI 10.1111/j.1365-2664.2010.01788.x; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Shaffer GP, 2009, J COASTAL RES, P152, DOI 10.2112/SI54-006.1; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Thomas P, 2004, J APPL MICROBIOL, V97, P114, DOI 10.1111/j.1365-2672.2004.02279.x; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; Viswanath B., 2014, ENZYME RES, V2014, P1, DOI [DOI 10.1155/2014/163242, 10.1155/2014/163242]; Weishampel PA, 2006, MYCORRHIZA, V16, P495, DOI 10.1007/s00572-006-0064-7; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yule KM, 2013, OIKOS, V122, P1512, DOI 10.1111/j.1600-0706.2012.00229.x; Zengel S, 2014, INT OIL SPILL C P, P1985, DOI DOI 10.7901/2169-3358-2014.1.1985; Zengel S, 2013, DEEPWATER HORIZON OI, P74; [Zhang Shumei 张淑梅], 2008, [微生物学通报, Microbiology], V35, P1593; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	75	34	34	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122378	10.1371/journal.pone.0122378	http://dx.doi.org/10.1371/journal.pone.0122378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923203	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600012
J	Liu, J; Zhang, W				Liu, Jin; Zhang, Wei			The Influence of the Environment and Clothing on Human Exposure to Ultraviolet Light	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; PROTECTION; RADIATION; TRANSMISSION; POLLUTION; IMPACT	Objection The aim of this study is to determine the effect of clothing and the environment on human exposure to ultraviolet light. Methods The ultraviolet (ultraviolet A and ultraviolet B) light intensity was measured, and air quality parameters were recorded in 2014 in Beijing, China. Three types of clothing (white polyester cloth, pure cotton white T-shirt, and pure cotton black T-shirt) were individually placed on a mannequin. The ultraviolet (ultraviolet A and ultraviolet B) light intensities were measured above and beneath each article of clothing, and the percentage of ultraviolet light transmission through the clothing was calculated. Results (1) The ultraviolet light transmission was significantly higher through white cloth than through black cloth; the transmission was significantly higher through polyester cloth than through cotton. (2) The weather significantly influenced ultraviolet light transmission through white polyester cloth; transmission was highest on clear days and lowest on overcast days (ultraviolet A: P=0.000; ultraviolet B: P=0.008). (3) Air quality parameters (air quality index and particulate matter 2.5 and 10) were inversely related to the ultraviolet light intensity that reached the earth's surface. Ultraviolet B transmission through white polyester cloth was greater under conditions of low air pollution compared with high air pollution. Conclusion Clothing color and material and different types of weather affected ultraviolet light transmission; for one particular cloth, the transmission decreased with increasing air pollution.	[Liu, Jin; Zhang, Wei] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China	Capital Medical University	Zhang, W (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China.	zw2966@sina.com						Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136/adc.87.2.111; Bogh MKB, 2012, SCAND J CLIN LAB INV, V72, P24, DOI 10.3109/00365513.2012.681929; Buka Irena, 2006, Paediatr Child Health, V11, P513; Chen B, 2015, ENVIRON SCI POLLUT R, V22, P5139, DOI 10.1007/s11356-014-4024-z; Davis S, 1997, INT J DERMATOL, V36, P374, DOI 10.1046/j.1365-4362.1997.00046.x; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Gambichler T, 2001, BRIT J DERMATOL, V144, P484, DOI 10.1046/j.1365-2133.2001.04072.x; Gao Q, 2011, BIOMED ENVIRON SCI, V24, P499, DOI 10.3967/0895-3988.2011.05.007; Gies P, 2007, PHOTODERMATOL PHOTO, V23, P264, DOI 10.1111/j.1600-0781.2007.00309.x; Godar DE, 2012, ENVIRON HEALTH PERSP, V120, P139, DOI 10.1289/ehp.1003195; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Kelishadi R, 2014, PAEDIATR INT CHILD H, V34, P50, DOI 10.1179/2046905513Y.0000000080; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lucas RM, 2008, INT J EPIDEMIOL, V37, P654, DOI 10.1093/ije/dyn017; Salih FM, 2004, PHOTODERMATOL PHOTO, V20, P53, DOI 10.1111/j.1600-0781.2004.00068.x; Seckmeyer G, 2013, PHOTOCHEM PHOTOBIOL, V89, P974, DOI 10.1111/php.12074; STANFORD DG, 1995, MED J AUSTRALIA, V162, P422, DOI 10.5694/j.1326-5377.1995.tb139972.x; Wang SQ, 2001, J AM ACAD DERMATOL, V44, P767, DOI 10.1067/mjd.2001.112384; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Wilson CA, 2006, TEXT RES J, V76, P216, DOI 10.1177/0040517506060907	20	15	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124758	10.1371/journal.pone.0124758	http://dx.doi.org/10.1371/journal.pone.0124758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923778	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600103
J	Robertson, DA; Savva, GM; King-Kallimanis, BL; Kenny, RA				Robertson, Deirdre A.; Savva, George M.; King-Kallimanis, Bellinda L.; Kenny, Rose Anne			Negative Perceptions of Aging and Decline in Walking Speed: A Self-Fulfilling Prophecy	PLOS ONE			English	Article							OLDER-ADULTS; GAIT SPEED; LONGITUDINAL FINDINGS; PREDICT MORTALITY; BODY-COMPOSITION; POSITIVE VIEW; HEALTH; AGE; GO; INTERVENTION	Introduction Walking speed is a meaningful marker of physical function in the aging population. While it is a primarily physical measure, experimental studies have shown that merely priming older adults with negative stereotypes about aging results in immediate declines in objective walking speed. What is not clear is whether this is a temporary experimental effect or whether negative aging stereotypes have detrimental effects on long term objective health. We sought to explore the association between baseline negative perceptions of aging in the general population and objective walking speed 2 years later. Method 4,803 participations were assessed over 2 waves of The Irish Longitudinal Study on Ageing (TILDA), a prospective, population representative study of adults aged 50+ in the Republic of Ireland. Wave 1 measures - which included the Aging Perceptions Questionnaire, walking speed and all covariates - were taken between 2009 and 2011. Wave 2 measures - which included a second measurement of walking speed and covariates - were collected 2 years later between March and December 2012. Walking speed was measured as the number of seconds to complete the Timed Up-And-Go (TUG) task. Participations with a history of stroke, Parkinson's disease or an MMSE < 18 were excluded. Results After full adjustment for all covariates (age, gender, level of education, disability, chronic conditions, medications, global cognition and baseline TUG) negative perceptions of aging at baseline were associated with slower TUG speed 2 years later (B=.03, 95%CI=.01 to 05, p<.05). Conclusions Walking speed has previously been considered to be a consequence of physical decline but these results highlight the direct role of psychological state in predicting an objective aging outcome. Negative perceptions about aging are a potentially modifiable risk factor of some elements of physical decline in aging.	[Robertson, Deirdre A.; King-Kallimanis, Bellinda L.; Kenny, Rose Anne] Univ Dublin Trinity Coll, Dept Med Gerontol, TILDA Irish Longitudinal Study Ageing, Dublin 2, Ireland; [Savva, George M.] Univ E Anglia, Sch Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Kenny, Rose Anne] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland	Trinity College Dublin; University of East Anglia; Trinity College Dublin	Robertson, DA (corresponding author), Univ Dublin Trinity Coll, Dept Med Gerontol, TILDA Irish Longitudinal Study Ageing, Dublin 2, Ireland.	droberts@tcd.ie	Robertson, Deirdre A/AAG-4990-2021; Savva, George M/E-9670-2011	Robertson, Deirdre A/0000-0002-2829-1722; Savva, George M/0000-0001-9190-124X; Kenny, Rose Anne/0000-0002-9336-8124	Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health and Atlantic Philanthropies; Irish Life	Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health and Atlantic Philanthropies; Irish Life	Funding was gratefully received from the Atlantic Philanthropies (www.atlanticphilanthropies.org), the Irish Government, the Health Research Board (www.hrb.ie). TILDA is funded by the Department of Health and Atlantic Philanthropies, along with support from Irish Life in the form of a charitable gift. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Barker M., 2007, BMC GERIATR, V7, P9, DOI [10.1186/1471-2318-7-9, DOI 10.1186/1471-2318-7-9]; Borsch-Supan Axel, 2005, Eur J Ageing, V2, P245, DOI 10.1007/s10433-005-0014-9; Buchner DM, 1996, J GERONTOL A-BIOL, V51, pM297, DOI 10.1093/gerona/51A.6.M297; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Demakakos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068632; Dugravot A, 2009, J EPIDEMIOL COMMUN H, V63, P675, DOI 10.1136/jech.2008.081281; Elbaz A, 2013, AGE, V35, P943, DOI 10.1007/s11357-012-9387-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; KESSLER RC, 1995, EPIDEMIOL REV, V17, P192, DOI 10.1093/oxfordjournals.epirev.a036176; Kotter-Gruhn D, 2009, PSYCHOL AGING, V24, P654, DOI 10.1037/a0016510; Lachman M. E., 2010, HDB PSYCHOL AGING, P175; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Levy BR, 2004, PREV MED, V39, P625, DOI 10.1016/j.ypmed.2004.02.029; Levy BR, 2002, J GERONTOL B-PSYCHOL, V57, pP409, DOI 10.1093/geronb/57.5.P409; Maurois A., 2007, AN ART OF LIVING; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Peeters GMEE, 2008, CLIN ENDOCRINOL, V69, P673, DOI 10.1111/j.1365-2265.2008.03212.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rabe-Hesketh S, 2003, STATA J, V3, P386; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sargent-Cox KA, 2014, J GERONTOL B-PSYCHOL, V69, P168, DOI 10.1093/geronb/gbt005; Sargent-Cox KA, 2012, PSYCHOL AGING, V27, P750, DOI 10.1037/a0027578; Sarkisian CA, 2007, J AM GERIATR SOC, V55, P1842, DOI 10.1111/j.1532-5415.2007.01427.x; Savva GM, 2013, J GERONTOL A-BIOL, V68, P441, DOI 10.1093/gerona/gls190; Sexton E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-44; Sneed JR, 2005, J SOC ISSUES, V61, P375, DOI 10.1111/j.1540-4560.2005.00411.x; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Stewart TL, 2012, PSYCHOL HEALTH, V27, P881, DOI 10.1080/08870446.2011.630735; Weiss D, 2013, PSYCHOL AGING, V28, P1140, DOI 10.1037/a0033811; Weiss D, 2012, PSYCHOL AGING, V27, P153, DOI 10.1037/a0024887; White DK, 2013, J GERONTOL A-BIOL, V68, P456, DOI 10.1093/gerona/gls197; Wolff JK, 2014, PSYCHOL HEALTH, V29, P915, DOI 10.1080/08870446.2014.896464; Wurm S, 2008, EUR J AGEING, V5, P117, DOI 10.1007/s10433-008-0077-5; Wurm S, 2007, J GERONTOL B-PSYCHOL, V62, pP156, DOI 10.1093/geronb/62.3.P156; Wurm S, 2014, PSYCHOL HEALTH, V29, P832, DOI 10.1080/08870446.2014.891737; Wurm S, 2010, PSYCHOL HEALTH, V25, P25, DOI 10.1080/08870440802311314	37	39	40	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123260	10.1371/journal.pone.0123260	http://dx.doi.org/10.1371/journal.pone.0123260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923334	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600037
J	Marsango, S; Caltabiano, G; Pou, C; Liste, MJV; Milligan, G				Marsango, Sara; Caltabiano, Gianluigi; Pou, Chantevy; Varela Liste, Mara Jose; Milligan, Graeme			Analysis of Human Dopamine D-3 Receptor Quaternary Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; OLIGOMERIC ORGANIZATION; OPIOID RECEPTOR; INTERFACE; COMPLEX; GPCR; DIMERIZATION; COOPERATIVITY; EXPRESSION	The dopamine D-3 receptor is a class A, rhodopsin-like G protein-coupled receptor that can form dimers and/or higher order oligomers. However, the molecular basis for production of these complexes is not well defined. Using combinations of molecular modeling, site-directed mutagenesis, and homogenous time-resolved FRET, the interfaces that allow dopamine D-3 receptor monomers to interact were defined and used to describe likely quaternary arrangements of the receptor. These were then compared with published crystal structures of dimeric beta(1)-adrenoreceptor, beta-opioid, and CXCR4 receptors. The data indicate important contributions of residues from within each of transmembrane domains I, II, IV, V, VI, and VII as well as the intracellular helix VIII in the formation of D-3-D-3 receptor interfaces within homo-oligomers and are consistent with the D-3 receptor adopting a beta(1)-adrenoreceptor-like quaternary arrangement. Specifically, results suggest that D-3 protomers can interact with each other via at least two distinct interfaces: the first one comprising residues from transmembrane domains I and II along with those from helix VIII and a second one involving transmembrane domains IV and V. Moreover, rather than existing only as distinct dimeric species, the results are consistent with the D-3 receptor also assuming a quaternary structure in which two transmembrane domain I-II-helix VIII dimers interact to form a "rhombic" tetramer via an interface involving residues from transmembrane domains VI and VII. In addition, the results also provide insights into the potential contribution of molecules of cholesterol to the overall organization and potential stability of the D-3 receptor and possibly other GPCR quaternary structures.	[Marsango, Sara; Pou, Chantevy; Varela Liste, Mara Jose; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Caltabiano, Gianluigi] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain	University of Glasgow; Autonomous University of Barcelona	Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Caltabiano, Gianluigi/F-4654-2010	Caltabiano, Gianluigi/0000-0002-2929-7069	Medical Research Council (United Kingdom) [MR/L023806/1, G0900050]; Istituto Pasteur, Fondazione Cenci-Bolognetti; European Molecular Biology Organization short term fellowship; Fundacion Pedro Barrie de la Maza; MRC [MR/L023806/1, G0900050] Funding Source: UKRI; Medical Research Council [MR/L023806/1, G0900050] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Istituto Pasteur, Fondazione Cenci-Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); European Molecular Biology Organization short term fellowship; Fundacion Pedro Barrie de la Maza; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council (United Kingdom) Grants MR/L023806/1 and G0900050 (to G. M.).; Supported by the Istituto Pasteur, Fondazione Cenci-Bolognetti.; Recipient of a European Molecular Biology Organization short term fellowship.; Supported by the Fundacion Pedro Barrie de la Maza.	[Anonymous], PYMOL MOL GRAPH SYST; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Borroto-Escuela DO, 2010, BIOCHEM BIOPH RES CO, V402, P801, DOI 10.1016/j.bbrc.2010.10.122; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Dong MQ, 2010, J BIOL CHEM, V285, P9919, DOI 10.1074/jbc.M109.089730; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Franco R, 2010, SYNAPSE, V64, P566, DOI 10.1002/syn.20775; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gonzalez A, 2012, CHEMBIOCHEM, V13, P1393, DOI 10.1002/cbic.201200189; Gorinski N, 2012, MOL PHARMACOL, V82, P448, DOI 10.1124/mol.112.079137; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hasbi A, 2014, FASEB J, V28, P4806, DOI 10.1096/fj.14-254037; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Joyce JN, 2001, SYNAPSE, V40, P137, DOI 10.1002/syn.1035; Kasai RS, 2014, CURR OPIN CELL BIOL, V27, P78, DOI 10.1016/j.ceb.2013.11.008; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Le Foll B., 2014, EUR NEUROPSYCHOPHARM, DOI [10.1016/j.euroneuro.2014.08.017, DOI 10.1016/J.EUR0NEURO.2014.08.017]; Liste MJV, 2015, MOL PHARMACOL, V87, P936, DOI 10.1124/mol.114.096925; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Maggio R, 2010, CURR OPIN PHARMACOL, V10, P100, DOI 10.1016/j.coph.2009.10.001; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Nimchinsky EA, 1997, J BIOL CHEM, V272, P29229, DOI 10.1074/jbc.272.46.29229; Oates J, 2012, BBA-BIOMEMBRANES, V1818, P2228, DOI 10.1016/j.bbamem.2012.04.010; Park PSH, 2002, BIOCHEMISTRY-US, V41, P5588, DOI 10.1021/bi011746s; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Perreault ML, 2011, CNS NEUROSCI THER, V17, P52, DOI 10.1111/j.1755-5949.2010.00228.x; Pou C, 2012, J BIOL CHEM, V287, P8864, DOI 10.1074/jbc.M111.326678; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Redka DS, 2014, J BIOL CHEM, V289, P24347, DOI 10.1074/jbc.M114.559294; Schetz J. A., 2007, HDB CONT NEUROPHARMA, P221; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tsai SJ, 2003, SCHIZOPHR RES, V63, P197, DOI 10.1016/S0920-9964(02)00436-X; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Ward RJ, 2015, J BIOL CHEM, V290, P12844, DOI 10.1074/jbc.M115.644724; Ward RJ, 2011, J BIOL CHEM, V286, P37414, DOI 10.1074/jbc.M111.287649; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Worth CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-185; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu JB, 2010, SYNAPSE, V64, P449, DOI 10.1002/syn.20748; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	55	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15146	15162		10.1074/jbc.M114.630681	http://dx.doi.org/10.1074/jbc.M114.630681			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25931118	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000356177300029
J	Zhang, YH; Laumet, G; Chen, SR; Hittelman, WN; Pan, HL				Zhang, Yuhao; Laumet, Geoffroy; Chen, Shao-Rui; Hittelman, Walter N.; Pan, Hui-Lin			Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; GENE-EXPRESSION; NERVE INJURY; HUMAN GENOME; SPINAL-CORD; HISTONE H3; CHANNELS; ACTIVATION; RECEPTOR; INTERLEUKIN-1-BETA	Pannexin-1 (Panx1) is a large-pore membrane channel involved in the release of ATP and other signaling mediators. Little is known about the expression and functional role of Panx1 in the dorsal root ganglion (DRG) in the development of chronic neuropathic pain. In this study, we determined the epigenetic mechanism involved in increased Panx1 expression in the DRG after nerve injury. Spinal nerve ligation in rats significantly increased the mRNA and protein levels of Panx1 in the DRG but not in the spinal cord. Immunocytochemical labeling showed that Panx1 was primarily expressed in a subset of medium and large DRG neurons in control rats and that nerve injury markedly increased the number of Panx1-immunoreactive DRG neurons. Nerve injury significantly increased the enrichment of two activating histone marks (H3K4me2 and H3K9ac) and decreased the occupancy of two repressive histone marks (H3K9me2 and H3K27me3) around the promoter region of Panx1 in the DRG. However, nerve injury had no effect on the DNA methylation level around the Panx1 promoter in the DRG. Furthermore, intrathecal injection of the Panx1 blockers or Panx1-specific siRNA significantly reduced pain hypersensitivity induced by nerve injury. In addition, siRNA knockdown of Panx1 expression in a DRG cell line significantly reduced caspase-1 release induced by neuronal depolarization. Our findings suggest that nerve injury increases Panx1 expression levels in the DRG through altered histone modifications. Panx1 up-regulation contributes to the development of neuropathic pain and stimulation of inflammasome signaling.	[Zhang, Yuhao; Laumet, Geoffroy; Chen, Shao-Rui; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Hittelman, Walter N.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 110, Dept Anesthesiol & Perioperat Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	zhang, yuhao/O-4356-2015; Regan, Clinton/E-6250-2012; Laumet, Geoffroy/O-7480-2019	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [R01 DE022015]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE022015. This work was also supported by the N. G. and Helen T. Hawkins Endowment (to H. L. P.).	Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bravo D, 2014, PAIN, V155, P2108, DOI 10.1016/j.pain.2014.07.024; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen MC, 2013, DERMATOL CLIN, V31, P461, DOI 10.1016/j.det.2013.04.002; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; Cunha TM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-63; Dansereau MA, 2008, J NEUROCHEM, V106, P757, DOI 10.1111/j.1471-4159.2008.05429.x; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gupta-Agarwal S, 2012, J NEUROSCI, V32, P5440, DOI 10.1523/JNEUROSCI.0147-12.2012; Hanstein R., 2012, 2012 NEUR M NEW ORL; Huang L. Y., 2012, 2012 NEUR M NEW ORL; Huang LYM, 2013, GLIA, V61, P1571, DOI 10.1002/glia.22541; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Li Q, 2013, NEUROSCIENCE, V254, P230, DOI 10.1016/j.neuroscience.2013.09.028; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Luo MC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-29; Ma C, 2005, PAIN, V113, P106, DOI 10.1016/j.pain.2004.10.001; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pan HL, 1999, J PHARMACOL EXP THER, V288, P1026; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Santiago MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025178; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shibasaki M, 2010, PAIN, V149, P514, DOI 10.1016/j.pain.2010.03.023; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Zappala A, 2006, NEUROSCIENCE, V141, P167, DOI 10.1016/j.neuroscience.2006.03.053; Zelenka M, 2005, PAIN, V116, P257, DOI 10.1016/j.pain.2005.04.018	50	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14647	14655		10.1074/jbc.M115.650218	http://dx.doi.org/10.1074/jbc.M115.650218			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25925949	Green Published, hybrid			2022-12-26	WOS:000355754600035
J	Chang, XL; Riemann, M; Liu, Q; Nick, P				Chang, Xiaoli; Riemann, Michael; Liu, Qiong; Nick, Peter			Actin as Deathly Switch? How Auxin Can Suppress Cell-Death Related Defence	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; PHOSPHATIDIC-ACID; GENE-EXPRESSION; PLANT; CYTOSKELETON; GROWTH; IMMUNITY; BINDING; GLUTATHIONYLATION; SUPERFAMILY	Plant innate immunity is composed of two layers - a basal immunity, and a specific effector-triggered immunity, which is often accompanied by hypersensitive cell death. Initiation of cell death depends on a complex network of signalling pathways. The phytohormone auxin as central regulator of plant growth and development represents an important component for the modulation of plant defence. In our previous work, we showed that cell death is heralded by detachment of actin from the membrane. Both, actin response and cell death, are triggered by the bacterial elicitor harpin in grapevine cells. In this study we investigated, whether harpin-triggered actin bundling is necessary for harpin-triggered cell death. Since actin organisation is dependent upon auxin, we used different auxins to suppress actin bundling. Extracellular alkalinisation and transcription of defence genes as the basal immunity were examined as well as cell death. Furthermore, organisation of actin was observed in response to pharmacological manipulation of reactive oxygen species and phospholipase D. We find that induction of defence genes is independent of auxin. However, auxin can suppress harpin-induced cell death and also counteract actin bundling. We integrate our findings into a model, where harpin interferes with an auxin dependent pathway that sustains dynamic cortical actin through the activity of phospholipase D. The antagonism between growth and defence is explained by mutual competition for signal molecules such as superoxide and phosphatidic acid. Perturbations of the auxin-actin pathway might be used to detect disturbed integrity of the plasma membrane and channel defence signalling towards programmed cell death.	[Chang, Xiaoli] Sichuan Agr Univ, Coll Agr, Dept Plant Pathol, Chengdu 611130, Peoples R China; [Riemann, Michael; Liu, Qiong; Nick, Peter] Univ Karlsruhe, Inst Bot, Mol Cell Biol, D-76128 Karlsruhe, Germany	Sichuan Agricultural University; Helmholtz Association; Karlsruhe Institute of Technology	Chang, XL (corresponding author), Sichuan Agr Univ, Coll Agr, Dept Plant Pathol, Chengdu 611130, Peoples R China.	xl_changkit@126.com	Liu, Qiong/AAD-5099-2019	Riemann, Michael/0000-0003-0287-2112	fellowships of the Chinese Scholarship Council; BACCHUS Interreg project	fellowships of the Chinese Scholarship Council; BACCHUS Interreg project	This work was supported by fellowships of the Chinese Scholarship Council to Xiaoli Chang for living expenses and by funds from the BACCHUS Interreg project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Campanoni P, 2005, PLANT PHYSIOL, V137, P939, DOI 10.1104/pp.104.053843; Cernadas RA, 2009, PLANT SCI, V177, P190, DOI 10.1016/j.plantsci.2009.05.006; Chang X, 2010, PLOS ONE, V6; Chang X, 2010, PLOS ONE, V7; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Crawford LE, 1996, J BIOL CHEM, V271, P26863, DOI 10.1074/jbc.271.43.26863; Deeks MJ, 2012, CURR BIOL, V22, P1595, DOI 10.1016/j.cub.2012.06.041; Deeks MJ, 2010, J CELL SCI, V123, P1209, DOI 10.1242/jcs.065557; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; Durst S, 2014, J PLANT PHYSIOL, V171, P97, DOI 10.1016/j.jplph.2013.10.007; Durst S, 2013, J PLANT PHYSIOL, V170, P1057, DOI 10.1016/j.jplph.2013.03.002; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Ferrari S, 2008, PLANT PHYSIOL, V146, P669, DOI 10.1104/pp.107.109686; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; GAFF DF, 1971, J EXP BOT, V22, P756, DOI 10.1093/jxb/22.3.756; Gopalan Suresh, 2008, BMC Res Notes, V1, P126, DOI 10.1186/1756-0500-1-126; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Guan X, 2013, J EXP BOT, V64, P1805, DOI 10.1093/jxb/ert042; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Henty-Ridilla JL, 2014, PLANT CELL, V26, P340, DOI 10.1105/tpc.113.122499; Henty-Ridilla JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003290; Hohenberger P, 2011, BBA-BIOMEMBRANES, V1808, P2304, DOI 10.1016/j.bbamem.2011.05.019; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Kortekamp A, 2006, PLANT PHYSIOL BIOCH, V44, P58, DOI 10.1016/j.plaphy.2006.01.008; KURKDJIAN A, 1989, ANNU REV PLANT PHYS, V40, P271, DOI 10.1146/annurev.pp.40.060189.001415; Lager I, 2010, PLANT CELL ENVIRON, V33, P1513, DOI 10.1111/j.1365-3040.2010.02161.x; Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056; Li JJ, 2012, PLANT CELL, V24, P3742, DOI 10.1105/tpc.112.103945; Liu Q, 2013, BBA-BIOMEMBRANES, V1828, P2111, DOI 10.1016/j.bbamem.2013.04.027; Maisch J, 2007, PLANT PHYSIOL, V143, P1695, DOI 10.1104/pp.106.094052; Moldovan L, 1999, ANTIOXID REDOX SIGN, V1, P29, DOI 10.1089/ars.1999.1.1-29; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nick P, 2000, PROTOPLASMA, V211, P234, DOI 10.1007/BF01304491; Nick P, 2010, PLANT SIGNAL BEHAV, V5, P94, DOI 10.4161/psb.5.2.10337; Nick P, 2009, PLANT PHYSIOL, V151, P155, DOI 10.1104/pp.109.140111; Qiao F, 2010, J EXP BOT, V61, P4021, DOI 10.1093/jxb/erq221; Qiao F, 2010, J EXP BOT, V61, P503, DOI 10.1093/jxb/erp319; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Savatin DV, 2011, PLANT PHYSIOL, V157, P1163, DOI 10.1104/pp.111.184663; Smertenko A, 2011, CELL DEATH DIFFER, V18, P1263, DOI 10.1038/cdd.2011.39; Smertenko A, 2014, PLANT CELL MONOGR, V22, P131, DOI 10.1007/978-3-642-41787-0_5; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Su H, 2007, J INTEGR PLANT BIOL, V49, P1183, DOI 10.1111/j.1672-9072.2007.00546.x; Tampakaki AP, 2010, ANNU REV PHYTOPATHOL, V48, P347, DOI 10.1146/annurev-phyto-073009-114407; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Waller F, 1997, PROTOPLASMA, V200, P154, DOI 10.1007/BF01283291; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Weernink PAO, 2007, N-S ARCH PHARMACOL, V374, P399, DOI 10.1007/s00210-007-0131-4; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Wu HM, 2011, PLANT CELL, V23, P1208, DOI 10.1105/tpc.111.083907; Zust T, 2011, P ROY SOC B-BIOL SCI, V278, P2598, DOI 10.1098/rspb.2010.2475	63	22	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125498	10.1371/journal.pone.0125498	http://dx.doi.org/10.1371/journal.pone.0125498			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933033	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100115
J	Chitete, L; Puoane, T				Chitete, Lusungu; Puoane, Thandi			What Health Service Provider Factors Are Associated with Low Delivery of HIV Testing to Children with Acute Malnutrition in Dowa District of Malawi?	PLOS ONE			English	Article							NUTRITION; CARE	Background The Community-based Management of Acute Malnutrition is the national program for treating acute malnutrition in Malawi. Under this program's guidelines all children enrolled should undergo an HIV test, so that those infected can receive appropriate treatment and care. However, the national data of 2012 shows a low delivery of testing. Prior studies have investigated client-related factors affecting uptake of HIV testing in Community-based Management of Acute Malnutrition program. Lacking is the information on the service provider factors that are associated with the delivery of testing. This study investigated service provider factors that affect delivery of HIV testing among children enrolled in the program and explored ways in which this could be improved. Methods A descriptive study that used qualitative methods of data collection. Client registers were reviewed to obtain the number of children enrolled in Community-based Management of Acute Malnutrition and the number of children who were tested for HIV over a 12-month period. In-depth interviews were conducted with Community-based Management of Acute Malnutrition and HIV Testing and Counselling focal persons to investigate factors affecting HIV test delivery. Descriptive statistics were used to analyze data from client registers. Information from interviews was analyzed using a thematic approach. Results Quantitative data revealed that 1738 (58%) of 2981 children enrolled in Community-based Management of Acute Malnutrition were tested for HIV. From in-depth interviews four themes emerged, that is, lack of resources for HIV tests; shortage of staff skilled in HIV testing and counseling; lack of commitment among staff in referring children for HIV testing; and inadequately trained staff. Conclusion There is a need for a functioning health system to help reduce child mortality resulting from HIV related conditions.	[Chitete, Lusungu; Puoane, Thandi] Univ Western Cape, Sch Publ Hlth, Cape Town, Western Cape Pr, South Africa	University of the Western Cape	Chitete, L (corresponding author), Univ Western Cape, Sch Publ Hlth, Cape Town, Western Cape Pr, South Africa.	Lusunguchitete@gmail.com						Annan RA, 2011, TREATMENT SEVERE ACU; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bahwere P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-106; Fergusson P, 2010, MATERN CHILD NUTR, V6, P89, DOI 10.1111/j.1740-8709.2009.00191.x; GRAMLICH LM, 1995, J NUTR BIOCHEM, V6, P2, DOI 10.1016/0955-2863(94)00001-3; Hendricks MK, 2007, MATERN CHILD NUTR, V3, P322, DOI 10.1111/j.1740-8709.2007.00116.x; Jenniskens F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1071; Lufesi NN, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-86; Makwiza I, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-13; Manongi Rachel N, 2006, Hum Resour Health, V4, P6, DOI 10.1186/1478-4491-4-6; Mccoy D, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-16; Ministry of Health, 2007, GUID PED HIV TEST CO; Ministry of Health, 2011, NAT CMAM DAT; Ministry of Health, INT GUID MAN AC MALN; National Statistical Office, 2010, DEM HLTH SURV; National Statistical Office, 2008, POP HOUS CENS; Palmer D, 2006, REPROD HEALTH MATTER, V14, P27, DOI 10.1016/S0968-8080(06)27244-6; Puoane T, 2006, Curationis, V29, P73; Thurstans S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-22; UNAIDS, 2010, GLOB REP UNAIDS REP, DOI [10.1189/jlb.0811394, DOI 10.1189/JLB.0811394]	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123021	10.1371/journal.pone.0123021	http://dx.doi.org/10.1371/journal.pone.0123021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933164	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100012
J	Hatziagelaki, E; Herder, C; Tsiavou, A; Teichert, T; Chounta, A; Nowotny, P; Pacini, G; Dimitriadis, G; Roden, M				Hatziagelaki, Erifili; Herder, Christian; Tsiavou, Anastasia; Teichert, Tom; Chounta, Athina; Nowotny, Peter; Pacini, Giovanni; Dimitriadis, George; Roden, Michael			Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; DIABETES-MELLITUS; BARIATRIC SURGERY; NATURAL-HISTORY; ADIPOSE-TISSUE; WEIGHT-LOSS; OBESITY; SENSITIVITY; STEATOHEPATITIS	The novel adipokine chemerin has been related to insulin-resistant states such as obesity and non alcoholic fatty liver disease (NAFLD). However, its association with insulin resistance and beta cell function remains controversial. The main objective was to examine whether serum chemerin levels associate with insulin sensitivity and beta cell function independently of body mass index (BMI), by studying consecutive outpatients of the hepatology clinics of a European university hospital. Individuals (n=196) with NAFLD were stratified into persons with normal glucose tolerance (NGT; n=110), impaired glucose tolerance (IGT; n=51) and type 2 diabetes (T2D; n=35) and the association between serum chemerin and measures of insulin sensitivity and beta cell function as assessed during fasting and during oral glucose tolerance test (OGTT) was measured. Our results showed that serum chemerin positively associated with BMI (P=0.0007) and C peptide during OGTT (P<0.004), but not with circulating glucose, insulin, lipids or liver enzymes (all P>0.18). No BMI independent relationships of chemerin with fasting and OGTT derived measures of insulin sensitivity were found (P>0.5). Chemerin associated positively with fasting beta cell function as well as the OGTT derived insulinogenic index IGI_cp and the adaptation index after adjustment for age, sex and BMI (P=0.002-0.007), and inversely with the insulin/C peptide ratio (P=0.007). Serum chemerin neither related to the insulinogenic index IGI_ins nor the disposition index. In conclusion, circulating chemerin is likely linked to enhanced beta cell function but not to insulin sensitivity in patients with NAFLD.	[Hatziagelaki, Erifili; Tsiavou, Anastasia; Dimitriadis, George] Univ Athens, Attikon Univ Gen Hosp, Res Inst, Dept Internal Med 2, Athens, Greece; [Hatziagelaki, Erifili; Tsiavou, Anastasia; Dimitriadis, George] Univ Athens, Attikon Univ Gen Hosp, Ctr Diabet, Athens, Greece; [Herder, Christian; Teichert, Tom; Nowotny, Peter; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Herder, Christian; Teichert, Tom; Nowotny, Peter; Roden, Michael] German Ctr Diabet Res, Partner Dusseldorf, Dusseldorf, Germany; [Chounta, Athina] Attikon Univ Gen Hosp, Dept Internal Med 4, Athens, Greece; [Pacini, Giovanni] CNR, Inst Neurosci, Metab Unit, Padua, Italy; [Roden, Michael] Univ Hosp Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany	National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; University Hospital Attikon; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University Hospital Attikon; Consiglio Nazionale delle Ricerche (CNR); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Roden, M (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	michael.roden@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019		German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science and Research of the State of North Rhine Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF); Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases (ICEMED)	German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science and Research of the State of North Rhine Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases (ICEMED)	The German Diabetes Center is funded by the German Federal Ministry of Health (Berlin, Germany) and the Ministry of Innovation, Science and Research of the State of North Rhine Westphalia (Dusseldorf, Germany). This study was supported in part by grants from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.) and from the Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases (ICEMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alfadda AA, 2012, MOL CELLS, V33, P591, DOI 10.1007/s10059-012-0012-7; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Catalan V, 2013, SURG OBES RELAT DIS, V9, P306, DOI 10.1016/j.soard.2011.11.001; Chakaroun R, 2012, METABOLISM, V61, P706, DOI 10.1016/j.metabol.2011.10.008; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034710; Docke S, 2013, EUR J ENDOCRINOL, V169, P547, DOI 10.1530/EJE-13-0112; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; El-Mesallamy HO, 2011, DIABETIC MED, V28, P1194, DOI 10.1111/j.1464-5491.2011.03353.x; Emanuel E, 2008, HEPATOLOGY, V48, P2086, DOI 10.1002/hep.22622; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Fatima SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057113; Genuth S, 2003, DIABETES CARE, V26, P3160; Jialal I, 2013, J CLIN ENDOCR METAB, V98, pE514, DOI 10.1210/jc.2012-3673; Kim SH, 2014, CLIN ENDOCRINOL, V80, P825, DOI 10.1111/cen.12249; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kralisch S, 2009, REGUL PEPTIDES, V154, P102, DOI 10.1016/j.regpep.2009.02.010; Kukla M, 2010, SCAND J GASTROENTERO, V45, P235, DOI 10.3109/00365520903443852; Landgraf K, 2012, J CLIN ENDOCR METAB, V97, pE556, DOI 10.1210/jc.2011-2937; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Lin XH, 2012, CLIN LAB, V58, P539; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Ouwens DM, 2012, ARCH PHYSIOL BIOCHEM, V118, P135, DOI 10.3109/13813455.2012.654800; Pacini G, 2003, BEST PRACT RES CL EN, V17, P305, DOI 10.1016/S1521-690X(03)00042-3; Pfau D, 2010, DIABETES CARE, V33, P171, DOI 10.2337/dc09-1351; Pinto HC, 1996, DIGEST DIS SCI, V41, P172, DOI 10.1007/BF02208601; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Ress C, 2010, EUR J CLIN INVEST, V40, P277, DOI 10.1111/j.1365-2362.2010.02255.x; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Shin HY, 2012, CLIN ENDOCRINOL, V77, P47, DOI 10.1111/j.1365-2265.2011.04217.x; Stefanov T, 2014, ENDOCRINE, V45, P382, DOI 10.1007/s12020-013-0003-2; Stepan H, 2011, REGUL PEPTIDES, V168, P69, DOI 10.1016/j.regpep.2011.03.005; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Takahashi M, 2013, ENDOCR J, V60, P37, DOI 10.1507/endocrj.EJ12-0201; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005; Yan Q, 2012, ENDOCRINE, V41, P281, DOI 10.1007/s12020-011-9550-6; Yilmaz Y, 2011, SCAND J GASTROENTERO, V46, P91, DOI 10.3109/00365521.2010.516452; Yilmaz Y, 2009, WORLD J GASTROENTERO, V15, P4346, DOI 10.3748/wjg.15.4346; Yoshimura T, 2008, J EXP MED, V205, P2187, DOI 10.1084/jem.20081736; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200	46	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124935	10.1371/journal.pone.0124935	http://dx.doi.org/10.1371/journal.pone.0124935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933030	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100066
J	Schechtman, H; Souza, MO				Schechtman, Helio; Souza, Max O.			Costly Inheritance and the Persistence of Insecticide Resistance in Aedes aegypti Populations	PLOS ONE			English	Article							LIFE TABLE MODEL; GLOBAL DISTRIBUTION; ALBOPICTUS DIPTERA; CONTROL STRATEGIES; LUCILIA-CUPRINA; SODIUM-CHANNEL; VECTOR CONTROL; FITNESS COSTS; DENGUE; CULICIDAE	Global emergence of arboviruses is a growing public health concern, since most of these diseases have no vaccine or prevention treatment available. In this scenario, vector control through the use of chemical insecticides is one of the most important prevention tools. Nevertheless, their effectiveness has been increasingly compromised by the development of strong resistance observed in field populations, even in spite of fitness costs usually associated to resistance. Using a stage-structured deterministic model parametrised for the Aedes aegypti-the main vector for dengue-we investigated the persistence of resistance by studying the time for a population which displays resistance to insecticide to revert to a susceptible population. By means of a comprehensive series of in-silico experiments, we studied this reversal time as a function of fitness costs and the initial presence of the resistance allele in the population. The resulting map provides both a guiding and a surveillance tool for public health officers to address the resistance situation of field populations. Application to field data from Brazil indicates that reversal can take, in some cases, decades even if fitness costs are not small. As by-products of this investigation, we were able to fit very simple formulas to the reversal times as a function of either cost or initial presence of the resistance allele. In addition, the in-silico experiments also showed that density dependent regulation plays an important role in the dynamics, slowing down the reversal process.	[Schechtman, Helio] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil; [Souza, Max O.] Univ Fed Fluminense, Dept Matemat Aplicada, Niteroi, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Schechtman, H (corresponding author), Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.	h.schechtman@fiocruz.br	Souza, Max/V-6908-2019; Souza, Max O/B-6399-2008; Schechtman, Helio/Q-5269-2019	Souza, Max/0000-0001-8200-1899; Souza, Max O/0000-0001-8200-1899; Schechtman, Helio/0000-0002-8753-4579	CNPq [308113/2012-8]; PRONEX Dengue, under CNPq [550030/2010-7]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX Dengue, under CNPq; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MOS was partially supported by CNPq under grant # 308113/2012-8. HS and MOS were partially supported by the PRONEX Dengue, under CNPq grant # 550030/2010-7. This work was supported by CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2; Bedhomme S, 2003, J EVOLUTION BIOL, V16, P721, DOI 10.1046/j.1420-9101.2003.00576.x; Belinato TA, 2012, MEM I OSWALDO CRUZ, V107, P916, DOI 10.1590/S0074-02762012000700013; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Castaneda LE, 2011, PHYSIOL ENTOMOL, V36, P253, DOI 10.1111/j.1365-3032.2011.00793.x; CDC, 2012, GEOGR DISTR CHIK VIR; Chan HH, 2013, J MED ENTOMOL, V50, P362, DOI 10.1603/ME12182; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Christophers, 1960, AEDES AEGYPTI L YELL; Churcher TS, 2006, J ANIM ECOL, V75, P1313, DOI 10.1111/j.1365-2656.2006.01154.x; David MR, 2012, THESIS FUNDACAO O CR; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Duerr HP, 2005, TRENDS PARASITOL, V21, P88, DOI 10.1016/j.pt.2004.11.011; Ewens WJ., 2004, MATH POPULATION GENE, V1, P1; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Garcia GdA, 2012, THESIS FUNDACAO O CR; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guillemaud T, 1998, EVOLUTION, V52, P443, DOI [10.2307/2411080, 10.1111/j.1558-5646.1998.tb01644.x]; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hoppensteadt F, 1975, REGIONAL C SERIES AP; IRAC, 2014, ARTHR PEST RES DAT; Jaramillo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096379; Juliano SA, 2007, J AM MOSQUITO CONTR, V23, P265, DOI 10.2987/8756-971X(2007)23[265:PD]2.0.CO;2; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Luz PM, 2009, EPIDEMIOL INFECT, V137, P1203, DOI 10.1017/S0950268808001799; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889; Martins AJ, 2009, AM J TROP MED HYG, V81, P108, DOI 10.4269/ajtmh.2009.81.108; MCKENZIE JA, 1980, AUST J BIOL SCI, V33, P85, DOI 10.1071/BI9800085; MCKENZIE JA, 1982, HEREDITY, V49, P1, DOI 10.1038/hdy.1982.60; Ministerio da Saude, 2006, REUN TECN DISC STAT; NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709; Norrby R, 2014, CLIN MICROBIOL INFEC, V20, P92, DOI 10.1111/1469-0691.12442; Norton HTJ, 1928, P LOND MATH SOC, V28, P1, DOI 10.1112/plms/s2-28.1.1; Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007; Oki M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001367; Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Powers AM, 2010, CLIN LAB MED, V30, P209, DOI 10.1016/j.cll.2009.10.003; Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P1, DOI 10.1079/9781845933531.0000; WHO, 2014, PEST EV SCHEM WHOPES; World Health Organization (WHO), 2014, DENG VACC RES; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040	59	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123961	10.1371/journal.pone.0123961	http://dx.doi.org/10.1371/journal.pone.0123961			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933383	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100027
J	Whitacre, DC; Espinosa, DA; Peters, CJ; Jones, JE; Tucker, AE; Peterson, DL; Zavala, FP; Milich, DR				Whitacre, David C.; Espinosa, Diego A.; Peters, Cory J.; Jones, Joyce E.; Tucker, Amy E.; Peterson, Darrell L.; Zavala, Fidel P.; Milich, David R.			P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections	PLOS ONE			English	Article							HEPATITIS-B SURFACE; PREERYTHROCYTIC MALARIA VACCINES; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE-PROTEIN; CELL RECOGNITION; EFFICACY; PROTECTION; CANDIDATE; ANTIGEN; RODENT	In order to design P. falciparum preerythrocytic vaccine candidates, a library of circumsporozoite (CS) T and B cell epitopes displayed on the woodchuck hepatitis virus core antigen (WHcAg) VLP platform was produced. To test the protective efficacy of the WHcAg-CS VLPs, hybrid CS P. berghei/P. falciparum (Pb/Pf) sporozoites were used to challenge immunized mice. VLPs carrying 1 or 2 different CS repeat B cell epitopes and 3 VLPs carrying different CS non-repeat B cell epitopes elicited high levels of anti-insert antibodies (Abs). Whereas, VLPs carrying CS repeat B cell epitopes conferred 98% protection of the liver against a 10,000 Pb/Pf sporozoite challenge, VLPs carrying the CS non-repeat B cell eptiopes were minimally-to-non-protective. One-to-three CS-specific CD4/CD8 T cell sites were also fused to VLPs, which primed CS-specific as well as WHcAg-specific T cells. However, a VLP carrying only the 3 T cell domains failed to protect against a sporozoite challenge, indicating a requirement for anti-CS repeat Abs. A VLP carrying 2 CS repeat B cell epitopes and 3 CS T cell sites in alum adjuvant elicited high titer anti-CS Abs (endpoint dilution titer >1x10(6)) and provided 80-100% protection against blood stage malaria. Using a similar strategy, VLPs were constructed carrying P. vivax CS repeat B cell epitopes (WHc-Pv-78), which elicited high levels of anti-CS Abs and conferred 99% protection of the liver against a 10,000 Pb/Pv sporozoite challenge and elicited sterile immunity to blood stage infection. These results indicate that immunization with epitope-focused VLPs carrying selected B and T cell epitopes from the P. falciparum and P. vivax CS proteins can elicit sterile immunity against blood stage malaria. Hybrid WHcAg-CS VLPs could provide the basis for a bivalent P. falciparum/P. vivax malaria vaccine.	[Whitacre, David C.; Peters, Cory J.; Jones, Joyce E.; Milich, David R.] Vaccine Res Inst San Diego, San Diego, CA 92109 USA; [Whitacre, David C.; Peters, Cory J.; Jones, Joyce E.; Tucker, Amy E.; Milich, David R.] VLP Biotech Inc, San Diego, CA USA; [Espinosa, Diego A.; Zavala, Fidel P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Peterson, Darrell L.] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Virginia Commonwealth University	Milich, DR (corresponding author), Vaccine Res Inst San Diego, San Diego, CA 92109 USA.	dmilich@vlp-biotech.com	milich, david/W-6493-2019; Espinosa, Diego/AAT-6950-2020	Espinosa, Diego A./0000-0002-4364-5031; Whitacre, David/0000-0003-3803-9157	Malaria Research Institute; NIH-NIAID [R01AI44375, RO1AI082740]; Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044375, R01AI082740] Funding Source: NIH RePORTER	Malaria Research Institute; NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DAE received a pre-doctoral fellowship from the Malaria Research Institute (http://malaria.jhsph.edu/). DAE and FPZ thank the Bloomberg Family Foundation (http://www.bloomberg.org/) for continued support. Research is funded in part by NIH-NIAID grants R01AI44375 to FPZ and RO1AI082740 to DRM DLP FPZ. VLP Biotech, Inc provided support in the form of salaries for authors DCW, JEJ, AET and DRM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; ALEY SB, 1986, J EXP MED, V164, P1915, DOI 10.1084/jem.164.6.1915; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALPER CA, 1995, EXP CLIN IMMUNOGENET, V12, P171; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Betancourt AA, 2007, INT J INFECT DIS, V11, P394, DOI 10.1016/j.ijid.2006.09.010; Billaud JN, 2007, VACCINE, V25, P1593, DOI 10.1016/j.vaccine.2006.11.013; Billaud JN, 2005, J VIROL, V79, P13656, DOI 10.1128/JVI.79.21.13656-13666.2005; Birkett A, 2002, INFECT IMMUN, V70, P6860, DOI 10.1128/IAI.70.12.6860-6870.2002; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; CALLE JMC, 1992, J IMMUNOL, V149, P2695; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; David Whitacre, 2015, VIRAL NANOTECHNOLOGY, P536; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Espinosa DA, 2013, INFECT IMMUN, V81, P2882, DOI 10.1128/IAI.00461-13; GOOD MF, 1986, J EXP MED, V164, P655, DOI 10.1084/jem.164.2.655; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; HOFFNAGLE JH, 1973, LANCET, V2, P869; Kaba SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048304; Kastenmuller K, 2013, INFECT IMMUN, V81, P789, DOI 10.1128/IAI.01108-12; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lee BO, 2009, J IMMUNOL, V182, P6670, DOI 10.4049/jimmunol.0803683; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Milich DR, 2001, VACCINE, V20, P771, DOI 10.1016/S0264-410X(01)00400-5; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Porter MD, 2013, CLIN VACCINE IMMUNOL, V20, P803, DOI 10.1128/CVI.00066-13; Przysiecki C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00146; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; SCHODEL F, 1994, J EXP MED, V180, P1037, DOI 10.1084/jem.180.3.1037; Schodel F, 1997, BEHRING I MITT, V98, P114; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Walther M, 2005, VACCINE, V23, P857, DOI 10.1016/j.vaccine.2004.08.020; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; WHITE K, 1993, VACCINE, V11, P1341, DOI 10.1016/0264-410X(93)90105-7; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	48	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124856	10.1371/journal.pone.0124856	http://dx.doi.org/10.1371/journal.pone.0124856			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933001	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100059
J	Chen, Z; Yu, GR; Ge, JP; Wang, QF; Zhu, XJ; Xu, ZW				Chen, Zhi; Yu, Guirui; Ge, Jianping; Wang, Qiufeng; Zhu, Xianjin; Xu, Zhiwei			Roles of Climate, Vegetation and Soil in Regulating the Spatial Variations in Ecosystem Carbon Dioxide Fluxes in the Northern Hemisphere	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; TERRESTRIAL ECOSYSTEMS; LONG-TERM; INTERANNUAL VARIABILITY; FOREST ECOSYSTEMS; WATER-VAPOR; EXCHANGE; RESPIRATION; PATTERNS; ENERGY	Climate, vegetation, and soil characteristics play important roles in regulating the spatial variation in carbon dioxide fluxes, but their relative influence is still uncertain. In this study, we compiled data from 241 eddy covariance flux sites in the Northern Hemisphere and used Classification and Regression Trees and Redundancy Analysis to assess how climate, vegetation, and soil affect the spatial variations in three carbon dioxide fluxes (annual gross primary production (AGPP), annual ecosystem respiration (ARE), and annual net ecosystem production (ANEP)). Our results showed that the spatial variations in AGPP, ARE, and ANEP were significantly related to the climate and vegetation factors (correlation coefficients, R = 0.22 to 0.69, P < 0.01) while they were not related to the soil factors (R = -0.11 to 0.14, P > 0.05) in the Northern Hemisphere. The climate and vegetation together explained 60% and 58% of the spatial variations in AGPP and ARE, respectively. Climate factors (mean annual temperature and precipitation) could account for 45-47 % of the spatial variations in AGPP and ARE, but the climate constraint on the vegetation index explained approximately 75 %. Our findings suggest that climate factors affect the spatial variations in AGPP and ARE mainly by regulating vegetation properties, while soil factors exert a minor effect. To more accurately assess global carbon balance and predict ecosystem responses to climate change, these discrepant roles of climate, vegetation, and soil are required to be fully considered in the future land surface models. Moreover, our results showed that climate and vegetation factors failed to capture the spatial variation in ANEP and suggest that to reveal the underlying mechanism for variation in ANEP, taking into account the effects of other factors (such as climate change and disturbances) is necessary.	[Chen, Zhi; Yu, Guirui; Wang, Qiufeng; Zhu, Xianjin; Xu, Zhiwei] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observ & Modeling, Chinese Ecosyst Res Network,Synth Res Ctr, Beijing, Peoples R China; [Chen, Zhi; Xu, Zhiwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ge, Jianping] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Normal University	Yu, GR (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observ & Modeling, Chinese Ecosyst Res Network,Synth Res Ctr, Beijing, Peoples R China.	yugr@igsnrr.ac.cn	Zhu, XianJin/B-2779-2009; wang, qiufeng/C-1654-2013; 于, 贵瑞/C-1768-2014	Zhu, XianJin/0000-0002-5662-3472; 于, 贵瑞/0000-0002-1859-8966	International Cooperation and Exchange Program of National Natural Science Foundation of China [31420103917]; Key Program of National Natural Science Foundation of China [31290221]; Chinese Academy of Sciences Strategic Priority Research Program [XDA05050602]	International Cooperation and Exchange Program of National Natural Science Foundation of China; Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Strategic Priority Research Program	This research was funded by the International Cooperation and Exchange Program of National Natural Science Foundation of China (grant no. 31420103917), the Key Program of National Natural Science Foundation of China (grant no. 31290221), and the Chinese Academy of Sciences Strategic Priority Research Program (grant no. XDA05050602). The authors declare that no additional external funding was received in support of this study. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Arneth A, 2002, TELLUS B, V54, P514, DOI 10.1034/j.1600-0889.2002.01349.x; Aubinet M, 2005, BOUND-LAY METEOROL, V116, P63, DOI 10.1007/s10546-004-7091-8; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Baldocchi D, 2014, GLOBAL CHANGE BIOL, V20, P3600, DOI 10.1111/gcb.12649; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Chen Z, 2013, AGR FOREST METEOROL, V182, P266, DOI 10.1016/j.agrformet.2013.04.026; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; Finnigan JJ, 2003, BOUND-LAY METEOROL, V107, P1, DOI 10.1023/A:1021554900225; Gilmanov TG, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002023; Gough CM, 2004, FOREST ECOL MANAG, V191, P353, DOI 10.1016/j.foreco.2004.01.011; Hirata R, 2008, AGR FOREST METEOROL, V148, P761, DOI 10.1016/j.agrformet.2007.11.016; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jung M, 2009, BIOGEOSCIENCES, V6, P2001, DOI 10.5194/bg-6-2001-2009; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Kato T, 2008, GLOBAL CHANGE BIOL, V14, P2333, DOI 10.1111/j.1365-2486.2008.01646.x; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LIETH H, 1973, HUM ECOL, V1, P303, DOI 10.1007/BF01536729; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Massman WJ, 2000, AGR FOREST METEOROL, V104, P185, DOI 10.1016/S0168-1923(00)00164-7; Massman WJ, 2002, AGR FOREST METEOROL, V113, P121, DOI 10.1016/S0168-1923(02)00105-3; Matsuura Y, 2007, P 7 INT C GLOB CHANG, V312, P258; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Oksanen J., 2015, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; PASTOR J, 1993, CLIMATIC CHANGE, V23, P111, DOI 10.1007/BF01097332; Piao SL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037381; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; PRENTICE KC, 1990, J GEOPHYS RES-ATMOS, V95, P11811, DOI 10.1029/JD095iD08p11811; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027880; Rodeghiero M, 2005, GLOBAL CHANGE BIOL, V11, P1024, DOI 10.1111/j.1365-2486.2005.00963.x; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Sun J, 2013, BIOGEOSCIENCES, V10, P1707, DOI 10.5194/bg-10-1707-2013; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WOFSY SC, 2002, N AM CARBON PROGRAM, P1; Xia JZ, 2014, REMOTE SENS-BASEL, V6, P1783, DOI 10.3390/rs6031783; Yi CX, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034007; Yu GR, 2013, GLOBAL CHANGE BIOL, V19, P798, DOI 10.1111/gcb.12079; Yu GR, 2010, ENVIRON SCI TECHNOL, V44, P6074, DOI 10.1021/es100979s; Yuan WP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5270; Yuan WP, 2009, GLOBAL CHANGE BIOL, V15, P2905, DOI 10.1111/j.1365-2486.2009.01870.x; Zheng ZM, 2010, ENVIRON MANAGE, V46, P633, DOI 10.1007/s00267-010-9509-z; Zhou XH, 2009, ECOSYSTEMS, V12, P1369, DOI 10.1007/s10021-009-9296-7; 王兴昌, 2008, [中国科学. D辑, 地球科学, Science in China. Series D, Earth Sciences], V38, P1092	56	26	29	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125265	10.1371/journal.pone.0125265	http://dx.doi.org/10.1371/journal.pone.0125265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928452	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100075
J	Sekiguchi, H; Shimamoto, K; Sekiguchi, N; Ozaki, Y; Shimizu, K; Takahashi, Y; Sakai, A; Tatsumi, F; Ishizuka, N; Kawana, M				Sekiguchi, Haruki; Shimamoto, Ken; Sekiguchi, Naoki; Ozaki, Yuri; Shimizu, Kaoru; Takahashi, Yufuko; Sakai, Akiko; Tatsumi, Fujio; Ishizuka, Naoko; Kawana, Masatoshi			Gender Differences in Predictors of Left Ventricular Myocardial Relaxation in Non-Obese, Healthy Individuals	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; METABOLIC RISK-FACTORS; HEART-FAILURE; DIASTOLIC FUNCTION; FILLING PRESSURES; DYSFUNCTION; COMMUNITY; OBESITY; AGE; ASSOCIATION	Background Previous studies indicate that individuals with metabolic syndrome (MetS) might be at risk for left ventricular (LV) diastolic dysfunction. However, little is known about which metabolic factors contribute to the development of LV dysfunction in individuals who are not obese or overweight and who do not have diabetes mellitus and/or cardiovascular disease. Methods Participants without diabetes mellitus, systolic dysfunction, or other heart diseases underwent a thorough physical examination, including tissue Doppler echocardiography. A peak early mitral annular velocity (e') of <5.0 was designated as indicating abnormal LV myocardial relaxation (LVMR). We performed single and multiple logistic regression analyses of e' and cardiovascular risk factors, including MetS factors and indicators of major organ dysfunction. Normal-weight subjects (body mass index <25 kg/m(2)) were also analyzed. Results A total of 1055 individuals (mean age, 63 +/- 13 years) participated, of which 307 (29.1%) had MetS and 199 (18.9%) had abnormal LVMR. Multiple logistic regression analysis revealed waist circumference (WC) (odds ratio [OR] 1.04, P < 0.05) and age (OR 1.10, P < 0.05) to be predictors of abnormal LVMR. In normal-weight subjects (n = 806), aging (OR 1.08, P < 0.01), abnormalWC (OR 3.80, P < 0.01), and renal dysfunction (OR 2.14, P < 0.01) were predictors of abnormal LVMR. Among MetS factors, abnormal WC in men (OR 3.70, P < 0.01) and high diastolic blood pressure (DBP) in women (OR 4.00, P = 0.01) were related to abnormal LVMR.	[Sekiguchi, Haruki; Shimamoto, Ken; Sekiguchi, Naoki; Ozaki, Yuri; Shimizu, Kaoru; Takahashi, Yufuko; Sakai, Akiko; Tatsumi, Fujio; Ishizuka, Naoko; Kawana, Masatoshi] Tokyo Womens Med Univ, Aoyama Hosp, Dept Cardiol, Tokyo, Japan; [Sekiguchi, Haruki; Shimamoto, Ken; Ozaki, Yuri; Shimizu, Kaoru; Takahashi, Yufuko; Sakai, Akiko; Tatsumi, Fujio; Ishizuka, Naoko; Kawana, Masatoshi] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Sekiguchi, Haruki] Natl Hosp Org Yokohama Med Ctr, Dept Cardiol, Kanagawa, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Kawana, M (corresponding author), Tokyo Womens Med Univ, Aoyama Hosp, Dept Cardiol, Tokyo, Japan.	kawana.masatoshi@twmu.ac.jp						Ammar KA, 2007, CIRCULATION, V115, P1563, DOI 10.1161/CIRCULATIONAHA.106.666818; [Anonymous], 2005, NIHON NAIKA GAKKAI Z, V94, P794; Bahrami H, 2008, J AM COLL CARDIOL, V51, P1775, DOI 10.1016/j.jacc.2007.12.048; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Burchfiel CM, 2005, CIRCULATION, V112, P819, DOI 10.1161/CIRCULATIONAHA.104.518498; Canepa M, 2012, AM J CARDIOL, V109, P1171, DOI 10.1016/j.amjcard.2011.11.054; CaulinGlaser T, 1997, CIRC RES, V81, P885; Chinali M, 2004, AM J CARDIOL, V93, P40, DOI 10.1016/j.amjcard.2003.09.009; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; de las Fuentes L, 2007, EUR HEART J, V28, P553, DOI 10.1093/eurheartj/ehl526; de Simone G, 2002, J HYPERTENS, V20, P323, DOI 10.1097/00004872-200202000-00024; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kaku K, 2011, J AM SOC ECHOCARDIOG, V24, P541, DOI 10.1016/j.echo.2011.01.011; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lam CSP, 2011, CIRCULATION, V124, P24, DOI 10.1161/CIRCULATIONAHA.110.979203; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Ommen SR, 2000, CIRCULATION, V102, P1788; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; REIS SE, 1994, CIRCULATION, V89, P52, DOI 10.1161/01.CIR.89.1.52; Russo C, 2011, J AM COLL CARDIOL, V57, P1368, DOI 10.1016/j.jacc.2010.10.042; Turkbey EB, 2010, JACC-CARDIOVASC IMAG, V3, P266, DOI 10.1016/j.jcmg.2009.10.012; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Villari B, 1997, J AM COLL CARDIOL, V29, P181, DOI 10.1016/S0735-1097(96)00440-8; Zabalgoitia M, 1998, AM J CARDIOL, V82, P604, DOI 10.1016/S0002-9149(98)00404-4; Zimmet P., 2005, DIABETES VOICE, V50, P31	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125107	10.1371/journal.pone.0125107	http://dx.doi.org/10.1371/journal.pone.0125107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927927	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100068
J	Ying, H; Qin, A; Cheng, TS; Pavlos, NJ; Rea, S; Dai, KR; Zheng, MH				Ying, Hua; Qin, An; Cheng, Tak S.; Pavlos, Nathan J.; Rea, Sarah; Dai, Kerong; Zheng, Ming H.			Disulfiram Attenuates Osteoclast Differentiation In Vitro: A Potential Antiresorptive Agent	PLOS ONE			English	Article							NF-KAPPA-B; BONE-RESORPTION; PYRROLIDINE DITHIOCARBAMATE; H+-ATPASE; MECHANISMS; PROTEASOME; INDUCTION; COMPLEX; FUSION; ACIDIFICATION	Disulfiram (DSF), a cysteine modifying compound, has long been clinically employed for the treatment of alcohol addiction. Mechanistically, DSF acts as a modulator of MAPK and NF-kappa B pathways signaling pathways. While these pathways are crucial for osteoclast (OC) differentiation, the potential influence of DSF on OC formation and function has not been directly assessed. Here, we explore the pharmacological effects of DSF on OC differentiation, activity and the modulation of osteoclastogenic signaling cascades. We first analyzed cytotoxicity of DSF on bone marrow monocytes isolated from C57BL/6J mice. Upon the establishment of optimal dosage, we conducted osteoclastogenesis and bone resorption assays in the presence or absence of DSF treatment. Luciferase assays in RAW264.7 cells were used to examine the effects of DSF on major transcription factors activation. Western blot, reverse transcription polymerase chain reaction, intracellular acidification and proton influx assays were employed to further dissect the underlying mechanism. DSF treatment dose-dependently inhibited both mouse and human osteoclastogenesis, especially at early stages of differentiation. This inhibition correlated with a decrease in the expression of key osteoclastic marker genes including CtsK, TRAP, DC-STAMP and Atp6v0d2 as well as a reduction in bone resorption in vitro. Suppression of OC differentiation was found to be due, at least in part, to the blockade of several key receptor activators of nuclear factor kappa-B ligand (RANKL)-signaling pathways including ERK, NF-kappa B and NFATc1. On the other hand, DSF failed to suppress intracellular acidification and proton influx in mouse and human osteoclasts using acridine orange quenching and microsome-based proton transport assays. Our findings indicate that DSF attenuates OC differentiation via the collective suppression of several key RANKL-mediated signaling cascades, thus making it an attractive agent for the treatment of OC-mediated disorders.	[Ying, Hua; Qin, An; Cheng, Tak S.; Pavlos, Nathan J.; Zheng, Ming H.] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Perth, WA 6009, Australia; [Qin, An; Dai, Kerong] Shanghai Jiao Tong Univ, Sch Med, Ninth Peoples Hosp, Dept Orthopaed, Shanghai 200030, Peoples R China; [Rea, Sarah] Harry Perkins Inst Med Res, Perth, WA, Australia; [Rea, Sarah] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia	University of Western Australia; Shanghai Jiao Tong University; Harry Perkins Institute of Medical Research; University of Western Australia	Dai, KR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ninth Peoples Hosp, Dept Orthopaed, Shanghai 200030, Peoples R China.	krdai@sibs.ac.cn; minghao.zheng@uwa.edu.au	YING, HUA/AAT-6663-2021; Rea, Sarah/GYJ-4753-2022	Zheng, Minghao/0000-0003-1185-4768; Pavlos, Nathan/0000-0001-7003-188X; Rea, Sarah Lyn/0000-0002-2181-9491; /0000-0002-2151-3433	National Health and Medical Research Council, Australia [APP572670]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study is supported by grant APP572670 issued to MHZ from National Health and Medical Research Council, Australia. MHZ analyzed the data and contributed to the writing of the manuscript [http://www.nhmrc.gov.au/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2001, J BIOL CHEM, V276, P30499, DOI 10.1074/jbc.M104725200; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Ang ESM, 2007, J CELL PHYSIOL, V212, P787, DOI 10.1002/jcp.21076; BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Chen D, 2005, FRONT BIOSCI-LANDMRK, V10, P2932, DOI 10.2741/1749; Chen JS, 2012, NAT REV ENDOCRINOL, V8, P81, DOI 10.1038/nrendo.2011.146; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DAVID P, 1994, J BIOL CHEM, V269, P30158; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; FULLER RK, 1986, JAMA-J AM MED ASSOC, V256, P1449, DOI 10.1001/jama.256.11.1449; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Guo XX, 2010, CANCER LETT, V290, P104, DOI 10.1016/j.canlet.2009.09.002; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kim I, 2004, EXP CELL RES, V298, P229, DOI 10.1016/j.yexcr.2004.04.017; KITSON TM, 1977, J STUD ALCOHOL, V38, P96, DOI 10.15288/jsa.1977.38.96; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Mittal M, 2014, TOXICOL SCI; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ng PY, 2013, J BONE MINER RES, V28, P119, DOI 10.1002/jbmr.1725; PERIS P, 1994, J BONE MINER RES, V9, P1607; Qin A, 2012, INT J BIOCH CELL BIO; Qin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034132; Qin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027155; Rea SL, 2006, J BONE MINER RES, V21, P1136, DOI 10.1359/JBMR.060405; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sorensen MG, 2007, J BONE MINER RES, V22, P1640, DOI 10.1359/JBMR.070613; Suh JJ, 2006, J CLIN PSYCHOPHARM, V26, P290, DOI 10.1097/01.jcp.0000222512.25649.08; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Xu J, J BONE MINERAL, P2178; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	44	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125696	10.1371/journal.pone.0125696	http://dx.doi.org/10.1371/journal.pone.0125696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928135	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100111
J	Hao, YX; Gao, JM; Zhang, XH; Liu, N; Li, JS; Zheng, LS; Duan, ZJ				Hao, Yexia; Gao, Jimin; Zhang, Xiaohong; Liu, Na; Li, Jinsong; Zheng, Lishu; Duan, Zhaojun			Seroepidemiology of Human Bocaviruses 1 and 2 in China	PLOS ONE			English	Article							REAL-TIME PCR; VIRUS-LIKE PARTICLES; HUMAN PARVOVIRUS; HIGH PREVALENCE; INFECTION; CHILDREN; ASSAYS; ANTIBODIES; DIAGNOSIS; B19	Seroepidemiology studies had been used to research the newly discovered human boca-viruses (HBoVs). Antibodies against the HBoV1-4 VP2 protein virus-like particles (VLPs) were found to be cross-reactive. The aim of the present study was to characterize the seroprevalence of HBoV1 and 2 among healthy populations in China. Recombinant HBoV1 and 2 VLPs were used to establish enzyme-linked immunosorbent assays (ELISAs) for detection of cross-reactivity between HBoV1 and HBoV2 in 1391 serum samples collected from healthy individuals in China. Of these, 884 samples were collected from Beijing and 507 were from Nanjing. Infection with HBoV1 and 2 was prevalent in healthy Chinese people, with the seroprevalence of HBoV1 and 2 in Beijing at 69.2 (612/884) and 64.4% (569/884), respectively. Highest seroprevalence was observed in 3-5-year-olds. The seroprevalence of HBoV1 was significantly decreased between 10-13-year-olds (80.3%) and 14-20-yearolds (62.3%, p<0.05). For individuals over 20 years, seroprevalence was relatively constant at about 60%. Similar trends were observed in children from Nanjing, with seroprevalence of HBoV1 and 2 for healthy children at 80.7% (409/507) and 81.3% (412/507), respectively. Moreover, both mouse and human antibodies against HBoV1 and HBoV2 VLPs were found to be cross-reactive and 58.4% (813/1391) serum samples were seropositive for both HBoV1 and HBoV2. This finding suggests HBoV is highly prevalent in China and the antibodies produced as a result of infection with either HBoV1 or HBoV 2 will offer future protection. The cross-reactivity between HBoVs is crucial for accurately determining HBoV seroepidemiology.	[Hao, Yexia; Liu, Na; Li, Jinsong; Zheng, Lishu; Duan, Zhaojun] China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China; [Hao, Yexia; Gao, Jimin] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiaohong] Natl Inst Sport Med, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Wenzhou Medical University	Zheng, LS (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China.	zhenglishu2006@aliyun.com; zhaojund@126.com	Zhang, Hao/HHM-1940-2022		State Megaproject for Infectious Diseases Research of China [2013ZX10004-001]	State Megaproject for Infectious Diseases Research of China	This study was funded from the State Megaproject for Infectious Diseases Research of China (2013ZX10004-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2006, EMERG INFECT DIS, V12, P848, DOI 10.3201/eid1205.051424; Bastien N, 2007, J CLIN MICROBIOL, V45, P610, DOI 10.1128/JCM.01044-06; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Cecchini S, 2009, CLIN VACCINE IMMUNOL, V16, P597, DOI 10.1128/CVI.00470-08; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Choi JH, 2008, J CLIN VIROL, V42, P249, DOI 10.1016/j.jcv.2008.02.010; Don M, 2010, PEDIATR PULM, V45, P120, DOI 10.1002/ppul.21151; Endo R, 2007, J CLIN MICROBIOL, V45, P3218, DOI 10.1128/JCM.02140-06; Guido M, 2012, CLIN MICROBIOL INFEC, V18, pE74, DOI 10.1111/j.1469-0691.2011.03756.x; Guo LN, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-636; Hedman L, 2010, J CLIN VIROL, V48, P44, DOI 10.1016/j.jcv.2010.02.003; Hustedt JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038206; Jin Y, 2011, J CLIN VIROL, V52, P251, DOI 10.1016/j.jcv.2011.07.012; Kahn JS, 2008, J INFECT DIS, V198, P41, DOI 10.1086/588674; Kantola K, 2008, CLIN INFECT DIS, V46, P540, DOI 10.1086/526532; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kantola K, 2010, J CLIN MICROBIOL, V48, P4044, DOI 10.1128/JCM.00686-10; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kelly HA, 2000, EPIDEMIOL INFECT, V124, P449, DOI 10.1017/S0950268899003817; Korppi M, 2010, PEDIATR INFECT DIS J, V29, P387, DOI 10.1097/INF.0b013e3181ce8e81; Lin F, 2008, J VIROL METHODS, V149, P110, DOI 10.1016/j.jviromet.2007.12.016; Lindner J, 2008, VIRAL IMMUNOL, V21, P443, DOI 10.1089/vim.2008.0045; Lindner J, 2008, J INFECT DIS, V198, P1677, DOI 10.1086/592985; Lu XY, 2006, J CLIN MICROBIOL, V44, P3231, DOI 10.1128/JCM.00889-06; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Neske F, 2007, J CLIN MICROBIOL, V45, P2116, DOI 10.1128/JCM.00027-07; Neske F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-215; Regamey N, 2007, PEDIATR INFECT DIS J, V26, P177, DOI 10.1097/01.inf.0000250623.43107.bc; Schildgen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068020; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Smith-Whitley K, 2004, BLOOD, V103, P422, DOI 10.1182/blood-2003-01-0069; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Zhao LQ, 2009, CHINESE MED J-PEKING, V122, P1289, DOI 10.3760/cma.j.issn.0366-6999.2009.11.010	41	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122751	10.1371/journal.pone.0122751	http://dx.doi.org/10.1371/journal.pone.0122751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923974	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600021
J	Li, X; Peng, MK; Li, Y; Kang, Z; Hao, YH; Sun, H; Gao, LJ; Jiao, ML; Wu, QH; Quan, HD				Li, Xia; Peng, Mingkai; Li, Yuan; Kang, Zheng; Hao, Yanhua; Sun, Hong; Gao, Lijun; Jiao, Mingli; Wu, Qunhong; Quan, Hude			Chinese Herbal Therapy and Western Drug Use, Belief and Adherence for Hypertension Management in the Rural Areas of Heilongjiang Province, China	PLOS ONE			English	Article							ALTERNATIVE MEDICINE USE; RHEUMATIC-DISEASES; BLOOD-PRESSURE; PREVALENCE; KNOWLEDGE; AWARENESS; VALIDITY; EQ-5D	Background Traditional Chinese medicine (TCM) including Chinese herbal therapy has been widely practiced in China. However, little is known about Chinese herbal therapy use for hypertension management, which is one of the most prevalent chronic conditions in China. Thus we described Chinese herbal therapy and western drug users, beliefs, hypertension knowledge, and Chinese herbal and western drug adherence and determinants of Chinese herbal therapy use among patients with hypertension in rural areas of Heilongjiang Province, China. Methodology and Principal Findings This face-to-face cross sectional survey included 665 hypertensive respondents aged 30 years or older in rural areas of Heilongjiang Province, China. Of 665 respondents, 39.7% were male, 27.4% were aged 65 years or older. At the survey, 14.0% reported using Chinese herbal therapy and 71.3% reported using western drug for hypertension management. A majority of patients had low level of treatment adherence (80.6% for the Chinese herbal therapy users and 81.2% for the western drug users). When respondents felt that their blood pressure was under control, 72.0% of the Chinese herbal therapy users and 69.2% of the western drug users sometimes stopped taking their medicine. Hypertensive patients with high education level or better quality of life are more likely use Chinese herbal therapy. Conclusions and Significance Majority of patients diagnosed with hypertension use western drugs to control blood pressure. Chinese herbal therapy use was associated with education level and quality of life.	[Li, Xia; Li, Yuan; Kang, Zheng; Hao, Yanhua; Sun, Hong; Gao, Lijun; Jiao, Mingli; Wu, Qunhong; Quan, Hude] Harbin Med Univ, Sch Publ Hlth, Dept Social Med, Harbin, Peoples R China; [Peng, Mingkai; Quan, Hude] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Li, Xia] Harbin Med Univ, Coll Pharm, Harbin, Peoples R China	Harbin Medical University; University of Calgary; Harbin Medical University	Wu, QH (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Social Med, Harbin, Peoples R China.	wuqunhong@163.com	hao, yan/HGB-0465-2022	Quan, Hude/0000-0002-7848-7256	China Medical Board [08-929]; key program National Natural Science Foundation of China [71333003]; Fund of Heilongjiang Province Education Department [12511316]; Heilongjiang Postdoctoral fund [LBH-Z14175]	China Medical Board; key program National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Heilongjiang Province Education Department; Heilongjiang Postdoctoral fund	This study was funded by China Medical Board grant (Grant No. 08-929), the key program National Natural Science Foundation of China (Grant No. 71333003), Fund of Heilongjiang Province Education Department (Grant No. 12511316) and Heilongjiang Postdoctoral fund (Grant No. LBH-Z14175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CARDIOVASCULAR DIS R; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Burstein HJ, 1999, NEW ENGL J MED, V340, P1733, DOI 10.1056/NEJM199906033402206; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chou P, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P191; Cunningham CT, 2014, ETHNIC DIS, V24, P276; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Fang YY, 2001, CHINESE J INFORM TRA, V8, P1; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Hilsden RJ, 2011, INFLAMM BOWEL DIS, V17, P655, DOI 10.1002/ibd.21360; Hoeymans N, 2005, QUAL LIFE RES, V14, P655, DOI 10.1007/s11136-004-1214-z; Kim MH, 2005, QUAL LIFE RES, V14, P1401, DOI 10.1007/s11136-004-5681-z; King KM, 2011, J ADV NURS, V67, P2267, DOI 10.1111/j.1365-2648.2011.05679.x; Lam TP, 2001, J EPIDEMIOL COMMUN H, V55, P762, DOI 10.1136/jech.55.10.762; Liao CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/387164; Luo N, 2003, ANN ACAD MED SINGAP, V32, P685; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Makridakis S, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000048; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Quan H, 2007, CAN J CARDIOL, V23, P635, DOI 10.1016/S0828-282X(07)70225-8; Quan HD, 2008, CAN FAM PHYSICIAN, V54, P1563; Sanne S, 2008, ETHNIC DIS, V18, P42; Shi NN, 2013, J ALTERN COMPLEM MED, V19, P1, DOI 10.1089/acm.2011.0776; Tan Jie, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P897; Verhoef Marja J, 2005, Integr Cancer Ther, V4, P274, DOI 10.1177/1534735405282361; Wang HX, 2008, CHINESE ARCH TRADITI, V26, P338; Wang LD, 2005, COMPREHENSIVE REPORT; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Yang TY, 2012, PHYTOTHER RES, V26, P291, DOI 10.1002/ptr.3548; Zhang JJ, 2002, SOC SCI MED, V55, P1795, DOI 10.1016/S0277-9536(01)00311-2; Zhao YK, 2005, CHINESE HLTH SERVICE, P504; Zhong GW, 2011, CHIN J INTEGR MED, V17, P414, DOI 10.1007/s11655-011-0761-6	32	3	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123508	10.1371/journal.pone.0123508	http://dx.doi.org/10.1371/journal.pone.0123508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923438	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600050
J	Sahlin, E; Sirotkina, M; Marnerides, A; Iwarsson, E; Papadogiannakis, N				Sahlin, Ellika; Sirotkina, Meeli; Marnerides, Andreas; Iwarsson, Erik; Papadogiannakis, Nikos			Fetal Calcifications Are Associated with Chromosomal Abnormalities	PLOS ONE			English	Article							HEPATIC CALCIFICATIONS; PRENATAL-DIAGNOSIS; LIVER CALCIFICATIONS; HYPERECHOGENICITIES; FOCI	Objective The biological importance of calcifications occasionally noted in fetal tissues (mainly liver) at autopsy or ultrasound is largely unexplored. Previous reports hint at an association to infection, circulatory compromise, malformations or chromosomal abnormalities. To identify factors associated with calcifications, we have performed a case-control study on the largest cohort of fetuses with calcifications described thus far. Methods One-hundred and fifty-one fetuses with calcifications and 302 matched controls were selected from the archives of the Department of Pathology, Karolinska University Hospital. Chromosome analysis by karyotyping or quantitative fluorescence-polymerase chain reaction was performed. Autopsy and placenta reports were scrutinized for presence of malformations and signs of infection. Results Calcifications were mainly located in the liver, but also in heart, bowel, and other tissues. Fetuses with calcifications showed a significantly higher proportion of chromosomal abnormalities than controls; 50% vs. 20%(p<0.001). The most frequent aberrations among cases included trisomy 21 (33%), trisomy 18 (22%), and monosomy X (18%). A similar distribution was seen among controls. When comparing cases and controls with chromosomal abnormalities, the cases had a significantly higher prevalence of malformations (95% vs. 77%, p=0.004). Analyzed the other way around, cases with malformations had a significantly higher proportion of chromosomal abnormalities compared with controls, (66% vs. 31%, p<0.001). Conclusion The presence of fetal calcifications is associated with high risk of chromosomal abnormality in combination with malformations. Identification of a calcification together with a malformation at autopsy more than doubles the probability of detecting a chromosomal abnormality, compared with identification of a malformation only. We propose that identification of a fetal tissue calcification at autopsy, and potentially also at ultrasound examination, should infer special attention towards co-existence of malformations, as this would be a strong indicator for a chromosomal abnormality.	[Sahlin, Ellika; Iwarsson, Erik] Karolinska Univ Hosp, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Sahlin, Ellika; Iwarsson, Erik] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Sirotkina, Meeli; Marnerides, Andreas; Papadogiannakis, Nikos] Karolinska Univ Hosp, Ctr Perinatal Pathol, Huddinge, Sweden; [Sirotkina, Meeli; Marnerides, Andreas; Papadogiannakis, Nikos] Karolinska Univ Hosp, Dept Pathol, Huddinge, Sweden; [Sirotkina, Meeli; Marnerides, Andreas; Papadogiannakis, Nikos] Karolinska Inst, S-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Sahlin, E (corresponding author), Karolinska Univ Hosp, Dept Mol Med & Surg, CMM L8 02, S-17176 Stockholm, Sweden.	ellika.sahlin@ki.se	Iwarsson, Erik/J-4677-2019	Iwarsson, Erik/0000-0002-3827-0263	Department of Pathology, Karolinska University Hospital; Department of Center for Molecular Medicine, Karolinska University Hospital	Department of Pathology, Karolinska University Hospital; Department of Center for Molecular Medicine, Karolinska University Hospital	The authors are grateful for the financial support with grants from the Departments of Pathology and Center for Molecular Medicine, Karolinska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron R, 1996, ULTRASOUND OBST GYN, V7, P251, DOI 10.1046/j.1469-0705.1996.07040251.x; AVNI EF, 1994, PEDIATR RADIOL, V24, P569, DOI 10.1007/BF02012734; BRONSHTEIN M, 1995, OBSTET GYNECOL, V86, P739, DOI 10.1016/0029-7844(95)00278-Y; Donaghue C, 2003, PRENATAL DIAG, V23, P201, DOI 10.1002/pd.569; HAWASS ND, 1990, PEDIATR RADIOL, V20, P528, DOI 10.1007/BF02011383; Kidron D, 2012, VIRCHOWS ARCH, V460, P399, DOI 10.1007/s00428-012-1214-2; KOGUTT MS, 1991, AM J ROENTGENOL, V156, P634, DOI 10.2214/ajr.156.3.1899768; Koopman E, 1998, PRENATAL DIAG, V18, P339; Kovacs Christopher S, 2011, Curr Osteoporos Rep, V9, P274, DOI 10.1007/s11914-011-0073-0; Mann K, 2004, EUR J HUM GENET, V12, P907, DOI 10.1038/sj.ejhg.5201224; NGUYEN DL, 1986, AM J ROENTGENOL, V147, P596, DOI 10.2214/ajr.147.3.596; Pata O, 2012, J TURK-GER GYNECOL A, V13, P67, DOI 10.5152/jtgga.2011.66; ROBERTS DJ, 1992, HUM PATHOL, V23, P1130, DOI 10.1016/0046-8177(92)90031-W; SATGE D, 1994, PRENATAL DIAG, V14, P303, DOI 10.1002/pd.1970140411; Simchen MJ, 2002, AM J OBSTET GYNECOL, V187, P1617, DOI 10.1067/mob.2002.127899; Slotnick RN, 1996, LANCET, V347, P85, DOI 10.1016/S0140-6736(96)90210-X; STEIN B, 1995, RADIOLOGY, V197, P489, DOI 10.1148/radiology.197.2.7480699; Suzumori N, 2010, CURR MED CHEM, V17, P3431, DOI 10.2174/092986710793176302; Tennstedt C, 2000, PRENATAL DIAG, V20, P287, DOI 10.1002/(SICI)1097-0223(200004)20:4<287::AID-PD802>3.0.CO;2-K; YAMASHITA Y, 1989, ACTA PAEDIATR SCAND, V78, P965, DOI 10.1111/j.1651-2227.1989.tb11187.x	20	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123343	10.1371/journal.pone.0123343	http://dx.doi.org/10.1371/journal.pone.0123343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923652	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600040
J	Thys, A; Vandenberghe, P; Hague, P; Klein, OD; Erneux, C; Vanderwinden, JM				Thys, An; Vandenberghe, Pierre; Hague, Perrine; Klein, Ophir D.; Erneux, Christophe; Vanderwinden, Jean-Marie			Hyperplasia of Interstitial Cells of Cajal in Sprouty Homolog 4 Deficient Mice	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE KIT; C-KIT; CONSTITUTIVE ACTIVATION; SIGNALING PATHWAYS; GENE-EXPRESSION; SMALL-INTESTINE; ORIGIN; MODEL; MECHANISMS	Gastrointestinal stromal tumors, which are thought to derive from interstitial cells of Cajal or their precursors, often harbor an oncogenic mutation of the KIT receptor tyrosine kinase. Sprouty homolog 4, a known negative regulator of ERK pathway, has been identified in the interstitial cells of Cajal in the Kit(K641E) murine model of gastrointestinal stromal tumors. Sprouty homolog 4 was upregulated both at the mRNA and protein level in these cells, suggesting that Sprouty homolog 4 is downstream of oncogenic KIT activation and potentially engaged in the negative feedback loop of ERK activation in this model. Here, we used Kit(K641E) heterozygous and Sprouty homolog 4 knock out animals to quantify interstitial cells of Cajal in situ, using quantitative immunofluorescence for the receptor tyrosine kinase Kit and for phosphodiesterase 3a (PDE3A). In the antrum of Sprouty homolog 4 knock out mice, hyperplasia of interstitial cells of Cajal was reminiscent of the Kit(K641E) heterozygous mice antrum. Additionally, the density of interstitial cells of Cajal was higher in the colon of adult Sprouty homolog 4 knock out mice than in WT littermates, although hyperplasia seemed more severe in Kit(K641E) heterozygous mice. Functional transit studies also show similarities between Sprouty homolog 4 knock out and Kit(K641E) heterozygous mice, as the total transit time in 9 month old animals was significantly increased in both genotypes compared to WT littermates. We concluded that the lack of Sprouty homolog 4 expression leads to hyperplasia of the interstitial cells of Cajal and is functionally associated with a delayed transit time.	[Thys, An; Vandenberghe, Pierre; Hague, Perrine; Vanderwinden, Jean-Marie] Univ Libre Bruxelles, Fac Med, Neurophysiol Lab, Brussels, Belgium; [Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Erneux, Christophe] Univ Libre Bruxelles, Fac Med, IRIBHM, Brussels, Belgium	Universite Libre de Bruxelles; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universite Libre de Bruxelles	Vanderwinden, JM (corresponding author), Univ Libre Bruxelles, Fac Med, Neurophysiol Lab, Brussels, Belgium.	jmvdwin@ulb.ac.be		Thys, An/0000-0002-6838-312X; Klein, Ophir/0000-0002-6254-7082	Fonds National de la Recherche Scientifique Medicale (Belgium) [7.4552.10, 7.4557.12F]; Fonds National de la Recherche Scientifique Medicale [PDR T.0004.13]; Fondation Rose et Jean Hoguet [2014-20145]	Fonds National de la Recherche Scientifique Medicale (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fondation Rose et Jean Hoguet	This work is supported the Fonds National de la Recherche Scientifique Medicale (Belgium) http://www.fnrs.be/, Televie grants no 7.4552.10 and 7.4557.12F to JMV & CE, Fonds National de la Recherche Scientifique Medicale (PDR T.0004.13) to CE and Fondation Rose et Jean Hoguet http://www.fondation-hoguet.be/, fellowship 2014-20145 to AT. The funders had no role in study design, data collection and analys, decision to publish, or preparation of the manuscript.	Ali S, 2007, GENE, V401, P38, DOI 10.1016/j.gene.2007.06.017; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Baik SH, 2007, SURG TODAY, V37, P455, DOI 10.1007/s00595-006-3424-1; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Bellier S, 2005, AM J PHYSIOL-GASTR L, V288, pG151, DOI 10.1152/ajpgi.00048.2004; Beltran Marcelo A, 2007, Int J Surg, V5, P183, DOI 10.1016/j.ijsu.2006.05.006; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Deneubourg L, 2011, CELL SIGNAL, V23, P1857, DOI 10.1016/j.cellsig.2011.06.023; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Frolov A, 2003, MOL CANCER THER, V2, P699; Gromova P, 2009, J CELL MOL MED, V13, P1536, DOI 10.1111/j.1582-4934.2009.00768.x; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hirota S, 2006, PATHOL INT, V56, P1, DOI 10.1111/j.1440-1827.2006.01924.x; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; IEMURA A, 1994, AM J PATHOL, V144, P321; Isozaki K, 2000, AM J PATHOL, V157, P1581, DOI 10.1016/S0002-9440(10)64795-5; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Kitamura Y, 2008, J GASTROENTEROL, V43, P499, DOI 10.1007/s00535-008-2200-y; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kluppel M, 1998, DEV DYNAM, V211, P60; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Ledda F, 2007, BIOMARK INSIGHTS, V2, P45; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Linnekin D, 1999, INT J BIOCHEM CELL B, V31, P1053, DOI 10.1016/S1357-2725(99)00078-3; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; Manouras A, 2009, ACTA GASTRO-ENT BELG, V72, P257; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; OKA H, 1995, CANCER RES, V55, P4182; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Renouf DJ, 2009, CLIN CANCER RES, V15, P3908, DOI 10.1158/1078-0432.CCR-08-1622; Rios-Moreno MJ, 2011, ANTICANCER RES, V31, P3019; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Rumessen JJ, 2003, INT REV CYTOL, V229, P115, DOI 10.1016/S0074-7696(03)29004-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Swaminathan M, 2010, HUM PATHOL, V41, P1097, DOI 10.1016/j.humpath.2009.12.012; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Taniguchi K, 2009, CANCER SCI, V100, P1648, DOI 10.1111/j.1349-7006.2009.01214.x; Thomsen L, 1998, NAT MED, V4, P848, DOI 10.1038/nm0798-848; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Vanderwinden JM, 2000, CELL TISSUE RES, V302, P145, DOI 10.1007/s004410000264; Vanderwinden JM, 2006, CELL SIGNAL, V18, P661, DOI 10.1016/j.cellsig.2005.06.008; Ward SM, 1995, AM J PHYSIOL-CELL PH, V269, pC1577, DOI 10.1152/ajpcell.1995.269.6.C1577; Wu JJ, 2000, J NEUROSCI RES, V59, P384, DOI 10.1002/(SICI)1097-4547(20000201)59:3<384::AID-JNR13>3.0.CO;2-4; Yang J, 2012, INT J CANCER, V130, P959, DOI 10.1002/ijc.26095; Yang Xiaolin, 2013, Evid Based Complement Alternat Med, V2013, P926928, DOI 10.1155/2013/926928; Young HM, 1999, MICROSC RES TECHNIQ, V47, P303, DOI 10.1002/(SICI)1097-0029(19991201)47:5<303::AID-JEMT1>3.0.CO;2-T; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	58	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124861	10.1371/journal.pone.0124861	http://dx.doi.org/10.1371/journal.pone.0124861			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923139	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600107
J	Vargas-Sanchez, GB; Romero-Valdovinos, M; Ramirez-Guerrero, C; Vargas-Hernandez, I; Ramirez-Miranda, ME; Martinez-Ocana, J; Valadez, A; Ximenez, C; Lopez-Escamilla, E; Hernandez-Campos, ME; Villalobos, G; Martinez-Hernandez, F; Maravilla, P				Vargas-Sanchez, Gie-Bele; Romero-Valdovinos, Mirza; Ramirez-Guerrero, Celedonio; Vargas-Hernandez, Ines; Elena Ramirez-Miranda, Maria; Martinez-Ocana, Joel; Valadez, Alicia; Ximenez, Cecilia; Lopez-Escamilla, Eduardo; Elena Hernandez-Campos, Maria; Villalobos, Guiehdani; Martinez-Hernandez, Fernando; Maravilla, Pablo			Blastocystis Isolates from Patients with Irritable Bowel Syndrome and from Asymptomatic Carriers Exhibit Similar Parasitological Loads, but Significantly Different Generation Times and Genetic Variability across Multiple Subtypes	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; INTESTINAL PARASITES; SEQUENCE ALIGNMENT; PREVALENCE; EVOLUTION; HOMINIS; INDIVIDUALS; CULTIVATION; MICROBIOTA; PHYLOGENY	Blastocystis spp is a common intestinal parasite of humans and animals that has been associated to the etiology of irritable bowel syndrome (IBS); however, some studies have not found this association. Furthermore, many biological features of Blastocystis are little known. The objective of present study was to assess the generation times of Blastocystis cultures, from IBS patients and from asymptomatic carriers. A total of 100 isolates were obtained from 50 IBS patients and from 50 asymptomatic carriers. Up to 50 mg of feces from each participant were cultured in Barret's and in Pavlova's media during 48 h. Initial and final parasitological load were measured by microscopy and by quantitative PCR. Amplicons were purified, sequenced and submitted to GenBank; sequences were analysed for genetic diversity and a Bayesian inference allowed identifying genetic subtypes (ST). Generation times for Blastocystis isolates in both media, based on microscopic measures and molecular assays, were calculated. The clinical symptoms of IBS patients and distribution of Blastocystis ST 1, 2 and 3 in both groups was comparable to previous reports. Interestingly, the group of cases showed scarce mean nucleotide diversity (pi) as compared to the control group (0.011 +/- 0.016 and 0.118 +/- 0.177, respectively), whilst high gene flow and small genetic differentiation indexes between different ST were found. Besides, Tajima's D test showed negative values for ST1-ST3. No statistical differences regarding parasitological load between cases and controls in both media, as searched by microscopy and by qPCR, were detected except that parasites grew faster in Barret's than in Pavlova's medium. Interestingly, slow growth of isolates recovered from cases in comparison to those of controls was observed (p<0.05). We propose that generation times of Blastocystis might be easily affected by intestinal environmental changes due to IBS probably because virulent strains with slow growth may be selected, reducing their genetic variability.	[Vargas-Sanchez, Gie-Bele; Elena Hernandez-Campos, Maria] Inst Politecn Nacl, Escuela Super Med, Mexico City 11340, DF, Mexico; [Romero-Valdovinos, Mirza; Elena Ramirez-Miranda, Maria; Martinez-Ocana, Joel; Lopez-Escamilla, Eduardo; Martinez-Hernandez, Fernando; Maravilla, Pablo] Hosp Gen Dr Manuel Gea Gonzalez, Mexico City 14080, DF, Mexico; [Ramirez-Guerrero, Celedonio] Hosp Infantil Mexico Dr Federico Gomez, Mexico City 06720, DF, Mexico; [Valadez, Alicia; Ximenez, Cecilia] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Villalobos, Guiehdani] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Instituto Politecnico Nacional - Mexico; Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Maravilla, P (corresponding author), Hosp Gen Dr Manuel Gea Gonzalez, Calzada Tlalpan 4800,Secc XVI, Mexico City 14080, DF, Mexico.	maravillap@yahoo.com	Martínez-Ocaña, Joel/AGB-4819-2022; Hernandez-Campos, Maria Elena/R-3852-2018	Martínez-Ocaña, Joel/0000-0002-2189-749X; Hernandez-Campos, Maria Elena/0000-0002-1439-523X; Maravilla, Pablo/0000-0003-2534-9447; XIMENEZ, CECILIA/0000-0003-0574-4538	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [182089, 168619]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was sponsored by Consejo Nacional de Ciencia y Tecnologia (CONACYT) grant numbers 182089 and 168619.	Adam RD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-424; Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; BARRET Harvey P., 1921, Annals of Tropical Medicine and Parasitology, V15, P113; Bedi B, 2015, J EUKARYOT MICROBIOL, V62, P44, DOI 10.1111/jeu.12164; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Doeschl-Wilson AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007508; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; DuPont HL, 2014, ALIMENT PHARM THER, V39, P1033, DOI 10.1111/apt.12728; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ramirez-Miranda ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-96; Jimenez-Gonzalez DE, 2012, PARASITOL RES, V110, P1269, DOI 10.1007/s00436-011-2626-7; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Giacometti A, 2003, J PARASITOL, V89, P490, DOI 10.1645/0022-3395(2003)089[0490:POIPAI]2.0.CO;2; Gomez C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/726045; Gonzalez-Bosquet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014522; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hyland NP, 2014, WORLD J GASTROENTERO, V20, P8859, DOI 10.3748/wjg.v20.i27.8859; Irikov OA, 2009, B EXP BIOL MED+, V148, P99, DOI 10.1007/s10517-009-0651-7; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Krogsgaard LR, 2015, CLIN GASTROENTEROL H, V13, P507, DOI 10.1016/j.cgh.2014.07.065; Leelayoova S, 2002, ANN TROP MED PARASIT, V96, P803, DOI 10.1179/000349802125002275; Little TJ, 2008, PARASITOLOGY, V135, P303, DOI 10.1017/S0031182007003939; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mertz HR, 2003, NEW ENGL J MED, V349, P2136, DOI 10.1056/NEJMra035579; Olivo-Diaz A, 2012, PARASITOL RES, V111, P487, DOI 10.1007/s00436-012-2830-0; Pavlova E. A., 1938, Medical Parasitology and Parasitic Diseases Moscow, V7, P224; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; QADRI SMH, 1989, J CLIN MICROBIOL, V27, P2407, DOI 10.1128/JCM.27.11.2407-2409.1989; Ragavan ND, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-404; Ramirez-Miranda M E, 2011, Rev Gastroenterol Mex, V76, P309; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Aguillon F, 2013, J INFECT DEV COUNTR, V7, P763, DOI 10.3855/jidc.3512; Santos HJ, 2013, ASIAN PAC J TROP MED, V6, P780, DOI 10.1016/S1995-7645(13)60138-8; Scanlan PD, 2013, TRENDS PARASITOL, V29, P523, DOI 10.1016/j.pt.2013.08.006; Sistrom M, 2014, GENOME BIOL EVOL, V6, P2811, DOI 10.1093/gbe/evu222; Stensvold CR, 2009, EPIDEMIOL INFECT, V137, P1655, DOI 10.1017/S0950268809002672; Stensvold CR, 2012, INFECT GENET EVOL, V12, P263, DOI 10.1016/j.meegid.2011.11.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Termmathurapoj S, 2004, PARASITOL RES, V93, P445, DOI 10.1007/s00436-004-1157-x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Tomasini N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103131; Tovy A, 2010, FUTURE MICROBIOL, V5, P1875, DOI 10.2217/FMB.10.140; Villalobos G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0461-2; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Yakoob J, 2004, AM J TROP MED HYG, V70, P383, DOI 10.4269/ajtmh.2004.70.383; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x; Zerpa LR, 2000, REV MEX PATOL CLIN, V47, P17; Zhang X, 2012, INT J INFECT DIS, V16, pE23, DOI 10.1016/j.ijid.2011.09.012	62	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124006	10.1371/journal.pone.0124006	http://dx.doi.org/10.1371/journal.pone.0124006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923708	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600066
J	Jiang, L; Ge, M; Zhao, H; Zhang, TF				Jiang, Lu; Ge, Min; Zhao, Han; Zhang, Tifu			Analysis of Heterosis and Quantitative Trait Loci for Kernel Shape Related Traits Using Triple Testcross Population in Maize	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; BIOMASS-RELATED TRAITS; GRAIN-YIELD; TEMPERATE MAIZE; GENETIC-BASIS; QTL DETECTION; MAPPING QTLS; MAJOR QTL; COMPONENTS; PHOSPHORUS	Kernel shape related traits (KSRTs) have been shown to have important influences on grain yield. The previous studies that emphasize kernel length (KL) and kernel width (KW) lack a comprehensive evaluation of characters affecting kernel shape. In this study, materials of the basic generations (B73, Mo17, and B73 x Mo17), 82 intermated B73 x Mo17 (IBM) individuals, and the corresponding triple testcross (TTC) populations were used to evaluate heterosis, investigate correlations, and characterize the quantitative trait loci (QTL) for six KSRTs: KL, KW, length to width ratio (LWR), perimeter length (PL), kernel area (KA), and circularity (CS). The results showed that the mid-parent heterosis (MPH) for most of the KSRTs was moderate. The performance of KL, KW, PL, and KA exhibited significant positive correlation with heterozygosity but their Pearson's R values were low. Among KSRTs, the strongest significant correlation was found between PL and KA with R values was up to 0.964. In addition, KW, PL, KA, and CS were shown to be significant positive correlation with 100-kernel weight (HKW). 28 QTLs were detected for KSRTs in which nine were augmented additive, 13 were augmented dominant, and six were dominance x additive epistatic. The contribution of a single QTL to total phenotypic variation ranged from 2.1% to 32.9%. Furthermore, 19 additive x additive digenic epistatic interactions were detected for all KSRTs with the highest total R-2 for KW(78.8%), and nine dominance x dominance digenic epistatic interactions detected for KL, LWR, and CS with the highest total R-2 (55.3%). Among significant digenic interactions, most occurred between genomic regions not mapped with main-effect QTLs. These findings display the complexity of the genetic basis for KSRTs and enhance our understanding on heterosis of KSRTs from the quantitative genetic perspective.	[Jiang, Lu; Ge, Min; Zhao, Han; Zhang, Tifu] Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China; [Jiang, Lu] Univ Nottingham, Sch Biosci, Loughborough, Notts, England	Jiangsu Academy of Agricultural Sciences; University of Nottingham	Zhang, TF (corresponding author), Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China.	zhangtifu@jaas.ac.cn			NSFC [31301391]; Jiangsu Natural Science Foundation [BK2012375]; Jiangsu Agriculture Science and Technology Innovation Fund [CX(12)5020, CX(14)5055]	NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Agriculture Science and Technology Innovation Fund	This work was supported by the NSFC (No. 31301391; http://www.nsfc.gov.cn/), Jiangsu Natural Science Foundation (No. BK2012375), and Jiangsu Agriculture Science and Technology Innovation Fund (No. CX(12)5020 and No. CX(14)5055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger DK, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-60; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; East EM, 1936, GENETICS, V21, P375; Eghball B, 1999, SOIL SCI SOC AM J, V63, P895, DOI 10.2136/sssaj1999.634895x; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; GALLAIS A, 1993, AGRONOMIE, V13, P723, DOI 10.1051/agro:19930805; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Guo TT, 2014, THEOR APPL GENET, V127, P2149, DOI 10.1007/s00122-014-2368-x; Han YP, 2012, THEOR APPL GENET, V125, P671, DOI 10.1007/s00122-012-1859-x; HARBERD NP, 1989, GENETICS, V121, P827; Hirel B, 2001, PLANT PHYSIOL, V125, P1258, DOI 10.1104/pp.125.3.1258; JANSEN RC, 1994, GENETICS, V136, P1447; KEARSEY MJ, 1968, HEREDITY, V23, P403, DOI 10.1038/hdy.1968.52; Kusterer B, 2007, GENETICS, V177, P1839, DOI 10.1534/genetics.107.077628; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Li LZ, 2013, J GENET, V92, P529, DOI 10.1007/s12041-013-0311-6; Li L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003202; Li M, 2010, PLANT SCI, V178, P454, DOI 10.1016/j.plantsci.2010.02.019; Li YL, 2007, THEOR APPL GENET, V115, P129, DOI 10.1007/s00122-007-0549-6; Li YL, 2009, EUPHYTICA, V169, P273, DOI 10.1007/s10681-009-9966-8; Liu XH, 2010, MAYDICA, V55, P127; Liu Y, 2014, THEOR APPL GENET, V127, P1019, DOI 10.1007/s00122-014-2276-0; Ma XQ, 2007, MOL BREEDING, V20, P41, DOI 10.1007/s11032-006-9071-9; Mansfield BD, 2014, CROP SCI, V54, P157, DOI 10.2135/cropsci2013.04.0252; Melchinger AE, 2007, GENETICS, V177, P1815, DOI 10.1534/genetics.107.077537; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Peng B, 2013, THEOR APPL GENET, V126, P773, DOI 10.1007/s00122-012-2017-1; Peng B, 2011, THEOR APPL GENET, V122, P1305, DOI 10.1007/s00122-011-1532-9; Qi HH, 2013, THEOR APPL GENET, V126, P369, DOI 10.1007/s00122-012-1985-5; Qiu XJ, 2012, THEOR APPL GENET, V125, P1717, DOI 10.1007/s00122-012-1948-x; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Revilla P, 1999, CROP SCI, V39, P654, DOI 10.2135/cropsci1999.0011183X003900020007x; Sangoi L., 2001, Ciencia Rural, V31, P159, DOI 10.1590/S0103-84782001000100027; SHULL G.H., 1908, J HERED, V4, P296; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Tanabata T, 2012, PLANT PHYSIOL, V160, P1871, DOI 10.1104/pp.112.205120; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Tao YF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-162; Tollenaar M, 1999, CROP SCI, V39, P1597, DOI 10.2135/cropsci1999.3961597x; Wan XY, 2008, GENETICS, V179, P2239, DOI 10.1534/genetics.108.089862; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Williams K, 2014, CROP SCI, V54, P98, DOI 10.2135/cropsci2012.10.0609; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xu Y, 2011, THEOR APPL GENET, V122, P581, DOI 10.1007/s00122-010-1471-x; Yan JB, 2006, EUPHYTICA, V149, P121, DOI 10.1007/s10681-005-9060-9; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang GD, 2013, THEOR APPL GENET, V126, P1545, DOI 10.1007/s00122-013-2072-2; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089645	57	22	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124779	10.1371/journal.pone.0124779	http://dx.doi.org/10.1371/journal.pone.0124779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919458	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400061
J	Singhal, N; Srivastava, A; Kumar, M; Virdi, JS				Singhal, Neelja; Srivastava, Abhishikha; Kumar, Manish; Virdi, Jugsharan Singh			Structural Variabilities in beta-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for beta-Lactam Antibiotic and beta-Lactamase Inhibitor Susceptibilities	PLOS ONE			English	Article								Yersiniosis caused by Yersinia enterocolitica has been reported from all continents. The bacterial species is divided into more than fifty serovars and six biovars viz. 1A, 1B, 2, 3, 4 and 5 which differ in geographical distribution, ecological niches and pathogenicity. Most Y. enterocolitica strains harbor chromosomal genes for two beta-lactamases, blaA an Ambler class A penicillinase and blaB an Ambler class C inducible cephalosporinase. In the present study, susceptibility to b-lactam antibiotics and beta-lactamase inhibitor was studied for Y. enterocolitica strains of biovars 1A, 1B, 2 and 4. We observed that beta-lactamases were expressed differentially among strains of different biovars. To understand the molecular mechanisms underlying such differential expression, the sequences of genes and promoters of blaA were compared. Also, the variants of blaA present in different biovars were modeled and docked with amoxicillin and clavulanic acid. The mRNA secondary structures of blaA variants were also predicted in-silico. Our findings indicated that neither variations in the promoter regions, nor the secondary structures of mRNA contributed to higher/lower expression of blaA in different biovars. Analysis of H-bonding residues of blaA variants with amoxicillin and clavulanic acid revealed that if amino acid residues of a beta-lactamase interacting with amoxicillin and the clavulanic acid were similar, clavulanic acid was effective in engaging the enzyme, accounting for a significant reduction in MIC of amoxicillin-clavulanate. This finding might aid in designing better beta-lactamase inhibitors with improved efficiencies in future.	[Singhal, Neelja; Virdi, Jugsharan Singh] Univ Delhi, Dept Microbiol, New Delhi, India; [Srivastava, Abhishikha; Kumar, Manish] Univ Delhi, Dept Biophys, New Delhi, India	University of Delhi; University of Delhi	Virdi, JS (corresponding author), Univ Delhi, Dept Microbiol, South Campus,Benito Juarez Rd, New Delhi, India.	virdi_dusc@rediffmail.com	Singhal, Neelja/AAD-2505-2022; Kumar, Manish/AGP-1250-2022; Virdi, Jugsharan Singh/L-8241-2015	Kumar, Manish/0000-0002-7936-9892; Virdi, Jugsharan Singh/0000-0002-6282-0018	UGC; Indian Council of Medical Research [AMR/17/2011-ECD-1]; DU-DST-PURSE grant; UGC-Special Assistance Programme (DRS-I)	UGC(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); DU-DST-PURSE grant; UGC-Special Assistance Programme (DRS-I)	Funding: Neelja Singhal is supported by UGC-Dr. D. S. Kothari Postdoctoral Fellowship. Abhishikha Srivastava was supported by Indian Council of Medical Research grant (Grant no. AMR/17/2011-ECD-1). The project was supported by Indian Council of Medical Research grant (Grant no. AMR/17/2011-ECD-1), DU-DST-PURSE grant and the UGC-Special Assistance Programme (DRS-I) to the Department of Microbiology, University of Delhi South Campus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner A, 2007, INT J FOOD MICROBIOL, V115, P110, DOI 10.1016/j.ijfoodmicro.2006.10.008; Bent ZW, 2010, ANTIMICROB AGENTS CH, V54, P4000, DOI 10.1128/AAC.01754-09; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Bradford Patricia A., 2001, Curr Infect Dis Rep, V3, P13, DOI 10.1007/s11908-001-0054-z; Clinical and Laboratory Standards Institute, 2010, M100S20 CLINLAB STAN; Dhara L, 2014, INT J ANTIMICROB AG, V43, P518, DOI 10.1016/j.ijantimicag.2014.03.002; Fournier B, 1999, ANTIMICROB AGENTS CH, V43, P850, DOI 10.1128/AAC.43.4.850; Kumar KM, 2014, J BIOMOL STRUCT DYN, V32, P1953, DOI 10.1080/07391102.2013.847804; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Neelja Singhal, 2014, Scientific Reports, V4, P05270; PHAM JN, 1991, J ANTIMICROB CHEMOTH, V28, P19, DOI 10.1093/jac/28.1.19; Sarovich Derek S, 2012, Infect Drug Resist, V5, P129, DOI 10.2147/IDR.S35529; Sharma S, 2006, FEMS MICROBIOL LETT, V257, P319, DOI 10.1111/j.1574-6968.2006.00191.x; Yi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037585	16	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123564	10.1371/journal.pone.0123564	http://dx.doi.org/10.1371/journal.pone.0123564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919756	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400030
J	Conley, AC; Marquez, J; Parsons, MW; Fulham, WR; Heathcote, A; Karayanidis, F				Conley, Alexander C.; Marquez, Jodie; Parsons, Mark W.; Fulham, W. Ross; Heathcote, Andrew; Karayanidis, Frini			Anodal tDCS over the Motor Cortex on Prepared and Unprepared Responses in Young Adults	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; NONINVASIVE BRAIN-STIMULATION; EXCITABILITY; TASK; POLARIZATION; INHIBITION; MODULATION; HANDEDNESS	Anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) has been proposed as a possible therapeutic rehabilitation technique for motor impairment. However, despite extensive investigation into the effects of anodal tDCS on motor output, there is little information on how anodal tDCS affects response processes. In this study, we used a cued go/nogo task with both directional and non-directional cues to assess the effects of anodal tDCS over the dominant (left) primary motor cortex on prepared and unprepared motor responses. Three experiments explored whether the effectiveness of tDCS varied with timing between stimulation and test. Healthy, right-handed young adults participated in a double-blind randomised controlled design with crossover of anodal tDCS and sham stimulation. In Experiment 1, twenty-four healthy young adults received anodal tDCS over dominant M1 at least 40 mins before task performance. In Experiment 2, eight participants received anodal tDCS directly before task performance. In Experiment 3, twenty participants received anodal tDCS during task performance. In all three experiments, participants responded faster to directional compared to non-directional cues and with their right hand. However, anodal tDCS had no effect on go/nogo task performance at any stimulation - test interval. Bayesian analysis confirmed that anodal stimulation had no effect on response speed. We conclude that anodal tDCS over M1 does not improve response speed of prepared or unprepared responses of young adults in a go/nogo task.	[Conley, Alexander C.; Fulham, W. Ross; Heathcote, Andrew; Karayanidis, Frini] Univ Newcastle, Sch Psychol, Funct Neuroimaging Lab, Newcastle, NSW 2300, Australia; [Conley, Alexander C.; Marquez, Jodie; Parsons, Mark W.; Fulham, W. Ross; Heathcote, Andrew; Karayanidis, Frini] Univ Newcastle, Prior Res Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Conley, Alexander C.; Marquez, Jodie; Parsons, Mark W.; Fulham, W. Ross; Heathcote, Andrew; Karayanidis, Frini] Hunter Med Res Inst, Newcastle, NSW, Australia; [Marquez, Jodie] Univ Newcastle, Sch Hlth Sci, Newcastle, NSW 2300, Australia; [Parsons, Mark W.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle	Karayanidis, F (corresponding author), Univ Newcastle, Sch Psychol, Funct Neuroimaging Lab, Newcastle, NSW 2300, Australia.	Frini.karayanidis@newcastle.edu.au	Karayanidis, Frini/I-9269-2012; Heathcote, Andrew/C-1856-2008; marquez, jodie L/G-8105-2013; Conley, Alexander Christian/O-1700-2019	Karayanidis, Frini/0000-0002-3317-9954; Heathcote, Andrew/0000-0003-4324-5537; marquez, jodie L/0000-0002-9845-5788; Conley, Alexander Christian/0000-0003-1159-5524	University of Newcastle Post-Graduate Research Scholarship [3092298]	University of Newcastle Post-Graduate Research Scholarship	This work was funded by a University of Newcastle Post-Graduate Research Scholarship for ACC (Reference No. 3092298).	Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Bortoletto M, 2015, BRAIN STIMUL, V8, P269, DOI 10.1016/j.brs.2014.11.006; Miranda PC, 2013, NEUROIMAGE, V70, P48, DOI 10.1016/j.neuroimage.2012.12.034; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; Gomes-Osman J, 2013, J MOTOR BEHAV, V45, P361, DOI 10.1080/00222895.2013.808604; Hayduk-Costa G, 2013, BEHAV BRAIN RES, V257, P208, DOI 10.1016/j.bbr.2013.09.030; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; Jeffreys H, 1961, THE THEORY OF PROBAB; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kwon YH, 2013, J PHYS THER SCI, V25, P1083, DOI 10.1589/jpts.25.1083; Leite J., 2011, PLOS ONE, V6; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; Miniussi C, 2013, NEUROSCI BIOBEHAV R, V37, P1702, DOI 10.1016/j.neubiorev.2013.06.014; Miyaguchi S, 2013, BRAIN RES, V1529, P83, DOI 10.1016/j.brainres.2013.07.026; Morey R. D., 2013, BAYESFACTOR COMPUTAT; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellicciari MC, 2013, NEUROIMAGE, V83, P569, DOI 10.1016/j.neuroimage.2013.06.076; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Schmidt SL, 2000, BRAIN COGNITION, V44, P445, DOI 10.1006/brcg.1999.1204; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vines BW, 2008, EUR J NEUROSCI, V28, P1667, DOI 10.1111/j.1460-9568.2008.06459.x; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Wechsler D., 1997, WECHSLER ADULT INTEL; Zimerman M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00149	35	9	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124509	10.1371/journal.pone.0124509	http://dx.doi.org/10.1371/journal.pone.0124509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933204	Green Published, gold			2022-12-26	WOS:000353887100047
J	Feeley, K				Feeley, Kenneth			Are We Filling the Data Void? An Assessment of the Amount and Extent of Plant Collection Records and Census Data Available for Tropical South America	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; FUTURE DISTRIBUTIONS; BIG DATA; CONSERVATION; BIODIVERSITY; DIVERSITY; LIMITATIONS; PATTERNS; ENDEMISM; ECOLOGY	Large-scale studies are needed to increase our understanding of how large-scale conservation threats, such as climate change and deforestation, are impacting diverse tropical ecosystems. These types of studies rely fundamentally on access to extensive and representative datasets (i.e., "big data"). In this study, I asses the availability of plant species occurrence records through the Global Biodiversity Information Facility (GBIF) and the distribution of networked vegetation census plots in tropical South America. I analyze how the amount of available data has changed through time and the consequent changes in taxonomic, spatial, habitat, and climatic representativeness. I show that there are large and growing amounts of data available for tropical South America. Specifically, there are almost 2,000,000 unique geo-referenced collection records representing more than 50,000 species of plants in tropical South America and over 1,500 census plots. However, there is still a gaping "data void" such that many species and many habitats remain so poorly represented in either of the databases as to be functionally invisible for most studies. It is important that we support efforts to increase the availability of data, and the representativeness of these data, so that we can better predict and mitigate the impacts of anthropogenic disturbances.	[Feeley, Kenneth] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Feeley, Kenneth] Fairchild Trop Bot Garden, Coral Gables, FL USA	State University System of Florida; Florida International University	Feeley, K (corresponding author), Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA.	kjfeeley@gmail.com	Feeley, Kenneth James/A-7631-2009	Feeley, Kenneth James/0000-0002-3618-1144	FIU Library's Open Access Publishing Fund; Direct For Biological Sciences [1257655] Funding Source: National Science Foundation	FIU Library's Open Access Publishing Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	I gratefully acknowledge the thousands of hardworking scientists and workers who contribute to online databases and plot networks worldwide and thus help to make big ecology possible. I thank M. Silman for his contributions to the original "data void" assessment and A. Duque, W. Farfan, and all of the FIU Tropical Ecology and Conservation lab for their comments and suggestions on this manuscript. Publication of this article was funded in part by FIU Library's Open Access Publishing Fund. This is contribution #299 from the Tropical Biology Program of FIU.	Anderson-Teixeira K.J., 2014, GLOBAL CHANGE BIOL; Collen B, 2008, TROP CONSERV SCI, V1, P75, DOI 10.1177/194008290800100202; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P1335, DOI 10.1111/j.1365-2486.2011.02602.x; Feeley KJ, 2011, DIVERS DISTRIB, V17, P1132, DOI 10.1111/j.1472-4642.2011.00813.x; Feeley KJ, 2011, GLOBAL CHANGE BIOL, V17, P626, DOI 10.1111/j.1365-2486.2010.02239.x; Feeley KJ, 2010, J BIOGEOGR, V37, P733, DOI 10.1111/j.1365-2699.2009.02240.x; Feeley KJ, 2009, P NATL ACAD SCI USA, V106, P12382, DOI 10.1073/pnas.0900698106; Feeley KJ, 2015, AM J BOT, V102, P1, DOI [10.3732/ajb.102.1.1, DOI 10.3732/AJB.102.1.1]; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guitet S, 2014, FOREST ECOL MANAG, V328, P270, DOI 10.1016/j.foreco.2014.05.045; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Moerman DE, 2006, J BIOGEOGR, V33, P1969, DOI 10.1111/j.1365-2699.2006.01549.x; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pitman NCA, 2011, TROP CONSERV SCI, V4, P64, DOI 10.1177/194008291100400107; Ramirez-Villegas J, 2014, J NAT CONSERV, V22, P391, DOI 10.1016/j.jnc.2014.03.007; Soranno PA, 2014, FRONT ECOL ENVIRON, V12, P3, DOI 10.1890/1540-9295-12.1.3; Swenson JJ, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-1; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Tobler M, 2007, BIODIVERS CONSERV, V16, P659, DOI 10.1007/s10531-005-3373-9; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	37	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125629	10.1371/journal.pone.0125629	http://dx.doi.org/10.1371/journal.pone.0125629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927831	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100107
J	Hauck, T; Tanigawa, N; Probst, M; Wohlschlaeger, A; Ille, S; Sollmann, N; Maurer, S; Zimmer, C; Ringel, F; Meyer, B; Krieg, SM				Hauck, Theresa; Tanigawa, Noriko; Probst, Monika; Wohlschlaeger, Afra; Ille, Sebastian; Sollmann, Nico; Maurer, Stefanie; Zimmer, Claus; Ringel, Florian; Meyer, Bernhard; Krieg, Sandro M.			Task Type Affects Location of Language-Positive Cortical Regions by Repetitive Navigated Transcranial Magnetic Stimulation Mapping	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; BRAIN-STIMULATION; SPOKEN LANGUAGE; VERB GENERATION; WORD PRODUCTION; NEURAL SYSTEMS; NAMING ERRORS; READING ALOUD; SPEECH; NOUNS	Objectives Recent repetitive TMS (rTMS) mapping protocols for language mapping revealed deficits of this method, mainly in posterior brain regions. Therefore this study analyzed the impact of different language tasks on the localization of language-positive brain regions and compared their effectiveness, especially with regard to posterior brain regions. Methods Nineteen healthy, right-handed subjects performed object naming, pseudoword reading, verb generation, and action naming during rTMS language mapping of the left hemisphere. Synchronically, 5 Hz/10 pulses were applied with a 0 ms delay Results The object naming task evoked the highest error rate (14%), followed by verb generation (13%) and action naming (11%). The latter revealed more errors in posterior than in anterior areas. Pseudoword reading barely generated errors, except for phonological paraphasias. Conclusions In general, among the evaluated language tasks, object naming is the most discriminative task to detect language-positive regions via rTMS. However, other tasks might be used for more specific questions.	[Hauck, Theresa; Ille, Sebastian; Sollmann, Nico; Maurer, Stefanie; Ringel, Florian; Meyer, Bernhard; Krieg, Sandro M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, D-80290 Munich, Germany; [Tanigawa, Noriko] Univ Oxford, Fac Linguist Philol & Phonet, Oxford, England; [Probst, Monika; Wohlschlaeger, Afra; Zimmer, Claus] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, Neuroradiol Sect, D-80290 Munich, Germany	Technical University of Munich; University of Oxford; Technical University of Munich	Krieg, SM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, D-80290 Munich, Germany.	Sandro.Krieg@lrz.tum.de	Ringel, Florian/E-4933-2014; Meyer, Bernhard/AAH-3329-2019; Meyer, Bernhard/Q-9413-2016; Krieg, Sandro M./L-8902-2016	Meyer, Bernhard/0000-0001-6486-7955; Krieg, Sandro M./0000-0003-4050-1531; Sollmann, Nico/0000-0002-8120-2223; Probst, Monika/0000-0003-1687-0409	BrainLab AG	BrainLab AG	BrainLab AG provided support in the form of salaries for authors [SK, FR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almairac F., 2014, BRAIN STRUCT FUNCT; Bonner MF, 2013, NEUROIMAGE, V71, P175, DOI 10.1016/j.neuroimage.2013.01.006; Brennan NMP, 2007, NEUROIMAGE, V37, pS100, DOI 10.1016/j.neuroimage.2007.04.052; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Corina DP, 2010, BRAIN LANG, V115, P101, DOI 10.1016/j.bandl.2010.04.001; Corina DP, 2005, HUM BRAIN MAPP, V24, P1, DOI 10.1002/hbm.20063; Corina I, 2005, J INFUS MURS, V28, P12, DOI 10.1097/00000446-200503001-00004; DAMASIO AR, 1993, P NATL ACAD SCI USA, V90, P4957, DOI 10.1073/pnas.90.11.4957; DANIELE A, 1994, NEUROPSYCHOLOGIA, V32, P1325, DOI 10.1016/0028-3932(94)00066-2; DeLeon J, 2007, BRAIN, V130, P1408, DOI 10.1093/brain/awm011; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Duffau H, 2013, BRAIN LANG; Epstein CM, 1996, NEUROLOGY, V47, P1590, DOI 10.1212/WNL.47.6.1590; Felty R. A, 2007, CONTEXT EFFECTS SPOK; Frings M, 2006, NEUROSCI LETT, V409, P19, DOI 10.1016/j.neulet.2006.08.058; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P599, DOI 10.1017/S014271640606053X; Gow DW, 2012, BRAIN LANG, V121, P273, DOI 10.1016/j.bandl.2012.03.005; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Graves WW, 2010, CEREB CORTEX, V20, P1799, DOI 10.1093/cercor/bhp245; Henseler I, 2014, J COGNITIVE NEUROSCI, V26, P1403, DOI 10.1162/jocn_a_00572; Hermann BP, 1999, NEUROPSYCHOLOGY, V13, P3, DOI 10.1037/0894-4105.13.1.3; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Krieg SM, 2014, NEUROIMAGE, V100, P219, DOI 10.1016/j.neuroimage.2014.06.016; Krieg SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075403; Lioumis P, 2012, J NEUROSCI METH, V204, P349, DOI 10.1016/j.jneumeth.2011.11.003; Melby-Lervag M, 2012, PSYCHOL BULL, V138, P322, DOI 10.1037/a0026744; Moseley RL, 2014, BRAIN LANG, V132, P28, DOI 10.1016/j.bandl.2014.03.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papagno C, 2011, NEUROIMAGE, V55, P1306, DOI 10.1016/j.neuroimage.2011.01.005; Papathanassiou D, 2000, NEUROIMAGE, V11, P347, DOI 10.1006/nimg.2000.0546; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Picht T, 2013, NEUROSURGERY, V72, P808, DOI 10.1227/NEU.0b013e3182889e01; Picht T, 2009, NEUROSURGERY, V65, P93, DOI 10.1227/01.NEU.0000348009.22750.59; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2005, HUM BRAIN MAPP, V25, P70, DOI 10.1002/hbm.20132; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Roux FE, 2004, BRAIN, V127, P1796, DOI 10.1093/brain/awh204; Salmelin R, 2000, J CLIN NEUROPHYSIOL, V17, P163, DOI 10.1097/00004691-200003000-00005; Scott SK, 2003, NEUROIMAGE, V19, P870, DOI 10.1016/S1053-8119(03)00083-1; Simos PG, 2002, CEREB CORTEX, V12, P297, DOI 10.1093/cercor/12.3.297; Siri S, 2008, CEREB CORTEX, V18, P171, DOI 10.1093/cercor/bhm043; Sollmann N, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-150; Sollmann N, 2013, J NEUROSURG, V118, P175, DOI 10.3171/2012.9.JNS121053; Soros P, 2003, NEUROIMAGE, V19, P1787, DOI 10.1016/S1053-8119(03)00217-9; Tarapore PE, 2013, NEUROIMAGE, V82, P260, DOI 10.1016/j.neuroimage.2013.05.018; Taylor JSH, 2013, PSYCHOL BULL, V139, P766, DOI 10.1037/a0030266; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Thurling M, 2011, NEUROIMAGE, V57, P1184, DOI 10.1016/j.neuroimage.2011.05.045; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Wassermann EM, 1999, NEUROPSYCHOLOGIA, V37, P537, DOI 10.1016/S0028-3932(98)00102-X	52	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125298	10.1371/journal.pone.0125298	http://dx.doi.org/10.1371/journal.pone.0125298			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928744	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100078
J	Jiang, X; Lim, CZH; Li, ZM; Lee, PL; Yatim, SMJM; Guan, PY; Li, JT; Zhou, JB; Pan, JX; Chng, WJ; Chai, CLL; Yu, Q				Jiang, Xia; Lim, Cheryl Zi Hui; Li, Zhimei; Lee, Puay Leng; Yatim, Siti Maryam J. M.; Guan, Peiyong; Li, Juntao; Zhou, Jianbiao; Pan, Jingxuan; Chng, Wee-Joo; Chai, Christina L. L.; Yu, Qiang			Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML)	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE METHYLTRANSFERASE EZH2; MEDIATED DRUG-RESISTANCE; SMALL-MOLECULE INHIBITOR; STEM-CELLS; PHARMACOLOGICAL DISRUPTION; EPIGENETIC THERAPY; TUMOR-CELLS; CANCER; 3-DEAZANEPLANOCIN	Aberrant epigenetic events contribute to tumorigenesis of all human cancers. Significant efforts are underway in developing new generation of epigenetic cancer therapeutics. Although clinical trials for agents targeting DNA hypermethylation and histone deacetylation have yielded promising results, developing agents that target histone methylation remains to be in the early stage. We and others have previously reported that 3-Deazaneplanocin A (DZNep) is a histone methylation inhibitor that has a wide range of anticancer effects in various human cancers. Here, focusing on acute myeloid leukemia (AML) as a model, we reported a less toxic analog of DZNep, named D9, which is shown to be efficacious in AML cell lines and patient-derived samples in vitro, as well as AML tumorigenesis in vivo. Gene expression analysis in a panel of AML cell lines treated with D9 identified a set of genes that is associated with D9 sensitivity and implicated in multiple oncogenic signaling pathways. Moreover, we show that D9 is able to deplete the leukemia stem cells (LSC) and abolish chemotherapy-induced LSC enrichment, leading to dramatic elimination of AML cell survival. Thus, D9 appears to be a robust epigenetic compound that may constitute a potential for AML therapy.	[Jiang, Xia; Lim, Cheryl Zi Hui; Li, Zhimei; Lee, Puay Leng; Yatim, Siti Maryam J. M.; Yu, Qiang] ASTAR, Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Biopolis, Singapore 138672, Singapore; [Guan, Peiyong; Li, Juntao] ASTAR, Genome Inst Singapore, Computat & Syst Biol, Biopolis, Singapore 138672, Singapore; [Zhou, Jianbiao; Chng, Wee-Joo] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Pan, Jingxuan] Sun Yat Sen Univ, Sch Med, Dept Pathophysiol, Guangzhou 510089, Guangdong, Peoples R China; [Chng, Wee-Joo] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore; [Chng, Wee-Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Chai, Christina L. L.] Inst Chem & Engn Sci, Singapore 138665, Singapore; [Chai, Christina L. L.] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore; [Yu, Qiang] Jinan Univ, Inst Canc, Guangzhou 510632, Guangdong, Peoples R China; [Yu, Qiang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Sun Yat Sen University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2); National University of Singapore; Jinan University; National University of Singapore	Yu, Q (corresponding author), ASTAR, Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Biopolis, Singapore 138672, Singapore.	yuq@gis.a-star.edu.sg	Chai, Christina L/A-3133-2014; Guan, Peiyong/A-3715-2015	Guan, Peiyong/0000-0001-9958-0137; Yu, Qiang/0000-0003-2132-8278; Chai, Christina/0000-0002-9199-851X	Joint Council Office and Exploit Technology of Agency for Science, Technology, and Research (A*STAR); Singapore National Research Foundation; Ministry of Education; National Medical Research Council; A*STAR graduate fellowship	Joint Council Office and Exploit Technology of Agency for Science, Technology, and Research (A*STAR); Singapore National Research Foundation(National Research Foundation, Singapore); Ministry of Education; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); A*STAR graduate fellowship	This work was supported by the Joint Council Office and Exploit Technology of Agency for Science, Technology, and Research (A*STAR) to Q.Y. and C.C.; by the Singapore National Research Foundation; and by the Ministry of Education under the Research Centre of Excellence Program to W.-J. C.W.-J.C. was supported by the National Medical Research Council Clinician Scientist Investigator Award. X.J. was supported by A*STAR graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Asanuma H, 2005, CANCER RES, V65, P11018, DOI 10.1158/0008-5472.CAN-05-0491; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Damiano JS, 2000, LEUKEMIA LYMPHOMA, V38, P71, DOI 10.3109/10428190009060320; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Hayden A, 2011, BREAST CANCER RES TR, V127, P109, DOI 10.1007/s10549-010-0982-0; Hu XT, 1998, LEUKEMIA RES, V22, P817, DOI 10.1016/S0145-2126(98)00073-3; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Kikuchi J, 2012, LUNG CANCER, V78, P138, DOI 10.1016/j.lungcan.2012.08.003; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Liu F, 2010, J MED CHEM, V53, P5844, DOI 10.1021/jm100478y; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Milella M, 2005, CURR PHARM DESIGN, V11, P2779, DOI 10.2174/1381612054546842; Ninomiya M, 2007, LEUKEMIA, V21, P136, DOI 10.1038/sj.leu.2404432; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Roboz GJ, 2011, HEMATOL-AM SOC HEMAT, P43, DOI 10.1182/asheducation-2011.1.43; Roboz GJ, 2009, EXPERT REV HEMATOL, V2, P663, DOI [10.1586/ehm.09.53, 10.1586/EHM.09.53]; Stone RM, 2007, BEST PRACT RES CL HA, V20, P39, DOI 10.1016/j.beha.2006.11.006; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tam EKW, 2015, CHEMMEDCHEM, V10, P173, DOI 10.1002/cmdc.201402315; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Trowbridge JJ, 2012, GENE DEV, V26, P344, DOI 10.1101/gad.184341.111; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Wee ZN, 2014, CELL REP; YATES JW, 1973, CANCER CHEMOTH REP 1, V57, P485; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	46	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122983	10.1371/journal.pone.0122983	http://dx.doi.org/10.1371/journal.pone.0122983			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928216	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100012
J	Lukowski, A; Giertych, MJ; Zadworny, M; Mucha, J; Karolewski, P				Lukowski, Adrian; Giertych, Marian J.; Zadworny, Marcin; Mucha, Joanna; Karolewski, Piotr			Preferential Feeding and Occupation of Sunlit Leaves Favors Defense Response and Development in the Flea Beetle, Altica brevicollis coryletorum - A Pest of Corylus avellana	PLOS ONE			English	Article							SPECIALIST HERBIVORES; LARVAL PERFORMANCE; INSECT HERBIVORE; QUERCUS-ROBUR; FOOD QUALITY; FOREST; TEMPERATURE; GROWTH; CHEMISTRY; SHADE	The monophagous beetle, Altica brevicollis coryletorum, is a major leaf pest of Corylus avellana (common hazel). In contrast to majority of the other studied species of shrubs, sunlit leaves are grazed to a much greater extent than shaded leaves. Since the observation of a link between leaf irradiance level and A. brevicollis feeding is unique, we hypothesized that feeding preference of this beetle species is related to the speed needed to escape threats i.e. faster jumping. We also hypothesized that sunlit leaves are more nutritious and easier to consume than the leaves of shaded shrubs. Results indicated that beetle mass was greater in beetles occupying sunlit leaves, which is consistent with our second hypothesis. The study also confirmed under laboratory conditions, that larvae, pupae and beetles that were fed full-light (100% of full light) leaves were significantly heavier than those fed with shaded leaves (15% of full light). In the high irradiance conditions (higher temperature) duration of larval development is also reduced. Further results indicated that neither the concentration of soluble phenols, leaf toughness, or the number of trichomes could explain the insect's preference for sunlit leaves. Notably, measurements of jump length of beetles of this species, both in the field and under laboratory conditions, indicated that the defense pattern related to jumping was associated with light conditions. The jump length of beetles in the sun was significantly higher than in the shade. Additionally, in laboratory tests, beetle defense (jumping) was more strongly affected by temperature (15, 25, or 35 degrees C for 24h) than by leaf type. The effect of sunlit, higher nutrient leaves (greater level of non-structural carbohydrates) on defense (jumping) appears to be indirect, having a positive effect on insect mass in all developmental stages.	[Lukowski, Adrian; Giertych, Marian J.; Zadworny, Marcin; Mucha, Joanna; Karolewski, Piotr] Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland; [Lukowski, Adrian] Poznan Univ Life Sci, Fac Forestry, Dept Forest Protect, Poznan, Poland; [Giertych, Marian J.] Univ Zielona Gora, Fac Biol Sci, Zielona Gora, Poland	Polish Academy of Sciences; Poznan University of Life Sciences; University of Zielona Gora	Lukowski, A (corresponding author), Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland.	adrian.lukowski@gmail.com	Łukowski, Adrian/K-2923-2019; Giertych, Marian J/A-1618-2008	Łukowski, Adrian/0000-0002-4860-4984; Giertych, Marian/0000-0001-5578-9545; Zadworny, Marcin/0000-0002-7352-5786; Karolewski, Piotr/0000-0003-3064-1274; Mucha, Joanna/0000-0002-1290-9639	Institute of Dendrology Polish Academy of Sciences in Kornik	Institute of Dendrology Polish Academy of Sciences in Kornik	The research was financially supported by the statutory activities of the Institute of Dendrology Polish Academy of Sciences in Kornik. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1992, TREE PHYSIOL, V10, P343, DOI 10.1093/treephys/10.4.343; Alonso C, 2000, ACTA OECOL, V21, P257, DOI 10.1016/S1146-609X(00)01082-1; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BARTKOWSKA J, 1975, Polskie Pismo Entomologiczne, V45, P633; Bauerfeind SS, 2013, ENTOMOL EXP APPL, V149, P148, DOI 10.1111/eea.12118; Bjorkman C, 1997, OIKOS, V79, P45, DOI 10.2307/3546088; Chaneton EJ, 2010, J ECOL, V98, P488, DOI 10.1111/j.1365-2745.2009.01631.x; Chen YG, 2008, ENTOMOL EXP APPL, V126, P244, DOI 10.1111/j.1570-7458.2007.00662.x; Crawley MJ, 1986, PLANT ECOLOGY; Crone EE, 1999, J CHEM ECOL, V25, P635, DOI 10.1023/A:1020966206840; DEACON J, 1974, NEW PHYTOL, V73, P1055, DOI 10.1111/j.1469-8137.1974.tb01331.x; Decocq G, 2004, J APPL ECOL, V41, P1065, DOI 10.1111/j.0021-8901.2004.00960.x; Dominy NJ, 2003, J EXP BOT, V54, P2007, DOI 10.1093/jxb/erg224; FEDER N, 1968, AM J BOT, V55, P123, DOI 10.2307/2440500; FURTH D G, 1980, Israel Journal of Entomology, V14, P55; Gantner M., 2002, Acta Scientiarum Polonorum - Hortorum Cultus, V1, P55; Gantner M., 2000, Annales Universitatis Mariae Curie-Sklodowska. Sectio EEE, Horticultura, V8, P155; Giertych MJ, 2007, FOREST ECOL MANAG, V242, P700, DOI 10.1016/j.foreco.2007.02.005; Giertych MJ, 2005, ENTOMOL EXP APPL, V117, P59, DOI 10.1111/j.1570-7458.2005.00332.x; Gokirmak T, 2009, GENET RESOUR CROP EV, V56, P147, DOI 10.1007/s10722-008-9352-8; Gromysz-Kalkowska Kazimiera, 2011, Annales Universitatis Mariae Curie-Sklodowska Sectio C Biologia, V66, P143; Gruev Blagoy, 1997, Scopolia, V37, P1; Hardin JW, 1997, J TORREY BOT SOC, V124, P124, DOI 10.2307/2996580; Hwang SY, 1997, OECOLOGIA, V111, P99, DOI 10.1007/s004420050213; Jansen MPT, 1997, ENTOMOL EXP APPL, V82, P319, DOI 10.1023/A:1002916325052; Jaworski Tomasz, 2013, Lesne Prace Badawcze, V74, P345; Kaitaniemi P, 1998, OECOLOGIA, V116, P182, DOI 10.1007/s004420050578; Kaplan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093714; Karolewski P, 2007, DENDROBIOLOGY, V58, P43; Karolewski P, 2007, POL J ECOL, V55, P595; Karolewski P, 2013, ACTA OECOL, V53, P19, DOI 10.1016/j.actao.2013.08.004; Koksal AH, 2006, FOOD CHEM, V99, P509, DOI 10.1016/j.foodchem.2005.08.013; Koricheva J, 1998, ANNU REV ENTOMOL, V43, P195, DOI 10.1146/annurev.ento.43.1.195; Kral J., 1964, Entomologische Blaetter Krefeld, V60, P126; Lee KP, 2010, ENTOMOL EXP APPL, V136, P151, DOI 10.1111/j.1570-7458.2010.01018.x; Lee M.R., 2004, BRUSH MANAGEMENT PRE; Levesque KR, 2002, B ENTOMOL RES, V92, P127, DOI 10.1079/BER2002153; Mathur V, 2011, ENTOMOL EXP APPL, V139, P215, DOI 10.1111/j.1570-7458.2011.01122.x; McNeill S., 1978, BIOCH ASPECTS PLANT, P77; Molina-Montenegro MA, 2006, ACTA OECOL, V30, P147, DOI 10.1016/j.actao.2006.02.008; Mooney EH, 2009, OIKOS, V118, P1181, DOI 10.1111/j.1600-0706.2009.17228.x; Oliveira I, 2007, FOOD CHEM, V105, P1018, DOI 10.1016/j.foodchem.2007.04.059; Perez-Contreras T, 2014, ACTA OECOL, V55, P15, DOI 10.1016/j.actao.2013.10.006; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Schmitt Michael, 2004, P161; Snedecor G W, 1976, STAT METHODS; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Tremmel M, 2013, BEHAV ECOL, V24, P386, DOI 10.1093/beheco/ars175; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wennstrom A, 2010, CHEMOECOLOGY, V20, P35, DOI 10.1007/s00049-010-0040-8	50	16	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126072	10.1371/journal.pone.0126072	http://dx.doi.org/10.1371/journal.pone.0126072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927706	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100126
J	MacIntyre, R; Stein, A; Harrison, C; Britt, H; Mahimbo, A; Cunningham, A				MacIntyre, Raina; Stein, Alicia; Harrison, Christopher; Britt, Helena; Mahimbo, Abela; Cunningham, Anthony			Increasing Trends of Herpes Zoster in Australia	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTHERPETIC NEURALGIA; VARICELLA VACCINATION; GENERAL-PRACTICE; IMPACT; EPIDEMIOLOGY; VIRUS; MANAGEMENT; RISK; PREVENTION	Background Increasing trends in incidence of herpes zoster (HZ) have been reported in Australia and internationally. This may reflect the impact of childhood VZV vaccination programs introduced universally in Australia in late 2005. The objective of this study was to evaluate changes in incidence of HZ and PHN in Australia over time, and associated healthcare resource utilisation. Methods Australian data on general practice (GP) encounters for HZ, specific antiviral prescribing data from the pharmaceutical benefits scheme, emergency department presentations from the states of NSWand Victoria and national hospitalisation data for HZ were analysed for time trends using regression models. Two time periods (2000-2006 and 2006-2013) were compared which correspond broadly with the pre- and post-universal VZV vaccination period. Results All data sources showed increasing rates of HZ with age and over time. The GP database showed a significant annual increase in encounters for HZ of 2.5 per 100,000 between 1998 and 2013, and the rates of prescriptions for HZ increased by 4.2% per year between 2002 and 2012. In the 60+ population HZ incidence was estimated to increase from 11.9 to 15.4 per 1,000 persons using GP data or from 12.8 to 14.2 per 1,000 persons using prescription data (p<0.05, between the two periods). Hospitalisation data did not show the same increasing trend over time, except for the age group >= 80 years. Most emergency visits for HZ were not admitted, and showed significant increases over time. Discussion The burden of HZ in Australia is substantial, and continues to increase over time. This increase is seen both pre-and post-universal VZV vaccination in 2005, and is most prominent in the older population. The substantial burden of HZ, along with ageing of the Australian population and the importance of healthy ageing, warrants consideration of HZ vaccination for the elderly.	[MacIntyre, Raina; Mahimbo, Abela] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [MacIntyre, Raina] Natl Ctr Immunisat Res NCIRS, Sydney, NSW, Australia; [Stein, Alicia] bioCSL, Melbourne, Vic, Australia; [Harrison, Christopher; Britt, Helena] Univ Sydney, Family Med Res Ctr, Sydney, NSW 2006, Australia; [Cunningham, Anthony] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research	MacIntyre, R (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	r.macintyre@unsw.edu.au	Mahimbo, Abela/AAR-6184-2020	Mahimbo, Abela/0000-0003-2058-6881; MacIntyre, C Raina/0000-0002-3060-0555; Harrison, Christopher/0000-0002-8769-6877	bioCSL	bioCSL	bioCSL provided support in the form of salaries for author Alicia Stein, who contributed to this publication as part of her employment role. bioCSL also funded all fees due for ethics review and data extraction to the various third parties involved as detailed below. The specific roles of this author are articulated in the 'author contributions' section. Merck and GSK did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Aust Fam Physician, V32, P59; Australian Bureau of Statistics (ABS), 2013, 3101 0 AUSTRALIAN DE; Australian Bureau of Statistics (ABS), 2007, SERIES B PROJECTIONS; Australian Institute of Health and Welfare (AIHW), 2013, HOSPITAL DATA; Australian Institute of Health and Welfare (AIHW), 2007, INTERACTIVE NATIONAL; Australian Technical Advisory Group on Immunisation (ATAGI), 2008, SYSTEMATIC REVIEW OF; Brisson M., 2003, Journal of Medical Virology, V70, pS9, DOI 10.1002/jmv.10313; Brisson M., 2003, Journal of Medical Virology, V70, pS31, DOI 10.1002/jmv.10317; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; Brisson M, 2010, VACCINE, V28, P3385, DOI 10.1016/j.vaccine.2010.02.079; Britt H, 2012, GENERAL PRACTICE ACT; Carville KS, 2010, VACCINE, V28, P2532, DOI 10.1016/j.vaccine.2010.01.036; Cunningham AL, 2008, MED J AUSTRALIA, V188, P171, DOI 10.5694/j.1326-5377.2008.tb01566.x; Drolet M, 2010, CAN MED ASSOC J, V182, P1731, DOI 10.1503/cmaj.091711; Fleming DM, 2004, EUR J EPIDEMIOL, V19, P1113, DOI 10.1007/s10654-004-2219-1; FMRC, 2014, ICPC 2 PLUS DEMONSTR, DOI 10.1186/s12998-015-0051-1; Gao Z, 2010, EPIDEMIOL INFECT, V138, P457, DOI 10.1017/S0950268809990860; GARNETT GP, 1992, EPIDEMIOL INFECT, V108, P513, DOI 10.1017/S0950268800050019; Grant KA, 2010, MED J AUSTRALIA, V193, P483, DOI 10.5694/j.1326-5377.2010.tb04009.x; Hales CM, 2013, ANN INTERN MED, V159, P739, DOI 10.7326/0003-4819-159-11-201312030-00006; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; ICPC, 1998, ICPC 2 INTERNATIONAL; Jardine A, 2011, EPIDEMIOL INFECT, V139, P658, DOI 10.1017/S0950268810001949; Johnson RW, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-37; Johnson RW, 2008, DRUG AGING, V25, P991, DOI 10.2165/0002512-200825120-00002; Johnson RW, 2001, J ANTIMICROB CHEMOTH, V47, P1, DOI 10.1093/jac/47.suppl_1.1; Karhunen M, 2010, EPIDEMIOL INFECT, V138, P469, DOI 10.1017/S0950268809990768; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Krzywinski M, 2013, NAT METHODS, V10, P921, DOI 10.1038/nmeth.2659; Langan SM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001420; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; MacIntyre C. R., 2013, Health, V5, P80; MacIntyre CR, 2003, EPIDEMIOL INFECT, V131, P675, DOI 10.1017/S0950268803008690; National Health and Medical Research Council, 2008, THE AUSTRALIAN IMMUN; Nelson MR, 2010, MED J AUSTRALIA, V193, P110, DOI 10.5694/j.1326-5377.2010.tb03818.x; NHMRC, 2008, AUSTRALIAN IMMUNIZAT; Ogunjimi B, 2014, CLIN VACCINE IMMUNOL, V21, P417, DOI 10.1128/CVI.00818-13; Ogunjimi B, 2011, VIRAL IMMUNOL, V24, P151, DOI 10.1089/vim.2010.0031; Opstelten W, 2002, FAM PRACT, V19, P471, DOI 10.1093/fampra/19.5.471; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Perez-Farinos N, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-59; Pinchinat S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-170; Rimland D, 2010, CLIN INFECT DIS, V50, P1000, DOI 10.1086/651078; Schmader KE, 2012, CLIN INFECT DIS, V55, P1320, DOI 10.1093/cid/cis638; Schmader KE, 2002, CLIN J PAIN, V18, P350, DOI 10.1097/00002508-200211000-00002; Schuette MC, 1999, B MATH BIOL, V61, P1031, DOI 10.1006/bulm.1999.0126; Serpell M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-92; Stein AN, 2009, VACCINE, V27, P520, DOI 10.1016/j.vaccine.2008.11.012; Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; Yawn BP, 2013, NEUROLOGY, V81, P928, DOI 10.1212/WNL.0b013e3182a3516e; Yih WK, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-68	54	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125025	10.1371/journal.pone.0125025	http://dx.doi.org/10.1371/journal.pone.0125025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928713	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100058
J	Podder, MP; Banfield, SE; Keefe, GP; Whitney, HG; Tahlan, K				Podder, Milka P.; Banfield, Susan E.; Keefe, Greg P.; Whitney, Hugh G.; Tahlan, Kapil			Typing of Mycobacterium avium Subspecies paratuberculosis Isolates from Newfoundland Using Fragment Analysis	PLOS ONE			English	Article							CROHNS-DISEASE; JOHNES-DISEASE; VARIABLE-NUMBER; CATTLE HERDS; SEQUENCE; LOCI; INFECTION; COMBINATION; PREVALENCE; STABILITY	Short Sequence Repeat (SSR) typing of Mycobacterium avium subspecies paratuberculosis (Map) isolates is one of the most commonly used method for genotyping this pathogen. Currently used techniques have challenges in analyzing mononucleotide repeats >15 bp, which include some of the Map SSRs. Fragment analysis is a relatively simple technique, which can accurately measure the size of DNA fragments and can be used to calculate the repeat length of the target SSR loci. In the present study, fragment analysis was used to analyze 4 Map SSR loci known to provide sufficient discriminatory power to determine the relationship between Map isolates. Eighty-five Map isolates from 18 animals from the island of Newfoundland were successfully genotyped using fragment analysis. To the best of our knowledge, this is the first report on Map SSR diversity from Newfoundland dairy farms. Previously unreported Map SSR-types or combinations were also identified during the course of the described work. In addition, multiple Map SSR-types were isolated from a single animal in many cases, which is not a common finding.	[Podder, Milka P.; Banfield, Susan E.; Tahlan, Kapil] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Keefe, Greg P.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Whitney, Hugh G.] Newfoundland & Labrador Dept Nat Resources, Div Anim Hlth, St John, NF, Canada	Memorial University Newfoundland; University of Prince Edward Island	Whitney, HG (corresponding author), Newfoundland & Labrador Dept Nat Resources, Div Anim Hlth, St John, NF, Canada.	hughwhitney@gov.nl.ca; ktahlan@mun.ca			Department of Natural Resources, Government of Newfoundland and Labrador (DNR-NL); Dairy Farmers of Newfoundland and Labrador; Natural Sciences and Engineering Research Council of Canada (NSERC); Research & Development Corporation of Newfoundland and Labrador (RDC-NL); Canada Foundation for Innovation (CFI); NSERC; Memorial University of Newfoundland (MUN)	Department of Natural Resources, Government of Newfoundland and Labrador (DNR-NL); Dairy Farmers of Newfoundland and Labrador; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Research & Development Corporation of Newfoundland and Labrador (RDC-NL); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Memorial University of Newfoundland (MUN)	The described work was funded by the Department of Natural Resources, Government of Newfoundland and Labrador (DNR-NL) and was supported by the Dairy Farmers of Newfoundland and Labrador. Equipment used in the study was purchased with funding from the Natural Sciences and Engineering Research Council of Canada (NSERC), Research & Development Corporation of Newfoundland and Labrador (RDC-NL), and the Canada Foundation for Innovation (CFI) to KT and from DNR-NL. We would also like to acknowledge NSERC and the Memorial University of Newfoundland (MUN) for additional financial assistance to MPP and SEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; Ahlstrom C, 2014, APPL ENVIRON MICROB, V80, P534, DOI 10.1128/AEM.03212-13; Amonsin A, 2004, J CLIN MICROBIOL, V42, P1694, DOI 10.1128/JCM.42.4.1694-1702.2004; Bannantine JP, 2013, LETT APPL MICROBIOL, V57, P165, DOI 10.1111/lam.12109; Bannantine JP, 2008, PROTEOMICS, V8, P463, DOI 10.1002/pmic.200700644; Castellanos E, 2009, APPL ENVIRON MICROB, V75, P676, DOI 10.1128/AEM.01683-08; El-Sayed A, 2009, J MICROBIOL, V47, P253, DOI 10.1007/s12275-008-0257-1; Ferrouillet C, 2009, PREV VET MED, V88, P128, DOI 10.1016/j.prevetmed.2008.08.001; Forde T, 2012, J WILDLIFE DIS, V48, P1, DOI 10.7589/0090-3558-48.1.1; Ghadiali AH, 2004, J CLIN MICROBIOL, V42, P5345, DOI 10.1128/JCM.42.11.5345-5348.2004; Harris NB, 2006, J CLIN MICROBIOL, V44, P2970, DOI 10.1128/JCM.00584-06; Hermon-Taylor J, 2002, DIGEST LIVER DIS, V34, P9, DOI 10.1016/S1590-8658(02)80052-4; Kalis CHJ, 2004, PREV VET MED, V65, P189, DOI 10.1016/j.prevetmed.2004.07.005; Kasnitz N, 2013, VET MICROBIOL, V167, P573, DOI 10.1016/j.vetmic.2013.09.008; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Liu XF, 2001, FEMS MICROBIOL LETT, V202, P233, DOI 10.1111/j.1574-6968.2001.tb10809.x; Manning EJB, 2001, REV SCI TECH OIE, V20, P133, DOI 10.20506/rst.20.1.1275; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Oakey J, 2014, J VET DIAGN INVEST, V26, P651, DOI 10.1177/1040638714547257; Pradhan AK, 2011, J CLIN MICROBIOL, V49, P893, DOI 10.1128/JCM.01107-10; Prantera C, 1999, ITAL J GASTROENTEROL, V31, P244; Ricchi M, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-54; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Sohal JS, 2014, J CLIN MICROBIOL, V52, P2764, DOI 10.1128/JCM.00386-14; Stabel JR, 2000, AM J VET RES, V61, P754, DOI 10.2460/ajvr.2000.61.754; Tiwari A, 2006, CAN VET J, V47, P874; Whittington RJ, 2011, J CLIN MICROBIOL, V49, P1822, DOI 10.1128/JCM.00210-11	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126071	10.1371/journal.pone.0126071	http://dx.doi.org/10.1371/journal.pone.0126071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927612	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100125
J	Zhou, M; Tan, S; Guo, MJ; Zhang, L				Zhou, Min; Tan, Shukui; Guo, Mingjing; Zhang, Lu			Locational Determinants of Emissions from Pollution-Intensive Firms in Urban Areas	PLOS ONE			English	Article							SPATIAL DETERMINANTS; QIANTANG RIVER; STREAM WATER; CHINA	Industrial pollution has remained as one of the most daunting challenges for many regions around the world. Characterizing the determinants of industrial pollution should provide important management implications. Unfortunately, due to the absence of high-quality data, rather few studies have systematically examined the locational determinants using a geographical approach. This paper aimed to fill the gap by accessing the pollution source census dataset, which recorded the quantity of discharged wastes (waste water and solid waste) from 717 pollution-intensive firms within Huzhou City, China. Spatial exploratory analysis was applied to analyze the spatial dependency and local clusters of waste emissions. Results demonstrated that waste emissions presented significantly positive autocorrelation in space. The high-high hotspots generally concentrated towards the city boundary, while the low-low clusters approached the Taihu Lake. Their locational determinants were identified by spatial regression. In particular, firms near the city boundary and county road were prone to discharge more wastes. Lower waste emissions were more likely to be observed from firms with high proximity to freight transfer stations or the Taihu Lake. Dense populous districts saw more likelihood of solid waste emissions. Firms in the neighborhood of rivers exhibited higher waste water emissions. Besides, the control variables (firm size, ownership, operation time and industrial type) also exerted significant influence. The present methodology can be applicable to other areas, and further inform the industrial pollution control practices. Our study advanced the knowledge of determinants of emissions from pollution-intensive firms in urban areas.	[Zhou, Min; Tan, Shukui; Zhang, Lu] Huazhong Univ Sci & Technol, Nontradit Secur Ctr, Wuhan 430074, Peoples R China; [Zhou, Min; Tan, Shukui; Zhang, Lu] Huazhong Univ Sci & Technol, Coll Publ Adm, Wuhan 430074, Peoples R China; [Guo, Mingjing] China Univ Geosci, Sch Econ & Management, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; China University of Geosciences	Tan, S (corresponding author), Huazhong Univ Sci & Technol, Nontradit Secur Ctr, Wuhan 430074, Peoples R China.	tansk@126.com	GUO, MINGJING/AAS-6028-2021	GUO, MINGJING/0000-0003-4398-3863	National 985 Project of Non-traditional Security at Huazhong University of Science and Technology; National Natural Science Foundation of China [41401631, 41401192]	National 985 Project of Non-traditional Security at Huazhong University of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 985 Project of Non-traditional Security at Huazhong University of Science and Technology and National Natural Science Foundation of China (No. 41401631 and No. 41401192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Antoci A, 2014, J ECON DYN CONTROL, V47, P211, DOI 10.1016/j.jedc.2014.08.009; Apergis N, 2013, ECOL ECON, V88, P57, DOI 10.1016/j.ecolecon.2012.12.024; Ben Kheder S, 2012, ECOL ECON, V77, P48, DOI 10.1016/j.ecolecon.2011.10.005; Card D, 2010, J PUBLIC ECON, V94, P222, DOI 10.1016/j.jpubeco.2009.11.010; Chohaney ML, 2014, APPL GEOGR, V53, P32, DOI 10.1016/j.apgeog.2014.05.019; Cole MA, 2013, J ENVIRON ECON MANAG, V65, P290, DOI 10.1016/j.jeem.2012.07.002; Devos E, 2014, J CORP FINANC, V29, P20, DOI 10.1016/j.jcorpfin.2014.08.005; Dijkstra BR, 2006, EUR ECON REV, V50, P425, DOI 10.1016/j.euroecorev.2004.09.006; Duvivier C, 2011, ENVIRON DEV ECON, V18, P1; Geng Y, 2007, REG ENVIRON CHANGE, V7, P123, DOI 10.1007/s10113-007-0026-4; Geng Y, 2014, J CLEAN PROD, V76, P116, DOI 10.1016/j.jclepro.2014.04.047; He CF, 2003, PAP REG SCI, V82, P351, DOI 10.1007/s10110-003-0168-9; Hu YA, 2013, ENVIRON DEV, V8, P57, DOI 10.1016/j.envdev.2013.06.001; Jiang LL, 2014, J COMP ECON, V42, P118, DOI 10.1016/j.jce.2013.07.007; Kang JH, 2010, WATER RES, V44, P4143, DOI 10.1016/j.watres.2010.05.009; Kendy E, 2004, HYDROL PROCESS, V18, P2289, DOI 10.1002/hyp.5529; LeSage J, 2009, STAT TEXTB MONOGR, P1; Ma CB, 2010, ECOL ECON, V69, P1869, DOI 10.1016/j.ecolecon.2010.05.005; Meng QM, 2009, CAN J FOREST RES, V39, P2283, DOI 10.1139/X09-136; Ministry of Environmental Protection, 2009, 2008 CHIN STAT ENV; Ministry of Water Resources, 2012, 2010 CHIN WAT RES B; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Petrakis E, 2003, RESOUR ENERGY ECON, V25, P197, DOI 10.1016/S0928-7655(02)00026-X; Su SL, 2013, REG ENVIRON CHANGE, V13, P77, DOI 10.1007/s10113-012-0313-6; Su SL, 2013, ECOL INDIC, V24, P375, DOI 10.1016/j.ecolind.2012.07.015; Su SL, 2011, APPL GEOGR, V31, P439, DOI 10.1016/j.apgeog.2010.10.008; Taguchi H, 2010, ENVIRON DEV ECON, V15, P363, DOI 10.1017/S1355770X10000033; Wang H, 2002, POLICY RES WORKING P, V2756; Warren KA, 1999, ENVIRON IMPACT ASSES, V19, P521, DOI 10.1016/S0195-9255(99)00030-X; Wei JC, 2012, J ENVIRON MANAGE, V113, P263, DOI 10.1016/j.jenvman.2012.08.040; World Bank, 2007, CHIN 2020 CLEAR WAT; Xue B, 2014, ECOL INDIC, V38, P272, DOI 10.1016/j.ecolind.2013.11.020; Ye XY, 2011, APPL GEOGR, V31, P800, DOI 10.1016/j.apgeog.2010.08.006; Yu S, 2014, SCI TOTAL ENVIRON, V488, P61, DOI [10.1016/j.scitotenv2014.04.061, 10.1016/j.scitotenv.2014.04.061]; Zhu SJ, 2014, GEOFORUM, V55, P53, DOI 10.1016/j.geoforum.2014.05.004	36	2	2	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125348	10.1371/journal.pone.0125348	http://dx.doi.org/10.1371/journal.pone.0125348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927438	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100083
J	Gong, P; Lu, ZD; Xing, J; Wang, N; Zhang, Y				Gong, Ping; Lu, Zhidan; Xing, Jing; Wang, Na; Zhang, Yu			Traditional Chinese Medicine Xuebijing Treatment Is Associated with Decreased Mortality Risk of Patients with Moderate Paraquat Poisoning	PLOS ONE			English	Article							NF-KAPPA-B; HERBICIDE PARAQUAT; IN-VIVO; INJECTION; CELLS; MACROPHAGES; EXPRESSION; IDENTIFICATION; INFLAMMATION; ACTIVATION	Paraquat poisoning causes multiple organ injury and high mortality due to severe toxicity and lack of effective treatment. Xuebijing (XBJ) injection, a traditional Chinese medicine preparation of five Chinese herbs (Radix Salviae Miltiorrhiae, Rhizoma Chuanxiong, Flos Carthami, Angelica Sinensis and Radix Paeoniae Rubra), has an anti-inflammatory effect and is widely used in the treatment of sepsis. This retrospective study was designed to evaluate the effects of XBJ combined with conventional therapy on mortality risk of patients with acute paraquat poisoning. Out of 68 patients, 27 were treated with conventional therapy (control group) and 41 were treated with intravenous administration of XBJ (100 ml, twice a day, up to 7 days) plus conventional therapy (XBJ group). Vital organ function, survival time within 28 days and adverse events during the treatment were reviewed. Results indicated that XBJ treatment significantly increased median survival time among patients ingesting 1030 ml of paraquat (P=0.02) compared with the control group. After adjustment for covariates, XBJ treatment was associated significantly with a lower mortality risk (adjusted HR 0.242, 95% CI 0.113 to 0.516, P=0.001) compared with the control group. Additionally, compared with Day 1, on Day 3 the value of PaO2/FiO(2) was significantly decreased, and the values of serum alanine aminotransferase, creatinine and troponin T were significantly increased in the control group (all P<0.05), but these values were significant improved in the XBJ group (all P<0.05). Only one patient had skin rash with itch within 30 minutes after injection and no severe adverse events were found in the XBJ group. In conclusion, XBJ treatment is associated with decreased mortality risk of patients with moderate paraquat poisoning, which may be attributed to improved function of vital organs with no severe adverse events.	[Gong, Ping; Lu, Zhidan; Xing, Jing; Wang, Na; Zhang, Yu] Dalian Med Univ, Affiliated Hosp 1, Emergency Dept, Dalian 116011, Liaoning Provin, Peoples R China	Dalian Medical University	Zhang, Y (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Emergency Dept, Dalian 116011, Liaoning Provin, Peoples R China.	dljizhen@sina.cn	Gong, Ping/AAV-1936-2021	Gong, Ping/0000-0001-9910-7948	Liaoning Province Nature Science Foundation [2013023020]; Training Programs of Talents in Science and Technology [2013D003]	Liaoning Province Nature Science Foundation; Training Programs of Talents in Science and Technology	This study was supported by the Liaoning Province Nature Science Foundation (2013023020) and the Training Programs of Talents in Science and Technology (2013D003). The funders had no role in study design, data collection/analysis, decision to publish, or preparation of the manuscript.	Aires RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073562; Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chao WW, 2010, J ETHNOPHARMACOL, V129, P244, DOI 10.1016/j.jep.2010.03.022; Chen Y, 2013, J TRADIT CHIN MED, V33, P243, DOI 10.1016/S0254-6272(13)60133-8; China's State Food and Drug Administration, 2014, QUAL CONTR STAND DRU; Deng J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010109.pub2; Dinis-Oliveira RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007149; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Hsieh YW, 2013, PEDIATR EMERG CARE, V29, P487, DOI 10.1097/PEC.0b013e31828a347e; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048397; Hsu HH, 2003, J TOXICOL-CLIN TOXIC, V41, P89, DOI 10.1081/CLT-120018278; Huang H, 2011, PHYTOCHEM ANALYSIS, V22, P330, DOI 10.1002/pca.1284; Jia P, 2013, TALANTA, V107, P103, DOI 10.1016/j.talanta.2012.12.031; Jiang M, 2013, J ETHNOPHARMACOL, V147, P426, DOI 10.1016/j.jep.2013.03.032; Jiang WY, 2013, INT IMMUNOPHARMACOL, V16, P160, DOI 10.1016/j.intimp.2013.03.028; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; [孔飞飞 Kong Feifei], 2012, [中国新药杂志, Chinese Journal New Drugs], V21, P100; Koo JR, 2002, AM J KIDNEY DIS, V39, P55, DOI 10.1053/ajkd.2002.29880; Kratsovnik E, 2005, J MOL NEUROSCI, V26, P27, DOI 10.1385/JMN:26:1:027; Li M, 2012, PHYTOTHER RES, V26, P1195, DOI 10.1002/ptr.3680; Lin NC, 2003, J TOXICOL-CLIN TOXIC, V41, P877, DOI 10.1081/CLT-120025356; Liu L, 2005, PLANTA MED, V71, P808, DOI 10.1055/s-2005-871231; Qi F, 2011, J TRADIT CHIN MED, V31, P46, DOI 10.1016/S0254-6272(11)60011-3; Ran X, 2011, PHARM BIOL, V49, P1180, DOI 10.3109/13880209.2011.576346; Ren ZH, 2010, PHYTOMEDICINE, V17, P212, DOI 10.1016/j.phymed.2009.08.010; Saw CLL, 2013, BIOPHARM DRUG DISPOS, V34, P303, DOI 10.1002/bdd.1846; Schoonbroodt S, 2000, BIOCHEM PHARMACOL, V60, P1075, DOI 10.1016/S0006-2952(00)00371-3; Shi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040911; Song LJ, 2013, FITOTERAPIA, V84, P107, DOI 10.1016/j.fitote.2012.11.004; Su YW, 2011, INT IMMUNOPHARMACOL, V11, P1166, DOI 10.1016/j.intimp.2011.03.014; Sun JP, 2010, EXP LUNG RES, V36, P211, DOI 10.3109/01902140903312123; Sun ML, 2009, J ALTERN COMPLEM MED, V15, P1375, DOI 10.1089/acm.2009.0049; Tang S, 2011, INFLAMMATION, V34, P111, DOI 10.1007/s10753-010-9214-3; Wang CC, 2011, J SCI FOOD AGR, V91, P218, DOI 10.1002/jsfa.4172; Weng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051743; Yang W, 2007, J TOXICOL ENV HEAL A, V70, P1849, DOI 10.1080/15287390701459262; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]; Zheng XB, 2012, J TRADIT CHIN MED, V32, P584, DOI 10.1016/S0254-6272(13)60075-8	40	21	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123504	10.1371/journal.pone.0123504	http://dx.doi.org/10.1371/journal.pone.0123504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923333	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600049
J	Gonzalez-Zalba, MF; Ciccarelli, C; Zarbo, LP; Irvine, AC; Campion, RC; Gallagher, BL; Jungwirth, T; Ferguson, AJ; Wunderlich, J				Gonzalez-Zalba, M. Fernando; Ciccarelli, Chiara; Zarbo, Liviu P.; Irvine, Andrew C.; Campion, Richard C.; Gallagher, Bryan L.; Jungwirth, Tomas; Ferguson, Andrew J.; Wunderlich, Joerg			Reconfigurable Boolean Logic Using Magnetic Single-Electron Transistors	PLOS ONE			English	Article							BLOCKADE ANISOTROPIC MAGNETORESISTANCE; OSCILLATIONS; CIRCUITS	We propose a novel hybrid single-electron device for reprogrammable low-power logic operations, the magnetic single-electron transistor (MSET). The device consists of an aluminium single-electron transistor with a GaMnAs magnetic back-gate. Changing between different logic gate functions is realized by reorienting the magnetic moments of the magnetic layer, which induces a voltage shift on the Coulomb blockade oscillations of the MSET. We show that we can arbitrarily reprogram the function of the device from an n-type SET for in-plane magnetization of the GaMnAs layer to p-type SET for out-of-plane magnetization orientation. Moreover, we demonstrate a set of reprogrammable Boolean gates and its logical complement at the single device level. Finally, we propose two sets of reconfigurable binary gates using combinations of two MSETs in a pull-down network.	[Gonzalez-Zalba, M. Fernando; Wunderlich, Joerg] Hitachi Cambridge Lab, Cambridge CB3 0HE, England; [Ciccarelli, Chiara; Irvine, Andrew C.; Ferguson, Andrew J.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Zarbo, Liviu P.; Jungwirth, Tomas; Wunderlich, Joerg] Acad Sci Czech Republ, Inst Phys, Vvi, Prague 16253 6, Czech Republic; [Campion, Richard C.; Gallagher, Bryan L.; Jungwirth, Tomas] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England	University of Cambridge; University of Cambridge; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; University of Nottingham	Gonzalez-Zalba, MF (corresponding author), Hitachi Cambridge Lab, Cambridge CB3 0HE, England.	mg507@cam.ac.uk	Zarbo, Liviu P/O-4960-2014; Jungwirth, Tomas/G-8952-2014; Ciccarelli, Chiara/AAF-9932-2019; Gallagher, Bryan/B-8116-2013	Zarbo, Liviu P/0000-0001-6019-2567; Jungwirth, Tomas/0000-0002-9910-1674; Ciccarelli, Chiara/0000-0003-2299-3704; Irvine, Andy/0000-0002-2097-3614; Gonzalez Zalba, Miguel Fernando/0000-0001-6964-3758; Gallagher, Bryan/0000-0001-8310-0899; Ferguson, Andrew/0000-0003-4868-7166	European Community [318397]; EU European Research Council (ERC) [268066]; Ministry of Education of the Czech Republic [LM2011026]; Grant Agency of the Czech Republic [14-37427G]; Hitachi Ltd.	European Community(European Commission); EU European Research Council (ERC)(European Research Council (ERC)); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Hitachi Ltd.	European Community's Seventh Framework under the Grant Agreement No. 318397 (http://www.tolop.eu) supported MFGZ. EU European Research Council (ERC) advance grant no. 268066, the Ministry of Education of the Czech Republic grant no. LM2011026, and the Grant Agency of the Czech Republic grant no. 14-37427G were received by TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hitachi Ltd. provided support in the form of salaries for authors M. Fernando Gonzalez-Zalba and Joerg Wunderlich, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barnas J, 2000, PHYS REV B, V62, P12363, DOI 10.1103/PhysRevB.62.12363; BEENAKKER CWJ, 1991, PHYS REV B, V44, P1646, DOI 10.1103/PhysRevB.44.1646; Betz AC, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863538; Ciccarelli C, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4752013; Dery H, 2007, NATURE, V447, P573, DOI 10.1038/nature05833; Gonzalez-Zalba MF, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4750251; Hai PN, 2007, JPN J APPL PHYS 1, V46, P6579, DOI 10.1143/JJAP.46.6579; Heinzig A, 2012, NANO LETT, V12, P119, DOI 10.1021/nl203094h; Ishikuro H, 1998, INTERNATIONAL ELECTRON DEVICES MEETING 1998 - TECHNICAL DIGEST, P119, DOI 10.1109/IEDM.1998.746293; Jalil MBA, 2009, J APPL PHYS, V105, DOI 10.1063/1.3055271; Joo S, 2013, NATURE, V494, P72, DOI 10.1038/nature11817; KASTNER MA, 1992, REV MOD PHYS, V64, P849, DOI 10.1103/RevModPhys.64.849; Kirchner S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.206401; Klein M, 2009, CHEMPHYSCHEM, V10, P162, DOI 10.1002/cphc.200800568; Mizuno Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2724771; Mol JA, 2011, P NATL ACAD SCI USA, V108, P13969, DOI 10.1073/pnas.1109935108; Ono K, 1997, J PHYS SOC JPN, V66, P1261, DOI 10.1143/JPSJ.66.1261; Shirakashi J., 2001, Journal of the Magnetics Society of Japan, V25, P783, DOI 10.3379/jmsjmag.25.783; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Takiguchi M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.043101; TUCKER JR, 1992, J APPL PHYS, V72, P4399, DOI 10.1063/1.352206; Uchida K., 2002, 2002 IEEE International Solid-State Circuits Conference. Digest of Technical Papers (Cat. No.02CH37315), P206, DOI 10.1109/ISSCC.2002.993008; Wang H, 2010, IEEE ELECTR DEVICE L, V31, P906, DOI 10.1109/LED.2010.2052017; Wunderlich J, 2007, J MAGN MAGN MATER, V310, P1883, DOI 10.1016/j.jmmm.2006.10.676; Wunderlich J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.077201; Yu WJ, 2009, NANO LETT, V9, P1401, DOI 10.1021/nl803066v; Zhu C, 2007, DES AUT CON, P312, DOI 10.1109/DAC.2007.375178	27	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125142	10.1371/journal.pone.0125142	http://dx.doi.org/10.1371/journal.pone.0125142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923789	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600128
J	Mishra, DR; Chaudhary, S; Krishna, BM; Mishra, SK				Mishra, Dipti Ranjan; Chaudhary, Sanjib; Krishna, B. Madhu; Mishra, Sandip K.			Identification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SP1; PROTEIN-30 GENE PROMOTER; HUMAN GASTRIC-CANCER; POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN ACCESSIBILITY; INCREASED EXPRESSION; MASS-SPECTROMETRY; BINDING-ACTIVITY; CYCLE ARREST; LIVER	Cytosolic inorganic pyrophosphatase plays an important role in the cellular metabolism by hydrolyzing inorganic pyrophosphate (PPi) formed as a by-product of various metabolic reactions. Inorganic pyrophosphatases are known to be associated with important functions related to the growth and development of various organisms. In humans, the expression of inorganic pyrophosphatase (PPA1) is deregulated in different types of cancer and is involved in the migration and invasion of gastric cancer cells and proliferation of ovarian cancer cells. However, the transcriptional regulation of the gene encoding PPA1 is poorly understood. To gain insights into PPA1 gene regulation, a 1217 bp of its 5'-flanking region was cloned and analyzed. The 5'-deletion analysis of the promoter revealed a 266 bp proximal promoter region exhibit most of the transcriptional activity and upon sequence analysis, three putative Sp1 binding sites were found to be present in this region. Binding of Sp1 to the PPA1 promoter was confirmed by Electrophoretic mobility shift assay (EMSA) and Chromatin immunoprecipitation (ChIP) assay. Importance of these binding sites was verified by site-directed mutagenesis and overexpression of Sp1 transactivates PPA1 promoter activity, upregulates protein expression and increases chromatin accessibility. p300 binds to the PPA1 promoter and stimulates Sp1 induced promoter activity. Trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor induces PPA1 promoter activity and protein expression and HAT activity of p300 was important in regulation of PPA1 expression. These results demonstrated that PPA1 is positively regulated by Sp1 and p300 coactivates Sp1 induced PPA1 promoter activity and histone acetylation/deacetylation may contribute to a local chromatin remodeling across the PPA1 promoter. Further, knockdown of PPA1 decreased colony formation and viability of MCF7 cells.	[Mishra, Dipti Ranjan; Chaudhary, Sanjib; Krishna, B. Madhu; Mishra, Sandip K.] Inst Life Sci, Canc Biol Lab, Gene Funct & Regulat Grp, Bhubaneswar, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Mishra, SK (corresponding author), Inst Life Sci, Canc Biol Lab, Gene Funct & Regulat Grp, Bhubaneswar, Odisha, India.	sandipkmishra@hotmail.com		Mishra, Sandip/0000-0002-0776-6581	core grant of Institute of Life Sciences, Department of Biotechnology, Government of India; Indian Council of Medical Research; Department of Biotechnology, India	core grant of Institute of Life Sciences, Department of Biotechnology, Government of India; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by core grant of Institute of Life Sciences, Department of Biotechnology, Government of India. DRM was supported by research fellowship from Indian Council of Medical Research and, SC and BMK were supported by research fellowships from Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; Archer Michael C, 2011, Genes Cancer, V2, P712, DOI 10.1177/1947601911423029; Baykov A A, 1999, Prog Mol Subcell Biol, V23, P127; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Cerella Claudia, 2013, Int J Cell Biol, V2013, P639401, DOI 10.1155/2013/639401; Chahed K, 2005, INT J ONCOL, V27, P1425; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Chen GA, 2002, CLIN CANCER RES, V8, P2298; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chiefari E, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-35; Cho KS, 2004, CURR OPIN GENET DEV, V14, P308, DOI 10.1016/j.gde.2004.04.015; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cruickshank M, 2008, BIOCHEM BIOPH RES CO, V367, P349, DOI 10.1016/j.bbrc.2007.12.121; Garnis C, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-9; Giri K, 2014, BIOCONJUGATE CHEM, V25, P1078, DOI 10.1021/bc500084f; Hamler RL, 2004, PROTEOMICS, V4, P562, DOI 10.1002/pmic.200300606; Islam MK, 2005, INFECT IMMUN, V73, P1995, DOI 10.1128/IAI.73.4.1995-2004.2005; Jeong SH, 2012, TUMOR BIOL, V33, P1889, DOI 10.1007/s13277-012-0449-5; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Kachman MT, 2002, ANAL CHEM, V74, P1779, DOI 10.1021/ac011159c; Kharbhih WJ, 2014, BIOGERONTOLOGY, V15, P81, DOI 10.1007/s10522-013-9481-0; Ko KM, 2007, FEBS LETT, V581, P5445, DOI 10.1016/j.febslet.2007.10.047; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; Li JJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000910; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Megger DA, 2013, MOL CELL PROTEOMICS, V12, P2006, DOI 10.1074/mcp.M113.028027; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; Panda H, 2007, BIOGERONTOLOGY, V8, P517, DOI 10.1007/s10522-007-9094-6; Panda H, 2007, GENE EXPRESSION, V14, P13, DOI 10.3727/000000007783991754; Papavassiliou AG, 2001, EMBO REP, V2, P80, DOI 10.1093/embo-reports/kve033; Rath B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-43; Sambrook J., 2001, MOL CLONING LAB MANU; Sar P, 2012, J CANC SCI THER, V4, P227; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serrano-Bueno G, 2013, J BIOL CHEM, V288, P13082, DOI 10.1074/jbc.M112.439349; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Sun FY, 2009, NUCLEIC ACIDS RES, V37, P3897, DOI 10.1093/nar/gkp261; Supakar PC, 2000, BIOCHEM BIOPH RES CO, V272, P436, DOI 10.1006/bbrc.2000.2799; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Terzic N, 2003, J GERONTOL A-BIOL, V58, P297; Tezuka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061649; Tomonaga T, 2004, CLIN CANCER RES, V10, P2007, DOI 10.1158/1078-0432.CCR-03-0321; Vindevoghel L, 1997, J BIOL CHEM, V272, P10196; Wang GG, 2007, TRENDS MOL MED, V13, P373, DOI 10.1016/j.molmed.2007.07.004; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang JY, 2010, BIOCHEM BIOPH RES CO, V393, P291, DOI 10.1016/j.bbrc.2010.01.127; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang LW, 2005, CLIN EXP METASTAS, V22, P205, DOI 10.1007/s10585-005-5684-3; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Zannetti A, 2000, CANCER RES, V60, P1546	53	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124864	10.1371/journal.pone.0124864	http://dx.doi.org/10.1371/journal.pone.0124864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923237	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600108
J	Dai, X; Chen, X; Chen, Q; Shi, L; Liang, HW; Zhou, Z; Liu, Q; Pang, WJ; Hou, DX; Wang, C; Zen, K; Yuan, YZ; Zhang, CY; Xia, L				Dai, Xin; Chen, Xi; Chen, Qun; Shi, Lei; Liang, Hongwei; Zhou, Zhen; Liu, Qian; Pang, Wenjing; Hou, Dongxia; Wang, Cheng; Zen, Ke; Yuan, Yaozong; Zhang, Chen-Yu; Xia, Lu			MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; inflammatory bowel disease (IBD); microRNA (miRNA); mucosal immunology; peptide transport	NF-KAPPA-B; OLIGOPEPTIDE TRANSPORTER PEPT-1; INDUCED COLITIS; BOWEL-DISEASE; EXPRESSION; FMLP; MICRORNAS; CELLS; ACTIVATION; APOPTOSIS	Background: The involvement of miRNAs in the host mucosal immune response to gut microbes in colitis is still unclear. Results: miR-193a-3p down-regulates PepT1, and intracolonic-delivery of miR-193a-3p ameliorated the severity of colitis. Conclusion: miRNA-193a-3p can target colonic PepT1 and reduce intestinal inflammation. Significance: Our study illustrates the new role of miRNAs in regulating the host immune response to microbes during colitis. Intestinal inflammation is characterized by epithelial disruption, leading to the loss of barrier function, recruitment of immune cells, and host immune responses to gut microbiota. PepT1, a di/tripeptide transporter that uptakes bacterial products, is up-regulated in inflamed colon tissue, which implies its role in bacterium-associated intestinal inflammation. Although microRNA (miRNA)-mediated gene regulation has been found to be involved in various processes of inflammatory bowel disease (IBD), the biological function of miRNAs in the pathogenesis of IBD remains to be explored. In this study we detected miRNA expression patterns in colon tissues during colitis and investigated the mechanism underlying the regulation of colonic PepT1 by miRNAs. We observed an inverse correlation between PepT1 and miR-193a-3p in inflamed colon tissues with active ulcerative colitis, and we further demonstrated that miR-193a-3p reduced PepT1 expression and activity as a target gene and subsequently suppressed the NF-B pathway. Intracolonic delivery of miR-193a-3p significantly ameliorated dextran sodium sulfate-induced colitis, whereas the overexpression of colonic PepT1 via PepT1 3-untranslated region mutant lentivirus vector abolished the anti-inflammatory effect of miR-193a-3p. Furthermore, antibiotic treatment eliminated the difference in the dextran sodium sulfate-induced inflammation between the presence and absence of miR-193a-3p. These findings suggest that miR-193a-3p regulation of PepT1 mediates the uptake of bacterial products and is a potent mechanism during the colonic inflammation process. Overall, we believe miR-193a-3p may be a potent regulator of colonic PepT1 for maintaining intestinal homeostasis.	[Dai, Xin; Liu, Qian; Pang, Wenjing; Yuan, Yaozong; Xia, Lu] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China; [Chen, Xi; Chen, Qun; Shi, Lei; Liang, Hongwei; Zhou, Zhen; Hou, Dongxia; Wang, Cheng; Zen, Ke; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Nanjing University	Yuan, YZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, 197 Ruijin Second Rd, Shanghai 200025, Peoples R China.	yyz28@medmail.com.cn; cyzhang@nju.edu.cn; xialu@medmail.com.cn	Wang, Cheng/O-7206-2016; Zhou, Zhen/L-7152-2019; Shi, Lei/AAJ-1586-2020	Wang, Cheng/0000-0002-1834-2119; Shi, Lei/0000-0002-6631-6732	National Natural Science Foundation of China [81200281, 81101330, 31271378, 81250044, J1103512]; Natural Science Foundation of Jiangsu Province [BK2011013, BK2012014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China Grants 81200281, 81101330, 31271378, 81250044, and J1103512 and Natural Science Foundation of Jiangsu Province Grants BK2011013 and BK2012014. The authors declare that they have no conflicts of interest with the contents of this article.	Adibi SA, 2003, AM J PHYSIOL-GASTR L, V285, pG779, DOI 10.1152/ajpgi.00056.2003; Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Andersen V, 2011, WORLD J GASTROENTERO, V17, P197, DOI 10.3748/wjg.v17.i2.197; Ando Y, 2012, HEPATOLOGY, V56, P1418, DOI 10.1002/hep.25803; Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Ayyadurai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087614; Ayyadurai S, 2013, LAB INVEST, V93, P888, DOI 10.1038/labinvest.2013.77; Bantel H, 2000, AM J GASTROENTEROL, V95, P1845; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Burns KA, 2004, CURR BIOL, V14, pR1040, DOI 10.1016/j.cub.2004.11.040; Buyse M, 2002, AM J PHYSIOL-CELL PH, V283, pC1795, DOI 10.1152/ajpcell.00186.2002; Carlson RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1070, DOI 10.1152/ajpgi.00417.2006; Chen LY, 2009, J IMMUNOL, V182, P2518, DOI 10.4049/jimmunol.0713933; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen Y, 2013, BIOCHEM BIOPH RES CO, V438, P133, DOI 10.1016/j.bbrc.2013.07.040; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; Dalmasso G, 2008, GASTROENTEROLOGY, V134, P166, DOI 10.1053/j.gastro.2007.10.026; Dalmasso G, 2011, GASTROENTEROLOGY, V141, P1334, DOI 10.1053/j.gastro.2011.06.080; Dalmasso G, 2011, AM J PHYSIOL-GASTR L, V300, pG52, DOI 10.1152/ajpgi.00394.2010; Dalmasso G, 2010, AM J PHYSIOL-GASTR L, V299, pG687, DOI 10.1152/ajpgi.00527.2009; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hindlet P, 2007, J PHARMACOL EXP THER, V323, P192, DOI 10.1124/jpet.107.125799; Hindlet P, 2009, J BIOL CHEM, V284, P6801, DOI 10.1074/jbc.M805564200; Huang Z, 2014, GUT, V63, P1247, DOI 10.1136/gutjnl-2012-304213; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Kwon JE, 2013, APOPTOSIS, V18, P896, DOI 10.1007/s10495-013-0841-7; Li LM, 2011, J IMMUNOL, V186, P2552, DOI 10.4049/jimmunol.1001633; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Salvi A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-162; Shi B, 2006, J SURG RES, V136, P38, DOI 10.1016/j.jss.2006.05.025; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu W, 2015, GUT, V64, P1755, DOI 10.1136/gutjnl-2014-307980; Xue XC, 2014, EUR J IMMUNOL, V44, P673, DOI 10.1002/eji.201343717; Xue XC, 2011, J IMMUNOL, V187, P5879, DOI 10.4049/jimmunol.1100535; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	43	59	65	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16099	16115		10.1074/jbc.M115.659318	http://dx.doi.org/10.1074/jbc.M115.659318			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25931122	hybrid, Green Published			2022-12-26	WOS:000356930100016
J	Hossain, ST; Malhotra, A; Deutscher, MP				Hossain, Sk Tofajjen; Malhotra, Arun; Deutscher, Murray P.			The Helicase Activity of Ribonuclease R Is Essential for Efficient Nuclease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Escherichia coli (E; coli); ribonuclease; RNA degradation; RNA helicase	MESSENGER-RNA DECAY; ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; STRUCTURED RNA; RIBOSOMAL-RNA; BINDING; DEGRADOSOME; COMPLEX; ATP; DEGRADATION	Background:Escherichia coli RNase R contains an intrinsic RNA helicase activity. Results: Walker A and Walker B motifs located in the C- and N-terminal regions, respectively, are required for helicase activity. Conclusion: RNase R helicase activity utilizes the nuclease catalytic channel and stimulates the nuclease activity. Significance: These findings help to explain how RNase R efficiently degrades structured RNA. RNase R, which belongs to the RNB family of enzymes, is a 3 to 5 hydrolytic exoribonuclease able to digest highly structured RNA. It was previously reported that RNase R possesses an intrinsic helicase activity that is independent of its ribonuclease activity. However, the properties of this helicase activity and its relationship to the ribonuclease activity were not clear. Here, we show that helicase activity is dependent on ATP and have identified ATP-binding Walker A and Walker B motifs that are present in Escherichia coli RNase R and in 88% of mesophilic bacterial genera analyzed, but absent from thermophilic bacteria. We also show by mutational analysis that both of these motifs are required for helicase activity. Interestingly, the Walker A motif is located in the C-terminal region of RNase R, whereas the Walker B motif is in its N-terminal region implying that the two parts of the protein must come together to generate a functional ATP-binding site. Direct measurement of ATP binding confirmed that ATP binds only when double-stranded RNA is present. Detailed analysis of the helicase activity revealed that ATP hydrolysis is not required because both adenosine 5-O-(thiotriphosphate) and adenosine 5-(,-imino)triphosphate can stimulate helicase activity, as can other nucleoside triphosphates. Although the nuclease activity of RNase R is not needed for its helicase activity, the helicase activity is important for effective nuclease activity against a dsRNA substrate, particularly at lower temperatures and with more stable duplexes. Moreover, competition experiments and mutational analysis revealed that the helicase activity utilizes the same catalytic channel as the nuclease activity. These findings indicate that the helicase activity plays an essential role in the catalytic efficiency of RNase R.	[Hossain, Sk Tofajjen; Malhotra, Arun; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu	Malhotra, Arun/Z-5140-2019; Regan, Clinton/E-6250-2012	Malhotra, Arun/0000-0001-6656-7841; Hossain, Sk Tofajjen/0000-0002-1448-1015	National Institutes of Health [GM 16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 16317 (to M. P. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Awano N, 2007, J BACTERIOL, V189, P5808, DOI 10.1128/JB.00655-07; Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Liang WX, 2012, J BIOL CHEM, V287, P33472, DOI 10.1074/jbc.M112.375287; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	26	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15697	15706		10.1074/jbc.M115.650176	http://dx.doi.org/10.1074/jbc.M115.650176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25931119	Green Published, hybrid			2022-12-26	WOS:000356527400032
J	Li, XD; Yang, YJ; Wang, LY; Qiao, SB; Lu, XF; Wu, YJ; Xu, B; Li, HF; Gu, DF				Li, Xiangdong; Yang, Yuejin; Wang, Laiyuan; Qiao, Shubin; Lu, Xiangfeng; Wu, Yongjian; Xu, Bo; Li, Hongfan; Gu, Dongfeng			Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; DIAGNOSIS; CANCER	Objective We evaluated the potentiality of plasma microRNAs (miRNAs, or miRs) that were considered as novel biomarkers for acute coronary syndrome (ACS), including acute myocardial infarction (AMI) and unstable angina (UA). Methods and Results We initially identified plasma miR-122, -140-3p, -144, -720, -1225-3p, -2861, and -3149 as candidate miRNAs associated with AMI (>= 2 fold and P < 0.05) by comparing expression differences of miRNAs among AMI, non-coronary heart disease (non-CHD) and stable angina (SA) groups, using miRNA microarrays (n = 8 independent arrays in each group). Those seven plasma miRNAs were further examined with qRT-PCR analyses in two replications including 111 and 428 patients separately, and the results demonstrated that plasma miR-122, -140-3p, -720, -2861, and -3149 were elevated in the ACS group vs. the non-ACS (non-CHD + SA) group (P < 0.01). The area under the receiver operating characteristic curve (AUC) of the five miRNAs for ACS classification was 0.838, 0.818, 0.865, 0.852, and 0.670, respectively (all P < 0.001), while the values reached 0.843 and 0.925 when simultaneously with miR-122 and -3149 or with miR-122, -2861, and -3149 together (all P < 0.001). In plasma of pigs after coronary ligation, miR-122 was increased from 180 min to 240 min and miR-3149 was augmented from 30 min to 240 min compared with the sham pigs (all P < 0.05). Conclusion Plasma miR-122, -140-3p, -720, -2861, and -3149 were associated with and potentially novel biomarkers for ACS.	[Li, Xiangdong; Wang, Laiyuan; Lu, Xiangfeng; Li, Hongfan; Gu, Dongfeng] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Epidemiol,State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China; [Li, Xiangdong; Yang, Yuejin; Wang, Laiyuan; Qiao, Shubin; Lu, Xiangfeng; Wu, Yongjian; Xu, Bo; Li, Hongfan; Gu, Dongfeng] Peking Union Med Coll, Beijing 100037, Peoples R China; [Li, Xiangdong; Yang, Yuejin; Qiao, Shubin; Wu, Yongjian; Xu, Bo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Gu, DF (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Epidemiol,State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China.	gudongfeng@vip.sina.com	Duarte, Graziela Biude Silva/Q-7728-2016	Wu, Yongjian/0000-0002-5590-8396	National Basic Research Program (973 Program) in China [2011CB503901, 2012CB518602]; China Postdoctoral Science Foundation [2012M510355]; National Science Foundation of China [81270334]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program (973 Program) in China (http://www.most.gov.cn/) (No. 2011CB503901 (Dr. Dong-Feng Gu) and 2012CB518602 (Dr. Yue-Jin Yang)), China Postdoctoral Science Foundation (http://res.chinapostdoctor.org.cn/) (Dr. Xiang-Dong Li, No. 2012M510355), and the National Science Foundation of China (http://www.nsfc.gov.cn/) (Dr. Lai-Yuan Wang, No. 81270334).	Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Arbab-Zadeh A, 2012, CIRCULATION, V125, P1147, DOI 10.1161/CIRCULATIONAHA.111.047431; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dangwal S, 2012, THROMB HAEMOSTASIS, V108, P599, DOI 10.1160/TH12-03-0211; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Goch A, 2009, CLIN CARDIOL, V32, pE46, DOI DOI 10.1002/CLC.20354; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Haver VG, 2010, TRENDS CARDIOVAS MED, V20, P65, DOI 10.1016/j.tcm.2010.04.002; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Kukreja RC, 2011, MOL PHARMACOL, V80, P558, DOI 10.1124/mol.111.073528; Li LZ, 2014, CARCINOGENESIS, V35, P469, DOI 10.1093/carcin/bgt330; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Pleister A, 2013, BIOMARK MED, V7, P287, DOI [10.2217/bmm.13.8, 10.2217/BMM.13.8]; Raitoharju E, 2013, CLIN CHEM, V59, P1708, DOI 10.1373/clinchem.2013.204917; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang Y, 2013, MOL MED REP, V7, P1506, DOI 10.3892/mmr.2013.1384; Wang Zhiguo, 2010, World J Biol Chem, V1, P41, DOI 10.4331/wjbc.v1.i4.41; Wang ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0577-9; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wu AHB, 1998, EUR HEART J, V19, pN25	30	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125430	10.1371/journal.pone.0125430	http://dx.doi.org/10.1371/journal.pone.0125430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933289	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100111
J	Bijarnia, RK; Bachtler, M; Chandak, PG; van Goor, H; Pasch, A				Bijarnia, Rakesh K.; Bachtler, Matthias; Chandak, Prakash G.; van Goor, Harry; Pasch, Andreas			Sodium Thiosulfate Ameliorates Oxidative Stress and Preserves Renal Function in Hyperoxaluric Rats	PLOS ONE			English	Article							OXALATE CRYSTAL DEPOSITION; CALCIUM-OXALATE; VASCULAR CALCIFICATION; HEMODIALYSIS-PATIENTS; STONE FORMATION; CELL INJURY; VITAMIN-E; KIDNEY; DISEASE; CALCIPHYLAXIS	Background Hyperoxaluria causes crystal deposition in the kidney, which leads to oxidative stress and to injury and damage of the renal epithelium. Sodium thiosulfate (STS, Na2S2O3) is an antioxidant, which has been used in human medicine for decades. The effect of STS on hyperoxaluria-induced renal damage is not known. Methods Hyperoxaluria and renal injury were induced in healthy male Wistar rats by chronic exposure to ethylene glycol (EG, 0.75%) in the drinking water for 4 weeks. The treatment effects of STS, NaCl or Na2SO4 were compared. Furthermore, the effects of STS on oxalate-induced oxidative stress were investigated in vitro in renal LLC-PK1 cells. Results Chronic EG exposure led to hyperoxaluria, oxidative stress, calcium oxalate crystalluria and crystal deposition in the kidneys. Whereas all tested compounds significantly reduced crystal load, only STS-treatment maintained tissue superoxide dismutase activity and urine 8-isoprostaglandin levels in vivo and preserved renal function. In in vitro studies, STS showed the ability to scavenge oxalate-induced ROS accumulation dose dependently, reduced cell-released hydrogen peroxide and preserved superoxide dismutase activity. As a mechanism explaining this finding, STS was able to directly inactivate hydrogen peroxide in cell-free experiments. Conclusions STS is an antioxidant, which preserves renal function in a chronic EG rat model. Its therapeutic use in oxidative-stress induced renal-failure should be considered.	[Bijarnia, Rakesh K.; Bachtler, Matthias; Chandak, Prakash G.; Pasch, Andreas] Univ Hosp Bern, Dept Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland; [Bijarnia, Rakesh K.; Bachtler, Matthias; Chandak, Prakash G.; Pasch, Andreas] Univ Bern, Inselspital, CH-3010 Bern, Switzerland; [Bijarnia, Rakesh K.; Bachtler, Matthias; Chandak, Prakash G.; Pasch, Andreas] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Groningen	Pasch, A (corresponding author), Univ Hosp Bern, Dept Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland.	andreas.pasch@insel.ch	van+Goor, Harry/AAS-7712-2020	van Goor, Harry/0000-0002-6670-1577	Kohler Chemie, the provider of sodium thiosulfate	Kohler Chemie, the provider of sodium thiosulfate	AP has received an unrestricted research grant from Kohler Chemie, the provider of sodium thiosulfate. Kohler Chemie had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplin JR, 2009, J AM SOC NEPHROL, V20, P1246, DOI 10.1681/ASN.2008070754; Bashir S, 2011, EUR J PHARMACOL, V651, P168, DOI 10.1016/j.ejphar.2010.10.076; Bijarnia RK, 2008, FOOD CHEM TOXICOL, V46, P2274, DOI 10.1016/j.fct.2008.03.007; Bodakhe KS, 2013, CHIN J NAT MEDICINES, V11, P466, DOI 10.1016/S1875-5364(13)60085-0; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Failli P, 2002, NITRIC OXIDE-BIOL CH, V7, P277, DOI 10.1016/S1089-8603(02)00120-9; Farese S, 2011, CLIN J AM SOC NEPHRO, V6, P1447, DOI 10.2215/CJN.10241110; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Gaspar S, 2010, BIOSENS BIOELECTRON, V25, P1729, DOI 10.1016/j.bios.2009.12.013; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-4; Hirose M, 2010, INT J UROL, V17, P83, DOI 10.1111/j.1442-2042.2009.02410.x; Holt C, 2014, J STRUCT BIOL, V185, P383, DOI 10.1016/j.jsb.2013.11.009; Huang S, 2009, AM J PHYSIOL-RENAL, V296, pF34, DOI 10.1152/ajprenal.90309.2008; Khan SR, 2013, J UROLOGY, V189, P803, DOI 10.1016/j.juro.2012.05.078; LaGrange CA, 2009, J ENDOUROL, V23, P529, DOI 10.1089/end.2008.0204; Lee HW, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-500; Li CY, 2009, UROL RES, V37, P211, DOI 10.1007/s00240-009-0197-1; Lorenzo V, 2014, NEFROLOGIA, V34, P398, DOI 10.3265/Nefrologia.pre2014.Jan.12335; Malbos S, 2014, RHEUMATOLOGY, V53, P547, DOI 10.1093/rheumatology/ket388; Mathews SJ, 2011, AM J NEPHROL, V33, P131, DOI 10.1159/000323550; Meimaridou E, 2005, FREE RADICAL BIO MED, V38, P1553, DOI 10.1016/j.freeradbiomed.2005.02.020; Meissner M, 2006, DERMATOLOGY, V212, P373, DOI 10.1159/000092290; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Mulder GM, 2010, J PATHOL, V221, P183, DOI 10.1002/path.2698; Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4; Park HK, 2008, J UROLOGY, V179, P1620, DOI 10.1016/j.juro.2007.11.039; Pasch A, 2008, KIDNEY INT, V74, P1444, DOI 10.1038/ki.2008.455; Samarneh Majed Mark, 2012, J Clin Med Res, V4, P56, DOI 10.4021/jocmr525w; Schepers MSJ, 2005, KIDNEY INT, V68, P1543, DOI 10.1111/j.1523-1755.2005.00566.x; Selvam R, 2000, INDIAN J MED RES, V111, P62; Selvam R, 2002, UROL RES, V30, P35, DOI 10.1007/s00240-001-0228-z; Smith VM, 2012, CLIN EXP DERMATOL, V37, P874, DOI 10.1111/j.1365-2230.2012.04350.x; Tanriverdi O, 2012, UROL RES, V40, P17, DOI 10.1007/s00240-011-0388-4; Thamilselvan S, 2005, BJU INT, V96, P117, DOI 10.1111/j.1464-410X.2005.05579.x; Thamilselvan V, 2014, BJU INT, V114, P140, DOI 10.1111/bju.12642; Thamilselvan V, 2009, AM J PHYSIOL-RENAL, V297, pF1399, DOI 10.1152/ajprenal.00051.2009; Tuan LQ, 2009, ENZYME MICROB TECH, V44, P101, DOI 10.1016/j.enzmictec.2008.10.012; ULLRICH KJ, 1980, PFLUG ARCH EUR J PHY, V387, P127, DOI 10.1007/BF00584263; van den Berg E, 2014, J AM SOC NEPHROL, V25, P1303, DOI 10.1681/ASN.2013050497; Xue KY, 2004, ACTA PHYS-CHIM SIN, V20, P772, DOI 10.3866/PKU.WHXB20040722; YATZIDIS H, 1985, CLIN NEPHROL, V23, P63; Yonova DH, 2014, INT J ARTIF ORGANS, V37, P308, DOI 10.5301/ijao.5000309; Zuo J, 2011, NEPHROL DIAL TRANSPL, V26, P1785, DOI 10.1093/ndt/gfr035	43	32	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124881	10.1371/journal.pone.0124881	http://dx.doi.org/10.1371/journal.pone.0124881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928142	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100051
J	Lu, L; Yu, YY; Guo, YE; Wang, YW; Chang, EB; Claud, EC				Lu, Lei; Yu, Yueyue; Guo, Yuee; Wang, Yunwei; Chang, Eugene B.; Claud, Erika C.			Transcriptional Modulation of Intestinal Innate Defense/Inflammation Genes by Preterm Infant Microbiota in a Humanized Gnotobiotic Mouse Model	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NECROTIZING ENTEROCOLITIS; BACTERIAL-COLONIZATION; GROWTH IMPAIRMENT; CROHNS-DISEASE; GUT MICROBIOTA; KAPPA-B; INFLAMMATION; INTERLEUKIN-6; MICROFLORA	Background and Aims It is known that postnatal functional maturation of the small intestine is facilitated by microbial colonization of the gut. Preterm infants exhibit defects in gut maturation, weak innate immunity against intestinal infection and increased susceptibility to inflammatory disorders, all of which may be related to the inappropriate microbial colonization of their immature intestines. The earliest microbes to colonize the preterm infant gut encounter a naive, immature intestine. Thus this earliest microbiota potentially has the greatest opportunity to fundamentally influence intestinal development and immune function. The aim of this study was to characterize the effect of early microbial colonization on global gene expression in the distal small intestine during postnatal gut development. Methods Gnotobiotic mouse models with experimental colonization by early (prior to two weeks of life) intestinal microbiota from preterm human infants were utilized. Microarray analysis was used to assess global gene expression in the intestinal epithelium. Results and Conclusion Multiple intestinal genes involved in metabolism, cell cycle regulation, cell-cell or cell-extracellular matrix communication, and immune function are developmental-and intestinal microbiota-regulated. Using a humanized gnotobiotic mouse model, we demonstrate that certain early preterm infant microbiota from prior to 2 weeks of life specifically induce increased NF-kappa B activation and a phenotype of increased inflammation whereas other preterm microbiota specifically induce decreased NF-kappa B activation. These fundamental differences correlate with altered clinical outcomes and suggest the existence of optimal early microbial communities to improve health outcomes.	[Lu, Lei; Yu, Yueyue; Guo, Yuee; Claud, Erika C.] Univ Chicago, Dept Pediat Neonatol, Chicago, IL 60637 USA; [Chang, Eugene B.; Claud, Erika C.] Univ Chicago, Dept Med Gastroenterol, Chicago, IL 60637 USA; [Wang, Yunwei] Univ Nevada, Sch Med, Internal Med Residency Program Reno, Reno, NV 89557 USA	University of Chicago; University of Chicago; Nevada System of Higher Education (NSHE); University of Nevada Reno	Claud, EC (corresponding author), Univ Chicago, Dept Pediat Neonatol, Chicago, IL 60637 USA.	eclaud@peds.bsd.uchicago.edu			R01 Human Development [059123]; P30 Digestive and Kidney [42086]; National Institute of Health Human Microbiome Demonstration Project UH3 Digestive and Kidney [083993]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097268] Funding Source: NIH RePORTER	R01 Human Development; P30 Digestive and Kidney; National Institute of Health Human Microbiome Demonstration Project UH3 Digestive and Kidney; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding Support: R01 Human Development 059123 (Erika Claud), P30 Digestive and Kidney 42086 (Digestive Disease Research Core Center), National Institute of Health Human Microbiome Demonstration Project UH3 Digestive and Kidney 083993 (Eugene Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azooz O, 2000, GASTROENTEROLOGY, V118, pA62, DOI 10.1016/S0016-5085(00)82322-7; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Ballinger A, 2002, HORM RES, V58, P7, DOI 10.1159/000064756; Barrett E, 2013, ARCH DIS CHILD-FETAL, V98, pF334, DOI 10.1136/archdischild-2012-303035; Burns RC, 2001, GASTROENTEROLOGY, V121, P1428, DOI 10.1053/gast.2001.29568; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cilieborg MS, 2012, EARLY HUM DEV, V88, pS41, DOI 10.1016/j.earlhumdev.2011.12.027; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Claud Erika C., 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P248; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; De Benedetti F, 2002, HORM RES, V58, P24, DOI 10.1159/000064757; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; DeSantis TZ, 2003, BIOINFORMATICS, V19, P1461, DOI 10.1093/bioinformatics/btg200; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Fell JME, 2005, EARLY HUM DEV, V81, P117, DOI 10.1016/j.earlhumdev.2004.10.001; Hallstrom M, 2004, EUR J CLIN MICROBIOL, V23, P463, DOI 10.1007/s10096-004-1146-0; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; HYDUK SJ, 2007, PROG INFLAM RES, P141; Kestler HA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-67; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Patsos G, 2009, BIOL CHEM, V390, P581, DOI 10.1515/BC.2009.052; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Speer CP, 2001, BIOL NEONATE, V79, P205; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; The center for computational and integrative biology Massachusetts General Hospital School HM, 2011, PCR PRIM GEN EXPR DE; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	43	24	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124504	10.1371/journal.pone.0124504	http://dx.doi.org/10.1371/journal.pone.0124504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928420	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100035
J	Qi, RL; Li, MH; Ma, YY; Chen, NH				Qi, Renli; Li, Minghong; Ma, Yuanye; Chen, Nanhui			State-Dependent Changes in Auditory Sensory Gating in Different Cortical Areas in Rats	PLOS ONE			English	Article							EVOKED-POTENTIALS; NEUROPHYSIOLOGICAL EVIDENCE; TEMPORAL VARIABILITY; P50 COMPONENT; HUMAN SLEEP; BRAIN-STEM; NREM SLEEP; K-COMPLEX; NON-REM; EEG	Sensory gating is a process in which the brain's response to a repetitive stimulus is attenuated; it is thought to contribute to information processing by enabling organisms to filter extraneous sensory inputs from the environment. To date, sensory gating has typically been used to determine whether brain function is impaired, such as in individuals with schizophrenia or addiction. In healthy subjects, sensory gating is sensitive to a subject's behavioral state, such as acute stress and attention. The cortical response to sensory stimulation significantly decreases during sleep; however, information processing continues throughout sleep, and an auditory evoked potential (AEP) can be elicited by sound. It is not known whether sensory gating changes during sleep. Sleep is a non-uniform process in the whole brain with regional differences in neural activities. Thus, another question arises concerning whether sensory gating changes are uniform in different brain areas from waking to sleep. To address these questions, we used the sound stimuli of a Conditioning-testing paradigm to examine sensory gating during waking, rapid eye movement (REM) sleep and Non-REM (NREM) sleep in different cortical areas in rats. We demonstrated the following: 1. Auditory sensory gating was affected by vigilant states in the frontal and parietal areas but not in the occipital areas. 2. Auditory sensory gating decreased in NREM sleep but not REM sleep from waking in the frontal and parietal areas. 3. The decreased sensory gating in the frontal and parietal areas during NREM sleep was the result of a significant increase in the test sound amplitude.	[Qi, Renli] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Qi, Renli; Li, Minghong; Ma, Yuanye; Chen, Nanhui] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Brain & Cognit Sci, Kunming, Yunnan, Peoples R China; [Li, Minghong] Yunnan Univ Tradit Chinese Med, Kunming, Peoples R China; [Ma, Yuanye] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Ma, Yuanye; Chen, Nanhui] Yunnan Key Lab Primate Biomed Res, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University of Chinese Medicine; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ma, YY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Brain & Cognit Sci, Kunming, Yunnan, Peoples R China.	yuanma0716@vip.sina.com; nhchen@mail.kiz.ac.cn			Ministry of Science and Technology of the People's Republic of China [2011BAK04B04]; NSFC [61178051]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the Ministry of Science and Technology of the People's Republic of China (No. 2011BAK04B04) and a grant from NSFC (No. 61178051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; ADLER LE, 1986, BIOL PSYCHIAT, V21, P787, DOI 10.1016/0006-3223(86)90244-1; Anstrom KK, 2007, NEUROSCIENCE, V146, P515, DOI 10.1016/j.neuroscience.2007.01.060; BICKFORDWIMER PC, 1990, BIOL PSYCHIAT, V27, P183, DOI 10.1016/0006-3223(90)90648-L; BOUTROS NN, 1991, CLIN ELECTROENCEPHAL, V22, P40, DOI 10.1177/155005949102200109; Broyd SJ, 2013, INT J PSYCHOPHYSIOL, V89, P381, DOI 10.1016/j.ijpsycho.2013.04.015; Budd TW, 2013, BRAIN RES, V1498, P59, DOI 10.1016/j.brainres.2012.12.033; Cajochen C, 1999, Sleep Res Online, V2, P65; Colrain IM, 2007, SLEEP MED REV, V11, P277, DOI 10.1016/j.smrv.2007.05.001; Cote KA, 2002, INT J PSYCHOPHYSIOL, V46, P227, DOI 10.1016/S0167-8760(02)00114-9; CULLUM CM, 1993, SCHIZOPHR RES, V10, P131, DOI 10.1016/0920-9964(93)90048-N; de Bruin NMWJ, 2001, BIOL PSYCHOL, V55, P195, DOI 10.1016/S0301-0511(00)00084-3; De Bruin NMWJ, 2001, NEUROSCIENCE, V105, P169, DOI 10.1016/S0306-4522(01)00183-X; DI S, 1992, J NEUROPHYSIOL, V68, P425, DOI 10.1152/jn.1992.68.2.425; Dissanayake DWN, 2013, NEUROPHARMACOLOGY, V67, P66, DOI 10.1016/j.neuropharm.2012.10.011; Dissanayake DWN, 2009, BRAIN RES, V1298, P153, DOI 10.1016/j.brainres.2009.08.032; Feinberg I, 2011, SLEEP, V34, P325, DOI 10.1093/sleep/34.3.325; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; FREEDMAN R, 1983, BIOL PSYCHIAT, V18, P537; FREEDMAN R, 1987, SCHIZOPHRENIA BULL, V13, P669, DOI 10.1093/schbul/13.4.669; GUTERMAN Y, 1992, INT J PSYCHOPHYSIOL, V12, P197, DOI 10.1016/0167-8760(92)90011-Y; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; Jellema T, 2004, NEUROSCIENCE, V129, P283, DOI 10.1016/j.neuroscience.2004.07.046; Jin Y, 1997, PSYCHIAT RES, V70, P71, DOI 10.1016/S0165-1781(97)03091-6; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; JUDD LL, 1992, AM J PSYCHIAT, V149, P488; Kisley MA, 2001, CLIN NEUROPHYSIOL, V112, P1154, DOI 10.1016/S1388-2457(01)00578-8; Knott V, 2013, J PSYCHOPHARMACOL, V27, P790, DOI 10.1177/0269881113490449; Maquet P, 2000, J SLEEP RES, V9, P207; Massimini M, 2003, J NEUROPHYSIOL, V89, P1205, DOI 10.1152/jn.00373.2002; MIYAZATO H, 1995, BRAIN RES BULL, V37, P247, DOI 10.1016/0361-9230(95)00003-W; Miyazato H, 1996, NEUROSCIENCE, V75, P289, DOI 10.1016/0306-4522(96)00176-5; NAGAMOTO HT, 1991, SCHIZOPHR RES, V4, P31, DOI 10.1016/0920-9964(91)90007-E; Nicholas CL, 2006, NEUROSCI LETT, V404, P127, DOI 10.1016/j.neulet.2006.05.022; Nir Y, 2015, CEREB CORTEX, V25, P1362, DOI 10.1093/cercor/bht328; Patterson JV, 2000, ARCH GEN PSYCHIAT, V57, P57, DOI 10.1001/archpsyc.57.1.57; Phillips DJ, 2011, SLEEP, V34, P1527, DOI 10.5665/sleep.1392; Rector DM, 2009, NEUROSCIENCE, V159, P115, DOI 10.1016/j.neuroscience.2008.11.031; SHAW NA, 1995, PROG NEUROBIOL, V47, P95, DOI 10.1016/0301-0082(95)00021-M; Shinba T, 1997, EVOKED POTENTIAL, V104, P447, DOI 10.1016/S0168-5597(97)00047-6; STERIADE M, 1990, J NEUROSCI, V10, P2541; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Steriade MM, 2007, BRAIN CONTROL WAKEFU; van Luijtelaar ELJM, 1998, ACTA NEUROBIOL EXP, V58, P263; Vuillier L, 2015, CLIN EEG NEUROSCI, V46, P81, DOI 10.1177/1550059414523417; Werth E, 1997, J SLEEP RES, V6, P102, DOI 10.1046/j.1365-2869.1997.d01-36.x; Werth E, 1996, NEUROREPORT, V8, P123, DOI 10.1097/00001756-199612200-00025; White PM, 1997, PSYCHOPHYSIOLOGY, V34, P703, DOI 10.1111/j.1469-8986.1997.tb02145.x; Witten L, 2014, BEHAV BRAIN RES, V266, P85, DOI 10.1016/j.bbr.2014.02.048; Yang CM, 2007, INT J PSYCHOPHYSIOL, V63, P87, DOI 10.1016/j.ijpsycho.2006.08.006; Zouridakis G, 1997, PSYCHIAT RES, V69, P169, DOI 10.1016/S0165-1781(96)02979-4	51	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126684	10.1371/journal.pone.0126684	http://dx.doi.org/10.1371/journal.pone.0126684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928147	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100131
J	Truppa, V; Carducci, P; Trapanese, C; Hanus, D				Truppa, Valentina; Carducci, Paola; Trapanese, Cinzia; Hanus, Daniel			Does Presentation Format Influence Visual Size Discrimination in Tufted Capuchin Monkeys (Sapajus spp.)?	PLOS ONE			English	Article							MATCHING-TO-SAMPLE; SAME-DIFFERENT CONCEPTUALIZATION; BABOONS PAPIO-PAPIO; LONG-TERM-MEMORY; QUANTITY DISCRIMINATION; PAN-TROGLODYTES; CEBUS-APELLA; COGNITIVE PERFORMANCE; GORILLA-GORILLA; GREAT APES	Most experimental paradigms to study visual cognition in humans and non-human species are based on discrimination tasks involving the choice between two or more visual stimuli. To this end, different types of stimuli and procedures for stimuli presentation are used, which highlights the necessity to compare data obtained with different methods. The present study assessed whether, and to what extent, capuchin monkeys' ability to solve a size discrimination problem is influenced by the type of procedure used to present the problem. Capuchins' ability to generalise knowledge across different tasks was also evaluated. We trained eight adult tufted capuchin monkeys to select the larger of two stimuli of the same shape and different sizes by using pairs of food items (Experiment 1), computer images (Experiment 1) and objects (Experiment 2). Our results indicated that monkeys achieved the learning criterion faster with food stimuli compared to both images and objects. They also required consistently fewer trials with objects than with images. Moreover, female capuchins had higher levels of acquisition accuracy with food stimuli than with images. Finally, capuchins did not immediately transfer the solution of the problem acquired in one task condition to the other conditions. Overall, these findings suggest that - even in relatively simple visual discrimination problems where a single perceptual dimension (i.e., size) has to be judged - learning speed strongly depends on the mode of presentation.	[Truppa, Valentina; Carducci, Paola; Trapanese, Cinzia] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Carducci, Paola] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Hanus, Daniel] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Rome Tor Vergata; Max Planck Society	Truppa, V (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.	valentina.truppa@istc.cnr.it	Truppa, Valentina/AAK-4510-2021					Addessi E, 2008, ANIM COGN, V11, P275, DOI 10.1007/s10071-007-0111-6; Addessi E, 2011, P ROY SOC B-BIOL SCI, V278, P849, DOI 10.1098/rspb.2010.1602; Agrillo C, 2007, ANIM COGN, V10, P63, DOI 10.1007/s10071-006-0036-5; Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; Alfaro JWL, 2012, J BIOGEOGR, V39, P272, DOI 10.1111/j.1365-2699.2011.02609.x; Barros RD, 2002, PSYCHOL REC, V52, P441; Bayer K, 2009, J VET BEHAV, V4, P51; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Beran MJ, 2008, ANIM COGN, V11, P109, DOI 10.1007/s10071-007-0094-3; Beran MJ, 1998, PSYCHOL REC, V48, P3, DOI 10.1007/BF03395255; Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; Bovet D, 1998, LEARN MOTIV, V29, P309, DOI 10.1006/lmot.1998.1009; Bovet D, 2001, PSYCHON B REV, V8, P470, DOI 10.3758/BF03196181; Boysen ST, 2001, J COMP PSYCHOL, V115, P106, DOI 10.1037/0735-7036.115.1.106; Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; Brosnan SF, 2004, FOLIA PRIMATOL, V75, P317, DOI 10.1159/000080209; Cook RG, 1997, J EXP PSYCHOL ANIM B, V23, P417, DOI 10.1037/0097-7403.23.4.417; COOK RG, 1995, J EXP PSYCHOL ANIM B, V21, P253, DOI 10.1037/0097-7403.21.3.253; Cook RG, 2003, BEHAV PROCESS, V62, P125, DOI 10.1016/S0376-6357(03)00022-6; Cori M, 2012, NEUROPSYCHOLOGIA, V50, P1838, DOI 10.1016/j.neuropsychologia.2012.04.009; Cronin AL, 2014, ANIM COGN, V17, P1261, DOI 10.1007/s10071-014-0758-8; D'AMATO M R, 1972, Learning and Motivation, V3, P304, DOI 10.1016/0023-9690(72)90026-4; d'Amato M.R., 1984, P149; DAMATO MR, 1985, J EXP PSYCHOL ANIM B, V11, P35, DOI 10.1037/0097-7403.11.1.35; di Sorrentino EP, 2014, ANIM COGN, V17, P1081, DOI 10.1007/s10071-014-0740-5; Evans TA, 2008, BEHAV RES METHODS, V40, P590, DOI 10.3758/BRM.40.2.590; Fagot J, 2011, PSYCHOL SCI, V22, P1304, DOI 10.1177/0956797611422916; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Fagott J, 2006, P NATL ACAD SCI USA, V103, P17564, DOI 10.1073/pnas.0605184103; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Flemming TM, 2011, J EXP PSYCHOL ANIM B, V37, P353, DOI 10.1037/a0022142; Fobes J.L., 1982, P219; Fragaszy D, 2003, ANIM COGN, V6, P149, DOI 10.1007/s10071-002-0137-8; French R.M., 1995, SUBTLETY SAMENESS TH; Galvao ODF, 2005, PSYCHOL REC, V55, P219; Galvao OD, 2008, REV NEUROSCIENCE, V19, P149; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; Hanggi EB, 2009, ANIM COGN, V12, P451, DOI 10.1007/s10071-008-0205-9; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; HERMAN LM, 1989, J EXP PSYCHOL ANIM B, V15, P124, DOI 10.1037/0097-7403.15.2.124; HERMAN LM, 1974, J EXP ANAL BEHAV, V21, P17; Hopkins WD, 2002, ANIM COGN, V5, P27, DOI 10.1007/s10071-001-0121-8; Howard AM, 2014, AM J PRIMATOL, V76, P828, DOI 10.1002/ajp.22271; KASTAK D, 1994, ANIM LEARN BEHAV, V22, P427, DOI 10.3758/BF03209162; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; Katz JS, 2002, J EXP PSYCHOL ANIM B, V28, P358, DOI 10.1037//0097-7403.28.4.358; Kennedy EH, 2008, J COMP PSYCHOL, V122, P167, DOI 10.1037/0735-7036.122.2.167; Manrique HM, 2011, ANIM COGN, V14, P775, DOI 10.1007/s10071-011-0410-9; Martin-Ordas G., 2009, INT J COMP PSYCHOL, V22, P43; Martin-Ordas G, 2011, BIOL LETTERS, V7, P829, DOI 10.1098/rsbl.2011.0437; MENZEL EW, 1960, SCIENCE, V131, P1527, DOI 10.1126/science.131.3412.1527; MENZEL EW, 1961, J COMP PHYSIOL PSYCH, V54, P588, DOI 10.1037/h0044421; Mercado E, 2000, BEHAV PROCESS, V50, P79, DOI 10.1016/S0376-6357(00)00100-5; MISHKIN M, 1975, J EXP PSYCHOL-ANIM B, V1, P326, DOI 10.1037/0097-7403.1.4.326; Moll FW, 2014, BEHAV PROCESS, V107, P142, DOI 10.1016/j.beproc.2014.08.009; Mueller-Paul J, 2014, BEHAV PROCESS, V106, P187, DOI 10.1016/j.beproc.2014.06.003; NISSEN HW, 1948, J COMP PHYSIOL PSYCH, V41, P62, DOI 10.1037/h0061040; ODEN DL, 1988, J EXP PSYCHOL ANIM B, V14, P140, DOI 10.1037/0097-7403.14.2.140; Ortony A., 1989, SIMILARITY ANALOGICA; Osman-Hill WC, 1960, PRIMATES COMP ANAT A; PACK AA, 1991, ANIM LEARN BEHAV, V19, P37, DOI 10.3758/BF03197858; Pena T, 2006, J EXP ANAL BEHAV, V85, P203, DOI 10.1901/jeab.2006.111-04; PEPPERBERG IM, 1987, ANIM LEARN BEHAV, V15, P423, DOI 10.3758/BF03205051; Premack D., 1978, COGNITIVE PROCESS, P423; Range F, 2008, ANIM COGN, V11, P339, DOI 10.1007/s10071-007-0123-2; Scarf D, 2011, SCIENCE, V334, P1664, DOI 10.1126/science.1213357; Schmitt V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1262; Spinozzi G, 2003, J COMP PSYCHOL, V117, P15, DOI 10.1037/0735-7036.117.1.15; Thorndike EL, 1901, PSYCHOL REV, V8, P247, DOI 10.1037/h0071363; Truppa V, 2014, BEHAV BRAIN RES, V271, P240, DOI 10.1016/j.bbr.2014.05.023; Truppa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023809; Truppa V, 2010, ANIM COGN, V13, P835, DOI 10.1007/s10071-010-0332-y; Truppa V, 2009, BEHAV PROCESS, V82, P140, DOI 10.1016/j.beproc.2009.05.004; Tudusciuc O, 2010, EXP BRAIN RES, V207, P221, DOI 10.1007/s00221-010-2452-7; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Veit L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3878; Vonk J, 2003, ANIM COGN, V6, P77, DOI 10.1007/s10071-003-0159-x; Vonk J, 2013, PEERJ, V1, DOI 10.7717/peerj.158; Walker Stephen, 1983, ANIMAL THOUGHT; WASSERMAN EA, 1992, PSYCHOL SCI, V3, P374, DOI 10.1111/j.1467-9280.1992.tb00050.x; WASSERMAN EA, 1995, J EXP PSYCHOL ANIM B, V21, P248, DOI 10.1037/0097-7403.21.3.248; Wasserman EA, 2001, J COMP PSYCHOL, V115, P42, DOI 10.1037/0735-7036.115.1.42; WASSERMAN EA, 1988, J EXP PSYCHOL ANIM B, V14, P235, DOI 10.1037/0097-7403.14.3.235; Weatherall D., 2006, USE NONHUMAN PRIMATE; WILSON B, 1985, Q J EXP PSYCHOL-B, V37, P313, DOI 10.1080/14640748508401173; Wright AA, 1997, PSYCHOL SCI, V8, P119, DOI 10.1111/j.1467-9280.1997.tb00693.x; WRIGHT AA, 1988, ANIM LEARN BEHAV, V16, P436, DOI 10.3758/BF03209384; Wright AA, 2003, J EXP PSYCHOL ANIM B, V29, P184, DOI 10.1037/0097-7403.29.3.184; Young ME, 1997, PSYCHON B REV, V4, P552, DOI 10.3758/BF03214348; ZENTALL TR, 1981, J EXP PSYCHOL ANIM B, V7, P70, DOI 10.1037/0097-7403.7.1.70	91	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126001	10.1371/journal.pone.0126001	http://dx.doi.org/10.1371/journal.pone.0126001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927363	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100122
J	Wang, JJ; Liu, HL; Liu, W; Zheng, DX; Zhao, YL; Li, Y; Wang, YL; Ge, SQ; Lv, Y; Zuo, YY; Yu, SM; Wang, ZL				Wang, Jingjing; Liu, Hualei; Liu, Wei; Zheng, Dongxia; Zhao, Yunling; Li, Yin; Wang, Yingli; Ge, Shengqiang; Lv, Yan; Zuo, Yuanyuan; Yu, Songmei; Wang, Zhiliang			Genomic Characterizations of Six Pigeon Paramyxovirus Type 1 Viruses Isolated from Live Bird Markets in China during 2011 to 2013	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; PROTEIN CLEAVAGE SITE; HEMAGGLUTININ-NEURAMINIDASE; MONOCLONAL-ANTIBODIES; NUCLEOTIDE-SEQUENCE; GENE RECOMBINATION; RACING PIGEONS; GENOTYPE; DIVERSITY; EVOLUTION	The genomes of six pigeon paramyxovirus type 1 (PPMV-1) isolated from symptomless pigeons in live poultry markets during the national active surveillance from 2011 to 2013 were sequenced and analyzed in this study. The complete genome lengths of all isolates were 15,192 nucleotides with the gene order of 3'-NP-P-M-F-HN-L-5'. All isolates had the same motif of (112)RRQKRF(117) at the cleavage site of the fusion protein, which was typical of velogenic Newcastle disease virus (NDV). Several mutations were identified in the functional domains of F and HN proteins, including fusion peptide, heptad repeat region, transmembrane domains and neutralizing epitopes. Phylogenetic analysis based on sequences of complete genomes and six genes revealed that all isolates belonged to genotype VI in class II, but at least 2 sub-genotypes were identified. Most isolates were placed into sub-genotype VIb with the exception of pi/GX/1015/13, which was classified in sub-genotype VIa. The obvious antigenic difference between PPMV-1 isolates and La Sota strain was found based on the R-value calculated by cross hemagglutination inhibition (HI) assay. These results provided the evidence that PPMV-1 could be detected from healthy pigeons, and our study may be useful in designing vaccines used in pigeon, and developing molecular diagnostic tools to monitor and prevent future PPMV-1 outbreaks.	[Wang, Jingjing; Liu, Hualei; Zheng, Dongxia; Zhao, Yunling; Wang, Yingli; Ge, Shengqiang; Lv, Yan; Zuo, Yuanyuan; Yu, Songmei; Wang, Zhiliang] China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao 266032, Peoples R China; [Liu, Wei] China Anim Dis Control Ctr, Beijing 100125, Peoples R China; [Li, Yin] China Anim Hlth & Epidemiol Ctr, Div Epidemiol Survey, Qingdao 266032, Peoples R China	China Animal Health & Epidemiology Center; China Animal Health & Epidemiology Center	Wang, ZL (corresponding author), China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao 266032, Peoples R China.	zlwang111@163.com	Li, Yin/X-5635-2018; WANG, JINGYI/GSJ-1241-2022; Li, Yin/AAE-6546-2022; wang, jing/GRS-7509-2022	Li, Yin/0000-0002-7367-380X; Li, Yin/0000-0001-5720-5267; 	Chinese Special Fund for Agro-scientific Research in the Public Interest [201303033]	Chinese Special Fund for Agro-scientific Research in the Public Interest	This work was funded by the Chinese Special Fund for Agro-scientific Research in the Public Interest (201303033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous EW, 2010, AVIAN PATHOL, V39, P519, DOI 10.1080/03079457.2010.530938; Aldous EW, 2004, AVIAN PATHOL, V33, P258, DOI 10.1080/0307945042000195768; ALEXANDER DJ, 1987, AVIAN PATHOL, V16, P553, DOI 10.1080/03079458708436406; ALEXANDER DJ, 1984, VET REC, V114, P444, DOI 10.1136/vr.114.18.444; ALEXANDER DJ, 1984, VET REC, V115, P213, DOI 10.1136/vr.115.9.213; ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; BallagiPordany A, 1996, ARCH VIROL, V141, P243, DOI 10.1007/BF01718397; Cai SX, 2011, VET MICROBIOL, V152, P46, DOI 10.1016/j.vetmic.2011.04.014; CHAMBERS P, 1986, J GEN VIROL, V67, P475, DOI 10.1099/0022-1317-67-3-475; Chen F, 2012, J VIROL, V86, P12461, DOI 10.1128/JVI.02314-12; Cho SH, 2008, J CLIN MICROBIOL, V46, P1541, DOI 10.1128/JCM.00187-08; Cho SH, 2007, VIRUS GENES, V35, P293, DOI 10.1007/s11262-007-0078-z; COLLINS MS, 1989, ARCH VIROL, V104, P53, DOI 10.1007/BF01313807; COLLINS MS, 1994, ARCH VIROL, V134, P403, DOI 10.1007/BF01310577; Courtney SC, 2013, J CLIN MICROBIOL, V51, P508, DOI 10.1128/JCM.02393-12; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Leeuw OS, 2003, J GEN VIROL, V84, P475, DOI 10.1099/vir.0.18714-0; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dortmans JCFM, 2010, VET MICROBIOL, V143, P139, DOI 10.1016/j.vetmic.2009.11.021; Guo HB, 2013, ARCH VIROL, V158, P1121, DOI 10.1007/s00705-012-1572-8; Han GZ, 2008, VIROLOGY, V371, P54, DOI 10.1016/j.virol.2007.09.038; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Hu SL, 2010, VET MICROBIOL, V140, P92, DOI 10.1016/j.vetmic.2009.07.029; KALETA EF, 1985, AVIAN PATHOL, V14, P553, DOI 10.1080/03079458508436258; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Kim LM, 2007, J CLIN MICROBIOL, V45, P1310, DOI 10.1128/JCM.02594-06; Liang R, 2002, VET MICROBIOL, V87, P193, DOI 10.1016/S0378-1135(02)00050-0; Liu HL, 2006, AVIAN DIS, V50, P636, DOI 10.1637/7618-042606R1.1; Liu XW, 2009, AVIAN PATHOL, V38, P377, DOI 10.1080/03079450903183637; Marlier D, 2006, VET J, V172, P40, DOI 10.1016/j.tvjl.2005.02.026; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meulemans G, 2002, AVIAN PATHOL, V31, P515, DOI 10.1080/0307945021000005897; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Oberdorfer A, 1998, AVIAN PATHOL, V27, P237, DOI 10.1080/03079459808419330; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Qin ZM, 2008, J CLIN MICROBIOL, V46, P601, DOI 10.1128/JCM.01356-07; Qin ZM, 2008, VIRUS RES, V131, P299, DOI 10.1016/j.virusres.2007.10.001; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; Snoeck CJ, 2013, J CLIN MICROBIOL, V51, P2250, DOI 10.1128/JCM.00684-13; TANTAWI HH, 1979, AVIAN DIS, V23, P785, DOI 10.2307/1589594; TOYODA T, 1989, VIROLOGY, V169, P273, DOI 10.1016/0042-6822(89)90152-9; Ujvari D, 2006, VIRUS GENES, V32, P49, DOI 10.1007/s11262-005-5845-0; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; Umali DV, 2014, VIRUS GENES, V49, P89, DOI 10.1007/s11262-014-1075-7; Van Borm S, 2013, VIRUS RES, V171, P186, DOI 10.1016/j.virusres.2012.11.017; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Zhang R, 2010, VIRUS RES, V151, P45, DOI 10.1016/j.virusres.2010.03.015	48	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124261	10.1371/journal.pone.0124261	http://dx.doi.org/10.1371/journal.pone.0124261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928057	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100030
J	Arponen, O; Muuronen, A; Taina, M; Sipola, P; Hedman, M; Jakala, P; Vanninen, R; Pulkki, K; Mustonen, P				Arponen, Otso; Muuronen, Antti; Taina, Mikko; Sipola, Petri; Hedman, Marja; Jakala, Pekka; Vanninen, Ritva; Pulkki, Kari; Mustonen, Pirjo			Acute Phase IL-10 Plasma Concentration Associates with the High Risk Sources of Cardiogenic Stroke	PLOS ONE			English	Article							ANTIINFLAMMATORY CYTOKINE INTERLEUKIN-10; ISCHEMIC-STROKE; ECHOCARDIOGRAPHY; INFLAMMATION; ACTIVATION; MECHANISMS; PLATELETS; ELEVATION; CELLS	Background Etiological assessment of stroke is essential for accurate treatment decisions and for secondary prevention of recurrence. There is evidence that interleukin-10 (IL-10) associates with ischemic stroke. The aim of this prospective study was to assess the levels of IL-10 in ischemic stroke with unknown or suspected cardiogenic etiology, and evaluate the correlation between IL-10 plasma concentration and the number of diagnosed high risk sources for cardioembolism. Methods A total of 141 patients (97 males; mean age 61 +/- 11 years) with acute ischemic stroke with unknown etiology or suspected cardiogenic etiology other than known atrial fibrillation (AF) underwent imaging investigations to assess high risk sources for cardioembolic stroke established by the European Association of Echocardiography (EAE). IL-10 was measured on admission to the hospital and on a three month follow-up visit. Results Acute phase IL-10 concentration was higher in patients with EAE high risk sources, and correlated with their number (p<0.01). In patients with no risk sources (n = 104), the mean IL-10 concentration was 2.7 +/- 3.1 ng/L (range 0.3-16.3 ng/L), with one risk source (n = 26) 3.7 +/- 5.5 ng/L (0.3-23.6 ng/L), with two risk sources (n = 10) 7.0 +/- 10.0 ng/L (1.29-34.8 ng/L) and with three risk sources (n = 1) 37.2 ng/L. IL-10 level was not significantly associated with cerebral infarct volume, presence of previous or recent myocardial infarction, carotid/vertebral artery atherosclerosis, paroxysmal AF registered on 24-hour ECG Holter monitoring or given intravenous thrombolytic treatment. Conclusion IL-10 plasma concentration correlates independently with the number of EAE cardioembolic risk sources in patients with acute stroke. IL-10 may have potential to improve differential diagnostics of stroke with unknown etiology.	[Arponen, Otso; Muuronen, Antti; Taina, Mikko; Sipola, Petri; Hedman, Marja; Vanninen, Ritva] Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Arponen, Otso; Muuronen, Antti; Sipola, Petri; Vanninen, Ritva] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Neurol Unit, Kuopio, Finland; [Pulkki, Kari] Univ Eastern Finland, Dept Clin Chem, Kuopio, Finland; [Pulkki, Kari] Eastern Finland Lab Ctr, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital	Arponen, O (corresponding author), Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Otso.Arponen@kuh.fi		Pulkki, Kari/0000-0003-0690-9883	Kuopio University Hospital [5063519]	Kuopio University Hospital	This study is supported by the Kuopio University Hospital (grant number 5063519; www.psshp.fi/web/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Anguera I, 2002, AM HEART J, V144, P811, DOI 10.1067/mhj.2002.124831; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; DOLHABERRIAGUE L, 1989, STROKE, V20, P1648, DOI 10.1161/01.STR.20.12.1648; Downing LJ, 1998, J IMMUNOL, V161, P1471; Emsley HCA, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-5; Ferro JM, 2003, LANCET NEUROL, V2, P177, DOI 10.1016/S1474-4422(03)00324-7; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Gudbrandsdottir S, 2013, J IMMUNOL, V191, P4059, DOI 10.4049/jimmunol.1201103; Hagihara M, 2004, J IMMUNOL, V172, P5297, DOI 10.4049/jimmunol.172.9.5297; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; JUNGI TW, 1994, THROMB RES, V76, P463, DOI 10.1016/0049-3848(95)90178-I; Kilic T, 2006, HEART, V92, P1041, DOI 10.1136/hrt.2005.080382; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Leftheriotis DI, 2009, INT J CARDIOL, V135, P361, DOI 10.1016/j.ijcard.2008.04.012; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Osmancik P, 2012, J THROMB THROMBOLYS, V33, P349, DOI 10.1007/s11239-011-0659-5; Pajkrt D, 1997, BLOOD, V89, P2701, DOI 10.1182/blood.V89.8.2701; Pelidou SH, 1999, EUR J NEUROL, V6, P437, DOI 10.1046/j.1468-1331.1999.640437.x; Pepi M, 2010, EUR J ECHOCARDIOGR, V11, P461, DOI 10.1093/ejechocard/jeq045; Rodriguez-Yanez M, 2011, STROKE, V42, P2813, DOI 10.1161/STROKEAHA.111.614503; Sahlman J, 2010, J SLEEP RES, V19, P341, DOI 10.1111/j.1365-2869.2009.00787.x; Sikka G, 2013, EXP GERONTOL, V48, P128, DOI 10.1016/j.exger.2012.11.001; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Strle K, 2001, CRIT REV IMMUNOL, V21, P427; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Uyemura K, 1996, J CLIN INVEST, V97, P2130, DOI 10.1172/JCI118650; van Exel E, 2002, STROKE, V33, P1135, DOI 10.1161/01.STR.0000014206.05597.9E; Vasse M, 1996, BRIT J HAEMATOL, V93, P955, DOI 10.1046/j.1365-2141.1996.d01-1731.x; Xie GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074126; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507	39	7	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0120910	10.1371/journal.pone.0120910	http://dx.doi.org/10.1371/journal.pone.0120910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923658	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600004
J	Bertolini, F; Ghionda, MC; D'Alessandro, E; Geraci, C; Chiofalo, V; Fontanesi, L				Bertolini, Francesca; Ghionda, Marco Ciro; D'Alessandro, Enrico; Geraci, Claudia; Chiofalo, Vincenzo; Fontanesi, Luca			A Next Generation Semiconductor Based Sequencing Approach for the Identification of Meat Species in DNA Mixtures	PLOS ONE			English	Article							READ ALIGNMENT; GENOME; AUTHENTICATION; TECHNOLOGIES; TOOLS; SEQ	The identification of the species of origin of meat and meat products is an important issue to prevent and detect frauds that might have economic, ethical and health implications. In this paper we evaluated the potential of the next generation semiconductor based sequencing technology (Ion Torrent Personal Genome Machine) for the identification of DNA from meat species (pig, horse, cattle, sheep, rabbit, chicken, turkey, pheasant, duck, goose and pigeon) as well as from human and rat in DNA mixtures through the sequencing of PCR products obtained from different couples of universal primers that amplify 12S and 16S rRNA mitochondrial DNA genes. Six libraries were produced including PCR products obtained separately from 13 species or from DNA mixtures containing DNA from all species or only avian or only mammalian species at equimolar concentration or at 1: 10 or 1: 50 ratios for pig and horse DNA. Sequencing obtained a total of 33,294,511 called nucleotides of which 29,109,688 with Q20 (87.43%) in a total of 215,944 reads. Different alignment algorithms were used to assign the species based on sequence data. Error rate calculated after confirmation of the obtained sequences by Sanger sequencing ranged from 0.0003 to 0.02 for the different species. Correlation about the number of reads per species between different libraries was high for mammalian species (0.97) and lower for avian species (0.70). PCR competition limited the efficiency of amplification and sequencing for avian species for some primer pairs. Detection of low level of pig and horse DNA was possible with reads obtained from different primer pairs. The sequencing of the products obtained from different universal PCR primers could be a useful strategy to overcome potential problems of amplification. Based on these results, the Ion Torrent technology can be applied for the identification of meat species in DNA mixtures.	[Bertolini, Francesca; Ghionda, Marco Ciro; Geraci, Claudia; Fontanesi, Luca] Univ Bologna, Div Anim Sci, Dept Agr & Food Sci, I-40127 Bologna, Italy; [Ghionda, Marco Ciro; D'Alessandro, Enrico; Chiofalo, Vincenzo] Univ Messina, Polo Univ Annunziata, Dept Vet Sci, Anim Prod Unit, I-98168 Messina, Italy; [Chiofalo, Vincenzo] Polo Univ Annunziata, Meat Res Consortium, I-98168 Messina, Italy	University of Bologna; University of Messina	Fontanesi, L (corresponding author), Univ Bologna, Div Anim Sci, Dept Agr & Food Sci, Viale Fanin 46, I-40127 Bologna, Italy.	luca.fontanesi@unibo.it	D'ALESSANDRO, ENRICO/AAW-3539-2021; D'Alessandro, Enrico/ABB-9744-2021; bertolini, francesca/AAX-3836-2021; Fontanesi, Luca/L-1770-2014	D'ALESSANDRO, ENRICO/0000-0002-2282-0267; Fontanesi, Luca/0000-0001-7050-3760; Geraci, Claudia/0000-0002-4948-0725; Bertolini, Francesca/0000-0003-4181-3895	University of Bologna RFO funds; Italian MiPAAF Innovagen project; PAN lab European Project [PONa3 00166/F1]	University of Bologna RFO funds; Italian MiPAAF Innovagen project; PAN lab European Project	This work was supported by University of Bologna RFO funds, Italian MiPAAF Innovagen project, and PAN lab European Project PONa3 00166/F1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballin NZ, 2010, MEAT SCI, V86, P577, DOI 10.1016/j.meatsci.2010.06.001; Bertolini F, 2014, ANIM GENET, V45, P304, DOI 10.1111/age.12121; Chaves PB, 2012, MOL ECOL RESOUR, V12, P18, DOI 10.1111/j.1755-0998.2011.03056.x; Chen SY, 2012, ANIM BIOTECHNOL, V23, P213, DOI 10.1080/10495398.2012.696568; Cheng XW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05147; Chisholm J, 2008, EUR FOOD RES TECHNOL, V228, P39, DOI 10.1007/s00217-008-0904-0; Coghlan Megan L, 2013, Investig Genet, V4, P27, DOI 10.1186/2041-2223-4-27; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Dalton DL, 2011, FORENSIC SCI INT, V207, pE51, DOI 10.1016/j.forsciint.2010.12.017; Fajardo V, 2010, TRENDS FOOD SCI TECH, V21, P408, DOI 10.1016/j.tifs.2010.06.002; Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110; Fonseca NA, 2012, BIOINFORMATICS, V28, P3169, DOI 10.1093/bioinformatics/bts605; Forde BM, 2013, BRIEF FUNCT GENOMICS, V12, P440, DOI 10.1093/bfgp/els062; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Galan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048374; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horreo JL, 2013, J SCI FOOD AGR, V93, P354, DOI 10.1002/jsfa.5766; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y; Li H, 2013, ARXIV 1303 3997V2; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin CC, 2014, MEAT SCI, V96, P922, DOI 10.1016/j.meatsci.2013.09.001; Mafra I, 2008, EUR FOOD RES TECHNOL, V227, P649, DOI 10.1007/s00217-007-0782-x; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagarajan N, 2010, METHODS MOL BIOL, V673, P1, DOI 10.1007/978-1-60761-842-3_1; O'Mahony PJ, 2013, QJM-INT J MED, V106, P595, DOI 10.1093/qjmed/hct087; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ripp F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-639; Rodriguez-Ramirez R, 2011, ANAL CHIM ACTA, V685, P120, DOI 10.1016/j.aca.2010.11.021; Rogberg-Munoz Andres, 2013, Recent Pat Food Nutr Agric, V5, P3; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tillmar AO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083761; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	44	51	58	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0121701	10.1371/journal.pone.0121701	http://dx.doi.org/10.1371/journal.pone.0121701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923709	gold, Green Submitted, Green Published			2022-12-26	WOS:000353711600005
J	Bryniarski, K; Ptak, W; Martin, E; Nazimek, K; Szczepanik, M; Sanak, M; Askenase, PW				Bryniarski, Krzysztof; Ptak, Wlodzimierz; Martin, Emilia; Nazimek, Katarzyna; Szczepanik, Marian; Sanak, Marek; Askenase, Philip W.			Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells	PLOS ONE			English	Article							T-CELLS; MICRORNAS; VESICLES; MIR-150; MICROVESICLES; RECRUITMENT; BIOMARKERS; INITIATION; DELIVERY; PROTEIN	Lymph node and spleen cells of mice doubly immunized by epicutaneous and intravenous hapten application produce a suppressive component that inhibits the action of the effector T cells that mediate contact sensitivity reactions. We recently re-investigated this phenomenon in an immunological system. CD8+ T lymphocyte-derived exosomes transferred suppressive miR-150 to the effector T cells antigen-specifically due to exosome surface coat of antibody light chains made by B1a lymphocytes. Extracellular RNA (exRNA) is protected from plasma RNases by carriage in exosomes or by chaperones. Exosome transfer of functional RNA to target cells is well described, whereas the mechanism of transfer of exRNA free of exosomes remains unclear. In the current study we describe extracellular miR-150, extracted from exosomes, yet still able to mediate antigen-specific suppression. We have determined that this was due to miR-150 association with antibody-coated exosomes produced by B1a cell companions of the effector T cells, which resulted in antigen-specific suppression of their function. Thus functional cell targeting by free exRNA can proceed by transfecting companion cell exosomes that then transfer RNA cargo to the acceptor cells. This contrasts with the classical view on release of RNA-containing exosomes from the multivesicular bodies for subsequent intercellular targeting. This new alternate pathway for transfer of exRNA between cells has distinct biological and immunological significance, and since most human blood exRNA is not in exosomes may be relevant to evaluation and treatment of diseases.	[Bryniarski, Krzysztof; Askenase, Philip W.] Yale Univ, Sch Med, Dept Internal Med, Sect Allergy & Clin Immunol, New Haven, CT 06510 USA; [Bryniarski, Krzysztof; Ptak, Wlodzimierz; Martin, Emilia; Nazimek, Katarzyna] Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland; [Szczepanik, Marian] Jagiellonian Univ, Coll Med, Dept Med Biol, Krakow, Poland; [Sanak, Marek] Jagiellonian Univ, Coll Med, Dept Internal Med, Krakow, Poland	Yale University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Askenase, PW (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Allergy & Clin Immunol, New Haven, CT 06510 USA.	philip.askenase@yale.edu	Bryniarski, Krzysztof/X-8312-2018; Sanak, Marek/AAV-1628-2021; Szczepanik, Marian/ABA-7001-2021; Nazimek, Katarzyna/X-8292-2018	Bryniarski, Krzysztof/0000-0001-8537-9176; Sanak, Marek/0000-0001-7635-8103; Nazimek, Katarzyna/0000-0003-1302-117X; Martin, Emilia/0000-0001-9847-9811	Polish Ministry of Science and Higher Education [N40109231/2076]; Polish National Scientific Center [2013/11/B/NZ6/02041, 2013/09/N/NZ6/00753]; NIH from NIH / NIDA [AI-05981, AI-076366, AI-07174, U54 DA036134]; KNOW - Leading National Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007174, R21AI076366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA036134] Funding Source: NIH RePORTER	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Scientific Center; NIH from NIH / NIDA; KNOW - Leading National Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	KB was supported by grants from the Polish Ministry of Science and Higher Education: N40109231/2076 and Polish National Scientific Center: 2013/11/B/NZ6/02041; PWA by the NIH: AI-05981, AI-076366, AI-07174, and U54 DA036134 from NIH / NIDA; and KN by Polish National Scientific Center: 2013/09/N/NZ6/00753. The authors would like to express their gratitude to the KNOW - Leading National Research Centre 2012-2017 for the financial support of the process of printing the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Askenase PW, 2004, TRENDS IMMUNOL, V25, P441, DOI 10.1016/j.it.2004.06.003; Askenase PW, 2000, CURR TOP MICROBIOL, V252, P171; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Bryniarski K, 2014, CENTR EUR J IMMUN S1, V39, P20; Bryniarski K, 2013, J ALLERGY CLIN IMMUN, V132, P170, DOI 10.1016/j.jaci.2013.04.048; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; England T E, 1980, Methods Enzymol, V65, P65; FERRERI NR, 1993, J IMMUNOL, V150, P2102; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Hussein K, 2010, LEUKEMIA RES, V34, P328, DOI 10.1016/j.leukres.2009.06.014; Hutchinson AT, 2012, IMMUNOL LETT, V142, P75, DOI 10.1016/j.imlet.2011.10.013; Kerfoot SM, 2008, J IMMUNOL, V181, P1717, DOI 10.4049/jimmunol.181.3.1717; Lasser C, 2015, EXPERT OPIN BIOL TH, V15, P103, DOI 10.1517/14712598.2015.977250; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Liang HW, 2014, WIRES RNA, V5, P285, DOI 10.1002/wrna.1208; Nazimek Katarzyna, 2014, Folia Med Cracov, V54, P37; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Paliwal V, 2002, J IMMUNOL, V169, P4113, DOI 10.4049/jimmunol.169.8.4113; PTAK W, 1980, IMMUNOBIOLOGY, V156, P400, DOI 10.1016/S0171-2985(80)80073-8; Ptak W, 2015, ARCH IMMUNOL THER EX, V63, P345, DOI 10.1007/s00005-015-0331-4; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Redegeld FA, 2002, NAT MED, V8, P694, DOI 10.1038/nm722; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Sheinerman KS, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-304; Szczepanik M, 2003, J IMMUNOL, V171, P6225, DOI 10.4049/jimmunol.171.11.6225; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2012, RNA BIOL, V9, P1066, DOI 10.4161/rna.21083; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu L, 2014, BIO-MED MATER ENG, V24, P3917, DOI 10.3233/BME-141223; Zheng QH, 2012, J IMMUNOL, V188, P2118, DOI 10.4049/jimmunol.1103342; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	45	54	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122991	10.1371/journal.pone.0122991	http://dx.doi.org/10.1371/journal.pone.0122991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923429	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600026
J	Frey, S; Gorlich, D				Frey, Steffen; Goerlich, Dirk			The Xenopus laevis Atg4B Protease: Insights into Substrate Recognition and Application for Tag Removal from Proteins Expressed in Pro- and Eukaryotic Hosts	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEINS; RECEPTOR-ASSOCIATED PROTEIN; ENGINEERED SUMO FUSIONS; SELECTIVE AUTOPHAGY; CRYSTAL-STRUCTURE; RECOMBINANT PROTEINS; STRUCTURAL BASIS; AFFINITY TAGS; CLEAVING PROTEASES; SOLUBILITY PARTNER	During autophagy, members of the ubiquitin-like Atg8 protein family get conjugated to phosphatidylethanolamine and act as protein-recruiting scaffolds on the autophagosomal membrane. The Atg4 protease produces mature Atg8 from C-terminally extended precursors and deconjugates lipid-bound Atg8. We now found that Xenopus laevis Atg4B (xAtg4B) is ideally suited for proteolytic removal of N-terminal tags from recombinant proteins. To implement this strategy, an Atg8 cleavage module is inserted in between tag and target protein. An optimized xAtg4B protease fragment includes the so far uncharacterized C-terminus, which crucially contributes to recognition of the Xenopus Atg8 homologs xLC3B and xGATE16. xAtg4B-mediated tag cleavage is very robust in solution or on-column, efficient at 4 degrees C and orthogonal to TEV protease and the recently introduced proteases bdSENP1, bdNEDP1 and xUsp2. Importantly, xLC3B fusions are stable in wheat germ extract or when expressed in Saccharomyces cerevisiae, but cleavable by xAtg4B during or following purification. We also found that fusions to the bdNEDP1 substrate bdNEDD8 are stable in S. cerevisiae. In combination, or findings now provide a system, where proteins and complexes fused to xLC3B or bdNEDD8 can be expressed in a eukaryotic host and purified by successive affinity capture and proteolytic release steps.	[Frey, Steffen; Goerlich, Dirk] Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany	Max Planck Society	Frey, S (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany.	sfrey@mpibpc.mpg.de; goerlich@mpibpc.mpg.de	Görlich, Dirk/B-8296-2017	Görlich, Dirk/0000-0002-4343-5210; Steffen, Frey/0000-0002-5134-9961	Max-Planck-Geselleschaft; Deutsche Forschungsgemeinschaft [SFB860]	Max-Planck-Geselleschaft; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Max-Planck-Geselleschaft (www.mpg.de) and the Deutsche Forschungsgemeinschaft (SFB860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; CONZELMANN A, 1988, EMBO J, V7, P2233, DOI 10.1002/j.1460-2075.1988.tb03063.x; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Frey S, 2014, J CHROMATOGR A, V1337, P106, DOI 10.1016/j.chroma.2014.02.030; Frey S, 2014, J CHROMATOGR A, V1337, P95, DOI 10.1016/j.chroma.2014.02.029; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Knight D, 2002, J BIOL CHEM, V277, P5556, DOI 10.1074/jbc.M109753200; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liu L, 2008, PROTEIN EXPRES PURIF, V62, P21, DOI 10.1016/j.pep.2008.07.010; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Michaelis L, 1913, BIOCHEM Z, V49, P333; Mijaljica D, 2012, AUTOPHAGY, V8, P1701, DOI 10.4161/auto.21332; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, J BIOL CHEM, V287, P28503, DOI 10.1074/jbc.C112.387514; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Peroutka RJ, 2008, PROTEIN SCI, V17, P1586, DOI 10.1110/ps.035576.108; Pimentel-Muinos FX, 2014, AUTOPHAGY, V10, P397, DOI 10.4161/auto.27244; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Renicke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067915; RIEZMAN H, 1983, EMBO J, V2, P2161, DOI 10.1002/j.1460-2075.1983.tb01717.x; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rozenknop A, 2011, J MOL BIOL, V410, P477, DOI 10.1016/j.jmb.2011.05.003; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Sorensen HP, 2003, PROTEIN EXPRES PURIF, V32, P252, DOI 10.1016/j.pep.2003.07.001; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Taxis C, 2012, METHODS MOL BIOL, V832, P611, DOI 10.1007/978-1-61779-474-2_43; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; Urabe M, 1999, BIOCHEM BIOPH RES CO, V266, P92, DOI 10.1006/bbrc.1999.1788; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Woo J, 2014, P NATL ACAD SCI USA, V111, P863, DOI 10.1073/pnas.1318207111; Wood DW, 2014, CURR OPIN STRUC BIOL, V26, P54, DOI 10.1016/j.sbi.2014.04.006; Yang WC, 2011, PROTEIN EXPRES PURIF, V80, P145, DOI 10.1016/j.pep.2011.06.017; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155	66	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125099	10.1371/journal.pone.0125099	http://dx.doi.org/10.1371/journal.pone.0125099			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923686	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600124
J	Li, G; Wang, JX; Ye, JP; Zhang, YM; Zhang, Y				Li, Ge; Wang, Jianxiong; Ye, Jianping; Zhang, Yimin; Zhang, Ying			PPAR alpha Protein Expression Was Increased by Four Weeks of Intermittent Hypoxic Training via AMPK alpha 2-Dependent Manner in Mouse Skeletal Muscle	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; FATTY-ACID OXIDATION; LIPID-METABOLISM; GENE-EXPRESSION; KINASE; EXERCISE; TRANSPORT; PATHWAY; HEALTH; ROLES	Peroxisome proliferator-activated receptor alpha (PPAR alpha) is critical for muscle endurance due to its role in the regulation of fatty acid oxidation. The 5'-AMP-activated protein kinase (AMPK) is an energy sensor in cells, but its role in PPARa regulation in vivo remains unknown. In this study, we examined PPAR alpha expression in the skeletal muscle of AMPK alpha 2 overexpression (OE), knockout (KO) and wild-type (WT) mice after four weeks of exercise under intermittent hypoxia. WT, OE and KO mice were used at 40 mice/strain and randomly subdivided into four subgroups: control (C), running (R), hypoxia (H), and running plus hypoxia (R+H) at 10 mice/group. The treadmill running was performed at the speed of 12 m/min, 60 min/day with a slope of 0 degree for four weeks. The hypoxia treatment was performed in daytime with normobaric hypoxia (11.20% oxygen, 8 hours/day). In the R+H group, the treadmill running was conducted in the hypoxic condition. AMPK alpha 2, phosphor-AMPK alpha (p-AMPK alpha) (Thr172), nuclear PPAR alpha proteins were measured by Western blot and the medium chain acyl coenzyme A dehydrogenase (MCAD) mRNA, the key enzyme for fatty acid oxidation and one of the PPAR alpha target genes, was also measured in skeletal muscles after the interventions. The results showed that nuclear PPAR alpha protein was significantly increased by R+H in WT muscles, the increase was enhanced by 41% (p<0.01) in OE mice, but was reduced by 33% (p<0.01) in KO mice. The MCAD mRNA expression was increased after four weeks of R+H intervention. The change in MCAD mRNA followed a similar trend as that of PPAR alpha protein in OE and KO mice. Our data suggest that the increase in nuclear PPAR alpha protein by four-week exercise training under the intermittent hypoxia was dependent on AMPK activation.	[Li, Ge; Zhang, Ying] Beijing Sport Univ, Inst Sports Sci, Div Exercise Biochem, Beijing, Peoples R China; [Wang, Jianxiong] Univ So Queensland, Fac Hlth Engn & Sci, Sch Hlth & Wellbeing, Toowoomba, Qld 4350, Australia; [Ye, Jianping] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Zhang, Yimin] Beijing Sport Univ, Key Lab Exercise & Phys Fitness, Minist Educ Peoples Republ China, Beijing, Peoples R China	Beijing Sport University; University of Southern Queensland; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Beijing Sport University; Ministry of Education, China	Zhang, Y (corresponding author), Beijing Sport Univ, Inst Sports Sci, Div Exercise Biochem, Beijing, Peoples R China.	zhyi9256@126.com	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X	National Natural Science Foundation of China [31171140]; China Higher Education Research Fund for the Doctoral Program [20111112110005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Higher Education Research Fund for the Doctoral Program	This study was funded by grants from the National Natural Science Foundation of China (31171140) and China Higher Education Research Fund for the Doctoral Program (20111112110005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbach WG, 2004, SPORTS MED, V34, P91, DOI 10.2165/00007256-200434020-00003; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955; Chen YC, 2011, HIGH ALT MED BIOL, V12, P371, DOI 10.1089/ham.2010.1088; Chiu LL, 2004, J BIOMED SCI, V11, P838, DOI 10.1159/000081831; Cresci S, 1996, AM J PHYSIOL-CELL PH, V270, pC1413, DOI 10.1152/ajpcell.1996.270.5.C1413; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Everett L, 2000, LIVER, V20, P191, DOI 10.1034/j.1600-0676.2000.020003191.x; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Fan WW, 2013, J MOL ENDOCRINOL, V51, pT87, DOI 10.1530/JME-13-0258; FERNANDO P, 1993, CAN J PHYSIOL PHARM, V71, P854, DOI 10.1139/y93-128; Fluckey JD, 1999, ACTA PHYSIOL SCAND, V167, P77; Gong HJ, 2011, MED SCI SPORT EXER, V43, P1441, DOI 10.1249/MSS.0b013e31820f6093; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Helge JW, 2007, EUR J APPL PHYSIOL, V101, P105, DOI 10.1007/s00421-007-0479-7; Horowitz JF, 2000, AM J PHYSIOL-ENDOC M, V279, pE348, DOI 10.1152/ajpendo.2000.279.2.E348; Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lecoultre V, 2010, EXP PHYSIOL, V95, P315, DOI 10.1113/expphysiol.2009.050690; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leff T, 2003, BIOCHEM SOC T, V31, P224; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mor Vijay, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P206; Morash AJ, 2013, AM J PHYSIOL-REG I, V305, pR534, DOI 10.1152/ajpregu.00510.2012; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Ponsot E, 2006, J APPL PHYSIOL, V100, P1249, DOI 10.1152/japplphysiol.00361.2005; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Schmutz S, 2010, EXP PHYSIOL, V95, P723, DOI 10.1113/expphysiol.2009.051029; Sozio MS, 2011, AM J PHYSIOL, V301, P739; Staels B, 2007, THERAPIE, V62, P319, DOI 10.2515/therapie:2007051; Tunstall RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66, DOI 10.1152/ajpendo.00475.2001; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhuang JG, 1999, BIOL SIGNAL RECEPT, V8, P316	44	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122593	10.1371/journal.pone.0122593	http://dx.doi.org/10.1371/journal.pone.0122593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923694	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000353711600017
J	Loheswaran, G; Soklaridis, S; Selby, P; Le Foll, B				Loheswaran, Genane; Soklaridis, Sophie; Selby, Peter; Le Foll, Bernard			Screening and Treatment for Alcohol, Tobacco and Opioid Use Disorders: A Survey of Family Physicians across Ontario	PLOS ONE			English	Article							SUBSTANCE USE; PRIMARY-CARE; ADOLESCENT ALCOHOL; NONMEDICAL USE; GLOBAL BURDEN; UNITED-STATES; DRUG-ABUSE; TRENDS; INTERVENTIONS; INSTRUMENTS	Introduction As a primary point of contact within the health care system, family physicians are able to play a vital role in identifying individuals with substance use disorders and connecting them to the appropriate treatment. However, there is very little data available on whether family physicians are actively screening for and treating substance use disorders. The objective of the current survey was to assess whether family physicians in Ontario are screening for alcohol, opioid and tobacco use disorders, using validated tools and providing treatment. Methods An online survey consisting of a series of 38 primarily close-ended questions was circulated to family physicians in Ontario. Rates of screening for alcohol, opioid and tobacco dependence, use of validated tools for screening, providing treatment for dependent individuals and the current barriers to the prescription of pharmacotherapies for these drug dependences were assessed. Results The use of validated screening tools was limited for all three substances. Screening by family physicians for the substance use disorders among adolescents was much lower than screening among adults. Pharmacotherapy was more commonly used as an intervention for tobacco dependence than for alcohol and opioid dependence. This was explained by the lack of knowledge among family physicians on the pharmacotherapies for alcohol and opioid dependence. Conclusions Findings from the current study suggest there is a need for family physicians to integrate screening for substance use disorders using validated tools into their standard medical practice. Furthermore, there is a need for increased knowledge on pharmacotherapies for alcohol and opioid use disorders. It is important to note that the low response rate is a major limitation to this study. One possible reason for this low response rate may be a lack of interest and awareness among family physicians on the importance of screening and treatment of substance use disorders in Ontario.	[Loheswaran, Genane; Le Foll, Bernard] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Translat Addict Res Lab, Toronto, ON, Canada; [Loheswaran, Genane; Le Foll, Bernard] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Soklaridis, Sophie] Ctr Addict & Mental Hlth, CAMH Educ, Toronto, ON, Canada; [Soklaridis, Sophie; Selby, Peter; Le Foll, Bernard] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Soklaridis, Sophie; Selby, Peter; Le Foll, Bernard] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Selby, Peter; Le Foll, Bernard] Ctr Addict & Mental Hlth, Ambulatory Care & Struct Treatments, Toronto, ON, Canada; [Selby, Peter] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Le Foll, B (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Translat Addict Res Lab, Toronto, ON, Canada.	bernard.lefoll@camh.ca	Soklaridis, Sophie/ABG-2223-2020; Le Foll, Bernard/K-2952-2014	Soklaridis, Sophie/0000-0001-5119-8473; Le Foll, Bernard/0000-0002-6406-4973	Development and Dissemination Funds	Development and Dissemination Funds	Financial support for this survey was provided by the Development and Dissemination Funds, which are internal Centre for Addiction and Mental Health funds awarded to Dr. Peter Selby and Dr. Bernard Le Foll. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons GA, 1999, J ADOLESCENT HEALTH, V24, P412, DOI 10.1016/S1054-139X(99)00006-3; [Anonymous], 2007, REP INT NAR CONTR BO; [Anonymous], 1998, TOB FREE IN; [Anonymous], 2002, BEST PRACTICES CONCU; Borland T, 2010, DELIVERING TOBACCO P; Brands B, 2004, DRUG ALCOHOL DEPEN, V73, P199, DOI 10.1016/j.drugalcdep.2003.10.012; BREWSTER JM, 1990, CAN MED ASSOC J, V143, P1076; Bush Donna M, 2002, Occup Med, V17, P13; CBC, 2007, 5 EST; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Couwenbergh C, 2009, SUBST USE MISUSE, V44, P823, DOI 10.1080/10826080802484264; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Donovan DM, 2008, J STUD ALCOHOL DRUGS, V69, P5, DOI 10.15288/jsad.2008.69.5; DuRant RH, 1999, ARCH PEDIAT ADOL MED, V153, P286; Fischer B, 2006, EUR ADDICT RES, V12, P230, DOI 10.1159/000094425; Fischer B, 2006, CAN MED ASSOC J, V175, P1385, DOI 10.1503/cmaj.060729; Fischer B, 2006, CAN J PSYCHIAT, V51, P624, DOI 10.1177/070674370605101002; Fischer B, 2006, CAN J PSYCHIAT, V51, P621, DOI 10.1177/070674370605101001; FISHER JC, 1975, J STUD ALCOHOL, V36, P949, DOI 10.15288/jsa.1975.36.949; Fournier ME, 2006, CURR OPIN PEDIATR, V18, P352, DOI 10.1097/01.mop.0000236381.33907.9d; FRIEDMAN AS, 1989, J DRUG EDUC, V19, P285, DOI 10.2190/XBU5-9MAB-C2R5-0M96; FULLER PG, 1995, PEDIATR CLIN N AM, V42, P295; GELLER G, 1989, JAMA-J AM MED ASSOC, V261, P3115, DOI 10.1001/jama.261.21.3115; Gilson AM, 2004, J PAIN SYMPTOM MANAG, V28, P176, DOI 10.1016/j.jpainsymman.2004.01.003; Gruenewald PJ, 1990, RESULTS PRELIMINARY; Herie M, 2012, PATIENT EDUC COUNS, V86, P49, DOI 10.1016/j.pec.2011.04.018; Maheux B, 1999, CAN MED ASSOC J, V160, P1830; Martin TL, 2006, J ANAL TOXICOL, V30, P603, DOI 10.1093/jat/30.8.603; Mayer J, 1979, Curr Alcohol, V7, P169; McCabe SE, 2007, J ADOLESCENT HEALTH, V40, P76, DOI 10.1016/j.jadohealth.2006.07.016; McPherson TL, 2000, J SUBST ABUSE TREAT, V18, P193, DOI 10.1016/S0740-5472(99)00028-8; Merikangas KR, 2012, HUM GENET, V131, P779, DOI 10.1007/s00439-012-1168-0; MEYERS K, 1995, J SUBST ABUSE TREAT, V12, P181, DOI 10.1016/0740-5472(95)00009-T; MoHaL-T Care, 2013, ONT HLEP MOR SMOK QU; Pilowsky DJ, 2013, ADDICT BEHAV, V38, P2146, DOI 10.1016/j.addbeh.2013.01.015; Rahdert, 1991, PROBLEM ORIENTED SCR; Rawson RA, 2000, J PSYCHOACTIVE DRUGS, V32, P371, DOI 10.1080/02791072.2000.10400238; Rehm J., 2006, COST SUBSTANCE ABUSE; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rehm J, 2006, DRUG ALCOHOL REV, V25, P503, DOI 10.1080/09595230600944453; RUSH B, 1994, CAN FAM PHYSICIAN, V40, P1557; RUSH BR, 1995, CAN MED ASSOC J, V152, P863; Rush BR, 2003, ADDICTION, V98, P895, DOI 10.1046/j.1360-0443.2003.00410.x; SCHWARTZ RH, 1990, CLIN PEDIATR, V29, P38, DOI 10.1177/000992289002900106; Sung HE, 2005, J ADOLESCENT HEALTH, V37, P44, DOI 10.1016/j.jadohealth.2005.02.013; Swahn MH, 2010, ADDICT BEHAV, V35, P452, DOI 10.1016/j.addbeh.2009.12.017; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; WISNIEWSKI NM, 1985, ADDICT BEHAV, V10, P55, DOI 10.1016/0306-4603(85)90053-X; World Health Organization, 1992, INT STAT CLASS DIS R; Wu LT, 2011, ARCH GEN PSYCHIAT, V68, P1176, DOI 10.1001/archgenpsychiatry.2011.120; Xie XD, 1998, HEALTH ECON, V7, P81, DOI 10.1002/(SICI)1099-1050(199802)7:1<81::AID-HEC330>3.0.CO;2-I	51	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124402	10.1371/journal.pone.0124402	http://dx.doi.org/10.1371/journal.pone.0124402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923976	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600081
J	Mendes-Moreira, P; Alves, ML; Satovic, Z; dos Santos, JP; Santos, JN; Souza, JC; Pego, SE; Hallauer, AR; Patto, MCV				Mendes-Moreira, Pedro; Alves, Mara L.; Satovic, Zlatko; dos Santos, Joao Pacheco; Santos, Joao Nina; Souza, Joao Candido; Pego, Silas E.; Hallauer, Arnel R.; Vaz Patto, Maria Carlota			Genetic Architecture of Ear Fasciation in Maize (Zea mays) under QTL Scrutiny	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MERISTEM CELL FATE; BARREN INFLORESCENCE2; HERITABLE CHARACTERS; GRAIN-YIELD; NONSTRESS ENVIRONMENTS; TRANSCRIPTION FACTOR; CO-ORTHOLOG; ENCODES; TASSEL	Maize ear fasciation Knowledge of the genes affecting maize ear inflorescence may lead to better grain yield modeling. Maize ear fasciation, defined as abnormal flattened ears with high kernel row number, is a quantitative trait widely present in Portuguese maize landraces. Material and Methods Using a segregating population derived from an ear fasciation contrasting cross (consisting of 149 F-2:3 families) we established a two location field trial using a complete randomized block design. Correlations and heritabilities for several ear fasciation-related traits and yield were determined. Quantitative Trait Loci (QTL) involved in the inheritance of those traits were identified and candidate genes for these QTL proposed. Results and Discussion Ear fasciation broad-sense heritability was 0.73. Highly significant correlations were found between ear fasciation and some ear and cob diameters and row number traits. For the 23 yield and ear fasciation-related traits, 65 QTL were identified, out of which 11 were detected in both environments, while for the three principal components, five to six QTL were detected per environment. Detected QTL were distributed across 17 genomic regions and explained individually, 8.7% to 22.4% of the individual traits or principal components phenotypic variance. Several candidate genes for these QTL regions were proposed, such as bearded-ear1, branched silkless1, compact plant1, ramosa2, ramosa3, tasselseed4 and terminal ear1. However, many QTL mapped to regions without known candidate genes, indicating potential chromosomal regions not yet targeted for maize ear traits selection. Conclusions Portuguese maize germplasm represents a valuable source of genes or allelic variants for yield improvement and elucidation of the genetic basis of ear fasciation traits. Future studies should focus on fine mapping of the identified genomic regions with the aim of mapbased cloning.	[Mendes-Moreira, Pedro; dos Santos, Joao Pacheco; Santos, Joao Nina] Inst Politecn Coimbra, Escola Super Agr Coimbra, Dept Ciencias Agron, Coimbra, Portugal; [Mendes-Moreira, Pedro; Alves, Mara L.; Vaz Patto, Maria Carlota] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal; [Satovic, Zlatko] Univ Zagreb, Fac Agr, Dept Seed Sci & Technol, Zagreb 41000, Croatia; [Souza, Joao Candido] Univ Fed Lavras, Dept Biol UFLA, Lavras, MG, Brazil; [Pego, Silas E.] Fundacao Bomfim, Braga, Portugal; [Hallauer, Arnel R.] Iowa State Univ, Dept Agron, Ames, IA USA	Instituto Politecnico de Coimbra (IPC); Universidade Nova de Lisboa; University of Zagreb; Universidade Federal de Lavras; Iowa State University	Mendes-Moreira, P (corresponding author), Inst Politecn Coimbra, Escola Super Agr Coimbra, Dept Ciencias Agron, Coimbra, Portugal.	pmm@esac.pt	Šatović, Zlatko/AAA-9626-2020; Patto, Maria Carlota Vaz/C-8775-2011; Mendes-Moreira, Pedro M R/D-4663-2009; Mendes-Moreira, Pedro/AAU-1693-2020	Šatović, Zlatko/0000-0002-9848-1601; Patto, Maria Carlota Vaz/0000-0002-8469-7508; Mendes-Moreira, Pedro M R/0000-0001-7809-1115; Mendes-Moreira, Pedro/0000-0001-7809-1115; Alves, Mara/0000-0003-3515-2082	VASO project; Fundacao para a Ciencia e a Tecnologia, Portugal [PEst-OE/EQB/LA0004/2011, PTDC/AGR-ALI/099285/2008, PTDC/AGR-AAM/70845/2006]; Ciencia Program;  [SFRH/BD/22188/2005];  [SFRH/PROTEC/50365/2009]	VASO project; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Ciencia Program; ; 	This study was funded by the VASO project and by Fundacao para a Ciencia e a Tecnologia, Portugal (www.fct.pt), through the research projects PEst-OE/EQB/LA0004/2011, PTDC/AGR-ALI/099285/2008 and PTDC/AGR-AAM/70845/2006; research contract by the Ciencia 2008 Program (MCVP) and by the research grants SFRH/BD/22188/2005 and SFRH/PROTEC/50365/2009 (PMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; Bai F, 2012, P NATL ACAD SCI USA, V109, P12225, DOI 10.1073/pnas.1202439109; BEAVIS WD, 1991, THEOR APPL GENET, V83, P141, DOI 10.1007/BF00226242; Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Brewbaker JL, 2009, MAIZE GENETICS COOPE, V1; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Carillo P, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-21; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Chuck G, 2008, DEVELOPMENT, V135, P3013, DOI 10.1242/dev.024273; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; CHURCHILL GA, 1994, GENETICS, V138, P963; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Eckardt NA, 2007, PLANT CELL, V19, P3315, DOI 10.1105/tpc.107.057497; Emerson RA, 1912, AMER BREED ASS AN RE, V8, P385; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; FERRAO JEM, 1992, AVENTURA PLANTAS DES; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Gallavotti A, 2010, DEVELOPMENT, V137, P2849, DOI 10.1242/dev.051748; Hayes HK, 1939, MAIZE GENET COOP NEW, V13, P1; IBPGR, 1991, DESCRIPTORS FOR MAIZ; IPGRI, 2000, DESCRITORES PARA O M; IRISH EE, 1994, DEV GENET, V15, P155, DOI 10.1002/dvg.1020150206; Jackson D, 2009, MNL, V2; Jackson Dave, 2009, P1, DOI 10.1007/978-0-387-79418-1_1; Jackson DP, 2009, NUCLEOTIDE SEQUENCES; JANSEN RC, 1994, GENETICS, V136, P1447; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kempton JH, 1923, J HERED, V14, P243, DOI 10.1093/oxfordjournals.jhered.a102330; Kempton JH, 1934, J HERED, V25, P29, DOI 10.1093/oxfordjournals.jhered.a103835; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER ES, 1989, GENETICS, V121, P185; Lawrence Carolyn J, 2008, Int J Plant Genomics, V2008, P496957, DOI 10.1155/2008/496957; Liu RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049836; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; MATTHEWS DL, 1974, J AGR SCI-CAMBRIDGE, V82, P433, DOI 10.1017/S0021859600051327; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; McSteen P, 2001, DEVELOPMENT, V128, P2881; McSteen P, 2007, PLANT PHYSIOL, V144, P1000, DOI 10.1104/pp.107.098558; Mena M, 1995, PLANT J, V8, P845, DOI 10.1046/j.1365-313X.1995.8060845.x; Moreira PMRM, 2008, EUPHYTICA, V163, P481, DOI 10.1007/s10681-008-9683-8; Mendes-Moreira PMR, 2014, FIELD CROP RES, V161, P75, DOI 10.1016/j.fcr.2014.02.015; Modarres AM, 1998, MAYDICA, V43, P227; MONACO MK, 2013, PLANT GENOME, DOI DOI 10.3835/PLANTGENOME2009.01.0001; NELSON OE, 1957, SCIENCE, V125, P1200, DOI 10.1126/science.125.3259.1200; NELSON OLIVER E., 1961, AGRON JOUR, V53, P208; Neuffer MG, 1997, MUTANTS MAIZE; NICKERSON NORTON H., 1955, ANN MISSOURI BOT GARDEN, V42, P195, DOI 10.2307/2394655; Patto MCV, 2004, EUPHYTICA, V137, P63, DOI 10.1023/B:EUPH.0000040503.48448.97; Patto MCV, 2003, THEOR APPL GENET, V106, P1283, DOI 10.1007/s00122-003-1195-2; Pautler M, 2013, PLANT CELL PHYSIOL, V54, P302, DOI 10.1093/pcp/pct025; Pego S, 1982, THESIS; PEGO SE, 1984, MAYDICA, V29, P39; Phipps IF, 1928, J HERED, V19, P399, DOI 10.1093/oxfordjournals.jhered.a103030; Pressoir G, 2009, PLANT J, V58, P618, DOI 10.1111/j.1365-313X.2009.03802.x; Ribaut JM, 2007, MOL BREEDING, V20, P15, DOI 10.1007/s11032-006-9041-2; Ribaut JM, 1997, THEOR APPL GENET, V94, P887, DOI 10.1007/BF00221905; Ritchie SW, 1993, IOWA STATE UNIVERSIT, V48; Runge EC, 2004, CORN ORIGIN HISTORY; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; Schrag TA, 2006, THEOR APPL GENET, V113, P1037, DOI 10.1007/s00122-006-0363-6; Skirpan A, 2008, PLANT J, V55, P787, DOI 10.1111/j.1365-313X.2008.03546.x; Skirpan A, 2009, PLANT CELL PHYSIOL, V50, P652, DOI 10.1093/pcp/pcp006; Steinhoff J, 2012, THEOR APPL GENET, V125, P1539, DOI 10.1007/s00122-012-1933-4; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Thompson BE, 2009, PLANT CELL, V21, P2578, DOI 10.1105/tpc.109.067751; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; USDA & ARS-GRIN, 2013, WF9 AMES 19293 ZEA M; Van Ooijen J, 2002, MAP QTL 4; Van Ooijen J. W, 2006, JOINMAP 4 SOFTWARE F; Patto MCV, 2007, GENET RESOUR CROP EV, V54, P1555, DOI 10.1007/s10722-006-9168-3; VEIT B, 1993, PLANT CELL, V5, P1205, DOI 10.1105/tpc.5.10.1205; Veit B, 1998, NATURE, V393, P166, DOI 10.1038/30239; VELDBOOM LR, 1994, THEOR APPL GENET, V88, P7, DOI 10.1007/BF00222387; VELDBOOM LR, 1994, THEOR APPL GENET, V89, P451, DOI 10.1007/BF00225380; Veldboom LR, 1996, CROP SCI, V36, P1320, DOI 10.2135/cropsci1996.0011183X003600050041x; Veldboom LR, 1996, CROP SCI, V36, P1310, DOI 10.2135/cropsci1996.0011183X003600050040x; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Vollbrecht Erik, 2009, P13, DOI 10.1007/978-0-387-79418-1_2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weber A, 2007, GENETICS, V177, P2349, DOI 10.1534/genetics.107.080424; Weber AL, 2008, GENETICS, V180, P1221, DOI 10.1534/genetics.108.090134; WHITE OE, 1948, BOT REV, V14, P319, DOI 10.1007/BF02861723; Wu XT, 2009, PLANT PHYSIOL, V149, P205, DOI 10.1104/pp.108.125005; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Young ND, 1996, ANNU REV PHYTOPATHOL, V34, P479, DOI 10.1146/annurev.phyto.34.1.479; Zhang GD, 2013, THEOR APPL GENET, V126, P1545, DOI 10.1007/s00122-013-2072-2; Zhang HM, 2010, AFR J AGR RES, V5, P626; Zhou ML, 2014, J PLANT GROWTH REGUL, V33, P256, DOI 10.1007/s00344-013-9368-y	96	17	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124543	10.1371/journal.pone.0124543	http://dx.doi.org/10.1371/journal.pone.0124543			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923975	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600092
J	Pantaleon, V; Soavelomandroso, AP; Bouttier, S; Briandet, R; Roxas, B; Chu, M; Collignon, A; Janoir, C; Vedantam, G; Candela, T				Pantaleon, Veronique; Soavelomandroso, Anna Philibertine; Bouttier, Sylvie; Briandet, Romain; Roxas, Bryan; Chu, Michele; Collignon, Anne; Janoir, Claire; Vedantam, Gayatri; Candela, Thomas			The Clostridium difficile Protease Cwp84 Modulates both Biofilm Formation and Cell-Surface Properties	PLOS ONE			English	Article							CYSTEINE PROTEASE; PROTEINS; SPORULATION; INFECTION; BACTERIA; INSIGHTS; LAYER; WALL	Clostridium difficile is responsible for 15-20% of antibiotic-associated diarrheas, and nearly all cases of pseudomembranous colitis. Among the cell wall proteins involved in the colonization process, Cwp84 is a protease that cleaves the S-layer protein SlpA into two subunits. A cwp84 mutant was previously shown to be affected for in vitro growth but not in its virulence in a hamster model. In this study, the cwp84 mutant elaborated biofilms with increased biomass compared with the parental strain, allowing the mutant to grow more robustly in the biofilm state. Proteomic analyses of the 630 Delta erm bacteria growing within the biofilm revealed the distribution of abundant proteins either in cell surface, matrix or supernatant fractions. Of note, the toxin TcdA was found in the biofilm matrix. Although the overall proteome differences between the cwp84 mutant and the parental strains were modest, there was still a significant impact on bacterial surface properties such as altered hydrophobicity. In vitro and in vivo competition assays revealed that the mutant was significantly impaired for growth only in the planktonic state, but not in biofilms or in vivo. Taken together, our results suggest that the phenotypes in the cwp84 mutant come from either the accumulation of uncleaved SlpA, or the ability of Cwp84 to cleave as yet undetermined proteins.	[Pantaleon, Veronique; Soavelomandroso, Anna Philibertine; Bouttier, Sylvie; Collignon, Anne; Janoir, Claire; Candela, Thomas] Univ Paris 11, Fac Pharm, EA4043, F-92290 Chatenay Malabry, France; [Briandet, Romain] INRA, UMR1319, Jouy En Josas, France; [Briandet, Romain] AgroParisTech, UMR Micalis, Massy, France; [Roxas, Bryan; Chu, Michele; Vedantam, Gayatri] Univ Arizona, Sch Anim & Comparat Biomed Sci, Dept Immunobiol, Tucson, AZ USA; [Vedantam, Gayatri] Southern Arizona VA Healthcare Syst, Tucson, AZ USA	UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; University of Arizona; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System	Candela, T (corresponding author), Univ Paris 11, Fac Pharm, EA4043, F-92290 Chatenay Malabry, France.	thomas.candela@u-psud.fr	Candela, Thomas/ABA-6367-2021; Briandet, Romain/AAD-2102-2020; Candela, Thomas/AAC-9583-2021	Briandet, Romain/0000-0002-8123-3492; Candela, thomas/0000-0002-4686-2533	French Research Ministry (MNRT); US Dept. of Veterans Affairs; USDA AZRT [570410- A-02-139]	French Research Ministry (MNRT); US Dept. of Veterans Affairs; USDA AZRT	VP and APS were funded by the French Research Ministry (MNRT). Work in the GV laboratory is funded by the US Dept. of Veterans Affairs and experiments for this study were specifically funded by a USDA AZRT 570410- A-02-139 award.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6; Bouillaut Laurent, 2011, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09a02s20; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Burns DA, 2011, J MICROBIOL METH, V87, P133, DOI 10.1016/j.mimet.2011.07.017; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; ChapetonMontes D, 2011, J BACTERIOL, V193, P5314, DOI 10.1128/JB.00326-11; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Crowther GS, 2014, J ANTIMICROB CHEMOTH, V69, P2137, DOI 10.1093/jac/dku116; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Dawson LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050527; de la Riva L, 2011, J BACTERIOL, V193, P3276, DOI 10.1128/JB.00248-11; Donelli G, 2012, FEMS IMMUNOL MED MIC, V65, P318, DOI 10.1111/j.1574-695X.2012.00962.x; Fagan RP, 2011, J MED MICROBIOL, V60, P1225, DOI 10.1099/jmm.0.028472-0; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Giaouris E, 2009, INT J FOOD MICROBIOL, V131, P2, DOI 10.1016/j.ijfoodmicro.2008.09.006; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Janoir C, 2007, J BACTERIOL, V189, P7174, DOI 10.1128/JB.00578-07; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McQuade R, 2012, ANAEROBE, V18, P614, DOI 10.1016/j.anaerobe.2012.09.004; Mergenhagen KA, 2014, PHARMACOECONOMICS, V32, P639, DOI 10.1007/s40273-014-0161-y; Merrigan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078404; Miller J.H., 1972, EXPT MOL GENETICS; Ng YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056051; Pantaleon V, 2014, ANAEROBE; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Semenyuk EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087757; Spigaglia P, 2013, J MED MICROBIOL, V62, P1386, DOI 10.1099/jmm.0.056556-0; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; WEXLER H, 1984, REV INFECT DIS, V6, pS229	35	45	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124971	10.1371/journal.pone.0124971	http://dx.doi.org/10.1371/journal.pone.0124971			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922949	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600118
J	Sise, ME; Backman, ES; Wenger, JB; Wood, BR; Sax, PE; Chung, RT; Thadhani, R; Kim, AY				Sise, Meghan E.; Backman, Elke S.; Wenger, Julia B.; Wood, Brian R.; Sax, Paul E.; Chung, Raymond T.; Thadhani, Ravi; Kim, Arthur Y.			Short and Long-Term Effects of Telaprevir on Kidney Function in Patients with Hepatitis C Virus Infection: A Retrospective Cohort Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CHRONIC HCV INFECTION; GENOTYPE 1; DISEASE; RISK; THERAPY; INJURY; ASSOCIATION; OUTCOMES; PEGINTERFERON	Background Recent reports suggest that telaprevir, a protease inhibitor used to treat hepatitis C infection, is associated with decline in kidney function during therapy, particularly in patients with baseline renal impairment. Methods Patients treated with telaprevir in a single healthcare network were retrospectively reviewed. Kidney function was determined at baseline, during therapy, and twelve weeks and twelve months after telaprevir discontinuation. Significant creatinine rise during therapy was defined as an increase in serum creatinine >= 0.3mg/dL from baseline during treatment with telaprevir. Results Between July 2011 to January 2013, seventy-eight patients began treatment. The majority completed the prescribed twelve weeks of telaprevir therapy; 32% discontinued due to side effects. The average rise in serum creatinine during therapy was 0.22mg/dL (standard deviation 0.22mg/dL). Thirty-one percent experienced a significant creatinine rise during therapy. Decline in estimated glomerular filtration rate (eGFR) was lower in those with baseline eGFR < 90 mL/min/1.73m(2) compared to the group with baseline eGFR >= 90 mL/min/ 1.73m(2) (12 vs. 18 mL/min/1.73m(2), P = 0.047). Serum creatinine fully normalized by twelve weeks after cessation of telaprevir in 83% of patients, however experiencing a significant creatinine rise during telaprevir use was associated with a 6.6mL/min/1.73m(2) decrease in estimated glomerular filtration rate at twelve months in an adjusted model. Conclusions Decline in kidney function during therapy with telaprevir is common and is not associated with baseline eGFR < 90mL/min/1.73m(2) as previously reported.	[Sise, Meghan E.; Wenger, Julia B.; Thadhani, Ravi] Harvard Univ, Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA; [Backman, Elke S.] Harvard Univ, Massachusetts Gen Hosp, Dept Pharm, Boston, MA 02115 USA; [Wood, Brian R.] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Sax, Paul E.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Sax, Paul E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chung, Raymond T.] Harvard Univ, Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02115 USA; [Kim, Arthur Y.] Harvard Univ, Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Sise, ME (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA.	msise@mgh.harvard.edu			National Institute of Health [K24 DK078772]; American Society of Nephrology Foundation Fellowship Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK094872, K24DK078772] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology Foundation Fellowship Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institute of Health - K24 DK078772 (RTC); American Society of Nephrology Foundation Fellowship Grant (MES), https://www.asn-online.org/grants/fellowships/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Gervasoni C, 2014, AIDS, V28, P285, DOI 10.1097/QAD.0000000000000088; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Gordon SC, 2014, J HEPATOL; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Karino Y, 2014, J VIRAL HEPATITIS, V21, P341, DOI 10.1111/jvh.12162; Kikuchi H, 2014, EUR J GASTROEN HEPAT, V26, P244, DOI 10.1097/MEG.0000000000000005; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Kunze A, 2012, BIOCHEM PHARMACOL, V84, P1096, DOI 10.1016/j.bcp.2012.07.032; Lee JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100790; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Loustaud- Ratti V, 2014, LIVER INT; Mauss S, 2014, HEPATOLOGY, V59, P46, DOI 10.1002/hep.26602; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Medapalli RK, 2012, JAIDS-J ACQ IMM DEF, V60, P393, DOI 10.1097/QAI.0b013e31825b70d9; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Prowle JR, 2014, CLIN J AM SOC NEPHRO, V9, P1015, DOI 10.2215/CJN.11141113; Roujeau JC, 2013, JAMA DERMATOL, V149, P152, DOI 10.1001/jamadermatol.2013.938; Saadoun D, 2006, ARTHRITIS RHEUM-US, V54, P3696, DOI 10.1002/art.22168; Schwartz EJ, 2005, J AM SOC NEPHROL, V16, P2412, DOI 10.1681/ASN.2005040340; Su FH, 2012, AM J KIDNEY DIS, V60, P553, DOI 10.1053/j.ajkd.2012.04.003; Tsui JI, 2007, ARCH INTERN MED, V167, P1271, DOI 10.1001/archinte.167.12.1271; Van den Eynde E, 2014, AIDS, V28, P1538, DOI 10.1097/QAD.0000000000000265; Veiga Z, 2014, EUR J GASTROEN HEPAT, V26, P687, DOI 10.1097/MEG.0000000000000069; Virlogeux V, 2014, J VIRAL HEPATITIS, V21, pE98, DOI 10.1111/jvh.12237; Yoshida EM, 2015, HEPATOLOGY, V61, P41, DOI 10.1002/hep.27366; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124139	10.1371/journal.pone.0124139	http://dx.doi.org/10.1371/journal.pone.0124139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923243	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600072
J	Volland, S; Esteve-Rudd, J; Hoo, J; Yee, C; Williams, DS				Volland, Stefanie; Esteve-Rudd, Julian; Hoo, Juyea; Yee, Claudine; Williams, David S.			A Comparison of Some Organizational Characteristics of the Mouse Central Retina and the Human Macula	PLOS ONE			English	Article							PIGMENT-EPITHELIUM; LIPOFUSCIN ACCUMULATION; BRUCHS MEMBRANE; OUTER SEGMENTS; BLOOD-FLOW; AGE; PHOTORECEPTOR; DEGENERATION; MICE; DEPOSITS	Mouse models have greatly assisted our understanding of retinal degenerations. However, the mouse retina does not have a macula, leading to the question of whether the mouse is a relevant model for macular degeneration. In the present study, a quantitative comparison between the organization of the central mouse retina and the human macula was made, focusing on some structural characteristics that have been suggested to be important in predisposing the macula to stresses leading to degeneration: photoreceptor density, phagocytic load on the RPE, and the relative thinness of Bruch's membrane. Light and electron microscopy measurements from retinas of two strains of mice, together with published data on human retinas, were used for calculations and subsequent comparisons. As in the human retina, the central region of the mouse retina possesses a higher photoreceptor cell density and a thinner Bruch's membrane than in the periphery; however, the magnitudes of these periphery to center gradients are larger in the human. Of potentially greater relevance is the actual photoreceptor cell density, which is much greater in the mouse central retina than in the human macula, underlying a higher phagocytic load for the mouse RPE. Moreover, at eccentricities that correspond to the peripheral half of the human macula, the rod to cone ratio is similar between mouse and human. Hence, with respect to photoreceptor density and phagocytic load of the RPE, the central mouse retina models at least the more peripheral part of the macula, where macular degeneration is often first evident.	[Williams, David S.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Ophthalmol,Stein Eye Inst,Mol Biol Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Neurobiol,Stein Eye Inst,Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Williams, DS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Ophthalmol,Stein Eye Inst,Mol Biol Inst, Los Angeles, CA 90095 USA.	dswilliams@ucla.edu			National Institutes of Health [R01EY07042, P30EY00331]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY007042, P30EY000331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grant R01EY07042 (DW) and Core Grant P30EY00331 (Stein Eye research group), and a Research to Prevent Blindness Jules and Doris Stein Professorship (to DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNELT PK, 1987, J COMP NEUROL, V255, P18, DOI 10.1002/cne.902550103; ALM A, 1973, EXP EYE RES, V15, P15, DOI 10.1016/0014-4835(73)90185-1; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Beatty S, 1999, BRIT J OPHTHALMOL, V83, P867, DOI 10.1136/bjo.83.7.867; Beltran WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090390; BESHARSE JC, 1979, INVEST OPHTH VIS SCI, V18, P1019; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; BONE RA, 1993, INVEST OPHTH VIS SCI, V34, P2033; BORWEIN B, 1980, AM J ANAT, V159, P125, DOI 10.1002/aja.1001590202; BRAEKEVELT CR, 1983, ANAT EMBRYOL, V166, P415, DOI 10.1007/BF00305927; BRESSLER NM, 1989, ARCH OPHTHALMOL-CHIC, V107, P847, DOI 10.1001/archopht.1989.01070010869032; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Curcio C.A., 2013, RETINA-J RET VIT DIS, VVolume 1, P465; Curcio CA, 2005, EXP EYE RES, V80, P761, DOI 10.1016/j.exer.2004.09.017; Curcio CA, 1996, INVEST OPHTH VIS SCI, V37, P1236; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; Delori FC, 2000, INVEST OPHTH VIS SCI, V41, P496; DOBELLE WH, 1969, SCIENCE, V166, P1508, DOI 10.1126/science.166.3912.1508; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Esteve-Rudd J., 2012, INVESTIG OPHTHALMOL, V53, P4756; FARBER DB, 1985, INVEST OPHTH VIS SCI, V26, P1558; FEENEY L, 1973, INVEST OPHTH VISUAL, V12, P635; FEENEYBURNS L, 1983, T OPHTHAL SOC UK, V103, P416; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Geng LJ, 1999, EXP EYE RES, V69, P539, DOI 10.1006/exer.1999.0735; Green W R, 1999, Mol Vis, V5, P27; Hendrickson A, 2005, MACULAR DEGENERATION, P1, DOI 10.1007/3-540-26977-0_1; HENDRICKSON A, 1992, BEHAV BRAIN RES, V49, P21, DOI 10.1016/S0166-4328(05)80191-3; HOGAN M J, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P64; Jeon CJ, 1998, J NEUROSCI, V18, P8936; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Keeler CE, 1924, P NATL ACAD SCI USA, V10, P329, DOI 10.1073/pnas.10.7.329; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; LATIES AM, 1971, INVEST OPHTH VISUAL, V10, P69; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; NEWSOME DA, 1987, CURR EYE RES, V6, P1211, DOI 10.3109/02713688709025231; Nork TM, 2006, ARCH OPHTHALMOL-CHIC, V124, P860, DOI 10.1001/archopht.124.6.860; OBRIEN B, 1951, J OPT SOC AM, V41, P882, DOI 10.1364/JOSA.41.000882; Osterberg G, 1935, Acta Ophthalmol., V13, P11; Pikuleva IA, 2014, PROG RETIN EYE RES, V41, P64, DOI 10.1016/j.preteyeres.2014.03.002; Polyak S., 1957, VERTEBRATE VISUAL SY; Polyak S. L., 1941, RETINA-J RET VIT DIS; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Rickman CB, 2013, INVEST OPHTH VIS SCI, V54, pORSF68, DOI 10.1167/iovs.13-12757; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; STEINBERG RH, 1973, J COMP NEUROL, V148, P229, DOI 10.1002/cne.901480209; Sterratt DC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002921; TSO MOM, 1968, ARCH OPHTHALMOL-CHIC, V80, P214, DOI 10.1001/archopht.1968.00980050216012; Wavre-Shapton ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057769; YAMADA E, 1969, ARCH OPHTHALMOL-CHIC, V82, P151; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645	64	108	108	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125631	10.1371/journal.pone.0125631	http://dx.doi.org/10.1371/journal.pone.0125631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923208	Green Published, gold			2022-12-26	WOS:000353711600156
J	Xeuatvongsa, A; Mirza, S; Winter, C; Feldon, K; Vongphrachanh, P; Phonekeo, D; Denny, J; Khanthamaly, V; Kounnavong, B; Lylianou, D; Phousavath, S; Norasingh, S; Boutta, N; Olsen, S; Bresee, J; Moen, A; Corwin, A				Xeuatvongsa, Anonh; Mirza, Sara; Winter, Christian; Feldon, Keith; Vongphrachanh, Phengta; Phonekeo, Darouny; Denny, Justin; Khanthamaly, Viengphone; Kounnavong, Bounheuang; Lylianou, Doualy; Phousavath, Sisouphane; Norasingh, Sisouveth; Boutta, Nao; Olsen, Sonja; Bresee, Joseph; Moen, Ann; Corwin, Andrew			The Lao Experience in Deploying Influenza A (H1N1)pdm09 Vaccine: Lessons Made Relevant in Preparing for Present Day Pandemic Threats	PLOS ONE			English	Article								The Lao PDR, as did most countries of the Mekong Region, embarked on a pandemic vaccine initiative to counter the threat posed by influenza A(H1N1)pdm09. Overall, estimated vaccine coverage of the Lao population was 14%, with uptake in targeted health care workers and pregnant women 99% and 41%, respectively. Adverse Events Following Immunization accounted for only 6% of survey driven, reported vaccination experiences, with no severe consequences or deaths. Public acceptability of the vaccine campaign was high (98%). Challenges to vaccine deployment included: 1) no previous experience in fielding a seasonal influenza vaccine, 2) safety and efficacy concerns, and 3) late arrival of vaccine 10 months into the pandemic. The Lao success in surmounting these hurdles was in large measure attributed to the oversight assigned the National Immunization Program, and national sensitivities in responding to the avian influenza A(H5N1) crisis in the years leading up to the pandemic. The Lao "lessons learned" from pandemic vaccine deployment are made even more relevant four years on, given the many avian influenza strains circulating in the region, all with pandemic potential.	[Xeuatvongsa, Anonh; Norasingh, Sisouveth] Minist Hlth, Natl Immunizat Program, Viangchan, Laos; [Mirza, Sara; Olsen, Sonja; Bresee, Joseph; Moen, Ann] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Winter, Christian; Denny, Justin] World Hlth Org Western Pacific Reg, Emerging Dis Surveillance & Response Unit, Country Off, Viangchan, Laos; [Feldon, Keith] WHO, Country Off, Expanded Program Immunizat, Viangchan, Laos; [Vongphrachanh, Phengta; Phonekeo, Darouny] Minist Hlth, Natl Ctr Lab & Epidemiol, Viangchan, Laos; [Khanthamaly, Viengphone; Kounnavong, Bounheuang] US Ctr Dis Control & Prevent, Country Off, Viangchan, Laos; [Lylianou, Doualy; Phousavath, Sisouphane] Minist Hlth, Field Epidemiol Training Program, Natl Ctr Lab & Epidemiol, Viangchan, Laos; [Boutta, Nao] Minist Hlth, Cabinet, Viangchan, Laos	Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization	Corwin, A (corresponding author), US Ctr Dis Control & Prevent, Country Off, Viangchan, Laos.	Corwinal2e@yahoo.com	Winter, Christian/AAP-1643-2020	Denny, Justin/0000-0001-8311-3550	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], REPORT WHO PANDEMIC; [Anonymous], 2012, REP REG WORKSH INFL; [Anonymous], 2012, REP WHO PAND INFL H1; Chan Paul K. S., 2014, SEASONAL FLU CONTROL; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Khamphaphongphane B, 2008, EPIDEMIOLOGICAL VIRO, DOI 10.111/j.1750-2659.2012.00394.x; Lao PDR National Immunization Program, 2011, LAO PDR NATL IMMUNIZ; Phengxay M, 2015, INFLUENZA OTHER RESP, DOI 10.1111/irv.12299; Ungchusak K, 2012, EMERG INFECT DIS, V18, P1058, DOI 10.3201/eid1807.110976; Weekly Epidemiological Record, 2014, PAND INFL H1N1 2009, V84, P505; World Health Organisation, 2009, GLOB AL RESP INFL IL; 2009, MMWR MORB MORTAL WKL, V58, P453	12	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0121717	10.1371/journal.pone.0121717	http://dx.doi.org/10.1371/journal.pone.0121717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923779	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600007
J	Gao, X; Su, Y; Chen, YL; Han, MY; Yuan, YY; Xu, JC; Xin, F; Zhang, MG; Huang, SS; Wang, GJ; Kang, DY; Guan, LP; Zhang, JG; Dai, P				Gao, Xue; Su, Yu; Chen, Yu-Lan; Han, Ming-Yu; Yuan, Yong-Yi; Xu, Jin-Cao; Xin, Feng; Zhang, Mei-Guang; Huang, Sha-Sha; Wang, Guo-Jian; Kang, Dong-Yang; Guan, Li-Ping; Zhang, Jian-Guo; Dai, Pu			Identification of Two Novel Compound Heterozygous PTPRQ Mutations Associated with Autosomal Recessive Hearing Loss in a Chinese Family	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CAUSE OVARIAN DYSGENESIS; PHOSPHATIDYLINOSITOL PHOSPHATASE; PERRAULT SYNDROME; DEAFNESS; ADHESION; DOMAIN	Mutations in PTPRQ are associated with deafness in humans due to defects of stereocilia in hair cells. Using whole exome sequencing, we identified responsible gene of family 1572 with autosomal recessively non-syndromic hearing loss (ARNSHL). We also used DNA from 74 familial patients with ARNSHL and 656 ethnically matched control chromosomes to perform extended variant analysis. We identified two novel compound heterozygous missense mutations, c.3125 A>G p.D1042G (maternal allele) and c.5981 A>G p.E1994G (paternal allele), in the PTPRQ gene, as the cause of recessively inherited sensorineural hearing loss in family 1572. Both variants co-segregated with hearing loss phenotype in family 1572, but were absent in 74 familial patients. Heterozygosity for c.3125 A>G was identified in two samples from unaffected Chinese individuals (656 chromosomes). Therefore, the hearing loss in this family was caused by two novel compound heterozygous mutations in PTPRQ.	[Gao, Xue; Su, Yu; Han, Ming-Yu; Yuan, Yong-Yi; Xin, Feng; Huang, Sha-Sha; Wang, Guo-Jian; Kang, Dong-Yang; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Gao, Xue; Su, Yu; Yuan, Yong-Yi; Dai, Pu] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Otolaryngol, Sanya, Peoples R China; [Gao, Xue; Xu, Jin-Cao; Zhang, Mei-Guang] Second Artillery Gen Hosp, Dept Otorhinolaryngol, Beijing, Peoples R China; [Chen, Yu-Lan; Guan, Li-Ping; Zhang, Jian-Guo] BGI Shenzhen, Shenzhen 518083, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Beijing Genomics Institute (BGI)	Dai, P (corresponding author), Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	daipu301@vip.sina.com		Yuan, Yongyi/0000-0002-7936-4776	National Natural Science Foundation of China [30801285, 81230020, 81200751, 81371098, 81371096, 81400471, 81371352]; China Postdoctoral Science Foundation [2012M521878, 2013T60947]; Beijing Natural Science Foundation [7132177, 7122172]; Military Twelfth Five-year Project of China [CWS115034]; National Basic Research Program of China (973 Program) [2014CB541706, 2014CB541701];  [2012BAI09B02];  [201202005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Military Twelfth Five-year Project of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China); ; 	This work was supported by grants from the Project of the National Natural Science Foundation of China (30801285, 81230020, 81200751, 81371098, 81371096, 81400471, 81371352), grants from China Postdoctoral Science Foundation (2012M521878, 2013T60947), a grant from the Project of Beijing Natural Science Foundation (7132177, 7122172), a grant from Minister of Science and Technology of China (2012BAI09B02), a grant from Military Twelfth Five-year Project of China (CWS115034), grants from the National Basic Research Program of China (973 Program) (2014CB541706, 2014CB541701) and a grant from Minister of Health of China (201202005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ChiRosso G, 1997, J BIOL CHEM, V272, P31447, DOI 10.1074/jbc.272.50.31447; Delmaghani S, 2012, HUM MOL GENET, V21, P3835, DOI 10.1093/hmg/dds212; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Gao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063026; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Imtiaz A, 2014, HUM MUTAT, V35, P618, DOI 10.1002/humu.22545; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Schraders M, 2010, AM J HUM GENET, V86, P604, DOI 10.1016/j.ajhg.2010.02.015; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; Shahin H, 2010, J MED GENET, V47, P643, DOI 10.1136/jmg.2009.075697; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; WEBER P, 1995, J BIOL CHEM, V270, P4619, DOI 10.1074/jbc.270.9.4619; Wright MB, 1998, J BIOL CHEM, V273, P23929, DOI 10.1074/jbc.273.37.23929; Yona Simon, 2010, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1415s88; Zheng J, 2011, P NATL ACAD SCI USA, V108, P4218, DOI 10.1073/pnas.1005842108	26	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124757	10.1371/journal.pone.0124757	http://dx.doi.org/10.1371/journal.pone.0124757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919374	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400060
J	Li, R; Perneczky, R; Yakushev, I; Forster, S; Kurz, A; Drzezga, A; Kramer, S				Li, Rui; Perneczky, Robert; Yakushev, Igor; Foerster, Stefan; Kurz, Alexander; Drzezga, Alexander; Kramer, Stefan		Alzheimers Dis Neuroimaging Initia	Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease	PLOS ONE			English	Article							DIAGNOSIS; PET; MILD; PREDICTION	We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer's disease. In the work, the term "pattern" stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called "region of interest (ROI)". In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the characteristics of the given data, given some prior anatomical knowledge. A Gaussian Mixture Model (GMM) and model selection are combined to return a clustering of voxels that may serve for the definition of ROIs. Experiments on both an in-house dataset and data of the Alzheimer's Disease Neuroimaging Initiative (ADNI) suggest that the proposed approach arrives at a better diagnosis than a merely anatomical approach or conventional statistical hypothesis testing.	[Li, Rui] Tech Univ Munich, Inst Informat I12, Garching, Germany; [Perneczky, Robert; Kurz, Alexander] Tech Univ Munich, Klin & Poliklin Psychiat & Psychotherapie, D-80290 Munich, Germany; [Yakushev, Igor; Foerster, Stefan] Tech Univ Munich, Nukl Med Klin, D-80290 Munich, Germany; [Drzezga, Alexander] Univ Cologne, Nukl Med Klin & Poliklin, D-50931 Cologne, Germany; [Kramer, Stefan] Johannes Gutenberg Univ Mainz, Inst Informat, D-55122 Mainz, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Cologne; Johannes Gutenberg University of Mainz	Kramer, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Informat, D-55122 Mainz, Germany.	kramer@informatik.uni-mainz.de	Preda, Adrian/K-8889-2013; Hsiung, Robin/AAT-1661-2021; Perneczky, Robert/AAJ-2550-2020	Preda, Adrian/0000-0003-3373-2438; Hsiung, Robin/0000-0002-8017-0856; Perneczky, Robert/0000-0003-1981-7435; Ponto, Laura/0000-0003-1197-6714; Drzezga, Alexander/0000-0001-6018-716X; Yakushev, Igor/0000-0003-4764-798X	TUM Graduate School of Information Science in Health (GSISH), Technische Universitat Munchen; Johannes Gutenberg-Universitat Mainz; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, P50AG005134] Funding Source: NIH RePORTER	TUM Graduate School of Information Science in Health (GSISH), Technische Universitat Munchen; Johannes Gutenberg-Universitat Mainz; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: RL received PhD scholarship from the TUM Graduate School of Information Science in Health (GSISH), Technische Universitat Munchen. The authors acknowledge the Johannes Gutenberg-Universitat Mainz for publication funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALZ, 2008, ALZH DIS INT; Bishop Christopher M., 2006, PATTERN RECOGNITION; Bouckaert RR, 2004, LECT NOTES ARTIF INT, V3056, P3; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; de Leon MJ, 2007, J NEUROL, V254, P1666, DOI 10.1007/s00415-007-0610-z; Degroote P, 2009, ASTRON ASTROPHYS, V506, P111, DOI 10.1051/0004-6361/200911782; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Drzezga A, 2009, BEHAV NEUROL, V21, P101, DOI [10.3233/BEN-2009-0228, 10.1155/2009/276026]; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Echeverria AE, 2013, RADIOTHER ONCOL, V106, P124, DOI 10.1016/j.radonc.2012.09.003; Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010; Gorriz JM, 2011, APPL SOFT COMPUT, V11, P2313, DOI 10.1016/j.asoc.2010.08.012; Gorriz JM, 2009, NEUROSCI LETT, V460, P108, DOI 10.1016/j.neulet.2009.05.039; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Li R, 2010, P 13 C ART INT MED B, P60; Liu MH, 2012, NEUROIMAGE, V60, P1106, DOI 10.1016/j.neuroimage.2012.01.055; Lopez M, 2009, ELECTRON LETT, V45, P389, DOI 10.1049/el.2009.0176; Lu LJ, 2012, PHYS MED BIOL, V57, P5035, DOI 10.1088/0031-9155/57/15/5035; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Metz CE, 1999, INT CONGR SER, V1182, P543; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Naik PA, 2007, J AM STAT ASSOC, V102, P244, DOI 10.1198/016214506000000861; Nobili F, 2008, EUR J NUCL MED MOL I, V35, P2191, DOI 10.1007/s00259-008-0869-z; Preacher KJ, 2013, MULTIVAR BEHAV RES, V48, P28, DOI 10.1080/00273171.2012.710386; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Salaun PY, 2014, EUR J NUCL MED MOL I, V41, P1501, DOI 10.1007/s00259-014-2772-0; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segovia F, 2012, NEUROCOMPUTING, V75, P64, DOI 10.1016/j.neucom.2011.03.050; Sharif MS, 2012, ADV FUZZY SYST, V2012, DOI 10.1155/2012/327861; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Witten IH, 2011, MOR KAUF D, P1; Yakushev I, 2008, PSYCHIAT RES-NEUROIM, V164, P143, DOI 10.1016/j.pscychresns.2007.11.004; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122731	10.1371/journal.pone.0122731	http://dx.doi.org/10.1371/journal.pone.0122731			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919662	Green Published, gold			2022-12-26	WOS:000353659400018
J	Gerlits, O; Tian, JH; Das, A; Langan, P; Heller, WT; Kovalevsky, A				Gerlits, Oksana; Tian, Jianhui; Das, Amit; Langan, Paul; Heller, William T.; Kovalevsky, Andrey			Phosphoryl Transfer Reaction Snapshots in Crystals: INSIGHTS INTO THE MECHANISM OF PROTEIN KINASE A CATALYTIC SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mechanism; molecular dynamics; phosphoryl transfer; protein kinase	ACTIVE-SITE; MAGNETIC-RESONANCE; COMPLEXES; ADENOSINE; DYNAMICS; ANGSTROM; FEATURES; MUTANT	Background: PKAc (catalytic subunit) catalyzes phosphorylation of protein substrates thereby regulating a myriad of cellular processes. Results: X-ray structures of PKAc complexes along the phosphoryl transfer reaction have been obtained. Conclusion: The phosphotransfer follows a multistep mechanism, including conformational changes of the substrate and product groups, a loose transition state, and metal movement. Significance: Mechanistic knowledge about the phosphorylation by PKAc will contribute to understanding of the kinase function and regulation. To study the catalytic mechanism of phosphorylation catalyzed by cAMP-dependent protein kinase (PKA) a structure of the enzyme-substrate complex representing the Michaelis complex is of specific interest as it can shed light on the structure of the transition state. However, all previous crystal structures of the Michaelis complex mimics of the PKA catalytic subunit (PKAc) were obtained with either peptide inhibitors or ATP analogs. Here we utilized Ca2+ ions and sulfur in place of the nucleophilic oxygen in a 20-residue pseudo-substrate peptide (CP20) and ATP to produce a close mimic of the Michaelis complex. In the ternary reactant complex, the thiol group of Cys-21 of the peptide is facing Asp-166 and the sulfur atom is positioned for an in-line phosphoryl transfer. Replacement of Ca2+ cations with Mg2+ ions resulted in a complex with trapped products of ATP hydrolysis: phosphate ion and ADP. The present structural results in combination with the previously reported structures of the transition state mimic and phosphorylated product complexes complete the snapshots of the phosphoryl transfer reaction by PKAc, providing us with the most thorough picture of the catalytic mechanism to date.	[Gerlits, Oksana; Tian, Jianhui; Das, Amit; Langan, Paul; Heller, William T.; Kovalevsky, Andrey] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Heller, WT (corresponding author), Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA.	hellerwt@ornl.gov; kovalevskyay@ornl.gov	Heller, William/ABE-1104-2020; Langan, Paul/N-5237-2015	Heller, William/0000-0001-6456-2975; Langan, Paul/0000-0002-0247-3122; Kovalevsky, Andrey/0000-0003-4459-9142	National Institutes of Health from the NIGMS [1R01GM071939-01]; Laboratory Directed Research and Development grant from Oak Ridge National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071939] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Laboratory Directed Research and Development grant from Oak Ridge National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM071939-01 from the NIGMS (to P. L.) and a Laboratory Directed Research and Development grant from Oak Ridge National Laboratory (to A. D., J. T., W. T. H., O. G., and P. L.).	ADAMS JA, 1993, PROTEIN SCI, V2, P2177, DOI 10.1002/pro.5560021217; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; ARMSTRONG RN, 1979, BIOCHEMISTRY-US, V18, P1230, DOI 10.1021/bi00574a018; Bastidas AC, 2013, J AM CHEM SOC, V135, P4788, DOI 10.1021/ja312237q; Bastidas AC, 2012, J MOL BIOL, V422, P215, DOI 10.1016/j.jmb.2012.05.021; BHATNAGAR D, 1983, BIOCHEMISTRY-US, V22, P6310, DOI 10.1021/bi00295a042; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Bruice TC, 2002, ACCOUNTS CHEM RES, V35, P139, DOI 10.1021/ar0001665; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerlits O, 2014, BIOCHEMISTRY-US, V53, P3179, DOI 10.1021/bi5000965; Gerlits O, 2013, BIOCHEMISTRY-US, V52, P3721, DOI 10.1021/bi400066a; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; GRANOT J, 1980, BIOCHEMISTRY-US, V19, P3537, DOI 10.1021/bi00556a019; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; HO MF, 1988, J AM CHEM SOC, V110, P2680, DOI 10.1021/ja00216a068; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jin Y, 2012, ANGEW CHEM INT EDIT, V51, P12242, DOI 10.1002/anie.201204266; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Khavrutskii IV, 2009, BIOCHEMISTRY-US, V48, P11532, DOI 10.1021/bi901475g; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KNIGHT WB, 1989, BIOCHEMISTRY-US, V28, P5728, DOI 10.1021/bi00440a005; Kovalevsky AY, 2012, ACTA CRYSTALLOGR D, V68, P854, DOI 10.1107/S0907444912014886; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; MENDELOW M, 1993, J BIOL CHEM, V268, P12289; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MOLL GW, 1976, J BIOL CHEM, V251, P3993; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Perez-Gallegos A, 2015, PHYS CHEM CHEM PHYS, V17, P3497, DOI 10.1039/c4cp03579h; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Shaffer J, 1999, BIOCHEMISTRY-US, V38, P12072, DOI 10.1021/bi991109q; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sims PC, 2013, J AM CHEM SOC, V135, P7861, DOI 10.1021/ja311604j; Smith M. B, 2007, MARCHS ADV ORGANIC C; Srivastava AK, 2014, STRUCTURE, V22, P1735, DOI 10.1016/j.str.2014.09.010; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Valiev M, 2007, J PHYS CHEM B, V111, P13455, DOI 10.1021/jp074853q; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; YOON MY, 1987, BIOCHEMISTRY-US, V26, P4118, DOI 10.1021/bi00387a056; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zhou J, 1997, BIOCHEMISTRY-US, V36, P2977, DOI 10.1021/bi9619132	52	18	18	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15538	15548		10.1074/jbc.M115.643213	http://dx.doi.org/10.1074/jbc.M115.643213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25925954	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000356527400019
J	Holder, PG; Jones, LC; Drake, PM; Barfield, RM; Banas, S; de Hart, GW; Baker, J; Rabuka, D				Holder, Patrick G.; Jones, Lesley C.; Drake, Penelope M.; Barfield, Robyn M.; Banas, Stefanie; de Hart, Gregory W.; Baker, Jeanne; Rabuka, David			Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catalysis; enzyme kinetics; metalloenzyme; monoclonal antibody; post-translational modification (PTM); aldehyde tag; antibody drug conjugation	MULTIPLE SULFATASE DEFICIENCY; COUPLED ELECTRON-TRANSFER; INTEGRATED RATE-EQUATIONS; PICTET-SPENGLER LIGATION; ENDOPLASMIC-RETICULUM; CHEMICAL-MODIFICATION; PROTEIN MODIFICATION; CATALYZED 1ST-ORDER; 2ND-ORDER REACTIONS; GALACTOSE-OXIDASE	Background: Aerobic formylglycine-generating enzyme (FGE) converts cysteine to formylglycine in vivo. Results: Purified FGE requires preactivation with copper to convert cysteine to formylglycine in vitro. Conclusion: FGE is a metalloenzyme. It is also a useful biocatalyst for the production of proteins that contain aldehyde tags. Significance: Understanding FGE biochemistry informs research on sulfatases and enables expanded biotechnology applications of the aldehyde tag. To further our aim of synthesizing aldehyde-tagged proteins for research and biotechnology applications, we developed methods for recombinant production of aerobic formylglycine-generating enzyme (FGE) in good yield. We then optimized the FGE biocatalytic reaction conditions for conversion of cysteine to formylglycine in aldehyde tags on intact monoclonal antibodies. During the development of these conditions, we discovered that pretreating FGE with copper(II) is required for high turnover rates and yields. After further investigation, we confirmed that both aerobic prokaryotic (Streptomyces coelicolor) and eukaryotic (Homo sapiens) FGEs contain a copper cofactor. The complete kinetic parameters for both forms of FGE are described, along with a proposed mechanism for FGE catalysis that accounts for the copper-dependent activity.	[Holder, Patrick G.; Jones, Lesley C.; Drake, Penelope M.; Barfield, Robyn M.; Banas, Stefanie; de Hart, Gregory W.; Baker, Jeanne; Rabuka, David] Catalent Pharma Solut, Emeryville, CA 94608 USA		Rabuka, D (corresponding author), 5703 Hollis St, Emeryville, CA 94608 USA.	david.rabuka@catalent.com	Holder, Patrick/O-4876-2016	Holder, Patrick/0000-0003-0971-191X				Agarwal P, 2013, BIOCONJUGATE CHEM, V24, P846, DOI 10.1021/bc400042a; Agarwal P, 2013, P NATL ACAD SCI USA, V110, P46, DOI 10.1073/pnas.1213186110; Appel MJ, 2015, ACS CHEM BIOL, V10, P72, DOI 10.1021/cb500897w; Bertolotti-Ciarlet A, 2009, MOL IMMUNOL, V46, P1878, DOI 10.1016/j.molimm.2009.02.002; BLACKBURN NJ, 1984, BIOCHEM J, V220, P447, DOI 10.1042/bj2200447; Bleck G. T., 2006, BIOPROCESS J, V5, P36; BOEKER EA, 1985, BIOCHEM J, V226, P29, DOI 10.1042/bj2260029; BOEKER EA, 1984, BIOCHEM J, V223, P15, DOI 10.1042/bj2230015; Capozzi G., 1974, THIOL GROUP, P785; Carlson BL, 2008, J BIOL CHEM, V283, P20117, DOI 10.1074/jbc.M800217200; Carrico IS, 2007, NAT CHEM BIOL, V3, P321, DOI 10.1038/nchembio878; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Ennemann EC, 2013, J BIOL CHEM, V288, P5828, DOI 10.1074/jbc.M112.405159; Farver O, 2011, COORDIN CHEM REV, V255, P757, DOI 10.1016/j.ccr.2010.08.005; Finney J, 2014, ARCH BIOCHEM BIOPHYS, V546, P19, DOI 10.1016/j.abb.2013.12.022; Gande SL, 2008, FEBS J, V275, P1118, DOI 10.1111/j.1742-4658.2008.06271.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hammes-Schiffer S, 2012, ENERG ENVIRON SCI, V5, P7696, DOI 10.1039/c2ee03361e; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Kishishita S, 2003, J AM CHEM SOC, V125, P1041, DOI 10.1021/ja017899k; Klinman JP, 2006, J BIOL CHEM, V281, P3013, DOI 10.1074/jbc.R500011200; Kudirka R, 2015, CHEM BIOL, V22, P293, DOI 10.1016/j.chembiol.2014.11.019; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mariappan M, 2008, J BIOL CHEM, V283, P11556, DOI 10.1074/jbc.M707858200; Mariappan M, 2008, J BIOL CHEM, V283, P6375, DOI 10.1074/jbc.M709171200; McGuirl MA, 1997, J BIOL INORG CHEM, V2, P336, DOI 10.1007/s007750050140; Montoya LA, 2012, CHEM COMMUN, V48, P4767, DOI 10.1039/c2cc30730h; Patterson DM, 2014, ACS CHEM BIOL, V9, P592, DOI 10.1021/cb400828a; Peng HJ, 2011, ANGEW CHEM INT EDIT, V50, P9672, DOI 10.1002/anie.201104236; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Rabuka D, 2012, NAT PROTOC, V7, P1052, DOI 10.1038/nprot.2012.045; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Roeser D, 2005, ACTA CRYSTALLOGR D, V61, P1057, DOI 10.1107/S0907444905013831; Roeser D, 2007, ACTA CRYSTALLOGR D, V63, P621, DOI 10.1107/S0907444907009961; Saaranen MJ, 2010, ANTIOXID REDOX SIGN, V12, P15, DOI 10.1089/ars.2009.2674; Sasaki T, 2008, BIOORG MED CHEM LETT, V18, P4550, DOI 10.1016/j.bmcl.2008.07.033; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; Tipton K. F., 2014, PERSPECT SCI, V1, P131, DOI [10.1016/j.pisc.2014.02.012, DOI 10.1016/J.PISC.2014.02.012]; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K; Wang WR, 2011, MOL IMMUNOL, V48, P860, DOI 10.1016/j.molimm.2010.12.009; Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; WHITTAKER MM, 1993, BIOPHYS J, V64, P762, DOI 10.1016/S0006-3495(93)81437-1; Wu P, 2009, P NATL ACAD SCI USA, V106, P3000, DOI 10.1073/pnas.0807820106; Zhou Q, 2014, BIOCONJUGATE CHEM, V25, P510, DOI 10.1021/bc400505q	51	47	54	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15730	15745		10.1074/jbc.M115.652669	http://dx.doi.org/10.1074/jbc.M115.652669			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25931126	Green Published, hybrid			2022-12-26	WOS:000356527400035
J	Bozzi, M; Cassetta, A; Covaceuszach, S; Bigotti, MG; Bannister, S; Hubner, W; Sciandra, F; Lamba, D; Brancaccio, A				Bozzi, Manuela; Cassetta, Alberto; Covaceuszach, Sonia; Bigotti, Maria Giulia; Bannister, Saskia; Huebner, Wolfgang; Sciandra, Francesca; Lamba, Doriano; Brancaccio, Andrea			The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy	PLOS ONE			English	Article							O-MANNOSYLATION PATHWAY; N-TERMINAL REGION; PROTEIN; WATER; GLYCOSYLATION; DYSTROPHIN; BINDING; HYPOGLYCOSYLATION; RECOGNITION; EXPRESSION	The severe dystroglycanopathy known as a form of limb-girdle muscular dystrophy (LGMD2P) is an autosomal recessive disease caused by the point mutation T192M in alpha-dystroglycan. Functional expression analysis in vitro and in vivo indicated that the mutation was responsible for a decrease in posttranslational glycosylation of dystroglycan, eventually interfering with its extracellular-matrix receptor function and laminin binding in skeletal muscle and brain. The X-ray crystal structure of the missense variant T190M of the murine N-terminal domain of alpha-dystroglycan (50-313) has been determined, and showed an overall topology (Ig-like domain followed by a basket-shaped domain reminiscent of the small subunit ribosomal protein S6) very similar to that of the wild-type structure. The crystallographic analysis revealed a change of the conformation assumed by the highly flexible loop encompassing residues 159-180. Moreover, a solvent shell reorganization around Met190 affects the interaction between the B1-B5 anti-parallel strands forming part of the floor of the basket-shaped domain, with likely repercussions on the folding stability of the protein domain (s) and on the overall molecular flexibility. Chemical denaturation and limited proteolysis experiments point to a decreased stability of the T190M variant with respect to its wild-type counterpart. This mutation may render the entire L-shaped protein architecture less flexible. The overall reduced flexibility and stability may affect the functional properties of alpha-dystroglycan via negatively influencing its binding behavior to factors needed for dystroglycan maturation, and may lay the molecular basis of the T190M-driven primary dystroglycanopathy.	[Bozzi, Manuela] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, I-00168 Rome, Italy; [Cassetta, Alberto; Covaceuszach, Sonia; Lamba, Doriano] CNR, Ist Cristallog, I-34149 Trieste, Italy; [Bigotti, Maria Giulia; Brancaccio, Andrea] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Bannister, Saskia; Huebner, Wolfgang] Univ Bielefeld, Dept Phys, D-33615 Bielefeld, Germany; [Sciandra, Francesca; Brancaccio, Andrea] Univ Cattolica Sacro Cuore, CNR, Ist Chim Riconoscimento Mol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); University of Bristol; University of Bielefeld; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Cassetta, A (corresponding author), CNR, Ist Cristallog, I-34149 Trieste, Italy.	alberto.cassetta@ts.ic.cnr.it; andrea.brancaccio@icrm.cnr.it	Brancaccio, Andrea/C-5876-2009; Cassetta, A./AAG-8712-2019; Lamba, Doriano/B-2961-2011; Sciandra, Francesca/AAY-4650-2020; Lamba, Doriano/L-9808-2018; Covaceuszach, Sonia/AAA-4116-2021; Hubner, Wolfgang/O-7907-2016	Brancaccio, Andrea/0000-0003-4690-8826; Cassetta, A./0000-0002-8600-4162; Lamba, Doriano/0000-0001-6859-7868; Sciandra, Francesca/0000-0002-2123-1516; Lamba, Doriano/0000-0001-6859-7868; Hubner, Wolfgang/0000-0002-1128-6468; Bigotti, Giulia/0000-0001-9595-3338	Wellcome Trust Career Re-entry fellowship	Wellcome Trust Career Re-entry fellowship(Wellcome Trust)	This work was supported by a Wellcome Trust Career Re-entry fellowship to MGB.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bhattacharya S, 2014, GENE, V537, P108, DOI 10.1016/j.gene.2013.11.071; Bozic D, 2004, J BIOL CHEM, V279, P44812, DOI 10.1074/jbc.C400353200; Bozzi M, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-15; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Brancaccio A, 1997, EUR J BIOCHEM, V246, P166, DOI 10.1111/j.1432-1033.1997.00166.x; Brancaccio A, 2013, NEUROMUSCULAR DISORD, V23, P867, DOI 10.1016/j.nmd.2013.06.371; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Covalt JC, 2001, J MOL BIOL, V307, P657, DOI 10.1006/jmbi.2001.4482; De Rosa MC, 2011, J MOL GRAPH MODEL, V29, P1015, DOI 10.1016/j.jmgm.2011.04.008; Di Stasio E, 2004, BIOPHYS CHEM, V107, P197, DOI 10.1016/j.bpc.2003.09.005; Dong MR, 2015, NEUROLOGY, V84, P273, DOI 10.1212/WNL.0000000000001162; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuroki K, 2014, P NATL ACAD SCI USA, V111, P8877, DOI 10.1073/pnas.1324105111; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Liu MA, 2008, BIOPOLYMERS, V90, P358, DOI 10.1002/bip.20847; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Morlacchi S, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-14; Praveen S, 2008, J APPL CRYSTALLOGR, V41, P952, DOI 10.1107/S0021889808022073; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schrodinger L., 2020, PYMOL; Sciandra F, 2013, CURR PROTEIN PEPT SC, V14, P626; Sciandra F, 2009, FEBS J, V276, P4933, DOI 10.1111/j.1742-4658.2009.07196.x; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Stanley P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005199; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	48	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124277	10.1371/journal.pone.0124277	http://dx.doi.org/10.1371/journal.pone.0124277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932631	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100036
J	Ferreira, LJ; Azevedo, V; Maroco, J; Oliveira, MM; Santos, AP				Ferreira, Liliana J.; Azevedo, Vanessa; Maroco, Joao; Margarida Oliveira, M.; Santos, Ana Paula			Salt Tolerant and Sensitive Rice Varieties Display Differential Methylome Flexibility under Salt Stress	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; DNA METHYLATION; SALINITY STRESS; ABIOTIC STRESS; AMPLIFIED POLYMORPHISM; EPIGENETIC INHERITANCE; GENE-EXPRESSION; ARABIDOPSIS; CHROMATIN; GENOTYPES	DNA methylation has been referred as an important player in plant genomic responses to environmental stresses but correlations between the methylome plasticity and specific traits of interest are still far from being understood. In this study, we inspected global DNA methylation levels in salt tolerant and sensitive rice varieties upon salt stress imposition. Global DNA methylation was quantified using the 5-methylcytosine (5mC) antibody and an ELISA-based technique, which is an affordable and quite pioneer assay in plants, and in situ imaging of methylation sites in interphase nuclei of tissue sections. Variations of global DNA methylation levels in response to salt stress were tissue- and genotype-dependent. We show a connection between a higher ability of DNA methylation adjustment levels and salt stress tolerance. The salt-tolerant rice variety Pokkali was remarkable in its ability to quickly relax DNA methylation in response to salt stress. In spite of the same tendency for reduction of global methylation under salinity, in the salt-sensitive rice variety IR29 such reduction was not statistically supported. In 'Pokkali', the salt stress-induced demethylation may be linked to active demethylation due to increased expression of DNA demethylases under salt stress. In 'IR29', the induction of both DNA demethylases and methyltransferases may explain the lower plasticity of DNA methylation. We further show that mutations for epigenetic regulators affected specific phenotypic parameters related to salinity tolerance, such as the root length and biomass. This work emphasizes the role of differential methylome flexibility between salt tolerant and salt sensitive rice varieties as an important player in salt stress tolerance, reinforcing the need to better understand the connection between epigenetic networks and plant responses to environmental stresses.	[Ferreira, Liliana J.; Azevedo, Vanessa; Margarida Oliveira, M.; Santos, Ana Paula] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Genom Plant Stress, P-2780157 Oeiras, Portugal; [Maroco, Joao] ISPA Inst Univ, UIPES, Lisbon, Portugal	Universidade Nova de Lisboa; Instituto Superior Psicologia Aplicada (ISPA)	Santos, AP (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Genom Plant Stress, Av Republ, P-2780157 Oeiras, Portugal.	apsantos@itqb.unl.pt	Marôco, João P./A-5729-2010; Oliveira, M. Margarida/H-9318-2012; Marôco, João/H-3622-2019; Santos, Ana Paula/D-3154-2012	Marôco, João P./0000-0001-9214-5378; Oliveira, M. Margarida/0000-0002-0095-1952; Marôco, João/0000-0001-9214-5378; Saavedra Azevedo, Vanessa/0000-0003-0057-4381; Duarte Ferreira, Liliana de Jesus/0000-0003-0727-6678; Santos, Ana Paula/0000-0002-8108-1863	Portuguese Foundation for Science and Technology (FCT) [BIA/BCM/111645/2009]; FCT [BPD/74197/2010, BD/61428/2009]; Research unit GREEN-it "Bioresources for Sustainability" [UID/Multi/04551/2013]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/111645/2009] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Research unit GREEN-it "Bioresources for Sustainability"; Fundação para a Ciência e a Tecnologia	The work was funded by Portuguese Foundation for Science and Technology (FCT) through the project "Epigenetic regulation of the rice genome under environmental stresses-BIA/BCM/111645/2009". APS and LF were financially supported by the following FCT grants: BPD/74197/2010 e BD/61428/2009, respectively. Research unit GREEN-it "Bioresources for Sustainability" (UID/Multi/04551/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cotsaftis O, 2011, MOL PLANT, V4, P25, DOI 10.1093/mp/ssq056; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Henikoff S, 1998, GENETICS, V149, P307; HERNANDEZ JA, 1995, PLANT SCI, V105, P151, DOI 10.1016/0168-9452(94)04047-8; HERNANDEZ JA, 1993, PHYSIOL PLANTARUM, V89, P103, DOI 10.1111/j.1399-3054.1993.tb01792.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kankel MW, 2003, GENETICS, V163, P1109; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kinnally EL, 2011, BRAIN BEHAV IMMUN, V25, P1548, DOI 10.1016/j.bbi.2011.05.001; Komatsu M, 2003, PLANT CELL, V15, P1934, DOI 10.1105/tpc.011809; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kumar K, 2013, RICE, V6, DOI 10.1186/1939-8433-6-27; La HG, 2011, P NATL ACAD SCI USA, V108, P15498, DOI 10.1073/pnas.1112704108; Lafon-Placette C, 2013, NEW PHYTOL, V197, P416, DOI 10.1111/nph.12026; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Marconi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075597; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Ramos M, 2013, TREE GENET GENOMES, V9, P1481, DOI 10.1007/s11295-013-0652-6; Santos AP, 2011, CYTOGENET GENOME RES, V132, P297, DOI 10.1159/000322287; Santos AP, 2011, OMICS, V15, P839, DOI 10.1089/omi.2011.0095; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; Sohn YG, 2005, J PLANT BIOL, V48, P201, DOI 10.1007/BF03030409; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zeng LH, 2005, PLANT SOIL, V268, P51, DOI 10.1007/s11104-004-0180-0; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	58	58	65	8	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124060	10.1371/journal.pone.0124060	http://dx.doi.org/10.1371/journal.pone.0124060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932633	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100029
J	Wang, HC; Hsu, SP; Lee, WS				Wang, Hui-Chen; Hsu, Sung-Po; Lee, Wen-Sen			Extra-Nuclear Signaling Pathway Involved in Progesterone-Induced Up-Regulations of p21(cip1) and p27(kip1) in Male Rat Aortic Smooth Muscle Cells	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; CORONARY-HEART-DISEASE; CYCLE PROGRESSION; MICE LACKING; INHIBITION; KINASE; PHOSPHORYLATION; PROLIFERATION; ATHEROSCLEROSIS; HYPERPLASIA	Previously, we demonstrated that progesterone (P4) at physiologic levels (5-500 nM) inhibited proliferation in cultured rat aortic smooth muscle cells (RASMCs) through a P4 receptor (PR)-dependent pathway. We also showed that P4-induced cell cycle arrest in RASMCs occurs when the cyclin-CDK2 system is inhibited just as p21(cip1) and p27(kip1) protein levels are augmented. In the present study, we further investigated the molecular mechanism underlying P4-induced up-regulations of p21(cip1) and p27(kip1) in RASMCs. We used pharmacological inhibitors as well as dominant negative constructs and conducted Western blot analyses to delineate the signaling pathway involved. Our data suggest that P4 up-regulated the expression of p21(cip1) and p27(kip1) in RASMCs through increasing the level of p53 protein mediated by activating the cSrc/Kras/Raf-1/AKT/ERK/p38/I kappa B alpha/NF kappa B pathway. The findings of the present study highlight the molecular mechanism underlying P4-induced up-regulations in p21(cip1) and p27(kip1) in RASMCs.	[Wang, Hui-Chen; Lee, Wen-Sen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Hsu, Sung-Po; Lee, Wen-Sen] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei 110, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei 110, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan.	wslee@tmu.edu.tw	Hsu, Sung-Po/I-8383-2019	HSU, SUNG-PO/0000-0001-7527-9040	National Science Council [NSC 96-2320-B-038-023, NSC 97-2320-B-038-033-MY3, NSC 102-2320-B-038-023]; Taipei Medical University [TMU101-AE1-B45]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Medical University	This study was supported by the National Science Council grant (http://www.most.gov.tw) NSC 96-2320-B-038-023 and NSC 97-2320-B-038-033-MY3 to WSL and NSC 102-2320-B-038-023 to SPH and Taipei Medical University (http://www.tmu.edu.tw) TMU101-AE1-B45 to SPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MR, 1990, ARTERIOSCLEROSIS, V10, P1051, DOI 10.1161/01.ATV.10.6.1051; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Castellano E, 2002, NAT REV CANCER, V2, P489; Castellano E, 2014, GENES CANC, V2, P261; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FOEGH ML, 1994, J VASC SURG, V19, P722, DOI 10.1016/S0741-5214(94)70047-8; FURMAN RH, 1968, ANN NY ACAD SCI, V149, P822, DOI 10.1111/j.1749-6632.1968.tb53838.x; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; HAARBO J, 1991, J CLIN INVEST, V87, P1274, DOI 10.1172/JCI115129; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Ho PY, 2004, INT J CANCER, V111, P51, DOI 10.1002/ijc.20039; Hsu SP, 2015, ENDOCRINOLOGY, V156, P291, DOI 10.1210/en.2014-1629; Hsu SP, 2011, ATHEROSCLEROSIS, V217, P83, DOI 10.1016/j.atherosclerosis.2011.02.051; Hsu SP, 2011, MOL ENDOCRINOL, V25, P421, DOI 10.1210/me.2010-0424; Hsu YF, 2007, MOL CARCINOGEN, V46, P275, DOI 10.1002/mc.20274; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KUSHWAHA RS, 1991, ARTERIOSCLER THROMB, V11, P23, DOI 10.1161/01.ATV.11.1.23; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lee WS, 2003, ENDOCRINOLOGY, V144, P2785, DOI 10.1210/en.2003-0045; Lee WS, 1997, NAT MED, V3, P1005, DOI 10.1038/nm0997-1005; LIBBY P, 1991, LAB INVEST, V64, P5; Lin SY, 2012, ANGIOGENESIS, V15, P671, DOI 10.1007/s10456-012-9289-6; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Miyagawa K, 1997, NAT MED, V3, P324, DOI 10.1038/nm0397-324; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; MUNRO JM, 1988, LAB INVEST, V58, P249; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Naumann U, 1999, BIOCHEM BIOPH RES CO, V261, P890, DOI 10.1006/bbrc.1999.1126; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Renault VM, 2011, ONCOGENE, V30, P3207, DOI 10.1038/onc.2011.35; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sa G, 2004, EXP CELL RES, V300, P427, DOI 10.1016/j.yexcr.2004.07.032; SCHWARTZ SM, 1990, PHYSIOL REV, V70, P1177, DOI 10.1152/physrev.1990.70.4.1177; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shupnik MA, 2004, ONCOGENE, V23, P7979, DOI 10.1038/sj.onc.1208076; STAMLER J, 1953, CIRC RES, V1, P94, DOI 10.1161/01.RES.1.1.94; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; SULLIVAN TR, 1995, J CLIN INVEST, V96, P2482, DOI 10.1172/JCI118307; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang HC, 2014, ENDOCRINOLOGY, V155, P4473, DOI 10.1210/en.2014-1344; Wang HC, 2014, ENDOCRINOLOGY, V155, P1428, DOI 10.1210/en.2013-1838; WEIGENSBERG BI, 1984, ATHEROSCLEROSIS, V52, P253, DOI 10.1016/0021-9150(84)90055-8; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125903	10.1371/journal.pone.0125903	http://dx.doi.org/10.1371/journal.pone.0125903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932965	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100142
J	Yin, XY; Cheng, H; Lin, Y; Wineinger, NE; Zhou, FS; Sheng, YJ; Yang, C; Li, P; Li, F; Shen, CB; Yang, S; Schork, NJ; Zhang, XJ				Yin, Xianyong; Cheng, Hui; Lin, Yan; Wineinger, Nathan E.; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Schork, Nicholas J.; Zhang, Xuejun			A Weighted Polygenic Risk Score Using 14 Known Susceptibility Variants to Estimate Risk and Age Onset of Psoriasis in Han Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ANALYSIS IDENTIFIES 3; COMMON VARIANTS; LOCI; GENES	With numbers of common variants identified mainly through genome-wide association studies (GWASs), there is great interest in incorporating the findings into screening individuals at high risk of psoriasis. The purpose of this study is to establish genetic prediction models and evaluate its discriminatory ability in psoriasis in Han Chinese population. We built the genetic prediction models through weighted polygenic risk score (PRS) using 14 susceptibility variants in 8,819 samples. We found the risk of psoriasis among individuals in the top quartile of PRS was significantly larger than those in the lowest quartile of PRS (OR = 28.20, P < 2.0x10(-16)). We also observed statistically significant associations between the PRS, family history and early age onset of psoriasis. We also built a predictive model with all 14 known susceptibility variants and alcohol consumption, which achieved an area under the curve statistic of similar to 0.88. Our study suggests that 14 psoriasis known susceptibility loci have the discriminating potential, as is also associated with family history and age of onset. This is the genetic predictive model in psoriasis with the largest accuracy to date.	[Yin, Xianyong; Cheng, Hui; Lin, Yan; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Affiliated Hosp 1, Inst Dermatol, Dept Dermatol, Hefei, Anhui, Peoples R China; [Yin, Xianyong; Cheng, Hui; Lin, Yan; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Incubat Ctr, State Key Lab Dermatol, Key Lab Dermatol,Minist Educ, Hefei, Anhui, Peoples R China; [Yin, Xianyong; Cheng, Hui; Lin, Yan; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Zhang, Xuejun] Key Lab Gene Resource Utilizat Complex Dis, Hefei, Anhui, Peoples R China; [Yin, Xianyong; Cheng, Hui; Lin, Yan; Zhou, Fusheng; Sheng, Yujun; Yang, Chao; Li, Pan; Li, Feng; Shen, Changbing; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Collaborat Innovat Ctr Complex & Severe Dermatosi, Hefei, Anhui, Peoples R China; [Wineinger, Nathan E.] Scripps Hlth, La Jolla, CA USA; [Yin, Xianyong; Wineinger, Nathan E.] Scripps Translat Sci Inst, La Jolla, CA USA; [Yin, Xianyong] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Schork, Nicholas J.] J Craig Venter Inst, Human Biol, La Jolla, CA 92037 USA	Anhui Medical University; Anhui Medical University; Anhui Medical University; Scripps Research Institute; Scripps Research Institute; J. Craig Venter Institute	Schork, NJ (corresponding author), J Craig Venter Inst, Human Biol, La Jolla, CA 92037 USA.	nschork@jcvi.org; ayzxj@vip.sina.com	SHENG, Yu/GXZ-8269-2022	Schork, Nicholas/0000-0003-0920-5013	National Natural Science Foundation of China [81370044, 81130031, 81000692]; China Council of Scholarship [201208340003]; Anhui High Education Talent Fund and Anhui Medical University Ph.D. Fund [XJ201429]; NIGH [1UL1TR001114]; NIH [U19 AG023122-09, R01 DA030976-05, R01 MH094483-03, R01 AG035020-05, R01 MH100351-02, R21 AG045789-01A1]; Human Longeveity, Inc.; Johnson and Johnson; Tanner Foundation; Stand-Upto- Cancer organization; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100351, R01MH094483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG023122, R01AG035020, R21AG045789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030976] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Council of Scholarship; Anhui High Education Talent Fund and Anhui Medical University Ph.D. Fund; NIGH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Longeveity, Inc.; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Tanner Foundation; Stand-Upto- Cancer organization; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	XYY was supported by the National Natural Science Foundation of China (81370044 and 81000692), China Council of Scholarship (201208340003), Anhui High Education Talent Fund and Anhui Medical University Ph.D. Fund (XJ201429). XJZ was supported by the National Natural Science Foundation of China (81130031). NEW is supported by the NIGH grant 1UL1TR001114. NJS and his lab are supported by NIH grants U19 AG023122-09, R01 DA030976-05, R01 MH094483-03, R01 AG035020-05, R01 MH100351-02, R21 AG045789-01A1 as well as grants from Human Longeveity, Inc., Johnson and Johnson, the Tanner Foundation, and the Stand-Upto- Cancer organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao W, 2013, AM J EPIDEMIOL, V178, P1197, DOI 10.1093/aje/kwt123; Chatterjee N, 2011, CANCER EPIDEM BIOMAR, V20, P3, DOI 10.1158/1055-9965.EPI-10-1022; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Cheng H, 2013, J INVEST DERMATOL; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Ding XL, 2012, EUR J DERMATOL, V22, P663, DOI 10.1684/ejd.2012.1802; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Enamandram M, 2013, J INVEST DERMATOL, V133, P287, DOI 10.1038/jid.2012.434; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Knight J, 2012, HUM MOL GENET, V21, P5185, DOI 10.1093/hmg/dds344; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; Li Y, 2013, J MED GENET; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Scott IC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003808; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yarwood A, 2013, ANN RHEUM DIS; Yin XY, 2013, J DERMATOL SCI, V70, P94, DOI 10.1016/j.jdermsci.2013.02.006; Yin XY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-87; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhu KJ, 2012, J DERMATOL, V39, P770, DOI 10.1111/j.1346-8138.2012.01577.x	28	27	30	1	629	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125369	10.1371/journal.pone.0125369	http://dx.doi.org/10.1371/journal.pone.0125369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933357	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100104
J	Hill, JC; Thomas, E; Hill, S; Foster, NE; van der Windt, DA				Hill, Jonathan C.; Thomas, Elaine; Hill, Susan; Foster, Nadine E.; van der Windt, Danielle A.			Development and Validation of the Keele Musculoskeletal Patient Reported Outcome Measure (MSK-PROM)	PLOS ONE			English	Article							BACK-PAIN; CLINICAL-TRIALS; PRIMARY-CARE	Objective To develop and validate a patient report outcome measure (PROM) for clinical practice that can monitor health status of patients with a range of musculoskeletal (MSK) disorders. Methods Constructs for inclusion in the MSK-PROM were identified from a consensus process involving patients with musculoskeletal conditions, clinicians, purchasers of healthcare services, and primary care researchers. Psychometric properties of the brief tool, including face and construct validity, repeatability and responsiveness were assessed in a sample of patients with musculoskeletal pain consulting physiotherapy services in the United Kingdom (n=425). Results The consensus process identified 10 prioritised domains for monitoring musculoskeletal health status: pain intensity, quality of life, physical capacity, interference with social/leisure activities, emotional well-being, severity of most difficult thing, activities and roles, understanding independence, and overall impact. As the EuroQol (EQ-5D-5L) is a widely adopted PROMs tool and covers the first four domains listed, to reduce patient burden to a minimum the MSK-PROM was designed to capture the remaining six prioritised domains which are not measured by the EQ-5D-5L. The tool demonstrated excellent reliability, construct validity, responsiveness and acceptability to patients and clinicians for use in clinical practice. Conclusion We have validated a brief patient reported outcome measure (MSK-PROM) for use in clinical practice to measure musculoskeletal health status and monitor outcomes over time using domains that are meaningful to patients and sensitive to change. Further work will establish whether the MSK-PROM is useful in other musculoskeletal healthcare settings.	[Hill, Jonathan C.; Thomas, Elaine; Hill, Susan; Foster, Nadine E.; van der Windt, Danielle A.] Keele Univ, Inst Primary Care & Hlth Sci, Stoke On Trent, Staffs, England	Keele University	Hill, JC (corresponding author), Keele Univ, Inst Primary Care & Hlth Sci, Stoke On Trent, Staffs, England.	j.hill@keele.ac.uk	Hill, Jonathan/AAT-2744-2020	van der Windt, Danielle/0000-0002-7248-6703; Foster, Nadine/0000-0003-4429-9756	National Institute for Health Research (NIHR) [PB-PG-0909-20283]; NIHR [NIHR-RP-011-015]; National Institute for Health Research [PB-PG-0909-20283, NIHR-RP-011-015] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This abstract presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number PB-PG-0909-20283) (http://www.nihr.ac.uk/funding/research-for-patient-benefit.htm). Nadine Foster is supported through a NIHR Research Professorship (NIHR-RP-011-015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce MB, 2014, BMJ QUAL SAF, P6; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Darzi A., 2008, HIGH QUALITY CARE AL; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Devlin N., 2010, GETTING MOST OUT PRO; DONNER A, 1987, STAT MED, V6, P441, DOI 10.1002/sim.4780060404; Duncan EAS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-96; Dunn KM, 2005, SPINE, V30, P1887, DOI 10.1097/01.brs.0000173900.46863.02; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; FDA, GUID IND PAT REP OUT; Greenhalgh J, 2009, QUAL LIFE RES, V18, P115, DOI 10.1007/s11136-008-9430-6; Hanley B, 2004, INVOLVING PUBLIC NHS; Harmon SC, 2007, PSYCHOTHER RES, V17, P379, DOI 10.1080/10503300600702331; Hartvigsen J, 2013, BEST PRACT RES CL RH, V27, P613, DOI 10.1016/j.berh.2013.09.008; Haywood KL, 2010, RHEUMATOLOGY EVIDENC; Health and Social Care Information Centre, 2013, HOSP EP STAT PROV MO; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Imison C., 2011, TRANSFORMING OUR HLT; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Kamaleri Y, 2008, PAIN, V138, P41, DOI 10.1016/j.pain.2007.11.002; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; LIANG MH, 1990, MED CARE, V28, P632, DOI 10.1097/00005650-199007000-00008; Mokkink L B, 2006, BMC Med Res Methodol, V6, P2, DOI 10.1186/1471-2288-6-2; Newnham EA, 2009, CLIN PSYCHOL REV, V10, P1016; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Resnik L, 2008, PHYS THER, V88, P1078, DOI 10.2522/ptj.20070327; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Shao J, 2003, STAT MED, V22, P2429, DOI 10.1002/sim.1519; Van der Wees PJ, INTEGRATING USE PATI; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124557	10.1371/journal.pone.0124557	http://dx.doi.org/10.1371/journal.pone.0124557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25928807	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353713100039
J	Kuk, H; Hutchenreuther, J; Murphy-Marshman, H; Carter, D; Leask, A				Kuk, Hanna; Hutchenreuther, James; Murphy-Marshman, Hannah; Carter, David; Leask, Andrew			5Z-7-Oxozeanol Inhibits the Effects of TGF beta 1 on Human Gingival Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; TISSUE; MYOFIBROBLAST; SCLERODERMA; FIBROSIS; KINASE; CONTRACTION; INDUCTION; TAK1	Transforming growth factor (TGF)beta acts on fibroblasts to promote the production and remodeling of extracellular matrix (ECM). In adult humans, excessive action of TGF beta is associated with fibrotic disease and fibroproliferative conditions, including gingival hyperplasia. Understanding how the TGF beta 1 signals in fibroblasts is therefore likely to result in valuable insights into the fundamental mechanisms underlying fibroproliferative disorders. Previously, we used the TAK1 inhibitor (5Z)-7-Oxozeaenol to show that, in dermal fibroblasts, the non-canonical TAK1 pathway mediates the ability of TGF beta 1 to induce genes promoting tissue remodeling and repair. However, the extent to which TAK1 mediates fibroproliferative responses in fibroblasts in response to TGF beta 1 remains unclear. Herein, we show that, in gingival fibroblasts, (5Z)-7-Oxozeaenol blocks the ability of TGF beta 1 to induce expression of the pro-fibrotic mediator CCN2 (connective tissue growth factor, CTGF) and type I collagen protein. Moreover, genome-wide expression profiling revealed that, in gingival fibroblasts, (5Z)-7-Oxozeaenol reduces the ability of TGF beta 1 to induce mRNA expression of essentially all TGF beta 1-responsive genes (139/147), including those involved with a hyperproliferative response. Results from microarray analysis were confirmed using real time polymerase chain reaction analysis and a functional cell proliferation assay. Our results are consistent with the hypothesis that TAK1 inhibitors might be useful in treating fibroproliferative disorders, including that in the oral cavity.	[Kuk, Hanna; Hutchenreuther, James; Leask, Andrew] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Murphy-Marshman, Hannah; Leask, Andrew] Univ Western Ontario, Dept Dent, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Carter, David] Robarts Res Inst, London Reg Genom Ctr, London, ON N6A 5B7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Leask, A (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.	Andrew.Leask@schulich.uwo.ca	Leask, Andy/ABH-9433-2020; Leask, Andrew/G-5217-2015		Canadian Institutes for Health Research; Scleroderma Society of Ontario; JUMP program at the University of Western Ontario	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Ontario; JUMP program at the University of Western Ontario	This work was supported by Canadian Institutes for Health Research (AL) and Scleroderma Society of Ontario (AL). HMM was funded by the JUMP program at the University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg VF, 2014, J INVEST DERMATOL, V134, P1862, DOI 10.1038/jid.2014.90; Bitu CC, 2006, J CLIN PERIODONTOL, V33, P393, DOI 10.1111/j.1600-051X.2006.00928.x; Black SA, 2008, J BIOL CHEM, V283, P10835, DOI 10.1074/jbc.M710363200; Damasceno LS, 2012, BRAZ ORAL RES, V26, P373, DOI 10.1590/S1806-83242012005000012; EDDY RJ, 1988, AM J PATHOL, V130, P252; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Guo F, 2013, J INVEST DERMATOL, V133, P1646, DOI 10.1038/jid.2013.28; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027097; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Leask A, 2011, J CELL COMMUN SIGNAL, V5, P125, DOI 10.1007/s12079-011-0122-6; Liu JQ, 2014, J CELL PHYSIOL, V229, P1121, DOI 10.1002/jcp.24630; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Mah W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090715; MAUVIEL A, 1993, CURR BIOL, V3, P822, DOI 10.1016/0960-9822(93)90216-B; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; Moodley YP, 2003, AM J RESP CELL MOL, V29, P490, DOI 10.1165/rcmb.2002-0262OC; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Safwat N, 2005, ENDOCRINOLOGY, V146, P4814, DOI 10.1210/en.2005-0457; Sampson N, 2013, ENDOCRINOLOGY, V154, P2586, DOI 10.1210/en.2012-2259; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Thompson K, 2010, J DENT RES, V89, P1450, DOI 10.1177/0022034510379020; Thompson K, 2014, J CELL COMMUN SIGNAL, V8, P59, DOI 10.1007/s12079-014-0229-7; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393; VANCHEESWARAN R, 1994, J RHEUMATOL, V21, P1268; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200	37	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123689	10.1371/journal.pone.0123689	http://dx.doi.org/10.1371/journal.pone.0123689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927238	gold, Green Submitted, Green Published			2022-12-26	WOS:000353713100021
J	Sarwar, A; Katas, H; Samsudin, SN; Zin, NM				Sarwar, Atif; Katas, Haliza; Samsudin, Siti Noradila; Zin, Noraziah Mohamad			Regioselective Sequential Modification of Chitosan via Azide-Alkyne Click Reaction: Synthesis, Characterization, and Antimicrobial Activity of Chitosan Derivatives and Nanoparticles	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; DELIVERY	Recently, the attention of researchers has been drawn toward the synthesis of chitosan derivatives and their nanoparticles with enhanced antimicrobial activities. In this study, chitosan derivatives with different azides and alkyne groups were synthesized using click chemistry, and these were further transformed into nanoparticles by using the ionotropic gelation method. A series of chitosan derivatives was successfully synthesized by regioselective modification of chitosan via an azide-alkyne click reaction. The amino moieties of chitosan were protected during derivatization by pthaloylation and subsequently unblocked at the end to restore their functionality. Nanoparticles of synthesized derivatives were fabricated by ionic gelation to form complexes of polyanionic penta-sodium tripolyphosphate (TPP) and cationic chitosan derivatives. Particle size analysis showed that nanoparticle size ranged from 181.03 +/- 12.73 nm to 236.50 +/- 14.32 nm and had narrow polydispersity index and positive surface charge. The derivatives and corresponding nanoparticles were evaluated in vitro for antibacterial and antifungal activities against three gram-positive and gram-negative bacteria and three fungal strains, respectively. The minimum inhibitory concentration (MIC) of all derivatives ranged from 31.3 to 250 mu g/mL for bacteria and 188 to1500 mu g/mL for fungi and was lower than that of native chitosan. The nanoparticles with MIC ranging from 1.56 to 25 mu g/mLfor bacteria and 94 to 750 mu g/mL for fungi exhibited higher activity than the chitosan derivatives. Chitosan O-(1-methylbenzene) triazolyl carbamateand chitosan O-(1-methyl phenyl sulfide) triazolyl carbamate were the most active against the tested bacterial and fungal strains. The hemolytic assay on erythrocytes and cell viability test on two different cell lines (Chinese hamster lung fibroblast cells V79 and Human hepatic cell line WRL68) demonstrated the safety; suggesting that these derivatives could be used in future medical applications. Chitosan derivatives with triazole functionality, synthesized by Huisgen 1,3-dipolar cycloaddition, and their nanoparticles showed significant enhancement in antibacterial and antifungal activities in comparison to those associated with native, non-altered chitosan.	[Sarwar, Atif; Katas, Haliza; Samsudin, Siti Noradila] Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Malaysia; [Zin, Noraziah Mohamad] Univ Kebangsaan Malaysia, Fac Hlth Sci, Novel Antibiot Res Grp, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Katas, H (corresponding author), Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur Campus,Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia.	haliza.katas@gmail.com	Zin, Noraziah M/E-3326-2019; KATAS, HALIZA/I-6417-2016	KATAS, HALIZA/0000-0001-7249-1628; Zin, Noraziah/0000-0002-7839-1246	Ministry of Science, Technology and Innovation (MOSTI), Malaysia [02-01-02-SF0737]; Universiti Kebangsaan Malaysia	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Kebangsaan Malaysia	The authors are thankful to the Universiti Kebangsaan Malaysia and Ministry of Science, Technology and Innovation (MOSTI), Malaysia for support and award of grant (02-01-02-SF0737).	Ahmad N, 2014, MOL PHARM; Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028; Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028; Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4; Choi CY, 2007, CARBOHYD POLYM, V68, P122, DOI 10.1016/j.carbpol.2006.07.018; Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001; Araujo MGD, 2012, INT J MOL SCI, V13, P9260, DOI 10.3390/ijms13079260; Dedola S, 2007, ORG BIOMOL CHEM, V5, P1006, DOI 10.1039/b618048p; Demirbas N, 2004, EUR J MED CHEM, V39, P793, DOI 10.1016/j.ejmech.2004.06.007; Dhawade PP, 2012, ADV APPL SCI RES, V3, P1372; Dong YM, 2004, J APPL POLYM SCI, V93, P1553, DOI 10.1002/app.20630; El-Hefian EA, 2011, E-J CHEM, V8, P91, DOI 10.1155/2011/969062; Ezabadi RR, 2008, BIOORGAN MED CHEM, V16, P1150, DOI 10.1016/j.bmc.2007.10.082; Gao Y, 2009, BIOMACROMOLECULES, V10, P2175, DOI 10.1021/bm900341d; Holappa J, 2004, MACROMOLECULES, V37, P2784, DOI 10.1021/ma0358780; Ifuku S, 2011, CARBOHYD POLYM, V85, P653, DOI 10.1016/j.carbpol.2011.03.030; Ing LY, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/632698; Iqbal M, 2003, VACCINE, V21, P1478, DOI 10.1016/S0264-410X(02)00662-X; Jabbal-Gill I, 2012, EXPERT OPIN DRUG DEL, V9, P1051, DOI 10.1517/17425247.2012.697455; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Kulbokaite R, 2009, REACT FUNCT POLYM, V69, P771, DOI 10.1016/j.reactfunctpolym.2009.06.010; Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163; Li XF, 2008, IRAN POLYM J, V17, P843; Liao SK, 2004, MACROMOL RES, V12, P466, DOI 10.1007/BF03218428; Liu N, 2006, CARBOHYD POLYM, V64, P60, DOI 10.1016/j.carbpol.2005.10.028; Moon MS, 2006, FASEB J, V20, pA1017; Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002; Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005; No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6; Oh JK, 2009, PROG POLYM SCI, V34, P1261, DOI 10.1016/j.progpolymsci.2009.08.001; Oliveira JR, 2012, CARBOHYD POLYM, V87, P240, DOI 10.1016/j.carbpol.2011.07.043; Petrikkou E, 2001, J CLIN MICROBIOL, V39, P1345, DOI 10.1128/JCM.39.4.1345-1347.2001; Qi LF, 2006, BIOORG MED CHEM LETT, V16, P4243, DOI 10.1016/j.bmcl.2006.05.078; Ramdas M, 1999, J BIOMATER APPL, V13, P290, DOI 10.1177/088532829901300402; Sajomsang W, 2009, INT J BIOL MACROMOL, V44, P419, DOI 10.1016/j.ijbiomac.2009.03.003; Sarwar A, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2517-9; Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4; Shalini K, 2011, BEILSTEIN J ORG CHEM, V7, P668, DOI 10.3762/bjoc.7.79; Socrates G., 2004, INFRARED RAMAN CHARA; Sovadinova I, 2011, POLYMERS-BASEL, V3, P1512, DOI 10.3390/polym3031512; Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002; Tillman J, 2006, BIOMATERIALS, V27, P5618, DOI 10.1016/j.biomaterials.2006.07.006; Wang JF, 2012, CHEM COMMUN, V48, P916, DOI 10.1039/c1cc16432e; Zampano G, 2010, REACT FUNCT POLYM, V70, P272, DOI 10.1016/j.reactfunctpolym.2010.01.004; Zhang C, 2006, J AGR FOOD CHEM, V54, P8409, DOI 10.1021/jf061541w; Zhong ZM, 2007, CARBOHYD RES, V342, P2390, DOI 10.1016/j.carres.2007.07.015	47	65	66	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123084	10.1371/journal.pone.0123084	http://dx.doi.org/10.1371/journal.pone.0123084			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928293	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100013
J	Shaw, K; Baart, M; Depowski, N; Bortfeld, H				Shaw, Kathleen; Baart, Martijn; Depowski, Nicole; Bortfeld, Heather			Infants' Preference for Native Audiovisual Speech Dissociated from Congruency Preference	PLOS ONE			English	Article							PHONETIC INFORMATION; VISUAL SPEECH; INTERSENSORY PERCEPTION; 1ST YEAR; FACE; INTEGRATION; DISCRIMINATION; SYNCHRONY; ATTENTION; ADULTS	Although infant speech perception in often studied in isolated modalities, infants' experience with speech is largely multimodal (i.e., speech sounds they hear are accompanied by articulating faces). Across two experiments, we tested infants' sensitivity to the relationship between the auditory and visual components of audiovisual speech in their native (English) and non-native (Spanish) language. In Experiment 1, infants' looking times were measured during a preferential looking task in which they saw two simultaneous visual speech streams articulating a story, one in English and the other in Spanish, while they heard either the English or the Spanish version of the story. In Experiment 2, looking times from another group of infants were measured as they watched single displays of congruent and incongruent combinations of English and Spanish audio and visual speech streams. Findings demonstrated an age-related increase in looking towards the native relative to non-native visual speech stream when accompanied by the corresponding (native) auditory speech. This increase in native language preference did not appear to be driven by a difference in preference for native vs. non-native audiovisual congruence as we observed no difference in looking times at the audiovisual streams in Experiment 2.	[Shaw, Kathleen; Depowski, Nicole; Bortfeld, Heather] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Baart, Martijn] BCBL, Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain; [Bortfeld, Heather] Haskins Labs Inc, New Haven, CT USA	University of Connecticut; Yale University; Haskins Laboratories	Bortfeld, H (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	heather.bortfeld@uconn.edu	Baart, Martijn/L-2910-2013; Bortfeld, Heather/AAK-8553-2020	Baart, Martijn/0000-0002-5015-4265; Bortfeld, Heather/0000-0002-3545-5449; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892	National Institutes of Health [R01 DC010075]; National Science Foundation IGERT Grant [1144399]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation IGERT Grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Institutes of Health Grant R01 DC010075 (http://grants.nih.gov/grants/funding/r01.htm) to HB. KS was supported by a National Science Foundation IGERT Grant (1144399, http://www.igert.org/) to the University of Connecticut. The funders had no role in	Baart M, 2015, J EXP CHILD PSYCHOL, V129, P157, DOI 10.1016/j.jecp.2014.08.002; Baart M, 2014, COGNITION, V130, P31, DOI 10.1016/j.cognition.2013.09.006; BAHRICK LE, 1987, INFANT BEHAV DEV, V10, P387, DOI 10.1016/0163-6383(87)90039-7; Best CT, 2001, J ACOUST SOC AM, V109, P775, DOI 10.1121/1.1332378; Best CT, 2011, INT C AUD VIS SPEECH; Bristow D, 2009, J COGNITIVE NEUROSCI, V21, P905, DOI 10.1162/jocn.2009.21076; Desjardins RN, 2004, DEV PSYCHOBIOL, V45, P187, DOI 10.1002/dev.20033; Desjardins RN, 1997, J EXP CHILD PSYCHOL, V66, P85, DOI 10.1006/jecp.1997.2379; DODD B, 1979, COGNITIVE PSYCHOL, V11, P478, DOI 10.1016/0010-0285(79)90021-5; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Gogate LJ, 1998, J EXP CHILD PSYCHOL, V69, P133, DOI 10.1006/jecp.1998.2438; Kubicek C, 2014, INFANT BEHAV DEV, V37, P644, DOI 10.1016/j.infbeh.2014.08.010; Kubicek C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089275; Kubicek C, 2013, INT J BEHAV DEV, V37, P106, DOI 10.1177/0165025412473016; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kushnerenko E, 2008, P NATL ACAD SCI USA, V105, P11442, DOI 10.1073/pnas.0804275105; Kushnerenko E, 2013, EUR J NEUROSCI, V38, P3363, DOI 10.1111/ejn.12317; LAWSON KR, 1980, DEV PSYCHOL, V16, P185, DOI 10.1037/0012-1649.16.3.185; Lewkowicz DJ, 2013, INT J BEHAV DEV, V37, P90, DOI 10.1177/0165025412467582; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Lewkowicz DJ, 2010, DEV PSYCHOL, V46, P66, DOI 10.1037/a0015579; Lewkowicz DJ, 1996, J EXP PSYCHOL HUMAN, V22, P1094, DOI 10.1037/0096-1523.22.5.1094; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; Maidment DW, 2014, J SPEECH LANG HEAR R; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Palmer SB, 2012, CHILD DEV, V83, P543, DOI 10.1111/j.1467-8624.2011.01715.x; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Pons F, 2009, P NATL ACAD SCI USA, V106, P10598, DOI 10.1073/pnas.0904134106; Stein BE., 1993, MERGING SENSES; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; Tomalski P, 2013, EUR J DEV PSYCHOL, V10, P611, DOI 10.1080/17405629.2012.728076; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vouloumanos A, 2010, CHILD DEV, V81, P517, DOI 10.1111/j.1467-8624.2009.01412.x; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3	40	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126059	10.1371/journal.pone.0126059	http://dx.doi.org/10.1371/journal.pone.0126059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25927529	gold, Green Published			2022-12-26	WOS:000353713100124
J	Subramaniam, KS; Skinner, J; Ivan, E; Mutimura, E; Kim, RS; Feintuch, CM; Portugal, S; Anastos, K; Crompton, PD; Daily, JP				Subramaniam, Krishanthi S.; Skinner, Jeff; Ivan, Emil; Mutimura, Eugene; Kim, Ryung S.; Feintuch, Catherine M.; Portugal, Silvia; Anastos, Kathryn; Crompton, Peter D.; Daily, Johanna P.			HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults	PLOS ONE			English	Article							COTRIMOXAZOLE PROPHYLAXIS; IMMUNE-RESPONSES; UNSTABLE MALARIA; PREGNANT-WOMEN; INFECTION; IMMUNOSUPPRESSION; INDIVIDUALS; PROTECTION; IMMUNODEFICIENCY; THROMBOCYTOPENIA	HIV infected individuals in malaria endemic areas experience more frequent and severe malaria episodes compared to non HIV infected. This clinical observation has been linked to a deficiency in antibody responses to Plasmodium falciparum antigens; however, prior studies have only focused on the antibody response to <0.5% of P. falciparum proteins. To obtain a broader and less-biased view of the effect of HIV on antibody responses to malaria we compared antibody profiles of HIV positive (HIV+) and negative (HIV-) Rwandan adults with symptomatic malaria using a microarray containing 824 P. falciparum proteins. We also investigated the cellular basis of the antibody response in the two groups by analyzing B and T cell subsets by flow cytometry. Although HIV malaria co-infected individuals generated antibodies to a large number of P. falciparum antigens, including potential vaccine candidates, the breadth and magnitude of their response was reduced compared to HIV-individuals. HIV malaria co-infection was also associated with a higher percentage of atypical memory B cells (MBC) (CD19+CD10-CD21-CD27-) compared to malaria infection alone. Among HIV+ individuals the CD4(+) T cell count and HIV viral load only partially explained variability in the breadth of P. falciparum-specific antibody responses. Taken together, these data indicate that HIV malaria co-infection is associated with an expansion of atypical MBCs and a diminished antibody response to a diverse array of P. falciparum antigens, thus offering mechanistic insight into the higher risk of malaria in HIV+ individuals.	[Subramaniam, Krishanthi S.] Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England; [Skinner, Jeff; Portugal, Silvia; Crompton, Peter D.] NIAID, Malaria Infect Biol & Immun Unit, Immunogenet Lab, NIH, Bethesda, MD 20892 USA; [Ivan, Emil] Univ Rwanda, Dept Biomed Lab Sci, Coll Med & Hlth Sci, Kigali, Rwanda; [Mutimura, Eugene] Reg Alliance Sustainable Dev, Kigali, Rwanda; [Kim, Ryung S.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Feintuch, Catherine M.; Daily, Johanna P.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Anastos, Kathryn; Daily, Johanna P.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Liverpool School of Tropical Medicine; University of Liverpool; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Rwanda; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Daily, JP (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	jdaily@einstein.yu.edu	Crompton, Peter/N-1130-2016; Subramaniam, Krishanthi/AAW-8777-2021	Subramaniam, Krishanthi/0000-0002-1734-9351; Portugal, Silvia/0000-0003-4567-9101; Skinner, Jeff/0000-0001-5697-0442	Albert Einstein College of Medicine Global Health Pilot Grant; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health;  [NIAID: 1RC1AI086224]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070117, RC1AI086224, ZIAAI001155] Funding Source: NIH RePORTER	Albert Einstein College of Medicine Global Health Pilot Grant; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by A. JPD supported by NIAID: 1RC1AI086224 and an Albert Einstein College of Medicine Global Health Pilot Grant. B. JS, SP and PDC are supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Ataide R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022491; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Brahimi K, 2001, INFECT IMMUN, V69, P3845, DOI 10.1128/IAI.69.6.3845-3952.2001; Campbell JD, 2012, CLIN INFECT DIS, V54, P1204, DOI 10.1093/cid/cis013; Cavanagh DR, 1998, J IMMUNOL, V161, P347; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Courtin D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007590; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Denoeud-Ndam L, 2014, JAIDS-J ACQ IMM DEF, V65, P198, DOI 10.1097/QAI.0000000000000058; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Gonzalez R, 2012, EXPERT REV ANTI-INFE, V10, P153, DOI [10.1586/ERI.11.167, 10.1586/eri.11.167]; GRAU GE, 1988, IMMUNOLOGY, V65, P501; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Hasang W, 2014, J INFECT DIS, V210, P1407, DOI 10.1093/infdis/jiu262; Hendriksen ICE, 2012, CLIN INFECT DIS, V55, P1144, DOI 10.1093/cid/cis590; Hobbs CV, 2012, J INFECT DIS, V206, P1706, DOI 10.1093/infdis/jis602; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Iroezindu Michael O, 2012, Niger J Med, V21, P209; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Kardava L, 2014, J CLIN INVEST, V124, P3252, DOI 10.1172/JCI74351; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Khan Shiraz Jamal, 2012, Malar Res Treat, V2012, P405981, DOI 10.1155/2012/405981; Khosravi A, 2011, PARASITE IMMUNOL, V33, P145, DOI 10.1111/j.1365-3024.2010.01260.x; Klement E, 2014, CLIN INFECT DIS, V58, P651, DOI 10.1093/cid/cit806; Laufer MK, 2006, J INFECT DIS, V193, P872, DOI 10.1086/500245; LOOAREESUWAN S, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P44; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; MIEDEMA F, 1988, J CLIN INVEST, V82, P1908, DOI 10.1172/JCI113809; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Muema DKM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-55; Omoti CE, 2013, ASIAN PAC J TROP MED, V6, P126, DOI 10.1016/S1995-7645(13)60007-3; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; Puentes A, 2005, BIOCHIMIE, V87, P461, DOI 10.1016/j.biochi.2005.01.001; R Core Team, 2021, R LANGUAGE ENV STAT; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sboner A, 2009, J PROTEOME RES, V8, P5451, DOI 10.1021/pr900412k; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; Subramaniam K, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu066; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tatfeng Y. M., 2007, Journal of Vector Borne Diseases, V44, P111; Van Geertruyden JP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-258; Van Geertruyden JP, 2009, JAIDS-J ACQ IMM DEF, V50, P200, DOI 10.1097/QAI.0b013e3181900159; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; WHO, 2010, GUID TREATM MAL, V2nd; Yamaguchi S, 1997, AM J HEMATOL, V56, P183, DOI 10.1002/(SICI)1096-8652(199711)56:3&lt;183::AID-AJH9&gt;3.0.CO;2-U	56	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124412	10.1371/journal.pone.0124412	http://dx.doi.org/10.1371/journal.pone.0124412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928218	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100032
J	Tedford, SE; Persons, AL; Napier, TC				Tedford, Stephanie E.; Persons, Amanda L.; Napier, T. Celeste			Dopaminergic Lesions of the Dorsolateral Striatum in Rats Increase Delay Discounting in an Impulsive Choice Task	PLOS ONE			English	Article							INTRACRANIAL SELF-STIMULATION; PARKINSONS-DISEASE; INTERNAL CLOCK; REINFORCEMENT; TIME; PERFORMANCE; REWARD; APATHY; MECHANISMS; ATTENTION	Dysregulated dopamine transmission in striatal circuitry is associated with impulsivity. The current study evaluated the influence of dopaminergic inputs to the dorsolateral striatum on impulsive choice, one aspect of impulsive behavior. We implemented an operant task that measures impulsive choice in rats via delay discounting wherein intracranial self-stimulation (ICSS) was used as the positive reinforcer. To do so, rats were anesthetized to allow implanting of a stimulating electrode within the lateral hypothalamus of one hemisphere and bilateral dorsal striatal injections of the dopaminergic toxin, 6-OHDA (lesioned) or its vehicle (sham). Following recovery, rats were trained in a delay discounting task wherein they selected between a small ICSS current presented immediately after lever pressing, and a large ICSS current presented following a 0 to 15s delay upon pressing the alternate lever. Task acquisition and reinforcer discrimination were similar for lesioned and sham rats. All rats exhibited an initial preference for the large reinforcer, and as the delay was increased, preference for the large reinforcer was decreased indicating that the subjective value of the large reinforcer was discounted as a function of delay time. However, this discounting effect was significantly enhanced in lesioned rats for the longer delays. These data reveal a contribution of dopaminergic inputs to the dorsolateral striatum on impulsive choice behavior, and provide new insights into neural substrates underlying discounting behaviors.	[Tedford, Stephanie E.; Persons, Amanda L.; Napier, T. Celeste] Rush Univ, Dept Pharmacol, Chicago, IL 60612 USA; [Napier, T. Celeste] Rush Univ, Dept Psychiat, Chicago, IL 60612 USA; [Tedford, Stephanie E.; Persons, Amanda L.; Napier, T. Celeste] Rush Univ, Ctr Compuls Behav & Addict, Chicago, IL 60612 USA	Rush University; Rush University; Rush University	Tedford, SE (corresponding author), Rush Univ, Dept Pharmacol, Chicago, IL 60612 USA.	Stephanie_E_Tedford@rush.edu			Michael J. Fox Foundation; United States Public Health Service Guidelines [NS074014, DA033121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA033121] Funding Source: NIH RePORTER	Michael J. Fox Foundation; United States Public Health Service Guidelines; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Michael J. Fox Foundation (www.michaeljfox.org), and United States Public Health Service Guidelines #NS074014 and #DA033121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Beitz Janice M, 2014, Front Biosci (Schol Ed), V6, P65; Bickel WK, 2014, NEUROPHARMACOLOGY, V76, P518, DOI 10.1016/j.neuropharm.2013.06.013; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Bickel WK, 1999, PSYCHOPHARMACOLOGY, V146, P447, DOI 10.1007/PL00005490; BLACK J, 1985, BRAIN RES, V359, P113, DOI 10.1016/0006-8993(85)91418-0; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; Cardinal RN, 2006, NEURAL NETWORKS, V19, P1277, DOI 10.1016/j.neunet.2006.03.004; Decamp E, 2004, EUR J NEUROSCI, V20, P1371, DOI 10.1111/j.1460-9568.2004.03586.x; Drew MR, 2003, PHARMACOL BIOCHEM BE, V75, P9, DOI 10.1016/S0091-3057(03)00036-4; Dunnett SB, 2012, BRAIN RES BULL, V88, P251, DOI 10.1016/j.brainresbull.2011.04.002; FALK JL, 1961, J EXP ANAL BEHAV, V4, P213, DOI 10.1901/jeab.1961.4-213; Favier M, 2014, MOVEMENT DISORD, V29, P912, DOI 10.1002/mds.25837; Floresco SB, 2008, NEUROPSYCHOPHARMACOL, V33, P1966, DOI 10.1038/sj.npp.1301565; Fouriezos G, 1997, BEHAV BRAIN RES, V87, P111, DOI 10.1016/S0166-4328(97)02280-8; GIBSON WE, 1965, SCIENCE, V148, P1357, DOI 10.1126/science.148.3675.1357; Gregorios-Pippas L, 2009, J NEUROPHYSIOL, V101, P1507, DOI 10.1152/jn.90730.2008; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Harrington DL, 1998, J NEUROSCI, V18, P1085; Heilbronner SR, 2014, BEHAV PROCESS, V101, P123, DOI 10.1016/j.beproc.2013.09.013; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057831; Isella V, 2002, MOVEMENT DISORD, V17, P366, DOI 10.1002/mds.10041; Kayser AS, 2012, J NEUROSCI, V32, P9402, DOI 10.1523/JNEUROSCI.1180-12.2012; Koffarnus MN, 2011, BEHAV PHARMACOL, V22, P300, DOI 10.1097/FBP.0b013e3283473bcb; Lange KW, 1995, J NEURAL TRANSM-SUPP, P423; LINDHOLM EP, 1970, J COMP PHYSIOL PSYCH, V72, P318, DOI 10.1037/h0029462; MacDonald CJ, 2005, PSYCHOPHARMACOLOGY, V182, P232, DOI 10.1007/s00213-005-0074-8; Madden GJ, 2007, J GAMBL STUD, V23, P63, DOI 10.1007/s10899-006-9041-5; MALAPANI C, 1994, NEUROLOGY, V44, P319, DOI 10.1212/WNL.44.2.319; Mata R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039135; Matell MS, 2006, PSYCHOPHARMACOLOGY, V188, P201, DOI 10.1007/s00213-006-0489-x; Matell MS, 2004, BEHAV NEUROSCI, V118, P150, DOI 10.1037/0735-7044.118.1.150; McHugh MJ, 2013, AM J DRUG ALCOHOL AB, V39, P424, DOI 10.3109/00952990.2013.847446; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Minamimoto T, 2009, J NEUROPHYSIOL, V101, P437, DOI 10.1152/jn.90959.2008; Nenadic I, 2003, EXP BRAIN RES, V148, P238, DOI 10.1007/s00221-002-1188-4; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Raffard S, 2013, PSYCHIAT RES, V209, P393, DOI 10.1016/j.psychres.2013.04.016; Reynolds B, 2006, BEHAV PHARMACOL, V17, P651, DOI 10.1097/FBP.0b013e3280115f99; Rokosik SL, 2012, NEUROPSYCHOPHARMACOL, V37, P1397, DOI 10.1038/npp.2011.325; Rokosik SL, 2011, J NEUROSCI METH, V198, P260, DOI 10.1016/j.jneumeth.2011.04.025; Schuck-Paim C, 2004, PLOS BIOL, V2, P2305, DOI 10.1371/journal.pbio.0020402; Setlow B, 2009, BEHAV PHARMACOL, V20, P380, DOI 10.1097/FBP.0b013e3283305eb4; Sinha N, 2013, J NEUROPSYCHOL, V7, P255, DOI 10.1111/jnp.12013; SPIES G, 1965, J COMP PHYSIOL PSYCH, V60, P153, DOI 10.1037/h0022367; Tedford SE, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00215; Wearden JH, 2009, Q J EXP PSYCHOL, V62, P33, DOI 10.1080/17470210802229047; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	58	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122063	10.1371/journal.pone.0122063	http://dx.doi.org/10.1371/journal.pone.0122063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927685	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100006
J	Wang, TT; Zhao, L; Guo, YL; Zhang, MZ; Pei, HT				Wang, Tingting; Zhao, Li; Guo, Yunliang; Zhang, Meizeng; Pei, Haitao			Picroside II Inhibits Neuronal Apoptosis and Improves the Morphology and Structure of Brain Tissue following Cerebral Ischemic Injury in Rats	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; ARTERY OCCLUSION; CELL-DEATH; MODEL; ACTIVATION; EXPRESSION; PROTEIN	This paper aimed to explore the protective effects of picroside II against the neuronal apoptosis and changes in morphology and structure that follow cerebral ischemic injury in rats. A focal cerebral ischemic model was established by inserting a monofilament thread to achieve middle cerebral artery occlusion (MCAO) in 60 Wistar rats, and intraperitoneal injections of picroside II (20 mg/kg) were administered. The neurobehavioral functions were evaluated with the modified neurological severity score (mNSS) test. The cerebral infarct volumes were measured with tetrazolium chloride (TTC) staining. The morphology and ultrastructure of the cortical brain tissues were observed with hematoxylin-eosin staining and transmission electron microscopy, respectively. The apoptotic cells were counted with terminal deoxynucleotidyl transferase dUTP nick-end labeling and flow cytometry, and pERK1/2 expression was determined by immunohistochemical assay and Western blot. The results indicated that neurological behavioral malfunctions and cerebral infarcts were present in the MCAO rats. In the model group, the damage to the structures of the neurons and the blood brain barrier (BBB) in the cortex was more severe, and the numbers of apoptotic cells, the early apoptotic ratio (EAR) and pERK1/2 expression were significantly increased in this group compared to the control group (P<0.05). In the treatment group, the neurological behavioral function and the morphology and ultrastructure of the neurons and the BBB were improved including the number of Mi increased and relative area of condensed chromosome and basement (BM) thickness descreased, and the cerebral infarct volume, the number of apoptotic cells, the EAR and pERK1/2 expression were significantly decreased compared to the model group (P<0.05). These results suggest that picroside II reduced apoptosis and improved the morphology and ultrastructure of the neurons and the BBB and that these effects resulted in the recovery of the neurobehavioral function of rats with cerebral ischemia.	[Wang, Tingting; Zhao, Li; Guo, Yunliang; Zhang, Meizeng; Pei, Haitao] Qingdao Univ, Shandong Prov Collaborat Innovat Ctr Neurodegener, Taishan Scholars Construct Project Excellent Inno, Inst Cerebrovasc Dis,Affiliated Hosp, Qingdao 266003, Peoples R China	Qingdao University	Guo, YL (corresponding author), Qingdao Univ, Shandong Prov Collaborat Innovat Ctr Neurodegener, Taishan Scholars Construct Project Excellent Inno, Inst Cerebrovasc Dis,Affiliated Hosp, Qingdao 266003, Peoples R China.	guoqdsd@163.com	wang, tingting/AAK-2640-2020		 [81274116];  [81041092]	; 	This experiment was supported by grant-in-aids for the Natural Science Fund of China (81274116, 81041092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INT J MOL SCI; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Deng XH, 2013, BRAIN RES BULL, V94, P56, DOI 10.1016/j.brainresbull.2013.02.007; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Guo YL, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-43; Jin H, 2006, TOXICOL SCI, V90, P221, DOI 10.1093/toxsci/kfj066; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kovalska M, 2006, TOXICOL SCI, V90, P221; Li Q, 2012, CHINESE PHARMACOL B, V26, P342; Li Q, 2010, INT J MOL SCI, V11, P4580, DOI 10.3390/ijms11114580; Li XA, 2010, NEURAL REGEN RES, V5, P1403, DOI 10.3969/j.issn.1673-5374.2010.18.007; Li Zhen, 2010, Zhongguo Yaolixue Tongbao, V26, P52; Lobner D, 2004, NEUROCHEM RES, V29, P2303, DOI 10.1007/s11064-004-7040-4; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Sun L, 2011, NEURAL REGEN RES, V6, P1141, DOI 10.3969/j.issn.1673-5374.2011.15.004; Zhao Li, 2014, Chinese Pharmacological Bulletin, V30, P192, DOI 10.3969/j.issn.1001-1978.2014.02.011; Zhao L, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-25	22	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124099	10.1371/journal.pone.0124099	http://dx.doi.org/10.1371/journal.pone.0124099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927985	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100029
J	Braun, KVN; Christensen, D; Doernberg, N; Schieve, L; Rice, C; Wiggins, L; Schendel, D; Yeargin-Allsopp, M				Braun, Kim Van Naarden; Christensen, Deborah; Doernberg, Nancy; Schieve, Laura; Rice, Catherine; Wiggins, Lisa; Schendel, Diana; Yeargin-Allsopp, Marshalyn			Trends in the Prevalence of Autism Spectrum Disorder, Cerebral Palsy, Hearing Loss, Intellectual Disability, and Vision Impairment, Metropolitan Atlanta, 1991-2010	PLOS ONE			English	Article							DEVELOPMENTAL-DISABILITIES; CHILDREN	This study examined the prevalence and characteristics of autism spectrum disorder (ASD), cerebral palsy (CP), hearing loss (HL), intellectual disability (ID), and vision impairment (VI) over a 15-20 year time period, with specific focus on concurrent changes in ASD and ID prevalence. We used data from a population-based developmental disabilities surveillance program for 8-year-olds in metropolitan Atlanta. From 1991-2010, prevalence estimates of ID and HL were stable with slight increases in VI prevalence. CP prevalence was constant from 1993-2010. The average annual increase in ASD prevalence was 9.3% per year from 1996-2010, with a 269% increase from 4.2 per 1,000 in 1996 to 15.5 per 1,000 in 2010. From 2000-2010, the prevalence of ID without ASD was stable; during the same time, the prevalence of ASD with and without co-occurring ID increased by an average of 6.6% and 9.6% per year, respectively. ASD prevalence increases were found among both males and females, and among nearly all racial/ethnic subgroups and levels of intellectual ability. Average annual prevalence estimates from 1991-2010 underscore the significant community resources needed to provide early intervention and ongoing supports for children with ID (13.0 per 1,000), CP, (3.5 per 1,000), HL (1.4 per 1,000) and VI (1.3 in 1,000), with a growing urgency for children with ASD.	[Braun, Kim Van Naarden; Christensen, Deborah; Doernberg, Nancy; Schieve, Laura; Rice, Catherine; Wiggins, Lisa; Schendel, Diana; Yeargin-Allsopp, Marshalyn] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Dev Disabil Branch, iPSYCH, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Braun, KVN (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Dev Disabil Branch, iPSYCH, Atlanta, GA 30333 USA.	kbn5@cdc.gov	Rice, Catherine E/D-6305-2016; Romanova, Raisa/O-5724-2018	Schendel, Diana/0000-0002-8588-1227	Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], SEMINARS PEDIAT INFE; Avchen RN, 2011, J AUTISM DEV DISORD, V41, P227, DOI 10.1007/s10803-010-1050-7; BHASIN TK, 2006, MMWR SURVEILL SUMM, V55, P1; Blumberg Stephen J, 2013, Natl Health Stat Report, P1; Boulet SL, 2009, ARCH PEDIAT ADOL MED, V163, P19, DOI 10.1001/archpediatrics.2008.506; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Center for Disease Control and Prevention, 2012, MMWR SURVEILL SUMM, V61, P1; Centers for Disease Control and Prevention, 2011, WORKSH US DAT EV CHA; Centers for Disease Control and Prevention, 2013, WEBINAR         0629; Centers for Disease Control and Prevention, EST JUL 1 2000 JUL 1; Centers for Disease Control and Prevention (CDC), 2010, CDC MORB MORTAL WKLY, V63, P1; Christensen D, 2014, DEV MED CHILD NEUROL, V56, P59, DOI 10.1111/dmcn.12268; Crocker AC, 1989, DEV DISABILITIES DEL; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Hahn Robert, 2007, MMWR Recomm Rep, V56, P1; Jarquin VG, 2011, J DEV BEHAV PEDIATR, V32, P179, DOI 10.1097/DBP.0b013e31820b4260; King M, 2009, INT J EPIDEMIOL, V38, P1224, DOI 10.1093/ije/dyp261; Kirby RS, 2011, RES DEV DISABIL, V32, P462, DOI 10.1016/j.ridd.2010.12.042; Larson SA, 2005, PROBLEMS DEFINING ME, V7; Lazarus C, 2007, AM J MENT RETARD, V112, P462, DOI 10.1352/0895-8017(2007)112[462:IOPVIP]2.0.CO;2; Mendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033; Meyer Pamela A, 2003, MMWR Surveill Summ, V52, P1; *NAT CTR HLTH STAT, BRIDG RAC INT EST JU; National Center for Health Statistics, BRIDG RAC INT EST RE; National Center for Health Statistics, EST APR 1 2010 RES P; Newschaffer CJ, 2005, PEDIATRICS, V115, pE277, DOI 10.1542/peds.2004-1958; Obi O, 2011, AJIDD-AM J INTELLECT, V116, P360, DOI 10.1352/1944-7558-116.5.360; Oostenbrink R, 2002, SCAND J INFECT DIS, V34, P379, DOI 10.1080/00365540110080179; Ouellette-Kuntz H, 2005, CAN J PUBLIC HEALTH, V96, pS8, DOI 10.1007/BF03403699; Petrini JR, 2009, J PEDIATR-US, V154, P169, DOI 10.1016/j.jpeds.2008.08.020; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Schieve LA, 2011, ANN EPIDEMIOL; Sellier E, 2010, EUR J EPIDEMIOL, V25, P635, DOI 10.1007/s10654-010-9474-0; Shattuck PT, 2006, PEDIATRICS, V117, P1028, DOI 10.1542/peds.2005-1516; Wise MD, 2010, J DEV BEHAV PEDIATR, V31, P469, DOI 10.1097/DBP.0b013e3181e56db2; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; YEARGINALLSOPP M, 1992, PEDIATRICS, V89, P624; YEARGINALLSOPP M, 1995, AM J PUBLIC HEALTH, V85, P324, DOI 10.2105/AJPH.85.3.324	43	167	168	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124120	10.1371/journal.pone.0124120	http://dx.doi.org/10.1371/journal.pone.0124120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923140	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600071
J	Duitama, J; Silva, A; Sanabria, Y; Cruz, DF; Quintero, C; Ballen, C; Lorieux, M; Scheffler, B; Farmer, A; Torres, E; Oard, J; Tohme, J				Duitama, Jorge; Silva, Alexander; Sanabria, Yamid; Felipe Cruz, Daniel; Quintero, Constanza; Ballen, Carolina; Lorieux, Mathias; Scheffler, Brian; Farmer, Andrew; Torres, Edgar; Oard, James; Tohme, Joe			Whole Genome Sequencing of Elite Rice Cultivars as a Comprehensive Information Resource for Marker Assisted Selection	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM; VARIATION REVEALS; WIDE ASSOCIATION; AMYLOSE CONTENT; COPY NUMBER; IDENTIFICATION; RESISTANCE; DISEASE; TRAITS; ORIGIN	Current advances in sequencing technologies and bioinformatics revealed the genomic background of rice, a staple food for the poor people, and provided the basis to develop large genomic variation databases for thousands of cultivars. Proper analysis of this massive resource is expected to give novel insights into the structure, function, and evolution of the rice genome, and to aid the development of rice varieties through marker assisted selection or genomic selection. In this work we present sequencing and bioinformatics analyses of 104 rice varieties belonging to the major subspecies of Oryza sativa. We identified repetitive elements and recurrent copy number variation covering about 200 Mbp of the rice genome. Genotyping of over 18 million polymorphic locations within O. sativa allowed us to reconstruct the individual haplotype patterns shaping the genomic background of elite varieties used by farmers throughout the Americas. Based on a reconstruction of the alleles for the gene GBSSI, we could identify novel genetic markers for selection of varieties with high amylose content. We expect that both the analysis methods and the genomic information described here would be of great use for the rice research community and for other groups carrying on similar sequencing efforts in other crops.	[Duitama, Jorge; Silva, Alexander; Felipe Cruz, Daniel; Quintero, Constanza; Ballen, Carolina; Lorieux, Mathias; Torres, Edgar; Tohme, Joe] Ctr Int Agr Trop, Agrobiodivers Res Area, Cali, Colombia; [Sanabria, Yamid; Oard, James] Louisiana State Univ, Ctr Agr, Rice Res Stn, Rayne, LA USA; [Scheffler, Brian] ARS, Genom & Bioinformat Res Unit, USDA, Jamie Whitten Delta States Res Ctr, Stoneville, MS USA; [Farmer, Andrew] Natl Ctr Genome Resources, Santa Fe, NM USA; [Lorieux, Mathias] Inst Rech Dev, Plant Divers Adaptat & Dev Res Unit, Montpellier, France	Alliance; International Center for Tropical Agriculture - CIAT; Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA); National Center for Genome Resources (NCGR); Institut de Recherche pour le Developpement (IRD)	Duitama, J (corresponding author), Ctr Int Agr Trop, Agrobiodivers Res Area, Apartado Aereo 6713, Cali, Colombia.	j.duitama@cgiar.org	Castellanos, Jorge Alexander Duitama/I-6484-2019; Ballen-Taborda, Carolina/AAZ-4209-2020	Castellanos, Jorge Alexander Duitama/0000-0002-9105-6266; Sanabria, Yamid/0000-0002-3486-4662; Scheffler, Brian/0000-0003-1968-8952; Ballen Taborda, Carolina/0000-0002-4995-7802	Agricultural Research Service of the United States Department of Agriculture (USDA/ARS); RiceCAP project (USDA/CSREES) [2004-35317-14867]; Mississippi Rice Promotion Board; Rice Foundation; Louisiana Rice Research Board; International Center for Tropical Agriculture; Global Rice Science Partnership (GRiSP) project; National Science Foundation (NSF) [0965420]; ARS [ARS-0425248] Funding Source: Federal RePORTER	Agricultural Research Service of the United States Department of Agriculture (USDA/ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); RiceCAP project (USDA/CSREES); Mississippi Rice Promotion Board; Rice Foundation; Louisiana Rice Research Board; International Center for Tropical Agriculture; Global Rice Science Partnership (GRiSP) project; National Science Foundation (NSF)(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Agricultural Research Service of the United States Department of Agriculture (USDA/ARS); the RiceCAP project (USDA/CSREES http://www.uark.edu/ua/ricecap/) (2004-35317-14867 to J.O. and B.S.); The Mississippi Rice Promotion Board (http://rice.msstate.edu/members.html); The Rice Foundation (http://www.usarice.com/index.php); the Louisiana Rice Research Board (http://www.lsuagcenter.com/en/crops_livestock/crops/rice/Rice+Research+Board+Reports/From-the-Louisiana-Rice-Research-Board.htm); the International Center for Tropical Agriculture (http://ciat.cgiar.org/); the Global Rice Science Partnership (GRiSP) project (http://www.grisp.net/main/summary); and the National Science Foundation (NSF) (0965420 to J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Arai-Kichise Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086312; Ayres NM, 1997, THEOR APPL GENET, V94, P773, DOI 10.1007/s001220050477; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Christiaens JF, 2012, EMBO REP, V13, P1145, DOI 10.1038/embor.2012.157; DELWICHE SR, 1995, CEREAL CHEM, V72, P182; Dobo M, 2010, J CEREAL SCI, V52, P450, DOI 10.1016/j.jcs.2010.07.010; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Duitama J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1381; Falush D, 2003, GENETICS, V164, P1567; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Huang P, 2012, MOL ECOL, V21, P4593, DOI 10.1111/j.1365-294X.2012.05625.x; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jacquemin J, 2011, MOL BIOL EVOL, V28, P3139, DOI 10.1093/molbev/msr144; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lappalainen I, 2013, NUCLEIC ACIDS RES, V41, pD936, DOI 10.1093/nar/gks1213; Larkin PD, 2003, MOL BREEDING, V12, P335, DOI 10.1023/B:MOLB.0000006797.51786.92; Lyu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3138; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sazuka T, 2009, PLANT J, V60, P227, DOI 10.1111/j.1365-313X.2009.03952.x; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; Silva J, 2012, THEOR APPL GENET, V124, P63, DOI 10.1007/s00122-011-1687-4; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Xie XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020670; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yamamoto E, 2012, RICE, V5, DOI 10.1186/1939-8433-5-26; Yamamoto E, 2010, MOL GENET GENOMICS, V283, P305, DOI 10.1007/s00438-010-0514-y; Yang CC, 2012, MOL BIOL EVOL, V29, P1471, DOI 10.1093/molbev/msr315; Yu P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-649; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	47	48	50	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124617	10.1371/journal.pone.0124617	http://dx.doi.org/10.1371/journal.pone.0124617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923345	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600097
J	Liu, YJ; Lee, YH; Chang, HC; Huang, TY; Chiu, HC; Wang, CW; Chiou, TW; Hsu, K; Juan, CJ; Huang, GS; Hsu, HH				Liu, Yi-Jui; Lee, Yi-Hsiung; Chang, Hing-Chiu; Huang, Teng-Yi; Chiu, Hui-Chu; Wang, Chih-Wei; Chiou, Ta-Wei; Hsu, Kang; Juan, Chun-Jung; Huang, Guo-Shu; Hsu, Hsian-He			A Potential Risk of Overestimating Apparent Diffusion Coefficient in Parotid Glands	PLOS ONE			English	Article							LATE RADIATION-INJURY; SALIVARY-GLANDS; GUSTATORY STIMULATION; ECHO-PLANAR; MRI; MOTION; TUMORS; HEAD; NECK; RADIOTHERAPY	Objectives To investigate transient signal loss on diffusion weighted images (DWI) and overestimation of apparent diffusion coefficient (ADC) in parotid glands using single shot echoplanar DWI (EPDWI). Materials and Methods This study enrolled 6 healthy subjects and 7 patients receiving radiotherapy. All participants received dynamic EPDWI with a total of 8 repetitions. Imaging quality of DWI was evaluated. Probability of severe overestimation of ADC (soADC), defined by an ADC ratio more than 1.2, was calculated. Error on T2WI, DWI, and ADC was computed. Statistical analysis included paired Student t testing and Mann-Whitney U test. A P value less than 0.05 was considered statistically significant. Results Transient signal loss was visually detected on some excitations of DWI but not on T2WI or mean DWI. soADC occurred randomly among 8 excitations and 3 directions of diffusion encoding gradients. Probability of soADC was significantly higher in radiotherapy group (42.86%) than in healthy group (24.39%). The mean error percentage decreased as the number of excitations increased on all images, and, it was smallest on T2WI, followed by DWI and ADC in an increasing order. Conclusions Transient signal loss on DWI was successfully detected by dynamic EPDWI. The signal loss on DWI and overestimation of ADC could be partially remedied by increasing the number of excitations.	[Liu, Yi-Jui] Feng Chia Univ, Dept Automat Control Engn, Taichung 40724, Taiwan; [Lee, Yi-Hsiung] Feng Chia Univ, PhD Program Elect & Commun Engn, Taichung 40724, Taiwan; [Chang, Hing-Chiu] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC USA; [Chang, Hing-Chiu] GE Healthcare, Appl Sci Lab, Taipei, Taiwan; [Huang, Teng-Yi] Natl Taiwan Univ Sci & Technol, Dept Elect Engn, Taipei, Taiwan; [Chang, Hing-Chiu] Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan; [Wang, Chih-Wei; Juan, Chun-Jung; Huang, Guo-Shu; Hsu, Hsian-He] Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Wang, Chih-Wei; Juan, Chun-Jung; Huang, Guo-Shu; Hsu, Hsian-He] Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chiou, Ta-Wei] Taipei Med Univ, Dept Med, Taipei, Taiwan; [Hsu, Kang] Natl Def Med Ctr, Dept Dent, Taipei, Taiwan	Feng Chia University; Feng Chia University; Duke University; General Electric; National Taiwan University of Science & Technology; Chung Hua University; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; National Defense Medical Center	Juan, CJ (corresponding author), Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan.	peterjuancj@yahoo.com.tw	Liu, Yi-Jui/AAH-8540-2020; Juan, Chun-Jung/AAE-8438-2020	Liu, Yi-Jui/0000-0001-5865-6836; Chang, Hing-Chiu/0000-0001-8634-328X	National Science Council [NSC100-2314-B-016-009, NSC 101-2314-B-016-031-MY2]; National Defense Medical Center, Taiwan, R.O.C. [NDMC-D101-5-2]	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Center, Taiwan, R.O.C.	CJJ received grant support partly from National Science Council (NSC100-2314-B-016-009 and NSC 101-2314-B-016-031-MY2) and National Defense Medical Center (NDMC-D101-5-2), Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang HC, 2014, EUR RADIOL, V24, P2069, DOI 10.1007/s00330-014-3265-z; Cheng CC, 2013, MAGN RESON IMAGING, V31, P1278, DOI 10.1016/j.mri.2013.03.018; Dirix P, 2008, INT J RADIAT ONCOL, V71, P1365, DOI 10.1016/j.ijrobp.2007.12.011; Eida S, 2007, AM J NEURORADIOL, V28, P116; Habermann CR, 2007, AM J NEURORADIOL, V28, P1547, DOI 10.3174/ajnr.A0587; Ichikawa Y, 2012, AM J NEURORADIOL, V33, P761, DOI 10.3174/ajnr.A2834; Juan CJ, 2009, RADIOLOGY, V253, P144, DOI 10.1148/radiol.2531082228; Juan CJ, 2009, EUR RADIOL, V19, P94, DOI 10.1007/s00330-008-1104-9; Kato H, 2008, AM J NEURORADIOL, V29, P865, DOI 10.3174/ajnr.A0974; Kim S, 2009, CLIN CANCER RES, V15, P986, DOI 10.1158/1078-0432.CCR-08-1287; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Li J, 2005, INT J RADIAT ONCOL, V62, P1510, DOI 10.1016/j.ijrobp.2005.04.029; Liau J, 2012, J MAGN RESON IMAGING, V35, P318, DOI 10.1002/jmri.22816; Lu YG, 2012, J MAGN RESON IMAGING, V36, P1088, DOI 10.1002/jmri.23770; Matsushima N, 2007, J NEURORADIOLOGY, V34, P183, DOI 10.1016/j.neurad.2007.04.002; Nagler RM, 1998, ARCH ORAL BIOL, V43, P297, DOI 10.1016/S0003-9969(97)00120-9; Norris DG, 2001, J MAGN RESON IMAGING, V13, P486, DOI 10.1002/jmri.1072; Patel RR, 2004, AM J NEURORADIOL, V25, P16; STEPHENS LC, 1986, AM J PATHOL, V124, P469; Sumi M, 2002, AM J ROENTGENOL, V178, P959, DOI 10.2214/ajr.178.4.1780959; Thoeny HC, 2005, RADIOLOGY, V235, P629, DOI 10.1148/radiol.2352040127; Thoeny HC, 2004, J MAGN RESON IMAGING, V20, P786, DOI 10.1002/jmri.20196; Yabuuchi H, 2008, RADIOLOGY, V249, P909, DOI 10.1148/radiol.2493072045; Yoshino N, 2001, RADIOLOGY, V221, P837, DOI 10.1148/radiol.2213010131; Zhang L, 2001, J MAGN RESON IMAGING, V14, P223, DOI 10.1002/jmri.1177	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124118	10.1371/journal.pone.0124118	http://dx.doi.org/10.1371/journal.pone.0124118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922948	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600070
J	Paul, CD; Traore, DAK; Olsen, S; Devenish, RJ; Close, DW; Bell, TDM; Bradbury, A; Wilce, MCJ; Prescott, M				Paul, Craig Don; Traore, Daouda A. K.; Olsen, Seth; Devenish, Rodney J.; Close, Devin W.; Bell, Toby D. M.; Bradbury, Andrew; Wilce, Matthew C. J.; Prescott, Mark			X-Ray Crystal Structure and Properties of Phanta, a Weakly Fluorescent Photochromic GFP-Like Protein	PLOS ONE			English	Article							STATE PROTON-TRANSFER; RED FLUORESCENCE; GREEN; DRONPA; CHROMOPHORE; FRET; VARIANTS; DYNAMICS; CHROMOPROTEINS; ISOMERIZATION	Phanta is a reversibly photoswitching chromoprotein (Phi(F), 0.003), useful for pcFRET, that was isolated from a mutagenesis screen of the bright green fluorescent eCGP123 (Phi(F), 0.8). We have investigated the contribution of substitutions at positions His193, Thr69 and Gln62, individually and in combination, to the optical properties of Phanta. Single amino acid substitutions at position 193 resulted in proteins with very low Phi(F), indicating the importance of this position in controlling the fluorescence efficiency of the variant proteins. The substitution Thr69Val in Phanta was important for supressing the formation of a protonated chromophore species observed in some His193 substituted variants, whereas the substitution Gln62Met did not significantly contribute to the useful optical properties of Phanta. X-ray crystal structures for Phanta (2.3 angstrom), eCGP123(T69V) (2.0 angstrom) and eCGP123(H193Q) (2.2 angstrom) in their non-photoswitched state were determined, revealing the presence of a cis-coplanar chromophore. We conclude that changes in the hydrogen-bonding network supporting the cis-chromophore, and its contacts with the surrounding protein matrix, are responsible for the low fluorescence emission of eCGP123 variants containing a His193 substitution.	[Paul, Craig Don] Univ Med, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; [Traore, Daouda A. K.; Devenish, Rodney J.; Wilce, Matthew C. J.; Prescott, Mark] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Bell, Toby D. M.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Close, Devin W.; Bradbury, Andrew] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Olsen, Seth] Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia	Monash University; Monash University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Queensland	Wilce, MCJ (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton Campus, Clayton, Vic 3800, Australia.	Matthew.Wilce@monash.edu; Mark.Prescott@monash.edu	Olsen, Seth/A-6157-2010; Traore, Daouda/B-5242-2013; Bell, Toby/D-5776-2019	Traore, Daouda/0000-0003-1001-4716; Bradbury, Andrew/0000-0002-5567-8172; Bell, Toby/0000-0002-4570-5595	Monash University	Monash University(Monash University)	This work was funded internally by Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2009, J AM CHEM SOC, V131, P18063, DOI 10.1021/ja907296v; Adam V, 2009, BIOCHEMISTRY-US, V48, P4905, DOI 10.1021/bi900383a; Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Battad JM, 2007, J MOL BIOL, V368, P998, DOI 10.1016/j.jmb.2007.02.007; Bizzarri R, 2007, BIOCHEMISTRY-US, V46, P5494, DOI 10.1021/bi602646r; Brakemann T, 2011, NAT BIOTECHNOL, V29, P942, DOI 10.1038/nbt.1952; Bricogne G, 2011, BUSTER 2 10 0 ED; Bulina ME, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-7; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Close DW, 2014, PROTEINS STRUCTURE F; Cox RP, 2012, CHEM PHYS LETT, V521, P59, DOI 10.1016/j.cplett.2011.11.028; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Dai MH, 2007, PROTEIN ENG DES SEL, V20, P69, DOI 10.1093/protein/gzl056; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Drobizhev M, 2012, IEEE PHOTONICS J, V4, P1996, DOI 10.1109/JPHOT.2012.2221124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fron E, 2007, J AM CHEM SOC, V129, P4870, DOI 10.1021/ja069365v; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Grotjohann T, 2011, NATURE, V478, P204, DOI 10.1038/nature10497; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Henderson JN, 2005, P NATL ACAD SCI USA, V102, P12712, DOI 10.1073/pnas.0502250102; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Kaucikas M, 2015, J PHYS CHEM B, V119, P2350, DOI 10.1021/jp506640q; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Kiss C, 2009, PROTEIN ENG DES SEL, V22, P313, DOI 10.1093/protein/gzp006; Lakowicz J. R., 2006, PRINCIPLES OF FLUORE; Lukacs A, 2013, J PHYS CHEM B, V117, P11954, DOI 10.1021/jp406142g; Martynov VI, 2003, J BIOL CHEM, V278, P46288, DOI 10.1074/jbc.M306810200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; Mizuno H, 2008, P NATL ACAD SCI USA, V105, P9227, DOI 10.1073/pnas.0709599105; Mizuno H, 2010, J BIOMOL NMR, V48, P237, DOI 10.1007/s10858-010-9453-5; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nienhaus K, 2008, J AM CHEM SOC, V130, P12578, DOI 10.1021/ja8046443; Olsen S, 2012, THE JOURNAL OF CHEMI, V137; Olsen S, 2010, J AM CHEM SOC, V132, P1192, DOI 10.1021/ja907447k; Oltrogge LM, 2014, BIOCHEMISTRY-US, V53, P5947, DOI 10.1021/bi500147n; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075835; Paul CD, 2011, ACTA CRYSTALLOGR F, V67, P1266, DOI 10.1107/S1744309111028156; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pettikiriarachchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041028; Piatkevich KD, 2013, PNAS, V107, P5369; Pletnev S, 2012, ACTA CRYSTALLOGR D, V68, P1088, DOI 10.1107/S0907444912020598; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Rebane A, 2010, J LUMIN, V130, P1619, DOI 10.1016/j.jlumin.2009.12.005; Roy A, 2011, J AM CHEM SOC, V133, P18586, DOI 10.1021/ja2085355; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2008, NATURE; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Toniolo A, 2004, FARADAY DISCUSS, V127, P149, DOI 10.1039/b401167h; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Voityuk AA, 1998, CHEM PHYS, V231, P13, DOI 10.1016/S0301-0104(98)00080-9; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Warren MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2460; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wilmann PG, 2006, J MOL BIOL, V364, P213, DOI 10.1016/j.jmb.2006.08.089; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yadav D, 2015, J PHYS CHEM B, V119, P2404, DOI 10.1021/jp507094f; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	74	1	1	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123338	10.1371/journal.pone.0123338	http://dx.doi.org/10.1371/journal.pone.0123338			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923520	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353711600039
J	Jarrar, W; Dias, JM; Ericson, J; Arnold, HH; Holz, A				Jarrar, Wassan; Dias, Jose M.; Ericson, Johan; Arnold, Hans-Henning; Holz, Andreas			Nkx2.2 and Nkx2.9 Are the Key Regulators to Determine Cell Fate of Branchial and Visceral Motor Neurons in Caudal Hindbrain	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; AXON GUIDANCE; SPINAL-CORD; IDENTITY; PHOX2B; MOUSE; DIFFERENTIATION; SPECIFICATION; REQUIREMENT; EXPRESSION	Cranial motor nerves in vertebrates are comprised of the three principal subtypes of branchial, visceral, and somatic motor neurons, which develop in typical patterns along the anteroposterior and dorsoventral axes of hindbrain. Here we demonstrate that the formation of branchial and visceral motor neurons critically depends on the transcription factors Nkx2.2 and Nkx2.9, which together determine the cell fate of neuronal progenitor cells. Disruption of both genes in mouse embryos results in complete loss of the vagal and spinal accessory motor nerves, and partial loss of the facial and glossopharyngeal motor nerves, while the purely somatic hypoglossal and abducens motor nerves are not diminished. Cell lineage analysis in a genetically marked mouse line reveals that alterations of cranial nerves in Nkx2.2; Nkx2.9 double-deficient mouse embryos result from changes of cell fate in neuronal progenitor cells. As a consequence progenitors of branchiovisceral motor neurons in the ventral p3 domain of hindbrain are transformed to somatic motor neurons, which use ventral exit points to send axon trajectories to their targets. Cell fate transformation is limited to the caudal hindbrain, as the trigeminal nerve is not affected in double-mutant embryos suggesting that Nkx2.2 and Nkx2.9 proteins play no role in the development of branchiovisceral motor neurons in hindbrain rostral to rhombomere 4.	[Jarrar, Wassan; Arnold, Hans-Henning; Holz, Andreas] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Cell & Mol Biol, Braunschweig, Germany; [Dias, Jose M.; Ericson, Johan] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Braunschweig University of Technology; Karolinska Institutet	Arnold, HH (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Cell & Mol Biol, Braunschweig, Germany.	h.arnold@tu-bs.de; a.holz@tu-bs.de		Dias, Jose/0000-0002-1402-0323; Holz, Andreas/0000-0002-8886-0915; Ericson, Johan/0000-0002-8019-7127; Jarrar, Wassan/0000-0002-2863-9901	Deutsche Forschungsgemeinschaft [AR115/22-1]; Ministry of Science and Culture of Lower Saxony	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Science and Culture of Lower Saxony	This work was supported by AR115/22-1, Deutsche Forschungsgemeinschaft; Ministry of Science and Culture of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cordes SP, 2001, NAT REV NEUROSCI, V2, P611, DOI 10.1038/35090039; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; Dillon AK, 2005, J NEUROSCI, V25, P10119, DOI 10.1523/JNEUROSCI.3455-05.2005; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Glover JC, 2006, J NEUROBIOL, V66, P705, DOI 10.1002/neu.20272; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; Holz A, 2010, DEVELOPMENT, V137, P4249, DOI 10.1242/dev.053819; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kandel E., 2000, PRINCIPLES NEURAL SC; KEYNES R, 1994, ANNU REV NEUROSCI, V17, P109, DOI 10.1146/annurev.ne.17.030194.000545; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pabst O, 1998, MECH DEVELOP, V73, P85, DOI 10.1016/S0925-4773(98)00035-5; Pabst O, 2003, DEVELOPMENT, V130, P1193, DOI 10.1242/dev.00346; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Rhinn M, 2006, CURR OPIN NEUROBIOL, V16, P5, DOI 10.1016/j.conb.2006.01.005; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sussel L, 1998, DEVELOPMENT, V125, P2213; VALARCHE I, 1993, DEVELOPMENT, V119, P881; Ying LT, 2000, DEV DYNAM, V219, P143, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1050>3.3.CO;2-H	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124408	10.1371/journal.pone.0124408	http://dx.doi.org/10.1371/journal.pone.0124408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919494	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400049
J	Bosscher, MRF; van Leeuwen, BL; Hoekstra, HJ				Bosscher, Marianne R. F.; van Leeuwen, Barbara L.; Hoekstra, Harald J.			Current Management of Surgical Oncologic Emergencies	PLOS ONE			English	Article							CANCER-PATIENTS; TERMINAL CANCER; OF-LIFE; SURVIVAL; CARE; PREDICTION; PHYSICIANS; MORTALITY; ADMISSION; DURATION	Objectives For some oncologic emergencies, surgical interventions are necessary for dissolution or temporary relieve. In the absence of guidelines, the most optimal method for decision making would be in a multidisciplinary cancer conference (MCC). In an acute setting, the opportunity for multidisciplinary discussion is often not available. In this study, the management and short term outcome of patients after surgical oncologic emergency consultation was analyzed. Method A prospective registration and follow up of adult patients with surgical oncologic emergencies between 01-11-2013 and 30-04-2014. The follow up period was 30 days. Results In total, 207 patients with surgical oncologic emergencies were included. Postoperative wound infections, malignant obstruction, and clinical deterioration due to progressive disease were the most frequent conditions for surgical oncologic emergency consultation. During the follow up period, 40% of patients underwent surgery. The median number of involved medical specialties was two. Only 30% of all patients were discussed in a MCC within 30 days after emergency consultation, and only 41% of the patients who underwent surgery were discussed in a MCC. For 79% of these patients, the surgical procedure was performed before the MCC. Mortality within 30 days was 13%. Conclusion In most cases, surgery occurred without discussing the patient in a MCC, regardless of the fact that multiple medical specialties were involved in the treatment process. There is a need for prognostic aids and acute oncology pathways with structural multidisciplinary management. These will provide in faster institution of the most appropriate personalized cancer care, and prevent unnecessary investigations or invasive therapy.	[Bosscher, Marianne R. F.; van Leeuwen, Barbara L.; Hoekstra, Harald J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Oncol, Groningen, Netherlands	University of Groningen	Hoekstra, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg Oncol, Groningen, Netherlands.	h.j.hoekstra@umcg.nl	hoekstra, harald/AAR-3263-2021	van Leeuwen, Barbara/0000-0002-6745-4424	Groningen Melanoma and Sarcoma Foundation	Groningen Melanoma and Sarcoma Foundation	MRF Bosscher received a research grant from the Groningen Melanoma and Sarcoma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2012, SUPPORT CARE CANCER, V20, P2205, DOI 10.1007/s00520-012-1478-8; Barbera L, 2010, CAN MED ASSOC J, V182, P563, DOI 10.1503/cmaj.091187; Borras JM, 2014, EUR J CANCER, V50, P475, DOI 10.1016/j.ejca.2013.11.012; Bosscher MRF, 2014, CANCER TREAT REV, V40, P1028, DOI 10.1016/j.ctrv.2014.05.005; Burge F, 2003, MED CARE, V41, P992, DOI 10.1097/00005650-200308000-00012; Cervantes A, 2004, ANN ONCOL, V15, P299, DOI 10.1093/annonc/mdh943; Dumont F, 2014, J SURG ONCOL, V109, P721, DOI 10.1002/jso.23557; Geraci JM, 2006, SUPPORT CARE CANCER, V14, P1038, DOI 10.1007/s00520-006-0053-6; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Glare P, 2008, EUR J CANCER, V44, P1146, DOI 10.1016/j.ejca.2008.02.030; Glare Paul, 2005, J Support Oncol, V3, P331; Grudzen CR, 2012, J PAIN SYMPTOM MANAG, V43, P1, DOI 10.1016/j.jpainsymman.2011.03.022; Katabathina VS, 2013, RADIOGRAPHICS, V33, P1533, DOI 10.1148/rg.336135508; King J, 2011, BMJ QUAL SAF, V20, P718, DOI 10.1136/bmjqs.2010.044313; Knops AM, 2013, ANN SURG, V257, P860, DOI 10.1097/SLA.0b013e3182864fd6; Lane H, 2014, SUPPORT CARE CANCER, V22, P1029, DOI 10.1007/s00520-013-2054-6; Llobera J, 2000, EUR J CANCER, V36, P2036, DOI 10.1016/S0959-8049(00)00291-4; Mallol M, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-29; McArdle CS, 2004, BRIT J SURG, V91, P605, DOI 10.1002/bjs.4456; Navani V, 2014, CURR ONCOL, V21, P147, DOI 10.3747/co.21.1904; Porta M, 1998, BRIT J CANCER, V77, P477, DOI 10.1038/bjc.1998.76; Ramchandran KJ, 2013, CANCER-AM CANCER SOC, V119, P2074, DOI 10.1002/cncr.27974; Roses RE, 2014, J PALLIAT MED, V17, P37, DOI 10.1089/jpm.2013.0235; Selby D, 2011, J PAIN SYMPTOM MANAG, V42, P578, DOI 10.1016/j.jpainsymman.2011.01.012; Shin SH, 2014, J PAIN SYMPTOM MANAG, V47, P1028, DOI 10.1016/j.jpainsymman.2013.07.015; Vandyk AD, 2012, SUPPORT CARE CANCER, V20, P1589, DOI 10.1007/s00520-012-1459-y; Vigano A, 2004, CANCER, V101, P1090, DOI 10.1002/cncr.20472; Wright FC, 2010, J SURG ONCOL, V101, P425, DOI 10.1002/jso.21492; Yates M, 2009, CLIN ONCOL-UK, V21, P226, DOI 10.1016/j.clon.2008.12.006	29	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124641	10.1371/journal.pone.0124641	http://dx.doi.org/10.1371/journal.pone.0124641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933135	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100054
J	Carattoli, A; Seiffert, SN; Schwendener, S; Perreten, V; Endimiani, A				Carattoli, Alessandra; Seiffert, Salome N.; Schwendener, Sybille; Perreten, Vincent; Endimiani, Andrea			Differentiation of IncL and IncM Plasmids Associated with the Spread of Clinically Relevant Antimicrobial Resistance	PLOS ONE			English	Article							BETA-LACTAMASE GENE; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; IDENTIFICATION; CLASSIFICATION; ACQUISITION; DIVERSITY; INSERTION; INTEGRON; ISOLATE	Introduction bla(OXA-48), bla(NDM-1) and bla(CTX-M-3) are clinically relevant resistance genes, frequently associated with the broad-host range plasmids of the IncL/M group. The L and M plasmids belong to two compatible groups, which were incorrectly classified together by molecular methods. In order to understand their evolution, we fully sequenced four IncL/M plasmids, including the reference plasmids R471 and R69, the recently described bla(OXA-48)-carrying plasmid pKPN-El.Nr7 from a Klebsiella pneumoniae isolated in Bern (Switzerland), and the bla(SHV-5) carrying plasmid p202c from a Salmonella enterica from Tirana (Albania). Methods Sequencing was performed using 454 Junior Genome Sequencer (Roche). Annotation was performed using Sequin and Artemis software. Plasmid sequences were compared with 13 fully sequenced plasmids belonging to the IncL/M group available in GenBank. Results Comparative analysis of plasmid genomes revealed two distinct genetic lineages, each containing one of the R471 (IncL) and R69 (IncM) reference plasmids. Conjugation experiments demonstrated that plasmids representative of the IncL and IncM groups were compatible with each other. The IncL group is constituted by the blaOXA-48-carrying plasmids and R471. The IncM group contains two sub-types of plasmids named IncM1 and IncM2 that are each incompatible. Conclusion This work re-defines the structure of the IncL and IncM families and ascribes a definitive designation to the fully sequenced IncL/M plasmids available in GenBank.	[Carattoli, Alessandra; Seiffert, Salome N.; Endimiani, Andrea] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Carattoli, Alessandra] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Carattoli, Alessandra; Seiffert, Salome N.; Schwendener, Sybille; Perreten, Vincent] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Seiffert, Salome N.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	University of Bern; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Bern; University of Bern	Carattoli, A (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	alessandra.carattoli@iss.it	Perreten, Vincent/ABB-1144-2020; Seiffert, Salome Nadja/B-3777-2013; Carattoli, Alessandra/A-1324-2009; Endimiani, Andrea/H-4008-2019	Perreten, Vincent/0000-0001-5722-9445; Carattoli, Alessandra/0000-0002-6120-6526; Endimiani, Andrea/0000-0003-3186-5421	Institute of Infectious Diseases of Bern (IFIK); Institute of Veterinary Bacteriology (IVB); Hans Sigrist Foundation; Swiss Veterinary Federal Office (BVET) [1.12.06]	Institute of Infectious Diseases of Bern (IFIK); Institute of Veterinary Bacteriology (IVB); Hans Sigrist Foundation; Swiss Veterinary Federal Office (BVET)	Prof. Alessandra Carattoli received financial support from the Institute of Infectious Diseases of Bern (IFIK), the Institute of Veterinary Bacteriology (IVB), and the Hans Sigrist Foundation. This study was also partially financed by Grant 1.12.06 (2012-2014) from the Swiss Veterinary Federal Office (BVET).	Bonnin RA, 2013, ANTIMICROB AGENTS CH, V57, P674, DOI 10.1128/AAC.01086-12; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2006, EMERG INFECT DIS, V12, P1145, DOI 10.3201/eid1207.051555; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; CHABBERT YA, 1972, J BACTERIOL, V112, P666, DOI 10.1128/JB.112.2.666-675.1972; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; DATTA N, 1971, NATURE, V234, P222, DOI 10.1038/234222a0; Di Pilato V, 2014, J ANTIMICROB CHEMOTH, V69, P2620, DOI 10.1093/jac/dku216; Dolejska M, 2014, J ANTIMICROB CHEMOTH, V69, P2388, DOI 10.1093/jac/dku172; Foster GC, 2004, APPL ENVIRON MICROB, V70, P7539, DOI 10.1128/AEM.70.12.7539-7544.2004; Galimand A, 2005, ANTIMICROB AGENTS CH, V49, P2949, DOI 10.1128/AAC.49.7.2949-2953.2005; Garcia A, 2007, FEMS MICROBIOL LETT, V271, P71, DOI 10.1111/j.1574-6968.2007.00695.x; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Garcillan-Barcia MP, 2008, PLASMID, V60, P1, DOI 10.1016/j.plasmid.2008.03.002; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Golebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789, DOI 10.1128/AAC.00457-07; HEDGES RW, 1974, J BACTERIOL, V117, P56, DOI 10.1128/JB.117.1.56-62.1974; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; JORGENSEN RA, 1979, J BACTERIOL, V138, P705, DOI 10.1128/JB.138.3.705-714.1979; Mierzejewska J, 2007, PLASMID, V57, P95, DOI 10.1016/j.plasmid.2006.09.001; Phan MD, 2008, J INFECT DEV COUNTR, V2, P272; Miriagou V, 2005, ANTIMICROB AGENTS CH, V49, P3541, DOI 10.1128/AAC.49.8.3541-3543.2005; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Osborn AM, 2000, MICROBIOL-UK, V146, P2267, DOI 10.1099/00221287-146-9-2267; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6029, DOI 10.1128/AAC.01189-12; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P348, DOI 10.1128/AAC.48.1.348-351.2004; Potron A, 2014, ANTIMICROB AGENTS CH, V58, P467, DOI 10.1128/AAC.01344-13; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; RICHARDS H, 1979, PLASMID, V2, P293, DOI 10.1016/0147-619X(79)90048-9; Sakuma T, 2013, PLASMID, V69, P138, DOI 10.1016/j.plasmid.2012.11.004; Seiffert SN, 2014, INT J ANTIMICROB AG, V44, P260, DOI 10.1016/j.ijantimicag.2014.05.008; Seiffert SN, 2014, ANTIMICROB AGENTS CH, V58, P2446, DOI 10.1128/AAC.02417-13; SHAW WV, 1972, P NATL ACAD SCI USA, V69, P3049, DOI 10.1073/pnas.69.10.3049; Sherburne CK, 2000, NUCLEIC ACIDS RES, V28, P2177, DOI 10.1093/nar/28.10.2177; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tosini F, 1998, ANTIMICROB AGENTS CH, V42, P3053, DOI 10.1128/AAC.42.12.3053; Villa L, 2002, MICROB DRUG RESIST, V8, P1, DOI 10.1089/10766290252913692; Villa L, 2000, ANTIMICROB AGENTS CH, V44, P2911, DOI 10.1128/AAC.44.10.2911-2914.2000; Villa L, 2013, J ANTIMICROB CHEMOTH, V68, P2482, DOI 10.1093/jac/dkt235; Villa L, 2013, ANTIMICROB AGENTS CH, V57, P1965, DOI 10.1128/AAC.01297-12; Villa L, 2012, J ANTIMICROB CHEMOTH, V67, P1645, DOI 10.1093/jac/dks114; Zhu WH, 2009, ANTIMICROB AGENTS CH, V53, P5291, DOI 10.1128/AAC.00032-09	45	108	112	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123063	10.1371/journal.pone.0123063	http://dx.doi.org/10.1371/journal.pone.0123063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933288	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100013
J	Cluitmans, JCA; Tomelleri, C; Yapici, Z; Dinkla, S; Bovee-Geurts, P; Chokkalingam, V; De Franceschi, L; Brock, R; Bosman, GJGCM				Cluitmans, Judith C. A.; Tomelleri, Carlo; Yapici, Zuhal; Dinkla, Sip; Bovee-Geurts, Petra; Chokkalingam, Venkatachalam; De Franceschi, Lucia; Brock, Roland; Bosman, Giel J. G. C. M.			Abnormal Red Cell Structure and Function in Neuroacanthocytosis	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE CHANGES; CHOREA-ACANTHOCYTOSIS; BLOOD-CELLS; EXPRESSION; CLEAVAGE; FEATURES	Background Panthothenate kinase-associated neurodegeneration (PKAN) belongs to a group of hereditary neurodegenerative disorders known as neuroacanthocytosis (NA). This genetically heterogeneous group of diseases is characterized by degeneration of neurons in the basal ganglia and by the presence of deformed red blood cells with thorny protrusions, acanthocytes, in the circulation. Objective The goal of our study is to elucidate the molecular mechanisms underlying this aberrant red cell morphology and the corresponding functional consequences. This could shed light on the etiology of the neurodegeneration. Methods We performed a qualitative and semi-quantitative morphological, immunofluorescent, biochemical and functional analysis of the red cells of several patients with PKAN and, for the first time, of the red cells of their family members. Results We show that the blood of patients with PKAN contains not only variable numbers of acanthocytes, but also a wide range of other misshapen red cells. Immunofluorescent and immunoblot analyses suggest an altered membrane organization, rather than quantitative changes in protein expression. Strikingly, these changes are not limited to the red blood cells of PKAN patients, but are also present in the red cells of heterozygous carriers without neurological problems. Furthermore, changes are not only present in acanthocytes, but also in other red cells, including discocytes. The patients' cells, however, are more fragile, as observed in a spleen-mimicking device. Conclusion These morphological, molecular and functional characteristics of red cells in patients with PKAN and their family members offer new tools for diagnosis and present a window into the pathophysiology of neuroacanthocytosis.	[Cluitmans, Judith C. A.; Dinkla, Sip; Bovee-Geurts, Petra; Brock, Roland; Bosman, Giel J. G. C. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands; [Tomelleri, Carlo; De Franceschi, Lucia] Univ Verona, Policlin GB Rossi, Dept Med, AOUI Verona, I-37134 Verona, Italy; [Yapici, Zuhal] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Div Child Neurol, Istanbul, Turkey; [Chokkalingam, Venkatachalam] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Phys Organ Chem, NL-6525 AJ Nijmegen, Netherlands	Radboud University Nijmegen; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Istanbul University; Radboud University Nijmegen	Bosman, GJGCM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	Giel.Bosman@radboudumc.nl	Brock, Roland/O-9411-2019; Brock, Roland/K-2590-2012; DE FRANCESCHI, Lucia/AAB-8652-2022	Brock, Roland/0000-0003-1395-6127; DE FRANCESCHI, Lucia/0000-0001-7093-777X	EMINA project - ERare [40-41905-98-9005]; Telethon [GP13005]	EMINA project - ERare; Telethon(Fondazione Telethon)	This paper was supported by the EMINA project, funded by ERare (40-41905-98-9005) to GB (http://www.erare.eu/) and the Telethon grant GP13005 to LdF (https://www.telethon.it/en/scientists/calls-application). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSCH FH, 1992, BLOOD, V79, P254; Bosman G, 2008, NEUROACANTHOCYTOSIS, VII, P133; BOSMAN GJCGM, 1993, NEUROBIOL AGING, V14, P223, DOI 10.1016/0197-4580(93)90004-U; Cluitmans JCA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/764268; De Franceschi L, 2014, CURR OPIN HEMATOL, V21, P201, DOI 10.1097/MOH.0000000000000035; De Franceschi L, 2011, BLOOD, V118, P5652, DOI 10.1182/blood-2011-05-355339; Deplaine G, 2011, BLOOD, V117, pE88, DOI 10.1182/blood-2010-10-312801; Dinkla S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.143; Dinkla S, 2013, NANOMEDICINE-UK, V8, P1657, DOI [10.2217/NNM.13.149, 10.2217/nnm.13.149]; Foller M, 2012, FASEB J, V26, P1526, DOI 10.1096/fj.11-198317; Gov N, 2009, ADV PLANAR LIP BILAY, V10, P95, DOI 10.1016/S1554-4516(09)10004-2; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; JENNINGS ML, 1986, J BIOL CHEM, V261, P9002; Jung HH, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-68; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matte A, 2010, FREE RADICAL BIO MED, V49, P457, DOI 10.1016/j.freeradbiomed.2010.05.003; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mosca A, 2009, CLIN BIOCHEM, V42, P1797, DOI 10.1016/j.clinbiochem.2009.06.023; Neelam S, 2011, EXP BIOL MED, V236, P580, DOI 10.1258/ebm.2011.010394; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Prohaska R, 2012, NEUROBIOL DIS, V46, P607, DOI 10.1016/j.nbd.2012.03.006; Rampoldi L, 2002, J MOL MED-JMM, V80, P475, DOI 10.1007/s00109-002-0349-z; ROCHETTE J, 1994, BLOOD REV, V8, P213, DOI 10.1016/0268-960X(94)90109-0; Schaeffer EK, 2014, BLOOD CELL MOL DIS, V52, P214, DOI 10.1016/j.bcmd.2013.10.007; Siegl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076715; SKALAK R, 1969, SCIENCE, V164, P717, DOI 10.1126/science.164.3880.717; Willekens FLA, 1997, EUR J HAEMATOL, V58, P246	27	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125580	10.1371/journal.pone.0125580	http://dx.doi.org/10.1371/journal.pone.0125580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933379	Green Submitted, gold, Green Published			2022-12-26	WOS:000353887100118
J	Mustiana, A; Toribio, JA; Abdurrahman, M; Suadnya, IW; Hernandez-Jover, M; Putra, AAG; Ward, MP				Mustiana, Ana; Toribio, Jenny-Ann; Abdurrahman, Muktasam; Suadnya, I. Wayan; Hernandez-Jover, Marta; Putra, Anak Agung Gde; Ward, Michael P.			Owned and Unowned Dog Population Estimation, Dog Management and Dog Bites to Inform Rabies Prevention and Response on Lombok Island, Indonesia	PLOS ONE			English	Article							EPIDEMIC; DISEASE; INDIA; BALI	Although Indonesia has been rabies-infected since at least the 1880s, some islands remain rabies-free, such as Lombok. However, due to its adjacency to rabies-infected islands such as Bali and Flores, there is considerable risk of a rabies incursion. As part of a rabies risk assessment project, surveys were conducted to estimate the size of the dog population and to describe dog management practices of households belonging to different ethnic groups. A photographic-recapture method was employed and the number of unowned dogs was estimated. A total of 400 dog owning households were interviewed, 300 at an urban site and 100 at a rural site. The majority of the interviewed households belonged to the Balinese ethnic group. Owned dogs were more likely male, and non-pedigree or local breed. These households kept their dogs either fully restricted, semi-free roaming or free-roaming but full restriction was reported only at the urban site. Dog bite cases were reported to be higher at the urban site, and commonly affected children/young adults to 20 years old and males. A higher number of unowned dogs was observed at the urban site than at the rural site. Data generated within these surveys can inform rabies risk assessment models to quantify the probability of rabies being released into Lombok and resulting in the infection of the local dog population. The information gained is critical for efforts to educate dog owners about rabies, as a component of preparedness to prevent the establishment of rabies should an incursion occur.	[Mustiana, Ana; Toribio, Jenny-Ann; Hernandez-Jover, Marta; Ward, Michael P.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia; [Abdurrahman, Muktasam; Suadnya, I. Wayan] Univ Mataram, Fac Agr, Res Ctr Rural Dev, Lombok, Indonesia; [Hernandez-Jover, Marta] NSW Dept Primary Ind, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Putra, Anak Agung Gde] Dis Invest Ctr Denpasar, Minist Agr, Denpasar, Indonesia	University of Sydney; Universitas Mataram; NSW Department of Primary Industries; Charles Sturt University	Ward, MP (corresponding author), Univ Sydney, Fac Vet Sci, Camden, NSW, Australia.	michael.ward@sydney.edu.au	Ward, Michael Patrick/GRX-1851-2022; Toribio, Jenny-Ann LML/B-5032-2011; Ward, Michael Patrick/W-1897-2019; Abdurrahman, Muktasam/GQB-2748-2022; Hernandez-Jover, Marta/F-8688-2016; Ward, Michael/C-5758-2009	Ward, Michael Patrick/0000-0002-9921-4986; Ward, Michael/0000-0002-9921-4986; , Muktasam A/0000-0002-2074-9284; Hernandez-Jover, Marta/0000-0001-8803-9062	Australian Centre for International Agricultural Research via a Small Research Activity (SRA) [AH/2012/036]	Australian Centre for International Agricultural Research via a Small Research Activity (SRA)(Australian Ctr Intl Agr Res)	The study presented was funded by the Australian Centre for International Agricultural Research via a Small Research Activity (SRA) grant AH/2012/036 awarded to Professor Ward and a John Allwright Fellowship awarded to Ms. Ana Mustiana. The funders had no role in study design, data	Amaku M, 2010, MATH POPUL STUD, V17, P69, DOI 10.1080/08898481003689452; Amaral AC, 2014, PREV VET MED, V113, P608, DOI 10.1016/j.prevetmed.2013.11.012; Beck A.M., 1973, ECOLOGY STRAY DOGS S; Beck AM, 2000, HUMAN DOG RELATIONSH, P1; Belsare AV, 2013, PREV VET MED, V111, P139, DOI 10.1016/j.prevetmed.2013.04.003; BERAN GW, 1982, COMP IMMUNOL MICROB, V5, P265, DOI 10.1016/0147-9571(82)90047-9; Childs J.E., 2007, RABIES, P123; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Constable SE, 2012, THESIS U SYDNEY SYDN; Dias RA, 2013, PREV VET MED, V110, P263, DOI 10.1016/j.prevetmed.2012.12.002; Direktorat Jenderal Kebudayaan Republik Indonesia, KEB IND SUK SAS; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Durr S, 2009, EPIDEMIOL INFECT, V137, P1558, DOI 10.1017/S0950268809002386; Elliott R, 2010, APPL ANIM BEHAV SCI, V124, P121, DOI 10.1016/j.applanim.2010.02.006; FEKADU M, 1982, AM J EPIDEMIOL, V115, P266, DOI 10.1093/oxfordjournals.aje.a113298; Hossain M, 2012, EPIDEMIOL INFECT, V140, P1964, DOI 10.1017/S095026881100272X; Indonesia Ministry of Agriculture, 2013, SIT PERK ZOON PAD HE; Kato M, 2003, ACTA MED OKAYAMA, V57, P261; Knobel DL, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-5; LAKHANPAL U, 1985, INT J EPIDEMIOL, V14, P614, DOI 10.1093/ije/14.4.614; Matter HC, 2000, ACTA TROP, V75, P95, DOI 10.1016/S0001-706X(99)00085-6; NTB Bureau Statistic, 2012, NUSA TENGG BAR FIG 2; Putra AAG, 2011, B VET BBVET DENPASAR, V78, P15; Putra AAG, 2011, 3 RAB AS C COL SRI L; Putra AAG, 2013, EMERG INFECT DIS, V19, P648, DOI 10.3201/eid1904.120380; Ratsitorahina M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-21; Reece JF, 2007, VET REC, V161, P292, DOI 10.1136/vr.161.9.292; Scott-Orr H, 2009, MICROBIOL AUST, V30, P134; Serafini CAV, 2008, ZOONOSES PUBLIC HLTH, V55, P402, DOI 10.1111/j.1863-2378.2008.01171.x; Sparkes J, 2015, ZOONOSES PUBLIC HLTH, V62, P237, DOI 10.1111/zph.12142; Stavisky J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-163; Susetya H, 2008, VIRUS RES, V135, P144, DOI 10.1016/j.virusres.2008.03.001; Tenzin, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001391; Totton SC, 2010, PREV VET MED, V97, P51, DOI 10.1016/j.prevetmed.2010.07.009; Townsend SE, 2013, PLOS NEGLECT TROP D, V7, P8; Utami S, 2008, J SAINS VET G MADA U, V26, P66; WALTNERTOEWS D, 1990, PREV VET MED, V8, P295, DOI 10.1016/0167-5877(90)90087-X; Ward MP, 2014, PREV VET MED, V114, P11, DOI 10.1016/j.prevetmed.2014.01.009; Westgarth C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-102; Windiyaningsih Caecilia, 2004, Journal of the Medical Association of Thailand, V87, P1389; World Health Organisation, 2002, WHOCDSCSREPH20028	41	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124092	10.1371/journal.pone.0124092	http://dx.doi.org/10.1371/journal.pone.0124092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932916	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100030
J	Simonetto, C; Schollnberger, H; Azizova, TV; Grigoryeva, ES; Pikulina, MV; Eidemuller, M				Simonetto, Cristoforo; Schoellnberger, Helmut; Azizova, Tamara V.; Grigoryeva, Evgenia S.; Pikulina, Maria V.; Eidemueller, Markus			Cerebrovascular Diseases in Workers at Mayak PA: The Difference in Radiation Risk between Incidence and Mortality	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; NUCLEAR WORKERS; CARDIOVASCULAR-DISEASE; CIRCULATORY DISEASE; IONIZING-RADIATION; CANCER-MORTALITY; APOE(-/-) MICE; EXPOSURE; COHORT; ATHEROSCLEROSIS	A detailed analysis of cerebrovascular diseases (CeVD) for the cohort of workers at Mayak Production Association (PA) is presented. This cohort is especially suitable for the analysis of radiation induced circulatory diseases, due to the detailed medical surveillance and information on several risk factors. The risk after external, typically protracted, gamma exposure is analysed, accounting for potential additional internal alpha exposure. Three different endpoints have been investigated: incidence and mortality from all cerebrovascular diseases and incidence of stroke. Particular emphasis was given to the form of the dose-response relationship and the time dependence of the radiation induced risk. Young attained age was observed to be an important, aggravating modifier of radiation risk for incidence of CeVD and stroke. For incidence of CeVD, our analysis supports a dose response sub-linear for low doses. Finally, the excess relative risk per dose was confirmed to be significantly higher for incidence of CeVD compared to CeVD mortality and incidence of stroke. Arguments are presented for this difference to be based on a true biological effect.	[Simonetto, Cristoforo; Schoellnberger, Helmut; Eidemueller, Markus] Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany; [Azizova, Tamara V.; Grigoryeva, Evgenia S.; Pikulina, Maria V.] SUBI, Ozyorsk, Chelyabinsk Reg, Russia	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Southern Urals Biophysics Institute	Simonetto, C (corresponding author), Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany.	Cristoforo.Simonetto@helmholtz-muenchen.de	Bannikova, Maria V./Z-1343-2019; Schöllnberger, Helmut/K-1446-2016; Grigoryeva, Evgeniya S./B-9142-2016; Simonetto, Cristoforo/AAE-7124-2020; Azizova, Tamara V./R-5295-2019	Bannikova, Maria V./0000-0002-2755-6282; Schöllnberger, Helmut/0000-0002-4398-6565; Grigoryeva, Evgeniya S./0000-0003-1806-9922; Simonetto, Cristoforo/0000-0003-4816-3514; Azizova, Tamara V./0000-0001-6954-2674	German Federal Office for Radiation Protection [3611S30022]; EU [295823]	German Federal Office for Radiation Protection; EU(European Commission)	This work was supported by a project of the German Federal Office for Radiation Protection (contract 3611S30022) and by the EU project ProCardio (contract number 295823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Azizova TV, 2014, RADIAT RES, V182, P529, DOI 10.1667/RR13680.1; Azizova TV, 2013, RADIAT RES, V180, P610, DOI 10.1667/RR13228.1; Azizova TV, 2010, RADIAT RES, V174, P851, DOI 10.1667/RR1928.1; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Azizova TV, 2008, HEALTH PHYS, V94, P449, DOI 10.1097/01.HP.0000300757.00912.a2; Azizova TV, 2012, HEALTH PHYS, V103, P3, DOI 10.1097/HP.0b013e3182243a62; Azizova TV, 2011, RADIAT ENVIRON BIOPH, V50, P539, DOI 10.1007/s00411-011-0377-6; Bess JD, 2007, HEALTH PHYS, V93, P207, DOI 10.1097/01.HP.0000266741.42070.e8; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Eidemuller M, 2010, RADIAT ENVIRON BIOPH, V49, P477, DOI 10.1007/s00411-010-0289-x; Fokkema M, 2012, EUR J VASC ENDOVASC, V43, P643, DOI 10.1016/j.ejvs.2012.02.023; Gilbert ES, 2013, RADIAT RES, V179, P332, DOI 10.1667/RR3054.1; Hankey GJ, 2006, STROKE, V37, P2181, DOI 10.1161/01.STR.0000229883.72010.e4; Ivanov VK, 2006, HEALTH PHYS, V90, P199, DOI 10.1097/01.HP.0000175835.31663.ea; James F, 2004, MINUET USERS GUIDE; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; Killander F, 2014, EUR J CANCER, V50, P2201, DOI 10.1016/j.ejca.2014.04.033; Koshurnikova NA, 1999, RADIAT RES, V152, P352, DOI 10.2307/3580220; Little MP, 2010, RADIAT ENVIRON BIOPH, V49, P139, DOI 10.1007/s00411-009-0250-z; Little MP, 2013, RADIAT ENVIRON BIOPH, V52, P435, DOI 10.1007/s00411-013-0484-7; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Metz-Flamant C, 2013, OCCUP ENVIRON MED, V70, P630, DOI 10.1136/oemed-2012-101149; Mitchel REJ, 2013, RADIAT RES, V179, P190, DOI 10.1667/RR3140.1; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Monceau V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057052; Moseeva MB, 2014, RADIAT ENVIRON BIOPH, V53, P469, DOI 10.1007/s00411-014-0517-x; Neylon A, 2013, PROG CARDIOVASC DIS, V55, P574, DOI 10.1016/j.pcad.2013.03.009; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Santoro F, 2014, CLIN RES CARDIOL, V103, P955, DOI 10.1007/s00392-014-0718-y; Schollnberger H, 2012, RADIAT ENVIRON BIOPH, V51, P165, DOI 10.1007/s00411-012-0410-4; Scott AS, 2009, RADIOTHER ONCOL, V90, P163, DOI 10.1016/j.radonc.2008.12.019; Shilnikova NS, 2003, RADIAT RES, V159, P787, DOI 10.1667/0033-7587(2003)159[0787:CMRAWA]2.0.CO;2; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Simonetto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096309; Sokolnikov ME, 2008, INT J CANCER, V123, P905, DOI 10.1002/ijc.23581; Takahashi I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000654; Tretyakov FD, 2012, RADIOACTIVE SOURCE 4, P4; United Nations Scientific Committee on the Effects of Atomic Radiation Sources, 1982, ION RAD SOURC BIOL E; van der Wal AC, 1999, CARDIOVASC RES, V41, P334, DOI 10.1016/S0008-6363(98)00276-4; Vasilenko EK, 2007, HEALTH PHYS, V93, P190, DOI 10.1097/01.HP.0000266071.43137.0e; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Walsh L, 2011, RADIAT ENVIRON BIOPH, V50, P21, DOI 10.1007/s00411-010-0337-6; Xu JP, 2013, INTERV NEUROL, V2, P183, DOI 10.1159/000363068; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Zablotska Lydia B, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002159	53	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125904	10.1371/journal.pone.0125904	http://dx.doi.org/10.1371/journal.pone.0125904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933038	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100143
J	Song, G; Liu, J; Ren, WD; Qiao, W; Zhang, J; Zhan, Y; Bi, WJ				Song, Guang; Liu, Jing; Ren, Weidong; Qiao, Wei; Zhang, Jing; Zhan, Ying; Bi, Wenjing			Reversible Changes of Left Atrial Function during Pregnancy Assessed by Two-Dimensional Speckle Tracking Echocardiography	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; STRAIN; QUANTIFICATION; RESERVOIR; PRESSURE; SIZE	Background Left ventricular diastolic function is impaired during pregnancy. However, changes in left atrial (LA) function remain unclear. We aimed to evaluate changes in LA function during pregnancy using two-dimensional speckle tracking echocardiography (2DSTE). Methods and Results 50 pregnant and 50 healthy nulliparous (control group) women were enrolled in this study. All pregnant women were followed up postpartum in sixth-month. The LA maximum volume, LA minimal volume and LA preatrial contraction volume were obtained using biplane modified Simpson's method. LA filling volume, LA expansion index, LA ejection fraction, passive volume, passive emptying index, active volume, and active emptying index were calculated. LA longitudinal systolic strain (SS), systolic strain rate (s-SR), early diastolic strain rate (e-SR), and late diastolic strain rate (a-SR) were obtained by 2DSTE. Compared to the control group, the reservoir function was increased in pregnant patients (P<0.05); conduit function was decreased in pregnant patients (P<0.05); booster pump function was increased in pregnant patients (P<0.05). There was no statistically significant difference between the control group and postpartum group. Conclusions LA reservoir and booster pump function were increased, while conduit function was decreased during pregnancy using 2DSTE. The changes were reversible. 2DSTE can easily assess LA function during pregnancy with good repeatability.	[Song, Guang; Ren, Weidong; Qiao, Wei; Zhang, Jing; Zhan, Ying; Bi, Wenjing] China Med Univ, Shengjing Hosp, Dept Ultrasound, Shenyang 110001, Peoples R China; [Liu, Jing] China Med Univ, Affiliated Hosp 1, Dept Obstet, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Ren, WD (corresponding author), China Med Univ, Shengjing Hosp, Dept Ultrasound, Shenyang 110001, Peoples R China.	renwd01@126.com		Liu, Jing/0000-0002-6730-9198; Song, Guang/0000-0002-5459-6247				Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Anwar AM, 2007, HEART, V93, P1393, DOI 10.1136/hrt.2006.099366; Bamfo JEAK, 2007, ULTRASOUND OBST GYN, V29, P414, DOI 10.1002/uog.3966; Barbier P, 1999, CIRCULATION, V100, P427, DOI 10.1161/01.CIR.100.4.427; Cameli M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-4; Fok WY, 2006, ULTRASOUND OBST GYN, V28, P789, DOI 10.1002/uog.3849; Cianciulli TF, 2010, WORLD J CARDIOL, V2, P163, DOI 10.4330/wjc.v2.i7.163; GREENBERG B, 1979, AM HEART J, V98, P742, DOI 10.1016/0002-8703(79)90473-3; Hibbard JU, 1999, OBSTET GYNECOL, V94, P311, DOI 10.1016/S0029-7844(99)00293-8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Mesa A, 1999, CIRCULATION, V99, P511, DOI 10.1161/01.CIR.99.4.511; Nikitin N P, 2003, Eur J Echocardiogr, V4, P36, DOI 10.1053/euje.2002.0611; Okamatsu K, 2009, J AM SOC ECHOCARDIOG, V22, P70, DOI 10.1016/j.echo.2008.11.006; Qirko S, 1996, ARCH MAL COEUR VAISS, V89, P1003; Saraiva RM, 2010, J AM SOC ECHOCARDIOG, V23, P172, DOI 10.1016/j.echo.2009.11.003; Sirbu C, 2006, EUR J ECHOCARDIOGR, V7, P199, DOI 10.1016/j.euje.2005.06.001; Spencer KT, 2001, HEART, V85, P272, DOI 10.1136/heart.85.3.272; SUGA H, 1974, CIRC RES, V35, P39, DOI 10.1161/01.RES.35.1.39; Wakami K, 2009, J AM SOC ECHOCARDIOG, V22, P847, DOI 10.1016/j.echo.2009.04.026; Yosefy C, 2012, ECHOCARDIOGR-J CARD, V29, P1096, DOI 10.1111/j.1540-8175.2012.01745.x	20	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125347	10.1371/journal.pone.0125347	http://dx.doi.org/10.1371/journal.pone.0125347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933100	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100102
J	Supindham, T; Chariyalertsak, S; Utaipat, U; Miura, T; Ruanpeng, D; Chotirosniramit, N; Kosashunhanan, N; Sugandhavesa, P; Saokhieo, P; Songsupa, R; Siriaunkgul, S; Wongthanee, A				Supindham, Taweewat; Chariyalertsak, Suwat; Utaipat, Utaiwan; Miura, Toshiyuki; Ruanpeng, Darin; Chotirosniramit, Nuntisa; Kosashunhanan, Natthapol; Sugandhavesa, Patcharaphan; Saokhieo, Pongpun; Songsupa, Radchanok; Siriaunkgul, Sumalee; Wongthanee, Antika			High Prevalence and Genotype Diversity of Anal HPV Infection among MSM in Northern Thailand	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; UNINFECTED MEN; RISK-FACTORS; SEX	Background HPV infection is common and may cause cancer among men who have sex with men (MSM). Anal HPV infection (HPV+) was found in 85% of HIV-positive (HIV+) and 59% of HIV-negative (HIV-) MSM in Bangkok, central Thailand. As little is known about HPV in this group in northern Thailand, we studied MSM subgroups comprised of gay men (GM), bisexual men (BM), and transgender women (TGW). Methods From July 2012 through January 2013, 85 (42.5% of 200) GM, 30 (15%) BM, and 85 (42.5%) TGW who practiced receptive anal intercourse were recruited after informed consent, followed by self-assisted computer interview, HIV testing, and anal swabs for HPV genotyping. Results Of 197 adequate specimens, the overall prevalence of any HPV was 157 (80%). Prevalence was 89% (76/85) in GM, 48% (14/29) in BM, and 81% (67/83) in TGW. The most common high-risk types were HPV16 (27% of 197), HPV58 (23%), and HPV51 (18%). Prevalence of high-risk types was 74% in 85 GM, 35% in 29 BM, and 71% in 83 TGW. Prevalence of any HPV type, or high-risk type, was 100% and 94%, respectively, among 48 HIV+ MSM, 70% and 54% among 120 HIV- MSM. Of the 197 specimens, 36% (70) had HPV types 16 and/or 18 in the bivalent vaccine, compared to 48% (95) with >= 1 of types 16/18/06/11 in the quadrivalent, 56% (111) for 16/18/31/33/45/52/58 in the 7-valent, and 64% (126) for 16/18/31/33/45/52/58/06/11 in the 9-valent. HIV+, GM, and TGW were independently associated with HPV infection. Conclusions We found higher rates of both any HPV and high-risk types than previous studies. Among the heretofore unstudied TGW, their equivalent HPV rates were comparable to GM. Current and investigational HPV vaccines could substantially protect GM, BM, and TGW from the serious consequences of HPV infection especially among HIV + MSM.	[Supindham, Taweewat; Chariyalertsak, Suwat; Utaipat, Utaiwan; Ruanpeng, Darin; Chotirosniramit, Nuntisa; Kosashunhanan, Natthapol; Sugandhavesa, Patcharaphan; Saokhieo, Pongpun; Songsupa, Radchanok; Wongthanee, Antika] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Miura, Toshiyuki] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Siriaunkgul, Sumalee] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai 50000, Thailand	Chiang Mai University; Nagasaki University; Chiang Mai University	Chariyalertsak, S (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	suwat@rihes.org			Ministry of Education, Culture, Sports, Science and Technology(MEXT) of Japan [23406032]; Thailand's Office of the Higher Education Commission	Ministry of Education, Culture, Sports, Science and Technology(MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Thailand's Office of the Higher Education Commission	This study was supported by a Grant-inAid for Scientific Research (B) (23406032) to Dr. Toshiyuki Miura from the Ministry of Education, Culture, Sports, Science and Technology(MEXT) of Japan. It was also supported in part by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2013, ACAD PEDIATR, V13, P466, DOI 10.1016/j.acap.2013.03.006; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Guimaraes MDC, 2011, JAIDS-J ACQ IMM DEF, V57, pS217, DOI 10.1097/QAI.0b013e31821e9994; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Gaisa M, 2013, AIDS; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guadamuz TE, 2011, AIDS BEHAV, V15, P650, DOI 10.1007/s10461-010-9850-5; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Lau JT, 2013, ARCH SEX BEHAV; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; Phanuphak N, 2011, 18 C RETR OPP INF CR; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Rahman M, 2013, VACCINE; Schwartz LM, 2013, J INFECT DIS, V208, P1768, DOI 10.1093/infdis/jit374; Senba M, 2006, J MED VIROL, V78, P1341, DOI 10.1002/jmv.20703; Tong W, 2013, HIV MED; Wiley DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079492; Winitdhama G, 2006, ESTIMATES MEN HAVING; Yu CT, 2013, AIDS BEHAV, V17, P1211, DOI 10.1007/s10461-012-0173-6	23	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124499	10.1371/journal.pone.0124499	http://dx.doi.org/10.1371/journal.pone.0124499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932915	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100044
J	Uddin, MJ; Khan, WA; Ismail, AIM				Uddin, Mohammed J.; Khan, Waqar A.; Ismail, Ahmad Izani Md.			G-Jitter Induced Magnetohydrodynamics Flow of Nanofluid with Constant Convective Thermal and Solutal Boundary Conditions	PLOS ONE			English	Article							POROUS-MEDIUM; MIXED CONVECTION; NATURAL-CONVECTION; FLAT-PLATE; LAYER-FLOW; TRANSPORT; SURFACE	Taking into account the effect of constant convective thermal and mass boundary conditions, we present numerical solution of the 2-D laminar g-jitter mixed convective boundary layer flow of water-based nanofluids. The governing transport equations are converted into non-similar equations using suitable transformations, before being solved numerically by an implicit finite difference method with quasi-linearization technique. The skin friction decreases with time, buoyancy ratio, and thermophoresis parameters while it increases with frequency, mixed convection and Brownian motion parameters. Heat transfer rate decreases with time, Brownian motion, thermophoresis and diffusion-convection parameters while it increases with the Reynolds number, frequency, mixed convection, buoyancy ratio and conduction-convection parameters. Mass transfer rate decreases with time, frequency, thermophoresis, conduction-convection parameters while it increases with mixed convection, buoyancy ratio, diffusion-convection and Brownian motion parameters. To the best of our knowledge, this is the first paper on this topic and hence the results are new. We believe that the results will be useful in designing and operating thermal fluids systems for space materials processing. Special cases of the results have been compared with published results and an excellent agreement is found.	[Uddin, Mohammed J.] Amer Int Univ Bangladesh, Dept Math, Dhaka, Bangladesh; [Khan, Waqar A.] Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan; [Ismail, Ahmad Izani Md.] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia	American International University Bangladesh (AIUB); National University of Sciences & Technology - Pakistan; Universiti Sains Malaysia	Khan, WA (corresponding author), Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan.	wkhan_2000@yahoo.com	Khan, Waqar/H-3886-2013	Khan, Waqar/0000-0002-8328-850X; Ahmad Izani, Ismail/0000-0003-1092-5579; Uddin, Dr. Md. Jashim/0000-0002-3243-3455	Universiti Sains Malaysia, RU Grant [1001/PMATHS/811252]	Universiti Sains Malaysia, RU Grant(Universiti Sains Malaysia)	The authors acknowledge financial support from Universiti Sains Malaysia, RU Grant 1001/PMATHS/811252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PM, 1998, ANNU REV FLUID MECH, V20, P35; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; Beg OA, 2008, ACTA MECH, V200, P129, DOI 10.1007/s00707-008-0040-8; Bhadauria BS, 2013, TRANSPORT POROUS MED, V97, P185, DOI 10.1007/s11242-012-0117-7; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; CHEN H, 1994, J CRYST GROWTH, V142, P362, DOI 10.1016/0022-0248(94)90347-6; Chen WY, 1999, J FLUID MECH, V395, P327, DOI 10.1017/S0022112099006011; Choi S. U. S., 1995, 231MD ASME FED, V66, P99; Dey D, 2014, APPL MATH, V2014; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2011, CHEM ENG SCI, V66, P2660, DOI 10.1016/j.ces.2011.03.008; Gorla RSR, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-207; Hayat T, 2014, INT J NUMER METHOD H, V24, P342, DOI 10.1108/HFF-03-2012-0065; Kuznetsov AV, 2012, J POROUS MEDIA, V15, P233, DOI 10.1615/JPorMedia.v15.i3.30; LEE TS, 1982, INT J HEAT MASS TRAN, V25, P499, DOI 10.1016/0017-9310(82)90053-9; Magyari E, 2009, COMMUN NONLINEAR SCI, V14, P1064; Magyari E, 2009, COMMUN NONL SCI NUME, V6, P599; Makinde OD, 2010, INT J THERM SCI, V49, P1813, DOI 10.1016/j.ijthermalsci.2010.05.015; Mandi RA, 2015, RENEW SUST ENERG REV, V41, P715, DOI 10.1016/j.rser.2014.08.040; Merkin JH, 2013, TRANSPORT POROUS MED, V99, P413, DOI 10.1007/s11242-013-0193-3; Merkin JH, 2011, COMMUN NONLINEAR SCI, V16, P3602, DOI 10.1016/j.cnsns.2011.01.007; Mujeebu MA, 2010, PROG ENERG COMBUST, V36, P627, DOI 10.1016/j.pecs.2010.02.002; Murthy PVSN, 2013, INT COMMUN HEAT MASS, V47, P41, DOI 10.1016/j.icheatmasstransfer.2013.06.001; Nield DA, 2014, INT J HEAT MASS TRAN, V70, P430, DOI 10.1016/j.ijheatmasstransfer.2013.11.016; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Nield D.A., 2013, CONVECTION POROUS ME; Pantokratoras A, 2014, TRANSPORT POROUS MED, V104, P273, DOI 10.1007/s11242-014-0333-4; Pantokratoras A, 2014, INT J THERM SCI, V76, P221, DOI 10.1016/j.ijthermalsci.2013.09.006; Rees DAS, 2001, HEAT MASS TRANSFER, V37, P403, DOI 10.1007/s002310000178; Servati AA, 2014, ADV POWDER TECHNOL, V25, P666, DOI 10.1016/j.apt.2013.10.012; Shafie S, 2007, MECH RES COMMUN, V34, P115, DOI 10.1016/j.mechrescom.2006.05.004; Shu Y, 2001, NUMER HEAT TR A-APPL, V39, P245, DOI 10.1080/104077801300006571; Shu Y, 2002, NUMER HEAT TR A-APPL, V42, P345, DOI 10.1080/10407780290059594; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Uddin MJ, 2014, J MAGN MAGN MATER, V368, P252, DOI 10.1016/j.jmmm.2014.05.041; Uddin MJ, 2012, TRANSPORT POROUS MED, V92, P867, DOI 10.1007/s11242-011-9938-z; Uddin MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099384; Uddin MJ, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/179172; Vafai K, 2013, POROUS MEDIA APPL BI; Wasu S, 2011, MATHEMATICS IN SCIENCE AND TECHNOLOGY: MATHEMATICAL METHODS, MODELS AND ALGORITHMS IN SCIENCE AND TECHNOLOGY, P510; Yasin MH, 2012, ADV SCI LETT, V13, P833, DOI DOI 10.1166/ASL.2012.3863; Zueco J, 2011, CHEM ENG COMMUN, V198, P172, DOI 10.1080/00986445.2010.499842	42	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122663	10.1371/journal.pone.0122663	http://dx.doi.org/10.1371/journal.pone.0122663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933066	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100011
J	van 't Sant, J; Fiolet, ATL; ter Horst, IAH; Cramer, MJ; Mastenbroek, MH; van Everdingen, WM; Mast, TP; Doevendans, PA; Versteeg, H; Meine, M				van 't Sant, Jetske; Fiolet, Aernoud T. L.; ter Horst, Iris A. H.; Cramer, Maarten J.; Mastenbroek, Mirjam H.; van Everdingen, Wouter M.; Mast, Thomas P.; Doevendans, Pieter A.; Versteeg, Henneke; Meine, Mathias			Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; SEPTAL REBOUND STRETCH; HEART-FAILURE; HEALTH-STATUS; PREDICTOR; MORTALITY; SURVIVAL; INDEXES; DISEASE; MARKER	Aims Response to cardiac resynchronization therapy (CRT) is often assessed six months after implantation. Our objective was to assess the number of patients changing from responder to non-responder between six and 14 months, so-called late non-responders, and compare them to patients who were responder both at six and 14 months, so-called stable responders. Furthermore, we assessed predictive values of six and 14-month response concerning clinical outcome. Methods 105 patients eligible for CRT were enrolled. Clinical, laboratory, ECG, and echocardiographic parameters and patient-reported health status (Kansas City Cardiomyopathy Questionnaire [KCCQ]) were assessed before, and six and 14 months after implantation. Response was defined as >= 15% LVESV decrease as compared to baseline. Major adverse cardiac events (MACE) were registered until 24 months after implantation. Predictive values of six and 14-month response for MACE were examined. Results In total, 75 (71%) patients were six-month responders of which 12 (16%) patients became late non-responder. At baseline, late non-responders more often had ischemic cardiomyopathy and atrial fibrillation, higher BNP and less dyssynchrony compared to stable responders. At six months, late non-responders showed significantly less LVESV decrease, and higher creatinine levels. Mean KCCQ scores of late non-responders were lower than those of stable responders at every time point, with the difference being significant at 14 months. The 14 months response was a better predictor of MACE than six months response. Conclusions The assessment of treatment outcomes after six months of CRT could be premature and response rates beyond might better correlate to long-term clinical outcome.	[van 't Sant, Jetske; Fiolet, Aernoud T. L.; ter Horst, Iris A. H.; Cramer, Maarten J.; Mastenbroek, Mirjam H.; van Everdingen, Wouter M.; Mast, Thomas P.; Doevendans, Pieter A.; Versteeg, Henneke; Meine, Mathias] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Mastenbroek, Mirjam H.; Versteeg, Henneke] Tilburg Univ, CoRPS Ctr Res Psychol Somat Dis, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands	Utrecht University; Utrecht University Medical Center; Tilburg University	van 't Sant, J (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	j.vantsant@gmail.com	van Everdingen, Wouter M/Y-3603-2018; van Everdingen, Wouter/R-1666-2019	van Everdingen, Wouter M/0000-0003-3577-8923; van Everdingen, Wouter/0000-0003-3577-8923				Bongartz LG, 2005, EUR HEART J, V26, P11, DOI 10.1093/eurheartj/ehi020; Brignole M, 2013, EUROPACE, V15, P1070, DOI 10.1093/europace/eut206; Chan YH, 2013, J AM SOC ECHOCARDIOG, V26, P307, DOI 10.1016/j.echo.2012.11.012; Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; De Boeck BWL, 2009, EUR J HEART FAIL, V11, P863, DOI 10.1093/eurjhf/hfp107; Foley PWX, 2011, EUR J HEART FAIL, V13, P43, DOI 10.1093/eurjhf/hfq182; Fung JWH, 2007, INT J CARDIOL, V122, P10, DOI 10.1016/j.ijcard.2006.11.015; Ghio S, 2009, EUR J HEART FAIL, V11, P480, DOI 10.1093/eurjhf/hfp034; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Hayes DL, 2011, HEART RHYTHM, V8, P1469, DOI 10.1016/j.hrthm.2011.04.015; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Leenders GE, 2012, J CARD FAIL, V18, P404, DOI 10.1016/j.cardfail.2012.02.001; Linde C, 2013, EUR HEART J, V34, P2592, DOI 10.1093/eurheartj/eht160; Linde C, 2010, J AM COLL CARDIOL, V56, P1826, DOI 10.1016/j.jacc.2010.05.055; Lumens J, 2012, CIRC-CARDIOVASC IMAG, V5, P491, DOI 10.1161/CIRCIMAGING.112.973446; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; Mastenbroek MH, 2014, EUR J HEART FAIL, V16, P384, DOI 10.1002/ejhf.55; McCullough PA, 2003, J AM COLL CARDIOL, V41, P725, DOI 10.1016/S0735-1097(02)02955-8; Mor-Avi V, 2011, EUR J ECHOCARDIOGR, V12, P167, DOI 10.1093/ejechocard/jer021; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rickard J, 2014, HEART RHYTHM, V11, P412, DOI 10.1016/j.hrthm.2013.11.025; Schmidt S, 2014, EUR HEART J, V35, P1051, DOI 10.1093/eurheartj/eht514; Surawicz B, 2009, CIRCULATION, V119, pE235, DOI 10.1161/CIRCULATIONAHA.108.191095; Versteeg H, 2014, EUR J HEART FAIL, V16, P227, DOI 10.1002/ejhf.38; Vidal B, 2010, EUR J HEART FAIL, V12, P283, DOI 10.1093/eurjhf/hfq003; Wilton SB, 2011, HEART RHYTHM, V8, P1088, DOI 10.1016/j.hrthm.2011.02.014	28	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124323	10.1371/journal.pone.0124323	http://dx.doi.org/10.1371/journal.pone.0124323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933068	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100039
J	Horne, MK; McGregor, S; Bergquist, F				Horne, Malcolm K.; McGregor, Sarah; Bergquist, Filip			An Objective Fluctuation Score for Parkinson's Disease	PLOS ONE			English	Article							MOTOR FLUCTUATIONS; LEVODOPA; EVOLUTION; PHARMACODYNAMICS; THERAPY	Introduction Establishing the presence and severity of fluctuations is important in managing Parkinson's Disease yet there is no reliable, objective means of doing this. In this study we have evaluated a Fluctuation Score derived from variations in dyskinesia and bradykinesia scores produced by an accelerometry based system. Methods The Fluctuation Score was produced by summing the interquartile range of bradykinesia scores and dyskinesia scores produced every 2 minutes between 0900-1800 for at least 6 days by the accelerometry based system and expressing it as an algorithm. Results This Score could distinguish between fluctuating and non-fluctuating patients with high sensitivity and selectivity and was significant lower following activation of deep brain stimulators. The scores following deep brain stimulation lay in a band just above the score separating fluctuators from non-fluctuators, suggesting a range representing adequate motor control. When compared with control subjects the score of newly diagnosed patients show a loss of fluctuation with onset of PD. The score was calculated in subjects whose duration of disease was known and this showed that newly diagnosed patients soon develop higher scores which either fall under or within the range representing adequate motor control or instead go on to develop more severe fluctuations. Conclusion The Fluctuation Score described here promises to be a useful tool for identifying patients whose fluctuations are progressing and may require therapeutic changes. It also shows promise as a useful research tool. Further studies are required to more accurately identify therapeutic targets and ranges.	[Horne, Malcolm K.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Horne, Malcolm K.; McGregor, Sarah] St Vincents Hosp Melbourne, Ctr Clin Neurosci & Neurol Res, Fitzroy, Vic, Australia; [Bergquist, Filip] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden	Florey Institute of Neuroscience & Mental Health; University of Melbourne; St Vincent's Hospital Melbourne; University of Gothenburg	Horne, MK (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	malcolm.horne@florey.edu.au	Horne, Malcolm/AAL-5214-2020; Bergquist, Filip/G-1402-2010	Horne, Malcolm/0000-0001-9427-2100; Bergquist, Filip/0000-0002-3437-0267	Australian National Health and Medical research Council; Global Kinetics Corporationl	Australian National Health and Medical research Council(National Health and Medical Research Council (NHMRC) of Australia); Global Kinetics Corporationl	MH is a Practitioner Fellow funded by the Australian National Health and Medical research Council. An open grant was received from Global Kinetics Corporationl, the company that manufactures and supplies the PKG for SM's salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Griffiths RI, 2012, J PARKINSON DIS, V2, P47, DOI 10.3233/JPD-2012-11071; HELY MA, 1994, J NEUROL NEUROSUR PS, V57, P903, DOI 10.1136/jnnp.57.8.903; HUGHES AJ, 1994, J NEUROL NEUROSUR PS, V57, P430, DOI 10.1136/jnnp.57.4.430; McColl CD, 2002, MOVEMENT DISORD, V17, P1227, DOI 10.1002/mds.10244; Nutt JG, 2002, ANN NEUROL, V51, P686, DOI 10.1002/ana.10189; Nutt JG, 1997, ANN NEUROL, V42, P349, DOI 10.1002/ana.410420311; NUTT JG, 1995, CLIN EXP PHARMACOL P, V22, P837, DOI 10.1111/j.1440-1681.1995.tb01946.x; Nutt JG, 2008, MOVEMENT DISORD, V23, pS580, DOI 10.1002/mds.22037; Papapetropoulos SS, 2011, CNS NEUROSCIENCE THE; Reardon KA, 1999, MOVEMENT DISORD, V14, P605, DOI 10.1002/1531-8257(199907)14:4<605::AID-MDS1009>3.0.CO;2-H	10	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124522	10.1371/journal.pone.0124522	http://dx.doi.org/10.1371/journal.pone.0124522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928634	Green Published, gold			2022-12-26	WOS:000353713100037
J	Kapoor, S; Rodriguez, D; Riwanto, M; Edenhofer, I; Segerer, S; Mitchell, K; Wuthrich, RP				Kapoor, Sarika; Rodriguez, Daniel; Riwanto, Meliana; Edenhofer, Ilka; Segerer, Stephan; Mitchell, Katharyn; Wuthrich, Rudolf P.			Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats	PLOS ONE			English	Article							V2 RECEPTOR ANTAGONIST; SGLT2 INHIBITOR; VASOPRESSIN; DAPAGLIFLOZIN; WATER; OSMOREGULATION; NEPHROPATHY; MANAGEMENT; POTENT; MODEL	The sodium-glucose-cotransporter-2 (SGLT2) inhibitor dapagliflozin (DAPA) induces glucosuria and osmotic diuresis via inhibition of renal glucose reabsorption. Since increased diuresis retards the progression of polycystic kidney disease (PKD), we investigated the effect of DAPA in the PCK rat model of PKD. DAPA (10 mg/kg/d) or vehicle was administered by gavage to 6 week old male PCK rats (n=9 per group). Renal function, albuminuria, kidney weight and cyst volume were assessed after 6 weeks of treatment. Treatment with DAPA markedly increased glucose excretion (23.6 +/- 4.3 vs 0.3 +/- 0.1 mmol/d) and urine output (57.3 +/- 6.8 vs 19.3 +/- 0.8 ml/d). DAPA-treated PCK rats had higher clearances for creatinine (3.1 +/- 0.1 vs 2.6 +/- 0.2 ml/min) and BUN (1.7 +/- 0.1 vs 1.2 +/- 0.1 ml/min) after 3 weeks, and developed a 4-fold increase in albuminuria. Ultrasound imaging and histological analysis revealed a higher cyst volume and a 23% higher total kidney weight after 6 weeks of DAPA treatment. At week 6 the renal cAMP content was similar between DAPA and vehicle, and staining for Ki67 did not reveal an increase in cell proliferation. In conclusion, the inhibition of glucose reabsorption with the SGLT2-specific inhibitor DAPA caused osmotic diuresis, hyperfiltration, albuminuria and an increase in cyst volume in PCK rats. The mechanisms which link glucosuria to hyperfiltration, albuminuria and enhanced cyst volume in PCK rats remain to be elucidated.	[Kapoor, Sarika; Rodriguez, Daniel; Riwanto, Meliana; Edenhofer, Ilka; Segerer, Stephan; Wuthrich, Rudolf P.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Kapoor, Sarika; Rodriguez, Daniel; Riwanto, Meliana; Edenhofer, Ilka; Segerer, Stephan; Wuthrich, Rudolf P.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Mitchell, Katharyn] Univ Zurich, Clin Equine Internal Med, Vetsuisse Fac, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich	Wuthrich, RP (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	rudolf.wuethrich@usz.ch	Mitchell, Katharyn/G-7915-2016	Mitchell, Katharyn/0000-0002-5545-5630; Segerer, Stephan/0000-0002-1936-9719; Rodriguez Gutierrez, Daniel/0000-0002-2979-0769	Swiss National Science Foundation [320030_144093]; Hartmann Muller Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hartmann Muller Foundation	Supported by the Swiss National Science Foundation (grant number 320030_144093 to RPW) and by the Hartmann Muller Foundation (to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JH, 2005, J AM SOC NEPHROL, V16, P3517, DOI 10.1681/ASN.2005060601; CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1349; Chevalier RL, 1998, SEMIN NEPHROL, V18, P585; De Nicola L, 2014, AM J KIDNEY DIS, V64, P16, DOI 10.1053/j.ajkd.2014.02.010; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Devuyst O, 2013, CURR OPIN NEPHROL HY, V22, P459, DOI 10.1097/MNH.0b013e3283621510; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Hopp K, 2015, AM J PHYSIOL-RENAL, V308, pF261, DOI 10.1152/ajprenal.00345.2014; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; Meijer E, 2011, NEPHROL DIAL TRANSPL, V26, P2445, DOI 10.1093/ndt/gfr069; Meng W, 2008, J MED CHEM, V51, P1145, DOI 10.1021/jm701272q; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Obermeier M, 2010, DRUG METAB DISPOS, V38, P405, DOI 10.1124/dmd.109.029165; Reed B, 2012, NEPHROL DIAL TRANSPL, V27, P2862, DOI 10.1093/ndt/gfr744; Schrier RW, 2003, KIDNEY INT, V63, P678, DOI 10.1046/j.1523-1755.2003.00776.x; Skrtic M, 2014, DIABETOLOGIA, V57, P2599, DOI 10.1007/s00125-014-3396-4; Ho TA, 2012, KIDNEY INT, V82, P1121, DOI 10.1038/ki.2012.225; Thomson SC, 2012, AM J PHYSIOL-REG I, V302, pR75, DOI 10.1152/ajpregu.00357.2011; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Torres VE, 2009, CLIN J AM SOC NEPHRO, V4, P1140, DOI 10.2215/CJN.00790209; Wang CJ, 2011, CLIN J AM SOC NEPHRO, V6, P192, DOI 10.2215/CJN.03950510; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Wang XF, 2008, J AM SOC NEPHROL, V19, P102, DOI 10.1681/ASN.2007060688; Wang XQ, 2013, KIDNEY INT, V84, P962, DOI 10.1038/ki.2013.199; Wuthrich RP, 2014, EXPERT OPIN PHARMACO, V15, P1085, DOI 10.1517/14656566.2014.903923	31	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125603	10.1371/journal.pone.0125603	http://dx.doi.org/10.1371/journal.pone.0125603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927597	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000353713100105
J	Trnka, J; Elkalaf, M; Andel, M				Trnka, Jan; Elkalaf, Moustafa; Andel, Michal			Lipophilic Triphenylphosphonium Cations Inhibit Mitochondrial Electron Transport Chain and Induce Mitochondrial Proton Leak	PLOS ONE			English	Article							BIOMEMBRANE-PRODUCED ENERGY; RESPIRATORY-CHAIN; REACTIVE OXYGEN; ANTIOXIDANT; TRAP; UBIQUINONE; CONVERSION; KINETICS; EFFLUX; CELLS	Background The lipophilic positively charged moiety of triphenylphosphonium (TPP+) has been used to target a range of biologically active compounds including antioxidants, spin-traps and other probes into mitochondria. The moiety itself, while often considered biologically inert, appears to influence mitochondrial metabolism. Methodology/Principal Findings We used the Seahorse XF flux analyzer to measure the effect of a range of alkylTPP(+) on cellular respiration and further analyzed their effect on mitochondrial membrane potential and the activity of respiratory complexes. We found that the ability of alkylTPP(+) to inhibit the respiratory chain and decrease the mitochondrial membrane potential increases with the length of the alkyl chain suggesting that hydrophobicity is an important determinant of toxicity. Conclusions/Significance More hydrophobic TPP+ derivatives can be expected to have a negative impact on mitochondrial membrane potential and respiratory chain activity in addition to the effect of the biologically active moiety attached to them. Using shorter linker chains or adding hydrophilic functional groups may provide a means to decrease this negative effect.	[Trnka, Jan; Elkalaf, Moustafa] Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic; [Trnka, Jan; Elkalaf, Moustafa; Andel, Michal] Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic	Charles University Prague; Charles University Prague	Trnka, J (corresponding author), Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic.	jan.trnka@lf3.cuni.cz	Elkalaf, Moustafa/AAL-4938-2020; Anděl, Michal/E-4305-2012; Trnka, Jan/B-8951-2012	Elkalaf, Moustafa/0000-0002-0418-2732; Trnka, Jan/0000-0002-1786-7562	Charles University in Prague [PRVOUK P31, 260042/SVV/2014]	Charles University in Prague	This work was funded by grants from Charles University in Prague (www.cuni.cz) PRVOUK P31, and 260042/SVV/2014.	Antonenko YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061902; BAKEEVA LE, 1970, BIOCHIM BIOPHYS ACTA, V216, P13, DOI 10.1016/0005-2728(70)90154-4; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brown SE, 2007, FREE RADICAL BIO MED, V42, P1766, DOI 10.1016/j.freeradbiomed.2007.02.033; CERLETTI P, 1965, BIOCHEM BIOPH RES CO, V18, P259, DOI 10.1016/0006-291X(65)90750-3; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Cunniff B, 2013, J CELL PHYSIOL, V228, P835, DOI 10.1002/jcp.24232; Filipovska A, 2005, J BIOL CHEM, V280, P24113, DOI 10.1074/jbc.M501148200; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; FRY M, 1981, J BIOL CHEM, V256, P1874; GRINIUS LL, 1970, BIOCHIM BIOPHYS ACTA, V216, P1, DOI 10.1016/0005-2728(70)90153-2; Hardy M, 2007, CHEM RES TOXICOL, V20, P1053, DOI 10.1021/tx700101d; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Kelso GF, 2012, CHEM BIOL, V19, P1237, DOI 10.1016/j.chembiol.2012.08.005; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Leo S, 2008, ANN NY ACAD SCI, V1147, P264, DOI 10.1196/annals.1427.019; Luo C, 2008, CLIN CHIM ACTA, V395, P38, DOI 10.1016/j.cca.2008.04.025; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8; Nicholls DG, 2012, METHODS MOL BIOL, V810, P119, DOI 10.1007/978-1-61779-382-0_8; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Patkova J, 2014, CELL PHYSIOL BIOCHEM, V33, P1439, DOI 10.1159/000358709; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Quin C, 2009, TETRAHEDRON, V65, P8154, DOI 10.1016/j.tet.2009.07.081; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Ross MF, 2008, BIOCHEM J, V411, P633, DOI 10.1042/BJ20080063; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Trendeleva TA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1021, DOI 10.1134/S000629791209009X; Trnka J., 2008, THESIS U CAMBRIDGE; Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; WINGROVE DE, 1986, J BIOL CHEM, V261, P5166; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu YK, 2007, FREE RADICAL RES, V41, P1, DOI 10.1080/10715760600911147	42	89	95	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0121837	10.1371/journal.pone.0121837	http://dx.doi.org/10.1371/journal.pone.0121837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927600	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100005
J	Vemana, HP; Karim, ZA; Conlon, C; Khasawneh, FT				Vemana, Hari Priya; Karim, Zubair A.; Conlon, Christine; Khasawneh, Fadi T.			A Critical Role for the Transient Receptor Potential Channel Type 6 in Human Platelet Activation	PLOS ONE			English	Article							THROMBOXANE A(2) RECEPTORS; INTACT HUMAN-PLATELETS; OPERATED CA2+ ENTRY; G-PROTEINS; SHAPE CHANGE; FIBRINOGEN RECEPTOR; SIGNAL-TRANSDUCTION; MOUSE PLATELETS; G(I) PATHWAYS; A2 RECEPTOR	While calcium signaling is known to play vital roles in platelet function, the mechanisms underlying its receptor-operated calcium entry component (ROCE) remain poorly understood. It has been proposed, but never proven in platelets, that the canonical transient receptor potential channel-6 (TRPC6) mediates ROCE. Nonetheless, we have previously shown that the mouse TRPC6 regulates hemostasis, thrombogenesis by regulating platelet aggregation. In the present studies, we used a pharmacological approach to characterize the role of TRPC6 in human platelet biology. Thus, interestingly, we observed that a TRPC6 inhibitor exerted significant inhibitory effects on human platelet aggregation in a thromboxane receptor (TPR)-selective manner; no additional inhibition was observed in the presence of the calcium chelator BAPTA. This inhibitor also significantly inhibited human platelet secretion (dense and alpha granules), integrin IIb-IIIa, Akt and ERK phosphorylation, again, in a TPR-selective manner; no effects were observed in response to ADP receptor stimulation. Furthermore, there was a causal relationship between these inhibitory effects, and the capacity of the TRPC6 inhibitor to abrogate elevation in intracellular calcium, that was again found to be TPR-specific. This effect was not found to be due to antagonism of TPR, as the TRPC6 inhibitor did not displace the radiolabeled antagonist [H-3]SQ29,548 from its binding sites. Finally, our studies also revealed that TRPC6 regulates human clot retraction, as well as physiological hemostasis and thrombus formation, in mice. Taken together, our findings demonstrate, for the first time, that TRPC6 directly regulates TPR-dependent ROCE and platelet function. Moreover, these data highlight TRPC6 as a novel promising therapeutic strategy for managing thrombotic disorders.	[Vemana, Hari Priya; Karim, Zubair A.; Conlon, Christine; Khasawneh, Fadi T.] Western Univ Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Pomona, CA 91766 USA	Western University of Health Sciences	Khasawneh, FT (corresponding author), Western Univ Hlth Sci, Dept Pharmaceut Sci, Coll Pharm, Pomona, CA 91766 USA.	fkhasawneh@westernu.edu			American Heart Association [14GRNT20450127]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association, Grant Number 14GRNT20450127 (to FTK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirza WHM, 2012, CELL CALCIUM, V51, P12, DOI 10.1016/j.ceca.2011.10.001; Authi K. S., 2007, V179, P425; AUTHI KS, 1993, ADV EXP MED BIOL, V344, P83; Bauer M, 1999, BLOOD, V94, P1665, DOI 10.1182/blood.V94.5.1665.417k33_1665_1672; Behnke O, 1970, Int Rev Exp Pathol, V9, P1; Bhattacharya B, 2003, BRIT J PHARMACOL, V139, P156, DOI 10.1038/sj.bjp.0705208; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; Carter RN, 2006, J PHYSIOL-LONDON, V576, P151, DOI 10.1113/jphysiol.2006.113886; CHARO IF, 1977, J CLIN INVEST, V60, P866, DOI 10.1172/JCI108841; Djellas Y, 1999, J BIOL CHEM, V274, P14325, DOI 10.1074/jbc.274.20.14325; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Du X, 1997, THROMB HAEMOSTASIS, V78, P96; Espinosa EVP, 2012, BIOCHEM BIOPH RES CO, V417, P853, DOI 10.1016/j.bbrc.2011.12.058; Gao YL, 2001, J PHARMACOL EXP THER, V296, P426; GHALI NI, 1984, PROSTAGLANDINS, V27, P865, DOI 10.1016/S0090-6980(84)80006-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALUSHKA PV, 1989, ANNU REV PHARMACOL, V29, P213; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Huang ZH, 2014, INTERNATIONAL CONFERENCE ON MECHANICAL DESIGN, MANUFACTURE AND AUTOMATION ENGINEERING (MDMAE 2014), P112; HUNG SC, 1983, BIOCHIM BIOPHYS ACTA, V728, P171, DOI 10.1016/0005-2736(83)90468-6; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; KATTELMAN EJ, 1986, THROMB RES, V41, P471, DOI 10.1016/0049-3848(86)91692-0; Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; KNEZEVIC I, 1993, J BIOL CHEM, V268, P26011; Krizaj D, 2005, EUR J NEUROSCI, V22, P3292, DOI 10.1111/j.1460-9568.2005.04469.x; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; Murad JP, 2012, BIOCHEM BIOPH RES CO, V421, P456, DOI 10.1016/j.bbrc.2012.04.011; Murad JP, 2012, BIOCHEM PHARMACOL, V83, P88, DOI 10.1016/j.bcp.2011.10.002; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Nesbitt WS, 2003, J CELL BIOL, V160, P1151, DOI 10.1083/jcb.200207119; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1996, J BIOL CHEM, V271, P26044, DOI 10.1074/jbc.271.42.26044; Osdoit S, 2001, J BIOL CHEM, V276, P6703, DOI 10.1074/jbc.M008945200; OWEN NE, 1981, AM J PHYSIOL, V241, pH613, DOI 10.1152/ajpheart.1981.241.4.H613; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARISE LV, 1984, J PHARMACOL EXP THER, V228, P240; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; Ramanathan G, 2012, J THROMB HAEMOST, V10, P419, DOI 10.1111/j.1538-7836.2011.04596.x; Roedding AS, 2006, LIFE SCI, V80, P89, DOI 10.1016/j.lfs.2006.08.021; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; SHENKER A, 1991, J BIOL CHEM, V266, P9309; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; USHIKUBI F, 1994, MOL PHARMACOL, V46, P808; Varga-Szabo D, 2008, PFLUG ARCH EUR J PHY, V457, P377, DOI 10.1007/s00424-008-0531-4; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597; Yang X, 1997, THROMB RES, V88, P317, DOI 10.1016/S0049-3848(97)00261-2	53	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125764	10.1371/journal.pone.0125764	http://dx.doi.org/10.1371/journal.pone.0125764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928636	gold, Green Submitted, Green Published			2022-12-26	WOS:000353713100117
J	Alderliesten, T; de Vries, LS; Khalil, Y; van Haastert, IC; Benders, MJNL; Koopman-Esseboom, C; Groenendaal, F				Alderliesten, Thomas; de Vries, Linda S.; Khalil, Yara; van Haastert, Ingrid C.; Benders, Manon J. N. L.; Koopman-Esseboom, Corine; Groenendaal, Floris			Therapeutic Hypothermia Modifies Perinatal Asphyxia-Induced Changes of the Corpus Callosum and Outcome in Neonates	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; TERM INFANTS; WALLERIAN DEGENERATION; DIFFUSION; BRAIN; CHILDREN; PATTERN; MRI; LESIONS; INJURY	What Is Known about this Subject? Diffusion-weighted MRI has demonstrated changes in the corpus callosum of term neonates with perinatal asphyxia. The severity of cerebral changes demonstrated using diffusion-weighted MRI is difficult to assess without measuring values of the Apparent Diffusion Coefficient (ADC). What Is New? ADC values of the anterior part of the corpus callosum are slightly higher than of the posterior part in full term infants with perinatal asphyxia. Low ADC values of the corpus callosum were associated with an adverse outcome in infants with perinatal asphyxia. In infants treated with hypothermia lower ADC values than with normothermia were associated with a poor outcome, supporting neuroprotective effects of hypothermia Background Using MRI, changes can be detected in the corpus callosum (CC) following perinatal asphyxia which are associated with later neurodevelopmental outcome. Aim To study the association between the apparent diffusion coefficient of water (ADC) in the CC on MRI in neonates with perinatal asphyxia and neurodevelopmental outcome at 18 months of age. Subjects, Methods Of 121 infants 32 (26%) died and 13 (11%) survived with an adverse neurological outcome. Sixty-five (54%) received therapeutic hypothermia. MRI was performed within 7 days after birth using a 1.5 T or 3.0 T system, and ADC values were measured in the anterior and posterior CC. The association between ADC and composite outcome (death or abnormal neurodevelopment) was analyzed for both normothermia and hypothermia cases using receiver operating characteristics. Results ADC values of the posterior CC were lower than of the anterior part (mean difference 0.050 x 10(-3) mm(2)/s, p<0.001). Field strength did not affect ADC values. ADC values of the posterior part of the CC were significantly lower in infants with basal ganglia/thalamus or near total brain injury (p<0.001). Lower ADC values were associated with an adverse outcome, but cut-off levels were lower after hypothermia (1.024 x 10(-3) mm(2)/s vs 0.969 x 10(-3) mm(2)/s) Conclusion Low ADC values of the posterior part of the corpus callosum are associated with an adverse outcome in term or near term neonates with perinatal asphyxia. Therapeutic hypothermia slightly modifies this association, showing that lower values were needed for an adverse outcome.	[Alderliesten, Thomas; de Vries, Linda S.; Khalil, Yara; van Haastert, Ingrid C.; Benders, Manon J. N. L.; Koopman-Esseboom, Corine; Groenendaal, Floris] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Groenendaal, F (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands.	F.groenendaal@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021; Groenendaal, Floris/P-6872-2019	Groenendaal, Floris/0000-0002-9284-1637				Alderliesten T, 2011, RADIOLOGY, V261, P235, DOI 10.1148/radiol.11110213; Ancora G, 2013, NEURORADIOLOGY, V55, P1017, DOI 10.1007/s00234-013-1202-5; Bednarek N, 2012, NEUROLOGY, V78, P1420, DOI 10.1212/WNL.0b013e318253d589; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; de Vries LS, 2010, NEURORADIOLOGY, V52, P555, DOI 10.1007/s00234-010-0674-9; Dudink J, 2008, AM J NEURORADIOL, V29, P1966, DOI 10.3174/ajnr.A1241; EKEN P, 1994, NEUROPEDIATRICS, V25, P301, DOI 10.1055/s-2008-1073044; Epelman M, 2012, PEDIATR RADIOL, V42, P321, DOI 10.1007/s00247-011-2238-5; Griffiths R, 1984, ABILITIES YOUNG CHIL; Groenendaal F, 2006, SEMIN PERINATOL, V30, P146, DOI 10.1053/j.semperi.2006.04.005; Groenendaal F, 2013, NEONATOLOGY, V104, P15, DOI 10.1159/000348823; Harteman JC, 2013, J PEDIATR-US, V163, P968, DOI 10.1016/j.jpeds.2013.06.010; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kohlhauser C, 2000, LIFE SCI, V67, P2355, DOI 10.1016/S0024-3205(00)00816-X; Maneru C, 2003, BRAIN INJURY, V17, P1003, DOI 10.1080/0269905031000110454; Mazumdar A, 2003, AM J NEURORADIOL, V24, P1057; Nagy Z, 2005, PEDIATR RES, V58, P936, DOI 10.1203/01.pdr.0000186516.85702.61; NJIOKIKTJIEN C, 1994, BEHAV BRAIN RES, V64, P213, DOI 10.1016/0166-4328(94)90133-3; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Porter EJ, 2010, PEDIATR RES, V68, P205, DOI 10.1203/00006450-201011001-00399; RADEMAKERS RP, 1995, J COMPUT ASSIST TOMO, V19, P256, DOI 10.1097/00004728-199503000-00017; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V109, P8, DOI DOI 10.1111/J.1469-8749.2007.TB12610.X; Rutherford M, 2004, PEDIATRICS, V114, P1004, DOI 10.1542/peds.2004-0222; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; Sakai K, 2012, IEEE ENG MED BIO, P2291, DOI 10.1109/EMBC.2012.6346420; Shankaran S, 2012, ARCH DIS CHILD-FETAL, V97, pF398, DOI 10.1136/archdischild-2011-301524; Takenouchi T, 2010, PEDIATR NEUROL, V43, P190, DOI 10.1016/j.pediatrneurol.2010.04.014; Tekgul H, 2004, PEDIATR NEUROL, V31, P35, DOI 10.1016/j.pediatrneurol.2003.11.012; Twomey E, 2010, PEDIATR RADIOL, V40, P1526, DOI 10.1007/s00247-010-1692-9; van der Aa NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056784; Van Kooij BJM, 2008, PEDIATR RES, V63, P103, DOI 10.1203/PDR.0b013e31815b4435; van Rooij LGM, 2010, PEDIATRICS, V125, pE358, DOI 10.1542/peds.2009-0136; Vermeulen RJ, 2003, NEUROPEDIATRICS, V34, P72	33	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123230	10.1371/journal.pone.0123230	http://dx.doi.org/10.1371/journal.pone.0123230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923113	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600035
J	Dong, N; Xu, B; Chu, LQ; Tang, X				Dong, Ning; Xu, Bing; Chu, Liqun; Tang, Xin			Study of 27 Aqueous Humor Cytokines in Type 2 Diabetic Patients with or without Macular Edema	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VISUAL IMPAIRMENT; RISK-FACTORS; RETINOPATHY; INTERLEUKIN-6; ANGIOGENESIS; INHIBITION; EXPRESSION; FLUID; EYES	The aim of the present study was to compare the changes in the levels of 27 aqueous humor cytokines between diabetic patients with macular edema (ME) and diabetic patients without ME. Undiluted aqueous humor samples were obtained from 68 consecutive type 2 diabetic patients without ME and 56 consecutive type 2 diabetic patients with ME. The concentrations of 27 cytokines in the aqueous humor samples were measured using a multiplex bead immunoassay. Compared with diabetic patients without ME, diabetic patients with ME had significantly higher concentrations of IL-1 beta, IL-6, IL-8, IP-10, MCP-1, and VEGF in the aqueous humor. However, the concentrations of IL-10 and IL-12 were significantly lower in the diabetic patients with ME. The aqueous humor levels of IL-1 beta, IL-6, IL-8, MCP-1, IP-10, and VEGF were closely correlated with retinal macular thickness, retinal macular volume and the severity of ME. In addition, the aqueous humor levels of IL-10 and IL-12 decreased with increasing the severity of ME. A variety of cytokines associated with inflammation and angiogenesis may contribute to the pathogenesis of diabetic macular edema, and both anti-inflammatory and antiangiogenic agents should be included in the treatment of ME simultaneously.	[Dong, Ning; Xu, Bing; Chu, Liqun] Capital Med Univ, Beijing Shijitan Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Tang, Xin] Tianjin Med Univ, Tianjin Eye Hosp, Clin Coll Ophthalmol, Tianjin, Peoples R China	Capital Medical University; Tianjin Medical University	Tang, X (corresponding author), Tianjin Med Univ, Tianjin Eye Hosp, Clin Coll Ophthalmol, Tianjin, Peoples R China.	eye_tangxin@163.com						Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 1991, OPHTHALMOLOGY, V98, P823; BRESNICK GH, 1986, OPHTHALMOLOGY, V93, P989; Chernykh VV, 2015, INDIAN J OPHTHALMOL, V63, P33, DOI 10.4103/0301-4738.151464; Chou TH, 2009, EYE, V23, P1360, DOI 10.1038/eye.2008.279; Chu LQ, 2013, MOL VIS, V19, P2418; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; de Faria JML, 1999, ACTA OPHTHALMOL SCAN, V77, P170; Dieleman M, 2011, J CATARACT REFR SURG, V37, P1589, DOI 10.1016/j.jcrs.2011.03.049; Dong N, 2013, MOL VIS, V19, P1734; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Funatsu H, 2002, AM J OPHTHALMOL, V133, P70, DOI 10.1016/S0002-9394(01)01269-7; Funk M, 2010, RETINA-J RET VIT DIS, V30, P1412, DOI 10.1097/IAE.0b013e3181e095c0; Graves DT, 2008, FRONT BIOSCI-LANDMRK, V13, P1227, DOI 10.2741/2757; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Jonas JB, 2012, RETINA-J RET VIT DIS, V32, P2150, DOI 10.1097/IAE.0b013e3182576d07; Kim SJ, 2007, OPHTHALMOLOGY, V114, P881, DOI 10.1016/j.ophtha.2006.08.053; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Ko F, 2012, JAMA-J AM MED ASSOC, V308, P2361, DOI 10.1001/jama.2012.85685; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Silvestre JS, 2000, CIRC RES, V87, P448; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wu L, 2013, WORLD J DIABETES, V4, P290, DOI 10.4239/wjd.v4.i6.290; Xu AJ, 2010, MOL CELL BIOCHEM, V344, P163, DOI 10.1007/s11010-010-0539-x; Yao L, 1999, BLOOD, V93, P1612, DOI 10.1182/blood.V93.5.1612.405a13_1612_1621; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhou JZ, 2012, CURR EYE RES, V37, P416, DOI 10.3109/02713683.2012.661114	36	73	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125329	10.1371/journal.pone.0125329	http://dx.doi.org/10.1371/journal.pone.0125329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923230	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600144
J	Gwiazdowski, RA; Foottit, RG; Maw, HEL; Hebert, PDN				Gwiazdowski, Rodger A.; Foottit, Robert G.; Maw, H. Eric L.; Hebert, Paul D. N.			The Hemiptera (Insecta) of Canada: Constructing a Reference Library of DNA Barcodes	PLOS ONE			English	Article							IDENTIFICATION	DNA barcode reference libraries linked to voucher specimens create new opportunities for high-throughput identification and taxonomic re-evaluations. This study provides a DNA barcode library for about 45% of the recognized species of Canadian Hemiptera, and the publically available R workflow used for its generation. The current library is based on the analysis of 20,851 specimens including 1849 species belonging to 628 genera and 64 families. These individuals were assigned to 1867 Barcode Index Numbers (BINs), sequence clusters that often coincide with species recognized through prior taxonomy. Museum collections were a key source for identified specimens, but we also employed high-throughput collection methods that generated large numbers of unidentified specimens. Many of these specimens represented novel BINs that were subsequently identified by taxonomists, adding barcode coverage for additional species. Our analyses based on both approaches includes 94 species not listed in the most recent Canadian checklist, representing a potential 3% increase in the fauna. We discuss the development of our workflow in the context of prior DNA barcode library construction projects, emphasizing the importance of delineating a set of reference specimens to aid investigations in cases of nomenclatural and DNA barcode discordance. The identification for each specimen in the reference set can be annotated on the Barcode of Life Data System (BOLD), allowing experts to highlight questionable identifications; annotations can be added by any registered user of BOLD, and instructions for this are provided.	[Gwiazdowski, Rodger A.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Foottit, Robert G.; Maw, H. Eric L.] Agr & Agri Food Canada, Invertebrate Biodivers Natl Environm Hlth Program, Ottawa, ON K1A 0C6, Canada; [Foottit, Robert G.; Maw, H. Eric L.] Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON K1A 0C6, Canada	University of Guelph; Agriculture & Agri Food Canada	Gwiazdowski, RA (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	rodger.gwiazdowski@gmail.com	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	NSERC; Genome Canada through the Ontario Genomics Institute; Agriculture and Agri-Food Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research was enabled by funding from NSERC, Genome Canada through the Ontario Genomics Institute, and by Agriculture and Agri-Food Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich JM, 1919, ANN REPORT SMITH SON, P367; [Anonymous], 2014, GERMAN BARCODE LIFE, V5, P14; [Anonymous], 2014, QUARANTINE BARCODE L, V5, P14; Aylagas E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090529; Bartlett CR, 2002, ENTOMOL NEWS, V113, P97; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Burge S, 2012, DATABASE, V2012, P1; Chamberlain Scott A, 2013, F1000Res, V2, P191, DOI 10.12688/f1000research.2-191.v1; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DeWaard Jeremy R., 2008, V410, P275; Dietrich CH, 2006, B ILLINOIS NATURAL H, V37, P119, DOI DOI 10.1653/0015-4040(2005)88[; Foottit RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101385; Forbes S. A., 1885, ILLINOIS DEP AGR T, V22, P1; Gibson CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037528; Gleason J, 2012, BARCODE B NEWSLETTER, V2012, P8; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Grebennikov VV, 2014, ARTHROPOD SYST PHYLO, V72, P213; Hahn CW, 1833, ZEHSCHEN BUCHHANDLUN, P147; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Heraty M.J., 2012, CLADISTICS, P1; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; Kvist S, 2013, MOL PHYLOGENET EVOL, V69, P39, DOI 10.1016/j.ympev.2013.05.012; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Maddison DR, 2012, TRENDS ECOL EVOL, V27, P72, DOI 10.1016/j.tree.2011.10.010; Maw HEL, 2000, CHECKLIST HEMIPTERA; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller JA, 2013, ZOOKEYS, P245, DOI 10.3897/zookeys.365.5787; Palisot de Beauvois A.-M.-F.-J., 1818, INSECTES RECUEILLIS, P173; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Pigg S, 2013, STAR; Ratnasingham S, 2011, MOL ECOL RESOUR, V11, P941, DOI 10.1111/j.1755-0998.2011.03067.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; RDC Team R, 2013, R LANG ENV STAT COMP; Rebijith KB, 2012, ENVIRON ENTOMOL, V41, P1239, DOI 10.1603/EN12096; Roskov Y, 2000, SPECIES 2000 ITIS CA; Ruedas LA, 2000, MOL PHYLOGENET EVOL, V17, P129, DOI 10.1006/mpev.2000.0737; Santschi L, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001471; Smith CR, 1926, T KANSAS ACAD SCI, V31, P77; Steinke D., 2013, BARCODE B NEWSLETTER, P8; Suter W.R., 1974, Entomological News, V85, P298; Tembe S, 2014, META GENE, V2, P737, DOI 10.1016/j.mgene.2014.09.006; Uhler P.R., 1878, P BOSTON SOC NATURAL, V19, P365; Vasilevsky NA, 2013, PEERJ, V1, DOI 10.7717/peerj.148; Virgilio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031581; Wei LL, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.80; Wheeler QD, 2010, NATURE ED KNOWLEDGE, V3, P6; Zahniser JN, 2013, EUR J TAXON, V45, P1, DOI 10.5852/ejt.2013.45; Zhou CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034528	54	54	56	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125635	10.1371/journal.pone.0125635	http://dx.doi.org/10.1371/journal.pone.0125635			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923328	Green Published, gold			2022-12-26	WOS:000353711600157
J	Knabel, MK; Ramachandran, K; Karhadkar, S; Hwang, HW; Creamer, TJ; Chivukula, RR; Sheikh, F; Clark, KR; Torbenson, M; Montgomery, RA; Cameron, AM; Mendell, JT; Warren, DS				Knabel, Matthew K.; Ramachandran, Kalyani; Karhadkar, Sunil; Hwang, Hun-Way; Creamer, Tyler J.; Chivukula, Raghu R.; Sheikh, Farooq; Clark, K. Reed; Torbenson, Michael; Montgomery, Robert A.; Cameron, Andrew M.; Mendell, Joshua T.; Warren, Daniel S.			Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS; COLLAGEN EXPRESSION; PULMONARY-FIBROSIS; RENAL FIBROSIS; HUMAN-DISEASE; MICRORNAS; CELLS; CANCER; TRANSDUCTION; REGULATOR	Fibrosis refers to the accumulation of excess extracellular matrix (ECM) components and represents a key feature of many chronic inflammatory diseases. Unfortunately, no currently available treatments specifically target this important pathogenic mechanism. MicroRNAs (miRNAs) are short, non-coding RNAs that post-transcriptionally repress target gene expression and the development of miRNA-based therapeutics is being actively pursued for a diverse array of diseases. Because a single miRNA can target multiple genes, often within the same pathway, variations in the level of individual miRNAs can potently influence disease phenotypes. Members of the miR-29 family, which include miR-29a, miR-29b and miR-29c, are strong inhibitors of ECM synthesis and fibrosis-associated decreases in miR-29 have been reported in multiple organs. We observed downregulation of miR-29a/b/c in fibrotic livers of carbon tetrachloride (CCl4) treated mice as well as in isolated human hepatocytes exposed to the pro-fibrotic cytokine TGF-beta. Importantly, we demonstrate that a single systemic injection of a miR-29a expressing adeno-associated virus (AAV) can prevent and even reverse histologic and biochemical evidence of fibrosis despite continued exposure to CCl4. The observed therapeutic benefits were associated with AAV transduction of hepatocytes but not hepatic stellate cells, which are the main ECM producing cells in fibroproliferative liver diseases. Our data therefore demonstrate that delivery of miR-29 to the hepatic parenchyma using a clinically relevant gene delivery platform protects injured livers against fibrosis and, given the consistent fibrosis-associated downregulation of miR-29, suggests AAV-miR-29 based therapies may be effective in treating a variety of fibroproliferative disorders.	[Knabel, Matthew K.; Ramachandran, Kalyani; Creamer, Tyler J.; Montgomery, Robert A.; Cameron, Andrew M.; Warren, Daniel S.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Knabel, Matthew K.; Ramachandran, Kalyani; Creamer, Tyler J.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Karhadkar, Sunil] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19122 USA; [Hwang, Hun-Way] Rockefeller Univ, Lab Mol Neurooncol, New York, NY 10021 USA; [Chivukula, Raghu R.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sheikh, Farooq] Washington Hosp Ctr, Dept Cardiol, Washington, DC 20010 USA; [Clark, K. Reed] Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH USA; [Torbenson, Michael] Mayo Clin, Dept Pathol, Rochester, MN USA; [Mendell, Joshua T.] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX USA; [Mendell, Joshua T.] UT Southwestern Med Ctr, Ctr Regenerat Sci & Med, Dallas, TX USA; [Mendell, Joshua T.] UT Southwestern Med Ctr, Simmons Canc Ctr, Dallas, TX USA	Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Rockefeller University; Harvard University; Massachusetts General Hospital; MedStar Washington Hospital Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Warren, DS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.	warren@jhmi.edu	Karhadkar, Sunil/Y-9235-2019	Karhadkar, Sunil/0000-0001-7943-0203; Hwang, Hun-Way/0000-0003-0522-1577; Creamer, Tyler/0000-0003-1872-5248	NIH [R01CA120185, P01CA134292]; Cancer Prevention and Research Institute of Texas; Charles T. Bauer Foundation; NATIONAL CANCER INSTITUTE [P01CA134292, R01CA120185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Charles T. Bauer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01CA120185 and P01CA134292 (J. Mendell), the Cancer Prevention and Research Institute of Texas (J. Mendell) and by a grant from the Charles T. Bauer Foundation (D. Warren). K. Reed Clark's participation occurred during his prior affiliation with the Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital in Columbus, Ohio. Therefore, Dimension Therapeutics did not provide any financial support in the form of authors' salaries and/or research materials and played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bowen T, 2013, J PATHOL, V229, P274, DOI 10.1002/path.4119; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; Hu G, 2012, CELL DEATH DIS, V3, P381, DOI DOI 10.1038/CDDIS.2012.114; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kriegel AJ, MIR 29 FAMILY GENOMI; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Luna C, 2011, INVEST OPHTH VIS SCI, V52, P3567, DOI 10.1167/iovs.10-6448; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Roderburg C, 2010, HEPATOLOGY, V53, P209; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Song SH, 2004, P NATL ACAD SCI USA, V101, P2112, DOI 10.1073/pnas.0307833100; Thorsen SB, 2012, CANCER J, V18, P275, DOI 10.1097/PPO.0b013e318258b5d6; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vettori Serena, 2012, Open Rheumatol J, V6, P130, DOI 10.2174/1874312901206010130; Villarreal G, 2011, INVEST OPHTH VIS SCI, V52, P3391, DOI 10.1167/iovs.10-6165; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xiao J, 2012, MOL THER, V20, P1251, DOI 10.1038/mt.2012.36; Zhang YQ, 2012, J BIOL CHEM, V287, P14851, DOI 10.1074/jbc.M111.314922	38	34	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124411	10.1371/journal.pone.0124411	http://dx.doi.org/10.1371/journal.pone.0124411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923107	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600083
J	Stepanek, J; Kopecky, V; Turpin, PY; Li, ZL; Alpert, B; Zentz, C				Stepanek, Josef; Kopecky, Vladimir, Jr.; Turpin, Pierre-Yves; Li, Zhenlin; Alpert, Bernard; Zentz, Christian			DNA Electric Charge Oscillations Govern Protein-DNA Recognition	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; HUMAN C-FOS; TRANSCRIPTION FACTOR; RAMAN-SPECTROSCOPY; TEMPERATURE-DEPENDENCE; MELTING TRANSITIONS; BINDING; ELEMENT; IDENTIFICATION; SPECIFICITY	The transcriptional activity of the serum response factor (SRF) protein is triggered by its binding to a 10-base-pair DNA consensus sequence designated the CArG box, which is the core sequence of the serum response element (SRE). Sequence-specific recognition of the CArG box by a core domain of 100 amino acid residues of SRF (core-SRF) was asserted to depend almost exclusively on the intrinsic SRE conformation and on the degree of protein-induced SRE bending. Nevertheless, this paradigm was invalidated by a temperature-dependent Raman spectroscopy study of 20-mer oligonucleotides involved in bonding interactions with core-SRF that reproduced both wild type and mutated c-fos SREs. Indeed, the SRE moieties that are complexed with core-SRF exhibit permanent interconversion dynamics between bent and linear conformers. Thus, sequence-specific recognition of the CArG box by core-SRF cannot be explained only in terms of the three-dimensional structure of the SRE. A particular dynamic pairing process discriminates between the wild type and mutated complexes. Specific oscillations of the phosphate charge network of the SRE govern the recognition between both partners rather than an intrinsic set of conformations of the SRE.	[Stepanek, Josef; Turpin, Pierre-Yves] Univ Paris 06, CNRS, Lab Jean Perrin, FRE 3231, Paris, France; [Stepanek, Josef; Alpert, Bernard; Zentz, Christian] Univ Paris 06, ER12, Paris, France; [Stepanek, Josef; Kopecky, Vladimir, Jr.] Charles Univ Prague, Fac Math & Phys, Inst Phys, Prague, Czech Republic; [Li, Zhenlin] Univ Paris 06, UR4, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Charles University Prague; UDICE-French Research Universities; Sorbonne Universite	Kopecky, V (corresponding author), Charles Univ Prague, Fac Math & Phys, Inst Phys, Prague, Czech Republic.	kopecky@karlov.mff.cuni.cz	Kopecký, Vladimír/A-6965-2008; Stepanek, Josef/B-2309-2009; Li, Zhenlin/E-3937-2016	Kopecký, Vladimír/0000-0002-7331-9018; Stepanek, Josef/0000-0001-7307-2257; LI, Zhenlin/0000-0002-3706-4505	Czech Science Foundation [15-06785S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Czech Science Foundation (http://www.gacr.cz/; No. 15-06785S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benevides JM, 2005, J RAMAN SPECTROSC, V36, P279, DOI 10.1002/jrs.1324; Chen CY, 1997, MOL ENDOCRINOL, V11, P812, DOI 10.1210/me.11.6.812; Deng H, 2000, NUCLEIC ACIDS RES, V28, P3379, DOI 10.1093/nar/28.17.3379; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GUSTAFSON TA, 1989, P NATL ACAD SCI USA, V86, P2162, DOI 10.1073/pnas.86.7.2162; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Huet A, 2005, FEBS J, V272, P3105, DOI 10.1111/j.1742-4658.2005.04724.x; LEUNG S, 1989, NUCLEIC ACIDS RES, V17, P1177, DOI 10.1093/nar/17.3.1177; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Mericskay M, 2000, DEV BIOL, V226, P192, DOI 10.1006/dbio.2000.9865; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Mo Y, 2001, J MOL BIOL, V314, P495, DOI 10.1006/jmbi.2001.5138; Movileanu L, 2002, BIOPOLYMERS, V63, P181, DOI 10.1002/bip.10022; Movileanu L, 1999, J RAMAN SPECTROSC, V30, P637, DOI 10.1002/(SICI)1097-4555(199908)30:8<637::AID-JRS431>3.0.CO;2-B; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; NURRISH SJ, 1995, MOL CELL BIOL, V15, P4076; Overman SA, 1999, BIOCHEMISTRY-US, V38, P4018, DOI 10.1021/bi982901e; OVERMAN SA, 1995, BIOCHEMISTRY-US, V34, P5440, DOI 10.1021/bi00016a015; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; SHARROCKS AD, 1993, NUCLEIC ACIDS RES, V21, P215, DOI 10.1093/nar/21.2.215; Shepard W, 2011, FEBS J, V278, P2689, DOI 10.1111/j.1742-4658.2011.08195.x; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Stepanek J, 2007, FEBS J, V274, P2333, DOI 10.1111/j.1742-4658.2007.05768.x; Stepanek J, 2010, BIOCHEM BIOPH RES CO, V391, P203, DOI 10.1016/j.bbrc.2009.11.032; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Tuma R, 2005, J RAMAN SPECTROSC, V36, P307, DOI 10.1002/jrs.1323; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; West AG, 1997, MOL CELL BIOL, V17, P2876, DOI 10.1128/MCB.17.5.2876; Yu LP, 1996, BIOCHEMISTRY-US, V35, P9661, DOI 10.1021/bi960507f	34	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124444	10.1371/journal.pone.0124444	http://dx.doi.org/10.1371/journal.pone.0124444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923532	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600087
J	Lopez, DS; Wang, R; Tsilidis, KK; Zhu, HR; Daniel, CR; Sinha, A; Canfield, S				Lopez, David S.; Wang, Run; Tsilidis, Konstantinos K.; Zhu, Huirong; Daniel, Carrie R.; Sinha, Arup; Canfield, Steven			Role of Caffeine Intake on Erectile Dysfunction in US Men: Results from NHANES 2001-2004	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; RISK-FACTORS; PREVALENCE; OBESITY; ADULTS	Objectives Caffeine is consumed by more than 85% of adults and little is known about its role on erectile dysfunction (ED) in population-based studies. We investigated the association of caffeine intake and caffeinated beverages with ED, and whether these associations vary among comorbidities for ED. Material and Method Data were analyzed for 3724 men (>= 20 years old) who participated in the National Health and Nutrition Examination Survey (NHANES). ED was assessed by a single question during a self-paced, computer-assisted self-interview. We analyzed 24-h dietary recall data to estimate caffeine intake (mg/day). Multivariable logistic regression analyses using appropriate sampling weights were conducted. Results We found that men in the 3rd (85-170 mg/day) and 4th (171-303 mg/day) quintiles of caffeine intake were less likely to report ED compared to men in the lowest 1st quintile (0-7 mg/day) [OR: 0.58; 95% CI, 0.37-0.89; and OR: 0.61; 95% CI, 0.38-0.97, respectively], but no evidence for a trend. Similarly, among overweight/obese and hypertensive men, there was an inverse association between higher quintiles of caffeine intake and ED compared to men in the lowest 1st quintile, P <= 0.05 for each quintile. However, only among men without diabetes we found a similar inverse association (P-trend = 0.01). Conclusion Caffeine intake reduced the odds of prevalent ED, especially an intake equivalent to approximately 2-3 daily cups of coffee (170-375 mg/day). This reduction was also observed among overweight/obese and hypertensive, but not among diabetic men. Yet, these associations are warranted to be investigated in prospective studies.	[Lopez, David S.; Zhu, Huirong] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77004 USA; [Lopez, David S.; Wang, Run; Canfield, Steven] Univ Texas Houston, Sch Med, Div Urol, Houston, TX USA; [Tsilidis, Konstantinos K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Daniel, Carrie R.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Sinha, Arup] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Ioannina; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Lopez, DS (corresponding author), Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77004 USA.	David.S.Lopez@uth.tmc.edu		Lopez, David S./0000-0002-2321-0372; Tsilidis, Konstantinos/0000-0002-8452-8472	Division of Urology - The University of Texas- Medical School at Houston	Division of Urology - The University of Texas- Medical School at Houston	Funding: Dr. David S. Lopez was supported by the Division of Urology - The University of Texas- Medical School at Houston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi A, 2004, CLIN EXP PHARMACOL P, V31, P82, DOI 10.1111/j.1440-1681.2004.03955.x; Ahuja JKA, 2012, USDA FOOD NUTR DATAB; Akkus E, 2002, EUR UROL, V41, P298, DOI 10.1016/S0302-2838(02)00027-1; [Anonymous], 1994, Vital Health Stat 1, P1; Bernert JT, 1997, CLIN CHEM, V43, P2281; Berrada S, 2003, INT J IMPOT RES, V15, pS3, DOI 10.1038/sj.ijir.3900968; Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883; DIOKNO AC, 1990, ARCH INTERN MED, V150, P197, DOI 10.1001/archinte.150.1.197; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; Francis ME, 2007, J UROLOGY, V178, P591, DOI 10.1016/j.juro.2007.03.127; Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027; Guay Andre T, 2003, Endocr Pract, V9, P77; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Janiszewski PM, 2009, J SEX MED, V6, P1990, DOI 10.1111/j.1743-6109.2009.01302.x; Laumann EO, 2008, J SEX MED, V5, P2300, DOI 10.1111/j.1743-6109.2008.00974.x; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Martin SA, 2014, J SEX MED, V11, P1136, DOI 10.1111/jsm.12483; Moore CR, 2006, ASIAN J ANDROL, V8, P675, DOI 10.1111/j.1745-7262.2006.00223.x; National Center for Health Statistics. National Health and Nutrition Examination Survey, 2001 2004 DAT DOC CO; O'Donnell AB, 2005, J GEN INTERN MED, V20, P515, DOI 10.1111/j.1525-1497.2005.0076.x; O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035; Leon-Carmona JR, 2011, J PHYS CHEM B, V115, P4538, DOI 10.1021/jp201383y; Selvin E, 2007, AM J MED, V120, P151, DOI 10.1016/j.amjmed.2006.06.010; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Shiri R, 2004, INT J IMPOT RES, V16, P389, DOI 10.1038/sj.ijir.3901196; Walsh TJ, 2014, INT J IMPOT RES, V26, P112, DOI 10.1038/ijir.2013.46; Wessells H, 2007, J UROLOGY, V177, P1675, DOI 10.1016/j.juro.2007.01.057; Yang R, 2008, J ANDROL, V29, P586, DOI 10.2164/jandrol.107.004721; Zhang Q, 2009, ETHNIC HEALTH, V14, P439, DOI 10.1080/13557850802699155	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123547	10.1371/journal.pone.0123547	http://dx.doi.org/10.1371/journal.pone.0123547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919661	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400029
J	Hayashida, A; Amano, S; Gallo, RL; Linhardt, RJ; Liu, J; Park, PW				Hayashida, Atsuko; Amano, Shiro; Gallo, Richard L.; Linhardt, Robert J.; Liu, Jian; Park, Pyong Woo			2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); heparan sulfate; host defense; neutrophil; proteoglycan; syndecan; cathelicidin; keratitis	ANTIMICROBIAL PEPTIDE; BACTERIAL KERATITIS; ALPHA-TOXIN; BETA-TOXIN; PROTECTS; MICE; SUSCEPTIBILITY; CHAINS; 2-O-SULFOTRANSFERASE; PROTEOGLYCANS	Background: Syndecan-1 promotes bacterial infections, but how this is accomplished remains unclear. Results: Syndecan-1 and 2-O-sulfated heparan compounds specifically enhanced S. aureus corneal virulence and inhibited bacterial killing by CRAMP secreted from degranulated neutrophils. Conclusion: Specific structural motifs in syndecan-1 HS promote S. aureus corneal infection by inhibiting neutrophil CRAMP. Significance: This study uncovers a new pathogenic role for syndecan-1 in bacterial infection. Ablation of syndecan-1 in mice is a gain of function mutation that enables mice to significantly resist infection by several bacterial pathogens. Syndecan-1 shedding is induced by bacterial virulence factors, and inhibition of shedding attenuates bacterial virulence, whereas administration of purified syndecan-1 ectodomain enhances virulence, suggesting that bacteria subvert syndecan-1 ectodomains released by shedding for their pathogenesis. However, the pro-pathogenic functions of syndecan-1 ectodomain have yet to be clearly defined. Here, we examined how syndecan-1 ectodomain enhances Staphylococcus aureus virulence in injured mouse corneas. We found that syndecan-1 ectodomain promotes S. aureus corneal infection in an HS-dependent manner. Surprisingly, we found that this pro-pathogenic activity is dependent on 2-O-sulfated domains in HS, indicating that the effects of syndecan-1 ectodomain are structure-based. Our results also showed that purified syndecan-1 ectodomain and heparan compounds containing 2-O-sulfate motifs inhibit S. aureus killing by antimicrobial factors secreted by degranulated neutrophils, but does not affect intracellular phagocytic killing by neutrophils. Immunodepletion of antimicrobial factors with staphylocidal activities demonstrated that CRAMP, a cationic antimicrobial peptide, is primarily responsible for S. aureus killing among other factors secreted by degranulated neutrophils. Furthermore, we found that purified syndecan-1 ectodomain and heparan compounds containing 2-O-sulfate units potently and specifically inhibit S. aureus killing by synthetic CRAMP. These results provide compelling evidence that a specific subclass of sulfate groups, and not the overall charge of HS, permits syndecan-1 ectodomains to promote S. aureus corneal infection by inhibiting a key arm of neutrophil host defense.	[Hayashida, Atsuko; Amano, Shiro; Park, Pyong Woo] Harvard Univ, Sch Med, Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA; [Park, Pyong Woo] Harvard Univ, Sch Med, Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Liu, Jian] Univ N Carolina, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego; Rensselaer Polytechnic Institute; University of North Carolina; University of North Carolina Chapel Hill	Park, PW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, 320 Longwood Ave,Enders 461, Boston, MA 02115 USA.	pyong.park@childrens.harvard.edu	Gallo, Richard L/A-8931-2009; Regan, Clinton/E-6250-2012	Gallo, Richard L/0000-0002-1401-7861; Park, Pyong Woo/0000-0002-7979-4979	National Institutes of Health [R01 EY021765, R01 HL107472]; NATIONAL EYE INSTITUTE [R01EY021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107472, R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052453, R01AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 EY021765 and R01 HL107472.	Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Bartlett AH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001367; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Cadwalader EL, 2012, DEVELOPMENT, V139, P1296, DOI 10.1242/dev.078238; CASU B, 1990, HAEMOSTASIS, V20, P62; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Chen Y, 2007, J BIOL CHEM, V282, P159, DOI 10.1074/jbc.M608542200; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fechtner T, 2013, J BACTERIOL, V195, P5323, DOI 10.1128/JB.00780-13; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garner OB, 2011, DEV BIOL, V355, P394, DOI 10.1016/j.ydbio.2011.04.035; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Girgis DO, 2004, CURR EYE RES, V29, P269, DOI 10.1080/02713680490516783; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Gronert K, 2010, EXP EYE RES, V91, P478, DOI 10.1016/j.exer.2010.07.004; Hayashida A, 2011, J BIOL CHEM, V286, P3288, DOI 10.1074/jbc.M110.185165; Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394; Hayashida K, 2008, J BIOL CHEM, V283, P19895, DOI 10.1074/jbc.M801614200; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Hume EBH, 2000, INFECT IMMUN, V68, P6052, DOI 10.1128/IAI.68.10.6052-6055.2000; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Kobayashi F, 2012, GLYCOCONJUGATE J, V29, P211, DOI 10.1007/s10719-012-9388-z; Kobayashi T, 2007, J BIOL CHEM, V282, P19589, DOI 10.1074/jbc.M610707200; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; KOVENSKY J, 1993, CARBOHYD RES, V245, P361, DOI 10.1016/0008-6215(93)80085-S; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kumar A, 2010, MICROBES INFECT, V12, P978, DOI 10.1016/j.micinf.2010.06.007; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; LIMBERG M B, 1991, American Journal of Ophthalmology, V112, p2S; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Ly CN, 2006, CLIN EXP OPHTHALMOL, V34, P44, DOI 10.1111/j.1442-9071.2006.01143.x; Merres J, 2014, J INNATE IMMUN, V6, P205, DOI 10.1159/000353645; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; PARK PW, 1991, J BIOL CHEM, V266, P23399; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Schaefer F, 2001, BRIT J OPHTHALMOL, V85, P842, DOI 10.1136/bjo.85.7.842; SENGELOV H, 1995, J IMMUNOL, V154, P4157; SHERERTZ RJ, 1993, J INFECT DIS, V167, P98, DOI 10.1093/infdis/167.1.98; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Surewaard BGJ, 2013, CELL MICROBIOL, V15, P1427, DOI 10.1111/cmi.12130; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Wang GS, 2012, ANTIMICROB AGENTS CH, V56, P845, DOI 10.1128/AAC.05637-11; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Wilhelmus KR, 2002, OPHTHALMOLOGY, V109, P835, DOI 10.1016/S0161-6420(02)00963-6; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	68	17	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16157	16167		10.1074/jbc.M115.660852	http://dx.doi.org/10.1074/jbc.M115.660852			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25931123	Green Published, hybrid			2022-12-26	WOS:000356930100020
J	Balla, P; Maros, ME; Barna, G; Antal, I; Papp, G; Sapi, Z; Athanasou, NA; Benassi, MS; Picci, P; Krenacs, T				Balla, Peter; Maros, Mate Elod; Barna, Gabor; Antal, Imre; Papp, Gergo; Sapi, Zoltan; Athanasou, Nicholas Anthony; Benassi, Maria Serena; Picci, Pierro; Krenacs, Tibor			Prognostic Impact of Reduced Connexin43 Expression and Gap Junction Coupling of Neoplastic Stromal Cells in Giant Cell Tumor of Bone	PLOS ONE			English	Article							CORNEAL FIBROBLASTS; GENE-EXPRESSION; GROWTH-FACTOR; IN-VIVO; COMMUNICATION; MYOFIBROBLASTS; CX43; DIFFERENTIATION; MARROW; TISSUE	Missense mutations of the GJA1 gene encoding the gap junction channel protein connexin43 (Cx43) cause bone malformations resulting in oculodentodigital dysplasia (ODDD), while GJA1 null and ODDD mutant mice develop osteopenia. In this study we investigated Cx43 expression and channel functions in giant cell tumor of bone (GCTB), a locally aggressive osteolytic lesion with uncertain progression. Cx43 protein levels assessed by immunohistochemistry were correlated with GCTB cell types, clinico-radiological stages and progression free survival in tissue microarrays of 89 primary and 34 recurrent GCTB cases. Cx43 expression, phosphorylation, subcellular distribution and gap junction coupling was also investigated and compared between cultured neoplastic GCTB stromal cells and bone marow stromal cells or HDFa fibroblasts as a control. In GCTB tissues, most Cx43 was produced by CD163 negative neoplastic stromal cells and less by CD163 positive reactive monocytes/macrophages or by giant cells. Significantly less Cx43 was detected in alpha-smooth muscle actin positive than a-smooth muscle actin negative stromal cells and in osteoclast-rich tumor nests than in the adjacent reactive stroma. Progressively reduced Cx43 production in GCTB was significantly linked to advanced clinico-radiological stages and worse progression free survival. In neoplastic GCTB stromal cell cultures most Cx43 protein was localized in the paranuclear-Golgi region, while it was concentrated in the cell membranes both in bone marrow stromal cells and HDFa fibroblasts. In Western blots, alkaline phosphatase sensitive bands, linked to serine residues (Ser369, Ser372 or Ser373) detected in control cells, were missing in GCTB stromal cells. Defective cell membrane localization of Cx43 channels was in line with the significantly reduced transfer of the 622 Da fluorescing calcein dye between GCTB stromal cells. Our results show that significant downregulation of Cx43 expression and gap junction coupling in neoplastic stromal cells are associated with the clinical progression and worse prognosis in GCTB.	[Balla, Peter; Maros, Mate Elod; Barna, Gabor; Papp, Gergo; Sapi, Zoltan; Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Antal, Imre] Semmelweis Univ, Dept Orthopaed, H-1085 Budapest, Hungary; [Athanasou, Nicholas Anthony] Univ Oxford, Nuffield Orthopaed Ctr, Dept Pathol, Oxford, England; [Benassi, Maria Serena; Picci, Pierro] Inst Orthopaed Rizzoli, Expt Oncol Lab, Bologna, Italy; [Maros, Mate Elod] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neuroradiol, Mannheim, Germany; [Krenacs, Tibor] Semmelweis Univ, Hunragian Acad Sci, MTA SE Tumor Progress Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Nuffield Orthopaedic Centre; University of Oxford; Ruprecht Karls University Heidelberg; Semmelweis University	Krenacs, T (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary.	krenacst@gmail.com	Maros, Máté E./ABB-3203-2021; Picci, Piero/J-5979-2016	Maros, Máté E./0000-0002-1589-8699; Picci, Piero/0000-0002-8519-4101	EuroBoNet an EU - Network of Excellence Programme [LSHC-CT-2006-018814]	EuroBoNet an EU - Network of Excellence Programme	This work was supported by EuroBoNet an EU FP6 funded Network of Excellence Programme (LSHC-CT-2006-018814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghini M, 2010, VIRCHOWS ARCH, V456, P97, DOI 10.1007/s00428-009-0863-2; Amanatullah DF, 2014, ORTHOPEDICS, V37, P112, DOI 10.3928/01477447-20140124-08; Antal I, 1999, INT ORTHOP, V23, P315, DOI 10.1007/s002640050381; Asazuma-Nakamura Y, 2009, EXP CELL RES, V315, P1190, DOI 10.1016/j.yexcr.2008.12.021; Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Axelsen LN, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00130; Balke M, 2008, J CANCER RES CLIN, V134, P969, DOI 10.1007/s00432-008-0370-x; Baum JR, 2012, AM J PHYSIOL-HEART C, V302, pH790, DOI 10.1152/ajpheart.00498.2011; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008; Buo AM, 2014, FEBS LETT, V588, P1315, DOI 10.1016/j.febslet.2014.01.025; Burghardt RC, 1995, J MEMBRANE BIOL, V148, P243; CAMPANACCI M, 1987, J BONE JOINT SURG AM, V69A, P106, DOI 10.2106/00004623-198769010-00018; Chanson M, 2005, BBA-BIOMEMBRANES, V1711, P197, DOI 10.1016/j.bbamem.2004.10.005; Churko JM, 2011, HUM MUTAT, V32, P456, DOI 10.1002/humu.21472; Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005; Dickson BC, 2008, MODERN PATHOL, V21, P369, DOI 10.1038/modpathol.2008.29; Dunn CA, 2012, J BIOL CHEM, V287, P2600, DOI 10.1074/jbc.M111.276261; ENNEKING WF, 1986, CLIN ORTHOP RELAT R, P9; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Forsyth R, 2008, J PATHOL, V214, P555, DOI 10.1002/path.2301; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; Gorunova L, 2009, GENE CHROMOSOME CANC, V48, P583, DOI 10.1002/gcc.20667; Hemingway F, 2012, VIRCHOWS ARCH, V460, P525, DOI 10.1007/s00428-012-1235-x; Horvai AE, 2008, MODERN PATHOL, V21, P423, DOI 10.1038/modpathol.3801015; Horvai AE, 2012, MODERN PATHOL, V25, P1452, DOI 10.1038/modpathol.2012.110; Knowles HJ, 2008, J PATHOL, V215, P56, DOI 10.1002/path.2319; Knowles HJ, 2009, HISTOL HISTOPATHOL, V24, P337, DOI 10.14670/HH-24.337; Krenacs T, 1998, AM J PATHOL, V152, P993; Kumta SM, 2003, LIFE SCI, V73, P1427, DOI 10.1016/S0024-3205(03)00434-X; Lau YS, 2005, HUM PATHOL, V36, P945, DOI 10.1016/j.humpath.2005.07.005; Lee CH, 2008, MODERN PATHOL, V21, P531, DOI 10.1038/modpathol.3801023; Lee MJ, 1998, CLIN RADIOL, V53, P481, DOI 10.1016/S0009-9260(98)80166-9; Lehner B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-495; Li ZY, 2006, AM J PHYSIOL-CELL PH, V290, pC1248, DOI 10.1152/ajpcell.00428.2005; Lloyd SAJ, 2010, CLIN REV BONE MINER, V8, P189, DOI 10.1007/s12018-011-9084-8; Loiselle AE, 2013, BONE, V54, P205, DOI 10.1016/j.bone.2012.08.132; Moskovszky L, 2009, GENE CHROMOSOME CANC, V48, P468, DOI 10.1002/gcc.20656; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Oviedo-Orta E, 2000, IMMUNOLOGY, V99, P578, DOI 10.1046/j.1365-2567.2000.00991.x; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Balla P, 2011, HISTOPATHOLOGY, V59, P376, DOI 10.1111/j.1365-2559.2011.03948.x; Petridou S, 1996, INVEST OPHTH VIS SCI, V37, P1740; Plotkin LI, 2013, BONE, V52, P157, DOI 10.1016/j.bone.2012.09.030; ROCK MG, 1986, J BONE JOINT SURG AM, V68A, P1073, DOI 10.2106/00004623-198668070-00016; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Saez JC, 2014, FEBS LETT, V588, P1205, DOI 10.1016/j.febslet.2014.03.004; Schajnovitz A, 2011, NAT IMMUNOL, V12, P391, DOI 10.1038/ni.2017; Schilling AF, 2008, J CELL MOL MED, V12, P2497, DOI 10.1111/j.1582-4934.2008.00275.x; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Spanakis SG, 1998, INVEST OPHTH VIS SCI, V39, P1320; Steensma MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069101; SUNG HW, 1982, J BONE JOINT SURG AM, V64, P755, DOI 10.2106/00004623-198264050-00015; Szendroi M, 2004, J BONE JOINT SURG BR, V86B, P5, DOI 10.1302/0301-620X.86B1.14053; van der Heijden L, 2014, ONCOLOGIST, V19, P550, DOI 10.1634/theoncologist.2013-0432; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; Werner M, 2006, INT ORTHOP, V30, P484, DOI 10.1007/s00264-006-0215-7; Yogo K, 2002, FEBS LETT, V531, P132, DOI 10.1016/S0014-5793(02)03441-5; Zheng MH, 2000, HUM PATHOL, V31, P804, DOI 10.1053/hupa.2000.8441; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001	62	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125316	10.1371/journal.pone.0125316	http://dx.doi.org/10.1371/journal.pone.0125316			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933380	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353887100097
J	Leodolter, J; Warweg, J; Weber-Ban, E				Leodolter, Julia; Warweg, Jannis; Weber-Ban, Eilika			The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1	PLOS ONE			English	Article							COMPLEX-FORMATION; AAA+ PROTEINS; AXIAL CHANNEL; PEPTIDASE; ANTIBIOTICS; MODEL; DETERMINANTS; DEGRADATION; MUTAGENESIS; ACTIVATION	Clp chaperone-proteases are cylindrical complexes built from ATP-dependent chaper-one rings that stack onto a proteolytic ClpP double-ring core to carry out substrate pro tein degradation. Interaction of the ClpP particle with the chaperone is mediated by an N-terminal loop and a hydrophobic surface patch on the ClpP ring surface. In contrast to E. coli, Mycobacterium tuberculosis harbors not only one but two ClpP protease subunits, ClpP1 and ClpP2, and a homo-heptameric ring of each assembles to form the ClpP1P2 double-ring core. Consequently, this hetero double-ring presents two different potential binding surfaces for the interaction with the chaperones ClpX and ClpC1. To investigate whether ClpX or ClpC1 might preferentially interact with one or the other double-ring face, we mutated the hydrophobic chaperone-interaction patch on either ClpP1 or ClpP2, generating ClpP1P2 particles that are defective in one of the two binding patches and thereby in their ability to interact with their chaperone partners. Using chaperone-mediated degradation of ssrA-tagged model substrates, we show that both Mycobacterium tuberculosis Clp chaperones require the intact interaction face of ClpP2 to support degradation, resulting in an asymmetric complex where chaperones only bind to the ClpP2 side of the proteolytic core. This sets the Clp proteases of Mycobacterium tuberculosis, and probably other Actinobacteria, apart from the well-studied E. coli system, where chaperones bind to both sides of the protease core, and it frees the ClpP1 interaction interface for putative new binding partners.	[Leodolter, Julia; Warweg, Jannis; Weber-Ban, Eilika] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch		Weber-Ban, Eilika/0000-0002-5773-9274; Leodolter, Julia/0000-0003-3632-056X	Swiss National Science Foundation [31003A_141236]; ETH (Eidgenossische Technische Hochschule Zurich) Research Grant [ETH-1311-2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH (Eidgenossische Technische Hochschule Zurich) Research Grant	This work was supported by a Swiss National Science Foundation grant (31003A_141236) to EWB and an ETH (Eidgenossische Technische Hochschule Zurich) Research Grant (ETH-1311-2) to EWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Alexopoulos J, 2013, MOL MICROBIOL, V90, P167, DOI 10.1111/mmi.12356; Alexopoulos JA, 2012, J STRUCT BIOL, V179, P202, DOI 10.1016/j.jsb.2012.05.003; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Benaroudj N, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-61; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Compton CL, 2013, ACS CHEM BIOL, V8, P2669, DOI 10.1021/cb400577b; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Gur Eyal, 2013, Subcell Biochem, V66, P3, DOI 10.1007/978-94-007-5940-4_1; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kress W, 2009, J BIOL CHEM, V284, P31441, DOI 10.1074/jbc.M109.022319; Laederach J., 2014, MOL CHAPERONES INTER, P419; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Maglica Z, 2009, STRUCTURE, V17, P508, DOI 10.1016/j.str.2009.02.014; Matthews B., 2001, HYDROPHOBIC INTERACT; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Ollinger J, 2012, J BACTERIOL, V194, P663, DOI 10.1128/JB.06142-11; Personne Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060228; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schmitz KR, 2014, P NATL ACAD SCI USA, V111, pE4587, DOI 10.1073/pnas.1417120111; Schmitz KR, 2014, MOL MICROBIOL, V93, P617, DOI 10.1111/mmi.12694; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Viala J, 2002, MOL MICROBIOL, V44, P633, DOI 10.1046/j.1365-2958.2002.02907.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zeiler E, 2011, ANGEW CHEM INT EDIT, V50, P11001, DOI 10.1002/anie.201104391	50	33	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125345	10.1371/journal.pone.0125345	http://dx.doi.org/10.1371/journal.pone.0125345			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933022	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100101
J	Liu, SD; Jing, F; Yu, CX; Gao, L; Qin, YJ; Zhao, JJ				Liu, Shudong; Jing, Fei; Yu, Chunxiao; Gao, Ling; Qin, Yejun; Zhao, Jiajun			AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-2; DENSITY-LIPOPROTEIN UPTAKE; FATTY LIVER; SUBCLINICAL HYPOTHYROIDISM; ADIPOSE-TISSUE; CHOLESTEROL-METABOLISM; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; LIPID PROFILE; KINASE	Our previous study found that thyroid-stimulating hormone promoted sterol regulatory element- binding protein-2 (SREBP-2) expression and suppressed AMP-activated protein kinase (AMPK) activity in the liver, but it was unclear whether there was a direct link between TSH, AMPK and SREBP-2. Here, we demonstrate that the 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR)-induced activation of AMPK directly inhibited the expression of SREBP-2 and its target genes HMGCR and HMGCS, which are key enzymes in cholesterol biosynthesis, and suppressed the TSH-stimulated up-regulation of SREBP-2 in HepG2 cells; similar results were obtained in TSH receptor knockout mice. Furthermore, AMPK, an evolutionally conserved serine/threonine kinase, phosphorylated threonine residues in the precursor and nuclear forms of SREBP-2, and TSH interacted with AMPK to influence SREBP-2 phosphorylation. These findings may represent a molecular mechanism by which AMPK ameliorates the hepatic steatosis and hypercholesterolemia associated with high TSH levels in patients with subclinical hypothyroidism (SCH).	[Liu, Shudong; Jing, Fei; Yu, Chunxiao; Zhao, Jiajun] Shandong Univ, Prov Hosp, Dept Endocrinol, Jinan 250100, Peoples R China; [Gao, Ling] Shandong Univ, Prov Hosp, Cent Lab, Jinan 250100, Peoples R China; [Gao, Ling; Zhao, Jiajun] Shandong Acad Clin Med, Inst Endocrinol, Jinan, Peoples R China; [Qin, Yejun] Shandong Univ, Prov Hosp, Dept Pathol, Jinan 250100, Peoples R China; [Liu, Shudong] Shandong Rongjun Gen Hosp, Dept Endocrinol, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University	Gao, L (corresponding author), Shandong Univ, Prov Hosp, Cent Lab, Jinan 250100, Peoples R China.	gaoling1@medmail.com.cn; qinyejun@163.com; jjzhao@medmail.com.cn	Zhao, Jiajun/W-2963-2018; Liu, Shudong/L-1329-2018	Zhao, Jiajun/0000-0003-3267-9292; Liu, Shudong/0000-0002-8382-5328	National Basic Research Program [2012CB524900]; National Natural Science Foundation [81230018, 81430020, 81170794, 81270869, 81400828, 81471006]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program (2012CB524900), and the National Natural Science Foundation (81230018, 81430020, 81170794, 81270869, 81400828, 81471006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Andrade BM, 2011, AM J PHYSIOL-CELL PH, V300, pC1291, DOI 10.1152/ajpcell.00136.2010; Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Asvold BO, 2007, EUR J ENDOCRINOL, V156, P181, DOI 10.1530/eje.1.02333; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chung GE, 2012, J HEPATOL, V57, P150, DOI 10.1016/j.jhep.2012.02.027; Garduno-Garcia JD, 2010, EUR J ENDOCRINOL, V163, P273, DOI 10.1530/EJE-10-0312; Erem C, 2006, CLIN ENDOCRINOL, V64, P323, DOI 10.1111/j.1365-2265.2006.02464.x; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Karthick N, 2013, J CLIN DIAGN RES, V7, P2122, DOI 10.7860/JCDR/2013/5777.3448; Kim SJ, 2011, NEOPLASIA, V13, P167, DOI 10.1593/neo.10806; Knowles C, 2011, BIOCHEM BIOPH RES CO, V412, P249, DOI 10.1016/j.bbrc.2011.07.078; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Lee S, 2012, INT J MOL SCI, V13, P5729, DOI 10.3390/ijms13055729; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luboshitzky R, 2002, THYROID, V12, P421, DOI 10.1089/105072502760043512; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Peppa M, 2011, J LIPIDS, V2011, DOI 10.1155/2011/575840; Rice LM, 2014, J BIOL CHEM, V289, P17268, DOI 10.1074/jbc.M114.570390; Santos-Palacios S, 2013, CLIN ENDOCRINOL, V79, P874, DOI 10.1111/cen.12216; Sert A, 2013, PEDIATR CARDIOL, V34, P1166, DOI 10.1007/s00246-013-0638-z; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tian LM, 2010, HEPATOLOGY, V52, P1401, DOI 10.1002/hep.23800; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang TT, 2013, ENDOCR J, V60, P941; Xu L, 2012, J HEPATOL, V57, P1153, DOI 10.1016/j.jhep.2012.05.025; Yang J, 2008, BIOCHEM BIOPH RES CO, V370, P248, DOI 10.1016/j.bbrc.2008.03.094; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	36	37	41	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124951	10.1371/journal.pone.0124951	http://dx.doi.org/10.1371/journal.pone.0124951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933205	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100068
J	Xie, MQ; Xu, YJ; Zhang, YG; Hwang, TH; Kuang, R				Xie, MaoQiang; Xu, YingJie; Zhang, YaoGong; Hwang, TaeHyun; Kuang, Rui			Network-based Phenome-Genome Association Prediction by Bi-Random Walk	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; INFLAMMATORY-BOWEL-DISEASE; GLOBAL ALIGNMENT; GENES; INTERACTOME; PRIORITIZATION; BIOINFORMATICS; DATABASE; CANCER; IL-6	Motivation The availability of ontologies and systematic documentations of phenotypes and their genetic associations has enabled large-scale network-based global analyses of the association between the complete collection of phenotypes (phenome) and genes. To provide a fundamental understanding of how the network information is relevant to phenotype-gene associations, we analyze the circular bigraphs (CBGs) in OMIM human disease phenotype-gene association network and MGI mouse phentoype-gene association network, and introduce a bi-random walk (BiRW) algorithm to capture the CBG patterns in the networks for unveiling human and mouse phenome-genome association. BiRW performs separate random walk simultaneously on gene interaction network and phenotype similarity network to explore gene paths and phenotype paths in CBGs of different sizes to summarize their associations as predictions. Results The analysis of both OMIM and MGI associations revealed that majority of the phenotypegene associations are covered by CBG patterns of small path lengths, and there is a clear correlation between the CBG coverage and the predictability of the phenotype-gene associations. In the experiments on recovering known associations in cross-validations on human disease phenotypes and mouse phenotypes, BiRW effectively improved prediction performance over the compared methods. The constructed global human disease phenome-genome association map also revealed interesting new predictions and phenotype-gene modules by disease classes.	[Xie, MaoQiang; Xu, YingJie; Zhang, YaoGong] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China; [Hwang, TaeHyun] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Kuang, Rui] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA	Nankai University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Minnesota System; University of Minnesota Twin Cities	Kuang, R (corresponding author), Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	kuang@cs.umn.edu			National Science Foundation [III 1117153, III 1149697]; Direct For Computer & Info Scie & Enginr [1117153] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work is supported by grant III 1117153 and III 1149697 from National Science Foundation (www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baranzini SE, 2009, CURR OPIN IMMUNOL, V21, P596, DOI 10.1016/j.coi.2009.09.014; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Bult C, 2010, NUCLEIC ACIDS RES; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen Y, 2011, BIOINFORMATICS, V27, pI167, DOI 10.1093/bioinformatics/btr213; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dinan TG, 2008, AM J GASTROENTEROL, V103, P2570, DOI 10.1111/j.1572-0241.2008.01871.x; Edwards D, 2004, TRENDS BIOTECHNOL, V22, P232, DOI 10.1016/j.tibtech.2004.03.002; Espinosa O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019693; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldin RD, 2009, HISTOPATHOLOGY, V55, P218, DOI 10.1111/j.1365-2559.2008.03192.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang T., 2010, P SIAM INT C DAT MIN, P583; Hwang TH, 2011, BIOINFORMATICS, V27, P2692, DOI 10.1093/bioinformatics/btr463; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krishnan K, 2011, INFLAMM BOWEL DIS, V17, P410, DOI 10.1002/ibd.21316; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Laurent C, 2011, INFLAMM BOWEL DIS, V17, P232, DOI 10.1002/ibd.21451; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Maoqiang Xie, 2012, Advances in Knowledge Discovery and Data Mining. Proceedings 16th Pacific-Asia Conference (PAKDD 2012), P292, DOI 10.1007/978-3-642-30220-6_25; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mehan MR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S62; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Scriver CR, 2004, J INHERIT METAB DIS, V27, P305, DOI 10.1023/B:BOLI.0000031100.26546.6e; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Singh R, 2007, LECT NOTES COMPUT SC, V4453, P16; Strazzabosco M, 2011, GASTROENTEROLOGY, V140, P1855, DOI 10.1053/j.gastro.2011.04.030; Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu XB, 2009, BIOINFORMATICS, V25, P98, DOI 10.1093/bioinformatics/btn593; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502; Zhou DY, 2004, ADV NEUR IN, V16, P321	44	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125138	10.1371/journal.pone.0125138	http://dx.doi.org/10.1371/journal.pone.0125138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933025	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100080
J	Yuksel, A; Olmez, T				Yuksel, Ayhan; Olmez, Tamer			A Neural Network-Based Optimal Spatial Filter Design Method for Motor Imagery Classification	PLOS ONE			English	Article							EEG	In this study, a novel spatial filter design method is introduced. Spatial filtering is an important processing step for feature extraction in motor imagery-based brain-computer interfaces. This paper introduces a new motor imagery signal classification method combined with spatial filter optimization. We simultaneously train the spatial filter and the classifier using a neural network approach. The proposed spatial filter network (SFN) is composed of two layers: a spatial filtering layer and a classifier layer. These two layers are linked to each other with non-linear mapping functions. The proposed method addresses two shortcomings of the common spatial patterns (CSP) algorithm. First, CSP aims to maximize the between-classes variance while ignoring the minimization of within-classes variances. Consequently, the features obtained using the CSP method may have large within-classes variances. Second, the maximizing optimization function of CSP increases the classification accuracy indirectly because an independent classifier is used after the CSP method. With SFN, we aimed to maximize the between-classes variance while minimizing within-classes variances and simultaneously optimizing the spatial filter and the classifier. To classify motor imagery EEG signals, we modified the well-known feed-forward structure and derived forward and backward equations that correspond to the proposed structure. We tested our algorithm on simple toy data. Then, we compared the SFN with conventional CSP and its multi-class version, called one-versus-rest CSP, on two data sets from BCI competition III. The evaluation results demonstrate that SFN is a good alternative for classifying motor imagery EEG signals with increased classification accuracy.	[Yuksel, Ayhan; Olmez, Tamer] Istanbul Tech Univ, Dept Elect & Commun Engn, TR-80626 Istanbul, Turkey	Istanbul Technical University	Yuksel, A (corresponding author), Istanbul Tech Univ, Dept Elect & Commun Engn, TR-80626 Istanbul, Turkey.	yukselay@itu.edu.tr	Olmez, Tamer/ABE-7998-2020	Olmez, Tamer/0000-0001-6124-2394				[Anonymous], 2011, IND ELECT HDB; Barachant A, 2013, NEUROCOMPUTING, V112, P172, DOI 10.1016/j.neucom.2012.12.039; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; Blankertz B., 2007, ADV NEURAL INFORM PR, P113; Blankertz B, 2014, BCI COMPETITION 3 ON; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Falzon O, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045009; Fattahi D, 2013, NEUROCOMPUTING, V119, P165, DOI 10.1016/j.neucom.2013.03.044; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697; Levenberg K., 1944, Q APPL MATH, V2, P431; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Reuderink B, 2008, TRCTIT0852; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Samek W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026013; The MathWorks Inc, 2013, MATLAB VERS 8 1 0; Wang HX, 2012, IEEE T BIO-MED ENG, V59, P653, DOI 10.1109/TBME.2011.2177523; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yamashita N., 2001, TOPICS NUMERICAL ANA, P239	29	25	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125039	10.1371/journal.pone.0125039	http://dx.doi.org/10.1371/journal.pone.0125039			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933101	Green Published, gold			2022-12-26	WOS:000353887100074
J	Jordao, EMA; Onishi, BKA; Xavier, GF				Akagi Jordao, Elisa Mari; Amaral Onishi, Barbara Kazue; Xavier, Gilberto Fernando			Pre-Training Reversible Inactivation of the Basal Amygdala (BA) Disrupts Contextual, but Not Auditory, Fear Conditioning, in Rats	PLOS ONE			English	Article							HIPPOCAMPAL-FORMATION; MEMORY CONSOLIDATION; FUNCTIONAL INACTIVATION; BASOLATERAL AMYGDALA; RETROGRADE-AMNESIA; DORSAL HIPPOCAMPUS; PERIRHINAL CORTEX; LATERAL AMYGDALA; MUSCIMOL; NUCLEI	The basolateral amygdala complex (BLA), including the lateral (LA), basal (BA) and accessory basal (AB) nuclei, is involved in acquisition of contextual and auditory fear conditioning. The BA is one of the main targets for hippocampal information, a brain structure critical for contextual learning, which integrates several discrete stimuli into a single configural representation. Congruent with the hodology, selective neurotoxic damage to the BA results in impairments in contextual, but not auditory, fear conditioning, similarly to the behavioral impairments found after hippocampal damage. This study evaluated the effects of muscimol-induced reversible inactivation of the BA during a simultaneous contextual and auditory fear conditioning training on later fear responses to both the context and the tone, tested separately, without muscimol administration. As compared to control rats micro-infused with vehicle, subjects micro-infused with muscimol before training exhibited, during testing without muscimol, significant reduction of freezing responses to the conditioned context, but not to the conditioned tone. Therefore, reversible inactivation of the BA during training impaired contextual, but not auditory fear conditioning, thus confirming and extending similar behavioral observations following selective neurotoxic damage to the BA and, in addition, revealing that this effect is not related to the lack of a functional BA during testing.	[Akagi Jordao, Elisa Mari; Amaral Onishi, Barbara Kazue; Xavier, Gilberto Fernando] Univ Sao Paulo, Biosci Inst, Dept Physiol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Jordao, EMA (corresponding author), Univ Sao Paulo, Biosci Inst, Dept Physiol, Sao Paulo, SP, Brazil.	elisajordao@yahoo.com.br	Xavier, Gilberto F/B-9464-2013	Xavier, Gilberto F/0000-0002-8567-7031	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/04820-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2011/04820-7) http://www.fapesp.br/, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) http://www.capes.gov.br/ and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almada RC, 2013, J PSYCHOPHARMACOL, V27, P1160, DOI 10.1177/0269881113482840; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bergstrom HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015698; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Calandreau L, 2005, LEARN MEMORY, V12, P383, DOI 10.1101/lm.92305; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; Dalzell L, 2011, SYNAPSE, V65, P513, DOI 10.1002/syn.20869; Coelho CAD, 2013, HIPPOCAMPUS, V23, P545, DOI 10.1002/hipo.22118; Edeline JM, 2002, NEUROBIOL LEARN MEM, V78, P100, DOI 10.1006/nlme.2001.4035; Flavell CR, 2012, LEARN MEMORY, V19, P256, DOI 10.1101/lm.025403.111; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Lorenzini CGA, 1999, NEUROBIOL LEARN MEM, V71, P1; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Martin JH, 1999, J NEUROSCI METH, V86, P145, DOI 10.1016/S0165-0270(98)00163-0; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Onishi BKA, 2010, NEUROBIOL LEARN MEM, V93, P165, DOI 10.1016/j.nlm.2009.09.007; ONO T, 1995, PROG NEUROBIOL, V46, P401, DOI 10.1016/0301-0082(95)00008-J; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Pitkanen A, 2000, Folia Morphol (Warsz), V59, P1; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rudy JW, 1995, HIPPOCAMPUS, V5, P375, DOI 10.1002/hipo.450050502; RUDY JW, 1989, BEHAV BRAIN RES, V34, P97, DOI 10.1016/S0166-4328(89)80093-2; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Schafe GE, 2000, J NEUROSCI, V20, P8177; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tehovnik EJ, 1997, J NEUROSCI METH, V74, P17, DOI 10.1016/S0165-0270(97)02229-2; Toyomitsu Y, 2002, EUR J NEUROSCI, V15, P753, DOI 10.1046/j.1460-9568.2002.01889.x; van Duuren E, 2007, J PHARMACOL EXP THER, V323, P61, DOI 10.1124/jpet.107.124784; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000; Wilson YM, 2009, LEARN MEMORY, V16, P357, DOI 10.1101/lm.1361509; Yaniv D, 2004, BRAIN RES REV, V44, P179, DOI 10.1016/j.brainresrev.2003.08.008; Yaniv D, 2003, NEUROSCIENCE, V120, P1125, DOI 10.1016/S0306-4522(03)00386-5; Yaniv D, 2000, NEUROREPORT, V11, P525, DOI 10.1097/00001756-200002280-00020	46	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125489	10.1371/journal.pone.0125489	http://dx.doi.org/10.1371/journal.pone.0125489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928357	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100094
J	Cornish, AJ; Green, R; Gartner, K; Mason, S; Hegg, EL				Cornish, Adam J.; Green, Robin; Gaertner, Katrin; Mason, Saundra; Hegg, Eric L.			Characterization of Hydrogen Metabolism in the Multicellular Green Alga Volvox carteri	PLOS ONE			English	Article							GERM-SOMA DIFFERENTIATION; CHLAMYDOMONAS-REINHARDTII; SHEWANELLA-ONEIDENSIS; IRON HYDROGENASES; GENE-EXPRESSION; FE HYDROGENASE; EVOLUTION; PHOTOPRODUCTION; CLASSIFICATION; IDENTIFICATION	Hydrogen gas functions as a key component in the metabolism of a wide variety of microorganisms, often acting as either a fermentative end-product or an energy source. The number of organisms reported to utilize hydrogen continues to grow, contributing to and expanding our knowledge of biological hydrogen processes. Here we demonstrate that Volvox carteri f. nagariensis, a multicellular green alga with differentiated cells, evolves H-2 both when supplied with an abiotic electron donor and under physiological conditions. The genome of Volvox carteri contains two genes encoding putative [FeFe]-hydrogenases (HYDA1 and HYDA2), and the transcripts for these genes accumulate under anaerobic conditions. The HYDA1 and HYDA2 gene products were cloned, expressed, and purified, and both are functional [FeFe]-hydrogenases. Additionally, within the genome the HYDA1 and HYDA2 genes cluster with two putative genes which encode hydrogenase maturation proteins. This gene cluster resembles operon-like structures found within bacterial genomes and may provide further insight into evolutionary relationships between bacterial and algal [FeFe]-hydrogenase genes.	[Cornish, Adam J.; Green, Robin; Gaertner, Katrin; Mason, Saundra; Hegg, Eric L.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Cornish, Adam J.; Green, Robin; Gaertner, Katrin; Mason, Saundra; Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; United States Department of Energy (DOE); Michigan State University	Hegg, EL (corresponding author), Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.	erichegg@msu.edu			United States Department of Energy, Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]	United States Department of Energy, Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE))	This work was funded by the United States Department of Energy, Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1989, P NATL ACAD SCI USA, V86, P4932, DOI 10.1073/pnas.86.13.4932; Andersson JO, 2002, EUKARYOT CELL, V1, P304, DOI 10.1128/EC.1.2.304-310.2002; Antal TK, 2011, APPL MICROBIOL BIOT, V89, P3, DOI 10.1007/s00253-010-2879-6; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; Bolhuis H, 2010, ISME J, V4, P121, DOI 10.1038/ismej.2009.99; Bothe H, 2010, MICROBIOL MOL BIOL R, V74, P529, DOI 10.1128/MMBR.00033-10; BRAND JJ, 1989, BIOTECHNOL BIOENG, V33, P1482, DOI 10.1002/bit.260331116; Catalanotti C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00150; Chen M, 2010, J PROTEOME RES, V9, P3854, DOI 10.1021/pr100076c; Cornish AJ, 2011, J BIOL CHEM, V286, P38341, DOI 10.1074/jbc.M111.254664; D'Adamo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085812; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Fournier M, 2004, J BIOL CHEM, V279, P1787, DOI 10.1074/jbc.M307965200; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Godman JE, 2010, BIOCHEM J, V431, P345, DOI 10.1042/BJ20100932; Grossman AR, 2011, NEW PHYTOL, V190, P279, DOI 10.1111/j.1469-8137.2010.03534.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hansen J, 2004, P NATL ACAD SCI USA, V101, P16109, DOI 10.1073/pnas.0406982101; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Hemschemeier A, 2009, PHOTOSYNTH RES, V102, P523, DOI 10.1007/s11120-009-9415-5; Homann PH, 2003, PHOTOSYNTH RES, V76, P93, DOI 10.1023/A:1024935223225; Horner DS, 2002, TRENDS BIOCHEM SCI, V27, P148, DOI 10.1016/S0968-0004(01)02053-9; Horner DS, 2000, MOL BIOL EVOL, V17, P1695, DOI 10.1093/oxfordjournals.molbev.a026268; Hwang JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4234; Jinkerson RE, 2012, BIOENGINEERED, V4; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kirk DL, 1999, CURR OPIN PLANT BIOL, V2, P496, DOI 10.1016/S1369-5266(99)00019-9; Kirk MM, 1999, DEVELOPMENT, V126, P639; KOCHERT G, 1968, J PROTOZOOL, V15, P438, DOI 10.1111/j.1550-7408.1968.tb02154.x; Kosourov S, 2002, BIOTECHNOL BIOENG, V78, P731, DOI 10.1002/bit.10254; Kruse O, 2010, CURR OPIN BIOTECH, V21, P238, DOI 10.1016/j.copbio.2010.03.012; Marshall MJ, 2008, ENVIRON MICROBIOL, V10, P125, DOI 10.1111/j.1462-2920.2007.01438.x; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Meuser JE, 2012, BIOCHEM BIOPH RES CO, V417, P704, DOI 10.1016/j.bbrc.2011.12.002; Meuser JE, 2011, PLANTA, V234, P829, DOI 10.1007/s00425-011-1431-y; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Nematollahi G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-321; Nie W, 2012, CLIN SCI, V122, P575, DOI 10.1042/CS20110396; Nixon JEJ, 2003, BIOL BULL-US, V204, P1, DOI 10.2307/1543490; Noguchi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010132; Ozawa K, 2001, BIOSCI BIOTECH BIOCH, V65, P185, DOI 10.1271/bbb.65.185; Posewitz MC, 2005, BIOCHEM SOC T, V33, P102, DOI 10.1042/BST0330102; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Rupprecht J, 2009, J BIOTECHNOL, V142, P10, DOI 10.1016/j.jbiotec.2009.02.008; Schmitt R, 2003, CURR OPIN MICROBIOL, V6, P608, DOI 10.1016/j.mib.2003.10.007; Stark K, 2002, PROTIST, V153, P99, DOI 10.1078/1434-4610-00088; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; TAM LW, 1991, DEV BIOL, V145, P51, DOI 10.1016/0012-1606(91)90212-L; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; Tooming-Klunderud A, 2013, APPL ENVIRON MICROB, V79, P6803, DOI 10.1128/AEM.01455-13; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Waller RF, 2006, MOL BIOL EVOL, V23, P1437, DOI 10.1093/molbev/msl008; Winkler M, 2010, EUR J CELL BIOL, V89, P998, DOI 10.1016/j.ejcb.2010.06.018; Yamano T, 2011, PHOTOSYNTH RES, V109, P151, DOI 10.1007/s11120-010-9614-0; Zhang LP, 2002, PLANTA, V214, P552, DOI 10.1007/s004250100660	60	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125324	10.1371/journal.pone.0125324	http://dx.doi.org/10.1371/journal.pone.0125324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927230	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100081
J	Meland, K; Mees, J; Porter, M; Wittmann, KJ				Meland, Kenneth; Mees, Jan; Porter, Megan; Wittmann, Karl J.			Taxonomic Review of the Orders Mysida and Stygiomysida (Crustacea, Peracarida)	PLOS ONE			English	Review							BIOGEOGRAPHICAL DIVISION; STATOLITHS CRUSTACEA; LOPHOGASTRIDA; MALACOSTRACA; PHYLOGENY; DIVERSITY; RECORDS; SEA	The order Mysida (2 families, 178 genera, 1132 species) contains species across a broad range of habitats, such as subterranean, fresh, brackish, coastal, and surface to deep-sea habitats. The Stygiomysida (2 families, 2 genera, 16 species), however, are found primarily in subterranean waters, but always in waters with a marine influence. The Mysida and Stygiomysida body is divided into three main regions: cephalon, thorax, and abdomen. They are shrimp-like in appearance, containing morphological features earlier referred to as defining a "caridoid facies". The shrimp-like morphology was to some extent diagnostic for the historic Decapod taxon Schizopoda, containing the Nebalia, Mysida, Lophogastrida, and Euphausiacea. In 1904 the concept of Schizopoda was abandoned, and the Mysidacea (Mysida and Lophogastrida) along with Cumacea, Amphipoda, Isopoda, and Tanaidacea were placed in a new taxon, the Peracarida. Later discoveries of groundwater mysids led to the establishment of Stygiomysida, but placement to either Lophogastrida or Mysida remained unclear. The presence of oostegites and absence of podobranchiae, coupled with non-statocyst bearing uropods have been used to classify the Stygiomysida as a primitive Mysida family, comparable to Petalophthalmidae. On the other hand, equally suggestive characters, but for a Lophogastrida affiliation, was suggested for the archaic foregut characters and again, non-statocyst bearing uropods. With the inclusion of DNA sequence data of ribosomal genes, sister group relationships between Stygiomysida, Lophogastrida, and Mictacea within the Peracarida are observed, which supports a classification of the Stygiomysida as a separate order removed from the Mysida.	[Meland, Kenneth] Univ Bergen, Dept Biol, Bergen, Norway; [Mees, Jan] Flanders Marine Inst, Oostende, Belgium; [Mees, Jan] Univ Ghent, Oostende, Belgium; [Porter, Megan] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Wittmann, Karl J.] Med Univ Wien, Inst Umwelthygiene, Abt Okotoxikol, Vienna, Austria	University of Bergen; Ghent University; University of South Dakota; Medical University of Vienna	Meland, K (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	kenneth.meland@bio.uib.no	Porter, Megan L./X-1133-2019; Mees, Jan/HDN-5048-2022					Ariani AP, 2010, J CRUSTACEAN BIOL, V30, P384, DOI 10.1651/09-3150.1; ARIANI AP, 1993, BIOL BULL-US, V185, P393, DOI 10.2307/1542480; BACESCU M, 1986, Travaux du Museum d'Histoire Naturelle "Grigore Antipa", V28, P25; Bill PhC, 1914, MITTEILUNGEN GEOLOGI, V8, P289; BOAS J. E. V., 1883, MORPHOLOGISCHES JB, V8, P485; Bowman T.E., 1973, Bulletin Ass mex Cave Stud, VNo. 5,1973, P13; BOWMAN TE, 1984, P BIOL SOC WASH, V97, P637; Boxshall G. A., 2014, WORLD REGISTER MARIN; Brooks H. K., 1962, Bulletins of American Paleontology, V44, P163; Calman W. T., 1904, Annals of Natural History, V(7), P144; Calman WT, 1909, TREATISE ZOOLOGY A C, P171; Caroli E., 1937, Bollettino di Zoologia Torino, V8, P219; CASANOVA B, 1991, CR ACAD SCI III-VIE, V312, P461; CLARKE W. D., 1961, CRUSTACEANA, V2, P251, DOI 10.1163/156854061X00248; Czerniavsky V, 1882, PETERSBOURG, V13, P1; Czerniavsky V., 1882, T ST PETERBURGSKO OB, V13, P1; DAHL E, 1992, ACTA ZOOL-STOCKHOLM, V73, P339, DOI 10.1111/j.1463-6395.1992.tb01104.x; Dana JD, 1852, CRUSTACEA 1, VXIII, P635; Daneliya ME, 2011, RUSS J MAR BIOL+, V37, P85, DOI 10.1134/S1063074011020040; De Angeli Antonio, 2006, Societa Veneziana di Scienze Naturali Lavori, V31, P85; De Jong-Moreau L, 2001, ACTA ZOOL-STOCKHOLM, V82, P137, DOI 10.1046/j.1463-6395.2001.00077.x; Fabricius O, 1780, FAUNA GROENLANDICA S, p[i, 1]; Fage L., 1925, Archives de Zoologie Paris, V63, P525; Gordon I, 1960, ZOOLOGY, V6, P283, DOI DOI 10.5962/BHL.PART.26847; Hanamura Y, 2002, J NAT HIST, V36, P253, DOI 10.1080/00222930010004241; Hansen H. J., 1925, P1; Hansen H. J., 1893, Annals of Natural History, V(6), P417; Hansen H.J., 1910, SIBOGA EXPED, V37, P1; Hansen H.J., 1893, ZOOL ANZ, V16, P193; Hansen HJ, 1893, ZOOL ANZ, V16, P201; Haworth AH, 1825, PHILOS MAGAZINE J, V65, P183, DOI DOI 10.1080/14786442508628417; Hessler R.R., 1983, Crustacean Issues, V1, P145; Holt EWL, 1905, SCHIZOPODOUS CRUSTAC, P99; ICZN, 1999, INT COD ZOOL NOM, P1; Jarman SN, 2000, MOL PHYLOGENET EVOL, V17, P26, DOI 10.1006/mpev.2000.0823; Lamarck JBP, 1818, HIST NATURELLE ANIMA, V5, P109; Latreille P.A., 1802, HIST NATURELLE GEN P, V3; LATREILLE PA, 1825, FAMILLES NATURELLES, P1; Latreille PA, 1817, REGNE ANIMAL DISTRI, P5, DOI [10.1038/nature13704, DOI 10.1038/NATURE13704]; Leach W.E., 1814, EDINBURGH ENCY, P383, DOI DOI 10.5962/BHL.TITLE.30911; Leach W. E., 1814, T LINN SOC LOND, V11, P306, DOI DOI 10.1111/J.1096-3642.1813.TB00065.X; Martin J.W., 2001, UPDATED CLASSIFICATI, VVolume 39, P1; Mauchline J, 1977, Journal Tokyo Univ Fish, V64, P39; Mees J, 2012, WORLD LIS LOPHGASTRO; Meland K, 2004, ZOOTAXA, P1; Meland K, 2007, MOL PHYLOGENET EVOL, V44, P1083, DOI 10.1016/j.ympev.2007.02.009; Muller OF, 1776, ZOOLOGIAE DANICAE PR, p[I, 1], DOI DOI 10.5962/BHL.TITLE.13268; Murano Masaaki, 2008, National Museum of Nature and Science Monographs, P1; Neil D.M., 1975, Progress in Zoology, V23, P98; Norman A. M., 1892, ANN MAGAZINE NATURAL, V10, P143, DOI DOI 10.1080/00222939208677385; Nouvel H., 1999, MEMOIRES I OCEANOGRA, V19, P39; PANAMPUNNAYIL SU, 1991, HYDROBIOLOGIA, V209, P71, DOI 10.1007/BF00006720; Pesce GL, 2002, J NAT HIST, V36, P265, DOI 10.1080/00222930010005033; Petryashev V. V., 2005, Biologiya Morya (Vladivostok), V31, P233; Petryashev VV, 2007, RUSS J MAR BIOL+, V33, P1, DOI 10.1134/S1063074007010014; Petryashov VV, 2009, RUSS J MAR BIOL+, V35, P97, DOI 10.1134/S1063074009020011; Porter ML, 2008, HYDROBIOLOGIA, V595, P213, DOI 10.1007/s10750-007-9016-2; Remerie T, 2004, MOL PHYLOGENET EVOL, V32, P770, DOI 10.1016/j.ympev.2004.03.007; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; Sars GO, 1870, CHRISTIANIA, P1; Sars GO, 1877, ARCH MATH NATURVIDEN, V2, P10; Sars GO, 1879, CARCINOLOGISKE BIDRA, p[i, 1]; Sars GO, 1872, CARCINOLOGISKE BIDRA, P1; Sars GO., 1885, SCI RESULTS VOYAGE H, V13, P1; SCHLACHER TA, 1992, ZOOMORPHOLOGY, V112, P67, DOI 10.1007/BF01673808; SCHRAM F R, 1984, Transactions of the San Diego Society of Natural History, V20, P301; Schram FR, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P233; Schram FR, 1986, CRUSTACEA, P107; SECRETAN S, 1986, Annales de Paleontologie, V72, P295; Sieg J, 1983, CRUSTACEORUM CATALOG, P1; Spears T, 2005, P BIOL SOC WASH, V118, P117, DOI 10.2988/0006-324X(2005)118[117:PMAIPI]2.0.CO;2; Stebbing TRR, 1893, INT SCI SERIES, V71, P256; Tattersall Walter M., 1909, Mitteilungen aus der Zoologischen Station zu Neapel Berlin, V19; Tattersall WM., 1911, FISH IRELAND SCI INV, V1910, P1; Tattersall WM, 1951, BRIT MYSIDACEA, V136, P460; Taylor RS, 2001, J PALEONTOL, V75, P310, DOI 10.1666/0022-3360(2001)075<0310:ANUMTS>2.0.CO;2; Tchindonova YG, 1981, P 14 PAC SCI C, V1, P24; Thompson JV, 1828, ZOOL RES ILL NAT HIS, V1, P13; Thompson JV, 1829, ZOOLOGICAL RES ILLUS, V2, P37; VOICU G, 1981, Micropaleontology (New York), V27, P227, DOI 10.2307/1485236; VOICU G, 1974, Geologicky Zbornik, V25, P231; von Willemoes-Suhm R, 1875, T LINN SOC LOND, VI, P23; Watling L., 1983, Crustacean Issues, V1, P213; WATLING L, 1981, Journal of Crustacean Biology, V1, P201, DOI 10.2307/1548159; WATLING L., 1999, P 4 INT CRUST C AMST, V1, P73; Wittmann K.J., 2014, TREATISE ZOOLOGY ANA, Vvol 4 Part B, ppp 189; Wittmann K J., 1999, CRUSTACEANS BIODIVER, V1, P511; Wittmann KJ, 2013, ZOOMORPHOLOGY, V132, P389, DOI 10.1007/s00435-013-0198-z; WITTMANN KJ, 1993, J MORPHOL, V215, P31, DOI 10.1002/jmor.1052150103; Wittmann KJ, 1996, MAR ECOL-P S Z N I, V17, P213, DOI 10.1111/j.1439-0485.1996.tb00502.x	90	30	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124656	10.1371/journal.pone.0124656	http://dx.doi.org/10.1371/journal.pone.0124656			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927358	gold, Green Published			2022-12-26	WOS:000353713100042
J	Summers, SK; Rainey, R; Kaur, M; Graham, JP				Summers, Sarah K.; Rainey, Rochelle; Kaur, Maneet; Graham, Jay P.			CO2 and H2O: Understanding Different Stakeholder Perspectives on the Use of Carbon Credits to Finance Household Water Treatment Projects	PLOS ONE			English	Article							MICROBIOLOGICAL EFFECTIVENESS; HYGIENE BEHAVIOR; DRINKING-WATER; QUESTIONNAIRES; REACTIVITY; SENSORS; COST	Background Carbon credits are an increasingly prevalent market-based mechanism used to subsidize household water treatment technologies (HWT). This involves generating credits through the reduction of carbon emissions from boiling water by providing a technology that reduces greenhouse gas emissions linked to climate change. Proponents claim this process delivers health and environmental benefits by providing clean drinking water and reducing greenhouse gases. Selling carbon credits associated with HWT projects requires rigorous monitoring to ensure households are using the HWT and achieving the desired benefits of the device. Critics have suggested that the technologies provide neither the benefits of clean water nor reduced emissions. This study explores the perspectives of carbon credit and water, sanitation and hygiene (WASH) experts on HWT carbon credit projects. Methods Thirteen semi-structured, in-depth interviews were conducted with key informants from the WASH and carbon credit development sectors. The interviews explored perceptions of the two groups with respect to the procedures applied in the Gold Standard methodology for trading Voluntary Emission Reduction (VER) credits. Results Agreement among the WASH and carbon credit experts existed for the concept of suppressed demand and parameters in the baseline water boiling test. Key differences, however, existed. WASH experts' responses highlighted a focus on objectively verifiable data for monitoring carbon projects while carbon credit experts called for contextualizing observed data with the need for flexibility and balancing financial viability with quality assurance. Conclusions Carbon credit projects have the potential to become an important financing mechanism for clean energy in low- and middle-income countries. Based on this research we recommend that more effort be placed on building consensus on the underlying assumptions for obtaining carbon credits from HWT projects, as well as the approved methods for monitoring correct and consistent use of the HWT technologies in order to support public health impacts.	[Summers, Sarah K.; Graham, Jay P.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Global Hlth, Washington, DC 20052 USA; [Rainey, Rochelle] US Agcy Int Dev, Washington, DC 20523 USA; [Kaur, Maneet] Berkeley Air Monitoring Grp, Berkeley, CA USA	George Washington University; United States Agency for International Development (USAID)	Graham, JP (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Dept Global Hlth, Washington, DC 20052 USA.	jgraham@gwu.edu		Kaur, Maneet/0000-0002-5231-1260				Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Brown J, 2012, AM J TROP MED HYG, V87, P394, DOI 10.4269/ajtmh.2012.11-0715; CDM Methodology Booklet, 2014, UN FRAM CONV CLIM CH, V15; Centers for Disease Control and Prevention, 2013, FACT SHEET WHAT DO B; Clasen TF, 2008, ENVIRON SCI TECHNOL, V42, P4255, DOI 10.1021/es7024802; Cousens S, 1996, SOC SCI MED, V43, P1299, DOI 10.1016/0277-9536(95)00380-0; Hodge JM, 2014, ENVIRON SCI TECHNOL, V48, P12509, DOI 10.1021/es503155m; Jenner EA, 2006, J HOSP INFECT, V63, P418, DOI 10.1016/j.jhin.2006.03.012; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; Markit, 2014, REGISTRY PUBLIC VIEW; McCutcheon S, 2012, GLOBAL HLTH INNOVATI; Mukerjee M, 2009, SCI AM, V300, P18, DOI 10.1038/scientificamerican0609-18; Psutka R, 2011, ENVIRON SCI TECHNOL, V45, P6095, DOI 10.1021/es2004045; Ram PK, 2010, AM J TROP MED HYG, V83, P1070, DOI 10.4269/ajtmh.2010.09-0763; Rosa G, 2010, AM J TROP MED HYG, V82, P473, DOI 10.4269/ajtmh.2010.09-0320; Schiermeier Q, 2011, NATURE, V477, P517, DOI 10.1038/477517a; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; Starr K, 2012, ANOTHER LOOK CARBON; The Gold Standard Foundation, 2014, GUID CARR OUT US SUR; The Gold Standard Foundation, 2010, IND PROGR BAS MON ME; The Gold Standard Foundation, 2014, REQ QUAL STAND BE ME; The World Health Organization, 2014, HOUS POLL HLTH FACT; Thomas EA, 2012, GLOBAL WATER FORUM; Thomas EA, 2013, ENVIRON SCI TECHNOL, V47, P13602, DOI 10.1021/es403412x; United Nations Framework Convention on Climate Change, 2014, UN FRAM CONV CLIM CH; Williams M, 2013, ENVIRON LAW, V43, P517; Wilson K, 2011, ECOL LAW QUART, V38, P967; World Wildlife Foundation, 2008, MAK SENS VOL CARB MA; Yeo D, 2013, WATERLINES, V32, P308, DOI DOI 10.3362/1756-3488.2013.032	29	1	1	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122894	10.1371/journal.pone.0122894	http://dx.doi.org/10.1371/journal.pone.0122894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928139	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100011
J	Grimaldi, D; Ginsberg, PS; Thayer, L; McEvey, S; Hauser, M; Turelli, M; Brown, B				Grimaldi, David; Ginsberg, Paul S.; Thayer, Lesley; McEvey, Shane; Hauser, Martin; Turelli, Michael; Brown, Brian			Strange Little Flies in the Big City: Exotic Flower-Breeding Drosophilidae (Diptera) in Urban Los Angeles	PLOS ONE			English	Article							CHROMOSOMAL-POLYMORPHISM; MOLECULAR PHYLOGENY; UNITED-STATES; 1ST RECORDS; FLAVOPILOSA; SUZUKII; EUCALYPTUS; GLYCOSIDES; INVASION; FRUITS	Urban landscapes are commonly considered too mundane and corrupted to be biotically interesting. Recent insect surveys employing 29 Malaise traps throughout Los Angeles, California, however, have uncovered breeding populations of two unexpected species of one of the most studied and familiar groups of organisms, Drosophila "fruit" flies. Unlike most introduced species of drosophilids, which breed in fresh or decaying fruits, these are specialized flower-breeders. A common species in the survey was Drosophila (Drosophila) gentica Wheeler and Takada, previously collected only once, in El Salvador. It belongs to the flavopilosa species group, all species of which have been known until now from central Chile, Argentina and Uruguay, to Veracruz, Mexico and the Caribbean, breeding in flowers of Cestrum ("jessamine") and Sessea (Solanaceae). The Los Angeles populations are probably breeding in a native and/or introduced Cestrum; in addition, populations in San Luis Obispo County were visiting ornamental Cestrum. Drosophila gentica occurs as far north as San Francisco, where it was found breeding in Cestrum aurantiacum. D. gentica is redescribed and figured in detail for diagnostic and identification purposes. Specimens from Jamaica previously identified as D. gentica are a distinct species but are not formally described in lieu of complete male specimens. Rare in the Malaise traps was Drosophila (Sophophora) flavohirta Malloch, a common species in Australia on the blossoms of native Myrtaceae, found on introduced Eucalyptus in South Africa and both Eucalyptus and Syzygium in Madagascar; adults feed on myrtaceous pollen and nectar, larvae breed in the flowers. It is also redescribed in detail, including its unusual egg. This is the first New World report of this species; DNA sequences confirm it is a morphologically highly aberrant member of the D. melanogaster species group. This study reveals how intensive field sampling can uncover remarkable biodiversity in even the most urbanized areas.	[Grimaldi, David; Thayer, Lesley] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Ginsberg, Paul S.; Turelli, Michael] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [McEvey, Shane] Australian Museum, Dept Entomol, Sydney, NSW 2000, Australia; [Hauser, Martin] Calif Dept Food & Agr, Sacramento, CA 95814 USA; [Brown, Brian] Nat Hist Museum Los Angeles Cty, Entomol Sect, Los Angeles, CA USA	American Museum of Natural History (AMNH); University of California System; University of California Davis; Australian Museum; California Department of Food & Agriculture	Grimaldi, D (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	grimaldi@amnh.org	Brown, Brian/K-6558-2019; McEvey, Shane F/E-7084-2010	McEvey, Shane F/0000-0002-7747-789X	Seaver Foundation; Natural History Museum of Los Angeles County; National Institutes of Health [R01GM104325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104325] Funding Source: NIH RePORTER	Seaver Foundation; Natural History Museum of Los Angeles County; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BioSCAN project by BB was funded by the Seaver Foundation (website: none) and the Natural History Museum of Los Angeles County (website: www.nhm.org) Research by MT was supported in part by National Institutes of Health grant R01GM104325 (website: www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams L., 1917, FLORA ANGELES VICINI, V3, DOI [10.5962/bhl.title.7705, DOI 10.5962/BHL.TITLE.7705]; Ashburner M, 1981, GENET BIOL DROSOPHIL, V3a, P375; Ashburner M., 2004, DROSOPHILA LAB HDB; Bachli G., 2004, FAUNA ENTOMOL SCAD, V39; Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; Bannina O, 2007, DEV BIOL, V311, P277, DOI 10.1016/j.ydbio.2007.07.030; Blaustein R, 2013, BIOSCIENCE, V63, P72, DOI 10.1525/bio.2013.63.2.3; Bock I, 1976, AUST J ZOOL        S, V24, P1, DOI DOI 10.1071/AJZS040; BRNCIC D, 1978, Revista Brasileira de Biologia, V38, P647; BRNCIC D, 1966, EVOLUTION, V20, P16, DOI 10.1111/j.1558-5646.1966.tb03340.x; BRNCIC D, 1962, CHROMOSOMA, V13, P183, DOI 10.1007/BF00326570; Brncic D., 1983, Genetics and Biology of Drosophila, V3d, P333; BRNCIC D, 1976, CAN J GENET CYTOL, V18, P111, DOI 10.1139/g76-016; BRNCIC D, 1968, GENETICS, V59, P427; BRNCIC D, 1972, U TEXAS PUBL, V7213, P103; Brown GK, 2001, AUST SYST BOT, V14, P565, DOI 10.1071/SB00029; Buys B., 1983, South African Bee Journal, V55, P129; Castrezana S., 2010, Drosophila Information Service, V93, P93; Castrezana S, 2012, DROSOPHILA INFO SERV, V93, P91; Castro Flabeano L., 2001, Drosophila Information Service, V84, P15; Cini A, 2012, B INSECTOL, V65, P149; Da Lage JL, 2007, J ZOOL SYST EVOL RES, V45, P47, DOI 10.1111/j.1439-0469.2006.00389.x; DARCY WG, 1976, SOLANACEAE, V3, P75; Davis AJ, 1996, AFR ENTOMOL, V4, P277; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; dos Santos RDO, 2005, REV BRAS ENTOMOL, V49, P544, DOI 10.1590/S0085-56262005000400015; Doughty RW, 2000, EUCALYPTUS NATURAL C; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feinberg JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108213; Ferreira LB, 2005, BIODIVERS CONSERV, V14, P1809, DOI 10.1007/s10531-004-0701-4; Fourie A, 2011, AFR ENTOMOL, V19, P278, DOI 10.4001/003.019.0204; Gibson JF, 2011, ANN ENTOMOL SOC AM, V104, P976, DOI 10.1603/AN10153; HARLIM AF, 1971, PLANTA MED, V20, P44, DOI 10.1055/s-0028-1099663; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; HUGHES MR, 1977, NATURE, V268, P347, DOI 10.1038/268347a0; Kanzawa T, 1939, REV APPL ENTOMOLOGY, V29, p[49, 622]; Kingsbury JM, 1964, POISONOUS PLANTS US; Kohler R.E., 1994, LORDS FLY DROSOPHILA; KROOK L, 1975, CORNELL VET, V65, P557; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; MCEVEY SF, 1989, J AUST ENTOMOL SOC, V28, P53; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; MCLENNAN MW, 1984, AUST VET J, V61, P289, DOI 10.1111/j.1751-0813.1984.tb06013.x; Mimaki Y, 2001, J NAT PROD, V64, P17, DOI 10.1021/np0003701; Munz PA, 1959, COLLABORATION DD KE; Newman CE, 2012, MOL PHYLOGENET EVOL, V63, P445, DOI 10.1016/j.ympev.2012.01.021; NICOLSON SW, 1994, PHYSIOL ENTOMOL, V19, P58, DOI 10.1111/j.1365-3032.1994.tb01074.x; PEARCE CM, 1992, J CHEM SOC PERK T 1, P593, DOI 10.1039/p19920000593; PIPKIN SB, 1966, AM NAT, V100, P135, DOI 10.1086/282407; Robe LJ, 2013, FLY, V7, P59, DOI 10.4161/fly.23923; Robe LJ, 2010, J ZOOL SYST EVOL RES, V48, P310, DOI 10.1111/j.1439-0469.2009.00563.x; Robe LJ, 2005, MOL PHYLOGENET EVOL, V36, P623, DOI 10.1016/j.ympev.2005.05.005; Russo CAM, 2013, ZOOL J LINN SOC-LOND, V169, P765, DOI [10.1111/zoj12062, 10.1111/zoj.12062]; Schmitz HJ, 2010, THESIS U FEDERAL RI; Stewart B, 2002, NY TIMES; Sturtevant AH., 1921, CARNEGIE I WASH YR B, V301, P1; Sultana Farhat, 1999, Entomological Science, V2, P121; Toit A. P. du, 1987, South African Forestry Journal, P53; TSACAS L, 1988, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V142, P143; van der Linde K, 2006, FLA ENTOMOL, V89, P402, DOI 10.1653/0015-4040(2006)89[402:FROZID]2.0.CO;2; VELA D, 2004, REV ECUATORIANA MED, V26, P14; VELA D, 2005, REV ECUATORIANA MED, V27, P27; VILELA C R, 1992, Revista Brasileira de Entomologia, V36, P475; Vilela C.R., 1999, Drosophila Information Service, V82, P37; Vilela CR, 1984, REV BRAS ZOOL, V2, P63, DOI DOI 10.1590/S0101-81751983000200004; Wheeler M. R., 1962, P395	68	8	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122575	10.1371/journal.pone.0122575	http://dx.doi.org/10.1371/journal.pone.0122575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923661	Green Published, gold			2022-12-26	WOS:000353711600016
J	Hagen, CM; Aidt, FH; Havndrup, O; Hedley, PL; Jensen, MK; Kanters, JK; Pham, TT; Bundgaard, H; Christiansen, M				Hagen, Christian M.; Aidt, Frederik H.; Havndrup, Ole; Hedley, Paula L.; Jensen, Morten K.; Kanters, Jorgen K.; Pham, Tam T.; Bundgaard, Henning; Christiansen, Michael			Private Mitochondrial DNA Variants in Danish Patients with Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							MEDIAN-NETWORK ANALYSIS; TRANSFER-RNA MUTATIONS; POINT MUTATION; MTDNA MUTATIONS; RISK-FACTOR; DISEASE; PATHOGENICITY; PENETRANCE; GENES; HAPLOGROUPS	Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease primarily caused by mutations in genes coding for sarcomeric proteins. A molecular-genetic etiology can be established in similar to 60% of cases. Evolutionarily conserved mitochondrial DNA (mtDNA) haplogroups are susceptibility factors for HCM. Several polymorphic mtDNA variants are associated with a variety of late-onset degenerative diseases and affect mitochondrial function. We examined the role of private, non-haplogroup associated, mitochondrial variants in the etiology of HCM. In 87 Danish HCM patients, fullmtDNA sequencing revealed 446 variants. After elimination of 312 (69.9%) non-coding and synonymous variants, a further 109 (24.4%) with a global prevalence > 0.1%, three (0.7%) haplogroup associated and 19 (2.0%) variants with a low predicted in silico likelihood of pathogenicity, three variants: MT-TC: m.5772G>A, MT-TF: m.644A>G, and MT-CYB: m.15024G>A, p.C93Y remained. A detailed analysis of these variants indicated that none of them are likely to cause HCM. In conclusion, private mtDNA mutations are frequent, but they are rarely, if ever, associated with HCM.	[Hagen, Christian M.; Aidt, Frederik H.; Hedley, Paula L.; Pham, Tam T.; Christiansen, Michael] Statens Serum Inst, Dept Congenital Disorders, DK-2300 Copenhagen, Denmark; [Hagen, Christian M.; Kanters, Jorgen K.; Christiansen, Michael] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Havndrup, Ole] Roskilde Hosp, Dept Cardiol, Roskilde, Denmark; [Jensen, Morten K.; Bundgaard, Henning] Rigshosp, Ctr Heart, Dept Med B, DK-2100 Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; Rigshospitalet; University of Copenhagen	Christiansen, M (corresponding author), Statens Serum Inst, Dept Congenital Disorders, DK-2300 Copenhagen, Denmark.	mic@ssi.dk	Christiansen, Michael/B-4588-2009; Hedley, Paula L/E-6156-2011; Bundgaard, Henning/AAA-4381-2020	Christiansen, Michael/0000-0003-4713-755X; Hedley, Paula L/0000-0001-5801-960X; Bundgaard, Henning/0000-0002-0563-7049; Jensen, Morten Kvistholm/0000-0003-1144-4603; Kanters, Jorgen/0000-0002-3267-4910; Hagen, Christian/0000-0002-0513-7722	LUNDBECKFONDEN [R67-A6552]; Novo Nordisk Fonden [NNF14OC0012809] Funding Source: researchfish	LUNDBECKFONDEN(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	The work was supported by LUNDBECKFONDEN (grant no: R67-A6552), www.lundbeckfonden.com.	Andersen PS, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/685108; Andersen PS, 2009, HUM MUTAT, V30, P363, DOI 10.1002/humu.20862; Andersen PS, 2004, EUR J HUM GENET, V12, P673, DOI 10.1038/sj.ejhg.5201190; Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008; Arbustini E, 1998, HEART, V80, P548, DOI 10.1136/hrt.80.6.548; Bandelt HJ, 2008, INT J CARDIOL, V126, P439, DOI 10.1016/j.ijcard.2007.02.049; Bandelt HJ, 2009, J HUM GENET, V54, P174, DOI 10.1038/jhg.2009.9; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; Bruno C, 1999, J PEDIATR-US, V135, P197, DOI 10.1016/S0022-3476(99)70022-3; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Casali C, 1999, J AM COLL CARDIOL, V33, P1584, DOI 10.1016/S0735-1097(99)00079-0; CASALI C, 1995, BIOCHEM BIOPH RES CO, V213, P588, DOI 10.1006/bbrc.1995.2172; Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008; Chan PA, 2007, HUM MUTAT, V28, P683, DOI 10.1002/humu.20492; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Christiansen M, 2015, MITOCHONDRION, V20, P105, DOI 10.1016/j.mito.2014.07.010; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Elson JL, 2012, HUM MUTAT, V33, P1352, DOI 10.1002/humu.22118; Fernandez-Caggiano M, 2013, MITOCHONDRION, V13, P263, DOI 10.1016/j.mito.2013.03.005; Fernandez-Caggiano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044128; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Hagen CM, 2013, MOL GENET GENOM MED, V1, P54, DOI 10.1002/mgg3.5; Hagen CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071904, 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201]; Havndrup O, 2010, EUR J HEART FAIL, V12, P535, DOI 10.1093/eurjhf/hfq073; Hedley PL, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-12; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hudson G, 2014, PLOS GENET, pe10; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Jensen MK, 2013, CIRCULATION, V127, P48, DOI 10.1161/CIRCULATIONAHA.111.090514; Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5; Larsen S, 2014, BBA-BIOENERGETICS, V1837, P226, DOI 10.1016/j.bbabio.2013.10.009; Levinger L, 2004, J MOL BIOL, V337, P535, DOI 10.1016/j.jmb.2004.02.008; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; MERANTE F, 1994, AM J HUM GENET, V55, P437; Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.3.CO;2-Y; Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474; Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003; Oliva R, 2006, NUCLEIC ACIDS RES, V34, P865, DOI 10.1093/nar/gkj491; Perli E, 2012, HUM MOL GENET, V21, P85, DOI 10.1093/hmg/ddr440; Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rosca MG, 2013, J MOL CELL CARDIOL, V55, P31, DOI 10.1016/j.yjmcc.2012.09.002; Rossignol R, 2013, BIOCHEM J, V370, P751; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Shin WS, 2000, AM J HUM GENET, V67, P1617, DOI 10.1086/316896; Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110; Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389; Tang XW, 2010, MOL GENET METAB, V100, P57, DOI 10.1016/j.ymgme.2010.01.008; Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0; Teekakirikul P, 2013, J MOL DIAGN, V15, P158, DOI 10.1016/j.jmoldx.2012.09.002; TENCATE FJ, 1979, AM J CARDIOL, V43, P731, DOI 10.1016/0002-9149(79)90071-7; Towbin JA, 2009, PACE, V32, pS23, DOI 10.1111/j.1540-8159.2009.02381.x; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003; Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Wang J, 2012, GENET MED, V14, P620, DOI 10.1038/gim.2012.4; Wang M, 2013, BIOCHEM J, V453, P455, DOI 10.1042/BJ20130294; Williams S, 2012, ANAL IN SILICO TOOLS; Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575; Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27; Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169	75	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124540	10.1371/journal.pone.0124540	http://dx.doi.org/10.1371/journal.pone.0124540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923817	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600091
J	Pastorino, B; Baronti, C; Gould, EA; Charrel, RN; de Lamballerie, X				Pastorino, Boris; Baronti, Cecile; Gould, Ernest A.; Charrel, Remi N.; de Lamballerie, Xavier			Effect of Chemical Stabilizers on the Thermostability and Infectivity of a Representative Panel of Freeze Dried Viruses	PLOS ONE			English	Article							PETITS RUMINANTS VACCINE; LYOPHILIZATION; MICROORGANISMS; EFFICACY; STORAGE	As a partner of the European Virus Archive (EVA) FP7 project, our laboratory maintains a large collection of freeze-dried viruses. The distribution of these viruses to academic researchers, public health organizations and industry is one major aim of the EVA consortium. It is known that lyophilization requires appropriate stabilizers to prevent inactivation of the virus. However, few studies have investigated the influence of different stabilizers and lyophilization protocols on the thermostability of different viruses. In order to identify optimal lyophilization conditions that will deliver maximum retention of viral infectivity titre, different stabilizer formulations containing trehalose, sorbitol, sucrose or foetal bovine serum were evaluated for their efficacy in stabilizing a representative panel of freeze dried viruses at different storage temperatures (-20 degrees C, +4 degrees C and +20 degrees C) for one week, the two latter mimicking suboptimal shipping conditions. The Tissue Culture Infectious Dose 50% (TCID50) assay was used to compare the titres of infectious virus. The results obtained using four relevant and model viruses (enveloped/non enveloped RNA/DNA viruses) still serve to improve the freeze drying conditions needed for the development and the distribution of a large virus collection.	[Baronti, Cecile] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR 190 Emergence Pathol Virales, F-13385 Marseille, France; Aix Marseille Univ, IHU Inst Hosp Univ Mediterranee Infect, APHM Publ Hosp Marseille, F-13385 Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Baronti, C (corresponding author), Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR 190 Emergence Pathol Virales, F-13385 Marseille, France.	cecile.baronti@univ-amu.fr		baronti, cecile/0000-0002-2319-9484; Charrel, Remi/0000-0002-7675-8251; pastorino, boris/0000-0001-5233-5193	European Virus Archive (European Union 7th Framework Programme) [228292]; EDENext FP7 [261504 EU]; European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) from the European Centre for Disease Prevention and Control	European Virus Archive (European Union 7th Framework Programme); EDENext FP7; European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) from the European Centre for Disease Prevention and Control	This work was supported in part by (i) the European Virus Archive (European Union 7th Framework Programme under grant agreement no. 228292)(http://www.european-virus-archive.com/), (ii) the EDENext FP7-no261504 EU project and this paper is catalogued by the EDENext Steering Committee (http://www.edenext.eu), (iii) European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) funded from the European Centre for Disease Prevention and Control (http://www.enivd.de/index.htm). The work of RNC was done under the frame of EurNegVec COST Action TD1303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams G D, 1996, Methods Mol Med, V4, P167, DOI 10.1385/0-89603-334-1:167; Adams Gerald, 2007, Methods Mol Biol, V368, P15; Adebayo AA, 1998, BIOLOGICALS, V26, P309, DOI 10.1006/biol.1998.0157; Bedu-Addo FK, 2004, PHARM RES-DORDR, V21, P1353, DOI 10.1023/B:PHAM.0000036908.70139.f1; BOVARNICK MR, 1950, J BACTERIOL, V59, P509, DOI 10.1128/JB.59.4.509-522.1950; Day John G., 2007, METHOD MOL BIOL, P368; de Rizzo E, 1989, Bull Pan Am Health Organ, V23, P299; Gould EA, 2012, ANTIVIR RES, V95, P167, DOI 10.1016/j.antiviral.2012.05.005; HOWELL CL, 1983, J CLIN MICROBIOL, V18, P658, DOI 10.1128/JCM.18.3.658-662.1983; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Jamil RK, 2014, J VIROL METHODS, V199, P35, DOI 10.1016/j.jviromet.2013.12.020; Kang MS, 2010, POULTRY SCI, V89, P1167, DOI 10.3382/ps.2009-00620; MARINER JC, 1990, VET MICROBIOL, V21, P195, DOI 10.1016/0378-1135(90)90032-Q; Monath TP, 1996, DEV BIOL STAND, V87, P219; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Prabhu M, 2014, BIOLOGICALS, V42, P169, DOI 10.1016/j.biologicals.2014.02.001; Riyesh Thachamvally, 2011, Virologica Sinica, V26, P324, DOI 10.1007/s12250-011-3205-x; Sarkar J, 2003, VACCINE, V21, P4728, DOI 10.1016/S0264-410X(03)00512-7; Silva AC, 2014, VACCINE, V32, P2878, DOI 10.1016/j.vaccine.2014.02.039; Silva AC, 2011, VACCINE, V29, P4983, DOI 10.1016/j.vaccine.2011.04.102; TANNOCK GA, 1987, J CLIN MICROBIOL, V25, P1769, DOI 10.1128/JCM.25.9.1769-1771.1987; Terada S., 2013, BMC P S6, V7, pP104; Zhai SL, 2004, BIOTECHNOL PROGR, V20, P1113, DOI 10.1021/bp034362x	23	19	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0118963	10.1371/journal.pone.0118963	http://dx.doi.org/10.1371/journal.pone.0118963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923434	Green Published, gold			2022-12-26	WOS:000353711600002
J	Wang, JH; Zhao, YZ; Wang, C; Zhu, Q; Du, ZM; Hu, AG; Yang, Y				Wang, Jianhua; Zhao, Yuzheng; Wang, Chao; Zhu, Qian; Du, Zengmin; Hu, Aiguo; Yang, Yi			Organelle-Specific Nitric Oxide Detection in Living Cells via HaloTag Protein Labeling	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; LIVE CELLS; INDICATORS; PROBES; VISUALIZATION; SUPPRESSION; RECEPTOR; SENSORS; VITRO	Nitric oxide (NO) is a membrane-permeable signaling molecule that is constantly produced, transferred, and consumed in vivo. NO participates and plays important roles in multiple biological processes. However, spatiotemporal imaging of NO in living cells is challenging. To fill the gap in currently used techniques, we exploited the versatility of HaloTag technology and synthesized a novel organelle-targetable fluorescent probe called HTDAF-2DA. We demonstrate the utility of the probe by monitoring subcellular NO dynamics. The developed strategy enables precise determination of local NO function.	[Wang, Jianhua; Zhao, Yuzheng; Zhu, Qian; Du, Zengmin; Yang, Yi] E China Univ Sci & Technol, Synthet Biol & Biotechnol Lab, State Key Lab Bioreactor Engn, CAS Ctr Excellence Brain Sci, Shanghai 200237, Peoples R China; [Wang, Chao; Hu, Aiguo] E China Univ Sci & Technol, Shanghai Key Lab Adv Polymer Mat, Sch Mat Sci & Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology; East China University of Science & Technology	Hu, AG (corresponding author), E China Univ Sci & Technol, Shanghai Key Lab Adv Polymer Mat, Sch Mat Sci & Engn, 130 Mei Long Rd, Shanghai 200237, Peoples R China.	hagmhsn@ecust.edu.cn; yiyang@ecust.edu.cn	, hagmhsn/D-7164-2012; Yang, Yi/C-1297-2013	, hagmhsn/0000-0003-0456-7269; Zhao, Yuzheng/0000-0001-5400-0135; Yang, Yi/0000-0001-7896-1184	National Special Fund for State Key Laboratory of Bioreactor Engineering of China [2060204]; 973 Program [2013CB531200]; NSFC [31225008, 91313301, 31071260, 31170815, 91013012]; Specialized Research Fund for the Doctoral Program of Higher Education [20100074110010]; Shanghai Science and Technology Commission [12JC1402900, 11DZ2260600]; Dawn Program of Shanghai Education Commission [11SG31]; State Key Laboratory of Bioreactor Engineering; 111 Project [B07023]; Fundamental Research Funds for the Central Universities	National Special Fund for State Key Laboratory of Bioreactor Engineering of China; 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Dawn Program of Shanghai Education Commission; State Key Laboratory of Bioreactor Engineering; 111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Special Fund for State Key Laboratory of Bioreactor Engineering of China (2060204), 973 Program (2013CB531200), NSFC (31225008, 91313301, 31071260, 31170815, and 91013012), Specialized Research Fund for the Doctoral Program of Higher Education (20100074110010), Shanghai Science and Technology Commission (12JC1402900 and 11DZ2260600), Dawn Program of Shanghai Education Commission (11SG31), State Key Laboratory of Bioreactor Engineering, 111 Project (B07023), and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2012, EUR J PHARMACOL, V678, P61, DOI 10.1016/j.ejphar.2011.12.024; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brien JF, 1996, METHOD ENZYMOL, V268, P83; Brown FO, 2005, ANAL BIOANAL CHEM, V381, P964, DOI 10.1007/s00216-004-2964-8; Burke AJ, 2013, CARCINOGENESIS, V34, P503, DOI 10.1093/carcin/bgt034; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Frederiksen LJ, 2007, CLIN CANCER RES, V13, P2199, DOI 10.1158/1078-0432.CCR-06-1807; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gabe Y, 2004, J AM CHEM SOC, V126, P3357, DOI 10.1021/ja037944j; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kim YM, 1998, J IMMUNOL, V161, P4122; Kojima H, 2001, ANAL CHEM, V73, P1967, DOI 10.1021/ac001136i; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lee HLD, 2010, J AM CHEM SOC, V132, P15099, DOI 10.1021/ja1044192; Lee KS, 2012, BIOCHEM BIOPH RES CO, V418, P49, DOI 10.1016/j.bbrc.2011.12.123; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lowe G, 2008, NEUROSCIENCE, V153, P842, DOI 10.1016/j.neuroscience.2008.03.003; McQuade LE, 2010, P NATL ACAD SCI USA, V107, P8525, DOI 10.1073/pnas.0914794107; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Privett BJ, 2010, CHEM SOC REV, V39, P1925, DOI 10.1039/b701906h; Ridnour LA, 2006, ANTIOXID REDOX SIGN, V8, P1329, DOI 10.1089/ars.2006.8.1329; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Sharma M, 2013, J BIOL CHEM, V288, P12554, DOI 10.1074/jbc.M112.443945; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Strauch RC, 2011, J AM CHEM SOC, V133, P16346, DOI 10.1021/ja206134b; Taniguchi Y, 2010, LANGMUIR, V26, P10433, DOI 10.1021/la101658a; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Tantama M, 2011, J AM CHEM SOC, V133, P10034, DOI 10.1021/ja202902d; Ueno Y, 2004, SYNTHESIS-STUTTGART, P2591, DOI 10.1055/s-2004-829194; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; von Bohlen und Halbach O, 2002, NEUROIMAGE, V15, P633, DOI 10.1006/nimg.2001.1045; Wang Y, 2012, CANCER LETT, V320, P111, DOI 10.1016/j.canlet.2012.01.037; Yang Y, 2005, P NATL ACAD SCI USA, V102, P117, DOI 10.1073/pnas.0405989102; Yoshimura T, 1996, NAT BIOTECHNOL, V14, P992, DOI 10.1038/nbt0896-992; Zhang Y, 2006, ANGEW CHEM INT EDIT, V45, P4936, DOI 10.1002/anie.200601197; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	44	10	10	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123986	10.1371/journal.pone.0123986	http://dx.doi.org/10.1371/journal.pone.0123986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923693	gold, Green Published			2022-12-26	WOS:000353711600065
J	Sasaki, S; Kobayashi, M; Futagi, Y; Ogura, J; Yamaguchi, H; Iseki, K				Sasaki, Shotaro; Kobayashi, Masaki; Futagi, Yuya; Ogura, Jiro; Yamaguchi, Hiroaki; Iseki, Ken			Involvement of Histidine Residue His382 in pH Regulation of MCT4 Activity	PLOS ONE			English	Article							BLOOD-RETINAL BARRIER; MONOCARBOXYLATE TRANSPORTER; FOLATE TRANSPORTER; ACID; IDENTIFICATION; EXPRESSION; NICOTINATE; PROTEIN; CLONING; CELLS	Monocarboxylate transporter 4 (MCT4) is a pH-dependent bi-directional lactate transporter. Transport of lactate via MCT4 is increased by extracellular acidification. We investigated the critical histidine residue involved in pH regulation of MCT4 function. Transport of lactate via MCT4 was measured by using a Xenopus laevis oocyte expression system. MCT4-mediated lactate transport was inhibited by Zn2+ in a pH physiological condition but not in an acidic condition. The histidine modifier DEPC (diethyl pyrocarbonate) reduced MCT4 activity but did not completely inactivate MCT4. After treatment with DEPC, pH regulation of MCT4 function was completely knocked out. Inhibitory effects of DEPC were reversed by hydroxylamine and suppressed in the presence of excess lactate and Zn2+. Therefore, we performed an experiment in which the extracellular histidine residue was replaced with alanine. Consequently, the pH regulation of MCT4-H382A function was also knocked out. Our findings demonstrate that the histidine residue His382 in the extracellular loop of the transporter is essential for pH regulation of MCT4-mediated substrate transport activity.	[Sasaki, Shotaro; Kobayashi, Masaki; Futagi, Yuya; Ogura, Jiro; Yamaguchi, Hiroaki; Iseki, Ken] Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci,Lab Clin Pharmaceut & Therapeut, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iseki, Ken] Hokkaido Univ Hosp, Dept Pharm, Sapporo, Hokkaido 0608648, Japan	Hokkaido University; Hokkaido University	Iseki, K (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci,Lab Clin Pharmaceut & Therapeut, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	ken-i@pharm.hokudai.ac.jp	kobayashi, masaki/B-1638-2015; Yamaguchi, Hiroaki/G-9969-2012; Ogura, Jiro/F-7260-2012	Yamaguchi, Hiroaki/0000-0003-3021-6120; Ogura, Jiro/0000-0001-5139-137X; Futagi, Yuya/0000-0003-2829-2845	Northern Advancement Center for Science and Technology	Northern Advancement Center for Science and Technology	Funding: This work was funded in part by a grant from the Northern Advancement Center for Science and Technology and from the Grant-in-Aid for Young Scientists (B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird FE, 2006, BIOCHEM J, V397, P369, DOI 10.1042/BJ20060026; Boll M, 2003, GENOMICS, V82, P47, DOI 10.1016/S0888-7543(03)00099-5; Clemmitt RH, 2000, BIOTECHNOL BIOENG, V67, P206, DOI 10.1002/(SICI)1097-0290(20000120)67:2<206::AID-BIT10>3.0.CO;2-X; Emoto A, 2002, AM J PHYSIOL-CELL PH, V282, pC1064, DOI 10.1152/ajpcell.00179.2001; Fei YJ, 1997, BIOCHEMISTRY-US, V36, P452, DOI 10.1021/bi962058p; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Fujisawa Y, 2006, BIOL PHARM BULL, V29, P997, DOI 10.1248/bpb.29.997; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HEMDAN ES, 1989, P NATL ACAD SCI USA, V86, P1811, DOI 10.1073/pnas.86.6.1811; Hosoya K, 2001, PHARM RES-DORDR, V18, P1669, DOI 10.1023/A:1013310210710; Ju PC, 2004, J BIOL CHEM, V279, P22983, DOI 10.1074/jbc.M312484200; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959; Metzner L, 2008, BBA-BIOMEMBRANES, V1778, P1042, DOI 10.1016/j.bbamem.2007.12.026; Metzner L, 2006, EUR J PHARM BIOPHARM, V63, P360, DOI 10.1016/j.ejpb.2006.01.009; Miles E W, 1977, Methods Enzymol, V47, P431; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Plata C, 2007, J BIOL CHEM, V282, P11996, DOI 10.1074/jbc.M609313200; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Sasaki S, 2015, J BIOL CHEM, V290, P2303, DOI 10.1074/jbc.M114.581892; Sasaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067690; Shimada A, 2006, NEUROSCI LETT, V392, P207, DOI 10.1016/j.neulet.2005.09.030; Sloane RP, 1996, J BIOTECHNOL, V49, P231, DOI 10.1016/0168-1656(96)01538-6; Tachikawa M, 2011, MICROVASC RES, V82, P385, DOI 10.1016/j.mvr.2011.06.009; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Zong XG, 2001, J BIOL CHEM, V276, P6313, DOI 10.1074/jbc.M010326200	27	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122738	10.1371/journal.pone.0122738	http://dx.doi.org/10.1371/journal.pone.0122738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919709	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400019
J	Gulyas, G; Toth, JT; Toth, DJ; Kurucz, I; Hunyady, L; Balla, T; Varnai, P				Gulyas, Gergo; Toth, Jozsef T.; Toth, Daniel J.; Kurucz, Istvan; Hunyady, Laszlo; Balla, Tamas; Varnai, Peter			Measurement of Inositol 1,4,5-Trisphosphate in Living Cells Using an Improved Set of Resonance Energy Transfer-Based Biosensors	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE LEVELS; PROTEIN-COUPLED RECEPTOR; CALCIUM-ENTRY; FLUORESCENT PROTEIN; BINDING; DOMAINS; LIGAND; FRET; IDENTIFICATION; INDICATORS	Improved versions of inositol-1,4,5-trisphosphate (InsP(3)) sensors were created to follow intracellular InsP(3) changes in single living cells and in cell populations. Similar to previous InsP(3) sensors the new sensors are based on the ligand binding domain of the human type-I InsP(3) receptor (InsP(3)R-LBD), but contain a mutation of either R265K or R269K to lower their InsP(3) binding affinity. Tagging the InsP(3)R-LBD with N-terminal Cerulean and C-terminal Venus allowed measurement of InsP(3) in single-cell FRET experiments. Replacing Cerulean with a Luciferase enzyme allowed experiments in multi-cell format by measuring the change in the BRET signal upon stimulation. These sensors faithfully followed the agonist-induced increase in InsP(3) concentration in HEK 293T cells expressing the Gq-coupled AT1 angiotensin receptor detecting a response to agonist concentration as low as 10 pmol/L. Compared to the wild type InsP(3) sensor, the mutant sensors showed an improved off-rate, enabling a more rapid and complete return of the signal to the resting value of InsP(3) after termination of M3 muscarinic receptor stimulation by atropine. For parallel measurements of intracellular InsP(3) and Ca2+ levels in BRET experiments, the Cameleon D3 Ca2+ sensor was modified by replacing its CFP with luciferase. In these experiments depletion of plasma membrane Ptdlns(4,5)P-2 resulted in the fall of InsP(3) level, followed by the decrease of the Ca2+-signal evoked by the stimulation of the AT1 receptor. In contrast, when type-III PI 4-kinases were inhibited with a high concentration of wortmannin or a more specific inhibitor, A1, the decrease of the Ca2+-signal preceded the fall of InsP(3) level indicating an InsP(3)(-), independent, direct regulation of capacitative Ca2+ influx by plasma membrane inositol lipids. Taken together, our results indicate that the improved InsP(3) sensor can be used to monitor both the increase and decrease of InsP(3) levels in live cells suitable for high-throughput BRET applications.	[Gulyas, Gergo; Toth, Jozsef T.; Toth, Daniel J.; Hunyady, Laszlo; Varnai, Peter] Semmelweis Univ, Fac Med, Dept Physiol, H-1094 Budapest, Hungary; [Kurucz, Istvan; Balla, Tamas] NICHHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	Semmelweis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Varnai, P (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, H-1094 Budapest, Hungary.	varnai.peter@med.semmelweis-univ.hu	Gulyás, Gergő/I-8923-2017; Tóth, Dániel/M-7105-2019	Gulyás, Gergő/0000-0002-5491-8699; Tóth, Dániel/0000-0001-6670-3348; Toth, Jozsef/0000-0002-4993-4926; Balla, Tamas/0000-0002-9077-3335	Hungarian Scientific Research Fund (OTKA) [K105006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by Hungarian Scientific Research Fund (OTKA) K105006: PV, http://www.otka.hu/en.	Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; BALLA T, 1986, P NATL ACAD SCI USA, V83, P9323, DOI 10.1073/pnas.83.24.9323; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; BREDT DS, 1989, BIOCHEM BIOPH RES CO, V159, P976, DOI 10.1016/0006-291X(89)92204-3; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Calloway N, 2011, J CELL SCI, V124, P2602, DOI 10.1242/jcs.084178; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; Korzeniowski MK, 2009, J BIOL CHEM, V284, P21027, DOI 10.1074/jbc.M109.012252; Maleth J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6843; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nezu A, 2006, BBA-GEN SUBJECTS, V1760, P1274, DOI 10.1016/j.bbagen.2006.04.004; Nezu A, 2010, J CELL SCI, V123, P2292, DOI 10.1242/jcs.064410; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rodgers W, 2002, BIOTECHNIQUES, V32, P1044, DOI 10.2144/02325st05; Sato M, 2005, ANAL CHEM, V77, P4751, DOI 10.1021/ac040195j; Tanimura A, 2004, J BIOL CHEM, V279, P38095, DOI 10.1074/jbc.C400312200; Tanimura A, 2009, J BIOL CHEM, V284, P8901, DOI 10.1074/jbc.M805865200; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Toth DJ, 2012, J CELL SCI, V125, P2185, DOI 10.1242/jcs.097279; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Varnai P, 2005, P NATL ACAD SCI USA, V102, P7859, DOI 10.1073/pnas.0407535102; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884; Woo J, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-23; Yoshikawa F, 1999, J BIOL CHEM, V274, P328, DOI 10.1074/jbc.274.1.328	33	17	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125601	10.1371/journal.pone.0125601	http://dx.doi.org/10.1371/journal.pone.0125601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932648	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000353887100120
J	Hong, ZF; Zhao, WX; Yin, ZY; Xie, CR; Xu, YP; Chi, XQ; Zhang, S; Wang, XM				Hong, Zai-Fa; Zhao, Wen-Xiu; Yin, Zhen-Yu; Xie, Cheng-Rong; Xu, Ya-Ping; Chi, Xiao-Qin; Zhang, Sheng; Wang, Xiao-Min			Capsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced Autophagy	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; CANCER-CELLS; INDUCED APOPTOSIS; PATHWAYS; THERAPY; DIFFERENTIATION; MODULATION; ANTITUMOR	Cholangiocarcinoma (CCA), a devastating cancer with a poor prognosis, is resistant to the currently available chemotherapeutic agents. Capsaicin, the major pungent ingredient found in hot red chili peppers of the genus Capsicum, suppresses the growth of several malignant cell lines. Our aims were to investigate the role and mechanism of capsaicin with respect to the sensitivity of CCA cells to chemotherapeutic agents. The effect of capsaicin on CCA tumor sensitivity to 5-fluorouracil (5-FU) was assessed in vitro in CCA cells and in vivo in a xenograft model. The drug sensitivity of QBC939 to 5-FU was significantly enhanced by capsaicin compared with either agent alone. In addition, the combination of capsaicin with 5-FU was synergistic, with a combination index (CI) < 1, and the combined treatment also suppressed tumor growth in the CCA xenograft to a greater extent than 5-FU alone. Further investigation revealed that the autophagy induced by 5-FU was inhibited by capsaicin. Moreover, the decrease in AKT and S6 phosphorylation induced by 5-FU was effectively reversed by capsaicin, indicating that capsaicin inhibits 5-FU-induced autophagy by activating the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway in CCA cells. Taken together, these results demonstrate that capsaicin may be a useful adjunct therapy to improve chemosensitivity in CCA. This effect likely occurs via PI3K/AKT/mTOR pathway activation, suggesting a promising strategy for the development of combination drugs for CCA.	[Hong, Zai-Fa] Fujian Med Univ, Postgrad Coll, Fuzhou, Peoples R China; [Hong, Zai-Fa] Xiamen Tradit Hosp, Liver Dis Ctr, Dept Hepatobiliary Surg, Xiamen, Peoples R China; [Zhao, Wen-Xiu; Yin, Zhen-Yu; Xie, Cheng-Rong; Xu, Ya-Ping; Chi, Xiao-Qin; Zhang, Sheng; Wang, Xiao-Min] Xiamen Univ, Zhongshan Hosp, Dept Hepatobiliary Surg, Xiamen, Peoples R China; [Wang, Xiao-Min] Fujian Med Univ, Union Clin Med Coll, Fuzhou, Peoples R China	Fujian Medical University; Xiamen University; Fujian Medical University	Wang, XM (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Hepatobiliary Surg, Xiamen, Peoples R China.	wxm@xmzsh.com	Hong, zaifa/HGU-2883-2022; Yuhua, Xu/AFK-6705-2022	Yuhua, Xu/0000-0001-9285-3008	National Natural Science Foundation of China [81171976]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant from the National Natural Science Foundation of China (Grant No. 81171976). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Diaz-Laviada I, 2014, PROG DRUG RES, V68, P181, DOI 10.1007/978-3-0348-0828-6_8; Eskelinen EL, 2011, CURR OPIN PHARMACOL, V11, P294, DOI 10.1016/j.coph.2011.03.009; Fang YJ, 2012, CANCER SCI, V103, P1090, DOI 10.1111/j.1349-7006.2012.02272.x; Gil YG, 2008, LIFE SCI, V82, P997, DOI 10.1016/j.lfs.2008.02.020; Grunt TW, 2013, CURR CANCER DRUG TAR, V13, P188; Honscheid P, 2014, INT J RADIAT BIOL, V90, P628, DOI 10.3109/09553002.2014.907932; Hou YJ, 2011, LAB INVEST, V91, P1146, DOI 10.1038/labinvest.2011.97; Huang SP, 2009, ANTICANCER RES, V29, P165; Ip SW, 2012, ENVIRON TOXICOL, V27, P332, DOI 10.1002/tox.20646; Jin JZ, 2014, INT J BIOL SCI, V10, P285, DOI 10.7150/ijbs.7730; Kumar A, 2013, TOXICOL APPL PHARM, V273, P196, DOI 10.1016/j.taap.2013.09.005; Lang M, 2009, LIVER INT, V29, P670, DOI 10.1111/j.1478-3231.2009.01984.x; Lau JK, 2014, APOPTOSIS, V19, P1190, DOI 10.1007/s10495-014-1007-y; Lee JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083611; Li X, 2007, METHOD FIND EXP CLIN, V29, P607, DOI 10.1358/mf.2007.29.9.1139054; Liu H, 2014, J MOL MED; Liu ZH, 2011, MOL BIOL REP, V38, P1769, DOI 10.1007/s11033-010-0291-z; Mayer LD, 2006, MOL CANCER THER, V5, P1854, DOI 10.1158/1535-7163.MCT-06-0118; Naus PJ, 2007, J HEPATOL, V46, P222, DOI 10.1016/j.jhep.2006.08.012; Naveed Sidra, 2014, Oman Med J, V29, P391, DOI 10.5001/omj.2014.107; Rizvi S, 2014, DIGEST DIS, V32, P564, DOI 10.1159/000360502; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Shen DY, 2011, PHYTOTHER RES, V25, P1519, DOI 10.1002/ptr.3435; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Soory Mena, 2009, Infectious Disorders - Drug Targets, V9, P400; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Wojcik S, 2013, FOLIA HISTOCHEM CYTO, V51, P249, DOI 10.5603/FHC.2013.0036; Wu TTL, 2014, CELL CALCIUM, V56, P59, DOI 10.1016/j.ceca.2014.04.006	30	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0121538	10.1371/journal.pone.0121538	http://dx.doi.org/10.1371/journal.pone.0121538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933112	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100004
J	Nadendla, E; Teyssier, C; Delfosse, V; Vivat, V; Krishnasamy, G; Gronemeyer, H; Bourguet, W; Germain, P				Nadendla, Eswarkumar; Teyssier, Catherine; Delfosse, Vanessa; Vivat, Valerie; Krishnasamy, Gunasekaran; Gronemeyer, Hinrich; Bourguet, William; Germain, Pierre			An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor beta (RAR beta, NR1B2) Selective Agonist	PLOS ONE			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ANTAGONISTS; CANCER; GENE; IDENTIFICATION; MECHANISM	Retinoic acid is an important regulator of cell differentiation which plays major roles in embryonic development and tissue remodeling. The biological action of retinoic acid is mediated by three nuclear receptors denoted RAR alpha, beta and gamma. Multiple studies support that RAR beta possesses functional characteristics of a tumor suppressor and indeed, its expression is frequently lost in neoplastic tissues. However, it has been recently reported that RAR beta could also play a role in mammary gland tumorigenesis, thus demonstrating the important but yet incompletely understood function of this receptor in cancer development. As a consequence, there is a great need for RAR beta-selective agonists and antagonists as tools to facilitate the pharmacological analysis of this protein in vitro and in vivo as well as for potential therapeutic interventions. Here we provide experimental evidences that the novel synthetic retinoid BMS948 is an RAR beta-selective ligand exhibiting a full transcriptional agonistic activity and activating RAR beta as efficiently as the reference agonist TTNPB. In addition, we solved the crystal structures of the RAR beta ligand-binding domain in complex with BMS948 and two related compounds, BMS641 and BMS411. These structures provided a rationale to explain how a single retinoid can be at the same time an RAR alpha antagonist and an RAR beta full agonist, and revealed the structural basis of partial agonism. Finally, in addition to revealing that a flip by 180 degrees of the amide linker, that usually confers RAR alpha selectivity, accounts for the RAR beta selectivity of BMS948, the structural analysis uncovers guidelines for the rational design of RAR beta-selective antagonists.	[Nadendla, Eswarkumar; Teyssier, Catherine; Delfosse, Vanessa; Bourguet, William; Germain, Pierre] Ctr Biochim Struct, Inserm U1054, Montpellier, France; [Nadendla, Eswarkumar; Teyssier, Catherine; Delfosse, Vanessa; Bourguet, William; Germain, Pierre] Univ Montpellier I, CNRS UMR5048, Montpellier, France; [Nadendla, Eswarkumar; Teyssier, Catherine; Delfosse, Vanessa; Bourguet, William; Germain, Pierre] Univ Montpellier 2, Montpellier, France; [Nadendla, Eswarkumar; Krishnasamy, Gunasekaran] Univ Madras, CAS Crystallog & Biophys, Madras, Tamil Nadu, India; [Vivat, Valerie] Novalix, Illkirch Graffenstaden, CU De Strasbour, France; [Gronemeyer, Hinrich] IGBMC, CNRS INSERM UdS CERBM, Illkirch Graffenstaden, CU De Strasbour, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; University of Madras; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bourguet, W (corresponding author), Ctr Biochim Struct, Inserm U1054, Montpellier, France.	bourguet@cbs.cnrs.fr; germain@cbs.cnrs.fr	Bourguet, William/Y-6600-2019; Teyssier, Catherine/AAC-2395-2020; Bourguet, William/I-5569-2013; Nadendla, EswarKumar/AID-6966-2022; Gronemeyer, Hinrich/G-6240-2011; Gronemeyer, Hinrich/AAH-5575-2019; Gronemeyer, Hinrich/H-7002-2016	Bourguet, William/0000-0002-0643-7719; Teyssier, Catherine/0000-0003-4937-6503; Bourguet, William/0000-0002-0643-7719; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Eswarkumar, Nadendla/0000-0001-7938-8033; Germain, Pierre/0000-0003-2962-9593; Delfosse, Vanessa/0000-0002-7436-7935	Agence Nationale pour la Recherche [ANR-13-BSV6-0003-01]; Association pour la Recherche sur le Cancer [ARC A08/4/1056]; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique, Universite de Montpellier 1 2	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique, Universite de Montpellier 1 2	This work was supported by the Agence Nationale pour la Recherche (ANR-13-BSV6-0003-01), the Association pour la Recherche sur le Cancer (ARC A08/4/1056). It was also supported by funds from the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, Universite de Montpellier 1 & 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Alvarez R, 2014, CHEM REV, V114, P1, DOI 10.1021/cr400126u; Alvarez S, 2007, INT J BIOCHEM CELL B, V39, P1406, DOI 10.1016/j.biocel.2007.02.010; Alvarez S, 2009, CHEMMEDCHEM, V4, P1630, DOI 10.1002/cmdc.200900214; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Castillo L, 1997, CLIN CANCER RES, V3, P2137; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; Dawson M. I., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P199, DOI 10.2174/1568011043352975; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Gehin M, 1999, CHEM BIOL, V6, P519, DOI 10.1016/S1074-5521(99)80084-2; Germain P, 2004, EMBO REP, V5, P877, DOI 10.1038/sj.embor.7400235; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2009, CHEM BIOL, V16, P479, DOI 10.1016/j.chembiol.2009.03.008; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kagechika H, 2005, J MED CHEM, V48, P5875, DOI 10.1021/jm0581821; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; Klaholz BP, 2000, J MOL BIOL, V302, P155, DOI 10.1006/jmbi.2000.4032; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; le Maire A, 2012, CURR TOP MED CHEM, V12, P505, DOI 10.2174/156802612799436687; le Maire A, 2010, NAT STRUCT MOL BIOL, V17, P801, DOI 10.1038/nsmb.1855; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Liu XX, 2011, P NATL ACAD SCI USA, V108, P774, DOI 10.1073/pnas.1011845108; LOTAN R, 1995, NEW ENGL J MED, V332, P1405, DOI 10.1056/NEJM199505253322103; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Martinez C, 2014, ACS MED CHEM LETT, V5, P533, DOI 10.1021/ml400521f; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ortiz MA, 2002, DRUG RESIST UPDATE, V5, P162, DOI 10.1016/S1368-7646(02)00050-X; Osz J, 2012, P NATL ACAD SCI USA, V109, pE588, DOI 10.1073/pnas.1118192109; Pogenberg V, 2005, J BIOL CHEM, V280, P1625, DOI 10.1074/jbc.M409302200; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Shin DM, 1997, CLIN CANCER RES, V3, P875; Sirchia SM, 2002, CANCER RES, V62, P2455; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Widschwendter M, 2001, J MAMMARY GLAND BIOL, V6, P193, DOI 10.1023/A:1011360724350; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	41	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123195	10.1371/journal.pone.0123195	http://dx.doi.org/10.1371/journal.pone.0123195			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933005	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100017
J	Jin, YM; Raviv, N; Barnett, A; Bambakidis, NC; Filichia, E; Luo, Y				Jin, Yongmin; Raviv, Nataly; Barnett, Austin; Bambakidis, Nicholas C.; Filichia, Emily; Luo, Yu			The Shh Signaling Pathway Is Upregulated in Multiple Cell Types in Cortical Ischemia and Influences the Outcome of Stroke in an Animal Model	PLOS ONE			English	Article							ADULT SUBVENTRICULAR ZONE; SONIC-HEDGEHOG; STEM-CELLS; FUNCTIONAL RECOVERY; REACTIVE GLIA; PROLIFERATION; MAINTENANCE; MODULATION; PRECURSORS; SURVIVAL	Recently the sonic hedgehog (shh) signaling pathway has been shown to play an important role in regulating repair and regenerative responses after brain injury, including ischemia. However, the precise cellular components that express and upregulate the shh gene and the cellular components that respond to shh signaling remain to be identified. In this study, using a distal MCA occlusion model, our data show that the shh signal is upregulated both at the cortical area near the injury site and in the adjacent striatum. Multiple cell types upregulate shh signaling in ischemic brain, including neurons, reactive astrocytes and nestin-expressing cells. The shh signaling pathway genes are also expressed in the neural stem cells (NSCs) niche in the subventricular zone (SVZ). Conditional deletion of the shh gene in nestin-expressing cells both at the SVZ niche and at the ischemic site lead to significantly more severe behavioral deficits in these shh iKO mice after cortical stroke, measured using an automated open field locomotion apparatus (Student's t-test, p<0.05). In contrast, animals given post-stroke treatment with the shh signaling agonist (SAG) demonstrated less deficits in behavioral function, compared to vehicle-treated mice. At 7 days after stroke, SAG-treated mice showed higher values in multiple horizontal movement parameters compared to vehicle treated mice (Student's t-test, p<0.05) whereas there were no differences in pre-stroke measurements, (Student's t-test, p>0.05). In summary, our data demonstrate that shh signaling plays critical and ongoing roles in response to ischemic injury and modulation of shh signaling in vivo alters the functional outcome after cortical ischemic injury.	[Jin, Yongmin; Raviv, Nataly; Barnett, Austin; Bambakidis, Nicholas C.; Filichia, Emily; Luo, Yu] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA	Case Western Reserve University	Luo, Y (corresponding author), Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA.	yxl710@case.edu		Luo, Yu/0000-0002-7939-5505	American Heart Association National Scientist Development Award [13SDG17200019]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091213] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Award(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Yu Luo is funded by the American Heart Association National Scientist Development Award (13SDG17200019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 2002, NAT REV NEUROSCI, V3, P24; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Bambakidis NC, 2012, J NEUROSURG, V116, P1114, DOI 10.3171/2012.1.JNS111285; Bambakidis NC, 2010, NEUROSURGERY, V67, P1709, DOI 10.1227/NEU.0b013e3181f9b0a5; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Ding XS, 2013, J CEREBR BLOOD F MET, V33, P1015, DOI 10.1038/jcbfm.2013.50; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gilman S, 2006, EXP NEUROL, V199, P28, DOI 10.1016/j.expneurol.2006.03.002; Goldstein LB, 2007, CIRCULATION, V116, P1504, DOI 10.1161/CIRCULATIONAHA.106.670885; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Li NL, 2011, REJUV RES, V14, P261, DOI 10.1089/rej.2010.1115; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Luo Y, 2011, J NEURAL TRANSM, V118, P61, DOI 10.1007/s00702-010-0478-4; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460; Oniscu A, 2004, J PATHOL, V203, P909, DOI 10.1002/path.1591; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Pitter KL, 2014, GLIA, V62, P1595, DOI 10.1002/glia.22702; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rousselet E, 2012, JOVE-J VIS EXP, DOI 10.3791/4038; Shen H, 2008, NEUROSCI LETT, V442, P15, DOI 10.1016/j.neulet.2008.06.052; Shen H, 2010, J NEUROSCI METH, V186, P150, DOI 10.1016/j.jneumeth.2009.11.008; Sieber MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026288; Sims JR, 2009, STROKE, V40, P3618, DOI 10.1161/STROKEAHA.109.561951; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; Wang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085234, 10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0108223]; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wu MZ, 2012, J NEUROSCI, V32, P6651, DOI 10.1523/JNEUROSCI.4876-11.2012; Xia YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068891; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73	43	44	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124657	10.1371/journal.pone.0124657	http://dx.doi.org/10.1371/journal.pone.0124657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927436	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100043
J	Shi, YG; Liu, YC; Wang, JR; Jie, D; Yun, T; Li, W; Yan, L; Wang, KM; Feng, JF				Shi, Yongguo; Liu, Yangchen; Wang, Jirong; Jie, Ding; Yun, Tian; Li, Wang; Yan, Lin; Wang, Keming; Feng, Jifeng			Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregualtion of p21 Expression	PLOS ONE			English	Article							POOR-PROGNOSIS; LUNG-CANCER; INHIBITION; APOPTOSIS; GROWTH; GENES	BRAF activated non-coding RNA (BANCR), a long non-coding RNA (lncRNA), is crucial for cell migration in melanoma cells and non-small cell lung cancer (NSCLC) cells. However, little is known regarding the role of this gene in the proliferation of colorectal cancer. Therefore, we investigated the involvement of BANCR in the proliferation of colorectal cancer cells. In this study, we show that BANCR expression was significantly down-regulated in colorectal cancer tissues compared with normal tissues, and overexpression of BANCR suppressed colorectal cancer cell growth in vitro and in vivo. We also determined that pCDNA-BANCR-mediated colorectal cancer cell proliferation was associated with induction of G0/G1 cell-cycle arrest and apoptosis enhancement through regulation of p21, and its effects were most likely posttranscriptional. Taken together, our findings suggest that down-regulation of BANCR contributes to the proliferation of colorectal cancer cells, at least in part, through the regulation of p21 protein.	[Shi, Yongguo; Wang, Jirong; Jie, Ding; Yun, Tian; Li, Wang; Yan, Lin; Wang, Keming] Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Shi, Yongguo; Liu, Yangchen] Taixing Peoples Hosp, Taixing, Jiangsu, Peoples R China; [Feng, Jifeng] Canc Hosp Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, KM (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	kemingwang@njmu.edu.cn; fjif@medmail.com.cn			Outstanding Medical Academic Leader program of Jiangsu province [LG201126]; Six talents peak project of Jiangsu province [WSN-050]; Medical Science and Technology Development Fund Project of Nanjing [YKK13178]	Outstanding Medical Academic Leader program of Jiangsu province; Six talents peak project of Jiangsu province; Medical Science and Technology Development Fund Project of Nanjing	This work was supported by the Outstanding Medical Academic Leader program of Jiangsu province (LG201126), the Six talents peak project of Jiangsu province (WSN-050), and the Medical Science and Technology Development Fund Project of Nanjing (YKK13178).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Hu ZY, 2012, CARCINOGENESIS, V33, P1178, DOI 10.1093/carcin/bgs141; Huang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.541; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Joshi US, 1998, CANCER GENE THER, V5, P183; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; Liu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077293; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu KH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-461; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Negishi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095216; Qi P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-122; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; Quo QH, 2014, ONCOL LETT, V8, P869, DOI 10.3892/ol.2014.2154; Rossi Marianna Nicoletta, 2014, Int J Cell Biol, V2014, P473857, DOI 10.1155/2014/473857; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sostres Carlos, 2014, World J Gastrointest Pharmacol Ther, V5, P40, DOI 10.4292/wjgpt.v5.i1.40; Sun M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-68; Wu MH, 2009, CURR GENOMICS, V10, P216, DOI 10.2174/138920209788488481; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang F, 2009, CANCER BIOL THER, V8, P823, DOI 10.4161/cbt.8.9.8143	28	94	104	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122679	10.1371/journal.pone.0122679	http://dx.doi.org/10.1371/journal.pone.0122679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928067	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100010
J	Aerts, J; Metz, JR; Ampe, B; Decostere, A; Flik, G; De Saeger, S				Aerts, Johan; Metz, Juriaan Rogier; Ampe, Bart; Decostere, Annemie; Flik, Gert; De Saeger, Sarah			Scales Tell a Story on the Stress History of Fish	PLOS ONE			English	Article							PLASMA-CORTISOL; TRICAINE METHANESULFONATE; ANESTHETIC EFFICACY; RESPONSES; GROWTH; TROUT; WATER; METOMIDATE; ALLOSTASIS; PHYSIOLOGY	Fish faced with stressful stimuli launch an endocrine stress response through activation of the hypothalamic-pituitary-interrenal (HPI-) axis to release cortisol into the blood. Scientifically validated biomarkers to capture systemic cortisol exposure over longer periods of time are of utmost importance to assess chronic stress in governmental, wildlife, aquaculture and scientific settings. Here we demonstrate that cortisol in scales of common carp (Cyprinus carpio L.) is the long-sought biomarker for chronic stress. Undisturbed (CTR) and daily stressed (STRESS) carp were compared. Dexamethasone (DEX) or cortisol (CORT) fed fish served as negative and positive controls, respectively. Scale cortisol was quantified with a validated ultra-performance liquid chromatography tandem mass spectrometry method. An increase in scale cortisol content was found in STRESS and CORT but not in CTR and DEX fish. Scale cortisol content reflects its accumulation in a stressor and time dependent manner and validates the scale cortisol content as biomarker for chronic stress. Plasma analyses confirmed that (i) CTR, DEX and CORT treatments were effective, (ii) plasma cortisol of STRESS fish showed no signs of chronic HPI-axis activation, and (iii) plasma cortisol is a poor predictor for chronic stress. The expression of HPI key genes crf, pomc, and star were up-regulated in STRESS fish in the absence of a plasma cortisol response, as was the target gene of cortisol encoding subunit alpha 1 of the Na+/K+-ATPase in gills. When lost, scales of fish regenerate fast. Regenerated scales corroborate our findings, offering (i) unsurpassed time resolution for cortisol incorporation and as such for stressful events, and (ii) the possibility to investigate stress in a well defined and controlled environment and time frame creating novel opportunities for bone physiological research. We conclude that the cortisol content in ontogenetic and regenerated scales is an innovative biomarker for chronic stress offering ample applications in science and industry.	[Aerts, Johan] Inst Agr & Fisheries Res, Anim Sci Unit, Bioanal Res Grp, Melle, Belgium; [Aerts, Johan; De Saeger, Sarah] Univ Ghent, Fac Pharmaceut Sci, Dept Bioanal, Lab Food Anal, B-9000 Ghent, Belgium; [Metz, Juriaan Rogier; Flik, Gert] Radboud Univ Nijmegen, Fac Sci, Inst Water & Wetland Res, Dept Anim Physiol, NL-6525 ED Nijmegen, Netherlands; [Ampe, Bart] Inst Agr & Fisheries Res, Anim Sci Unit, Biostat & Data Modeling, Melle, Belgium; [Decostere, Annemie] Univ Ghent, Fac Vet Med, Dept Morphol, B-9000 Ghent, Belgium	Institute For Agricultural & Fisheries Research; Ghent University; Radboud University Nijmegen; Institute For Agricultural & Fisheries Research; Ghent University	Aerts, J (corresponding author), Inst Agr & Fisheries Res, Anim Sci Unit, Bioanal Res Grp, Melle, Belgium.	Johan.aerts@ilvo.vlaanderen.be	Flik, Gert/C-8229-2011; Metz, Juriaan R./A-3290-2012	Flik, Gert/0000-0001-9285-7957; Metz, Juriaan R./0000-0002-1515-1958	Institute for Agricultural and Fisheries Research; Laboratory of Food Analysis of the Faculty of Pharmaceutical Sciences of Ghent University; Department of Morphology of the Faculty of Veterinary Medicine of Ghent University; Department of Animal Physiology of Radboud University Nijmegen	Institute for Agricultural and Fisheries Research; Laboratory of Food Analysis of the Faculty of Pharmaceutical Sciences of Ghent University; Department of Morphology of the Faculty of Veterinary Medicine of Ghent University; Department of Animal Physiology of Radboud University Nijmegen	This research was financially supported by the Institute for Agricultural and Fisheries Research, the Laboratory of Food Analysis of the Faculty of Pharmaceutical Sciences of Ghent University, the Department of Morphology of the Faculty of Veterinary Medicine of Ghent University, and the Department of Animal Physiology of Radboud University Nijmegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PA, 2013, AQUACULT ENG, V54, P72, DOI 10.1016/j.aquaeng.2012.11.004; Anderson PA, 2011, AQUACULTURE, V311, P129, DOI 10.1016/j.aquaculture.2010.11.013; [Anonymous], 2004, 21748 ISOTS; [Anonymous], 2013, SUST AQ EUR; [Anonymous], Patent application, Patent No. [EP1319845, 1319845]; [Anonymous], 2007, 12007 EUR; Baker MR, 2013, J NAT CONSERV, V21, P309, DOI 10.1016/j.jnc.2013.03.003; Barnett V., 1994, OUTLIERS STAT DATA; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; BARTON BA, 1987, DIS AQUAT ORGAN, V2, P173; Bergqvist J, 2013, J AGR ENVIRON ETHIC, V26, P75, DOI 10.1007/s10806-011-9346-y; Bertotto D, 2010, AQUAC RES, V41, P1261, DOI 10.1111/j.1365-2109.2009.02417.x; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Boonstra R, 2013, FUNCT ECOL, V27, P7, DOI 10.1111/1365-2435.12048; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Bush SR, 2013, SCIENCE, V341, P1067, DOI 10.1126/science.1237314; Cadrin SX, 2013, STOCK IDENTIFICATION; Canalis E, 2002, ANN NY ACAD SCI, V966, P73, DOI 10.1111/j.1749-6632.2002.tb04204.x; Close DA, 2010, P NATL ACAD SCI USA, V107, P13942, DOI 10.1073/pnas.0914026107; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; COHEN SA, 1979, CLIN CHEM, V25, P1519; Cook NJ, 2012, CAN J ANIM SCI, V92, P227, DOI 10.4141/CJAS2012-045; Dang ZC, 2000, J EXP BIOL, V203, P2349; de Vrieze E, 2014, OSTEOPOROSIS INT, V25, P567, DOI 10.1007/s00198-013-2441-3; Diggles BK, 2011, REV FISH BIOL FISHER, V21, P739, DOI 10.1007/s11160-011-9206-x; EFSA, 2008, ANNEX 1 EFSA J, V843, P1; Ellis T, 2004, J FISH BIOL, V65, P1233, DOI 10.1111/j.0022-1112.2004.00499.x; *EN, 2005, 17025 EN ISOIEC; Eurachem, 2000, EUR CITAC GUID; Gorissen M, 2012, GEN COMP ENDOCR, V178, P75, DOI 10.1016/j.ygcen.2012.04.004; International Organization for Standardization Accuracy (Trueness and Precision) of Measurement Methods and Results, 1994, 5725 ISODIS; ISO GUM, 1995, NBN1040001 ISO GUM; Kawajiri M, 2011, ENVIRON BIOL FISH, V92, P285, DOI 10.1007/s10641-011-9839-6; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Lupica SJ, 2009, AQUAC RES, V40, P437, DOI 10.1111/j.1365-2109.2008.02112.x; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Metz JR, 2012, J APPL ICHTHYOL, V28, P382, DOI 10.1111/j.1439-0426.2012.01990.x; Nash RDM, 2006, FISHERIES, V31, P236; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Oliveira CCV, 2013, FISH PHYSIOL BIOCHEM, V39, P479, DOI 10.1007/s10695-012-9713-2; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Palic D, 2006, AQUACULTURE, V254, P675, DOI 10.1016/j.aquaculture.2005.11.004; Payan P, 2004, CAN J FISH AQUAT SCI, V61, P1247, DOI 10.1139/F04-059; Persson P, 2000, GEN COMP ENDOCR, V120, P35, DOI 10.1006/gcen.2000.7536; Pinto PIS, 2009, GEN COMP ENDOCR, V160, P19, DOI 10.1016/j.ygcen.2008.10.011; Richardson K, 2013, ANTHROPOGENICALLY IN; Romano MC, 2010, NEUROIMMUNOMODULAT, V17, P209, DOI 10.1159/000258726; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHONBORNER AA, 1979, CELL TISSUE RES, V202, P203; Schram E, 2010, AQUACULTURE, V306, P108, DOI 10.1016/j.aquaculture.2010.06.005; Simontacchi C, 2008, J FISH BIOL, V72, P747, DOI 10.1111/j.1095-8649.2007.01717.x; Small BC, 2003, AQUACULTURE, V218, P177, DOI 10.1016/S0044-8486(02)00302-2; Takahara T, 2011, HYDROBIOLOGIA, V675, P65, DOI 10.1007/s10750-011-0796-z; Tellis MS, 2012, COMP BIOCHEM PHYS C, V155, P281, DOI 10.1016/j.cbpc.2011.09.008; The Research Council of Norway, 2009, FISH RES ENV REQ WEL; Toorchi M, 2012, J APPL ICHTHYOL, V28, P130, DOI 10.1111/j.1439-0426.2011.01818.x; TSERPES G, 1995, FISH B-NOAA, V93, P594; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; [No title captured]	61	69	69	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123411	10.1371/journal.pone.0123411	http://dx.doi.org/10.1371/journal.pone.0123411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922947	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600046
J	Allan, TW; Francis, ST; Caballero-Gaudes, C; Morris, PG; Liddle, EB; Liddle, PF; Brookes, MJ; Gowland, PA				Allan, Thomas W.; Francis, Susan T.; Caballero-Gaudes, Cesar; Morris, Peter G.; Liddle, Elizabeth B.; Liddle, Peter F.; Brookes, Matthew J.; Gowland, Penny A.			Functional Connectivity in MRI Is Driven by Spontaneous BOLD Events	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SPONTANEOUS BRAIN ACTIVITY; RESTING-STATE NETWORKS; DEFAULT-MODE; SOMATOSENSORY CORTEX; MOTOR CORTEX; TASK; FMRI; DYNAMICS; MAGNETOENCEPHALOGRAPHY	Functional brain signals are frequently decomposed into a relatively small set of large scale, distributed cortical networks that are associated with different cognitive functions. It is generally assumed that the connectivity of these networks is static in time and constant over the whole network, although there is increasing evidence that this view is too simplistic. This work proposes novel techniques to investigate the contribution of spontaneous BOLD events to the temporal dynamics of functional connectivity as assessed by ultra-high field functional magnetic resonance imaging (fMRI). The results show that: 1) spontaneous events in recognised brain networks contribute significantly to network connectivity estimates; 2) these spontaneous events do not necessarily involve whole networks or nodes, but clusters of voxels which act in concert, forming transiently synchronising sub-networks and 3) a task can significantly alter the number of localised spontaneous events that are detected within a single network. These findings support the notion that spontaneous events are the main driver of the large scale networks that are commonly detected by seed-based correlation and ICA. Furthermore, we found that large scale networks are manifestations of smaller, transiently synchronising sub-networks acting dynamically in concert, corresponding to spontaneous events, and which do not necessarily involve all voxels within the network nodes oscillating in unison.	[Allan, Thomas W.; Francis, Susan T.; Morris, Peter G.; Brookes, Matthew J.; Gowland, Penny A.] Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Imagaing Ctr, Nottingham NG7 2RD, England; [Liddle, Elizabeth B.; Liddle, Peter F.] Univ Nottingham, Inst Mental Hlth, Nottingham NG7 2RD, England; [Caballero-Gaudes, Cesar] Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain	University of Nottingham; University of Nottingham	Gowland, PA (corresponding author), Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Imagaing Ctr, Univ Pk, Nottingham NG7 2RD, England.	penny.gowland@nottingham.ac.uk	Gowland, Penny A./I-9016-2012; Caballero-Gaudes, Cesar/H-6369-2015; Liddle, Peter/AAU-7939-2020; Liddle, Elizabeth/A-2034-2015	Gowland, Penny A./0000-0002-4900-4817; Caballero-Gaudes, Cesar/0000-0002-9068-5810; Liddle, Elizabeth/0000-0002-9299-094X; Brookes, Matthew/0000-0002-8687-8185; francis, sue/0000-0003-0903-7507; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892	'Realising the benefits of structural and functional MRI at ultra-high-field' - Medical Research Council Programme Grant [G0901321]; MRC [G0901321] Funding Source: UKRI; Medical Research Council [G0901321] Funding Source: researchfish	'Realising the benefits of structural and functional MRI at ultra-high-field' - Medical Research Council Programme Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Support was provided by 'Realising the benefits of structural and functional MRI at ultra-high-field' - Medical Research Council Programme Grant, (G0901321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, CEREB CORTEX, V20, P2188, DOI 10.1093/cercor/bhp284; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Chang C, 2010, FILM COMMENT, V46, P81; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Di X, 2015, BRAIN STRUCT FUNCT, V220, P37, DOI 10.1007/s00429-013-0634-3; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gaudes CC, 2013, HUM BRAIN MAPP, V34, P501, DOI 10.1002/hbm.21452; Gaudes CC, 2011, HUM BRAIN MAPP, V32, P1400, DOI 10.1002/hbm.21116; Gembris D, 2000, MAGN RESON MED, V43, P259, DOI 10.1002/(SICI)1522-2594(200002)43:2<259::AID-MRM13>3.0.CO;2-P; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gordon EM, 2014, HUM BRAIN MAPP, V35, P1004, DOI 10.1002/hbm.22230; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; HUTCHISON RM, 2012, HUM BRAIN MAPP, V34, P2154, DOI DOI 10.1002/HBM.22058; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Karahanoglu FI, 2013, NEUROIMAGE, V73, P121, DOI 10.1016/j.neuroimage.2013.01.067; Liu X, 2013, P NATL ACAD SCI USA, V110, P4392, DOI 10.1073/pnas.1216856110; Luckhoo H, 2012, NEUROIMAGE, V62, P530, DOI 10.1016/j.neuroimage.2012.04.046; Munchau A, 2002, J NEUROSCI, V22, P554, DOI 10.1523/JNEUROSCI.22-02-00554.2002; Nakai T, 2006, J NEUROSCI METH, V157, P158, DOI 10.1016/j.jneumeth.2006.04.017; Newton AT, 2011, HUM BRAIN MAPP, V32, P1649, DOI 10.1002/hbm.21138; Petridou N, 2013, HUM BRAIN MAPP, V34, P1319, DOI 10.1002/hbm.21513; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Saenz M, 2014, HEARING RES, V307, P42, DOI 10.1016/j.heares.2013.07.016; Sanchez-Panchuelo RM, 2010, J NEUROPHYSIOL, V103, P2544, DOI 10.1152/jn.01017.2009; Sanchez-Panchuelo RM, 2012, J NEUROSCI, V32, P15815, DOI 10.1523/JNEUROSCI.2501-12.2012; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531	44	29	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124577	10.1371/journal.pone.0124577	http://dx.doi.org/10.1371/journal.pone.0124577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922945	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600094
J	Altner, M; Reichenbacher, B				Altner, Melanie; Reichenbacher, Bettina			dagger Kenyaichthyidae fam. nov and dagger Kenyaichthys gen. nov - First Record of a Fossil Aplocheiloid Killifish (Teleostei, Cyprinodontiformes)	PLOS ONE			English	Article							VERTEBRAL COLUMN; LAGUNA-CHICHANCANAB; NATURAL-POPULATIONS; TAXONOMIC REVISION; SPINAL DEFORMITIES; CAUDAL SKELETON; SPECIES FLOCK; BARINGO BASIN; UPPER MIOCENE; FISHES	The extant Cyprinodontiformes (killifishes) with their two suborders Cyprinodontoidei and Aplocheiloidei represent a diverse and well-studied group of fishes. However, their fossil record is comparatively sparse and has so far yielded members of the Cyprinodontoidei only. Here we report on cyprinodontiform fossils from the upper Miocene Lukeino Formation in the Tugen Hills of the Central Rift Valley of Kenya, which represent the first fossil record of an aplocheiloid killifish. A total of 169 specimens - mostly extraordinarily well preserved and a sample of ten extant cyprinodontiform species were studied on the basis of morphometrics, meristics and osteology. A phylogenetic analysis using PAUP was also conducted for the fossils. Both the osteological data and the phylogenetic analysis provide strong evidence for the assignment of the fossils to the Aplocheiloidei, and justify the definition of the new family dagger Kenyaichthyidae, the new genus dagger Kenyaichthys and the new species dagger K. kipkechi sp. nov. The phylogenetic analysis unexpectedly places dagger Kenyaichthys gen. nov. in a sister relationship to the Rivulidae (a purely Neotropical group), a probable explanation might be lack of available synapomorphies for the Rivulidae, Nothobranchiidae and Aplocheilidae. The specimens of dagger K. kipkechi sp. nov. show several polymorphic characters and large overlap in meristic traits, which justifies their interpretation as a species flock in statu nascendi. Patterns of variation in neural and haemal spine dimensions in the caudal vertebrae of dagger Kenyaichthys gen. nov. and the extant species studied indicate that some previously suggested synapomorphies of the Cyprinodontoidei and Aplocheiloidei need to be revised.	[Altner, Melanie; Reichenbacher, Bettina] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany	University of Munich	Altner, M (corresponding author), Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany.	m.altner@lrz.uni-muenchen.de	Reichenbacher, Bettina/AAM-9684-2020	Reichenbacher, Bettina/0000-0001-6678-5080	Deutsche Forschungsgemeinschaft (DFG) [RE 113/18-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/); grant number is RE 113/18-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHL ERNST, 1934, ZOOL ANZ, V108, P304; Allen G.R., 1980, Records of the Western Australian Museum, V8, P449; [Anonymous], 1989, HEAVY METAL TOLERANC; [Anonymous], 2000, WORLD NUTR SIT NUTR, P136; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Bamford MK, 2013, GEOBIOS-LYON, V46, P253, DOI 10.1016/j.geobios.2013.02.001; BARLOW GEORGE W., 1961, AMER MIDLAND NAT, V65, P339, DOI 10.2307/2422959; BENGTSSON A, 1988, J FISH BIOL, V33, P517, DOI 10.1111/j.1095-8649.1988.tb05496.x; BENGTSSON B E, 1975, Ambio, V4, P166; Bensimon-Brito A, 2012, EVOL DEV, V14, P116, DOI 10.1111/j.1525-142X.2011.00526.x; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Bobe R, 2006, J ARID ENVIRON, V66, P564, DOI 10.1016/j.jaridenv.2006.01.010; Bogan Sergio, 2009, Pap. Avulsos Zool. (São Paulo), V49, P81, DOI 10.1590/S0031-10492009000500001; Bogutskaya NG, 2011, J FISH BIOL, V79, P991, DOI 10.1111/j.1095-8649.2011.03078.x; Briggs JC, 2003, SYST BIOL, V52, P548, DOI 10.1080/10635150390218385; Carnevale G, 2006, J GEOL SOC LONDON, V163, P75, DOI 10.1144/0016-764904-158; Cione Alberto L., 2007, Asociacion Paleontologica Argentina Publicacion Especial, V11, P195; Cione Alberto Luis, 1986, P101; COCKERELL T. D. A., 1936, AMER MUS NOVITATES, V886, P1; COLLETTE BRUCE B., 1966, AMER MUS NOVI TATES, V2274, P1; Collier GE, 2009, MOL PHYLOGENET EVOL, V50, P190, DOI 10.1016/j.ympev.2008.10.006; COSTA W J E M, 1990, Revista Brasileira de Biologia, V50, P65; Costa Wilson J.E.M., 2004, Ichthyological Exploration of Freshwaters, V15, P105; Costa WJEM, 2013, VERTEBR ZOOL, V63, P139; Costa WJEM, 2012, VERTEBR ZOOL, V62, P161; Costa WJEM, 2011, CYBIUM, V35, P181; Costa Wilson J. E. M., 2009, Vertebrate Zoology, V59, P31; Costa Wilson J.E.M., 1998, Journal of Comparative Biology, V3, P33; Costa Wilson J.E.M., 1998, P537; Costa Wilson J. E. M., 2007, Vertebrate Zoology, V57, P57; Costa WJEM, 2005, ZOOTAXA, P41; Cubells JF, 1994, GEOLOGIE MEDITERRANE, V21, P19; Dasilao JC, 1997, ICHTHYOL RES, V44, P101, DOI 10.1007/BF02678688; Dasilao JC, 1998, ICHTHYOL RES, V45, P303, DOI 10.1007/BF02673928; Dasilao Juanito C. Jr., 1998, Bulletin of Marine Sciences and Fisheries Kochi University, V0, P13; DEDI J, 1995, AQUACULTURE, V133, P135, DOI 10.1016/0044-8486(95)00015-T; Edenbrow M, 2012, J FISH BIOL, V80, P503, DOI 10.1111/j.1095-8649.2011.03181.x; Esmaeili HR, 2014, ZOOTAXA, V3786, P246, DOI 10.11646/zootaxa.3786.3.2; Ferrer J, 2008, NEOTROP ICHTHYOL, V6, P175, DOI 10.1590/S1679-62252008000200004; Froese R., 2011, FISHBASE WORLD WIDE; Fujita K., 1990, CAUDAL SKELETON TELE; Fuller RC, 2001, COPEIA, P823; Garcia G, 2012, J BIOGEOGR, V39, P1707, DOI 10.1111/j.1365-2699.2012.02722.x; GAUDANT J, 1993, GEOBIOS-LYON, V26, P449, DOI 10.1016/S0016-6995(06)80229-9; Gaudant Jean, 2002, Geodiversitas, V24, P691; Gaudant J, 2012, GEODIVERSITAS, V34, P409, DOI 10.5252/g2012n2a9; Gaudant J, 2011, GEODIVERSITAS, V33, P347, DOI 10.5252/g2011n2a9; Gavaia PJ, 2002, AQUACULTURE, V211, P305, DOI 10.1016/S0044-8486(02)00167-9; Gayet M., 1998, PHYLOGENY CLASSIFICA, P85; Gayet Mireille, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P393; Gayet Mireille, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P453; Geiger MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074901; Gholami Z, 2013, ZOOTAXA, V3619, P467, DOI 10.11646/zootaxa.3619.4.5; Gorman KF, 2007, COMP BIOCHEM PHYS C, V145, P28, DOI 10.1016/j.cbpc.2006.10.004; Greenwood P.H., 1984, P13; Guzman A. F., 2009, SETENTA CINCO ANOS E, P313; HAAS R, 1976, EVOLUTION, V30, P614, DOI 10.1111/j.1558-5646.1976.tb00938.x; Hertwig ST, 2008, ZOOL SCR, V37, P141, DOI 10.1111/j.1463-6409.2007.00314.x; HILL A, 1985, J HUM EVOL, V14, P759, DOI 10.1016/S0047-2484(85)80058-0; Hill A., 1986, Geological Society Special Publication, P285; Holcik J., 1989, FRESHWATER FISHES 2, V1; Horstkotte J, 2005, BIOL J LINN SOC, V85, P125, DOI 10.1111/j.1095-8312.2005.00476.x; Hosoya Kazumi, 1998, Bulletin of the National Research Institute of Fisheries Science, V0, P97; IBM Corp, 2012, IBM SPSS STAT MAC VE; Jacobs Bonnie F., 2010, P57; Karino K, 2006, ZOOL SCI, V23, P255, DOI 10.2108/zsj.23.255; Kessabi K, 2009, BIOL TRACE ELEM RES, V128, P72, DOI 10.1007/s12011-008-8255-z; Kingston JD, 2002, J HUM EVOL, V42, P95, DOI 10.1006/jhev.2001.0503; KODRICBROWN A, 1992, ENVIRON BIOL FISH, V35, P169, DOI 10.1007/BF00002191; Kumar P., 2010, GERF B BIOSCI, V1, P41, DOI DOI 10.1016/J.AQUAT0X.2003.11.010; Kvellestad A, 2000, DIS AQUAT ORGAN, V39, P97, DOI 10.3354/dao039097; Livingston TD, 2004, GEOLOGICAL SOC AM AB, V36, P286; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; Madsen L, 1999, AQUACULTURE, V171, P41, DOI 10.1016/S0044-8486(98)00427-X; Marchio EA, 2013, BIOL J LINN SOC, V109, P848, DOI 10.1111/bij.12076; Mayr E, 1984, EVOLUTION FISH SPECI, P3; Meisner AD, 2001, ZOOL J LINN SOC-LOND, V133, P199, DOI 10.1111/j.1096-3642.2001.tb00690.x; Messaoudi I, 2009, AFR J ECOL, V47, P360, DOI 10.1111/j.1365-2028.2008.00972.x; Messaoudi I, 2009, ENVIRON MONIT ASSESS, V156, P551, DOI 10.1007/s10661-008-0504-2; Miller R.R., 1986, P487; Murphy WJ, 1997, MOL BIOL EVOL, V14, P790, DOI 10.1093/oxfordjournals.molbev.a025819; Murphy WJ, 1999, MOL PHYLOGENET EVOL, V11, P351, DOI 10.1006/mpev.1998.0566; Murray AM, 2000, J VERTEBR PALEONTOL, V20, P651, DOI 10.1671/0272-4634(2000)020[0651:ECFFTE]2.0.CO;2; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Northcote TG, 2000, ADV ECOL RES, V31, P399, DOI 10.1016/S0065-2504(00)31021-2; PARENTI LR, 1984, B AM MUS NAT HIST, V178, P110; PARENTI LR, 1993, B MAR SCI, V52, P170; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494, DOI 10.1111/j.1096-3642.2008.00417.x; Parenti LR, 2014, RAFFLES B ZOOL, V62, P175; PARKER A, 1995, COPEIA, P8; PICKFORD M, 1975, NATURE, V256, P279, DOI 10.1038/256279a0; Pickford M, 2009, GEO PAL KENYA, V1, P72; Pickford MHL, 1978, GEOL SOC LOND SPEC P, V6, P263, DOI DOI 10.1144/GSL.SP.1978.006.01.19; Porto JC., 1982, 5 C LAT ARG ACT, VIV, P253; Rasband W., 2006, IMAGEJ; Reichenbacher B, 2009, PALAEOGEOGR PALAEOCL, V281, P43, DOI 10.1016/j.palaeo.2009.07.008; Rosen D. E., 1964, Bulletin of the American Museum of Natural History, V127, P217; Rosen D. E., 1981, AM MUS NOVIT, V2719, P1; Ruckert-Ulkumen N, 2002, MITTEILUNGEN BAYERIS, V42, P51; SAEED B, 1989, AUST J MAR FRESH RES, V40, P719; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; SHUTE PW, 1983, ENVIRON BIOL FISH, V8, P293, DOI 10.1007/BF00001095; SMITH GR, 1981, ANNU REV ECOL SYST, V12, P163, DOI 10.1146/annurev.es.12.110181.001115; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; STIASSNY MLJ, 1990, AM MUS NOVIT, P1; Strecker U, 2002, CYBIUM, V26, P301; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAYLOR W R, 1985, Cybium, V9, P107; Uyeno T., 1962, Copeia, V1962, P520, DOI 10.2307/1441173; Vasilyan D, 2009, PALAEONTOL Z, V83, P511, DOI 10.1007/s12542-009-0034-4; Villwock W., 1994, Ecological Studies, V106, P51; VILLWOCK W, 1982, Z ZOOL SYST EVOL, V20, P187; WEITZMAN SH, 1967, COPEIA, P89; Wiley E.O., 2010, P123	115	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123056	10.1371/journal.pone.0123056	http://dx.doi.org/10.1371/journal.pone.0123056			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923654	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600028
J	Fanti, F; Cau, A; Cantelli, L; Hassine, M; Auditore, M				Fanti, Federico; Cau, Andrea; Cantelli, Luigi; Hassine, Mohsen; Auditore, Marco			New Information on Tataouinea hannibalis from the Early Cretaceous of Tunisia and Implications for the Tempo and Mode of Rebbachisaurid Sauropod Evolution	PLOS ONE			English	Article							SOUTHERNMOST SOUTH-AMERICA; PHYLOGENETIC ANALYSIS; TECTONIC EVOLUTION; DINOSAUR BONE; DIPLODOCOIDEA; DEPOSITS; PALEOSOLS; BASIN; VERTEBRATES; DIVERSITY	The rebbachisaurid sauropod Tataouinea hannibalis represents the first articulated dinosaur skeleton from Tunisia and one of the best preserved in northern Africa. The type specimen was collected from the lower Albian, fluvio-estuarine deposits of the Ain el Guettar Formation (southern Tunisia). We present detailed analyses on the sedimentology and facies distribution at the main quarry and a revision of the vertebrate fauna associated with the skeleton. Data provide information on a complex ecosystem dominated by crocodilian and other brackish water taxa. Taphonomic interpretations indicate a multi-event, pre-burial history with a combination of rapid segregation in high sediment supply conditions and partial subaerial exposure of the carcass. After the collection in 2011 of the articulated sacrum and proximalmost caudal vertebrae, all showing a complex pattern of pneumatization, newly discovered material of the type specimen allows a detailed osteological description of Tataouinea. The sacrum, the complete and articulated caudal vertebrae 1-17, both ilia and ischia display asymmetrical pneumatization, with the left side of vertebrae and the left ischium showing a more extensive invasion by pneumatic features than their right counterparts. A pneumatic hiatus is present in caudal centra 7 to 13, whereas caudal centra 14-16 are pneumatised by shallow fossae. Bayesian inference analyses integrating morphological, stratigraphic and paleogeographic data support a flagellicaudatan-rebbachisaurid divergence at about 163 Ma and a South American ancestral range for rebbachisaurids. Results presented here suggest an exclusively South American Limaysaurinae and a more widely distributed Rebbachisaurinae lineage, the latter including the South American taxon Katepensaurus and a clade including African and European taxa, with Tataouinea as sister taxon of Rebbachisaurus. This scenario would indicate that South America was not affected by the end-Jurassic extinction of diplodocoids, and was most likely the centre of the rapid radiation of rebbachisaurids to Africa and Europe between 135 and 130 Ma.	[Fanti, Federico; Cau, Andrea; Cantelli, Luigi] Univ Bologna, Alma Mater Studiorum, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy; [Fanti, Federico; Cau, Andrea] Univ Bologna, Alma Mater Studiorum, Museo Geol Giovanni Capellini, Bologna, Italy; [Hassine, Mohsen] Off Natl Mines, Serv Patrimoine Geol, Tunis, Tunisia; [Auditore, Marco] Museo Paleontol Cittadino, Gorizia, Italy	University of Bologna; University of Bologna; Office National des Mines	Fanti, F (corresponding author), Univ Bologna, Alma Mater Studiorum, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy.	federico.fanti@unibo.it	Cau, Andrea/ABB-7972-2021; Cantelli, Luigi/A-5346-2016; Cau, Andrea/S-8546-2016; Fanti, Federico/K-6624-2015	Cau, Andrea/0000-0001-8761-3720; Cantelli, Luigi/0000-0001-6153-5170; Fanti, Federico/0000-0002-2961-8301	Fondazione Alma Mater; Integrated Geoscience Research Group (Department of Earth and Geo-Environmental Sciences, University of Bologna, Italy); TITAN Project; Museo Geologico Giovanni Capellini (Bologna, Italy)	Fondazione Alma Mater; Integrated Geoscience Research Group (Department of Earth and Geo-Environmental Sciences, University of Bologna, Italy); TITAN Project; Museo Geologico Giovanni Capellini (Bologna, Italy)	This research was conducted in collaboration with the Office National Des Mines, Tunis, and was financially supported by Fondazione Alma Mater (Professor G. Gabbianelli), the Integrated Geoscience Research Group (Department of Earth and Geo-Environmental Sciences, University of Bologna, Italy), the TITAN Project (Professor L. Cantelli) and the Museo Geologico Giovanni Capellini (Bologna, Italy) who supported field and laboratory activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PE, 2007, PALAEOGEOGR PALAEOCL, V243, P118, DOI 10.1016/j.palaeo.2006.07.015; Apesteguia S, 2007, GONDWANA RES, V12, P533, DOI 10.1016/j.gr.2007.04.007; Barale G, 2002, CRETACEOUS RES, V23, P707, DOI 10.1006/cres.2002.1025; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Benton MJ, 2000, PALAEOGEOGR PALAEOCL, V157, P227, DOI 10.1016/S0031-0182(99)00167-4; Bonaparte JF., 1997, AMEGHINIANA, V34, P116; Bouaziz S, 2002, TECTONOPHYSICS, V357, P227, DOI 10.1016/S0040-1951(02)00370-0; BOUAZIZ S, 1989, GEOLOGIE MEDITERRANE, V0015, P00067, DOI DOI 10.3406/geolm.1989.1415; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Carvalho ID, 2003, CRETACEOUS RES, V24, P697, DOI 10.1016/j.cretres.2003.07.005; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Courel L, 2003, PALAEOGEOGR PALAEOCL, V196, P157, DOI 10.1016/S0031-0182(03)00317-1; Crame JA, 1999, SCI MAR, V63, P1; CUNNINGHAM WD, 1995, J GEOPHYS RES-SOL EA, V100, P8257, DOI 10.1029/95JB00033; Cuny Gilles, 2004, Revue de Paleobiologie Volume Special, V9, P127; Cuny G, 2010, GEOBIOS-LYON, V43, P615, DOI 10.1016/j.geobios.2010.07.001; DELAPPARENT AF, 1951, CR HEBD ACAD SCI, V232, P1430; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fanti F., 2012, EARTH LIFE GLOBAL BI, P883; Fanti F, 2013, NATURE COMMUNICATION, V4, P2028, DOI [10.1038/ncomms3028, DOI 10.1038/NC0MMS3028]; Fanti F, 2014, PALAEOGEOGR PALAEOCL, V410, P39, DOI 10.1016/j.palaeo.2014.05.033; Fanti F, 2014, J AFR EARTH SCI, V90, P1, DOI 10.1016/j.jafrearsci.2013.10.010; Fanti F, 2012, J AFR EARTH SCI, V73-74, P1, DOI 10.1016/j.jafrearsci.2012.07.006; Fanti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031330; Gallina PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097128; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Guedes E, 2005, J S AM EARTH SCI, V18, P371, DOI 10.1016/j.jsames.2004.11.008; Harrison EP, 1973, THESIS TEXAS TU; Hasiotis ST, 1997, COMB ROCK MOUNT SOUT, V29, p13A; Ibiricu LM, 2013, J VERTEBR PALEONTOL, V33, P1351, DOI 10.1080/02724634.2013.776562; Ibiricu LM, 2012, CRETACEOUS RES, V34, P220, DOI 10.1016/j.cretres.2011.11.003; Canale JI, 2015, HIST BIOL, V27, P1, DOI 10.1080/08912963.2013.861830; Jokat W, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001802; Kilian C., 1931, COMPTES RENDUS SOMMA, V9, P109; Kilian C., 1937, CHRONIQUE MINES COLO, V58, P21; Kraus MJ, 2006, J SEDIMENT RES, V76, P633, DOI 10.2110/jsr.2006.052; Lapparent A. F. de, 1960, Memoires de la Societe Geologique de France Paleontologie, V88A, P1; Le Loeuff J, 2010, GEOL MAG, V147, P750, DOI 10.1017/S0016756810000178; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; LEFRANC JP, 1990, J AFR EARTH SCI, V10, P27, DOI 10.1016/0899-5362(90)90047-I; LEHMAN TM, 1989, GEOL SOC AM BULL, V101, P188, DOI 10.1130/0016-7606(1989)101<0188:UCMPIT>2.3.CO;2; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Carballido JL, 2012, HIST BIOL, V24, P631, DOI 10.1080/08912963.2012.672416; Macdonald D, 2003, MAR PETROL GEOL, V20, P287, DOI 10.1016/S0264-8172(03)00045-X; Mannion PD, 2013, CRETACEOUS RES, V45, P49, DOI 10.1016/j.cretres.2013.07.007; Mannion PD, 2011, CRETACEOUS RES, V32, P774, DOI 10.1016/j.cretres.2011.05.005; Mateus O, 2014, J VERTEBR PALEONTOL, V34, P618, DOI 10.1080/02724634.2013.822875; Ouaja M, 2004, GEOBIOS-LYON, V37, P89, DOI 10.1016/j.geobios.2002.12.002; Paik IS, 2000, PALAEOGEOGR PALAEOCL, V157, P213, DOI 10.1016/S0031-0182(99)00166-2; Pervinquiere L., 1912, B SOC GEOL FR, V4, P160; Philip J., 2000, ATLAS PERI TETHYS PA, P137; RAMBAUT A, TRACER MCMC TRACE AN; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Roberts E, 2003, J VERTEBR PALEONTOL, V23, p89A; Royo-Torres R, 2006, SCIENCE, V314, P1925, DOI 10.1126/science.1132885; SALGADO L, 1991, Ameghiniana, V28, P333; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Saneyoshi M, 2011, PALAEOGEOGR PALAEOCL, V311, P38, DOI 10.1016/j.palaeo.2011.07.024; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Torcida Fernandez-Baldor F, 2012, THESIS U ZARAGOZA; Fernandez-Baldor FT, 2011, ACTA PALAEONTOL POL, V56, P535, DOI 10.4202/app.2010.0003; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078213; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Whitlock JA, 2011, ZOOL J LINN SOC-LOND, V161, P872, DOI 10.1111/j.1096-3642.2010.00665.x; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, J VERTEBRAT IN PRESS; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; Wilson Jeffrey A., 2011, Contributions from the Museum of Paleontology University of Michigan, V32, P59; Yates AM, 2012, ACTA PALAEONTOL POL, V57, P85, DOI 10.4202/app.2010.0075; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zarbout M, 1994, STRATA, V6, P141	79	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123475	10.1371/journal.pone.0123475	http://dx.doi.org/10.1371/journal.pone.0123475			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923211	Green Submitted, gold, Green Published			2022-12-26	WOS:000353711600048
J	Jang, EK; Kim, WG; Kim, HC; Huh, JW; Kwon, H; Choi, YM; Jeon, MJ; Kim, TY; Shong, YK; Ryu, JS; Kim, WB				Jang, Eun Kyung; Kim, Won Gu; Kim, Ho-Cheol; Huh, Jin-Won; Kwon, Hyemi; Choi, Yun Mi; Jeon, Min Ji; Kim, Tae Yong; Shong, Young Kee; Ryu, Jin-Sook; Kim, Won Bae			Changes in the Pulmonary Function Test after Radioactive Iodine Treatment in Patients with Pulmonary Metastases of Differentiated Thyroid Cancer	PLOS ONE			English	Article							DISTANT METASTASES; RADIOIODINE THERAPY; PROGNOSTIC VARIABLES; RADIATION-THERAPY; CARCINOMA; LUNG; PAPILLARY; COMPLICATIONS; DIAGNOSIS; FIBROSIS	Objective Pulmonary function test (PFT) is a useful tool for an objective assessment of respiratory function. Impaired pulmonary function is critical for the survival and quality of life in patients with pulmonary metastases of solid cancers including thyroid cancer. This study aimed to evaluate clinical factors associated with severely impaired pulmonary function by serial assessment with PFT in patients with pulmonary metastasis of differentiated thyroid cancer (DTC) who received radioactive iodine treatment (RAIT). Patients This retrospective study enrolled 31 patients who underwent serial PFTs before and after RAIT for pulmonary metastasis of DTC. We evaluated the risk factors for severe impairment of pulmonary function. Results The median age of the patients was 44.1 years and 18 of them were female patients. Severe impairment of pulmonary function was observed in five patients (16%) after a median of three RAITs (cumulative I-131 activity = 20.4 GBq). These patients were older and more frequently had mild impairment of baseline pulmonary function, respiratory symptoms, or progressive disease compared with patients with stable pulmonary function. Neither cumulative dose nor number of RAIT was associated with decreased pulmonary function. Coexisting pulmonary diseases, presence of respiratory symptoms, and metastatic disease progression were significantly associated with severe decrease in forced vital capacity during follow-up (p =.047, p =. 011, and p =. 021, respectively). Conclusions Pulmonary function was severely impaired during follow-up in some patients with pulmonary metastasis of DTC after a high-dose RAITs. Neither the number of RAIT nor the cumulative I-131 activity was associated with decreased pulmonary function. Serial PFT might be considered for some high-risk patients during follow-up.	[Jang, Eun Kyung; Kim, Won Gu; Kwon, Hyemi; Choi, Yun Mi; Jeon, Min Ji; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Seoul 138736, South Korea; [Kim, Ho-Cheol; Huh, Jin-Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Pulmonol & Crit Care Med, Seoul 138736, South Korea; [Ryu, Jin-Sook] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul 138736, South Korea; [Jang, Eun Kyung] Dongnam Inst Radiol & Med Sci, Ctr Canc, Div Endocrinol, Busan, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Korea Institute of Radiological & Medical Sciences	Kim, WB (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Seoul 138736, South Korea.	wongukim@amc.seoul.kr	Kim, Tae Yong/C-1272-2009; Kim, Won Gu/AAG-2096-2019	Kim, Tae Yong/0000-0003-4982-4441; Kim, Won Gu/0000-0002-8404-7759; Jeon, Min Ji/0000-0002-1297-107X; Kim, Won Bae/0000-0003-4544-1750; Choi, Yun Mi/0000-0001-8209-874X; Shong, Young Kee/0000-0002-7911-9471	Asan Institute for Life Sciences [2014-582]; Korean Foundation for Cancer Research, Seoul, South Korea [CB-2011-03-02]	Asan Institute for Life Sciences; Korean Foundation for Cancer Research, Seoul, South Korea	This study was supported by research grant (No. 2014-582) from the Asan Institute for Life Sciences and research grant (CB-2011-03-02) of the Korean Foundation for Cancer Research, Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; BENUA RS, 1962, AMER J ROENTGENOL RA, V87, P171; BROWN AP, 1984, BRIT J RADIOL, V57, P323, DOI 10.1259/0007-1285-57-676-323; CASARA D, 1993, J NUCL MED, V34, P1626; Chen LB, 2010, THYROID, V20, P337, DOI 10.1089/thy.2009.0266; Cho SW, 2014, THYROID, V24, P277, DOI 10.1089/thy.2012.0654; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Choi YW, 2004, RADIOGRAPHICS, V24, P985, DOI 10.1148/rg.244035160; COGGLE JE, 1986, ENVIRON HEALTH PERSP, V70, P261, DOI 10.2307/3430363; CRAPO RO, 1994, NEW ENGL J MED, V331, P25, DOI 10.1056/NEJM199407073310107; DINNEEN SF, 1995, J CLIN ENDOCR METAB, V80, P2041, DOI 10.1210/jc.80.7.2041; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; GROSS NJ, 1977, ANN INTERN MED, V86, P81, DOI 10.7326/0003-4819-86-1-81; Hebestreit H, 2011, EUR J NUCL MED MOL I, V38, P1683, DOI 10.1007/s00259-011-1841-x; Jeon MJ, 2014, EUR J ENDOCRINOL, V170, P23, DOI 10.1530/EJE-13-0524; Jones LW, 2012, J CLIN ONCOL, V30, P2530, DOI 10.1200/JCO.2011.39.9014; Kim TY, 2014, ENDOCRINOL METAB, V29, P217, DOI 10.3803/EnM.2014.29.3.217; Kloos RT, 2002, J CLIN ENDOCR METAB, V87, P5817, DOI 10.1210/jc.2002-020210; Lee SL, 2010, J NATL COMPR CANC NE, V8, P1277, DOI 10.6004/jnccn.2010.0094; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; MASSIN JP, 1984, CANCER, V53, P982, DOI 10.1002/1097-0142(19840215)53:4<982::AID-CNCR2820530427>3.0.CO;2-E; Movsas B, 1997, CHEST, V111, P1061, DOI 10.1378/chest.111.4.1061; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; RALL JE, 1957, J CLIN ENDOCR METAB, V17, P1263; RUEGEMER JJ, 1988, J CLIN ENDOCR METAB, V67, P501, DOI 10.1210/jcem-67-3-501; Sabra MM, 2013, J CLIN ENDOCR METAB, V98, pE829, DOI 10.1210/jc.2012-3933; SAMAAN NA, 1985, J CLIN ENDOCR METAB, V60, P376, DOI 10.1210/jcem-60-2-376; Sampson E, 2007, CANCER, V110, P1451, DOI 10.1002/cncr.22956; SAMUEL AM, 1995, J NUCL MED, V36, P783; SCHLUMBERGER M, 1986, J CLIN ENDOCR METAB, V63, P960; Shoup M, 2003, J AM COLL SURGEONS, V197, P191, DOI 10.1016/S1072-7515(03)00332-6; ZIBRAK JD, 1990, ANN INTERN MED, V112, P763, DOI 10.7326/0003-4819-112-10-763	33	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125114	10.1371/journal.pone.0125114	http://dx.doi.org/10.1371/journal.pone.0125114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923702	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600125
J	Lin, TH; Yu, HY; Chen, CF; Chou, LS				Lin, Tzu-Hao; Yu, Hsin-Yi; Chen, Chi-Fang; Chou, Lien-Siang			Passive Acoustic Monitoring of the Temporal Variability of Odontocete Tonal Sounds from a Long-Term Marine Observatory	PLOS ONE			English	Article							AUTOMATIC DETECTION; TURSIOPS-TRUNCATUS; SIGNATURE WHISTLES; INFORMATION-THEORY; DOLPHIN WHISTLES; BEHAVIOR; FREQUENCY; WHALES; CLASSIFICATION; OCEAN	The developments of marine observatories and automatic sound detection algorithms have facilitated the long-term monitoring of multiple species of odontocetes. Although classification remains difficult, information on tonal sound in odontocetes (i.e., toothed whales, including dolphins and porpoises) can provide insights into the species composition and group behavior of these species. However, the approach to measure whistle contour parameters for detecting the variability of odontocete vocal behavior may be biased when the signal-to-noise ratio is low. Thus, methods for analyzing the whistle usage of an entire group are necessary. In this study, a local-max detector was used to detect burst pulses and representative frequencies of whistles within 4.5-48 kHz. Whistle contours were extracted and classified using an unsupervised method. Whistle characteristics and usage pattern were quantified based on the distribution of representative frequencies and the composition of whistle repertoires. Based on the one year recordings collected from the Marine Cable Hosted Observatory off northeastern Taiwan, odontocete burst pulses and whistles were primarily detected during the nighttime, especially after sunset. Whistle usage during the nighttime was more complex, and whistles with higher frequency were mainly detected during summer and fall. According to the multivariate analysis, the diurnal variation of whistle usage was primarily related to the change of mode frequency, diversity of representative frequency, and sequence complexity. The seasonal variation of whistle usage involved the previous three parameters, in addition to the diversity of whistle clusters. Our results indicated that the species and behavioral composition of the local odontocete community may vary among seasonal and diurnal cycles. The current monitoring platform facilitates the evaluation of whistle usage based on group behavior and provides feature vectors for species and behavioral classification in future studies.	[Lin, Tzu-Hao; Yu, Hsin-Yi; Chou, Lien-Siang] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10617, Taiwan; [Chen, Chi-Fang] Natl Taiwan Univ, Dept Engn Sci & Ocean Engn, Taipei 10617, Taiwan	National Taiwan University; National Taiwan University	Chou, LS (corresponding author), Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	chouls@ntu.edu.tw	Lin, Tzu-Hao/GLT-9168-2022; Lin, Tzu-Hao/T-3229-2019	Lin, Tzu-Hao/0000-0002-6973-3953; Lin, Tzu-Hao/0000-0002-6973-3953; Chou, Lien-Siang/0000-0003-4610-5257	Ministry of Science and Technology of Taiwan (R.O.C.) [NSC 101-2221-E-002-028-MY2, NSC 102-3113-P-002-032]	Ministry of Science and Technology of Taiwan (R.O.C.)	This study was supported by the Ministry of Science and Technology of Taiwan (R.O.C.) under the project of NSC 101-2221-E-002-028-MY2 and NSC 102-3113-P-002-032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2005, P ROY SOC B-BIOL SCI, V272, P797, DOI 10.1098/rspb.2004.3024; Akamatsu T, 2010, MAR BIOL, V157, P1879, DOI 10.1007/s00227-010-1459-8; Andre M, 2011, MAR POLLUT BULL, V63, P18, DOI 10.1016/j.marpolbul.2011.04.038; Baumgartner MF, 2011, J ACOUST SOC AM, V129, P2889, DOI 10.1121/1.3562166; Chang Y-L, 2009, J GEOPHYS RES, V114; Chen Y, 2001, THESIS U CHARLESTON; Chuang W.S., 1994, J OCEANOGR, V50, P531, DOI [10.1007/BF02235422, DOI 10.1007/BF02235422]; Doyle LR, 2008, ENTROPY, V10, P33, DOI 10.3390/entropy-e10020033; Erbe C, 2008, J ACOUST SOC AM, V124, P2833, DOI 10.1121/1.2982368; Fernandez R, 2013, CONT SHELF RES, V64, P88, DOI 10.1016/j.csr.2013.05.008; Frankel AS, 2010, J ACOUST SOC AM, V127, P3248, DOI 10.1121/1.3365259; Gannier A, 2010, APPL ACOUST, V71, P1063, DOI 10.1016/j.apacoust.2010.05.019; Gillespie D, 2013, J ACOUST SOC AM, V134, P2427, DOI 10.1121/1.4816555; Hernandez EN, 2010, J ACOUST SOC AM, V127, P3232, DOI 10.1121/1.3365254; Hsin YC, 2013, J GEOPHYS RES-OCEANS, V118, P4305, DOI 10.1002/jgrc.20323; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Lee MA, 2011, J MAR SCI TECH-TAIW, V19, P253; Lin T.-H., 2013, UND TECHN S UT 2013, P1; Lin TH, 2015, ESTUAR COAST, V38, P1376, DOI 10.1007/s12237-014-9886-2; Lin TH, 2013, J ACOUST SOC AM, V134, P2477, DOI 10.1121/1.4816572; Lin TH, 2013, MAR BIOL, V160, P1353, DOI 10.1007/s00227-013-2187-7; Lopez BD, 2011, MAMM BIOL, V76, P180, DOI 10.1016/j.mambio.2010.06.006; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Mallawaarachchi A, 2008, J ACOUST SOC AM, V124, P1159, DOI 10.1121/1.2945711; McCowan B, 1999, ANIM BEHAV, V57, P409, DOI 10.1006/anbe.1998.1000; MCCOWAN B, 1995, ETHOLOGY, V100, P177; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2011, J ACOUST SOC AM, V129, P4055, DOI 10.1121/1.3531926; Moore SE, 2006, BIOSCIENCE, V56, P49, DOI 10.1641/0006-3568(2006)056[0049:LFLWIT]2.0.CO;2; Oswald JN, 2003, MAR MAMMAL SCI, V19, P20, DOI 10.1111/j.1748-7692.2003.tb01090.x; Overstrom N.A., 1983, Zoo Biology, V2, P93, DOI 10.1002/zoo.1430020203; Roch MA, 2011, J ACOUST SOC AM, V130, P2212, DOI 10.1121/1.3624821; Seekings PJ, 2010, OC 10 IEEE SYDN NSW, P1, DOI DOI 10.1109/OCEANSSYD.2010.5603596; SMOLKER RA, 1993, BEHAV ECOL SOCIOBIOL, V33, P393; Soldevilla MS, 2011, MAR ECOL PROG SER, V423, P247, DOI 10.3354/meps08927; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Stanistreet JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061263; Sveegaard S, 2012, MAR ECOL PROG SER, V468, P245, DOI 10.3354/meps09959; Van Parijs SM, 2001, ETHOLOGY, V107, P701, DOI 10.1046/j.1439-0310.2001.00714.x; Wang D., 1995, SENSORY SYSTEMS AQUA, P299; Zaugg S, 2012, APPL ACOUST, V73, P281, DOI 10.1016/j.apacoust.2011.09.009	43	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123943	10.1371/journal.pone.0123943	http://dx.doi.org/10.1371/journal.pone.0123943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923338	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600061
J	Van Steenberge, M; Pariselle, A; Huyse, T; Volckaert, FAM; Snoeks, J; Vanhove, MPM				Van Steenberge, Maarten; Pariselle, Antoine; Huyse, Tine; Volckaert, Filip A. M.; Snoeks, Jos; Vanhove, Maarten P. M.			Morphology, Molecules, and Monogenean Parasites: An Example of an Integrative Approach to Cichlid Biodiversity	PLOS ONE			English	Article							LAKE TANGANYIKA; ANCYROCEPHALIDAE MONOGENEA; GILL PARASITES; SPECIES PLATYHELMINTHES; SYSTEMATIC REVISION; TELEOSTEI; HOST; SPECIATION; PHYLOGENY; TAXONOMY	The unparalleled biodiversity of Lake Tanganyika (Africa) has fascinated biologists for over a century; its unique cichlid communities are a preferred model for evolutionary research. Although species delineation is, in most cases, relatively straightforward, higher-order classifications were shown not to agree with monophyletic groups. Here, traditional morphological methods meet their limitations. A typical example are the tropheine cichlids currently belonging to Simochromis and Pseudosimochromis. The affiliations of these widespread and abundant cichlids are poorly understood. Molecular work suggested that genus and species boundaries should be revised. Moreover, previous morphological results indicated that intraspecific variation should be considered to delineate species in Lake Tanganyika cichlids. We review the genera Simochromis and Pseudosimochromis using an integrative approach. Besides a morphometric study and a barcoding approach, monogenean Cichlidogyrus (Platyhelminthes: Ancyrocephalidae) gill parasites, often highly species-specific, are used as complementary markers. Six new species are described. Cichlidogyrus raeymaekersi sp. nov., C. muterezii sp. nov. and C. banyankimbonai sp. nov. infect S. diagramma. Cichlidogyrus georgesmertensi sp. nov. was found on S. babaulti and S. pleurospilus, C. franswittei sp. nov. on both S. marginatus and P. curvifrons and C. frankwillemsi sp. nov. only on P. curvifrons. As relatedness between Cichlidogyrus species usually reflects relatedness between hosts, we considered Simochromis monotypic because the three Cichlidogyrus species found on S. diagramma belonged to a different morphotype than those found on the other Simochromis. The transfer of S. babaulti, S. marginatus, S. pleurospilus and S. margaretae to Pseudosimochromis was justified by the similarity of their Cichlidogyrus fauna and the intermediate morphology of S. margaretae. Finally parasite data also supported the synonymy between S. pleurospilus and S. babaulti, a species that contains a large amount of geographical morphological variation.	[Van Steenberge, Maarten; Huyse, Tine; Snoeks, Jos; Vanhove, Maarten P. M.] Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium; [Van Steenberge, Maarten; Huyse, Tine; Volckaert, Filip A. M.; Snoeks, Jos; Vanhove, Maarten P. M.] Univ Leuven, Dept Biol, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [Van Steenberge, Maarten] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Pariselle, Antoine] Univ Montpellier, CNRS, IRD, Inst Sci Evolut, F-34059 Montpellier, France; [Vanhove, Maarten P. M.] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Anavyssos, Greece	Royal Museum for Central Africa; KU Leuven; University of Graz; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Hellenic Centre for Marine Research	Van Steenberge, M (corresponding author), Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium.	maarten.vansteenberge@bio.kuleuven.be	Van Steenberge, Maarten/E-4052-2017; Van Steenberge, Maarten/AAC-7132-2020; Volckaert, Filip/AAC-7691-2019; Pariselle, Antoine/L-5776-2016; Vanhove, Maarten/AAF-6446-2020	Pariselle, Antoine/0000-0002-1591-7423; Vanhove, Maarten/0000-0003-3100-7566; Van Steenberge, Maarten/0000-0002-6964-9014	Research Foundation Flanders; King Leopold III Fund for Nature Exploration and Conservation; Czech Science Foundation [P505/12/G112]	Research Foundation Flanders(FWO); King Leopold III Fund for Nature Exploration and Conservation; Czech Science Foundation(Grant Agency of the Czech Republic)	At the time of conducting this research, M.V. S. and M.P.M.V. were Ph.D. fellows, and T.H. a post-doctoral fellow of the Research Foundation - Flanders (FWO-Vlaanderen). Field work was funded by two travel grants from the Research Foundation Flanders to M.P.M.V. and two grants from the King Leopold III Fund for Nature Exploration and Conservation to M.V.S. and M.P.M.V. Currently, M.P.M.V. is supported by the Czech Science Foundation, Project no. P505/12/G112 (European Centre of Ichthyoparasitology (ECIP) - Centre of excellence). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Arthofer W, 2013, MOL ECOL, V22, P3850, DOI 10.1111/mec.12340; Axelrod G.S., 1978, SIMOCHROMIS MARGARET, V19, P1; BAREL CDN, 1977, NETH J ZOOL, V27, P333; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; Boeger WA, 2003, ZOOL SCR, V32, P3, DOI 10.1046/j.1463-6409.2003.00109.x; Boulenger GA, 1898, P ZOOL SOC LOND, V1898, P494; Boulenger GA, 1898, T ZOOL SOC LONDON, V15, P1; Brichard P, 1989, P BRICHADS BOOK CICH; BROOKS DR, 1979, SYST ZOOL, V28, P299, DOI 10.2307/2412584; BROOKS DR, 1993, J PARASITOL, V79, P631, DOI 10.2307/3283396; Bukinga FM, 2012, PARASITOL RES, V111, P2049, DOI 10.1007/s00436-012-3052-1; Cohen AS, 1997, BASIN RES, V9, P107, DOI 10.1046/j.1365-2117.1997.00038.x; Combes Claude., 2001, PARASITISM ECOLOGY E; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Meeus T, 1998, PARASITOL TODAY, V14, P10, DOI 10.1016/S0169-4758(97)01163-0; Euzet L., 1981, Review of advances in parasitology. (Proc. 4th Internat. Congr. of Parasit. (ICOPA IV), Warsaw, 19-26 Aug. 1978)., P1003; FREY JK, 1992, J PARASITOL, V78, P930, DOI 10.2307/3283335; Gillardin C, 2012, PARASITOL RES, V110, P305, DOI 10.1007/s00436-011-2490-5; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; Gregoir AF, 2015, FRESHWATER BIOL, V60, P323, DOI 10.1111/fwb.12492; GUEGAN JF, 1990, SYST PARASITOL, V17, P153, DOI 10.1007/BF00009552; Gunther A, 1894, P ZOOL SOC LOND, V1893, P628; Gussev AV, 1962, KEY PARASITES FRESHW, P204; Haverty MI, 1996, SOCIOBIOLOGY, V28, P287; Hawlitschek O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016662; Huyse T, 2005, SYST BIOL, V54, P710, DOI 10.1080/10635150500221036; JOLICOEUR P, 1963, BIOMETRICS, V19, P497, DOI 10.2307/2527939; Justine JL, 2009, SYST PARASITOL, V72, P27, DOI 10.1007/s11230-008-9171-5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koblmuller S, 2008, MOL PHYLOGENET EVOL, V49, P153, DOI 10.1016/j.ympev.2008.05.045; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Koblmuller S, 2011, MOL ECOL, V20, P2272, DOI 10.1111/j.1365-294X.2011.05088.x; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A, 2015, TANGANYIKA CICHLIDS; KRITSKY DC, 1989, J PARASITOL, V75, P207, DOI 10.2307/3282767; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Laurent P, 2006, MOL PHYLOGENET EVOL, V38, P241, DOI 10.1016/j.ympev.2005.08.013; Lavoue Sebastien, 2010, Zootaxa, V2600, P1; Malmberg G., 1956, SKR SOD SVER FISKFOR, V1957, P19; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; NELISSEN M H J, 1976, Annales de la Societe Royale Zoologique de Belgique, V106, P167; Nelissen MHJ, 1978, REV ZOOLOGIE AFRICAI, V92, P3; Nelissen MHJ, 1977, REV ZOOLOGIE AFRICAI, V91, P1; Nelissen MHJ, 1979, SCI ZOOLOGIQUES B, V229, P1; Nelissen MHJ, 1974, ACTA ZOOL PATHOL ANT, V61, P31; Nieberding C, 2004, P ROY SOC B-BIOL SCI, V271, P2559, DOI 10.1098/rspb.2004.2930; Padial JM, 2008, ZOOL J LINN SOC-LOND, V152, P353, DOI 10.1111/j.1096-3642.2007.00341.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; PAPERNA ILAN, 1960, BAMIDGEH, V12, P20; Pariselle A, 2003, SYST PARASITOL, V56, P201, DOI 10.1023/B:SYPA.0000003807.27452.bd; Pariselle A, 2003, FOLIA PARASIT, V50, P195, DOI 10.14411/fp.2003.035; PARISELLE A, 1995, SYST PARASITOL, V30, P187, DOI 10.1007/BF00010469; Pariselle A, 1996, THESIS U PERPIGNAN; Pariselle A, 2015, CONTRIB ZOOL, V84, P25, DOI 10.1163/18759866-08401003; Pariselle A, 2015, HYDROBIOLOGIA, V748, P99, DOI 10.1007/s10750-014-1975-5; Pariselle Antoine, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/471480; Pariselle Antoine, 2003, P147; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; PAUGY D, 1990, CAN J ZOOL, V68, P1124, DOI 10.1139/z90-167; Pellegrin J., 1927, B MUSEUM NATL HIST N, V33, P499; Plaisance L, 2005, ZOOL SCR, V34, P425, DOI 10.1111/j.1463-6409.2005.00191.x; Poll M., 1956, Exploration Hydrobiol Lac Tanganyika (1946-47), V3, P1; POLL M, 1986, Academie Royale de Belgique Memoires de la Classe des Sciences Collection in Octavo, V45, P1; Poll M., 1942, Revue de Zoologie et de Botanique Africaines, V36, P343; Raeymaekers JAM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-41; RAMIREZ W, 1977, ANN MO BOT GARD, V64, P296; Risch S, 2008, ZOOTAXA, P21, DOI 10.11646/zootaxa.1857.1.2; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schliewen Ulrich K., 2004, Frontiers in Zoology, V1, P1; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2012, P ROY SOC LOND B BIO, V273, P1987; Simkova A, 2006, PARASITOLOGY, V133, P43, DOI 10.1017/S0031182006009942; Simkova A, 2003, SYST PARASITOL, V54, P1, DOI 10.1023/A:1022133608662; Smith AS, 2008, P NATL ACAD SCI USA, V105, P6906, DOI 10.1073/pnas.0801706105; Snoeks J, 2000, ADV ECOL RES, V31, P17, DOI 10.1016/S0065-2504(00)31005-4; Snoeks J., 2004, CICHLID DIVERSITY LA; Snoeks Jos, 2001, Journal of Aquariculture & Aquatic Sciences, V9, P150; Steindachner F, 1909, KAISERLICHE AKAD WIS, V26, P443; STURMBAUER C, 1992, NATURE, V358, P578, DOI 10.1038/358578a0; Sueur Jerome, 2007, Zootaxa, V1442, P55; Taborsky B, 2006, BIOL LETTERS, V2, P225, DOI 10.1098/rsbl.2005.0422; Takahashi T, 2003, ICHTHYOL RES, V50, P367, DOI 10.1007/s10228-003-0181-7; Takahashi T, 2014, ICHTHYOL RES, V61, P252, DOI 10.1007/s10228-014-0396-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trewavas E, 1966, WORLD S WARM WAT PON; Trewavas E., 1983, TILAPIINE FISHES GEN, DOI [DOI 10.5962/BHL.TITLE.123198, 10.1016/j.foodcont.2016.07.004]; Tsigenopoulos CS, 2002, HEREDITY, V88, P466, DOI 10.1038/sj.hdy.6800080; Van Steenberge M, 2015, HYDROBIOLOGIA, V748, P39, DOI 10.1007/s10750-013-1692-5; Van Steenberge M, 2011, ACTA ICHTHYOL PISCAT, V41, P201, DOI 10.3750/AIP2011.41.3.08; Vanhove M. P. M., 2012, THESIS KU LEUVEN; Vanhove MPM, 2014, PARASITOL RES, V113, P653, DOI 10.1007/s00436-013-3693-8; Vanhove MPM, 2013, ZOOTAXA, V3608, P398, DOI 10.11646/zootaxa.3608.5.8; Vanhove MPM, 2011, ZOOLOGIA-CURITIBA, V28, P253, DOI 10.1590/S1984-46702011000200016; Vanhove MPM, 2011, PARASITOLOGY, V138, P364, DOI 10.1017/S0031182010001356; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Wagner CE, 2012, MOL ECOL, V21, P3283, DOI 10.1111/j.1365-294X.2012.05607.x; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Yamaoka Kosaku, 1997, P25	102	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124474	10.1371/journal.pone.0124474	http://dx.doi.org/10.1371/journal.pone.0124474			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923665	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600088
J	Emiola, A; George, J; Andrews, SS				Emiola, Akintunde; George, John; Andrews, Steven S.			A Complete Pathway Model for Lipid A Biosynthesis in Escherichia coli	PLOS ONE			English	Article							UDP-N-ACETYLGLUCOSAMINE; ZINC-DEPENDENT DEACETYLASE; LIPOPOLYSACCHARIDE BIOSYNTHESIS; ANTIBACTERIAL AGENTS; 3-DEOXY-D-MANNO-OCTULOSONIC ACID; STOCHASTIC SIMULATION; CHEMICAL-MODIFICATION; MULTICOPY SUPPRESSOR; ANTIBIOTIC-ACTIVITY; METABOLIC-CONTROL	Lipid A is a highly conserved component of lipopolysaccharide (LPS), itself a major component of the outer membrane of Gram-negative bacteria. Lipid A is essential to cells and elicits a strong immune response from humans and other animals. We developed a quantitative model of the nine enzyme-catalyzed steps of Escherichia coli lipid A biosynthesis, drawing parameters from the experimental literature. This model accounts for biosynthesis regulation, which occurs through regulated degradation of the LpxC and WaaA (also called KdtA) enzymes. The LpxC degradation signal appears to arise from the lipid A disaccharide concentration, which we deduced from prior results, model results, and new LpxK overexpression results. The model agrees reasonably well with many experimental findings, including the lipid A production rate, the behaviors of mutants with defective LpxA enzymes, correlations between LpxC half-lives and cell generation times, and the effects of LpxK overexpression on LpxC concentrations. Its predictions also differ from some experimental results, which suggest modifications to the current understanding of the lipid A pathway, such as the possibility that LpxD can replace LpxA and that there may be metabolic channeling between LpxH and LpxB. The model shows that WaaA regulation may serve to regulate the lipid A production rate when the 3-deoxy-D-manno-oct-2-ulosonic acid (KDO) concentration is low and/or to control the number of KDO residues that get attached to lipid A. Computation of flux control coefficients showed that LpxC is the rate-limiting enzyme if pathway regulation is ignored, but that LpxK is the rate-limiting enzyme if pathway regulation is present, as it is in real cells. Control also shifts to other enzymes if the pathway substrate concentrations are not in excess. Based on these results, we suggest that LpxK may be a much better drug target than LpxC, which has been pursued most often.	[Emiola, Akintunde; George, John] Univ E London, Sch Hlth Sports & Biosci, London E15 4LZ, England; [Andrews, Steven S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of East London; Fred Hutchinson Cancer Center	Emiola, A (corresponding author), Univ E London, Sch Hlth Sports & Biosci, London E15 4LZ, England.	a.emiola@uel.ac.uk			National Institute of General Medical Science [R01 GM08666615]	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: SSA was funded in part by National Institute of General Medical Science grant R01 GM08666615, awarded to Roger Brent and Richard Yu. There were no addition internal/external funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; ANDERSON MS, 1988, BIOCHEMISTRY-US, V27, P1908, DOI 10.1021/bi00406a017; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Andrews S. S., 2009, ENCY COMPLEXITY SYST, V9, P8730, DOI DOI 10.1007/978-0-387-30440-3_524; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; BROZEK KA, 1990, J BIOL CHEM, V265, P15410; Bruce A., 2002, MOL BIOL CELL, V4th ed.; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; Cornish-Bowden A, 2001, EUR J BIOCHEM, V268, P6616, DOI 10.1046/j.0014-2956.2001.02616.x; DEMENDOZA D, 1983, J BIOL CHEM, V258, P2098; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Emiola A, 2013, COMPUT BIOL CHEM, V47, P1, DOI 10.1016/j.compbiolchem.2013.06.001; Emptage RP, 2012, P NATL ACAD SCI USA, V109, P12956, DOI 10.1073/pnas.1206072109; Fell D, 1971, UNDERSTANDING CONTRO; FELL DA, 1985, EUR J BIOCHEM, V148, P555, DOI 10.1111/j.1432-1033.1985.tb08876.x; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Fuhrer F, 2007, J MOL BIOL, V372, P485, DOI 10.1016/j.jmb.2007.06.083; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Garrett TA, 1998, J BIOL CHEM, V273, P12457, DOI 10.1074/jbc.273.20.12457; GHALAMBOR MA, 1966, J BIOL CHEM, V241, P3222; GOLDMAN R, 1987, NATURE, V329, P162, DOI 10.1038/329162a0; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; Jackman JE, 2000, J BIOL CHEM, V275, P11002, DOI 10.1074/jbc.275.15.11002; Jayasekera MMK, 2000, ARCH BIOCHEM BIOPHYS, V380, P103, DOI 10.1006/abbi.2000.1903; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; Katz C, 2008, J BACTERIOL, V190, P7117, DOI 10.1128/JB.00871-08; KELLY TM, 1993, J BIOL CHEM, V268, P19866; Kenanov D, 2010, FEBS J, V277, P1023, DOI 10.1111/j.1742-4658.2009.07546.x; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Mahalakshmi S, 2014, MOL MICROBIOL, V91, P145, DOI 10.1111/mmi.12452; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Marangoni AG, 2003, ENZYME KINETICS MODE, DOI [10.1002/0471267295.ch7, DOI 10.1002/0471267295.CH7]; MATTSBYBALTZER I, 1991, INFECT IMMUN, V59, P689, DOI 10.1128/IAI.59.2.689-695.1991; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Mendes Pedro, 2009, V500, P17, DOI 10.1007/978-1-59745-525-1_2; MENGINLECREULX D, 1983, J BACTERIOL, V154, P1284, DOI 10.1128/JB.154.3.1284-1290.1983; Metzger LE, 2009, BIOCHEMISTRY-US, V48, P11559, DOI 10.1021/bi901750f; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Narberhaus F, 2009, RES MICROBIOL, V160, P652, DOI 10.1016/j.resmic.2009.08.011; Nikaido H., 1996, ESCHERICHIA COLI SAL, P29; NISHIJIMA M, 1979, J BIOL CHEM, V254, P7837; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; PLANK LD, 1979, J GEN MICROBIOL, V115, P69, DOI 10.1099/00221287-115-1-69; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAY BL, 1987, J BIOL CHEM, V262, P1122; RAY PH, 1981, J BACTERIOL, V145, P1273, DOI 10.1128/JB.145.3.1273-1280.1981; Ridgway D, 2006, CURR OPIN BIOTECH, V17, P493, DOI 10.1016/j.copbio.2006.08.004; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Roberts E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002010; Sanft KR, 2011, BIOINFORMATICS, V27, P2457, DOI 10.1093/bioinformatics/btr401; Schakermann M, 2013, J BACTERIOL, V195, P1912, DOI 10.1128/JB.02134-12; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; Slominska M, 1999, VIROLOGY, V262, P431, DOI 10.1006/viro.1999.9907; Sorensen PG, 1996, J BIOL CHEM, V271, P25898, DOI 10.1074/jbc.271.42.25898; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; TAKAYAMA K, 1983, J BIOL CHEM, V258, P4245; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; Walker SL, 2004, LANGMUIR, V20, P7736, DOI 10.1021/la049511f; Walsh CT, 2014, J ANTIBIOT, V67, P7, DOI 10.1038/ja.2013.49; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Wyckoff TJO, 1999, J BIOL CHEM, V274, P27047, DOI 10.1074/jbc.274.38.27047; Yokoyama K, 2008, CHEMBIOCHEM, V9, P865, DOI 10.1002/cbic.200700717; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; Zeng DN, 2013, J BIOL CHEM, V288, P5475, DOI 10.1074/jbc.M112.447607; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	96	42	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121216	10.1371/journal.pone.0121216	http://dx.doi.org/10.1371/journal.pone.0121216			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919634	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000353659400006
J	Saito, S; Saito, W; Saito, M; Hashimoto, Y; Mori, S; Noda, K; Namba, K; Ishida, S				Saito, Saho; Saito, Wataru; Saito, Michiyuki; Hashimoto, Yuki; Mori, Shohei; Noda, Kousuke; Namba, Kenichi; Ishida, Susumu			Acute Zonal Occult Outer Retinopathy in Japanese Patients: Clinical Features, Visual Function, and Factors Affecting Visual Function	PLOS ONE			English	Article							BLOOD-FLOW-VELOCITY; SEGMENT; THERAPY; AZOOR	Purpose To evaluate the clinical features and investigate their relationship with visual function in Japanese patients with acute zonal occult outer retinopathy (AZOOR). Methods Fifty-two eyes of 38 Japanese AZOOR patients (31 female and 7 male patients; mean age at first visit, 35.0 years; median follow-up duration, 31 months) were retrospectively collected: 31 untreated eyes with good visual acuity and 21 systemic corticosteroid-treated eyes with progressive visual acuity loss. Variables affecting the logMAR values of best-corrected visual acuity (BCVA) and the mean deviation (MD) on Humphrey perimetry at initial and final visits were examined using multiple stepwise linear regression analysis. Results In untreated eyes, the mean MD at the final visit was significantly higher than that at the initial visit (P = 0.00002). In corticosteroid-treated eyes, the logMAR BCVA and MD at the final visit were significantly better than the initial values (P = 0.007 and P = 0.02, respectively). The final logMAR BCVA was 0.0 or less in 85% of patients. Variables affecting initial visual function were moderate anterior vitreous cells, myopia severity, and a-wave amplitudes on electroretinography; factors affecting final visual function were the initial MD values, female sex, moderate anterior vitreous cells, and retinal atrophy. Conclusions Our data indicated that visual functions in enrolled patients significantly improved spontaneously or after systemic corticosteroids therapy, suggesting that Japanese patients with AZOOR have good visual outcomes during the follow-up period of this study. Furthermore, initial visual field defects, gender, anterior vitreous cells, and retinal atrophy affected final visual functions in these patients.	[Saito, Saho; Saito, Wataru; Saito, Michiyuki; Hashimoto, Yuki; Mori, Shohei; Noda, Kousuke; Namba, Kenichi; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Saito, Wataru; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Saito, W (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan.	wsaito@med.hokudai.ac.jp		Saito, Wataru/0000-0001-8181-6252				Arai M, 1998, AM J OPHTHALMOL, V126, P466, DOI 10.1016/S0002-9394(98)00117-2; Chai Y, 2011, CLIN OPHTHALMOL, V5, P1235, DOI 10.2147/OPTH.S23194; Fagan XJ, 2014, CLIN EXP OPHTHALMOL, V42, P103, DOI 10.1111/ceo.12295; Fujiwara T, 2010, RETINA-J RET VIT DIS, V30, P1206, DOI 10.1097/IAE.0b013e3181e097f0; Gass JD, 2002, AM J OPHTHALMOL, V134, P329, DOI 10.1016/S0002-9394(02)01640-9; GASS JDM, 1993, J CLIN NEURO-OPHTHAL, V13, P79; Hirose S, 2008, ACTA OPHTHALMOL, V86, P902, DOI 10.1111/j.1755-3768.2008.01384.x; HOGAN MJ, 1959, AM J OPHTHALMOL, V47, P155, DOI 10.1016/S0002-9394(14)78239-X; Kitakawa T, 2012, DOC OPHTHALMOL, V124, P249, DOI 10.1007/s10633-012-9318-1; Li D, 2007, ARCH OPHTHALMOL-CHIC, V125, P1194, DOI 10.1001/archopht.125.9.1194; Monson DM, 2011, SURV OPHTHALMOL, V56, P23, DOI 10.1016/j.survophthal.2010.07.004; Mrejen S, 2014, JAMA OPHTHALMOL, V132, P1089, DOI 10.1001/jamaophthalmol.2014.1683; Neri P, 2014, INT OPHTHALMOL, V34, P359, DOI 10.1007/s10792-013-9801-z; Saito A, 2007, JPN J OPHTHALMOL, V51, P295, DOI 10.1007/s10384-007-0451-4; Saito M, 2014, CLIN EXP OPHTHALMOL, V42, P139, DOI 10.1111/ceo.12143; So K, 2011, CASE REP OPHTHALM, V2, P307, DOI 10.1159/000332734; Song ZM, 2008, OPHTHALMOLOGICA, V222, P149, DOI 10.1159/000126076; Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Takahashi A, 2014, OCUL IMMUNOL INFLAMM, V22, P409, DOI 10.3109/09273948.2014.902075; Takai Y, 2009, ACTA OPHTHALMOL, V87, P408, DOI 10.1111/j.1755-3768.2008.01269.x; Tsunoda K, 2011, ARCH OPHTHALMOL-CHIC, V129, P1099, DOI 10.1001/archophthalmol.2011.217	21	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125133	10.1371/journal.pone.0125133	http://dx.doi.org/10.1371/journal.pone.0125133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919689	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400073
J	Shen, GT; Hu, XY; Guan, GP; Wang, L				Shen, Gaotian; Hu, Xingyou; Guan, Guoping; Wang, Lu			Surface Modification and Characterisation of Silk Fibroin Fabric Produced by the Layer-by-Layer Self-Assembly of Multilayer Alginate/Regenerated Silk Fibroin	PLOS ONE			English	Article							BOMBYX-MORI SILK; PLATELET-ADHESION; ALGINATE; SCAFFOLDS; FILMS; DEPOSITION; CELLS	Silk-based medical products have a long history of use as a material for surgical sutures because of their desirable mechanical properties. However, silk fibroin fabric has been reported to be haemolytic when in direct contact with blood. The layer-by-layer self-assembly technique provides a method for surface modification to improve the biocompatibility of silk fibroin fabrics. Regenerated silk fibroin and alginate, which have excellent biocompatibility and low immunogenicity, are outstanding candidates for polyelectrolyte deposition. In this study, silk fabric was degummed and positively charged to create a silk fibroin fabric that could undergo self-assembly. The multilayer self-assembly of the silk fibroin fabric was achieved by alternating the polyelectrolyte deposition of a negatively charged alginate solution (pH = 8) and a positively charged regenerated silk fibroin solution (pH = 2). Finally, the negatively charged regenerated silk fibroin solution (pH = 8) was used to assemble the outermost layer of the fabric so that the surface would be negatively charged. A stable structural transition was induced using 75% ethanol. The thickness and morphology were characterised using atomic force microscopy. The properties of the self-assembled silk fibroin fabric, such as the bursting strength, thermal stability and flushing stability, indicated that the fabric was stable. In addition, the cytocompatibility and haemocompatibility of the self-assembled silk fibroin fabrics were evaluated. The results indicated that the biocompatibility of the self-assembled multilayers was acceptable and that it improved markedly. In particular, after the self-assembly, the fabric was able to prevent platelet adhesion. Furthermore, other non-haemolytic biomaterials can be created through self-assembly of more than 1.5 bilayers, and we propose that self-assembled silk fibroin fabric may be an attractive candidate for anticoagulation applications and for promoting endothelial cell adhesion for vascular prostheses.	[Shen, Gaotian; Hu, Xingyou; Guan, Guoping; Wang, Lu] Donghua Univ, Coll Text, Key Lab Text Sci & Technol, Minist Educ, Shanghai 201620, Peoples R China; [Guan, Guoping] Minist Educ, Engn Res Ctr Tech Text, Shanghai 201620, Peoples R China	Donghua University	Wang, L (corresponding author), Donghua Univ, Coll Text, Key Lab Text Sci & Technol, Minist Educ, Shanghai 201620, Peoples R China.	wanglu@dhu.edu.cn	Wang, Fujun/Y-2957-2019		National Natural Science Foundation of China [51003014, 31100682, 81371648]; Fundamental Research Funds for the Central Universities [2232015A3-02]; 111 Project "Biomedical Textile Materials Science and Technology" [B07024]; Chinese Universities Scientific Fund [CUSF-DH-D-2013031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project "Biomedical Textile Materials Science and Technology"; Chinese Universities Scientific Fund	This work was supported by the National Natural Science Foundation of China (Grant NO. 51003014, 31100682 and 81371648 to Lu Wang); the Fundamental Research Funds for the Central Universities (Grant NO. 2232015A3-02); the 111 Project "Biomedical Textile Materials Science and Technology" (Grant NO. B07024 to Lu Wang); and the Chinese Universities Scientific Fund (Grant NO. CUSF-DH-D-2013031 to Gaotian Shen).	Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393; Ariga K, 2011, ADV DRUG DELIVER REV, V63, P762, DOI 10.1016/j.addr.2011.03.016; Cao TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065654; Chue WL, 2004, J VASC SURG, V39, P859, DOI 10.1016/j.jvs.2003.03.003; Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036; de Moraes MA, 2015, BIOMACROMOLECULES, V16, P97, DOI 10.1021/bm5012135; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; Dinis TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109770; Elahi MF, 2014, J APPL POLYM SCI, V131, DOI [10.1002/app.40772, 10.1002/APP.40772]; Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005; Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5; Gouveia, 2010, MICROSCOPY SCI TECHN, P286; Jaganathan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091986; Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405; Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Konnova SA, 2013, CHEM COMMUN, V49, P4208, DOI 10.1039/c2cc38254g; Kotov NA, 1999, NANOSTRUCT MATER, V12, P789, DOI 10.1016/S0965-9773(99)00237-8; Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024; Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172; Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f; Lawrence BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050190; Lee JH, 2002, J BIOMED MATER RES, V60, P44, DOI 10.1002/jbm.10013; Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lin X, 2015, J NANOSCI NANOTECHNO, V15, P3893, DOI 10.1166/jnn.2015.9275; Liu XX, 2003, POLYMER, V44, P407, DOI 10.1016/S0032-3861(02)00771-1; Lojou T, 2004, LANGMUIR, V20, P748, DOI 10.1021/la030286w; LUPU C, 1988, ATHEROSCLEROSIS, V72, P77, DOI 10.1016/0021-9150(88)90065-2; LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020; LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026; Nuyttens BP, 2011, THROMB RES, V127, pS26, DOI 10.1016/S0049-3848(10)70151-1; Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; Qiu Y, 2014, THE FASEB JOURNAL SU, V28, P544; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Sarker B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107952; Sato M, 2010, MATER LETT, V64, P1786, DOI 10.1016/j.matlet.2010.05.024; Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027; Shchepelina O, 2011, ADV MATER, V23, P4655, DOI 10.1002/adma.201102234; Sutherland TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016489; Tamada Y, 2003, J APPL POLYM SCI, V87, P2377, DOI 10.1002/app.12022; van Gils JM, 2009, J LEUKOCYTE BIOL, V85, P195, DOI 10.1189/jlb.0708400; Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m; Whited BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061275; Woloszyk A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111010; Wu WL, 2014, SYNTHETIC MET, V193, P48, DOI 10.1016/j.synthmet.2014.03.029; Yagi T, 2011, J ARTIF ORGANS, V14, P89, DOI 10.1007/s10047-011-0554-z; Ye SQ, 2005, J BIOMAT SCI-POLYM E, V16, P909, DOI 10.1163/1568562054255691; You JO, 2001, J MICROENCAPSUL, V18, P521; Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022	55	28	29	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124811	10.1371/journal.pone.0124811	http://dx.doi.org/10.1371/journal.pone.0124811			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919690	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659400063
J	Efremov, AK; Qu, YY; Maruyama, H; Lim, CJ; Takeyasu, K; Yan, J				Efremov, Artem K.; Qu, Yuanyuan; Maruyama, Hugo; Lim, Ci J.; Takeyasu, Kunio; Yan, Jie			Transcriptional Repressor TrmBL2 from Thermococcus kodakarensis Forms Filamentous Nucleoprotein Structures and Competes with Histones for DNA Binding in a Salt- and DNA Supercoiling-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; atomic force microscopy (AFM); DNA-binding protein; extreme thermophile; gene regulation; protein-DNA interaction; single-molecule biophysics; DNA supercoiling; magnetic tweezers	NUCLEOID-ASSOCIATED PROTEIN; ESCHERICHIA-COLI; H-NS; (H3-H4)(2) TETRAMER; IN-VIVO; SINGLE; MOLECULES; ORGANIZATION; COMPARTMENTS; ARCHITECTURE	Background: TrmBL2 and histones maintain the genome functioning in hyperthermophilic euryarchaeal cells. Results: TrmBL2 forms filaments on DNA through cooperative binding and competes with histones in a salt- and DNA supercoiling-dependent manner. Conclusion: TrmBL2-histone collective behavior dynamically controls DNA organization. Significance: The discovered mechanisms provide insights into the regulation of the genome structure and global transcription profile by TrmBL2 and histones. Architectural DNA proteins play important roles in the chromosomal DNA organization and global gene regulation in living cells. However, physiological functions of some DNA-binding proteins from archaea remain unclear. Recently, several abundant DNA-architectural proteins including histones, Alba, and TrmBL2 have been identified in model euryarchaeon Thermococcus kodakarensis. Although histones and Alba proteins have been previously characterized, the DNA binding properties of TrmBL2 and its interplay with the other major architectural proteins in the chromosomal DNA organization and gene transcription regulation remain largely unexplored. Here, we report single-DNA studies showing that at low ionic strength (<300 mm KCl), TrmBL2 binds to DNA largely in non-sequence-specific manner with positive cooperativity, resulting in formation of stiff nucleoprotein filamentous patches, whereas at high ionic strength (>300 mm KCl) TrmBL2 switches to more sequence-specific interaction, suggesting the presence of high affinity TrmBL2-filament nucleation sites. Furthermore, in vitro assays indicate the existence of DNA binding competition between TrmBL2 and archaeal histones B from T. kodakarensis, which can be strongly modulated by DNA supercoiling and ionic strength of surrounding solution. Overall, these results advance our understanding of TrmBL2 DNA binding properties and provide important insights into potential functions of architectural proteins in nucleoid organization and gene regulation in T. kodakarensis.	[Efremov, Artem K.; Lim, Ci J.; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Efremov, Artem K.; Qu, Yuanyuan; Lim, Ci J.; Yan, Jie] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117546, Singapore; [Qu, Yuanyuan; Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Qu, Yuanyuan] Shandong Univ, Sch Phys, Jinan 250100, Peoples R China; [Maruyama, Hugo] Osaka Dent Univ, Dept Bacteriol, Hirakata, Osaka 5731121, Japan; [Lim, Ci J.; Yan, Jie] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 119077, Singapore; [Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Kyoto 6068501, Japan	National University of Singapore; National University of Singapore; National University of Singapore; Shandong University; National University of Singapore; Kyoto University	Takeyasu, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Kyoto 6068501, Japan.	takeyasu@lif.kyoto-u.ac.jp; phyyj@nus.edu.sg	Qu, Yuanyuan/AAI-8849-2021; Yan, Jie/G-2725-2012; Maruyama, Hugo/E-4141-2010; Maruyama, Hugo/AAS-3342-2020	Qu, Yuanyuan/0000-0001-9134-3567; Yan, Jie/0000-0002-8555-7291; Maruyama, Hugo/0000-0002-2190-7109; Efremov, Artem/0000-0002-1603-610X	Singapore Ministry of Education [MOE2012-T3-1-001, MOE2013-T2-1-154]; Mechanobiology Institute at National University of Singapore; JSPS KAKENHI [26850057]; Grants-in-Aid for Scientific Research [24115003] Funding Source: KAKEN	Singapore Ministry of Education(Ministry of Education, Singapore); Mechanobiology Institute at National University of Singapore(National University of Singapore); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Singapore Ministry of Education Academic Research Fund Tier 3 Grant MOE2012-T3-1-001) and Tier 2 Grant MOE2013-T2-1-154) and the Mechanobiology Institute at National University of Singapore (to J. Y.) and by JSPS KAKENHI Grant 26850057 (to H. M.).	Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Cabrera JE, 2003, MOL MICROBIOL, V50, P1493, DOI 10.1046/j.1365-2958.2003.03805.x; CHARBONNIER F, 1994, J BACTERIOL, V176, P1251, DOI 10.1128/jb.176.5.1251-1259.1994; Cunha S, 2001, J STRUCT BIOL, V136, P53, DOI 10.1006/jsbi.2001.4420; Dame RT, 2010, BACTERIAL CHROMATIN, P3, DOI 10.1007/978-90-481-3473-1_1; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Fishman DM, 1996, BIOPOLYMERS, V38, P535, DOI 10.1002/(SICI)1097-0282(199604)38:4<535::AID-BIP9>3.3.CO;2-H; Forth S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148301; Fu HX, 2011, CHROMOSOMA, V120, P245, DOI 10.1007/s00412-010-0307-4; Fu HX, 2010, NUCLEIC ACIDS RES, V38, P5594, DOI 10.1093/nar/gkq309; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Hamiche A, 1998, J BIOL CHEM, V273, P9261, DOI 10.1074/jbc.273.15.9261; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Hancock R, 2004, BIOL CELL, V96, P595, DOI 10.1016/j.biolcel.2004.05.003; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HENSEL R, 1988, FEMS MICROBIOL LETT, V49, P75, DOI 10.1111/j.1574-6968.1988.tb02685.x; Ishihama A, 2014, J BACTERIOL, V196, P2718, DOI 10.1128/JB.01579-14; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; Lim CJ, 2013, NUCLEIC ACIDS RES, V41, P746, DOI 10.1093/nar/gks1126; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; LopezGarcia P, 1997, MOL MICROBIOL, V23, P1267, DOI 10.1046/j.1365-2958.1997.3051668.x; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Marc F, 2002, J BIOL CHEM, V277, P30879, DOI 10.1074/jbc.M203674200; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Marko JF, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021926; Maruyama H, 2011, MOL BIOL CELL, V22, P386, DOI 10.1091/mbc.E10-08-0668; Maruyama H, 2013, EMBO REP, V14, P711, DOI 10.1038/embor.2013.94; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Murphy LD, 1997, J STRUCT BIOL, V119, P336, DOI 10.1006/jsbi.1997.3884; Musgrave D, 2000, MOL MICROBIOL, V35, P341, DOI 10.1046/j.1365-2958.2000.01689.x; Nalabothula N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-391; Noom MC, 2007, CURR BIOL, V17, pR913, DOI 10.1016/j.cub.2007.09.005; Odijk T, 2002, COLLOID SURFACE A, V210, P191, DOI 10.1016/S0927-7757(02)00374-6; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Qu Y, 2013, NUCLEIC ACIDS RES, V41, P5263, DOI 10.1093/nar/gkt249; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Sarkar A, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051903; Schlingman DJ, 2011, COLLOID SURFACE B, V83, P91, DOI 10.1016/j.colsurfb.2010.11.002; Schnurr Bernhard, 2006, Biophysical Reviews and Letters, V1, P29, DOI 10.1142/S1793048006000021; Sheinin MY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.108102; Starich MR, 1996, J MOL BIOL, V255, P187, DOI 10.1006/jmbi.1996.0016; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; van Noort J, 2004, P NATL ACAD SCI USA, V101, P6969, DOI 10.1073/pnas.0308230101; Vlijm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046306; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Winardhi RS, 2014, J BIOL CHEM, V289, P13739, DOI 10.1074/jbc.M113.545954; Winardhi RS, 2012, NUCLEIC ACIDS RES, V40, P8942, DOI 10.1093/nar/gks669; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905; Yan J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011905	65	18	18	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15770	15784		10.1074/jbc.M114.626705	http://dx.doi.org/10.1074/jbc.M114.626705			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25931116	Green Published, hybrid			2022-12-26	WOS:000356527400038
J	Jain, A; Rusten, TE; Katheder, N; Elvenes, J; Bruun, JA; Sjottem, E; Lamark, T; Johansen, T				Jain, Ashish; Rusten, Tor Erik; Katheder, Nadja; Elvenes, Julianne; Bruun, Jack-Ansgar; Sjottem, Eva; Lamark, Trond; Johansen, Terje			p62/Sequestosome-1, Autophagy-related Gene 8, and Autophagy in Drosophila Are Regulated by Nuclear Factor Erythroid 2-related Factor 2 (NRF2), Independent of Transcription Factor TFEB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KEAP1-NRF2 PATHWAY; SIGNALING PATHWAY; STRESS-RESPONSE; PB1 DOMAIN; IN-VIVO; PROTEIN; ACTIVATION; P62; DEGRADATION; P62/SQSTM1	The selective autophagy receptor p62/sequestosome 1 (SQSTM1) interacts directly with LC3 and is involved in oxidative stress signaling in two ways in mammals. First, p62 is transcriptionally induced upon oxidative stress by the NF-E2-related factor 2 (NRF2) by direct binding to an antioxidant response element in the p62 promoter. Second, p62 accumulation, occurring when autophagy is impaired, leads to increased p62 binding to the NRF2 inhibitor KEAP1, resulting in reduced proteasomal turnover of NRF2. This gives chronic oxidative stress signaling through a feed forward loop. Here, we show that the Drosophila p62/SQSTM1 orthologue, Ref(2)P, interacts directly with DmAtg8a via an LC3-interacting region motif, supporting a role for Ref(2) P in selective autophagy. The ref(2)P promoter also contains a functional antioxidant response element that is directly bound by the NRF2 orthologue, CncC, which can induce ref(2) P expression along with the oxidative stress-associated gene gstD1. However, distinct from the situation in mammals, Ref(2) P does not interact directly with DmKeap1 via a KEAP1-interacting region motif; nor does ectopically expressed Ref(2) P or autophagy deficiency activate the oxidative stress response. Instead, DmAtg8a interacts directly with DmKeap1, and DmKeap1 is removed upon programmed autophagy in Drosophila gut cells. Strikingly, CncC induced increased Atg8a levels and autophagy independent of TFEB/MitF in fat body and larval gut tissues. Thus, these results extend the intimate relationship between oxidative stress-sensing NRF2/CncC transcription factors and autophagy and suggest that NRF2/CncC may regulate autophagic activity in other organisms too.	[Jain, Ashish; Elvenes, Julianne; Bruun, Jack-Ansgar; Sjottem, Eva; Lamark, Trond; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [Rusten, Tor Erik; Katheder, Nadja] Univ Oslo, Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0379 Oslo, Norway; [Katheder, Nadja] Univ Oslo, Ctr Canc Biomed, N-0379 Oslo, Norway	UiT The Arctic University of Tromso; University of Oslo; University of Oslo	Rusten, TE (corresponding author), Univ Oslo, Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol,Ctr Canc Biomed, N-0379 Oslo, Norway.	tor.erik.rusten@rr-research.no; terje.johansen@uit.no	Jain, Ashish/H-7356-2017; Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021	Jain, Ashish/0000-0001-6549-2788; Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Rusten, Tor Erik/0000-0002-9150-2676; Katheder, Nadja/0000-0003-0460-0938; Sjottem, Eva/0000-0003-2668-1708; Lamark, Trond/0000-0001-6338-3342; Bruun, Jack-Ansgar/0000-0003-0614-2790	Norwegian Research Council [196898, 214448]; Norwegian Cancer Society [71043-PR-2006-0320]; Research Council of Norway through its Centres of Excellence funding scheme [179571]; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway through its Centres of Excellence funding scheme; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the FRIBIO and FRIBIOMED programs of the Norwegian Research Council (Grants 196898 and 214448) and Norwegian Cancer Society Grant 71043-PR-2006-0320 (to T.J.); partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571 (to T. E. R., awarded to Harald Stenmark); and supported by The Norwegian Cancer Society (T. E. R. and N. K.).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Avila A, 2002, MOL CELL BIOL, V22, P8787, DOI 10.1128/MCB.22.24.8787-8795.2002; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Carre-Mouka A, 2007, GENETICS, V176, P409, DOI 10.1534/genetics.106.063826; Cazanave SC, 2014, CELL DEATH DIFFER, V21, P1303, DOI 10.1038/cdd.2014.49; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034063; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; CONTAMINE D, 1989, GENETICS, V123, P525; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; Denton D, 2012, CELL DEATH DIFFER, V19, P1299, DOI 10.1038/cdd.2012.43; DEZELEE S, 1989, EMBO J, V8, P3437, DOI 10.1002/j.1460-2075.1989.tb08508.x; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Genau HM, 2015, MOL CELL, V57, P995, DOI 10.1016/j.molcel.2014.12.040; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hegedus K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470482; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Ishimura R, 2014, FEBS LETT, V588, P822, DOI 10.1016/j.febslet.2014.01.045; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jaiswal AK, 2004, METHOD ENZYMOL, V378, P221; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kalvari I, 2014, AUTOPHAGY, V10, P913, DOI 10.4161/auto.28260; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Mathers J, 2004, BIOCHEM SOC SYMP, V71, P157, DOI 10.1042/bss0710157; McGinnis N, 1998, DEVELOPMENT, V125, P4553; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Misra JR, 2013, INSECT BIOCHEM MOLEC, V43, P1116, DOI 10.1016/j.ibmb.2013.09.005; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; MOHLER J, 1991, MECH DEVELOP, V34, P3, DOI 10.1016/0925-4773(91)90086-L; MOHLER J, 1995, DEVELOPMENT, V121, P237; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Mulakkal NC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/273473; Nagy P, 2014, FEBS LETT, V588, P408, DOI 10.1016/j.febslet.2013.12.012; Nagy P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003664; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nezis Ioannis P, 2012, Int J Cell Biol, V2012, P146767, DOI 10.1155/2012/146767; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Ohtsubo T, 1999, CELL DEATH DIFFER, V6, P865, DOI 10.1038/sj.cdd.4400566; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pircs K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044214; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shravage BV, 2013, DEVELOPMENT, V140, P1321, DOI 10.1242/dev.089490; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wu H, 2009, MECH DEVELOP, V126, P624, DOI 10.1016/j.mod.2009.06.1082; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	81	45	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14945	14962		10.1074/jbc.M115.656116	http://dx.doi.org/10.1074/jbc.M115.656116			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25931115	hybrid, Green Published			2022-12-26	WOS:000356177300013
J	Chatwin, M; Tan, HL; Bush, A; Rosenthal, M; Simonds, AK				Chatwin, Michelle; Tan, Hui-Leng; Bush, Andrew; Rosenthal, Mark; Simonds, Anita Kay			Long Term Non-Invasive Ventilation in Children: Impact on Survival and Transition to Adult Care	PLOS ONE			English	Article							HOME MECHANICAL VENTILATION; SPINAL MUSCULAR-ATROPHY; POSITIVE-PRESSURE VENTILATION; NATURAL-HISTORY; DYSTROPHY; DISABILITY; LIFE	Background The number of children receiving domiciliary ventilatory support has grown over the last few decades driven largely by the introduction and widening applications of non-invasive ventilation. Ventilatory support may be used with the intention of increasing survival, or to facilitate discharge home and/or to palliate symptoms. However, the outcome of this intervention and the number of children transitioning to adult care as a consequence of longer survival is not yet clear. Methods In this retrospective cohort study, we analysed the outcome in children (< 17 years) started on home NIV at Royal Brompton Hospital over an 18 year period 1993-2011. The aim was to establish for different diagnostic groups: survival rate, likelihood of early death depending on diagnosis or discontinuation of ventilation, and the proportion transitioning to adult care. Results 496 children were commenced on home non invasive ventilation; follow-up data were available in 449 (91%). Fifty six per cent (n = 254) had neuromuscular disease. Ventilation was started at a median age (IQR) 10 (3-15) years. Thirteen percent (n = 59) were less than 1 year old. Forty percent (n = 181) have transitioned to adult care. Twenty four percent (n = 109) of patients have died, and nine percent (n = 42) were able to discontinue ventilatory support. Conclusion Long term ventilation is associated with an increase in survival in a range of conditions leading to ventilatory failure in children, resulting in increasing numbers surviving to adulthood. This has significant implications for planning transition and adult care facilities.	[Chatwin, Michelle; Simonds, Anita Kay] Royal Brompton & Harefield NHS Fdn Trust, Acad & Clin Dept Sleep & Breathing, London, England; [Tan, Hui-Leng; Bush, Andrew; Rosenthal, Mark] Royal Brompton & Harefield NHS Fdn Trust, Dept Paediat, London, England; [Chatwin, Michelle; Tan, Hui-Leng; Bush, Andrew; Rosenthal, Mark; Simonds, Anita Kay] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England	Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust	Chatwin, M (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, Acad & Clin Dept Sleep & Breathing, Sydney St, London, England.	m.chatwin@rbht.nhs.uk			NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; National Institute for Health Research [NF-SI-0510-10192] Funding Source: researchfish	NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors were supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2014, PEDIATR PULM, V49, P816, DOI 10.1002/ppul.22868; Bach JR, 2008, PAEDIATR RESPIR REV, V9, P45, DOI 10.1016/j.prrv.2007.11.003; Bach JR, 1997, CHEST, V112, P1024, DOI 10.1378/chest.112.4.1024; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Chatwin M, 2011, ARCH DIS CHILD, V96, P426, DOI 10.1136/adc.2009.177832; Chatwin M, 2010, EUR RESPIR J, V35, P310, DOI 10.1183/09031936.00073409; Chatwin M, 2008, RESP MED, V102, P1528, DOI 10.1016/j.rmed.2008.07.019; Chesson Jr A. L., 2007, THE AASM MANUAL FOR; DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P3, DOI 10.1016/0960-8966(94)00075-K; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; Dubowitz V, 1995, MUSCLE DISORDERS CHI, P540; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Fauroux B, 2005, INTENS CARE MED, V31, P965, DOI 10.1007/s00134-005-2669-2; Foley AR, 2013, BRAIN, V136, P3625, DOI 10.1093/brain/awt284; Goodwin S, 2011, EUR J PEDIATR, V170, P1187, DOI 10.1007/s00431-011-1430-9; Hill ME, 2006, NEUROMUSCULAR DISORD, V16, P107, DOI 10.1016/j.nmd.2005.11.011; Hull J, 2012, THORAX, V67, P1, DOI 10.1136/thoraxjnl-2012-201964; Ishikawa Y, 2011, NEUROMUSCULAR DISORD, V21, P47, DOI 10.1016/j.nmd.2010.09.006; Jeppesen J, 2003, NEUROMUSCULAR DISORD, V13, P804, DOI 10.1016/S0960-8966(03)00162-7; Katz S, 2004, ARCH DIS CHILD, V89, P121, DOI 10.1136/adc.2002.018655; Kohler M, 2005, AM J RESP CRIT CARE, V172, P1032, DOI 10.1164/rccm.200503-322OC; Lloyd-Owen SJ, 2005, EUR RESPIR J, V25, P1025, DOI 10.1183/09031936.05.00066704; Matsumura Tsuyoshi, 2011, Rinsho Shinkeigaku, V51, P743; McDougall CM, 2013, ARCH DIS CHILD, V98, P660, DOI 10.1136/archdischild-2012-303062; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; Paulides FM, 2012, INTENS CARE MED, V38, P847, DOI 10.1007/s00134-012-2545-9; Racca F, 2011, MINERVA ANESTESIOL, V77, P892; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Robb Stephanie A, 2010, Neuromuscul Disord, V20, P833, DOI 10.1016/j.nmd.2010.08.002; Shurayatcher Y, 2008, NEUROMUSCULAR DISORD, V18, P561, DOI 10.1016/j.nmd.2008.05.001; Toussaint M, 2006, EUR RESPIR J, V28, P549, DOI 10.1183/09031936.06.00004906; Vianello A, 2004, NEUROMUSCULAR DISORD, V14, P353, DOI 10.1061/j.nmd.2004.03.002; Wallis C, 2011, ARCH DIS CHILD, V96, P998, DOI 10.1136/adc.2010.192864; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	34	67	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125839	10.1371/journal.pone.0125839	http://dx.doi.org/10.1371/journal.pone.0125839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933065	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100137
J	de Carvalho, AX; Maiato, H; Maia, AF; Ribeiro, SA; Pontes, P; Bickmore, W; Earnshaw, WC; Sambade, C				de Carvalho, Ana Xavier; Maiato, Helder; Maia, Andre F.; Ribeiro, Susana A.; Pontes, Patricia; Bickmore, Wendy; Earnshaw, William C.; Sambade, Clara			Reed-Sternberg Cells Form by Abscission Failure in the Presence of Functional Aurora B Kinase	PLOS ONE			English	Article							HODGKINS-DISEASE; KELCH PROTEIN; EXPRESSION; CCL5/RANTES; INVOLVEMENT; REPRESENT; FUSION; GROWTH; L-428; LINES	Large multinucleated Reed-Sternberg cells (RS) and large mononucleated Hodgkin cells (H) are traditionally considered to be the neoplastic population in classical Hodgkin lymphoma, (cHL) and postulated to promote the disease. However, the contribution of these larger cells to the progression of cHL remains debatable. We used established cHL cell lines and cHL cellular fractions composed of small mononucleated cells only or enriched in large RS/H cells to investigate RS/H cell origin and to characterize the cells which they derive from. We confirm that the small mononucleated cells give rise to RS/H cells, and we show that the latter proliferate significantly more slowly than the small cells. By using live-cell imaging, we demonstrate that binucleated RS cells are generated by failure of abscission when a few small cells attempt to divide. Finally, our results reveal that the small mononucleated cells are chromosomally unstable, but this is unlikely to be related to a malfunctioning chromosomal passenger protein complex. We propose that the small mononucleated cells, rather than the RS/H cells, are the main drivers of cHL.	[de Carvalho, Ana Xavier; Maiato, Helder; Maia, Andre F.] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [Maiato, Helder] Univ Porto, Fac Med, Dept Expt Biol, Cell Div Unit, P-4100 Oporto, Portugal; [Ribeiro, Susana A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Ribeiro, Susana A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Pontes, Patricia; Sambade, Clara] Univ Porto, Inst Patol & Imunol Mol IPATIMUP, P-4100 Oporto, Portugal; [Bickmore, Wendy] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Earnshaw, William C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade do Porto; University of Edinburgh; University of Edinburgh	de Carvalho, AX (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	anacarvalho@ibmc.up.pt	Carvalho, Ana/J-4788-2013; Earnshaw, William/AAY-7438-2020; Maia, André/I-1565-2013; Maiato, Helder/J-9466-2013	Carvalho, Ana/0000-0002-2256-7134; Maia, André/0000-0001-5987-7016; Earnshaw, William/0000-0002-7191-0621; Maiato, Helder/0000-0002-6200-9997	project "Cell Homeostasis Tissue Organization and Organism Biology" [NORTE-07-0124-FEDER-000003]; Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER); FCT (Fundacao para a Ciencia e Tecnologia); Portuguese Association Leukemia study (APCL); Praxis XXI, (FCT) [BD21811/99]; Welcome II Program - (FCT); Programa Operacional Potencial Humano (POPH); Promocao do Emprego Cientifico [4.2]; FCT [SFRH/BPD/11592/2002, SFRH/BPD/71364/2010]; Wellcome Trust [073915]; MRC; Marie Curie Action COFUND; European Research Council;  [077707];  [092076]; MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	project "Cell Homeostasis Tissue Organization and Organism Biology"; Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER); FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); Portuguese Association Leukemia study (APCL); Praxis XXI, (FCT)(Portuguese Foundation for Science and Technology); Welcome II Program - (FCT); Programa Operacional Potencial Humano (POPH); Promocao do Emprego Cientifico; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Action COFUND; European Research Council(European Research Council (ERC)European Commission); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the project "NORTE-07-0124-FEDER-000003-Cell Homeostasis Tissue Organization and Organism Biology" co-funded by Programa Operacional Regional do Norte (ON.2-O Novo Norte), under the Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER) and by FCT (Fundacao para a Ciencia e Tecnologia) and by a grant from the Portuguese Association Leukemia study (APCL). A.X.C. was supported by Praxis XXI, BD21811/99 (FCT), the Welcome II Program (funded by FCT and the Marie Curie Action COFUND) and an IF position funded by FCT and co-financed by Programa Operacional Potencial Humano (POPH), 4.2 - Promocao do Emprego Cientifico. H.M. was supported by the postdoctoral research fellowship SFRH/BPD/11592/2002 from FCT and work in his lab is currently funded by a PRECISE grant from the European Research Council. A.F.M. was supported by the postdoctoral fellowship SFRH/BPD/71364/2010 from FCT. Work in the Earnshaw Lab was funded by The Wellcome Trust, of which W.C.E. is a Principal Research Fellow [grant number 073915]. The Wellcome Trust Centre for Cell Biology is supported by core grant numbers 077707 and 092076. W.B. is supported by the MRC.	Aldinucci D, 2008, INT J CANCER, V122, P769, DOI 10.1002/ijc.23119; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cattaruzza L, 2009, INT J CANCER, V125, P1092, DOI 10.1002/ijc.24389; DREXLER HG, 1989, INT J CANCER, V43, P1083, DOI 10.1002/ijc.2910430622; Fischer M, 2003, INT J CANCER, V107, P197, DOI 10.1002/ijc.11370; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; HSU SM, 1988, BLOOD, V71, P1382; Ikeda JI, 2010, AM J PATHOL, V177, P3081, DOI 10.2353/ajpath.2010.100089; Ioannou M, 2013, J MOL HIST      1224; Kanzler H, 1996, BLOOD, V87, P3429, DOI 10.1182/blood.V87.8.3429.bloodjournal8783429; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Krem MM, 2012, J BIOL CHEM, V287, P39083, DOI 10.1074/jbc.M112.390088; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kuppers R, 2001, BLOOD, V97, P818, DOI 10.1182/blood.V97.3.818; Marafioti T, 1997, NEW ENGL J MED, V337, P453, DOI 10.1056/NEJM199708143370703; Mori N, 2011, BIOCHEM PHARMACOL, V81, P1106, DOI 10.1016/j.bcp.2011.02.010; Muschen M, 2001, LAB INVEST, V81, P289, DOI 10.1038/labinvest.3780237; NEWCOM SR, 1988, INT J CELL CLONING, V6, P417, DOI 10.1002/stem.5530060606; Re D, 2001, AM J HEMATOL, V67, P6, DOI 10.1002/ajh.1068; Rengstl B, 2013, P NATL ACAD SCI USA, V110, P20729, DOI 10.1073/pnas.1312509110; Salipante SJ, 2009, P NATL ACAD SCI USA, V106, P14920, DOI 10.1073/pnas.0904231106; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124629	10.1371/journal.pone.0124629	http://dx.doi.org/10.1371/journal.pone.0124629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933052	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100053
J	Ogoina, D; Finomo, F; Harry, T; Inatimi, O; Ebuenyi, I; Tariladei, WW; Afolayan, AA				Ogoina, Dimie; Finomo, Finomo; Harry, Tubonye; Inatimi, Otonyo; Ebuenyi, Ikenna; Tariladei, Wolo-Wolo; Afolayan, Abimbola Anne			Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria	PLOS ONE			English	Article							HIV-INFECTED ADULTS; SUB-SAHARAN AFRICA; PREVENTION	Introduction Based on growing evidence mainly from countries outside Sub-Saharan Africa, the World Health Organisation (WHO) now recommends initiation of antiretroviral therapy (ART) in HIV-infected individuals in developing countries when CD4 cell count (CD4+) is <= 500cells/ul. Nigeria accounts for about 14% of the estimated HIV/AIDS burden in Sub-Saharan Africa. We evaluated the factors associated with timing of initiation of ART among treatment-ineligible HIV-infected adults from Nigeria. Methods We retrospectively reviewed the hospital records of ART ineligible HIV-infected adults who enrolled into HIV care between January 2008 and December 2012 at two major tertiary hospitals in Bayelsa State, South-South Nigeria. Demographic, clinical and laboratories data were obtained at presentation, at each subsequent visit at 6 monthly intervals and at time of initiation of ART. Cox proportional regression and Kaplan-Meier survival analysis were used to evaluate independent predictors of time to initiation of ART. Results Amongst the 280 study participants, 70.6% were females, 62.6% had CD4+ >= 500cells/ul, 48.4% had WHO HIV Stage 1 disease and 34.3% were lost to follow up. In a cohort of 180 participants followed up for >= 3months, participants with CD4+ of 351-500cells/ul and stage 2 disease were more likely to start ART earlier than those with CD4+ >500cells/ul (Hazard ratio [HR]-1.7, 95% confidence interval [CI] of 1.0-2.9) and stage 1 disease (HR-2.3 (95% CI-1.3-4.2) respectively. HIV-infected adults with faster CD4+ decay required earlier ART initiation, especially in the first year of follow up. Conclusion ART-ineligible HIV-infected adults on follow up in South-South Nigeria are more likely to require earlier initiation of ART if they have stage 2 HIV disease or CD4+ <= 500cells/ul at presentation. Our findings suggest faster progression of HIV-disease in these groups of individuals and corroborate the growing evidence in support for earlier initiation of ART.	[Ogoina, Dimie; Harry, Tubonye; Inatimi, Otonyo; Ebuenyi, Ikenna] Niger Delta Univ, Teaching Hosp, Dept Internal Med, Okolobiri, Bayelsa State, Nigeria; [Finomo, Finomo; Tariladei, Wolo-Wolo; Afolayan, Abimbola Anne] Fed Med Ctr, Dept Med, Yenagoa, Bayelsa State, Nigeria		Ogoina, D (corresponding author), Niger Delta Univ, Teaching Hosp, Dept Internal Med, Okolobiri, Bayelsa State, Nigeria.	dimostic@yahoo.co.uk	Ogoina, Dimie/H-4091-2019; Harry, Tubonye/A-2107-2012	Ogoina, Dimie/0000-0002-2098-6300; Harry, Tubonye/0000-0003-3773-5230; Ebuenyi, Ikenna/0000-0002-3329-6296				Agu KA, 2012, WORLD J AIDS, V2, P330, DOI [10.4236/wja.2012.24044, DOI 10.4236/WJA.2012.24044]; Aliyu M H, 2010, Afr J Med Med Sci, V39, P233; Aliyu MH, 2014, JAIDS-J ACQ IMM DEF, V65, pE41, DOI 10.1097/QAI.0b013e31829ceaec; Anglaret X, 2013, ANTIVIR THER, V18, P45, DOI 10.3851/IMP2231; Anglemyer A, 2014, AIDS, V28, pS105, DOI 10.1097/QAD.0000000000000232; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Cock KM, 2013, NEW ENGL J MED, V368, P886, DOI 10.1056/NEJMp1300458; Easterbrook PJ, 1999, J ANTIMICROB CHEMOTH, V43, P379, DOI 10.1093/jac/43.3.379; Federal Ministry of Health Nigeria, 2010, NATIONAL HIV SEROPRE; Federal Ministry of Health Nigeria, 2010, NATIONAL GUIDELINES; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lepri AC, 1998, EPIDEMIOL INFECT, V121, P369, DOI 10.1017/S095026889800140X; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; National Agency for Control of AIDS (NACA) Nigeria, 2011, FACT SHEET UPDATE ON, P1; Odafe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051254; Odafe S, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17424; Opravil M, 2002, AIDS, V16, P1371, DOI 10.1097/00002030-200207050-00009; Salamon R, 2002, J ACQ IMMUN DEF SYND, V29, P149, DOI 10.1097/00042560-200202010-00007; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; World Health Organization, 2013, COMPREHENSIVE CERVIC; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125665	10.1371/journal.pone.0125665	http://dx.doi.org/10.1371/journal.pone.0125665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933356	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100125
J	Ren, J; Huang, HR; Liu, Y; Zheng, X; Zou, QZ				Ren, Juan; Huang, Huarong; Liu, Yue; Zheng, Xi; Zou, Qingze			An Atomic Force Microscope Study Revealed Two Mechanisms in the Effect of Anticancer Drugs on Rate-Dependent Young's Modulus of Human Prostate Cancer Cells	PLOS ONE			English	Article							IN-VITRO; INHIBITION; DISULFIRAM; DIFFERENTIATION; MICRORHEOLOGY; CYTOSKELETON; FIBROBLASTS; MODULATION; ELASTICITY; MODEL	Mechanical properties of cells have been recognized as a biomarker for cellular cytoskeletal organization. As chemical treatments lead to cell cytoskeletal rearrangements, thereby, modifications of cellular mechanical properties, investigating cellular mechanical property variations provides insightful knowledge to effects of chemical treatments on cancer cells. In this study, the effects of eight different anticancer drugs on the mechanical properties of human prostate cancer cell (PC-3) are investigated using a recently developed control-based nanoindentation measurement (CNM) protocol on atomic force microscope (AFM). The CNM protocol overcomes the limits of other existing methods to in-liquid nanoindentation measurement of live cells on AFM, particularly for measuring mechanical properties of live cells. The Young's modulus of PC-3 cells treated by the eight drugs was measured by varying force loading rates over three orders of magnitude, and compared to the values of the control. The results showed that the Young's modulus of the PC-3 cells increased substantially by the eight drugs tested, and became much more pronounced as the force load rate increased. Moreover, two distinct trends were clearly expressed, where under the treatment of Disulfiram, paclitaxel, and MK-2206, the exponent coefficient of the frequency-modulus function remained almost unchanged, while with Celebrex, BAY, Totamine, TPA, and Vaproic acid, the exponential rate was significantly increased.	[Ren, Juan; Zou, Qingze] Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08855 USA; [Huang, Huarong; Zheng, Xi] Guangdong Univ Technol, Allan H Conney Lab Anticanc Res, Guangzhou 510006, Guangdong, Peoples R China; [Liu, Yue; Zheng, Xi] Rutgers State Univ, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ USA	Rutgers State University New Brunswick; Guangdong University of Technology; Rutgers State University New Brunswick	Zou, QZ (corresponding author), Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08855 USA.	qzzou@rci.rutgers.edu			NSF CAREER [CMMI-1066055]; IDBR [DBI-1353890]; Direct For Biological Sciences [1353890] Funding Source: National Science Foundation	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); IDBR; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF CAREER award grant CMMI-1066055 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1066055) and IDBR grant (DBI-1353890) (http://www.nsf.gov/awards/award_visualization_noscript.jsp?org=CMMI1@ion=US-NJ&instId= 0026294000).	Akunda JK, 2004, FASEB J, V18, P185, DOI 10.1096/fj.02-1192fje; Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Cen DZ, 2004, J MED CHEM, V47, P6914, DOI 10.1021/jm049568z; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Glass-Marmor L, 1999, EUR J PHARMACOL, V370, P195, DOI 10.1016/S0014-2999(99)00155-7; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Karcher H, 2003, BIOPHYS J, V85, P3336, DOI 10.1016/S0006-3495(03)74753-5; Kim KS, 2013, IEEE-ASME T MECH, V18, P1767, DOI 10.1109/TMECH.2012.2212912; Kim SH, 2007, ANN NY ACAD SCI, V1095, P82, DOI 10.1196/annals.1397.012; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lee GYH, 2007, TRENDS BIOTECHNOL, V25, P111, DOI 10.1016/j.tibtech.2007.01.005; Lee Juliet, 1993, Trends in Cell Biology, V3, P366, DOI 10.1016/0962-8924(93)90084-E; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018915; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Lekka M, 2009, NAT NANOTECHNOL, V4, P72, DOI 10.1038/nnano.2009.004; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Ma SH, 1997, GENE EXPRESSION, V6, P361; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Mofrad M.R.K., 2006, CYTOSKELETAL MECH; POTCHOO Y, 1986, INT J CLIN PHARM TH, V24, P499; RADMACHER M, 1993, BIOPHYS J, V64, P735, DOI 10.1016/S0006-3495(93)81433-4; Rebelo LM, 2014, SOFT MATTER, V10, P2141, DOI 10.1039/c3sm52045e; Rebelo LM, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/5/055102; Ren J, 2014, IEEE T NANOTECHNOL, V13, P46, DOI 10.1109/TNANO.2013.2287505; Ren J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052711; Ren J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804381; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Schillers H, 2010, BIOPHYS J, V99, P3639, DOI 10.1016/j.bpj.2010.09.048; Smith BA, 2005, BIOPHYS J, V88, P2994, DOI 10.1529/biophysj.104.046649; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Vaheri A, 1997, CURR OPIN CELL BIOL, V9, P659, DOI 10.1016/S0955-0674(97)80119-6; Venkatesan P, 2010, MICRON, V41, P247, DOI 10.1016/j.micron.2009.10.008; Werling U, 2001, MOL PHARMACOL, V59, P1269, DOI 10.1124/mol.59.5.1269; Xu ZH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3327450; Xu ZH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2990759; Zdunek A, 2013, SENSORS-BASEL, V13, P12175, DOI 10.3390/s130912175; Zhang HJ, 2010, CANCER RES, V70, P3996, DOI 10.1158/0008-5472.CAN-09-3752; Zheng X, 2006, CLIN CANCER RES, V12, P3444, DOI 10.1158/1078-0432.CCR-05-2823	44	35	36	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126107	10.1371/journal.pone.0126107	http://dx.doi.org/10.1371/journal.pone.0126107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932632	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100148
J	Yang, BR; Seong, JM; Choi, NK; Shin, JY; Lee, J; Kim, YJ; Kim, MS; Park, S; Song, HJ; Park, BJ				Yang, Bo Ram; Seong, Jong-Mi; Choi, Nam-Kyong; Shin, Ju-Young; Lee, Joongyub; Kim, Ye-Jee; Kim, Mi-Sook; Park, Soyoung; Song, Hong Ji; Park, Byung-Joo			Co-Medication of Statins with Contraindicated Drugs	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; AVERAGE CHOLESTEROL LEVELS; CYP3A4 INHIBITORS; ADMINISTRATIVE CLAIMS; MYOCARDIAL-INFARCTION; PLASMA-CONCENTRATIONS; PRIMARY PREVENTION; CORONARY EVENTS; ADVERSE EVENTS; RISK-FACTORS	Background The concomitant use of cytochrome P450 3A4 (CYP3A4) metabolized statins (simvastatin, lovastatin, and atorvastatin) with CYP3A4 inhibitors has been shown to increase the rate of adverse events. Objective This study was performed to describe the co-medication prevalence of CYP3A4-metabolized statins with contraindicated drugs. Methods The patients aged 40 or older receiving CYP3A4-metabolized statin prescriptions in 2009 were identified using the national patient sample from a Korea Health Insurance Review and Assessment Service database. Contraindicated co-medication was defined as prescription periods of statins and contraindicated drugs overlapping by at least one day. Co-medication patterns were classified into 3 categories as follows: co-medication in the same prescription, co-medication by the same medical institution, and co-medication by different medical institutions. The proportion of co-medication was analyzed by age, gender, co-morbidities, and the statin's generic name. Results A total of 2,119,401 patients received CYP3A4-metabolized statins and 60,254 (2.84%) patients were co-medicated with contraindicated drugs. The proportion of co-medication was 4.6%, 2.2%, and 1.8% in simvastatin, lovastatin, and atorvastatin users, respectively. The most frequent combination was atorvastatin-itraconazole, followed by simvastatin-clarithromycin and simvastatin-itraconazole. Among the co-medicated patients, 85.3% were prescribed two drugs by different medical institutions. Conclusion The proportion of co-medication of statins with contraindicated drugs was relatively lower than that of previous studies; however, the co-medication occurring by different medical institutions was not managed appropriately. There is a need to develop an effective system and to conduct outcomes research confirming the association between co-medication and the risk of unfavorable clinical outcomes.	[Yang, Bo Ram; Lee, Joongyub; Kim, Mi-Sook; Park, Soyoung; Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yang, Bo Ram; Choi, Nam-Kyong; Lee, Joongyub] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Seong, Jong-Mi; Shin, Ju-Young; Kim, Ye-Jee] Korea Inst Drug Safety & Risk Management, Seoul, South Korea; [Song, Hong Ji] Hallym Univ, Coll Med, Dept Family Med, Chunchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Hallym University	Park, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	bjpark@snu.ac.kr		Choi, Nam-Kyong/0000-0003-1153-9928; Shin, Ju-Young/0000-0003-1010-7525				Backman JT, 2000, CLIN PHARMACOL THER, V68, P122, DOI 10.1067/mcp.2000.108507; Bakhai A, 2012, PHARMACOEPIDEM DR S, V21, P485, DOI 10.1002/pds.2308; Ballantyne CM, 2003, ARCH INTERN MED, V163, P553, DOI 10.1001/archinte.163.5.553; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Buurma H, 2007, ANN PHARMACOTHER, V41, P2024, DOI 10.1345/aph.1K240; Cziraky MJ, 2006, AM J CARDIOL, V97, p61C, DOI 10.1016/j.amjcard.2005.12.011; Devold HM, 2009, BRIT J CLIN PHARMACO, V67, P234, DOI 10.1111/j.1365-2125.2008.03345.x; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Jacobson TA, 2004, AM J CARDIOL, V94, P1140, DOI 10.1016/j.amjcard.2004.07.080; Jones PH, 2005, AM J CARDIOL, V95, P120, DOI 10.1016/j.amjcard.2004.08.076; Kantola T, 1998, CLIN PHARMACOL THER, V64, P58, DOI 10.1016/S0009-9236(98)90023-6; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Korea Health Insurance Review and Assessment Service, 2010, DRUG UTILIZATION REV; Korea Ministry of Health and Welfare, 2004, REV DET REG APPL STA; Korea Ministry of Health and Welfare, 2005, REVISION OF DETAILS; Kyrklund C, 2001, CLIN PHARMACOL THER, V69, P340, DOI 10.1067/mcp.2001.115542; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lewis SJ, 1998, J AM COLL CARDIOL, V32, P140, DOI 10.1016/S0735-1097(98)00202-2; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Ming EE, 2008, J CLIN LIPIDOL, V2, P453, DOI 10.1016/j.jacl.2008.10.007; Ministry Of Food And Drug Safety, 2007, CONTRAINDICATION DRU; Molden E, 2008, DRUG SAFETY, V31, P587, DOI 10.2165/00002018-200831070-00004; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Page SR, 2014, INTERN MED J, V44, P690, DOI 10.1111/imj.12464; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; Ronaldson KJ, 2006, DRUG SAFETY, V29, P1061, DOI 10.2165/00002018-200629110-00005; Roques Sebastien LM, 2011, DRUG METABOLISM AND, V26, P2; Rowan CG, 2008, PHARMACOEPIDEM DR S, V17, pS231; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Silva MA, 2006, CLIN THER, V28, P26, DOI 10.1016/j.clinthera.2006.01.005; Stang Paul, 2007, Am J Ther, V14, P30, DOI 10.1097/01.mjt.0000208875.61480.c8; Tobi H, 2007, PHARMACOEPIDEM DR S, V16, P405, DOI 10.1002/pds.1304; Whitfield LR, 2011, J CLIN PHARMACOL, V51, P378, DOI 10.1177/0091270010366446	34	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125180	10.1371/journal.pone.0125180	http://dx.doi.org/10.1371/journal.pone.0125180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932626	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100085
J	Chavan, V; Willis, J; Walker, SK; Clark, HR; Liu, XR; Fox, MA; Srivastava, S; Mukherjee, K				Chavan, Vrushali; Willis, Jeffery; Walker, Sidney K.; Clark, Helen R.; Liu, Xinran; Fox, Michael A.; Srivastava, Sarika; Mukherjee, Konark			Central Presynaptic Terminals Are Enriched in ATP but the Majority Lack Mitochondria	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; SYNAPTIC VESICLES; AXONAL-TRANSPORT; CENTRAL SYNAPSES; OXIDATIVE-PHOSPHORYLATION; NEUROMUSCULAR-JUNCTIONS; BRAIN; CA2+; PROTEINS; RELEASE	Synaptic neurotransmission is known to be an energy demanding process. At the presynapse, ATP is required for loading neurotransmitters into synaptic vesicles, for priming synaptic vesicles before release, and as a substrate for various kinases and ATPases. Although it is assumed that presynaptic sites usually harbor local mitochondria, which may serve as energy powerhouse to generate ATP as well as a presynaptic calcium depot, a clear role of presynaptic mitochondria in biochemical functioning of the presynapse is not well-defined. Besides a few synaptic subtypes like the mossy fibers and the Calyx of Held, most central presynaptic sites are either en passant or tiny axonal terminals that have little space to accommodate a large mitochondrion. Here, we have used imaging studies to demonstrate that mitochondrial antigens poorly co-localize with the synaptic vesicle clusters and active zone marker in the cerebral cortex, hippocampus and the cerebellum. Confocal imaging analysis on neuronal cultures revealed that most neuronal mitochondria are either somatic or distributed in the proximal part of major dendrites. A large number of synapses in culture are devoid of any mitochondria. Electron micrographs from neuronal cultures further confirm our finding that the majority of presynapses may not harbor resident mitochondria. We corroborated our ultrastructural findings using serial block face scanning electron microscopy (SBFSEM) and found that more than 60% of the presynaptic terminals lacked discernible mitochondria in the wild-type mice hippocampus. Biochemical fractionation of crude synaptosomes into mitochondria and pure synaptosomes also revealed a sparse presence of mitochondrial antigen at the presynaptic boutons. Despite a low abundance of mitochondria, the synaptosomal membranes were found to be highly enriched in ATP suggesting that the presynapse may possess alternative mechanism/s for concentrating ATP for its function. The potential mechanisms including local glycolysis and the possible roles of ATP-binding synaptic proteins such as synapsins, are discussed.	[Chavan, Vrushali; Willis, Jeffery; Walker, Sidney K.; Clark, Helen R.; Fox, Michael A.; Srivastava, Sarika; Mukherjee, Konark] Virginia Tech Caril Res Inst, Roanoke, VA 24016 USA; [Fox, Michael A.; Mukherjee, Konark] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA; [Liu, Xinran] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Virginia Polytechnic Institute & State University; Yale University	Srivastava, S (corresponding author), Virginia Tech Caril Res Inst, Roanoke, VA 24016 USA.	Sarika_Srivastava@vtc.vt.edu; konark@vtc.vt.edu		Fox, Michael/0000-0002-1649-7782; Srivastava, Sarika/0000-0001-9634-5510	NEI NIH HHS [R01 EY021222] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY021222] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Bai Fengju, 2007, V43, P77, DOI 10.1007/978-1-4020-5943-8_6; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Chouhan AK, 2010, J NEUROSCI, V30, P1869, DOI 10.1523/JNEUROSCI.4701-09.2010; Dahlhaus M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005413; Gioio AE, 2001, J NEUROSCI RES, V64, P447, DOI 10.1002/jnr.1096; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; HAJOS F, 1971, J CELL BIOL, V51, P216, DOI 10.1083/jcb.51.1.216; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Harris JJ, 2013, J CEREBR BLOOD F MET, V33, P33, DOI 10.1038/jcbfm.2012.148; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Juranek J, 2006, EUR J NEUROSCI, V24, P3043, DOI 10.1111/j.1460-9568.2006.05183.x; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kawai Y, 2013, AM J PHYSIOL-CELL PH, V305, pC1139, DOI 10.1152/ajpcell.00199.2013; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Lee D, 2007, J NEUROSCI, V27, P13603, DOI 10.1523/JNEUROSCI.3985-07.2007; LEONG SF, 1984, J NEUROCHEM, V42, P1306, DOI 10.1111/j.1471-4159.1984.tb02788.x; Li JL, 2003, J COMP NEUROL, V460, P394, DOI 10.1002/cne.10646; Liotta A, 2012, J CEREBR BLOOD F MET, V32, P2076, DOI 10.1038/jcbfm.2012.116; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Novak P, 2013, NEURON, V79, P1067, DOI 10.1016/j.neuron.2013.07.012; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; Picard M, 2014, P NATL ACAD SCI USA, V111, P7, DOI 10.1073/pnas.1321881111; PINCHASI I, 1979, FEBS LETT, V108, P189, DOI 10.1016/0014-5793(79)81207-7; Ravera S, 2013, BIOCHIMIE, V95, P1991, DOI 10.1016/j.biochi.2013.07.003; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Schikorski T, 1997, J NEUROSCI, V17, P5858; Serra-Pages C, 2005, BIOCHEMISTRY-US, V44, P15715, DOI 10.1021/bi051434f; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shutov LP, 2013, J PHYSIOL-LONDON, V591, P2443, DOI 10.1113/jphysiol.2012.249219; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; SIMS NR, 1986, J NEUROCHEM, V47, P496; Spillane M, 2013, CELL REP, V5, P1564, DOI 10.1016/j.celrep.2013.11.022; Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093; STADLER H, 1984, EMBO J, V3, P3333, DOI 10.1002/j.1460-2075.1984.tb02300.x; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; TIALOWSKA B, 1991, ACTA BIOCHIM POL, V38, P165; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vivona S, 2013, J BIOL CHEM, V288, P24984, DOI 10.1074/jbc.M113.489807; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; WALZ W, 1988, GLIA, V1, P366, DOI 10.1002/glia.440010603; Wang LY, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-36; Yao J, 2008, J BIOL CHEM, V283, P20628, DOI 10.1074/jbc.M800738200; Yao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005315	56	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125185	10.1371/journal.pone.0125185	http://dx.doi.org/10.1371/journal.pone.0125185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928229	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100072
J	Pedersen, SK; Baker, RT; McEvoy, A; Murray, DH; Thomas, M; Molloy, PL; Mitchell, S; Lockett, T; Young, GP; LaPointe, LC				Pedersen, Susanne K.; Baker, Rohan T.; McEvoy, Aidan; Murray, David H.; Thomas, Melissa; Molloy, Peter L.; Mitchell, Sue; Lockett, Trevor; Young, Graeme P.; LaPointe, Lawrence C.			A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; PROGENITOR CELLS; IKAROS; NOTCH; BIOMARKER; PLASMA; HOMEOSTASIS; MARKERS; SERUM; GENE	Background Specific genes are methylated with high frequency in colorectal neoplasia, and may leak into blood. Detection of multiple methylated DNA biomarkers in blood may improve assay sensitivity for colorectal cancer (CRC) relative to a single marker. We undertook a case-control study evaluating the presence of two methylation DNA markers, BCAT1 and IKZF1, in circulation to determine if they were complementary for detection of CRC. Methods Methylation-specific PCR assays were developed to measure the level of methylated BCAT1 and IKZF1 in DNA extracted from plasma obtained from colonoscopy-confirmed 144 healthy controls and 74 CRC cases. Results DNA yields ranged from 2 to 730 ng/mL plasma (mean 18.6ng/mL; 95% CI 11-26 ng/mL) and did not correlate with gender, age or CRC status. Methylated BCAT1 and IKZF1 DNA were detected in respectively 48 (65%) and 50 (68%) of the 74 cancers. In contrast, only 5 (4%) and 7 (5%) controls were positive for BCAT1 and IKZF1 DNA methylation, respectively. A two-gene classifier model ("either or" rule) improved segregation of CRC from controls, with 57 of 74 cancers (77%) compared to only 11 of 144 (7.6%) controls being positive for BCAT1 and/or IKZF1 DNA methylation. Increasing levels of methylated DNA were observed as CRC stage progressed. Conclusions Detection of methylated BCAT1 and/or IKZF1 DNA in plasma may have clinical application as a novel blood test for CRC. Combining the results from the two methylation-specific PCR assays improved CRC detection with minimal change in specificity. Further validation of this two-gene blood test with a view to application in screening is now indicated.	[Pedersen, Susanne K.; Baker, Rohan T.; McEvoy, Aidan; Murray, David H.; Thomas, Melissa; LaPointe, Lawrence C.] Clin Genom Proprietary Ltd, Sydney, NSW, Australia; [Molloy, Peter L.; Mitchell, Sue; Lockett, Trevor] CSIRO, Food & Nutr Flagship, Sydney, NSW, Australia; [Young, Graeme P.] Flinders Univ South Australia, Flinders Ctr Innovat Canc, Adelaide, SA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Flinders University South Australia	Pedersen, SK (corresponding author), Clin Genom Proprietary Ltd, Sydney, NSW, Australia.	Susanne.pedersen@clinicalgenomics.com	Molloy, Peter L/H-7931-2013; Lockett, Trevor J/H-8970-2013; Murray, David Hugh/GPC-6570-2022	Molloy, Peter L/0000-0002-7788-3417; Lockett, Trevor J/0000-0002-8063-071X; Murray, David Hugh/0000-0002-3073-3593; , Susanne/0000-0002-5518-1959; Young, Graeme/0000-0001-9458-8383; LaPointe, Lawrence/0000-0002-8906-1867	Clinical Genomics Pty Ltd; Commonwealth Scientific and Industrial Research Organization (CSIRO)	Clinical Genomics Pty Ltd; Commonwealth Scientific and Industrial Research Organization (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was co-funded by Clinical Genomics Pty Ltd, and the Commonwealth Scientific and Industrial Research Organization (CSIRO). LCL, SKP, RTB, AM, DHM and MT are employed by Clinical Genomics Pty Ltd. PLM, SM and TL are employed by CSIRO. GPY is a paid consultant of Clinical Genomics Pty. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betge J, 2012, CANCER-AM CANCER SOC, V118, P628, DOI 10.1002/cncr.26310; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Iacobucci I, 2009, BLOOD, V114, P2159, DOI 10.1182/blood-2008-08-173963; Javierre BM, 2011, MOL CANCER RES, V9, P1139, DOI 10.1158/1541-7786.MCR-10-0515; Kibriya MG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-50; Klemke RL, 2012, CURR OPIN CELL BIOL, V24, P662, DOI 10.1016/j.ceb.2012.08.005; Koukourakis MI, 2005, CLIN CANCER RES, V11, P8653, DOI 10.1158/1078-0432.CCR-05-1464; LaPointe LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029059; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Malinge S, 2013, BLOOD, V121, P2440, DOI 10.1182/blood-2012-08-450627; Mead R, 2011, BRIT J CANCER, V105, P239, DOI 10.1038/bjc.2011.230; Menendez P, 2013, J SURG ONCOL, V107, P217, DOI 10.1002/jso.23245; Mitchell SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-54; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; Osborne J. M., 2012, Open Journal of Preventive Medicine, V2, P326; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Radtke F, 2006, CURR MOL MED, V6, P275, DOI 10.2174/156652406776894527; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Ross JP, 2013, EPIGENETICS-US, V8, P113, DOI 10.4161/epi.23330; Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707; Schwarzenbach H, 2008, ANN NY ACAD SCI, V1137, P190, DOI 10.1196/annals.1448.025; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Staton CA, 2007, GUT, V56, P1426, DOI 10.1136/gut.2007.125286; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Yoshikawa R, 2006, WORLD J GASTROENTERO, V12, P5884, DOI 10.3748/wjg.v12.i36.5884; Zhang ZF, 2013, ANAT REC, V296, P907, DOI 10.1002/ar.22700	40	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125041	10.1371/journal.pone.0125041	http://dx.doi.org/10.1371/journal.pone.0125041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928810	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100059
J	Tang, CQ; Yang, YC; Ohsawa, M; Momohara, A; Yi, SR; Robertson, K; Song, K; Zhang, SQ; He, LY				Tang, Cindy Q.; Yang, Yongchuan; Ohsawa, Masahiko; Momohara, Arata; Yi, Si-Rong; Robertson, Kevin; Song, Kun; Zhang, Shi-Qiang; He, Long-Yuan			Community Structure and Survival of Tertiary Relict Thuja sutchuenensis (Cupressaceae) in the Subtropical Daba Mountains, Southwestern China	PLOS ONE			English	Article							NIAGARA ESCARPMENT; CONSTRAINED GROWTH; PLANT-COMMUNITIES; NORTH-AMERICA; EASTERN ASIA; CLIFF FACES; OCCIDENTALIS; EVOLUTION; FORESTS; ENVIRONMENT	A rare coniferous Tertiary relict tree species, Thuja sutchuenensis Franch, has survived in the Daba Mountains of southwestern China. It was almost eliminated by logging during the past century. We measured size and age structures and interpreted regeneration dynamics of stands of the species in a variety of topographic contexts and community associations. Forest communities containing T. sutchuenensis were of three types: (1) the Thuja community dominated by T. sutchuenensis, growing on cliffs; (2) the Thuja-Quercus-Cyclobalanopsis community dominated by T. sutchuenensis, Quercus engleriana and Cyclobalanopsis oxyodon, along with Fagus engleriana and Carpinus fargesiana, on steep slopes; (3) the Thuja-Tsuga-Quercus community dominated by T. sutchuenensis, Tsuga chinensis, and Quercus spinosa, on crest ridges. The established seedlings/saplings were found in limestone crevices, on scarred cliff-faces, cliff-edges, fallen logs, canopy gaps and forest margins. The radial growth rate was 0.5-1.1 mm per year. Its growth forms were distorted. It had strong sprouting ability after disturbances. The T. sutchuenensis population thrives on cliffs where there is little competition from other species because of harsh conditions and rock-slide disturbances. It is shade-intolerant but stress-tolerant. Its regeneration has depended on natural disturbances.	[Tang, Cindy Q.; Ohsawa, Masahiko; He, Long-Yuan] Yunnan Univ, Inst Ecol & Geobot, Kunming 650091, Peoples R China; [Yang, Yongchuan] Chongqing Univ, Minist Educ, Key Lab Gorges Reservoir Reg Ecoenvironm 3, Chongqing 400045, Peoples R China; [Yang, Yongchuan] Chongqing Univ, Natl Ctr Int Res Low Carbon & Green Bldgs, Chongqing 400045, Peoples R China; [Momohara, Arata] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Yi, Si-Rong] Inst Med Plant Cultivat Chongqing, Nanchuan 408435, Peoples R China; [Robertson, Kevin] Tall Timbers Res Stn & Land Conservancy, Tallahassee, FL 32312 USA; [Song, Kun] E China Normal Univ, Dept Environm Sci, Shanghai 200062, Peoples R China; [Zhang, Shi-Qiang] Dabashan Natl Nat Reserve, Chengkou 405900, Peoples R China	Yunnan University; Chongqing University; Chongqing University; Chiba University; East China Normal University	Tang, CQ (corresponding author), Yunnan Univ, Inst Ecol & Geobot, Kunming 650091, Peoples R China.	cindyqtang@aol.com; ycyang@cqu.edu.cn	Tang, Cindy/AAC-3343-2022; Robertson, Kevin/AAT-9357-2021; Yang, Yongchuan/N-4226-2014	Tang, Cindy/0000-0003-3789-6771; Yang, Yongchuan/0000-0001-7627-7776; Song, Kun/0000-0001-8019-9707	Education Department of Yunnan Province for Foreign Experts; Natural Science Foundation Project of CQ CSTC [cstc2012jjA00014]; Visiting Scholar Foundation of the Key Laboratory of the Three Gorges Reservoir Region's Eco-Environment (Ministry of Education) of Chongqing University [B13041]; JSPS (Japan) [24405023]	Education Department of Yunnan Province for Foreign Experts; Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Visiting Scholar Foundation of the Key Laboratory of the Three Gorges Reservoir Region's Eco-Environment (Ministry of Education) of Chongqing University; JSPS (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study is financially supported by Yunnan University's Special Research Program under the auspices of the Education Department of Yunnan Province for Foreign Experts, by the Natural Science Foundation Project of CQ CSTC (cstc2012jjA00014), by the Visiting Scholar Foundation of the Key Laboratory of the Three Gorges Reservoir Region's Eco-Environment (Ministry of Education) of Chongqing University, 111 Project No. B13041, and by a JSPS Grant-in-Aid for Scientific Research (No. 24405023, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetiev MA, 1973, GEOL I T AKAD NAUK U, V247, P1; Axelrod D.I., 1998, FLORISTIC CHARACTERI, P43; Bennike O., 1990, Meddelelser om Gronland Geoscience, V23, P1; Chamber KL, 1993, FLORA N AM N MEXICO, V2; Christopher IE, 2015, GYMNOSPERM DATABASE; DANIELS LD, 1995, NORTHWEST SCI, V69, P175; DEBLOIS S, 1995, J VEG SCI, V6, P531, DOI 10.2307/3236352; Farjon A, 2001, WORLD CHECKLIST BIBL; Farjon A., 1999, STATUS SURVEY CONSER; Farjon A., 2008, NATURAL HIST CONIFER; Farjon A., 2013, IUCN 2013 IUCN RED L; Franchet A.R., 1899, J BOT, V13, P253; FRANKLIN JF, 1988, CAN J FOREST RES, V18, P633, DOI 10.1139/x88-093; Fu L.G., 1992, CHINA PLANT RED DATA, V1; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GUAN Z-T, 1986, Acta Botanica Sinica, V28, P646; Hannah PR, 2004, NORTH J APPL FOR, V21, P173, DOI 10.1093/njaf/21.4.173; Havill N.P., 2011, IMPLEMENTATION STATU, P3; Hofmeyer PV, 2009, NORTH J APPL FOR, V26, P21, DOI 10.1093/njaf/26.1.21; HUZIOKA K, 1973, B NATL SCI MUSEUM TO, V18, P661; IUCN, 2013, IUCN RED LIST THREAT; Jin JQ, 2012, THESIS CHINESE ACAD; KELLY PE, 1992, INT J PLANT SCI, V153, P117, DOI 10.1086/297013; Kong W.-S., 1993, PLANT GEOGRAPHY KORE; Larouche C, 2010, NORTH J APPL FOR, V27, P5, DOI 10.1093/njaf/27.1.5; LARSON DW, 1991, CAN J BOT, V69, P1628, DOI 10.1139/b91-206; LePage BA, 2003, AM J BOT, V90, P167, DOI 10.3732/ajb.90.2.167; Li JH, 2005, J INTEGR PLANT BIOL, V47, P651, DOI 10.1111/j.1744-7909.2005.00087.x; Liu JF, 2013, INT J MOL SCI, V14, P14860, DOI 10.3390/ijms140714860; Liu JianFeng, 2004, Acta Agriculturae Universitatis Jiangxiensis, V26, P377; LIU KB, 1988, QUATERNARY SCI REV, V7, P1, DOI 10.1016/0277-3791(88)90089-3; Liu Z.Y., 2000, PLANT MAGAZINE, V3, P8; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Luo J, 1990, J SW TEACHERS U, V15, P266; Matthes-Sears U, 1999, INT J PLANT SCI, V160, P122, DOI 10.1086/314105; MATTHESSEARS U, 1995, INT J PLANT SCI, V156, P311, DOI 10.1086/297252; McCune B., 2011, PC ORD MULTIVARIATE; MCIVER EE, 1989, CAN J BOT, V67, P1903, DOI 10.1139/b89-242; MIKI SHIGERU, 1958, JOUR INST POLYTECH OSAKA CITY UNIV SER D BIOL, V9, P125; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Minore D., 1983, PNWGTR150 USDA FOR S; Nakamura Y, 2005, CONIFEROUS FORESTS, P163; Nakane H, 1988, J FAC SCI SHINSHU U, V23, P33; Ohsawa M, 1984, PLANT ECOL, V57, P15; Peng D, 2008, MOL PHYLOGENET EVOL, V47, P1190, DOI 10.1016/j.ympev.2008.02.001; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Sawada H, 1995, STUDY REGENERATION D, V93, P21; Schweitzer H. J., 1974, PALAEONTOGRAPHICA AB, V149, P1; [石玲 SHI Ling], 2009, [工程地质学报, Journal of Engineering Geology], V17, P212; SHI YF, 1986, QUATERNARY SCI REV, V5, P503; Tang CQ, 2013, AM J BOT, V100, P2112, DOI 10.3732/ajb.1300057; Tang CQ, 2012, AM J BOT, V99, P1408, DOI 10.3732/ajb.1200168; Tang CQ, 2011, BIOL CONSERV, V144, P279, DOI 10.1016/j.biocon.2010.09.003; Tang CQ, 2002, FOLIA GEOBOT, V37, P93, DOI 10.1007/BF02803193; THORNE RF, 1972, Q REV BIOL, V47, P365, DOI 10.1086/407399; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Wang XiangFu, 2007, Forest Research, Beijing, V20, P673; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Whittaker R. H., 1975, COMMUNITY ECOSYSTEM; WISHEU IC, 1992, J VEG SCI, V3, P147, DOI 10.2307/3235675; Xiang QP, 2002, BOT J LINN SOC, V140, P93	64	18	26	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125307	10.1371/journal.pone.0125307	http://dx.doi.org/10.1371/journal.pone.0125307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928845	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100079
J	Wang, XM; Jiang, P; Wang, PQ; Yang, CS; Wang, XR; Feng, Q				Wang, Xuemin; Jiang, Pan; Wang, Pengqi; Yang, Chung S.; Wang, Xuerong; Feng, Qing			EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer	PLOS ONE			English	Article							ANTICANCER DRUG CISPLATIN; GREEN-TEA EGCG; CELLULAR ACCUMULATION; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; NEPHROTOXICITY; CHEMOTHERAPY; POLYPHENOLS; CARCINOMA; CELLS	Cisplatin is one of the first-line platinum-based chemotherapeutic agents for treatment of many types of cancer, including ovary cancer. CTR1 (copper transporter 1), a transmembrane solute carrier transporter, has previously been shown to increase the cellular uptake and sensitivity of cisplatin. It is hypothesized that increased CTR1 expression would enhance the sensitivity of cancer cells to cisplatin (cDDP). The present study demonstrates for the first time that (-)-epigallocatechin-3-gallate (EGCG), a major polyphenol from green tea, can enhance CTR1 mRNA and protein expression in ovarian cancer cells and xenograft mice. EGCG inhibits the rapid degradation of CTR1 induced by cDDP. The combination of EGCG and cDDP increases the accumulation of cDDP and DNA-Pt adducts, and subsequently enhances the sensitivity of ovarian cancer SKOV3 and OVCAR3 cells to the chemotherapeutic agent. In the OVCAR3 ovarian cancer xenograft nude mice model, the combination of the lower concentration of cDDP and EGCG strongly repressed the tumor growth and exhibited protective effect on the nephrotoxicity induced by cisplatin. Overall, these findings uncover a novel chemotherapy mechanism of EGCG as an adjuvant for the treatment of ovarian cancer.	[Wang, Xuemin; Jiang, Pan; Wang, Pengqi; Feng, Qing] Nanjing Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Key Lab Toxicol, Nanjing, Jiangsu, Peoples R China; [Yang, Chung S.] Rutgers State Univ, Ctr Canc Prevent Res, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ USA; [Wang, Xuerong] Nanjing Med Univ, Sch Basic Med Sci, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Wang, Xuemin] Beijing Res Inst Nutr Resources, Beijing, Peoples R China	Nanjing Medical University; Rutgers State University New Brunswick; Nanjing Medical University	Feng, Q (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Key Lab Toxicol, Nanjing, Jiangsu, Peoples R China.	qingfeng@njmu.edu.cn			National Natural Science Foundation of China [81472977]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [HG11-4302]; Foundation from Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation from Six Big Talent Peak of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Foundation from Priority Academic Program Development of Jiangsu Higher Education Institutions; Foundation from Six Big Talent Peak of Jiangsu Province	This work was supported by National Natural Science Foundation of China (81472977), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (HG11-4302), Foundation from Priority Academic Program Development of Jiangsu Higher Education Institutions, and Foundation from Six Big Talent Peak of Jiangsu Province.	Blair BG, 2011, MOL PHARMACOL, V79, P157, DOI 10.1124/mol.110.068411; Blair BG, 2010, MOL PHARMACOL, V77, P912, DOI 10.1124/mol.109.062836; Blair BG, 2009, CLIN CANCER RES, V15, P4312, DOI 10.1158/1078-0432.CCR-09-0311; Chan MM, 2006, J CELL PHYSIOL, V207, P389, DOI 10.1002/jcp.20569; Chen HHW, 2013, ANTICANCER RES, V33, P4157; Chen HP, 2013, J ONCOL, V2013, DOI 10.1155/2013/872957; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Ciarimboli G, 2010, AM J PATHOL, V176, P1169, DOI 10.2353/ajpath.2010.090610; Deng PB, 2013, CHIN J NAT MEDICINES, V11, P245, DOI [10.3724/SP.J.1009.2013.00245, 10.1016/S1875-5364(13)60023-0]; El-Mowafy AM, 2011, NAT PROD RES, V25, P850, DOI 10.1080/14786419.2010.533669; El-Mowafy AM, 2010, PHYTOMEDICINE, V17, P1067, DOI 10.1016/j.phymed.2010.08.004; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Hagen RM, 2013, INT J ONCOL, V43, P194, DOI 10.3892/ijo.2013.1920; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Holzer AK, 2004, CLIN CANCER RES, V10, P6744, DOI 10.1158/1078-0432.CCR-04-0748; Holzer AK, 2004, MOL PHARMACOL, V66, P817, DOI 10.1124/mol.104.001198; Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710; Garces AHI, 2015, CANCER CHEMOTH PHARM, V75, P221, DOI 10.1007/s00280-014-2581-y; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Ishida S, 2010, CANCER CELL, V17, P574, DOI 10.1016/j.ccr.2010.04.011; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jandial DD, 2009, CLIN CANCER RES, V15, P553, DOI 10.1158/1078-0432.CCR-08-2081; Larson CA, 2009, MOL PHARMACOL, V75, P324, DOI 10.1124/mol.108.052381; Lecumberri E, 2013, CLIN NUTR, V32, P894, DOI 10.1016/j.clnu.2013.03.008; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee SH, 2013, EUR J CANCER, V49, P3210, DOI 10.1016/j.ejca.2013.06.025; Liang ZD, 2012, MOL CANCER THER, V11, P2483, DOI 10.1158/1535-7163.MCT-12-0580; Liang ZD, 2012, MOL PHARMACOL, V81, P455, DOI 10.1124/mol.111.076422; Lin XJ, 2002, MOL PHARMACOL, V62, P1154, DOI 10.1124/mol.62.5.1154; Mei L, 2013, COCHRANE DB SYST REV, V6, pD7414; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Mortenson MM, 2004, CANCER CHEMOTH PHARM, V54, P343, DOI 10.1007/s00280-004-0811-4; Nakayama K, 2002, INT J CANCER, V101, P488, DOI 10.1002/ijc.10608; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Noordhuis P, 2008, BIOCHEM PHARMACOL, V76, P53, DOI 10.1016/j.bcp.2008.04.007; Safaei R, 2006, CANCER LETT, V234, P34, DOI 10.1016/j.canlet.2005.07.046; Safaei R, 2009, J INORG BIOCHEM, V103, P333, DOI 10.1016/j.jinorgbio.2008.11.012; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Samimi G, 2003, CLIN CANCER RES, V9, P5853; Shen M, 2012, ANTI-CANCER AGENT ME, V12, P891, DOI 10.2174/187152012802649978; Shervington A, 2009, MOL BIOL REP, V36, P1181, DOI 10.1007/s11033-008-9295-3; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; Tsigelny IF, 2012, CELL BIOCHEM BIOPHYS, V63, P223, DOI 10.1007/s12013-012-9358-x; Yang CS, 2014, J BIOMED RES, V28, P447, DOI 10.7555/JBR.28.20140079; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang H, 2011, CURR CANCER DRUG TAR, V11, P296, DOI 10.2174/156800911794519743; Yonezawa A, 2005, BIOCHEM PHARMACOL, V70, P1823, DOI 10.1016/j.bcp.2005.09.020; Zhou DH, 2014, NUTR CANCER, V66, P636, DOI 10.1080/01635581.2014.894101	49	38	40	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125402	10.1371/journal.pone.0125402	http://dx.doi.org/10.1371/journal.pone.0125402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927922	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100088
J	Wojcik, M; Lewandowski, W; Krol, M; Pawlowski, K; Mieczkowski, J; Lechowski, R; Zabielska, K				Wojcik, Michal; Lewandowski, Wiktor; Krol, Magdalena; Pawlowski, Karol; Mieczkowski, Jozef; Lechowski, Roman; Zabielska, Katarzyna			Enhancing Anti-Tumor Efficacy of Doxorubicin by Non-Covalent Conjugation to Gold Nanoparticles - In Vitro Studies on Feline Fibrosarcoma Cell Lines	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; MULTIDRUG-RESISTANCE; CANCER-CELLS; TOXICITY; SYSTEMS; CYCLODEXTRINS; CHEMOTHERAPY; COMBINATION; SARCOMAS; RELEASE	Background Feline injection-site sarcomas are malignant skin tumors of mesenchymal origin, the treatment of which is a challenge for veterinary practitioners. Methods of treatment include radical surgery, radiotherapy and chemotherapy. The most commonly used cytostatic drugs are cyclophosphamide, doxorubicin and vincristine. However, the use of cytostatics as adjunctive treatment is limited due to their adverse side-effects, low biodistribution after intravenous administration and multidrug resistance. Colloid gold nanoparticles are promising drug delivery systems to overcome multidrug resistance, which is a main cause of ineffective chemotherapy treatment. The use of colloid gold nanoparticles as building blocks for drug delivery systems is preferred due to ease of surface functionalization with various molecules, chemical stability and their low toxicity. Methods Stability and structure of the glutathione-stabilized gold nanoparticles non-covalently modified with doxorubicin (Au-GSH-Dox) was confirmed using XPS, TEM, FT-IR, SAXRD and SAXS analyses. MTT assay, Annexin V and Propidium Iodide Apoptosis assay and Rhodamine 123 and Verapamil assay were performed on 4 feline fibrosarcoma cell lines (FFS1WAW, FFS1, FFS3, FFS5). Statistical analyses were performed using Graph Pad Prism 5.0 (USA). Results A novel approach, glutathione-stabilized gold nanoparticles (4.3 +/- 1.1 nm in diameter) non-covalently modified with doxorubicin (Au-GSH-Dox) was designed and synthesized. A higher cytotoxic effect (p<0.01) of Au-GSH-Dox than that of free doxorubicin has been observed in 3 (FFS1, FFS3, FFS1WAW) out of 4 feline fibrosarcoma cell lines. The effect has been correlated to the activity of glycoprotein P (main efflux pump responsible for multidrug resistance). Conclusions The results indicate that Au-GSH-Dox may be a potent new therapeutic agent to increase the efficacy of the drug by overcoming the resistance to doxorubicin in feline fibrosarcoma cell lines. Moreover, as doxorubicin is non-covalently attached to glutathione coated nanoparticles the synthesized system is potentially suitable to a wealth of different drug molecules.	[Wojcik, Michal; Lewandowski, Wiktor; Mieczkowski, Jozef] Univ Warsaw, Fac Chem, Warsaw, Poland; [Krol, Magdalena; Pawlowski, Karol; Lechowski, Roman; Zabielska, Katarzyna] Warsaw Univ Life Sci, Fac Vet Med, Warsaw, Poland	University of Warsaw; Warsaw University of Life Sciences	Wojcik, M (corresponding author), Univ Warsaw, Fac Chem, Warsaw, Poland.	mwojcik@chem.uw.edu.pl; katarzyna_zabielska@sggw.pl	Lewandowski, Wiktor/F-5639-2011; Zabielska-Koczywąs, Katarzyna/AFU-6510-2022; Zabielska-Koczywąs, Katarzyna Agnieszka/AAS-8153-2021; Krol, Magdalena/A-5554-2019	Lewandowski, Wiktor/0000-0002-3503-2120; Zabielska-Koczywąs, Katarzyna Agnieszka/0000-0003-1691-3982; Pawlowski, Karol/0000-0003-4565-2873; Krol, Magdalena/0000-0003-0421-5167; Lechowski, Roman/0000-0002-1121-4288	Polish National Science Centre [2013/09/D/ST5/03875, DEC-2012/07/N/NZ4/02413, 2011/01/N/ST5/0329]	Polish National Science Centre	The authors would like to acknowledge support by the Polish National Science Centre (Project 2013/09/D/ST5/03875 [WL], Project No. DEC-2012/07/N/NZ4/02413 [KZ], and Project 2011/01/N/ST5/0329[MW]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Aryal S, 2009, J MATER CHEM, V19, P7879, DOI 10.1039/b914071a; Asadishad B, 2010, IND ENG CHEM RES, V49, P1958, DOI 10.1021/ie9011479; Barber LG, 2000, J AM ANIM HOSP ASSOC, V36, P416, DOI 10.5326/15473317-36-5-416; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Bregazzi VS, 2001, J AM VET MED ASSOC, V218, P547, DOI 10.2460/javma.2001.218.547; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Chang DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083239; Chen HY, 2012, BIOMATERIALS, V33, P8461, DOI 10.1016/j.biomaterials.2012.08.034; Chen L, 2014, SENSOR ACTUAT B-CHEM, V193, P857, DOI 10.1016/j.snb.2013.12.053; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; de Oliveira R, 2013, INT J PHARMACEUT, V454, P703, DOI 10.1016/j.ijpharm.2013.05.031; Ding Y, 2013, BIOMATERIALS, V34, P10217, DOI 10.1016/j.biomaterials.2013.09.008; Doane TL, 2012, CHEM SOC REV, V41, P2885, DOI 10.1039/c2cs15260f; Duncan B, 2010, J CONTROL RELEASE, V148, P122, DOI 10.1016/j.jconrel.2010.06.004; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gu YJ, 2012, NANOMED-NANOTECHNOL, V8, P204, DOI 10.1016/j.nano.2011.06.005; Gulyaev AE, 1999, PHARM RES-DORDR, V16, P1564, DOI 10.1023/A:1018983904537; Hahn KA, 2007, JAVMA-J AM VET MED A, V231, P742, DOI 10.2460/javma.231.5.742; Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2; Joshi P, 2011, J COLLOID INTERF SCI, V355, P402, DOI 10.1016/j.jcis.2010.12.032; Kayal S, 2010, J NANOSCI NANOTECHNO, V10, P5527, DOI 10.1166/jnn.2010.2461; LAMPIDIS TJ, 1985, CANCER RES, V45, P2626; Manju S, 2012, J COLLOID INTERF SCI, V368, P144, DOI 10.1016/j.jcis.2011.11.024; Martano M, 2011, VET J, V188, P136, DOI 10.1016/j.tvjl.2010.04.025; Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m; Mimeault M, 2008, CLIN PHARMACOL THER, V83, P673, DOI 10.1038/sj.clpt.6100296; Minati L, 2012, INT J PHARMACEUT, V438, P45, DOI 10.1016/j.ijpharm.2012.08.057; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Palmeira A, 2012, J PHARM PHARM SCI, V15, P31, DOI 10.18433/J3BG65; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pan Y, 2009, SMALL, V5, P2067, DOI 10.1002/smll.200900466; Pawlowski KM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-119; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Poirier VJ, 2002, J VET INTERN MED, V16, P726, DOI 10.1111/j.1939-1676.2002.tb02415.x; Riss T.L., CELL VIABILITY ASSAY; Samad Abdus, 2007, Current Drug Delivery, V4, P297, DOI 10.2174/156720107782151269; Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Simpson CA, 2013, NANOMED-NANOTECHNOL, V9, P257, DOI 10.1016/j.nano.2012.06.002; Tiwari G, 2010, J PHARM BIOALLIED SC, V2, P72, DOI 10.4103/0975-7406.67003; Tom RT, 2004, LANGMUIR, V20, P1909, DOI 10.1021/la0358567; von Erichsen J, 2012, VET PATHOL, V49, P648, DOI 10.1177/0300985811406887; Wang BY, 2014, BIOMATERIALS, V35, P5897, DOI 10.1016/j.biomaterials.2014.03.068; Wang F, 2011, ACS NANO, V5, P3679, DOI 10.1021/nn200007z; Williams LE, 2001, AM J VET RES, V62, P1354, DOI 10.2460/ajvr.2001.62.1354; Wu ZK, 2011, ADV FUNCT MATER, V21, P177, DOI 10.1002/adfm.201001120; Xie Y, 2014, BIOMATERIALS, V35, P7978, DOI 10.1016/j.biomaterials.2014.05.068; Zabielska K, 2012, VET RES COMMUN, V36, P227, DOI 10.1007/s11259-012-9535-9; Zhang XK, 2009, BIOMATERIALS, V30, P6041, DOI 10.1016/j.biomaterials.2009.07.025; Zhang XA, 2011, BIOCONJUGATE CHEM, V22, P235, DOI 10.1021/bc100374p; Zhou LJ, 2014, BIOMATERIALS, V35, P7666, DOI 10.1016/j.biomaterials.2014.05.051; Zhu D, 2014, RSC ADV, V4, P9372, DOI 10.1039/c3ra45491f	57	28	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124955	10.1371/journal.pone.0124955	http://dx.doi.org/10.1371/journal.pone.0124955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928423	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100055
J	Binh, CTT; Peterson, CG; Tong, TZ; Gray, KA; Gaillard, JF; Kelly, JJ				Chu Thi Thanh Binh; Peterson, Christopher G.; Tong, Tiezheng; Gray, Kimberly A.; Gaillard, Jean-Francois; Kelly, John J.			Comparing Acute Effects of a Nano-TiO2 Pigment on Cosmopolitan Freshwater Phototrophic Microbes Using High-Throughput Screening	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; PHYTOPLANKTON COMMUNITY STRUCTURE; OXIDATIVE DNA-DAMAGE; TIO2 NANOPARTICLES; METABOLIC-ACTIVITY; ALGAL GROWTH; TOXICITY; PHOTOSYNTHESIS; NANOMATERIALS; MARINE	Production of titanium-dioxide nanomaterials (nano-TiO2) is increasing, leading to potential risks associated with unintended release of these materials into aquatic ecosystems. We investigated the acute effects of nano-TiO2 on metabolic activity and viability of algae and cyanobacteria using high-throughput screening. The responses of three diatoms (Surirella angusta, Cocconeis placentula, Achnanthidium lanceolatum), one green alga (Scenedesmus quadricauda), and three cyanobacteria (Microcystis aeruginosa, Gloeocapsasp., Synechococcus cedrorum) to short-term exposure (15 to 60 min) to a common nano-TiO2 pigment (PW6; average crystallite size 81.5 nm) with simulated solar illumination were assessed. Five concentrations of nano-TiO2 (0.5, 2.5, 5, 10, and 25 mg L-1) were tested and a fluorescent reporter (fluorescein diacetate) was used to assess metabolic activity. Algae were sensitive to nano-TiO2, with all showing decreased metabolic activity after 30-min exposure to the lowest tested concentration. Microscopic observation of algae revealed increased abundance of dead cells with nano-TiO2 exposure. Cyanobacteria were less sensitive to nano-TiO2 than algae, with Gloeocapsashowing no significant decrease in activity with nano-TiO2 exposure and Synechococcusshowing an increase in activity. These results suggest that nanomaterial contamination has the potential to alter the distribution of phototrophic microbial taxa within freshwater ecosystems. The higher resistance of cyanobacteria could have significant implications as cyanobacteria represent a less nutritious food source for higher trophic levels and some cyanobacteria can produce toxins and contribute to harmful algal blooms.	[Chu Thi Thanh Binh; Kelly, John J.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Peterson, Christopher G.] Loyola Univ, Inst Environm Sustainabil, Chicago, IL 60626 USA; [Tong, Tiezheng; Gray, Kimberly A.; Gaillard, Jean-Francois] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA	Loyola University Chicago; Loyola University Chicago; Northwestern University	Kelly, JJ (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jkelly7@luc.edu	Gaillard, Jean-Francois/B-6981-2009; Gray, Kimberly A/B-6989-2009; Gaillard, Jean-Francois JF/E-9445-2013	Gaillard, Jean-Francois JF/0000-0002-8276-6418; Kelly, John/0000-0002-0894-137X; Tong, Tiezheng/0000-0002-9289-3330	National Science Foundation [CBET-1067439, CBET-1067751]	National Science Foundation(National Science Foundation (NSF))	The work described in this study was performed with support from the National Science Foundation (Grant No. CBET-1067439 to JK and CP and Grant No. CBET-1067751 to KG and J-FG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MS, 2004, ENVIRON TOXICOL CHEM, V23, P1957, DOI 10.1897/03-232; AGUSTI S, 1990, LIMNOL OCEANOGR, V35, P181, DOI 10.4319/lo.1990.35.1.0181; Munoz-Martin MA, 2014, SCI TOTAL ENVIRON, V475, P169, DOI 10.1016/j.scitotenv.2013.07.015; [Anonymous], [No title captured], DOI DOI 10.1007/978-94-007-3855-3; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Blaise C, 2008, ENVIRON TOXICOL, V23, P591, DOI 10.1002/tox.20402; Carmichael WW, 2006, SALINE SYSTEMS, V2, P1746; Chen JS, 2003, WATER RES, V37, P3815, DOI 10.1016/S0043-1354(03)00332-4; Chen LZ, 2012, ECOTOX ENVIRON SAFE, V84, P155, DOI 10.1016/j.ecoenv.2012.07.019; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Cherchi C, 2010, ENVIRON SCI TECHNOL, V44, P8302, DOI 10.1021/es101658p; Christoffersen Kirsten, 1996, Phycologia, V35, P42, DOI 10.2216/i0031-8884-35-6S-42.1; Binh CTT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106280; Binh CTT, 2014, ENVIRON TOXICOL CHEM, V33, P317, DOI 10.1002/etc.2442; COHEN RRH, 1984, LIMNOL OCEANOGR, V29, P170, DOI 10.4319/lo.1984.29.1.0170; COOPER WJ, 1983, SCIENCE, V220, P711, DOI 10.1126/science.220.4598.711; Cronin MTD, 2004, CHEM RES TOXICOL, V17, P545, DOI 10.1021/tx0342518; Dalai S, 2013, AQUAT TOXICOL, V138, P1, DOI 10.1016/j.aquatox.2013.04.005; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P1282, DOI 10.1021/es8023594; DORSEY J, 1989, CYTOMETRY, V10, P622, DOI 10.1002/cyto.990100518; Drury B, 2013, ENVIRON SCI TECHNOL, V47, P8923, DOI 10.1021/es401919k; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; Feng Y, 2013, ECOL ENG, V53, P306, DOI 10.1016/j.ecoleng.2012.12.066; Franklin NM, 2001, ARCH ENVIRON CON TOX, V40, P469; GARCIAPICHEL F, 1993, APPL ENVIRON MICROB, V59, P170, DOI 10.1128/AEM.59.1.170-176.1993; GILBERT F, 1992, MAR BIOL, V112, P199, DOI 10.1007/BF00702462; GRATZEL CK, 1990, J MOL CATAL, V60, P375, DOI 10.1016/0304-5102(90)85260-O; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Hader DP, 2002, PHOTOCH PHOTOBIO SCI, V1, P809, DOI 10.1039/b206152j; Hader DP, 2001, J PHOTOCH PHOTOBIO B, V62, P43, DOI 10.1016/S1011-1344(01)00162-2; HANELT D, 1992, BOT ACTA, V105, P278, DOI 10.1111/j.1438-8677.1992.tb00299.x; Hartmann NB, 2010, TOXICOLOGY, V269, P190, DOI 10.1016/j.tox.2009.08.008; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Hund-Rinke Kerstin, 2010, Umweltwissenschaften und Schadstoff-Forschung, V22, P517, DOI 10.1007/s12302-010-0147-0; Ji J, 2011, CHEM ENG J, V170, P525, DOI 10.1016/j.cej.2010.11.026; Jin X, 2010, ENVIRON SCI TECHNOL, V44, P7321, DOI 10.1021/es100854g; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; KANEY AR, 1973, ARCH MIKROBIOL, V92, P139, DOI 10.1007/BF00425011; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim SC, 2005, MICROCHEM J, V80, P227, DOI 10.1016/j.microc.2004.07.008; Kiser MA, 2009, ENVIRON SCI TECHNOL, V43, P6757, DOI 10.1021/es901102n; Kulacki KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047130; LAMPERT W, 1987, NEW ZEAL J MAR FRESH, V21, P483, DOI 10.1080/00288330.1987.9516244; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P8989, DOI 10.1021/es201675m; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P755, DOI 10.1021/es102266g; LIDHOLM J, 1987, PLANT CELL PHYSIOL, V28, P1133; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Loza V, 2014, WATER RES, V48, P622, DOI 10.1016/j.watres.2013.10.014; Machado MD, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1358-3; MARTIN TC, 1974, J PHYCOL, V10, P204; Martirosyan A, 2014, INT J ENV RES PUB HE, V11, P5720, DOI 10.3390/ijerph110605720; Oh HM, 2000, APPL ENVIRON MICROB, V66, P176, DOI 10.1128/AEM.66.1.176-179.2000; Orvos DR, 2002, ENVIRON TOXICOL CHEM, V21, P1338, DOI 10.1897/1551-5028(2002)021<1338:ATOT>2.0.CO;2; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; PENALOZA R, 1990, FRESHWATER BIOL, V24, P233, DOI 10.1111/j.1365-2427.1990.tb00705.x; PETERSON CG, 1993, J PHYCOL, V29, P442, DOI 10.1111/j.1529-8817.1993.tb00145.x; Peterson CG, 1998, FRESHWATER BIOL, V40, P607, DOI 10.1046/j.1365-2427.1998.00358.x; Reeves JF, 2008, MUTAT RES-FUND MOL M, V640, P113, DOI 10.1016/j.mrfmmm.2007.12.010; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Romero OC, 2011, ENVIRON SCI TECHNOL, V45, P10385, DOI 10.1021/es202067f; Sadiq IM, 2011, ECOTOX ENVIRON SAFE, V74, P1180, DOI 10.1016/j.ecoenv.2011.03.006; SAMUELSSON G, 1985, PLANT PHYSIOL, V79, P992, DOI 10.1104/pp.79.4.992; Shih YH, 2012, ENVIRON TOXICOL CHEM, V31, P1693, DOI 10.1002/etc.1898; Smith TE, 1998, J PLANKTON RES, V20, P1567, DOI 10.1093/plankt/20.8.1567; Sun TY, 2014, ENVIRON POLLUT, V185, P69, DOI 10.1016/j.envpol.2013.10.004; Szelag-Wasielewska E, 2003, HYDROBIOLOGIA, V506, P229, DOI 10.1023/B:HYDR.0000008587.33966.78; Boncagni NT, 2009, ENVIRON SCI TECHNOL, V43, P7699, DOI 10.1021/es900424n; Tong TZ, 2013, ENVIRON SCI TECHNOL, V47, P12486, DOI 10.1021/es403079h; Tong TZ, 2013, WATER RES, V47, P2352, DOI 10.1016/j.watres.2013.02.008; United States Geological Survey, 2008, MINERAL COMMODITY SU, P178; USEPA, 2002, SHORT TERM METHODS F; Velzeboer I, 2008, ENVIRON TOXICOL CHEM, V27, P1942, DOI 10.1897/07-509.1; WAKI K, 1995, J MOL CATAL A-CHEM, V95, P53, DOI 10.1016/1381-1169(94)00135-9; Wang JX, 2008, CHEMOSPHERE, V73, P1121, DOI 10.1016/j.chemosphere.2008.07.040; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; Weir A, 2012, ENVIRON SCI TECHNOL, V46, P2242, DOI 10.1021/es204168d; Westerhoff P, 2011, J ENVIRON MONITOR, V13, P1195, DOI 10.1039/c1em10017c; WHITELAM GC, 1983, PLANTA, V157, P561, DOI 10.1007/BF00396889; World Meteorological Organization (WMO), 2008, GUIDE TO METEOROLOGI; Zegura B, 2003, TOXICON, V41, P41, DOI 10.1016/S0041-0101(02)00207-6; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	81	6	7	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125613	10.1371/journal.pone.0125613	http://dx.doi.org/10.1371/journal.pone.0125613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923116	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600155
J	Gregory, SJ; Anderson, CWN; Camps-Arbestain, M; Biggs, PJ; Ganley, ARD; O'Sullivan, JM; McManus, MT				Gregory, Samuel J.; Anderson, Christopher W. N.; Camps-Arbestain, Marta; Biggs, Patrick J.; Ganley, Austen R. D.; O'Sullivan, Justin M.; McManus, Michael T.			Biochar in Co-Contaminated Soil Manipulates Arsenic Solubility and Microbiological Community Structure, and Promotes Organochlorine Degradation	PLOS ONE			English	Article							MICROBIAL BIOMASS; DDT; IMPACT; CARBON; BIOAVAILABILITY; MICROORGANISMS; INSECTICIDES; METABOLISM; PESTICIDES; AMENDMENTS	We examined the effect of biochar on the water-soluble arsenic (As) concentration and the extent of organochlorine degradation in a co-contaminated historic sheep-dip soil during a 180-d glasshouse incubation experiment. Soil microbial activity, bacterial community and structure diversity were also investigated. Biochar made from willow feedstock (Salix sp) was pyrolysed at 350 or 550 degrees C and added to soil at rates of 10 g kg(-1) and 20 g kg(-1) (representing 30 t ha(-1) and 60 t ha(-1)). The isomers of hexachlorocyclohexane (HCH) alpha-HCH and gamma-HCH (lindane), underwent 10-fold and 4-fold reductions in concentration as a function of biochar treatment. Biochar also resulted in a significant reduction in soil DDT levels (P < 0.01), and increased the DDE: DDT ratio. Soil microbial activity was significantly increased (P < 0.01) under all biochar treatments after 60 days of treatment compared to the control. 16S amplicon sequencing revealed that biochar-amended soil contained more members of the Chryseobacterium, Flavobacterium, Dyadobacter and Pseudomonadaceae which are known bioremediators of hydrocarbons. We hypothesise that a recorded short-term reduction in the soluble As concentration due to biochar amendment allowed native soil microbial communities to overcome As-related stress. We propose that increased microbiological activity (dehydrogenase activity) due to biochar amendment was responsible for enhanced degradation of organochlorines in the soil. Biochar therefore partially overcame the co-contaminant effect of As, allowing for enhanced natural attenuation of organochlorines in soil.	[Gregory, Samuel J.; Camps-Arbestain, Marta] Massey Univ, New Zealand Biochar Res Ctr, Palmerston North, New Zealand; [Anderson, Christopher W. N.] Massey Univ, Soil & Earth Sci, Inst Agr & Environm, Palmerston North, New Zealand; [Biggs, Patrick J.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Ganley, Austen R. D.] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand; [O'Sullivan, Justin M.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [McManus, Michael T.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University; Massey University; Massey University; Massey University; University of Auckland; Massey University	Anderson, CWN (corresponding author), Massey Univ, Soil & Earth Sci, Inst Agr & Environm, Palmerston North, New Zealand.	C.W.N.Anderson@massey.ac.nz	O'Sullivan, Justin/HDO-1639-2022; Biggs, Patrick Jon/H-3355-2014; Ganley, Austen/L-8120-2013	O'Sullivan, Justin/0000-0003-2927-450X; Biggs, Patrick Jon/0000-0002-0285-4101; Ganley, Austen/0000-0002-1917-7522; Camps Arbestain, Marta/0000-0002-5354-2087	Massey University Strategic Innovation Fund (SIF); New Zealand Microbiology Society; Maurice Wilkins Centre; Ministry of Science and Innovation (New Zealand)	Massey University Strategic Innovation Fund (SIF); New Zealand Microbiology Society; Maurice Wilkins Centre; Ministry of Science and Innovation (New Zealand)	Metagenomics work was funded by Massey University Strategic Innovation Fund (SIF) grant (to JMO), with support from the New Zealand Microbiology Society and the Maurice Wilkins Centre, and from commercial sources: Custom Science, Roche, New Zealand Genomics Limited and KapaBiosystems. The first author gratefully acknowledges the Ministry of Science and Innovation (New Zealand) for the award of a Ti Tipu Putaiao Fellowshop (PhD scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Acceptance of funding from the named sources does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ahmedna M, 1997, J SCI FOOD AGR, V75, P117, DOI [10.1002/(SICI)1097-0010(199709)75:1<117::AID-JSFA850>3.3.CO;2-D, 10.1002/(SICI)1097-0010(199709)75:1&lt;117::AID-JSFA850&gt;3.0.CO;2-M]; Aislabie JM, 1997, NEW ZEAL J AGR RES, V40, P269, DOI 10.1080/00288233.1997.9513247; Anderson CR, 2011, PEDOBIOLOGIA, V54, P309, DOI 10.1016/j.pedobi.2011.07.005; [Anonymous], 2006, ID INV MAN RISKS ASS; Antonious GF, 2003, J ENVIRON SCI HEAL B, V38, P479, DOI 10.1081/PFC-120021667; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Beesley L, 2011, ENVIRON POLLUT, V159, P474, DOI 10.1016/j.envpol.2010.10.016; Beesley L, 2010, ENVIRON POLLUT, V158, P2282, DOI 10.1016/j.envpol.2010.02.003; Blakemore L.C., 1987, NZ SOIL BUR SCI REP; Bruun S, 2008, ORG GEOCHEM, V39, P839, DOI 10.1016/j.orggeochem.2008.04.020; Camina F, 1998, SOIL BIOL BIOCHEM, V30, P1005, DOI 10.1016/S0038-0717(98)00010-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHANDER K, 1991, SOIL BIOL BIOCHEM, V23, P909, DOI 10.1016/0038-0717(91)90170-O; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; Chopra BK, 2007, SCI TOTAL ENVIRON, V378, P331, DOI 10.1016/j.scitotenv.2007.02.036; CORNFORTH I, 1998, PRACTICAL SOIL MANAG; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edvantoro BB, 2003, ECOTOX ENVIRON SAFE, V55, P344, DOI 10.1016/S0147-6513(02)00092-1; Elliott JE, 1994, ARCH ENV CONTAMINATI, V26, P35; Gaw SK, 2006, SCI TOTAL ENVIRON, V355, P31, DOI 10.1016/j.scitotenv.2005.02.020; Gomez JD, 2014, EUR J SOIL SCI, V65, P28, DOI 10.1111/ejss.12097; Graber ER, 2012, PLANT SOIL, V353, P95, DOI 10.1007/s11104-011-1012-7; Gregory S., 2013, THESIS MASSEY U NZ; Gregory SJ, 2014, AGR ECOSYST ENVIRON, V191, P133, DOI 10.1016/j.agee.2014.03.035; Hesse P. R., 1971, TXB SOIL CHEM ANAL; Hills Laboratories, 2014, SOIL TESTS INT; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P804, DOI 10.1016/j.soilbio.2010.12.015; Joseph SD, 2010, AUST J SOIL RES, V48, P501, DOI 10.1071/SR10009; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Klose S, 2004, SOIL BIOL BIOCHEM, V36, P1625, DOI 10.1016/j.soilbio.2004.07.009; Ko BG, 2008, AUST J SOIL RES, V46, P493, DOI 10.1071/SR07200; Kolb SE, 2009, SOIL SCI SOC AM J, V73, P1173, DOI 10.2136/sssaj2008.0232; Kookana RS, 2011, ADV AGRON, V112, P103, DOI 10.1016/B978-0-12-385538-1.00003-2; Kookana RS, 2010, AUST J SOIL RES, V48, P627, DOI 10.1071/SR10007; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; LAL R, 1982, MICROBIOL REV, V46, P95, DOI 10.1128/MMBR.46.1.95-127.1982; Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112, DOI 10.1128/AEM.62.9.3112-3120.1996; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Lo KV, 1998, ENVIRON TECHNOL, V19, P91, DOI 10.1080/09593331908616659; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lu GN, 2010, J HAZARD MATER, V177, P1145, DOI 10.1016/j.jhazmat.2009.12.051; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Margesin R, 2000, CHEMOSPHERE, V40, P339, DOI 10.1016/S0045-6535(99)00218-0; McBride GL., 1998, P WASTE MANAGEMENT I, P129; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Ministry of Agriculture and Fisheries, 1976, REP COMM INQ DIPP SH; National Rivers Authority, 1994, DISP SHEEP DIP WAST; Pampulha ME, 2006, CURR MICROBIOL, V53, P238, DOI 10.1007/s00284-006-0116-4; Pereira RC, 2011, ORG GEOCHEM, V42, P1331, DOI 10.1016/j.orggeochem.2011.09.002; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quilty JR, 2011, SOIL RES, V49, P1, DOI 10.1071/SR10059; RICE CP, 1973, B ENVIRON CONTAM TOX, V9, P116, DOI 10.1007/BF01684766; RICE CP, 1973, J AGR FOOD CHEM, V21, P148, DOI 10.1021/jf60186a012; Saimmai A, 2012, ANN MICROBIOL, V62, P1757, DOI 10.1007/s13213-012-0434-7; Singh BP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03687; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Sutton NB, 2013, APPL ENVIRON MICROB, V79, P619, DOI 10.1128/AEM.02747-12; Teixido M, 2013, ENVIRON SCI TECHNOL, V47, P6197, DOI 10.1021/es400911c; Tyagi M, 2011, BIODEGRADATION, V22, P231, DOI 10.1007/s10532-010-9394-4; Van Zwieten L, 2003, ENVIRON POLLUT, V124, P331, DOI 10.1016/S0269-7491(02)00463-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang T, 2012, PLANT SOIL, V357, P173, DOI 10.1007/s11104-012-1131-9; Warnock DD, 2007, PLANT SOIL, V300, P9, DOI 10.1007/s11104-007-9391-5; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Whitman W.B., 2010, BERGEYS MANUAL SYSTE, DOI [10.1007/978-0-387-68572-4, DOI 10.1007/978-0-387-68572-4]; Yang YN, 2003, ENVIRON SCI TECHNOL, V37, P3635, DOI 10.1021/es034006a; Yu XY, 2009, CHEMOSPHERE, V76, P665, DOI 10.1016/j.chemosphere.2009.04.001; Zhou Ying, 2006, Yingyong Shengtai Xuebao, V17, P1305	73	33	35	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125393	10.1371/journal.pone.0125393	http://dx.doi.org/10.1371/journal.pone.0125393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923541	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600147
J	Nansen, C; Ribeiro, LP; Dadour, I; Roberts, JD				Nansen, Christian; Ribeiro, Leandro Prado; Dadour, Ian; Roberts, John Dale			Detection of Temporal Changes in Insect Body Reflectance in Response to Killing Agents	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CUTICULAR HYDROCARBONS; OPTICAL-PROPERTIES; COLEOPTERA; HYMENOPTERA; LARVAE; HOST	Computer vision and reflectance-based analyses are becoming increasingly important methods to quantify and characterize phenotypic responses by whole organisms to environmental factors. Here, we present the first study of how a non-destructive and completely non-invasive method, body reflectance profiling, can be used to detect and time stress responses in adult beetles. Based on high-resolution hyperspectral imaging, we acquired time series of average reflectance profiles (70 spectral bands from 434-876 nm) from adults in two beetle species, maize weevils (Sitophilus zeamais) and larger black flour beetles (Cynaus angustus). For each species, we acquired reflectance data from untreated controls and from individuals exposed continuously to killing agents (an insecticidal plant extract applied to maize kernels or entomopathogenic nematodes applied to soil applied at levels leading to approximate to 100% mortality). In maize weevils (exposed to hexanic plant extract), there was no significant effect of the on reflectance profiles acquired from adult beetles after 0 and 12 hours of exposure, but a significant treatment response in spectral bands from 434 to 550 nm was detected after 36 to 144 hours of exposure. In larger black flour beetles, there was no significant effect of exposure to entomopathogenic nematodes after 0 to 26 hours of exposure, but a significant response in spectral bands from 434-480 nm was detected after 45 and 69 hours of exposure. Spectral bands were used to develop reflectance-based classification models for each species, and independent validation of classification algorithms showed sensitivity (ability to positively detect terminal stress in beetles) and specificity (ability to positively detect healthy beetles) of about 90%. Significant changes in body reflectance occurred at exposure times, which coincided with published exposure times and known physiological responses to each killing agent. The results from this study underscore the potential of hyperspectral imaging as an approach to non-destructively and non-invasively quantify stress detection in insects and other animals.	[Nansen, Christian] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Ribeiro, Leandro Prado] Univ Sao Paulo, Dept Entomol & Acarol, Piracicaba, SP, Brazil; [Dadour, Ian] Univ Western Australia, Ctr Forens Sci, Perth, WA 6009, Australia; [Roberts, John Dale] Univ Western Australia, Sch Anim Biol, Albany, WA, Australia; [Roberts, John Dale] Univ Western Australia, Ctr Evolutionary Biol, Albany, WA, Australia; [Roberts, John Dale] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia	University of California System; University of California Davis; Universidade de Sao Paulo; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Nansen, C (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.	christian.nansen@uwa.edu.au		Dadour, Ian Robert/0000-0001-7527-4936				Aw WC, 2012, G3-GENES GENOM GENET, V2, P1057, DOI 10.1534/g3.112.003103; Berggren A, 2010, INSECT SCI, V17, P400, DOI 10.1111/j.1744-7917.2010.01319.x; Bluhm BA, 2001, MAR BIOL, V138, P247, DOI 10.1007/s002270000458; Burleigh JG, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.085c713acafc8711b2ff7010a4b03733; Butler SM, 2009, MED VET ENTOMOL, V23, P426, DOI 10.1111/j.1365-2915.2009.00831.x; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Chapman RF., 2012, INSECTS STRUCTURE FU; Colom OA, 2008, J PEST SCI, V81, P85, DOI 10.1007/s10340-007-0189-2; Cotter SC, 2008, J EVOLUTION BIOL, V21, P1744, DOI 10.1111/j.1420-9101.2008.01587.x; De Loof A, 2010, J INSECT PHYSIOL, V56, P919, DOI 10.1016/j.jinsphys.2010.02.021; Faber NM, 2007, ANAL CHIM ACTA, V595, P98, DOI 10.1016/j.aca.2007.05.030; Ferreira-Caliman MJ, 2010, J INSECT PHYSIOL, V56, P800, DOI 10.1016/j.jinsphys.2010.02.004; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Freitak D, 2005, ENTOMOL EXP APPL, V116, P237, DOI 10.1111/j.1570-7458.2005.00330.x; FUZEAUBR.S, 1972, ANNU REV ENTOMOL, V17, P403, DOI 10.1146/annurev.en.17.010172.002155; GOODWIN TW, 1951, BIOCHEM J, V48, P199, DOI 10.1042/bj0480199; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Howard RW, 2003, ARCH INSECT BIOCHEM, V53, P1, DOI 10.1002/arch.10078; Howard RW, 2002, ARCH INSECT BIOCHEM, V50, P75, DOI 10.1002/arch.10034; Kastenbaum R, 1989, DEFINITIONS OF DEATH; Koc H, 2008, J CEREAL SCI, V48, P394, DOI 10.1016/j.jcs.2007.09.015; Lacoste C, ENV ENTOMOLOGY; Lammertyn J, 2000, POSTHARVEST BIOL TEC, V18, P121, DOI 10.1016/S0925-5214(99)00071-X; Lapointe SL, 2004, AGR FOREST ENTOMOL, V6, P251, DOI 10.1111/j.1461-9555.2004.00230.x; Mietchen D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003826; Nansen C, 2013, COMPUT ELECTRON AGR, V97, P21, DOI 10.1016/j.compag.2013.06.007; Nansen C, 2015, J PHOTOCHEMISTRY P B; Nansen C, 2008, J AGR FOOD CHEM, V56, P2933, DOI 10.1021/jf073237o; Nansen C, 2014, J EXP BIOL, V217, P1187, DOI 10.1242/jeb.095661; Nansen C, 2014, J FOOD ENG, V123, P17, DOI 10.1016/j.jfoodeng.2013.09.001; Nansen C, 2013, APPL SPECTROSC, V67, P1332, DOI 10.1366/12-06933; Nansen C, 2013, J ECON ENTOMOL, V106, P648, DOI 10.1603/EC12380; Nunes TM, 2009, GENET MOL RES, V8, P589, DOI 10.4238/vol8-2kerr012; Prabhakar M, 2012, CROP STRESS AND ITS MANAGEMENT: PERSPECTIVES AND STRATEGIES, P517, DOI 10.1007/978-94-007-2220-0_16; Qin JW, 2008, POSTHARVEST BIOL TEC, V49, P355, DOI 10.1016/j.postharvbio.2008.03.010; Ribeiro LD, 2013, J STORED PROD RES, V55, P6, DOI 10.1016/j.jspr.2013.06.001; Ribeiro LP, 2010, BIOPROSPECCAO EXTRAT; Robson SKA, 2009, AUST J ENTOMOL, V48, P102, DOI 10.1111/j.1440-6055.2009.00692.x; Rosa JS, 2002, J INVERTEBR PATHOL, V80, P46, DOI 10.1016/S0022-2011(02)00038-1; Roux O, 2008, MED VET ENTOMOL, V22, P309, DOI 10.1111/j.1365-2915.2008.00752.x; Singh CB, 2009, J STORED PROD RES, V45, P151, DOI 10.1016/j.jspr.2008.12.002; Singh CB, 2010, COMPUT ELECTRON AGR, V73, P118, DOI 10.1016/j.compag.2010.06.001; Wang J, 2011, POSTHARVEST BIOL TEC, V59, P272, DOI 10.1016/j.postharvbio.2010.09.017; Wang J, 2010, J FOOD ENG, V101, P78, DOI 10.1016/j.jfoodeng.2010.06.011; Webster TC, 2009, APIDOLOGIE, V40, P565, DOI 10.1051/apido/2009038; WILSON BC, 1990, IEEE J QUANTUM ELECT, V26, P2186, DOI 10.1109/3.64355; Zhang X, APPL SPECTROSCOPY; Zhu GH, 2006, MED VET ENTOMOL, V20, P438, DOI 10.1111/j.1365-2915.2006.00651.x	49	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124866	10.1371/journal.pone.0124866	http://dx.doi.org/10.1371/journal.pone.0124866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923362	Green Published, gold			2022-12-26	WOS:000353711600109
J	Quan, C; Xie, BX; Wang, HY; Chen, S				Quan, Chao; Xie, Bingxian; Wang, Hong Yu; Chen, Shuai			PKB-Mediated Thr(649) Phosphorylation of AS160/TBC1D4 Regulates the R-Wave Amplitude in the Heart	PLOS ONE			English	Article							GLUT4 TRANSLOCATION; RAB GTPASE; MYOCARDIAL-INFARCTION; PLASMA-MEMBRANE; INSULIN; AS160; AKT; TRAFFICKING; SENSITIVITY; DEFICIENCY	The Rab GTPase activating protein (RabGAP), AS160/TBC1D4, is an important substrate of protein kinase B (PKB), and regulates insulin-stimulated trafficking of glucose transporter 4. Besides, AS160/TBC1D4 has also been shown to regulate trafficking of many other membrane proteins including FA translocase/CD36 in cardiomyocytes. However, it is not clear whether it plays any role in regulating heart functions in vivo. Here, we found that PKB-mediated phosphorylation of Thr(649) on AS160/TBC1D4 represented one of the major PASbinding signals in the heart in response to insulin. Mutation of Thr(649) to a non-phosphorylatable alanine increased the R-wave amplitude in the AS160(Thr649Ala) knockin mice. However, this knockin mutation did not affect the heart functions under both normal and infarct conditions. Interestingly, myocardial infarction induced the expression of a related RabGAP, TBC1D1, in the infarct zone as well as in the border zone. Together, these data show that the Thr(649) phosphorylation of AS160/TBC1D4 plays an important role in the heart's electrical conduction system through regulating the R-wave amplitude.	[Quan, Chao; Xie, Bingxian; Wang, Hong Yu; Chen, Shuai] Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	Nanjing University	Wang, HY (corresponding author), Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China.	wanghy@nicemice.cn; schen6@163.com	Xie, Bingxian/Y-6487-2019		Ministry of Science and Technology of China [2014CB964704]; Ministry of Science and Technology of China (National Key Scientific Research Program of China); National Natural Science Foundation of China [31271498]; Ministry of Education of China [20120091120048, NCET-13-0270]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Science and Technology of China (National Key Scientific Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the Ministry of Science and Technology of China (Grant No. 2014CB964704; the National Key Scientific Research Program of China to SC), the National Natural Science Foundation of China (Grant No. 31271498 to SC), and the Ministry of Education of China (Grant Nos. 20120091120048 and NCET-13-0270 to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Chang Z, 2010, DEV BIOL, V347, P384, DOI 10.1016/j.ydbio.2010.08.033; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Comellas AP, 2010, J CELL SCI, V123, P1343, DOI 10.1242/jcs.066464; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; DeBosch B, 2006, J BIOL CHEM, V281, P32841, DOI 10.1074/jbc.M513087200; Di RM, 2012, BIOCHEM J, V441, P199, DOI 10.1042/BJ20110033; Ducommun S, 2012, AM J PHYSIOL-ENDOC M, V302, pE1036, DOI 10.1152/ajpendo.00379.2011; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; Laustsen PG, 2007, MOL CELL BIOL, V27, P1649, DOI 10.1128/MCB.01110-06; Liang XB, 2010, MOL BIOL CELL, V21, P2024, DOI 10.1091/mbc.E10-01-0042; Malmberg K, 1996, EUR HEART J, V17, P1337; Mazzaro Cdo L, 2008, ARQ BRAS CARDIOL, V90, P227; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sena S, 2009, J MOL CELL CARDIOL, V46, P910, DOI 10.1016/j.yjmcc.2009.02.014; von Bibra Helene, 2011, Curr Heart Fail Rep, V8, P242, DOI 10.1007/s11897-011-0070-8; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702	24	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124491	10.1371/journal.pone.0124491	http://dx.doi.org/10.1371/journal.pone.0124491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923736	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600089
J	Sorhus, E; Edvardsen, RB; Karlsen, O; Nordtug, T; van der Meeren, T; Thorsen, A; Harman, C; Jentoft, S; Meier, S				Sorhus, Elin; Edvardsen, Rolf B.; Karlsen, Orjan; Nordtug, Trond; van der Meeren, Terje; Thorsen, Anders; Harman, Christopher; Jentoft, Sissel; Meier, Sonnich			Unexpected Interaction with Dispersed Crude Oil Droplets Drives Severe Toxicity in Atlantic Haddock Embryos	PLOS ONE			English	Article							EARLY-LIFE STAGES; POLYCYCLIC AROMATIC-HYDROCARBONS; WATER-SOLUBLE FRACTION; FISH EMBRYOS; PINK SALMON; ONCORHYNCHUS-GORBUSCHA; EXXON-VALDEZ; AH RECEPTOR; LARVAE; CYTOCHROME-P4501A	The toxicity resulting from exposure to oil droplets in marine fish embryos and larvae is still subject for debate. The most detailed studies have investigated the effects of water-dissolved components of crude oil in water accommodated fractions (WAFs) that lack bulk oil droplets. Although exposure to dissolved petroleum compounds alone is sufficient to cause the characteristic developmental toxicity of crude oil, few studies have addressed whether physical interaction with oil micro-droplets are a relevant exposure pathway for open water marine speices. Here we used controlled delivery of mechanically dispersed crude oil to expose pelagic embryos and larvae of a marine teleost, the Atlantic haddock (Melanogrammus aeglefinus). Haddock embryos were exposed continuously to two different concentrations of dispersed crude oil, high and low, or in pulses. By 24 hours of exposure, micro-droplets of oil were observed adhering and accumulating on the chorion, accompanied by highly elevated levels of cyp1a, a biomarker for exposure to aromatic hydrocarbons. Embryos from all treatment groups showed abnormalities representative of crude oil cardiotoxicity at hatch (5 days of exposure), such as pericardial and yolk sac edema. Compared to other species, the frequency and severity of toxic effects was higher than expected for the waterborne PAH concentrations (e.g., 100% of larvae had edema at the low treatment). These findings suggest an enhanced tissue uptake of PAHs and/or other petroleum compounds from attached oil droplets. These studies highlight a novel property of haddock embryos that leads to greater than expected impact from dispersed crude oil. Given the very limited number of marine species tested in similar exposures, the likelihood of other species with similar properties could be high. This unanticipated result therefore has implications for assessing the ecological impacts of oil spills and the use of methods for dispersing oil in the open sea.	[Sorhus, Elin; Edvardsen, Rolf B.; Thorsen, Anders; Meier, Sonnich] Inst Marine Res, N-5024 Bergen, Norway; [Sorhus, Elin; Jentoft, Sissel] Univ Oslo, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Nordtug, Trond] SINTEF Mat & Chem, Trondheim, Norway; [Harman, Christopher] Norwegian Inst Water Res NIVA, Grimstad, Norway; [Karlsen, Orjan; van der Meeren, Terje] Inst Marine Res, Austevoll Res Stn, Storebo, Norway; [Karlsen, Orjan; van der Meeren, Terje] Hjort Ctr Marine Ecosyst Dynam, Storebo, Norway	Institute of Marine Research - Norway; University of Oslo; SINTEF; Norwegian Institute for Water Research (NIVA); Institute of Marine Research - Norway	Sorhus, E (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	elin.sorhus@imr.no	Karlsen, Ørjan/K-6137-2012; Thorsen, Anders/AAA-5911-2022; Nordtug, Trond/GZG-7597-2022	Karlsen, Ørjan/0000-0001-5801-4200; Nordtug, Trond/0000-0002-0269-2974; Edvardsen, Rolf/0000-0001-8430-8042; Sorhus, Elin/0000-0003-3542-4201; Jentoft, Sissel/0000-0001-8707-531X	VISTA foundation [6161]; Institute of Marine Research, Norway [14236]	VISTA foundation; Institute of Marine Research, Norway	This work was financed by the VISTA foundation (Project no. 6161, www.vista.no) and the Institute of Marine Research, Norway (Project no. 14236, www.imr.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2014, ENVIRON TOXICOL CHEM, V33, P107, DOI 10.1002/etc.2397; Agamy E, 2012, TOXICOL PATHOL, V40, P1128, DOI 10.1177/0192623312448936; Arukwe A, 2008, ENVIRON RES, V107, P362, DOI 10.1016/j.envres.2008.02.009; Barron MG, 2005, CHEMOSPHERE, V60, P105, DOI 10.1016/j.chemosphere.2004.12.006; Barron MG, 2003, ENVIRON TOXICOL CHEM, V22, P650, DOI 10.1002/etc.5620220326; Barron MG, 1999, AQUAT TOXICOL, V46, P253, DOI 10.1016/S0166-445X(98)00127-1; Bauder MB, 2005, ENVIRON TOXICOL CHEM, V24, P694, DOI 10.1897/04-23R.1; Blanchard A, 2014, MAR POLICY, V43, P313, DOI 10.1016/j.marpol.2013.07.001; Blazer VS, 2006, DIS AQUAT ORGAN, V72, P19, DOI 10.3354/dao072019; Bock KW, 2012, BIOCHEM PHARMACOL, V83, P833, DOI 10.1016/j.bcp.2011.12.006; Bogerd J, 2001, BIOL REPROD, V64, P1633, DOI 10.1095/biolreprod64.6.1633; Brette F, 2014, SCIENCE, V343, P772, DOI 10.1126/science.1242747; Carls MG, 2008, AQUAT TOXICOL, V88, P121, DOI 10.1016/j.aquatox.2008.03.014; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Carls MG, 2000, ENVIRON TOXICOL CHEM, V19, P1649, DOI 10.1002/etc.5620190624; Carroll J, 2011, SOC PETROLEUM ENG, V18, P481; Dubansky B, 2013, ENVIRON SCI TECHNOL, V47, P5074, DOI 10.1021/es400458p; Fallahtafti S, 2012, AQUAT TOXICOL, V106, P56, DOI 10.1016/j.aquatox.2011.10.007; Frantzen M, 2012, AQUAT TOXICOL, V108, P42, DOI 10.1016/j.aquatox.2011.09.022; FRIDGEIRSSON E, 1978, Rit Fiskideildar, V5, P1; Goksoyr Anders, 1998, EXS, V86, P165; Gonzalez-Doncel M, 2008, AQUAT TOXICOL, V87, P280, DOI 10.1016/j.aquatox.2008.02.013; Hauge KH, 2014, MAR POLICY, V44, P82, DOI 10.1016/j.marpol.2013.07.008; Heintz RA, 1999, ENVIRON TOXICOL CHEM, V18, P494, DOI 10.1002/etc.5620180318; Hjermann DO, 2007, MAR ECOL PROG SER, V339, P283, DOI 10.3354/meps339283; Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018; Incardona JP, 2014, P NATL ACAD SCI USA, V111, pE1510, DOI 10.1073/pnas.1320950111; Incardona JP, 2013, AQUAT TOXICOL, V142, P303, DOI 10.1016/j.aquatox.2013.08.011; Incardona JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030116; Incardona JP, 2011, TOXICOL APPL PHARM, V257, P242, DOI 10.1016/j.taap.2011.09.010; Incardona JP, 2011, J EXPO SCI ENV EPID, V21, P3, DOI 10.1038/jes.2010.51; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Ingvarsdottir A, 2012, J MARINE SYST, V93, P69, DOI 10.1016/j.jmarsys.2011.10.014; Jung JH, 2013, CHEMOSPHERE, V91, P1146, DOI 10.1016/j.chemosphere.2013.01.019; Kushman ME, 2007, TOXICOL SCI, V99, P51, DOI 10.1093/toxsci/kfm133; Landrum P, 1987, OIL FRESHWATER CHEM, P304; Leirvik F, 2004, HEIDRUM OLJE EGENSKA; Liao WQ, 2006, J BIOCHEM MOL TOXIC, V20, P114, DOI 10.1002/jbt.20125; Marty GD, 1997, CAN J ZOOL, V75, P989, DOI 10.1139/z97-120; Mattingly CJ, 2001, DEV DYNAM, V222, P645, DOI 10.1002/dvdy.1215; McIntosh S, 2010, ENVIRON TOXICOL CHEM, V29, P1160, DOI 10.1002/etc.134; Meier S, 2010, MAR ENVIRON RES, V70, P383, DOI 10.1016/j.marenvres.2010.08.002; Melbye AG, 2009, ENVIRON TOXICOL CHEM, V28, P1815, DOI 10.1897/08-545.1; Misund OA, 2013, ICES J MAR SCI, V70, P722, DOI 10.1093/icesjms/fst086; Mohamed Fatma A.S., 2009, World Journal of Fish and Marine Sciences, V1, P29; Morrison C, 1999, CAN J ZOOL, V77, P890, DOI 10.1139/cjz-77-6-890; MORTENSEN DG, 1994, ALASKA SEA, P183; Naas K.E, 1997, REV FISH SCI, V5, P367, DOI 10.1080/10641269709388606; NAAS KE, 1992, AQUACULTURE, V105, P143, DOI 10.1016/0044-8486(92)90126-6; Neff JM, 2000, ENVIRON TOXICOL CHEM, V19, P1809; Nordtug T, 2011, SCI TOTAL ENVIRON, V412, P148, DOI 10.1016/j.scitotenv.2011.10.021; Nordtug T, 2011, MAR POLLUT BULL, V62, P2106, DOI 10.1016/j.marpolbul.2011.07.015; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Olsen GH, 2013, MAR ENVIRON RES, V90, P9, DOI 10.1016/j.marenvres.2013.05.007; Olsvik PA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-702; Otte JC, 2010, AQUAT TOXICOL, V100, P38, DOI 10.1016/j.aquatox.2010.07.006; Patel S, 2008, FISH SHELLFISH IMMUN, V25, P570, DOI 10.1016/j.fsi.2008.08.007; Perquin M, 2001, J CANCER RES CLIN, V127, P368, DOI 10.1007/s004320000228; Petersen GI, 1998, ENVIRON TOXICOL CHEM, V17, P1385, DOI 10.1002/etc.5620170724; Pietrangelo Antonello, 1998, Journal of Hepatology, V28, P8, DOI 10.1016/S0168-8278(98)80368-1; Reinecke M, 1998, MAR ENVIRON RES, V46, P487, DOI 10.1016/S0141-1136(97)00120-7; Rhee JS, 2013, ENVIRON SCI TECHNOL, V47, P4804, DOI 10.1021/es400186r; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; Sarasquete C, 1999, HISTOL HISTOPATHOL, V14, P407, DOI 10.14670/HH-14.407; Solberg T., 1982, International Council for the Exploration of the Sea C.M., V1982/E:60, P1; Solemdal P, 1997, MATURATION SPAWING E; STEGEMAN JJ, 1989, MOL PHARMACOL, V36, P723; STIVER W, 1984, ENVIRON SCI TECHNOL, V18, P834, DOI 10.1021/es00129a006; Sundarapian SM., 2013, FOREST RES, V3, P1; TILSETH S, 1984, MAR ENVIRON RES, V11, P1, DOI 10.1016/0141-1136(84)90007-2; van der Meeren T, 2014, AQUACULT ENG, V62, P17, DOI 10.1016/j.aquaeng.2014.07.003; Vikebo FB, 2014, ICES J MAR SCI, V71, P970, DOI 10.1093/icesjms/fst131; Wang IC, 2010, J ENVIRON SCI HEAL A, V45, P201, DOI 10.1080/10934520903429873; WANG SY, 1993, CAN J FISH AQUAT SCI, V50, P996, DOI 10.1139/f93-115; Wells PG, 1997, MUTAT RES-FUND MOL M, V396, P65, DOI 10.1016/S0027-5107(97)00175-9; Weltzien FA, 2003, COMP BIOCHEM PHYS A, V134, P315, DOI 10.1016/S1095-6433(02)00266-0; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; Wu DM, 2012, ENVIRON TOXICOL CHEM, V31, P754, DOI 10.1002/etc.1739	80	61	61	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124376	10.1371/journal.pone.0124376	http://dx.doi.org/10.1371/journal.pone.0124376			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923774	Green Published, gold			2022-12-26	WOS:000353711600079
J	Chen, C; Song, YF; Zhuang, K; Li, L; Xia, Y; Shen, ZG				Chen, Chen; Song, Yufeng; Zhuang, Kai; Li, Lu; Xia, Yan; Shen, Zhenguo			Proteomic Analysis of Copper-Binding Proteins in Excess Copper-Stressed Roots of Two Rice (Oryza sativa L.) Varieties with Different Cu Tolerances	PLOS ONE			English	Article							METAL AFFINITY-CHROMATOGRAPHY; METHIONINE SULFOXIDE REDUCTASE; TRANSLATION INITIATION-FACTOR; MASS-SPECTROMETRY; DISULFIDE-ISOMERASE; OXIDATIVE STRESS; GENE-EXPRESSION; 2-DIMENSIONAL ELECTROPHORESIS; COMPREHENSIVE ANALYSIS; ARABIDOPSIS-THALIANA	To better understand the mechanisms involved in the heavy metal stress response and tolerance in plants, a proteomic approach was used to investigate the differences in Cu-binding protein expression in Cu-tolerant and Cu-sensitive rice varieties. Cu-binding proteins from Cu-treated rice roots were separated using a new IMAC method in which an IDA-sepharose column was applied prior to the Cu-IMAC column to remove metal ions from protein samples. More than 300 protein spots were reproducibly detected in the 2D gel. Thirty-five protein spots exhibited changes greater than 1.5-fold in intensity compared to the control. Twenty-four proteins contained one or more of nine putative metal-binding motifs reported by Smith et al., and 19 proteins (spots) contained one to three of the top six motifs reported by Kung et al. The intensities of seven protein spots were increased in the Cu-tolerant variety B1139 compared to the Cu-sensitive variety B1195 (p<0.05) and six protein spots were markedly up-regulated in B1139, but not detectable in B1195. Four protein spots were significantly up-regulated in B1139, but unchanged in B1195 under Cu stress. In contrast, two protein spots were significantly down-regulated in B1195, but unchanged in B1139. These Cu-responsive proteins included those involved in antioxidant defense and detoxification (spots 5, 16, 21, 22, 28, 29 and 33), pathogenesis (spots 5, 16, 21, 22, 28, 29 and 33), regulation of gene transcription (spots 8 and 34), amino acid synthesis (spots 8 and 34), protein synthesis, modification, transport and degradation (spots 1, 2, 4, 10, 15, 19, 30, 31, 32 and 35), cell wall synthesis (spot 14), molecular signaling (spot 3), and salt stress (spots 7, 9 and 27); together with other proteins, such as a putative glyoxylate induced protein, proteins containing dimeric alpha-beta barrel domains, and adenosine kinase-like proteins. Our results suggest that these proteins, together with related physiological processes, play an important role in the detoxification of excess Cu and in maintaining cellular homeostasis.	[Chen, Chen; Song, Yufeng; Zhuang, Kai; Li, Lu; Xia, Yan; Shen, Zhenguo] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Shen, ZG (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	zgshen@njau.edu.cn			Specialized Research Fund for the Doctoral Program of Higher Education [20120097130004]; National Natural Science Foundation of China [31172021, 31471938]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team Development Plan of the Ministry of Education of China	This work was financially supported by Specialized Research Fund for the Doctoral Program of Higher Education (20120097130004), the National Natural Science Foundation of China (31172021 and 31471938), and the Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Alvarez S, 2009, PROTEOMICS, V9, P3220, DOI [10.1002/pmic.200800478, 10.1002/pmic.200990042]; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; Balestrasse KB, 2006, PLANT SOIL, V284, P187, DOI 10.1007/s11104-006-0050-z; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V402, P637, DOI 10.1016/j.bbrc.2010.10.073; Barnett JP, 2012, ANAL BIOANAL CHEM, V402, P3311, DOI 10.1007/s00216-012-5743-y; Barrett A.J., 1986, PLANT PROTEOLYTIC EN, p1 ~16; Bechtold U, 2004, PLANT CELL, V16, P908, DOI 10.1105/tpc.015818; Bouchenak F, 2012, J PLANT PHYSIOL, V169, P1445, DOI 10.1016/j.jplph.2012.06.009; Breen J, 2010, FUNCT INTEGR GENOMIC, V10, P463, DOI 10.1007/s10142-010-0184-1; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chang HL, 2014, PHYSIOL PLANTARUM, V150, P550, DOI 10.1111/ppl.12102; Chen LM, 2012, J PLANT GENETIC RESO, V13, P858; Chen Z, 2012, PLANT SCI, V197, P10, DOI 10.1016/j.plantsci.2012.08.005; Chou WC, 2004, PHYSIOL PLANTARUM, V121, P50, DOI 10.1111/j.0031-9317.2004.00292.x; Christensen AB, 2004, MOL PLANT MICROBE IN, V17, P109, DOI 10.1094/MPMI.2004.17.1.109; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; El-Banna A, 2010, J BIOTECHNOL, V150, P277, DOI 10.1016/j.jbiotec.2010.09.934; Fu YP, 2007, J PLANT RES, V120, P465, DOI 10.1007/s10265-007-0080-5; Gajewska E, 2009, J PLANT PHYSIOL, V166, P1034, DOI 10.1016/j.jplph.2008.12.004; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gill T, 2012, J PLANT RES, V125, P165, DOI 10.1007/s10265-011-0421-2; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Jwa NS, 2006, PLANT PHYSIOL BIOCH, V44, P261, DOI 10.1016/j.plaphy.2006.06.010; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kung CCS, 2006, PROTEOMICS, V6, P2746, DOI 10.1002/pmic.200500108; LEBECHE D, 1994, BIOCHEM BIOPH RES CO, V202, P556, DOI 10.1006/bbrc.1994.1964; Lee HJ, 2013, PLANT CELL REP, V32, P1521, DOI 10.1007/s00299-013-1464-8; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Li F, 2009, PLANT MOL BIOL, V71, P251, DOI 10.1007/s11103-009-9521-y; Li LC, 2013, J PHYCOL, V49, P1181, DOI 10.1111/jpy.12129; Liu Z, 2008, J EXP BOT, V59, P939, DOI 10.1093/jxb/ern017; Llorens N, 2000, PLANT SCI, V160, P159, DOI 10.1016/S0168-9452(00)00379-4; Llorente A, 2003, J BIOL CHEM, V278, P35850, DOI 10.1074/jbc.M303425200; Mahajan NS, 2014, PLANT PHYSIOL BIOCH, V74, P212, DOI 10.1016/j.plaphy.2013.11.017; Martinez M, 2012, PHYSIOL PLANTARUM, V145, P85, DOI 10.1111/j.1399-3054.2012.01569.x; Murad AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098463; MURPHY A, 1995, PLANT PHYSIOL, V109, P945, DOI 10.1104/pp.109.3.945; Opella SJ, 2002, CURR OPIN CHEM BIOL, V6, P217, DOI 10.1016/S1367-5931(02)00314-9; Parkash J, 2014, GENE, V542, P1, DOI 10.1016/j.gene.2014.03.032; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Pechan T, 1999, PLANT MOL BIOL, V40, P111, DOI 10.1023/A:1026494813936; Rajalingam D, 2005, BIOCHEMISTRY-US, V44, P14431, DOI 10.1021/bi051387r; Rana NK, 2008, BIOL PLANTARUM, V52, P361, DOI 10.1007/s10535-008-0075-7; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Roth U, 2006, J EXP BOT, V57, P4003, DOI 10.1093/jxb/erl170; Rouhier N, 2006, PHOTOSYNTH RES, V89, P247, DOI 10.1007/s11120-006-9097-1; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sarowar S, 2005, PLANT CELL REP, V24, P216, DOI 10.1007/s00299-005-0928-x; Sharmin SA, 2012, PLANT SCI, V187, P113, DOI 10.1016/j.plantsci.2012.02.002; She YM, 2003, MOL CELL PROTEOMICS, V2, P1306, DOI 10.1074/mcp.M300080-MCP200; Shinya T, 2007, PLANT CELL PHYSIOL, V48, P1404, DOI 10.1093/pcp/pcm115; Smith AP, 2004, J BIOL CHEM, V279, P26098, DOI 10.1074/jbc.M402807200; Smith SD, 2004, J PROTEOME RES, V3, P834, DOI 10.1021/pr049941r; Song YF, 2014, BIOMETALS, V27, P265, DOI 10.1007/s10534-014-9707-x; Song YF, 2013, PLANT SOIL, V366, P647, DOI 10.1007/s11104-012-1458-2; Sun XS, 2011, PROTEOMICS, V11, P3288, DOI 10.1002/pmic.201000396; Tan YF, 2010, PLANT PHYSIOL, V152, P747, DOI 10.1104/pp.109.147942; Tang SS, 1996, FREE RADICAL BIO MED, V21, P955, DOI 10.1016/S0891-5849(96)00230-4; Utriainen M, 1998, PLANT CELL ENVIRON, V21, P821, DOI 10.1046/j.1365-3040.1998.00326.x; Vaas LAI, 2012, PLANT CELL REP, V31, P1061, DOI 10.1007/s00299-011-1225-5; Wang YQ, 2005, MOL PLANT MICROBE IN, V18, P385, DOI 10.1094/MPMI-18-0385; Wang Y, 2014, PLANT BIOSYST, V148, P88, DOI 10.1080/11263504.2013.770807; Wen R, 2008, PLANT CELL, V20, P213, DOI 10.1105/tpc.107.051862; Xia Y, 2012, J HAZARD MATER, V233, P65, DOI 10.1016/j.jhazmat.2012.06.047; Xu JY, 2011, PLANT MOL BIOL, V75, P167, DOI 10.1007/s11103-010-9716-2; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yanez M, 2012, ADV EXP MED BIOL, V740, P461, DOI 10.1007/978-94-007-2888-2_19; Yang GX, 2005, J PROTEOME RES, V4, P456, DOI 10.1021/pr049801h; Yang QS, 2007, PROTEOMICS, V7, P737, DOI 10.1002/pmic.200600703; Yruela I, 2009, FUNCT PLANT BIOL, V36, P409, DOI 10.1071/FP08288; Yu CL, 2008, PHYTOCHEMISTRY, V69, P1989, DOI 10.1016/j.phytochem.2008.04.006; Zang X, 2007, PHYTOCHEMISTRY, V68, P426, DOI 10.1016/j.phytochem.2006.11.005; Zhang HX, 2009, ANN BOT-LONDON, V103, P923, DOI 10.1093/aob/mcp012; Zhao L, 2011, CHEMOSPHERE, V85, P56, DOI 10.1016/j.chemosphere.2011.06.029; Zhou SP, 2009, J EXP BOT, V60, P1849, DOI 10.1093/jxb/erp065	81	33	34	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125367	10.1371/journal.pone.0125367	http://dx.doi.org/10.1371/journal.pone.0125367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919452	gold, Green Submitted, Green Published			2022-12-26	WOS:000353659400082
J	Nakashima, R; Shioiri, S				Nakashima, Ryoichi; Shioiri, Satoshi			Facilitation of Visual Perception in Head Direction: Visual Attention Modulation Based on Head Direction	PLOS ONE			English	Article							EYE-MOVEMENTS; SET-SIZE; SEARCH; PSYCHOPHYSICS; RESOLUTION; GAZE; AMPLITUDE; SELECTION; ACCURACY; DURATION	People usually see things using frontal viewing, and avoid lateral viewing ( or eccentric gaze) where the directions of the head and eyes are largely different. Lateral viewing interferes with attentive visual search performance, probably because the head is directed away from the target and/or because the head and eyes are misaligned. In this study, we examined which of these factors is the primary one for interference by conducting a visual identification experiment where a target was presented in the peripheral visual field. The critical manipulation was the participants' head direction and fixation position: the head was directed to the fixation location, the target position, or the opposite side of the fixation. The performance was highest when the head was directed to the target position even when there was misalignment of the head and eye, suggesting that visual perception can be influenced by both head direction and fixation position.	[Nakashima, Ryoichi] Tohoku Univ, Sendai, Miyagi 980, Japan; Japan Sci & Technol Agcy, Sendai, Miyagi, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Nakashima, R (corresponding author), Tohoku Univ, Sendai, Miyagi 980, Japan.	one.island.one@gmail.com	Shioiri, Satoshi/B-9625-2008	Shioiri, Satoshi/0000-0003-2149-6132	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST); JSPS KAKENHI [25780441]; Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University; Grants-in-Aid for Scientific Research [25780441] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding from The Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST) (http://www.jst.go.jp/kisoken/crest/research_area/ongoing/bunyah21-1.html) to RN and SS; JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/) Grant Number 25780441 to RN; and The Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University (http://www.riec.tohoku.ac.jp/nation-wide/index-j.shtml) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P468; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carrasco M, 1997, VISION RES, V37, P63, DOI 10.1016/S0042-6989(96)00102-2; Chelazzi L, 1995, BEHAV BRAIN RES, V71, P81, DOI 10.1016/0166-4328(95)00134-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Doshi A, 2012, J VISION, V12, DOI [10.1167/12.6.9, 10.1167/12.2.9]; Dunham DN, 1997, INT J PSYCHOPHYSIOL, V27, P171, DOI 10.1016/S0167-8760(97)00054-8; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Einhauser W, 2009, ANN NY ACAD SCI, V1164, P188, DOI 10.1111/j.1749-6632.2008.03714.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FULLER JH, 1992, EXP BRAIN RES, V92, P152; Fuller JH, 1996, EXP BRAIN RES, V109, P457; HENDERSON JM, 1989, PERCEPT PSYCHOPHYS, V45, P196, DOI 10.3758/BF03210697; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Irwin DE, 2011, ATTEN PERCEPT PSYCHO, V73, P1374, DOI 10.3758/s13414-011-0111-0; KERR JL, 1971, PERCEPT PSYCHOPHYS, V9, P375, DOI 10.3758/BF03212671; Khan AZ, 2009, J NEUROPHYSIOL, V101, P198, DOI 10.1152/jn.90815.2008; KITTERLE FL, 1986, BRAIN COGNITION, V5, P131, DOI 10.1016/0278-2626(86)90052-7; KLEIN R, 1989, PERCEPT PSYCHOPHYS, V46, P476, DOI 10.3758/BF03210863; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krebs RM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00193; Kunar MA, 2007, J EXP PSYCHOL HUMAN, V33, P816, DOI 10.1037/0096-1523.33.4.816; Loschky LC, 2005, VIS COGN, V12, P1057, DOI 10.1080/13506280444000652; Mannan SK, 1997, SPATIAL VISION, V11, P157, DOI 10.1163/156856897X00177; Nakashima R, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092284, DOI 10.1371/J0URNAL.P0NE.0092284]; Nakashima R, 2013, ATTEN PERCEPT PSYCHO, V75, P299, DOI 10.3758/s13414-012-0402-0; Oommen BS, 2005, BRAIN RES, V1065, P68, DOI 10.1016/j.brainres.2005.10.029; Oommen BS, 2004, EXP BRAIN RES, V155, P9, DOI 10.1007/s00221-003-1694-z; OSAKA N, 1992, J OPT SOC AM A, V9, P5, DOI 10.1364/JOSAA.9.000005; Parkhurst DJ, 2003, SPATIAL VISION, V16, P125, DOI 10.1163/15685680360511645; Pavlovskaya M, 2001, SPATIAL VISION, V14, P151, DOI 10.1163/156856801300202913; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; SAGI D, 1985, Spatial Vision, V1, P141, DOI 10.1163/156856885X00152; Stahl JS, 2001, EXP BRAIN RES, V136, P200, DOI 10.1007/s002210000593; Stahl JS, 1999, EXP BRAIN RES, V126, P41, DOI 10.1007/s002210050715; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Thumser ZC, 2009, EXP BRAIN RES, V195, P393, DOI 10.1007/s00221-009-1803-8; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WHITE CT, 1962, J OPT SOC AM, V52, P210, DOI 10.1364/JOSA.52.000210; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wright R.D, 2008, ORIENTING ATTENTION; Xu YD, 2010, J VISION, V10, DOI 10.1167/10.14.24; Zelinsky GJ, 1997, J EXP PSYCHOL HUMAN, V23, P244, DOI 10.1037/0096-1523.23.1.244; Zhao G, 2012, J VISION, V12, DOI 10.1167/12.6.11	50	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124367	10.1371/journal.pone.0124367	http://dx.doi.org/10.1371/journal.pone.0124367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919316	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400047
J	Crawford, RR; Prescott, ET; Sylvester, CF; Higdon, AN; Shan, JX; Kilberg, MS; Mungrue, IN				Crawford, Rebecca R.; Prescott, Eugenia T.; Sylvester, Charity F.; Higdon, Ashlee N.; Shan, Jixiu; Kilberg, Michael S.; Mungrue, Imran N.			Human CHAC1 Protein Degrades Glutathione, and mRNA Induction Is Regulated by the Transcription Factors ATF4 and ATF3 and a Bipartite ATF/CRE Regulatory Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; DNA transcription; DNA-protein interaction; endoplasmic reticulum stress (ER stress); oxidative stress; unfolded protein response (UPR); ATF3; ATF4; CEBP; CHAC1	ENDOPLASMIC-RETICULUM STRESS; ASPARAGINE SYNTHETASE GENE; ER-STRESS; ENDOTHELIAL-CELLS; INDUCIBLE GENE; EXPRESSION; APOPTOSIS; CHOP; ANTIOXIDANT; ACTIVATION	Using an unbiased systems genetics approach, we previously predicted a role for CHAC1 in the endoplasmic reticulum stress pathway, linked functionally to activating transcription factor 4 (ATF4) following treatment with oxidized phospholipids, a model for atherosclerosis. Mouse and yeast CHAC1 homologs have been shown to degrade glutathione in yeast and a cell-free system. In this report, we further defined the ATF4-CHAC1 interaction by cloning the human CHAC1 promoter upstream of a luciferase reporter system for in vitro assays in HEK293 and U2OS cells. Mutation and deletion analyses defined two major cis DNA elements necessary and sufficient for CHAC1 promoter-driven luciferase transcription under conditions of ER stress or ATF4 coexpression: the -267 ATF/cAMP response element (CRE) site and a novel -248 ATF/CRE modifier (ACM) element. We also examined the ability of the CHAC1 ATF/CRE and ACM sequences to bind ATF4 and ATF3 using immunoblot-EMSA and confirmed ATF4, ATF3, and CCAAT/enhancer-binding protein binding at the human CHAC1 promoter in the proximity of the ATF/CRE and ACM using ChIP. To further validate the function of CHAC1 in a human cell model, we measured glutathione levels in HEK293 cells with enhanced CHAC1 expression. Overexpression of CHAC1 led to a robust depletion of glutathione, which was alleviated in a CHAC1 catalytic mutant. These results suggest an important role for CHAC1 in oxidative stress and apoptosis with implications for human health and disease.	[Crawford, Rebecca R.; Prescott, Eugenia T.; Sylvester, Charity F.; Higdon, Ashlee N.; Mungrue, Imran N.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Shan, Jixiu; Kilberg, Michael S.] Univ Florida, Coll Med, Shands Canc Ctr, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Shan, Jixiu; Kilberg, Michael S.] Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mungrue, IN (corresponding author), 1901 Perdido St,MEB 5259, New Orleans, LA 70112 USA.	imungr@lsuhsc.edu	Regan, Clinton/E-6250-2012	Mungrue, Imran/0000-0002-0870-7161	National Institutes of Health [HL094709, DK92062, DK94729]; NSF-REU [1359140]; Louisiana Board of Regents [LESQSF(2012-17)-GF-08]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094709, K99HL094709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092062, R01DK094729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF-REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL094709 (to I. N. M.). This work was also supported by NSF-REU Site (Grant 1359140) studentship (to C. F. S.) and Louisiana Board of Regents Fellowship LESQSF(2012-17)-GF-08 (to R. R. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Grants DK92062 and DK94729.	Aquilano K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00196; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Berisha SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065003; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Chen GK, 2004, MOL PHARMACOL, V65, P906, DOI 10.1124/mol.65.4.906; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Chi ZK, 2014, CELL REP, V7, P681, DOI 10.1016/j.celrep.2014.03.048; Chi ZK, 2012, DEV CELL, V22, P707, DOI 10.1016/j.devcel.2012.02.011; Creech CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015416; Fu LC, 2013, PHYSIOL GENOMICS, V45, P127, DOI 10.1152/physiolgenomics.00160.2012; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Galluzzi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043249; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Goebel G, 2012, BRIT J CANCER, V106, P189, DOI 10.1038/bjc.2011.510; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Joo NE, 2012, CANCER MED-US, V1, P295, DOI 10.1002/cam4.35; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Magne L, 2011, J HEPATOL, V54, P729, DOI 10.1016/j.jhep.2010.07.023; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Oh-hashi K, 2013, MOL CELL BIOCHEM, V380, P97, DOI 10.1007/s11010-013-1663-1; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; Shan JX, 2012, J BIOL CHEM, V287, P36393, DOI 10.1074/jbc.M112.399600; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061093; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tsunoda S, 2014, ELIFE, V3, DOI 10.7554/eLife.03421; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Xiao GZ, 2013, J BIOL CHEM, V288, P25350, DOI 10.1074/jbc.M113.470526; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yasuda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093258; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Zhang WP, 2008, RES VET SCI, V84, P374, DOI 10.1016/j.rvsc.2007.05.015	45	97	98	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15878	15891		10.1074/jbc.M114.635144	http://dx.doi.org/10.1074/jbc.M114.635144			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25931127	Green Published, hybrid			2022-12-26	WOS:000356527400046
J	Ingold, I; Aichler, M; Yefremova, E; Roveri, A; Buday, K; Doll, S; Tasdemir, A; Hoffard, N; Wurst, W; Walch, A; Ursini, F; Angeli, JPF; Conrad, M				Ingold, Irina; Aichler, Michaela; Yefremova, Elena; Roveri, Antonella; Buday, Katalin; Doll, Sebastian; Tasdemir, Adrianne; Hoffard, Nils; Wurst, Wolfgang; Walch, Axel; Ursini, Fulvio; Angeli, Jose Pedro Friedmann; Conrad, Marcus			Expression of a Catalytically Inactive Mutant Form of Glutathione Peroxidase 4 (Gpx4) Confers a Dominant-negative Effect in Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; EMBRYONIC LETHALITY; SELENIUM DEFICIENCY; SPERM MATURATION; NUCLEAR FORM; VITAMIN-E; PROTEIN; MICE; SELENOENZYME; DISRUPTION	The selenoenzyme Gpx4 is essential for early embryogenesis and cell viability for its unique function to prevent phospholipid oxidation. Recently, the cytosolic form of Gpx4 was identified as an upstream regulator of a novel form of non-apoptotic cell death, called ferroptosis, whereas the mitochondrial isoform of Gpx4 was previously shown to be crucial for male fertility. Here, we generated and analyzed mice with a targeted mutation of the active site selenocysteine of Gpx4 (Gpx4_U46S). Mice homozygous for Gpx4_U46S died at the same embryonic stage (E7.5) as Gpx4(-/-) embryos as expected. Surprisingly, male mice heterozygous for Gpx4_U46S presented subfertility. Subfertility was manifested in a reduced number of litters from heterozygous breeding and an impairment of spermatozoa to fertilize oocytes in vitro. Morphologically, sperm isolated from heterozygous Gpx4_U46S mice revealed many structural abnormalities particularly in the spermatozoa midpiece due to improper oxidation and polymerization of sperm capsular proteins and malformation of the mitochondrial capsule surrounding and stabilizing sperm mitochondria. These findings are reminiscent of sperm isolated from selenium-deprived rodents or from mice specifically lacking mitochondrial Gpx4. Due to a strongly facilitated incorporation of Ser in the polypeptide chain as compared with selenocysteine at the UGA codon, expression of the catalytically inactive Gpx4_U46S was found to be strongly increased. Because the stability of the mitochondrial capsule of mature spermatozoa depends on the moonlighting function of Gpx4 both as an enzyme oxidizing capsular protein thiols and as a structural protein, tightly controlled expression of functional Gpx4 emerges as a key for full male fertility.	[Ingold, Irina; Yefremova, Elena; Buday, Katalin; Doll, Sebastian; Tasdemir, Adrianne; Hoffard, Nils; Wurst, Wolfgang; Angeli, Jose Pedro Friedmann; Conrad, Marcus] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Aichler, Michaela; Walch, Axel] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, D-85764 Neuherberg, Germany; [Roveri, Antonella; Ursini, Fulvio] Univ Padua, Dept Mol Med, I-35121 Padua, Italy; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, D-80336 Munich, Germany; [Wurst, Wolfgang] Univ Munich, Munich Cluster Syst Neurol SyNergy, Adolf Butenandt Inst, D-80336 Munich, Germany; [Wurst, Wolfgang] Tech Univ Munchen Weihenstephan, Lehrstuhl Entwicklungsgenet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Padua; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Conrad, M (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	marcus.conrad@helmholtz-muenchen.de	Roveri, Antonella/AAF-3669-2019; Walch, Axel/B-4554-2012; Friedmann Angeli, Jose/C-9038-2014; Conrad, Marcus/E-8792-2015; Angeli, J Pedro Friedmann/ABG-6270-2020; Aichler, Michaela/B-5356-2014	Roveri, Antonella/0000-0002-3252-0559; Walch, Axel/0000-0001-5578-4023; Conrad, Marcus/0000-0003-1140-5612; Angeli, J Pedro Friedmann/0000-0001-7706-1379; Wurst, Wolfgang/0000-0003-4422-7410; Doll, Sebastian/0000-0002-8933-5362	Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-3, CO 291/5-1]; Human Frontier Science Programme (HFSP) [RGP13/2014]; Humboldt Research Fellowship; Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain" (SMHB); German Federal Ministry of Education and Research (BMBF) through the Integrated Network Alcoholism (Alcohol Addiction: systems-oriented approach), under e:Med Programme [01ZX1311G]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Human Frontier Science Programme (HFSP)(Human Frontier Science Program); Humboldt Research Fellowship(Alexander von Humboldt Foundation); Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain" (SMHB); German Federal Ministry of Education and Research (BMBF) through the Integrated Network Alcoholism (Alcohol Addiction: systems-oriented approach), under e:Med Programme(Federal Ministry of Education & Research (BMBF))	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Grants CO 291/2-3 and CO 291/5-1 (to M. C.), Human Frontier Science Programme (HFSP) Grant RGP13/2014 (to M. C. and F. U.), and by a Humboldt Research Fellowship (to J. P. F. A.). This work was also funded in part by the Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain" (SMHB) and by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network Alcoholism (Alcohol Addiction: systems-oriented approach), under the auspices of the e:Med Programme (Grant 01ZX1311G (to W. W.)).	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Brutsch SH, 2015, ANTIOXID REDOX SIGN, V22, P281, DOI 10.1089/ars.2014.5967; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Conrad M, 2007, BIOL CHEM, V388, P1019, DOI 10.1515/BC.2007.130; Conrad M, 2015, BBA-GEN SUBJECTS, V1850, P1566, DOI 10.1016/j.bbagen.2014.10.020; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Maiorino M, 2005, J BIOL CHEM, V280, P38395, DOI 10.1074/jbc.M505983200; Mannes AM, 2011, FASEB J, V25, P2135, DOI 10.1096/fj.10-177147; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; Puglisi R, 2007, ENDOCRINOLOGY, V148, P4302, DOI 10.1210/en.2007-0348; Puglisi R, 2012, J CELL PHYSIOL, V227, P1420, DOI 10.1002/jcp.22857; ROVERI A, 1994, METHOD ENZYMOL, V233, P202; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; SHALGI R, 1989, BIOL REPROD, V40, P1037, DOI 10.1095/biolreprod40.5.1037; Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284; Ueta T, 2012, J BIOL CHEM, V287, P7675, DOI 10.1074/jbc.M111.335174; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; WALLACE E, 1983, GAMETE RES, V7, P377, DOI 10.1002/mrd.1120070409; WALLACE E, 1983, GAMETE RES, V7, P389, DOI 10.1002/mrd.1120070410; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; WU SH, 1973, BIOL REPROD, V8, P625, DOI 10.1093/biolreprod/8.5.625; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	32	46	51	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14668	14678		10.1074/jbc.M115.656363	http://dx.doi.org/10.1074/jbc.M115.656363			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25922076	hybrid, Green Published			2022-12-26	WOS:000355754600037
J	Kang, M; He, JF; Song, T; Rutherford, S; Wu, J; Lin, JY; Huang, GF; Tan, XH; Zhong, HJ				Kang, Min; He, Jianfeng; Song, Tie; Rutherford, Shannon; Wu, Jie; Lin, Jinyan; Huang, Guofeng; Tan, Xiaohua; Zhong, Haojie			Environmental Sampling for Avian Influenza A( H7N9) in Live-Poultry Markets in Guangdong, China	PLOS ONE			English	Article							HUMAN INFECTIONS; VIRUS-INFECTION; HONG-KONG; RISK; SURVEILLANCE; CLOSURE; SPREAD	Background To provide an increased understanding of avian influenza A(H7N9) activity in live-poultry market in space and time and hence improve H7N9 epidemic control, an ongoing environmental sampling program in multiple live-poultry markets across Guangdong, China was conducted during March 2013-June 2014. Methods A total of 625 live-poultry markets throughout 21 prefecture areas took part in the study. A total of 10 environmental sites in markets for sampling were identified to represent 4 different poultry-related activity areas. At least 10 environmental samples were collected from each market every month. The real time RT-PCR was performed to detect the avian influenza A(H7N9) virus. Field survey was conducted to investigate the sanitation status of live-poultry markets. Results There were 109 human infections with H7N9 avian influenza in Guangdong, of which 37 (34%) died. A total of 18741 environmental swabs were collected and subjected to real-time RT-PCR test, of which 905(4.83%) were found positive for H7N9 virus. There were 201 (32.16%) markets affected by H7N9 in 16 prefecture areas. The detection of H7N9 virus in markets spiked in winter months. 63.33% markets (38/60) had no physical segregation for poultry holding, slaughter or sale zones. Closing live-poultry market significantly decreased the H7N9 detection rate from 14.83% (112/755) to 1.67% (5/300). Conclusions This study indicates the importance of live-poultry market surveillance based on environmental sampling for H7N9 Avian Influenza control. Improving live-poultry market management and sanitation and changing consumer practices are critical to reduce the risk of H7N9 infection.	[Kang, Min; He, Jianfeng; Song, Tie; Wu, Jie; Lin, Jinyan; Huang, Guofeng; Tan, Xiaohua; Zhong, Haojie] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Rutherford, Shannon] Griffith Univ, Ctr Environm & Populat Hlth, Sch Environm, Brisbane, Qld 4111, Australia	Griffith University	Zhong, HJ (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	gdhaojie@126.com			Science and Technology Program of Guangdong, China [2013B020307007]; Medical Scientific Research Foundation of Guangdong, China [C2014002]; Chinese Center for Disease Control and Prevention and Guangdong Provincial Health and Family Planning Commission	Science and Technology Program of Guangdong, China; Medical Scientific Research Foundation of Guangdong, China; Chinese Center for Disease Control and Prevention and Guangdong Provincial Health and Family Planning Commission	This study is supported by Chinese Center for Disease Control and Prevention and Guangdong Provincial Health and Family Planning Commission. This study was supported by grants from Science and Technology Program of Guangdong, China (No. 2013B020307007) and the Medical Scientific Research Foundation of Guangdong, China (No. C2014002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2013, EUROSURVEILLANCE, V18, P4, DOI 10.2807/1560-7917.ES2013.18.26.20510; [Anonymous], WHO REAL TIM RT PCR; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Chen E, 2013, EURO SURVEILL, V18; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Fang LQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02722; Fournie G, 2014, LANCET, V383, P496, DOI 10.1016/S0140-6736(13)62109-1; Fournie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037986; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Hong Kong Centre for Health Protection of the Department of Health, AV INFL REP; Horm SV, 2013, EMERG INFECT DIS, V19, P305, DOI 10.3201/eid1902.121201; Lau EHY, 2007, EMERG INFECT DIS, V13, P1340, DOI 10.3201/eid1309.061549; Leung YHC, 2007, EMERG INFECT DIS, V13, P1380, DOI 10.3201/eid1309.070517; Leung YHC, 2012, EMERG INFECT DIS, V18, P1339, DOI 10.3201/eid1808.111879; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Lu J, 2014, J VIROL, V88, P8297, DOI 10.1128/JVI.00630-14; Magalhaes RJS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049712; Martin V, 2011, PREV VET MED, V102, P196, DOI 10.1016/j.prevetmed.2011.07.007; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; National Health and Family Planning Commission of Guangdong Province, HUM INF AV INFL A H7; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yuan J, 2014, CLIN INFECT DIS; Zhang C, 2013, EURO SURVEILL, V18; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532	28	38	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126335	10.1371/journal.pone.0126335	http://dx.doi.org/10.1371/journal.pone.0126335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933138	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100152
J	Li, Y; Kang, GB; Duan, LJ; Lu, WX; Katze, MG; Lewis, MG; Haase, AT; Li, QS				Li, Yue; Kang, Guobin; Duan, Lijie; Lu, Wuxun; Katze, Michael G.; Lewis, Mark G.; Haase, Ashley T.; Li, Qingsheng			SIV Infection of Lung Macrophages	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; BRONCHOALVEOLAR LAVAGE; REPLICATION; PATHOGENESIS; HIV; TISSUES	HIV-1 depletes CD4+ T cells in the blood, lymphatic tissues, gut and lungs. Here we investigated the relationship between depletion and infection of CD4+ T cells in the lung parenchyma. The lungs of 38 Indian rhesus macaques in early to later stages of SIVmac251 infection were examined, and the numbers of CD4+ T cells and macrophages plus the frequency of SIV RNA+ cells were quantified. We showed that SIV infected macrophages in the lung parenchyma, but only in small numbers except in the setting of interstitial inflammation where large numbers of SIV RNA+ macrophages were detected. However, even in this setting, the number of macrophages was not decreased. By contrast, there were few infected CD4+ T cells in lung parenchyma, but CD4+ T cells were nonetheless depleted by unknown mechanisms. The CD4+ T cells in lung parenchyma were depleted even though they were not productively infected, whereas SIV can infect large numbers of macrophages in the setting of interstitial inflammation without depleting them. These observations point to the need for future investigations into mechanisms of CD4+ T cell depletion at this mucosal site, and into mechanisms by which macrophage populations are maintained despite high levels of infection. The large numbers of SIV RNA+ macrophages in lungs in the setting of interstitial inflammation indicates that lung macrophages can be an important source for SIV persistent infection.	[Li, Yue; Kang, Guobin; Lu, Wuxun; Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68588 USA; [Li, Yue] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Duan, Lijie; Haase, Ashley T.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Katze, Michael G.] Washington Natl Primate Res Ctr, Seattle, WA USA; [Katze, Michael G.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Lewis, Mark G.] BIOQUAL Inc, Rockville, MD USA	University of Nebraska System; University of Nebraska Lincoln; Nankai University; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; BIOQUAL Inc.	Li, QS (corresponding author), Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68588 USA.	qli@unl.edu			National Institutes of Health [DK087625]; Fogarty International Center grant at the University of Nebraska-Lincoln [D43 TW001429]; NIH (Washington National Primate Research Center Core Grant) [P51 OD010425]; FOGARTY INTERNATIONAL CENTER [D43TW001429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087625] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center grant at the University of Nebraska-Lincoln; NIH (Washington National Primate Research Center Core Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants DK087625 (to Q. Li). Y. Li was supported by the Fogarty International Center grant at the University of Nebraska-Lincoln (D43 TW001429). Funding for studies at the University of Washington was provided by NIH P51 OD010425 (Washington National Primate Research Center Core Grant) and the Simian Vaccine Evaluation Unit (Division of AIDS, NIH-NIAID). Dr. Mark Lewis played a role in the macaque design and data collection for publication through an NIH funding mechanism and a subcontract. BIOQUAL Inc. provided support in the form of salaries for author Dr. Mark Lewis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the author contributions' section.	Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P49, DOI 10.1038/mi.2007.5; Cai YH, 2014, J IMMUNOL, V192, P2821, DOI 10.4049/jimmunol.1302269; Cline AN, 2005, J MED PRIMATOL, V34, P303; Das S, 2003, SEX TRANSM INFECT, V79, P88, DOI 10.1136/sti.79.2.88; Fernandez E, 1996, Arch Bronconeumol, V32, P271; Fuller CL, 2002, AM J PATHOL, V161, P969, DOI 10.1016/S0002-9440(10)64257-5; HAASE AT, 1986, NATURE, V322, P130, DOI 10.1038/322130a0; HAASE AT, 1994, ANN NY ACAD SCI, V724, P75, DOI 10.1111/j.1749-6632.1994.tb38897.x; Jambo KC, 2011, THORAX, V66, P375, DOI 10.1136/thx.2010.153825; Knox KS, 2010, J VIROL, V84, P9010, DOI 10.1128/JVI.01138-10; Li QS, 2000, J INFECT DIS, V181, P867, DOI 10.1086/315304; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mankowski JL, 1998, AM J PATHOL, V153, P1123, DOI 10.1016/S0002-9440(10)65656-8; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wang LX, 2014, P NATL ACAD SCI USA, V111, P3146, DOI 10.1073/pnas.1318175111; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	20	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125500	10.1371/journal.pone.0125500	http://dx.doi.org/10.1371/journal.pone.0125500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933119	Green Published, gold			2022-12-26	WOS:000353887100116
J	Sankaranarayanan, S; Barten, DM; Vana, L; Devidze, N; Yang, L; Cadelina, G; Hoque, N; DeCarr, L; Keenan, S; Lin, A; Cao, Y; Snyder, B; Zhang, B; Nitla, M; Hirschfeld, G; Barrezueta, N; Polson, C; Wes, P; Rangan, VS; Cacace, A; Albright, CF; Meredith, J; Trojanowski, JQ; Lee, VMY; Brunden, KR; Ahlijanian, M				Sankaranarayanan, Sethu; Barten, Donna M.; Vana, Laurel; Devidze, Nino; Yang, Ling; Cadelina, Gregory; Hoque, Nina; DeCarr, Lynn; Keenan, Stefanie; Lin, Alan; Cao, Yang; Snyder, Bradley; Zhang, Bin; Nitla, Magdalena; Hirschfeld, Gregg; Barrezueta, Nestor; Polson, Craig; Wes, Paul; Rangan, Vangipuram S.; Cacace, Angela; Albright, Charles F.; Meredith, Jere, Jr.; Trojanowski, John Q.; Lee, Virginia M-Y.; Brunden, Kurt R.; Ahlijanian, Michael			Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models	PLOS ONE			English	Article							NEUROFIBRILLARY TANGLES; ALZHEIMER-DISEASE; CEREBROSPINAL-FLUID; EXTRACELLULAR TAU; SYNTHETIC TAU; PROTEIN; IMMUNOTHERAPY; TRANSMISSION; PROPAGATION; SPREAD	In Alzheimer's disease (AD), an extensive accumulation of extracellular amyloid plaques and intraneuronal tau tangles, along with neuronal loss, is evident in distinct brain regions. Staging of tau pathology by postmortem analysis of AD subjects suggests a sequence of initiation and subsequent spread of neurofibrillary tau tangles along defined brain anatomical pathways. Further, the severity of cognitive deficits correlates with the degree and extent of tau pathology. In this study, we demonstrate that phospho-tau (p-tau) antibodies, PHF6 and PHF13, can prevent the induction of tau pathology in primary neuron cultures. The impact of passive immunotherapy on the formation and spread of tau pathology, as well as functional deficits, was subsequently evaluated with these antibodies in two distinct transgenic mouse tauopathy models. The rTg4510 transgenic mouse is characterized by inducible over-expression of P301L mutant tau, and exhibits robust age-dependent brain tau pathology. Systemic treatment with PHF6 and PHF13 from 3 to 6 months of age led to a significant decline in brain and CSF p-tau levels. In a second model, injection of preformed tau fibrils (PFFs) comprised of recombinant tau protein encompassing the microtubule-repeat domains into the cortex and hippocampus of young P301S mutant tau over-expressing mice (PS19) led to robust tau pathology on the ipsilateral side with evidence of spread to distant sites, including the contralateral hippocampus and bilateral entorhinal cortex 4 weeks post-injection. Systemic treatment with PHF13 led to a significant decline in the spread of tau pathology in this model. The reduction in tau species after p-tau antibody treatment was associated with an improvement in novel-object recognition memory test in both models. These studies provide evidence supporting the use of tau immunotherapy as a potential treatment option for AD and other tauopathies.	[Sankaranarayanan, Sethu; Barten, Donna M.; Devidze, Nino; Yang, Ling; Cadelina, Gregory; Hoque, Nina; DeCarr, Lynn; Keenan, Stefanie; Lin, Alan; Cao, Yang; Snyder, Bradley; Hirschfeld, Gregg; Barrezueta, Nestor; Polson, Craig; Wes, Paul; Cacace, Angela; Albright, Charles F.; Meredith, Jere, Jr.; Ahlijanian, Michael] Bristol Myers Squibb, Res & Dev, Wallingford, CT 06492 USA; [Vana, Laurel; Zhang, Bin; Nitla, Magdalena; Trojanowski, John Q.; Lee, Virginia M-Y.; Brunden, Kurt R.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Rangan, Vangipuram S.] Bristol Myers Squibb, Res & Dev, Redwood City, CA USA	Bristol-Myers Squibb; University of Pennsylvania; Pennsylvania Medicine; Bristol-Myers Squibb	Sankaranarayanan, S (corresponding author), Bristol Myers Squibb, Res & Dev, Wallingford, CT 06492 USA.	sethus2008@gmail.com; kbrunden@upenn.edu; Michael.Ahlijanian@bms.com			Bristol-Myers Squibb; NIH grant [AG17586]; Marian S. Ware Alzheimer Program; CurePSP; Karen Cohen Segal and Christopher S. Segal Alzheimer Drug Discovery Initiative Fund; Paula C. Schmerler Fund for Alzheimer's Research; Barrist Neurodegenerative Disease Research Fund; Eleanor Margaret Kurtz Endowed Fund; Mary Rasmus Endowed Fund for Alzheimer's Research; Mrs. Gloria J. Miller and Arthur Peck, M.D.; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marian S. Ware Alzheimer Program; CurePSP; Karen Cohen Segal and Christopher S. Segal Alzheimer Drug Discovery Initiative Fund; Paula C. Schmerler Fund for Alzheimer's Research; Barrist Neurodegenerative Disease Research Fund; Eleanor Margaret Kurtz Endowed Fund; Mary Rasmus Endowed Fund for Alzheimer's Research; Mrs. Gloria J. Miller and Arthur Peck, M.D.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from Bristol-Myers Squibb, and in part by NIH grant AG17586 and the Marian S. Ware Alzheimer Program, CurePSP, the Karen Cohen Segal and Christopher S. Segal Alzheimer Drug Discovery Initiative Fund, the Paula C. Schmerler Fund for Alzheimer's Research, the Barrist Neurodegenerative Disease Research Fund, the Eleanor Margaret Kurtz Endowed Fund, the Mary Rasmus Endowed Fund for Alzheimer's Research, Mrs. Gloria J. Miller and Arthur Peck, M.D. The funder provided support in the form of salaries for authors [SS, DB, ND, LY, GC, NH, LD, SK, AL, YC, BS, GH, NB, CP, PW, VR, AC, CA, JM, MA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Bright J, 2015, NEUROBIOL AGING, V36, P693, DOI 10.1016/j.neurobiolaging.2014.09.007; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Congdon EE, 2014, J ALZHEIMERS DIS, V40, pS113, DOI 10.3233/JAD-132435; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2013, FEBS LETT, V587, P717, DOI 10.1016/j.febslet.2013.01.051; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hardy J, 2012, NEW ENGL J MED, V366, P2126, DOI 10.1056/NEJMcibr1202401; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; Meredith JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076523; Paxinos, 2012, MOUSE BRAIN STEREOTA; Peeraer E, 2015, NEUROBIOL DIS, V73, P83, DOI 10.1016/j.nbd.2014.08.032; Polydoro M, 2014, ACTA NEUROPATHOL, V127, P257, DOI 10.1007/s00401-013-1215-5; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Rosenmann H, 2008, EXP NEUROL, V212, P71, DOI 10.1016/j.expneurol.2008.03.007; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Witter MP, 2007, LEARN MEMORY, V14, P705, DOI 10.1101/lm.725207; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	52	99	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125614	10.1371/journal.pone.0125614	http://dx.doi.org/10.1371/journal.pone.0125614			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933020	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100122
J	Vitezova, A; Cartolano, NS; Heeringa, J; Zillikens, MC; Hofman, A; Franco, OH; Kiefte-de Jong, JC				Vitezova, Anna; Cartolano, Natasha S.; Heeringa, Jan; Zillikens, M. Carola; Hofman, Albert; Franco, Oscar H.; Kiefte-de Jong, Jessica C.			Vitamin D and the Risk of Atrial Fibrillation The Rotterdam Study	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; ANGIOTENSIN-II; D DEFICIENCY; PREVALENCE; POPULATION; EPIDEMIOLOGY; VALIDATION; GUIDELINES; MANAGEMENT; SUBSTRATE	Atrial fibrillation (AF) is the most common chronic arrhythmia and it increases the risk of cardiovascular morbidity and mortality. Still there is not a complete understanding of its etiology and underlying pathways. Vitamin D might regulate renin-angiotensin-aldosterone system and might be involved in inflammation, both implicated in the pathophysiology of AF. The objective of this work was to investigate the association between vitamin D status with the risk of AF in the elderly. This study was conducted within the Rotterdam Study, a community-based cohort of middle-aged and elderly participants in Rotterdam, The Netherlands. We had 3,395 participants who were free of AF diagnosis at the start of our study and who had vitamin D data available. We analyzed the association between serum 25-hydroxivitamin D (25(OH)D) and incidence of AF using Cox regression models. Vitamin D deficiency was defined as serum 25(OH)D concentrations <50nmol/l, insufficiency between 50nmol/l and 75nmol/l, while serum 25(OH)D concentrations equal to and above 75nmol/l were considered as adequate. After mean follow-up of 12.0 years 263 (7.7%) participants were diagnosed with incident AF. Vitamin D status was not associated with AF in any of the 3 multivariate models tested (model adjusted for socio-demographic factors and life-style factors: HR per 10 unit increment in serum 25(OH)D 0.96, 95% CI: 0.91-1.02; HR for insufficiency: 0.82, 95% CI: 0.60-1.11, and HR for adequate status: 0.76, 95% CI: 0.52-1.12 compared to deficiency). This prospective cohort study does not support the hypothesis that vitamin D status is associated with AF.	[Vitezova, Anna; Cartolano, Natasha S.; Heeringa, Jan; Hofman, Albert; Franco, Oscar H.; Kiefte-de Jong, Jessica C.] Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Zillikens, M. Carola] Erasmus MC, Univ Med Ctr, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Vitezova, A (corresponding author), Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.	a.vitezova@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Kiefte-de Jong, Jessica/GLV-3216-2022	Franco, Óscar H/0000-0002-4606-4929; Kiefte-de Jong, Jessica/0000-0002-8136-0918	Erasmus MC and Erasmus University, Rotterdam, the Netherlands; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA; DSM Nutritional Products AG, Kaiseraugst, Switzerland; Erasmus Mundus Western Balkans (ERAWEB) - European Commission	Erasmus MC and Erasmus University, Rotterdam, the Netherlands(Netherlands Government); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA; DSM Nutritional Products AG, Kaiseraugst, Switzerland; Erasmus Mundus Western Balkans (ERAWEB) - European Commission	The Rotterdam Study is funded by Erasmus MC and Erasmus University, Rotterdam, the Netherlands; the Netherlands Organization for Scientific Research (NWO); the Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. NSC, AV, JCK and OHF work in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; and AXA. DSM Nutritional Products AG, Kaiseraugst, Switzerland provided funding for the assessment of vitamin D. AV has been supported by the Erasmus Mundus Western Balkans (ERAWEB), project funded by the European Commission. NSC is a Brazilian government sponsored student on the program Brazil Science Without Borders. These funding sources had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review or approval of the manuscript.	Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Calvo MS, 2005, J NUTR, V135, P310, DOI 10.1093/jn/135.2.310; Canning MO, 2001, EUR J ENDOCRINOL, V145, P351, DOI 10.1530/eje.0.1450351; Cardin S, 2003, CARDIOVASC RES, V60, P315, DOI 10.1016/j.cardiores.2003.08.014; CASPERSEN CJ, 1991, AM J EPIDEMIOL, V133, P1078, DOI 10.1093/oxfordjournals.aje.a115821; Chen WR, 2013, ANN NONINVASIVE ELEC; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; CORLESS D, 1979, GERONTOLOGY, V25, P350, DOI 10.1159/000212364; Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Demir M, 2012, CLIN APPL THROMB HEM; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Friberg J, 2003, AM J CARDIOL, V92, P1419, DOI 10.1016/j.amjcard.2003.08.050; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gaborit N, 2010, J MOL CELL CARDIOL, V49, P639, DOI 10.1016/j.yjmcc.2010.06.005; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goette A, 2000, CIRCULATION, V101, P2678, DOI 10.1161/01.CIR.101.23.2678; Goette A, 2008, EUROPACE, V10, P238, DOI 10.1093/europace/eum283; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Halligan SC, 2004, ANN INTERN MED, V140, P265, DOI 10.7326/0003-4819-140-4-200402170-00008; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Heeringa J, 2008, AM HEART J, V156, P1163, DOI 10.1016/j.ahj.2008.08.003; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Klein I, 1998, ENDOCRIN METAB CLIN, V27, P51, DOI 10.1016/S0889-8529(05)70297-8; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; Kors JA, 1996, J ELECTROCARDIOL, V29, P83, DOI 10.1016/S0022-0736(96)80025-2; Koura T, 2002, CIRCULATION, V105, P2092, DOI 10.1161/01.CIR.0000015506.36371.0D; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Kunadian V, 2014, AM HEART J, V167, P283, DOI 10.1016/j.ahj.2013.11.012; Lappegard KT, 2013, SCAND J IMMUNOL, V78, P112, DOI 10.1111/sji.12061; Leening MJG, 2012, EUR J EPIDEMIOL, V27, P173, DOI 10.1007/s10654-012-9668-8; Lelorier P, 2004, AM J CARDIOL, V93, P647, DOI 10.1016/j.amjcard.2003.11.042; Li YC, 2003, J CELL BIOCHEM, V88, P327, DOI 10.1002/jcb.10343; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Manjunath G, 2001, CURR OPIN NEPHROL HY, V10, P785, DOI 10.1097/00041552-200111000-00009; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Nakashima H, 2000, CIRCULATION, V101, P2612, DOI 10.1161/01.CIR.101.22.2612; Nanchen D, 2013, CIRC-HEART FAIL, V6, P403, DOI 10.1161/CIRCHEARTFAILURE.112.000171; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451; Ott A, 1997, STROKE, V28, P316, DOI 10.1161/01.STR.28.2.316; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Qayyum F, 2012, DAN MED J, V59; Rienstra M, 2011, AM HEART J, V162, P538, DOI 10.1016/j.ahj.2011.06.013; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Vacek JL, 2012, AM J CARDIOL, V109, P359, DOI 10.1016/j.amjcard.2011.09.020; van Lee L, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-49; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Woods CE, 2014, CIRC RES, V114, P1532, DOI 10.1161/CIRCRESAHA.114.302362; YU W, 1994, P ROY SOC B-BIOL SCI, V255, P125, DOI 10.1098/rspb.1994.0018; Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101; Zoni-Berisso M, 2014, CLIN EPIDEMIOL, V6, P213, DOI 10.2147/CLEP.S47385	62	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125161	10.1371/journal.pone.0125161	http://dx.doi.org/10.1371/journal.pone.0125161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933375	gold, Green Submitted, Green Published			2022-12-26	WOS:000353887100083
J	Akagi, T; Kato, K; Kobayashi, M; Kosaka, N; Ochiya, T; Ichiki, T				Akagi, Takanori; Kato, Kei; Kobayashi, Masashi; Kosaka, Nobuyoshi; Ochiya, Takahiro; Ichiki, Takanori			On-Chip Immunoelectrophoresis of Extracellular Vesicles Released from Human Breast Cancer Cells	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; MEMBRANE-VESICLES; EXOSOMES; MICROVESICLES; MICROPARTICLES; BLOOD; DYSFUNCTION; ANTIBODIES; EXCHANGE; DELIVERY	Extracellular vesicles (EVs) including exosomes and microvesicles have attracted considerable attention in the fields of cell biology and medicine. For a better understanding of EVs and further exploration of their applications, the development of analytical methods for biological nanovesicles has been required. In particular, considering the heterogeneity of EVs, methods capable of measuring individual vesicles are desired. Here, we report that on-chip immunoelectrophoresis can provide a useful method for the differential protein expression profiling of individual EVs. Electrophoresis experiments were performed on EVs collected from the culture supernatant of MDA-MB-231 human breast cancer cells using a measurement platform comprising a microcapillary electrophoresis chip and a laser dark-field microimaging system. The zeta potential distribution of EVs that reacted with an anti-human CD63 (exosome and microvesicle marker) antibody showed a marked positive shift as compared with that for the normal immunoglobulin G (IgG) isotype control. Thus, on-chip immunoelectrophoresis could sensitively detect the over-expression of CD63 glycoproteins on EVs. Moreover, to explore the applicability of on-chip immunoelectrophoresis to cancer diagnosis, EVs collected from the blood of a mouse tumor model were analyzed by this method. By comparing the zeta potential distributions of EVs after their immunochemical reaction with normal IgG, and the anti-human CD63 and anti-human CD44 (cancer stem cell marker) antibodies, EVs of tumor origin circulating in blood were differentially detected in the real sample. The result indicates that the present method is potentially applicable to liquid biopsy, a promising approach to the low-invasive diagnosis of cancer.	[Akagi, Takanori; Kato, Kei; Kobayashi, Masashi; Ichiki, Takanori] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, Tokyo 104, Japan	University of Tokyo; National Cancer Center - Japan	Ichiki, T (corresponding author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 2-11-16 Yayoi, Tokyo, Japan.	ichiki@bioeng.t.tu-tokyo.ac.jp	Ichiki, Takanori/E-6430-2014; Shimogaki, Yukihiro/O-7414-2015; Ochiya, Takahiro/AAH-7585-2019	Ichiki, Takanori/0000-0002-3917-7140; 	Center of Innovation Program from Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Ministry of Education, Culture, Sports, Science and Technology, Japan [24710114]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the JST [AS2531063P]	Center of Innovation Program from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the JST	This research was supported by the Center of Innovation Program from Japan Science and Technology Agency (JST) and the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)." In addition, this work was supported by a Grant-in-Aid for Young Scientists (B) (24710114 to TA) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a grant from the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) (AS2531063P to TI) from the JST. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Akagi T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JL01; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Bartolini E, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20181; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Diehl P, 2011, J THROMB THROMBOLYS, V31, P173, DOI 10.1007/s11239-010-0507-z; Fanni D, 2013, RENAL FAILURE, V35, P967, DOI 10.3109/0886022X.2013.808955; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Hamada Y, 2007, J PHOTOPOLYM SCI TEC, V20, P245, DOI 10.2494/photopolymer.20.245; Ichiki T, 2002, ELECTROPHORESIS, V23, P2029, DOI 10.1002/1522-2683(200207)23:13<2029::AID-ELPS2029>3.0.CO;2-R; ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Kato K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.06GK10; Kato K, 2013, ELECTROPHORESIS, V34, P1212, DOI 10.1002/elps.201200549; Kim DK, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20384; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; METZELAAR MJ, 1991, VIRCHOWS ARCH B, V61, P269; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Momen-Heravi F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00162; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; van der Vos KE, 2011, CELL MOL NEUROBIOL, V31, P949, DOI 10.1007/s10571-011-9697-y; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Verderio C, 2013, FRONT PHYSIOL, P4; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yoshioka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4591; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595	47	48	50	8	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123603	10.1371/journal.pone.0123603	http://dx.doi.org/10.1371/journal.pone.0123603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928805	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100019
J	Bakhtavar, MA; Afzal, I; Basra, SMA; Ahmad, AU; Noor, MA				Bakhtavar, Muhammad Amir; Afzal, Irfan; Basra, Shahzad Maqsood Ahmed; Ahmad, Azraf-ul-Haq; Noor, Mehmood Ali			Physiological Strategies to Improve the Performance of Spring Maize (Zea mays L.) Planted under Early and Optimum Sowing Conditions	PLOS ONE			English	Article							LEAF EXTRACT; TOLERANCE; ANTIOXIDANT; EXPRESSION; STRESS; LEAVES; WHEAT; SEED	Low temperature at stand establishment and high temperature at reproductive stage are involved in reduction of grain yield of spring maize. A field study was therefore conducted to evaluate different physiological strategies for improving performance of spring maize under temperature extremes. Seed priming and foliar spray with 3% moringa leaf extract (MLE) and 100 mg L-1 kinetin solution alone or in all possible combinations with each other at three growth stages (knee height, tasseling and grain filling stage) and hydropriming was compared with control. Seed priming plus foliar spray of MLE and kinetin significantly improved stand establishment especially under early sown crop as indicated by reduced mean emergence time (MET), improved emergence index (EI) and final emergence percentage (FEP). Similarly increased chlorophyll contents, crop growth rate, leaf area index, photosynthetic rate, transpiration rate, relative water content and decreased membrane permeability were recorded in both early and optimum sowing conditions in MLE priming plus foliar spray treatment. All these improvements were harvested in the form of increased yield and harvest index compared with control treatment. Overall crop sown at optimum time performed best but exogenous application of MLE through seed priming and foliar spray maximally improved the performance of early sown maize crop which is attributed more likely due to improved stand establishment, chlorophyll and phenolic contents, increased leaf area duration and grain filling period. It can be concluded that seed priming with MLE along with its foliar spray could increase production of maize under temperature extremes.	[Bakhtavar, Muhammad Amir; Afzal, Irfan; Basra, Shahzad Maqsood Ahmed] Univ Agr Faisalabad, Dept Crop Physiol, Faisalabad 38040, Pakistan; [Ahmad, Azraf-ul-Haq; Noor, Mehmood Ali] Univ Agr Faisalabad, Dept Agron, Faisalabad 38040, Pakistan; [Noor, Mehmood Ali] King Saud Univ, Coll Food & Agr Sci, Dept Agr Extens & Rural Soc, Riyadh, Saudi Arabia	University of Agriculture Faisalabad; University of Agriculture Faisalabad; King Saud University	Afzal, I (corresponding author), Univ Agr Faisalabad, Dept Crop Physiol, Faisalabad 38040, Pakistan.	iafzal@uaf.edu.pk	Afzal, Irfan/AAE-9266-2020; afzal, irfan/D-1495-2019; Bakhtavar, Muhammad Amir/ABG-1421-2021; Noor, Mehmood Ali/J-7419-2016; Noor, Mehmood Ali/P-7792-2018; Ahmad Basra, Shahzad Maqsood/G-7213-2015	afzal, irfan/0000-0001-5942-7672; Noor, Mehmood Ali/0000-0003-2459-2357; Noor, Mehmood Ali/0000-0003-2459-2357; Bakhtavar, Muhammad Amir/0000-0001-5246-7663	Higher Education Commission Pakistan	Higher Education Commission Pakistan(Higher Education Commission of Pakistan)	Higher Education Commission Pakistan.	Afzal I, 2008, SEED SCI TECHNOL, V36, P497, DOI 10.15258/sst.2008.36.2.26; Afzal I, 2012, SEED SCI TECHNOL, V40, P271, DOI 10.15258/sst.2012.40.2.13; Ajouri A, 2004, J PLANT NUTR SOIL SC, V167, P630, DOI 10.1002/jpln.200420425; Anjorin TS, 2010, INT J AGRIC BIOL, V12, P431; [Anonymous], 2001, MIRACLE TREE MORINGA; AOAC, 1990, OFFICIAL METHODS ANA, P770; AOSA, 1983, CONTRIBUTION HDB SEE, V32; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Basra SMA, 2011, INT J AGRIC BIOL, V13, P1006; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; COHN MA, 1978, AM J BOT, V65, P50, DOI 10.2307/2442553; Dezfuli P. M., 2008, Journal of Agricultural and Biological Science, V3, P22; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; ELLIS RH, 1981, SEED SCI TECHNOL, V9, P373; FAO, 2010, TRENDS CROP SECT; Farooq M, 2008, J AGRON CROP SCI, V194, P161, DOI 10.1111/j.1439-037X.2008.00300.x; FOIDL N., 2001, MIRACLE TREE MULTIPL, P45; Ghassemi-Golezani K, 2008, J FOOD AGRIC ENVIRON, V6, P196; Hunt, 1978, STUDIES BIOL, V96, P8; Irfan Afzal, 2005, [Журнал стресс-физиологии и биохимии, Zhurnal stress-fiziologii i biokhimii], V1, P6; Kaya C, 2010, TURK J AGRIC FOR, V34, P529, DOI 10.3906/tar-0906-173; Khan W, 2003, J PLANT PHYSIOL, V160, P485, DOI 10.1078/0176-1617-00865; Muhamman MA, 2013, INT J CHEM ENV BIOL, V1, P2320; Parida AK, 2004, AQUAT BOT, V80, P77, DOI 10.1016/j.aquabot.2004.07.005; Randhir R, 2004, ASIA PAC J CLIN NUTR, V13, P295; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Rizzardi M. A., 1994, Ciencia Rural, V24, P477, DOI 10.1590/S0103-84781994000300005; STIRLING CM, 1991, PLANT CELL ENVIRON, V14, P947, DOI 10.1111/j.1365-3040.1991.tb00964.x; Truong Q, 2013, J EXP BOT, V1, P1; Wahid A, 2007, J PLANT PHYSIOL, V164, P283, DOI 10.1016/j.jplph.2006.01.005; Waterhouse A. L., 2002, CURRENT PROTOCOLS FO, P1, DOI DOI 10.1002/0471142913.FAA0101S06; Yasmeen A, 2012, CHIL J AGR RES, V72, P92, DOI 10.4067/S0718-58392012000100015	32	37	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124441	10.1371/journal.pone.0124441	http://dx.doi.org/10.1371/journal.pone.0124441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928295	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100033
J	Fauteux, L; Cottrell, MT; Kirchman, DL; Borrego, CM; Garcia-Chaves, MC; del Giorgio, PA				Fauteux, Lisa; Cottrell, Matthew T.; Kirchman, David L.; Borrego, Carles M.; Garcia-Chaves, Maria Carolina; del Giorgio, Paul A.			Patterns in Abundance, Cell Size and Pigment Content of Aerobic Anoxygenic Phototrophic Bacteria along Environmental Gradients in Northern Lakes	PLOS ONE			English	Article							PHOTOHETEROTROPHIC BACTERIA; PELAGIC BACTERIA; GROWTH-RATES; ARCTIC-OCEAN; DIVERSITY; BACTERIOCHLOROPHYLL; CARBON; SUMMER; WATERS; ATLANTIC	There is now evidence that aerobic anoxygenic phototrophic (AAP) bacteria are widespread across aquatic systems, yet the factors that determine their abundance and activity are still not well understood, particularly in freshwaters. Here we describe the patterns in AAP abundance, cell size and pigment content across wide environmental gradients in 43 temperate and boreal lakes of Quebec. AAP bacterial abundance varied from 1.51 to 5.49 x 10(5) cells mL(-1), representing <1 to 37% of total bacterial abundance. AAP bacteria were present year-round, including the ice-cover period, but their abundance relative to total bacterial abundance was significantly lower in winter than in summer (2.6% and 7.7%, respectively). AAP bacterial cells were on average two-fold larger than the average bacterial cell size, thus AAP cells made a greater relative contribution to biomass than to abundance. Bacteriochlorophyll a (BChla) concentration varied widely across lakes, and was not related to AAP bacterial abundance, suggesting a large intrinsic variability in the cellular pigment content. Absolute and relative AAP bacterial abundance increased with dissolved organic carbon (DOC), whereas cell-specific BChla content was negatively related to chlorophyll a (Chla). As a result, both the contribution of AAP bacteria to total prokaryotic abundance, and the cell-specific BChla pigment content were positively correlated with the DOC: Chla ratio, both peaking in highly colored, low-chlorophyll lakes. Our results suggest that photoheterotrophy might represent a significant ecological advantage in highly colored, low-chlorophyll lakes, where DOC pool is chemically and structurally more complex.	[Fauteux, Lisa; Garcia-Chaves, Maria Carolina; del Giorgio, Paul A.] Univ Quebec, Dept Sci Biol, Grp Rech Interuniv Limnol, Montreal, PQ H3C 3P8, Canada; [Cottrell, Matthew T.; Kirchman, David L.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Borrego, Carles M.] Univ Girona, Inst Aquat Ecol, Grp Mol Microbial Ecol, E-17071 Girona, Spain	University of Quebec; University of Quebec Montreal; University of Delaware; Universitat de Girona	del Giorgio, PA (corresponding author), Univ Quebec, Dept Sci Biol, Grp Rech Interuniv Limnol, CP 8888, Montreal, PQ H3C 3P8, Canada.	del_giorgio.paul@uqam.ca	Cottrell, Matthew/C-3266-2009; Borrego, Carles M/M-8094-2014; del Giorgio, Paul/AAD-1315-2019; Borrego, Carles/GYV-0941-2022	Borrego, Carles M/0000-0002-2708-3753; del Giorgio, Paul/0000-0003-1866-8159; GARCIA CHAVES, MARIA CAROLINA/0000-0002-7600-533X; Cottrell, Matthew/0000-0003-0449-9999	National Science and Engineering Research Council of Canada; US National Science Foundation [DEB-0814918]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF))	The research was supported by grants from the National Science and Engineering Research Council of Canada to Paul del Giorgio, and a US National Science Foundation grant DEB-0814918 to Matthew Cottrell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty JT, 2002, PHOTOSYNTH RES, V73, P109, DOI 10.1023/A:1020493518379; Benner R., 2003, AQUATIC ECOSYSTEMS I, P121, DOI DOI 10.1016/B978-012256371-3/50006-8; Bertilsson S, 1999, AQUAT MICROB ECOL, V19, P47, DOI 10.3354/ame019047; BORREGO CM, 1994, PHOTOSYNTH RES, V41, P157, DOI 10.1007/BF02184156; Carignan R, 2000, LIMNOL OCEANOGR, V45, P189, DOI 10.4319/lo.2000.45.1.0189; Celussi M, 2015, AQUAT MICROB ECOL, V74, P235, DOI 10.3354/ame01738; Cottrell MT, 2010, ISME J, V4, P945, DOI 10.1038/ismej.2010.13; Cottrell MT, 2009, APPL ENVIRON MICROB, V75, P4958, DOI 10.1128/AEM.00117-09; Cottrell MT, 2006, APPL ENVIRON MICROB, V72, P557, DOI 10.1128/AEM.72.1.557-564.2006; Cuperova Z, 2013, APPL ENVIRON MICROB, V79, P6439, DOI 10.1128/AEM.01526-13; Docherty KM, 2006, MICROB ECOL, V52, P378, DOI 10.1007/s00248-006-9089-x; Eiler A, 2009, APPL ENVIRON MICROB, V75, P7221, DOI 10.1128/AEM.00960-09; Farjalla VF, 2009, ENVIRON SCI POLLUT R, V16, P531, DOI 10.1007/s11356-009-0165-x; Ferrera I, 2013, ENVIRON MICROBIOL, P1; Ferrera I, 2011, APPL ENVIRON MICROB, V77, P7451, DOI 10.1128/AEM.00208-11; Goericke R, 2002, LIMNOL OCEANOGR, V47, P290, DOI 10.4319/lo.2002.47.1.0290; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Grimm B., 2006, CHLOROPHYLLS BACTERI; Guillemette F, 2013, J GEOPHYS RES-BIOGEO, V118, P963, DOI 10.1002/jgrg.20077; Hauruseu D, 2012, APPL ENVIRON MICROB, V78, P7414, DOI 10.1128/AEM.01747-12; Hojerova E, 2011, ENVIRON MICROBIOL, V13, P2717, DOI 10.1111/j.1462-2920.2011.02540.x; Hutalle-Schmelzer KML, 2010, FEMS MICROBIOL ECOL, V72, P58, DOI 10.1111/j.1574-6941.2009.00831.x; IDSO SB, 1973, LIMNOL OCEANOGR, V18, P681, DOI 10.4319/lo.1973.18.4.0681; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; Kirchman DL, 2014, AQUAT MICROB ECOL, V73, P41, DOI 10.3354/ame01709; Kirchman DL, 2013, ENV MICROBIOL REP, V5, P188, DOI 10.1111/j.1758-2229.2012.00367.x; Koblizek M, 2007, ENVIRON MICROBIOL, V9, P2401, DOI 10.1111/j.1462-2920.2007.01354.x; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Lami R, 2007, APPL ENVIRON MICROB, V73, P4198, DOI 10.1128/AEM.02652-06; Lamy D, 2011, BIOGEOSCIENCES, V8, P973, DOI 10.5194/bg-8-973-2011; Lehours AC, 2010, FEMS MICROBIOL ECOL, V74, P397, DOI 10.1111/j.1574-6941.2010.00954.x; Liu RL, 2010, AQUAT MICROB ECOL, V58, P303, DOI 10.3354/ame01371; Masin M, 2008, ENVIRON MICROBIOL, V10, P1988, DOI 10.1111/j.1462-2920.2008.01615.x; Masin M, 2006, AQUAT MICROB ECOL, V45, P247, DOI 10.3354/ame045247; Masin M, 2012, AQUAT MICROB ECOL, V66, P77, DOI 10.3354/ame01558; Medova H, 2011, FEMS MICROBIOL ECOL, V76, P393, DOI 10.1111/j.1574-6941.2011.01059.x; Nikrad MP, 2012, APPL ENVIRON MICROB, V78, P2402, DOI 10.1128/AEM.07130-11; Pace ML, 2002, LIMNOL OCEANOGR, V47, P333, DOI 10.4319/lo.2002.47.2.0333; Palovaara J, 2014, P NATL ACAD SCI USA, V111, pE3650, DOI 10.1073/pnas.1402617111; Ruiz-Gonzalez C., 2012, FEMS MICROBIOL ECOL, P1; Ruiz-Gonzalez C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00131; Salka I, 2014, GENOME ANNOUNC, V2, P1; Salka I, 2008, APPL ENVIRON MICROB, V74, P4398, DOI 10.1128/AEM.02447-07; Salka I, 2011, ENVIRON MICROBIOL, V13, P2865, DOI 10.1111/j.1462-2920.2011.02562.x; Sieracki ME, 2006, LIMNOL OCEANOGR, V51, P38, DOI 10.4319/lo.2006.51.1.0038; SIMEK K, 1992, APPL ENVIRON MICROB, V58, P3715; Stegman MR, 2014, ISME J, P1; Waidner LA, 2008, APPL ENVIRON MICROB, V74, P4012, DOI 10.1128/AEM.02324-07; Waidner LA, 2007, APPL ENVIRON MICROB, V73, P3936, DOI 10.1128/AEM.00592-07; Yurkov V, 2008, NEW LIGHT AEROBIC AN, P31; Yurkova N, 2002, FEMS MICROBIOL ECOL, V40, P191, DOI 10.1111/j.1574-6941.2002.tb00952.x; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x	53	28	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124035	10.1371/journal.pone.0124035	http://dx.doi.org/10.1371/journal.pone.0124035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927833	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100027
J	Ilangovan, K; Nagaraja, SB; Ananthakrishnan, R; Jacob, AG; Tripathy, JP; Tamang, D				Ilangovan, Kumaravel; Nagaraja, Sharath Burugina; Ananthakrishnan, Ramya; Jacob, Anil G.; Tripathy, Jaya Prasad; Tamang, Deepak			TB Treatment Delays in Odisha, India: Is It Expected Even after These Many Years of RNTCP Implementation?	PLOS ONE			English	Article							DIAGNOSIS	Background In India, the Revised National TB Control Programme (RNTCP) envisages initiation of TB treatment within seven days of diagnosis among smear-positive patients. After nearly two decades of RNTCP implementation, treatment delays are usually not expected. Objectives To determine the proportion of sputum smear-positive TB patients who were initiated on treatment after seven days and their associated risk factors. Methods The study was conducted in Cuttack and Rayagada districts of Odisha. It was a retrospective cohort study that involves review of TB treatment registers and laboratory registers for 2013. Results Among 1,800 pulmonary TB (PTB) patients, 1,074 (60%) had been initiated on treatment within seven days of diagnosis, 721 (40%) had been initiated on treatment more than seven days, and 354 (20%) had delays of more than 15 days. The mean duration between TB diagnosis and treatment initiation was 21 days with a range of 8-207 days (median = 14 days). Odds of treatment delay of more than seven days were 4.9 times (95% confidence interval [CI] 3.3-6.6) among those who had been previously treated, 6.2 times (95% CI 1.3-29.7) among those infected with HIV, and 1.8 times (95% CI 1.1-2.9) among those diagnosed outside district DMC. Conclusion Delay in initiation of TB treatment occurred in majority of the smear-positive patients. The RNTCP should focus on core areas of providing quality TB services with time-tested strategies. To have real-time monitoring mechanisms for diagnosed smear-positive TB patients is expected to be the way forward.	[Ilangovan, Kumaravel] Hlth Syst Res India Initiat, Thirvananthapuram, India; [Nagaraja, Sharath Burugina] ESIC Med Coll, Dept Community Med, Bangalore, Karnataka, India; [Nagaraja, Sharath Burugina] PGIMSR, Bangalore, Karnataka, India; [Ananthakrishnan, Ramya] Resource Grp Educ & Advocacy Community Hlth REACH, Madras, Tamil Nadu, India; [Jacob, Anil G.; Tamang, Deepak] Int Union TB & Lung Dis Union, South East Asia Off, New Delhi, India; [Tripathy, Jaya Prasad] PGIMER, Sch Publ Hlth, Dept Community Med, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Ilangovan, K (corresponding author), Hlth Syst Res India Initiat, Thirvananthapuram, India.	kumaravelilangovan@gmail.com	Nagaraja, Sharath Burugina/ABD-7238-2021; , Kumaravel/AAJ-6200-2020; Nagaraja, Sharath Burugina/ABD-7748-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; , Kumaravel/0000-0003-0111-511X; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Tripathy, Jaya Prasad/0000-0002-2626-5977	American People through the United States Agency for International Development (USAID)	American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). The contents of this paper do not necessarily reflect the views of USAID, the United States Government, or International Union Against Tuberculosis and Lung Disease (The Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishnu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055229; Central Tuberculosis Division, 2012, ANN REP REV NAT TUB; Central Tuberculosis Division, 2005, STRAT DOC SUP MON RE; Central Tuberculosis Division, 2010, ANN REP REV NAT TUB; Central Tuberculosis Division, 2011, ANN REP REV NAT TUB; Central Tuberculosis Division, 2013, ANN REP REV NAT TUB; Central Tuberculosis Division India, RNTCP ANN PERF REP 2; Central Tuberculosis Division India, DOTS IN IND; Central Tuberculosis Division. RNTCP, 2013, SOC ACT PLAN INCL TR, P41; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Ministry of Finance Government of India, 2013, COMP DEV IND STAT, P49; Office of the Register General & Census Commissioner India. Ministry of Home Affairs Government of Inida, CENS 2011 DAT; Organisation W. H., 2013, GLOB TUB REP 2013, P306; Pathak Garima, 2011, SOCIAL ASSESSMENT ST, P134; Paul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039040; Reach the Unreached|Central Tuberculosis Division, 2014, ANN REP REV NAT TUB, V2014, P204; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15	18	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125465	10.1371/journal.pone.0125465	http://dx.doi.org/10.1371/journal.pone.0125465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928294	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100093
J	Chen, PC; Lip, GYH; Yeh, G; Lin, HJ; Chien, KL				Chen, Pei-Chun; Lip, Gregory Y. H.; Yeh, Grace; Lin, Hung-Ju; Chien, Kuo-Liong			Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study	PLOS ONE			English	Article							NET CLINICAL BENEFIT; ESC WORKING GROUP; ISCHEMIC-STROKE; ANTITHROMBOTIC THERAPY; CHA(2)DS(2)-VASC SCORE; PREDICTING STROKE; PREVENT STROKE; WARFARIN; STRATIFICATION; CHADS(2)	Background Data on the use of oral anticoagulation (OAC) and antiplatelet therapy and the risk of bleeding and stroke amongst Asian patients with atrial fibrillation (AF) are limited. We investigated the risks of bleeding and stroke with use of oral anticoagulation (OAC) and antiplatelet therapy as mono-or combination therapy, in patients with AF from a Chinese nationwide cohort study. Methods We studied a cohort of 10384 patients (57.2% men, age 67.8 +/- 13.2 yrs) between 1999 and 2010 from the National Health Insurance Research Database in Taiwan. Records of prescriptions were obtained during follow-up. The main outcome was a recurrent stroke during the follow-up period. Time-dependent Cox proportional hazards models were used for this analysis. Results We documented 1009 events for bleeding, as well as 224 hemorrhagic stroke and 1642 ischemic stroke events during a median 3.2 (interquartile range, 1.05-6.54) years' follow-up. Compared with warfarin users, patients with antiplatelet therapy had a lower risk of bleeding (adjusted relative risk [RR], 0.59, 95% confidence interval [CI], 0.49-0.71, p<0.001) whilst combination therapy had a non-statistically significant higher bleeding risk (RR, 1.33, 95%, 0.91-1.94, p = 0.20). Patients on antiplatelet monotherapy had a similar risk for ischemic stroke compared with OAC (RR 1.05, 95% CI, 0.89-1.25, p = 0.50), whilst those on combination therapy had a significantly higher risk (RR 1.90, 95% CI, 1.34-2.70, p<0.001). Conclusion In a national representative cohort, antiplatelet therapy had no significant difference in ischemic stroke risk to warfarin. For bleeding, aspirin had a lower risk compared to warfarin. This may reflect poor anticoagulation control, highlighting important missed opportunities for improved stroke prevention, especially in countries where anticoagulation management is suboptimal.	[Chen, Pei-Chun] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Yeh, Grace] Natl Taiwan Univ, Hlth Data Res Ctr, Taipei 10764, Taiwan; [Lin, Hung-Ju; Chien, Kuo-Liong] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Lin, Hung-Ju; Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Chang Gung University; University of Birmingham; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chien, KL (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	klchien@ntu.edu.tw		Chen, Pei-Chun/0000-0002-8713-8816; CHIEN, KUO-LIONG/0000-0003-4979-8351	National Science Council, Taiwan [NSC 102-2314-B-002 -080 -MY2, NSC 102-2314-B-002 -075]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported from the National Science Council, Taiwan (NSC 102-2314-B-002 -080 -MY2 and NSC 102-2314-B-002 -075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2013, THROMB HAEMOSTASIS, V110, P1074, DOI 10.1160/TH13-07-0552; Camm AJ, 2012, EUR HEART J, V33; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Chien KL, 2010, STROKE, V41, P1858, DOI 10.1161/STROKEAHA.110.586222; Chien KL, 2010, INT J CARDIOL, V139, P173, DOI 10.1016/j.ijcard.2008.10.045; De Caterina R, 2012, J AM COLL CARDIOL, V59, P1413, DOI 10.1016/j.jacc.2012.02.008; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Friberg L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3522; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gallagher AM, 2011, THROMB HAEMOSTASIS, V106, P968, DOI 10.1160/TH11-05-0353; Gomes T, 2013, CAN MED ASSOC J, V185, pE121, DOI 10.1503/cmaj.121218; Guo YT, 2013, INT J CARDIOL, V168, P515, DOI 10.1016/j.ijcard.2012.09.187; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990; Lee CH, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.10.014; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Lip GYH, 2011, THROMB HAEMOSTASIS, V106, P997, DOI 10.1160/TH11-10-0690; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lip GY, 2012, BMJ OPEN, P2; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Ogawa S, 2013, J ARRYTHM, V29, P190, DOI 10.1016/j.joa.2013.03.002; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Potpara TS, 2011, CEREBROVASC DIS, V32, P461, DOI 10.1159/000332030; Rother J, 2010, CEREBROVASC DIS, V30, P314, DOI 10.1159/000319608; Roldan V, 2013, J AM COLL CARDIOL, V62, P2199, DOI 10.1016/j.jacc.2013.08.1623; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Tsai WC, 2013, INT J MED SCI, V10, P804, DOI 10.7150/ijms.5998; Wallentin L, 2011, THROMB HAEMOSTASIS, V105, P760, DOI 10.1160/TH11-03-0162; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185; Wong RSM, 2003, DRUG SAFETY, V26, P585, DOI 10.2165/00002018-200326080-00004	36	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125257	10.1371/journal.pone.0125257	http://dx.doi.org/10.1371/journal.pone.0125257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923742	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600139
J	Masek, M; Palata, V; Bray, TC; Bocak, L				Masek, Michal; Palata, Vaclav; Bray, Timothy C.; Bocak, Ladislav			Molecular Phylogeny Reveals High Diversity, Geographic Structure and Limited Ranges in Neotenic Net-Winged Beetles Platerodrilus (Coleoptera: Lycidae)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SEA-LEVEL; ASIA; CLASSIFICATION; EVOLUTION; INFERENCE; PROGRAM; LARVAE; MODEL	The neotenic Platerodrilus net-winged beetles have strongly modified development where females do not pupate and retain larval morphology when sexually mature. As a result, dispersal propensity of females is extremely low and the lineage can be used for reconstruction of ancient dispersal and vicariance patterns and identification of centres of diversity. We identified three deep lineages in Platerodrilus occurring predominantly in (1) Borneo and the Philippines, (2) continental Asia, and (3) Sumatra, the Malay Peninsula and Java. We document limited ranges of all species of Platerodrilus and complete species level turnover between the Sunda Islands and even between individual mountain regions in Sumatra. Few dispersal events were recovered among the major geographical regions despite long evolutionary history of occurrence; all of them were dated at the early phase of Platerodrilus diversification up to the end of Miocene and no exchange of island faunas was identified during the Pliocene and Pleistocene despite the frequently exposed Sunda Shelf as sea levels fluctuated with each glacial cycle. We observed high diversity in the regions with persisting humid tropical forests during cool periods. The origins of multiple species were inferred in Sumatra soon after the island emerged and the mountain range uplifted 15 million years ago with the speciation rate lower since then. We suppose that the extremely low dispersal propensity makes Platerodrilus a valuable indicator of uninterrupted persistence of rainforests over a long time span. Additionally, if the diversity of these neotenic lineages is to be protected, a high dense system of protected areas would be necessary.	[Masek, Michal; Palata, Vaclav; Bray, Timothy C.; Bocak, Ladislav] Palacky Univ, Fac Sci, Dept Zool, Olomouc 77146, Czech Republic	Palacky University Olomouc	Bocak, L (corresponding author), Palacky Univ, Fac Sci, Dept Zool, 17 Listopadu 50, Olomouc 77146, Czech Republic.	ladislav.bocak@upol.cz	Bocak, Ladislav/J-5989-2019		Grant Agency of the Czech Republic [P506/11/1757]; Palacky University [IGA_PrF_2014013]; grant POST-UP - European Science Foundation; Ministry of Education of the Czech Republic [CZ.1.07/2.3.00/30.0004]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Palacky University; grant POST-UP - European Science Foundation; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Funding: The study was funded by the Grant Agency of the Czech Republic (P506/11/1757). MM and VP were additionally supported by the Internal Grant of the Palacky University (IGA_PrF_2014013) and TB was supported by the grant POST-UP funded by the European Science Foundation and the Ministry of Education of the Czech Republic (CZ.1.07/2.3.00/30.0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; Bocak L, 2008, P ROY SOC B-BIOL SCI, V275, P2015, DOI 10.1098/rspb.2008.0476; Bocak L, 2008, ANN ZOOL, V58, P695, DOI 10.3161/000345408X396639; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gathorne-Hardy FJ, 2002, BIOL J LINN SOC, V75, P453, DOI 10.1046/j.1095-8312.2002.00031.x; Gould S. J., 1977, ONTOGENY PHYLOGENY; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kazantsev Sergey V., 2009, Russian Entomological Journal, V18, P55; Levkanicova Z, 2009, SYST ENTOMOL, V34, P210, DOI 10.1111/j.1365-3113.2008.00457.x; Malohlava V, 2010, MOL ECOL, V19, P4800, DOI 10.1111/j.1365-294X.2010.04850.x; Masek M, 2014, RAFFLES B ZOOL, V62, P136; Masek M, 2014, ZOOKEYS, P29, DOI 10.3897/zookeys.426.7398; Mjoberg E., 1925, Psyche Boston, V32, P119, DOI 10.1155/1925/19784; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2014, TRACER V1 6; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sklenarova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067957; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wong ATC, 1996, RAFFLES B ZOOL, V44, P173; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3; Yu Y., 2012, RASP RECONSTRUCT ANC; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	31	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123855	10.1371/journal.pone.0123855	http://dx.doi.org/10.1371/journal.pone.0123855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919357	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400037
J	Richards, P; Pellegrina, H; VanWey, L; Spera, S				Richards, Peter; Pellegrina, Heitor; VanWey, Leah; Spera, Stephanie			Soybean Development: The Impact of a Decade of Agricultural Change on Urban and Economic Growth in Mato Grosso, Brazil	PLOS ONE			English	Article							DEFORESTATION; EXPANSION	In this research we consider the impact of export-driven, soybean agriculture in Mato Grosso on regional economic growth. Here we argue that the soybean sector has served as a motor to the state's economy by increasing the demand for services, housing, and goods, and by providing a source of investment capital to the non-agricultural sector. Specifically, we show that each square kilometer of soybean production supports 2.5 formal sector jobs outside of agriculture, and the equivalent of approximately 150,000US in annual, non-agricultural GDP. We also show that annual gains in non-agricultural employment and GDP are closely tied to soybean profitability, and thus vary from year to year. However, while this article highlights the potential of the agricultural sector as a driver of regional economic growth, it also acknowledges that this growth has been sustained by profits determined by externally set prices and the rate of exchange, and that future growth trajectories will be susceptible to potential currency of market shocks. We also show that while Mato Grosso's economic growth has come at a significant cost to the environment, value added by the agriculture sector, directly and indirectly, has surpassed the value of the CO2-e emitted through land clearings.	[Richards, Peter] Brown Univ, Inst Study Environm & Soc, Populat Studies & Training Ctr, Providence, RI 02912 USA; [Pellegrina, Heitor] Brown Univ, Inst Study Environm & Soc, Dept Econ, Providence, RI 02912 USA; [VanWey, Leah] Brown Univ, Inst Study Environm & Soc, Populat Studies & Training Ctr, Dept Sociol, Providence, RI 02912 USA; [Spera, Stephanie] Brown Univ, Inst Study Environm & Soc, Dept Geol Sci, Providence, RI 02912 USA	Brown University; Brown University; Brown University; Brown University	Richards, P (corresponding author), Brown Univ, Inst Study Environm & Soc, Populat Studies & Training Ctr, Providence, RI 02912 USA.	peter_richards@brown.edu	VanWey, Leah/A-2908-2013	Spera, Stephanie/0000-0002-8681-7315	National Science Foundation [SMA-1305489]; National Aeronautics and Space Administration [NNX11AH91G]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007338] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: National Science Foundation Grant #SMA-1305489 financed the salary of the lead author. National Aeronautics and Space Administration Grant # NNX11AH91G contributed to the land use classifications, and financed a portion of the second and fourth authors' salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral S, 2006, INT J REMOTE SENS, V27, P855, DOI 10.1080/01431160500181861; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Arima EY, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024010; Assuncao J.A., 2012, CLIMATE POLICY INITI, V01, P03, DOI DOI 10.1017/S1355770X15000078; Awokuse TO, 2014, CANADIAN J AGR EC; Brannstrom C, 2012, LAND USE POLICY, V29, P357, DOI 10.1016/j.landusepol.2011.07.006; Brazilian Institute of Geography and Statistics (IBGE), 2010, RES POP SEX HOUS SIT; Christiaensen L, 2011, J DEV ECON, V96, P239, DOI 10.1016/j.jdeveco.2010.10.006; Cohn AS, 2014, P NATL ACAD SCI USA, V07, P163; CONAB Companhia Nacional de Abastecimento, 2014, CONAB HIST TIM SER; Dercon S, 2014, ANNU REV RESOUR ECON, V6, P471, DOI 10.1146/annurev-resource-100913-012706; Foster AD, 2004, ECON DEV CULT CHANGE, V52, P509, DOI 10.1086/420968; Galford GL, 2011, ECOL APPL, V21, P750, DOI 10.1890/09-1957.1; Gardner BL, 2000, AM J AGR ECON, V82, P1059, DOI 10.1111/0002-9092.00104; Garrett RD, 2013, LAND USE POLICY, V31, P385, DOI 10.1016/j.landusepol.2012.08.002; Gemmell N, 2000, J AGR ECON, V51, P353, DOI 10.1111/j.1477-9552.2000.tb01236.x; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Henderson JV, 2012, AM ECON REV, V102, P994, DOI 10.1257/aer.102.2.994; IBGE, 2000, RES POP SEX HOUS SIT; IBGE, 2014, PROD AG MUN 1990 201, DOI [10.1016/S0176-1617(85)80065-1, DOI 10.1016/S0176-1617(85)80065-1]; IBGE Instituto Brasileiro de Geografia e Estatistica, 2014, TAB 21 PROD INT BRUT; IMEA Instituto Mato-grossense de Economia Agropecuaria, 2012, SOYB PRIC; JOHNSTON BF, 1961, AM ECON REV, V51, P566; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Lewis, 1954, MANCHESTER SCH EC SO, V22, P139, DOI [DOI 10.1111/J.1467-9957.1954.TB00021.X, 10.1111/j.1467-9957.1954.tb00021.x]; Macedo M, 2012, P NATL ACAD SCI US; May P.H., 2013, MUCH IS AMAZON WORTH; McDonald RI, 2011, P NATL ACAD SCI USA, V108, P6312, DOI 10.1073/pnas.1011615108; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; NOAA, 2013, VERS 4 DMSP OLS NIGH; PNUD, 2013, RANK IDH MUN BRAS 20; RAIS, 2014, REL AN INF SOC RAIS; Richards P, ANN ASS AM IN PRESS; Richards PD, 2014, GLOBAL ENVIRON CHANG, V29, P1, DOI 10.1016/j.gloenvcha.2014.06.011; Richards PD, 2012, GLOBAL ENVIRON CHANG, V22, P454, DOI 10.1016/j.gloenvcha.2012.01.004; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Spera SA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064010; Tiffen M, 2003, WORLD DEV, V31, P1343, DOI 10.1016/S0305-750X(03)00088-3; Tiffin R, 2006, AGR ECON-BLACKWELL, V35, P79, DOI 10.1111/j.1574-0862.2006.00141.x; VanWey LK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0168; Weinhold D, 2013, WORLD DEV, V52, P132, DOI 10.1016/j.worlddev.2012.11.016	43	46	46	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122510	10.1371/journal.pone.0122510	http://dx.doi.org/10.1371/journal.pone.0122510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SE	25919305	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400014
J	Pan, CC; Kumar, S; Shah, N; Bloodworth, JC; Hawinkels, LJAC; Mythreye, K; Hoyt, DG; Lee, NY				Pan, Christopher C.; Kumar, Sanjay; Shah, Nirav; Bloodworth, Jeffrey C.; Hawinkels, Lukas J. A. C.; Mythreye, Karthikeyan; Hoyt, Dale G.; Lee, Nam Y.			Endoglin Regulation of Smad2 Function Mediates Beclin1 Expression and Endothelial Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CELL PROLIFERATION; RECEPTOR; PROTEIN; ALK1; ANGIOGENESIS; ACTIVATION; APOPTOSIS; RESPONSES; PATHWAYS	Autophagy is the targeted degradation of proteins and organelles critical for homeostasis and cell survival. Transforming growth factor beta (TGF-beta) differentially regulates autophagy in a context-specific manner, although the precise intracellular mechanisms remain less clear. Importantly, how TGF-beta controls autophagic responses in endothelial cells (EC) during angiogenesis is unknown. Here we identified endoglin, an EC-specific TGF-beta co-receptor essential for angiogenesis, as a key determinant of autophagy. Among the two opposing TGF-beta Smad pathways in the EC system (Smad1/5/8 and Smad2/3), we found Smad2 as the major transcriptional regulator of autophagy that targets beclin1 (BECN1) gene expression. Smad2, but not Smad3, acts as a repressor upstream of the BECN1 promoter region. Overall, endoglin promotes autophagy by impeding Smad2 transcriptional repressor activity. Notably, increased beclin1 levels upon Smad2 knockdown directly correlated with enhanced autophagy during angiogenesis. Taken together, these results establish endoglin as a critical mediator of autophagy and demonstrate a new transcriptional mechanism by which Smad2 inhibits angiogenesis.	[Pan, Christopher C.; Kumar, Sanjay; Shah, Nirav; Hoyt, Dale G.; Lee, Nam Y.] Ohio State Univ, Div Pharmacol, Coll Pharm, Columbus, OH 43210 USA; [Lee, Nam Y.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Lee, Nam Y.] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Hawinkels, Lukas J. A. C.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [Bloodworth, Jeffrey C.] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Mythreye, Karthikeyan] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Loyola University Chicago; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Lee, NY (corresponding author), Ohio State Univ, Div Pharmacol, Coll Pharm, 500 West 12th Ave, Columbus, OH 43210 USA.	lee.5064@osu.edu	Hawinkels, Lukas/Q-5098-2019; Regan, Clinton/E-6250-2012; Karthikeyan, Mythreye/ABC-7345-2020; Lee, Nam/H-3073-2016	Hawinkels, Lukas/0000-0002-2274-9325; Karthikeyan, Mythreye/0000-0001-5478-0098; 	National Institutes of Health [CA178443]; Dutch Cancer Society/Alp d'huZes-Bas Mulder Award [UL2011-5051]; NATIONAL CANCER INSTITUTE [R01CA178443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society/Alp d'huZes-Bas Mulder Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant CA178443 (awarded to N. Y. L.), and the Dutch Cancer Society/Alp d'huZes-Bas Mulder Award (UL2011-5051) (to L. H.).	Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bohensky J, 2007, AUTOPHAGY, V3, P207, DOI 10.4161/auto.3708; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Chen G, 2013, CARDIOVASC RES, V98, P437, DOI 10.1093/cvr/cvt035; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Du JH, 2012, AM J PHYSIOL-CELL PH, V302, pC383, DOI 10.1152/ajpcell.00164.2011; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang D, 2009, J MOL CELL CARDIOL, V46, P25, DOI 10.1016/j.yjmcc.2008.10.019; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kumar S, 2014, ONCOGENE, V33, P3970, DOI 10.1038/onc.2013.386; Kumar S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.399; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lien SC, 2013, BBA-MOL CELL RES, V1833, P3124, DOI 10.1016/j.bbamcr.2013.08.023; Ota T, 2002, J CELL PHYSIOL, V193, P299, DOI 10.1002/jcp.10170; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Suzuki HI, 2010, AUTOPHAGY, V6, P645, DOI 10.4161/auto.6.5.12046; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	35	21	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14884	14892		10.1074/jbc.M114.630178	http://dx.doi.org/10.1074/jbc.M114.630178			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25931117	hybrid, Green Published			2022-12-26	WOS:000356177300008
J	Audusseau, H; Kolb, G; Janz, N				Audusseau, Helene; Kolb, Gundula; Janz, Niklas			Plant Fertilization Interacts with Life History: Variation in Stoichiometry and Performance in Nettle-Feeding Butterflies	PLOS ONE			English	Article							GROWTH-RATE; BIOLOGICAL STOICHIOMETRY; TRADE-OFFS; NITROGEN; PHOSPHORUS; SPECIALIZATION; LIMITATION; EVOLUTION; PREFERENCE; EFFICIENCY	Variation in food stoichiometry affects individual performance and population dynamics, but it is also likely that species with different life histories should differ in their sensitivity to food stoichiometry. To address this question, we investigated the ability of the three nettle-feeding butterflies (Aglais urticae, Polygonia c-album, and Aglais io) to respond adaptively to induced variation in plant stoichiometry in terms of larval performance. We hypothesized that variation in larval performance between plant fertilization treatments should be functionally linked to species differences in host plant specificity. We found species-specific differences in larval performance between plant fertilization treatments that could not be explained by nutrient limitation. We showed a clear evidence of a positive correlation between food stoichiometry and development time to pupal stage and pupal mass in Aglais urticae. The other two species showed a more complex response. Our results partly supported our prediction that host plant specificity affects larval sensitivity to food stoichiometry. However, we suggest that most of the differences observed may instead be explained by differences in voltinism (number of generations per year). We believe that the potential of some species to respond adaptively to variation in plant nutrient content needs further attention in the face of increased eutrophication due to nutrient leakage from human activities.	[Audusseau, Helene; Janz, Niklas] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Kolb, Gundula] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Audusseau, H (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	helene.audusseau@zoologi.su.se	Audusseau, Hélène/ABF-9178-2020; Janz, Niklas/B-1756-2010	Audusseau, Hélène/0000-0003-0312-4343; Janz, Niklas/0000-0002-6379-7905	Strategic Research Program Ekoklim at Stockholm University	Strategic Research Program Ekoklim at Stockholm University	Funding for this study was provided by the Strategic Research Program Ekoklim at Stockholm University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P500, DOI 10.1890/0012-9658(2000)081[0500:HREAAT]2.0.CO;2; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Apple JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007807; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Audusseau H, 2013, ECOL EVOL, V3, P3021, DOI 10.1002/ece3.696; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertram SM, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2601; Betzholtz Per-Eric, 2013, Proc Biol Sci, V280, P20122305, DOI 10.1098/rspb.2012.2305; Bishop JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013598; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Carrillo P, 2001, J PLANKTON RES, V23, P537, DOI 10.1093/plankt/23.5.537; Clesceri LS., 1998, TOTAL SUSPENDED SOLI; Crawley MJ, 2009, R BOOK, P569; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 2000, J EVOLUTION BIOL, V13, P845; Ergon T, 2001, NATURE, V411, P1043, DOI 10.1038/35082553; Faerovig PJ, 2003, FRESHWATER BIOL, V48, P1782, DOI 10.1046/j.1365-2427.2003.01128.x; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Feest A, 2014, ECOL INDIC, V39, P115, DOI 10.1016/j.ecolind.2013.12.008; Fischer K, 2000, OECOLOGIA, V124, P235, DOI 10.1007/s004420000365; Forister ML, 2007, J EVOLUTION BIOL, V20, P985, DOI 10.1111/j.1420-9101.2007.01310.x; FOX CW, 1994, OECOLOGIA, V97, P382, DOI 10.1007/BF00317329; Friberg M, 2009, OECOLOGIA, V159, P127, DOI 10.1007/s00442-008-1206-8; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; FUTUYMA DJ, 1981, ENTOMOL EXP APPL, V30, P106, DOI 10.1007/BF00300873; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janz N, 1997, P ROY SOC B-BIOL SCI, V264, P701, DOI 10.1098/rspb.1997.0100; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; Joern A, 1997, OECOLOGIA, V112, P201, DOI 10.1007/s004420050301; KARLSSON B, 1989, FUNCT ECOL, V3, P399, DOI 10.2307/2389613; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NYLIN S, 1988, OIKOS, V53, P381, DOI 10.2307/3565539; Pollard E, 1997, ECOL ENTOMOL, V22, P315, DOI 10.1046/j.1365-2311.1997.00064.x; Pullin AS, 1987, AGLAIS URTICAE OIKOS, P39, DOI [10.2307/3565552, DOI 10.2307/3565552]; R Core Team, 2021, R LANGUAGE ENV STAT; Sadeghi H, 1999, OECOLOGIA, V118, P405, DOI 10.1007/s004420050742; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Schoonhoven L. M., 2005, Insect-plant biology; Scriber J.M., 1992, P429; Singer MS, 2001, OIKOS, V93, P194, DOI 10.1034/j.1600-0706.2001.930203.x; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; SUTCLIFFE WH, 1970, J FISH RES BOARD CAN, V27, P606, DOI 10.1139/f70-065; Taylor K, 2009, J ECOL, V97, P1436, DOI 10.1111/j.1365-2745.2009.01575.x; Thompson JN, 1994, THE COEVOLUTIONARY P; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Wahlberg N, 2003, CLADISTICS, V19, P213, DOI [10.1016/S0748-3007(03)00027-6, 10.1111/j.1096-0031.2003.tb00364.x]; Watts T, 2006, J INSECT PHYSIOL, V52, P187, DOI 10.1016/j.jinsphys.2005.09.012	53	11	11	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124616	10.1371/journal.pone.0124616	http://dx.doi.org/10.1371/journal.pone.0124616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932628	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100050
J	Greaves, LM; Milojev, P; Huang, YS; Stronge, S; Osborne, D; Bulbulia, J; Grimshaw, M; Sibley, CG				Greaves, Lara M.; Milojev, Petar; Huang, Yanshu; Stronge, Samantha; Osborne, Danny; Bulbulia, Joseph; Grimshaw, Michael; Sibley, Chris G.			Regional Differences in the Psychological Recovery of Christchurch Residents Following the 2010/2011 Earthquakes: A Longitudinal Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC STRESS SYMPTOMS; NATURAL DISASTER; MENTAL-HEALTH; SURVIVORS; DISORDER; IMPACTS	We examined changes in psychological distress experienced by residents of Christchurch following two catastrophic earthquakes in late 2010 and early 2011, using data from the New Zealand Attitudes and Values Study (NZAVS), a national probability panel study of New Zealand adults. Analyses focused on the 267 participants (172 women, 95 men) who were living in central Christchurch in 2009 (i.e., before the Christchurch earthquakes), and who also provided complete responses to our yearly panel questionnaire conducted in late 2010 (largely between the two major earthquakes), late 2011, and late 2012. Levels of psychological distress were similar across the different regions of central Christchurch immediately following the September 2010 earthquake, and remained comparable across regions in 2011. By late 2012, however, average levels of psychological distress in the regions had diverged as a function of the amount of property damage experienced within each given region. Specifically, participants in the least damaged region (i.e., the Fendalton-Waimairi and Riccarton-Wigram wards) experienced greater drops in psychological distress than did those in the moderately damaged region (i.e., across the Spreydon-Heathcote and Hagley-Ferrymead wards). However, the level of psychological distress reported by participants in the most damaged region (i.e., across Shirley-Papanui and Burwood-Pegasus) were not significantly different to those in the least damaged region of central Christchurch. These findings suggest that different patterns of psychological recovery emerged across the different regions of Christchurch, with the moderately damaged region faring the worst, but only after the initial shock of the destruction had passed.	[Greaves, Lara M.; Milojev, Petar; Huang, Yanshu; Stronge, Samantha; Osborne, Danny; Sibley, Chris G.] Univ Auckland, Auckland 1, New Zealand; [Bulbulia, Joseph] Victoria Univ Wellington, Wellington, New Zealand; [Grimshaw, Michael] Univ Canterbury, Christchurch 1, New Zealand	University of Auckland; Victoria University Wellington; University of Canterbury	Greaves, LM (corresponding author), Univ Auckland, Auckland 1, New Zealand.	lara.greaves@auckland.ac.nz	Sibley, Chris G/D-2974-2009; Stronge, Samantha/AAK-9955-2020	Sibley, Chris G/0000-0002-4064-8800; Huang, Yanshu/0000-0003-2120-6609; Osborne, Danny/0000-0002-8513-4125; Greaves, Lara/0000-0003-0537-7125; Bulbulia, Joseph/0000-0002-5861-2056	Templeton World Charity Foundation Grant [0077]	Templeton World Charity Foundation Grant(Templeton World Charity Foundation)	This research was supported by a Templeton World Charity Foundation Grant (ID: 0077)	Altindag A, 2005, COMPR PSYCHIAT, V46, P328, DOI 10.1016/j.comppsych.2005.01.005; Bannister S, 2012, NEW ZEAL J GEOL GEOP, V55, P295, DOI 10.1080/00288306.2012.680475; Chou FHC, 2004, QUAL LIFE RES, V13, P1089, DOI 10.1023/B:QURE.0000031337.73269.64; Dorahy MJ, 2012, J LOSS TRAUMA, V17, P203, DOI 10.1080/15325024.2011.616737; Duncan E, 2013, J TRAUMA DISSOCIATIO, V14, P501, DOI 10.1080/15299732.2013.769479; Earthquake Commission, CANT EARTHQ 2010 201; Gawith E, 2013, DISASTER PREV MANAG, V22, P395, DOI 10.1108/DPM-10-2013-0180; Gawith L, 2011, NEW ZEAL J PSYCHOL, V40, P121; Gluckman P., 2011, PSYCHOSOCIAL CONSEQU; Helton WS, 2011, CONSCIOUS COGN, V20, P1732, DOI 10.1016/j.concog.2011.02.011; Kaiser A, 2011, ROUT STUD ARCHAEOL, P67; Kemp S., 2011, AUSTRALAS J DISASTER, V2, P11; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Krynen A., 2013, NZ J PSYCHOL, V42, P69; Kuijer RG, 2012, PSYCHOL TRAUMA-US, P361; Lewin TJ, 1998, AUST NZ J PSYCHIAT, V32, P15, DOI 10.1046/j.1440-1614.1998.00380.x; McColl GJ, 2012, DISASTER MED PUBLIC, V6, P33, DOI 10.1001/dmp.2012.8; MCFARLANE AC, 1992, J NERV MENT DIS, V180, P498, DOI 10.1097/00005053-199208000-00004; MCFARLANE AC, 1988, BRIT J PSYCHIAT, V152, P116, DOI 10.1192/bjp.152.1.116; MCFARLANE AC, 1987, J AM ACAD CHILD PSY, V26, P764, DOI 10.1097/00004583-198709000-00025; Mental Health Commission, 2012, NAT IND 2012 MEAS ME; Milojev P, 2014, SOC PSYCHOL PERS SCI, V5, P760, DOI 10.1177/1948550614528545; NIWA, FLOOD MOD HEATHC RIV; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Osborne D, 2013, DISASTER PREV MANAG, V22, P456, DOI 10.1108/DPM-09-2013-0161; Rogers N, 2014, EARTHQ SPECTRA, V30, P493, DOI 10.1193/021513EQS029M; Rowney C, 2010, NZJ PSYCHOL IN PRESS; Satherley N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121950; Sibley CG, NZAVS TECHNICAL DO E; Stevenson JR, 2011, BULL N Z SOC EARTHQ, V44, P65, DOI 10.5459/bnzsee.44.2.65-76; Wang XD, 2000, PSYCHIAT CLIN NEUROS, V54, P427, DOI 10.1046/j.1440-1819.2000.00732.x; Wu HC, 2006, AUST NZ J PSYCHIAT, V40, P355, DOI 10.1111/j.1440-1614.2006.01802.x; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124278	10.1371/journal.pone.0124278	http://dx.doi.org/10.1371/journal.pone.0124278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25932919	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100037
J	Liu, RP; Zhang, LY; Yang, J; Zhang, XX; Mikkelsen, R; Song, SY; Zhou, HP				Liu, Runping; Zhang, Luyong; Yang, Jing; Zhang, Xiaoxuan; Mikkelsen, Ross; Song, Shiyu; Zhou, Huiping			HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress	PLOS ONE			English	Article							DISRUPT BARRIER INTEGRITY; GROWTH ARREST; ER STRESS; SIGNALING PATHWAYS; LIPID-METABOLISM; MYELOMA CELLS; CANCER-CELL; IN-VITRO; NELFINAVIR; APOPTOSIS	Background Human head and neck squamous cell carcinoma (HNSCC) is the sixth most malignant cancer worldwide. Despite significant advances in the delivery of treatment and surgical reconstruction, there is no significant improvement of mortality rates for this disease in the past decades. Radiotherapy is the core component of the clinical combinational therapies for HNSCC. However, the tumor cells have a tendency to develop radiation resistance, which is a major barrier to effective treatment. HIV protease inhibitors (HIV PIs) have been reported with radiosensitizing activities in HNSCC cells, but the underlying cellular/molecular mechanisms remain unclear. Our previous study has shown that HIV PIs induce cell apoptosis via activation of endoplasmic reticulum (ER) stress. The aim of this study was to examine the role of ER stress in HIV PI-induced radiosensitivity in human HNSCC. Methodology and Principal Findings HNSCC cell lines, SQ20B and FaDu, and the most commonly used HIV PIs, lopinavir and ritonavir (L/R), were used in this study. Clonogenic assay was used to assess the radiosensitivity. Cell viability, apoptosis and cell cycle were analyzed using Cellometer Vision CBA. The mRNA and protein levels of ER stress-related genes (eIF2 alpha, CHOP, ATF-4, and XBP-1), as well as cell cycle related protein, cyclin D1, were detected by real time RT-PCR and Western blot analysis, respectively. The results demonstrated that L/R dose-dependently sensitized HNSCC cells to irradiation and inhibited cell growth. L/R-induced activation of ER stress was correlated to down-regulation of cyclin D1 expression and cell cycle arrest under G0/G1 phase. Conclusion and Significance HIV PIs sensitize HNSCC cells to radiotherapy by activation of ER stress and induction of cell cycle arrest. Our results provided evidence that HIV PIs can be potentially used in combination with radiation in the treatment of HNSCC.	[Liu, Runping; Zhang, Luyong; Yang, Jing; Zhang, Xiaoxuan] China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing 210009, Jiangsu, Peoples R China; [Liu, Runping; Yang, Jing; Zhang, Xiaoxuan; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Mikkelsen, Ross; Song, Shiyu] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23298 USA; [Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA	China Pharmaceutical University; Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Zhang, LY (corresponding author), China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing 210009, Jiangsu, Peoples R China.	lyzhang@cpu.edu.cn; hzhou@vcu.edu	Zhou, Huiping/J-3639-2015; Zhou, Huiping/H-6875-2019	Zhou, Huiping/0000-0002-0050-372X; yang, jing/0000-0003-3068-6595	NIH [R01 DK-057543, R01AT004148]; VA Merit Award [1I01BX001390]; National Science Foundation of China [81070245, 81270489]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants R01 DK-057543 and R01AT004148, VA Merit Award 1I01BX001390, and National Science Foundation of China Grants 81070245 and 81270489 to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein WB, 2008, CURR OPIN HIV AIDS, V3, P666, DOI 10.1097/COH.0b013e328313915d; Bose P, 2013, INT J CANCER, V133, P2013, DOI 10.1002/ijc.28112; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Bruning A, 2013, MOL ONCOL, V7, P1012, DOI 10.1016/j.molonc.2013.07.010; Cao RS, 2010, J PHARMACOL EXP THER, V334, P530, DOI 10.1124/jpet.110.168484; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Chen YF, 2014, CELL PHYSIOL BIOCHEM, V33, P1975, DOI 10.1159/000362974; Dionysopoulos D, 2013, STRAHLENTHER ONKOL, V189, P202, DOI 10.1007/s00066-012-0275-0; Fassbender JM, 2012, CURR NEUROVASC RES, V9, P274; Fokas E, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-48; George S, 2008, CLIN LUNG CANCER, V9, P160, DOI 10.3816/CLC.2008.n.024; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Gupta AK, 2001, CANCER RES, V61, P4278; Gupta AK, 2009, INT J RADIAT ONCOL, V74, P928, DOI 10.1016/j.ijrobp.2009.03.004; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Ikezoe T, 2004, MOL CANCER THER, V3, P473; Jiang W, 2007, CANCER RES, V67, P1221, DOI 10.1158/0008-5472.CAN-06-3377; Kim YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113442; Kraus M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.2; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu RP, 2014, HEPATOLOGY, V60, P908, DOI 10.1002/hep.27085; Marron M, 2010, INT J EPIDEMIOL, V39, P182, DOI 10.1093/ije/dyp291; Masuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000238; McKenna WG, 2003, ONCOGENE, V22, P5866, DOI 10.1038/sj.onc.1206699; Pang XL, 2013, WORLD J GASTROENTERO, V19, P1736, DOI 10.3748/wjg.v19.i11.1736; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Pore N, 2006, CANCER RES, V66, P9252, DOI 10.1158/0008-5472.CAN-06-1239; Pyrko P, 2007, CANCER RES, V67, P10920, DOI 10.1158/0008-5472.CAN-07-0796; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Safdari Y, 2014, CLIN BIOCHEM, V47, P1195, DOI 10.1016/j.clinbiochem.2014.05.066; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Steelman LS, 2011, CELL CYCLE, V10, P3003, DOI 10.4161/cc.10.17.17119; Su Nai-Wen, 2014, Onco Targets Ther, V7, P2197, DOI 10.2147/OTT.S70188; Suh Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.548; Taura M, 2013, FREE RADICAL BIO MED, V65, P778, DOI 10.1016/j.freeradbiomed.2013.08.161; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Toulany M, 2012, MOL CANCER RES, V10, P945, DOI 10.1158/1541-7786.MCR-11-0592; Wang F, 2009, CURR OPIN PHARMACOL, V9, P389, DOI 10.1016/j.coph.2009.06.005; Wang Y, 2013, HEPATOLOGY, V57, P1005, DOI 10.1002/hep.26107; Wu XD, 2010, GASTROENTEROLOGY, V138, P197, DOI 10.1053/j.gastro.2009.08.054; Yang Y, 2005, CANCER SCI, V96, P425, DOI 10.1111/j.1349-7006.2005.00063.x; Yang Y, 2006, BRIT J CANCER, V95, P1653, DOI 10.1038/sj.bjc.6603435; Yin XY, 2010, INT J CANCER, V126, P1216, DOI 10.1002/ijc.24815; Zha BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059514; Zha WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054349; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang XX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0107072, 10.1371/journal.pone.0110243]; Zhang XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090856; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006; Zhou HP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00112; Zhou HP, 2011, METHOD ENZYMOL, V490, P107, DOI 10.1016/B978-0-12-385114-7.00006-4	55	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125928	10.1371/journal.pone.0125928	http://dx.doi.org/10.1371/journal.pone.0125928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933118	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100144
J	Noutsos, C; Perera, AM; Nikolau, BJ; Seaver, SMD; Ware, DH				Noutsos, Christos; Perera, Ann M.; Nikolau, Basil J.; Seaver, Samuel M. D.; Ware, Doreen H.			Metabolomic Profiling of the Nectars of Aquilegia pubescens and A-Canadensis	PLOS ONE			English	Article							SUGAR COMPOSITION; AMINO-ACIDS; HUMMINGBIRDS; POLLINATION; ANNOTATION; PARENTS; HYBRIDS; SEED	To date, variation in nectar chemistry of flowering plants has not been studied in detail. Such variation exerts considerable influence on pollinator-plant interactions, as well as on flower traits that play important roles in the selection of a plant for visitation by specific pollinators. Over the past 60 years the Aquilegia genus has been used as a key model for speciation studies. In this study, we defined the metabolomic profiles of flower samples of two Aquilegia species, A. Canadensis and Aquilegia pubescens. We identified a total of 75 metabolites that were classified into six main categories: organic acids, fatty acids, amino acids, esters, sugars, and unknowns. The mean abundances of 25 of these metabolites were significantly different between the two species, providing insights into interspecies variation in floral chemistry. Using the PlantSEED biochemistry database, we found that the majority of these metabolites are involved in biosynthetic pathways. Finally, we explored the annotated genome of A. coerulea, using the PlantSEED pipeline and reconstructed the metabolic network of Aquilegia. This network, which contains the metabolic pathways involved in generating the observed chemical variation, is now publicly available from the DOE Systems Biology Knowledge Base (KBase; http://kbase.us).	[Noutsos, Christos; Ware, Doreen H.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Perera, Ann M.; Nikolau, Basil J.] Iowa State Univ, WM Keck Metabol Res Lab, Ames, IA USA; [Nikolau, Basil J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Seaver, Samuel M. D.] Argonne Natl Lab, Math & Comp Sci Div, Argonne, IL 60439 USA; [Seaver, Samuel M. D.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Ware, Doreen H.] USDA ARS, NAA, Robert W Holley Ctr, Ithaca, NY 14853 USA	Cold Spring Harbor Laboratory; Iowa State University; Iowa State University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; United States Department of Agriculture (USDA)	Noutsos, C (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	cnoutsos@cshl.edu	Noutsos, Christos/E-5601-2012; Seaver, Samuel M. D./C-2614-2008	Noutsos, Christos/0000-0003-1570-4724; Seaver, Samuel M. D./0000-0002-7674-5194	National Science Foundation of United States of America under Division of Biological Infrastructure [DBI-1265382]; Department of Energy [DE-AC02-98CH10886]; NSF [BDI-1265383]; iPlant Collaborative Project	National Science Foundation of United States of America under Division of Biological Infrastructure; Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); iPlant Collaborative Project	This work was funded by grants from the National Science Foundation of United States of America under the Division of Biological Infrastructure to Dr. Doreen Ware who is Co-Principal Investigator to the DBI-1265382. Financial support was provided by the Department of Energy (DE-AC02-98CH10886) for Seaver SMD and to Christos Noutsos from the NSF by the BDI-1265383, the iPlant Collaborative Project. Basil J. Nikolau and and Ann M. Perera received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER HG, 1977, BOT GAZ, V138, P183, DOI 10.1086/336914; Baker HG BI, 1983, FLORAL NECTAR SUGAR; BAKER I, 1976, NEW PHYTOL, V76, P87, DOI 10.1111/j.1469-8137.1976.tb01441.x; Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Bender R, 2012, FLORA, V207, P491, DOI 10.1016/j.flora.2012.06.005; Bernardello G, 1999, BIOCHEM SYST ECOL, V27, P779, DOI 10.1016/S0305-1978(99)00029-0; Bertazzini M, 2010, AMINO ACIDS, V39, P315, DOI 10.1007/s00726-010-0474-x; BIELESKI RL, 1980, AUST J PLANT PHYSIOL, V7, P15, DOI 10.1071/PP9800015; BRICE AT, 1991, PHYSIOL ZOOL, V64, P611, DOI 10.1086/physzool.64.2.30158193; Burke JM, 2000, J TORREY BOT SOC, V127, P200, DOI 10.2307/3088757; Canto A, 2007, ANN BOT-LONDON, V99, P653, DOI [10.1090/aob/mcl291, 10.1093/aob/mcl291]; Dupont YL, 2004, FUNCT ECOL, V18, P670, DOI 10.1111/j.0269-8463.2004.00891.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fenster CB, 2006, AM J BOT, V93, P1800, DOI 10.3732/ajb.93.12.1800; Gijbels P, 2014, J ECOL, V102, P136, DOI 10.1111/1365-2745.12183; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; GOTTSBERGER G, 1984, PLANT SYST EVOL, V145, P55, DOI 10.1007/BF00984031; GRANT VERNE, 1952, ALISO, V2, P341; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; HODGES SA, 1993, ECOLOGY, V74, P542, DOI 10.2307/1939314; Jones CE, 1983, LITTLE HDB EXPT POLL; Jurgens A, 2004, S AFR J BOT, V70, P191, DOI 10.1016/S0254-6299(15)30235-0; Kaczorowski RL, 2005, AM J BOT, V92, P1270, DOI 10.3732/ajb.92.8.1270; Kirk H, 2012, METABOLOMICS, V8, P211, DOI 10.1007/s11306-011-0301-8; Mato I, 2003, J FOOD PROTECT, V66, P2371, DOI 10.4315/0362-028X-66.12.2371; Nepi M, 2014, J ECOL, V102, P108, DOI 10.1111/1365-2745.12170; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Payan F, 2004, J BIOL CHEM, V279, P36029, DOI 10.1074/jbc.M404225200; Payson EB, 1918, N AM SPECIES AQUILEG; PYKE GH, 1981, BIOTROPICA, V13, P260, DOI 10.2307/2387804; Quanbeck SMM, 2012, FRONT PLANT SCI, P3; Roldan-Serrano AS, 2004, J HORTIC SCI BIOTECH, V79, P717, DOI 10.1080/14620316.2004.11511832; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; Seaver SMD, 2014, P NATL ACAD SCI USA, V111, P9645, DOI 10.1073/pnas.1401329111; Shalit M, 2003, PLANT PHYSIOL, V131, P1868, DOI 10.1104/pp.102.018572; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Witt T, 1999, PLANT BIOLOGY, V1, P334; Wolff D, 2006, ANN BOT-LONDON, V97, P767, DOI 10.1093/aob/mcl033; WYATT R, 1992, AM J BOT, V79, P636, DOI 10.2307/2444879; Zajacz E, 2011, NECTAR PRODUCTION SO	41	17	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124501	10.1371/journal.pone.0124501	http://dx.doi.org/10.1371/journal.pone.0124501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933103	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000353887100046
J	Wilkinson-Ryan, I; Kim, J; Kim, SJ; Ak, F; Dodson, L; Colonna, M; Powell, M; Mutch, D; Spitzer, D; Hansen, T; Goedegebuure, SP; Curiel, D; Hawkins, W				Wilkinson-Ryan, Ivy; Kim, Julius; Kim, Sojung; Ak, Ferhat; Dodson, Lindzy; Colonna, Marco; Powell, Matthew; Mutch, David; Spitzer, Dirk; Hansen, Ted; Goedegebuure, Simon P.; Curiel, David; Hawkins, William			Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy	PLOS ONE			English	Article							GENE-TRANSFER EFFICIENCY; OVARIAN-CANCER; TARGETING ADENOVIRUS; PHASE-I; MESOTHELIN; RECEPTORS; COMPLEX; ANTIGEN; CD80; IMMUNOBIOLOGY	One strategy in cancer immunotherapy is to capitalize on the key immunoregulatory and antigen presenting capabilities of dendritic cells (DCs). This approach is dependent on efficient delivery of tumor specific antigens to DCs, which subsequently induce an anti-tumor T-cell mediated immune response. Human adenovirus serotype 5 (HAdV5) has been used in human studies for gene delivery, but has limited infection in DCs, which lack the proper receptors. Addition of the porcine fiber knob (PK) from porcine adenovirus type 4 to HAdV5 allows the virus to deliver genetic material via binding to glycosylated surface proteins and bypasses the coxsackie-and-adenovirus receptor required by wild-type HAdV5. In this study we explored the potential therapeutic applications of an adenovirus with PK-based tropism against cancers expressing mesothelin. Infectivity and gene transfer assays were used to compare Ad5-PK to wild-type HAdV5. Mouse models were used to demonstrate peptide specificity and T-cell responses. We show that the PK modification highly augmented infection of DCs, including the CD141+DC subset, a key subset for activation of naive CD8+T-cells. We also show that Ad5-PK increases DC infectivity and tumor specific antigen expression. Finally, vaccination of mice with the Ad5-PK vector resulted in enhanced T-cell-mediated interferon gamma (IFN-gamma) release in response to both mesothelin peptide and a tumor line expressing mesothelin. Ad5-PK is a promising tool for cancer immunotherapy as it improves infectivity, gene transfer, protein expression, and subsequent T-cell activation in DCs compared to wild-type HAdV5 viruses.	[Wilkinson-Ryan, Ivy; Powell, Matthew; Mutch, David] Washington Univ, Sch Med, Div Gynecol Oncol, St Louis, MO USA; [Kim, Julius] Univ Chicago, Dept Neurooncol, Chicago, IL 60637 USA; [Kim, Sojung; Colonna, Marco; Hansen, Ted] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ak, Ferhat] St Jans Gathuis Hosp, Dept SJG Apotheek, Weert, Netherlands; [Dodson, Lindzy] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Spitzer, Dirk; Goedegebuure, Simon P.; Hawkins, William] Washington Univ, Sch Med, Div Surg, St Louis, MO USA; [Curiel, David] Washington Univ, Sch Med, Div Canc Biol, St Louis, MO USA	Washington University (WUSTL); University of Chicago; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Washington University (WUSTL)	Hawkins, W (corresponding author), Washington Univ, Sch Med, Div Surg, St Louis, MO 63130 USA.	hawkinsw@wudosis.wustl.edu		Colonna, Marco/0000-0001-5222-4987	Eberle Ovarian Cancer Fund; Family Rock Ovarian Cancer Fund (FamiliesROC)	Eberle Ovarian Cancer Fund; Family Rock Ovarian Cancer Fund (FamiliesROC)	Eberle Ovarian Cancer Fund and The Family Rock Ovarian Cancer Fund (FamiliesROC): MP and DM received these funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bauer C, 2011, CANCER IMMUNOL IMMUN, V60, P1097, DOI 10.1007/s00262-011-1023-5; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang MC, 2012, BIOCHEM J, V442, P293, DOI 10.1042/BJ20110282; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gregori S, 2011, TISSUE ANTIGENS, V77, P89, DOI 10.1111/j.1399-0039.2010.01615.x; Hangalapura BN, 2011, CANCER RES, V71, P5827, DOI 10.1158/0008-5472.CAN-11-0804; Hassan R, 2005, APPL IMMUNOHISTO M M, V13, P243, DOI 10.1097/01.pai.00000141545.36485.d6; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hemmi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/158128; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; Hung CF, 2007, VACCINE, V25, P127, DOI 10.1016/j.vaccine.2006.06.087; Kandalaft LE, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22664; Kanerva A, 2002, CLIN CANCER RES, V8, P275; KIM J, 2013, NATL GEOGR, V224, P8; Kim KH, 2013, GYNECOL ONCOL, V130, P518, DOI 10.1016/j.ygyno.2013.06.003; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Le DT, 2012, CLIN CANCER RES, V18, P858, DOI 10.1158/1078-0432.CCR-11-2121; Leao IC, 2008, CTS-CLIN TRANSL SCI, V1, P228, DOI 10.1111/j.1752-8062.2008.00070.x; Li LJ, 2010, VACCINE, V28, P1911, DOI 10.1016/j.vaccine.2009.10.096; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; McVey D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-276; Murakami M, 2010, VIROLOGY, V407, P196, DOI 10.1016/j.virol.2010.08.010; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Pereboev AV, 2004, MOL THER, V9, P712, DOI 10.1016/j.ymthe.2004.02.006; Primeau T, 2005, IMMUNOL RES, V32, P109, DOI 10.1385/IR:32:1-3:109; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Santin AD, 2006, GYNECOL ONCOL, V100, P469, DOI 10.1016/j.ygyno.2005.09.040; Sharma A, 2009, VIRUS RES, V143, P184, DOI 10.1016/j.virusres.2009.02.010; Short JJ, 2004, VIROLOGY, V322, P349, DOI 10.1016/j.virol.2004.02.016; Shurin GV, 2012, CANCER IMMUNOL IMMUN, V61, P223, DOI 10.1007/s00262-011-1138-8; Stoff-Khalili MA, 2005, GENE THER, V12, P1696, DOI 10.1038/sj.gt.3302588; Thacker EE, 2009, VACCINE, V27, P7116, DOI 10.1016/j.vaccine.2009.09.055; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Tillman BW, 2000, CANCER RES, V60, P5456; Ueno H, 2011, SEMIN IMMUNOL, V23, P21, DOI 10.1016/j.smim.2011.01.004; Ulasov IV, 2007, J NEUROSURG, V107, P617, DOI 10.3171/JNS-07/09/0617; van de Ven R, 2009, J IMMUNOTHER, V32, P895, DOI 10.1097/CJI.0b013e3181b56deb; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033214; Williams BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046981; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948	49	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125851	10.1371/journal.pone.0125851	http://dx.doi.org/10.1371/journal.pone.0125851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933160	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100138
J	Yamasaki, H; Funai, Y; Funao, T; Mori, T; Nishikawa, K				Yamasaki, Hiroyuki; Funai, Yusuke; Funao, Tomoharu; Mori, Takashi; Nishikawa, Kiyonobu			Effects of Tramadol on Substantia Gelatinosa Neurons in the Rat Spinal Cord: An In Vivo Patch-Clamp Analysis	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; DORSAL-HORN; INHIBITORY TRANSMISSION; SYNAPTIC-TRANSMISSION; VENTROMEDIAL MEDULLA; XENOPUS OOCYTES; PAIN; METABOLITE; ACTIVATION; MECHANISMS	Tramadol is thought to modulate synaptic transmissions in the spinal dorsal horn mainly by activating mu-opioid receptors and by inhibiting the reuptake of monoamines in the CNS. However, the precise mode of modulation remains unclear. We used an in vivo patch clamp technique in urethane-anesthetized rats to determine the antinociceptive mechanism of tramadol. In vivo whole-cell recordings of spontaneous inhibitory postsynaptic currents (sIPSCs) and spontaneous excitatory postsynaptic currents (sEPSCs) were made from substantia gelatinosa (SG) neurons (lamina II) at holding potentials of 0 mV and -70 mV, respectively. The effects of intravenous administration (0.5, 5, 15 mg/kg) of tramadol were evaluated. The effects of superfusion of tramadol on the surface of the spinal cord and of a tramadol metabolite (M1) were further analyzed. Intravenous administration of tramadol at doses >5 mg/kg decreased the sEPSCs and increased the sIPSCs in SG neurons. These effects were not observed following naloxone pretreatment. Tramadol superfusion at a clinically relevant concentration (10 mu M) had no effect, but when administered at a very high concentration (100 mu M), tramadol decreased sEPSCs, produced outward currents, and enhanced sIPSCs. The effects of M1 (1, 5 mg/kg intravenously) on sEPSCs and sIPSCs were similar to those of tramadol at a corresponding dose (5, 15 mg/kg). The present study demonstrated that systemically administered tramadol indirectly inhibited glutamatergic transmission, and enhanced GABAergic and glycinergic transmissions in SG neurons. These effects were mediated primarily by the activation of mu-opioid receptors. M1 may play a key role in the antinociceptive mechanisms of tramadol.	[Yamasaki, Hiroyuki; Funai, Yusuke; Funao, Tomoharu; Mori, Takashi; Nishikawa, Kiyonobu] Osaka City Univ, Grad Sch Med, Dept Anesthesiol, Osaka 558, Japan	Osaka Metropolitan University	Mori, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Anesthesiol, Osaka 558, Japan.	m1377033@med.osaka-cu.ac.jp		Funai, Yusuke/0000-0002-8757-3738	Japan Society for the Promotion of Science, Tokyo, Japan [24592355]; Grants-in-Aid for Scientific Research [25462448] Funding Source: KAKEN	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant-in-aid for scientific research (24592355) from the Japan Society for the Promotion of Science, Tokyo, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba H, 2000, ANESTHESIOLOGY, V92, P485, DOI 10.1097/00000542-200002000-00031; Baccei ML, 2004, J NEUROSCI, V24, P4749, DOI 10.1523/JNEUROSCI.5211-03.2004; CERVERO F, 1980, BRAIN, V103, P717, DOI 10.1093/brain/103.4.717; Codd EE, 2008, PAIN, V134, P254, DOI 10.1016/j.pain.2007.04.019; DRIESSEN B, 1992, BRIT J PHARMACOL, V105, P147, DOI 10.1111/j.1476-5381.1992.tb14226.x; Funai Y, 2014, PAIN, V155, P617, DOI 10.1016/j.pain.2013.12.018; Furue H, 2004, NEUROSCI RES, V48, P361, DOI 10.1016/j.neures.2003.12.005; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; Gillen C, 2000, N-S ARCH PHARMACOL, V362, P116, DOI 10.1007/s002100000266; Giusti P, 1997, BRIT J PHARMACOL, V122, P302, DOI 10.1038/sj.bjp.0701374; Grond S, 1999, BRIT J CLIN PHARMACO, V48, P254, DOI 10.1046/j.1365-2125.1999.00986.x; Hama A, 2007, EUR J PHARMACOL, V559, P32, DOI 10.1016/j.ejphar.2006.11.047; Hara K, 2005, ANESTH ANALG, V100, P1400, DOI 10.1213/01.ANE.0000150961.24747.98; HENNIES HH, 1988, ARZNEIMITTEL-FORSCH, V38-2, P877; Hurley RW, 2003, NEUROSCIENCE, V118, P789, DOI 10.1016/S0306-4522(03)00041-1; Ide S, 2006, NEUROPHARMACOLOGY, V51, P651, DOI 10.1016/j.neuropharm.2006.05.008; Kaneko K, 2014, NEUROSCI LETT, V562, P28, DOI 10.1016/j.neulet.2014.01.007; Kato G, 2006, J NEUROSCI, V26, P1787, DOI 10.1523/JNEUROSCI.4856-05.2006; Katsuki R, 2006, BRIT J PHARMACOL, V149, P319, DOI 10.1038/sj.bjp.0706868; Kawamata T, 2003, BRAIN RES, V978, P250, DOI 10.1016/S0006-8993(03)02952-4; Kimura M, 2012, ANESTH ANALG, V115, P443, DOI 10.1213/ANE.0b013e31825683c3; Klotz U, 2003, ARZNEIMITTELFORSCH, V53, P681; Koga A, 2005, BRIT J PHARMACOL, V145, P602, DOI 10.1038/sj.bjp.0706225; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Parasrampuria R, 2007, CHIRALITY, V19, P190, DOI 10.1002/chir.20360; Pinto M, 2008, J COMP NEUROL, V510, P175, DOI 10.1002/cne.21793; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; Shiraishi M, 2002, BRIT J PHARMACOL, V136, P207, DOI 10.1038/sj.bjp.0704703; Sonohata M, 2004, J PHYSIOL-LONDON, V555, P515, DOI 10.1113/jphysiol.2003.054932; Yoshimura M, 1996, PROG BRAIN RES, V113, P443, DOI 10.1016/S0079-6123(08)61103-6; Yoshimura M, 2006, J PHARMACOL SCI, V101, P107, DOI 10.1254/jphs.CRJ06008X	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125147	10.1371/journal.pone.0125147	http://dx.doi.org/10.1371/journal.pone.0125147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933213	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100082
J	Davies, HR; Nazareth, I; Petersen, I				Davies, Hilary R.; Nazareth, Irwin; Petersen, Irene			Trends of People Using Drugs and Opioid Substitute Treatment Recorded in England and Wales General Practice (1994-2012)	PLOS ONE			English	Article							PRIMARY-CARE; PERIODS; UK	Background Illicit drug use is a multifaceted public-health problem with potentially serious impacts. The United Kingdom has one of the highest prevalence of illegal drug use in Europe. Reduction of overall illegal drug use in England and Wales has decreased from 11% to 8.2% (2012/13) over the past 10 years. People who use drugs often seek help from their family doctors. Aims To investigate General Practitioners (family doctors) first recording of drug use and opioid substitute treatment in primary care settings. Design A descriptive study design. Males and females (16-64 years old) were extracted from The Health Improvement Network (THIN) database. Setting England and Wales primary care. Method The first recording of drug use and opioid substitution treatment in primary care was estimated for the period (1994-2012). Poisson regressions were conducted to estimate incidence risk ratios (IRR). Results We identified 33,508 first recordings of drug use and 10,869 individuals with prescriptions for opioid substitute treatment. Overall, males (IRR 2.02, 95% CI:1.97-2.07), people in the age-group; 16-24 (IRR 6.7, 95% CI:6.4-6.9) compared to those over 25 years and the most deprived (IRR 4.2, 95% CI:3.9-4.4) were more likely to have a recording of drug use. Males (IRR 1.2 95% CI:1.2-1.3), in the age-group; 25-34 (IRR 1.8 95% CI:1.7-1.9) and the most deprived (IRR 3.9 95% CI:3.6-4.3) were the groups more likely to have a opioid substitute treatment prescription. Conclusion It is evident from this study that there is little recording of drug use and opioid substitute treatment in primary care. Most drug users do not receive treatment in primary care.	[Davies, Hilary R.; Nazareth, Irwin; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England	University of London; University College London	Davies, HR (corresponding author), UCL, Dept Primary Care & Populat Hlth, Rowland Hill St, London NW3 2PF, England.	h.davies.12@ucl.ac.uk	Petersen, Irene/C-5702-2009	Petersen, Irene/0000-0002-0037-7524	National Institute of Health Research English National School for Primary Care Research studentship	National Institute of Health Research English National School for Primary Care Research studentship	Hilary Davies is funded by the National Institute of Health Research English National School for Primary Care Research studentship (http://www.nspcr.ac.uk/). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no conflicting interests.	[Anonymous], WORLD DRUG REP 2014; [Anonymous], DRUGM PSYCH INT PERS; Blak Betina T, 2011, Inform Prim Care, V19, P251; BMJ group, 2013, BRIT NAT FORM INT; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; CSD Medical Research website, THIN STAT; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; de Lusignan S, 2003, METHOD INFORM MED, V42, P416; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; European Monitoring Centre for Drugs and Drug Addiction, 2014, EUR DRUG REP; Ford C, 2013, GUIDANCE USE SUBSTIT; Frisher M, 2009, J PUBLIC HEALTH-UK, V31, P69, DOI 10.1093/pubmed/fdn081; Health Protection Agency, 2012, SHOOT INF PEOPL WHO; Horsfall L, 2013, PHARMACOEPIDEM DR S, V22, P64, DOI 10.1002/pds.3368; Huxley P, 1993, COMMON MENTAL DISORD; Leri F, 2003, ADDICTION, V98, P7, DOI 10.1046/j.1360-0443.2003.00236.x; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; Madgula R.M., 2014, EXPERT REV OBSTET GY, V6, DOI [DOI 10.1586/EOG.10.54, 10.1586/eog.10.54]; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; National Institute for Clinical Excellence, 2010, METH BUPR MAN OP DEP; National Treatment Agency for Substance Misuse, 2012, DRUG TREATM 2012 PRO; Office for National Statistics, 2013, CRIM SURV ENGL WAL; Pope C, 2014, J HEALTH SERV RES PO, V19, P67, DOI 10.1177/1355819614521181; Public Health England, OUR PRIOR 2013 14; Public Health England, NAT TREATM AG SUBST; Royal College of General Practitioners, 2013, SUBST MIS ASS HLTH; Royal College of General Practitioners, 2011, GUID US SUBST PRESCR; Social Exclusion Unit, 2002, RED RE OFF EXPR; Stewart, 2008, PROBL NEEDS NEWL SEN; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Townsend P, 1986, IN HLTH NO REG INT R; UK Drug Policy Commission, 2010, GETT SER STIGM PROBL; United Kingdom Drug Policy Commission, 2012, BRIEF PAP ILL DRUGS; Welsh Government, WELSH NAT DAT SUBST	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122626	10.1371/journal.pone.0122626	http://dx.doi.org/10.1371/journal.pone.0122626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923806	Green Published, gold			2022-12-26	WOS:000353711600020
J	Valentine, B; Kamenov, GD; Kenoyer, JM; Shinde, V; Mushrif-Tripathy, V; Otarola-Castillo, E; Krigbaum, J				Valentine, Benjamin; Kamenov, George D.; Kenoyer, Jonathan Mark; Shinde, Vasant; Mushrif-Tripathy, Veena; Otarola-Castillo, Erik; Krigbaum, John			Evidence for Patterns of Selective Urban Migration in the Greater Indus Valley (2600-1900 BC): A Lead and Strontium Isotope Mortuary Analysis	PLOS ONE			English	Article							ARCHAEOLOGY; FRONTIERS; IDENTITY; AGE	Just as modern nation-states struggle to manage the cultural and economic impacts of migration, ancient civilizations dealt with similar external pressures and set policies to regulate people's movements. In one of the earliest urban societies, the Indus Civilization, mechanisms linking city populations to hinterland groups remain enigmatic in the absence of written documents. However, isotopic data from human tooth enamel associated with Harappa Phase (2600-1900 BC) cemetery burials at Harappa (Pakistan) and Farmana (India) provide individual biogeochemical life histories of migration. Strontium and lead isotope ratios allow us to reinterpret the Indus tradition of cemetery inhumation as part of a specific and highly regulated institution of migration. Intra-individual isotopic shifts are consistent with immigration from resource-rich hinterlands during childhood. Furthermore, mortuary populations formed over hundreds of years and composed almost entirely of first-generation immigrants suggest that inhumation was the final step in a process linking certain urban Indus communities to diverse hinterland groups. Additional multi disciplinary analyses are warranted to confirm inferred patterns of Indus mobility, but the available isotopic data suggest that efforts to classify and regulate human movement in the ancient Indus region likely helped structure socioeconomic integration across an ethnically diverse landscape.	[Valentine, Benjamin] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Kamenov, George D.] Univ Florida, Dept Geol Sci, Gainesville, FL USA; [Kenoyer, Jonathan Mark] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Shinde, Vasant; Mushrif-Tripathy, Veena] Deccan Coll Postgrad & Res Inst, Dept Archaeol, Pune, Maharashtra, India; [Otarola-Castillo, Erik] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Krigbaum, John] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA	Dartmouth College; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison; Harvard University; State University System of Florida; University of Florida	Valentine, B (corresponding author), Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA.	benjamin.t.valentine@dartmouth.edu	Kamenov, George/AAE-6176-2020	Kamenov, George/0000-0002-6041-6687; Otarola-Castillo, Erik/0000-0002-7806-494X; Mushrif-Tripathy, Veena/0000-0002-4749-1316	American Institute of Indian Studies Junior Fellowship; Wenner-Gren Dissertation Fieldwork Grant [8383]	American Institute of Indian Studies Junior Fellowship; Wenner-Gren Dissertation Fieldwork Grant	Funding was provided by the American Institute of Indian Studies Junior Fellowship to BV, JK (www.indiastudies.org), and Wenner-Gren Dissertation Fieldwork Grant #8383 to BV, JK (www.wennergren.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D.P, 2000, ANCIENT METAL TECHNO; Agrawala R.C., 1984, FRONTIERS INDUS CIVI, P157; Alizai A, 2011, GLOBAL PLANET CHANGE, V76, P33, DOI 10.1016/j.gloplacha.2010.11.008; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; [Anonymous], REC J GEOL SURV INDI; [Anonymous], 2014, R LANG ENV STAT COMP; Beck L.A., 1995, REGIONAL APPROACHES; Begemann F, 2009, IRAN ANTIQ, V44, P1, DOI 10.2143/IA.44.0.2034374; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bhutta AM, 1992, ACTA MINERALOGICA PA, V6, P21; Blakey M., 1998, TRANSFORM ANTHROPOL, V7, P53, DOI [10.1525/tran.1998.7.1.53, DOI 10.1525/tran.1998.7.1.53]; Bruck J, 2004, J SOC ARCHAEOL, V4, P307, DOI 10.1177/1469605304046417; Burmeister S, 2009, MORTUARY PRACTICES S, P46; Burton JH, 2013, ACS SYM SER, V1147, P309; CANNON A, 1989, CURR ANTHROPOL, V30, P437, DOI 10.1086/203764; Carr C., 1995, J ARCHAEOL METHOD TH, V2, P105, DOI 10.1007/BF02228990; Chapman R., 1981, ARCHAEOLOGY DEATH; Cook G., 2001, RITUAL SACRIFICE ANC, P1; Dales G., 1991, HARAPPA EXCAVATIONS, P185; Dales GF, 1989, PAKISTAN ARCHAEOLOGY, V24, P68; DEB M, 1989, PRECAMBRIAN RES, V43, P1, DOI 10.1016/0301-9268(89)90002-8; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Francis D., 2005, THE SECRET CEMETERY; Garcon M, 2013, GEOCHEM GEOPHY GEOSY, V14, P3324, DOI 10.1002/ggge.20219; Gillespie SD, 2001, J ANTHROPOL ARCHAEOL, V20, P73, DOI 10.1006/jaar.2000.0369; Goldstein LG, 1980, MISSISSIPIAN MORTUAR; Gulson B, 2008, SCI TOTAL ENVIRON, V400, P75, DOI 10.1016/j.scitotenv.2008.06.059; Hargrave E., 2000, SE ARCHAEOLOGY, V19, P1; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HEMPHILL BE, 1991, HARAPPA EXCAVATIONS, P137; Hennig C., 2014, FPC FLEXIBLE PROCEDU; HILLSON S, 1996, DENT ANTHR; Hodder I., 1982, SYMBOLS ACTION ETHNO; Humphrey LT, 2008, P NATL ACAD SCI USA, V105, P6834, DOI 10.1073/pnas.0711513105; Jarrige C., 1995, MEHRGARH FIELD REPOR; Kamenov GD, 2004, J ANAL ATOM SPECTROM, V19, P1262, DOI 10.1039/b403222e; Kamenov GD, 2008, ENVIRON GEOL, V55, P669, DOI 10.1007/s00254-007-1017-y; Kamenov GD, 2014, SCI TOTAL ENVIRON, V490, P861, DOI 10.1016/j.scitotenv.2014.05.085; Kamp K.A., 1998, CROSS-CULT RES, V32, P79, DOI [10.1177/106939719803200103, DOI 10.1177/106939719803200103]; Karim A, 2000, CHEM GEOL, V170, P153, DOI 10.1016/S0009-2541(99)00246-6; Kennedy K. A. R., 2000, GOD APES FOSSIL MEN; KENNEDY KAR, 1984, AM J PHYS ANTHROPOL, V64, P105, DOI 10.1002/ajpa.1330640203; Kenoyer J.M, 1998, ANCIENT CITIES INDUS; Kenoyer JM, 2013, J ARCHAEOL SCI, V40, P2286, DOI 10.1016/j.jas.2012.12.040; KENOYER JM, 1991, J WORLD PREHIST, V5, P331, DOI 10.1007/BF00978474; Kenoyer JM, 2000, ORDER LEGITIMACY WEA, P88; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Law RW, 2011, CURRENT STUDIES INDU, V8; LIGHTFOOT KG, 1995, ANNU REV ANTHROPOL, V24, P471, DOI 10.1146/annurev.an.24.100195.002351; Mant M, 2012, MORTALITY, V17, P18; Mengoni LE, 2010, J SOC ARCHAEOL, V10, P198, DOI 10.1177/1469605310365044; Miller HML, 2006, SPACE AND SPATIAL ANALYSIS IN ARCHAEOLOGY, P281; Montgomery J., 2002, THESIS U BRADFORD; Montgomery J, 2007, APPL GEOCHEM, V22, P1502, DOI 10.1016/j.apgeochem.2007.02.009; Mughal M. R., 1968, PAKISTAN ARCHAEOLOGY, V5, P63; Nath A, 1998, PURATATTVA, V28, P39; Nath A, 1999, PURATATTVA, V29, P46; Naum M, 2010, J ARCHAEOL METHOD TH, V17, P101, DOI 10.1007/s10816-010-9077-9; Parker Pearson M., 2000, ARCHAEOLOGY DEATH BU; Parker Pearson Michael, 1982, SYMBOLIC STRUCTURAL, P99, DOI DOI 10.1017/CBO9780511558252; Parkes P, 2001, COMP STUD SOC HIST, V43, P4, DOI 10.1017/S0010417501003565; Pollard AM, 2008, ROYAL SOC CHEM; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; RAHA PK, 1978, J GEOL SOC INDIA, V19, P221; Rao S R, 1979, LOTHAL HARAPPAN PORT, V1; Rao S.R., 1985, LOTHAL HARAPPAN PORT, VII; Rao SR, 1973, LOTHAL INDUS VALLEY; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Rizvi U. Z., 2007, THESIS U PENNSYLVANI; Rugg J., 1998, MORTALITY, V3, P111; Rugg J., 2000, MORTALITY, V5, P259, DOI [10.1080/713686011, DOI 10.1080/713686011]; Sastri KN, 1965, NEW LIGHT INDUS CIVI, V2; Saxe A.A., 1970, THESIS U MICHIGAN; Schloen D., 2008, EXPLORING LONGUE DUR, P251; Sharma AK, 1999, DEPARTED HARAPPANS K; Shinde V, 2011, EXCAVATIONS FARMANA, P27; Shinde V, 2011, EXCAVATIONS FARMANA, P550; Stein GJ, 2002, AM ANTHROPOL, V104, P903, DOI 10.1525/aa.2002.104.3.903; Tripathi JK, 2013, CHEM GEOL, V344, P12, DOI 10.1016/j.chemgeo.2013.02.016; Trivedi PK, 2009, EXCAVATIONS TARKHANE; Vaishnav Ragini, 2001, Indian Journal of Pharmacology, V33, P46; Valentine B, 2008, J ARCHAEOL SCI, V35, P1463, DOI 10.1016/j.jas.2007.10.016; Wheeler Robert Eric Mortimer, 1946, ANCIENT INDIA, V2, P58; Wright RP, 2010, ANCIENT IDUS URBANIS	85	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123103	10.1371/journal.pone.0123103	http://dx.doi.org/10.1371/journal.pone.0123103			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CH0LO	25923705	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600030
J	Hanelt, I; Jensen, S; Wunnicke, D; Slotboom, DJ				Hanelt, Inga; Jensen, Sonja; Wunnicke, Dorith; Slotboom, Dirk Jan			Low Affinity and Slow Na+ Binding Precedes High Affinity Aspartate Binding in the Secondary-active Transporter Glt(Ph)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; membrane protein; membrane transport; pre-steady-state kinetics; transporter; glutamate transport; Sodium-coupled transport; tryptophan fluorescence; binding kinetics; secondary transport	NEURONAL GLUTAMATE TRANSPORTER; HOMOLOG GLT(PH); PYROCOCCUS-HORIKOSHII; EXTRACELLULAR GATE; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; SODIUM; EAAC1; MECHANISM; DYNAMICS	Background: Glt(Ph) couples uptake of one aspartate to the cotransport of three Na+. Results: Slow binding of Na+ takes place before aspartate binding and has high activation energy. Conclusion: Binding of Na+ is accompanied by a large conformational change enabling subsequent high affinity binding of aspartate. Significance: Insight into the binding kinetics of coupling ions is essential to deduce a mechanism of transport. Glt(Ph) from Pyrococcus horikoshii is a homotrimeric Na+-coupled aspartate transporter. It belongs to the widespread family of glutamate transporters, which also includes the mammalian excitatory amino acid transporters that take up the neurotransmitter glutamate. Each protomer in Glt(Ph) consists of a trimerization domain involved in subunit interactions and a transport domain containing the substrate binding site. Here, we have studied the dynamics of Na+ and aspartate binding to Glt(Ph). Tryptophan fluorescence measurements on the fully active single tryptophan mutant F273W revealed that Na+ binds with low affinity to the apoprotein (K-d 120 mm), with a particularly low k(on) value (5.1 m(-1)s(-1)). At least two sodium ions bind before aspartate. The binding of Na+ requires a very high activation energy (E-a 106.8 kJ mol(-1)) and consequently has a large Q(10) value of 4.5, indicative of substantial conformational changes before or after the initial binding event. The apparent affinity for aspartate binding depended on the Na+ concentration present. Binding of aspartate was not observed in the absence of Na+, whereas in the presence of high Na+ concentrations (above the K-d for Na+) the dissociation constants for aspartate were in the nanomolar range, and the aspartate binding was fast (k(on) of 1.4 x 10(5) m(-1)s(-1)), with low E-a and Q(10) values (42.6 kJ mol(-1) and 1.8, respectively). We conclude that Na+ binding is most likely the rate-limiting step for substrate binding.	[Hanelt, Inga; Jensen, Sonja; Wunnicke, Dorith; Slotboom, Dirk Jan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, NL-9747 AG Groningen, Netherlands	University of Groningen	Slotboom, DJ (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	d.j.slotboom@rug.nl	Hänelt, Inga/N-2982-2016	Hänelt, Inga/0000-0003-1495-3163	Deutsche Forschungsgemeinschaft [HA 6322/1-1]; NWO (Netherlands Organisation for Scientific Research; a NWO vici grant); European Union (European Drug Initiative on Channels and Transporters program and a European Research Council starting grant)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NWO (Netherlands Organisation for Scientific Research; a NWO vici grant); European Union (European Drug Initiative on Channels and Transporters program and a European Research Council starting grant)	This work was supported by the Deutsche Forschungsgemeinschaft (HA 6322/1-1; to I. H.), the NWO (Netherlands Organisation for Scientific Research; a NWO vici grant; to D. J. S.), and by the European Union (European Drug Initiative on Channels and Transporters program and a European Research Council starting grant (to D. J. S.).	Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bergles DE, 2002, J NEUROSCI, V22, P10153; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DeChancie J, 2011, MOL BIOSYST, V7, P832, DOI 10.1039/c0mb00175a; Erkens GB, 2013, NATURE, V502, P119, DOI 10.1038/nature12538; Erkens GB, 2010, BIOCHEMISTRY-US, V49, P3203, DOI 10.1021/bi100154r; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; Gameiro A, 2011, BIOPHYS J, V100, P2623, DOI 10.1016/j.bpj.2011.04.034; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Grazioso G, 2012, J AM CHEM SOC, V134, P453, DOI 10.1021/ja208485w; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	38	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15962	15972		10.1074/jbc.M115.656876	http://dx.doi.org/10.1074/jbc.M115.656876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25922069	Green Published, hybrid			2022-12-26	WOS:000356930100006
J	DiStefano, MT; Danai, LV; Flach, RJR; Chawla, A; Pedersen, DJ; Guilherme, A; Czech, MP				DiStefano, Marina T.; Danai, Laura V.; Flach, Rachel J. Roth; Chawla, Anil; Pedersen, David J.; Guilherme, Adilson; Czech, Michael P.			The Lipid Droplet Protein Hypoxia-inducible Gene 2 Promotes Hepatic Triglyceride Deposition by Inhibiting Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; DEFICIENT MICE; ACID OXIDATION; METABOLISM; STEATOSIS; LIPASE; EXPRESSION; STORAGE	The liver is a major site of glucose, fatty acid, and triglyceride (TG) synthesis and serves as a major regulator of whole body nutrient homeostasis. Chronic exposure of humans or rodents to high-calorie diets promotes non-alcoholic fatty liver disease, characterized by neutral lipid accumulation in lipid droplets (LD) of hepatocytes. Here we show that the LD protein hypoxia-inducible gene 2 (Hig2/Hilpda) functions to enhance lipid accumulation in hepatocytes by attenuating TG hydrolysis. Hig2 expression increased in livers of mice on a high-fat diet and during fasting, two states associated with enhanced hepatic TG content. Hig2 expressed in primary mouse hepatocytes localized to LDs and promoted LD TG deposition in the presence of oleate. Conversely, tamoxifen-inducible Hig2 deletion reduced both TG content and LD size in primary hepatocytes from mice harboring floxed alleles of Hig2 and a cre/ERT2 transgene controlled by the ubiquitin C promoter. Hepatic TG was also decreased by liver-specific deletion of Hig2 in mice with floxed Hig2 expressing cre controlled by the albumin promoter. Importantly, we demonstrate that Hig2-deficient hepatocytes exhibit increased TG lipolysis, TG turnover, and fatty acid oxidation as compared with controls. Interestingly, mice with liver-specific Hig2 deletion also display improved glucose tolerance. Taken together, these data indicate that Hig2 plays a major role in promoting lipid sequestration within LDs in mouse hepatocytes through a mechanism that impairs TG degradation.	[DiStefano, Marina T.; Danai, Laura V.; Flach, Rachel J. Roth; Chawla, Anil; Pedersen, David J.; Guilherme, Adilson; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantation St, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R37-DK030898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R37-DK030898 (to M. P. C.).	Aibara D, 2013, BIOL PHARM BULL, V36, P1766; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Beylot M, 2012, METABOLISM, V61, P415, DOI 10.1016/j.metabol.2011.07.019; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Denko N, 2000, CLIN CANCER RES, V6, P480; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gandotra S, 2011, J BIOL CHEM, V286, P34998, DOI 10.1074/jbc.M111.278853; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Mattijssen F, 2014, J BIOL CHEM, V289, P19279, DOI 10.1074/jbc.M114.570044; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Nishimura S, 2011, EUR J GYNAECOL ONCOL, V32, P146; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Patel S, 2014, P NATL ACAD SCI USA, V111, P9163, DOI 10.1073/pnas.1318791111; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120; TOVE SB, 1956, J BIOL CHEM, V218, P275; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhou LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6949; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	42	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15175	15184		10.1074/jbc.M115.650184	http://dx.doi.org/10.1074/jbc.M115.650184			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922078	Green Published, hybrid			2022-12-26	WOS:000356177300031
J	Zhao, WW; Wu, MH; Chen, F; Jiang, S; Su, H; Liang, JF; Deng, CH; Hu, CH; Yu, SH				Zhao, Wei-Wei; Wu, Menghua; Chen, Fan; Jiang, Shuai; Su, Hui; Liang, Jianfen; Deng, Chunhua; Hu, Chaohui; Yu, Shihui			Robertsonian Translocations: An Overview of 872 Robertsonian Translocations Identified in a Diagnostic Laboratory in China	PLOS ONE			English	Article							DOWN-SYNDROME; UNIPARENTAL DISOMY; CHROMOSOME REARRANGEMENTS; EPIDEMIOLOGIC FINDINGS; PRENATAL DETECTION; UNITED-STATES; SEX-RATIO; MOSAICISM; ABNORMALITIES; POPULATION	Robertsonian translocations (ROBs) have an estimated incidence rate of 1/1000 births, making this type of rearrangement the most common structural chromosomal abnormalities seen in the general population. In this study, we reports 872 cases of ROBs from 205,001 specimens karyotyped postnatally in a single accredited laboratory in China, including 583 balanced ROBs, 264 unbalanced ROBs, 9 mosaic ROBs, and 18 complex ROBs. Ninety-three percent of the balanced ROBs observed were adults with infertility, miscarriage, or offspring( s) with known chromosomal abnormalities. Significant excess of females were found to be carriers of balanced ROBs with an adjusted male/female ratio of 0.77. Ninety-eight percent of the unbalanced ROBs observed were children with variable referral reasons. Almost all of the unbalanced ROBs involved chromosome 21 except a single ROB with [46, XX, der(13; 14),+ 13] identified in a newborn girl with multiple congenital anomalies. Multiple novel ROB karyotypes were reported in this report. This study represents the largest collections of ROBs in Chinese population.	[Zhao, Wei-Wei; Wu, Menghua; Chen, Fan; Jiang, Shuai; Su, Hui; Liang, Jianfen; Deng, Chunhua; Hu, Chaohui; Yu, Shihui] KingMed Genome Diagnost Lab, Guangzhou, Guangdong, Peoples R China; [Yu, Shihui] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Yu, Shihui] Seattle Childrens Hosp, Seattle, WA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Yu, SH (corresponding author), KingMed Genome Diagnost Lab, Guangzhou, Guangdong, Peoples R China.	shihui.yu@seattlechildrens.org			KingMed Genome Diagnostic Laboratory	KingMed Genome Diagnostic Laboratory	KingMed Genome Diagnostic Laboratory provided support in the form of salaries for authors WWZ, MHW, FC, SJ, JFL, CHD, CHH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfarawati S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003025; Bandyopadhyay R, 2003, AM J MED GENET A, V116A, P159, DOI 10.1002/ajmg.a.10113; Bandyopadhyay R, 2002, AM J HUM GENET, V71, P1456, DOI 10.1086/344662; Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P235, DOI 10.1023/A:1016652621226; Benn P, 1998, AM J MED GENET, V79, P121, DOI 10.1002/(SICI)1096-8628(19980901)79:2<121::AID-AJMG8>3.0.CO;2-T; Berend SA, 1998, AM J MED GENET, V80, P252, DOI 10.1002/(SICI)1096-8628(19981116)80:3<252::AID-AJMG14>3.0.CO;2-Q; Berend SA, 2000, AM J HUM GENET, V66, P1787, DOI 10.1086/302916; Berend SA, 2002, AM J MED GENET, V111, P362, DOI 10.1002/ajmg.10566; Bishop J, 1997, AM J EPIDEMIOL, V145, P134; Carothers AD, 1999, J MED GENET, V36, P386; Choi Byung Ho, 2013, Ann Pediatr Endocrinol Metab, V18, P111, DOI 10.6065/apem.2013.18.3.111; CLARKE MJ, 1989, J MED GENET, V26, P198, DOI 10.1136/jmg.26.3.198; DANIEL A, 1989, AM J MED GENET, V33, P14, DOI 10.1002/ajmg.1320330105; Franssen MTM, 2006, BMJ-BRIT MED J, V332, P759, DOI 10.1136/bmj.38735.459144.2F; Gardner R, 2012, CHROMOSOME ABNORMALI, V4th; Griffin DK, 1996, AM J HUM GENET, V59, P1108; HAMERTON JL, 1975, CLIN GENET, V8, P223; Hook EB, 1999, AM J MED GENET, V84, P316, DOI 10.1002/(SICI)1096-8628(19990604)84:4<316::AID-AJMG2>3.3.CO;2-T; Huether CA, 1996, AM J MED GENET, V63, P492, DOI 10.1002/(SICI)1096-8628(19960614)63:3<492::AID-AJMG15>3.0.CO;2-H; Iwarsson E, 2009, AM J MED GENET A, V149A, P1706, DOI 10.1002/ajmg.a.32984; Jamal A, 2012, IRAN J PUBLIC HEALTH, V41, P91; Kim SR, 2002, GENET TEST, V6, P163, DOI 10.1089/109065702761403315; Kochhar PK, 2013, J OBSTET GYNAECOL RE, V39, P113, DOI 10.1111/j.1447-0756.2012.01905.x; Kovaleva NV, 2005, AM J MED GENET A, V136A, P401, DOI 10.1002/ajmg.a.30815; Lau TK, 1998, AM J MED GENET, V75, P386, DOI 10.1002/(SICI)1096-8628(19980203)75:4<386::AID-AJMG7>3.3.CO;2-D; Lesniewicz R, 2009, FOLIA HISTOCHEM CYTO, V47, pS137, DOI 10.2478/v10042-009-0053-8; LIEBER E, 1982, J MED GENET, V19, P229, DOI 10.1136/jmg.19.3.229; Mai CT, 2013, BIRTH DEFECTS RES A, V97, P709, DOI 10.1002/bdra.23198; Morris JK, 2012, AM J MED GENET A, V158A, P1151, DOI 10.1002/ajmg.a.35248; Mutton D, 1996, J MED GENET, V33, P387, DOI 10.1136/jmg.33.5.387; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Qian Wei-Ping, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P258; Qin Jing, 2009, Yichuan, V31, P142, DOI 10.3724/SP.J.1005.2009.00142; Ruggeri A, 2004, PRENATAL DIAG, V24, P997, DOI 10.1002/pd.961; Shaffer LG, 2006, PRENATAL DIAG, V26, P303, DOI 10.1002/pd.1384; Shin M, 2010, AM J MED GENET A, V152A, P800, DOI 10.1002/ajmg.a.33295; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Zhu JL, 2013, GENET MED, V15, P64, DOI 10.1038/gim.2012.93	39	21	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122647	10.1371/journal.pone.0122647	http://dx.doi.org/10.1371/journal.pone.0122647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932913	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100009
J	Amaya, M; Keck, F; Lindquist, M; Voss, K; Scavone, L; Kehn-Hall, K; Roberts, B; Bailey, C; Schmaljohn, C; Narayanan, A				Amaya, Moushimi; Keck, Forrest; Lindquist, Michael; Voss, Kelsey; Scavone, Lauren; Kehn-Hall, Kylene; Roberts, Brian; Bailey, Charles; Schmaljohn, Connie; Narayanan, Aarthi			The Ubiquitin Proteasome System Plays a Role in Venezuelan Equine Encephalitis Virus Infection	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; ATTENUATED VACCINE; MULTIPLE-MYELOMA; CAPSID PROTEIN; OLD-WORLD; INHIBITION; REPLICATION; ALPHAVIRUSES; BORTEZOMIB; CELLS	Many viruses have been implicated in utilizing or modulating the Ubiquitin Proteasome System (UPS) to enhance viral multiplication and/or to sustain a persistent infection. The mosquito-borne Venezuelan equine encephalitis virus (VEEV) belongs to the Togaviridae family and is an important biodefense pathogen and select agent. There are currently no approved vaccines or therapies for VEEV infections; therefore, it is imperative to identify novel targets for therapeutic development. We hypothesized that a functional UPS is required for efficient VEEV multiplication. We have shown that at non-toxic concentrations Bortezomib, a FDA-approved inhibitor of the proteasome, proved to be a potent inhibitor of VEEV multiplication in the human astrocytoma cell line U87MG. Bortezomib inhibited the virulent Trinidad donkey (TrD) strain and the attenuated TC-83 strain of VEEV. Additional studies with virulent strains of Eastern equine encephalitis virus (EEEV) and Western equine encephalitis virus (WEEV) demonstrated that Bortezomib is a broad spectrum inhibitor of the New World alphaviruses. Time-of-addition assays showed that Bortezomib was an effective inhibitor of viral multiplication even when the drug was introduced many hours post exposure to the virus. Mass spectrometry analyses indicated that the VEEV capsid protein is ubiquitinated in infected cells, which was validated by confocal microscopy and immunoprecipitation assays. Subsequent studies revealed that capsid is ubiquitinated on K48 during early stages of infection which was affected by Bortezomib treatment. This study will aid future investigations in identifying host proteins as potential broad spectrum therapeutic targets for treating alphavirus infections.	[Amaya, Moushimi; Keck, Forrest; Voss, Kelsey; Scavone, Lauren; Kehn-Hall, Kylene; Bailey, Charles; Narayanan, Aarthi] George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA; [Lindquist, Michael; Schmaljohn, Connie] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Roberts, Brian] Leidos Hlth Life Sci, Frederick, MD USA	George Mason University	Narayanan, A (corresponding author), George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA.	anaraya1@gmu.edu	Kehn-Hall, Kylene/I-5752-2013	Voss, Kelsey/0000-0003-1732-2682	George Mason University	George Mason University	This work was supported by George Mason University start up funds to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634; Amaya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086745; Atasheva S, 2010, J VIROL, V84, P10004, DOI 10.1128/JVI.01151-10; Atasheva S, 2010, J VIROL, V84, P4158, DOI 10.1128/JVI.02554-09; BARBER TL, 1978, AM J VET RES, V39, P621; Pisano MB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002551; Bhomia M, 2013, ANTIVIR RES, V100, P429, DOI 10.1016/j.antiviral.2013.08.010; Curran MP, 2009, DRUGS, V69, P859, DOI 10.2165/00003495-200969070-00006; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Foy NJ, 2013, J VIROL, V87, P1997, DOI 10.1128/JVI.02853-12; Garmashova N, 2007, J VIROL, V81, P13552, DOI 10.1128/JVI.01576-07; Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Jackson G, 2005, CANCER TREAT REV, V31, P591, DOI 10.1016/j.ctrv.2005.10.001; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Julander JG, 2008, ANTIVIR RES, V78, P230, DOI 10.1016/j.antiviral.2008.01.007; Kehn-Hall K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034761; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; Kim DY, 2013, J VIROL, V87, P4202, DOI 10.1128/JVI.03142-12; KINNEY RM, 1989, VIROLOGY, V170, P19, DOI 10.1016/0042-6822(89)90347-4; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lamb K, 2010, VIROLOGY, V406, P261, DOI 10.1016/j.virol.2010.07.009; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Ma XZ, 2010, J VIROL, V84, P12419, DOI 10.1128/JVI.01219-10; Mateos MV, 2008, EXPERT REV HEMATOL, V1, P17, DOI 10.1586/17474086.1.1.17; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Narayanan A, 2012, J BIOL CHEM, V287, P33198, DOI 10.1074/jbc.M112.356535; Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08; Schneider M, 2012, J VIROL, V86, P10112, DOI 10.1128/JVI.01001-12; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Spurgers KB, 2013, J VIROL METHODS, V193, P226, DOI 10.1016/j.jviromet.2013.06.007; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; Taylor RT, 2011, METHODS, V55, P166, DOI 10.1016/j.ymeth.2011.08.003; Tretyakova I, 2013, VACCINE, V31, P1019, DOI 10.1016/j.vaccine.2012.12.050; Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Widjaja I, 2010, J VIROL, V84, P9625, DOI 10.1128/JVI.01048-10; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023	43	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124792	10.1371/journal.pone.0124792	http://dx.doi.org/10.1371/journal.pone.0124792			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927990	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100049
J	Liu, W; Du, PJ; Wang, DC				Liu, Wei; Du, Peijun; Wang, Dongchen			Ensemble Learning for Spatial Interpolation of Soil Potassium Content Based on Environmental Information	PLOS ONE			English	Article							3-D OBJECT RETRIEVAL; PREDICTION; RECOGNITION	One important method to obtain the continuous surfaces of soil properties from point samples is spatial interpolation. In this paper, we propose a method that combines ensemble learning with ancillary environmental information for improved interpolation of soil properties (hereafter, EL-SP). First, we calculated the trend value for soil potassium contents at the Qinghai Lake region in China based on measured values. Then, based on soil types, geology types, land use types, and slope data, the remaining residual was simulated with the ensemble learning model. Next, the EL-SP method was applied to interpolate soil potassium contents at the study site. To evaluate the utility of the EL-SP method, we compared its performance with other interpolation methods including universal kriging, inverse distance weighting, ordinary kriging, and ordinary kriging combined geographic information. Results show that EL-SP had a lower mean absolute error and root mean square error than the data produced by the other models tested in this paper. Notably, the EL-SP maps can describe more locally detailed information and more accurate spatial patterns for soil potassium content than the other methods because of the combined use of different types of environmental information; these maps are capable of showing abrupt boundary information for soil potassium content. Furthermore, the EL-SP method not only reduces prediction errors, but it also compliments other environmental information, which makes the spatial interpolation of soil potassium content more reasonable and useful.	[Liu, Wei; Du, Peijun; Wang, Dongchen] Nanjing Univ, Jiangsu Prov Key Lab Geog Informat Sci & Technol, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Wei] Jiangsu Normal Univ, Sch Geodesy & Geometr, Xuzhou, Jiangsu, Peoples R China	Nanjing University; Jiangsu Normal University	Du, PJ (corresponding author), Nanjing Univ, Jiangsu Prov Key Lab Geog Informat Sci & Technol, Nanjing 210008, Jiangsu, Peoples R China.	dupjrs@126.com		Du, Peijun/0000-0002-2488-2656	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAH31B00]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [14KJD170001]; Natural Science Foundation of the Jiangsu Provincial Bureau of Surveying and mapping geographic information of China [14KJD170001, JSCHKY201405]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Provincial Bureau of Surveying and mapping geographic information of China	This study is supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (Grant No. 2012BAH31B00), by the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 14KJD170001), by the Natural Science Foundation of the Jiangsu Provincial Bureau of Surveying and mapping geographic information of China (Grant No. JSCHKY201405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLI M, 1995, MATH GEOL, V27, P641, DOI 10.1007/BF02093905; Bishop T, 2011, GEODERMA, V103, P149; Collins F. C., 1996, COMP SPATIAL INTERPO; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Florinsky IV, 2002, ENVIRON MODELL SOFTW, V17, P295, DOI 10.1016/S1364-8152(01)00067-6; Gao Y, 2014, IEEE T IND ELECTRON, V61, P2088, DOI 10.1109/TIE.2013.2262760; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Gilardi N, 2002, THESIS U LAUSANNE; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Guan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098806; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Kravchenko A, 1999, AGRON J, V91, P393, DOI 10.2134/agronj1999.00021962009100030007x; Li J, 2011, ENVIRON MODELL SOFTW, V26, P1647, DOI 10.1016/j.envsoft.2011.07.004; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mosammam AM, 2013, J APPL STAT, V40, P923, DOI 10.1080/02664763.2012.750474; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Panagopoulos T, 2006, EUR J AGRON, V24, P1, DOI 10.1016/j.eja.2005.03.001; Shi WJ, 2012, J GEOGR SCI, V22, P752, DOI 10.1007/s11442-012-0960-z; Shi WJ, 2011, GEODERMA, V162, P347, DOI 10.1016/j.geoderma.2011.03.007; Triantafilis J, 2001, SOIL SCI, V166, P415, DOI 10.1097/00010694-200106000-00007; Wei BC, 2014, IEEE MULTIMEDIA, V21, P41, DOI 10.1109/MMUL.2013.65; Zhao N, 2014, THEOR APPL CLIMATOL, V116, P273, DOI 10.1007/s00704-013-0952-7	28	6	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124383	10.1371/journal.pone.0124383	http://dx.doi.org/10.1371/journal.pone.0124383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928138	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100031
J	Maebe, K; Meeus, I; De Riek, J; Smagghe, G				Maebe, Kevin; Meeus, Ivan; De Riek, Jan; Smagghe, Guy			Quantitative Trait Loci for Light Sensitivity, Body Weight, Body Size, and Morphological Eye Parameters in the Bumblebee, Bombus terrestris	PLOS ONE			English	Article							APIS-MELLIFERA; LINKAGE MAP; GENETIC ARCHITECTURE; CONSTRUCTION; EVOLUTION; INSECT; BEE; MICROSATELLITES; HYMENOPTERA; POPULATIONS	Bumblebees such as Bombus terrestris are essential pollinators in natural and managed ecosystems. In addition, this species is intensively used in agriculture for its pollination services, for instance in tomato and pepper greenhouses. Here we performed a quantitative trait loci (QTL) analysis on B. terrestris using 136 microsatellite DNA markers to identify genes linked with 20 traits including light sensitivity, body size and mass, and eye and hind leg measures. By composite interval mapping (IM), we found 83 and 34 suggestive QTLs for 19 of the 20 traits at the linkage group wide significance levels of p = 0.05 and 0.01, respectively. Furthermore, we also found five significant QTLs at the genome wide significant level of p = 0.05. Individual QTLs accounted for 7.5-53.3% of the phenotypic variation. For 15 traits, at least one QTL was confirmed with multiple QTL model mapping. Multivariate principal components analysis confirmed 11 univariate suggestive QTLs but revealed three suggestive QTLs not identified by the individual traits. We also identified several candidate genes linked with light sensitivity, in particular the Phosrestin-1-like gene is a primary candidate for its phototransduction function. In conclusion, we believe that the suggestive and significant QTLs, and markers identified here, can be of use in marker-assisted breeding to improve selection towards light sensitive bumblebees, and thus also the pollination service of bumblebees.	[Maebe, Kevin; Meeus, Ivan; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium; [De Riek, Jan] Inst Agr & Fisheries Res ILVO, Plant Sci Unit, B-9090 Melle, Belgium	Ghent University; Institute For Agricultural & Fisheries Research	Maebe, K (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Coupure Links 653, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be; guy.smagghe@ugent.be	Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; Maebe, Kevin/0000-0002-3741-2143				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; [Anonymous], 2004, MAPQTL VERSION 5 0 S; Ayabe T, 2004, CHROMOSOME RES, V12, P215, DOI 10.1023/B:CHRO.0000021880.83639.4b; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blacquiere T., 2006, P NETH ENTOMOL SOC M, V17, P93; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blacquiere Tjeerd, 2007, Proceedings of the Netherlands Entomological Society Meeting, V18, P71; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Choe E, 2012, EUPHYTICA, V183, P243, DOI 10.1007/s10681-011-0452-8; CHURCHILL GA, 1994, GENETICS, V138, P963; De Keyser E, 2013, EUPHYTICA, V189, P445, DOI 10.1007/s10681-012-0809-7; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; ESTOUP A, 1995, MOL BIOL EVOL, V12, P1074; ESTOUP A, 1993, NUCLEIC ACIDS RES, V21, P1427, DOI 10.1093/nar/21.6.1427; Funk CR, 2006, MOL ECOL NOTES, V6, P83, DOI 10.1111/j.1471-8286.2005.01147.x; Gadau J, 2001, HEREDITY, V87, P234, DOI 10.1046/j.1365-2540.2001.00919.x; Gerloff CU, 2003, FUNCT ECOL, V17, P582, DOI 10.1046/j.1365-2435.2003.00769.x; Gorley C.K., 2006, GETTING STARTED PRIM; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Heinrich B., 1979, BUMBLEBEE EC; Johansen NS, 2011, ANN APPL BIOL, V159, P1, DOI 10.1111/j.1744-7348.2011.00483.x; Kapustjanskij A, 2007, FUNCT ECOL, V21, P1130, DOI 10.1111/j.1365-2435.2007.01329.x; LANGE K, 1982, AM J HUM GENET, V34, P842; Maebe K, 2013, J INSECT PHYSIOL, V59, P913, DOI 10.1016/j.jinsphys.2013.06.012; Maebe K, 2013, APIDOLOGIE, V44, P188, DOI 10.1007/s13592-012-0170-9; Moghaddam HH, 2012, EUPHYTICA, V184, P413, DOI 10.1007/s10681-011-0616-6; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morandin LA, 2001, CAN ENTOMOL, V133, P883, DOI 10.4039/Ent133883-6; Owen R. E., 2012, MORPHOMETRICS, P1, DOI DOI 10.5772/34745; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roman A, 2008, J APIC SCI, V52, P93; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Slate J, 2005, MOL ECOL, V14, P363, DOI 10.1111/j.1365-294X.2004.02378.x; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Stolle E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-48; Stolle E, 2009, MOL ECOL RESOUR, V9, P1345, DOI 10.1111/j.1755-0998.2009.02610.x; Van Oojen JW, 2006, SOFTWARE CALCULATION; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Warrant EJ, 2004, CURR BIOL, V14, P1309, DOI 10.1016/j.cub.2004.07.057; Wcislo WT, 2009, BIOL REV, V84, P19, DOI 10.1111/j.1469-185X.2008.00059.x; Wilfert L, 2007, MOL ECOL, V16, P1327, DOI 10.1111/j.1365-294X.2007.03234.x; Wilfert L, 2009, INSECT SOC, V56, P44, DOI 10.1007/s00040-008-1034-1; Wilfert L, 2007, EVOLUTION, V61, P804, DOI 10.1111/j.1558-5646.2007.00079.x; Wilfert L, 2006, GENOME, V49, P1215, DOI 10.1139/G06-075; Williams JL, 2005, REV SCI TECH OIE, V24, P379, DOI 10.20506/rst.24.1.1571; Xiong B, 2013, TRENDS NEUROSCI, V36, P652, DOI 10.1016/j.tins.2013.08.003; Xu SZ, 2003, GENETICS, V165, P2259	51	2	2	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125011	10.1371/journal.pone.0125011	http://dx.doi.org/10.1371/journal.pone.0125011			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928544	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100056
J	Naipal, KAT; Raams, A; Bruens, ST; Brandsma, I; Verkaik, NS; Jaspers, NGJ; Hoeijmakers, JHJ; van Leenders, GJLH; Pothof, J; Kanaar, R; Boormans, J; van Gent, DC				Naipal, Kishan A. T.; Raams, Anja; Bruens, Serena T.; Brandsma, Inger; Verkaik, Nicole S.; Jaspers, Nicolaas G. J.; Hoeijmakers, Jan H. J.; van Leenders, Geert J. L. H.; Pothof, Joris; Kanaar, Roland; Boormans, Joost; van Gent, Dik C.			Attenuated XPC Expression Is Not Associated with Impaired DNA Repair in Bladder Cancer	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; GROUP-C; POLYMORPHISMS; SUSCEPTIBILITY; DEFECT; RISK	Bladder cancer has a high incidence with significant morbidity and mortality. Attenuated expression of the DNA damage response protein Xeroderma Pigmentosum complementation group C (XPC) has been described in bladder cancer. XPC plays an essential role as the main initiator and damage-detector in global genome nucleotide excision repair (NER) of UV-induced lesions, bulky DNA adducts and intrastrand crosslinks, such as those made by the chemotherapeutic agent Cisplatin. Hence, XPC protein might be an informative biomarker to guide personalized therapy strategies in a subset of bladder cancer cases. Therefore, we measured the XPC protein expression level and functional NER activity of 36 bladder tumors in a standardized manner. We optimized conditions for dissociation and in vitro culture of primary bladder cancer cells and confirmed attenuated XPC expression in approximately 40% of the tumors. However, NER activity was similar to co-cultured wild type cells in all but one of 36 bladder tumors. We conclude, that (i) functional NER deficiency is a relatively rare phenomenon in bladder cancer and (ii) XPC protein levels are not useful as biomarker for NER activity in these tumors.	[Naipal, Kishan A. T.; Raams, Anja; Bruens, Serena T.; Brandsma, Inger; Verkaik, Nicole S.; Jaspers, Nicolaas G. J.; Hoeijmakers, Jan H. J.; Pothof, Joris; Kanaar, Roland; van Gent, Dik C.] Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands; [van Leenders, Geert J. L. H.] Erasmus Univ, Dept Pathol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Kanaar, Roland] Erasmus Univ, Med Ctr, Dept Radiat Oncol, NL-3000 DR Rotterdam, Netherlands; [Boormans, Joost] Erasmus Univ, Dept Urol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Kanaar, Roland] Erasmus Univ, Med Ctr, Canc Genom Netherlands, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Gent, DC (corresponding author), Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands.	d.vangent@erasmusmc.nl	Hoeijmakers, Jan/AAX-6972-2021	Brandsma, Inger/0000-0003-3257-2540; Naipal, Kishan/0000-0001-8267-8218; van Gent, Dik C./0000-0003-1473-8148	European Community's Seventh Framework Programme [HEALTH-F2-2010-259893]; Dutch Cancer Society (KWF) [2011-5030]; Vereniging Trustfonds Erasmus University Rotterdam	European Community's Seventh Framework Programme; Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Vereniging Trustfonds Erasmus University Rotterdam	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F2-2010-259893 (DDResponse) to JH, RK and DvG, URL: http://cordis.europa.eu/fp7/home_en.html; Dutch Cancer Society (KWF) grant nr. 2011-5030 to JH, URL: http://www.kwf.nl/Pages/default.aspx; and Vereniging Trustfonds Erasmus University Rotterdam to JB, URL: http://www.eur.nl/eur/fondsen/trustfonds/. The funders had no role in study design, data	Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chen ZW, 2007, CANCER RES, V67, P4578, DOI 10.1158/0008-5472.CAN-06-0877; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Dai QS, 2013, GENE, V528, P335, DOI 10.1016/j.gene.2013.06.092; Dollfus H, 2003, SURV OPHTHALMOL, V48, P107, DOI 10.1016/S0039-6257(02)00400-9; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kaemmerer D, 2012, INT J CLIN EXP PATHO, V5, P187; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Stern MC, 2009, CANCER RES, V69, P6857, DOI 10.1158/0008-5472.CAN-09-1091; Sternberg CN, 2007, UROLOGY, V69, P62, DOI 10.1016/j.urology.2006.10.041; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Theil AF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003431; Wang YF, 2014, TUMOR BIOL, V35, P3155, DOI 10.1007/s13277-013-1412-9; Wen H, 2013, ACTAS UROL ESP, V37, P259, DOI 10.1016/j.acuro.2012.04.007; Yang J, 2010, J UROLOGY, V184, P336, DOI 10.1016/j.juro.2010.03.044	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126029	10.1371/journal.pone.0126029	http://dx.doi.org/10.1371/journal.pone.0126029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927440	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100123
J	Behringer, D; Zimmermann, H; Ziegenhagen, B; Liepelt, S				Behringer, David; Zimmermann, Heike; Ziegenhagen, Birgit; Liepelt, Sascha			Differential Gene Expression Reveals Candidate Genes for Drought Stress Response in Abies alba (Pinaceae)	PLOS ONE			English	Article							PINUS-PINASTER AIT.; REAL-TIME PCR; CLIMATE-CHANGE; WATER-STRESS; CA2+ CHANNEL; RNA-SEQ; IDENTIFICATION; SEQUENCE; TRANSCRIPTOME; ADAPTATION	Increasing drought periods as a result of global climate change pose a threat to many tree species by possibly outpacing their adaptive capabilities. Revealing the genetic basis of drought stress response is therefore implemental for future conservation strategies and risk assessment. Access to informative genomic regions is however challenging, especially for conifers, partially due to their large genomes, which puts constraints on the feasibility of whole genome scans. Candidate genes offer a valuable tool to reduce the complexity of the analysis and the amount of sequencing work and costs. For this study we combined an improved drought stress phenotyping of needles via a novel terahertz water monitoring technique with Massive Analysis of cDNA Ends to identify candidate genes for drought stress response in European silver fir (Abies alba Mill.). A pooled cDNA library was constructed from the cotyledons of six drought stressed and six well-watered silver fir seedlings, respectively. Differential expression analyses of these libraries revealed 296 candidate genes for drought stress response in silver fir (247 up-and 49 down-regulated) of which a subset was validated by RT-qPCR of the twelve individual cotyledons. A majority of these genes code for currently uncharacterized proteins and hint on new genomic resources to be explored in conifers. Furthermore, we could show that some traditional reference genes from model plant species (GAPDH and eIF4A2) are not suitable for differential analysis and we propose a new reference gene, TPC1, for drought stress expression profiling in needles of conifer seedlings.	[Behringer, David; Zimmermann, Heike; Ziegenhagen, Birgit; Liepelt, Sascha] Univ Marburg, Conservat Biol Grp, D-35032 Marburg, Germany	Philipps University Marburg	Behringer, D (corresponding author), Univ Marburg, Conservat Biol Grp, D-35032 Marburg, Germany.	david.behringer@biologie.uni-marburg.de	Liepelt, Sascha/H-1047-2011; Zimmermann, Heike H/Y-2973-2018; Zimmermann, Heike/AAC-8404-2022	Liepelt, Sascha/0000-0001-6529-2882; Zimmermann, Heike H/0000-0002-0225-5176; 	LinkTree: Linking genetic variability with ecological responses to environmental changes: forest trees as model systems [01LC0822A]	LinkTree: Linking genetic variability with ecological responses to environmental changes: forest trees as model systems	Support was provided by LinkTree: Linking genetic variability with ecological responses to environmental changes: forest trees as model systems (Grant number: 01LC0822A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Born N, 2014, PLANT PHYSIOL, V164, P1571, DOI 10.1104/pp.113.233601; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bu QY, 2009, PLANT PHYSIOL, V150, P463, DOI 10.1104/pp.109.135269; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cailleret M, 2014, ANN FOREST SCI, V71, P643, DOI 10.1007/s13595-013-0265-0; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Desprez-Loustau ML, 2006, ANN FOREST SCI, V63, P597, DOI 10.1051/forest:2006040; Dubos C, 2003, PLANT MOL BIOL, V51, P249, DOI 10.1023/A:1021168811590; Durand-Gillmann M, 2014, ANN FOREST SCI, V71, P659, DOI 10.1007/s13595-012-0251-y; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Fossdal CG, 2007, PHYSIOL MOL PLANT P, V70, P161, DOI 10.1016/j.pmpp.2007.09.002; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Goncalves S, 2005, PLANTA, V222, P556, DOI 10.1007/s00425-005-1562-0; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Guo Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S2; Hamanishi ET, 2011, FORESTRY, V84, P273, DOI 10.1093/forestry/cpr012; Hansen OK, 2005, MOL ECOL NOTES, V5, P784, DOI 10.1111/j.1471-8286.2005.01062.x; IPCC, 2007, CLIMATE CHANGE 2007; Kahl G, 2012, J PLANT BIOCHEM BIOT, V21, pS119, DOI 10.1007/s13562-012-0129-y; Konczal M, 2014, MOL ECOL RESOUR, V14, P381, DOI 10.1111/1755-0998.12186; KONNERT M, 1995, PLANT SYST EVOL, V196, P19, DOI 10.1007/BF00985333; Kubista M, 2012, QUANTITATIVE REAL-TIME PCR IN APPLIED MICROBIOLOGY, P63; Kurusu T, 2005, PLANT J, V42, P798, DOI 10.1111/j.1365-313X.2005.02415.x; Lebourgeois F, 2007, ANN FOREST SCI, V64, P333, DOI 10.1051/forest:2007010; Lenz TL, 2013, MOL ECOL, V22, P774, DOI 10.1111/j.1365-294X.2012.05756.x; Linares J. C., 2012, FORESTRY, V2012, DOI [10.5402/2012/437690, DOI 10.5402/2012/437690]; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Macias M, 2006, CLIMATIC CHANGE, V79, P289, DOI 10.1007/s10584-006-9071-0; MALEHORN DE, 1994, PLANT PHYSIOL, V106, P1471, DOI 10.1104/pp.106.4.1471; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Muller T, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0816-z; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nourtier M, 2014, ANN FOREST SCI, V71, P683, DOI 10.1007/s13595-012-0229-9; Palovaara J, 2008, PLANT MOL BIOL, V66, P533, DOI 10.1007/s11103-008-9289-5; Pauletto M, 2014, FISH SHELLFISH IMMUN, V37, P154, DOI 10.1016/j.fsi.2014.01.017; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peguero-Pina JJ, 2007, FLORA, V202, P226, DOI 10.1016/j.flora.2006.06.004; Perdiguero P, 2012, PLANT PHYSIOL BIOCH, V50, P44, DOI 10.1016/j.plaphy.2011.09.022; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, 3 2 MARKERS OF A SUC, P90; Pinosio S, 2014, MOL ECOL RESOUR, V14, P846, DOI 10.1111/1755-0998.12232; Piovani P, 2011, TREE PHYSIOL, V31, P500, DOI 10.1093/treephys/tpr029; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-484; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Siqueira M, 2013, COMPREHENSIVE SURVEY, DOI [10.1016/j.yrtph.2010.06.017, DOI 10.1016/J.YRTPH.2010.06.017]; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tenea Gabriela N, 2011, BMC Res Notes, V4, P373, DOI 10.1186/1756-0500-4-373; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Toromani E, 2011, CAN J FOREST RES, V41, P1795, DOI [10.1139/x11-096, 10.1139/X11-096]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco-Conde T, 2012, TREE GENET GENOMES, V8, P957, DOI 10.1007/s11295-012-0476-9; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang YJ, 2005, J EXP BOT, V56, P3051, DOI 10.1093/jxb/eri302; Witmer X, 2003, SEED SCI RES, V13, P167, DOI 10.1079/SSR2003134; WU SC, 1994, PLANT PHYSIOL, V106, P1709, DOI 10.1104/pp.106.4.1709; Yakovlev I, 2012, SEED SCI RES, V22, P63, DOI 10.1017/S0960258511000535; Yang YZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-140; Zhao XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111915; Zheng XM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S13-S7	76	34	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124564	10.1371/journal.pone.0124564	http://dx.doi.org/10.1371/journal.pone.0124564			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25924061	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600093
J	Deng, Q; Hui, DF; Wang, JM; Iwuozo, S; Yu, CL; Jima, T; Smart, D; Reddy, C; Dennis, S				Deng, Qi; Hui, Dafeng; Wang, Junming; Iwuozo, Stephen; Yu, Chih-Li; Jima, Tigist; Smart, David; Reddy, Chandra; Dennis, Sam			Corn Yield and Soil Nitrous Oxide Emission under Different Fertilizer and Soil Management: A Three-Year Field Experiment in Middle Tennessee	PLOS ONE			English	Article							GREENHOUSE-GAS FLUXES; N2O EMISSIONS; SLOW PYROLYSIS; BIOCHAR; TILLAGE; TEMPERATURE; DYNAMICS; SYSTEMS; CARBON	Background A three-year field experiment was conducted to examine the responses of corn yield and soil nitrous oxide (N2O) emission to various management practices in middle Tennessee. Methodology/Principal Findings The management practices include no-tillage + regular applications of urea ammonium nitrate (NT-URAN); no-tillage + regular applications of URAN + denitrification inhibitor (NT-inhibitor); no-tillage + regular applications of URAN + biochar (NT-biochar); no-tillage + 20% applications of URAN + chicken litter (NT-litter), no-tillage + split applications of URAN (NT-split); and conventional tillage + regular applications of URAN as a control (CT-URAN). Fertilizer equivalent to 217 kg N ha(-1) was applied to each of the experimental plots. Results showed that no-tillage (NT-URAN) significantly increased corn yield by 28% over the conventional tillage (CT-URAN) due to soil water conservation. The management practices significantly altered soil N2O emission, with the highest in the CT-URAN (0.48 mg N(2)Om(-2) h(-1)) and the lowest in the NT-inhibitor (0.20 mg N(2)Om(-2) h(-1)) and NT-biochar (0.16 mg N(2)Om(-2) h(-1)) treatments. Significant exponential relationships between soil N2O emission and water filled pore space were revealed in all treatments. However, variations in soil N2O emission among the treatments were positively correlated with the moisture sensitivity of soil N2O emission that likely reflects an interactive effect between soil properties and WFPS. Conclusion/Significance Our results indicated that improved fertilizer and soil management have the potential to maintain highly productive corn yield while reducing greenhouse gas emissions.	[Deng, Qi; Hui, Dafeng; Iwuozo, Stephen; Yu, Chih-Li; Jima, Tigist; Reddy, Chandra; Dennis, Sam] Tennessee State Univ, Coll Agr Human & Nat Sci, Nashville, TN 37209 USA; [Wang, Junming] Univ Illinois, Prairie Res Inst, Illinois State Water Survey, Climate Sci Sect, Champaign, IL 61802 USA; [Smart, David] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	Tennessee State University; Illinois State Water Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis	Hui, DF (corresponding author), Tennessee State Univ, Coll Agr Human & Nat Sci, Nashville, TN 37209 USA.	dhui@tnstate.edu	Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	USDA- Capacity Building Grants; Evans-Allen grants	USDA- Capacity Building Grants; Evans-Allen grants	This work was financially supported by USDA- Capacity Building Grants and Evans-Allen grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adviento-Borbe MAA, 2007, GLOBAL CHANGE BIOL, V13, P1972, DOI 10.1111/j.1365-2486.2007.01421.x; Asai H, 2009, FIELD CROP RES, V111, P81, DOI 10.1016/j.fcr.2008.10.008; AULAKH MS, 1984, J ENVIRON QUAL, V13, P130, DOI 10.2134/jeq1984.00472425001300010024x; Bhatia A, 2010, AGR ECOSYST ENVIRON, V136, P247, DOI 10.1016/j.agee.2010.01.004; Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chen Y, 2011, SOIL TILL RES, V115, P56, DOI 10.1016/j.still.2011.06.007; Choudhary MA, 2002, AGR ECOSYST ENVIRON, V93, P33, DOI 10.1016/S0167-8809(02)00005-1; CRS, 2010, R40874 CRS; Cullum RF, 2012, SOIL TILL RES, V119, P1, DOI 10.1016/j.still.2011.11.011; Davidson E. A., 1991, Microbial production and consumption of greenhouse gases: methane, nitrogen oxides, and halomethanes., P219; DAVIDSON EA, 1986, APPL ENVIRON MICROB, V52, P1287, DOI 10.1128/AEM.52.6.1287-1292.1986; DeFelice MS, 2006, CROP MANAGEMENT, V5, DOI [10.1094/CM-2006-0626-01-RS, DOI 10.1094/CM-2006-0626-01-RS]; Dobbie KE, 2003, GLOBAL CHANGE BIOL, V9, P204, DOI 10.1046/j.1365-2486.2003.00563.x; Downie A., 2009, BIOCHAR ENV MANAGEME, V13, P32, DOI [10.4324/9781849770552, DOI 10.4324/9781849770552]; EPA, 2009, MAJ CROPS GROWN US A; Franzluebbers AJ, 2005, SOIL TILL RES, V83, P120, DOI 10.1016/j.still.2005.02.012; FRANZLUEBBERS AJ, 1995, SOIL SCI SOC AM J, V59, P1618, DOI 10.2136/sssaj1995.03615995005900060016x; Halvorson AD, 2005, AGRON J, V97, P1222, DOI 10.2134/agronj2004.0279; Huang H, 2014, ATMOS CHEM PHYS, V14, P12839, DOI 10.5194/acp-14-12839-2014; Kelliher FM, 2008, SOIL BIOL BIOCHEM, V40, P1878, DOI 10.1016/j.soilbio.2008.03.013; Kennedy TL, 2013, AGR ECOSYST ENVIRON, V170, P16, DOI 10.1016/j.agee.2013.02.002; Kim DG, 2013, AGR ECOSYST ENVIRON, V168, P53, DOI 10.1016/j.agee.2012.02.021; Kloss S, 2012, J ENVIRON QUAL, V41, P990, DOI 10.2134/jeq2011.0070; Lentz RD, 2014, J ENVIRON QUAL, V41, P1033; Linquist B, 2012, GLOBAL CHANGE BIOL, V18, P194, DOI 10.1111/j.1365-2486.2011.02502.x; Ma BL, 2010, GLOBAL CHANGE BIOL, V16, P156, DOI 10.1111/j.1365-2486.2009.01932.x; McSwiney CP, 2005, GLOBAL CHANGE BIOL, V11, P1712, DOI 10.1111/j.1365-2486.2005.01040.x; Menneer JC, 2008, AUST J SOIL RES, V46, P323, DOI 10.1071/SR06180; Molodovskaya M, 2011, SOIL SCI SOC AM J, V75, P1829, DOI 10.2136/sssaj2010.0415; Mosier A., 2000, CHEM GLOB CHANG SCI, V2, P465, DOI [10.1016/S1465-9972, DOI 10.1016/S1465-9972(00)00039-8, 10.1016/S1465-9972(00)00039-8]; Neftel A, 2007, TELLUS B, V59, P470, DOI 10.1111/j.1600-0889.2007.00273.x; Ogle S, 2008, LIFECYCLE CARBON FOO, P11; Parkin TB, 2006, J ENVIRON QUAL, V35, P1496, DOI 10.2134/jeq2005.0183; Phillips RL, 2009, J ENVIRON QUAL, V38, P1569, DOI 10.2134/jeq2008.0483; Rochette P, 2010, EUR J SOIL SCI, V61, P186, DOI 10.1111/j.1365-2389.2009.01222.x; Saarnio S, 2013, SOIL BIOL BIOCHEM, V58, P99, DOI 10.1016/j.soilbio.2012.10.035; Sainju UM, 2014, J ENVIRON QUAL, V43, P777, DOI 10.2134/jeq2013.10.0405; Schellenberg DL, 2012, AGR ECOSYST ENVIRON, V155, P7, DOI 10.1016/j.agee.2012.03.008; Singurindy O, 2009, AGR ECOSYST ENVIRON, V132, P74, DOI 10.1016/j.agee.2009.03.001; Smart DR, 2011, ACS SYM SER, V1072, P227; Ussiri DAN, 2009, SOIL TILL RES, V104, P247, DOI 10.1016/j.still.2009.03.001; Van Groenigen JW, 2010, EUR J SOIL SCI, V61, P903, DOI 10.1111/j.1365-2389.2009.01217.x; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; Venterea RT, 2011, J ENVIRON QUAL, V40, P1521, DOI 10.2134/jeq2011.0039; Verhoeven E, 2014, AGR ECOSYST ENVIRON, V191, P27, DOI 10.1016/j.agee.2014.03.008; Zheng JY, 2012, J ENVIRON QUAL, V41, P1361, DOI 10.2134/jeq2012.0019	48	25	25	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125406	10.1371/journal.pone.0125406	http://dx.doi.org/10.1371/journal.pone.0125406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923716	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600150
J	Eren, MK; Kilincli, A; Eren, O				Eren, Mehtap Kilic; Kilincli, Ayten; Eren, Ozkan			Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation	PLOS ONE			English	Article							CELLULAR SENESCENCE; LIFE-SPAN; IN-VIVO; CANCER; CELLS; PATHWAYS; SIRTUINS; HEALTHSPAN; INHIBITORS; STRESS	The natural polyphenolic compound resveratrol (3,4,5-trihydroxy-trans-stilbene) has broad spectrum health beneficial activities including antioxidant, anti-inflammatory, anti-aging, anti-cancer, cardioprotective, and neuroprotective effects. Remarkably, resveratrol also induces apoptosis and cellular senescence in primary and cancer cells. Resveratrol's anti-aging effects both in vitro and in vivo attributed to activation of a (NAD)-dependent histone deacetylase family member sirtuin-1 (SIRT1) protein. In mammals seven members (SIRT17) of sirtuin family have been identified. Among those, SIRT1 is the most extensively studied with perceptive effects on mammalian physiology and suppression of the diseases of aging. Yet no data has specified the role of sirtuins, under conditions where resveratrol treatment induces senescence. Current study was undertaken to investigate the effects of resveratrol in human primary dermal fibroblasts (BJ) and to clarify the role of sirtuin family members in particular SIRT1 and SIRT2 that are known to be involved in cellular stress responses and cell cycle, respectively. Here, we show that resveratrol decreases proliferation of BJ cells in a time and dose dependent manner. In addition the increase in senescence associated beta-galactosidase (SA-beta-gal) activity and methylated H3K9-me indicate the induction of premature senescence. A significant increase in phosphorylation of gamma-H2AX, a surrogate of DNA double strand breaks, as well as in levels of p53, p21(CIP1) and p16(INK4A) is also detected. Interestingly, at concentrations where resveratrol induced premature senescence we show a significant decrease in SIRT1 and SIRT2 levels by Western Blot and quantitative RT-PCR analysis. Conversely inhibition of SIRT1 and SIRT2 via siRNA or sirtinol treatment also induced senescence in BJ fibroblasts associated with increased SA-beta-gal activity, gamma-H2AX phosphorylation and p53, p21CIP1 and p16INK4A levels. Interestingly DNA damaging agent doxorubicin also induced senescence in BJ fibroblasts associated with decreased SIRT1/2 levels. In conclusion our data reveal that resveratrol induced premature senescence is associated with SIRT1 and SIRT2 down regulation in human dermal fibroblasts. Here we suggest that the concomitant decline in SIRT1/2 expression in response to resveratrol treatment may be a cause for induction of senescence, which is most likely mediated by a regulatory mechanism activated by DNA damage response.	[Eren, Mehtap Kilic] Adnan Menderes Univ, Sch Med, Dept Med Biol, Aydin, Turkey; [Eren, Mehtap Kilic] Adnan Menderes Univ, Sci & Technol Res & Applicat Ctr, ADU BILTEM, Aydin, Turkey; [Kilincli, Ayten; Eren, Ozkan] Adnan Menderes Univ, Dept Biol, Aydin, Turkey	Adnan Menderes University; Adnan Menderes University; Adnan Menderes University	Eren, MK (corresponding author), Adnan Menderes Univ, Sch Med, Dept Med Biol, Aydin, Turkey.	mkilic@adu.edu.tr	Kilincli, Ayten/ABI-3408-2020	Kilincli, Ayten/0000-0003-0907-0737	Adnan Menderes University Scientific Research Foundation [FEF-12036]; TUBITAK [108S3789, 108S3789 Cost-BM0703CANGENIN]	Adnan Menderes University Scientific Research Foundation(Adnan Menderes University); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work is supported by Adnan Menderes University Scientific Research Foundation to OE (FEF-12036) and by TUBITAK (http://www.tubitak.gov.tr/en) grant to MKE (108S3789 Cost-BM0703CANGENIN). AK was financed by TUBITAK (108S3789 to MKE).	Agarwal B, 2011, ANN NY ACAD SCI, V1215, P138, DOI 10.1111/j.1749-6632.2010.05850.x; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Binda O, 2008, ONCOGENE, V27, P3384, DOI 10.1038/sj.onc.1211014; Borriello A, 2014, CANCER TREAT RES, V159, P167, DOI 10.1007/978-3-642-38007-5_10; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Cao C, 2009, J CELL MOL MED, V13, P3632, DOI 10.1111/j.1582-4934.2008.00453.x; Carnero Amancio, 2013, Methods Mol Biol, V965, P63, DOI 10.1007/978-1-62703-239-1_4; Carter LG, 2014, ENDOCR-RELAT CANCER, V21, pR209, DOI 10.1530/ERC-13-0171; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dehennaut V, 2013, J BIOL CHEM, V288, P10254, DOI 10.1074/jbc.M112.421610; Demidenko ZN, 2009, CELL CYCLE, V8, P1901, DOI 10.4161/cc.8.12.8810; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eren MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101064; Faragher RGA, 2011, AGE, V33, P555, DOI 10.1007/s11357-010-9201-5; Gao Z, 2011, BIOCHEM BIOPH RES CO, V407, P271, DOI 10.1016/j.bbrc.2011.02.008; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Guarente L, 2007, COLD SH Q B, V72, P483, DOI 10.1101/sqb.2007.72.024; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kilic M, 2008, BEYOND APOPTOSIS CEL, P273; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Lee James T, 2013, Genes Cancer, V4, P112, DOI 10.1177/1947601913484496; Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Rood BR, 2013, EXPERT OPIN THER TAR, V17, P811, DOI 10.1517/14728222.2013.788152; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Stefani M, 2007, ANN NY ACAD SCI, V1114, P407, DOI 10.1196/annals.1396.001; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Yamashita S, 2012, BIOCHEM BIOPH RES CO, V417, P630, DOI 10.1016/j.bbrc.2011.12.021; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070627	43	39	40	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124837	10.1371/journal.pone.0124837	http://dx.doi.org/10.1371/journal.pone.0124837			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25924011	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600105
J	Terranova, C; Narla, ST; Lee, YW; Bard, J; Parikh, A; Stachowiak, EK; Tzanakakis, ES; Buck, MJ; Birkaya, B; Stachowiak, MK				Terranova, Christopher; Narla, Sridhar T.; Lee, Yu-Wei; Bard, Jonathan; Parikh, Abhirath; Stachowiak, Ewa K.; Tzanakakis, Emmanuel S.; Buck, Michael J.; Birkaya, Barbara; Stachowiak, Michal K.			Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1)	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PATHWAY MEDIATES ACTIVATION; GROUP PROTEIN SUZ12; RETINOIC-ACID; INTRACELLULAR TRAFFICKING; MORPHOGENETIC MOVEMENT; SIGNALING PATHWAY; ANGIOTENSIN-II; NITRIC-OXIDE; NEUROGENESIS	Genetic studies have placed the Fgfr1 gene at the top of major ontogenic pathways that enable gastrulation, tissue development and organogenesis. Using genome-wide sequencing and loss and gain of function experiments the present investigation reveals a mechanism that underlies global and direct gene regulation by the nuclear form of FGFR1, ensuring that pluripotent Embryonic Stem Cells differentiate into Neuronal Cells in response to Retinoic Acid. Nuclear FGFR1, both alone and with its partner nuclear receptors RXR and Nur77, targets thousands of active genes and controls the expression of pluripotency, homeobox, neuronal and mesodermal genes. Nuclear FGFR1 targets genes in developmental pathways represented by Wnt/beta-catenin, CREB, BMP, the cell cycle and cancer-related TP53 pathway, neuroectodermal and mesodermal programing networks, axonal growth and synaptic plasticity pathways. Nuclear FGFR1 targets the consensus sequences of transcription factors known to engage CREB-binding protein, a common coregulator of transcription and established binding partner of nuclear FGFR1. This investigation reveals the role of nuclear FGFR1 as a global genomic programmer of cell, neural and muscle development.	[Terranova, Christopher; Narla, Sridhar T.; Lee, Yu-Wei; Stachowiak, Ewa K.; Birkaya, Barbara; Stachowiak, Michal K.] SUNY Buffalo, Dept Pathol & Anat Sci, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14260 USA; [Bard, Jonathan] SUNY Buffalo, Next Generat Sequencing & Express Anal Core, Buffalo, NY 14260 USA; [Parikh, Abhirath; Tzanakakis, Emmanuel S.] SUNY Buffalo, Dept Chem & Biol Engn, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14260 USA; [Buck, Michael J.] SUNY Buffalo, Dept Biochem Genom & Bioinformat Core, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Stachowiak, MK (corresponding author), SUNY Buffalo, Dept Pathol & Anat Sci, Western New York Stem Cell Culture & Anal Ctr, Buffalo, NY 14260 USA.	mks4@buffalo.edu	Tzanakakis, Emmanuel S/F-6868-2015; Tzanakakis, Emmanuel/S-7617-2019	Tzanakakis, Emmanuel S/0000-0002-6677-352X; Tzanakakis, Emmanuel/0000-0002-6677-352X; Narla, Sridhar/0000-0001-9066-2072; Bard, Jonathan/0000-0001-7433-0086; Terranova, Christopher/0000-0002-3674-7013	Western New York Stem Cell Center [C026415, C026714]; Patrick Lee Foundation; National Institute of Heath [HL103709]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103709] Funding Source: NIH RePORTER	Western New York Stem Cell Center; Patrick Lee Foundation; National Institute of Heath; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by Western New York Stem Cell Center C026415, C026714 to MKS and EKS; Patrick Lee Foundation to MKS; National Institute of Heath HL103709 to EST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Akanuma Hiromi, 2012, Frontiers in Genetics, V3, P141, DOI 10.3389/fgene.2012.00141; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Baron O, 2012, J BIOL CHEM, V287, P19827, DOI 10.1074/jbc.M112.347831; Bertrand S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-226; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Bobbs AS, 2012, J BIOL CHEM, V287, P38505, DOI 10.1074/jbc.M112.400598; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chioni AM, 2012, J CELL BIOL, V197, P801, DOI 10.1083/jcb.201108077; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; Clarke WE, 2001, MOL CELL NEUROSCI, V17, P17, DOI 10.1006/mcne.2000.0920; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Coleman SJ, 2014, EMBO MOL MED, V6, P467, DOI 10.1002/emmm.201302698; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dottori M, 2001, DEVELOPMENT, V128, P4127; Dunham-Ems SM, 2009, MOL BIOL CELL, V20, P2401, DOI 10.1091/mbc.E08-06-0600; Fang XH, 2005, J BIOL CHEM, V280, P28451, DOI 10.1074/jbc.M504400200; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Horbinski C, 2002, J NEUROCHEM, V80, P54, DOI 10.1046/j.0022-3042.2001.00657.x; Hu YF, 2004, J BIOL CHEM, V279, P29325, DOI 10.1074/jbc.M311144200; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kehoe DE, 2008, BIOTECHNOL PROGR, V24, P1342, DOI 10.1002/btpr.57; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Lee YM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210604; Lee YW, 2012, J CELL BIOCHEM, V113, P2920, DOI 10.1002/jcb.24170; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maher PA, 1996, J CELL BIOL, V134, P529, DOI 10.1083/jcb.134.2.529; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Montavon T, 2014, SEMIN CELL DEV BIOL, V34, P76, DOI 10.1016/j.semcdb.2014.06.005; MorrissKay GM, 1996, FASEB J, V10, P961, DOI 10.1096/fasebj.10.9.8801178; Myers JM, 2003, J CELL BIOCHEM, V88, P1273, DOI 10.1002/jcb.10476; Narla ST, 2013, STEM CELL TRANSL MED, V2, P776, DOI 10.5966/sctm.2012-0103; Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pendaries V, 2003, ONCOGENE, V22, P8212, DOI 10.1038/sj.onc.1206913; Peng H, 2002, J NEUROCHEM, V81, P506, DOI 10.1046/j.1471-4159.2002.00833.x; Peng H, 2001, MOL BIOL CELL, V12, P449, DOI 10.1091/mbc.12.2.449; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popovici C, 2006, EXP CELL RES, V312, P1484, DOI 10.1016/j.yexcr.2006.01.012; Qin LL, 2013, BLOOD, V121, P2154, DOI 10.1182/blood-2012-07-443903; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; SHERMAN L, 1993, DEVELOPMENT, V118, P1313; Stachowiak EK, 2003, J NEUROCHEM, V84, P1296, DOI 10.1046/j.1471-4159.2003.01624.x; Stachowiak EK, 2011, STEM CELLS MECH TECH, P333; Stachowiak EK, 2009, INTEGR BIOL-UK, V1, P394, DOI 10.1039/b902617g; Stachowiak M. K., 2011, STEM CELLS MECH TECH, P87; Stachowiak MK, 2007, DNA CELL BIOL, V26, P811, DOI 10.1089/dna.2007.0664; Stachowiak MK, 1996, MOL BIOL CELL, V7, P1299, DOI 10.1091/mbc.7.8.1299; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stachowiak MK, 1996, MOL BRAIN RES, V38, P161, DOI 10.1016/0169-328X(96)00010-1; Stuhlmiller TJ, 2012, DEVELOPMENT, V139, P289, DOI 10.1242/dev.070276; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uchimura K, 2001, HEPATOLOGY, V33, P91, DOI 10.1053/jhep.2001.21145; Xiao Z, 2006, MOL CANCER THER, V5, P1935, DOI 10.1158/1535-7163.MCT-06-0077; Zhang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4330; Zhao DZ, 2011, P NATL ACAD SCI USA, V108, P12066, DOI 10.1073/pnas.1018438108	71	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123380	10.1371/journal.pone.0123380	http://dx.doi.org/10.1371/journal.pone.0123380			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923916	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600045
J	Xu, YC; Chu, LL; Jin, QJ; Wang, YJ; Chen, X; Zhao, H; Xue, ZY				Xu, Yingchun; Chu, Lingling; Jin, Qijiang; Wang, Yanjie; Chen, Xian; Zhao, Hui; Xue, Zeyun			Transcriptome-Wide Identification of miRNAs and Their Targets from Typha angustifolia by RNA-Seq and Their Response to Cadmium Stress	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; GRAPEVINE MICRORNAS; NONCODING RNAS; ARABIDOPSIS; GENES; TOOL; MERCURY; ANNOTATION; BIOGENESIS; DISCOVERY	MicroRNAs (miRNAs) play important roles in plant responses to environmental stress. In this work, we used high-throughput sequencing to analyze transcriptome and small RNAs (sRNAs) in Typha angustifoliaunder cadmium (Cd) stress. 57,608,230 raw reads were obtained from deep sequencing of a pooled cDNA library. Sequence assembly and analysis yielded 102,473 unigenes. We subsequently sequenced two sRNA libraries from T. angustifolia with or without Cd exposure respectively. Based on transcriptome data of T. angustifolia, we catalogued and analyzed the sRNAs, resulting in the identification of 114 conserved miRNAs and 41 novel candidate miRNAs in both small RNA libraries. In silicoanalysis revealed 764 targets for 89 conserved miRNAs and 21 novel miRNAs. Statistical analysis on sequencing reads abundance and experimental validation revealed that 4 conserved and 6 novel miRNAs showed specific expression. Combined with function of target genes, these results suggested that miRNAs might play a role in plant Cd stress response. This study provided the first transcriptome-based analysis of miRNAs and their targets responsive to Cd stress in T. angustifolia, which provide a framework for further analysis of miRNAs and their role in regulating plant responses to Cd stress.	[Xu, Yingchun; Chu, Lingling; Jin, Qijiang; Wang, Yanjie; Chen, Xian; Zhao, Hui; Xue, Zeyun] Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xu, YC (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China.	xyc@njau.edu.cn			Natural Science Foundation of Jiangsu Province [BK2011640]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research was supported by the Natural Science Foundation of Jiangsu Province (Grant No. BK2011640, YX received this funding).	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bah AM, 2011, BIOL TRACE ELEM RES, V142, P77, DOI 10.1007/s12011-010-8746-6; Montero-Palmero MB, 2014, NEW PHYTOL, V201, P116, DOI 10.1111/nph.12486; Black H, 1995, ENVIRON HEALTH PERSP, V103, P1106, DOI 10.2307/3432605; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bressan R, 2009, MOL PLANT, V2, P1, DOI 10.1093/mp/ssn097; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Chakraborty D., 2013, INT J ENV SCI, V3, P2291, DOI DOI 10.6088/IJES.2013030600045; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gielen H, 2012, INT J MOL SCI, V13, P15826, DOI 10.3390/ijms131215826; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Khraiwesh B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060774; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindow M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-119; Macovei A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-183; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Martin RC, 2010, SEED SCI RES, V20, P79, DOI 10.1017/S0960258510000085; Martinka M, 2014, PLANT CELL MONOGR, V22, P209, DOI 10.1007/978-3-642-41787-0_7; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Patra M, 2004, ENVIRON EXP BOT, V52, P199, DOI 10.1016/j.envexpbot.2004.02.009; Patra M, 2000, BOT REV, V66, P379, DOI 10.1007/BF02868923; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rellan-Alvarez R, 2006, PLANT SOIL, V279, P41, DOI 10.1007/s11104-005-3900-1; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xu L, 2013, J EXP BOT, V64, P4271, DOI 10.1093/jxb/ert240; Xu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069995; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072840; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	19	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125462	10.1371/journal.pone.0125462	http://dx.doi.org/10.1371/journal.pone.0125462			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923807	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600152
J	Goodlin, GT; Roos, AK; Roos, TR; Hawkins, C; Beache, S; Baur, S; Kim, SK				Goodlin, Gabrielle T.; Roos, Andrew K.; Roos, Thomas R.; Hawkins, Claire; Beache, Sydney; Baur, Stephen; Kim, Stuart K.			Applying Personal Genetic Data to Injury Risk Assessment in Athletes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CRUCIATE LIGAMENT RUPTURES; PROFESSIONAL SOCCER PLAYERS; ELITE SPORTING PERFORMANCE; SOFT-TISSUE INJURIES; ACHILLES TENDINOPATHY; COL5A1 GENE; RUNNING INJURIES; COMMON VARIANTS; POLYMORPHISM	Recent studies have identified genetic markers associated with risk for certain sports-related injuries and performance-related conditions, with the hope that these markers could be used by individual athletes to personalize their training and diet regimens. We found that we could greatly expand the knowledge base of sports genetic information by using published data originally found in health and disease studies. For example, the results from large genome-wide association studies for low bone mineral density in elderly women can be re-purposed for low bone mineral density in young endurance athletes. In total, we found 124 single-nucleotide polymorphisms associated with: anterior cruciate ligament tear, Achilles tendon injury, low bone mineral density and stress fracture, osteoarthritis, vitamin/mineral deficiencies, and sickle cell trait. Of these single nucleotide polymorphisms, 91% have not previously been used in sports genetics. We conducted a pilot program on fourteen triathletes using this expanded knowledge base of genetic variants associated with sports injury. These athletes were genotyped and educated about how their individual genetic make-up affected their personal risk profile during an hour-long personal consultation. Overall, participants were favorable of the program, found it informative, and most acted upon their genetic results. This pilot program shows that recent genetic research provides valuable information to help reduce sports injuries and to optimize nutrition. There are many genetic studies for health and disease that can be mined to provide useful information to athletes about their individual risk for relevant injuries.	[Goodlin, Gabrielle T.; Baur, Stephen; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Goodlin, Gabrielle T.; Baur, Stephen; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Roos, Andrew K.; Roos, Thomas R.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA; [Hawkins, Claire; Beache, Sydney] Stanford Univ, Dept Human Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA.	stuartkm@stanford.edu		Roos, Thomas/0000-0003-3677-3219	NIH/Stanford University [S13-064]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	NIH/Stanford University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported by a Spectrum grant from NIH/Stanford University (#S13-064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Alfredson H, 1998, AM J SPORT MED, V26, P360, DOI 10.1177/03635465980260030301; [Anonymous], 2013, WORLD TRIATHL SER RE; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Bennell K, 1999, SPORTS MED, V28, P91, DOI 10.2165/00007256-199928020-00004; Bennell K, 2012, NAT REV RHEUMATOL, V8, P747, DOI 10.1038/nrrheum.2012.119; Bohl CH, 2002, CRIT REV FOOD SCI, V42, P533, DOI 10.1080/20024091054247; Caine DJ, 2011, BRIT J SPORT MED, V45, P298, DOI 10.1136/bjsm.2010.081984; Collins M, 2010, BRIT J SPORT MED, V44, P915, DOI 10.1136/bjsm.2009.058040; Collins M, 2010, BRIT J SPORT MED, V44, P1063, DOI 10.1136/bjsm.2008.056184; Cupeiro R, 2010, J SCI MED SPORT, V13, P526, DOI 10.1016/j.jsams.2009.07.004; Daneshjoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050979; Egermann M, 2003, INT J SPORTS MED, V24, P271, DOI 10.1055/s-2003-39498; Eichner E Randy, 2007, Curr Sports Med Rep, V6, P134, DOI 10.1007/s11932-007-0016-9; Eirale C, 2013, BRIT J SPORT MED, V47, P807, DOI 10.1136/bjsports-2012-091040; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Field AE, 2011, ARCH PEDIAT ADOL MED, V165, P723, DOI 10.1001/archpediatrics.2011.34; Fujii K., 1994, SPORTS TRAUMATOL ART, V2, P229, DOI DOI 10.1007/BF01845593; Ghansah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034565; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hootman JM, 2007, J ATHL TRAINING, V42, P311; INGRAM VM, 1959, BIOCHIM BIOPHYS ACTA, V36, P402, DOI 10.1016/0006-3002(59)90183-0; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Jin H, 2011, OSTEOPOROSIS INT, V22, P911, DOI 10.1007/s00198-010-1364-5; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kader D, 2002, BRIT J SPORT MED, V36, P239, DOI 10.1136/bjsm.36.4.239; Kambouris M, 2014, TRANSL MED UNISA, V9, P18; Kambouris Marios, 2012, Recent Pat DNA Gene Seq, V6, P229; Kapur K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001035; Khoschnau S, 2008, AM J SPORT MED, V36, P2432, DOI 10.1177/0363546508320805; Klossner D, 2012, 2012 2013 NCAA SPORT; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Lange LA, 2010, HUM MOL GENET, V19, P2050, DOI 10.1093/hmg/ddq062; Lewiecki EM, 2009, J CLIN DENSITOM, V12, P135, DOI 10.1016/j.jocd.2009.02.002; Lin XL, 2012, HUM MOL GENET, V21, P2610, DOI 10.1093/hmg/dds062; Lopes AD, 2012, SPORTS MED, V42, P891, DOI [10.2165/11631170-000000000-00000, 10.1007/BF03262301]; Maffulli N, 2004, J ROY SOC MED, V97, P472, DOI 10.1258/jrsm.97.10.472; Maffulli Nicola, 2013, Muscles Ligaments Tendons J, V3, P173; Mafi N, 2001, KNEE SURG SPORT TR A, V9, P42, DOI 10.1007/s001670000148; Major JM, 2011, HUM MOL GENET, V20, P3876, DOI 10.1093/hmg/ddr296; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Mokone GG, 2006, SCAND J MED SCI SPOR, V16, P19, DOI 10.1111/j.1600-0838.2005.00439.x; Mokone GG, 2005, AM J SPORT MED, V33, P1016, DOI 10.1177/0363546504271986; Nell EM, 2012, J ORTHOP RES, V30, P1719, DOI 10.1002/jor.22144; O'Seaghdha CM, 2010, HUM MOL GENET, V19, P4296, DOI 10.1093/hmg/ddq342; OBrien M, 1997, SCAND J MED SCI SPOR, V7, P55; Oexle K, 2011, HUM MOL GENET, V20, P1042, DOI 10.1093/hmg/ddq538; OTOOLE ML, 1989, AM J SPORT MED, V17, P514, DOI 10.1177/036354658901700411; Pare G, 2009, CIRC-CARDIOVASC GENE, V2, P142, DOI 10.1161/CIRCGENETICS.108.829804; Paternoster L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001217; Pitsiladis Y, 2013, BRIT J SPORT MED, V47, P550, DOI 10.1136/bjsports-2013-092400; Posthumus M, 2012, SCAND J MED SCI SPOR, V22, P523, DOI 10.1111/j.1600-0838.2010.01270.x; Posthumus M, 2009, BRIT J SPORT MED, V43, P352, DOI 10.1136/bjsm.2008.056150; Posthumus M, 2010, RHEUMATOLOGY, V49, P2090, DOI 10.1093/rheumatology/keq072; Posthumus M, 2010, BRIT J SPORT MED, V44, P1160, DOI 10.1136/bjsm.2009.060756; Posthumus M, 2009, AM J SPORT MED, V37, P2234, DOI 10.1177/0363546509338266; Pruna R, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-221; Puddu G, 1976, Am J Sports Med, V4, P145, DOI 10.1177/036354657600400404; Raleigh SM, 2009, BRIT J SPORT MED, V43, P514, DOI 10.1136/bjsm.2008.053892; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Ryan K, 2010, BRIT J HAEMATOL, V149, P35, DOI 10.1111/j.1365-2141.2009.08054.x; Schneider KI, 2014, J COMMUN GENET, V5, P31, DOI 10.1007/s12687-013-0160-2; Schwellnus MP, 2013, BRIT J SPORT MED, V47, P530, DOI 10.1136/bjsports-2013-092515; September AV, 2009, BRIT J SPORT MED, V43, P357, DOI 10.1136/bjsm.2008.048793; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Teupser D, 2010, CIRC-CARDIOVASC GENE, V3, P331, DOI 10.1161/CIRCGENETICS.109.907873; Valdes AM, 2011, ANN RHEUM DIS, V70, P873, DOI 10.1136/ard.2010.134155; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wagner JK, 2012, J PERS MED, V2, P119, DOI 10.3390/jpm2030119; Wagner JK, 2013, VA SPORTS ENTERTAINM, V12, P1; Wang G, 2013, ADV GENET, V84, P123, DOI 10.1016/B978-0-12-407703-4.00004-9; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zhang LS, 2012, OSTEOPOROSIS INT, V23, P1867, DOI 10.1007/s00198-011-1863-z	77	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122676	10.1371/journal.pone.0122676	http://dx.doi.org/10.1371/journal.pone.0122676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919592	Green Published, gold			2022-12-26	WOS:000353659400017
J	Monen, J; Hattersley, N; Muroyama, A; Stevens, D; Oegema, K; Desai, A				Monen, Joost; Hattersley, Neil; Muroyama, Andrew; Stevens, Deanna; Oegema, Karen; Desai, Arshad			Separase Cleaves the N-Tail of the CENP-A Related Protein CPAR-1 at the Meiosis I Metaphase-Anaphase Transition in C-elegans	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHROMOSOME SEGREGATION; GENOME DUPLICATION; CELL-DIVISION; AUTO-CLEAVAGE; KINETOCHORE; CHROMATIN; EMBRYO; MEI-1/KATANIN; SUBSTRATE	Centromeres are defined epigenetically in the majority of eukaryotes by the presence of chromatin containing the centromeric histone H3 variant CENP-A. Most species have a single gene encoding a centromeric histone variant whereas C. elegans has two: HCP-3 (also known as CeCENP-A) and CPAR-1. Prior RNAi replacement experiments showed that HCP-3 is the functionally dominant isoform, consistent with CPAR-1 not being detectable in embryos. GFP::CPAR-1 is loaded onto meiotic chromosomes in diakinesis and is enriched on bivalents until meiosis I. Here we show that GFP:: CPAR-1 signal loss from chromosomes precisely coincides with homolog segregation during anaphase I. This loss of GFP:: CPAR-1 signal reflects proteolytic cleavage between GFP and the histone fold of CPAR-1, as CPAR-1:: GFP, in which GFP is fused to the C-terminus of CPAR-1, does not exhibit any loss of GFP signal. A focused candidate screen implicated separase, the protease that initiates anaphase by cleaving the kleisin subunit of cohesin, in this cleavage reaction. Examination of the N-terminal tail sequence of CPAR-1 revealed a putative separase cleavage site and mutation of the signature residues in this site eliminated the cleavage reaction, as visualized by retention of GFP::CPAR-1 signal on separating homologous chromosomes at the metaphase-anaphase transition of meiosis I. Neither cleaved nor uncleavable CPAR-1 were centromere-localized in mitosis and instead localized throughout chromatin, indicating that centromere activity has not been retained in CPAR-1. Although the functions of CPAR-1 and of its separase-dependent cleavage remain to be elucidated, this effort reveals a new substrate of separase and provides an in vivo biosensor to monitor separase activity at the onset of meiosis I anaphase.	[Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	abdesai@ucsd.edu		Muroyama, Andrew/0000-0003-0701-212X	NIH [GM074215]; Institutional Ruth L. Kirschstein National Research Service Award from the National Institute for General Medical Sciences [T32 GM008666]; Ramapo College Foundation and Faculty Development Fund; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215, T32GM007184, T32GM008666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Ruth L. Kirschstein National Research Service Award from the National Institute for General Medical Sciences; Ramapo College Foundation and Faculty Development Fund; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant (GM074215) to AD. JM was supported by an Institutional Ruth L. Kirschstein National Research Service Award from the National Institute for General Medical Sciences to the UCSD Genetics Training Program (T32 GM008666) and by a grant from the Ramapo College Foundation and Faculty Development Fund. AD and KO received salary and other support from the Ludwig Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Drinnenberg IA, 2014, ELIFE, V3, DOI 10.7554/eLife.03676; Dumont J, 2010, NAT CELL BIOL, V12, P894, DOI 10.1038/ncb2093; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016; Gassmann R, 2012, NATURE, V484, P534, DOI 10.1038/nature10973; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Heckmann S, 2013, PLANT CENTROMERE BIOLOGY, P83; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maddox PS, 2012, CURR OPIN GENET DEV, V22, P139, DOI 10.1016/j.gde.2011.11.005; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Papi M, 2005, NAT CELL BIOL, V7, P1029, DOI 10.1038/ncb1303; Pellettieri J, 2014, CELL, V5, P451, DOI [10.1016/S1534-5807(03)00231-4, DOI 10.1016/S1534-5807(03)00231-4]; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Praitis V, 2001, GENETICS, V157, P1217; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Robertson S, 2013, ADV EXP MED BIOL, V757, P351, DOI 10.1007/978-1-4614-4015-4_12; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sekulic N, 2012, TRENDS BIOCHEM SCI, V37, P220, DOI 10.1016/j.tibs.2012.01.003; Severson AF, 2014, ELIFE, V3, DOI 10.7554/eLife.03467; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Srayko M, 2000, GENE DEV, V14, P1072; Sullivan M, 2004, J BIOL CHEM, V279, P1191, DOI 10.1074/jbc.M309761200; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Verlhac MH, 2010, CURR OPIN CELL BIOL, V22, P758, DOI 10.1016/j.ceb.2010.09.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westhorpe FG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015818; Zou H, 2002, FEBS LETT, V528, P246, DOI 10.1016/S0014-5793(02)03238-6	47	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125382	10.1371/journal.pone.0125382	http://dx.doi.org/10.1371/journal.pone.0125382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919583	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400083
J	Berent-Maoz, B; Montecino-Rodriguez, E; Fice, M; Casero, D; Seet, CS; Crooks, GM; Lowry, W; Dorshkind, K				Berent-Maoz, Beata; Montecino-Rodriguez, Encarnacion; Fice, Michael; Casero, David; Seet, Christopher S.; Crooks, Gay M.; Lowry, William; Dorshkind, Kenneth			The Expansion of Thymopoiesis in Neonatal Mice Is Dependent on Expression of High Mobility Group A 2 Protein (Hmga2)	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; FETAL; PROGENITORS; AXIS	Cell number in the mouse thymus increases steadily during the first two weeks after birth. It then plateaus and begins to decline by seven weeks after birth. The factors governing these dramatic changes in cell production are not well understood. The data herein correlate levels of High mobility group A 2 protein (Hmga2) expression with these temporal changes in thymopoiesis. Hmga2 is expressed at high levels in murine fetal and neonatal early T cell progenitors (ETP), which are the most immature intrathymic precursors, and becomes almost undetectable in these progenitors after 5 weeks of age. Hmga2 expression is critical for the initial, exponential expansion of thymopoiesis, as Hmga2 deficient mice have a deficit of ETPs within days after birth, and total thymocyte number is repressed compared to wild type littermates. Finally, our data raise the possibility that similar events occur in humans, because Hmga2 expression is high in human fetal thymic progenitors and falls in these cells during early infancy.	[Berent-Maoz, Beata; Montecino-Rodriguez, Encarnacion; Fice, Michael; Casero, David; Crooks, Gay M.; Dorshkind, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Berent-Maoz, Beata; Seet, Christopher S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Crooks, Gay M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Lowry, William] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Dorshkind, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu	Casero, David/E-7365-2010	Casero, David/0000-0002-7347-3330; Seet, Christopher/0000-0002-4821-1400; Montecino Rodriguez, Encarnacion/0000-0002-2826-7503; Fice, Michael/0000-0002-6406-1211	National Institutes of Health [AG034875, P01 HL073104]; California Institute for Regenerative Medicine [RM1-01707]; Jonsson Comprehensive Cancer Center (NIH) [CA16042, AI28697]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073104, T32HL066992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Jonsson Comprehensive Cancer Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant AG034875 from the National Institutes of Health (KD), P01 HL073104 from the National Institutes of Health (GMC), and RM1-01707 from the California Institute for Regenerative Medicine (GMC). Flow cytometry was performed in the cores operated by the Broad Stem Cell Research Center and the Jonsson Comprehensive Cancer Center (supported by NIH grants CA16042 and AI28697).	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berent-Maoz B, 2012, BLOOD, V119, P5715, DOI 10.1182/blood-2011-12-400002; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Copley MR, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.98; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Min H, 2004, J IMMUNOL, V173, P245, DOI 10.4049/jimmunol.173.1.245; MontecinoRodriguez E, 1997, J IMMUNOL, V159, P2712; PENIT C, 1989, J IMMUNOL, V142, P3369; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Xiao SY, 2003, CELL RES, V13, P265, DOI 10.1038/sj.cr.7290171; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125414	10.1371/journal.pone.0125414	http://dx.doi.org/10.1371/journal.pone.0125414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933067	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100109
J	Bhandary, YP; Shetty, SK; Marudamuthu, AS; Midde, KK; Ji, HL; Shams, H; Subramaniam, R; Fu, J; Idell, S; Shetty, S				Bhandary, Yashodhar P.; Shetty, Shwetha K.; Marudamuthu, Amarnath S.; Midde, Krishna K.; Ji, Hong-Long; Shams, Homoyoun; Subramaniam, Renuka; Fu, Jian; Idell, Steven; Shetty, Sreerama			Plasminogen Activator Inhibitor-1 in Cigarette Smoke Exposure and Influenza A Virus Infection-Induced Lung Injury	PLOS ONE			English	Article							EPITHELIAL-CELL APOPTOSIS; MYELOPEROXIDASE ACTIVITY; FIBRINOLYTIC SYSTEM; PULMONARY-FIBROSIS; UP-REGULATION; PROTEIN P53; II CELLS; MICE; EXPRESSION; UROKINASE	Parenchymal lung inflammation and airway and alveolar epithelial cell apoptosis are associated with cigarette smoke exposure (CSE), which contributes to chronic obstructive pulmonary disease (COPD). Epidemiological studies indicate that people exposed to chronic cigarette smoke with or without COPD are more susceptible to influenza A virus (IAV) infection. We found increased p53, PAI-1 and apoptosis in AECs, with accumulation of macrophages and neutrophils in the lungs of patients with COPD. In Wild-type (WT) mice with passive CSE (PCSE), p53 and PAI-1 expression and apoptosis were increased in AECs as was lung inflammation, while those lacking p53 or PAI-1 resisted AEC apoptosis and lung inflammation. Further, inhibition of p53-mediated induction of PAI-1 by treatment of WT mice with caveolin-1 scaffolding domain peptide (CSP) reduced PCSE-induced lung inflammation and reversed PCSE-induced suppression of eosinophil-associated RNase1 (EAR1). Competitive inhibition of the p53-PAI-1 mRNA interaction by expressing p53-binding 3'UTR sequences of PAI-1 mRNA likewise suppressed CS-induced PAI-1 and AEC apoptosis and restored EAR1 expression. Consistent with PCSE-induced lung injury, IAV infection increased p53, PAI-1 and apoptosis in AECs in association with pulmonary inflammation. Lung inflammation induced by PCSE was worsened by subsequent exposure to IAV. Mice lacking PAI-1 that were exposed to IAV showed minimal viral burden based on M2 antigen and hemagglutination analyses, whereas transgenic mice that overexpress PAI-1 without PCSE showed increased M2 antigen and inflammation after IAV infection. These observations indicate that increased PAI-1 expression promotes AEC apoptosis and exacerbates lung inflammation induced by IAV following PCSE.	[Bhandary, Yashodhar P.; Shetty, Shwetha K.; Marudamuthu, Amarnath S.; Midde, Krishna K.; Ji, Hong-Long; Shams, Homoyoun; Subramaniam, Renuka; Idell, Steven; Shetty, Sreerama] Univ Texas Tyler, Hlth Sci Ctr, Texas Lung Injury Inst, Dept Med, Tyler, TX 75799 USA; [Fu, Jian] Univ Kentucky, Coll Med, Ctr Res Environm Dis & Toxicol, Lexington, KY USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Kentucky	Shetty, S (corresponding author), Univ Texas Tyler, Hlth Sci Ctr, Texas Lung Injury Inst, Dept Med, Tyler, TX 75799 USA.	sreerama.shetty@uthct.edu	Bhandary, Yashodhar P/J-9078-2017; Midde, Krishna/AAM-2438-2020	Shetty, Shwetha Kumari/0000-0003-1762-8040	Flight Attendant Medical Research Institute Clinical Innovator Award [FAMRI-ID-123010]; American Heart Association [GRNT19020001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095435, R01HL087017] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute Clinical Innovator Award; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by a Flight Attendant Medical Research Institute Clinical Innovator Award (FAMRI-ID-123010) and an American Heart Association grant (GRNT19020001) to SS.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Balsara RD, 2008, THROMB HAEMOSTASIS, V100, P1029, DOI 10.1160/TH08-07-0427; Bhandary YP, 2013, AM J PATHOL, V183, P131, DOI 10.1016/j.ajpath.2013.03.022; Bhandary YP, 2012, AM J PHYSIOL-LUNG C, V302, pL463, DOI 10.1152/ajplung.00099.2011; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Cho S, 2005, GENOMICS, V85, P208, DOI 10.1016/j.ygeno.2004.10.008; Cho SH, 2004, EXP BIOL MED, V229, P138, DOI 10.1177/153537020422900202; Cho SH, 2000, J IMMUNOL, V165, P3154, DOI 10.4049/jimmunol.165.6.3154; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Foronjy RF, 2005, EXP LUNG RES, V31, P547, DOI 10.1080/019021490951522; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Gelbman BD, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-10; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Heffner JE, 2010, CHEST, V137, P1181, DOI 10.1378/chest.09-2306; Hoshino Y, 2001, AM J PHYSIOL-LUNG C, V281, pL509, DOI 10.1152/ajplung.2001.281.2.L509; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Hurd S, 2000, CHEST, V117, P1; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; JINOT J, 1994, J CLIN EPIDEMIOL, V47, P339, DOI 10.1016/0895-4356(94)90154-6; JUHANVAGUE I, 1984, THROMB RES, V33, P523, DOI 10.1016/0049-3848(84)90018-5; Kosmider B, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-43; Kotani N, 2001, ANESTHESIOLOGY, V94, P999, DOI 10.1097/00000542-200106000-00013; KRUITHOF EKO, 1988, THROMB HAEMOSTASIS, V59, P7; Kucharewicz I, 2003, THROMB RES, V112, P1, DOI 10.1016/j.thromres.2003.10.011; Maestrelli P, AM J RESPIR CRIT CAR, V64, pS76; Marudamuthu AS, 2015, AM J PATHOL, V185, P55, DOI 10.1016/j.ajpath.2014.08.027; Masha AE, 2010, THE J OF INF DIS, V201, P794; Morrow SAM, 2011, AM J RESP CELL MOL B, V45, P610, DOI [10.1165/rcmb.2010-0259OC, DOI 10.1165/RCMB.2010-0259OC]; O'Reilly MA, 2012, AM J PATHOL, V181, P441, DOI 10.1016/j.ajpath.2012.05.005; Park YJ, 2008, P NATL ACAD SCI USA, V105, P11784, DOI 10.1073/pnas.0801394105; Pletz MWR, 2004, EUR RESPIR J, V23, P532, DOI 10.1183/09031936.04.00089004; Rana SN, 2005, J LEUKOCYTE BIOL, V77, P719, DOI 10.1189/jlb.0704396; Rangasamy T, 2009, AM J PHYSIOL-LUNG C, V296, pL888, DOI 10.1152/ajplung.90369.2008; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; Shetty SK, 2012, AM J RESP CELL MOL, V47, P474, DOI 10.1165/rcmb.2011-0390OC; Shetty S, 2010, AM J RESP CRIT CARE, V181, P1355, DOI 10.1164/rccm.200901-0015OC; Shetty S, 2008, J BIOL CHEM, V283, P19570, DOI 10.1074/jbc.M710268200; Simet SM, 2010, AM J RESP CELL MOL, V43, P635, DOI 10.1165/rcmb.2009-0297OC; Simpson AJ, 1997, BRIT J HAEMATOL, V97, P208, DOI 10.1046/j.1365-2141.1997.d01-2137.x; Sisson TH, 2007, CURR DRUG TARGETS, V8, P1016, DOI 10.2174/138945007781662319; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Technau-Ihling K, 2001, ARCH VIROL, V146, P1655, DOI 10.1007/s007050170054; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016; Yu HP, 2006, AM J PHYSIOL-LUNG C, V291, pL400, DOI 10.1152/ajplung.00537.2005; Zidovetzki R, 1999, STROKE, V30, P651, DOI 10.1161/01.STR.30.3.651	54	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123187	10.1371/journal.pone.0123187	http://dx.doi.org/10.1371/journal.pone.0123187			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932922	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100016
J	El-Arab, KK; Pudasaini, A; Zoltowski, BD				El-Arab, Kaley K.; Pudasaini, Ashutosh; Zoltowski, Brian D.			Short LOV Proteins in Methylocystis Reveal Insight into LOV Domain Photocycle Mechanisms	PLOS ONE			English	Article							HYPOCREA-JECORINA; SIGNAL-TRANSDUCTION; INTEGRATING LIGHT; PHOTORECEPTOR; PHOTOTROPIN; OXYGEN; ENVOY; DIMERIZATION; NEUROSPORA; RESPONSES	Light Oxygen Voltage (LOV) proteins are widely used in optogenetic devices, however universal signal transduction pathways and photocycle mechanisms remain elusive. In particular, short-LOV (sLOV) proteins have been discovered in bacteria and fungi, containing only the photoresponsive LOV element without any obvious signal transduction domains. These sLOV proteins may be ideal models for LOV domain function due to their ease of study as full-length proteins. Unfortunately, characterization of such proteins remains limited to select systems. Herein, we identify a family of bacterial sLOV proteins present in Methylocystis. Sequence analysis of Methylocystis LOV proteins (McLOV) demonstrates conservation with sLOV proteins from fungal systems that employ competitive dimerization as a signaling mechanism. Cloning and characterization of McLOV proteins confirms functional dimer formation and reveal unexpected photocycle mechanisms. Specifically, some McLOV photocycles are insensitive to external bases such as imidazole, in contrast to previously characterized LOV proteins. Mutational analysis identifies a key residue that imparts insensitivity to imidazole in two McLOV homologs and affects adduct decay by two orders of magnitude. The resultant data identifies a new family of LOV proteins that indicate a universal photocycle mechanism may not be present in LOV proteins.	[El-Arab, Kaley K.; Pudasaini, Ashutosh; Zoltowski, Brian D.] So Methodist Univ, Dept Chem, Ctr Drug Discovery Design & Delivery, Dallas, TX 75275 USA	Southern Methodist University	Zoltowski, BD (corresponding author), So Methodist Univ, Dept Chem, Ctr Drug Discovery Design & Delivery, Dallas, TX 75275 USA.	bzoltowski@smu.edu		Pudasaini, Ashutosh/0000-0002-3566-1314	Herman Frasch Foundation [739-HF12]	Herman Frasch Foundation	This work was supported by a grant from Herman Frasch Foundation, 739-HF12 to BDZ. http://www.acs.org/content/acs/en/funding-and-awards/grants/frasch.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Buttani V, 2007, PHOTOCHEM PHOTOBIOL, V6; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Chan RH, 2013, PHOTOCHEM PHOTOBIOL, V89, P361, DOI 10.1111/php.12004; Chan RH, 2012, J PHYS CHEM B, V116, P10609, DOI 10.1021/jp304934t; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Domratcheva T, 2006, J CHEM THEORY COMPUT, V2, P1565, DOI 10.1021/ct0600114; Gin E, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.24; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hendrischk AK, 2009, PHOTOCHEM PHOTOBIOL, V85, P1254, DOI 10.1111/j.1751-1097.2009.00554.x; Jentzsch K, 2009, BIOCHEMISTRY-US, V48, P10321, DOI 10.1021/bi901115z; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Kennis JTM, 2004, J AM CHEM SOC, V126, P4512, DOI 10.1021/ja031840r; Kraiselburd I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080930; Krauss U, 2005, PHYS CHEM CHEM PHYS, V7, P2804, DOI 10.1039/b504554a; Lamb JS, 2008, J AM CHEM SOC, V130, P12226, DOI 10.1021/ja804236f; Lamb JS, 2009, J MOL BIOL, V393, P909, DOI 10.1016/j.jmb.2009.08.045; Lokhandwala J, 2015, STRUCTURE, V23, P116, DOI 10.1016/j.str.2014.10.020; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Moglich A, 2010, J MOL BIOL, V400, P477, DOI 10.1016/j.jmb.2010.05.019; Pudasaini A, 2013, BIOCHEMISTRY-US, V52, P7150, DOI 10.1021/bi401027n; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; Rambow-Larsen AA, 2009, TRENDS MICROBIOL, V17, P371, DOI 10.1016/j.tim.2009.05.006; Rani R, 2013, BIOCHEMISTRY-US, V52, P4460, DOI 10.1021/bi400311r; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; Schuster A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-449; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Seibel C, 2012, EUKARYOT CELL, V11, P885, DOI 10.1128/EC.05321-11; Zoltowski BD, 2008, BIOCHEMISTRY-US, V47, P7012, DOI 10.1021/bi8007017; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2013, BIOCHEMISTRY-US, V52, P6653, DOI 10.1021/bi401040m; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P8771, DOI 10.1021/bi200976a; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	40	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124874	10.1371/journal.pone.0124874	http://dx.doi.org/10.1371/journal.pone.0124874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933162	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100061
J	Huang, WY; Dai, SP; Chang, YC; Sun, WH				Huang, Wei-Yu; Dai, Shih-Ping; Chang, Yan-Ching; Sun, Wei-Hsin			Acidosis Mediates the Switching of G(s)-PKA and G(i)-PKC epsilon Dependence in Prolonged Hyperalgesia Induced by Inflammation	PLOS ONE			English	Article							EXPERIMENTAL TISSUE ACIDOSIS; KINASE-C-EPSILON; EXTRACELLULAR ACIDIFICATION; MECHANICAL HYPERALGESIA; MOLECULAR-MECHANISMS; CYTOKINE PRODUCTION; SENSORY NEURONS; PKC-EPSILON; RAT SKIN; PROTEIN	Chronic inflammatory pain, when not effectively treated, is a costly health problem and has a harmful effect on all aspects of health-related quality of life. Previous studies suggested that in male Sprague Dawley rats, prostaglandin E-2 (PGE(2))-induced short-term hyperalgesia depends on protein kinase A (PKA) activity, whereas long-lasting hyperalgesia induced by PGE(2) with carrageenan pre-injection, requires protein kinase C-epsilon (PKC epsilon). However, the mechanism underlying the kinase switch with short-to long-term hyperalgesia remains unclear. In this study, we used the inflammatory agents carrageenan or complete Freund's adjuvant (CFA) to induce long-term hyperalgesia, and examined PKA and PKC epsilon dependence and switching time. Hyperalgesia induced by both agents depended on PKA/PKC epsilon and G(s)/Gi-proteins, and the switching time from PKA to PKC epsilon and from G(s) to G(i) was about 3 to 4 h after inflammation induction. Among the single inflammatory mediators tested, PGE(2) and 5-HT induced transient hyperalgesia, which depended on PKA and PKC epsilon, respectively. Only acidic solution-induced hyperalgesia required G(s)-PKA and G(i)-PKC epsilon, and the switch time for kinase dependency matched inflammatory hyperalgesia, in approximately 2 to 4 h. Thus, acidosis in inflamed tissues may be a decisive factor to regulate switching of PKA and PKC epsilon dependence via proton-sensing G-protein-coupled receptors.	[Huang, Wei-Yu; Dai, Shih-Ping; Chang, Yan-Ching; Sun, Wei-Hsin] Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan; [Sun, Wei-Hsin] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan	National Central University; National Central University	Sun, WH (corresponding author), Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan.	weihsin@cc.ncu.edu.tw	Sun, Wei-Hsin/AFR-0191-2022	Sun, Wei-Hsin/0000-0003-3009-520X	Ministry of Science and Technology, Taiwan [NSC 101-2321-B-008-001, NSC 102-2321-B-008-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, Taiwan (grant no. NSC 101-2321-B-008-001 and NSC 102-2321-B-008-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aley KO, 1999, J NEUROSCI, V19, P2181; Aley KO, 2000, J NEUROSCI, V20, P4680, DOI 10.1523/JNEUROSCI.20-12-04680.2000; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BECK PW, 1974, PFLUG ARCH EUR J PHY, V347, P209, DOI 10.1007/BF00592598; Belkouch M, 2011, J NEUROSCI, V31, P18381, DOI 10.1523/JNEUROSCI.3386-11.2011; Bolick DT, 2007, CIRC RES, V100, P572, DOI 10.1161/01.RES.0000258877.57836.d2; Chen WH, 2014, J CO2 UTIL, V5, P1, DOI 10.1016/j.jcou.2013.11.001; Chen YJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-39; Cui M, 2006, J NEUROSCI, V26, P9385, DOI 10.1523/JNEUROSCI.1246-06.2006; Decaris E, 1999, ARTHRITIS RHEUM-US, V42, P1951, DOI 10.1002/1529-0131(199909)42:9<1951::AID-ANR22>3.3.CO;2-4; Di Castro A, 2006, P NATL ACAD SCI USA, V103, P4699, DOI 10.1073/pnas.0508005103; Dina OA, 2009, NEUROSCIENCE, V160, P501, DOI 10.1016/j.neuroscience.2009.03.001; Fitzgerald EM, 1999, J PHYSIOL-LONDON, V516, P433, DOI 10.1111/j.1469-7793.1999.0433v.x; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Gao YJ, 2010, PAIN, V148, P309, DOI 10.1016/j.pain.2009.11.017; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Hang LH, 2012, EUR J NEUROSCI, V36, P2107, DOI 10.1111/j.1460-9568.2012.08087.x; Honore P, 2005, J PHARMACOL EXP THER, V314, P410, DOI 10.1124/jpet.105.083915; Huang CW, 2007, MOL CELL NEUROSCI, V36, P195, DOI 10.1016/j.mcn.2007.06.010; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Jin Y, 2014, J NEUROCHEM, V129, P683, DOI 10.1111/jnc.12661; Joseph EK, 2007, PAIN, V132, P67, DOI 10.1016/j.pain.2007.01.027; Joseph EK, 2010, PAIN, V150, P17, DOI 10.1016/j.pain.2010.02.011; Joseph EK, 2010, J NEUROSCI, V30, P4660, DOI 10.1523/JNEUROSCI.5530-09.2010; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KESSLER W, 1992, EXP BRAIN RES, V91, P467; Khasar SG, 2008, J NEUROSCI, V28, P5721, DOI 10.1523/JNEUROSCI.0256-08.2008; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Khasar SG, 1999, J NEUROPHYSIOL, V81, P1104, DOI 10.1152/jn.1999.81.3.1104; Kim YH, 2012, NEURON, V74, P640, DOI 10.1016/j.neuron.2012.02.039; Kress M, 1997, NEUROSCI LETT, V224, P37, DOI 10.1016/S0304-3940(97)13450-4; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Nagakura Y, 2003, J PHARMACOL EXP THER, V306, P490, DOI 10.1124/jpet.103.050781; Onozawa Y, 2012, EUR J PHARMACOL, V683, P325, DOI 10.1016/j.ejphar.2012.03.007; Parada CA, 2005, PAIN, V113, P185, DOI 10.1016/j.pain.2004.10.021; Parada CA, 2003, NEUROSCIENCE, V120, P219, DOI 10.1016/S0306-4522(03)00267-7; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; SCHAIBLE HG, 1988, J PHYSIOL-LONDON, V403, P91, DOI 10.1113/jphysiol.1988.sp017240; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; STEEN KH, 1993, NEUROSCI LETT, V154, P113, DOI 10.1016/0304-3940(93)90184-M; Steen KH, 1996, PAIN, V66, P163, DOI 10.1016/0304-3959(96)03034-5; STEEN KH, 1995, PAIN, V62, P339, DOI 10.1016/0304-3959(95)00011-G; STEEN KH, 1995, NEUROSCI LETT, V199, P29, DOI 10.1016/0304-3940(95)12002-L; STEEN KH, 1992, J NEUROSCI, V12, P86; STEEN KH, 1995, J NEUROSCI, V15, P3982; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200	50	27	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125022	10.1371/journal.pone.0125022	http://dx.doi.org/10.1371/journal.pone.0125022			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933021	gold, Green Submitted, Green Published			2022-12-26	WOS:000353887100073
J	Kristensen, K; Henriksen, JR; Andresen, TL				Kristensen, Kasper; Henriksen, Jonas R.; Andresen, Thomas L.			Adsorption of Cationic Peptides to Solid Surfaces of Glass and Plastic	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; PHOSPHOLIPID-VESICLES; QUANTITATIVE-ANALYSIS; BINDING; PERMEABILIZATION; CHROMATOGRAPHY; POLYPROPYLENE; MEMBRANES; LIPOSOMES; MECHANISM	Cationic membrane-active peptides have been studied for years in the hope of developing them into novel types of therapeutics. In this article, we investigate an effect that might have significant experimental implications for investigators who wish to study these peptides, namely, that the peptides adsorb to solid surfaces of glass and plastic. Specifically, we use analytical HPLC to systematically quantify the adsorption of the three cationic membrane-active peptides mastoparan X, melittin, and magainin 2 to the walls of commonly used glass and plastic sample containers. Our results show that, at typical experimental peptide concentrations, 90% or more of the peptides might be lost from solution due to rapid adsorption to the walls of the sample containers. Thus, our results emphasize that investigators should always keep these adsorption effects in mind when designing and interpreting experiments on cationic membrane-active peptides. We conclude the article by discussing different strategies for reducing the experimental impact of these adsorption effects.	[Kristensen, Kasper; Andresen, Thomas L.] Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Henriksen, Jonas R.] Tech Univ Denmark, DTU Chem, Dept Chem, DK-2800 Lyngby, Denmark; [Kristensen, Kasper; Henriksen, Jonas R.; Andresen, Thomas L.] Tech Univ Denmark, Ctr Nanomed & Theranost, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark; Technical University of Denmark	Andresen, TL (corresponding author), Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	tlan@nanotech.dtu.dk	Kristensen, Kasper/M-9179-2013	Kristensen, Kasper/0000-0003-3596-4056; Henriksen, Jonas Rosager/0000-0001-9154-6639; Andresen, Thomas Lars/0000-0002-1048-127X	NanoMorph consortium; Danish Council for Technology and Innovation; Technical University of Denmark	NanoMorph consortium; Danish Council for Technology and Innovation; Technical University of Denmark	KK was partially funded by the NanoMorph consortium, funded by the Danish Council for Technology and Innovation, and partially funded by the Technical University of Denmark. JRH and TLA were funded by the Technical University of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuzova A, 1999, BBA-BIOMEMBRANES, V1420, P139, DOI 10.1016/S0005-2736(99)00098-X; Bark SJ, 2007, J PROTEOME RES, V6, P4511, DOI 10.1021/pr070294o; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Chico DE, 2003, PEPTIDES, V24, P3, DOI 10.1016/S0196-9781(02)00270-X; DUNCAN M, 1994, J COLLOID INTERF SCI, V165, P341, DOI 10.1006/jcis.1994.1238; DUNCAN MR, 1995, INT J PHARMACEUT, V120, P179, DOI 10.1016/0378-5173(94)00402-Q; Etzerodt T, 2011, BIOPHYS J, V100, P399, DOI 10.1016/j.bpj.2010.11.040; Goebel-Stengel M, 2011, ANAL BIOCHEM, V414, P38, DOI 10.1016/j.ab.2011.02.009; GRANT E, 1992, BIOCHEMISTRY-US, V31, P9912, DOI 10.1021/bi00156a008; Gregory SM, 2009, BIOPHYS J, V96, P116, DOI 10.1016/j.bpj.2008.09.017; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; JOOSTEN HMLJ, 1995, LETT APPL MICROBIOL, V21, P389, DOI 10.1111/j.1472-765X.1995.tb01089.x; Kraut A, 2009, J PROTEOME RES, V8, P3778, DOI 10.1021/pr900095u; Kristensen K, 2014, BBA-BIOMEMBRANES, V1838, P2994, DOI 10.1016/j.bbamem.2014.08.007; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Persson D, 2003, BIOCHEMISTRY-US, V42, P421, DOI 10.1021/bi026453t; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; TOSTESON MT, 1985, J MEMBRANE BIOL, V87, P35, DOI 10.1007/BF01870697; van Midwoud PM, 2007, J PROTEOME RES, V6, P781, DOI 10.1021/pr0604099; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	24	41	42	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122419	10.1371/journal.pone.0122419	http://dx.doi.org/10.1371/journal.pone.0122419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932639	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100008
J	An, F; Zou, Z; Cai, XQ; Wang, J; Rookes, J; Lin, WF; Cahill, D; Kong, LX				An, Feng; Zou, Zhi; Cai, Xiuqing; Wang, Jin; Rookes, James; Lin, Weifu; Cahill, David; Kong, Lingxue			Regulation of HbPIP2;3, a Latex-Abundant Water Transporter, Is Associated with Latex Dilution and Yield in the Rubber Tree (Hevea brasiliensis Muell. Arg.)	PLOS ONE			English	Article							PLANT AQUAPORINS; EXPRESSION; CHANNELS; GENE; ETHYLENE; STIMULATION; SEQUENCE; DROUGHT; CLONING; POPLAR	Rubber tree (Hevea brasiliensis) latex, the source of natural rubber, is synthesised in the cytoplasm of laticifers. Efficient water inflow into laticifers is crucial for latex flow and production since it is the determinant of the total solid content of latex and its fluidity after tapping. As the mature laticifer vessel rings are devoid of plasmodesmata, water exchange between laticifers and surrounding cells is believed to be governed by plasma membrane intrinsic proteins (PIPs). To identify the most important PIP aquaporin in the water balance of laticifers, the transcriptional profiles of ten-latex-expressed PIPs were analysed. One of the most abundant transcripts, designated HbPIP2; 3, was characterised in this study. When tested in Xenopus laevis oocytes HbPIP2; 3 showed a high efficiency in increasing plasmalemma water conductance. Expression analysis indicated that the HbPIP2; 3 gene was preferentially expressed in latex, and the transcripts were up-regulated by both wounding and exogenously applied Ethrel (a commonly-used ethylene releaser). Although regular tapping upregulated the expression of HbPIP2; 3 during the first few tappings of the virginal rubber trees, the transcriptional kinetics of HbPIP2; 3 to Ethrel stimulation in the regularly tapped tree exhibited a similar pattern to that of the previously reported HbPIP2; 1 in the virginal rubber trees. Furthermore, the mRNA level of HbPIP2; 3 was associated with clonal yield potential and the Ethrel stimulation response. Together, these results have revealed the central regulatory role of HbPIP2; 3 in laticifer water balance and ethylene stimulation of latex production in Hevea.	[An, Feng; Zou, Zhi; Wang, Jin; Lin, Weifu] Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou Invest & Expt Stn Trop Crops, Minist Agr, Danzhou 571737, Peoples R China; [An, Feng; Kong, Lingxue] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3216, Australia; [Cai, Xiuqing] Hainan Univ, Coll Agron, Haikou 570228, Peoples R China; [Rookes, James; Cahill, David] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3216, Australia	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Deakin University; Hainan University; Deakin University	An, F (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou Invest & Expt Stn Trop Crops, Minist Agr, Danzhou 571737, Peoples R China.	an-f@163.com; lingxue.kong@deakin.edu.au	Zou, Zhi/F-1266-2018; Kong, Lingxue/D-8216-2011	Zou, Zhi/0000-0003-2881-1932; Kong, Lingxue/0000-0001-6219-3897; rookes, jim/0000-0003-1479-2339; Cahill, David/0000-0002-2556-0528	National Natural Science Foundation of China [31100460]; Earmarked Fund for China Agriculture Research System [CARS-34]; Natural Science Foundation of Hainan Province [312026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for China Agriculture Research System; Natural Science Foundation of Hainan Province	This work was supported by grants from the National Natural Science Foundation of China (31100460), the Earmarked Fund for China Agriculture Research System (CARS-34) and the Natural Science Foundation of Hainan Province (312026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1987, J BIOL CHEM, V262, P17497; Almeida-Rodriguez AM, 2010, PHYSIOL PLANTARUM, V140, P321, DOI 10.1111/j.1399-3054.2010.01405.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azad AK, 2013, PHYSIOL PLANTARUM, V148, P397, DOI 10.1111/j.1399-3054.2012.01717.x; Bae EK, 2011, GENE, V483, P43, DOI 10.1016/j.gene.2011.05.015; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Chervin C, 2008, PHYSIOL PLANTARUM, V134, P534, DOI 10.1111/j.1399-3054.2008.01158.x; Chow Keng-See, 2014, BMC Res Notes, V7, P69, DOI 10.1186/1756-0500-7-69; D'Auzac J., 1997, Recent Research Developments in Plant Physiology, V1, P273; D'Auzac J., 1989, PHYSL RUBBER TREE LA; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; DEFAY E, 1989, PROTOPLASMA, V149, P155, DOI 10.1007/BF01322987; Dusotoit-Coucaud A, 2010, TREE PHYSIOL, V30, P1586, DOI 10.1093/treephys/tpq088; Dusotoit-Coucaud A, 2010, PLANT CELL PHYSIOL, V51, P1878, DOI 10.1093/pcp/pcq151; Dusotoit-Coucaud A, 2009, ANN BOT-LONDON, V104, P635, DOI 10.1093/aob/mcp150; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Gao X, 2009, ZHONGGUO NONG TONG B, V3, P275; Gohet E, 2003, P IRRDB WORKSH EXPL, V203, P199; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; GOODING EGB, 1952, NEW PHYTOL, V51, P139, DOI 10.1111/j.1469-8137.1952.tb06122.x; Hachez C, 2010, ADV EXP MED BIOL, V679, P1; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Hua YW, 2010, PLANT BREEDING, V129, P202, DOI 10.1111/j.1439-0523.2009.01663.x; Huang DeBao, 2010, Journal of Tropical and Subtropical Botany, V18, P170; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kaldenhoff R, 2006, ACTA PHYSIOL, V187, P169, DOI 10.1111/j.1748-1716.2006.01563.x; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; Katsuhara M, 2002, PLANT CELL PHYSIOL, V43, P885, DOI 10.1093/pcp/pcf102; Kelly G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087888; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; LINCOLN T, 2006, PLANT PHYSL; Lovisolo C, 2010, FUNCT PLANT BIOL, V37, P98, DOI 10.1071/FP09191; Marjanovic Z, 2005, PLANTA, V222, P258, DOI 10.1007/s00425-005-1539-z; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; MONTGOMERY J, 1993, P NATL ACAD SCI USA, V90, P5939, DOI 10.1073/pnas.90.13.5939; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nair KPP, 2010, ELSEV INSIGHT, P237, DOI 10.1016/B978-0-12-384677-8.00008-4; Pakianathan SW, 1967, J RUBBER RES I MALAY, P23; PARANJOTHY K, 1979, J RUBBER RES I MALAY, V27, P159; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Priyadarshan PM, 2011, BIOLOGY OF HEVEA RUBBER, P1, DOI 10.1079/9781845936662.0000; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Rawat R, 2005, PLANT MOL BIOL, V57, P629, DOI 10.1007/s11103-005-0954-7; Sabir F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102087; Secchi F, 2007, PLANTA, V225, P381, DOI 10.1007/s00425-006-0365-2; Sethuraj MR., 2012, CULTIVATION TECHNOLO; STEIN WD, 1956, DISCUSS FARADAY SOC, P238, DOI 10.1039/df9562100238; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang CR, 2007, J BIOCHEM BIOPH METH, V70, P749, DOI 10.1016/j.jbbm.2007.04.002; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Tapia G, 2005, PLANT PHYSIOL, V138, P2075, DOI 10.1104/pp.105.059766; Tungngoen K, 2011, J PLANT PHYSIOL, V168, P253, DOI 10.1016/j.jplph.2010.06.009; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; Tupy J, 1985, MUEL ARG BIOL PLANT, V1, P51; Tyerman SD, 1999, J EXP BOT, V50, P1055, DOI 10.1093/jexbot/50.suppl_1.1055; Van Gils G. E., 1951, ARCH RUBBERCULTURE, V28, P61; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Xu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079618; Xu W, 1990, RE DAI ZUO WU XUE BA, V11, P11; Zhou Y, 2007, PLANT CELL ENVIRON, V30, P1566, DOI 10.1111/j.1365-3040.2007.01732.x; Zhuang Hai-yan, 2010, Xibei Zhiwu Xuebao, V30, P861	72	17	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125595	10.1371/journal.pone.0125595	http://dx.doi.org/10.1371/journal.pone.0125595			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927524	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100104
J	Korol, SV; Jin, Z; Birnir, B				Korol, Sergiy V.; Jin, Zhe; Birnir, Bryndis			The GLP-1 Receptor Agonist Exendin-4 and Diazepam Differentially Regulate GABA(A) Receptor-Mediated Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; AMINOBUTYRIC ACID(A) RECEPTORS; BENZODIAZEPINE BINDING-SITE; BRAIN; PHARMACOLOGY; CHANNELS; PHYSIOLOGY; SUBTYPES; INSULIN; CULTURE	Glucagon-like peptide-1 (GLP-1) is a metabolic hormone that is secreted in a glucose-dependent manner and enhances insulin secretion. GLP-1 receptors are also found in the brain where their signalling affects neuronal activity. We have previously shown that the GLP-1 receptor agonists, GLP-1 and exendin-4 enhanced GABA-activated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons. The hippocampus is the centre for memory and learning and is important for cognition. Here we examined if exendin-4 similarly enhanced the GABA-activated currents in the presence of the benzodiazepine diazepam. In whole-cell recordings in rat brain slices, diazepam (1 mu M), an allosteric positive modulator of GABA(A) receptors, alone enhanced the spontaneous inhibitory postsynaptic current (sIPSC) amplitude and frequency by a factor of 1.3 and 1.6, respectively, and doubled the tonic GABA(A) current normally recorded in the CA3 pyramidal cells. Importantly, in the presence of exendin-4 (10 nM) plus diazepam (1 mu M), only the tonic but not the sIPSC currents transiently increased as compared to currents recorded in the presence of diazepam alone. The results suggest that exendin-4 potentiates a subpopulation of extrasynaptic GABA(A) receptors in the CA3 pyramidal neurons.	[Korol, Sergiy V.; Jin, Zhe; Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Birnir, B (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	bryndis.birnir@neuro.uu.se	Korol, Sergiy V./S-3442-2016; Jin, Zhe/C-5150-2008	Korol, Sergiy V./0000-0001-8279-2790; Jin, Zhe/0000-0002-4717-1558; Birnir, Bryndis/0000-0002-1763-0266	Swedish research council [2012-1789]; EXODIAB, a consortium - Swedish government; M.A.H. Landells Foundation; M. Sjostroms Foundation, Uppsala University	Swedish research council(Swedish Research CouncilEuropean Commission); EXODIAB, a consortium - Swedish government; M.A.H. Landells Foundation; M. Sjostroms Foundation, Uppsala University	This study was supported by the Swedish research council grant 2012-1789 to BB, http://vr.se/forskningvistodjer/projektdatabasen.4.14f1901d125640ed5ab80003173.html. SVK held a postdoctoral fellowship from EXODIAB, a consortium funded by the Swedish government. ZJ held a postdoctoral fellowship from M.A.H. Landells Foundation and M. Sjostroms Foundation, Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; Birnir B, 2000, BRIT J PHARMACOL, V131, P695, DOI 10.1038/sj.bjp.0703621; BIRNIR B, 1994, J MEMBRANE BIOL, V142, P93; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Deuker L, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00064; Duarte AI, 2013, BBA-MOL BASIS DIS, V1832, P527, DOI 10.1016/j.bbadis.2013.01.008; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067228; Jin Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016188; Korol SV, 2015, DIABETES, V64, P79, DOI 10.2337/db14-0668; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; Levi S, 2015, NEUROPHARMACOLOGY, V88, P199, DOI 10.1016/j.neuropharm.2014.06.002; Li P, 2013, ANESTHESIOLOGY, V118, P1417, DOI 10.1097/ALN.0b013e318289bcd3; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; Marder TJ, 2014, DIABETES, V63, P3112, DOI 10.2337/db13-1783; McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023; Middendorp SJ, 2014, ACS CHEM BIOL, V9, P1846, DOI 10.1021/cb500186a; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Patrone C, 2014, LANCET DIABETES ENDO, V2, P256, DOI 10.1016/S2213-8587(13)70125-6; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]; Roberts RO, 2014, NEUROLOGY, V82, P1132, DOI 10.1212/WNL.0000000000000269; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; Schneeberger M, 2014, J ENDOCRINOL, V220, pT25, DOI 10.1530/JOE-13-0398; SEGAL M, 1984, J NEUROPHYSIOL, V52, P469, DOI 10.1152/jn.1984.52.3.469; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792	35	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124765	10.1371/journal.pone.0124765	http://dx.doi.org/10.1371/journal.pone.0124765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927918	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100048
J	Abril-Gil, M; Garcia-Just, A; Perez-Cano, FJ; Franch, A; Castell, M				Abril-Gil, Mar; Garcia-Just, Alba; Perez-Cano, Francisco J.; Franch, Angels; Castell, Margarida			Development and Characterization of an Effective Food Allergy Model in Brown Norway Rats	PLOS ONE			English	Article							HOUSE-DUST MITE; ORAL-EXPOSURE; MAST-CELLS; BETA-LACTOGLOBULIN; IGE SYNTHESIS; COWS MILK; OVALBUMIN; ALLERGENICITY; SENSITIZATION; EXPRESSION	Background Food allergy (FA) is an adverse health effect produced by the exposure to a given food. Currently, there is no optimal animal model of FA for the screening of immunotherapies or for testing the allergenicity of new foods. Objective The aim of the present study was to develop an effective and rapid model of FA in Brown Norway rats. In order to establish biomarkers of FA in rat, we compared the immune response and the anaphylactic shock obtained in this model with those achieved with only intraperitoneal immunization. Methods Rats received an intraperitoneal injection of ovalbumin (OVA) with alum and toxin from Bordetella pertussis, and 14 days later, OVA by oral route daily for three weeks (FA group). A group of rats receiving only the i.p. injection (IP group) were also tested. Serum anti-OVA IgE, IgG1, IgG2a, IgG2b and IgA antibodies were quantified throughout the study. After an oral challenge, body temperature, intestinal permeability, motor activity, and mast cell protease II (RMCP-II) levels were determined. At the end of the study, anti-OVA intestinal IgA, spleen cytokine production, lymphocyte composition of Peyer's patches and mesenteric lymph nodes, and gene expression in the small intestine were quantified. Results Serum OVA-specific IgG1, IgG2a and IgG2b concentrations rose with the i.p. immunization but were highly augmented after the oral OVA administration. Anti-OVA IgE increased twofold during the first week of oral OVA gavage. The anaphylaxis in both IP and FA groups decreased body temperature and motor activity, whereas intestinal permeability increased. Interestingly, the FA group showed a much higher RMCP II serum protein and intestinal mRNA expression. Conclusions These results show both an effective and relatively rapid model of FA assessed by means of specific antibody titres and the high production of RMCP-II and its intestinal gene expression.	[Abril-Gil, Mar; Garcia-Just, Alba; Perez-Cano, Francisco J.; Franch, Angels; Castell, Margarida] Univ Barcelona, Fac Farm, Dept Fisiol, E-08028 Barcelona, Spain; [Abril-Gil, Mar; Garcia-Just, Alba; Perez-Cano, Francisco J.; Franch, Angels; Castell, Margarida] Univ Barcelona INSA UB, Inst Recerca Nutr & Seguretat Alimentaria, Barcelona, Spain	University of Barcelona; University of Barcelona	Castell, M (corresponding author), Univ Barcelona, Fac Farm, Dept Fisiol, E-08028 Barcelona, Spain.	margaridacastell@ub.edu	Abril-Gil, Mar/AAO-4061-2021; Castell, Margarida/G-9078-2015; Franch, Àngels/G-5669-2019; Perez-Cano, Francisco J/G-6516-2019	Abril-Gil, Mar/0000-0003-0318-6755; Castell, Margarida/0000-0001-5408-0593; Franch, Àngels/0000-0002-2362-1374; Perez-Cano, Francisco J/0000-0001-6243-9164	Spanish Ministry of Science and Innovation [AGL2008-02790]; Spanish Ministry of Economy and Competitivity [AGL2011-24279]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitivity(Spanish Government)	This study was supported by grants from the Spanish Ministries of Science and Innovation (AGL2008-02790) and Economy and Competitivity (AGL2011-24279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril-Gil M, 2015, EXP BIOL MED MAYWOOD; Abril-Gil M, 2012, PHARMACOL RES, V65, P603, DOI 10.1016/j.phrs.2012.02.001; Ahrens B, 2014, INT ARCH ALLERGY IMM, V164, P89, DOI 10.1159/000363109; Ahuja V, 2010, ARCH TOXICOL, V84, P909, DOI 10.1007/s00204-010-0582-0; Albert N, 2013, BEHAV BRAIN RES, V252, P347, DOI 10.1016/j.bbr.2013.06.025; Aldemir H, 2009, REGUL TOXICOL PHARM, V54, pS52, DOI 10.1016/j.yrtph.2008.11.004; Ando T, 2013, J INVEST DERMATOL, V133, P2695, DOI 10.1038/jid.2013.250; Bailon E, 2012, J IMMUNOL METHODS, V381, P41, DOI 10.1016/j.jim.2012.04.007; Bellou A, 2003, SCAND J IMMUNOL, V57, P271, DOI 10.1046/j.1365-3083.2003.01233.x; Berin MC, 2009, MUCOSAL IMMUNOL, V2, P24, DOI 10.1038/mi.2008.72; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bogh KL, 2009, CLIN EXP ALLERGY, V39, P1611, DOI 10.1111/j.1365-2222.2009.03333.x; Bogh KL, 2013, INT ARCH ALLERGY IMM, V161, P21, DOI 10.1159/000343042; Boyce JA, 2011, J AM ACAD DERMATOL, V64, P175, DOI [10.1016/j.jaad.2010.11.020, 10.1016/j.nutres.2011.01.001]; Buchanan BB, 2002, ANN NY ACAD SCI, V964, P173; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Camps-Bossacoma M, 2015, CLIN IMMUNO IN PRESS; Cao SS, 2012, REGUL TOXICOL PHARM, V63, P181, DOI 10.1016/j.yrtph.2012.03.017; de Jonge JD, 2008, J IMMUNOTOXICOL, V5, P385, DOI 10.1080/15476910802586126; Dearman RJ, 2001, TOXICOLOGY, V167, P217, DOI 10.1016/S0300-483X(01)00462-0; Dong W, 2003, TOXICOL SCI, V72, P113, DOI 10.1093/toxsci/kfg015; Duncker Swantje C, 2012, PLoS One, V7, pe39841, DOI 10.1371/journal.pone.0039841; Fattouh R, 2005, AM J RESP CRIT CARE, V172, P314, DOI 10.1164/rccm.200502-198OC; Fox M, 2013, EUR J PUBLIC HEALTH, V23, P757, DOI 10.1093/eurpub/ckt010; Fritsche R, 2003, TOXICOL LETT, V140, P303, DOI 10.1016/S0378-4274(03)00026-2; Ganeshan K, 2009, J ALLERGY CLIN IMMUN, V123, P231, DOI 10.1016/j.jaci.2008.10.011; GIBSON S, 1987, IMMUNOLOGY, V62, P621; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; Gracie JA, 1996, EUR J IMMUNOL, V26, P1217, DOI 10.1002/eji.1830260605; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; Huang JA, 2010, FEMS IMMUNOL MED MIC, V60, P132, DOI 10.1111/j.1574-695X.2010.00727.x; Jardi F, 2012, NEUROGASTROENT MOTIL, V24, pe580, DOI 10.1111/nmo.12027; Chiesa JJ, 2010, J BIOL RHYTHM, V25, P37, DOI 10.1177/0748730409352843; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Kimber I, 2002, ENV HLTH PERSPECT, V111, P1125; KITAGAWA S, 1995, AM J MED SCI, V310, P183, DOI 10.1097/00000441-199511000-00002; Knippels LMJ, 1999, TOXICOL APPL PHARM, V156, P161, DOI 10.1006/taap.1999.8641; Knippels LMJ, 1999, FOOD CHEM TOXICOL, V37, P881, DOI 10.1016/S0278-6915(99)00064-2; Knippels LMJ, 1998, J ALLERGY CLIN IMMUN, V101, P815, DOI 10.1016/S0091-6749(98)70309-4; Konstantinou GN, 2014, PEDIAT ALLERG IMM-UK, V25, P64, DOI 10.1111/pai.12143; Kroghsbo S, 2011, INT ARCH ALLERGY IMM, V155, P212, DOI 10.1159/000321200; Leonard SA, 2012, J ALLERGY CLIN IMMUN, V129, P1579, DOI 10.1016/j.jaci.2012.04.009; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Massot-Cladera M, 2012, ARCH BIOCHEM BIOPHYS, V527, P105, DOI 10.1016/j.abb.2012.05.015; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Ogawa T, 2004, AM J PHYSIOL-GASTR L, V286, pG702, DOI 10.1152/ajpgi.00183.2003; Oka T, 2013, J ALLERGY CLIN IMMUN, V132, P922, DOI 10.1016/j.jaci.2013.05.004; Okada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044338; Orivuori L, 2014, PEDIAT ALLERG IMM-UK, V25, P329, DOI 10.1111/pai.12246; Oyoshi MK, 2014, J ALLERGY CLIN IMMUN, V133, P309, DOI 10.1016/j.jaci.2013.12.1045; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Patel DA, 2011, J ALLERGY CLIN IMMUN, V128, P110, DOI 10.1016/j.jaci.2011.03.013; Penninks AH, 2001, TOXICOL LETT, V120, P171, DOI 10.1016/S0378-4274(01)00275-2; Perez-Berezo T, 2012, EXP BIOL MED, V237, P1181, DOI [10.1258/ebm.2012.012083, 10.1258/]; Perez-Berezo T, 2011, MOL NUTR FOOD RES, V55, pS56, DOI 10.1002/mnfr.201000588; Piacentini GL, 2003, ANN ALLERG ASTHMA IM, V91, P61, DOI 10.1016/S1081-1206(10)62060-1; Pilegaard K, 2004, TOXICOLOGY, V196, P247, DOI 10.1016/j.tox.2003.11.010; Ramiro-Puig E, 2008, J NUTR BIOCHEM, V19, P555, DOI 10.1016/j.jnutbio.2007.07.002; Ruiter B, 2012, J ALLERGY CLIN IMMUN, V129, P921, DOI 10.1016/j.jaci.2012.01.080; Saavedra Y, 2005, NEUROGASTROENT MOTIL, V17, P112, DOI 10.1111/j.1365-2982.2004.00597.x; Sakamoto Y, 1998, PEDIATR ALLERGY IMMU, V9, P20, DOI 10.1111/j.1399-3038.1998.tb00295.x; Shindo T, 2012, J TOXICOL SCI, V37, P307, DOI 10.2131/jts.37.307; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2006, J ALLERGY CLIN IMMUN, V117, pS470, DOI 10.1016/j.jaci.2005.05.048; Sun JF, 2007, J IMMUNOL, V179, P6696, DOI 10.4049/jimmunol.179.10.6696; Sun N, 2013, J IMMUNOTOXICOL, V10, P67, DOI 10.3109/1547691X.2012.693546; Terhune TD, 2013, J IMMUNOTOXICOL, V10, P210, DOI 10.3109/1547691X.2012.708366; Teuber SS, 2002, J ALLERGY CLIN IMMUN, V110, P921, DOI 10.1067/mai.2002.130056; Traver E, 2010, NEUROGASTROENT MOTIL, V22, pE34, DOI 10.1111/j.1365-2982.2009.01377.x; Vazquez-Ortiz M, 2013, ALLERGY, V68, P1327, DOI 10.1111/all.12217; Vinje NE, 2009, CLIN EXP ALLERGY, V39, P1255, DOI 10.1111/j.1365-2222.2009.03269.x; Zanardo V, 2007, PEDIATR RES, V62, P191, DOI 10.1203/PDR.0b013e31809871c9; Zhong Y, 2012, FEMS IMMUNOL MED MIC, V66, P71, DOI 10.1111/j.1574-695X.2012.00991.x	75	16	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125314	10.1371/journal.pone.0125314	http://dx.doi.org/10.1371/journal.pone.0125314			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923134	gold, Green Published			2022-12-26	WOS:000353711600143
J	Zhao, XG; Sun, RJ; Yang, XY; Liu, DY; Lei, DP; Jin, T; Pan, XL				Zhao, Xing-guo; Sun, Rui-jie; Yang, Xiao-yan; Liu, Da-yu; Lei, Da-peng; Jin, Tong; Pan, Xin-liang			Chloroquine-Enhanced Efficacy of Cisplatin in the Treatment of Hypopharyngeal Carcinoma in Xenograft Mice	PLOS ONE			English	Article							CELL LUNG-CANCER; CONCURRENT CHEMORADIOTHERAPY; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; AUTOPHAGY; RESISTANCE; INHIBITION; APOPTOSIS; TUMORIGENESIS; COMBINATION	Hypopharyngeal squamous cell carcinoma (HSCC) has the worst prognosis among head and neck cancers. Cisplatin (DDP)-based chemotherapy is an important part of multimodal treatments. However, resistance to DDP severely impairs the effectiveness of chemotherapy for HSCC. Chloroquine (CQ) has been reported to enhance the effectiveness of chemotherapy and radiotherapy in liver, pancreas, breast, prostate and colon tumors, but it is unclear whether CQ could increase the efficacy of DDP for treating HSCC. We inoculated BALB/c nude mice with a subcutaneous injection of human hypopharyngeal FaDu cells to generate our animal model. Mice were randomly divided into 4 groups and treated with vehicle control, CQ (60 mg/kg/day), DDP (5 mg/kg/6 days), or a combination of DDP and CQ. Tumor growth and survival of the mice were monitored. We found that CQ inhibited autophagy and increased DDP-induced apoptosis in the xenograft mouse model. CQ enhanced the efficacy of DDP, resulting in decreased tumor growth and prolonged survival of the mice. To test whether blocking autophagy enhanced the efficacy of DDP, FaDu cells were infected with lentiviral shRNA to Beclin-1 and inoculated into the flanks of nude mice. Inhibition of autophagy markedly enhanced the DDP-induced antitumor effect. Our study suggests that the addition of CQ to DDP-based chemotherapy could be a potential therapeutic strategy for treating HSCC, and the inhibition of autophagy may contribute to chemotherapy sensitization in HSCC.	[Zhao, Xing-guo; Sun, Rui-jie; Liu, Da-yu; Lei, Da-peng; Jin, Tong; Pan, Xin-liang] Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Shandong, Peoples R China; [Yang, Xiao-yan] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Pan, XL (corresponding author), Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Shandong, Peoples R China.	pan_xinl@163.com			Independent Innovation Foundation of Shandong University (IIFSDU) [2012TS156]; Shandong Provincial Natural Science Foundation, China [ZR2013HM107]	Independent Innovation Foundation of Shandong University (IIFSDU); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work was supported by Independent Innovation Foundation of Shandong University (IIFSDU, #2012TS156 for DYL) and Shandong Provincial Natural Science Foundation, China (#ZR2013HM107 for XLP). XLP had a role in the study design. DYL had a role in data analysis.	Adelstein DJ, 2006, J CLIN ONCOL, V24, P1064, DOI 10.1200/JCO.2005.01.5867; Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; Bristol ML, 2013, J PHARMACOL EXP THER, V344, P544, DOI 10.1124/jpet.112.199802; Chang MFT, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-91; Chatterjee T, 1998, MUTAGENESIS, V13, P619, DOI 10.1093/mutage/13.6.619; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Cufi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02469; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Del BB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057236, DOI 10.1371/JOURNAL.PONE.0057236]; Ding ZB, 2011, CLIN CANCER RES, V17, P6229, DOI 10.1158/1078-0432.CCR-11-0816; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Ghadimi MP, 2012, MOL CANCER THER, V11, P1758, DOI 10.1158/1535-7163.MCT-12-0015; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Hall SF, 2008, LARYNGOSCOPE, V118, P1362, DOI 10.1097/MLG.0b013e318173dc4a; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kogashiwa Y, 2009, ONCOL REP, V22, P1163, DOI 10.3892/or_00000550; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Maes H, 2014, CANCER CELL, V26, P190, DOI 10.1016/j.ccr.2014.06.025; Martirosyan A, 2006, J PHARMACOL EXP THER, V317, P546, DOI 10.1124/jpet.105.096891; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peng YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074407; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Takes RP, 2012, HEAD NECK-J SCI SPEC, V34, P270, DOI 10.1002/hed.21613; Thome R, 2013, IMMUNOL LETT, V153, P50, DOI 10.1016/j.imlet.2013.07.004; Wang JR, 2013, NONLINEAR ANAL-HYBRI, V8, P1, DOI 10.1016/j.nahs.2012.08.003; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu L, 2014, CANCER LETT, V355, P34, DOI 10.1016/j.canlet.2014.09.020; Zinn RL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-16; Zou YY, 2013, J THORAC ONCOL, V8, P693, DOI 10.1097/JTO.0b013e31828c7210	40	44	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126147	10.1371/journal.pone.0126147	http://dx.doi.org/10.1371/journal.pone.0126147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923669	gold, Green Submitted, Green Published			2022-12-26	WOS:000353711600172
J	Sechler, M; Borowicz, S; Van Scoyk, M; Avasarala, S; Zerayesus, S; Edwards, MG; Rathinam, MKK; Zhao, XM; Wu, PY; Tang, K; Bikkavilli, RK; Winn, RA				Sechler, Marybeth; Borowicz, Stanley; Van Scoyk, Michelle; Avasarala, Sreedevi; Zerayesus, Sereke; Edwards, Michael G.; Rathinam, Manoj Kumar Karuppusamy; Zhao, Xiangmin; Wu, Pei-Ying; Tang, Ke; Bikkavilli, Rama Kamesh; Winn, Robert A.			Novel Role for -Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CATENIN; BETA-CATENIN; LUNG-CANCER; E-CADHERIN; FACTOR/SCATTER FACTOR; SIGNALING PATHWAY; CARCINOMA-CELLS; HGF-ACTIVATOR; N-CADHERIN; PLAKOGLOBIN	Background: -Catenin is a tumor suppressor in lung cancer. Results: -Catenin is a novel regulator of HAI-1 and cell migration. Conclusion: -Catenin and HAI-1 regulate cell migration and sensitize NSCLC cells to c-MET inhibitor. Significance: Targeting -catenin-mediated HAI-1 expression might be a new strategy to treat lung cancer. -catenin (Plakoglobin), a well-described structural protein functioning at the adherens junctions and desmosomes, was shown to be either lost or weakly expressed in non-small cell lung cancer (NSCLC) cells and tumor tissues. However, the tumor suppressive affects of -catenin were not fully understood. In this study, we have identified a novel role for the affects of -catenin on non-small cell lung cancer (NSCLC) cell migration. Expression of -catenin in NSCLC cells resulted in reduced cell migration as determined by both scratch assays and trans-well cell migration assays. Moreover, the affects of -catenin on cell migration were observed to be p53-dependent. Mechanistically, the anti-migratory effects seen via -catenin were driven by the expression of hepatocyte growth factor activator inhibitor Type I (HAI-1 or SPINT-1), an upstream inhibitor of the c-MET signaling pathway. Furthermore, the re-expression of -catenin sensitized NSCLC cells to c-MET inhibitor-mediated growth inhibition. Taken together, we identify -catenin as a novel regulator of HAI-1, which is a critical regulator of HGF/c-MET signaling. Therefore, targeting -catenin-mediated HAI-1 expression might be a useful strategy to sensitize NSCLC to c-MET inhibitors.	[Sechler, Marybeth] Univ Colorado, Canc Biol Program, Aurora, CO 80045 USA; [Edwards, Michael G.] Univ Colorado, Div Pulm Sci & Crit Care Med, Sch Med, Aurora, CO 80045 USA; [Borowicz, Stanley] Univ Illinois, Dept Med, Div Hematol & Oncol, Chicago, IL 60612 USA; [Van Scoyk, Michelle; Avasarala, Sreedevi; Zerayesus, Sereke; Rathinam, Manoj Kumar Karuppusamy; Zhao, Xiangmin; Wu, Pei-Ying; Tang, Ke; Bikkavilli, Rama Kamesh; Winn, Robert A.] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60612 USA; [Winn, Robert A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Winn, RA (corresponding author), Univ Illinois, Coll Med, Dept Med, Div Pulm Crit Care Sleep & Allergy, Rm 5160,Res Bldg,909 S Wolcott Ave, Chicago, IL 60612 USA.	rwinn@uic.edu	Regan, Clinton/E-6250-2012	Tang, Ke/0000-0002-1804-5093	United States Dept. of Veterans Affairs; National Institutes of Health [R01CA138528]; NATIONAL CANCER INSTITUTE [R01CA138528, P50CA058187] Funding Source: NIH RePORTER	United States Dept. of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a Merit Award from the United States Dept. of Veterans Affairs, and National Institutes of Health Grant R01CA138528 (to R. W.).	Aktary Z, 2013, J CELL SCI, V126, P3031, DOI 10.1242/jcs.120642; Breault JE, 2005, CLIN CANCER RES, V11, P557; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Eigenbrot C, 2010, FEBS J, V277, P2215, DOI 10.1111/j.1742-4658.2010.07638.x; Feng Y, 2012, J THORAC ONCOL, V7, P459, DOI 10.1097/JTO.0b013e3182417e44; Hoshiko S., CANC RES, V73, P2659; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Kataoka H, 2000, CANCER RES, V60, P6148; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kataoka H, 2003, CANCER METAST REV, V22, P223, DOI 10.1023/A:1023051500010; KNUDSEN KA, 1992, J CELL BIOL, V118, P671, DOI 10.1083/jcb.118.3.671; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Momparler RL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00188; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Nagashima H, 1997, HEART VESSELS, P110; Nakamura K, 2010, INT J ONCOL, V37, P605, DOI 10.3892/ijo_00000709; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Pantel K, 1998, J CLIN ONCOL, V16, P1407, DOI 10.1200/JCO.1998.16.4.1407; Parker HR, 1998, CELL MOTIL CYTOSKEL, V40, P87, DOI 10.1002/(SICI)1097-0169(1998)40:1<87::AID-CM8>3.0.CO;2-C; Parr C, 2001, INT J ONCOL, V19, P857; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pigors M, 2011, HUM MOL GENET, V20, P1811, DOI 10.1093/hmg/ddr064; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; Sadiq AA, 2013, J CLIN ONCOL, V31, P1089, DOI 10.1200/JCO.2012.43.9422; Sattler Martin, 2009, Update Cancer Ther, V3, P109, DOI 10.1016/j.uct.2009.01.001; Sechler M, 2013, PHARMACOGN PERS MED, V6, P25, DOI 10.2147/PGPM.S26058; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Tjin EPM, 2004, BLOOD, V104, P2172, DOI 10.1182/blood-2003-12-4386; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Yin TF, 2005, J BIOL CHEM, V280, P40355, DOI 10.1074/jbc.M506692200; Zhurinsky J, 2000, J CELL SCI, V113, P3127	37	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15610	15620		10.1074/jbc.M114.631820	http://dx.doi.org/10.1074/jbc.M114.631820			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25925948	Green Published, hybrid			2022-12-26	WOS:000356527400025
J	Pamir, N; Liu, NC; Irwin, A; Becker, L; Peng, YF; Ronsein, GE; Bornfeldt, KE; Duffield, JS; Heinecke, JW				Pamir, Nathalie; Liu, Ning-Chun; Irwin, Angela; Becker, Lev; Peng, YuFeng; Ronsein, Graziella E.; Bornfeldt, Karin E.; Duffield, Jeremy S.; Heinecke, Jay W.			Granulocyte/Macrophage Colony-stimulating Factor-dependent Dendritic Cells Restrain Lean Adipose Tissue Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREADIPOCYTE FACTOR-I; MOUSE BONE-MARROW; ADIPOCYTE DIFFERENTIATION; GM-CSF; GENE-EXPRESSION; ENERGY-BALANCE; OBESITY; MICE; ADIPOGENESIS; HETEROGENEITY	The physiological roles of macrophages and dendritic cells (DCs) in lean white adipose tissue homeostasis have received little attention. Because DCs are generated from bone marrow progenitors in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF), we used GM-CSF-deficient (Csf2(-/-)) mice fed a low fat diet to test the hypothesis that adipose tissue DCs regulate the development of adipose tissue. At 4 weeks of age, Csf2(-/-) mice had 75% fewer CD45(+)Cd11b(+) Cd11c(+)MHCII(+) F4/80(-) DCs in white adipose tissue than did wild-type controls. Furthermore, the Csf2(-/-) mice showed a 30% increase in whole body adiposity, which persisted to adulthood. Adipocytes from Csf2(-/-) mice were 50% larger by volume and contained higher levels of adipogenesis gene transcripts, indicating enhanced adipocyte differentiation. In contrast, adipogenesis/adipocyte lipid accumulation was inhibited when preadipocytes were co-cultured with CD45(+)Cd11b(+)Cd11c(+) MHCII(+)F4/80(-) DCs. Medium conditioned by DCs, but not by macrophages, also inhibited adipocyte lipid accumulation. Proteomic analysis revealed that matrix metalloproteinase 12 and fibronectin 1 were greatly enriched in the medium conditioned by DCs compared with that conditioned by macrophages. Silencing fibronectin or genetic deletion of matrix metalloproteinase 12 in DCs partially reversed the inhibition of adipocyte lipid accumulation. Our observations indicate that DCs residing in adipose tissue play a critical role in suppressing normal adipose tissue expansion.	[Pamir, Nathalie; Liu, Ning-Chun; Irwin, Angela; Ronsein, Graziella E.; Bornfeldt, Karin E.; Heinecke, Jay W.] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Peng, YuFeng] Univ Washington, Dept Rheumatol, Seattle, WA 98109 USA; [Bornfeldt, Karin E.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Duffield, Jeremy S.] Univ Washington, Div Nephrol & Lung Biol, Seattle, WA 98109 USA; [Becker, Lev] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago	Pamir, N (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	pamir@ohsu.edu	Regan, Clinton/E-6250-2012; Bornfeldt, Karin/AAI-2241-2019; Ronsein, Graziella E/H-8676-2014; peng, yu/GXW-2071-2022	Bornfeldt, Karin/0000-0001-9208-6523; Ronsein, Graziella E/0000-0002-2340-6770; Pamir, Nathalie/0000-0002-2074-888X	National Institutes of Health [HL092969, HL097365, HL062887, P30 DK035816, P30 DK017047, HL108897, HL112625]; Quantitative and Functional Proteomics Core of the Diabetes Research Center (University of Washington); NORC Energy Balance and Glucose Metabolism Core; American Heart Association [11POST7390072]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108897, R01HL097365, R01HL062887, R01HL112625, P01HL092969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093493, P30DK035816, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Quantitative and Functional Proteomics Core of the Diabetes Research Center (University of Washington); NORC Energy Balance and Glucose Metabolism Core; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092969, HL097365, HL062887, P30 DK035816, P30 DK017047, HL108897, and HL112625. This work was also supported in part by the Quantitative and Functional Proteomics Core of the Diabetes Research Center (University of Washington), the NORC Energy Balance and Glucose Metabolism Core, and American Heart Association Grant 11POST7390072.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; AOTA S, 1991, BIOCHEM SOC T, V19, P830, DOI 10.1042/bst0190830; Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033297; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; Gagnon A, 2012, LIPIDS, V47, P873, DOI 10.1007/s11745-012-3696-8; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guyenet SJ, 2012, J CLIN ENDOCR METAB, V97, P745, DOI 10.1210/jc.2011-2525; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton JA, 2012, CYTOKINE, V57, P30, DOI 10.1016/j.cyto.2011.10.021; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ingraham CA, 2011, J BIOL CHEM, V286, P17649, DOI 10.1074/jbc.M111.229427; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim DH, 2008, AM J PHYSIOL-ENDOC M, V295, pE1038, DOI 10.1152/ajpendo.00061.2008; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Lee JT, 2014, ENDOCRINOLOGY, V155, P3409, DOI 10.1210/en.2014-1037; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CX, 2010, ENDOCRINOLOGY, V151, P2189, DOI 10.1210/en.2009-1194; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; McLean J. A., 1987, HUMAN ANIMAL CALORIM, P52; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Mystkowski P, 2000, INT J OBESITY, V24, P719, DOI 10.1038/sj.ijo.0801231; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; O'Connell J, 2011, J CLIN ENDOCR METAB, V96, pE680, DOI 10.1210/jc.2010-2026; Pamir N, 2012, AM J PHYSIOL-ENDOC M, V302, pE961, DOI 10.1152/ajpendo.00447.2011; Pamir N, 2009, ENDOCRINOLOGY, V150, P4124, DOI 10.1210/en.2009-0137; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Plenz G, 2003, FASEB J, V17, P1451, DOI 10.1096/fj.02-1035com; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Schreyer SA, 1996, J BIOL CHEM, V271, P26174, DOI 10.1074/jbc.271.42.26174; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wang YH, 2010, CLIN LIPIDOL, V5, P109, DOI 10.2217/CLP.09.80; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866	53	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14656	14667		10.1074/jbc.M115.645820	http://dx.doi.org/10.1074/jbc.M115.645820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25931125	hybrid, Green Published			2022-12-26	WOS:000355754600036
J	Farrow, DC; Burke, DS; Rosenfeld, R				Farrow, David C.; Burke, Donald S.; Rosenfeld, Roni			Computational Characterization of Transient Strain-Transcending Immunity against Influenza A	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; SEASONAL INFLUENZA; LETHAL INFECTION; VIRUS-INFECTION; CROSS-IMMUNITY; EVOLUTION; RESPONSES; MICE; TRANSMISSION; FERRETS	The enigmatic observation that the rapidly evolving influenza A (H3N2) virus exhibits, at any given time, a limited standing genetic diversity has been an impetus for much research. One of the first generative computational models to successfully recapitulate this pattern of consistently constrained diversity posits the existence of a strong and short-lived strain-transcending immunity. Building on that model, we explored a much broader set of scenarios (parameterizations) of a transient strain-transcending immunity, ran long-term simulations of each such scenario, and assessed its plausibility with respect to a set of known or estimated influenza empirical measures. We evaluated simulated outcomes using a variety of measures, both epidemiological (annual attack rate, epidemic duration, reproductive number, and peak weekly incidence), and evolutionary (pairwise antigenic diversity, fixation rate, most recent common ancestor, and kappa, which quantifies the potential for antigenic evolution). Taking cumulative support from all these measures, we show which parameterizations of strain-transcending immunity are plausible with respect to the set of empirically derived target values. We conclude that strain-transcending immunity which is milder and longer lasting than previously suggested is more congruent with the observed short-and long-term behavior of influenza.	[Farrow, David C.; Rosenfeld, Roni] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Burke, Donald S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Farrow, David C.] Joint Carnegie Mellon Univ Univ Pittsburgh, Ph D Program Computat Biol, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Rosenfeld, R (corresponding author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	Roni.Rosenfeld@cs.cmu.edu		Rosenfeld, Ronald/0000-0002-3274-5862; Farrow, David/0000-0001-5798-1215; /0000-0002-5704-8094	National Institutes of Health T32 training grant , Howard Hughes Medical Institute-National Institute of Biomedical Imaging and Bioengineering Interfaces Initiative [T32 EB009403]; National Institute of General Medical Science of the National Institutes of Health [U54GM088491]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	National Institutes of Health T32 training grant , Howard Hughes Medical Institute-National Institute of Biomedical Imaging and Bioengineering Interfaces Initiative; National Institute of General Medical Science of the National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DF was a predoctoral trainee supported by National Institutes of Health T32 training grant T32 EB009403 as part of the Howard Hughes Medical Institute-National Institute of Biomedical Imaging and Bioengineering Interfaces Initiative. Research reported in this publication was supported by the National Institute of General Medical Science of the National Institutes of Health under award number U54GM088491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2004, P ROY SOC B-BIOL SCI, V271, P2431, DOI 10.1098/rspb.2004.2877; Andreasen V, 2006, THEOR POPUL BIOL, V70, P164, DOI 10.1016/j.tpb.2006.04.004; Beaumont MA, 2002, GENETICS, V162, P2025; Bedford T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-38; Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044; Bodewes R, 2010, J VIROL, V84, P7943, DOI 10.1128/JVI.00549-10; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cheng X, 2013, J INFECT DIS, V208, P594, DOI 10.1093/infdis/jit207; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Flahault A, 1998, JAMA-J AM MED ASSOC, V280, P1330, DOI 10.1001/jama.280.15.1330; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Koelle K, 2011, P ROYAL SOC B; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Koelle K, 2009, EPIDEMICS-NETH, V1, P129, DOI 10.1016/j.epidem.2009.05.003; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Kreijtz JHCM, 2009, VACCINE, V27, P4983, DOI 10.1016/j.vaccine.2009.05.079; Kucharski AJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002082; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nukiwa-Souma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033046; Omori R, 2010, J THEOR BIOL, V262, P48, DOI 10.1016/j.jtbi.2009.09.015; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; TANNOCK GA, 1987, ARCH VIROL, V92, P121, DOI 10.1007/BF01310067; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Towers S, 2010, SHORT TERM HETEROLOG; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Truscott J, 2011, J ROYAL SOC INTERFAC; Wheaton William D, 2009, Methods Rep RTI Press, V2009, P905; Zinder D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003104	39	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125047	10.1371/journal.pone.0125047	http://dx.doi.org/10.1371/journal.pone.0125047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933195	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000353887100075
J	Plieninger, T; Levers, C; Mantel, M; Costa, A; Schaich, H; Kuemmerle, T				Plieninger, Tobias; Levers, Christian; Mantel, Martin; Costa, Augusta; Schaich, Harald; Kuemmerle, Tobias			Patterns and Drivers of Scattered Tree Loss in Agricultural Landscapes: Orchard Meadows in Germany (1968-2009)	PLOS ONE			English	Article							EVERGREEN OAK WOODLANDS; LAND-USE; FUTURE; AGROFORESTRY; MANAGEMENT; EUROPE; FRAGMENTATION; MAINTENANCE; VEGETATION; PASTURES	Scattered trees support high levels of farmland biodiversity and ecosystem services in agricultural landscapes, but they are threatened by agricultural intensification, urbanization, and land abandonment. This study aimed to map and quantify the decline of orchard meadows (scattered fruit trees of high nature conservation value) for a region in Southwestern Germany for the 1968 2009 period and to identify the driving forces of this decline. We derived orchard meadow loss from 1968 and 2009 aerial images and used a boosted regression trees modelling framework to assess the relative importance of 18 environmental, demographic, and socio-economic variables to test five alternative hypothesis explaining orchard meadow loss. We found that orchard meadow loss occurred in flatter areas, in areas where smaller plot sizes and fragmented orchard meadows prevailed, and in areas near settlements and infrastructure. The analysis did not confirm that orchard meadow loss was higher in areas where agricultural intensification was stronger and in areas of lower implementation levels of conservation policies. Our results demonstrated that the influential drivers of orchard meadow loss were those that reduce economic profitability and increase opportunity costs for orchards, providing incentives for converting orchard meadows to other, more profitable land uses. These insights could be taken up by local-and regional-level conservation policies to identify the sites of persistent orchard meadows in agricultural landscapes that would be prioritized in conservation efforts.	[Plieninger, Tobias] Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg C, Denmark; [Levers, Christian; Mantel, Martin; Kuemmerle, Tobias] Humboldt Univ, Dept Geog, D-10099 Berlin, Germany; [Costa, Augusta] Univ Nova Lisboa, Ctr Environm & Sustainabil Res CENSE, Caparica, Portugal; [Schaich, Harald] Univ Freiburg, Chair Landscape Management, D-79106 Freiburg, Germany; [Kuemmerle, Tobias] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10099 Berlin, Germany	University of Copenhagen; Humboldt University of Berlin; Universidade Nova de Lisboa; University of Freiburg; Humboldt University of Berlin	Plieninger, T (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg C, Denmark.	tobias.plieninger@ign.ku.dk	Schaich, Harald/B-1907-2010; Costa, Augusta/J-3644-2013; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Kuemmerle, Tobias/B-4340-2008; Levers, Christian/L-9204-2013; Plieninger, Tobias/E-3861-2010	Schaich, Harald/0000-0003-4845-7678; Costa, Augusta/0000-0002-0400-8523; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Kuemmerle, Tobias/0000-0002-9775-142X; Levers, Christian/0000-0003-4810-9024; Plieninger, Tobias/0000-0003-1478-2587	European Community [613520, 265104, 603447]; Einstein Foundation Berlin	European Community(European Commission); Einstein Foundation Berlin	This study has been funded through the European Community's 7th Framework Programme (http://ec.europa.eu/research/fp7/index_en.cfm) under Grant Agreements No. 613520 (Project AGFORWARD), No. 265104 (VOLANTE), and No. 603447 (Project HERCULES) and the Einstein Foundation Berlin (http://www.einsteinfoundation.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker MM, 2005, AGR ECOSYST ENVIRON, V105, P467, DOI 10.1016/j.agee.2004.07.009; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Bernkopf S, 1994, ALTE OBSTSORTEN STRE, P41; Bieling C, 2013, LANDSCAPE RES, V38, P649, DOI 10.1080/01426397.2012.691469; Biro M, 2013, LANDSCAPE ECOL, V28, P789, DOI 10.1007/s10980-012-9818-0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bunce R. G. H., 2009, V6, P321; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Campos P., 2013, MEDITERRANEAN OAK WO; Chetelat J, 2013, ECOL SOC, V18, DOI 10.5751/ES-05287-180139; Costa A, 2014, J ENVIRON MANAGE, V133, P18, DOI 10.1016/j.jenvman.2013.11.026; Costa A, 2011, LANDSCAPE URBAN PLAN, V102, P164, DOI 10.1016/j.landurbplan.2011.04.002; de Foresta H., 2013, ASSESSMENT TREES OUT; Deuschle J, 2008, B INSECTOL, V61, P73; Deutscher Wetterdienst, 2015, KLIM DEUTSCHL; Eichhorn MP, 2006, AGROFOREST SYST, V67, P29, DOI 10.1007/s10457-005-1111-7; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fischer J, 2010, P NATL ACAD SCI USA, V107, P19597, DOI 10.1073/pnas.1008476107; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Fischer J, 2009, P NATL ACAD SCI USA, V106, P10386, DOI 10.1073/pnas.0900110106; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Hartel T, 2013, BIOL CONSERV, V166, P267, DOI 10.1016/j.biocon.2013.06.020; Harvey CA, 2011, FOREST ECOL MANAG, V261, P1664, DOI 10.1016/j.foreco.2010.11.004; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Herrmann JD, 2010, LANDSCAPE ECOL, V25, P1375, DOI 10.1007/s10980-010-9518-6; Herzog F, 2005, AGR ECOSYST ENVIRON, V108, P189, DOI 10.1016/j.agee.2005.02.003; Herzog F., 2000, Unasylva (English ed.), V51, P42; Herzog F, 1998, AGROFOREST SYST, V42, P61, DOI 10.1023/A:1006152127824; Hijmans R.J., 2014, DISMO SPECIES DISTRI; Horak J, 2013, AGR ECOSYST ENVIRON, V178, P71, DOI 10.1016/j.agee.2013.06.020; Levers C, 2014, FOREST ECOL MANAG, V315, P160, DOI 10.1016/j.foreco.2013.12.030; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; MLR, 2009, STREUOBSTW BAD WURTT; Monteiro AT, 2011, LANDSCAPE URBAN PLAN, V100, P287, DOI 10.1016/j.landurbplan.2010.12.015; Muller D, 2013, AGR SYST, V117, P66, DOI 10.1016/j.agsy.2012.12.010; Muller J., 2005, LANDSCHAFTSELEMENTE; Nerlich K., 2012, AGROFOREST SYST, V87, P475, DOI [10.1007/s10457-012-9560-2, DOI 10.1007/S10457-012-9560-2]; Newton AC, 2009, PROG PHYS GEOG, V33, P528, DOI 10.1177/0309133309346882; Paprstein F, 2015, GENET RESOUR CROP EV, V62, P5, DOI 10.1007/s10722-014-0181-7; Plieninger T, 2006, LANDSCAPE ECOL, V21, P91, DOI 10.1007/s10980-005-8294-1; Plieninger T, 2012, APPL GEOGR, V32, P566, DOI 10.1016/j.apgeog.2011.06.015; Plieninger T, 2012, LAND USE POLICY, V29, P233, DOI 10.1016/j.landusepol.2011.06.011; Plieninger T, 2011, LANDSCAPE RES, V36, P435, DOI 10.1080/01426397.2011.582943; Pointereau P, 2008, REFLECTING ENV LAND; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; R Developement Core Team, 2012, LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Schleyer C, 2011, ENVIRON CONSERV, V38, P454, DOI 10.1017/S0376892911000361; Schmitzberger I, 2005, AGR ECOSYST ENVIRON, V108, P274, DOI 10.1016/j.agee.2005.02.009; Schonhart M, 2011, AGR SYST, V104, P122, DOI 10.1016/j.agsy.2010.03.014; Schonhart M, 2011, J ENVIRON PLANN MAN, V54, P115, DOI 10.1080/09640568.2010.502763; Schupbach B, 2008, J ENVIRON MANAGE, V89, P222, DOI 10.1016/j.jenvman.2007.01.060; Smith J, 2013, RENEW AGR FOOD SYST, V28, P80, DOI 10.1017/S1742170511000585; Steffan-Dewenter I, 2003, CONSERV BIOL, V17, P1036, DOI 10.1046/j.1523-1739.2003.01575.x; Steffan-Dewenter I, 2003, BIODIVERS CONSERV, V12, P1953, DOI 10.1023/A:1024199513365; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Weller F, 1996, NATURLANDSCHAFT KULT, P137; Weller F., 2006, HDB NATURSCHUTZ LAND, P1; Zehnder M, 2011, STREUOBSTBAU	59	42	45	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0126178	10.1371/journal.pone.0126178	http://dx.doi.org/10.1371/journal.pone.0126178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932914	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100149
J	Renner, DN; Jin, F; Litterman, AJ; Balgeman, AJ; Hanson, LM; Gamez, JD; Chae, M; Carlson, BL; Sarkaria, JN; Parney, IF; Ohlfest, JR; Pirko, I; Pavelko, KD; Johnson, AJ				Renner, Danielle N.; Jin, Fang; Litterman, Adam J.; Balgeman, Alexis J.; Hanson, Lisa M.; Gamez, Jeffrey D.; Chae, Michael; Carlson, Brett L.; Sarkaria, Jann N.; Parney, Ian F.; Ohlfest, John R.; Pirko, Istvan; Pavelko, Kevin D.; Johnson, Aaron J.			Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+T Cell Responses	PLOS ONE			English	Article							EXPERIMENTAL BRAIN-TUMORS; SENECA VALLEY VIRUS; T-CELLS; GLIOBLASTOMA-MULTIFORME; IN-VIVO; SUPPRESSOR-CELLS; CANCER VACCINE; THEILERS VIRUS; MODEL; CHEMOTHERAPY	Glioblastoma (GBM) is among the most invasive and lethal of cancers, frequently infiltrating surrounding healthy tissue and giving rise to rapid recurrence. It is therefore critical to establish experimental model systems and develop therapeutic approaches that enhance antitumor immunity. In the current study, we have employed a newly developed murine glioma model to assess the efficacy of a novel picornavirus vaccination approach for the treatment of established tumors. The GL261-Quad system is a variation of the GL261 syngeneic glioma that has been engineered to expresses model T cell epitopes including OVA(257-264). MRI revealed that both GL261 and GL261-Quad tumors display characteristic features of human gliomas such as heterogeneous gadolinium leakage and larger T2 weighted volumes. Analysis of brain-infiltrating immune cells demonstrated that GL261-Quad gliomas generate detectable CD8+ T cell responses toward the tumor-specific K-b:OVA(257-264) antigen. Enhancing this response via a single intracranial or peripheral vaccination with picornavirus expressing the OVA(257-264) antigen increased anti-tumor CD8+ T cells infiltrating the brain, attenuated progression of established tumors, and extended survival of treated mice. Importantly, the efficacy of the picornavirus vaccination is dependent on functional cytotoxic activity of CD8+ T cells, as the beneficial response was completely abrogated in mice lacking perforin expression. Therefore, we have developed a novel system for evaluating mechanisms of anti-tumor immunity in vivo, incorporating the GL261-Quad model, 3D volumetric MRI, and picornavirus vaccination to enhance tumor-specific cytotoxic CD8+ T cell responses and track their effectiveness at eradicating established gliomas in vivo.	[Renner, Danielle N.] Mayo Clin, Neurobiol Dis Grad Program, Rochester, MN USA; [Renner, Danielle N.; Jin, Fang; Hanson, Lisa M.; Parney, Ian F.; Pavelko, Kevin D.; Johnson, Aaron J.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Litterman, Adam J.; Ohlfest, John R.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN USA; [Balgeman, Alexis J.] Mayo Clin, Summer Undergrad Res Fellowship, Rochester, MN USA; [Gamez, Jeffrey D.; Pirko, Istvan] Mayo Clin, Dept Neurol, Rochester, MN USA; [Chae, Michael; Parney, Ian F.] Mayo Clin, Dept Neurosurg, Rochester, MN USA; [Carlson, Brett L.; Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Pavelko, KD (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	Pavelko.Kevin@mayo.edu; Johnson.Aaron2@mayo.edu	Ramos, Joe W./L-6189-2013; Pavelko, Kevin D/K-7072-2019	Ramos, Joe W./0000-0002-9708-2115; Pavelko, Kevin D/0000-0001-7555-1315; Parney, Ian/0000-0002-9702-8047	Lefkofsky Family Foundation; Mayo Clinic Brain Tumor SPORE Development Research Project Award [CA108961]; National Institutes of Health [R01 CA154345, R01 CA160782, RSG-09-189-01-LIB, R01 NS060881, R21 CA186976, F31 CA180299]; NATIONAL CANCER INSTITUTE [R01CA154345, R21CA186976, R01CA160782, P50CA108961, F31CA180299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060881] Funding Source: NIH RePORTER	Lefkofsky Family Foundation; Mayo Clinic Brain Tumor SPORE Development Research Project Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the generous gift from the Lefkofsky Family Foundation to the Mayo Clinic Cancer Center and a Mayo Clinic Brain Tumor SPORE Development Research Project Award (CA108961) (AJJ). Additional support was provided by the National Institutes of Health: R01 CA154345, R01 CA160782, RSG-09-189-01-LIB to JRO; R01 NS060881, R21 CA186976 to AJJ; F31 CA180299 to DNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; AUSMAN JI, 1970, CANCER RES, V30, P2394; Barcia C, 2009, AM J PATHOL, V175, P786, DOI 10.2353/ajpath.2009.081034; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Cantini G, 2011, CANCER IMMUNOL IMMUN, V60, P1739, DOI 10.1007/s00262-011-1069-4; Chen XZ, 2012, AM J NEURORADIOL, V33, P1907, DOI 10.3174/ajnr.A3106; Dethlefs S, 1997, J VIROL, V71, P5361, DOI 10.1128/JVI.71.7.5361-5365.1997; Dziurzynski K, 2011, CLIN CANCER RES, V17, P4642, DOI 10.1158/1078-0432.CCR-11-0414; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Eyupoglu IY, 2005, J NEUROSURG, V102, P738, DOI 10.3171/jns.2005.102.4.0738; Fadul CE, 2011, J IMMUNOTHER, V34, P382, DOI 10.1097/CJI.0b013e318215e300; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grauer OM, 2008, J IMMUNOL, V181, P6720, DOI 10.4049/jimmunol.181.10.6720; Hammoud MA, 1996, J NEUROONCOL, V27; Hatano Manabu, 2004, J Transl Med, V2, P40, DOI 10.1186/1479-5876-2-40; Iizuka Y, 2006, INT J CANCER, V118, P942, DOI 10.1002/ijc.21432; IWAMA T, 1991, Neurological Research, V13, P48; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Johnson HL, 2012, J IMMUNOL, V189, P1937, DOI 10.4049/jimmunol.1200658; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; Learn CA, 2006, CLIN CANCER RES, V12, P7306, DOI 10.1158/1078-0432.CCR-06-1727; Litterman AJ, 2013, J IMMUNOL, V190, P6259, DOI 10.4049/jimmunol.1203539; Maes W, 2011, CANCER IMMUNOL IMMUN, V60, P153, DOI 10.1007/s00262-010-0946-6; Maes W, 2009, NEURO-ONCOLOGY, V11, P529, DOI 10.1215/15228517-2009-004; Morton CL, 2010, PEDIATR BLOOD CANCER, V55, P295, DOI 10.1002/pbc.22535; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Nieder C, 2000, CANCER TREAT REV, V26, P397, DOI 10.1053/ctrv.2000.0191; Ohlfest JR, 2013, J IMMUNOL, V190, P613, DOI 10.4049/jimmunol.1201557; Pafundi DH, 2013, NEURO-ONCOLOGY, V15, P1058, DOI 10.1093/neuonc/not002; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; Pavelko KD, 2013, MOL THER, V21, P1087, DOI 10.1038/mt.2013.52; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; Pirko I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-31; Prins RM, 2003, CANCER RES, V63, P8487; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Reddy PS, 2007, J NATL CANCER I, V99, P1623, DOI 10.1093/jnci/djm198; Rodrigues JC, 2010, NEURO-ONCOLOGY, V12, P351, DOI 10.1093/neuonc/nop023; Rudin CM, 2011, CLIN CANCER RES, V17, P888, DOI 10.1158/1078-0432.CCR-10-1706; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Ueda R, 2009, CLIN CANCER RES, V15, P6551, DOI 10.1158/1078-0432.CCR-09-1067; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Wu A, 2007, J IMMUNOTHER, V30, P789, DOI 10.1097/CJI.0b013e318155a0f6; Xiong ZM, 2011, J IMMUNOTHER, V34, P264, DOI 10.1097/CJI.0b013e318209eed4; Yang J, 2010, P NATL ACAD SCI USA, V107, P4716, DOI 10.1073/pnas.0911587107; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	51	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125565	10.1371/journal.pone.0125565	http://dx.doi.org/10.1371/journal.pone.0125565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933216	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100117
J	Fand, BB; Sul, NT; Bal, SK; Minhas, PS				Fand, Babasaheb B.; Sul, Nitin T.; Bal, Santanu K.; Minhas, P. S.			Temperature Impacts the Development and Survival of Common Cutworm (Spodoptera litura): Simulation and Visualization of Potential Population Growth in India under Warmer Temperatures through Life Cycle Modelling and Spatial Mapping	PLOS ONE			English	Article							CLIMATE-CHANGE; FUTURE DISTRIBUTION; PHENOLOGY MODEL; LEPIDOPTERA; FECUNDITY; FERTILITY; ABUNDANCE; MEALYBUG; PEST	The common cutworm, Spodoptera litura, has become a major pest of soybean (Glycine max) throughout its Indian range. With a changing climate, there is the potential for this insect to become an increasingly severe pest in certain regions due to increased habitat suitability. To examine this possibility, we developed temperature-based phenology model for S. litura, by constructing thermal reaction norms for cohorts of single life stages, at both constant and fluctuating temperatures within the ecologically relevant range (15-38 degrees C) for its development. Life table parameters were estimated stochastically using cohort updating and rate summation approach. The model was implemented in the geographic information system to examine the potential future pest status of S. litura using temperature change projections from SRES A(1)B climate change scenario for the year 2050. The changes were visualized by means of three spatial indices demonstrating the risks for establishment, number of generations per year and pest abundance according to the temperature conditions. The results revealed that the development rate as a function of temperature increased linearly for all the immature stages of S. litura until approximately 34-36 degrees C, after which it became non-linear. The extreme temperature of 38 degrees C was found lethal to larval and pupal stages of S. litura wherein no development to the next stage occurred. Females could lay no eggs at the extreme low (15 degrees C) and high (>35 degrees C) test temperatures, demonstrating the importance of optimum temperature in determining the suitability of climate for the mating and reproduction in S. litura. The risk mapping predicts that due to temperature increase under future climate change, much of the soybean areas in Indian states like Madhya Pradesh, Maharashtra and Rajasthan, will become suitable for S. litura establishment and increased pest activity, indicating the expansion of the suitable and favourable areas over time. This has serious implication in terms of soybean production since these areas produce approximately 95% of the total soybeans in India. As the present model results are based on temperature only, and the effects of other abiotic and biotic factors determining the pest population dynamics were excluded, it presents only the potential population growth parameters for S. litura. However, if combined with the field observations, the model results could certainly contribute to gaining insight into the field dynamics of S. litura.	[Fand, Babasaheb B.; Sul, Nitin T.; Bal, Santanu K.; Minhas, P. S.] ICAR Natl Inst Abiot Stress Management NIASM, Pune, Maharashtra, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Abiotic Stress Management	Fand, BB (corresponding author), ICAR Natl Inst Abiot Stress Management NIASM, Pune, Maharashtra, India.	babasahebfand@gmail.com	Fand, Babasaheb/AAF-9417-2020	Fand, Babasaheb/0000-0002-4957-1002; Minhas, Paramjit Singh/0000-0002-2108-6048	Science and Engineering Research Board (SERB) (Department of Science and Technology), Ministry of Science and Technology, Government of India [SB/YS/LS-06/2013]	Science and Engineering Research Board (SERB) (Department of Science and Technology), Ministry of Science and Technology, Government of India	This research was supported by grants from the Science and Engineering Research Board (SERB) (Department of Science and Technology), Ministry of Science and Technology, Government of India, under the "Fast Track Scheme for Young Scientists" program (Grant No. SB/YS/LS-06/2013).	Ahire M. C., 2013, Indian Research Journal of Extension Education, V13, P108; Ahmed AM, 1979, J AUSTR ENTOMOL SOC, Vl, P363; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; ALLEN JC, 1995, ENVIRON ENTOMOL, V24, P996, DOI 10.1093/ee/24.5.996; [Anonymous], 2012, CROP PEST SURV ADV P; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Berzitis EA, 2014, GLOBAL CHANGE BIOL, V20, P2778, DOI 10.1111/gcb.12557; Bharathi JL, 2007, TOBACCO RES, V33, P36; BOARDMAN L A, 1977, New Zealand Entomologist, V6, P316; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; *CABI, 2014, INV SPEC COMP DAT MA; Chelliah S., 1985, P139; Choudhary A. K., 2007, International Journal of Agricultural Sciences, V3, P15; CURRY GL, 1978, THEOR POPUL BIOL, V13, P197, DOI 10.1016/0040-5809(78)90042-4; Dhaliwal GS, 2010, QUEST PESTS MANAGEME; Dhir BC, 1992, INDIAN J PLANT PROTE, V20, P215; EPPO, 2013, PQR DAT EUR MED PLAN; Fand BB, 2014, ECOL MODEL, V288, P62, DOI 10.1016/j.ecolmodel.2014.05.018; Fand BB, 2014, CROP PROT, V55, P98, DOI 10.1016/j.cropro.2013.10.020; GARAD GP, 1984, P INDIAN AS-ANIM SCI, V93, P29, DOI 10.1007/BF03186223; Gedia M. V., 2008, Annals of Plant Protection Sciences, V16, P62; HASHMAT M, 1978, Z ANGEW ENTOMOL, V85, P215; HASHMAT M, 1977, J ANIM MORPHOL PHYSL, V24, P203; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; *IIE, 1993, DISTR MAPS PLANT PES; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jarvis Claire H., 2001, Diversity and Distributions, V7, P237, DOI 10.1046/j.1366-9516.2001.00114.x; Jarvis Claire H., 2001, Diversity and Distributions, V7, P223, DOI 10.1046/j.1366-9516.2001.00113.x; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Kim DS, 2003, ECOL MODEL, V162, P145, DOI 10.1016/S0304-3800(02)00402-7; Kocmankova E, 2011, J AGR SCI, V149, P185, DOI 10.1017/S0021859610001140; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Lee Geung-Joo, 2007, V2, P1; MACK TP, 1987, ECOL MODEL, V39, P269, DOI 10.1016/0304-3800(87)90004-4; Manimanjari D, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu159; Mason PG, 2011, CAN ENTOMOL, V143, P185, DOI 10.4039/n10-058; MIYASHITA K, 1971, Applied Entomology and Zoology, V6, P105; Moussa AM, 1960, B SEC ENT EGPT, V44, P241; Parry M. L., 2007, CONTRIBUTION WORKING, P976; Patil R. K., 1996, Journal of Oilseeds Research, V13, P18; Patil RA, 2014, ENTOMOLOGY ORNITHOLO, V3, P2161, DOI DOI 10.4172/2161-0983.1000118; Patil RH, 2002, THESIS U AGR SCI DHA; Prasad JV, 2004, TOBACCO RES, V30, P42; Punithavalli M, 2014, PHYTOPARASITICA, V42, P213, DOI 10.1007/s12600-013-0354-5; Ramirez J, 2010, 1 INT CTR TROP AGT; RAO GVR, 1989, ENVIRON ENTOMOL, V18, P548, DOI 10.1093/ee/18.4.548; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Shahout H. A., 2011, Asian Journal of Agricultural Sciences, V3, P291; Sharma AN, 2014, DIRECYTORTE PLANT PR, P41; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Smith IM, 1997, QUARANTINE PESTS EUR, V2, P518; Sporleder M, 2004, ENVIRON ENTOMOL, V33, P477, DOI 10.1603/0046-225X-33.3.477; Sporleder M, 2008, ADV CROP RES, V10, P15; Sporleder M., 2013, ILCYM INSECT LIFE CY, P193; Sridhar V, 2014, CLIMAX SIMULATIONS T, P4; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P475, DOI 10.1093/aesa/77.5.475; Wang R.S., 1982, ACTA ECOLOGICA SINIC, V2, P47; Xue M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2201; You L., 2000, SPATIAL PRODUCTION A	60	41	46	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124682	10.1371/journal.pone.0124682	http://dx.doi.org/10.1371/journal.pone.0124682			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927609	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100045
J	Wilcox, KC; Marunde, MR; Das, A; Velasco, PT; Kuhns, BD; Marty, MT; Jiang, HM; Luan, CH; Sligar, SG; Klein, WL				Wilcox, Kyle C.; Marunde, Matthew R.; Das, Aditi; Velasco, Pauline T.; Kuhns, Benjamin D.; Marty, Michael T.; Jiang, Haoming; Luan, Chi-Hao; Sligar, Stephen G.; Klein, William L.			Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated A beta Oligomers	PLOS ONE			English	Article							PRION PROTEIN; MOLECULAR-BASIS; MOUSE MODEL; RECEPTOR; DISEASE; TOXICITY; BRAIN; NEURODEGENERATION; PERMEABILIZATION; PHOSPHORYLATION	Despite their value as sources of therapeutic drug targets, membrane proteomes are largely inaccessible to high-throughput screening (HTS) tools designed for soluble proteins. An important example comprises the membrane proteins that bind amyloid beta oligomers (A beta Os). A beta Os are neurotoxic ligands thought to instigate the synapse damage that leads to Alzheimer's dementia. At present, the identities of initial A beta O binding sites are highly uncertain, largely because of extensive protein-protein interactions that occur following attachment of A beta Os to surface membranes. Here, we show that A beta O binding sites can be obtained in a state suitable for unbiased HTS by encapsulating the solubilized synaptic membrane proteome into nanoscale lipid bilayers (Nanodiscs). This method gives a soluble membrane protein library (SMPL)-a collection of individualized synaptic proteins in a soluble state. Proteins within SMPL Nanodiscs showed enzymatic and ligand binding activity consistent with conformational integrity. A beta Os were found to bind SMPL Nanodiscs with high affinity and specificity, with binding dependent on intact synaptic membrane proteins, and selective for the higher molecular weight oligomers known to accumulate at synapses. Combining SMPL Nanodiscs with a mix-incubate-read chemiluminescence assay provided a solution-based HTS platform to discover antagonists of A beta O binding. Screening a library of 2700 drug-like compounds and natural products yielded one compound that potently reduced A beta O binding to SMPL Nanodiscs, synaptosomes, and synapses in nerve cell cultures. Although not a therapeutic candidate, this small molecule inhibitor of synaptic A beta O binding will provide a useful experimental antagonist for future mechanistic studies of A beta Os in Alzheimer's model systems. Overall, results provide proof of concept for using SMPLs in high throughput screening for A beta O binding antagonists, and illustrate in general how a SMPL Nanodisc system can facilitate drug discovery for membrane protein targets.	[Wilcox, Kyle C.; Marunde, Matthew R.; Velasco, Pauline T.; Kuhns, Benjamin D.; Jiang, Haoming; Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Das, Aditi] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61801 USA; [Das, Aditi; Sligar, Stephen G.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Marty, Michael T.; Sligar, Stephen G.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Luan, Chi-Hao] Northwestern Univ, High Throughput Anal Lab, Evanston, IL USA; [Luan, Chi-Hao] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA	Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University	Klein, WL (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	wklein@northwestern.edu	Marty, Michael T/C-5897-2013	Marty, Michael T/0000-0001-8115-1772; Kuhns, Benjamin/0000-0002-0593-481X	National Institutes of Health [AG029460, AG022547, AG041953, GM33775, AG020506, AG039171]; National Science Foundation [EEC-0647560]; Alzheimer's Association Zenith Award [ZEN-09-133875]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118145, R01GM033775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506, R21AG041953, R01AG022547, R01AG029460, F32AG039171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Alzheimer's Association Zenith Award(Alzheimer's Association); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG029460, AG022547, AG041953, GM33775, AG020506, AG039171; National Science Foundation grant EEC-0647560, and The Alzheimer's Association Zenith Award ZEN-09-133875. Additional funding was provided by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cooper MA, 2004, J MOL RECOGNIT, V17, P286, DOI 10.1002/jmr.675; CUATRECASAS P, 1973, BIOCHEMISTRY-US, V12, P3547, DOI 10.1021/bi00742a031; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; DODD PR, 1981, BRAIN RES, V226, P107, DOI 10.1016/0006-8993(81)91086-6; Dodgson K, 2009, J RECEPT SIG TRANSD, V29, P163, DOI 10.1080/10799890903079844; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Gotz J, 2011, CELL MOL LIFE SCI, V68, P3359, DOI 10.1007/s00018-011-0750-2; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; Johnson EN, 2008, ASSAY DRUG DEV TECHN, V6, P327, DOI 10.1089/adt.2007.113; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khoury K, 2012, CURR PHARM DESIGN, V18, P4668, DOI 10.2174/138161212802651580; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee M, 2012, NEUROBIOL AGING, V33, P2237, DOI 10.1016/j.neurobiolaging.2011.12.005; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Malchiodi-Albedi Fiorella, 2011, Int J Alzheimers Dis, V2011, P906964, DOI 10.4061/2011/906964; MARKWELL MAK, 1981, P NATL ACAD SCI-BIOL, V78, P5406, DOI 10.1073/pnas.78.9.5406; Marty MT, 2013, ANAL BIOANAL CHEM, V405, P4009, DOI 10.1007/s00216-013-6790-8; Mustata GM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3697682; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Pitt J, 2013, FASEB J, V27, P199, DOI 10.1096/fj.12-211896; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Viola KL, 2015, NAT NANOTECHNOL, V10, P91, DOI [10.1038/NNANO.2014.254, 10.1038/nnano.2014.254]; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060; Xiao C, 2013, J ALZHEIMERS DIS, V35, P777, DOI 10.3233/JAD-122419; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182; Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015	67	29	29	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125263	10.1371/journal.pone.0125263	http://dx.doi.org/10.1371/journal.pone.0125263			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928376	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100074
J	Ewan, VC; Sails, AD; Walls, AWG; Rushton, S; Newton, JL				Ewan, Victoria C.; Sails, Andrew D.; Walls, Angus W. G.; Rushton, Steven; Newton, Julia L.			Dental and Microbiological Risk Factors for Hospital-Acquired Pneumonia in Non-Ventilated Older Patients	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE-UNIT; PLAQUE ANTISEPTIC DECONTAMINATION; POTENTIAL RESPIRATORY PATHOGENS; NOSOCOMIAL INFECTIONS; BACTERIAL-COLONIZATION; ELDERLY-PEOPLE; HIP FRACTURE; IMPACT; MORTALITY	Hospital acquired pneumonia (HAP) is often fatal in older patients. The mouth is the main reservoir of infection and studies have suggested that oral hygiene interventions may prevent HAP. The aim of this study was to investigate associations between HAP and preceding a) heavy dental plaque and b) oral carriage of potential respiratory pathogens in older patients with lower limb fracture to determine the target for intervention studies. Methods We obtained a time series of tongue/throat swabs from 90 patients with lower limb fracture, aged 65-101 in a general hospital in the North East of England between April 2009-July 2010. We used novel real-time multiplex PCR assays to detect S. aureus, MRSA, E. coli, P. aeruginosa, S. pneumoniae, H. influenza and Acinetobacter spp. We collected data on dental/denture plaque (modified Quigley-Hein index) and outcomes of clinician-diagnosed HAP. Results The crude incidence of HAP was 10% (n = 90), with mortality of 80% at 90 days post discharge. 50% of cases occurred within the first 25 days. HAP was not associated with being dentate, tooth number, or heavy dental/denture plaque. HAP was associated with prior oral carriage with E. coli/S. aureus/P. aeruginosa/MRSA (p = 0.002, OR 9.48 95% CI 2.28-38.78). The incidence of HAP in those with carriage was 35% (4% without), with relative risk 6.44 (95% CI 2.04-20.34, p = 0.002). HAP was associated with increased length of stay (Fishers exact test, p=0.01), with mean 30 excess days (range -11.5-115). Target organisms were first detected within 72 hours of admission in 90% participants, but HAP was significantly associated with S. aureus/MRSA/P. aeruginosa/E. coli being detected at days 5 (OR 4.39, 95% CI1.73-11.16) or 14 (OR 6.69, 95% CI 2.40-18.60). Conclusions Patients with lower limb fracture who were colonised orally with E. coli/S. aureus/MRSA/P. aeruginosa after 5 days in hospital were at significantly greater risk of HAP (p = 0.002).	[Ewan, Victoria C.; Newton, Julia L.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sails, Andrew D.] Publ Hlth England, Microbiol Serv, Newcastle Lab, Newcastle Upon Tyne, Tyne & Wear, England; [Walls, Angus W. G.] Univ Edinburgh, Edinburgh Dent Inst, Edinburg, TX USA; [Rushton, Steven] Newcastle Univ, Biol Modelling, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Public Health England; Newcastle University - UK	Ewan, VC (corresponding author), Newcastle Univ, Inst Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Victoria.ewan@ncl.ac.uk		Newton, Julia/0000-0002-1249-5253	Medical Research Counciil UK [G0800440]; MRC [G0800440] Funding Source: UKRI; Medical Research Council [G0800440] Funding Source: researchfish; National Institute for Health Research [CL-2012-01-004, 2311] Funding Source: researchfish	Medical Research Counciil UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	VE received a Clinical research training fellowship from the Medical Research Counciil UK, grant number G0800440. www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bassim CW, 2008, J AM GERIATR SOC, V56, P1601, DOI 10.1111/j.1532-5415.2008.01825.x; Belda J, 2005, CHEST, V128, P1571, DOI 10.1378/chest.128.3.1571; Berdal JE, 2007, CLIN MICROBIOL INFEC, V13, P476, DOI 10.1111/j.1469-0691.2006.01678.x; Binkley CJ, 2009, ORAL SURG ORAL MED O, V108, P722, DOI 10.1016/j.tripleo.2009.06.027; Brook I, 2011, J DENT RES, V90, P704, DOI 10.1177/0022034510391794; CELIS R, 1988, CHEST, V93, P318, DOI 10.1378/chest.93.2.318; Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; Chlebicki MN, 2007, CRIT CARE MED, V35, P595, DOI 10.1097/01.CCM.0000253395.70708.AC; Demidenko E., STAT MED, V26, P3385; Dickson RP, 2014, LANCET RESP MED, V2, P238, DOI 10.1016/S2213-2600(14)70028-1; DILWORTH JP, 1991, THORAX, V46, P165, DOI 10.1136/thx.46.3.165; El-Solh AA, 2004, CHEST, V126, P1575, DOI 10.1378/chest.126.5.1575; Ewan V, 2010, AGE AGEING, V39, P122, DOI 10.1093/ageing/afp166; Ewig S, 1999, AM J RESP CRIT CARE, V159, P188, DOI 10.1164/ajrccm.159.1.9803097; Fourrier F, 2000, INTENS CARE MED, V26, P1239, DOI 10.1007/s001340000585; Fourrier F, 2005, CRIT CARE MED, V33, P1728, DOI 10.1097/01.CCM.0000171537.03493.B0; Fourrier F, 1998, CRIT CARE MED, V26, P301, DOI 10.1097/00003246-199802000-00032; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Garcia-Alvarez F, 2010, ARCH GERONTOL GERIAT, V50, P51, DOI 10.1016/j.archger.2009.01.009; Griscelli F, 2001, J CLIN MICROBIOL, V39, P4362, DOI 10.1128/JCM.39.12.4362-4369.2001; HANSON LC, 1992, AM J MED, V92, P161, DOI 10.1016/0002-9343(92)90107-M; Health Protection Agency, 2012, ENGL NAT POINT PREV; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Khasraghi FA, 2003, ORTHOPEDICS, V26, P49; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; LEU HS, 1989, AM J EPIDEMIOL, V129, P1258, DOI 10.1093/oxfordjournals.aje.a115245; Lieberman D, 2006, J CLIN MICROBIOL, V44, P525, DOI 10.1128/JCM.44.2.525-528.2006; MAHONEY F I, 1965, Md State Med J, V14, P61; Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162; Mobbs KJ, 1999, RESP MED, V93, P540, DOI 10.1016/S0954-6111(99)90152-X; Mojon P, 1997, Gerodontology, V14, P9, DOI 10.1111/j.1741-2358.1997.00009.x; Morris AC, 2009, THORAX, V64, P516, DOI 10.1136/thx.2008.110239; Morris AC, 2011, CRIT CARE MED, V39, P2218, DOI 10.1097/CCM.0b013e3182227d52; Mylotte JM, 2001, INFECT CONT HOSP EP, V22, P83, DOI 10.1086/501868; NICOLLE LE, 1986, AGE AGEING, V15, P47, DOI 10.1093/ageing/15.1.47; Niederman M S, 1990, Semin Respir Infect, V5, P173; Palmer LB, 2001, AM J RESP CRIT CARE, V164, P464, DOI 10.1164/ajrccm.164.3.2008149; Preston AJ, 1999, GERONTOLOGY, V45, P49, DOI 10.1159/000022055; QUIGLEY GA, 1962, J AM DENT ASSOC, V65, P26, DOI 10.14219/jada.archive.1962.0184; Quinn B, 2014, J NURS SCHOLARSHIP, V46, P11, DOI 10.1111/jnu.12050; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2008, J AM GERIATR SOC, V56, P1213, DOI 10.1111/j.1532-5415.2008.01773.x; Rothan-Tondeur M, 2003, J AM GERIATR SOC, V51, P997, DOI 10.1046/j.1365-2389.2003.51314.x; Russell S L, 1999, Spec Care Dentist, V19, P128, DOI 10.1111/j.1754-4505.1999.tb01413.x; Saeed K, 2010, CURR ORTHOP PRACT, V21, P628, DOI 10.1097/BCO.0b013e3181f20439; SCANNAPIECO FA, 1992, CRIT CARE MED, V20, P740, DOI 10.1097/00003246-199206000-00007; Scannapieco FA, 2009, CRIT CARE, V13, DOI 10.1186/cc7967; Sumi Yasunori, 2003, Gerodontology, V20, P84, DOI 10.1111/j.1741-2358.2003.00084.x; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Thompson DA, 2006, ANN SURG, V243, P547, DOI 10.1097/01.sla.0000207097.38963.3b; TURESKY S, 1970, J PERIODONTOL, V41, P41, DOI 10.1902/jop.1970.41.1.41; Vergis EN, 2001, ARCH INTERN MED, V161, P2378, DOI 10.1001/archinte.161.19.2378; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x	55	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123622	10.1371/journal.pone.0123622	http://dx.doi.org/10.1371/journal.pone.0123622			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923662	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600052
J	Sinn, DH; Cho, JY; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Yoo, BC				Sinn, Dong Hyun; Cho, Ju-Yeon; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon; Yoo, Byung Chul			Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread	PLOS ONE			English	Article							SURGICAL RESECTION; SORAFENIB; CHEMOEMBOLIZATION; INTERMEDIATE; CHEMOTHERAPY; RADIOTHERAPY; FEASIBILITY; IMPACT	Portal vein invasion (PVI) and extrahepatic spread (ES) are two tumor-related factors that define advanced stage in the Barcelona Clinic Liver Cancer (BCLC) staging system (BCLC stage C), and the recommended first line therapy in this stage is sorafenib. However, the extent of PVI and the type of ES may affect patient prognosis as well as treatment outcome. This study analyzed survival of BCLC stage C HCC patients in order to see whether subclassification of BCLC stage C is necessary. A total of 582 treatment naive, BCLC stage C HCC patients [age: 54.3 +/- 10.8 years, males = 494 (84.9%), hepatitis B virus (458, 78.7%)], defined by PVI and/or ES, were analyzed. Extent of PVI was divided into none, type I-segmental/ sectoral branches, type II-left and/or right portal vein, and type III-main portal vein trunk. Type of ES was divided into nodal and distant metastasis. The extent of PVI and type of ES were independent factors for survival. When patients were sub-classified according to the extent of PVI and type of ES, the median survival was significantly different [11.7 months, 5.7 months, 4.9 months and 2.3 months for C1 (PVI-O/I without distant ES), C2 (PVI-II/III without distant ES), C3 (PVI-0/I with distant ES), and C4 (PVI-II/III with distant ES), respectively, P = 0.01]. Patients' survival was different according to the treatment modality in each sub-stage. Sub-classification of BCLC stage C according to the extent of PVI and type of ES resulted in a better prediction of survival. Also, different outcome was observed by treatment modalities in each sub-stage. Sub-classification of BCLC stage C is required to minimize heterogeneity within the same tumor stage, that will help better predict survival and to select optimal treatment strategies.	[Sinn, Dong Hyun; Cho, Ju-Yeon; Gwak, Geum-Youn; Paik, Yong-Han; Choi, Moon Seok; Lee, Joon Hyeok; Koh, Kwang Cheol; Paik, Seung Woon; Yoo, Byung Chul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Gwak, GY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	gy.gwak@samsung.com	Gwak, Geum Youn/F-4605-2014; Sinn, Dong Hyun/O-5941-2014; Sinn, Dong Hyun/L-3701-2019	Sinn, Dong Hyun/0000-0002-7126-5554; 				Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cha J, 2013, YONSEI MED J, V54, P1178, DOI 10.3349/ymj.2013.54.5.1178; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cho JY, 2014, LIVER INT, V34, P795, DOI 10.1111/liv.12445; Choi GH, 2013, RADIOLOGY, V269, P602, DOI 10.1148/radiol.13130150; Cillo U, 2013, DIGEST LIVER DIS, V45, P460, DOI 10.1016/j.dld.2013.03.010; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hasegawa K, 2014, ANN SURG, V259, P166, DOI 10.1097/SLA.0b013e31828d4960; Kee KM, 2013, DIGEST DIS SCI, V58, P2721, DOI 10.1007/s10620-013-2716-8; Kim DY, 2012, DIGEST DIS, V30, P598, DOI 10.1159/000343088; Korean Liver Cancer Study Group and National Cancer Center Korea, 2009, Korean J Hepatol, V15, P391, DOI 10.3350/kjhep.2009.15.3.391; Lee HS, 2011, DIGEST DIS, V29, P333, DOI 10.1159/000327572; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077240; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Livraghi T, 2010, J SURG ONCOL, V102, P868, DOI 10.1002/jso.21733; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mazzaferro V, 2013, HEPATOLOGY, V57, P1826, DOI 10.1002/hep.26014; Memon K, 2013, J HEPATOL, V58, P73, DOI 10.1016/j.jhep.2012.09.003; Osaki Y, 2015, HEPATOL RES, V45, P59, DOI 10.1111/hepr.12378; Park JY, 2007, CANCER-AM CANCER SOC, V110, P129, DOI 10.1002/cncr.22759; Park KW, 2008, J GASTROEN HEPATOL, V23, P467, DOI 10.1111/j.1440-1746.2007.05112.x; Prajapati HJ, 2013, J VASC INTERV RADIOL, V24, P307, DOI 10.1016/j.jvir.2012.11.026; Shi J, 2010, ANN SURG ONCOL, V17, P2073, DOI 10.1245/s10434-010-0940-4; Yang T, 2012, J CANCER RES CLIN, V138, P1121, DOI 10.1007/s00432-012-1188-0; Yoo EJ, 2013, ONCOTARGETS THER, V6, DOI 10.2147/OTT.S45602; Yoon EL, 2014, J CLIN GASTROENTEROL, V48, pE22, DOI 10.1097/MCG.0b013e3182a54ec8	27	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124434	10.1371/journal.pone.0124434	http://dx.doi.org/10.1371/journal.pone.0124434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923439	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600086
J	Yoshihama, N; Yamaguchi, K; Chigita, S; Mine, M; Abe, M; Ishii, K; Kobayashi, Y; Akimoto, N; Mori, Y; Sugiura, T				Yoshihama, Naoya; Yamaguchi, Koujiro; Chigita, Satomi; Mine, Mariko; Abe, Masakazu; Ishii, Kotaro; Kobayashi, Yosuke; Akimoto, Naonari; Mori, Yoshihide; Sugiura, Tsuyoshi			A Novel Function of CD82/KAI1 in Sialyl Lewis Antigen-Mediated Adhesion of Cancer Cells: Evidence for an Anti-Metastasis Effect by Down-Regulation of Sialyl Lewis Antigens	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; COLORECTAL-CANCER; CARCINOMA-CELLS; KAI1 GENE; GLYCOSYLTRANSFERASES; COMPLEXES; PROTEIN; IV	We have recently elucidated a novel function for CD82 in E-cadherin-mediated homocellular adhesion; due to this function, it can inhibit cancer cell dissociation from the primary cancer nest and limit metastasis. However, the effect of CD82 on selectin ligand-mediated heterocellular adhesion has not yet been elucidated. In this study, we focused on the effects of the metastasis suppressor CD82/KAI1 on heterocellular adhesion of cancer cells to the endothelium of blood vessels in order to further elucidate the function of tetraspanins. The over-expression of CD82 in cancer cells led to the inhibition of experimentally induced lung metastases in mice and significantly inhibited the adhesion of these cells to human umbilical vein epithelial cells (HUVECs) in vitro. Pre-treatment of the cells with function-perturbing antibodies against sLe(a/x) significantly inhibited the adhesion of CD82-negative cells to HUVECs. In addition, cells over-expressing CD82 exhibited reduced expression of sLe(a/x) compared to CD82-negative wild-type cells. Significant down-regulation of ST3 beta-galactoside alpha-2, 3-sialyltransferase 4 (ST3GAL4) was detected by cDNA microarray, real-time PCR, and western blotting analyses. Knockdown of ST3GAL4 on CD82-negative wild-type cells inhibited expression of sLe(x) and reduced cell adhesion to HUVECs. We concluded that CD82 decreases sLe(a/x) expression via the down-regulation of ST3GAL4 expression and thereby reduces the adhesion of cancer cells to blood vessels, which results in inhibition of metastasis.	[Yoshihama, Naoya; Chigita, Satomi; Mine, Mariko; Abe, Masakazu; Ishii, Kotaro; Kobayashi, Yosuke; Akimoto, Naonari; Mori, Yoshihide] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Surg,Higashi Ku, Fukuoka 8128582, Japan; [Yamaguchi, Koujiro; Sugiura, Tsuyoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oral & Maxillofacial Rehabil, Dept Maxillofacial Diagnost & Surg Sci, Kagoshima 8908544, Japan	Kyushu University; Kagoshima University	Sugiura, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oral & Maxillofacial Rehabil, Dept Maxillofacial Diagnost & Surg Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	sugiura@dent.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390465]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (KAKEN No. 23390465) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. Sugiura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, CANCER LETT, V266, P163, DOI 10.1016/j.canlet.2008.02.058; Adachi M, 1998, J CLIN ONCOL, V16, P1397, DOI 10.1200/JCO.1998.16.4.1397; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; CHANDRASEKARAN EV, 1992, J BIOL CHEM, V267, P23806; Chigita S, 2012, INT J ONCOL, V41, P2021, DOI 10.3892/ijo.2012.1671; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Guo XZ, 1996, CANCER RES, V56, P4876; Ito H, 1997, INT J CANCER, V71, P556, DOI 10.1002/(SICI)1097-0215(19970516)71:4<556::AID-IJC9>3.3.CO;2-J; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; LEBELBINAY S, 1994, CELL IMMUNOL, V154, P468, DOI 10.1006/cimm.1994.1092; Muneyuki T, 2001, ANTICANCER RES, V21, P3581; Ogawa J, 1996, CANCER RES, V56, P325; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; Petretti T, 1999, BBA-GEN SUBJECTS, V1428, P209, DOI 10.1016/S0304-4165(99)00080-X; Recchi MA, 1998, CANCER RES, V58, P4066; Renkonen R, 1997, GLYCOCONJUGATE J, V14, P593, DOI 10.1023/A:1018536509950; Saito S, 2002, ONCOL REP, V9, P1251; SASAKI K, 1993, J BIOL CHEM, V268, P22782; Seki K, 2005, ORAL SCI INT, V2, P36, DOI 10.1016/S1348-8643(05)80005-9; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Tagawa K, 1999, JPN J CANCER RES, V90, P970, DOI 10.1111/j.1349-7006.1999.tb00843.x; TAKADA A, 1991, BIOCHEM BIOPH RES CO, V179, P713, DOI 10.1016/0006-291X(91)91875-D; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Takaoka A, 1998, ONCOGENE, V16, P1443, DOI 10.1038/sj.onc.1201648; Yu Y, 1997, CLIN CANCER RES, V3, P1045	27	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124743	10.1371/journal.pone.0124743	http://dx.doi.org/10.1371/journal.pone.0124743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923697	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600101
J	Daya, M; van der Merwe, L; van Helden, PD; Moller, M; Hoal, EG				Daya, Michelle; van der Merwe, Lize; van Helden, Paul D.; Moeller, Marlo; Hoal, Eileen G.			Investigating the Role of Gene-Gene Interactions in TB Susceptibility	PLOS ONE			English	Article							MISSING HERITABILITY; BENEFICIAL MUTATIONS; ASSOCIATION; EPISTASIS; TUBERCULOSIS; POLYMORPHISMS; POPULATION; STRATEGIES; VARIANTS; LOCI	Tuberculosis (TB) is the second leading cause of mortality from infectious disease worldwide. One of the factors involved in developing disease is the genetics of the host, yet the field of TB susceptibility genetics has not yielded the answers that were expected. A commonly posited explanation for the missing heritability of complex disease is gene-gene interactions, also referred to as epistasis. In this study we investigate the role of gene-gene interactions in genetic susceptibility to TB using a cohort recruited from a high TB incidence community from Cape Town, South Africa. Our discovery data set incorporates genotypes from a large a number of candidate gene studies as well as genome-wide data. After limiting our search space to pairs of putative TB susceptibility genes, as well as pairs of genes that have been curated in online databases as potential interactors, we use statistical modelling to identify pairs of interacting SNPs. We attempt to validate the top models identified in our discovery data set using an independent genome-wide TB case-control data set from The Gambia. A number of models were successfully validated, indicating that interplay between the NRG1-NRG3, GRIK1-GRIK3 and IL23R-ATG4C gene pairs may modify susceptibility to TB. Gene pairs involved in the NF-kappa B pathway were also identified in the discovery data set (SFTPD-NOD2, ISG15-TLR8 and NLRC5-IL12RB1), but could not be tested in the Gambian study group due to lack of overlapping data.	[Daya, Michelle; van der Merwe, Lize; van Helden, Paul D.; Moeller, Marlo; Hoal, Eileen G.] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,SA MRC Ctr TB Res, Cape Town, South Africa	National Research Foundation - South Africa; Stellenbosch University	Hoal, EG (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,SA MRC Ctr TB Res, Cape Town, South Africa.	egvh@sun.ac.za	Moller, Marlo/AAC-6973-2020; van der Merwe, Lize/C-9445-2013	Moller, Marlo/0000-0002-0805-6741; van der Merwe, Lize/0000-0001-9705-8126	South African National Research Foundation	South African National Research Foundation(National Research Foundation - South Africa)	Funding: South African National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brinza D, 2010, BIOINFORMATICS, V26, P2856, DOI 10.1093/bioinformatics/btq529; Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368; Buzkova P, 2011, ANN HUM GENET, V75, P36, DOI 10.1111/j.1469-1809.2010.00572.x; Chen GJ, 2012, BIOINFORM BIOL INSIG, V6, P169, DOI 10.4137/BBI.S9867; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Chimusa ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073971; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Collins RL, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-4; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Daya M, 2014, TUBERCULOSIS, V94, P413, DOI 10.1016/j.tube.2014.03.012; Daya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082224; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; de Wit E, 2010, MAMM GENOME, P1; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Edwards DRV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032275; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Fallahi-Sichani M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00170; FERGUSON EL, 1989, GENETICS, V123, P109; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fukami T, 2003, GENE, V323, P11, DOI 10.1016/j.gene.2003.09.018; Fukuhara H, 2001, ONCOGENE, V20, P5401, DOI 10.1038/sj.onc.1204696; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gallant CJ, 2010, INT J TUBERC LUNG D, V14, P952; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Hoal EG, 2004, INT J TUBERC LUNG D, V8, P1464; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kam-Thong Tony, 2011, Eur J Hum Genet, V19, P465, DOI 10.1038/ejhg.2010.196; Kanakry CG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001369; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kerr KF, 2009, BIOINFORMATICS, V25, P2035, DOI 10.1093/bioinformatics/btp363; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kingma PS, 2006, J BIOL CHEM, V281, P24496, DOI 10.1074/jbc.M600651200; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036408; Linden RO, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-45; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Luce MJ, 1999, GENE, V231, P121, DOI 10.1016/S0378-1119(99)00093-1; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002714; Marballi K, 2010, J MOL MED, V88, P1133, DOI 10.1007/s00109-010-0653-y; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McKinney BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000432; McLeod IX, 2012, J LEUKOCYTE BIOL, V92, P409, DOI 10.1189/jlb.0612269; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Motsinger-Reif AA, 2008, GENET EPIDEMIOL, V32, P325, DOI 10.1002/gepi.20307; Motsinger-Reif AA, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-37; MRC, 2006, REV BURD DIS EST COM; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Okser S, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-5; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Ravikumar M., 1999, Tubercle and Lung Disease, V79, P309, DOI 10.1054/tuld.1999.0213; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Rosenzweig SD, 2005, IMMUNOL REV, V203, P38, DOI 10.1111/j.0105-2896.2005.00227.x; Rothman KJ, 2014, J GEN INTERN MED, P1; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Shriner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008398; Sinnwell JP, 2013, HAPLO STATS STAT ANA; Songane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041618; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Turner SD, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-5; Ueki M, 2012, PLOS GENET, V8, P141, DOI 10.1371/journal.pgen.1002625; UHLINHANSEN L, 1989, J BIOL CHEM, V264, P14916; Velez DR, 2009, INT J TUBERC LUNG D, V13, P1068; Warnes G, 2012, GENETICS POPULATION; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Wellek S, 2009, HUM HERED, V67, P128, DOI 10.1159/000179560; Wenning AS, 2011, BBA-MOL CELL RES, V1813, P412, DOI 10.1016/j.bbamcr.2010.12.022; White MJ, 2014, GENES IMMUN, V15, P370, DOI 10.1038/gene.2014.28; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2021, 10 THREATS GLOB HLTH; Wu XS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001131; Zhang X, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-1; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	110	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123970	10.1371/journal.pone.0123970	http://dx.doi.org/10.1371/journal.pone.0123970			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919455	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400038
J	Than, A; He, HL; Chua, SH; Xu, D; Sun, L; Leow, MKS; Chen, P				Than, Aung; He, Hui Ling; Chua, Si Hui; Xu, Dan; Sun, Lei; Leow, Melvin Khee-Shing; Chen, Peng			Apelin Enhances Brown Adipogenesis and Browning of White Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; UNCOUPLING PROTEIN; INSULIN-RESISTANCE; TRANSCRIPTIONAL CONTROL; GLUCOSE-HOMEOSTASIS; PPAR-GAMMA; FAT; EXPRESSION; RECEPTOR; DIFFERENTIATION	Brown adipose tissue expends energy in the form of heat via the mitochondrial uncoupling protein UCP1. Recent studies showed that brown adipose tissue is present in adult humans and may be exploited for its anti-obesity and anti-diabetes actions. Apelin is an adipocyte-derived hormone that plays important roles in energy metabolism. Here, we report that apelin-APJ signaling promotes brown adipocyte differentiation by increasing the expressions of brown adipogenic and thermogenic transcriptional factors via the PI3K/Akt and AMPK signaling pathways. It is also found that apelin relieves the TNF alpha inhibition on brown adipogenesis. In addition, apelin increases the basal activity of brown adipocytes, as evidenced by the increased PGC1 alpha and UCP1 expressions, mitochondrial biogenesis, and oxygen consumption. Finally, we provide both in vitro and in vivo evidence that apelin is able to increase the brown-like characteristics in white adipocytes. This study, for the first time, reveals the brown adipogenic and browning effects of apelin and suggests a potential therapeutic route to combat obesity and related metabolic disorders.	[Than, Aung; He, Hui Ling; Chua, Si Hui; Chen, Peng] Nanyang Technol Univ, Sch Chem & Biomed Engn, Bioengn Program, 70 Nanyang Dr, Singapore 637457, Singapore; [Xu, Dan; Sun, Lei] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Leow, Melvin Khee-Shing] Tan Tock Seng Hosp, Endocrine & Diabet Clin, Singapore 308433, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Tan Tock Seng Hospital	Chen, P (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Bioengn Program, 70 Nanyang Dr, Singapore 637457, Singapore.	chenpeng@ntu.edu.sg	Leow, Melvin/H-3129-2019; Chen, Peng/G-6202-2010; Leow, Melvin/AAJ-1168-2020	Leow, Melvin/0000-0002-2837-5889; Chen, Peng/0000-0003-3730-1846; aung, than/0000-0003-1558-7310	Singapore National Research Foundation under CBRG [NMRC/CBRG/0070/2014]; Singapore Ministry of Education under AcRF [RGT7/13]	Singapore National Research Foundation under CBRG(National Research Foundation, Singapore); Singapore Ministry of Education under AcRF(Ministry of Education, Singapore)	This research is supported by the Singapore National Research Foundation under CBRG Grant (NMRC/CBRG/0070/2014) administrated by the Singapore Ministry of Health's National Medical Research Council. This work is also supported by the Singapore Ministry of Education under AcRF Tier 1 Grant RGT7/13.	Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Attane C, 2012, DIABETES, V61, P310, DOI 10.2337/db11-0100; Than A, 2014, J BIOL CHEM, V289, P3763, DOI 10.1074/jbc.M113.526210; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Besse-Patin A, 2014, INT J OBESITY, V38, P707, DOI 10.1038/ijo.2013.158; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Buravkov SV, 2014, B EXP BIOL MED+, V157, P654, DOI 10.1007/s10517-014-2637-3; Butruille L, 2013, PEPTIDES, V46, P94, DOI 10.1016/j.peptides.2013.05.013; Cancello R, 1998, ENDOCRINOLOGY, V139, P4747, DOI 10.1210/en.139.11.4747; Carey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091997; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Chechi K, 2013, TRENDS ENDOCRIN MET, V24, P408, DOI 10.1016/j.tem.2013.04.002; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Festuccia WT, 2009, AM J PHYSIOL-REG I, V296, pR1327, DOI 10.1152/ajpregu.91012.2008; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; Hinoi E, 2014, BIOCHEM BIOPH RES CO, V450, P255, DOI 10.1016/j.bbrc.2014.05.108; Johnson I., 2010, MOL PROBES HDB GUIDE, V11th; Kadoglou NPE, 2012, MED SCI MONITOR, V18, pCR290, DOI 10.12659/MSM.882734; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Karastergiou K, 2010, MOL CELL ENDOCRINOL, V318, P69, DOI 10.1016/j.mce.2009.11.011; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Kim HJ, 2014, DIABETES, V63, P4045, DOI 10.2337/db14-0466; Knudsen JG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084910, 10.1371/journal.pone.0086457]; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lehr L, 2009, INT J OBESITY, V33, P680, DOI 10.1038/ijo.2009.46; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2010, NAT REV ENDOCRINOL, V6, P319, DOI 10.1038/nrendo.2010.64; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; Matsuo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016446; Mazzucotelli A, 2008, REGUL PEPTIDES, V150, P33, DOI 10.1016/j.regpep.2008.04.003; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Pitkin SL, 2010, PHARMACOL REV, V62, P331, DOI 10.1124/pr.110.002949; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Scott MA, 2011, STEM CELLS DEV, V20, P1793, DOI 10.1089/scd.2011.0040; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Than A, 2013, J BIOL CHEM, V288, P15520, DOI 10.1074/jbc.M113.459792; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; Than A, 2012, MOL CELL ENDOCRINOL, V351, P296, DOI 10.1016/j.mce.2012.01.005; Than A, 2011, MOL CELL ENDOCRINOL, V332, P261, DOI 10.1016/j.mce.2010.11.002; Trayhurn P, 2006, J NUTR, V136, p1935S, DOI 10.1093/jn/136.7.1935S; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valladares A, 2001, FEBS LETT, V493, P6, DOI 10.1016/S0014-5793(01)02264-5; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vijgen GHEJ, 2012, J CLIN ENDOCR METAB, V97, pE1229, DOI 10.1210/jc.2012-1289; Vila-Bedmar R, 2010, ENDOCRINOLOGY, V151, P980, DOI 10.1210/en.2009-0810; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163; Ye F, 2010, J ENDOCRINOL, V206, P27, DOI 10.1677/JOE-10-0090; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zhang J, 2006, LIFE SCI, V79, P1153, DOI 10.1016/j.lfs.2006.03.040; Zhen EY, 2013, ANAL BIOCHEM, V442, P1, DOI 10.1016/j.ab.2013.07.006; Zhu SM, 2011, MOL CELL BIOCHEM, V353, P305, DOI 10.1007/s11010-011-0799-0	74	65	67	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14679	14691		10.1074/jbc.M115.643817	http://dx.doi.org/10.1074/jbc.M115.643817			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25931124	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000355754600038
J	Hung, CL; Chien, JY; Ou, CY				Hung, Chung-Lin; Chien, Jung-Yien; Ou, Chih-Ying			Associated Factors for Tuberculosis Recurrence in Taiwan: A Nationwide Nested Case-Control Study from 1998 to 2010	PLOS ONE			English	Article							RISK-FACTORS; PULMONARY TUBERCULOSIS; RELAPSE; REINFECTION; POPULATION	Background The contribution of human immunodeficiency virus (HIV) co-infection to tuberculosis (TB) recurrence is well established worldwide. We conducted this study to investigate associated factors for recurrent TB in Taiwan, which has a relatively low prevalence of HIV. Methods A case-control study nested within a nationwide population-based cohort was performed using the Taiwan National Health Insurance (NHI) database from 1998 to 2010. Patients with notified TB were identified according to diagnosis codes and prescriptions of anti-TB drugs for more than 60 days. Recurrent TB was defined as cases being retreated for more than 60 days and 6 months after the end of previous TB episode. Four controls were randomly selected from cohort and matched to each case by observational period within a calendar year. Socio-demographic variables and comorbidities were evaluated as factors associated with TB recurrence. Results There were totally 760 patients being investigated (608 controls and 152 cases). During an average 5.12 years of follow-up, 3.76% of all developed recurrent TB and the incidence of TB recurrence was 734 per 100,000 person-years. About half of recurrence (55%) was notified within three years of follow-up, and most (86%) recurrences were intrapulmonary. Independent associated factors for TB recurrence included: male (odds ratio, OR: 2.23, 95% confidence interval, CI: 1.40-3.53), diabetes mellitus (DM) (OR: 1.51, 95% CI: 1.02-2.13), chronic obstructive pulmonary disease (COPD) (OR: 1.59, 95% CI: 1.08-2.36) and lower socio-economic status (p=0.001 between groups). Conclusions Despite low prevalence of HIV in the Taiwanese population, the incidence of recurrent TB among Taiwanese was not less than that of other countries. Identification of subgroups such as male gender, low economic status, DM and COPD should be a high priority in TB control programs.	[Hung, Chung-Lin] Dalin Tzu Chi Hosp, Tzu Chi Med Fdn, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Chien, Jung-Yien] Natl Taiwan Univ Hosp, Dept Internal Med, Div Chest Med, Taipei 100, Taiwan; [Chien, Jung-Yien] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Ou, Chih-Ying] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Chest Med, Tainan 70101, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Cheng Kung University; National Cheng Kung University Hospital	Chien, JY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Chest Med, Taipei 100, Taiwan.	jychien@ntu.edu.tw; budda0714@gmail.com		CHIEN, JUNG-YIEN/0000-0002-7718-0594	Clinical Research Fund of National Cheng Kung University Medical Center, Tainan, Taiwan [NCKUH-10406032]	Clinical Research Fund of National Cheng Kung University Medical Center, Tainan, Taiwan	This study was funded by NCKUH-10406032 grant from the Clinical Research Fund of National Cheng Kung University Medical Center, Tainan, Taiwan.	Aber V R, 1978, Bull Int Union Tuberc, V53, P276; Bang D, 2010, INT J TUBERC LUNG D, V14, P447; Centers for Disease Control, 2013, CDC ANN REP; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; Driver CR, 2001, CLIN INFECT DIS, V33, P1762, DOI 10.1086/323784; Huang SH, 2012, TAIWAN EPIDEMIOL B, V28, P269; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lee CH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-194; Lee PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092623; Liao CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-29; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Millet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064898; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Pascopella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026541; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Selassie AW, 2005, ANN EPIDEMIOL, V15, P519, DOI 10.1016/j.annepidem.2005.03.002; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; World Health Organization, 1995, WHOTB95183; Yang SL, 2012, TUBERCULOSIS CONTROL	21	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124822	10.1371/journal.pone.0124822	http://dx.doi.org/10.1371/journal.pone.0124822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932917	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100058
J	Ruchi, R; Genovese, G; Lee, J; Charoonratana, VT; Bernhardy, AJ; Alper, SL; Kopp, JB; Thadhani, R; Friedman, DJ; Pollak, MR				Ruchi, Rupam; Genovese, Giulio; Lee, Jessica; Charoonratana, Victoria T.; Bernhardy, Andrea J.; Alper, Seth L.; Kopp, Jeffrey B.; Thadhani, Ravi; Friedman, David J.; Pollak, Martin R.			Copy Number Variation at the APOL1 Locus	PLOS ONE			English	Article							APOLIPOPROTEIN-L GENE; SEGMENTAL DUPLICATIONS; HUMAN GENOME; KIDNEY-DISEASE; EVOLUTION; VARIANTS; AFRICAN; REARRANGEMENTS; ARCHITECTURE; INITIATION	Two coding variants in the APOL1 gene (G1 and G2) explain most of the high rate of kidney disease in African Americans. APOL1-associated kidney disease risk inheritance follows an autosomal recessive pattern: The relative risk of kidney disease associated with inheritance of two high-risk variants is 7-30 fold, depending on the specific kidney phenotype. We wished to determine if the variability in phenotype might in part reflect structural differences in APOL1 gene. We analyzed sequence coverage from 1000 Genomes Project Phase 3 samples as well as exome sequencing data from African American kidney disease cases for copy number variation. 8 samples sequenced in the 1000 Genomes Project showed increased coverage over a similar to 100kb region that includes APOL2, APOL1 and part of MYH9, suggesting the presence of APOL1 copy number greater than 2. We reasoned that such duplications should be enriched in apparent G1 heterozygotes with kidney disease. Using a PCR-based assay, we observed the presence of this duplication in additional samples from apparent G0G1 or G0G2 individuals. The frequency of this APOL1 duplication was compared among cases (n = 123) and controls (n = 255) with apparent G0G1 heterozygosity. The presence of APOL1 duplication was observed in 4.06% of cases and 0.78% controls, preliminary evidence that this APOL1 duplication may alter susceptibility to kidney disease (p = 0.03). Taqman-based copy number assays confirmed the presence of 3 APOL1 copies in individuals positive for this specific duplication by PCR assay, but also identified a small number of individuals with additional APOL1 copies of presumably different structure. These observations motivate further studies to better assess the contribution of APOL1 copy number on kidney disease risk and on APOL1 function. Investigators and clinicians genotyping APOL1 should also consider whether the particular genotyping platform used is subject to technical errors when more than two copies of APOL1 are present.	[Ruchi, Rupam; Lee, Jessica; Charoonratana, Victoria T.; Bernhardy, Andrea J.; Alper, Seth L.; Friedman, David J.; Pollak, Martin R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Ruchi, Rupam] Univ Florida, Dept Med, Div Nephrol, Gainesville, FL USA; [Ruchi, Rupam; Alper, Seth L.; Friedman, David J.; Pollak, Martin R.] Harvard Univ, Sch Med, Boston, MA USA; [Genovese, Giulio; Alper, Seth L.] Broad Inst Harvard & MIT, Stanley Ctr, Cambridge, MA USA; [Genovese, Giulio; Pollak, Martin R.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Kopp, Jeffrey B.] NIH, Kidney Dis Branch, Bethesda, MD 20892 USA; [Thadhani, Ravi] Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02114 USA; [Friedman, David J.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; State University System of Florida; University of Florida; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Pollak, MR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA.	mpollak@bidmc.harvard.edu	Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X; Ruchi, Rupam/0000-0001-7973-6050; Friedman, David/0000-0002-0301-9298	NIH [MD007092]; NephCure Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054931, ZIADK043308] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NephCure Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The work was supported by NIH MD007092 and NephCure Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Duchateau PN, 2001, J LIPID RES, V42, P620; Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519; Genovese G, 2013, NAT REV NEPHROL, V9, P240, DOI 10.1038/nrneph.2013.34; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Kanji Z, 2011, J AM SOC NEPHROL, V22, P2091, DOI 10.1681/ASN.2010121234; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Sahoo T, 2015, EUR J HUM GENET, V23, P61, DOI 10.1038/ejhg.2014.53; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shastry BS, 2009, MOL MED REP, V2, P143, DOI 10.3892/mmr_00000074; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Tzur S, 2012, NEPHROL DIAL TRANSPL, V27, P1498, DOI 10.1093/ndt/gfr796; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Whitley E, 2002, CRIT CARE, V6, P335; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; 2005, NATURE, V437, P69, DOI DOI 10.1038/NATURE04072	26	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125410	10.1371/journal.pone.0125410	http://dx.doi.org/10.1371/journal.pone.0125410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933006	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100108
J	Wang, H; Sun, RT; Li, Y; Yang, YF; Xiao, FJ; Zhang, YK; Wang, SX; Sun, HY; Zhang, QW; Wu, CT; Wang, LS				Wang, Hua; Sun, Rui-Ting; Li, Yang; Yang, Yue-Feng; Xiao, Feng-Jun; Zhang, Yi-Kun; Wang, Shao-Xia; Sun, Hui-Yan; Zhang, Qun-Wei; Wu, Chu-Tse; Wang, Li-Sheng			HGF Gene Modification in Mesenchymal Stem Cells Reduces Radiation-Induced Intestinal Injury by Modulating Immunity	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; STROMAL CELLS; THERAPY; TISSUE; IRRADIATION; REPAIR; TRIAL; TH1	Background Effective therapeutic strategies to address intestinal complications after radiation exposure are currently lacking. Mesenchymal stem cells (MSCs), which display the ability to repair the injured intestine, have been considered as delivery vehicles for repair genes. In this study, we evaluated the therapeutic effect of hepatocyte growth factor (HGF)-gene-modified MSCs on radiation-induced intestinal injury (RIII). Methods Female 6- to 8-week-old mice were radiated locally at the abdomen with a single 13-Gy dose of radiation and then treated with saline control, Ad-HGF or Ad-Null-modified MSCs therapy. The transient engraftment of human MSCs was detected via real-time PCR and immunostaining. The therapeutic effects of non-and HGF-modified MSCs were evaluated via FACS to determine the lymphocyte immunophenotypes; via ELISA to measure cytokine expression; via immunostaining to determine tight junction protein expression; via PCNA staining to examine intestinal epithelial cell proliferation; and via TUNEL staining to detect intestinal epithelial cell apoptosis. Results The histopathological recovery of the radiation-injured intestine was significantly enhanced following non-or HGF-modified MSCs treatment. Importantly, the radiation-induced immunophenotypic disorders of the mesenteric lymph nodes and Peyer's patches were attenuated in both MSCs-treated groups. Treatment with HGF-modified MSCs reduced the expression and secretion of inflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha) and interferon-gamma (IFN-gamma), increased the expression of the anti-inflammatory cytokine IL-10 and the tight junction protein ZO-1, and promoted the proliferation and reduced the apoptosis of intestinal epithelial cells. Conclusions Treatment of RIII with HGF-gene-modified MSCs reduces local inflammation and promotes the recovery of small intestinal histopathology in a mouse model. These findings might provide an effective therapeutic strategy for RIII.	[Wang, Hua; Sun, Rui-Ting; Yang, Yue-Feng; Xiao, Feng-Jun; Zhang, Yi-Kun; Sun, Hui-Yan; Zhang, Qun-Wei; Wu, Chu-Tse; Wang, Li-Sheng] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing 100850, Peoples R China; [Sun, Rui-Ting] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100022, Peoples R China; [Li, Yang; Wang, Shao-Xia] Beijing Inst Radiat Med, Dept Expt Pathol, Beijing 100850, Peoples R China; [Wu, Chu-Tse] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China	Academy of Military Medical Sciences - China; Beijing University of Technology; Academy of Military Medical Sciences - China; Sichuan University	Wu, CT (corresponding author), Beijing Inst Radiat Med, Dept Expt Hematol, Beijing 100850, Peoples R China.	wuct@bmi.ac.cn; wangls@bmi.ac.cn		Wu, Chu-tse/0000-0003-0417-8925	Chinese High-Tech '863' Program [2012AA020807]; Chinese National Basic Research and Development '973' [2012CB518205]; National Natural Science Foundation of China [81072240, 81342927]	Chinese High-Tech '863' Program(National High Technology Research and Development Program of China); Chinese National Basic Research and Development '973'(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese High-Tech '863' Program (No. 2012AA020807), the Chinese National Basic Research and Development '973' Grants (No. 2012CB518205) and the National Natural Science Foundation of China (No. 81072240 and No. 81342927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian L, 2009, IN VIVO, V23, P21; Billiard F, 2011, INT J RADIAT ONCOL, V80, P869, DOI 10.1016/j.ijrobp.2010.12.041; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Hamada K, 2010, CANCER CHEMOTH PHARM, V66, P1031, DOI 10.1007/s00280-010-1253-9; Hernigou P, 2014, INT ORTHOP, V38, P1913, DOI 10.1007/s00264-014-2285-2; Hu ZB, 2008, CANCER GENE THER, V15, P173, DOI 10.1038/sj.cgt.7701105; Ido A, 2005, J GASTROENTEROL, V40, P925, DOI 10.1007/s00535-005-1705-x; Kanayama M, 2007, AM J PHYSIOL-GASTR L, V293, pG230, DOI 10.1152/ajpgi.00068.2007; Kudo K, 2010, J RADIAT RES, V51, P73, DOI 10.1269/jrr.09091; Lange C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014486; Linard C, 2012, INT J RADIAT ONCOL, V84, P266, DOI 10.1016/j.ijrobp.2011.11.027; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Madrigal M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0260-8; Matsumoto K, 1997, BIOCHEM BIOPH RES CO, V239, P639, DOI 10.1006/bbrc.1997.7517; Monti P., 2005, BRIT J RADIOL, P89, DOI DOI 10.1259/BJR/53186341; Onal C, 2011, DIGEST DIS SCI, V56, P359, DOI 10.1007/s10620-010-1322-2; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Reagan MR, 2012, J BREAST CANCER, V15, P273, DOI 10.4048/jbc.2012.15.3.273; Rodrigo SF, 2013, J CARDIOVASC TRANSL, V6, P816, DOI 10.1007/s12265-013-9507-7; Selleri S, 2013, STEM CELLS DEV, V22, P1063, DOI 10.1089/scd.2012.0315; Semont A, 2010, CELL DEATH DIFFER, V17, P952, DOI 10.1038/cdd.2009.187; Setoyama H, 2011, LIFE SCI, V89, P269, DOI 10.1016/j.lfs.2011.06.019; Tanaka F, 2008, LIFE SCI, V83, P771, DOI 10.1016/j.lfs.2008.09.016; Turner JD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001269; Wang H, 2013, HUM GENE THER, V24, P343, DOI 10.1089/hum.2012.177; Xu LF, 2011, ARCH PHARM RES, V34, P245, DOI 10.1007/s12272-011-0210-4; Yang C, 2013, CURR GENE THER, V13, P305, DOI 10.2174/15665232113136660027; Zhang J, 2008, J BIOMED SCI, V15, P585, DOI 10.1007/s11373-008-9256-9	31	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124420	10.1371/journal.pone.0124420	http://dx.doi.org/10.1371/journal.pone.0124420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933295	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100041
J	Wang, SY; Li, W; Lian, BF; Liu, XY; Zhang, Y; Dai, EY; Yu, XX; Meng, FL; Jiang, W; Li, X				Wang, Shuyuan; Li, Wei; Lian, Baofeng; Liu, Xinyi; Zhang, Yan; Dai, Enyu; Yu, Xuexin; Meng, Fanlin; Jiang, Wei; Li, Xia			(TM) REC: A Database of Transcription Factor and MiRNA Regulatory Cascades in Human Diseases	PLOS ONE			English	Article							GENE-REGULATION; HUMAN MICRORNA; MIR-181C; TARGET; CELLS; PROLIFERATION; INVASION	Over the past decades, studies have reported that the combinatorial regulation of transcription factors (TFs) and microRNAs (miRNAs) is essential for the appropriate execution of biological events and developmental processes. Dysregulations of these regulators often cause diseases. However, there are no available resources on the regulatory cascades of TFs and miRNAs in the context of human diseases. To fulfill this vacancy, we established the (TM) REC database in this study. First, we integrated curated transcriptional and post-transcriptional regulations to construct the TFs and miRNA regulatory network. Next, we identified all linear paths using the Breadth First Search traversal method. Finally, we used known disease-related genes and miRNAs to measure the strength of association between cascades and diseases. Currently, (TM) REC consists of 74,248 cascades and 25,194 cascade clusters, involving in 412 TFs, 266 miRNAs and 545 diseases. With the expanding of experimental support regulation data, we will regularly update the database. (TM) REC aims to help experimental biologists to comprehensively analyse gene expression regulation, to understand the aetiology and to predict novel therapeutic targets. (TM) REC is freely available at http://bioinfo.hrbmu.edu.cn/TMREC/.	[Wang, Shuyuan; Li, Wei; Lian, Baofeng; Liu, Xinyi; Zhang, Yan; Dai, Enyu; Yu, Xuexin; Meng, Fanlin; Jiang, Wei; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China; [Li, Wei] Fudan Univ, Inst Biomed Sci, EpiRNA Lab, Shanghai 200032, Peoples R China; [Lian, Baofeng] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Lian, Baofeng] Shanghai Ctr Bioinformat Technol, Shanghai 201203, Peoples R China	Harbin Medical University; Fudan University; Shanghai Jiao Tong University; Chinese Academy of Sciences	Jiang, W (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.	jiangwei@hrbmu.edu.cn; lixia@hrbmu.edu.cn	li, xia/HHZ-7468-2022; liu, xinyi/GWZ-8739-2022	Zhang, Yan/0000-0002-1011-6184	Funds for the Graduate Innovation Fund of Heilongjiang Province [YJSCX2012-250HLJ]; Creative Research Groups of The National Natural Science Foundation of China [81121003]; National Natural Science Foundation of China [30900837, 61170154, 81202074]; Program for Young Talents of Science and Technology in Harbin [2013RFQXJ057]; Heilong Jiang Postdoctoral Funds for Scientific Research Initiation [LBH-Q11042]	Funds for the Graduate Innovation Fund of Heilongjiang Province; Creative Research Groups of The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Young Talents of Science and Technology in Harbin; Heilong Jiang Postdoctoral Funds for Scientific Research Initiation	This work was supported by the Funds for the Graduate Innovation Fund of Heilongjiang Province (YJSCX2012-250HLJ), the Creative Research Groups of The National Natural Science Foundation of China (81121003), the National Natural Science Foundation of China (30900837, 61170154 and 81202074), the Program for Young Talents of Science and Technology in Harbin (2013RFQXJ057), the Heilong Jiang Postdoctoral Funds for Scientific Research Initiation (LBH-Q11042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2013, MOL GENET GENOMICS, V288, P77, DOI 10.1007/s00438-013-0734-z; Becker KG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-61; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Davies AH, 2014, STEM CELLS, V32, P1437, DOI 10.1002/stem.1707; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Green CD, 2007, MOL CANCER RES, V5, P1191, DOI 10.1158/1541-7786.MCR-07-0123; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jiang W, 2013, BIOINFORMATICS, V29, P2596, DOI 10.1093/bioinformatics/btt423; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Li Y, 2014, ACTA BIOCH BIOPH SIN, V46, P48, DOI 10.1093/abbs/gmt124; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Ruan J, 2015, NEUROREPORT, V26, P66, DOI 10.1097/WNR.0000000000000302; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Wang YQ, 2011, GENOMICS, V98, P73, DOI 10.1016/j.ygeno.2011.04.011; Wu JH, 2013, GENE, V518, P139, DOI 10.1016/j.gene.2012.11.056; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zhang Y, 2015, TOXICOL LETT, V232, P481, DOI 10.1016/j.toxlet.2014.11.028; Zitman-Gal T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-8	25	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125222	10.1371/journal.pone.0125222	http://dx.doi.org/10.1371/journal.pone.0125222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932650	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100092
J	Wu, XJ; Conlin, VS; Morampudi, V; Ryz, NR; Nasser, Y; Bhinder, G; Bergstrom, KS; Yu, HB; Waterhouse, CCM; Buchan, AMJ; Popescu, OE; Gibson, WT; Waschek, JA; Vallance, BA; Jacobson, K				Wu, Xiujuan; Conlin, Victoria S.; Morampudi, Vijay; Ryz, Natasha R.; Nasser, Yasmin; Bhinder, Ganive; Bergstrom, Kirk S.; Yu, Hong B.; Waterhouse, Chris C. M.; Buchan, Allison M. J.; Popescu, Oana E.; Gibson, William T.; Waschek, James A.; Vallance, Bruce A.; Jacobson, Kevan			Vasoactive Intestinal Polypeptide Promotes Intestinal Barrier Homeostasis and Protection Against Colitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RODENTIUM-INDUCED COLITIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; CITROBACTER-RODENTIUM; TREFOIL FACTOR; GENE-EXPRESSION; MURINE MODEL; STEM-CELLS; RAT COLON	Inflammatory bowel disease is a chronic gastrointestinal inflammatory disorder associated with changes in neuropeptide expression and function, including vasoactive intestinal peptide (VIP). VIP regulates intestinal vasomotor and secretomotor function and motility; however, VIP's role in development and maintenance of colonic epithelial barrier homeostasis is unclear. Using VIP deficient (VIPKO) mice, we investigated VIP's role in epithelial barrier homeostasis, and susceptibility to colitis. Colonic crypt morphology and epithelial barrier homeostasis were assessed in wildtype (WT) and VIPKO mice, at baseline. Colitic responses were evaluated following dinitrobenzene sulfonic acid (DNBS) or dextran-sodium sulfate (DSS) exposure. Mice were also treated with exogenous VIP. At baseline, VIPKO mice exhibited distorted colonic crypts, defects in epithelial cell proliferation and migration, increased apoptosis, and altered permeability. VIPKO mice also displayed reduced goblet cell numbers, and reduced expression of secreted goblet cell factors mucin 2 and trefoil factor 3. These changes were associated with reduced expression of caudal type homeobox 2 (Cdx2), a master regulator of intestinal function and homeostasis. DNBS and DSS-induced colitis were more severe in VIPKO than WT mice. VIP treatment rescued the phenotype, protecting VIPKO mice against DSS colitis, with results comparable to WT mice. In conclusion, VIP plays a crucial role in the development and maintenance of colonic epithelial barrier integrity under physiological conditions and promotes epithelial repair and homeostasis during colitis.	[Wu, Xiujuan; Conlin, Victoria S.; Morampudi, Vijay; Ryz, Natasha R.; Nasser, Yasmin; Bhinder, Ganive; Bergstrom, Kirk S.; Yu, Hong B.; Vallance, Bruce A.; Jacobson, Kevan] BC Childrens Hosp, Dept Pediat, Div Gastroenterol, Vancouver, BC, Canada; [Wu, Xiujuan; Conlin, Victoria S.; Morampudi, Vijay; Ryz, Natasha R.; Nasser, Yasmin; Bhinder, Ganive; Bergstrom, Kirk S.; Yu, Hong B.; Popescu, Oana E.; Gibson, William T.; Vallance, Bruce A.; Jacobson, Kevan] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wu, Xiujuan; Conlin, Victoria S.; Morampudi, Vijay; Ryz, Natasha R.; Nasser, Yasmin; Bhinder, Ganive; Bergstrom, Kirk S.; Yu, Hong B.; Gibson, William T.; Vallance, Bruce A.; Jacobson, Kevan] BC Childrens Hosp, Child & Family Res Inst, Vancouver, BC, Canada; [Bergstrom, Kirk S.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Waterhouse, Chris C. M.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Buchan, Allison M. J.] Univ Toronto, Fac Med, Toronto, ON M5S 1A1, Canada; [Popescu, Oana E.] BC Childrens Hosp, Dept Pathol, Vancouver, BC, Canada; [Gibson, William T.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; [Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	BC Childrens Hospital; University of British Columbia; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia; Oklahoma Medical Research Foundation; University of Calgary; University of Toronto; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jacobson, K (corresponding author), BC Childrens Hosp, Dept Pediat, Div Gastroenterol, Vancouver, BC, Canada.	kjacobson@cw.bc.ca	, Kevan/AAD-4896-2021; Gibson, William/AFL-3634-2022; Nasser, Yasmin/AAR-4334-2021; Bergstrom, Kirk/AAZ-8856-2021	Gibson, William/0000-0002-6552-402X; Vallance, Bruce/0000-0003-1345-6747; Buchan, Alison/0000-0003-3642-1328; Popescu, Oana-Eugenia/0000-0002-2033-883X; Jacobson, Kevan/0000-0001-7269-8557	Crohn's and Colitis Foundation of Canada; joint Michael Smith Foundation for Health Research/Crohn's and Colitis Foundation of Canada postdoctoral fellowship; Child and Family Research Institute (CFRI) Clinician Scientists Award Program, University of British Columbia; CHILD Foundation	Crohn's and Colitis Foundation of Canada; joint Michael Smith Foundation for Health Research/Crohn's and Colitis Foundation of Canada postdoctoral fellowship; Child and Family Research Institute (CFRI) Clinician Scientists Award Program, University of British Columbia; CHILD Foundation	This work was supported by Crohn's and Colitis Foundation of Canada (www.crohnsandcolitis.ca) to BV and KJ. VM holds a joint Michael Smith Foundation for Health Research/Crohn's and Colitis Foundation of Canada postdoctoral fellowship (http://www.msfhr.org and www.crohnsandcolitis.ca). BAV is the Children with Intestinal and Liver Disorders (CHILD) Foundation Chair in Pediatric Gastroenterology and the Canada Research Chair in Pediatric Gastroenterology (http://www.child.ca/). KJ and WG are Senior Clinician Scientists supported by the Child and Family Research Institute (CFRI) Clinician Scientists Award Program, University of British Columbia (www.cfri.ca). KJ is supported by the CHILD Foundation, (http://www.child.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Abad C, 2015, NEUROIMMUNOMODULAT, V22, P203, DOI 10.1159/000364912; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Arranz A, 2008, NEUROIMMUNOMODULAT, V15, P46, DOI 10.1159/000135623; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Boyd M, 2010, J BIOL CHEM, V285, P25115, DOI 10.1074/jbc.M109.089516; Boyer L, 2007, AUTON NEUROSCI-BASIC, V134, P106, DOI 10.1016/j.autneu.2007.03.001; Calon A, 2007, GUT, V56, P1688, DOI 10.1136/gut.2007.125542; Conlin VS, 2009, AM J PHYSIOL-GASTR L, V297, pG735, DOI 10.1152/ajpgi.90551.2008; Coskun M, 2011, BBA-MOL BASIS DIS, V1812, P283, DOI 10.1016/j.bbadis.2010.11.008; Coskun M, 2010, J CELL BIOCHEM, V109, P1118, DOI 10.1002/jcb.22490; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hokari R, 2005, AM J PHYSIOL-GASTR L, V289, pG949, DOI 10.1152/ajpgi.00142.2005; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jonsson M, 2012, DIGEST DIS SCI, V57, P303, DOI 10.1007/s10620-011-1985-3; Keller MS, 2004, AM J PHYSIOL-GASTR L, V287, pG104, DOI 10.1152/ajpgi.00484.2003; KIMURA M, 1994, PATHOL INT, V44, P624, DOI 10.1111/j.1440-1827.1994.tb01723.x; Lakhan SE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-37; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Liu Z, 2005, ACTA PAEDIATR, V94, P386, DOI 10.1080/08035250410023304; Martinez C, 1999, J NEUROIMMUNOL, V93, P126, DOI 10.1016/S0165-5728(98)00216-1; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; MCROBERTS JA, 1985, J BIOL CHEM, V260, P4163; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Mesquita P, 2003, J BIOL CHEM, V278, P51549, DOI 10.1074/jbc.M309019200; Morampudi V, 2014, JOVE-J VIS EXP, DOI 10.3791/51297; Moro F, 2001, REGUL PEPTIDES, V101, P35, DOI 10.1016/S0167-0115(01)00257-9; Nasser Y, 2006, J COMP NEUROL, V495, P529, DOI 10.1002/cne.20898; Ogata H, 1997, AM J PHYSIOL-GASTR L, V273, pG348, DOI 10.1152/ajpgi.1997.273.2.G348; Ooi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086366; Plaisancie P, 1998, AM J PHYSIOL-GASTR L, V275, pG1073, DOI 10.1152/ajpgi.1998.275.5.G1073; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Ryz NR, 2012, AM J PHYSIOL-GASTR L, V303, pG1299, DOI 10.1152/ajpgi.00320.2012; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sipos F, 2010, SCAND J GASTROENTERO, V45, P440, DOI 10.3109/00365521003624144; Snoek SA, 2010, CURR PHARM DESIGN, V16, P1091, DOI 10.2174/138161210790963814; Stillie R, 2009, INFLAMM BOWEL DIS, V15, P1515, DOI 10.1002/ibd.20951; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Urbanska A, 2012, J MOL NEUROSCI, V46, P10, DOI 10.1007/s12031-011-9526-2; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vu JP, 2014, J MOL NEUROSCI, V52, P37, DOI 10.1007/s12031-013-0205-3; Yadav M, 2011, CELL IMMUNOL, V267, P124, DOI 10.1016/j.cellimm.2011.01.001; Yamamoto H, 2003, BIOCHEM BIOPH RES CO, V300, P813, DOI 10.1016/S0006-291X(02)02935-2; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Yusta B, 2012, ENDOCRINOLOGY, V153, P2623, DOI 10.1210/en.2012-1069	53	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125225	10.1371/journal.pone.0125225	http://dx.doi.org/10.1371/journal.pone.0125225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932952	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100093
J	Stark, K; Scott, DE; Tsyusko, O; Coughlin, DP; Hinton, TG				Stark, Karolina; Scott, David E.; Tsyusko, Olga; Coughlin, Daniel P.; Hinton, Thomas G.			Multi-Level Effects of Low Dose Rate Ionizing Radiation on Southern Toad, Anaxyrus [Bufo] terrestris	PLOS ONE			English	Article							ADAPTIVE RESPONSE; COMET ASSAY; DNA-DAMAGE; METAMORPHOSIS; IRRADIATION; EXPOSURE; SIZE; FROG; REDISTRIBUTION; CONTAMINANTS	Despite their potential vulnerability to contaminants from exposure at multiple life stages, amphibians are one of the least studied groups of vertebrates in ecotoxicology, and research on radiation effects in amphibians is scarce. We used multiple endpoints to assess the radiosensitivity of the southern toad (Anaxyrus [Bufo] terrestris) during its pre-terrestrial stages of development -embryonic, larval, and metamorphic. Toads were exposed, from several hours after oviposition through metamorphosis (up to 77 days later), to four low dose rates of Cs-137 at 0.13, 2.4, 21, and 222 mGy d(-1), resulting in total doses up to 15.8 Gy. Radiation treatments did not affect hatching success of embryos, larval survival, or the length of the larval period. The individual family variation in hatching success of embryos was larger than the radiation response. In contrast, newly metamorphosed individuals from the higher dose-rate treatments had higher mass and mass/length body indices, a measure which may relate to higher post-metamorphic survival. The increased mass and index at higher dose rates may indicate that the chronic, low dose rate radiation exposures triggered secondary responses. Additionally, the increases in growth were linked to a decrease in DNA damage (as measured by the Comet Assay) in red blood cells at a dose rate of 21 mGy d(-1) and a total dose of 1.1 Gy. In conclusion, the complex effects of low dose rates of ionizing radiation may trigger growth and cellular repair mechanisms in amphibian larvae.	[Stark, Karolina] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Stark, Karolina; Scott, David E.; Tsyusko, Olga; Coughlin, Daniel P.; Hinton, Thomas G.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Tsyusko, Olga] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Hinton, Thomas G.] Inst Radiat Protect & Nucl Safety, Dept Radioecol Environm Modeling & Ecotoxicol, Cadarache, France	Stockholm University; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University of Kentucky	Stark, K (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	karolina.stark@su.se	Scott, David/V-7683-2019	Scott, David/0000-0003-2937-0593; Tsyusko, Olga/0000-0001-8196-1062	Savannah River Ecology Laboratory's Education Program; L. Namowitsky's foundation; Swedish Radiation Protection Authority (SSI); U.S. Department of Energy [DE-FC09-96SR18546, FC09-07SR22506]	Savannah River Ecology Laboratory's Education Program; L. Namowitsky's foundation; Swedish Radiation Protection Authority (SSI); U.S. Department of Energy(United States Department of Energy (DOE))	This study was financed by the Savannah River Ecology Laboratory's Education Program, the L. Namowitsky's foundation, the Swedish Radiation Protection Authority (SSI), and the U.S. Department of Energy under Award Number DE-FC09-96SR18546 and FC09-07SR22506 to the University of Georgia Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amburgey S, 2012, HERPETOLOGICA, V68, P456, DOI 10.1655/HERPETOLOGICA-D-11-00093; [Anonymous], 2008, ICRP PUBL; Audette-Stuart M, 2011, J ENVIRON RADIOACTIV, V102, P566, DOI 10.1016/j.jenvrad.2011.03.001; Baker LA, 1992, ECOL ENG, V1, P1, DOI [10.1016/0925-8574(92)90023-U, DOI 10.1016/0925-8574(92)90023-U]; Beard KH, 2002, OECOLOGIA, V133, P583, DOI 10.1007/s00442-002-1071-9; Beck CW, 1999, CAN J ZOOL, V77, P944, DOI 10.1139/cjz-77-6-944; Beresford Nicholas A., 2011, Integrated Environmental Assessment and Management, V7, P371, DOI 10.1002/ieam.238; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; BRIDGES C. M., 2003, AMPHIBIAN DECLINE IN; Calabrese EJ, 2008, ENVIRON TOXICOL CHEM, V27, P1451, DOI 10.1897/07-541; Duellman W. E., 1986, BIOL AMPHIBIANS; Eggen RIL, 2004, ENVIRON SCI TECHNOL, V38, p58A, DOI 10.1021/es040349c; Gibbons JW, 2006, CONSERV BIOL, V20, P1457, DOI 10.1111/j.1523-1739.2006.00443.x; Gosner K. L., 1960, Herpetologica, V16, P183; Hinton TG, 2013, J ENVIRON RADIOACTIV, V115, P73, DOI 10.1016/j.jenvrad.2012.07.011; Hinton T G, 2005, SCI TRENDS RADIOLOGI; Hinton TG, 2004, J ENVIRON RADIOACTIV, V74, P43, DOI 10.1016/j.jenvrad.2004.01.014; Howard BJ, 2010, J RADIOL PROT, V30, P195, DOI 10.1088/0952-4746/30/2/S01; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; IAEA, 1992, IAEA TECHN REP SER, V332; Jagoe C. H., 2002, P INT C RAD EC CONT, P873; Jarvis RB, 2003, MUTAT RES-GEN TOX EN, V541, P63, DOI 10.1016/S1383-5718(03)00182-7; Kerby JL, 2010, ECOL LETT, V13, P60, DOI 10.1111/j.1461-0248.2009.01399.x; Lance SL, 2013, ENVIRON POLLUT, V177, P135, DOI 10.1016/j.envpol.2013.02.009; LANDRETH HF, 1974, RADIAT RES, V58, P432, DOI 10.2307/3573912; Larsson C-M, 2011, ANN ICRP, P208; Larsson C-M, 2004, DEL 6 FRAM ASS ENV I; Loat's Associates, 2000, IM AN SOFTW; MACKLIS RM, 1991, J NUCL MED, V32, P350; McNamee JP, 2000, MUTAT RES-GEN TOX EN, V466, P63, DOI 10.1016/S1383-5718(00)00004-8; Metts BS, 2013, ENVIRON SCI TECHNOL, V47, P2846, DOI 10.1021/es303989u; Metts BS, 2012, ENVIRON POLLUT, V164, P211, DOI 10.1016/j.envpol.2012.01.042; PANTER HC, 1986, J EXP ZOOL, V238, P193, DOI 10.1002/jez.1402380209; Ryan TJ, 2001, AM MIDL NAT, V145, P46, DOI 10.1674/0003-0031(2001)145[0046:EOHOMI]2.0.CO;2; Sazykina T, 2006, J ENVIRON RADIOACTIV, V88, P11, DOI 10.1016/j.jenvrad.2005.12.009; SCOTT DE, 1994, ECOLOGY, V75, P1383, DOI 10.2307/1937462; SEALE DB, 1980, ECOLOGY, V61, P1531, DOI 10.2307/1939059; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sparling D. W., 2000, ECOTOXICOLOGY AMPHIB, V904, P1124; Stark K, 2006, J ENVIRON RADIOACTIV, V87, P175, DOI 10.1016/j.jenvrad.2005.11.008; Stark K, 2012, ECOTOX ENVIRON SAFE, V79, P283, DOI 10.1016/j.ecoenv.2012.01.014; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tsyusko O, 2011, MUTAT RES-GEN TOX EN, V718, P18, DOI 10.1016/j.mrgentox.2010.11.001; Ulsh B, 2003, J ENVIRON RADIOACTIV, V66, P121, DOI 10.1016/S0265-931X(02)00119-4; Ulsh BA, 2004, J ENVIRON RADIOACTIV, V74, P73, DOI 10.1016/j.jenvrad.2004.01.005; *UNSCEAR, 1996, SOURC EFF ION RAD; WALLING DE, 1988, ENVIRON GEOCHEM HLTH, V10, P35, DOI 10.1007/BF01758590	48	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125327	10.1371/journal.pone.0125327	http://dx.doi.org/10.1371/journal.pone.0125327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927361	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100082
J	Bueno, PD; Yochite, JNU; Derigge-Pisani, GF; de Farias, KCRM; de Avo, LRD; Voltarelli, JC; Leal, AMD				Bueno, Patricia de Godoy; Ueda Yochite, Juliana Navarro; Derigge-Pisani, Graziela Fernanda; Ribeiro Malmegrim de Farias, Kelen Cristina; da Silva de Avo, Lucimar Retto; Voltarelli, Julio Cesar; de Oliveira Leal, Angela Merice			Metabolic and Pancreatic Effects of Bone Marrow Mesenchymal Stem Cells Transplantation in Mice Fed High-Fat Diet	PLOS ONE			English	Article							IN-VIVO DISTRIBUTION; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; STROMAL CELLS; ALPHA-CELLS; MOUSE MODEL; HYPERGLYCEMIA; SECRETION; THERAPY; MASS	The purpose of this study was to investigate the effects of multiple infusions of allogeneic MSCs on glucose homeostasis and morphometry of pancreatic islets in high-fat diet (HFD) fed mice. Swiss mice were fed standard diet (C group) or HFD (HFD group). After 8 weeks, animals of HFD group received sterile phosphate-buffered saline infusions (HFD-PBS) or four infusions of MSCs one week apart (HFD-MSCs). Fasting glycemia (FG) was determined weekly and glucose (GTT) and insulin (ITT) tolerance tests were performed 4, 8, 12, and 16 weeks after the infusions of MSCs. The MSCs transplanted mice were classified as responder (FG < 180 mg/dL, 72.2% of transplanted mice) or non-responder (FG > 180mg/dL, 28.8%) Seven weeks after MSCs infusions, FG decreased in HFD-MSCs responder mice compared with the HFD-PBS group. Sixteen weeks post MSCs infusions, GTT and ITT areas under the curve (AUC) decreased in HFD-MSCs responder mice compared to HFD-PBS group. Serum insulin concentration was higher in HFD-PBS group than in control animals and was not different compared with the other groups. The relative volume of alpha-cells was significantly smaller in HFD-PBS group than in C group and significantly higher in HFD-MSCs-NR than in HFD-PBS and HFD-MSCs-R groups. Cell apoptosis in the islets was higher in HFD-PBS group than in C group, and lower in HFD-MSCs responder mice than in HFD-PBS group and non-responder animals. The results demonstrate the ability of multiple infusions of MSCs to promote prolonged decrease in hyperglycemia and apoptosis in pancreatic islets and increase in insulin sensitivity in HFD fed mice.	[Bueno, Patricia de Godoy; Derigge-Pisani, Graziela Fernanda] Univ Fed Sao Carlos, Dept Physiol Sci, Ctr Biol Sci & Hlth, Sao Paulo, Brazil; [Ueda Yochite, Juliana Navarro] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Sao Paulo, Brazil; [Ribeiro Malmegrim de Farias, Kelen Cristina] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Clin Toxicol & Bromatol Anal, Sao Paulo, Brazil; [da Silva de Avo, Lucimar Retto; de Oliveira Leal, Angela Merice] Univ Fed Sao Carlos, Dept Med, Sao Paulo, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Leal, AMD (corresponding author), Univ Fed Sao Carlos, Dept Med, Sao Paulo, Brazil.	angelaleal@ufscar.br	Leal, Angela M O/O-7535-2016; Malmegrim, Kelen/H-1016-2015	Malmegrim, Kelen/0000-0002-9303-0086	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). PGB, AMOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asghar Z, 2006, DIABETOLOGIA, V49, P90, DOI 10.1007/s00125-005-0045-y; Bhansali A, 2009, STEM CELLS DEV, V18, P1407, DOI 10.1089/scd.2009.0164; Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004; Burdon TJ, 2011, BONE MARROW RES, DOI 10.1155/2011/207326; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cheng CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036085; Choi JB, 2003, DIABETOLOGIA, V46, P1366, DOI 10.1007/s00125-003-1182-9; Chung Cheng-Ho, 2010, Rev Diabet Stud, V7, P124, DOI 10.1900/RDS.2010.7.124; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; Dinarvand P, 2010, BIOL PHARM BULL, V33, P1212, DOI 10.1248/bpb.33.1212; Ezquer F, 2012, STEM CELLS, V30, P1664, DOI 10.1002/stem.1132; Ezquer F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016566; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Gao XD, 2008, BIOCHEM BIOPH RES CO, V371, P132, DOI 10.1016/j.bbrc.2008.04.033; Gosmain Y, 2013, J DIABETES, V5, P102, DOI 10.1111/1753-0407.12022; Habener JF, 2012, ISLETS, V4, P188, DOI 10.4161/isl.20500; Hao HJ, 2013, BIOCHEM BIOPH RES CO, V436, P418, DOI 10.1016/j.bbrc.2013.05.117; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; HELLMAN B., 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P35; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Ho JH, 2012, CELL TRANSPLANT, V21, P997, DOI 10.3727/096368911X603611; Hu JX, 2014, ENDOCRINE, V45, P279, DOI 10.1007/s12020-013-9984-0; Hughey CC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-128; Jiang Ranhua, 2011, Front Med, V5, P94, DOI 10.1007/s11684-011-0116-z; Jurewicz M, 2010, DIABETES, V59, P3139, DOI 10.2337/db10-0542; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Laschke MW, 2014, ACTA BIOMATER; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Levesque J. -P., 2007, V180, P3; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Lin P, 2009, TRANSPL P, V41, P1891, DOI 10.1016/j.transproceed.2009.02.078; Meier JJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE717, DOI 10.1152/ajpendo.00315.2010; Meyerrose TE, 2007, STEM CELLS, V25, P220, DOI 10.1634/stemcells.2006-0243; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Schwasinger-Schmidt T, 2013, PHARMACOL RES, V76, P58, DOI 10.1016/j.phrs.2013.07.005; Scuteri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084309; Si YL, 2011, AGEING RES REV, V10, P93, DOI 10.1016/j.arr.2010.08.005; Si YL, 2012, DIABETES, V61, P1616, DOI 10.2337/db11-1141; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Thorel F, 2010, M S-MED SCI, V26, P906, DOI 10.1051/medsci/20102611906; Urban VS, 2008, STEM CELLS, V26, P244, DOI 10.1634/stemcells.2007-0267; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Voltarelli JC, 2009, DIABETOL METAB SYNDR, V1, DOI [10.1186/1758-5996-1-19, 10.1186/1758-5996-1-4]; Wilson T, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/345806; Xu YX, 2008, MED HYPOTHESES, V71, P390, DOI 10.1016/j.mehy.2008.03.046; Yanai G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064499; Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189; Zenari L, 2013, DIABETES OBES METAB, V15, P17, DOI 10.1111/dom.12143; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhou H, 2009, CHINESE MED J-PEKING, V122, P2573, DOI 10.3760/cma.j.issn.0366-6999.2009.21.009	67	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124369	10.1371/journal.pone.0124369	http://dx.doi.org/10.1371/journal.pone.0124369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923733	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600078
J	Hojgard, S; Aspevall, O; Bengtsson, B; Haeggman, S; Lindberg, M; Mieziewska, K; Nilsson, S; Unnerstad, HE; Viske, D; Wahlstrom, H				Hojgard, Soren; Aspevall, Olov; Bengtsson, Bjorn; Haeggman, Sara; Lindberg, Maria; Mieziewska, Kristina; Nilsson, Svante; Unnerstad, Helle Ericsson; Viske, Diana; Wahlstrom, Helene			Preventing Introduction of Livestock Associated MRSA in a Pig Population - Benefits, Costs, and Knowledge Gaps from the Swedish Perspective	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SLAUGHTERHOUSE WORKERS; ST398; PREVALENCE; CARRIAGE; TRANSMISSION; FARMERS; HUMANS	Antibiotic resistance is a growing concern in human, as well as in veterinary medicine. Part of the problem concerns how to respond to the risk presented by animal reservoirs of resistant bacteria with the potential of spreading to humans. One example is livestock associated methicillin-resistant Staphylococcus aureus (LA-MRSA). In countries where LA-MRSA is endemic in the pig population, people in contact with pigs have a higher risk of being colonised with LA-MRSA, and persons from this group are subjected to precautionary measures when visiting health care facilities. In the present study, it is assumed that, if LA-MRSA was introduced to the Swedish pig population, the prevalence in the risk groups would be the same as in Denmark or the Netherlands (two countries with low human prevalence that have implemented measures to detect, trace and isolate human LA-MRSA cases and, therefore, have comprehensive data with good coverage regarding prevalence of LA-MRSA), and that similar interventions would be taken in Swedish health care facilities. It is also assumed that the Swedish pig population is free of MRSA or that the prevalence is very low. We analyse if it would be efficient for Sweden to prevent its introduction by testing imported live breeding pigs. Given that quarantining and testing at import will prevent introduction to the pig population, the study shows that the preventive measures may indeed generate a societal net benefit. Benefits are estimated to be between (sic) 870 720 and (sic) 1 233 511, and costs to (sic) 211 129. Still, due to gaps in knowledge, the results should be confirmed when more information become available.	[Hojgard, Soren] Swedish Univ Agr Sci, Uppsala, Sweden; [Hojgard, Soren] AgriFood Econ Ctr, Uppsala, Sweden; [Aspevall, Olov; Haeggman, Sara] Publ Hlth Agcy Sweden, Solna, Sweden; [Bengtsson, Bjorn; Unnerstad, Helle Ericsson; Wahlstrom, Helene] Natl Vet Inst, S-75007 Uppsala, Sweden; [Lindberg, Maria] Federat Swedish Farmers, Stockholm, Sweden; [Lindberg, Maria] Swedish Anim Hlth Serv, Uppsala, Sweden; [Mieziewska, Kristina; Nilsson, Svante; Viske, Diana] Swedish Board Agr, Jonkoping, Sweden	Swedish University of Agricultural Sciences; Public Health Agency of Sweden; National Veterinary Institute SVA	Hojgard, S (corresponding author), Swedish Univ Agr Sci, Uppsala, Sweden.	soren.hojgard@slu.se						Andre M, 2008, SCAND J INFECT DIS, V40, P648, DOI 10.1080/00365540801932439; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; [Anonymous], 2013, US ANT AG OCC ANT RE; [Anonymous], NOT FOLK VURD RIS KO; [Anonymous], 201323 SJVFS; [Anonymous], 200940 SJVFS; Aspiroz C, 2010, EMERG INFECT DIS, V16, P157, DOI 10.3201/eid1601.090694; Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378; Boardman AE, 2011, J BENEFIT-COST ANAL, V2, DOI 10.2202/2152-2812.1050; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Broens EM, 2011, PREV VET MED, V98, P182, DOI 10.1016/j.prevetmed.2010.10.010; County Council of Vastra Gotaland, 2008, HALS OCH SJUKV KOSTN; Cuny C, 2013, INT J MED MICROBIOL, V303, P331, DOI 10.1016/j.ijmm.2013.02.010; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; DANMAP, 2012, US ANT AG OCC ANT RE; DANMAP, 2013, US ANT AG OCC ANT RE; Department of Communicable Diseases Control and Prevention Stockholm County Council, 2011, HANDL VID AVSKR CONT; Drummond MF., 2005, METHODS EC EVALUATIO, P55; EFSA (European Food Safety Authority), 2009, EFSAQ200900612; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Finnish Food Authority Finnish Medicines Agency Fimea University of Helsinki FINRES-Vet 2020, 2021, FINN VET ANT RES MON; Frank Robert H., 2010, MICROECONOMICS BEHAV; Garcia-Graells C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065512; Gilbert MJ, 2012, OCCUP ENVIRON MED, V69, P472, DOI 10.1136/oemed-2011-100069; Groves MD, 2014, J ANTIMICROB CHEMOTH, V69, P1428, DOI [10.1093/jac/dkt499, DOI 10.1093/JAC/DKT499]; Hanberger H, 2011, ANTIBIOTIKA VUXNA PA; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Mas-Colell A., 1995, MICROECONOMIC THEORY; NethMap, 2014, CONS ANT AG ANT RES; NETHMAP and MARAN, 2013, CONS ANT AG ANT RES; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Porphyre T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047504; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; SJV, 2009, 20098 SJV SWED BOARD; Statens Seruminstitut, 2014, EPI NYT 24A 2014; Sundhedsstyrelsen, 2012, VEJL FOR SPREAD MRSA; Swedish Board of Health and Welfare, 2013, DIAGN SLUT VARD; Swedish Medical Products Agency, 2009, FARM BEH BAKT HUD OC; Swedish Pharmacies, 2014, FASS; SWEDRES SVARM, 2013, US ANT OCC ANT RES S; SWEDRES-SVARM, 2010, US ANT OCC ANT RES S; SWEDRES-SVARM, 2011, US ANT OCC ANT RES S; Vading M, 2013, ANTIBIOTIKA OPPEN OC; van Cleef BAGL, 2014, CLIN MICROBIOL INFEC, V20, pO764, DOI 10.1111/1469-0691.12582; van Cleef BAGL, 2010, EPIDEMIOL INFECT, V138, P756, DOI 10.1017/S0950268810000245; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073096; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; van Rijen MML, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-3; Verkade E, 2013, INFECT GENET EVOL; Verkade E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100823; Vose D., 2000, RISK ANAL QUANTITATI; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Werner G, 2012, VET MICROBIOL, V160, P162, DOI [10.1016/j.vetmic.2012.05.019, 10.1016/j.vetmic.2012.05.005]; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	58	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122875	10.1371/journal.pone.0122875	http://dx.doi.org/10.1371/journal.pone.0122875			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923329	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600025
J	Ma, YH; Zhang, XL; Xu, XX; Shen, L; Yao, Y; Yang, ZY; Liu, PS				Ma, Yanhui; Zhang, Xiaolei; Xu, Xiaoxuan; Shen, Liang; Yao, Yao; Yang, Ziyan; Liu, Peishu			STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SUPPRESSES GROWTH; GENE-THERAPY; ACTIVATION; DELIVERY; PATHWAY; CYTOTOXICITY; SLN	Recent advances in the synthesis of multi-functional nanoparticles have opened up tremendous opportunities for the targeted delivery of genes of interest. Cationic solid lipid nanoparticles (SLN) can efficiently bind nucleic acid molecules and transfect genes in vitro. Few reports have combined SLN with therapy using decoy oligodeoxynucleotides (ODN). In the present study, we prepared SLN to encapsulate STAT3 decoy ODN; then, the properties and in vitro behavior of SLN-STAT3 decoy ODN complexes were investigated. SLN-STAT3 decoy ODN complexes were efficiently taken up by human ovarian cancer cells and significantly suppressed cell growth. Blockage of the STAT3 pathway by SLN-STAT3 decoy ODN complexes resulted in an evident induction of cell death, including apoptotic and autophagic death. The mechanism involved the increased expression of cleaved caspase 3, Bax, Beclin-1 and LC3-II and reduced expression of Bcl-2, pro-caspase 3, Survivin, p-Akt and p-mTOR. In addition, SLN-STAT3 decoy ODN complexes inhibited cell invasion by up-regulating E-cadherin expression and down-regulating Snail and MMP-9 expression. These findings confirmed that SLN as STAT3 decoy ODN carriers can induce cell death and inhibit invasion of ovarian cancer cells. We propose that SLN represent a potential approach for targeted gene delivery in cancer therapy.	[Ma, Yanhui; Zhang, Xiaolei; Xu, Xiaoxuan; Yang, Ziyan; Liu, Peishu] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Shen, Liang] Shandong Univ, Prov Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Yao, Yao] Shandong Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Liu, PS (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China.	peishuliu@126.com			National Natural Science Foundation of China [81101984, 81101982]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by National Natural Science Foundation of China (No. 81101984 and No. 81101982). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 1998, NATURE, V392, P25; Assi H, 2012, NEUROSCI LETT, V527, P71, DOI 10.1016/j.neulet.2012.08.003; Basarkar A, 2007, INT J PHARM, V343, P247, DOI 10.1016/j.ijpharm.2007.05.023; Brenner Malcolm K, 2009, Hematology Am Soc Hematol Educ Program, P675, DOI 10.1182/asheducation-2009.1.675; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Caldera V, 2008, J ONCOL, V2008, DOI 10.1155/2008/219241; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chobanian N, 2008, SURG CLIN N AM, V88, P285, DOI 10.1016/j.suc.2007.12.002; Cortesi R, 2014, NEW BIOTECHNOL, V31, P44, DOI 10.1016/j.nbt.2013.10.001; de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277, DOI 10.1016/S0169-409X(01)00110-7; del Pozo-Rodriguez A, 2007, INT J PHARMACEUT, V339, P261, DOI 10.1016/j.ijpharm.2007.03.015; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Garg Minal, 2013, World J Stem Cells, V5, P188, DOI 10.4252/wjsc.v5.i4.188; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Gu JH, 2008, J NEURO-ONCOL, V89, P9, DOI 10.1007/s11060-008-9590-9; Han S, 2000, MOL THER, V2, P302, DOI 10.1006/mthe.2000.0142; Heydenreich AV, 2003, INT J PHARM, V254, P83, DOI 10.1016/S0378-5173(02)00688-9; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Jonchere Barbara, 2013, JAKSTAT, V2, pe24353, DOI 10.4161/jkst.24353; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Keeler AM, 2012, HUM GENE THER, V23, P548, DOI 10.1089/hum.2012.087; Kim MJ, 2014, CANCER LETT, V354, P33, DOI 10.1016/j.canlet.2014.06.023; Klein JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081819; Lee MY, 2012, AM J TRANSL RES, V4, P1; Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7; Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4; Nefedova Y, 2007, CURR CANCER DRUG TAR, V7, P71, DOI 10.2174/156800907780006887; Olbrich C, 2001, J CONTROL RELEASE, V77, P345, DOI 10.1016/S0168-3659(01)00506-5; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Savarese TM, 2002, CYTOKINE, V17, P324, DOI 10.1006/cyto.2002.1022; Schubert MA, 2005, EUR J PHARM BIOPHARM, V61, P77, DOI 10.1016/j.ejpb.2005.03.006; Shi SJ, 2012, PHARM RES-DORDR, V29, P97, DOI 10.1007/s11095-011-0514-6; Shi SJ, 2013, ANGEW CHEM INT EDIT, V52, P3901, DOI 10.1002/anie.201208077; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Souissi I, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-14; Sun XX, 2008, CANCER LETT, V262, P201, DOI 10.1016/j.canlet.2007.12.009; Tabatt K, 2004, EUR J PHARM BIOPHARM, V57, P155, DOI 10.1016/j.ejpb.2003.10.015; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Ye JS, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/28/285708; Yu WY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215102; Yuan Q, 2014, INT J NANOMED, V9, P4829, DOI 10.2147/IJN.S70919; Zhang XL, 2013, INT J MOL MED, V32, P623, DOI 10.3892/ijmm.2013.1431; Zhang XL, 2010, CANCER GENET CYTOGEN, V197, P46, DOI 10.1016/j.cancergencyto.2009.10.004	49	28	29	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124924	10.1371/journal.pone.0124924	http://dx.doi.org/10.1371/journal.pone.0124924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923701	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600113
J	Sahlmann, C; Gu, J; Kortner, TM; Lein, I; Krogdahl, A; Bakke, AM				Sahlmann, Christian; Gu, Jinni; Kortner, Trond M.; Lein, Ingrid; Krogdahl, Ashild; Bakke, Anne Marie			Ontogeny of the Digestive System of Atlantic Salmon (Salmo salar L.) and Effects of Soybean Meal from Start-Feeding	PLOS ONE			English	Article							DISTAL INTESTINE; GASTROINTESTINAL-TRACT; ENZYME-ACTIVITIES; INDUCED ENTERITIS; GENE-EXPRESSION; ABSORPTION; SUPPLEMENTATION; ENTEROPATHY; TRYPSIN; STOMACH	Despite a long history of rearing Atlantic salmon in hatcheries in Norway, knowledge of molecular and physiological aspects of juvenile development is still limited. To facilitate introduction of alternative feed ingredients and feed additives during early phases, increased knowledge regarding the ontogeny of the digestive apparatus in salmon is needed. In this study, we characterized the development of the gastrointestinal tract and accessory digestive organs for five months following hatch by using histological, biochemical and molecular methods. Furthermore, the effects of a diet containing 16.7% soybean meal (SBM) introduced at start-feeding were investigated, as compared to a fishmeal based control diet. Salmon yolk sac alevins and fry were sampled at 18 time points from hatch until 144 days post hatch (dph). Histomorphological development was investigated at 7, 27, 46, 54 and 144 dph. Ontogenetic expression patterns of genes encoding key digestive enzymes, nutrient transporters, gastrointestinal peptide hormones and T-cell markers were analyzed from 13 time points by qPCR. At 7 dph, the digestive system of Atlantic salmon alevins was morphologically distinct with an early stomach, liver, pancreas, anterior and posterior intestine. About one week before the yolk sac was internalized and exogenous feeding was started, gastric glands and developing pyloric caeca were observed, which coincided with an increase in gene expression of gastric and pancreatic enzymes and nutrient transporters. Thus, the observed organs seemed ready to digest external feed well before the yolk sac was absorbed into the abdominal cavity. In contrast to post-smolt Atlantic salmon, inclusion of SBM did not induce intestinal inflammation in the juveniles. This indicates that SBM can be used in compound feeds for salmon fry from start-feeding to at least 144 dph and/or 4-5 g body weight.	[Sahlmann, Christian; Gu, Jinni; Kortner, Trond M.; Krogdahl, Ashild; Bakke, Anne Marie] Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Lein, Ingrid] Nofima AS, Sunndalsora, Norway	Norwegian University of Life Sciences; Nofima	Bakke, AM (corresponding author), Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Oslo, Norway.	annemarie.bakke@nmbu.no			Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre" (APC) [145949/120]; European Union [211820]	Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre" (APC); European Union(European Commission)	The study was financed by the Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre" (APC, grant no. 145949/120) and a European Union Seventh Framework Programme grant "Biomarkers for post market monitoring of short and long-term effects of genetically modified organisms on animal and human health" (GMSAFOOD, grant no. 211820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; BISBAL GA, 1995, J FISH BIOL, V47, P277, DOI 10.1006/jfbi.1995.0133; BOULHIC M, 1992, AQUACULTURE, V102, P373, DOI 10.1016/0044-8486(92)90190-V; Buddington RK, 2004, COMP BIOCHEM PHYS A, V139, P261, DOI 10.1016/j.cbpb.2004.09.007; Chikwati EM, 2013, AQUACULTURE, V402, P28, DOI 10.1016/j.aquaculture.2013.03.023; DAHLQVIST A, 1970, ENZYMOL BIOL CLIN, V11, P52, DOI 10.1159/000458348; Darias MJ, 2007, AQUACULTURE, V270, P369, DOI 10.1016/j.aquaculture.2007.04.045; Darias MJ, 2005, AQUACULTURE, V248, P245, DOI 10.1016/j.aquaculture.2005.04.044; Deng XY, 2001, AM J PHYSIOL-REG I, V281, pR645, DOI 10.1152/ajpregu.2001.281.2.R645; Douglas SE, 2000, AQUACULTURE, V190, P247, DOI 10.1016/S0044-8486(00)00398-7; Einarsdottir IE, 2011, CELL TISSUE RES, V344, P481, DOI 10.1007/s00441-011-1158-x; Einarsson S, 1997, COMP BIOCHEM PHYS C, V117, P63, DOI 10.1016/S0742-8413(96)00226-5; Faulk CK, 2007, J FISH BIOL, V70, P567, DOI 10.1111/j.1095-8649.2007.01330.x; Froystad MK, 2006, COMP BIOCHEM PHYS A, V145, P479, DOI 10.1016/j.cbpa.2006.08.003; Gargiulo AM, 1998, ANAT HISTOL EMBRYOL, V27, P89, DOI 10.1111/j.1439-0264.1998.tb00162.x; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; GAWLICKA A, 1995, FISH PHYSIOL BIOCHEM, V14, P357, DOI 10.1007/BF00003374; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; GOVONI JJ, 1986, ENVIRON BIOL FISH, V16, P59, DOI 10.1007/BF00005160; Gu JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099932; Gu JN, 2013, BRIT J NUTR, V109, P1408, DOI 10.1017/S000711451200325X; Gu M, 2014, BRIT J NUTR, V111, P432, DOI 10.1017/S0007114513002717; GUNNES K, 1979, AQUACULTURE, V16, P211, DOI 10.1016/0044-8486(79)90109-1; GUYOT E, 1995, J FISH BIOL, V47, P427, DOI 10.1111/j.1095-8649.1995.tb01912.x; He T, 2012, FISH PHYSIOL BIOCHEM, V38, P297, DOI 10.1007/s10695-011-9507-y; Heming T.A., 1988, P407; HEMING TA, 1982, CAN J FISH AQUAT SCI, V39, P184, DOI 10.1139/f82-021; Hernandez MPG, 2001, ANAT EMBRYOL, V204, P39, DOI 10.1007/s004290100173; Infante JLZ, 2001, COMP BIOCHEM PHYS C, V130, P477, DOI 10.1016/S1532-0456(01)00274-5; Jantzen Stuart G, 2011, BMC Res Notes, V4, P88, DOI 10.1186/1756-0500-4-88; KAKADE ML, 1973, J NUTR, V103, P1772, DOI 10.1093/jn/103.12.1772; Killeen J, 1999, J FISH BIOL, V55, P382, DOI 10.1111/j.1095-8649.1999.tb00686.x; KNOPH MB, 1992, COMP BIOCHEM PHYS C, V101, P275, DOI 10.1016/0742-8413(92)90273-A; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Kortner TM, 2014, BRIT J NUTR, V111, P2089, DOI 10.1017/S0007114514000373; Kortner TM, 2013, BRIT J NUTR, V109, P593, DOI 10.1017/S0007114512002024; Kortner TM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-101; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Krogdahl A, 2000, AQUACULT NUTR, V6, P77; Krogdahl A, 1999, AQUACULT NUTR, V5, P121; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; KUROKAWA T, 1995, CAN J FISH AQUAT SCI, V52, P1030, DOI 10.1139/f95-101; Lazo J.P., 2011, LARVAL FISH NUTR, P5, DOI DOI 10.1002/dvdy.22113; Lilleeng E, 2007, COMP BIOCHEM PHYS A, V147, P25, DOI 10.1016/j.cbpa.2006.10.043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macqueen DJ, 2008, BIOL LETTERS, V4, P294, DOI 10.1098/rsbl.2007.0620; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Moen AGG, 2010, DEV NEUROBIOL, V70, P649, DOI 10.1002/dneu.20803; Murashita K, 2006, GEN COMP ENDOCR, V145, P287, DOI 10.1016/j.ygcen.2005.09.008; Murashita K, 2009, GEN COMP ENDOCR, V160, P223, DOI 10.1016/j.ygcen.2008.11.024; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; NOAILLACDEPEYRE J, 1973, Z ZELLFORSCH MIK ANA, V146, P525, DOI 10.1007/BF02347181; NRC, 1993, NUTR REQ FISH, DOI [10.17226/2115, DOI 10.17226/2115]; PEDERSEN T, 1992, J FISH BIOL, V41, P449, DOI 10.1111/j.1095-8649.1992.tb02673.x; Pena R, 2003, AQUACULTURE, V219, P633, DOI 10.1016/S0044-8486(02)00352-6; Pradhan PK, 2012, FISH PHYSIOL BIOCHEM, V38, P1601, DOI 10.1007/s10695-012-9655-8; ROMBOUGH PJ, 1982, CAN J ZOOL, V60, P2006, DOI 10.1139/z82-258; Ronnestad I, 2007, AQUACULTURE, V268, P82, DOI 10.1016/j.aquaculture.2007.04.031; Sahlmann C, 2013, FISH SHELLFISH IMMUN, V34, P599, DOI 10.1016/j.fsi.2012.11.031; Sanden M, 2005, J FISH DIS, V28, P317, DOI 10.1111/j.1365-2761.2005.00618.x; SARASQUETE MC, 1995, AQUACULTURE, V130, P79, DOI 10.1016/0044-8486(94)00175-N; SEGNER H, 1994, MAR BIOL, V119, P471, DOI 10.1007/BF00347544; Segner Helmut, 1993, Journal of the World Aquaculture Society, V24, P121, DOI 10.1111/j.1749-7345.1993.tb00001.x; Skugor S, 2011, AQUACULT NUTR, V17, P505, DOI 10.1111/j.1365-2095.2010.00832.x; STROBAND HWJ, 1981, CELL TISSUE RES, V215, P397; Tacon AG, 2011, 56487 FAO, P56487; TAKAHASHI K, 1978, Tohoku Journal of Agricultural Research, V29, P98; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Uran PA, 2008, J FISH BIOL, V73, P2571, DOI 10.1111/j.1095-8649.2008.02091.x; VANDENINGH TSGAM, 1991, AQUACULTURE, V94, P297, DOI 10.1016/0044-8486(91)90174-6; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Zhou J, 2010, LIPIDS, V45, P301, DOI 10.1007/s11745-010-3396-1	75	40	40	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124179	10.1371/journal.pone.0124179	http://dx.doi.org/10.1371/journal.pone.0124179			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923375	Green Published, Green Accepted, gold			2022-12-26	WOS:000353711600073
J	Thibault, R; Makhlouf, AM; Kossovsky, MP; Iavindrasana, J; Chikhi, M; Meyer, R; Pittet, D; Zingg, W; Pichard, C				Thibault, Ronan; Makhlouf, Anne-Marie; Kossovsky, Michel P.; Iavindrasana, Jimison; Chikhi, Marinette; Meyer, Rodolphe; Pittet, Didier; Zingg, Walter; Pichard, Claude			Healthcare-Associated Infections Are Associated with Insufficient Dietary Intake: An Observational Cross-Sectional Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HOSPITAL STAY; FOOD-INTAKE; ENTERAL NUTRITION; ESPEN GUIDELINES; RISK-FACTORS; IMPACT; MORTALITY; MALNUTRITION; SURGERY	Background Indicators to predict healthcare-associated infections (HCAI) are scarce. Malnutrition is known to be associated with adverse outcomes in healthcare but its identification is time-consuming and rarely done in daily practice. This cross-sectional study assessed the association between dietary intake, nutritional risk, and the prevalence of HCAI, in a general hospital population. Methods and findings Dietary intake was assessed by dedicated dieticians on one day for all hospitalized patients receiving three meals per day. Nutritional risk was assessed using Nutritional Risk Screening (NRS)-2002, and defined as a NRS score >= 3. Energy needs were calculated using 110% of Harris-Benedict formula. HCAIs were diagnosed based on the Center for Disease Control criteria and their association with nutritional risk and measured energy intake was done using a multivariate logistic regression analysis. From 1689 hospitalised patients, 1024 and 1091 were eligible for the measurement of energy intake and nutritional risk, respectively. The prevalence of HCAI was 6.8%, and 30.1% of patients were at nutritional risk. Patients with HCAI were more likely identified with decreased energy intake (i.e. <= 70% of predicted energy needs) (30.3% vs. 14.5%, P = 0.002). The proportion of patients at nutritional risk was not significantly different between patients with and without HCAI (35.6% vs. 29.7%, P = 0.28), respectively. Measured energy intake <= 70% of predicted energy needs (odds ratio: 2.26; 95% CI: 1.24 to 4.11, P = 0.008) and moderate severity of the disease (odds ratio: 3.38; 95% CI: 1.49 to 7.68, P = 0.004) were associated with HCAI in the multivariate analysis. Conclusion Measured energy intake <= 70% of predicted energy needs is associated with HCAI in hospitalised patients. This suggests that insufficient dietary intake could be a risk factor of HCAI, without excluding reverse causality. Randomized trials are needed to assess whether improving energy intake in patients identified with decreased dietary intake could be a novel strategy for HCAI prevention.	[Thibault, Ronan; Makhlouf, Anne-Marie; Chikhi, Marinette; Pichard, Claude] Univ Hosp Geneva, Nutr Unit, Geneva, Switzerland; [Kossovsky, Michel P.] Univ Hosp Geneva, Rehabil & Geriatr, Geneva, Switzerland; [Iavindrasana, Jimison] Univ Hosp Geneva, Business Intelligence Div, Geneva, Switzerland; [Meyer, Rodolphe] Univ Hosp Geneva, Dept Informat, Geneva, Switzerland; [Pittet, Didier; Zingg, Walter] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Pichard, C (corresponding author), Univ Hosp Geneva, Nutr Unit, Geneva, Switzerland.	claude.pichard@unige.ch		Thibault, Ronan/0000-0002-6038-5649; Pittet, Didier/0000-0002-3667-7131; Meyer, Rodolphe/0000-0002-5712-0607	BBraun; Fresenius-Kabi; Nutricia; Nestle; Baxter; Swiss National Science Foundation; Public Foundation Nutrition 2000plus; Nestle Nutrition; Abbott; B. Braun; Danone-Nutricia; Cosmed	BBraun; Fresenius-Kabi; Nutricia(Danone Nutricia); Nestle(Nestle SA); Baxter; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Public Foundation Nutrition 2000plus; Nestle Nutrition(Nestle SA); Abbott(Abbott Laboratories); B. Braun; Danone-Nutricia(Danone Nutricia); Cosmed	Dr. Thibault reports grants from BBraun, Fresenius-Kabi, Nutricia, Nestle, Baxter, In addition, Dr. Pichard reports grants from Swiss National Science Foundation, grants from Public Foundation Nutrition 2000plus, Nestle Nutrition, Abbott, B. Braun, Fresenius-Kabi, Danone-Nutricia, Cosmed, Baxter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal E, 2013, CLIN NUTR, V32, P737, DOI 10.1016/j.clnu.2012.11.021; Benkovic V, 2014, CLIN NUTR, V33, P689, DOI 10.1016/j.clnu.2013.09.006; Bouadma L, 2010, CLIN INFECT DIS, V51, P1115, DOI 10.1086/656737; Braga M, 1999, ARCH SURG-CHICAGO, V134, P428, DOI 10.1001/archsurg.134.4.428; Chambrier C, 2012, J VISC SURG, V149, pE325, DOI 10.1016/j.jviscsurg.2012.06.006; Chima CS, 1997, J AM DIET ASSOC, V97, P975, DOI 10.1016/S0002-8223(97)00235-6; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Dupertuis YM, 2003, CLIN NUTR, V22, P115, DOI 10.1054/clnu.2002.0623; Gianotti L, 2002, GASTROENTEROLOGY, V122, P1763, DOI 10.1053/gast.2002.33587; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Hiesmayr M, 2009, CLIN NUTR, V28, P484, DOI 10.1016/j.clnu.2009.05.013; Johansen N, 2004, CLIN NUTR, V23, P539, DOI 10.1016/j.clnu.2003.10.008; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Lean M, 2008, BRIT MED J, V336, P290, DOI 10.1136/bmj.39449.723090.80; Leandro-Merhi VA, 2011, JPEN-PARENTER ENTER, V35, P241, DOI 10.1177/0148607110374477; National Institute for Health and Care Excellence (NICE), 2006, NUTR SUPP AD OR NUTR; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Olmsted R. N., 1996, APIC INFECT CONTROL, pA1; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; Saint S, 2013, JAMA INTERN MED, V173, P874, DOI 10.1001/jamainternmed.2013.101; Schneider SM, 2004, BRIT J NUTR, V92, P105, DOI 10.1079/BJN20041152; Scott RD, 2009, DIRECT MED COSTS HEA; Senesse P, 2012, NUTR CLIN METAB, V26, P151, DOI 10.1016/j.nupar.2012.10.002; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Tangvik RJ, 2014, CLIN NUTR, V33, P634, DOI 10.1016/j.clnu.2013.09.008; Thibault R, 2011, CLIN NUTR, V30, P289, DOI 10.1016/j.clnu.2010.10.002; Thibault R, 2009, CLIN NUTR, V28, P134, DOI 10.1016/j.clnu.2009.01.003; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Weimann A, 2006, CLIN NUTR, V25, P224, DOI 10.1016/j.clnu.2006.01.015; Zingg W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093898; Zingg W, 2014, INFECT CONT HOSP EP, V35, P674, DOI 10.1086/676424; Zingg W, 2009, CRIT CARE MED, V37, P2167, DOI 10.1097/CCM.0b013e3181a02d8f	37	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123695	10.1371/journal.pone.0123695	http://dx.doi.org/10.1371/journal.pone.0123695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923783	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600056
J	Pu, SH; Nakagome, K; Yamada, T; Matsumura, H; Yokoyama, K; Kaneko, K; Kurosawa, Y				Pu, Shenghong; Nakagome, Kazuyuki; Yamada, Takeshi; Matsumura, Hiroshi; Yokoyama, Katsutoshi; Kaneko, Koichi; Kurosawa, Yoichi			Association between Fish Consumption and Prefrontal Function during a Cognitive Task in Male Japanese Workers: A Multi-Channel Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; WORKING-MEMORY TASK; VERBAL FLUENCY TASK; DOCOSAHEXAENOIC ACID; OMEGA-3-FATTY-ACID LEVELS; SEAFOOD CONSUMPTION; ECOLOGICAL ANALYSIS; CORTEX ACTIVATION; MAJOR DEPRESSION; DOUBLE-BLIND	The purpose of this study was to examine the relationship between fish consumption and prefrontal function during a cognitive task in male Japanese workers. The study included 208 male workers who underwent medical health examinations 3 months after a change in their work assignment. We measured the hemoglobin concentration changes in the prefrontal region during working memory tasks using 52-channel near-infrared spectroscopy. The frequency of fish consumption was calculated on the basis of the subjects' self-reported customary intake frequency over the previous 3 months. A significant positive relationship was observed between fish consumption and left dorsolateral prefrontal function during a working memory task. To our knowledge, this is the first study to report an association between fish consumption and functional cortical activity with an ample sample size, suggesting that fish consumption modulates functional activity in the left dorsolateral prefrontal cortex.	[Pu, Shenghong; Yamada, Takeshi; Matsumura, Hiroshi; Yokoyama, Katsutoshi; Kaneko, Koichi] Tottori Univ, Fac Med, Div Neuropsychiat, Dept Brain & Neurosci, Yonago, Tottori 683, Japan; [Nakagome, Kazuyuki] Natl Ctr Neurol & Psychiat Hosp, Dept Psychiat, Tokyo, Japan; [Kurosawa, Yoichi] Tottori Univ, Fac Med, Div Hlth Adm & Promot, Dept Social Med, Yonago, Tottori 683, Japan	Tottori University; Tottori University	Pu, SH (corresponding author), Tottori Univ, Fac Med, Div Neuropsychiat, Dept Brain & Neurosci, Yonago, Tottori 683, Japan.	pshh0517@yahoo.co.jp		Nakagome, Kazuyuki/0000-0003-2919-8180	National Center of Neurology and Psychiatry (NCNP) [23-10, 26-3]	National Center of Neurology and Psychiatry (NCNP)	Funding: This study was supported by the Intramural Research Grant (23-10 and 26-3) for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP). Funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 1996, LIPIDS, V31, pS157, DOI 10.1007/BF02637069; Aihara H, 2003, J EPIDEMIOL, V13, P56, DOI 10.2188/jea.13.56; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Barberger-Gateau P, 2005, EUR J CLIN NUTR, V59, P817, DOI 10.1038/sj.ejcn.1602145; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Borsonelo EC, 2008, PROSTAG LEUKOTR ESS, V78, P237, DOI 10.1016/j.plefa.2008.03.005; Bosc M, 1997, EUR NEUROPSYCHOPHARM, V7, pS57, DOI 10.1016/S0924-977X(97)00420-3; Bourre JM, 2007, BIOMED PHARMACOTHER, V61, P105, DOI 10.1016/j.biopha.2006.09.015; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Colangelo LA, 2009, NUTRITION, V25, P1011, DOI 10.1016/j.nut.2008.12.008; Condray R, 2008, SCHIZOPHR RES, V106, P13, DOI 10.1016/j.schres.2008.03.009; da Silva TM, 2008, J AFFECT DISORDERS, V111, P351, DOI 10.1016/j.jad.2008.03.008; Daniels JL, 2004, EPIDEMIOLOGY, V15, P394, DOI 10.1097/01.ede.0000129514.46451.ce; Das UN, 2000, PROSTAG LEUKOTR ESS, V63, P351, DOI 10.1054/plef.2000.0226; Frasure-Smith N, 2004, BIOL PSYCHIAT, V55, P891, DOI 10.1016/j.biopsych.2004.01.021; Gale CR, 2008, J CHILD PSYCHOL PSYC, V49, P1061, DOI 10.1111/j.1469-7610.2008.01908.x; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Goto M, 2005, CLIN PSYCHIATR, V47, P483, DOI DOI 10.11477/mf.1405100063; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hibbeln JR, 2002, J AFFECT DISORDERS, V69, P15, DOI 10.1016/S0165-0327(01)00374-3; Jackson PA, 2012, BIOL PSYCHOL, V89, P183, DOI 10.1016/j.biopsycho.2011.10.006; Kawakami Norito, 2007, Nihon Rinsho, V65, P1578; Kimura T, 2001, Nihon Rinsho, V59, P1444; Lin PY, 2010, BIOL PSYCHIAT, V68, P140, DOI 10.1016/j.biopsych.2010.03.018; Maes M, 1999, PSYCHIAT RES, V85, P275, DOI 10.1016/S0165-1781(99)00014-1; Mamalakis G, 2002, PROSTAG LEUKOTR ESS, V67, P311, DOI 10.1054/plef.2002.0435; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39; Ministry of Health Labour and Welfare of Japan, 2001, PAT SURV 1999, VI; Ministry of Health Labour and Welfare of Japan, 2004, PAT SURV 2002, VI; Ministry of Health Labour and Welfare of Japan, 2007, PAT SURV 2005, VI; Noaghiul S, 2003, AM J PSYCHIAT, V160, P2222, DOI 10.1176/appi.ajp.160.12.2222; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Peet M, 2004, BRIT J PSYCHIAT, V184, P404, DOI 10.1192/bjp.184.5.404; Peet M, 1998, BIOL PSYCHIAT, V43, P315, DOI 10.1016/S0006-3223(97)00206-0; Pu S, 2013, PSYCHIAT RES-NEUROIM, V214, P73, DOI 10.1016/j.pscychresns.2013.05.011; Pu SH, 2012, PSYCHIAT RES-NEUROIM, V203, P222, DOI 10.1016/j.pscychresns.2012.01.007; Pu S, 2011, NEUROSCI RES, V70, P91, DOI 10.1016/j.neures.2011.01.001; Raji CA, 2014, AM J PREV MED, V47, P444, DOI 10.1016/j.amepre.2014.05.037; Richardson AJ, 2002, PROG NEURO-PSYCHOPH, V26, P233, DOI 10.1016/S0278-5846(01)00254-8; Riemer S, 2010, J AFFECT DISORDERS, V123, P173, DOI 10.1016/j.jad.2009.08.004; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Skosnik PD, 2003, PROSTAG LEUKOTR ESS, V69, P367, DOI 10.1016/j.plefa.2003.08.008; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Sugano M, 2000, AM J CLIN NUTR, V71, p189S, DOI 10.1093/ajcn/71.1.189S; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Tanskanen A, 2001, PSYCHIATR SERV, V52, P529, DOI 10.1176/appi.ps.52.4.529; Timonen M, 2004, J AFFECT DISORDERS, V82, P447, DOI 10.1016/j.jad.2004.02.002; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Trivedi MH, 2014, J AFFECT DISORDERS, V152, P19, DOI 10.1016/j.jad.2013.09.012; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Virtanen JK, 2008, NEUROLOGY, V71, P439, DOI 10.1212/01.wnl.0000324414.12665.b0; Wakai K, 2005, J EPIDEMIOL, V15, P211, DOI 10.2188/jea.15.211; Yamashita Y, 1996, OPT ENG, V35, P1046, DOI 10.1117/1.600721; Yatoh S, 2010, MED TECHNOLOGY, V38, P1347; Zhao HJ, 2002, PHYS MED BIOL, V47, P2075, DOI 10.1088/0031-9155/47/12/306; Zimmer L, 2002, AM J CLIN NUTR, V75, P662, DOI 10.1093/ajcn/75.4.662	66	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123972	10.1371/journal.pone.0123972	http://dx.doi.org/10.1371/journal.pone.0123972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919586	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400039
J	Collins, PE; Grassia, G; Colleran, A; Kiely, PA; Ialenti, A; Maffia, P; Carmody, RJ				Collins, Patricia E.; Grassia, Gianluca; Colleran, Amy; Kiely, Patrick A.; Ialenti, Armando; Maffia, Pasquale; Carmody, Ruaidhri J.			Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor B (NF-B) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; NF-B; peptide array; peptides; transcription; BCL-3	FACTOR-KAPPA-B; GENE-EXPRESSION; ANKYRIN REPEAT; PROTEIN; DOMAIN; MICE; TRANSCRIPTION; MEMBRANE; SURVIVAL; ROLES	The NF-B transcriptional response is tightly regulated by a number of processes including the phosphorylation, ubiquitination, and subsequent proteasomal degradation of NF-B subunits. The IB family protein BCL-3 stabilizes a NF-B p50 homodimer.DNA complex through inhibition of p50 ubiquitination. This complex inhibits the binding of the transcriptionally active NF-B subunits p65 and c-Rel on the promoters of NF-B target genes and functions to suppress inflammatory gene expression. We have previously shown that the direct interaction between p50 and BCL-3 is required for BCL-3-mediated inhibition of pro-inflammatory gene expression. In this study we have used immobilized peptide array technology to define regions of BCl-3 that mediate interaction with p50 homodimers. Our data show that BCL-3 makes extensive contacts with p50 homodimers and in particular with ankyrin repeats (ANK) 1, 6, and 7, and the N-terminal region of Bcl-3. Using these data we have designed a BCL-3 mimetic peptide based on a region of the ANK1 of BCL-3 that interacts with p50 and shares low sequence similarity with other IB proteins. When fused to a cargo carrying peptide sequence this BCL-3-derived peptide, but not a mutated peptide, inhibited Toll-like receptor-induced cytokine expression in vitro. The BCL-3 mimetic peptide was also effective in preventing inflammation in vivo in the carrageenan-induced paw edema mouse model. This study demonstrates that therapeutic strategies aimed at mimicking the functional activity of BCL-3 may be effective in the treatment of inflammatory disease.	[Collins, Patricia E.; Grassia, Gianluca; Maffia, Pasquale; Carmody, Ruaidhri J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Ctr Immunobiol, Glasgow G12 8TA, Lanark, Scotland; [Kiely, Patrick A.] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Kiely, Patrick A.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Colleran, Amy] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland; [Ialenti, Armando] Univ Naples Federico II, Dept Pharm, I-80131 Naples, Italy	University of Glasgow; University of Limerick; University of Limerick; University College Cork; University of Naples Federico II	Carmody, RJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Ctr Immunobiol, Glasgow G12 8TA, Lanark, Scotland.	ruaidhri.carmody@glasgow.ac.uk	Carmody, Ruaidhri/H-5396-2019; Grassia, Gianluca/H-7677-2019	Grassia, Gianluca/0000-0001-7846-5594; Collins, Patricia/0000-0002-0218-7847	Science Foundation Ireland [08/IN.1/B1843]; Biotechnology and Biological Sciences Research Council [BB/M003671/1]; Institute of Infection, Immunity and Inflammation at the University of Glasgow; Engineering and Physical Sciences Research Council [EP/L014165/1]; BBSRC [BB/M003671/1] Funding Source: UKRI; EPSRC [EP/L014165/1] Funding Source: UKRI; MRC [MR/M010694/1] Funding Source: UKRI; Medical Research Council [MR/M010694/1] Funding Source: researchfish	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute of Infection, Immunity and Inflammation at the University of Glasgow; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Science Foundation Ireland Grant 08/IN.1/B1843, Biotechnology and Biological Sciences Research Council Grant BB/M003671/1 and the Institute of Infection, Immunity and Inflammation at the University of Glasgow. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Engineering and Physical Sciences Research Council Research Grant EP/L014165/1.	Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Collins PE, 2014, J BIOL CHEM, V289, P7059, DOI 10.1074/jbc.M114.551986; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Huxford T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000075; Ialenti A, 2005, MOL PHARMACOL, V67, P1620, DOI 10.1124/mol.104.004895; Kramer A, 1998, METH MOL B, V87, P25; Kreisel D, 2011, J CLIN INVEST, V121, P265, DOI 10.1172/JCI42596; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Manavalan B., 2010, PLOS ONE, V5; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Mitchell TC, 2002, ANN NY ACAD SCI, V975, P132, DOI 10.1111/j.1749-6632.2002.tb05947.x; Mitchell TC, 2002, ANN NY ACAD SCI, V975, P114, DOI 10.1111/j.1749-6632.2002.tb05946.x; Muhlbauer M, 2008, J BIOL CHEM, V283, P14182, DOI 10.1074/jbc.M709029200; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Pene F, 2011, J IMMUNOL, V186, P2412, DOI 10.4049/jimmunol.1001331; Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650; Ruan QG, 2010, DIABETES, V59, P2549, DOI 10.2337/db10-0480; Tang WH, 2014, IMMUNITY, V41, P555, DOI 10.1016/j.immuni.2014.09.017; Tassi I, 2014, J IMMUNOL, V193, P4303, DOI 10.4049/jimmunol.1401505; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915	29	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15687	15696		10.1074/jbc.M115.643700	http://dx.doi.org/10.1074/jbc.M115.643700			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25922067	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000356527400031
J	Dobson, KL; Jackson, C; Balakrishnan, S; Bellamy, TC				Dobson, Katharine L.; Jackson, Claire; Balakrishnan, Saju; Bellamy, Tomas C.			Caffeine Modulates Vesicle Release and Recovery at Cerebellar Parallel Fibre Terminals, Independently of Calcium and Cyclic AMP Signalling	PLOS ONE			English	Article							LONG-TERM DEPRESSION; DEPENDENT PROTEIN-KINASE; PURKINJE-CELL SYNAPSES; BERGMANN GLIAL-CELLS; CLIMBING FIBER; MULTIVESICULAR RELEASE; RYANODINE RECEPTORS; ECTOPIC RELEASE; GRANULE CELL; PLASTICITY	Background Cerebellar parallel fibres release glutamate at both the synaptic active zone and at extrasynaptic sites-a process known as ectopic release. These sites exhibit different short-term and long-term plasticity, the basis of which is incompletely understood but depends on the efficiency of vesicle release and recycling. To investigate whether release of calcium from internal stores contributes to these differences in plasticity, we tested the effects of the ryanodine receptor agonist caffeine on both synaptic and ectopic transmission. Methods Whole cell patch clamp recordings from Purkinje neurons and Bergmann glia were carried out in transverse cerebellar slices from juvenile (P16-20) Wistar rats. Key Results Caffeine caused complex changes in transmission at both synaptic and ectopic sites. The amplitude of postsynaptic currents in Purkinje neurons and extrasynaptic currents in Bergmann glia were increased 2-fold and 4-fold respectively, but paired pulse ratio was substantially reduced, reversing the short-term facilitation observed under control conditions. Caffeine treatment also caused synaptic sites to depress during 1 Hz stimulation, consistent with inhibition of the usual mechanisms for replenishing vesicles at the active zone. Unexpectedly, pharmacological intervention at known targets for caffeine-intracellular calcium release, and cAMP signalling-had no impact on these effects. Conclusions We conclude that caffeine increases release probability and inhibits vesicle recovery at parallel fibre synapses, independently of known pharmacological targets. This complex effect would lead to potentiation of transmission at fibres firing at low frequencies, but depression of transmission at high frequency connections.	[Dobson, Katharine L.; Bellamy, Tomas C.] Univ Nottingham, Sch Life Sci, Sch Med, Queens Med Ctr, Nottingham NG7 2RD, England; [Jackson, Claire; Balakrishnan, Saju; Bellamy, Tomas C.] Babraham Inst, Mol Signalling Lab, Cambridge, England; [Balakrishnan, Saju] Inst Neuro & Sensory Physiol, Gottingen, Germany	University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Dobson, KL (corresponding author), Univ Nottingham, Sch Life Sci, Sch Med, Queens Med Ctr, Nottingham NG7 2RD, England.	katharine.dobson@nottingham.ac.uk	Dobson, Katharine/AAG-8618-2020; Dobson, Katharine/D-5344-2015	Dobson, Katharine/0000-0003-4117-8684; Dobson, Katharine/0000-0003-4117-8684; Bellamy, Tomas/0000-0003-0204-7366	Biotechnology and Biological Sciences Research Council, UK [BB/D018501/1, BB/J015660/1]; Biotechnology and Biological Sciences Research Council [BB/D018501/1, BB/J015660/1] Funding Source: researchfish; BBSRC [BB/D018501/1, BB/J015660/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK (www.bbsrc.ac.uk, grant numbers: BB/D018501/1 and BB/J015660/1). Both grants were awards made to TCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MT, 2003, CELL CALCIUM, V33, P27, DOI 10.1016/S0143-4160(02)00179-3; Balakrishnan S, 2011, GLIA, V59, P82, DOI 10.1002/glia.21078; Balakrishnan S, 2009, GLIA, V57, P393, DOI 10.1002/glia.20768; Balezina OP, 2001, NEUROPHYSIOLOGY+, V33, P79, DOI 10.1023/A:1012324008410; BATCHELOR AM, 1992, EUR J NEUROSCI, V4, P1059, DOI 10.1111/j.1460-9568.1992.tb00132.x; Bellamy TC, 2006, EUR J NEUROSCI, V23, P581, DOI 10.1111/j.1460-9568.2005.04588.x; Bellamy TC, 2005, GLIA, V52, P325, DOI 10.1002/glia.20248; Bellamy TC, 2007, NEUROPHARMACOLOGY, V52, P368, DOI 10.1016/j.neuropharm.2006.08.009; Bender VA, 2009, J NEUROSCI, V29, P10974, DOI 10.1523/JNEUROSCI.2123-09.2009; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; BEZPROZVANNY I, 1994, MOL BIOL CELL, V5, P97, DOI 10.1091/mbc.5.1.97; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; Bouchard R, 2003, PROG NEUROBIOL, V69, P391, DOI 10.1016/S0301-0082(03)00053-4; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Carter AG, 2002, J NEUROSCI, V22, P21, DOI 10.1523/JNEUROSCI.22-01-00021.2002; Chen CF, 1997, J NEUROSCI, V17, P8687; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Cousin MA, 2011, J PHYSIOL-LONDON, V589, P1943, DOI 10.1113/jphysiol.2010.200477; Crowley JJ, 2007, J NEUROSCI, V27, P5448, DOI 10.1523/JNEUROSCI.1186-07.2007; Dittman JS, 1996, J NEUROSCI, V16, P1623; Dittman JS, 1997, J NEUROSCI, V17, P9048; Foster KA, 2005, J NEUROSCI, V25, P11655, DOI 10.1523/JNEUROSCI.4029-05.2005; Hagenston AM, 2009, CELL CALCIUM, V45, P310, DOI 10.1016/j.ceca.2008.11.003; Hegg CC, 2009, GLIA, V57, P634, DOI 10.1002/glia.20792; Isope P, 2002, J NEUROSCI, V22, P9668; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Kaeser PS, 2008, P NATL ACAD SCI USA, V105, P14680, DOI 10.1073/pnas.0806679105; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Kimura T, 2005, P NATL ACAD SCI USA, V102, P17160, DOI 10.1073/pnas.0508190102; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Linden DJ, 1999, J NEUROSCI, V19, P10221; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Matsui K, 2004, J NEUROSCI, V24, P8932, DOI 10.1523/JNEUROSCI.2650-04.2004; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Morton-Jones RT, 2008, CELL CALCIUM, V43, P356, DOI 10.1016/j.ceca.2007.07.003; Neale SA, 2001, NEUROPHARMACOLOGY, V41, P42, DOI 10.1016/S0028-3908(01)00046-6; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; ONEILL SC, 1990, J PHYSIOL-LONDON, V425, P55, DOI 10.1113/jphysiol.1990.sp018092; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; Ribeiro JA, 2010, J ALZHEIMERS DIS, V20, pS3, DOI 10.3233/JAD-2010-1379; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SABATINI BL, 1995, NEUROPHARMACOLOGY, V34, P1453, DOI 10.1016/0028-3908(95)00129-T; Saleem H, 2014, BRIT J PHARMACOL, V171, P3298, DOI 10.1111/bph.12685; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Simpson PB, 1996, J NEUROCHEM, V67, P364; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Tazzeo T, 2012, AM J PHYSIOL-LUNG C, V303, pL334, DOI 10.1152/ajplung.00103.2012; Valera AM, 2012, J NEUROSCI, V32, P3267, DOI 10.1523/JNEUROSCI.3175-11.2012; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125974	10.1371/journal.pone.0125974	http://dx.doi.org/10.1371/journal.pone.0125974			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933382	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100146
J	Huang, HY; Shen, HH; Tien, CH; Li, CJ; Fan, SK; Liu, CH; Hsu, WS; Yao, DJ				Huang, Hong-Yuan; Shen, Hsien-Hua; Tien, Chang-Hung; Li, Chin-Jung; Fan, Shih-Kang; Liu, Cheng-Hsien; Hsu, Wen-Syang; Yao, Da-Jeng			Digital Microfluidic Dynamic Culture of Mammalian Embryos on an Electrowetting on Dielectric (EWOD) Chip	PLOS ONE			English	Article							DEVELOPMENT IN-VITRO; PREIMPLANTATION EMBRYOS; LIQUID DROPLETS; SYSTEM; MOUSE; ACTUATION; GROWTH; EXTRACTION; TRANSPORT; CELLS	Current human fertilization in vitro (IVF) bypasses the female oviduct and manually inseminates, fertilizes and cultivates embryos in a static microdrop containing appropriate chemical compounds. A microfluidic microchannel system for IVF is considered to provide an improved in-vivo-mimicking environment to enhance the development in a culture system for an embryo before implantation. We demonstrate a novel digitalized microfluidic device powered with electrowetting on a dielectric (EWOD) to culture an embryo in vitro in a single droplet in a microfluidic environment to mimic the environment in vivo for development of the embryo and to culture the embryos with good development and live births. Our results show that the dynamic culture powered with EWOD can manipulate a single droplet containing one mouse embryo and culture to the blastocyst stage. The rate of embryo cleavage to a hatching blastocyst with a dynamic culture is significantly greater than that with a traditional static culture (p<0.05). The EWOD chip enhances the culture of mouse embryos in a dynamic environment. To test the reproductive outcome of the embryos collected from an EWOD chip as a culture system, we transferred embryos to pseudo-pregnant female mice and produced live births. These results demonstrate that an EWOD-based microfluidic device is capable of culturing mammalian embryos in a microfluidic biological manner, presaging future clinical application.	[Huang, Hong-Yuan; Li, Chin-Jung] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Huang, Hong-Yuan] Chang Gung Univ, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Huang, Hong-Yuan] Coll Med, Taoyuan, Taiwan; [Shen, Hsien-Hua; Yao, Da-Jeng] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu, Taiwan; [Tien, Chang-Hung; Fan, Shih-Kang] Natl Taiwan Univ, Dept Mech Engn, Taipei 10764, Taiwan; [Liu, Cheng-Hsien; Yao, Da-Jeng] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan; [Hsu, Wen-Syang] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Tsing Hua University; National Taiwan University; National Tsing Hua University; National Yang Ming Chiao Tung University	Yao, DJ (corresponding author), Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu, Taiwan.	djyao@mx.nthu.edu.tw		Liu, Cheng-Hsien/0000-0003-1882-3892; Hsu, Wensyang/0000-0002-0189-9578; FAN, SHIH-KANG/0000-0002-1740-2992	National Science Council grant, Taiwan [NSC 982314-B-182A-106, 101-2314-B-182A-133, 101-2120-M-002-017]; Chang Gung Memorial Hospital/National Tsing Hua University Collaboration grant (CMRPG) [300211/371332]	National Science Council grant, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital/National Tsing Hua University Collaboration grant (CMRPG)	Part of the research was supported in part by National Science Council grant, Taiwan (NSC 982314-B-182A-106, 101-2314-B-182A-133, 101-2120-M-002-017) and Chang Gung Memorial Hospital/National Tsing Hua University Collaboration grant (CMRPG 300211/371332), both to H.Y.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry S, 2006, J COLLOID INTERF SCI, V303, P517, DOI 10.1016/j.jcis.2006.08.004; Biggers JD, 2005, HUM REPROD, V20, P3376, DOI 10.1093/humrep/dei228; Bogojevic D, 2012, LAB CHIP, V12, P627, DOI 10.1039/c2lc20893h; Brody JP, 1997, SENSOR ACTUAT A-PHYS, V58, P13, DOI 10.1016/S0924-4247(97)80219-1; BYATTSMITH JG, 1991, HUM REPROD, V6, P52, DOI 10.1093/oxfordjournals.humrep.a137258; Cho BS, 2003, ANAL CHEM, V75, P1671, DOI 10.1021/ac020579e; Cho SK, 2003, J MICROELECTROMECH S, V12, P70, DOI 10.1109/JMEMS.2002.807467; Clark SG, 2005, LAB CHIP, V5, P1229, DOI 10.1039/b504397m; Eydelnant IA, 2012, LAB CHIP, V12, P750, DOI 10.1039/c2lc21004e; Fan SK, 2009, LAB CHIP, V9, P1236, DOI 10.1039/b816535a; Fauci LJ, 2006, ANNU REV FLUID MECH, V38, P371, DOI 10.1146/annurev.fluid.37.061903.175725; Han C, 2010, LAB CHIP, V10, P2848, DOI 10.1039/c005296e; Heo YS, 2012, LAB CHIP, V12, P2240, DOI 10.1039/c2lc21050a; Hickman DL, 2002, COMPARATIVE MED, V52, P122; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; Huang H.-Y., 2014, J NANOMED NANOTECHNO, V5, P199, DOI [10.4172/2157-7439.1000199., DOI 10.4172/2157-7439.1000199, 10.4172/2157-7439.1000199]; Huang HY, 2014, JALA-J LAB AUTOM, V19, P91, DOI 10.1177/2211068213486650; Huang WH, 2004, ANAL CHEM, V76, P483, DOI 10.1021/ac035026y; Hunter HC, 2009, PHYS CHEM CHEM PHYS, V11, P6156, DOI 10.1039/b820457h; JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Kim MS, 2009, ELECTROPHORESIS, V30, P3276, DOI 10.1002/elps.200900157; Kolle S, 2009, BIOL REPROD, V81, P267, DOI 10.1095/biolreprod.108.073874; Krivokharchenko A, 2003, BIOL REPROD, V68, P829, DOI 10.1095/biolreprod.102.006494; Lane M, 2007, BEST PRACT RES CL OB, V21, P83, DOI 10.1016/j.bpobgyn.2006.09.009; Lee J, 2002, SENSOR ACTUAT A-PHYS, V95, P259, DOI 10.1016/S0924-4247(01)00734-8; Lin HC, 2010, JALA-J LAB AUTOM, V15, P210, DOI 10.1016/j.jala.2010.01.010; Lin YY, 2012, SENSOR ACTUAT B-CHEM, V173, P338, DOI 10.1016/j.snb.2012.07.022; Lin YY, 2010, SENSOR ACTUAT B-CHEM, V150, P465, DOI 10.1016/j.snb.2010.06.059; Liu YJ, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/4/045017; Luk VN, 2008, LANGMUIR, V24, P6382, DOI 10.1021/la7039509; Malic L, 2010, LAB CHIP, V10, P418, DOI 10.1039/b917668c; Melin J, 2009, DEV DYNAM, V238, P950, DOI 10.1002/dvdy.21918; Nagy A, 2002, MANIPULATING THE MOU, P251; PARIA BC, 1990, P NATL ACAD SCI USA, V87, P4756, DOI 10.1073/pnas.87.12.4756; PATEL N, 1982, J NEUROSCI, V2, P483; Pollack MG, 2002, LAB CHIP, V2, P96, DOI 10.1039/b110474h; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534; Popova E, 2011, HUM REPROD, V26, P662, DOI 10.1093/humrep/deq379; Pyne DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108128; Raty S, 2004, LAB CHIP, V4, P186, DOI 10.1039/b316437c; RICKORDS LF, 1992, MOL REPROD DEV, V32, P259, DOI 10.1002/mrd.1080320311; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Sano H, 2010, THERIOGENOLOGY, V74, P863, DOI 10.1016/j.theriogenology.2010.04.011; Seo DB, 2007, MICROFLUID NANOFLUID, V3, P561, DOI 10.1007/s10404-006-0142-3; Sharma Sanjiv, 2013, Methods Mol Biol, V949, P207, DOI 10.1007/978-1-62703-134-9_15; Smith GD, 2011, SEMIN REPROD MED, V29, P5, DOI 10.1055/s-0030-1268699; Smith GS, 2012, NEUROPSYCHOPHARMACOL, V37, P1, DOI 10.1038/npp.2011.233; Srigunapalan S, 2012, LAB CHIP, V12, P369, DOI 10.1039/c1lc20844f; STEPTOE PC, 1978, LANCET, V2, P366; Sugimura S, 2010, BIOL REPROD, V83, P970, DOI 10.1095/biolreprod.110.085522; Suh RS, 2006, HUM REPROD, V21, P477, DOI 10.1093/humrep/dei323; Suzuki Hiroyuki, 2001, Journal of Reproduction and Development, V47, P227, DOI 10.1262/jrd.47.227; Swain JE, 2011, HUM REPROD UPDATE, V17, P541, DOI 10.1093/humupd/dmr006; Swain JE, 2008, J CLIN EMBRYOL, V11, P3; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Tomlinson AJ, 1995, J CAPILLARY ELECTROP, V2, P247; Verpoorte E, 2002, ELECTROPHORESIS, V23, P677, DOI 10.1002/1522-2683(200203)23:5<677::AID-ELPS677>3.0.CO;2-8; Wang XQ, 2009, REPRODUCTION, V138, P527, DOI 10.1530/REP-09-0148; Welters WJJ, 1998, LANGMUIR, V14, P1535, DOI 10.1021/la971153b; WESTROM L, 1977, FERTIL STERIL, V28, P955; Wheeler MB, 2007, THERIOGENOLOGY, V68, pS178, DOI 10.1016/j.theriogenology.2007.04.042; Xie Y, 2007, MOL REPROD DEV, V74, P1287, DOI 10.1002/mrd.20563; Zhang J, 1999, FERTIL STERIL, V72, P509, DOI 10.1016/S0015-0282(99)00264-2	64	34	41	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124196	10.1371/journal.pone.0124196	http://dx.doi.org/10.1371/journal.pone.0124196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933003	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100031
J	Barbosa, IAJ; Boon, MY; Khuu, SK				Jimenez Barbosa, Ingrid Astrid; Boon, Mei Ying; Khuu, Sieu K.			Exposure to Organic Solvents Used in Dry Cleaning Reduces Low and High Level Visual Function	PLOS ONE			English	Article							COLOR-VISION LOSS; OCCUPATIONAL-EXPOSURE; CONTRAST-SENSITIVITY; NEUROTOXIC SYMPTOMS; Q16 QUESTIONNAIRE; MOTION PERCEPTION; PATTERN DETECTION; GLASS PATTERNS; WORKERS; STYRENE	Purpose To investigate whether exposure to occupational levels of organic solvents in the dry cleaning industry is associated with neurotoxic symptoms and visual deficits in the perception of basic visual features such as luminance contrast and colour, higher level processing of global motion and form (Experiment 1), and cognitive function as measured in a visual search task (Experiment 2). Methods The Q16 neurotoxic questionnaire, a commonly used measure of neurotoxicity (by the World Health Organization), was administered to assess the neurotoxic status of a group of 33 dry cleaners exposed to occupational levels of organic solvents (OS) and 35 age-matched non dry-cleaners who had never worked in the dry cleaning industry. In Experiment 1, to assess visual function, contrast sensitivity, colour/hue discrimination (Munsell Hue 100 test), global motion and form thresholds were assessed using computerised psychophysical tests. Sensitivity to global motion or form structure was quantified by varying the pattern coherence of global dot motion (GDM) and Glass pattern (oriented dot pairs) respectively (i.e., the percentage of dots/dot pairs that contribute to the perception of global structure). In Experiment 2, a letter visual-search task was used to measure reaction times (as a function of the number of elements: 4, 8, 16, 32, 64 and 100) in both parallel and serial search conditions. Results Dry cleaners exposed to organic solvents had significantly higher scores on the Q16 compared to non dry-cleaners indicating that dry cleaners experienced more neurotoxic symptoms on average. The contrast sensitivity function for dry cleaners was significantly lower at all spatial frequencies relative to non dry-cleaners, which is consistent with previous studies. Poorer colour discrimination performance was also noted in dry cleaners than non dry-cleaners, particularly along the blue/yellow axis. In a new finding, we report that global form and motion thresholds for dry cleaners were also significantly higher and almost double than that obtained from non dry-cleaners. However, reaction time performance on both parallel and serial visual search was not different between dry cleaners and non dry-cleaners. Conclusions Exposure to occupational levels of organic solvents is associated with neurotoxicity which is in turn associated with both low level deficits (such as the perception of contrast and discrimination of colour) and high level visual deficits such as the perception of global form and motion, but not visual search performance. The latter finding indicates that the deficits in visual function are unlikely to be due to changes in general cognitive performance.	[Jimenez Barbosa, Ingrid Astrid; Boon, Mei Ying; Khuu, Sieu K.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Jimenez Barbosa, Ingrid Astrid] Univ La Salle, Hlth & Sci Fac, Bogota, Bogota DC, Colombia	University of New South Wales Sydney; Universidad de La Salle	Barbosa, IAJ (corresponding author), Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	injimenez@unisalle.edu.co	Khuu, Sieu/N-7957-2019; Boon, Mei Ying/F-2194-2016; Jimenez-Barbosa, Ingrid Astrid/AIC-7372-2022	Khuu, Sieu/0000-0003-1850-0225; Boon, Mei Ying/0000-0002-9759-8402; Jimenez-Barbosa, Ingrid Astrid/0000-0001-7874-2598	Administrative Department of Science, Technology and Innovation from Colombia (Colciencias); Laspau the Academic and Professional Programs for the Americas; Universidad de La Salle Colombia; Australian Research Council [DP110104713]	Administrative Department of Science, Technology and Innovation from Colombia (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Laspau the Academic and Professional Programs for the Americas; Universidad de La Salle Colombia; Australian Research Council(Australian Research Council)	IAJB is funded by the Administrative Department of Science, Technology and Innovation from Colombia (Colciencias) and Laspau the Academic and Professional Programs for the Americas, as well as by the Universidad de La Salle Colombia. SK is funded by Australian Research Council Discovery Project Grant: Number: DP110104713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGAZZOTTI G, 1994, SCI TOTAL ENVIRON, V156, P133, DOI 10.1016/0048-9697(94)90349-2; ALTMANN L, 1990, INT ARCH OCC ENV HEA, V62, P493, DOI 10.1007/BF00381179; Anger W, 1999, CURRENT PROTOCOLS TO, P17; ANGER WK, 1990, NEUROTOXICOLOGY, V11, P629; AXELSON O, 1976, Scandinavian Journal of Work Environment and Health, V2, P14; Axelson O, 1988, HLTH EFFECTS SOLVENT; Badcock DR, 2005, VISION RES, V45, P881, DOI 10.1016/j.visres.2004.09.042; Badcock DR, 2001, PSYCHOL RES-PSYCH FO, V65, P50, DOI 10.1007/s004260000020; BAKER EL, 1994, J OCCUP ENVIRON MED, V36, P1079, DOI 10.1097/00043764-199410000-00010; Bast-Pettersen R, 2006, SCAND J WORK ENV HEA, P41; Bockelmann I, 2003, OPHTHALMOLOGE, V100, P133, DOI 10.1007/s00347-002-0712-z; Boeckelmann I, 2003, J OCCUP ENVIRON MED, V45, P25, DOI 10.1097/00043764-200301000-00009; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Broadbent D. E., 1958, NATURE, V182, P1572; BROADWELL DK, 1995, AM J IND MED, V27, P677, DOI 10.1002/ajim.4700270505; CAMPAGNA D, 1995, SCAND J WORK ENV HEA, V21, P382, DOI 10.5271/sjweh.53; CAMPBELL FW, 1964, J OPT SOC AM, V54, P581; Candura S M, 1991, G Ital Med Lav, V13, P17; Cardinal KS, 2003, J VISION, V3, P199, DOI 10.1167/3.3.2; CARRICABURU P, 1980, ANN PHARM FR, V38, P155; CARRICABURU P, 1979, ANN PHARM FR, V37, P531; Castillo L, 2001, AM J IND MED, V39, P351, DOI 10.1002/ajim.1025; Cavalleri A, 2000, ARCH ENVIRON HEALTH, V55, P399, DOI 10.1080/00039890009604037; CAVALLERI A, 1994, NEUROSCI LETT, V179, P162, DOI 10.1016/0304-3940(94)90959-8; Chen CC, 2004, VISION RES, V44, P915, DOI 10.1016/j.visres.2003.11.017; CHERRY N, 1980, BRIT J IND MED, V37, P234; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Costa T, 2012, PLOS ONE, V7; CULLEN MR, 1995, CLIN CHEM, V41, P1809; Lacerda EMDB, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/784390; Dain SJ, 1998, VISION RES, V38, P3473, DOI 10.1016/S0042-6989(98)00099-6; Dakin SC, 1997, PERCEPTION, V26, P253, DOI 10.1068/p260253; Dick FD, 2006, OCCUP ENVIRON MED, V63, P221, DOI 10.1136/oem.2005.022400; Donoghue AM, 1995, J OCCUP ENVIRON MED, V37, P1357, DOI 10.1097/00043764-199512000-00005; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; ECHEVERRIA D, 1995, J OCCUP ENVIRON MED, V37, P667, DOI 10.1097/00043764-199506000-00008; EDLING C, 1993, BRIT J IND MED, V50, P843; EDWARDS M, 1994, VISION RES, V34, P2849, DOI 10.1016/0042-6989(94)90054-X; Ehrenberg R, 1989, AM J PUBLIC HLTH, V79; Farnsworth D, 1957, FRANSWORTH MUNSELL 1; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRENETTE B, 1991, OPTOMETRY VISION SCI, V68, P556, DOI 10.1097/00006324-199107000-00009; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Gamberale F, 1989, ARBETE HALSA, V6, P1; Glass L, 1969, NATURE, P223; GOBBA F, 1991, J OCCUP ENVIRON MED, V33, P761, DOI 10.1097/00043764-199107000-00006; Hogstedt C, 1984, BIOL MONITORING SURV; HSIA, 1999, PERCHL WHIT PAP; Hyejin Y, 2009, VISION RES, V49, P2095, DOI [10.1016/j.visres.2009.05.017, DOI 10.1016/J.VISRES.2009.05.017]; Ihrig A, 2003, IND HEALTH, V41, P39, DOI 10.2486/indhealth.41.39; Ihrig A, 2001, OCCUP ENVIRON MED, V58, P19, DOI 10.1136/oem.58.1.19; Iregren A, 2002, NEUROTOXICOLOGY, V23, P719, DOI 10.1016/S0161-813X(02)00088-8; Iyaniwura T, 2004, RESPONSE TOXIC CHEM; Jimenez I, 2011, CIENCIA TECHNOLOGIA, V9, P19; Khuu S, 2011, J VISION, V11; Khuu S, 2003, PERCEPTION, V32; Khuu S, 2006, VISION RES; Khuu SK, 2012, J VISION, V12, DOI 10.1167/12.6.19; Khuu SK, 2005, VISION RES, V45, P2461, DOI 10.1016/j.visres.2005.02.019; Khuu SK, 2002, VISION RES, V42, P3031, DOI 10.1016/S0042-6989(02)00384-X; Kinnear PR, 2002, BRIT J OPHTHALMOL, V86, P1408, DOI 10.1136/bjo.86.12.1408; Kulig BM, 1996, ENVIRON HEALTH PERSP, V104, P317, DOI 10.2307/3432651; Legge G, 2007, PSYCHOHYSICS READING; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; Li WO, 2008, VISION RES, V48, P167, DOI 10.1016/j.visres.2007.10.019; Likert R., 1932, ACTA PSYCHOL, V140, P44; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Lundberg I, 1997, OCCUP ENVIRON MED, V54, P343, DOI 10.1136/oem.54.5.343; McGraw PV, 2004, PERCEPTION, V33, P121, DOI 10.1068/p5210; MERGLER D, 1990, NEUROTOXICOL TERATOL, V12, P669, DOI 10.1016/0892-0362(90)90084-P; MERGLER D, 1988, TOXICOLOGY, V49, P341, DOI 10.1016/0300-483X(88)90017-0; MERGLER D, 1987, INT ARCH OCC ENV HEA, V59, P313, DOI 10.1007/BF00405275; MERGLER D, 1991, ARCH ENVIRON HEALTH, V46, P326, DOI 10.1080/00039896.1991.9934398; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muttray A, 1997, INT ARCH OCC ENV HEA, V70, P407, DOI 10.1007/s004200050237; NAKATSUKA H, 1992, INT ARCH OCC ENV HEA, V64, P113, DOI 10.1007/BF00381478; Nasanen R, 2005, ENVIRON TOXICOL PHAR, V19, P497, DOI 10.1016/j.etap.2004.12.013; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Nguyen-Tri D, 2003, INVEST OPHTH VIS SCI, V44, P3698, DOI 10.1167/iovs.02-1191; PALMER J, 1994, VISION RES, V34, P1703, DOI 10.1016/0042-6989(94)90128-7; Paramei GV, 2004, NEUROTOXICOLOGY, V25, P803, DOI 10.1016/j.neuro.2004.01.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pirsaraei SRA, 2009, IND HEALTH, V47, P155, DOI 10.2486/indhealth.47.155; RAITTA C, 1981, J OCCUP ENVIRON MED, V23, P189; RODEZNO RA, 1995, AM J IND MED, V28, P505, DOI 10.1002/ajim.4700280407; Rutchik J, 2009, ORGANIC SOLVENTS; SAITO H, 1986, J NEUROSCI, V6, P145; Schaper M, 2004, TOXICOL LETT, V151, P193, DOI 10.1016/j.toxlet.2004.01.020; Schreiber JS, 2002, ENVIRON HEALTH PERSP, V110, P655, DOI 10.1289/ehp.02110655; SEEBER A, 1989, NEUROTOXICOL TERATOL, V11, P579, DOI 10.1016/0892-0362(89)90041-X; Smith A, 1994, J OPT SOC AM A, V11, P1; Smith MA, 2002, J NEUROSCI, V22, P8334, DOI 10.1523/jneurosci.22-18-08334.2002; Smith MA, 2007, J VISION, V7, DOI 10.1167/7.3.5; Snowden RJ, 1994, VISUAL DETECTION MOT, P51; Soderkvist P, 1996, SCAND J WORK ENV HEA, V5, P360; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Trick LM, 1998, COGNITIVE DEV, V13, P369, DOI 10.1016/S0885-2014(98)90016-8; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; White R, 1997, SOLVENTS NEUROTOXICI, P349; WHO WHO, 1985, CHRON EFF ORG SOLV C; WHO WHO, 1986, 60 WHO ENV HLTH CRIT; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; Wilson HR, 1998, VISION RES, V38, P2933, DOI 10.1016/S0042-6989(98)00109-6; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfreys Julian, 2002, VICTORIAN HAUNTINGS, P1; Xintaras C, 1984, BEHAV TOXICOLOGY, P126; Zahiruddin Kowser, 2010, Korean J Ophthalmol, V24, P159, DOI 10.3341/kjo.2010.24.3.159; Zavalic M, 1998, INT ARCH OCC ENV HEA, V71, P194, DOI 10.1007/s004200050270; ZEKI S, 1983, NEUROSCIENCE, V9, P741, DOI 10.1016/0306-4522(83)90265-8	113	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0121422	10.1371/journal.pone.0121422	http://dx.doi.org/10.1371/journal.pone.0121422			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933026	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100003
J	Kmiecik, AM; Pula, B; Suchanski, J; Olbromski, M; Gomulkiewicz, A; Owczarek, T; Kruczak, A; Ambicka, A; Rys, J; Ugorski, M; Podhorska-Okolow, M; Dziegiel, P				Kmiecik, Alicja M.; Pula, Bartosz; Suchanski, Jaroslaw; Olbromski, Mateusz; Gomulkiewicz, Agnieszka; Owczarek, Tomasz; Kruczak, Anna; Ambicka, Aleksandra; Rys, Janusz; Ugorski, Maciej; Podhorska-Okolow, Marzena; Dziegiel, Piotr			Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression	PLOS ONE			English	Article							ALZHEIMERS-DISEASE BRAIN; GROWTH-INHIBITORY FACTOR; MT EXPRESSION; MESSENGER-RNA; HUMAN KIDNEY; ISOFORM 3; CARCINOMA; PROSTATE; INVASION; PROTEIN	It has been recently found that metallothionein-3 (MT3) enhances the invasiveness and tumorigenesis of prostate cancer cells. This finding is in contrast to those of earlier studies, which indicated that overexpression of MT3 in breast cancer and prostate cancer cell lines inhibits their growth in vitro. Therefore, to clarify the role of MT3 in breast cancer progression, we analyzed the effect of MT3-overexpression on proliferation, invasiveness, migration, and tumorigenesis of breast cancer MDA-MB-231/BO2 cells. It was found that MDA-MB-231/BO2 cells overexpressing MT3 were characterized by increased invasiveness in vitro, compared to the control cells. Interestingly, this increased invasiveness correlated with a highly increased concentration of MMP3 in the culture supernatants (p<0.0001). Our data suggest that MT3 may regulate breast cancer cell invasiveness by modulating the expression of MMP3. These experimental results, obtained using triple-negative MDA-MB-231/BO2 cells, were further supported by clinical data. It was found that, in triple-negative breast cancer (TNBC), nuclear MT3 immunoreactivity in cancer cells tended to be associated with patients' shorter disease-specific survival, suggesting that nuclear MT3 expression may be a potential marker of poor prognosis of triple-negative TNBC cases.	[Kmiecik, Alicja M.; Owczarek, Tomasz; Ugorski, Maciej] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol & Cell Interact, Wroclaw, Poland; [Pula, Bartosz; Olbromski, Mateusz; Gomulkiewicz, Agnieszka; Podhorska-Okolow, Marzena; Dziegiel, Piotr] Med Univ, Dept Histol & Embryol, Wroclaw, Poland; [Suchanski, Jaroslaw; Ugorski, Maciej] Univ Environm & Life Sci, Fac Vet Med, Dept Biochem Pharmacol & Toxicol, Wroclaw, Poland; [Kruczak, Anna; Ambicka, Aleksandra; Rys, Janusz] Maria Sklodowska Curie Mem Canc Ctr, Dept Tumor Pathol, Krakow, Poland; [Kruczak, Anna; Ambicka, Aleksandra; Rys, Janusz] Inst Oncol, Krakow, Poland; [Dziegiel, Piotr] Univ Wroclaw, Sch Phys Educ, Dept Physiotherapy, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw Medical University; Wroclaw University of Environmental & Life Sciences; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Wroclaw	Dziegiel, P (corresponding author), Med Univ, Dept Histol & Embryol, Wroclaw, Poland.	piotr.dziegiel@umed.wroc.pl	Kmiecik, Alicja/AAY-1543-2020; Ugorsku, Maciej/AAJ-1050-2020; Puła, Bartosz/AAO-3209-2020	Kmiecik, Alicja/0000-0002-6498-717X; Puła, Bartosz/0000-0003-0116-5002; Ugorski, Maciej/0000-0003-0299-8372; Suchanski, Jaroslaw/0000-0002-2672-1020; Podhorska-Okolow, Marzenna/0000-0003-2215-5997; Olbromski, Mateusz/0000-0002-1972-1524; Kruczak, Anna/0000-0001-6298-6950; Dziegiel, Piotr/0000-0002-8292-1385; Owczarek, Tomasz/0000-0002-5095-8642; Gomulkiewicz, Agnieszka/0000-0003-2256-1055	Polish Ministry of Science and Higher Education [N N401 048038]; Foundation for Polish Science; START	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); START(Austrian Science Fund (FWF))	This study was supported by a grant from the Polish Ministry of Science and Higher Education, no. N N401 048038. Bartosz Pula is supported by the "START" stipend awarded by the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOUREUX MC, 1995, BIOCHEM BIOPH RES CO, V214, P639, DOI 10.1006/bbrc.1995.2334; Asai M, 1999, JPN J CANCER RES, V90, P86, DOI 10.1111/j.1349-7006.1999.tb00670.x; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Deng DJ, 2003, CARCINOGENESIS, V24, P25, DOI 10.1093/carcin/24.1.25; Dutta R, 2002, PROSTATE, V52, P89, DOI 10.1002/pros.10097; Dziegiel P, 2005, HISTOL HISTOPATHOL, V20, P83, DOI 10.14670/HH-20.83; Dziegiel Piotr, 2004, Polish Journal of Pathology, V55, P3; ELSTON CW, 1987, DIAGNOSTIC HISTOPATH, P300; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Garrett SH, 1999, TOXICOL LETT, V105, P207, DOI 10.1016/S0378-4274(99)00003-X; Garrett SH, 1999, PROSTATE, V41, P196, DOI 10.1002/(SICI)1097-0045(19991101)41:3<196::AID-PROS7>3.0.CO;2-U; Gobel H, 2000, VIRCHOWS ARCH, V437, P528, DOI 10.1007/s004280000260; Gurel V, 2003, BREAST CANCER RES TR, V80, P181, DOI 10.1023/A:1024520801262; Hoey JG, 1997, TOXICOL LETT, V92, P149, DOI 10.1016/S0378-4274(97)00049-0; Juang HH, 2013, PROSTATE, V73, P1495, DOI 10.1002/pros.22697; Kim HG, 2011, FEBS LETT, V585, P421, DOI 10.1016/j.febslet.2010.12.030; Kobierzycki C, 2012, ANTICANCER RES, V32, P773; Krizkova S, 2012, DRUG METAB REV, V44, P287, DOI 10.3109/03602532.2012.725414; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Nielsen AE, 2006, BIOMARK INSIGHTS, V1, P99; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P29, DOI 10.1016/j.proghi.2008.10.001; Peng D, 2011, PLOS ONE, DOI 10.1371/journal.pone.0022009; Person RJ, 2013, TOXICOL APPL PHARM, V273, P281, DOI 10.1016/j.taap.2013.06.013; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; Pula B, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-26; Ryu HH, 2012, INT J ONCOL, V41, P1305, DOI 10.3892/ijo.2012.1570; Sens MA, 2001, AM J PATHOL, V159, P21, DOI 10.1016/S0002-9440(10)61668-9; Sens MA, 2000, ENVIRON HEALTH PERSP, V108, P413; Smith E, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-42; Somji Seema, 2010, Toxicol Environ Chem, V92, P1673; Surowiak P, 2005, HISTOL HISTOPATHOL, V20, P1037, DOI 10.14670/HH-20.1037; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; TSUJI S, 1992, EMBO J, V11, P4843, DOI 10.1002/j.1460-2075.1992.tb05590.x; UCHIDA Y, 1989, BRAIN RES, V481, P190, DOI 10.1016/0006-8993(89)90503-9; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Werynska B, 2013, ANTICANCER RES, V33, P965; Wojnar A, 2011, ANTICANCER RES, V31, P3027; Zitka O, 2011, ELECTROPHORESIS, V32, P857, DOI 10.1002/elps.201000526	38	24	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124865	10.1371/journal.pone.0124865	http://dx.doi.org/10.1371/journal.pone.0124865			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933064	Green Submitted, gold, Green Published			2022-12-26	WOS:000353887100060
J	Li, ML; Deng, QY; Jin, XA				Li, Meilian; Deng, Qingying; Jin, Xian'an			A General Method for Computing the Homfly Polynomial of DNA Double Crossover 3-Regular Links	PLOS ONE			English	Article							POLYHEDRAL LINKS; KNOTS; INVARIANT; GRAPHS	In the last 20 years or so, chemists and molecular biologists have synthesized some novel DNA polyhedra. Polyhedral links were introduced to model DNA polyhedra and study topological properties of DNA polyhedra. As a very powerful invariant of oriented links, the Homfly polynomial of some of such polyhedral links with small number of crossings has been obtained. However, it is a challenge to compute Homfly polynomials of polyhedral links with large number of crossings such as double crossover 3-regular links considered here. In this paper, a general method is given for computing the chain polynomial of the truncated cubic graph with two different labels from the chain polynomial of the original labeled cubic graph by substitutions. As a result, we can obtain the Homfly polynomial of the double crossover 3-regular link which has relatively large number of crossings.	[Li, Meilian; Deng, Qingying; Jin, Xian'an] Xiamen Univ, Sch Math Sci, Xiamen, Fujian, Peoples R China; [Li, Meilian] Longyan Univ, Sch Math & Comp Sci, Longyan, Fujian, Peoples R China	Xiamen University; Longyan University	Jin, XA (corresponding author), Xiamen Univ, Sch Math Sci, Xiamen, Fujian, Peoples R China.	xajin@xmu.edu.cn			National Natural Science Foundation of China [J 11271307]; Natural Science Foundation of Fujian Province of China [J 2012J01019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by J 11271307 National Natural Science Foundation of China and J 2012J01019 Natural Science Foundation of Fujian Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C., 2004, KNOT BOOK; Alexander JW, 1928, T AM MATH SOC, V30, P275, DOI 10.2307/1989123; [Anonymous], KOBE J MATH; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Cheng XS, 2014, J MATH CHEM, V52, P23, DOI 10.1007/s10910-013-0241-9; Cheng XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048968; Cheng XS, 2012, J MATH CHEM, V50, P1386, DOI 10.1007/s10910-012-9976-y; Cheng XS, 2009, MATCH-COMMUN MATH CO, V62, P115; Cheng XS, 2010, MATCH COMMUN MATH CO, V63, P115; Comoglio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018693; Conway J., 1970, COMPUTATIONAL PROBLE, P329; Cromwell P., 2004, KNOTS LINKS; Duan JW, 2014, MATCH-COMMUN MATH CO, V72, P475; Erben CM, 2007, J AM CHEM SOC, V129, P6992, DOI 10.1021/ja071493b; FRANKS J, 1987, T AM MATH SOC, V303, P97, DOI 10.2307/2000780; FREYD P, 1985, B AM MATH SOC, V12, P239, DOI 10.1090/S0273-0979-1985-15361-3; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Goodman RP, 2004, CHEM COMMUN, P1372, DOI 10.1039/b402293a; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; He Y, 2010, ANGEW CHEM INT EDIT, V49, P748, DOI 10.1002/anie.200904513; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Hosokawa F., 1958, OSAKA MATH J, V10, P273; HOSTE J, 1985, P AM MATH SOC, V95, P299, DOI 10.2307/2044531; Hu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026308; Jin XA, 2012, P AM MATH SOC, V140, P1459, DOI 10.1090/S0002-9939-2011-11050-5; Jin XA, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/07/P07011; Jin XA, 2011, MATCH-COMMUN MATH CO, V65, P501; Jin XA, 2010, ELECTRON J COMB, V17; Jin XA, 2010, MATCH-COMMUN MATH CO, V63, P657; JONES VFR, 1985, B AM MATH SOC, V12, P103, DOI 10.1090/S0273-0979-1985-15304-2; Kuzuya A, 2010, NANOSCALE, V2, P310, DOI 10.1039/b9nr00246d; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; MORTON HR, 1986, MATH PROC CAMBRIDGE, V99, P107, DOI 10.1017/S0305004100063982; Murasugi K., 1996, KNOT THEORY ITS APPL; OHYAMA Y, 1993, CAN J MATH, V45, P117, DOI 10.4153/CJM-1993-007-x; Read RC, 2003, DISCRETE MATH, V265, P213, DOI 10.1016/S0012-365X(02)00581-2; Read RC, 1999, DISCRETE MATH, V204, P337, DOI 10.1016/S0012-365X(98)00378-1; Shahmohamad H, 2002, UTILITAS MATHEMATICA, V62, P13; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sun XB, 2014, MATCH-COMMUN MATH CO, V72, P489; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; Zhang C, 2009, J AM CHEM SOC, V131, P1413, DOI 10.1021/ja809666h; Zhang HP, 2015, MATCH-COMMUN MATH CO, V73, P473; Zhang HP, 2015, MATCH-COMMUN MATH CO, V73, P457; Zimmermann J, 2008, ANGEW CHEM INT EDIT, V47, P3626, DOI 10.1002/anie.200702682	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125184	10.1371/journal.pone.0125184	http://dx.doi.org/10.1371/journal.pone.0125184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932998	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100087
J	Shui, RH; Yu, BH; Bi, R; Yang, F; Yang, WT				Shui, Ruohong; Yu, Baohua; Bi, Rui; Yang, Fei; Yang, Wentao			An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer	PLOS ONE			English	Article							LABELING INDEX; INTERNATIONAL KI67; PROLIFERATION; KI-67; METAANALYSIS; PROGNOSIS; ACCURACY; MARKER	Background Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast cancer. However, standardised methodologies for measurement are lacking which has limited its application in clinical practice. In this study, we evaluated the interobserver concordance of visual assessment of Ki67 LI in breast cancer. Methods Ki67-immunostained slides of 160 cases of primary invasive breast cancer were visual assessed by five breast pathologists with two different methods to choose the scoring fields: (1) hot-spot score, (2) average score. Proportions of positive invasive tumor cells at 10 % intervals were scored. The intra-class correlation coefficient (ICC) was used to assess the interobserver reproducibility. Results (1) A perfect concordance of Ki67 LI was demonstrated according to both score methods (P<0.0001). Average score method (ICC, 0.904) demonstrated a better correlation than hotspot score method (ICC, 0.894). (2) By respective means according to two score methods, all cases were classified into three groups (<= 10%, 11%-30% and >30% Ki-67 LI). The concordance was relatively low in intermediate Ki67 LI group compared with low and high Ki67 LI groups. (3) All cases were classified into three groups by paired-difference (d) between means of hot-spot score and average score (d<5, 5 <= d<10, d >= 10). The consistency was observed to decrease with increasing paired-difference according to both methods. Conclusions Visual assessment of Ki67 LI at 10% intervals is a candidate for a standard method in breast cancer clinical practice. Average score and hot-spot score of visual assessment both demonstrated a perfect concordance, and an overall average assessment across the whole section including hot spots may be a better method. Interobserver concordance of intermediate Ki67 LI in which most cutoffs are located for making clinical decisions was relatively low.	[Shui, Ruohong; Yu, Baohua; Bi, Rui; Yang, Fei; Yang, Wentao] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China; [Shui, Ruohong; Yu, Baohua; Bi, Rui; Yang, Fei; Yang, Wentao] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Yang, WT (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China.	yangwt2000@163.com			Priority of Shanghai Key Discipline of Medicine [ZZZZ1302-3]	Priority of Shanghai Key Discipline of Medicine	This work was supported by Priority of Shanghai Key Discipline of Medicine (ZZZZ1302-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Cserni G, 2014, BREAST, V23, P259, DOI 10.1016/j.breast.2014.02.003; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Hida AI, 2015, BREAST CANCER-TOKYO, V22, P129, DOI 10.1007/s12282-013-0460-8; Jonat W, 2011, ANN ONCOL, V22, P500, DOI 10.1093/annonc/mdq732; Laurinavicius A, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3639; Mikami Y, 2013, CANCER SCI, V104, P1539, DOI 10.1111/cas.12245; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; Ohno S, 2013, BREAST CANCER RES TR, V142, P69, DOI 10.1007/s10549-013-2691-y; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Voros A, 2013, PATHOBIOLOGY, V80, P111, DOI 10.1159/000343795; von Minckwitz G, 2013, CLIN CANCER RES, V19, P4521, DOI 10.1158/1078-0432.CCR-12-3628; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	20	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125131	10.1371/journal.pone.0125131	http://dx.doi.org/10.1371/journal.pone.0125131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932921	gold, Green Published			2022-12-26	WOS:000353887100079
J	Tung, HC; Lee, FY; Wang, SS; Tsai, MH; Lee, JY; Huo, TI; Huang, HC; Chuang, CL; Lin, HC; Lee, SD				Tung, Hung-Chun; Lee, Fa-Yauh; Wang, Sun-Sang; Tsai, Ming-Hung; Lee, Jing-Yi; Huo, Teh-Ia; Huang, Hui-Chun; Chuang, Chiao-Lin; Lin, Han-Chieh; Lee, Shou-Dong			The Beneficial Effects of P2X(7) Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis	PLOS ONE			English	Article							PORTAL HYPERTENSIVE-RATS; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR-BETA; EXTRACELLULAR ATP; INTERLEUKIN-1-BETA RELEASE; INCREASED ANGIOGENESIS; PURINERGIC MODULATION; ENDOTHELIAL-CELLS; LIVER FIBROSIS	Splanchnic angiogenesis in liver cirrhosis often leads to complications as gastroesophageal variceal hemorrhage and the treatment efficacy is adversely affected by poor portal-systemic collateral vasoresponsiveness related to nitric oxide (NO). Purinergic receptor subtype P2X(7) participates in the modulation of inflammation, angiogenesis, fibrogenesis and vasoresponsiveness, but the relevant influence in cirrhosis is unknown. Common bile duct-ligated (CBDL) or sham-operated Spraque-Dawley rats received brilliant blue G (BBG, a P2X(7) antagonist and food additive) or vehicle from the 15th to 28th day after operations, then hemodynamics, mesenteric angiogenesis, portal-systemic shunting, liver fibrosis, and protein expressions of angiogenic and fibrogenic factors were evaluated. The influence of oxidized ATP (oATP, another P2X(7) receptor antagonist) on the collateral vasoresponsiveness to arginine vasopressin (AVP) was also surveyed. BBG decreased superior mesenteric artery (SMA) flow, portal-systemic shunting, mesenteric vascular density, and mesenteric protein expressions of vascular endothelial growth factor (VEGF), VEGF receptor 2 (VEGFR2), phospho (p)-VEGFR2, platelet-derived growth factor (PDGF), PDGF receptor beta (PDGFR beta), cyclooxygenase (COX)-1, COX-2, and endothelial NO synthase (eNOS) in CBDL rats. BBG also ameliorated liver fibrosis and down-regulated hepatic interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), PDGF, IL-1 beta, transforming growth factor-beta (TGF-beta), p-extracellular-signal-regulated kinases (ERK), and alpha-smooth muscle actin (alpha-SMA) expressions in CBDL rats. The collateral vasocontractility to AVP was enhanced by oATP. oATP down-regulated eNOS, inducible NOS (iNOS), VEGF, Akt, p-Akt, and nuclear factor-kappa B (NF-kappa B) expressions in splenorenal shunt, the most prominent intra-abdominal collateral vessel in rodents. P2X(7) antagonism alleviates splanchnic hyperemia, severity of portal-systemic shunting, mesenteric angiogenesis, liver fibrosis, and enhances portal-systemic collateral vasoresponsiveness in cirrhotic rats. P2X(7) blockade may be a feasible strategy to control cirrhosis and complications.	[Tung, Hung-Chun; Lee, Jing-Yi; Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lee, Fa-Yauh; Wang, Sun-Sang; Huang, Hui-Chun; Chuang, Chiao-Lin; Lin, Han-Chieh; Lee, Shou-Dong] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Lee, Fa-Yauh; Lee, Jing-Yi; Huo, Teh-Ia; Huang, Hui-Chun; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Chuang, Chiao-Lin] Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan; [Wang, Sun-Sang] Taipei Vet Gen Hosp, Dept Med Affair & Planning, Taipei, Taiwan; [Tsai, Ming-Hung] Chang Gung Mem Hosp, Div Digest Therapeut Endoscopy, Taipei 10591, Taiwan; [Tsai, Ming-Hung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Cheng Hsin General Hospital	Huang, HC (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan.	hchuang2@vghtpe.gov.tw			Ministry of Science and Technology, Taipei, Taiwan [99-2314-B-075-021-MY3]	Ministry of Science and Technology, Taipei, Taiwan	This work was supported by the Ministry of Science and Technology, Taipei, Taiwan (grant number 99-2314-B-075-021-MY3).	Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Balboa MA, 1999, J BIOL CHEM, V274, P36764, DOI 10.1074/jbc.274.51.36764; BISSELL DM, 1995, J CLIN INVEST, V96, P447, DOI 10.1172/JCI118055; BORZELLECA JF, 1990, FOOD CHEM TOXICOL, V28, P221, DOI 10.1016/0278-6915(90)90034-K; Bosch J, 2008, J HEPATOL, V48, pS68, DOI 10.1016/j.jhep.2008.01.021; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; CAMERON GR, 1958, J PATHOL BACTERIOL, V75, P333, DOI 10.1002/path.1700750212; Chan CC, 1999, HEPATOLOGY, V30, P630, DOI 10.1002/hep.510300317; Chiao CW, 2008, J PHARMACOL EXP THER, V326, P864, DOI 10.1124/jpet.107.135350; Chiao CW, 2013, CLIN SCI, V125, P131, DOI 10.1042/CS20120479; CHOJKIER M, 1981, AM J PHYSIOL, V240, pG371, DOI 10.1152/ajpgi.1981.240.5.G371; Chuang CL, 2015, J GASTROEN HEPATOL, V30, P199, DOI 10.1111/jgh.12670; COLOMBATO LA, 1991, AM J PHYSIOL, V260, pG1, DOI 10.1152/ajpgi.1991.260.1.G1; Cooke CLM, 2002, AM J PHYSIOL-CELL PH, V282, pC395, DOI 10.1152/ajpcell.00295.2001; Dong A, 2014, ANGIOGENESIS, V17, P553, DOI 10.1007/s10456-013-9402-5; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; Fernandez M, 2005, J HEPATOL, V43, P98, DOI 10.1016/j.jhep.2005.02.022; Fernandez M, 2004, GASTROENTEROLOGY, V126, P886, DOI 10.1053/j.gastro.2003.12.012; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Franco F, 1979, ARCH SURG-CHICAGO, V114, P1064; Garcia-Pagan JC, 2012, J HEPATOL, V57, P458, DOI 10.1016/j.jhep.2012.03.007; Geerts AM, 2006, LIVER INT, V26, P889, DOI 10.1111/j.1478-3231.2006.01308.x; Goncalves RG, 2006, KIDNEY INT, V70, P1599, DOI 10.1038/sj.ki.5001804; Gupta RA, 2003, CANCER RES, V63, P906; HAMILTON RL, 1974, J LIPID RES, V15, P182; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Hu Y, 1998, J BIOL CHEM, V273, P27170, DOI 10.1074/jbc.273.42.27170; Huang CS, 2014, MOL MED REP, V9, P57, DOI 10.3892/mmr.2013.1807; Huang HC, 2000, SCAND J GASTROENTERO, V35, P1308; Huang HC, 2012, HEPATOLOGY, V56, P248, DOI 10.1002/hep.25625; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Laleman W, 2005, LIVER INT, V25, P1079, DOI 10.1111/j.1478-3231.2005.01163.x; Lee FY, 1997, J HEPATOL, V26, P687, DOI 10.1016/S0168-8278(97)80436-9; Martins JP, 2012, BRIT J PHARMACOL, V165, P183, DOI 10.1111/j.1476-5381.2011.01535.x; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Moncao-Ribeiro LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110185; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Seki S, 2012, PHARM ANAL ACTA, V3, P9; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Shun CT, 2003, HEPATO-GASTROENTEROL, V50, P988; Solini A, 2005, KIDNEY INT, V67, P875, DOI 10.1111/j.1523-1755.2005.00152.x; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sumanovski LT, 1999, HEPATOLOGY, V29, P1044, DOI 10.1002/hep.510290436; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Suzuki S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-224; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; Tamodiunas AE, 2003, SEMIN CARDIOL, V9, P53; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Vidal O, 2008, J GASTROINTEST SURG, V12, P1005, DOI 10.1007/s11605-007-0336-3; Wang CM, 2003, CELL SIGNAL, V15, P1129, DOI 10.1016/S0898-6568(03)00112-8	55	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124654	10.1371/journal.pone.0124654	http://dx.doi.org/10.1371/journal.pone.0124654			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933224	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100055
J	Park, JH; Chae, J; Roh, K; Kil, EJ; Lee, M; Auh, CK; Lee, MA; Yeom, CH; Lee, S				Park, Jin-Hee; Chae, Jisook; Roh, Kangsan; Kil, Eui-Joon; Lee, Minji; Auh, Chung-Kyun; Lee, Myung-Ah; Yeom, Chang-Hwan; Lee, Sukchan			Oxaliplatin-Induced Peripheral Neuropathy via TRPA1 Stimulation in Mice Dorsal Root Ganglion Is Correlated with Aluminum Accumulation	PLOS ONE			English	Article							NERVOUS-SYSTEM; CHANNELS; NEURONS; COLD; CHEMOTHERAPY; CANCER; PAIN; RAT; ADENOCARCINOMA; ENCEPHALOPATHY	Oxaliplatin is a platinum-based anticancer drug used to treat metastatic colorectal, breast, and lung cancers. While oxaliplatin kills cancer cells effectively, it exhibits several side effects of varying severity. Neuropathic pain is commonly experienced during treatment with oxaliplatin. Patients describe symptoms of paresthesias or dysesthesias that are triggered by cold (acute neuropathy), or as abnormal sensory or motor function (chronic neuropathy). In particular, we found that aluminum levels were relatively high in some cancer patients suffering from neuropathic pain based on clinical observations. Based on these findings, we hypothesized that aluminum accumulation in the dorsal root ganglion (DRG) in the course of oxaliplatin treatment exacerbates neuropathic pain. In mice injected with oxaliplatin (three cycles of 3 mg/kg i.p. daily for 5 days, followed by 5 days of rest), we detected cold allodynia using the acetone test, but not heat hyperalgesia using a hot plate. However, co-treatment with aluminum chloride (AlCl(3 center dot)6H(2)O; 7 mg/kg i.p. for 14 days: equivalent 0.78 mg/kg of elemental Al) and oxaliplatin (1 cycle of 3 mg/kg i.p. daily for 5 days, followed by 5 days of rest) synergistically induced cold allodynia as well as increased TRPAl mRNA and protein expression. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) analysis showed a significant increase in aluminum concentrations in the DRG of mice treated with aluminum chloride and oxaliplatin compared to aluminum chloride alone. Similarly, in a mouse induced-tumor model, aluminum concentrations were increased in DRG tissue and tumor cells after oxaliplatin treatment. Taken together, these findings suggest that aluminum accumulation in the DRG may exacerbate neuropathic pain in oxaliplatin-treated mice.	[Park, Jin-Hee] Catholic Univ Korea, Coll Med, Inst Canc Res, Seoul, South Korea; [Chae, Jisook; Roh, Kangsan; Kil, Eui-Joon; Lee, Minji; Lee, Sukchan] Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea; [Kil, Eui-Joon] Sungkyunkwan Univ, Inst Life Sci & Technol, Suwon, South Korea; [Auh, Chung-Kyun] Mokpo Natl Univ, Dept Biol Sci, Muan, South Korea; [Lee, Myung-Ah] Catholica Univ Korea, Seoul St Marys Hosp, Dept Med Oncol, Seoul, South Korea; [Yeom, Chang-Hwan] Yeoms Family Med Clin, Seoul, South Korea	Catholic University of Korea; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Mokpo National University; Catholic University of Korea; Seoul St. Mary's Hospital	Yeom, CH (corresponding author), Yeoms Family Med Clin, Seoul, South Korea.	lymphych@hanmail.net; cell4u@skku.edu	Kil, Eui-Joon/AAZ-9823-2020		Korean Association for Vitamin Research; National Research Foundation of Korea [2013R1A2A2A04014661]	Korean Association for Vitamin Research; National Research Foundation of Korea(National Research Foundation of Korea)	This work is supported by grants from the Korean Association for Vitamin Research and the National Research Foundation of Korea (2013R1A2A2A04014661, CKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram SE, 2006, ANESTHESIOLOGY, V105, P146, DOI 10.1097/00000542-200607000-00024; ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402; Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Anand U, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-82; Argyriou AA, 2007, ACTA ONCOL, V46, P1131, DOI 10.1080/02841860701355055; Bardin L, 2009, BEHAV BRAIN RES, V205, P360, DOI 10.1016/j.bbr.2009.07.005; Becaria A, 2002, TOXICOL IND HEALTH, V18, P309, DOI 10.1191/0748233702th157oa; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bondy SC, 2010, NEUROTOXICOLOGY, V31, P575, DOI 10.1016/j.neuro.2010.05.009; Caspani O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007383; Cassidy J, 2002, SEMIN ONCOL; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Farah Ibrahim O, 2010, Biomed Sci Instrum, V46, P404; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Galaris D, 2002, CRIT REV ONCOL HEMAT, V42, P93, DOI 10.1016/S1040-8428(01)00212-8; Gauchan P, 2009, NEUROSCI LETT, V458, P93, DOI 10.1016/j.neulet.2009.04.029; Gu CW, 2009, NEUROCHEM RES, V34, P1150, DOI 10.1007/s11064-008-9891-6; Guindon J, 2013, PHARMACOL RES, V67, P94, DOI 10.1016/j.phrs.2012.10.013; Gunn A, 2011, J PAIN, V12, P222, DOI 10.1016/j.jpain.2010.06.011; Guo CH, 2009, ENVIRON TOXICOL PHAR, V27, P176, DOI 10.1016/j.etap.2008.10.001; Holzer P, 2011, CURR PHARM BIOTECHNO, V12, P24, DOI 10.2174/138920111793937862; Kawahara M, 2001, BRAIN RES BULL, V55, P211, DOI 10.1016/S0361-9230(01)00475-0; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kumar V, 2009, ARCH TOXICOL, V83, P965, DOI 10.1007/s00204-009-0455-6; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Labat-Moleur F, 1998, J HISTOCHEM CYTOCHEM, V46, P327, DOI 10.1177/002215549804600306; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; Lorgis V, 2012, ANTICANCER RES, V32, P4125; Mailloux RJ, 2011, EXP CELL RES, V317, P2231, DOI 10.1016/j.yexcr.2011.07.009; Mantyh PW, 2006, NAT REV NEUROSCI, V7, P797, DOI 10.1038/nrn1914; Materazzi S, 2012, PFLUG ARCH EUR J PHY, V463, P561, DOI 10.1007/s00424-011-1071-x; McKeage MJ, 2001, BRIT J CANCER, V85, P1219, DOI 10.1054/bjoc.2001.2024; Morgan M, 2008, TRANSL ONCOL, V1, P44, DOI 10.1593/tlo.07118; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Nayak P, 2002, ENVIRON RES, V89, P101, DOI 10.1006/enrs.2002.4352; Peto MV, 2010, REJUV RES, V13, P589, DOI 10.1089/rej.2009.0995; PLATTS MM, 1977, BRIT MED J, V2, P657, DOI 10.1136/bmj.2.6088.657; Raymond E, 1998, ANN ONCOL, V9, P1053, DOI 10.1023/A:1008213732429; Renn CL, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-29; Saijilafu, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1568; Sakurai M, 2009, PAIN, V147, P165, DOI 10.1016/j.pain.2009.09.003; Sapunar Damir, 2012, J Pain Res, V5, P31, DOI 10.2147/JPR.S26603; Sato S, 2009, CANCER SCI, V100, P546, DOI 10.1111/j.1349-7006.2008.01065.x; Shati AA, 2011, NEUROSCIENCE, V175, P66, DOI 10.1016/j.neuroscience.2010.11.043; Sorich Joan, 2004, Clin J Oncol Nurs, V8, P251, DOI 10.1188/04.CJON.251-256; Staaf S, 2009, PAIN, V144, P187, DOI 10.1016/j.pain.2009.04.013; Stein A, 2012, EXPERT OPIN PHARMACO, V13, P125, DOI 10.1517/14656566.2012.643870; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Ta LE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-9; United States Department of Health and Human Services, 1999, TOX PROF AL; Vasudevaraju BP, 2008, INDIAN J MED RES, V128, P545; Wang BA, 2010, ENVIRON TOXICOL PHAR, V29, P308, DOI 10.1016/j.etap.2010.03.007; WANG MK, 1983, CLAY CLAY MINER, V31, P65, DOI 10.1346/CCMN.1983.0310111; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yokel RA, 2002, COORDIN CHEM REV, V228, P97, DOI 10.1016/S0010-8545(02)00078-4; Zhang ZW, 1997, SCI TOTAL ENVIRON, V205, P179, DOI 10.1016/S0048-9697(97)00197-6; Zhao M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-55	60	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124875	10.1371/journal.pone.0124875	http://dx.doi.org/10.1371/journal.pone.0124875			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928068	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100050
J	Xiao, WW; Liu, S; Tian, YM; Guan, Y; Huang, SM; Lin, CG; Zhao, C; Lu, TX; Han, F				Xiao, WeiWei; Liu, Shuai; Tian, YunMing; Guan, Ying; Huang, ShaoMin; Lin, ChengGuang; Zhao, Chong; Lu, TaiXiang; Han, Fei			Prognostic Significance of Tumor Volume in Locally Recurrent Nasopharyngeal Carcinoma Treated with Salvage Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							T-STAGE; SURVIVAL	Introduction To evaluate the prognostic value of gross tumor volume (TV) in patients with locally recurrent, nonmetastatic nasopharyngeal carcinoma. Methods Between 2001 and 2012, 291 consecutive patients with locally recurrent, nonmetastatic nasopharyngeal carcinoma underwent salvage IMRT were retrospectively reviewed. The correlations between TV and recurrent T classification were analyzed. Survival analyses were performed. Receiver operating characteristic (ROC) curves were calculated to identify cutoff point of TV. The Akaike information criterion and Harrell's concordance index (c-index) were utilized to test the prognostic value. Results The median TV significantly increased with advancing recurrent T classification (P<0.001). The 5-year overall survival rate was 33.2% for the entire cohort. On multivariate analysis, TV was an independent negative prognostic factor for distant metastasis-free survival (hazard ratio = 1.013, P = 0.003), overall survival (hazard ratio = 1.015, P<0.001) and toxicityrelated death (hazard ratio = 1.014, P<0.001). The 5-year overall survival rates were 63.1% and 20.8% for patients with a TV < 22 cm(3) and TV >= 22 cm(3), respectively (P < 0.001). In patient with TV < 22 cm(3), locoregional failure is the leading cause of death. In patients with TV >= 22 cm(3), distant metastasis rate is higher and occurred within short term after local recurrence; meanwhile, radiation-induced injuries became more common and led to half of deaths in this group. The Akaike information criterion and c-index analyses indicated that the predictive ability of recurrent T classification improved when combined with TV. Conclusions Our data suggests TV is a significant prognostic factor for predicting the distant metastasis, overall survival and toxicity-related death of patients with locally recurrent, nonmetastatic nasopharyngeal carcinoma after salvage IMRT. TV should be considered when designing personalized salvage treatments for these patients. For patients with bulky local recurrent tumor, radiation may need to be de-emphasized in favor of systemic treatment or best supportive care.	[Xiao, WeiWei; Liu, Shuai; Guan, Ying; Huang, ShaoMin; Lin, ChengGuang; Zhao, Chong; Lu, TaiXiang; Han, Fei] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiotherapy,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Tian, YunMing] Hui Zhou Municipal Cent Hosp, Dept Radiat Oncol, Huizhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Han, F (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiotherapy,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	hanfei@sysucc.org.cn	Han, Fei/AAD-7348-2021	Han, Fei/0000-0002-1598-9048; Xiao, WeiWei/0000-0002-9922-640X	Science and Technology Planning Project of Guangdong Province, China [2012B061700089]; Sun Yat-sen University, China [12ykpy57]	Science and Technology Planning Project of Guangdong Province, China; Sun Yat-sen University, China	This work was supported by Grant: Science and Technology Planning Project of Guangdong Province, China (No. 2012B061700089) and Young scientists fund of Sun Yat-sen University, China (No 12ykpy57). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Chang CC, 2003, J OTOLARYNGOL, V32, P87, DOI 10.2310/7070.2003.37253; Chen CB, 2011, JPN J CLIN ONCOL, V41, P537, DOI 10.1093/jjco/hyq242; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073918; Chen MK, 2004, CANCER-AM CANCER SOC, V100, P2160, DOI 10.1002/cncr.20210; Chua DTT, 2006, INT J RADIAT ONCOL, V66, P1415, DOI 10.1016/j.ijrobp.2006.07.1364; De Jaeger K, 1998, INT J RADIAT ONCOL, V42, P717, DOI 10.1016/S0360-3016(98)00323-X; Edge SB, 2009, AJCC CANC STAGING MA, V7; Evans SM, 2003, CANCER LETT, V195, P1, DOI 10.1016/S0304-3835(03)00012-0; Guo R, 2012, RADIOTHER ONCOL, V104, P294, DOI 10.1016/j.radonc.2012.09.001; Han F, 2012, CLIN ONCOL-UK, V24, P569, DOI 10.1016/j.clon.2011.11.010; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hua YJ, 2012, EUR J CANCER, V48, P3422, DOI 10.1016/j.ejca.2012.06.016; Lee CC, 2008, ACTA OTO-LARYNGOL, V128, P93, DOI 10.1080/00016480701361921; Sarisahin M, 2011, AURIS NASUS LARYNX, V38, P250, DOI 10.1016/j.anl.2010.09.002; Suarez C, 2010, EUR ARCH OTO-RHINO-L, V267, P1811, DOI 10.1007/s00405-010-1385-x; Sze WM, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.10.027; Tian YM, 2014, BRIT J CANCER, V110, P297, DOI 10.1038/bjc.2013.715; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wu Z, 2013, HEAD NECK-J SCI SPEC, V35, P689, DOI 10.1002/hed.23010; Yu KJ, 2011, CLIN CANCER RES, V17, P1906, DOI 10.1158/1078-0432.CCR-10-1681; ZWEIG MH, 1993, CLIN CHEM, V39, P561	22	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125351	10.1371/journal.pone.0125351	http://dx.doi.org/10.1371/journal.pone.0125351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927527	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100084
J	Marzola, E; Desedime, N; Giovannone, C; Amianto, F; Fassino, S; Abbate-Daga, G				Marzola, Enrica; Desedime, Nadia; Giovannone, Cristina; Amianto, Federico; Fassino, Secondo; Abbate-Daga, Giovanni			Atypical Antipsychotics as Augmentation Therapy in Anorexia Nervosa	PLOS ONE			English	Article							COMPULSIVE PERSONALITY-TRAITS; PSYCHIATRY WFSBP GUIDELINES; EATING-DISORDERS; DOUBLE-BLIND; OPEN-LABEL; WORLD FEDERATION; ANXIETY; INDIVIDUALS; FLUOXETINE; OLANZAPINE	Anorexia nervosa (AN) is a life-threatening and difficult to treat mental illness with the highest mortality rates of any psychiatric disorder. We aimed to garner preliminary data on the real-world use of olanzapine and aripiprazole as augmentation agents of Selective Serotonin Reuptake Inhibitors (SSRIs) in adult inpatients affected by AN. We retrospectively evaluated the clinical charts of patients who were hospitalized between 2012 and 2014. Patients were evaluated upon admission and discharge. We investigated eating symptomatology, and both general and eating psychopathology using: Hamilton Rating Scale for Anxiety, Hamilton Rating Scale for Depression, and Yale-Brown-Cornell Eating Disorders Scale. The charts of 75 patients were included in this study. The sample resulted equally distributed among those receiving SSRIs and either aripiprazole or olanzapine in addition to SSRIs. Notwithstanding a few baseline clinical differences, upon discharge all groups were significantly improved on all measures. Interestingly, aripiprazole showed the greatest effectiveness in reducing eating-related preoccupations and rituals with a large effect size. The body of evidence on medication management in AN is in dismal condition. Augmentation therapy is a well-established approach to a variety of mental disorders and it is often used in every-day clinical practice with patients affected by AN as well. Nevertheless, to date very little data is available on this topic. Results from our sample yielded promising results on the effectiveness of aripiprazole augmentation in reducing eating-related obsessions and compulsions. Randomized controlled trials are warranted to confirm these encouraging findings.	[Marzola, Enrica; Desedime, Nadia; Giovannone, Cristina; Amianto, Federico; Fassino, Secondo; Abbate-Daga, Giovanni] Univ Turin, Dept Neurosci, Eating Disorders Ctr Treatment & Res, Turin, Italy	University of Turin	Abbate-Daga, G (corresponding author), Univ Turin, Dept Neurosci, Eating Disorders Ctr Treatment & Res, Turin, Italy.	giovanni.abbatedaga@unito.it	Abbate Daga, Giovanni/AAE-3155-2022; Marzola, Enrica/I-5984-2012	Marzola, Enrica/0000-0003-1328-9678; Abbate-Daga, Giovanni/0000-0002-5826-5664				Abbate-Daga G, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-294; Abdel-Ahad P, 2013, CURR CLIN PHARMACOL; Aigner M, 2011, WORLD J BIOL PSYCHIA, V12, P400, DOI 10.3109/15622975.2011.602720; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; Bailer UF, 2007, BIOL PSYCHIAT, V61, P1090, DOI 10.1016/j.biopsych.2006.07.018; Bailer UF, 2012, INT J EAT DISORDER, V45, P263, DOI 10.1002/eat.20937; Barbarich NC, 2004, J CLIN PSYCHIAT, V65, P1480, DOI 10.4088/JCP.v65n1106; Bauer M, 2013, WORLD J BIOL PSYCHIA, V14, P334, DOI 10.3109/15622975.2013.804195; Bissada H, 2008, AM J PSYCHIAT, V165, P1281, DOI 10.1176/appi.ajp.2008.07121900; Blinder BJ, 2006, PSYCHOSOM MED, V68, P454, DOI 10.1097/01.psy.0000221254.77675.f5; Bosanac P, 2007, HUM PSYCHOPHARM CLIN, V22, P223, DOI 10.1002/hup.845; Brambilla F, 2007, INT CLIN PSYCHOPHARM, V22, P197, DOI 10.1097/YIC.0b013e328080ca31; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Court A, 2010, J PSYCHIATR RES, V44, P1027, DOI 10.1016/j.jpsychires.2010.03.011; Crane AM, 2007, INT J EAT DISORDER, V40, P581, DOI 10.1002/eat.20419; Daga GA, 2011, PSYCHOTHER PSYCHOSOM, V80, P319, DOI 10.1159/000324761; Dold M, 2015, PSYCHOTHER PSYCHOSOM, V84, P110, DOI 10.1159/000369978; Fairburn C. G., 2008, COGNITIVE BEHAVIOR T; Fassino S, 2002, EUR NEUROPSYCHOPHARM, V12, P453, DOI 10.1016/S0924-977X(02)00058-5; First M., 1997, STRUCTURED CLIN INTE; Flament MF, 2012, INT J NEUROPSYCHOPH, V15, P189, DOI 10.1017/S1461145711000381; Gable KN, 2005, CURR THER RES CLIN E, V66, P572, DOI 10.1016/j.curtheres.2005.12.011; Halmi KA, 2008, AM J PSYCHIAT, V165, P1227, DOI 10.1176/appi.ajp.2008.08060957; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hoffman ER, 2012, EUR EAT DISORD REV, V20, pe129, DOI 10.1002/erv.2161; Jon DI, 2013, CLIN NEUROPHARMACOL, V36, P157, DOI 10.1097/WNF.0b013e3182a31f3d; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Kaye WH, 2001, BIOL PSYCHIAT, V49, P644, DOI 10.1016/S0006-3223(00)01013-1; Kishi Taro, 2012, J Clin Psychiatry, V73, pe757, DOI 10.4088/JCP.12r07691; Klump KL, 2009, INT J EAT DISORDER, V42, P97, DOI 10.1002/eat.20589; Lebow J, 2013, INT J EAT DISORDER, V46, P332, DOI 10.1002/eat.22059; Leucht S, 2014, SCHIZOPHRENIA BULL, V40, P314, DOI 10.1093/schbul/sbu001; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; MAZURE CM, 1994, J PSYCHIATR RES, V28, P425, DOI 10.1016/0022-3956(94)90002-7; McKnight RF, 2010, EUR EAT DISORD REV, V18, P10, DOI 10.1002/erv.988; Miotto P, 2010, PSYCHIAT RES, V175, P237, DOI 10.1016/j.psychres.2009.03.011; Mischoulon D, 2011, J AFFECT DISORDERS, V130, P470, DOI 10.1016/j.jad.2010.10.043; Mondraty Naresh, 2005, Australas Psychiatry, V13, P72, DOI 10.1111/j.1440-1665.2004.02154.x; National Institute for Clinical Excellence (NICE), 2004, CORE INTERVENTIONS I; Powers PS, 2007, INT J EAT DISORDER, V40, P21, DOI 10.1002/eat.20325; Ruggiero GM, 2001, PROG NEURO-PSYCHOPH, V25, P1049, DOI 10.1016/S0278-5846(01)00174-9; Steinglass Joanna E, 2007, J Psychiatr Pract, V13, P65, DOI 10.1097/01.pra.0000265762.79753.88; Swinbourne J, 2012, AUST NZ J PSYCHIAT, V46, P118, DOI 10.1177/0004867411432071; Trajkovic G, 2011, PSYCHIAT RES, V189, P1, DOI 10.1016/j.psychres.2010.12.007; Trunko ME, 2011, INT J EAT DISORDER, V44, P269, DOI 10.1002/eat.20807; Walsh BT, 2006, JAMA-J AM MED ASSOC, V295, P2605, DOI 10.1001/jama.295.22.2605; Wright BM, 2013, PHARMACOTHERAPY, V33, P344, DOI 10.1002/phar.1204	49	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125569	10.1371/journal.pone.0125569	http://dx.doi.org/10.1371/journal.pone.0125569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922939	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600154
J	Mendonsa, AM; Chalfant, MC; Gorden, LD; VanSaun, MN				Mendonsa, Alisha M.; Chalfant, Madeleine C.; Gorden, Lee D.; VanSaun, Michael N.			Modulation of the Leptin Receptor Mediates Tumor Growth and Migration of Pancreatic Cancer Cells	PLOS ONE			English	Article							HIGH-FAT; ACTIVATION; OBESITY; INVASION; PROMOTE; PROLIFERATION; DISSEMINATION; INFLAMMATION; ADIPONECTIN; CARCINOMA	Obesity has been implicated as a significant risk factor for development of pancreatic cancer. In the setting of obesity, a systemic chronic inflammatory response is characterized by alterations in the production and secretion of a wide variety of growth factors. Leptin is a hormone whose level increases drastically in the serum of obese patients. High fat diet induced obesity in mice leads to an overall increased body weight, pancreatic weight, serum leptin, and pancreatic tissue leptin levels. Here we report the contribution of obesity and leptin to pancreatic cancer growth utilizing an in vivo orthotopic murine pancreatic cancer model, which resulted in increased tumor proliferation with concomitant increased tumor burden in the diet induced obese mice compared to lean mice. Human and murine pancreatic cancer cell lines were found to express the short as well as the long form of the leptin receptor and functionally responded to leptin induced activation through an increased phosphorylation of AKT473. In vitro, leptin stimulation increased cellular migration which was blocked by addition of a PI3K inhibitor. In vivo, depletion of the leptin receptor through shRNA knockdown partially abrogated increased orthotopic tumor growth in obese mice. These findings suggest that leptin contributes to pancreatic tumor growth through activation of the PI3K/AKT pathway, which promotes pancreatic tumor cell migration.	[Mendonsa, Alisha M.; Chalfant, Madeleine C.; Gorden, Lee D.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Gorden, Lee D.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [VanSaun, Michael N.] Univ Miami, Sylvester Canc Ctr, Dept Surg, Div Surg Oncol, Miami, FL 33177 USA	Vanderbilt University; Vanderbilt University; University of Miami	VanSaun, MN (corresponding author), Univ Miami, Sylvester Canc Ctr, Dept Surg, Div Surg Oncol, Miami, FL 33177 USA.	mvansaun@med.miami.edu		VanSaun, Michael/0000-0002-2538-8107	Pancreatic Cancer Action Network-AACR Career Development Award [10-20-25-VANS]; NIH [5U01CA143072]; NATIONAL CANCER INSTITUTE [U01CA143072] Funding Source: NIH RePORTER	Pancreatic Cancer Action Network-AACR Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by the 2010 Pancreatic Cancer Action Network-AACR Career Development Award, Grant Number 10-20-25-VANS and NIH #5U01CA143072 provided salary support for AMM, MCC, MNV, and LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer S, 2008, CANC FACTS FIG 2008, P6979; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Barone I, 2012, CANCER RES, V72, P1416, DOI 10.1158/0008-5472.CAN-11-2558; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Chen CC, 2013, INT J ONCOL, V42, P1113, DOI 10.3892/ijo.2013.1789; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cheon EC, 2011, INT J CANCER, V128, P2783, DOI 10.1002/ijc.25622; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; CORBETT TH, 1984, CANCER RES, V44, P717; Cottrell Elizabeth C, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-24716-3_1; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Dawson DW, 2013, CANCER PREV RES, V6, P1064, DOI 10.1158/1940-6207.CAPR-13-0065; De Luis DA, 2011, NUTR HOSP, V26, P91, DOI 10.3305/nh.2011.26.1.4685; Ebert T, 2014, HORM METAB RES, V46, P41, DOI 10.1055/s-0033-1353198; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Fantuzzi G, 2005, CLIN EXP IMMUNOL, V142, P31, DOI 10.1111/j.1365-2249.2005.02898.X; Fava G, 2008, CANCER RES, V68, P6752, DOI 10.1158/0008-5472.CAN-07-6682; Ghilardi N, 1997, MOL ENDOCRINOL, V11, P393, DOI 10.1210/me.11.4.393; Giordano C, 2013, MOL ONCOL, V7, P379, DOI 10.1016/j.molonc.2012.11.002; Han GS, 2012, BRAIN RES BULL, V87, P274, DOI 10.1016/j.brainresbull.2011.11.007; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Inadera Hidekuni, 2008, Int J Med Sci, V5, P248; Islam MS, 1997, BIOCHEM BIOPH RES CO, V238, P851, DOI 10.1006/bbrc.1997.7399; Jaffe T, 2008, INT J CANCER, V123, P2543, DOI 10.1002/ijc.23821; Khan M, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/328592; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; Lanza-Jacoby S, 2013, EXP BIOL MED, V238, P787, DOI 10.1177/1535370213493727; Li C, 1999, P NATL ACAD SCI USA, V96, P9677, DOI 10.1073/pnas.96.17.9677; Liu Y, 2011, J HUAZHONG U SCI-MED, V31, P365, DOI 10.1007/s11596-011-0382-7; Lopez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079708; Mathur A, 2009, J AM COLL SURGEONS, V208, P989, DOI 10.1016/j.jamcollsurg.2008.12.026; Murakami T, 1997, BIOCHEM BIOPH RES CO, V231, P26, DOI 10.1006/bbrc.1996.6030; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Pitt Henry A, 2007, HPB (Oxford), V9, P92, DOI 10.1080/13651820701286177; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Shen XM, 2009, J GASTROINTEST SURG, V13, P1955, DOI 10.1007/s11605-009-1002-8; Somasundar P, 2003, J SURG RES, V113, P50, DOI 10.1016/S0022-4804(03)00166-5; VanSaun MN, 2013, CLIN CANCER RES, V19, P1926, DOI 10.1158/1078-0432.CCR-12-0930; VanSaun MN, 2009, AM J PATHOL, V175, P355, DOI 10.2353/ajpath.2009.080703; Wang D, 2012, J BIOSCIENCES, V37, P91, DOI 10.1007/s12038-011-9172-4; Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4; Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266; White PB, 2010, J GASTROINTEST SURG, V14, P1888, DOI 10.1007/s11605-010-1349-x; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773; Zyromski NJ, 2009, SURGERY, V146, P258, DOI 10.1016/j.surg.2009.02.024	53	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0126686	10.1371/journal.pone.0126686	http://dx.doi.org/10.1371/journal.pone.0126686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919692	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400095
J	Lopez-Abarrategui, C; McBeth, C; Mandal, SM; Sun, ZYJ; Heffron, G; Alba-Menendez, A; Migliolo, L; Reyes-Acosta, O; Garcia-Villarino, M; Nolasco, DO; Falcao, R; Cherobim, MD; Dias, SC; Brandt, W; Wessjohann, L; Starnbach, M; Franco, OL; Otero-Gonzalez, AJ				Lopez-Abarrategui, Carlos; McBeth, Christine; Mandal, Santi M.; Sun, Zhenyu J.; Heffron, Gregory; Alba-Menendez, Annia; Migliolo, Ludovico; Reyes-Acosta, Osvaldo; Garcia-Villarino, Monica; Nolasco, Diego O.; Falcao, Rosana; Cherobim, Mariana D.; Dias, Simoni C.; Brandt, Wolfgang; Wessjohann, Ludger; Starnbach, Michael; Franco, Octavio L.; Otero-Gonzalez, Anselmo J.			Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae)	FASEB JOURNAL			English	Article						antimicrobial peptide; Candida albicans; systemic candidiasis	HELICAL ANTIMICROBIAL PEPTIDES; HOST-DEFENSE PEPTIDES; C-TERMINAL REGIONS; CANDIDACIDAL MECHANISM; ANTIBACTERIAL ACTIVITY; MEMBRANE; NMR; CANDIDIASIS; PLANT; CELL	Antimicrobial peptides form part of the first line of defense against pathogens for many organisms. Current treatments for fungal infections are limited by drug toxicity and pathogen resistance. Cm-p5 (SRSE-LIVHQRLF), a peptide derived from the marine mollusk Cenchritis muricatus peptide Cm-p1, has a significantly increased fungistatic activity against pathogenic Candida albicans (minimal inhibitory concentration, 10 mu g/ml; EC50, 1.146 mu g/ml) while exhibiting low toxic effects against a cultured mammalian cell line. Cm-p5 as characterized by circular dichroism and nuclear magnetic resonance revealed an alpha-helical structure in membranemimetic conditions and a tendency to random coil folding in aqueous solutions. Additional studies modeling Cm-p5 binding to a phosphatidylserine bilayer in silico and isothermal titration calorimetry using lipid monophases demonstrated that Cm-p5 has a high affinity for the phospholipids of fungal membranes (phosphatidylserine and phosphatidylethanolamine), only moderate interactions with a mammalian membrane phospholipid, low interaction with ergosterol, and no interaction with chitin. Adhesion of Cm-p5 to living C. albicans cells was confirmed by fluorescence microscopy with FITC-labeled peptide. In a systemic candidiasis model in mice, intraperitoneal administration of Cm-p5 was unable to control the fungal kidney burden, although its low amphiphaticity could be modified to generate new derivatives with improved fungicidal activity and stability.	[Lopez-Abarrategui, Carlos; Garcia-Villarino, Monica; Otero-Gonzalez, Anselmo J.] Univ Havana, Fac Biol, Ctr Prot Studies, Havana, Cuba; [Alba-Menendez, Annia] Inst Trop Med Pedro Kouri, Branch Parasitol, Havana, Cuba; [Reyes-Acosta, Osvaldo] Ctr Genet Engn & Biotechnol, Lab Peptide Anal & Synth, Havana, Cuba; [McBeth, Christine; Starnbach, Michael] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol NRB, Boston, MA USA; [Sun, Zhenyu J.; Heffron, Gregory] Harvard Univ, Sch Med, Biomol NMR Lab, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Mandal, Santi M.] Vidyasagar Univ, Antiinfect Res Lab, Dept Microbiol, Midnapore, India; [Migliolo, Ludovico; Nolasco, Diego O.; Cherobim, Mariana D.; Dias, Simoni C.; Franco, Octavio L.] Univ Catolica Brasilia, Ctr Biochem & Prote Anal, Brasilia, DF, Brazil; [Falcao, Rosana] Brazil Agr Res Corp EMBRAPA, Natl Ctr Res Genet Resources & Biotechnol CENARGE, EMBRAPA, Brasilia, DF, Brazil; [Brandt, Wolfgang; Wessjohann, Ludger] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Saale, Germany; [Franco, Octavio L.] Univ Catolica Dom Bosco, Dept Biotechnol, Campo Grande, Brazil	Universidad de la Habana; Centro de Ingenieria Genetica y Biotecnologia; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Vidyasagar University; Universidade Catolica de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Leibniz Institut fur Pflanzenbiochemie; Universidade Catolica Dom Bosco (UCDB)	Franco, OL (corresponding author), Univ Catolica Brasilia, Ctr Biochem & Prote Anal, SGAN 916,Av W5,Block C,Room 219, BR-70790160 Brasilia, DF, Brazil.	ocfranco@gmail.com	Wessjohann, Ludger/AAZ-3838-2021; Nolasco, Diego O/O-6743-2014; Nolasco, Diego O./D-1241-2017; Mandal, Santi M./AAF-7156-2020; Franco, Octavio L/T-3020-2017; MIGLIOLO, LUDOVICO/AAV-6913-2021	Nolasco, Diego O/0000-0001-7931-5475; Nolasco, Diego O./0000-0001-7931-5475; MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Mandal, Santi M/0000-0002-0119-7138; Franco, Octavio/0000-0001-9546-0525; Alba Menendez, Annia/0000-0003-3190-8786; Wessjohann, Ludger A./0000-0003-2060-8235; McBeth, Christine/0000-0002-1648-2417	International Foundation of Science (IFS), Sweden [F 4614, F/5199]; Organization for the Prohibition of Chemical Weapons (OPCW), The Netherlands; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039558] Funding Source: NIH RePORTER	International Foundation of Science (IFS), Sweden(International Foundation for Science); Organization for the Prohibition of Chemical Weapons (OPCW), The Netherlands; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank CNPq, FAPDF, FUNDECT, CAPES-MES, Brazil; International Foundation of Science (IFS), Sweden (F 4614 and F/5199 projects); and David Rockefeller Center for Latin American Studies (DRCLAS), Harvard University. It was also relevant the support of the Organization for the Prohibition of Chemical Weapons (OPCW), The Netherlands. Furthermore, they also appreciate the efforts of Dr. A. Porcel from the Leibniz Institute of Plant Biochemistry, Department of Bio-organic Chemistry, Halle (Saale), Germany, for her assistance with CD experiments. They also extend their sincerest thanks and appreciation to Dr. J. David, Richard Pearson Strong Professor of Tropical Public Health, Emeritus, Harvard School of Public Health, for his critical review and advice.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Andes D, 2005, METH MOLEC MED, V118, P111; Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Arnold Tamra M, 2010, Proc Am Thorac Soc, V7, P222, DOI 10.1513/pats.200906-048AL; Belguesmia Y, 2013, LETT APPL MICROBIOL, V56, P237, DOI 10.1111/lam.12037; Bhattacharjya S, 2009, FEBS J, V276, P6465, DOI 10.1111/j.1742-4658.2009.07357.x; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Brandelli A, 2012, MINI-REV MED CHEM, V12, P731, DOI 10.2174/138955712801264774; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Caillon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075528; Cho J, 2012, J MICROBIOL BIOTECHN, V22, P1367, DOI 10.4014/jmb.1205.05040; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V2nd, P3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Destoumieux-Garzon D, 2001, J BIOL CHEM, V276, P47070, DOI 10.1074/jbc.M103817200; Domingues TM, 2013, LANGMUIR, V29, P8609, DOI 10.1021/la401596s; Drew RH, 2013, EXPERT OPIN PHARMACO, V14, P2361, DOI 10.1517/14656566.2013.838217; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haney EF, 2009, BBA-BIOMEMBRANES, V1788, P1639, DOI 10.1016/j.bbamem.2009.01.002; Helmerhorst EJ, 2001, J BIOL CHEM, V276, P5643, DOI 10.1074/jbc.M008229200; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; Hetru C, 1997, Methods Mol Biol, V78, P35; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jiang ZQ, 2008, CHEM BIOL DRUG DES, V72, P483, DOI 10.1111/j.1747-0285.2008.00728.x; Keller R., 2004, COMPUTER AIDED RESON, V1; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lee J, 2010, J MICROBIOL BIOTECHN, V20, P1192, DOI 10.4014/jmb.1004.04041; Lequin O, 2006, BIOCHEMISTRY-US, V45, P468, DOI 10.1021/bi051711i; Lequin O, 2003, BIOCHEMISTRY-US, V42, P10311, DOI 10.1021/bi034401d; Lopez-Abarrategui C, 2013, CURR PROTEIN PEPT SC, V14, P595; Lopez-Abarrategui C, 2012, BIOCHIMIE, V94, P968, DOI 10.1016/j.biochi.2011.12.016; Lupetti A, 2007, J INFECT DIS, V196, P1416, DOI 10.1086/522427; Mahalka AK, 2009, BBA-BIOMEMBRANES, V1788, P1600, DOI 10.1016/j.bbamem.2009.04.012; Mahata D, 2014, INT J BIOL MACROMOL, V69, P5, DOI 10.1016/j.ijbiomac.2014.05.017; Martins IM, 2011, J BIOL CHEM, V286, P3484, DOI 10.1074/jbc.M110.174300; Matejuk A, 2010, DRUG FUTURE, V35, P197, DOI 10.1358/dof.2010.035.03.1452077; MERRIFIELD B, 1986, SCIENCE, V232, P341, DOI 10.1126/science.3961484; Munoz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054813; MURPHY JB, 1960, BIOCHIM BIOPHYS ACTA, V45, P382, DOI 10.1016/0006-3002(60)91464-5; Pal T, 2006, INT J ANTIMICROB AG, V27, P525, DOI 10.1016/j.ijantimicag.2006.01.010; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Peman J, 2009, EXPERT REV ANTI-INFE, V7, P453, DOI [10.1586/eri.09.18, 10.1586/ERI.09.18]; Phoenix D.A., 2013, ANTIMICROBIAL PEPTID, DOI DOI 10.1002/9783527652853; Phoenix DA, 2002, MOL MEMBR BIOL, V19, P1, DOI 10.1080/09687680110103631; Polonelli L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034105; Poon IKH, 2014, ELIFE, V3, DOI 10.7554/eLife.01808; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Puri S, 2014, EUKARYOT CELL, V13, P958, DOI 10.1128/EC.00095-14; Pushpanathan M, 2012, J PEPT SCI, V18, P657, DOI 10.1002/psc.2445; Ribeiro PD, 2003, PEPTIDES, V24, P1807, DOI 10.1016/j.peptides.2003.08.021; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sikorska E, 2014, BBA-BIOMEMBRANES, V1838, P2625, DOI 10.1016/j.bbamem.2014.06.016; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Su YC, 2013, AMINO ACIDS, V44, P821, DOI 10.1007/s00726-012-1421-9; Sundararajan VS, 2012, NUCLEIC ACIDS RES, V40, pD1108, DOI 10.1093/nar/gkr1063; Tavares PM, 2008, ANTIMICROB AGENTS CH, V52, P4522, DOI 10.1128/AAC.00448-08; van der Weerden NL, 2013, CELL MOL LIFE SCI, V70, P3545, DOI 10.1007/s00018-013-1260-1; Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280; Waghu FH, 2014, NUCLEIC ACIDS RES, V42, pD1154, DOI 10.1093/nar/gkt1157; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wilkinson S., 1988, MICROBIAL LIPIDS; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	66	31	33	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3315	3325		10.1096/fj.14-269860	http://dx.doi.org/10.1096/fj.14-269860			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25921828	Green Published			2022-12-26	WOS:000358796900019
J	Olsan, EE; Matsushita, T; Rezaei, M; Weimbs, T				Olsan, Erin E.; Matsushita, Tamami; Rezaei, Mina; Weimbs, Thomas			Exploitation of the Polymeric Immunoglobulin Receptor for Antibody Targeting to Renal Cyst Lumens in Polycystic Kidney Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; drug development; genetic disease; IgA; STAT transcription factor; STAT6; dimeric IgA; drug targeting; polycystic kidney disease; polymeric immunoglobulin receptor	EPITHELIAL-CELLS; IG RECEPTOR; IN-VIVO; IMMUNE-RESPONSES; GROWTH-FACTOR; EXPRESSION; STAT6; TRANSCYTOSIS; INFLAMMATION; STIMULATION	Background: Mitogenic cyst fluid in polycystic kidney disease is not accessible to therapeutic IgG antibodies. Results: STAT6 drives expression of the polymeric immunoglobulin receptor, which can transcytose dimeric IgA from the circulation into cyst fluid. Conclusion: Dimeric IgA antibodies target to renal cyst lumens. Significance: Therapeutic antibodies, reformatted to dIgA, could be evaluated for the treatment of polycystic kidney disease. Autosomal-dominant polycystic kidney disease (ADPKD) is a common life-threatening genetic disease that leads to renal failure. No treatment is available yet to effectively slow disease progression. Renal cyst growth is, at least in part, driven by the presence of growth factors in the lumens of renal cysts, which are enclosed spaces lacking connections to the tubular system. We have shown previously shown that IL13 in cyst fluid leads to aberrant activation of STAT6 via the IL4/13 receptor. Although antagonistic antibodies against many of the growth factors implicated in ADPKD are already available, they are IgG isotype antibodies that are not expected to gain access to renal cyst lumens. Here we demonstrate that targeting antibodies to renal cyst lumens is possible with the use of dimeric IgA (dIgA) antibodies. Using human ADPKD tissues and polycystic kidney disease mouse models, we show that the polymeric immunoglobulin receptor (pIgR) is highly expressed by renal cyst-lining cells. pIgR expression is, in part, driven by aberrant STAT6 pathway activation. pIgR actively transports dIgA from the circulation across the cyst epithelium and releases it into the cyst lumen as secretory IgA. dIgA administered by intraperitoneal injection is preferentially targeted to polycystic kidneys whereas injected IgG is not. Our results suggest that pIgR-mediated transcytosis of antagonistic antibodies in dIgA format can be exploited for targeted therapy in ADPKD.	[Weimbs, Thomas] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Weimbs, Thomas] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Weimbs, T (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	weimbs@lifesci.ucsb.edu	Regan, Clinton/E-6250-2012	Weimbs, Thomas/0000-0001-9423-5561	National Institutes of Health [R01 DK62338]; Swiss National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK62338 and a gift from the Lillian Goldman Charitable Trust (to T. W.). This work was also supported by a Swiss National Science Foundation early postdoctoral mobility grant (to M. R). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAMOWSKY CR, 1986, AM J PATHOL, V125, P571; Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Asano M, 2004, SCAND J IMMUNOL, V60, P267, DOI 10.1111/j.0300-9475.2004.01456.x; Barlucchi L, 2001, CIRC RES, V88, P298, DOI 10.1161/01.RES.88.3.298; Boross P, 2013, EMBO MOL MED, V5, P1213, DOI 10.1002/emmm.201201929; Braathen R, 2006, J BIOL CHEM, V281, P7075, DOI 10.1074/jbc.M508509200; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; DAVIDSON LA, 1987, ACTA PAEDIATR SCAND, V76, P733, DOI 10.1111/j.1651-2227.1987.tb10557.x; Dell KM, 2001, KIDNEY INT, V60, P1240, DOI 10.1046/j.1523-1755.2001.00963.x; DU J, 1995, AM J PHYSIOL-CELL PH, V269, pC487, DOI 10.1152/ajpcell.1995.269.2.C487; EVERSON GT, 1990, HEPATOLOGY, V11, P557, DOI 10.1002/hep.1840110406; Gallagher AR, 2010, ADV CHRONIC KIDNEY D, V17, P118, DOI 10.1053/j.ackd.2010.01.002; GARDNER KD, 1991, KIDNEY INT, V39, P718, DOI 10.1038/ki.1991.87; Giffroy D, 1998, INT IMMUNOL, V10, P347, DOI 10.1093/intimm/10.3.347; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Hassane S, 2010, J PATHOL, V222, P21, DOI 10.1002/path.2734; HORIE S, 1994, LANCET, V344, P789, DOI 10.1016/S0140-6736(94)92344-2; Jansson K, 2012, AM J PHYSIOL-RENAL, V303, pF982, DOI 10.1152/ajprenal.00677.2011; Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37; Johansen FE, 2004, TRENDS IMMUNOL, V25, P150, DOI 10.1016/j.it.2004.01.001; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; Lohse S, 2012, J BIOL CHEM, V287, P25139, DOI 10.1074/jbc.M112.353060; Lohse S, 2011, J IMMUNOL, V186, P3770, DOI 10.4049/jimmunol.1003082; Loman S, 1999, IMMUNOLOGY, V96, P537; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Monteiro RC, 2010, J CLIN IMMUNOL, V30, P1, DOI 10.1007/s10875-009-9338-0; Mostov KE, 1995, COLD SPRING HARB SYM, V60, P775, DOI 10.1101/SQB.1995.060.01.083; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Olsan EE, 2011, P NATL ACAD SCI USA, V108, P18067, DOI 10.1073/pnas.1111966108; Rice JC, 1999, AM J PHYSIOL-RENAL, V276, pF666, DOI 10.1152/ajprenal.1999.276.5.F666; Rice JC, 1998, AM J PHYSIOL-RENAL, V274, pF966, DOI 10.1152/ajprenal.1998.274.5.F966; Schjerven H, 2000, J IMMUNOL, V165, P3898, DOI 10.4049/jimmunol.165.7.3898; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; SOLARI R, 1985, J BIOL CHEM, V260, P1141; Torres VE, 2012, NAT REV NEPHROL, V8, P66, DOI 10.1038/nrneph.2011.196; White KD, 2002, J EXP MED, V196, P551, DOI 10.1084/jem.20020581	38	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15679	15686		10.1074/jbc.M114.607929	http://dx.doi.org/10.1074/jbc.M114.607929			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25922073	hybrid, Green Published			2022-12-26	WOS:000356527400030
J	Oskarsson, ME; Singh, K; Wang, J; Vlodavsky, I; Li, JP; Westermark, GT				Oskarsson, Marie E.; Singh, Kailash; Wang, Jian; Vlodavsky, Israel; Li, Jin-ping; Westermark, Gunilla T.			Heparan Sulfate Proteoglycans Are Important for Islet Amyloid Formation and Islet Amyloid Polypeptide-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL APOPTOSIS; AMYLIN; BINDING; IAPP; OVEREXPRESSION; ACTIVATION; EXPRESSION; MECHANISM; INTERNALIZATION; IDENTIFICATION	Deposition of beta cell toxic islet amyloid is a cardinal finding in type 2 diabetes. In addition to the main amyloid component islet amyloid polypeptide (IAPP), heparan sulfate proteoglycan is constantly present in the amyloid deposit. Heparan sulfate (HS) side chains bind to IAPP, inducing conformational changes of the IAPP structure and an acceleration of fibril formation. We generated a double-transgenic mouse strain (hpa-hIAPP) that overexpresses human heparanase and human IAPP but is deficient of endogenous mouse IAPP. Culture of hpa-hIAPP islets in 20 mM glucose resulted in less amyloid formation compared with the amyloid load developed in cultured islets isolated from littermates expressing human IAPP only. A similar reduction of amyloid was achieved when human islets were cultured in the presence of heparin fragments. Furthermore, we used CHO cells and the mutant CHO pgsD-677 cell line (deficient in HS synthesis) to explore the effect of cellular HS on IAPP-induced cytotoxicity. Seeding of IAPP aggregation on CHO cells resulted in caspase-3 activation and apoptosis that could be prevented by inhibition of caspase-8. No IAPP-induced apoptosis was seen in HS-deficient CHO pgsD-677 cells. These results suggest that beta cell death caused by extracellular IAPP requires membrane-bound HS. The interaction between HS and IAPP or the subsequent effects represent a possible therapeutic target whose blockage can lead to a prolonged survival of beta cells.	[Oskarsson, Marie E.; Singh, Kailash; Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden; [Wang, Jian; Li, Jin-ping] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Wang, Jian] Ningxia Peoples Hosp, Yinchuan 750021, Peoples R China; [Vlodavsky, Israel] Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel	Uppsala University; Uppsala University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Li, JP (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 571, S-75123 Uppsala, Sweden.	Jin-ping.Li@imbim.uu.se; Westermark@mcb.uu.se		Singh, Kailash/0000-0002-6771-7757	Family Ernfors Research Fund; Swedish Diabetes Foundation; Novo Nordisk Research Fund [VR K2012-67X-21128-04-4]; Cancerfonden Grant [120762];  [VR K2013-55x-20326-07-3]; Novo Nordisk Fonden [NNF15OC0016502] Funding Source: researchfish	Family Ernfors Research Fund; Swedish Diabetes Foundation; Novo Nordisk Research Fund; Cancerfonden Grant; ; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Grant VR K2013-55x-20326-07-3 (to G. T. W.), the Family Ernfors Research Fund, the Swedish Diabetes Foundation, the Novo Nordisk Research Fund, Grant VR K2012-67X-21128-04-4 (to J. P. L.), and Cancerfonden Grant 120762.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; Abedini A, 2006, BIOCHEMISTRY-US, V45, P9228, DOI 10.1021/bi0510936; ANDERSSO.A, 1972, DIABETES, V21, P546, DOI 10.2337/diab.21.2.S546; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Bag N, 2013, CHEM COMMUN, V49, P9155, DOI 10.1039/c3cc44880k; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Cabric S, 2007, DIABETES, V56, P2008, DOI 10.2337/db07-0358; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; De Carufel CA, 2013, BIOPOLYMERS, V100, P645, DOI 10.1002/bip.22243; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Hass G, 1942, ARCH PATHOL, V34, P92; HOOK M, 1982, ANAL BIOCHEM, V119, P236, DOI 10.1016/0003-2697(82)90580-2; Hull RL, 2007, AM J PHYSIOL-CELL PH, V293, pC1586, DOI 10.1152/ajpcell.00208.2007; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jendresen CB, 2015, J BIOL CHEM, V290, P5053, DOI 10.1074/jbc.M114.600569; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Kohler M, 2003, DIABETES, V52, P2943, DOI 10.2337/diabetes.52.12.2943; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Ma LJ, 2014, J INORG BIOCHEM, V140, P143, DOI 10.1016/j.jinorgbio.2014.07.002; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Nobuhisa T, 2005, BIOCHEM BIOPH RES CO, V331, P175, DOI 10.1016/j.bbrc.2005.03.129; NORLING B, 1988, CLIN EXP IMMUNOL, V73, P333; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; Park YJ, 2012, DIABETOLOGIA, V55, P1035, DOI 10.1007/s00125-012-2451-2; Park YJ, 2014, DIABETOLOGIA, V57, P765, DOI 10.1007/s00125-013-3152-1; Paulsson JF, 2006, DIABETOLOGIA, V49, P1237, DOI 10.1007/s00125-006-0206-7; Paulsson JF, 2005, DIABETES, V54, P2117, DOI 10.2337/diabetes.54.7.2117; Paulsson JF, 2008, EXP DIABETES RES, DOI 10.1155/2008/865850; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Radhakrishnan P, 2008, INT J BIOCHEM CELL B, V40, P1944, DOI 10.1016/j.biocel.2008.02.014; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Shin JT, 2012, AMYLOID, V19, P191, DOI 10.3109/13506129.2012.733741; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; SNOW AD, 1991, J HISTOCHEM CYTOCHEM, V39, P1321, DOI 10.1177/39.10.1940305; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Trikha S, 2011, J BIOL CHEM, V286, P36086, DOI 10.1074/jbc.M111.240762; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; Westermark GT, 2000, MOL MED, V6, P998, DOI 10.1007/BF03402051; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WESTERMARK P, 1995, DIABETOLOGIA, V38, P543, DOI 10.1007/BF00400722; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhang SP, 2003, J BIOL CHEM, V278, P52810, DOI 10.1074/jbc.M308244200; Zhang SP, 1999, FEBS LETT, V455, P315, DOI 10.1016/S0014-5793(99)00894-7; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	60	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15121	15132		10.1074/jbc.M114.631697	http://dx.doi.org/10.1074/jbc.M114.631697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922077	hybrid, Green Published			2022-12-26	WOS:000356177300027
J	Foumani, M; Vuong, TV; MacCormick, B; Master, ER				Foumani, Maryam; Vuong, Thu V.; MacCormick, Benjamin; Master, Emma R.			Enhanced Polysaccharide Binding and Activity on Linear beta-Glucans through Addition of Carbohydrate-Binding Modules to Either Terminus of a Glucooligosaccharide Oxidase	PLOS ONE			English	Article							OLIGOSACCHARIDE OXIDASE; TRICHODERMA-REESEI; SUBSTRATE-SPECIFICITY; ACREMONIUM-STRICTUM; CATALYTIC-ACTIVITY; DOMAINS; THERMOSTABILITY; DETERMINANTS; CONSTRUCTION; HYDROLYSIS	The gluco-oligosaccharide oxidase from Sarocladium strictum CBS 346.70 (GOOX) is a single domain flavoenzyme that favourably oxidizes gluco- and xylo-oligosaccharides. In the present study, GOOX was shown to also oxidize plant polysaccharides, including cellulose, glucomannan, beta-(1 -> 3,1 -> 4)-glucan, and xyloglucan, albeit to a lesser extent than oligomeric substrates. To improve GOOX activity on polymeric substrates, three carbohydrate binding modules (CBMs) from Clostridium thermocellum, namely CtCBM3 (type A), CtCBM11 (type B), and CtCBM44 (type B), were separately appended to the amino and carboxy termini of the enzyme, generating six fusion proteins. With the exception of GOOX-CtCBM3 and GOOX-CtCBM44, fusion of the selected CBMs increased the catalytic activity of the enzyme (kcat) on cellotetraose by up to 50%. All CBM fusions selectively enhanced GOOX binding to soluble and insoluble polysaccharides, and the immobilized enzyme on a solid cellulose surface remained stable and active. In addition, the CBM fusions increased the activity of GOOX on soluble glucomannan by up to 30% and on insoluble crystalline as well as amorphous cellulose by over 50 %.	[Foumani, Maryam; Vuong, Thu V.; MacCormick, Benjamin; Master, Emma R.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada	University of Toronto	Master, ER (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.	emma.master@utoronto.ca	Master, Emma/O-3554-2014		Government of Ontario for the project "Forest FAB: Applied Genomics for Functionalized Fibre and Biochemicals" [ORF-RE-05-005]; Natural Sciences and Engineering Research Council of Canada through the "NSERC Bioconversion Network"	Government of Ontario for the project "Forest FAB: Applied Genomics for Functionalized Fibre and Biochemicals"; Natural Sciences and Engineering Research Council of Canada through the "NSERC Bioconversion Network"(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the Government of Ontario for the project "Forest FAB: Applied Genomics for Functionalized Fibre and Biochemicals" (ORF-RE-05-005), and by the Natural Sciences and Engineering Research Council of Canada through the "NSERC Bioconversion Network". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Cumpstey Ian, 2013, ISRN Org Chem, V2013, P417672, DOI 10.1155/2013/417672; Dias FMV, 2004, FEMS MICROBIOL LETT, V238, P71, DOI 10.1016/j.femsle.2004.07.019; Fan ZL, 2000, BIOTECHNOL BIOENG, V68, P231, DOI 10.1002/(SICI)1097-0290(20000420)68:2<231::AID-BIT12>3.3.CO;2-4; Foumani M., 2012, Glucooligosaccharide oxidases from Acremonium strictum and uses thereof, Patent No. [WO 2012/116431, 2012116431, WO/2012/116431]; Foumani M, 2011, BIOTECHNOL BIOENG, V108, P2261, DOI 10.1002/bit.23149; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; Furtado GP, 2015, APPL MICROBIOL BIOT, V99, P5095, DOI 10.1007/s00253-014-6324-0; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; He J, 2009, NEW BIOTECHNOL, V26, P53, DOI 10.1016/j.nbt.2009.04.002; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Heuts DPHM, 2007, FEBS LETT, V581, P4905, DOI 10.1016/j.febslet.2007.09.019; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Kataeva IA, 2001, PROTEIN ENG, V14, P167, DOI 10.1093/protein/14.3.167; Koseki T, 2010, APPL MICROBIOL BIOT, V86, P155, DOI 10.1007/s00253-009-2224-0; Kurokawa T, 2002, J CHEM ENG JPN, V35, P1277, DOI 10.1252/jcej.35.1277; Le Costaouec T, 2013, BIORESOURCE TECHNOL, V143, P196, DOI 10.1016/j.biortech.2013.05.079; Lee MH, 2005, APPL ENVIRON MICROB, V71, P8881, DOI 10.1128/AEM.71.12.8881-8887.2005; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; LIN SF, 1991, BIOCHIM BIOPHYS ACTA, V1118, P41, DOI 10.1016/0167-4838(91)90439-7; LIN SF, 1993, BIOTECHNOL ADV, V11, P417, DOI 10.1016/0734-9750(93)90011-B; Mamo G, 2007, EXTREMOPHILES, V11, P169, DOI 10.1007/s00792-006-0023-4; Mangala SL, 2003, J MOL CATAL B-ENZYM, V21, P221, DOI 10.1016/S1381-1177(02)00226-6; Meng DD, 2015, APPL ENVIRON MICROB, V81, P2006, DOI 10.1128/AEM.03677-14; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011; Parikka K, 2010, J AGR FOOD CHEM, V58, P262, DOI 10.1021/jf902930t; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi XZ, 2003, PROTEIN EXPRES PURIF, V28, P321, DOI 10.1016/S1046-5928(02)00706-4; Telke AA, 2012, BIORESOURCE TECHNOL, V112, P10, DOI 10.1016/j.biortech.2012.02.066; Varela O, 2003, ADV CARBOHYD CHEM BI, V58, P307, DOI 10.1016/S0065-2318(03)58006-4; Varnai A, 2014, ADV APPL MICROBIOL, V88, P103, DOI 10.1016/B978-0-12-800260-5.00004-8; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Viegas A, 2008, FEBS J, V275, P2524, DOI 10.1111/j.1742-4658.2008.06401.x; Voutilainen SP, 2014, APPL MICROBIOL BIOT, V98, P2991, DOI 10.1007/s00253-013-5177-2; Vuong TV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095170; Vuong TV, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-148; Whittaker JW, 2005, ARCH BIOCHEM BIOPHYS, V433, P227, DOI 10.1016/j.abb.2004.08.034; Xu F, 2001, EUR J BIOCHEM, V268, P1136, DOI 10.1046/j.1432-1327.2001.01982.x; Yaniv O, 2011, ACTA CRYSTALLOGR D, V67, P506, DOI 10.1107/S0907444911011322; Ye XH, 2011, APPL MICROBIOL BIOT, V92, P551, DOI 10.1007/s00253-011-3346-8; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zou G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-21	48	12	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125398	10.1371/journal.pone.0125398	http://dx.doi.org/10.1371/journal.pone.0125398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932926	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100107
J	Gits-Muselli, M; Peraldi, MN; de Castro, N; Delcey, V; Menotti, J; Guigue, N; Hamane, S; Raffoux, E; Bergeron, A; Valade, S; Molina, JM; Bretagne, S; Alanio, A				Gits-Muselli, Maud; Peraldi, Marie-Noelle; de Castro, Nathalie; Delcey, Veronique; Menotti, Jean; Guigue, Nicolas; Hamane, Samia; Raffoux, Emmanuel; Bergeron, Anne; Valade, Sandrine; Molina, Jean-Michel; Bretagne, Stephane; Alanio, Alexandre			New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards	PLOS ONE			English	Article							RENAL-TRANSPLANT RECIPIENTS; HIV-INFECTED PATIENTS; F-SP HOMINIS; ASPERGILLUS-FUMIGATUS; CARINII-PNEUMONIA; CANDIDA-ALBICANS; INTERHUMAN TRANSMISSION; MICROSATELLITE MARKERS; PCR-SSCP; OUTBREAK	Pneumocystis pneumonia is a severe opportunistic infection in immunocompromised patients caused by the unusual fungus Pneumocystis jirovecii. Transmission is airborne, with both immunocompromised and immunocompetent individuals acting as a reservoir for the fungus. Numerous reports of outbreaks in renal transplant units demonstrate the need for valid genotyping methods to detect transmission of a given genotype. Here, we developed a short tandem repeat (STR)-based molecular typing method for P. jirovecii. We analyzed the P. jirovecii genome and selected six genomic STR markers located on different contigs of the genome. We then tested these markers in 106 P. jirovecii PCR-positive respiratory samples collected between October 2010 and November 2013 from 91 patients with various underlying medical conditions. Unique (one allele per marker) and multiple (more than one allele per marker) genotypes were observed in 34 (32%) and 72 (68%) samples, respectively. A genotype could be assigned to 55 samples (54 patients) and 61 different genotypes were identified in total with a discriminatory power of 0.992. Analysis of the allelic distribution of the six markers and minimum spanning tree analysis of the 61 genotypes identified a specific genotype (Gt21) in our hospital, which may have been transmitted between 10 patients including six renal transplant recipients. Our STR-based molecular typing method is a quick, cheap and reliable approach to genotype Pneumocystis jirovecii in hospital settings and is sensitive enough to detect minor genotypes, thus enabling the study of the transmission and pathophysiology of Pneumocystis pneumonia.	[Gits-Muselli, Maud; Menotti, Jean; Guigue, Nicolas; Hamane, Samia; Bretagne, Stephane; Alanio, Alexandre] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Lab Parasitol Mycol, Paris, France; [Peraldi, Marie-Noelle] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Transplantat Renale, Paris, France; [Peraldi, Marie-Noelle; Menotti, Jean; Guigue, Nicolas; Bergeron, Anne; Molina, Jean-Michel; Bretagne, Stephane; Alanio, Alexandre] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [de Castro, Nathalie; Molina, Jean-Michel] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Malad Infect & Trop, Paris, France; [Delcey, Veronique] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Med Interne, Paris, France; [Menotti, Jean; Bretagne, Stephane; Alanio, Alexandre] Ctr Natl Reference Mycoses Invas & Antifong, Inst Pasteur, Unite Mycol Mol, Paris, France; [Menotti, Jean; Bretagne, Stephane; Alanio, Alexandre] CNRS, URA3012, Paris, France; [Raffoux, Emmanuel] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Hematol Adulte, Paris, France; [Bergeron, Anne] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Pneumol, Paris, France; [Valade, Sandrine] Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Serv Reanimat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Alanio, A (corresponding author), Grp Hosp St Louis Lariboisiere Femand Widal, AP HP, Lab Parasitol Mycol, Paris, France.	alexandre.alanio@aphp.fr	BRETAGNE, Stephane/H-6655-2019; BRETAGNE, Stephane/GLT-8879-2022; Menotti, Jean/AFV-1886-2022; De Castro, Nathalie/AFQ-4610-2022; Alanio, Alexandre/N-8472-2016	BRETAGNE, Stephane/0000-0001-6870-3800; Alanio, Alexandre/0000-0001-9726-3082; Menotti, Jean/0000-0001-5703-8403; GITS-MUSELLI, Maud/0000-0002-0470-6866; Bergeron, Anne/0000-0003-2156-254X				Alanio A, 2011, CLIN MICROBIOL INFEC, V17, P1531, DOI 10.1111/j.1469-0691.2010.03400.x; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Botterel F, 2001, J CLIN MICROBIOL, V39, P4076, DOI 10.1128/JCM.39.11.4076-4081.2001; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Chabe M, 2004, EUR J CLIN MICROBIOL, V23, P89, DOI 10.1007/s10096-003-1092-2; Choukri F, 2010, CLIN INFECT DIS, V51, P259, DOI 10.1086/653933; Cisse OH, 2013, MBIO, V4, DOI 10.1128/mBio.00428-12; Cushion MT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001009; Davidson S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-614; de Boer MGJ, 2007, CLIN INFECT DIS, V44, P1143, DOI 10.1086/513198; De Castro N, 2005, BONE MARROW TRANSPL, V36, P879, DOI 10.1038/sj.bmt.1705149; De Castro N, 2012, REV MAL RESPIR, V29, P793, DOI 10.1016/j.rmr.2011.10.975; De Castro N, 2010, CLIN MICROBIOL INFEC, V16, P1375, DOI [10.1111/j.1469-0691.2009.03143.x, 10.1111/j.1469-0691.2010.03143.x]; de Valk HA, 2009, CLIN MICROBIOL INFEC, V15, P180, DOI 10.1111/j.1469-0691.2008.02656.x; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; de Valk HA, 2007, J MICROBIOL METH, V69, P268, DOI 10.1016/j.mimet.2007.01.009; Enache-Angoulvant A, 2010, J CLIN MICROBIOL, V48, P4028, DOI 10.1128/JCM.02140-09; Esteves F, 2011, J CLIN MICROBIOL, V49, P1810, DOI 10.1128/JCM.02303-10; Esteves F, 2010, INFECT GENET EVOL, V10, P192, DOI 10.1016/j.meegid.2009.12.007; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Garcia-Hermoso D, 1999, J CLIN MICROBIOL, V37, P3204, DOI 10.1128/JCM.37.10.3204-3209.1999; Garcia-Hermoso D, 2007, J CLIN MICROBIOL, V45, P3958, DOI 10.1128/JCM.01261-07; Garcia-Hermoso D, 2010, J CLIN MICROBIOL, V48, P2578, DOI 10.1128/JCM.00040-10; Gianella S, 2010, TRANSPL INFECT DIS, V12, P1, DOI 10.1111/j.1399-3062.2009.00447.x; Gigliotti F, 2003, INFECT IMMUN, V71, P3852, DOI 10.1128/IAI.71.7.3852-3856.2003; Gigliotti F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003025; Hauser P, 2009, EMERG INFECT DIS, V15, P506, DOI 10.3201/eid1503.081350; Hauser PM, 2004, INFECT GENET EVOL, V4, P199, DOI 10.1016/j.meegid.2004.01.011; Hauser PM, 1997, J CLIN MICROBIOL, V35, P3086, DOI 10.1128/JCM.35.12.3086-3091.1997; Hauser PM, 1996, J EUKARYOT MICROBIOL, V43, pS34, DOI 10.1111/j.1550-7408.1996.tb04970.x; Hauser PM, 2001, AIDS, V15, P461, DOI 10.1097/00002030-200103090-00004; Helweg-Larsen J, 2001, J CLIN MICROBIOL, V39, P3789, DOI 10.1128/JCM.39.10.3789-3792.2001; Hocker B, 2005, EMERG INFECT DIS, V11, P330; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Illnait-Zaragozi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009124; Le Gal S, 2012, CLIN INFECT DIS, V54, pE62, DOI 10.1093/cid/cir996; Maitte C, 2013, J CLIN MICROBIOL, V51, P2843, DOI 10.1128/JCM.01073-13; Mori S, 2012, RHEUMATOLOGY, V51, P2120, DOI 10.1093/rheumatology/kes244; Nahimana A, 2000, J MED MICROBIOL, V49, P753, DOI 10.1099/0022-1317-49-8-753; Olsson M, 2001, SCAND J INFECT DIS, V33, P285, DOI 10.1080/003655401300077324; Pagano L, 2002, BRIT J HAEMATOL, V117, P379, DOI 10.1046/j.1365-2141.2002.03419.x; Parobek CM, 2014, J CLIN MICROBIOL, V52, P1391, DOI 10.1128/JCM.02531-13; Phipps LM, 2011, TRANSPLANTATION, V92, P1327, DOI 10.1097/TP.0b013e3182384b57; Pliquett RU, 2012, EUR J CLIN MICROBIOL, V31, P2429, DOI 10.1007/s10096-012-1586-x; Rabodonirina L, 2004, EMERG INFECT DIS, V10, P1766; Reid AB, 2011, CURR OPIN INFECT DIS, V24, P534, DOI 10.1097/QCO.0b013e32834cac17; Roblot F, 2003, J INFECTION, V47, P19, DOI 10.1016/S0163-4453(03)00038-0; Schildgen V, 2014, MBIO, V5, DOI 10.1128/mBio.01186-14; Tasaka S, 2012, J INFECT CHEMOTHER, V18, P793, DOI 10.1007/s10156-012-0453-0; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; Wissmann G, 2011, EUR J CLIN INVEST, V41, P343, DOI 10.1111/j.1365-2362.2010.02415.x; Yazaki H, 2009, TRANSPLANTATION, V88, P380, DOI 10.1097/TP.0b013e3181aed389	53	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125763	10.1371/journal.pone.0125763	http://dx.doi.org/10.1371/journal.pone.0125763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933203	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100131
J	Jaiswal, AS; Panda, H; Law, BK; Sharma, J; Jani, J; Hromas, R; Narayan, S				Jaiswal, Aruna S.; Panda, Harekrushna; Law, Brian K.; Sharma, Jay; Jani, Jitesh; Hromas, Robert; Narayan, Satya			NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase beta and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells	PLOS ONE			English	Article							BASE EXCISION-REPAIR; ADENOMATOUS POLYPOSIS-COLI; LONG-PATCH; CELLULAR SENESCENCE; MISMATCH REPAIR; POLY(ADP-RIBOSE) POLYMERASE-1; ALKYLATING-AGENTS; GROWTH ARREST; GLIOMA-CELLS; G(2) ARREST	Recently approved chemotherapeutic agents to treat colorectal cancer (CRC) have made some impact; however, there is an urgent need for newer targeted agents and strategies to circumvent CRC growth and metastasis. CRC frequently exhibits natural resistance to chemotherapy and those who do respond initially later acquire drug resistance. A mechanism to potentially sensitize CRC cells is by blocking the DNA polymerase beta (Pol-beta) activity. Temozolomide (TMZ), an alkylating agent, and other DNA-interacting agents exert DNA damage primarily repaired by a Pol-beta-directed base excision repair (BER) pathway. In previous studies, we used structure-based molecular docking of Pol-beta and identified a potent small molecule inhibitor (NSC666715). In the present study, we have determined the mechanism by which NSC666715 and its analogs block Fen1-induced strand-displacement activity of Pol-beta-directed LP-BER, cause apurinic/apyrimidinic (AP) site accumulation and induce S-phase cell cycle arrest. Induction of S-phase cell cycle arrest leads to senescence and apoptosis of CRC cells through the p53/p21 pathway. Our initial findings also show a 10-fold reduction of the IC50 of TMZ when combined with NSC666715. These results provide a guide for the development of a target-defined strategy for CRC chemotherapy that will be based on the mechanisms of action of NSC666715 and TMZ. This combination strategy can be used as a framework to further reduce the TMZ dosages and resistance in CRC patients.	[Jaiswal, Aruna S.; Hromas, Robert] Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL 32610 USA; [Panda, Harekrushna; Narayan, Satya] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Law, Brian K.] Univ Florida, Dept Pharmacol & Expt Therapeut, Gainesville, FL 32610 USA; [Sharma, Jay; Jani, Jitesh] Celprogen Inc, Torrance, CA 90503 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Narayan, S (corresponding author), Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	snarayan@ufl.edu	Law, Brian/L-6043-2019		National Institutes of Health (NIH) [R01-CA097031]; Celprogen Inc.; NATIONAL CANCER INSTITUTE [R01CA097031] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celprogen Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The financial support for these studies was provided by the National Institutes of Health (NIH) grant R01-CA097031. Celprogen Inc. provided support in the form of salaries for authors Jay Sharma and Jitesh Jani, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balusu R, 2007, BIOCHEMISTRY-US, V46, P13961, DOI 10.1021/bi701632e; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cohen MH, 2005, CLIN CANCER RES, V11, P6767, DOI 10.1158/1078-0432.CCR-05-0722; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Das A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-36; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Gupte M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074071; Hayashi T, 2013, J NEURO-ONCOL, V115, P169, DOI 10.1007/s11060-013-1220-5; Hirose Y, 2005, CANCER RES, V65, P4861, DOI 10.1158/0008-5472.CAN-04-2633; Itahana Koji, 2013, Methods Mol Biol, V965, P143, DOI 10.1007/978-1-62703-239-1_8; Jaiswal AS, 2006, BIOCHEMISTRY-US, V45, P15903, DOI 10.1021/bi0607958; Jaiswal AS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-3; Jaiswal AS, 2013, NEOPLASIA, V15, P454, DOI 10.1593/neo.13176; Jaiswal AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016691; Jaiswal AS, 2009, MOL CANCER RES, V7, P1973, DOI 10.1158/1541-7786.MCR-09-0309; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Jekimovs C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00086; Kaina B, 2002, INT J CLIN PHARM TH, V40, P354; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; Khan OA, 2008, BRIT J CANCER, V98, P1614, DOI 10.1038/sj.bjc.6604366; Knizhnik AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055665; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kumar M, ACTA BIOMED, V83, P220; Liu L, 1999, CLIN CANCER RES, V5, P2908; Liu Lili, 2004, Curr Opin Investig Drugs, V5, P623; Liu LL, 1996, CANCER RES, V56, P5375; Longley DB, 2006, BBA-REV CANCER, V1766, P184, DOI 10.1016/j.bbcan.2006.08.001; Ma WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002059; Marin JJG, 2012, DRUG METAB REV, V44, P148, DOI 10.3109/03602532.2011.638303; Martinkova E, 2010, INT J CANCER, V127, P1240, DOI 10.1002/ijc.25187; McWhirter D, 2013, CRIT REV ONCOL HEMAT, V88, P404, DOI 10.1016/j.critrevonc.2013.05.011; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Nakamura J, 1998, CANCER RES, V58, P222; Narayan S, 2005, J BIOL CHEM, V280, P6942, DOI 10.1074/jbc.M409200200; Narayan S, 2001, BRIT J CANCER, V85, P898, DOI 10.1054/bjoc.2001.2002; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Savonarola A, 2012, PHARMACOGENOMICS J, V12, P277, DOI 10.1038/tpj.2012.28; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Spiro TP, 2001, CLIN CANCER RES, V7, P2309; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Tentori L, 1998, J PHARMACOL EXP THER, V285, P884; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; TSANG LLH, 1991, CANCER CHEMOTH PHARM, V27, P342, DOI 10.1007/BF00688855; Venturelli S, 2013, MOL CANCER THER, V12, P2226, DOI 10.1158/1535-7163.MCT-13-0137; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Weizman N, 2003, J BIOL CHEM, V278, P6741, DOI 10.1074/jbc.M211168200	61	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123808	10.1371/journal.pone.0123808	http://dx.doi.org/10.1371/journal.pone.0123808			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933036	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100024
J	Motl, RW; Putzki, N; Pilutti, LA; Cadavid, D				Motl, Robert W.; Putzki, Norman; Pilutti, Lara A.; Cadavid, Diego			Longitudinal Changes in Self-Reported Walking Ability in Multiple Sclerosis	PLOS ONE			English	Article							TIMED 25-FOOT WALK; IMPACT SCALE MSIS-29; FUNCTIONAL COMPOSITE; CLINICALLY MEANINGFUL; DISEASE PROGRESSION; CONTROLLED-TRIAL; OUTCOME MEASURE; MS; VALIDITY; PERFORMANCE	Background Patient-reported outcomes are increasingly used to understand the clinical meaningfulness of multiple sclerosis disability and its treatments. For example, the 12-item Multiple Sclerosis Walking Scale (MSWS-12) measures the patient-reported impact of the disease on walking ability. Objective We studied longitudinal changes in walking ability using the MSWS-12 in a cohort of 108 patients with relapsing-remitting multiple sclerosis and moderate-to-severe disability from a single US center cohort study investigating multiple sclerosis symptoms and physical activity. Methods The MSWS-12 was completed every 6 months over 2 years together with self-reported measures of disease impact on daily life (Multiple Sclerosis Impact Scale) and walking disability (Patient Determined Disease Steps scale). Results The results revealed a high frequency of self-reported changes in walking ability at the individual level, affecting approximately 80% of patients for all four time periods. MSWS-12 scores remained stable at the group level for all four time periods. The magnitude of observed changes at the individual level was higher than the proposed minimal clinically important differences of 4 or 6 points and correlated better with Multiple Sclerosis Impact Scale physical scores than psychological scores, but little with self-reported Patient Determined Disease Steps Scale scores. Conclusions This novel finding of frequent fluctuations in self-reported walking ability is new and requires further investigation.	[Motl, Robert W.; Pilutti, Lara A.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Putzki, Norman; Cadavid, Diego] Biogen, Clin Dev Grp, Cambridge, MA 02142 USA	University of Illinois System; University of Illinois Urbana-Champaign; Biogen	Cadavid, D (corresponding author), Biogen, Clin Dev Grp, Cambridge, MA 02142 USA.	diego.cadavid@biogen.com			Biogen; National Multiple Sclerosis Society [RG 3926A2/1]	Biogen(Biogen); National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This study was funded by Biogen and by a grant from the National Multiple Sclerosis Society (RG 3926A2/1). Biogen also provided support in the form of salaries for authors (NP, DC) and funding for editorial assistance, and they reviewed an early draft of the manuscript, but the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Benedict RHB, 2006, J NEUROL SCI, V245, P67, DOI 10.1016/j.jns.2005.05.020; Bosma LVAE, 2010, MULT SCLER J, V16, P862, DOI 10.1177/1352458510370464; Cadavid D, 2009, NEUROLOGY, V72, P1976, DOI 10.1212/01.wnl.0000345970.73354.17; Cadavid D, 2011, MULT SCLER J, V17, P1113, DOI 10.1177/1352458511405375; Cadavid D, 2010, REV NEUROLOGIA, V51, P321, DOI 10.33588/rn.5106.2010390; Coleman CI, 2012, CURR MED RES OPIN, V28, P49, DOI 10.1185/03007995.2011.639752; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Goldman MD, 2013, NEUROLOGY, V81, P1856, DOI 10.1212/01.wnl.0000436065.97642.d2; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Hobart J, 2000, BRAIN, V123, P1027, DOI 10.1093/brain/123.5.1027; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart JC, 2005, J NEUROL NEUROSUR PS, V76, P1539, DOI 10.1136/jnnp.2005.064584; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Hobart J, 2013, NEUROLOGY, V80, P1509, DOI 10.1212/WNL.0b013e31828cf7f3; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Holland A, 2006, J NEUROL, V253, P1594, DOI 10.1007/s00415-006-0272-2; Kragt JJ, 2006, MULT SCLER J, V12, P594, DOI 10.1177/1352458506070768; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LaRocca NG, 2011, PATIENT, V4, P189, DOI 10.2165/11591150-000000000-00000; Learmonth YC, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-37; Lincoln JA, 2009, ARCH NEUROL-CHICAGO, V66, P412, DOI 10.1001/archneurol.2009.26; Liu C, 2000, J NEUROL NEUROSUR PS, V68, P450, DOI 10.1136/jnnp.68.4.450; Meier DS, 2010, NEUROLOGY, V75, P799, DOI 10.1212/WNL.0b013e3181f0734c; Motl RW, 2014, EUR NEUROL, V71, P196, DOI 10.1159/000356116; Motl RW, 2013, J NEUROL SCI, V335, P169, DOI 10.1016/j.jns.2013.09.024; Motl RW, 2010, J NERV MENT DIS, V198, P213, DOI 10.1097/NMD.0b013e3181d14131; Orbach R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045409; Paltamaa J, 2007, ARCH PHYS MED REHAB, V88, P1649, DOI 10.1016/j.apmr.2007.07.032; Paltamaa J, 2005, PHYSIOTHER RES INT, V10, P93, DOI 10.1002/pri.30; Riazi A, 2004, MULT SCLER J, V10, P61, DOI 10.1191/1352458504ms986oa; Riazi A, 2002, J NEUROL NEUROSUR PS, V73, P701, DOI 10.1136/jnnp.73.6.701; Schwid SR, 2002, NEUROLOGY, V58, P1294, DOI 10.1212/WNL.58.8.1294; Sutliff MH, 2010, CURR MED RES OPIN, V26, P109, DOI 10.1185/03007990903433528	34	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125002	10.1371/journal.pone.0125002	http://dx.doi.org/10.1371/journal.pone.0125002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932911	Green Submitted, gold, Green Published			2022-12-26	WOS:000353887100072
J	Ahmed, M; Fayyaz-ul-Hassan				Ahmed, Mukhtar; Fayyaz-ul-Hassan			Response of Spring Wheat (Triticum aestivum L.) Quality Traits and Yield to Sowing Date	PLOS ONE			English	Article							GRAIN QUALITY; HEAT-SHOCK; NITROGEN MANAGEMENT; HIGH-TEMPERATURE; PROTEIN-CONTENT; WATER-DEFICIT; BREAD WHEAT; STRESS; DURUM; DROUGHT	The unpredictability and large fluctuation of the climatic conditions in rainfed regions do affect spring wheat yield and grain quality. These variations offer the opportunity for the production of better quality wheat. The effect of variable years, locations and sowing managements on wheat grain yield and quality was studied through field experiments using three genotypes, three locations for two years under rainfed conditions. The two studied years as contrasting years at three locations and sowing dates depicted variability in temperature and water stress during grain filling which resulted considerable change in grain yield and quality. Delayed sowing, years (2009-10) and location (Talagang) with high temperature and water stress resulted increased proline, and grain quality traits i.e. grain protein (GP) and grain ash (GA) than optimum conditions (during 2008-09, at Islamabad and early sowing). However, opposite trend was observed for dry gluten (DG), sodium dodecyl sulphate (SDS), SPAD content and grain yield irrespective of genotypes. The influence of variable climatic conditions was dominant in determining the quality traits and inverse relationship was observed among some quality traits and grain yield. It may be concluded that by selecting suitable locations and different sowing managements for subjecting the crop to desirable environmental conditions (temperature and water) quality traits of wheat crop could be modified.	[Ahmed, Mukhtar] Pir Mehr Ali Shah Arid Agr Univ, Dept Agron, Rawalpindi, Punjab, Pakistan; [Ahmed, Mukhtar] Washington State Univ, Dept Biol Syst Engn, Pullman, WA 99164 USA; [Fayyaz-ul-Hassan] CIIT Ctr Hlth Res, COMSATS, Dept Biosci, Islamabad, Pakistan	Arid Agriculture University; Washington State University; COMSATS University Islamabad (CUI)	Ahmed, M (corresponding author), Pir Mehr Ali Shah Arid Agr Univ, Dept Agron, Rawalpindi, Punjab, Pakistan.	mukhtar.ahmed@wsu.edu	Ahmad, Mukhtar/G-7346-2012; Ahmed, Mukhtar/HIR-3483-2022	Ahmad, Mukhtar/0000-0002-7223-5541; 	Higher Education Commison Pakistan	Higher Education Commison Pakistan	Mukhtar Ahmed received funding from Higher Education Commison Pakistan for PhD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[AACC] American Association of Cereal Chemists, 2010, INT APPR METH, P55; AACC International, 1999, 080101 AACC INT; Akhkha A, 2011, INT J AGRIC BIOL, V13, P215; Allen R. G., 1998, FAO Irrigation and Drainage Paper; BLUMENTHAL CS, 1993, J CEREAL SCI, V18, P3, DOI 10.1006/jcrs.1993.1030; BORGHI B, 1995, AUST J AGR RES, V46, P1365, DOI 10.1071/AR9951365; Carter TR, 2007, CLIMATE CHANGE 2007, P131; Ciaffi M, 1996, J CEREAL SCI, V24, P91, DOI 10.1006/jcrs.1996.0042; Coventry DR, 2011, FIELD CROP RES, V123, P214, DOI 10.1016/j.fcr.2011.05.017; [邓志英 DENG ZhiYing], 2006, [生态学报, Acta Ecologica Sinica], V26, P2757; Dhyani K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24564; Erbs M, 2010, AGR ECOSYST ENVIRON, V136, P59, DOI 10.1016/j.agee.2009.11.009; Fernando N, 2014, AGR ECOSYST ENVIRON, V185, P24, DOI 10.1016/j.agee.2013.11.023; Fischer G, 2002, GLOBAL AGROECOLOGICA; Flagella Z, 2010, EUR J AGRON, V33, P197, DOI 10.1016/j.eja.2010.05.006; Gil DH, 2011, FIELD CROP RES, V123, P1, DOI 10.1016/j.fcr.2011.04.001; Vendruscolo ECG, 2007, J PLANT PHYSIOL, V164, P1367, DOI 10.1016/j.jplph.2007.05.001; Gutierrez M, 2010, J EXP BOT, V61, P3291, DOI 10.1093/jxb/erq156; Gutierrez M, 2010, CROP SCI, V50, P197, DOI 10.2135/cropsci2009.07.0381; Gutierrez-Rodriguez M, 2004, AUST J AGR RES, V55, P1139, DOI 10.1071/AR04214; Guttieri MJ, 2001, CROP SCI, V41, P327, DOI 10.2135/cropsci2001.412327x; Hamblin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092529; Hayat S, 2014, J PLANT INTERACT, V9, P35, DOI 10.1080/17429145.2012.751635; Hurkman WJ, 2009, J CEREAL SCI, V49, P12, DOI 10.1016/j.jcs.2008.06.014; Jiang D, 2009, J AGRON CROP SCI, V195, P89, DOI 10.1111/j.1439-037X.2008.00353.x; Labuschagne MT, 2009, CEREAL CHEM, V86, P61, DOI 10.1094/CCHEM-86-1-0061; Larsson H, 1997, J TEXTURE STUD, V28, P487, DOI 10.1111/j.1745-4603.1997.tb00132.x; Li YF, 2013, J CEREAL SCI, V57, P398, DOI 10.1016/j.jcs.2013.01.005; Miller RO, 1999, P 4 INT C PREC AGR A; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; Moinuddin, 2005, AGRON J, V97, P1062, DOI 10.2134/agronj2004.0152; Moldestad A, 2014, J CEREAL SCI, V60, P406, DOI 10.1016/j.jcs.2014.05.003; Motzo R, 2007, J SCI FOOD AGR, V87, P1480, DOI 10.1002/jsfa.2855; Noorka IR, 2009, PAK J BOT, V41, P2917; Otteson BN, 2008, CROP SCI, V48, P749, DOI 10.2135/cropsci2007.08.0473; R Core Team, 2018, R LANG ENV STAT COMP; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Singh S, 2010, FOOD CHEM, V122, P559, DOI 10.1016/j.foodchem.2010.03.010; Souza EJ, 2004, CROP SCI, V44, P425, DOI 10.2135/cropsci2004.0425; Sun M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075191; Tausz M, 2013, ENVIRON EXP BOT, V88, P71, DOI 10.1016/j.envexpbot.2011.12.005; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Toscano P, 2014, EUR J AGRON, V61, P1, DOI 10.1016/j.eja.2014.08.003; van Ogtrop F, 2014, METEOROL APPL, V21, P431, DOI 10.1002/met.1429; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; Wang YX, 2011, AGR ECOSYST ENVIRON, V141, P271, DOI 10.1016/j.agee.2011.03.017; Wardlaw IF, 2002, FUNCT PLANT BIOL, V29, P25, DOI 10.1071/PP00147; WARDLAW IF, 1995, AUST J PLANT PHYSIOL, V22, P391, DOI 10.1071/PP9950391; Zhao Hui, 2007, Acta Agronomica Sinica, V33, P2021	49	24	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126097	10.1371/journal.pone.0126097	http://dx.doi.org/10.1371/journal.pone.0126097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927839	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100127
J	Colazzo, F; Castiglioni, L; Sironi, L; Fontana, L; Nobili, E; Franzosi, M; Guerrini, U				Colazzo, Francesca; Castiglioni, Laura; Sironi, Luigi; Fontana, Lucia; Nobili, Elena; Franzosi, Matteo; Guerrini, Uliano			Murine Left Atrium and Left Atrial Appendage Structure and Function: Echocardiographic and Morphologic Evaluation	PLOS ONE			English	Article							VENTRICULAR-FUNCTION; SYSTOLIC FUNCTION; CARDIAC-FUNCTION; HEART; MICE; MOUSE; DETERMINANTS; HYPERTROPHY; ULTRASOUND; FLOW	Aim of this study was to provide an echocardiographic protocol for the description of the normal murine venous reservoir (atrium, appendage and pulmonary veins) and to investigate the possibility to use this approach to discriminate changes on left atrium (LA) and left atrial appendage (LAA) in a stress-induced model such us myocardial infarction. Global left ventricular function and the venous reservoir were assessed by a Vevo2100 in 20 female C57BL/6N. LA and LAA were also studied in 10 CD-1 and 10 FVB mice, whereas modifications investigated in 15 C57BL/6N subjected to coronary artery ligation. Left ventricle function was evaluated as well as pulsed Doppler mitral valve, pulmonary vein, and LAA velocities. From 2D view monoplane LA volumes were obtained and LAA long axis measured. Macroscopic inspection with casts and immunohistochemistry were performed. Results show that compared to humans, in C57BL/6N mice left atrium was disproportionately smaller (5.2 +/- 1.4 mu L) than the left ventricle (53 +/- 8 mu L) and connected through a duct by a large LAA and posteriorly to three pulmonary veins. The LA volume increased 2-fold during reservoir with two distinct phases, early and late divided by a short pause. LAA long axis (4.1 +/- 0.5mm) was almost 2 times longer than the LA. LAA flow volume together with LA volume reservoir account for about 36% of stroke volume and the rest was provided by conduit flow. Linear regressions showed that stroke volume was strongly influenced by LAA flow, LA early filling volume and left ventricle base descent. Moreover, we also report the ability to assess LA and LAA in other mice strains and discriminate size increase following myocardial infarction. In conclusion, we performed a complete characterization of murine left venous reservoir establishing an optimized protocol that can be used in both investigative and pharmacological studies requiring rapid and serial determination of cardiac structure and function.	[Colazzo, Francesca; Sironi, Luigi; Nobili, Elena] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Castiglioni, Laura; Sironi, Luigi; Fontana, Lucia; Franzosi, Matteo; Guerrini, Uliano] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan	Guerrini, U (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	labtremoli@gmail.com	Sironi, Luigi/S-8174-2016; Fontana, Lucia/J-8778-2015	COLAZZO, FRANCESCA/0000-0002-5782-1606; castiglioni, laura/0000-0002-0772-3231; Fontana, Lucia/0000-0001-9564-2310; SIRONI, LUIGI/0000-0002-4738-3454	Region Lombardy (Italy) [1137]; Institutional Funding (Ricerca Corrente) at Centro Cardiologico Monzino	Region Lombardy (Italy); Institutional Funding (Ricerca Corrente) at Centro Cardiologico Monzino	This study was partially granted by Region Lombardy (Italy) (deliberation no 1137 - 10/12/2010) in support to innovative research and by Institutional Funding (Ricerca Corrente) at Centro Cardiologico Monzino.	Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Barbier P, 1999, CIRCULATION, V100, P427, DOI 10.1161/01.CIR.100.4.427; Barbier P, 2000, J AM COLL CARDIOL, V35, P1947, DOI 10.1016/S0735-1097(00)00642-2; Baumann PQ, 2008, ECHOCARDIOGR-J CARD, V25, P739, DOI 10.1111/j.1540-8175.2008.00680.x; Bose AK, 2007, ECHOCARDIOGR-J CARD, V24, P412, DOI 10.1111/j.1540-8175.2007.00402.x; Collins KA, 2003, PHYSIOL GENOMICS, V13, P227, DOI 10.1152/physiolgenomics.00005.2003; Dewald O, 2003, P NATL ACAD SCI USA, V100, P2700, DOI 10.1073/pnas.0438035100; Fayssoil A, 2013, HEART FAIL REV, V18, P511, DOI 10.1007/s10741-012-9345-8; Franzosi M, 2011, COMPUT BIOL MED, V41, P829, DOI 10.1016/j.compbiomed.2011.06.021; GARDIN JM, 1995, CIRC RES, V76, P907, DOI 10.1161/01.RES.76.5.907; Gottlieb S, 1995, J Am Soc Echocardiogr, V8, P149, DOI 10.1016/S0894-7317(05)80404-3; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hoit BD, 2006, TOXICOL PATHOL, V34, P105, DOI 10.1080/01926230500369535; HOIT BD, 1993, CIRC RES, V72, P167, DOI 10.1161/01.RES.72.1.167; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; KALMANSON D, 1971, CARDIOVASC RES, V5, P293, DOI 10.1093/cvr/5.3.293; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Kruithof BPT, 2003, DEV DYNAM, V227, P1, DOI 10.1002/dvdy.10269; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Ponten A, 2003, AM J PATHOL, V163, P673, DOI 10.1016/S0002-9440(10)63694-2; RAJAGOPALAN B, 1979, CARDIOVASC RES, V13, P677, DOI 10.1093/cvr/13.12.677; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; SUGA H, 1974, CIRC RES, V35, P39, DOI 10.1161/01.RES.35.1.39; Triposkiadis F, 2007, J AM SOC ECHOCARDIOG, V20, P177, DOI 10.1016/j.echo.2006.08.013; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967; Zhang Y, 2007, AM J PHYSIOL-HEART C, V292, pH1187, DOI 10.1152/ajpheart.00895.2006; Zhou YQ, 2004, PHYSIOL GENOMICS, V18, P232, DOI 10.1152/physiolgenomics.00026.2004; Zhou YQ, 2003, AM J PHYSIOL-HEART C, V285, pH1563, DOI 10.1152/ajpheart.00384.2003	30	7	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125541	10.1371/journal.pone.0125541	http://dx.doi.org/10.1371/journal.pone.0125541			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928887	Green Published, gold			2022-12-26	WOS:000353713100100
J	Li, R; Xiao, J; Qing, XT; Xing, JH; Xia, YF; Qi, J; Liu, XJ; Zhang, S; Sheng, X; Zhang, XY; Ji, XP				Li, Rui; Xiao, Jie; Qing, Xiaoteng; Xing, Junhui; Xia, Yanfei; Qi, Jia; Liu, Xiaojun; Zhang, Sen; Sheng, Xi; Zhang, Xinyu; Ji, Xiaoping			Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-beta and MAPKs Pathways in Cardiac Fibroblasts	PLOS ONE			English	Article							MATRIX GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; DNA-BINDING ACTIVITY; NF-KAPPA-B; COLLAGEN GENE; DOWN-REGULATION; TRANSCRIPTION; PROLIFERATION; MICRORNAS; CELLS	MicroRNA-7a/b (miR-7a/b) protects cardiac myocytes from apoptosis during ischemia/reperfusion injury; however, its role in angiotensin II (ANG II)-stimulated cardiac fibroblasts (CFs) remains unknown. Therefore, the present study investigated the anti-fibrotic mechanism of miR-7a/b in ANG II-treated CFs. ANG II stimulated the expression of specific protein 1 (Sp1) and collagen I in a dose-and time-dependent manner, and the overexpression of miR-7a/b significantly down-regulated the expression of Sp1 and collagen I stimulated by ANG II (100 nM) for 24 h. miR-7a/b overexpression effectively inhibited MMP-2 expression/activity and MMP-9 expression, as well as CF proliferation and migration. In addition, miR7a/b also repressed the activation of TGF-beta, ERK, JNK and p38 by ANG II. The inhibition of Sp1 binding activity by mithramycin prevented collagen I overproduction; however, miR-7a/b down-regulation reversed this effect. Further studies revealed that Sp1 also mediated miR-7a/b-regulated MMP expression and CF migration, as well as TGF-beta and ERK activation. In conclusion, miR-7a/b has an anti-fibrotic role in ANG II-treated CFs that is mediated by Sp1 mechanism involving the TGF-beta and MAPKs pathways.	[Li, Rui; Xiao, Jie; Qing, Xiaoteng; Xing, Junhui; Xia, Yanfei; Sheng, Xi; Zhang, Xinyu; Ji, Xiaoping] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Li, Rui; Xiao, Jie; Qing, Xiaoteng; Xing, Junhui; Xia, Yanfei; Sheng, Xi; Zhang, Xinyu; Ji, Xiaoping] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Xing, Junhui] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Shandong, Peoples R China; [Qi, Jia; Liu, Xiaojun] Cent Hosp Zibo, Dept Cardiol, Zibo, Shandong, Peoples R China; [Zhang, Sen] Shandong Univ, Qilu Hosp, Dept Cardiol, Qingdao, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Ji, XP (corresponding author), Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China.	jxp1964@hotmail.com			National Natural Science Foundation of China [81070087]; National 973 Basic Research Program of China [2012CB722406]; Natural Science Foundation of Shandong Province [ZR2010HM063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the the National Natural Science Foundation of China [81070087], and the National 973 Basic Research Program of China [2012CB722406], The Natural Science Foundation of Shandong Province [ZR2010HM063]. The URL of the funder's website: http://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracey NA, 2014, J BIOL CHEM, V289, P19571, DOI 10.1074/jbc.M114.550624; Chae YM, 2006, GENE THER, V13, P430, DOI 10.1038/sj.gt.3302696; Cui Y, 2014, STEM CELLS DEV, V23, P393, DOI 10.1089/scd.2013.0342; Cutroneo KR, 2000, MOL BIOL REP, V27, P191, DOI 10.1023/A:1007206014638; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Etoh M, 2013, ARCH DERMATOL RES, V305, P9, DOI 10.1007/s00403-012-1287-4; Feng HJ, 2014, BRAZ J MED BIOL RES, V47, P361, DOI 10.1590/1414-431X20142937; FERREIRA J, 1988, FEBS LETT, V234, P485, DOI 10.1016/0014-5793(88)80143-1; Gonzalez GE, 2015, J HYPERTENS, V33, P144, DOI 10.1097/HJH.0000000000000358; Haase M, 2000, INT J RADIAT BIOL, V76, P487, DOI 10.1080/095530000138484; Hitraya EG, 1998, ARTHRITIS RHEUM-US, V41, P2048, DOI 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X; Hori Y, 2012, AM J PHYSIOL-CELL PH, V303, pC947, DOI 10.1152/ajpcell.00401.2011; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Ihn H, 1996, J BIOL CHEM, V271, P26717, DOI 10.1074/jbc.271.43.26717; Ihn H, 2000, J INVEST DERMATOL, V114, P1011, DOI 10.1046/j.1523-1747.2000.00956.x; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; Iwata M, 2011, J MOL CELL CARDIOL, V51, P542, DOI 10.1016/j.yjmcc.2010.12.003; Jia LF, 2014, ORAL ONCOL, V50, P1062, DOI 10.1016/j.oraloncology.2014.07.010; Jiang BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059621; Jiang L, 2013, EXP CELL RES, V319, P2254, DOI 10.1016/j.yexcr.2013.06.007; Jiang XY, 2013, J PHYSIOL SCI, V63, P31, DOI 10.1007/s12576-012-0230-y; Ju HS, 1996, MOL CELL BIOCHEM, V164, P231, DOI 10.1007/BF00408663; Kajihara I, 2012, AM J PATHOL, V180, P703, DOI 10.1016/j.ajpath.2011.10.030; Kum YS, 2007, BIOCHEM BIOPH RES CO, V363, P368, DOI 10.1016/j.bbrc.2007.08.176; Li B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090096; Li LP, 2014, HYPERTENSION, V64, P94, DOI 10.1161/HYPERTENSIONAHA.113.03021; Li YY, 2000, P NATL ACAD SCI USA, V97, P12746, DOI 10.1073/pnas.97.23.12746; Lijnen PJ, 2012, CARDIOVASC THER, V30, pe1, DOI 10.1111/j.1755-5922.2010.00205.x; Marzioni M, 2014, HEPATOLOGY, V60, P1324, DOI 10.1002/hep.27262; Okada M, 2010, J VET MED SCI, V72, P735, DOI 10.1292/jvms.09-0582; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Papakrivopoulou J, 2004, CARDIOVASC RES, V61, P736, DOI 10.1016/j.cardiores.2003.12.018; Park JH, 2009, J GENE MED, V11, P824, DOI 10.1002/jgm.1355; Parthasarathy A, 2013, MOL CELL BIOCHEM, V378, P217, DOI 10.1007/s11010-013-1612-z; Pires PW, 2011, AM J PHYSIOL-HEART C, V301, pH87, DOI 10.1152/ajpheart.01206.2010; Reddy VS, 2010, AM J PHYSIOL-HEART C, V299, pH1242, DOI 10.1152/ajpheart.00451.2010; RIPPE RA, 1995, HEPATOLOGY, V22, P241, DOI 10.1016/0270-9139(95)90378-X; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Siddesha JM, 2014, CELL SIGNAL, V26, P933, DOI 10.1016/j.cellsig.2014.01.005; Siddesha JM, 2013, J MOL CELL CARDIOL, V65, P9, DOI 10.1016/j.yjmcc.2013.09.015; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Wang WK, 2014, INT J CARDIOL, V172, P202, DOI 10.1016/j.ijcard.2014.01.011; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016/j.jmb.2011.09.027; Wei LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070195; Wei LH, 2013, CARDIOVASC RES, V99, P665, DOI 10.1093/cvr/cvt151; Yang HC, 2014, NUCLEIC ACIDS RES, V42, P13573, DOI 10.1093/nar/gku1145; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhao XH, 2012, MOL BIOL CELL, V23, P2867, DOI 10.1091/mbc.E12-04-0270	55	29	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125513	10.1371/journal.pone.0125513	http://dx.doi.org/10.1371/journal.pone.0125513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923922	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600153
J	Reimer, JJ; Vargas, R; Rivas, D; Gaxiola-Castro, G; Hernandez-Ayon, JM; Lara-Lara, R				Reimer, Janet J.; Vargas, Rodrigo; Rivas, David; Gaxiola-Castro, Gilberto; Martin Hernandez-Ayon, J.; Lara-Lara, Ruben			Sea Surface Temperature Influence on Terrestrial Gross Primary Production along the Southern California Current	PLOS ONE			English	Article							BAJA-CALIFORNIA; GREENHOUSE-GAS; COASTAL; VARIABILITY; WATER; EVOLUTION; MOISTURE; FUTURE; WINDS; FOG	Some land and ocean processes are related through connections (and synoptic-scale tele-connections) to the atmosphere. Synoptic-scale atmospheric (El Nino/Southern Oscillation [ENSO], Pacific Decadal Oscillation [PDO], and North Atlantic Oscillation [NAO]) decadal cycles are known to influence the global terrestrial carbon cycle. Potentially, smaller scale land-ocean connections influenced by coastal upwelling (changes in sea surface temperature) may be important for local-to-regional water-limited ecosystems where plants may benefit from air moisture transported from the ocean to terrestrial ecosystems. Here we use satellite-derived observations to test potential connections between changes in sea surface temperature (SST) in regions with strong coastal upwelling and terrestrial gross primary production (GPP) across the Baja California Peninsula. This region is characterized by an arid/semiarid climate along the southern California Current. We found that SST was correlated with the fraction of photosynthetic active radiation (fPAR; as a proxy for GPP) with lags ranging from 0 to 5 months. In contrast ENSO was not as strongly related with fPAR as SST in these coastal ecosystems. Our results show the importance of local-scale changes in SST during upwelling events, to explain the variability in GPP in coastal, water-limited ecosystems. The response of GPP to SST was spatially-dependent: colder SST in the northern areas increased GPP (likely by influencing fog formation), while warmer SST at the southern areas was associated to higher GPP (as SST is in phase with precipitation patterns). Interannual trends in fPAR are also spatially variable along the Baja California Peninsula with increasing secular trends in subtropical regions, decreasing trends in the most arid region, and no trend in the semi-arid regions. These findings suggest that studies and ecosystem process based models should consider the lateral influence of local-scale ocean processes that could influence coastal ecosystem productivity.	[Reimer, Janet J.; Vargas, Rodrigo] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Reimer, Janet J.; Rivas, David; Gaxiola-Castro, Gilberto; Lara-Lara, Ruben] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Reimer, Janet J.] Programa Mexicano Carbono, Texcoco, Estado De Mexic, Mexico; [Martin Hernandez-Ayon, J.] Univ Autonoma Baja California, Inst Invest Oceanol, Ensenada, Baja California, Mexico	University of Delaware; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Autonoma de Baja California	Vargas, R (corresponding author), Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA.	rvargas@udel.edu	Rivas, David/B-3439-2017; Hernandez-Ayon, Jose Martin/AAV-9088-2021; Vargas, Rodrigo/C-4720-2008	Hernandez-Ayon, Jose Martin/0000-0001-6869-6225; Vargas, Rodrigo/0000-0001-6829-5333; Rivas, David/0000-0002-7855-4797	Mexican Carbon Program (Programa Mexicano del Carbono); Centro de Investigacion Cientifica y de Educacion Superior de Ensenada's (CICESE) [625118]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB-2009-128940-F]; CICESE's internal projects; CONACYT [CB 2009/129140]; NASA under Carbon Monitoring System [NNX13AQ06G]; USDA [2014-67003-22070]	Mexican Carbon Program (Programa Mexicano del Carbono); Centro de Investigacion Cientifica y de Educacion Superior de Ensenada's (CICESE); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CICESE's internal projects; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NASA under Carbon Monitoring System; USDA(United States Department of Agriculture (USDA))	The Mexican Carbon Program (Programa Mexicano del Carbono) provided a Postdoctoral scholarship to JJR for the elaboration of this work. JJR also thanks the University of Delaware for fostering a Visiting Scholar position which allowed for collaborations with RV in the early stages of this project. DR has been funded by Centro de Investigacion Cientifica y de Educacion Superior de Ensenada's (CICESE) budget through the internal project number 625118, and Consejo Nacional de Ciencia y Tecnologia (CONACYT) project CB-2009-128940-F. GGC and RLL have also been funded through CICESE's internal projects and CONACYT project CB 2009/129140. This work is part of the North American Carbon Program, and RV acknowledges support from NASA under Carbon Monitoring System (NNX13AQ06G) and USDA (2014-67003-22070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badan A., 2003, GEOFISICA INT, V42, P567; Bakun A, 2004, ECOL LETT, V7, P1015, DOI 10.1111/j.1461-0248.2004.00665.x; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Bane JM, 2005, J GEOPHYS RES, V110; Carbone MS, 2013, GLOBAL CHANGE BIOL, V19, P484, DOI 10.1111/gcb.12054; Casey KS, 2001, J CLIMATE, V14, P3801, DOI 10.1175/1520-0442(2001)014<3801:GARSST>2.0.CO;2; Cavazos T, 2004, CLIM RES, V25, P229, DOI 10.3354/cr025229; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Di Lorenzo E, 2005, J PHYS OCEANOGR, V35, P336, DOI 10.1175/JPO-2690.1; Durazo R, 2002, PROG OCEANOGR, V54, P7, DOI 10.1016/S0079-6611(02)00041-1; Feng WM, 2014, EARTH PLANET SC LETT, V401, P47, DOI 10.1016/j.epsl.2014.05.046; Fischer DT, 2009, J BIOGEOGR, V36, P783, DOI 10.1111/j.1365-2699.2008.02025.x; Garcia-Oliva F., 1991, Geografiska Annaler, Series A, Physical Geography, V73A, P179; Garreaud R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000709; Gimeno L, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000389; Gimeno L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043712; Goldstein AH, 2000, AGR FOREST METEOROL, V101, P113, DOI 10.1016/S0168-1923(99)00168-9; Houghton RA, 2003, TREATISE GEOCHEMISTR, V8, P473, DOI [DOI 10.1016/B0-08-043751-6/08168-8, 10.1016/B0-08-043751-6/08168-8]; Hsieh WW, 1992, FISH OCEANOGR, V1, P333, DOI DOI 10.1111/J.1365-2419.1992.TB00005.X; Knippertz P, 2010, J CLIMATE, V23, P987, DOI 10.1175/2009JCLI3333.1; Koracin D, 2005, BOUND-LAY METEOROL, V117, P447, DOI 10.1007/s10546-005-2772-5; Lewis J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002833; Linacre L, 2010, CONT SHELF RES, V30, P1730, DOI 10.1016/j.csr.2010.07.011; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Muenchow J, 2013, BIOTROPICA, V45, P557, DOI 10.1111/btp.12049; Nyquist H., 1928, T AM I ELECT ING, V47, P617, DOI [10.1109/T-AIEE.1928.5055024, DOI 10.1109/T-AIEE.1928.5055024]; Palacios DM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002380; Pares-Sierra A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016716; Pavia EG, 1998, GEOPHYS RES LETT, V25, P3855, DOI 10.1029/1998GL900029; Pegau WS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014076; Piao SL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002848; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schwinning S, 2001, J ECOL, V89, P464, DOI 10.1046/j.1365-2745.2001.00576.x; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Tian YH, 2000, IEEE T GEOSCI REMOTE, V38, P2387, DOI 10.1109/36.868894; Tokinaga H, 2009, J GEOPHYS RES, V114; Trenberth K, 2005, SCIENCE, V308, P1753, DOI 10.1126/science.1112551; Turner Raymond M., 1965, CHANGING MILE ECOLOG; Vargas R, 2013, ECOSYSTEMS, V16, P749, DOI 10.1007/s10021-013-9648-1; Wharton S, 2009, GLOBAL CHANGE BIOL, V15, P2187, DOI 10.1111/j.1365-2486.2009.01952.x; Zaytsev O, 2003, J OCEANOGR, V59, P489, DOI 10.1023/A:1025544700632	41	7	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125177	10.1371/journal.pone.0125177	http://dx.doi.org/10.1371/journal.pone.0125177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923109	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600131
J	Yu, W; Chen, XJ; Yi, Q; Chen, Y; Zhang, Y				Yu, Wei; Chen, Xinjun; Yi, Qian; Chen, Yong; Zhang, Yang			Variability of Suitable Habitat of Western Winter-Spring Cohort for Neon Flying Squid in the Northwest Pacific under Anomalous Environments	PLOS ONE			English	Article							REMOTE-SENSING DATA; OMMASTREPHES-BARTRAMII; SUITABILITY INDEX; DOSIDICUS-GIGAS; FISHING GROUNDS; LIFE-HISTORY; TUNA; FISHERY; CATCH; IMPACTS	We developed a habitat suitability index (HSI) model to evaluate the variability of suitable habitat for neon flying squid (Ommastrephes bartramii) under anomalous environments in the Northwest Pacific Ocean. Commercial fisheries data from the Chinese squid-jigging vessels on the traditional fishing ground bounded by 35 degrees-45 degrees N and 150 degrees-175 degrees E from July to November during 1998-2009 were used for analyses, as well as the environmental variables including sea surface temperature (SST), chlorophyll-a (Chl-a) concentration, sea surface height anomaly (SSHA) and sea surface salinity (SSS). Two empirical HSI models (arithmeticmean model, AMM; geometric mean model, GMM) were established according to the frequency distribution of fishing efforts. The AMM model was found to perform better than the GMM model. The AMM-based HSI model was further validated by the fishery and environmental data in 2010. The predicted HSI values in 1998 (high catch), 2008 (average catch) and 2009 (low catch) indicated that the squid habitat quality was strongly associated with the ENSO-induced variability in the oceanic conditions on the fishing ground. The La Nina events in 1998 tended to yield warm SST and favorable range of Chl-a concentration and SSHA, resulting in high-quality habitats for O. bartramii. While the fishing ground in the El Nino year of 2009 experienced anomalous cool waters and unfavorable range of Chl-a concentration and SSHA, leading to relatively low-quality squid habitats. Our findings suggest that the La Nina event in 1998 tended to result in more favorable habitats for O. bartramii in the Northwest Pacific with the gravity centers of fishing efforts falling within the defined suitable habitat and yielding high squid catch; whereas the El Nino event in 2009 yielded less favorable habitat areas with the fishing effort distribution mismatching the suitable habitat and a dramatic decline of the catch of O. bartramii. This study might provide some potentially valuable insights into exploring the relationship between the underlying squid habitat and the inter-annual environmental change.	[Yu, Wei; Chen, Xinjun; Yi, Qian; Zhang, Yang] Shanghai Ocean Univ, Coll Marine Sci, Shanghai 201306, Peoples R China; [Chen, Xinjun; Yi, Qian] Shanghai Ocean Univ, Natl Engn Res Ctr Ocean Fisheries, Shanghai 201306, Peoples R China; [Chen, Xinjun; Yi, Qian] Shanghai Ocean Univ, Key Lab Sustainable Exploitat Ocean Fisheries Res, Minist Educ, Shanghai 201306, Peoples R China; [Chen, Yong] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Yu, Wei; Chen, Xinjun; Yi, Qian; Chen, Yong] Collaborat Innovat Ctr Distant Water Fisheries, Shanghai 201306, Peoples R China	Shanghai Ocean University; National Engineering Research Center for Oceanic Fisheries; Shanghai Ocean University; Shanghai Ocean University; University of Maine System; University of Maine Orono	Chen, XJ (corresponding author), Shanghai Ocean Univ, Coll Marine Sci, Shanghai 201306, Peoples R China.	xjchen@shou.edu.cn			National High-Tech R&D Program (863 Program) of China [2012AA092303]; Project of Shanghai Science and Technology Innovation [12231203900]; Industrialization Program of National Development and Reform Commission [2159999]; National Key Technologies R&D Program of China [2013BAD13B00]; Shanghai Universities First-Class Disciplines Project (Fisheries A); Funding Program for Outstanding Dissertations in Shanghai Ocean University; Shanghai Ocean University International Center for Marine Studies	National High-Tech R&D Program (863 Program) of China(National High Technology Research and Development Program of China); Project of Shanghai Science and Technology Innovation; Industrialization Program of National Development and Reform Commission; National Key Technologies R&D Program of China(National Key Technology R&D Program); Shanghai Universities First-Class Disciplines Project (Fisheries A); Funding Program for Outstanding Dissertations in Shanghai Ocean University; Shanghai Ocean University International Center for Marine Studies	This study was financially supported by the National High-Tech R&D Program (863 Program) of China (2012AA092303), the Project of Shanghai Science and Technology Innovation (12231203900), the Industrialization Program of National Development and Reform Commission (2159999), the National Key Technologies R&D Program of China (2013BAD13B00), the Shanghai Universities First-Class Disciplines Project (Fisheries A), and the Funding Program for Outstanding Dissertations in Shanghai Ocean University. Y. Chen's involvement is supported by the Shanghai Ocean University International Center for Marine Studies.	Anderson CIH, 2001, FISH RES, V54, P133, DOI 10.1016/S0165-7836(01)00378-2; Arguelles J, 2001, FISH RES, V54, P51, DOI 10.1016/S0165-7836(01)00380-0; Bertrand A, 2002, CAN J FISH AQUAT SCI, V59, P1002, DOI 10.1139/F02-073; Bovee K, 1988, P WORKSH DEV EV HAB, P11; Cao J, 2009, MAR ECOL PROG SER, V381, P119, DOI 10.3354/meps07969; Chang YJ, 2013, ICES J MAR SCI, V70, P1000, DOI 10.1093/icesjms/fss190; Chen Chih-Shin, 1999, Acta Zoologica Taiwanica, V10, P135; Chen X.J., 1997, J SHANGHAI FISH U, V6, P285; Chen X. J., 2009, CEPHALOPOD WORLD, P60; Chen X. J., 2005, PERIODICAL OCEAN U C, V35, P101; Chen XJ, 2007, ICES J MAR SCI, V64, P1152, DOI 10.1093/icesjms/fsm103; Chen Xin-Jun, 2013, Zhongguo Haiyang Daxue Xuebao, V43, P29; Chen Xin-jun, 2005, Shanghai Shuichan Daxue Xuebao, V14, P168; Chen Xin-Jun, 2009, Oceanologia et Limnologia Sinica, V40, P707; Chen XJ, 2008, FISH RES, V92, P221, DOI 10.1016/j.fishres.2008.01.011; Chen XJ, 2014, ACTA OCEANOL SIN, V33, P45, DOI 10.1007/s13131-014-0452-3; Chen XJ, 2011, CHIN J OCEANOL LIMN, V29, P493, DOI 10.1007/s00343-011-0058-y; Chen XJ, 2010, FISH B-NOAA, V108, P1; Chen XJ, 2009, J OCEANOGR, V65, P93, DOI 10.1007/s10872-009-0009-9; Chen XJ, 2004, FISHERIES RESOURCES, P121; Chen XJ, 2012, PERIODICAL OCEAN U C, V42, P052; [程家骅 Cheng Jiahua], 2003, [中国水产科学, Journal of Fishery Sciences of China], V10, P507; [樊伟 Fan Wei], 2004, [高技术通讯, High Technology Letters], V14, P84; Fan W, 2009, CHIN J OCEANOL LIMN, V27, P408, DOI 10.1007/s00343-009-9107-1; [冯波 FENG Bo], 2007, [水产学报, Journal of Fisheries of China], V31, P805; Gillenwater D, 2006, ECOL ENG, V28, P311, DOI 10.1016/j.ecoleng.2006.08.003; Gong CX, 2012, J OCEAN U CHINA, V11, P241, DOI 10.1007/s11802-012-1898-6; Gore JA, 1996, REGUL RIVER, V12, P459; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Ichii T, 2009, MAR ECOL PROG SER, V378, P1, DOI 10.3354/meps07873; Lee PF, 2005, ZOOL STUD, V44, P260; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Li G, 2014, INT J REMOTE SENS, V35, P4399, DOI 10.1080/01431161.2014.916057; Maddock I, 1999, FRESHWATER BIOL, V41, P373, DOI 10.1046/j.1365-2427.1999.00437.x; Mohri Masahiko, 1999, Journal of National Fisheries University, V47, P43; MURATA M, 1990, MAR BEHAV PHYSIOL, V18, P19, DOI 10.1080/10236249009378779; Murata M., 1998, INT S LARG PEL SQUID, P13; Murphy EJ, 1999, EVOL ECOL, V13, P517, DOI 10.1023/A:1006783902331; Nigmatullin CM, 2001, FISH RES, V54, P9, DOI 10.1016/S0165-7836(01)00371-X; Nishikawa H, 2014, FISH OCEANOGR, V23, P289, DOI 10.1111/fog.12064; Rodhouse PG, 2001, FISH RES, V54, P3, DOI 10.1016/S0165-7836(01)00370-8; Roper CFE, 1984, FAO FISH SYNOP; Seki Michael P., 1993, International North Pacific Fisheries Commission Bulletin, V53, P207; Su NJ, 2011, ICES J MAR SCI, V68, P1072, DOI 10.1093/icesjms/fsr028; Swain DP, 2003, CAN J FISH AQUAT SCI, V60, P897, DOI 10.1139/F03-076; TANG FH, 2011, OCEAN TECHNOLOGY, V30, P7; Terrel JW, 1984, P WORKSH FISH HAB SU, P6; Tian SQ, 2009, CHIN J OCEANOL LIMN, V27, P729, DOI 10.1007/s00343-009-9199-7; Tian SQ, 2009, FISH RES, V95, P181, DOI 10.1016/j.fishres.2008.08.012; Vinagre C, 2006, FISH RES, V82, P140, DOI 10.1016/j.fishres.2006.07.011; Waluda CM, 2006, FISH RES, V79, P56, DOI 10.1016/j.fishres.2006.02.017; Wang WY, 2010, INT J REMOTE SENS, V31, P4515, DOI 10.1080/01431161.2010.485139; Xu Bing, 2012, Journal of Fisheries of China, V36, P696; Yamagata T., 1985, J OCEANOGR SOC JAPAN, V41, P274, DOI DOI 10.1007/BF02109276; Yatsu A, 1997, FISH RES, V29, P257, DOI 10.1016/S0165-7836(96)00541-3; Yatsu A, 1998, INT S LARG PEL SQUID, P31; Yen KW, 2012, INT J REMOTE SENS, V33, P7507, DOI 10.1080/01431161.2012.685973; Yu W, 2012, J GUANGDONG OCEAN U, V32, P74; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	59	31	51	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122997	10.1371/journal.pone.0122997	http://dx.doi.org/10.1371/journal.pone.0122997			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923519	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600027
J	Zhang, GM; Bao, CY; Wan, FN; Cao, DL; Qin, XJ; Zhang, HL; Zhu, Y; Dai, B; Shi, GH; Ye, DW				Zhang, Gui-Ming; Bao, Chun-Yang; Wan, Fang-Ning; Cao, Da-Long; Qin, Xiao-Jian; Zhang, Hai-Liang; Zhu, Yao; Dai, Bo; Shi, Guo-Hai; Ye, Ding-Wei			MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; REPRESSION	Micro (mi) RNAs are important regulators involved in various physical and pathological processes, including cancer. The miRNA-302 family has been documented as playing a critical role in carcinogenesis. In this study, we investigated the role of miRNA-302a in prostate cancer (PCa). MiRNA-302a expression was detected in 44 PCa tissues and 10 normal prostate tissues, and their clinicopathological significance was analyzed. Cell proliferation and cell cycle analysis were performed on PCa cells that stably expressed miRNA-302a. The target gene of miRNA-302a and the downstream pathway were further investigated. Compared with normal prostate tissues, miRNA-302a expression was downregulated in PCa tissues, and was even lower in PCa tissues with a Gleason score >= 8. Overexpression of miRNA-302a induced G1/S cell cycle arrest in PCa cells, and suppressed PCa cell proliferation both in vitro and in vivo. Furthermore, miRNA-302a inhibits AKT expression by directly binding to its 3' untranslated region, resulting in subsequent alterations of the AKT-GSK3 beta-cyclin D1 and AKT-p27(Kip1) pathway. These results reveal miRNA-302a as a tumor suppressor in PCa, suggesting that miRNA-302a may be used as a potential target for therapeutic intervention in PCa.	[Zhang, Gui-Ming; Wan, Fang-Ning; Cao, Da-Long; Qin, Xiao-Jian; Zhang, Hai-Liang; Zhu, Yao; Dai, Bo; Shi, Guo-Hai; Ye, Ding-Wei] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China; [Zhang, Gui-Ming; Wan, Fang-Ning] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Bao, Chun-Yang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Shi, GH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China.	guohaishi@126.com; dwyeli@163.com	Zhang, Hailiang/AAF-4937-2020		National Natural Science Foundation of China [NSFC 81202003]; Science Foundation of Shanghai Municipal Commission of Health and Family Planning [2010145]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanghai Municipal Commission of Health and Family Planning	This study was supported by grants from National Natural Science Foundation of China (Grant No. NSFC 81202003) (http://www.nsfc.gov.cn/) and Science Foundation of Shanghai Municipal Commission of Health and Family Planning (Grant No. 2010145) (http://www.wsjsw.gov.cn/wsj/) to GHS.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourguignon LYW, 2012, J BIOL CHEM, V287, P32800, DOI 10.1074/jbc.M111.308528; Cai N, 2013, RNA, V19, P85, DOI 10.1261/rna.035295.112; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fareh M, 2012, CELL DEATH DIFFER, V19, P232, DOI 10.1038/cdd.2011.89; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; He J., 2012, CHINESE CANC REGISTR; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Huang JX, 2012, ONCOL LETT, V4, P607, DOI 10.3892/ol.2012.814; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Liang ZX, 2013, PHARM RES-DORDR, V30, P1008, DOI 10.1007/s11095-012-0936-9; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Toker A, 2014, ADV BIOL REGUL; Wang LM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-448; Zhu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032170	22	49	50	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124410	10.1371/journal.pone.0124410	http://dx.doi.org/10.1371/journal.pone.0124410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922934	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600082
J	Coumou, J; Wagemakers, A; Trentelman, JJ; Nijhof, AM; Hovius, JW				Coumou, Jeroen; Wagemakers, Alex; Trentelman, Jos J.; Nijhof, Ard M.; Hovius, Joppe W.			Vaccination against Bm86 Homologues in Rabbits Does Not Impair Ixodes ricinus Feeding or Oviposition	PLOS ONE			English	Article							TICK-BORNE DISEASES; BOOPHILUS-MICROPLUS; CATTLE; INFESTATIONS; ANTIGEN; EFFICACY; TRANSMISSION; ANTIBODIES; PROTEINS; BINDING	Human tick-borne diseases that are transmitted by Ixodes ricinus, such as Lyme borreliosis and tick borne encephalitis, are on the rise in Europe. Diminishing I. ricinus populations in nature can reduce tick exposure to humans, and one way to do so is by developing an anti-vector vaccine against tick antigens. Currently, there is only one anti-vector vaccine available against ticks, which is a veterinary vaccine based on the tick antigen Bm86 in the gut of Rhipicephalus microplus. Bm86 vaccine formulations cause a reduction in the number of Rhipicephalus microplus ticks that successfully feed, i.e. lower engorgement weights and a decrease in the number of oviposited eggs. Furthermore, Bm86 vaccines reduce transmission of bovine Babesia spp. Previously two conserved Bm86 homologues in I. ricinus ticks, designated as Ir86-1 and Ir86-2, were described. Here we investigated the effect of a vaccine against recombinant Ir86-1, Ir86-2 or a combination of both on Ixodes ricinus feeding. Recombinant Ixodes ricinus Bm86 homologues were expressed in a Drosophila expression system and rabbits were immunized with rIr86-1, rIr86-2, a combination of both or ovalbumin as a control. Each animal was infested with 50 female adults and 50 male adults Ixodes ricinus and tick mortality, engorgement weights and egg mass were analyzed. Although serum IgG titers against rIr86 proteins were elicited, no effect was found on tick feeding between the rIr86 vaccinated animals and ovalbumin vaccinated animals. We conclude that vaccination against Bm86 homologues in Ixodes ricinus is not an effective approach to control Ixodes ricinus populations, despite the clear effects of Bm86 vaccination against Rhipicephalus microplus.	[Coumou, Jeroen; Wagemakers, Alex; Trentelman, Jos J.; Hovius, Joppe W.] Univ Amsterdam, Acad Med Ctr Amsterdam, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Nijhof, Ard M.] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Hovius, Joppe W.] Univ Amsterdam, Acad Med Ctr Amsterdam, Amsterdam Multidisciplinary Lyme Borreliosis Ctr, Amsterdam, Netherlands; [Hovius, Joppe W.] Univ Amsterdam, Acad Med Ctr Amsterdam, Dept Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Coumou, J (corresponding author), Univ Amsterdam, Acad Med Ctr Amsterdam, Ctr Expt & Mol Med, Amsterdam, Netherlands.	j.coumou@amc.uva.nl	Hovius, Joppe/GZL-6894-2022	Hovius, Joppe/0000-0003-0066-2437; Wagemakers, Alex/0000-0001-9632-7830; Nijhof, Ard/0000-0001-7373-2243	VENI from Netherlands Organization for Health Research and Development (ZonMw) [91611065]; European Union [602272]	VENI from Netherlands Organization for Health Research and Development (ZonMw); European Union(European Commission)	Funding: JWH is a recipient of a VENI stipend (91611065) from the Netherlands Organization for Health Research and Development (ZonMw). This work was supported by funding from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No. 602272 (project ANTIDotE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhahianambi P, 2009, PARASITE IMMUNOL, V31, P111, DOI 10.1111/j.1365-3024.2008.01082.x; Canales M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-29; Dai JF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001205; Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006; de la Fuente Jose, 2007, Animal Health Research Reviews, V8, P23, DOI 10.1017/S1466252307001193; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; De Vos S, 2001, EXP APPL ACAROL, V25, P245, DOI 10.1023/A:1010609007009; Galai Y, 2012, VACCINE, V30, P7084, DOI 10.1016/j.vaccine.2012.09.051; GOUGH JM, 1993, J PARASITOL, V79, P900, DOI 10.2307/3283728; Hajdusek O, 2010, VACCINE, V28, P2993, DOI 10.1016/j.vaccine.2010.02.008; Hofhuis A, 2010, INFECTIEZIEKTEN B, V3, P84; Labuda M, 2006, PLOS PATHOG, V2, P251, DOI 10.1371/journal.ppat.0020027; Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735; Narasimhan S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000451; Nijhof AM, 2010, INT J PARASITOL, V40, P1587, DOI 10.1016/j.ijpara.2010.06.003; Odongo D, 2007, VACCINE, V25, P1287, DOI 10.1016/j.vaccine.2006.09.085; Pages F, 2014, VECTOR-BORNE ZOONOT, V14, P85, DOI 10.1089/vbz.2013.1410; Rodriguez-Valle M, 2012, VACCINE, V30, P3453, DOI 10.1016/j.vaccine.2012.03.020; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Schuijt TJ, 2011, CELL HOST MICROBE, V10, P136, DOI 10.1016/j.chom.2011.06.010; Schuijt TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015926; Sprong H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-77; Trager W, 1939, J PARASITOL, V7, P15; WILLADSEN P, 1989, J IMMUNOL, V143, P1346	24	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123495	10.1371/journal.pone.0123495	http://dx.doi.org/10.1371/journal.pone.0123495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919587	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400028
J	Rutanga, C; Lowrance, DW; Oeltmann, JE; Mutembayire, G; Willis, M; Uwizeye, CB; Hinda, R; Bassirou, C; Gutreuter, S; Gasana, M				Rutanga, Claude; Lowrance, David W.; Oeltmann, John E.; Mutembayire, Grace; Willis, Matt; Uwizeye, Claude Bernard; Hinda, Ruton; Bassirou, Chitou; Gutreuter, Steve; Gasana, Michel			Latent Tuberculosis Infection and Associated Factors among Health Care Workers in Kigali, Rwanda	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANT; RISK-FACTORS; 2 HOSPITALS; PREVALENCE; OUTBREAK; DISEASE; STAFF	Introduction Data are limited regarding tuberculosis (TB) and latent TB infection prevalence in Rwandan health facilities. Methods We conducted a cross-sectional survey among healthcare workers (HCWs) in Kigali during 2010. We purposively selected the public referral hospital, both district hospitals, and randomly selected 7 of 17 health centers. School workers (SWs) from the nearest willing public schools served as a local reference group. We tested for latent TB infection (LTBI) using tuberculin skin testing (TST) and asked about past TB disease. We assessed risk of LTBI and past history of TB disease associated with hospital employment. Among HCWs, we assessed risk associated with facility type (district hospital, referral hospital, health center), work setting (inpatient, outpatient), and occupation. Results Age, gender, and HIV status was similar between the enrolled 1,131 HCWs and 381 SWs. LTBI was more prevalent among HCWs (62%) than SWs (39%). Adjusted odds of a positive TST result were 2.71 (95% CI 2.01-3.67) times greater among HCWs than SWs. Among HCWs, there was no detectable difference between prevalence of LTBI according to facility type, work setting, or occupation. Conclusion HCWs are at greater risk of LTBI, regardless of facility type, work setting, or occupation. The current status of TB infection control practices should be evaluated in the entire workforce in all Rwandan healthcare facilities.	[Rutanga, Claude; Mutembayire, Grace; Gasana, Michel] Rwanda Biomed Ctr, Div TB & Other Resp Communicable Dis, Kigali, Rwanda; [Lowrance, David W.; Uwizeye, Claude Bernard; Bassirou, Chitou] Ctr Dis Control & Prevent, Div Global HIV AIDS, Kigali, Rwanda; [Oeltmann, John E.; Willis, Matt] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Hinda, Ruton] Rwanda Biomed Ctr, Sexually Transmitted Infect, Div HIV AIDS, Kigali, Rwanda; [Hinda, Ruton] Rwanda Biomed Ctr, Other Blood Borne Dis, Kigali, Rwanda; [Gutreuter, Steve] Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA	Rwanda Biomedical Center; Centers for Disease Control & Prevention - USA; Rwanda Biomedical Center; Rwanda Biomedical Center; Centers for Disease Control & Prevention - USA	Rutanga, C (corresponding author), Rwanda Biomed Ctr, Div TB & Other Resp Communicable Dis, Kigali, Rwanda.	rutanga75@yahoo.fr	Gutreuter, Steve/ABC-7980-2020	Gutreuter, Steve/0000-0002-0733-2900; UWIZEYE, CLAUDE BERNARD/0000-0002-3858-6567	US Centres for Disease Control and Prevention [5U2GPS000643-03]	US Centres for Disease Control and Prevention	Implementaion of this study was supported with funding from the US Centres for Disease Control and Prevention under the cooperative agreement between the Department of Health and Human Services/National Centre for HIV, Viral hepatitis, STDs and TB prevention, and the Rwanda Treatment/Research on AIDS Centre, on the grant number: 5U2GPS000643-03. The Centres for Disease Control and Prevention played a role in the study design, data analysis which was performed anonymously, decision to publish and preparation of the manuscript.	Alonso-Echanove J, 2001, CLIN INFECT DIS, V33, P589, DOI 10.1086/321892; American Thoracic Society Centers for Disease Control and Prevention, 2000, 49RR6 CTR DIS CONTR; [Anonymous], 2010, RWAND DEM HLTH SURV; [Anonymous], 2009, TB HIV FACTS 2009; Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Cain KR, 2007, INT J TUBERC LUNG D, V11, P1008; CDC, TUB SKIN TEST; Do AN, 1999, INT J TUBERC LUNG D, V3, P377; Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055; Galgalo T, 2008, INT J TUBERC LUNG D, V12, P949; Garcia-Garcia MD, 2001, INFECT CONT HOSP EP, V22, P88, DOI 10.1086/501869; Granich R, 2010, CLIN INFECT DIS, V50, pS215, DOI 10.1086/651494; He GX, 2012, INT J TUBERC LUNG D, V16, P1485, DOI 10.5588/ijtld.12.0193; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kassim S, 2000, INT J TUBERC LUNG D, V4, P321; Kayanja HK, 2005, INT J TUBERC LUNG D, V9, P686; Kenyon TA, 1997, ANN INTERN MED, V127, P32, DOI 10.7326/0003-4819-127-1-199707010-00006; Keskiner R, 2004, INFECT CONT HOSP EP, V25, P1067, DOI 10.1086/502345; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Moro ML, 1998, AIDS, V12, P1095, DOI 10.1097/00002030-199809000-00017; Moss AR, 1997, INT J TUBERC LUNG D, V1, P115; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Powell K, 2011, INT J TUBERC LUNG D, V15, P1643, DOI 10.5588/ijtld.11.0207; Rafiza S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-19; Sherman HA, 2011, INT J TUBERC LUNG D, V15, P1050, DOI 10.5588/ijtld.10.0344; Wahome E, 2013, PUBLIC HEALTH ACTION, V3, P323, DOI 10.5588/pha.13.0054; *WHO, 2009, GLOB TUB CONTR SHORT; World Health Organization, 2014, TUB COUNTR PROF RWAN	34	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124485	10.1371/journal.pone.0124485	http://dx.doi.org/10.1371/journal.pone.0124485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919759	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400052
J	Tabak, RG; Hipp, JA; Marx, CM; Brownson, RC				Tabak, Rachel G.; Hipp, J. Aaron; Marx, Christine M.; Brownson, Ross C.			Workplace Social and Organizational Environments and Healthy-Weight Behaviors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; WORKSITE HEALTH; OBESITY; OVERWEIGHT; CLIMATE; IPAQ; ASSOCIATION; PERCEPTIONS; RELIABILITY; MORTALITY	Background The workplace is an important setting for health promotion including nutrition and physical activity behaviors to prevent obesity. This paper explores the relationship between workplace social environment and cultural factors and diet and physical activity (PA) behaviors and obesity among employees. Methods Between 2012 and 2013, telephone interviews were conducted with participants residing in four Missouri metropolitan areas. Questions included demographic characteristics, workplace socio/organizational factors related to activity and diet, and individual diet and PA behaviors, and obesity. Multivariate logistic regression was used to examine associations between the workplace socio/organizational environment and nutrition, PA, and obesity. Results There were differences in reported health behaviors and socio/organizational environment by gender, race, age, income, and worksite size. For example, agreement with the statement the 'company values my health' was highest among Whites, older employees, and higher income workers. As worksite size increased, the frequency of reporting seeing co-workers doing several types of healthy behaviors (eat fruits and vegetables, doing PA, and doing PA on breaks at work) increased. In adjusted analyses, employees agreeing the company values my health were more likely to engage in higher PA levels (aOR=1.54, 95% CI: 1.09-2.16) and less likely to be obese (aOR=0.73, 95% CI: 0.54-0.98). Seeing co-workers eating fruits and vegetables was associated with increased reporting of eating at least one vegetable per day (aOR=1.43, 95% CI: 1.06-1.91) and seeing co-workers being active was associated with higher PA levels (aOR 1.56, 95% CI: 1.19-2.05). Conclusions This research suggests that social/organizational characteristics of the workplace environment, particularly feeling the company values the workers' health and to seeing co-workers engaging in healthy behaviors, may be related to nutrition and PA behaviors and obesity. These findings point to the potential for intervention targets including environment and policy changes.	[Tabak, Rachel G.; Hipp, J. Aaron; Brownson, Ross C.] Washington Univ, Brown Sch, Prevent Res Ctr St Louis, St Louis, MO 63130 USA; [Marx, Christine M.; Brownson, Ross C.] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO USA; [Brownson, Ross C.] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Tabak, RG (corresponding author), Washington Univ, Brown Sch, Prevent Res Ctr St Louis, St Louis, MO 63130 USA.	rtabak@wustl.edu	Hipp, J. Aaron/AAF-9869-2021	Hipp, J. Aaron/0000-0002-2394-7112	Transdisciplinary Research on Energetics and Cancer (TREC) Center at Washington University in St. Louis; National Cancer Institute at National Institutes of Health (NIH) [U54 CA155496]; Washington University; Siteman Cancer Center; Centers for Disease Control and Prevention [U48/DP001903]; NIH/NIDDK Washington University Center for Diabetes Translation Research (WU-CDTR) [P30DK092950]; NATIONAL CANCER INSTITUTE [U54CA155496] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092950] Funding Source: NIH RePORTER	Transdisciplinary Research on Energetics and Cancer (TREC) Center at Washington University in St. Louis; National Cancer Institute at National Institutes of Health (NIH); Washington University; Siteman Cancer Center; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH/NIDDK Washington University Center for Diabetes Translation Research (WU-CDTR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Transdisciplinary Research on Energetics and Cancer (TREC) Center at Washington University in St. Louis. The TREC Center is funded by the National Cancer Institute at National Institutes of Health (NIH) (U54 CA155496), (http://www.nih.gov/), Washington University and the Siteman Cancer Center (http:// www.siteman.wustl.edu/) (RGT, JAH, CMM, RCB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article is a product of a Prevention Research Center and was also supported by Cooperative Agreement Number U48/DP001903 from the Centers for Disease Control and Prevention (http://www.cdc.gov/) (RGT, AJH, RCB). This publication was also supported by NIH/NIDDK P30DK092950 Washington University Center for Diabetes Translation Research (WU-CDTR) (http://cdtr.wustl.edu/) (RGT and RCB). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the WU-CDTR, National Institute of Diabetes and Digestive Kidney Diseases or NIH. The authors thank the Health and Behavioral Risk Research Center (HBRRC) at the University of Missouri-Columbia School of Medicine for their assistance in implementing the sampling frame and for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha D, 2015, AM J PREV MED, V48, P104, DOI 10.1016/j.amepre.2014.08.023; [Anonymous], 2011, WIRELESS SUBSTITUTIO; [Anonymous], PHYS ACT GUID ADV CO; Basen-Engquist K, 1998, PREV MED, V27, P111, DOI 10.1006/pmed.1997.0253; Blanck H. M., 2007, Morbidity and Mortality Weekly Report, V56, P213; BRAY GA, 1987, ANN NY ACAD SCI, V499, P14, DOI 10.1111/j.1749-6632.1987.tb36194.x; California Department of Public Health, 2012, CHECK FOR HLTH; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Centers for Disease Control and Prevention (CDC), 2011, BEH RISK FACT SURV S; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Ervin R.B., 2013, NCHS DATA BRIEF, V122, P1, DOI DOI 10.1089/152460902753668448; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Fryer Cheryl D, 2013, NCHS Data Brief, P1; Fugas CS, 2011, J OCCUP HEALTH PSYCH, V16, P67, DOI 10.1037/a0021731; Grimm KA, 2012, J ACAD NUTR DIET, V112, P2014, DOI 10.1016/j.jand.2012.08.030; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Harris CD, 2013, MMWR-MORBID MORTAL W, V62, P326; Harris JR, 2014, ANNU REV PUBLIC HEAL; Heinen L, 2009, MILBANK Q, V87, P101, DOI 10.1111/j.1468-0009.2009.00549.x; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hiza HAB, 2013, J ACAD NUTR DIET, V113, P297, DOI 10.1016/j.jand.2012.08.011; Hoehner CM, 2013, J PUBLIC HEALTH MAN, V19, pS105, DOI 10.1097/PHH.0b013e3182849f21; Institute of Medicine, 2003, FUT PUBL HLTH 21 CEN, P60; Kimmons Joel, 2009, Medscape J Med, V11, P26; Kruger J., 2007, Morbidity and Mortality Weekly Report, V56, P301; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lemon SC, 2009, AM J HEALTH BEHAV, V33, P299; Lewis M.A., 2002, HLTH BEHAV HLTH ED T, Vthird, P240; Linnan L, 2007, AM J HEALTH PROMOT, V21, P521, DOI 10.4278/0890-1171-21.6.521; Lucove JC, 2007, AM J HEALTH PROMOT, V21, P196, DOI 10.4278/0890-1171-21.3.196; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Quintiliani L., 2008, WORKPLACE SETTING IN; RIBISL KM, 1993, J OCCUP ENVIRON MED, V35, P812, DOI 10.1097/00043764-199308000-00019; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Schmitz MKH, 2000, MED CLIN N AM, V84, P491, DOI 10.1016/S0025-7125(05)70233-9; Sliter KA, 2013, J OCCUP HEALTH PSYCH, V18, P350, DOI 10.1037/a0033132; Smith-McLallen Aaron, 2008, Psychol Health Med, V13, P389, DOI 10.1080/13548500701842933; Sorensen G, 2004, PREV MED, V39, pS94, DOI 10.1016/j.ypmed.2003.12.020; Stokols D, 2003, AM J HEALTH PROMOT, V18, P4, DOI 10.4278/0890-1171-18.1.4; TREC Coordination Center-Fred Hutchinson Cancer Research Center, 2015, TRANSD RES EN CANC; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilson MG, 2004, J OCCUP ORGAN PSYCH, V77, P565, DOI 10.1348/0963179042596522; Yang L, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140286; Yun D, 2011, HEALTH COMMUN, V26, P275, DOI 10.1080/10410236.2010.549814	49	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125424	10.1371/journal.pone.0125424	http://dx.doi.org/10.1371/journal.pone.0125424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SE	25919659	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659400084
J	Talib, WH; Saleh, S				Talib, Wamidh H.; Saleh, Suhair			Propionibacterium acnes Augments Antitumor, Anti-Angiogenesis and Immunomodulatory Effects of Melatonin on Breast Cancer Implanted in Mice	PLOS ONE			English	Article							TUMOR-SPECIFIC IMMUNITY; CORYNEBACTERIUM-PARVUM; T-CELLS; IN-VIVO; BACTERIOLYTIC THERAPY; RECEPTOR EXPRESSION; COMBINATION; CHEMOTHERAPY; MECHANISMS; PROLIFERATION	Breast cancer is one of the most invasive cancers with high mortality. The immune stimulating Propionibacterium acnes is a Gram positive bacterium that has the ability to cause inflammation and activate Th1-type cytokine immune response. Antitumor response was associated with the inflammation induced by P. acnes, but the antitumor effect of this bacterium was not evaluated in combination with other agents. The aim of this study was to test the antitumor potential of a combination of melatonin and P. acnes against breast cancer implanted in mice. Balb/C mice were transplanted with EMT6/P cell line and in vivo antitumor effect was assessed for P. acnes, melatonin, and a combination of melatonin and P. acnes. Tumor and organs sections were examined using hematoxylin/eosin staining protocol, and TUNEL colorimetric assay was used to detect apoptosis. The expression of vascular endothelial growth factor (VEGF) was measured in tumor sections and serum levels of INF-gamma, and IL-4 were measured to evaluate the immune system function. To evaluate the toxicity of our combination, AST and ALT levels were measured in the serum of treated mice. The combination of melatonin and P. acnes has high efficiency in targeting breast cancer in mice. Forty percent of treated mice were completely cured using this combination and the combination inhibited metastasis of cancer cells to other organs. The combination therapy reduced angiogenesis, exhibited no toxicity, induced apoptosis, and stimulates strong Th1-type cytokine antitumor immune response. The combination of melatonin and P. acnes represents a promising option to treat breast cancer. However, carful preclinical and clinical evaluation is needed before considering this combination for human therapy.	[Talib, Wamidh H.] Appl Sci Univ, Dept Clin Pharm & Therapeut, Amman, Jordan; [Saleh, Suhair] Appl Sci Univ, Dept Pharmaceut Sci & Pharmaceut, Amman, Jordan	Applied Science University - Jordan; Applied Science University - Jordan	Talib, WH (corresponding author), Appl Sci Univ, Dept Clin Pharm & Therapeut, Amman, Jordan.	w_talib@asu.edu.jo	Talib, Wamidh H./H-9831-2017	Talib, Wamidh H./0000-0003-1942-8982	Applied Science University [DRGS-2012-2013-14]	Applied Science University	The full financial support granted to this research project (Grant NO. DRGS-2012-2013-14) was provided by Applied Science University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Al-Ghamdi MS, 2003, AM J CHINESE MED, V31, P721, DOI 10.1142/S0192415X03001399; Alvarez-Garcia V, 2013, MICROVASC RES, V87, P25, DOI 10.1016/j.mvr.2013.02.008; Apte SH, 2010, J IMMUNOL, V185, P998, DOI 10.4049/jimmunol.0903372; Bennett IC, 2000, BREAST, V9, P247, DOI 10.1054/brst.2000.0208; CONLEY FK, 1990, J NATL CANCER I, V82, P1340, DOI 10.1093/jnci/82.16.1340; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Di Bella G, 2013, INT J MOL SCI, V14, P2410, DOI 10.3390/ijms14022410; Diener-West M, 2004, J CLIN ONCOL, V22, P2438, DOI 10.1200/jco.2004.08.194; Drott JB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-126; DYE ES, 1981, J EXP MED, V154, P609, DOI 10.1084/jem.154.3.609; El All HSA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FISHER B, 1990, CANCER-AM CANCER SOC, V66, P220, DOI 10.1002/1097-0142(19900715)66:2<220::AID-CNCR2820660205>3.0.CO;2-6; GarciaMaurino S, 1997, J IMMUNOL, V159, P574; Giannoulia-Karantana A, 2006, NEUROIMMUNOMODULAT, V13, P133, DOI 10.1159/000097258; Jardim-Perassi BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085311; Kitagawa H, 2011, EXP DERMATOL, V20, P157, DOI 10.1111/j.1600-0625.2010.01180.x; Kumaraguruparan R, 2007, MOL CARCINOGEN, V46, P797, DOI 10.1002/mc.20309; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Lee CH, 2008, CLIN CANCER RES, V14, P1905, DOI 10.1158/1078-0432.CCR-07-2050; LICHTENSTEIN AK, 1984, CANCER RES, V44, P5118; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Miller SC, 2006, INT J EXP PATHOL, V87, P81, DOI 10.1111/j.0959-9673.2006.00474.x; MILLS CD, 1981, J EXP MED, V154, P621, DOI 10.1084/jem.154.3.621; MITCHESON HD, 1980, BRIT J CANCER, V41, P407, DOI 10.1038/bjc.1980.64; MOORE K, 1983, BRIT J CANCER, V47, P797, DOI 10.1038/bjc.1983.133; Morioka H, 2003, CLIN CANCER RES, V9, P1211; NISSENMEYER R, 1989, ACTA ONCOL, V28, P903, DOI 10.3109/02841868909092329; OJO E, 1979, CELL IMMUNOL, V45, P182, DOI 10.1016/0008-8749(79)90374-5; OLIVOTTO M, 1974, INT J CANCER, V13, P478, DOI 10.1002/ijc.2910130406; Olsson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051434; Olsson J, 2012, APMIS, V120, P778, DOI 10.1111/j.1600-0463.2012.02905.x; Sahin K, 2011, NUTR CANCER, V63, P1279, DOI 10.1080/01635581.2011.606955; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Souter RG, 1982, BRIT J CANCER, V44, P496; Steiner H, 2003, AM J PATHOL, V162, P655, DOI 10.1016/S0002-9440(10)63859-X; Talib Wamidh H, 2013, Sci Pharm, V81, P519, DOI 10.3797/scipharm.1211-15; Talib WH, 2012, J CANCER RES THER, V8, P417, DOI 10.4103/0973-1482.103523; Tchaptchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039155; Tsuda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029020; TUTTLE RL, 1976, J RETICULOENDOTH SOC, V20, P209; Vermeulen PB, 2001, J PATHOL, V195, P336, DOI 10.1002/path.966; Walker RA, 1997, CANCER METAST REV, V16, P5, DOI 10.1023/A:1005740222307; Wang JS, 2013, J PINEAL RES, V54, P406, DOI 10.1111/jpi.12035; Xiao Y, 1990, Hua Xi Yi Ke Da Xue Xue Bao, V21, P318; Yamamoto M, 2009, ONCOL REP, V22, P337, DOI 10.3892/or_00000442	47	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124384	10.1371/journal.pone.0124384	http://dx.doi.org/10.1371/journal.pone.0124384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919398	gold, Green Submitted, Green Published			2022-12-26	WOS:000353659400048
J	Tremblay, MG; Herdman, C; Guillou, F; Mishra, PK; Baril, J; Bellenfant, S; Moss, T				Tremblay, Michel G.; Herdman, Chelsea; Guillou, Francois; Mishra, Prakash K.; Baril, Joelle; Bellenfant, Sabrina; Moss, Tom			Extended Synaptotagmin Interaction with the Fibroblast Growth Factor Receptor Depends on Receptor Conformation, Not Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dimerization; fibroblast growth factor receptor (FGFR); receptor endocytosis; receptor modification; receptor structure-function; receptor tyrosine kinase; ESyt-FGFR complex; Extended-Synaptotagmin (ESyt1; 2; 3); FGFR activity; FGFR conformation	POINT MUTATION; BINDING-SITE; SH2 DOMAIN; IN-VIVO; KINASE; PROTEINS; AUTOPHOSPHORYLATION; ENDOCYTOSIS; CELLS; POLYETHYLENIMINE	Background: Extended Synaptotagmins selectively bind the active FGF receptor but the mechanism is unknown. Results: ESyt2 and 3 but not ESyt1 recognize the active conformation of the FGF receptor independently of catalytic activity. Conclusion: ESyt2 and probably ESyt3 access the active cleft of the FGFR1 kinase domain. Significance: How ESyts recognize FGFRs is essential to understanding how they modulate receptor signaling. We previously demonstrated that ESyt2 interacts specifically with the activated FGF receptor and is required for a rapid phase of receptor internalization and for functional signaling via the ERK pathway in early Xenopus embryos. ESyt2 is one of the three-member family of Extended Synaptotagmins that were recently shown to be implicated in the formation of endoplasmic reticulum (ER)-plasma membrane (PM) junctions and in the Ca2+ dependent regulation of these junctions. Here we show that ESyt2 is directed to the ER by its putative transmembrane domain, that the ESyts hetero- and homodimerize, and that ESyt2 homodimerization in vivo requires a TM adjacent sequence but not the SMP domain. ESyt2 and ESyt3, but not ESyt1, selectively interact in vivo with activated FGFR1. In the case of ESyt2, this interaction requires a short TM adjacent sequence and is independent of receptor autophosphorylation, but dependent on receptor conformation. The data show that ESyt2 recognizes a site in the upper kinase lobe of FGFR1 that is revealed by displacement of the kinase domain activation loop during receptor activation.	[Moss, Tom] Quebec Univ Hosp Res Ctr, Canc Div, St Patrick Res Grp Basic Oncol, Lab Growth & Dev, Quebec City, PQ G1R 3S3, Canada; Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1R 3S3, Canada	Laval University	Moss, T (corresponding author), Quebec Univ Hosp Res Ctr, Canc Div, St Patrick Res Grp Basic Oncol, Lab Growth & Dev, Edifice St Patrick,9 Rue McMahon, Quebec City, PQ G1R 3S3, Canada.	Tom.Moss@crhdq.ulaval.ca		Moss, Thomas (Tom)/0000-0003-2047-4783	Cancer Research Society (CRS/SRC); FRSQ (Quebec)	Cancer Research Society (CRS/SRC); FRSQ (Quebec)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a Cancer Research Society (CRS/SRC) grant (to T. M.). The Quebec University Hospital Research Centre (CR-CHU de Quebec) is supported by a grant from the FRSQ (Quebec). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen CBF, 2014, TRENDS BIOCHEM SCI, V39, P82, DOI 10.1016/j.tibs.2013.12.003; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Bae JH, 2010, P NATL ACAD SCI USA, V107, P2866, DOI 10.1073/pnas.0914157107; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Creutz CE, 2004, CELL MOL LIFE SCI, V61, P1208, DOI 10.1007/s00018-004-4029-8; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Herdman C, 2014, CELL CYCLE, V13, P2616, DOI 10.4161/15384101.2014.943573; Jean S, 2012, BIOL OPEN, V1, P731, DOI 10.1242/bio.2012968; Jean S, 2010, DEV CELL, V19, P426, DOI 10.1016/j.devcel.2010.08.007; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Moghadam Paanteha K, 2013, Front Endocrinol (Lausanne), V4, P124, DOI 10.3389/fendo.2013.00124; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Morris NJ, 1999, BBA-PROTEIN STRUCT M, V1431, P525, DOI 10.1016/S0167-4838(99)00068-0; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Schauder CM, 2014, NATURE, V510, P552, DOI 10.1038/nature13269; Scott RP, 2005, J BIOL CHEM, V280, P13442, DOI 10.1074/jbc.M500507200; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Yamashita T, 2012, NEUROSCI RES, V73, P1, DOI 10.1016/j.neures.2012.02.012	31	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16142	16156		10.1074/jbc.M115.656918	http://dx.doi.org/10.1074/jbc.M115.656918			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25922075	Green Published, hybrid			2022-12-26	WOS:000356930100019
J	Escobedo-Hinojosa, WI; Vences-Guzman, MA; Schubotz, F; Sandoval-Calderon, M; Summons, RE; Lopez-Lara, IM; Geiger, O; Sohlenkamp, C				Escobedo-Hinojosa, Wendy Itzel; Vences-Guzman, Miguel Angel; Schubotz, Florence; Sandoval-Calderon, Mario; Summons, Roger E.; Lopez-Lara, Isabel Maria; Geiger, Otto; Sohlenkamp, Christian			OlsG (Sinac_1600) Is an Ornithine Lipid N-Methyltransferase from the Planctomycete Singulisphaera acidiphila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-LIPIDS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; SINORHIZOBIUM-MELILOTI; GENE; IDENTIFICATION; ACCUMULATION; EXPRESSION; SYMBIOSIS; ENZYMES	Ornithine lipids (OLs) are phosphorus-free membrane lipids widespread in bacteria but absent from archaea and eukaryotes. In addition to the unmodified OLs, a variety of OL derivatives hydroxylated in different structural positions has been reported. Recently, methylated derivatives of OLs were described in several planctomycetes isolated from a peat bog in Northern Russia, although the gene/enzyme responsible for the N-methylation of OL remained obscure. Here we identify and characterize the OL N-methyltransferase OlsG (Sinac_1600) from the planctomycete Singulisphaera acidiphila. When OlsG is co-expressed with the OL synthase OlsF in Escherichia coli, methylated OL derivatives are formed. An in vitro characterization shows that OlsG is responsible for the 3-fold methylation of the terminal delta-nitrogen of OL. Methylation is dependent on the presence of the detergent Triton X-100 and the methyldonor S-adenosylmethionine.	[Escobedo-Hinojosa, Wendy Itzel; Vences-Guzman, Miguel Angel; Sandoval-Calderon, Mario; Lopez-Lara, Isabel Maria; Geiger, Otto; Sohlenkamp, Christian] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62210, Morelos, Mexico; [Schubotz, Florence; Summons, Roger E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02144 USA	Universidad Nacional Autonoma de Mexico; Massachusetts Institute of Technology (MIT)	Sohlenkamp, C (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Ave Univ S-N,Apdo Postal 565-A, Cuernavaca 62210, Morelos, Mexico.	chsohlen@ccg.unam.mx	Summons, Roger Everett/AAL-3789-2020; Lopez-Lara, Isabel/E-3153-2016; Geiger, Otto/F-6356-2019; Sohlenkamp, Christian/C-6219-2018	Lopez-Lara, Isabel/0000-0002-5066-3158; Geiger, Otto/0000-0002-7794-1568; Sohlenkamp, Christian/0000-0002-9962-2859; Sandoval-Calderon, Mario/0000-0001-7888-4334	CONACyT (Consejo Nacional de Ciencia y Tecnologia) [153200]; PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico) [IN202413]; University of California-Mexus/CONACyT [CN-12-552]; Massachusetts Institute of Technology Mexico Seed Fund; NASA (National Aeronautics and Space Administration) Astrobiology Grant [NNA13AA90A]; University of Bremen; DGAPA (Direccion General de Asuntos del Personal Academico)-UNAM (Universidad Nacional Autonoma de Mexico)	CONACyT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico); University of California-Mexus/CONACyT; Massachusetts Institute of Technology Mexico Seed Fund; NASA (National Aeronautics and Space Administration) Astrobiology Grant; University of Bremen; DGAPA (Direccion General de Asuntos del Personal Academico)-UNAM (Universidad Nacional Autonoma de Mexico)	This work has been supported by CONACyT (Consejo Nacional de Ciencia y Tecnologia) Grant 153200, PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico) Grant IN202413, University of California-Mexus/CONACyT Grant CN-12-552, the Massachusetts Institute of Technology Mexico Seed Fund, NASA (National Aeronautics and Space Administration) Astrobiology Grant NNA13AA90A, the University of Bremen, and a postdoctoral fellowship from the DGAPA (Direccion General de Asuntos del Personal Academico)-UNAM (Universidad Nacional Autonoma de Mexico) (to W.I. E.-H.).	Vences-Guzman MA, 2015, ENVIRON MICROBIOL, V17, P1487, DOI 10.1111/1462-2920.12562; Vences-Guzman MA, 2013, ENVIRON MICROBIOL, V15, P895, DOI 10.1111/j.1462-2920.2012.02867.x; ARONDEL V, 1993, J BIOL CHEM, V268, P16002; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; de Rudder KEE, 1999, J BIOL CHEM, V274, P20011, DOI 10.1074/jbc.274.28.20011; de Rudder KEE, 2000, MOL MICROBIOL, V37, P763, DOI 10.1046/j.1365-2958.2000.02032.x; deRudder KEE, 1997, J BACTERIOL, V179, P6921, DOI 10.1128/jb.179.22.6921-6928.1997; Diercks H, 2015, J BACTERIOL, V197, P497, DOI 10.1128/JB.02004-14; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Gao JL, 2004, MOL MICROBIOL, V53, P1757, DOI 10.1111/j.1365-2958.2004.04240.x; Geiger O, 1999, MOL MICROBIOL, V32, P63, DOI 10.1046/j.1365-2958.1999.01325.x; Geiger O, 2013, BBA-MOL CELL BIOL L, V1831, P503, DOI 10.1016/j.bbalip.2012.08.009; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; Gonzalez-Silva N, 2011, BIOCHEMISTRY-US, V50, P6396, DOI 10.1021/bi200706v; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hacker S, 2008, J BACTERIOL, V190, P571, DOI 10.1128/JB.01423-07; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Kulichevskaya IS, 2008, INT J SYST EVOL MICR, V58, P1186, DOI 10.1099/ijs.0.65593-0; Lopez-Lara IM, 2005, MOL PLANT MICROBE IN, V18, P973, DOI 10.1094/MPMI-18-0973; Martinez-Morales F, 2003, MICROBIOL-SGM, V149, P3461, DOI 10.1099/mic.0.26522-0; Minder AC, 2001, MOL MICROBIOL, V39, P1186, DOI 10.1111/j.1365-2958.2001.02325.x; Moore EK, 2013, APPL ENVIRON MICROB, V79, P6874, DOI 10.1128/AEM.02169-13; Riekhof WR, 2014, EUKARYOT CELL, V13, P749, DOI 10.1128/EC.00004-14; Riekhof WR, 2005, ARCH BIOCHEM BIOPHYS, V441, P96, DOI 10.1016/j.abb.2005.07.001; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Ritchie RJ, 1996, BIOCHEM EDUC, V24, P196, DOI 10.1016/S0307-4412(96)00089-1; Rojas-Jimenez K, 2005, MOL PLANT MICROBE IN, V18, P1175, DOI 10.1094/MPMI-18-1175; Sohlenkamp C, 2000, J BIOL CHEM, V275, P27500; Sohlenkamp C, 2003, PROG LIPID RES, V42, P115, DOI 10.1016/S0163-7827(02)00050-4; Sohlenkamp C., 2015, FEMS MICROB IN PRESS; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Vences-Guzman MA, 2012, FEMS MICROBIOL LETT, V335, P1, DOI 10.1111/j.1574-6968.2012.02623.x; Vences-Guzman MA, 2011, MOL MICROBIOL, V79, P1496, DOI 10.1111/j.1365-2958.2011.07535.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weissenmayer B, 2002, MOL MICROBIOL, V45, P721, DOI 10.1046/j.1365-2958.2002.03043.x; Wilderman PJ, 2002, J BACTERIOL, V184, P4792, DOI 10.1128/JB.184.17.4792-4799.2002; Wormer L, 2013, ORG GEOCHEM, V59, P10, DOI 10.1016/j.orggeochem.2013.03.004	41	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15102	15111		10.1074/jbc.M115.639575	http://dx.doi.org/10.1074/jbc.M115.639575			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25925947	hybrid, Green Published			2022-12-26	WOS:000356177300025
J	Masia-Balague, M; Izquierdo, I; Garrido, G; Cordomi, A; Perez-Benito, L; Miller, NLG; Schlaepfer, DD; Gigoux, V; Aragay, AM				Masia-Balague, Miriam; Izquierdo, Ismael; Garrido, Georgina; Cordomi, Arnau; Perez-Benito, Laura; Miller, Nichol L. G.; Schlaepfer, David D.; Gigoux, Veronique; Aragay, Anna M.			Gastrin-stimulated G alpha(13) Activation of Rgnef Protein (ArhGEF28) in DLD-1 Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HETEROTRIMERIC G-PROTEINS; FOCAL ADHESION KINASE; RHO-GTPASES; BINDING PROTEIN; G12 FAMILY; P190RHOGEF; CHOLECYSTOKININ; DOMAIN; RAC1	The guanine nucleotide exchange factor Rgnef (also known as ArhGEF28 or p190RhoGEF) promotes colon carcinoma cell motility and tumor progression via interaction with focal adhesion kinase (FAK). Mechanisms of Rgnef activation downstream of integrin or G protein-coupled receptors remain undefined. In the absence of a recognized G protein signaling homology domain in Rgnef, no proximal linkage to G proteins was known. Utilizing multiple methods, we have identified Rgnef as a new effector for G alpha(13) downstream of gastrin and the type 2 cholecystokinin receptor. In DLD-1 colon carcinoma cells depleted of G alpha(13), gastrin-induced FAK Tyr(P)-397 and paxillin Tyr(P)-31 phosphorylation were reduced. RhoA GTP binding and promoter activity were increased by Rgnef in combination with active G alpha(13). Rgnef co-immunoprecipitated with activated G alpha(13)Q226L but not G alpha(12)Q229L. The Rgnef C-terminal (CT, 1279 - 1582) region was sufficient for co-immunoprecipitation, and Rgnef-CT exogenous expression prevented G alpha(13)-stimulated SRE activity. A domain at the C terminus of the protein close to the FAK binding domain is necessary to bind to G alpha(13). Point mutations of Rgnef-CT residues disrupt association with active G alpha(13) but not G alpha(q). These results show that Rgnef functions as an effector of G alpha(13) signaling and that this linkage may mediate FAK activation in DLD-1 colon carcinoma cells.	[Masia-Balague, Miriam; Izquierdo, Ismael; Garrido, Georgina; Aragay, Anna M.] CSIC, Mol Biol Inst Barcelona, Barcelona 08028, Spain; [Cordomi, Arnau; Perez-Benito, Laura] Univ Autonoma Barcelona, Unitat Bioestadist, Dept Pediat, E-08193 Barcelona, Spain; [Miller, Nichol L. G.; Schlaepfer, David D.] Univ Toulouse 3, INSERM, Receptol & Ciblage Therapeut Cancerol, F-31062 Toulouse, France; [Miller, Nichol L. G.; Schlaepfer, David D.] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92093 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Autonomous University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California San Diego	Aragay, AM (corresponding author), CSIC, Inst Biol Mol Barcelona, Parc Sci Baldiri Reixac 15, E-08028 Barcelona, Spain.	aarbmc@ibmb.csic.es	Aragay, Anna M/K-3813-2014; Regan, Clinton/E-6250-2012; Gigoux, Véronique/AAE-6090-2020; Garrido Antequera, Georgina/H-3469-2015; Cordomi, Arnau/A-1686-2009	Aragay, Anna M/0000-0002-8240-4126; Gigoux, Véronique/0000-0003-1408-5335; Garrido Antequera, Georgina/0000-0001-7702-7998; Cordomi, Arnau/0000-0002-3848-2928; Izquierdo Villalba, Ismael/0000-0001-6142-0250; Perez Benito, Laura/0000-0001-9607-9048	National Institutes of Health [CA180769]; Spanish Ministerio de Economia y Competitividad [BFU2011-30080]; Agencia de Gestio d'Ajuts Universitaris i de Recerca; NATIONAL CANCER INSTITUTE [R01CA102310, R01CA087038, R01CA180769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Economia y Competitividad(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA180769 (to D. S.). This work was also supported by Spanish Ministerio de Economia y Competitividad Grant BFU2011-30080.; Supported by a Fellowship for Young Research Fellows from Agencia de Gestio d'Ajuts Universitaris i de Recerca. Present address: Center for Biosciences, Dept. of Biosciences and Nutrition, Karolinska Institute, Stockholm SE-171 77, Sweden.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; Ardawatia VV, 2011, EXP CELL RES, V317, P293, DOI 10.1016/j.yexcr.2010.10.017; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Beninca C, 2014, CELL SIGNAL, V26, P1135, DOI 10.1016/j.cellsig.2014.01.009; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Chu SJ, 2013, CURR OPIN GASTROEN, V29, P636, DOI 10.1097/MOG.0b013e328365efc7; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Dutt P, 2002, FEBS LETT, V531, P565, DOI 10.1016/S0014-5793(02)03625-6; Escrieut C, 2002, J BIOL CHEM, V277, P7546, DOI 10.1074/jbc.M108563200; Fourmy D, 2011, GASTROENTEROLOGY, V141, P814, DOI 10.1053/j.gastro.2011.07.006; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gardner JA, 2013, PANCREAS, V42, P819, DOI 10.1097/MPA.0b013e318279c577; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Grabocka E, 2007, MOL PHARMACOL, V72, P993, DOI 10.1124/mol.107.035162; Hajicek N, 2011, J BIOL CHEM, V286, P20625, DOI 10.1074/jbc.M110.201392; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JIANG HP, 1993, FEBS LETT, V330, P319, DOI 10.1016/0014-5793(93)80896-3; Johansson BB, 2005, FEBS J, V272, P5365, DOI 10.1111/j.1742-4658.2005.04934.x; Jones TLZ, 1998, BIOCHEMISTRY-US, V37, P3196, DOI 10.1021/bi972253j; Juneja J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026085; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kim H, 2008, BIOCHEM BIOPH RES CO, V377, P636, DOI 10.1016/j.bbrc.2008.10.030; Kim JS, 2006, BIOCHEM BIOPH RES CO, V351, P903, DOI 10.1016/j.bbrc.2006.10.135; Koh TJ, 2000, REGUL PEPTIDES, V93, P37, DOI 10.1016/S0167-0115(00)00176-2; Krakstad BF, 2004, P NATL ACAD SCI USA, V101, P10314, DOI 10.1073/pnas.0401366101; Kumar RN, 2006, ONCOGENE, V25, P899, DOI 10.1038/sj.onc.1209132; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leve F, 2012, J CELL BIOCHEM, V113, P2549, DOI 10.1002/jcb.24153; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lin H, 2005, HUM MOL GENET, V14, P3643, DOI 10.1093/hmg/ddi392; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Miller NLG, 2013, J CELL SCI, V126, P5074, DOI 10.1242/jcs.135509; Miller NLG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037830; Niu JX, 2003, CIRC RES, V93, P848, DOI 10.1161/01.RES.0000097607.14733.0C; Rasheed SAK, 2013, J BIOL CHEM, V288, P7986, DOI 10.1074/jbc.M112.437749; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sabbatini ME, 2010, AM J PHYSIOL-CELL PH, V298, pC592, DOI 10.1152/ajpcell.00448.2009; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Suzuki N, 2009, J BIOL CHEM, V284, P5000, DOI 10.1074/jbc.M804073200; Taniguchi T, 1996, ONCOGENE, V12, P1357; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wu JH, 2003, MOL BRAIN RES, V117, P27, DOI 10.1016/S0169-328X(03)00263-8; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200	64	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15197	15209		10.1074/jbc.M114.628164	http://dx.doi.org/10.1074/jbc.M114.628164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922072	Green Published, hybrid			2022-12-26	WOS:000356177300033
J	Zhang, YL; Nguyen, T; Tang, P; Kennedy, NJ; Jiao, HP; Zhang, ML; Reynolds, JM; Jaeschke, A; Martin-Orozco, N; Chung, YS; He, WM; Wang, C; Jia, WP; Ge, BX; Davis, RJ; Fiavell, RA; Dong, C				Zhang, Yongliang; Thang Nguyen; Tang, Peng; Kennedy, Norman J.; Jiao, Huipeng; Zhang, Mingliang; Reynolds, Joseph M.; Jaeschke, Anja; Martin-Orozco, Natalia; Chung, Yeonseok; He, Wei-min; Wang, Chen; Jia, Weiping; Ge, Baoxue; Davis, Roger J.; Fiavell, Richard A.; Dong, Chen			Regulation of Adipose Tissue Inflammation and Insulin Resistance by MAPK Phosphatase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE POLARIZATION; GLUCOSE-HOMEOSTASIS; VISCERAL ADIPOSITY; IMMUNE-RESPONSES; IKK-BETA; OBESITY; MICE; FAT; SENSITIVITY; MECHANISMS	Obesity and metabolic disorders such as insulin resistance and type 2 diabetes have become a major threat to public health globally. The mechanisms that lead to insulin resistance in type 2 diabetes have not been well understood. In this study, we show that mice deficient in MAPK phosphatase 5 (MKP5) develop insulin resistance spontaneously at an early stage of life and glucose intolerance at a later age. Increased macrophage infiltration in white adipose tissue of young MKP5-deficient mice correlates with the development of insulin resistance. Glucose intolerance in MKP5-deficient mice is accompanied by significantly increased visceral adipose weight, reduced AKT activation, enhanced p38 activity, and increased inflammation in visceral adipose tissue when compared with wild-type (WT) mice. Deficiency of MKP5 resulted in increased inflammatory activation in macrophages. These findings thus demonstrate that MKP5 critically controls inflammation in white adipose tissue and the development of metabolic disorders.	[Zhang, Yongliang; Tang, Peng; Jiao, Huipeng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Zhang, Yongliang; Tang, Peng; Jiao, Huipeng] Natl Univ Singapore, Inst Life Sci, Immunol Programme, Singapore 117597, Singapore; [Thang Nguyen] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Kennedy, Norman J.; Davis, Roger J.] Univ Massachusetts, Howard Hughes Med Inst, Worcester, MA 01606 USA; [Zhang, Mingliang; Wang, Chen; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China; [Reynolds, Joseph M.; Martin-Orozco, Natalia; Chung, Yeonseok] MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Jaeschke, Anja] Univ Cincinnati, Pathobiol & Mol Med Grad Program, Cincinnati, OH 45215 USA; [He, Wei-min] Texas A&M Univ, Syst Hlth Sci Ctr, Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX 77030 USA; [Ge, Baoxue] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Signal Transduct, Shanghai 200025, Peoples R China; [Ge, Baoxue] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Fiavell, Richard A.] Yale Univ, Howard Hughes Med Inst, Dept Immunol, New Haven, CT 06520 USA; [Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China	National University of Singapore; National University of Singapore; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; University of Cincinnati; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Howard Hughes Medical Institute; Yale University; Tsinghua University	Fiavell, RA (corresponding author), Yale Univ, Howard Hughes Med Inst, Dept Immunol, New Haven, CT 06520 USA.	Richard.flavell@yale.edu; chendong@tsinghua.edu.cn	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841; Jiao, Huipeng/0000-0001-9632-6176; Davis, Roger/0000-0002-0130-1652	Office of Deputy President, National University of Singapore; National Medical Research Council of Singapore [IRG10nov091, CBRG11nov101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	Office of Deputy President, National University of Singapore(National University of Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Office of Deputy President, National University of Singapore and the National Medical Research Council (IRG10nov091 and CBRG11nov101) of Singapore (to Y. Z.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Koistinen HA, 2003, DIABETOLOGIA, V46, P1324, DOI 10.1007/s00125-003-1196-3; Lim JH, 2009, CELL SIGNAL, V21, P169, DOI 10.1016/j.cellsig.2008.10.004; LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P109, DOI 10.1016/0889-1605(88)90001-8; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Pettus LH, 2008, CURR TOP MED CHEM, V8, P1452, DOI 10.2174/156802608786264245; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	40	16	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14875	14883		10.1074/jbc.M115.660969	http://dx.doi.org/10.1074/jbc.M115.660969			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922079	Green Published, hybrid			2022-12-26	WOS:000356177300007
J	Hou, HF; Yuan, N; Guo, Q; Sun, T; Li, C; Liu, JB; Li, QW; Jiang, BF				Hou, Hai-Feng; Yuan, Na; Guo, Qing; Sun, Tao; Li, Cheng; Liu, Jian-Bao; Li, Qun-Wei; Jiang, Bao-Fa			Citreoviridin Enhances Atherogenesis in Hypercholesterolemic ApoE-Deficient Mice via Upregulating Inflammation and Endothelial Dysfunction	PLOS ONE			English	Article							GROWTH-FACTOR; ATHEROSCLEROSIS; ADHESION; ACTIVATION; MECHANISMS; EXPRESSION	Vascular endothelial dysfunction and inflammatory response are early events during initiation and progression of atherosclerosis. In vitro studies have described that CIT markedly upregulates expressions of ICAM-1 and VCAM-1 of endothelial cells, which result from NF-kappa B activation induced by CIT. In order to determine whether it plays a role in atherogenesis in vivo, we conducted the study to investigate the effects of CIT on atherosclerotic plaque development and inflammatory response in apolipoprotein E deficient (apoE(-/-)) mice. Five-week-old apoE(-/-) mice were fed high-fat diets and treated with CIT for 15 weeks, followed by assay of atherosclerotic lesions. Nitric oxide (NO), vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) were detected in serum. Levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesionmolecule-1 (VCAM-1), VEGF, and ET-1 in plaque areas of artery walls were examined. NF-kappa B p65 expression and NF-kappa B activation in aorta also were assessed. CIT treatment significantly augmented atherosclerotic plaques and increased expressions of ICAM-1, VCAM-1, VEGF and ET-1 in aorta. Mechanistic studies showed that activation of NF-kappa B was significantly elevated by CIT treatment, indicating the effect of CIT on atherosclerosismay be regulated by activation of NF-kappa B.	[Hou, Hai-Feng; Yuan, Na; Sun, Tao; Liu, Jian-Bao; Li, Qun-Wei] Taishan Med Univ, Sch Publ Hlth, Tai An 271000, Shandong, Peoples R China; [Hou, Hai-Feng; Jiang, Bao-Fa] Shandong Univ, Sch Publ Hlth, Jinan 250012, Peoples R China; [Guo, Qing] Taian City Cent Hosp, Tai An 271000, Shandong, Peoples R China; [Li, Cheng] Shanghai Jiao Tong Univ, Coll Med, Ruijin Hosp, Shanghai 200025, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shanghai Jiao Tong University	Hou, HF (corresponding author), Taishan Med Univ, Sch Publ Hlth, Tai An 271000, Shandong, Peoples R China.	hfhou@163.com		Hou, Haifeng/0000-0002-1131-1619	National Natural Science Foundation of China (NSFC) [81202170]; Shandong Provincial Natural Science Foundation, China [ZR20010HQ006]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This study was supported by the National Natural Science Foundation of China (Grants: NSFC, No. 81202170), Shandong Provincial Natural Science Foundation, China (No. ZR20010HQ006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2008, RHEUMATOLOGY, V47, pV23, DOI 10.1093/rheumatology/ken282; Addabbo F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1143, DOI 10.1152/ajpendo.00208.2011; Almeida MI, 2012, FOOD ADDIT CONTAM A, V29, P694, DOI 10.1080/19440049.2011.651750; Lima HCAV, 2010, TROP DOCT, V40, P95, DOI 10.1258/td.2009.090439; Blann AD, 2001, AM J CARDIOL, V87, P1160, DOI 10.1016/S0002-9149(01)01486-2; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Cao CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064930; Cavieres V, 2014, AM J CARDIOVASC DIS, V4, P114; Fang YQ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-123; Giannotti G, 2007, HERZ, V32, P568, DOI 10.1007/s00059-007-3073-1; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Hou HF, 2015, TOXICOL IND HEALTH, V31, P193, DOI 10.1177/0748233713483194; Iglarz M, 2007, J CARDIOVASC PHARM, V50, P621, DOI 10.1097/FJC.0b013e31813c6cc3; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Jin N, 2014, TOXICON, V90, P226, DOI 10.1016/j.toxicon.2014.08.057; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kong BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113242; Krieglstein CF, 2001, AM J HYPERTENS, V14, p44S, DOI 10.1016/S0895-7061(01)02069-6; Li D, 2009, CHIN J CTRL ENDEM DI, V24, P226; Maier W, 2005, CIRCULATION, V111, P1355, DOI 10.1161/01.CIR.0000158479.58589.0A; Nespereira B, 2003, ATHEROSCLEROSIS, V171, P67, DOI 10.1016/j.atherosclerosis.2003.08.009; NISHIE K, 1988, RES COMMUN CHEM PATH, V59, P31; Pateras I, 2014, EXPERT OPIN THER TAR, V18, P1089, DOI 10.1517/14728222.2014.938051; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Sessa R, 2014, WORLD J CLIN CASES, V2, P240, DOI 10.12998/wjcc.v2.i7.240; Sun SQ, 2010, MED HYPOTHESES, V74, P841, DOI 10.1016/j.mehy.2009.11.043; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; [万悦竹 WAN Yuezhu], 2011, [中国地方病学杂志, Chinese Journal of Endemiology], V30, P379; Wang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098070; Yu JiaNan, 2012, Chinese Journal of Endemiology, V31, P385	30	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125956	10.1371/journal.pone.0125956	http://dx.doi.org/10.1371/journal.pone.0125956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933220	gold, Green Submitted, Green Published			2022-12-26	WOS:000353887100145
J	Hu, TT; Weng, SQ; Tang, WQ; Xue, RY; Chen, S; Cai, GX; Cai, Y; Shen, XZ; Zhang, S; Dong, L				Hu, Tingting; Weng, Shuqiang; Tang, Wenqing; Xue, Ruyi; Chen, She; Cai, Guoxiang; Cai, Yu; Shen, Xizhong; Zhang, Si; Dong, Ling			Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer	PLOS ONE			English	Article							S-PHASE ARREST; 1ST-LINE TREATMENT; APOPTOSIS PROTEIN; POOR-PROGNOSIS; CELL-GROWTH; IAP; APOLLON; BRUCE; GENE; EXPRESSION	Background and Objective Inhibitors of apoptosis proteins (IAPs) have been well investigated in human cancers, where they are frequently overexpressed and associated with poor prognosis. Here we explored the role of baculoviral IAP repeat containing 6 (BIRC6), a member of IAPs, in human colorectal cancer (CRC). Methods We used Western blotting and immunohistochemistry to examine BIRC6 expression in 7 CRC cell lines and 126 CRC clinical samples. We determined the biological significance of BIRC6 in CRC cell lines by a lentivirus-mediated silencing method. Results We reported that BIRC6 was overexpressed in CRC cell lines and clinical CRC tissues. BIRC6 overexpression was correlated with tumor size and invasion depth of CRC. BIRC6 overexpression is associated with worse overall survival (OS) (P = 0.001) and shorter disease- free survival (DFS) (P = 0.010). BIRC6 knockdown inhibited cell proliferation, arrested cell cycle at S phase, downregulated cyclin A2, B1, D1 and E1 levels, and sensitized CRC cells to chemotherapy in vitro and in vivo. Conclusions Taken together, these data suggests that BIRC6 overexpression is a predictor of poor prognosis in colorectal cancer and BIRC6 could be a potential target of CRC therapy.	[Hu, Tingting; Weng, Shuqiang; Tang, Wenqing; Xue, Ruyi; Cai, Yu; Shen, Xizhong; Dong, Ling] Fudan Univ, Zhongshan Hosp, Shanghai Inst Liver Dis, Dept Gastroenterol & Hepatol, Shanghai 200433, Peoples R China; [Hu, Tingting] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Wenzhou, Peoples R China; [Chen, She; Zhang, Si] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Cai, Guoxiang] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200433, Peoples R China; [Cai, Guoxiang] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Wenzhou Medical University; Fudan University; Fudan University; Fudan University	Zhang, S (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.	zhangsi@fudan.edu.cn; dong.ling@zs-hospital.sh.cn	zhang, si/AAG-9094-2021	Xue, Ruyi/0000-0002-5710-0091; zhang, Si/0000-0002-5682-4995	Shanghai Science and Technology Commission [10411950100, 12ZR1405300]; National Natural Science Foundation of China [81100344, 81173078, 81371268, 81172273, 81272388, 81472673, 81400628]; National Clinical Key Special Subject of China [371]; Shanghai Pujiang Program [13PJD008]	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Clinical Key Special Subject of China; Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by Shanghai Science and Technology Commission (grant numbers: 10411950100 to XS, 12ZR1405300 to YC), National Natural Science Foundation of China (grant numbers: 81100344, 81173078 to SZ, 81371268 to SC, 81172273, 81272388 to LD, 81472673 to YC, 81272388, 81400628 to XS), the National Clinical Key Special Subject of China (grant number: 371 to XS), and Shanghai Pujiang Program(grant number: No. 13PJD008 to GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin O, 2012, CA-CANCER J CLIN, V62, P364, DOI 10.3322/caac.21156; Akiyoshi T, 2008, GASTROENTEROLOGY, V134, P131, DOI 10.1053/j.gastro.2007.10.008; Athanasoula KC, 2014, CANCER LETT, V347, P175, DOI 10.1016/j.canlet.2014.02.014; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bianchini M, 2006, INT J ONCOL, V29, P83; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; Chu L, 2008, GENE THER, V15, P484, DOI 10.1038/gt.2008.6; Dong X, 2013, J THORAC ONCOL, V8, P161, DOI 10.1097/JTO.0b013e31827d5237; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Findeisen P, 2005, CANCER RES, V65, P8072, DOI 10.1158/0008-5472.CAN-04-4146; Fuchs CS, 2008, J CLIN ONCOL, V26, P689, DOI 10.1200/JCO.2007.15.5390; Fulda S, 2014, LEUKEMIA, V28, P1414, DOI 10.1038/leu.2014.56; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Guicciardi ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092124; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lamers F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-285; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee YS, 2013, J NAT PROD, V76, P2195, DOI 10.1021/np4005135; Lopergolo A, 2009, BRIT J CANCER, V100, P739, DOI 10.1038/sj.bjc.6604927; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Low CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055837; Morikawa T, 2012, INT J CANCER, V131, P1169, DOI 10.1002/ijc.26495; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Qiu XB, 2005, J BIOL CHEM, V280, P174, DOI 10.1074/jbc.M411430200; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sung KW, 2007, CLIN CANCER RES, V13, P5109, DOI 10.1158/1078-0432.CCR-07-0693; Suzuki K, 2010, CANCER SCI, V101, P1163, DOI 10.1111/j.1349-7006.2010.01504.x; Van Houdt WJ, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011353-1, 10.1074/mcp.M111.011353]; Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Zaanan A, 2011, CELL ONCOL, V34, P155, DOI 10.1007/s13402-011-0024-x; Zhao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073461	40	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125281	10.1371/journal.pone.0125281	http://dx.doi.org/10.1371/journal.pone.0125281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933218	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100096
J	Martinez-Hernandez, A; Cordova, EJ; Rosillo-Salazar, O; Garcia-Ortiz, H; Contreras-Cubas, C; Islas-Andrade, S; Revilla-Monsalve, C; Salas-Labadia, C; Orozco, L				Martinez-Hernandez, Angelica; Cordova, Emilio J.; Rosillo-Salazar, Oscar; Garcia-Ortiz, Humberto; Contreras-Cubas, Cecilia; Islas-Andrade, Sergio; Revilla-Monsalve, Cristina; Salas-Labadia, Consuelo; Orozco, Lorena			Association of HMOX1 and NQO1 Polymorphisms with Metabolic Syndrome Components	PLOS ONE			English	Article							HEME OXYGENASE-1 GENE; OXIDATIVE STRESS; CARBON-MONOXIDE; NAD(P)H-QUINONE OXIDOREDUCTASE-1; ENDOTHELIAL DYSFUNCTION; MICROSATELLITE REPEATS; C609T POLYMORPHISM; NATIONAL-HEALTH; IRON STATUS; PROMOTER	Metabolic syndrome (MetS) is among the most important public health problems worldwide, and is recognized as a major risk factor for various illnesses, including type 2 diabetes mellitus, obesity, and cardiovascular diseases. Recently, oxidative stress has been suggested as part of MetS aetiology. The heme oxygenase 1 (HMOX1) and NADH: quinone oxidoreductase 1 (NQO1) genes are crucial mediators of cellular defence against oxidative stress. In the present study, we analysed the associations of HMOX1 (GT)n and NQO1 C609T polymorphisms with MetS and its components. Our study population comprised 735 Mexican Mestizos unrelated volunteers recruited from different tertiary health institutions from Mexico City. In order to know the HMOX1 (GT) n and NQO1 C609T allele frequencies in Amerindians, we included a population of 241 Amerindian native speakers. Their clinical and demographic data were recorded. The HMOX1 (GT) n polymorphism was genotyped using PCR and fluorescence technology. NQO1 C609T polymorphism genotyping was performed using TaqMan probes. Short allele (<25 GT repeats) of the HMOX1 polymorphism was associated with high systolic and diastolic blood pressure, and the T allele of the NQO1 C609T polymorphism was associated with increased triglyceride levels and decreased HDL-c levels, but only in individuals with MetS. This is the first study to analyse the association between MetS and genes involved in oxidative stress among Mexican Mestizos. Our data suggest that polymorphisms of HMOX1 and NQO1 genes are associated with a high risk of metabolic disorders, including high systolic and diastolic blood pressure, hypertriglyceridemia, and low HDL-c levels in Mexican Mestizo individuals.	[Martinez-Hernandez, Angelica; Cordova, Emilio J.; Rosillo-Salazar, Oscar; Garcia-Ortiz, Humberto; Contreras-Cubas, Cecilia; Orozco, Lorena] Inst Nacl Med Genom, SS, Immunogen & Metab Dis Lab, Mexico City, DF, Mexico; [Islas-Andrade, Sergio; Revilla-Monsalve, Cristina] IMSS, Ctr Med Nacl Siglo 21, Med Res Unit Metab Dis, Mexico City, DF, Mexico; [Salas-Labadia, Consuelo] Inst Nacl Pediat, SS, Dept Human Genet, Tissue Culture Lab, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Mexicano del Seguro Social	Orozco, L (corresponding author), Inst Nacl Med Genom, SS, Immunogen & Metab Dis Lab, Mexico City, DF, Mexico.	lorozco@inmegen.gob.mx	/ABI-8453-2020; Revilla-Monsalve, Cristina/ABG-6663-2021	/0000-0002-9402-4219; Orozco, Lorena/0000-0002-5801-9180; Rosillo Salazar, Oscar Daniel/0000-0002-6393-2409; Garcia-Ortiz, Humberto/0000-0002-0453-980X; salas, consuelo/0000-0002-3301-7357; Revilla Monsalve, Maria Cristina/0000-0002-6202-1160				Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Arredondo M, 2007, AM J CLIN NUTR, V86, P1347, DOI 10.1093/ajcn/86.5.1347; Arredondo M, 2011, BIOL TRACE ELEM RES, V143, P625, DOI 10.1007/s12011-010-8895-7; Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003; Cordova EJ, 2012, CLIN EXP RHEUMATOL, V30, P297; Cordova EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088069; Ford ES, 2003, DIABETES, V52, P2346, DOI 10.2337/diabetes.52.9.2346; Funke C, 2009, J NEURAL TRANSM, V116, P853, DOI 10.1007/s00702-009-0237-6; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Gregorek AC, 2013, BIOCHEM GENET, V51, P482, DOI 10.1007/s10528-013-9579-8; Han SJ, 2009, MOL GENET METAB, V97, P85, DOI 10.1016/j.ymgme.2009.01.012; Hassan N, 2013, N-S ARCH PHARMACOL, V386, P217, DOI 10.1007/s00210-012-0822-3; Hong CC, 2007, CANCER EPIDEM BIOMAR, V16, P1784, DOI 10.1158/1055-9965.EPI-07-0247; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Idriss NK, 2008, J AM COLL CARDIOL, V52, P971, DOI 10.1016/j.jacc.2008.06.019; Ilkun O, 2013, CURR PHARM DESIGN, V19, P4806, DOI 10.2174/1381612811319270003; Islam T, 2008, AM J RESP CRIT CARE, V177, P388, DOI 10.1164/rccm.200706-863OC; Javanmard SH, 2012, MOL BIOL REP, V39, P3355, DOI 10.1007/s11033-011-1105-7; Johnson FK, 2006, AM J PHYSIOL-REG I, V290, pR601, DOI 10.1152/ajpregu.00308.2005; Katana EP, 2011, CHINESE MED J-PEKING, V124, P3408, DOI 10.3760/cma.j.issn.0366-6999.2011.20.036; Kim DH, 2008, J PHARMACOL EXP THER, V325, P833, DOI 10.1124/jpet.107.135285; Kral A, 2011, FOLIA BIOL-PRAGUE, V57, P182; Leffler CW, 1999, AM J PHYSIOL-HEART C, V276, pH1641, DOI 10.1152/ajpheart.1999.276.5.H1641; Leiva E, 2013, BIOL TRACE ELEM RES, V151, P1, DOI 10.1007/s12011-012-9525-3; Martin NJ, 2009, MUTAT RES-GEN TOX EN, V674, P93, DOI 10.1016/j.mrgentox.2008.09.009; Mustafa S, 2008, J VASC SURG, V47, P566, DOI 10.1016/j.jvs.2007.09.060; Ono K, 2003, J HYPERTENS, V21, P1497, DOI 10.1097/00004872-200308000-00013; Palmieri VO, 2006, J NUTR, V136, P3022, DOI 10.1093/jn/136.12.3022; Palming J, 2007, J CLIN ENDOCR METAB, V92, P2346, DOI 10.1210/jc.2006-2476; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramprasath T, 2012, MOL CELL BIOCHEM, V361, P143, DOI 10.1007/s11010-011-1098-5; Rojas R, 2010, SALUD PUBLICA MEXICO, V52, pS11, DOI 10.1590/s0036-36342010000700004; Rojas-Martinez R, 2012, SALUD PUBLICA MEXICO, V54, P13; Rueda B, 2007, ARTHRITIS RHEUM-US, V56, P3953, DOI 10.1002/art.23048; Saraiva RM, 2007, NITRIC OXIDE-BIOL CH, V16, P331, DOI 10.1016/j.niox.2006.12.001; Sarbia M, 2003, INT J CANCER, V107, P381, DOI 10.1002/ijc.11430; Sheu CC, 2009, INTENS CARE MED, V35, P1343, DOI 10.1007/s00134-009-1504-6; Teran FJ, 2005, AM J PHYSIOL-REG I, V288, pR615, DOI 10.1152/ajpregu.00123.2004; Vazquez-Armenta G, 2013, TOHOKU J EXP MED, V231, P201, DOI 10.1620/tjem.231.201; Wan Hua-ying, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P285; Wang GY, 2006, BIOCHEM BIOPH RES CO, V341, P310, DOI 10.1016/j.bbrc.2005.12.195; Wu MM, 2011, ATHEROSCLEROSIS, V219, P704, DOI 10.1016/j.atherosclerosis.2011.08.047; Zhang JH, 2003, CARCINOGENESIS, V24, P905, DOI 10.1093/carcin/bgg019; Zierold KM, 2004, AM J PUBLIC HEALTH, V94, P1936, DOI 10.2105/AJPH.94.11.1936	44	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123313	10.1371/journal.pone.0123313	http://dx.doi.org/10.1371/journal.pone.0123313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933176	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100019
J	Popken, J; Graf, A; Krebs, S; Blum, H; Schmid, VJ; Strauss, A; Guengoer, T; Zakhartchenko, V; Wolf, E; Cremer, T				Popken, Jens; Graf, Alexander; Krebs, Stefan; Blum, Helmut; Schmid, Volker J.; Strauss, Axel; Guengoer, Tuna; Zakhartchenko, Valeri; Wolf, Eckhard; Cremer, Thomas			Remodeling of the Nuclear Envelope and Lamina during Bovine Preimplantation Development and Its Functional Implications	PLOS ONE			English	Article							PORE COMPLEX; GENOME ACTIVATION; FIBROBLAST NUCLEI; MICROSCOPY; DYNAMICS; ORGANIZATION; ARCHITECTURE; PERIPHERY; REVEALS; PROTEIN	The present study demonstrates a major remodeling of the nuclear envelope and its underlying lamina during bovine preimplantation development. Up to the onset of major embryonic genome activation (MGA) at the 8-cell stage nuclei showed a non-uniform distribution of nuclear pore complexes (NPCs). NPCs were exclusively present at sites where DNA contacted the nuclear lamina. Extended regions of the lamina, which were not contacted by DNA, lacked NPCs. In post-MGA nuclei the whole lamina was contacted rather uniformly by DNA. Accordingly, NPCs became uniformly distributed throughout the entire nuclear envelope. These findings shed new light on the conditions which control the integration of NPCs into the nuclear envelope. The switch from maternal to embryonic production of mRNAs was accompanied by multiple invaginations covered with NPCs, which may serve the increased demands of mRNA export and protein import. Other invaginations, as well as interior nuclear segments and vesicles without contact to the nuclear envelope, were exclusively positive for lamin B. Since the abundance of these invaginations and vesicles increased in concert with a massive nuclear volume reduction, we suggest that they reflect a mechanism for fitting the nuclear envelope and its lamina to a shrinking nuclear size during bovine preimplantation development. In addition, a deposit of extranuclear clusters of NUP153 (a marker for NPCs) without associated lamin B was frequently observed from the zygote stage up to MGA. Corresponding RNA-Seq data revealed deposits of spliced, maternally provided NUP153 mRNA and little unspliced, newly synthesized RNA prior to MGA, which increased strongly at the initiation of embryonic expression of NUP153at MGA.	[Popken, Jens; Cremer, Thomas] Ludwig Maximilians Univ Munchen, Bioctr, Div Anthropol & Human Genet, Planegg Martinsried, Germany; [Popken, Jens; Guengoer, Tuna; Zakhartchenko, Valeri; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Graf, Alexander; Krebs, Stefan; Blum, Helmut; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Schmid, Volker J.] Ludwig Maximilians Univ Munchen, Inst Stat, Munich, Germany; [Strauss, Axel] Ludwig Maximilians Univ Munchen, Bioctr, Div Genet, Planegg Martinsried, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Popken, J (corresponding author), Ludwig Maximilians Univ Munchen, Bioctr, Div Anthropol & Human Genet, Planegg Martinsried, Germany.	Jens.Popken@campus.lmu.de; ewolf@lmb.uni-muenchen.de; Thomas.Cremer@lrz.uni-muenchen.de	Schmid, Volker/F-3251-2010; Strauß, Axel/G-8473-2013; Cremer, Thomas/D-7979-2011	Schmid, Volker/0000-0003-2195-8130; Cremer, Thomas/0000-0002-1830-9589; Cremer, Thomas/0000-0001-7135-7216; Zakhartchenko, Valeri/0000-0002-5974-9759; Wolf, Eckhard/0000-0002-0430-9510	Deutsche Forschungsgemeinschaft [CR 59/26, FOR 1041, ZA 425/1-3]; EU grant Plurisys, FP7 Health 534 project [HEALTH-F4-2009-223485]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU grant Plurisys, FP7 Health 534 project	This study was supported by grants from the Deutsche Forschungsgemeinschaft to T.C, E.W. and V.Z. (CR 59/26, FOR 1041, ZA 425/1-3), In addition, research of E.W. and V.Z. was supported by the EU grant Plurisys, HEALTH-F4-2009-223485 FP7 Health 534 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SA, 2001, GENOME BIOL, V2; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Amendola M, 2014, CURR OPIN CELL BIOL, V28, P61, DOI 10.1016/j.ceb.2014.03.003; Arlucea J, 1998, J STRUCT BIOL, V124, P51, DOI 10.1006/jsbi.1998.4054; Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45; Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Baum M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5494; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Cremer C, 2013, EUR PHYS J H, V38, P281, DOI 10.1140/epjh/e2012-20060-1; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Daddysman MK, 2013, J PHYS CHEM B, V117, P1241, DOI 10.1021/jp310348s; Doucet CM, 2010, CHROMOSOMA, V119, P469, DOI 10.1007/s00412-010-0289-2; EVERINGH.JW, 1968, J CELL BIOL, V37, P540, DOI 10.1083/jcb.37.2.540; FAKAN S, 1980, BIOL CELLULAIRE, V37, P211; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hiendleder S, 2006, BIOL REPROD, V75, P17, DOI 10.1095/biolreprod.105.043919; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Holm P, 2002, REPRODUCTION, V123, P553, DOI 10.1530/rep.0.1230553; HSU WS, 1963, Z ZELLFORSCH MIK ANA, V58, P660; Kanka J, 2009, THERIOGENOLOGY, V72, P572, DOI 10.1016/j.theriogenology.2009.04.014; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Markaki Y, 2010, COLD SH Q B, V75, P475, DOI 10.1101/sqb.2010.75.042; Markaki Y, 2012, BIOESSAYS, V34, P412, DOI 10.1002/bies.201100176; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Popken J, 2014, NUCLEUS-PHILA, V5, P555, DOI 10.4161/19491034.2014.979712; Popken J, 2014, NUCLEUS-PHILA, V5, P542, DOI 10.4161/19491034.2014.970107; Rothballer A, 2013, TRENDS BIOCHEM SCI, V38, P292, DOI 10.1016/j.tibs.2013.04.001; Rouquette J, 2010, INT REV CEL MOL BIO, V282, P1, DOI 10.1016/S1937-6448(10)82001-5; Rouquette J, 2009, CHROMOSOME RES, V17, P801, DOI 10.1007/s10577-009-9070-x; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Shimi T, 2012, CURR OPIN CELL BIOL, V24, P71, DOI 10.1016/j.ceb.2011.11.007; Smeets D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-8; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; Wandke C, 2013, CELL, V152, P1222, DOI 10.1016/j.cell.2013.02.046; Zuela N, 2012, EMBO REP, V13, P1070, DOI 10.1038/embor.2012.167	49	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124619	10.1371/journal.pone.0124619	http://dx.doi.org/10.1371/journal.pone.0124619			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932910	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100051
J	Torso, M; Serra, L; Giulietti, G; Spano, B; Tuzzi, E; Koch, G; Caltagirone, C; Cercignani, M; Bozzali, M				Torso, Mario; Serra, Laura; Giulietti, Giovanni; Spano, Barbara; Tuzzi, Elisa; Koch, Giacomo; Caltagirone, Carlo; Cercignani, Mara; Bozzali, Marco			Strategic Lesions in the Anterior Thalamic Radiation and Apathy in Early Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER HYPERINTENSITIES; VOXEL-BASED MORPHOMETRY; NEUROPSYCHIATRIC SYMPTOMS; DEMENTIA; RISK; DISCONNECTION; ASSOCIATION; DYSFUNCTION; DEPRESSION	Background Behavioural disorders and psychological symptoms of Dementia (BPSD) are commonly observed in Alzheimer's disease (AD), and strongly contribute to increasing patients' disability. Using voxel-lesion-symptom mapping (VLSM), we investigated the impact of white matter lesions (WMLs) on the severity of BPSD in patients with amnestic mild cognitive impairment (a-MCI). Methods Thirty-one a-MCI patients (with a conversion rate to AD of 32% at 2 year follow-up) and 26 healthy controls underwent magnetic resonance imaging (MRI) examination at 3T, including T2-weighted and fluid-attenuated-inversion-recovery images, and T1-weighted volumes. In the patient group, BPSD was assessed using the Neuropsychiatric Inventory-12. After quantitative definition of WMLs, their distribution was investigated, without an a priori anatomical hypothesis, against patients' behavioural symptoms. Unbiased regional grey matter volumetrics was also used to assess the contribution of grey matter atrophy to BPSD. Results Apathy, irritability, depression/dysphoria, anxiety and agitation were shown to be the most common symptoms in the patient sample. Despite a more widespread anatomical distribution, a-MCI patients did not differ from controls in WML volumes. VLSM revealed a strict association between the presence of lesions in the anterior thalamic radiations (ATRs) and the severity of apathy. Regional grey matter atrophy did not account for any BPSD. Conclusions This study indicates that damage to the ATRs is strategic for the occurrence of apathy in patients with a-MCI. Disconnection between the prefrontal cortex and the mediodorsal and anterior thalamic nuclei might represent the pathophysiological substrate for apathy, which is one of the most common psychopathological symptoms observed in dementia.	[Torso, Mario; Serra, Laura; Giulietti, Giovanni; Spano, Barbara; Tuzzi, Elisa; Cercignani, Mara; Bozzali, Marco] IRCCS, Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Koch, Giacomo; Caltagirone, Carlo] IRCCS, Santa Lucia Fdn, Dept Clin & Behav Neurol, Rome, Italy; [Koch, Giacomo; Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Cercignani, Mara] Brighton & Sussex Med Sch, CISC, Brighton, E Sussex, England	IRCCS Santa Lucia; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Brighton; University of Sussex	Bozzali, M (corresponding author), IRCCS, Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy.	m.bozzali@hsantalucia.it	Koch, Giacomo/G-3155-2012; Giulietti, Giovanni/D-2771-2009; Serra, Laura/K-5637-2016; Spano', Barbara/K-9535-2016; Torso, Mario/ADO-3442-2022; Bozzali, Marco/AAC-1031-2022; Spano', Barbara/AAG-1671-2021	Serra, Laura/0000-0002-2717-1286; Spano', Barbara/0000-0002-5291-0984; Spano', Barbara/0000-0002-5291-0984; Torso, Mario/0000-0002-5284-9167; Cercignani, Mara/0000-0002-4550-2456; Bozzali, Marco/0000-0002-0568-2026; KOch, Giacomo/0000-0001-6155-9439	Italian Ministry of Health [150/RF-2009-1491699]	Italian Ministry of Health(Ministry of Health, Italy)	The current study was performed with the financial support of the Italian Ministry of Health (http://www.salute.gov.it/) (Grant number: 150/RF-2009-1491699, given to Marco Bozzali). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; [Anonymous], 2000, DSM 4 TR DIAGN STAT; Apostolova LG, 2007, NEUROLOGY, V13, P165; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Benedictus MR, 2013, NEUROBIOL AGING, V34, P2488, DOI 10.1016/j.neurobiolaging.2013.04.023; Benoit M, 2002, PSYCHIAT RES-NEUROIM, V114, P103, DOI 10.1016/S0925-4927(02)00003-3; Birdsill AC, 2014, NEUROBIOL AGING, V35, P769, DOI 10.1016/j.neurobiolaging.2013.10.072; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Busch D, 2010, LATERALITY, V15, P610, DOI 10.1080/13576500903081806; Carlesimo GA, 2011, NEUROPSYCHOLOGIA, V49, P2199, DOI 10.1016/j.neuropsychologia.2010.11.013; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; Drijgers RL, 2011, INT PSYCHOGERIATR, V23, P1327, DOI 10.1017/S1041610211001037; Erten-Lyons D, 2013, NEUROLOGY, V81, P977, DOI 10.1212/WNL.0b013e3182a43e45; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Ghika-Schmid F, 2000, ANN NEUROL, V48, P220, DOI 10.1002/1531-8249(200008)48:2<220::AID-ANA12>3.0.CO;2-M; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Heo JH, 2009, J GERIATR PSYCH NEUR, V22, P207, DOI 10.1177/0891988709335800; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Kimberg DY, 2007, J COGNITIVE NEUROSCI, V19, P1067, DOI 10.1162/jocn.2007.19.7.1067; Knutson KM, 2013, HUM BRAIN MAPP, V35, P1; Kraft A, 2014, CORTEX, V56, P38, DOI 10.1016/j.cortex.2012.10.004; Lawlor BA, 2004, J CLIN PSYCHIAT, V65, P5; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Marin, 1996, Semin Clin Neuropsychiatry, V1, P304; Marshall GA, 2007, ARCH NEUROL-CHICAGO, V64, P1015, DOI 10.1001/archneur.64.7.1015; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; O'Dwyer L, 2011, J ALZHEIMERS DIS, V26, P667, DOI 10.3233/JAD-2011-110137; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2013, ANN NEUROL, V74, P199, DOI 10.1002/ana.23931; Quaranta Davide, 2012, Curr Gerontol Geriatr Res, V2012, P719250, DOI 10.1155/2012/719250; Serra L, 2013, J ALZHEIMERS DIS, V33, P1157, DOI 10.3233/JAD-2012-121663; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; Serra L, 2010, J ALZHEIMERS DIS, V19, P147, DOI 10.3233/JAD-2010-1223; Snow AL, 2012, AGING MENT HEALTH, V16, P592, DOI 10.1080/13607863.2011.644518; Starkstein SE, 2009, J NEUROPSYCH CLIN N, V21, P259, DOI 10.1176/appi.neuropsych.21.3.259; Stoub TR, 2006, P NATL ACAD SCI USA, V103, P10041, DOI 10.1073/pnas.0603414103; Stuss DT, 2000, NEUROPSYCHOLOGY EMOT, P340; Teng E, 2007, DEMENT GERIATR COGN, V24, P253, DOI 10.1159/000107100; Vallet GT, 2013, CORTEX, V49, P2402, DOI 10.1016/j.cortex.2012.10.010; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f; Zahodne LB, 2013, INT J GERIATR PSYCH, V28, P50, DOI 10.1002/gps.3789	55	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124998	10.1371/journal.pone.0124998	http://dx.doi.org/10.1371/journal.pone.0124998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932637	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000353887100071
J	Chen, Z; Chen, X; Yan, HW; Li, WW; Li, Y; Cai, RH; Xiang, Y				Chen, Zhu; Chen, Xue; Yan, Hanwei; Li, Weiwei; Li, Yuan; Cai, Ronghao; Xiang, Yan			The Lipoxygenase Gene Family in Poplar: Identification, Classification, and Expression in Response to MeJA Treatment	PLOS ONE			English	Article							COMPREHENSIVE ANALYSIS; SEX DETERMINATION; ARABIDOPSIS; DEFENSE; GENOME; OXYLIPINS; INSECT; CONSEQUENCES; ADAPTATION; DIVERSITY	Background Lipoxygenases (LOXs) are important dioxygenases in cellular organisms. LOXs contribute to plant developmental processes and environmental responses. However, a systematic and comprehensive analysis has not been focused on the LOX gene family in poplar. Therefore, in the present study, we performed a comprehensive analysis of the LOX gene family in poplar. Results Using bioinformatics methods, we identified a total of 20 LOX genes. These LOX genes were clustered into two subfamilies. The gene structure and motif composition of each subfamily were relatively conserved. These genes are distributed unevenly across nine chromosomes. The PtLOX gene family appears to have expanded due to high tandem and low segmental duplication events. Microarray analysis showed that a number of PtLOX genes have different expression pattern across disparate tissues and under various stress treatments. Quantitative real-time PCR (qRT-PCR) analysis was further performed to confirm the responses to MeJA treatment of the 20 poplar LOX genes. The results show that the PtLOX genes are regulated by MeJA (Methyl jasmonate) treatment. Conclusions This study provides a systematic analysis of LOX genes in poplar. The gene family analysis reported here will be useful for conducting future functional genomics studies to uncover the roles of LOX genes in poplar growth and development.	[Chen, Zhu; Chen, Xue; Yan, Hanwei; Li, Weiwei; Li, Yuan; Xiang, Yan] Anhui Agr Univ, Lab Modern Biotechnol, Hefei, Peoples R China; [Cai, Ronghao; Xiang, Yan] Anhui Agr Univ, Key Lab Biomass Improvement & Convers, Hefei, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Xiang, Y (corresponding author), Anhui Agr Univ, Lab Modern Biotechnol, Hefei, Peoples R China.	xiangyanahau@sina.com			National Natural Science Foundation [31370561]; Specialized Research Fund for the Doctoral Program of Higher Education [20133418110005]; Anhui Provincial Natural Science Foundation [1308085MC36]; Anhui Agricultural University disciplinary construction Foundation [XKTS2013001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Agricultural University disciplinary construction Foundation	This work was supported by fundings from National Natural Science Foundation (31370561), Specialized Research Fund for the Doctoral Program of Higher Education (20133418110005), Anhui Provincial Natural Science Foundation (1308085MC36), Anhui Agricultural University disciplinary construction Foundation (XKTS2013001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2010, METHODS FOR CONTROLL; Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailly C, 2002, SEED SCI RES, V12, P47, DOI 10.1079/SSR200197; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Basso B, 1995, PLANT BIOSYST, V129, P935; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 1999, CURRENT BIOLOGY, V9; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Bryfczynski SP, 2009, GRAPHPAD A GRAPH CRE; Caldelari D, 2011, PLANT MOL BIOL, V75, P25, DOI 10.1007/s11103-010-9701-9; Cao J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-465; Chai GH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-253; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Cheng Q, 2006, PLANT SCI, V170, P1027, DOI 10.1016/j.plantsci.2005.12.012; Chuck G, 2010, ADV BOT RES, V54, P53, DOI 10.1016/S0065-2296(10)54002-3; Dai LM, 2009, ENVIRON MANAGE, V43, P1162, DOI 10.1007/s00267-008-9229-9; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110896; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fortier J, 2012, FOREST CHRON, V88, P391, DOI 10.5558/tfc2012-075; GASEN JB, 1990, J EDUC COMPUT RES, V6, P17, DOI 10.2190/N7C0-8KLA-REY8-F1K2; Gobel C., 2001, UNTERSUCHUNGEN ZUR F; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hall T., 2011, GERF B BIOSCI, V2, P60; Heidel AJ, 2010, CHEMOECOLOGY, V20, P149, DOI 10.1007/s00049-009-0031-9; HILDEBRAND DF, 1989, PHYSIOL PLANTARUM, V76, P249, DOI 10.1111/j.1399-3054.1989.tb05641.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Itoh A, 2001, J BIOL CHEM, V276, P3620, DOI 10.1074/jbc.M008964200; Kolomiets MV, 2001, PLANT CELL, V13, P613, DOI 10.1105/tpc.13.3.613; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liu SQ, 2011, GENET MOL RES, V10, P2613, DOI 10.4238/2011.October.25.9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Philippe RN, 2007, CAN J BOT, V85, P1111, DOI 10.1139/B07-109; Podolyan A., 2010, STUDY GREEN LEAF VOL; Ponting CP, 1999, CURR BIOL, V9, pR585, DOI 10.1016/S0960-9822(99)80379-0; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Richardson J J., 2001, POPLAR CULTURE N AM, P43; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosahl S, 1995, JOURNAL OF BIOSCIENC, V51, P123; Shah J, 2009, CURR OPIN PLANT BIOL, V12, P459, DOI 10.1016/j.pbi.2009.05.011; SHIBATA D, 1987, J BIOL CHEM, V262, P10080; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; STECZKO J, 1992, BIOCHEMISTRY-US, V31, P4053, DOI 10.1021/bi00131a022; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tattersall EAR, 2007, FUNCT INTEGR GENOMIC, V7, P317, DOI 10.1007/s10142-007-0051-x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Umate P, 2011, PLANT SIGNAL BEHAV, V6, P335, DOI 10.4161/psb.6.3.13546; VanDoorn A, 2010, PLANT SIGNAL BEHAV, V5, P1674, DOI 10.4161/psb.5.12.14036; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Vogt J, 2013, TREE GENET GENOMES, V9, P1493, DOI 10.1007/s11295-013-0653-5; Yang XY, 2012, INT J MOL SCI, V13, P2481, DOI 10.3390/ijms13022481; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang B, 2006, J EXP BOT, V57, P3825, DOI 10.1093/jxb/erl151; Zheng SJ, 2007, MOL PLANT MICROBE IN, V20, P1332, DOI 10.1094/MPMI-20-11-1332; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	78	39	42	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125526	10.1371/journal.pone.0125526	http://dx.doi.org/10.1371/journal.pone.0125526			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928711	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100098
J	Lehrberg, J; Gardiner, DM				Lehrberg, Jeffrey; Gardiner, David M.			Regulation of Axolotl (Ambystoma mexicanum) Limb Blastema Cell Proliferation by Nerves and BMP2 in Organotypic Slice Culture	PLOS ONE			English	Article							DORSAL-ROOT-GANGLIA; ADULT NEWT; IN-VITRO; FORELIMB REGENERATION; CYCLE; INVITRO; GROWTH; VIRIDESCENS; INDUCTION; IDENTIFICATION	We have modified and optimized the technique of organotypic slice culture in order to study the mechanisms regulating growth and pattern formation in regenerating axolotl limb blastemas. Blastema cells maintain many of the behaviors that are characteristic of blastemas in vivo when cultured as slices in vitro, including rates of proliferation that are comparable to what has been reported in vivo. Because the blastema slices can be cultured in basal medium without fetal bovine serum, it was possible to test the response of blastema cells to signaling molecules present in serum, as well as those produced by nerves. We also were able to investigate the response of blastema cells to experimentally regulated changes in BMP signaling. Blastema cells responded to all of these signals by increasing the rate of proliferation and the level of expression of the blastema marker gene, Prrx-1. The organotypic slice culture model provides the opportunity to identify and characterize the spatial and temporal co-regulation of pathways in order to induce and enhance a regenerative response.	[Lehrberg, Jeffrey; Gardiner, David M.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Gardiner, DM (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	dmgardin@uci.edu			United States Army Multidisciplinary University Research Initiative (MURI) subcontract from Tulane University [TUL 589-09/10]; National Science Foundation through the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington; Grass Foundation	United States Army Multidisciplinary University Research Initiative (MURI) subcontract from Tulane University; National Science Foundation through the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington; Grass Foundation	Research funded by a United States Army Multidisciplinary University Research Initiative (MURI) subcontract from Tulane University (TUL 589-09/10), and the National Science Foundation through its support of the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington. JL was funded in part by a research fellowship from the Grass Foundation (www.grassfoundation.org) for a summer research internship at the Marine Biological Laboratory, Woods Hole, Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athippozhy A, 2014, REGENERATION, V1, P1, DOI 10.1002/reg2.14; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Boilly B, 1988, Monogr Dev Biol, V21, P1; BRYANT SV, 1976, DEV BIOL, V50, P212, DOI 10.1016/0012-1606(76)90079-8; CARLONE RL, 1979, J EXP ZOOL, V210, P245, DOI 10.1002/jez.1402100207; CHOO AF, 1978, J EXP ZOOL, V206, P347, DOI 10.1002/jez.1402060306; CONN ME, 1979, IN VITRO CELL DEV B, V15, P409, DOI 10.1007/BF02618408; DALTON HC, 1950, J EXP ZOOL, V115, P17; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; FERRETTI P, 1988, J EXP ZOOL, V247, P77, DOI 10.1002/jez.1402470111; FIMIAN WJ, 1959, J EXP ZOOL, V140, P125, DOI 10.1002/jez.1401400107; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; GLOBUS M, 1975, J EMBRYOL EXP MORPH, V33, P813; GLOBUS M, 1977, DEV BIOL, V56, P316, DOI 10.1016/0012-1606(77)90273-1; GOLDHAMER DJ, 1992, J EXP ZOOL, V262, P71, DOI 10.1002/jez.1402620110; GOLDHAMER DJ, 1987, DEVELOPMENT, V100, P619; GROELL AL, 1993, ROUX ARCH DEV BIOL, V202, P170, DOI 10.1007/BF00365307; Guimond JC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-15; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; HINTERBERGER TJ, 1983, J EXP ZOOL, V226, P399, DOI 10.1002/jez.1402260310; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; Holtfreter J, 1929, UBER HISTOLOGISCHE D; Honda Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03420; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; JABAILY JA, 1982, J EXP ZOOL, V219, P67, DOI 10.1002/jez.1402190108; KAMRIN ANNE A., 1959, JOUR MORPHOL, V104, P415, DOI 10.1002/jmor.1051040303; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kumar Anoop, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5367; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; MADEN M, 1978, J EMBRYOL EXP MORPH, V48, P169; Makanae A, 2013, DEV BIOL, V381, P213, DOI 10.1016/j.ydbio.2013.05.010; Mayer H, 1996, CALCIFIED TISSUE INT, V58, P249; McCusker C, 2014, REGENERATION, V1, P27, DOI 10.1002/reg2.10; McCusker CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077064; MESCHER AL, 1981, J EXP ZOOL, V216, P235, DOI 10.1002/jez.1402160204; Mescher AL, 1997, DEV GROWTH DIFFER, V39, P677; MONNICKE.MA, 1973, EXPERIENTIA, V29, P1, DOI 10.1007/BF01913222; MONNICKENDAM MA, 1970, J MORPHOL, V132, P453, DOI 10.1002/jmor.1051320406; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; OUDKHIR M, 1986, EXPERIENTIA, V42, P189, DOI 10.1007/BF01952461; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Salley-Guydon JD, 2006, WOUND REPAIR REGEN, V14, P479, DOI 10.1111/j.1743-6109.2006.00154.x; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Satoh A, 2012, DEV BIOL, V366, P374, DOI 10.1016/j.ydbio.2012.03.022; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; Sidman R. L., 1951, American Journal of Physiology, V165, P257; SINGER M, 1947, J EXP ZOOL, V104, P223, DOI 10.1002/jez.1401040204; SINGER M, 1946, J EXP ZOOL, V101, P299, DOI 10.1002/jez.1401010303; SINGER M, 1948, J EXP ZOOL, V108, P279, DOI 10.1002/jez.1401080207; SINGER M, 1949, J EXP ZOOL, V111, P295, DOI 10.1002/jez.1401110208; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; TASSAVA RA, 1987, BIOCHEM CELL BIOL, V65, P739, DOI 10.1139/o87-097; Todd T. J., 1823, Q J SCI LIT ARTS, V16, P84; TOMLINSON BL, 1984, J EXP ZOOL, V232, P249, DOI 10.1002/jez.1402320212; Wallace, 1981, VERTEBRATE LIMB REGE; WALLACE H, 1976, J CELL SCI, V20, P539; Wang Q, 2011, MOL VIS, V17, P647; Whited JL, 2011, DEV DYNAM, V240, P1249, DOI 10.1002/dvdy.22548; WILDE CE, 1950, J MORPHOL, V86, P73, DOI 10.1002/jmor.1050860106; Wong GA, 2003, AM J PHYSIOL-ENDOC M, V284, pE972, DOI 10.1152/ajpendo.00385.2002; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yokoyama H, 2011, J INVEST DERMATOL, V131, P2477, DOI 10.1038/jid.2011.223; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	74	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123186	10.1371/journal.pone.0123186	http://dx.doi.org/10.1371/journal.pone.0123186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923915	Green Published, gold			2022-12-26	WOS:000353711600033
J	Menger, DJ; Omusula, P; Holdinga, M; Homan, T; Carreira, AS; Vandendaele, P; Derycke, JL; Mweresa, CK; Mukabana, WR; van Loon, JJA; Takken, W				Menger, David J.; Omusula, Philemon; Holdinga, Maarten; Homan, Tobias; Carreira, Ana S.; Vandendaele, Patrice; Derycke, Jean-Luc; Mweresa, Collins K.; Mukabana, Wolfgang Richard; van Loon, Joop J. A.; Takken, Willem			Field Evaluation of a Push-Pull System to Reduce Malaria Transmission	PLOS ONE			English	Article							LASTING INSECTICIDAL NETS; ANOPHELES-GAMBIAE COMPLEX; SPATIAL REPELLENCY; MOSQUITOS DIPTERA; CARBON-DIOXIDE; TRAP CATCHES; HOUSE ENTRY; FUNESTUS; CULICIDAE; VECTORS	Malaria continues to place a disease burden on millions of people throughout the tropics, especially in sub-Saharan Africa. Although efforts to control mosquito populations and reduce human-vector contact, such as long-lasting insecticidal nets and indoor residual spraying, have led to significant decreases in malaria incidence, further progress is now threatened by the widespread development of physiological and behavioural insecticide-resistance as well as changes in the composition of vector populations. A mosquito-directed push-pull system based on the simultaneous use of attractive and repellent volatiles offers a complementary tool to existing vector-control methods. In this study, the combination of a trap baited with a five-compound attractant and a strip of net-fabric impregnated with micro-encapsulated repellent and placed in the eaves of houses, was tested in a malaria-endemic village in western Kenya. Using the repellent delta-undecalactone, mosquito house entry was reduced by more than 50%, while the traps caught high numbers of outdoor flying mosquitoes. Model simulations predict that, assuming area-wide coverage, the addition of such a push-pull system to existing prevention efforts will result in up to 20-fold reductions in the entomological inoculation rate. Reductions of such magnitude are also predicted when mosquitoes exhibit a high resistance against insecticides. We conclude that a push-pull system based on non-toxic volatiles provides an important addition to existing strategies for malaria prevention.	[Menger, David J.; Holdinga, Maarten; Homan, Tobias; Mweresa, Collins K.; van Loon, Joop J. A.; Takken, Willem] Wageningen Univ, Entomol Lab, NL-6700 EH Wageningen, Netherlands; [Omusula, Philemon; Mweresa, Collins K.; Mukabana, Wolfgang Richard] Int Ctr Insect Physiol & Ecol, Gpo Nairobi, Kenya; [Carreira, Ana S.] Univ Coimbra, Dept Chem Engn, CIEPQPF, P-3030790 Coimbra, Portugal; [Carreira, Ana S.] Devan Micropolis, P-4470605 Maia, Portugal; [Vandendaele, Patrice] Devan Chem NV, B-9600 Ronse, Belgium; [Derycke, Jean-Luc] Utexbel NV, B-9600 Ronse, Belgium; [Mukabana, Wolfgang Richard] Univ Nairobi, Sch Biol Sci, Gpo Nairobi, Kenya	Wageningen University & Research; International Centre of Insect Physiology & Ecology (ICIPE); Universidade de Coimbra; University of Nairobi	Menger, DJ (corresponding author), Wageningen Univ, Entomol Lab, POB 8031, NL-6700 EH Wageningen, Netherlands.	david.menger@wur.nl	van Loon, Joop J.A./B-3744-2009	van Loon, Joop J.A./0000-0002-4260-0501	European Union [NMP2-2009-228639]; Foundation for the National Institutes of Health [121]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BDE/51601/2011]	European Union(European Commission); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The laboratory work was funded by the European Union through NMP2-2009-228639, FP7, NOBUG project; the fieldwork was funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH#121). Ana S. Carreira gratefully acknowledges the Fundacao para a Ciencia e Tecnologia, Portugal, for the financial support under the PhD grant (SFRH/BDE/51601/2011), which includes the encapsulation work. Devan Chemicals and Utexbel provided support in the form of salaries	Baker, 2000, EVALUATING IMPACT DE; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Campos E, 2013, EUR POLYM J, V49, P2005, DOI 10.1016/j.eurpolymj.2013.04.033; Chaiyasat P, 2013, ENRGY PROCED, V34, P656, DOI 10.1016/j.egypro.2013.06.797; Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Costantini C, 1998, B ENTOMOL RES, V88, P503, DOI 10.1017/S000748530002602X; Dabire RK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-127; DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126; Hiscox A, 2012, MALARIA J, V11, pO45; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167; Kampango A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-99; Kawada H, 2008, J AM MOSQUITO CONTR, V24, P404, DOI 10.2987/5743.1; Khan Z, 2011, INT J AGR SUSTAIN, V9, P162, DOI 10.3763/ijas.2010.0558; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Koureas M, 2012, TOXICOL LETT, V210, P155, DOI 10.1016/j.toxlet.2011.10.007; LIN F M, 1970, Journal of Food Science, V35, P538, DOI 10.1111/j.1365-2621.1970.tb04802.x; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Mahajan SS, 2004, J DAIRY SCI, V87, P4057, DOI 10.3168/jds.S0022-0302(04)73547-X; Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875; Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11; Maxwell CA, 1998, MED VET ENTOMOL, V12, P325, DOI 10.1046/j.1365-2915.1998.00108.x; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Menger DJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-119; Specos MMM, 2010, T ROY SOC TROP MED H, V104, P653, DOI 10.1016/j.trstmh.2010.06.004; Mnyone LL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-87; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Mukabana WR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-202; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Mweresa CK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-376; Mweresa CK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-160; N'Guessan R, 2008, T ROY SOC TROP MED H, V102, P259, DOI 10.1016/j.trstmh.2007.10.012; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Ogoma SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-54; Okumu F, 2010, J MED ENTOMOL, V47, P274, DOI 10.1603/ME09114; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Russell TL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-56; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Senhorini GA, 2012, MAT SCI ENG C-MATER, V32, P1121, DOI 10.1016/j.msec.2012.02.027; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; SNOW WF, 1987, MED VET ENTOMOL, V1, P9, DOI 10.1111/j.1365-2915.1987.tb00318.x; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Spitzen J, 2008, PHYSIOL ENTOMOL, V33, P116, DOI 10.1111/j.1365-3032.2008.00612.x; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042	58	34	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123415	10.1371/journal.pone.0123415	http://dx.doi.org/10.1371/journal.pone.0123415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923114	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600047
J	Raquin, V; Moro, CV; Saucereau, Y; Tran, FH; Potier, P; Mavingui, P				Raquin, Vincent; Moro, Claire Valiente; Saucereau, Yoann; Tran, Florence-Helene; Potier, Patrick; Mavingui, Patrick			Native Wolbachia from Aedes albopictus Blocks Chikungunya Virus Infection In Cellulo	PLOS ONE			English	Article							DENGUE VIRUS; VECTOR COMPETENCE; AEGYPTI MOSQUITOS; HOST MICRORNAS; STRAIN WMEL; REPLICATION; PIPIENTIS; LINE; TRANSMISSION; TEMPERATURE	Wolbachia, a widespread endosymbiont of terrestrial arthropods, can protect its host against viral and parasitic infections, a phenotype called "pathogen blocking". However, in some cases Wolbachia may have no effect or even enhance pathogen infection, depending on the host-Wolbachia-pathogen combination. The tiger mosquito Aedes albopictus is naturally infected by two strains of Wolbachia, wAlbA and wAlbB, and is a competent vector for different arboviruses such as dengue virus (DENV) and chikungunya virus (CHIKV). Interestingly, it was shown in some cases that Ae. albopictus native Wolbachia strains are able to inhibit DENV transmission by limiting viral replication in salivary glands, but no such impact was measured on CHIKV replication in vivo. To better understand the Wolbachia/CHIKV/Ae. albopictus interaction, we generated a cellular model using Ae. albopictus derived C6/36 cells that we infected with the wAlbB strain. Our results indicate that CHIKV infection is negatively impacted at both RNA replication and virus assembly/secretion steps in presence of wAlbB. Using FISH, we observed CHIKV and wAlbB in the same mosquito cells, indicating that the virus is still able to enter the cell in the presence of the bacterium. Further work is needed to decipher molecular pathways involved in Wolbachia-CHIKV interaction at the cellular level, but this cellular model can be a useful tool to study the mechanism behind virus blocking phenotype induced by Wolbachia. More broadly, this put into question the ecological role of Wolbachia symbiont in Ae. albopictus, but also the ability of the CHIKV to counteract Wolbachia's antiviral potential in vivo.	[Raquin, Vincent; Moro, Claire Valiente; Saucereau, Yoann; Tran, Florence-Helene; Potier, Patrick; Mavingui, Patrick] Univ Lyon 1, CNRS, INRA USC1190, UMR5557 Ecol Microbienne,VetAgro Sup, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Raquin, V (corresponding author), Inst Pasteur, Genomes & Genet Dept, Insects Viruses Interact Grp, Paris, France.	vincent.raquin@gmail.com; patrick.mavingui@univ-lyon1.fr		valiente moro, claire/0000-0002-7193-405X; RAQUIN, Vincent/0000-0001-6814-4199	Agence Nationale de la Recherche (ANR) [ANR-2010-BLAN-170101]; Fondation pour la Recherche et la Biodiversite (FRB) [FRBCD-AOOI-07-12]; Action Concertee InterPasteurienne (ACIP) [A-10-2009]; ERA-Net BiodivERsA network; ANR France [ANR-13-EBID-0007-01]; FWF Austria [FWF I-1437]; DFG Germany [DFG KL 2087/6-1]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche et la Biodiversite (FRB); Action Concertee InterPasteurienne (ACIP); ERA-Net BiodivERsA network; ANR France(French National Research Agency (ANR)); FWF Austria(Austrian Science Fund (FWF)); DFG Germany(German Research Foundation (DFG))	This work was partially funded by the Agence Nationale de la Recherche (ANR, http://www.agence-nationale-recherche.fr/) grant ANR-2010-BLAN-170101 (ImmunSymbArt), the Fondation pour la Recherche et la Biodiversite (FRB, http://www.fondationbiodiversite.fr/) grant FRBCD-AOOI-07-12, the Action Concertee InterPasteurienne (ACIP) grant A-10-2009 and the ERA-Net BiodivERsA network (http://www.biodiversa.org/) with the national funders ANR France (ANR-13-EBID-0007-01), FWF Austria (FWF I-1437), and DFG Germany (DFG KL 2087/6-1), part of the 2012-2013 BiodivERsA call for research proposals.	Angelini R, 2007, Euro Surveill, V12; Baldridge GD, 2014, MOL MICROBIOL, V94, P537, DOI 10.1111/mmi.12768; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4; Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459; Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488; Christodoulou M, 2011, LANCET INFECT DIS, V11, P84, DOI 10.1016/S1473-3099(11)70017-2; Darby AC, 2014, ISME J, V8, P925, DOI 10.1038/ismej.2013.192; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Fallon AM, 2013, IN VITRO CELL DEV-AN, V49, P66, DOI 10.1007/s11626-012-9571-3; Fallon AM, 2009, IN VITRO CELL DEV-AN, V45, P460, DOI 10.1007/s11626-009-9193-6; Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621; Fenollar F, 2003, J CLIN MICROBIOL, V41, P5434, DOI 10.1128/JCM.41.12.5434-5441.2003; Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296; Hussain M, 2013, RNA BIOL, V10, P1868, DOI 10.4161/rna.27392; Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Khoo CCH, 2013, B ENTOMOL RES, V103, P251, DOI 10.1017/S0007485312000648; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989; Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932; ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x; Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2; Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Raquin V, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-243; Richards SL, 2012, J MED ENTOMOL, V49, P1502, DOI 10.1603/ME12054; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Slatko BE, 2014, MOL BIOCHEM PARASIT, V195, P88, DOI 10.1016/j.molbiopara.2014.07.004; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892; Venard CMP, 2011, LETT APPL MICROBIOL, V52, P168, DOI 10.1111/j.1472-765X.2010.02986.x; Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; [WHO WHO], WHO ABOUT VECTOR BOR; WHO, WHO CHIKUNGUNYA FRAN; Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837; Zhang GM, 2014, INSECT BIOCHEM MOLEC, V53, P81, DOI 10.1016/j.ibmb.2014.08.003; Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	73	28	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125066	10.1371/journal.pone.0125066	http://dx.doi.org/10.1371/journal.pone.0125066			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923352	gold, Green Published			2022-12-26	WOS:000353711600121
J	Sonani, RR; Gupta, GD; Madamwar, D; Kumar, V				Sonani, Ravi Raghav; Gupta, Gagan Deep; Madamwar, Datta; Kumar, Vinay			Crystal Structure of Allophycocyanin from Marine Cyanobacterium Phormidium sp A09DM	PLOS ONE			English	Article							ENERGY-TRANSFER; PURIFICATION; PHYCOCYANIN; PHYCOBILISOMES; ANGSTROM; PHYCOERYTHRIN; VISUALIZATION; ARCHITECTURE; ANTIOXIDANT; COMPONENTS	Isolated phycobilisome (PBS) sub-assemblies have been widely subjected to X-ray crystallography analysis to obtain greater insights into the structure-function relationship of this light harvesting complex. Allophycocyanin (APC) is the phycobiliprotein always found in the PBS core complex. Phycocyanobilin (PCB) chromophores, covalently bound to conserved Cys residues of alpha- and beta-subunits of APC, are responsible for solar energy absorption from phycocyanin and for transfer to photosynthetic apparatus. In the known APC structures, heterodimers of alpha- and beta-subunits (known as alpha beta monomers) assemble as trimer or hexamer. We here for the first time report the crystal structure of APC isolated from a marine cyanobacterium (Phormidium sp. A09DM). The crystal structure has been refined against all the observed data to the resolution of 2.51 angstrom to R-work (R-free) of 0.158 (0.229) with good stereochemistry of the atomic model. The Phormidium protein exists as a trimer of alpha beta monomers in solution and in crystal lattice. The overall tertiary structures of alpha- and beta-subunits, and trimeric quaternary fold of the Phormidium protein resemble the other known APC structures. Also, configuration and conformation of the two covalently bound PCB chromophores in the marine APC are same as those observed in fresh water cyanobacteria and marine red algae. More hydrophobic residues, however, constitute the environment of the chromophore bound to alpha-subunit of the Phormidium protein, owing mainly to amino acid substitutions in the marine protein.	[Sonani, Ravi Raghav; Madamwar, Datta] Sardar Patel Univ, BRD Sch Biosci, Vallabh Vidyanagar 388120, Gujarat, India; [Gupta, Gagan Deep; Kumar, Vinay] Bhabha Atom Res Ctr, Div Solid State Phys, Prot Crystallog Sect, Mumbai 400085, Maharashtra, India	Sardar Patel University; Bhabha Atomic Research Center (BARC)	Madamwar, D (corresponding author), Sardar Patel Univ, BRD Sch Biosci, Vadtal Rd,Satellite Campus, Vallabh Vidyanagar 388120, Gujarat, India.	datta_madamwar@yahoo.com; vinay@barc.gov.in	Sonani, Ravi/Q-5096-2019	Sonani, Ravi/0000-0002-6212-2869; Gupta, Gagan Deep/0000-0003-2549-3190				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N., 2008, PHOTOSYNTHETIC PROTE, P243, DOI DOI 10.1002/9783527623464.CH11; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bibby TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004601; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; David L, 2011, J MOL BIOL, V405, P201, DOI 10.1016/j.jmb.2010.10.036; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GANTT E, 1973, BIOCHIM BIOPHYS ACTA, V292, P858, DOI 10.1016/0005-2728(73)90036-4; GARFIN DE, 1990, METHOD ENZYMOL, V182, P425; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; HUBER R, 1989, EMBO J, V8, P2125, DOI 10.1002/j.1460-2075.1989.tb08337.x; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Liu JY, 1999, J BIOL CHEM, V274, P16945, DOI 10.1074/jbc.274.24.16945; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDELL DJ, 1981, J BIOL CHEM, V256, P3580; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MacColl R, 2004, BBA-BIOENERGETICS, V1657, P73, DOI 10.1016/j.bbabio.2004.04.005; Marx A, 2014, PHOTOSYNTH RES, V121, P87, DOI 10.1007/s11120-014-9996-5; Marx A, 2013, BBA-BIOENERGETICS, V1827, P311, DOI 10.1016/j.bbabio.2012.11.006; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGregor A, 2008, J MOL BIOL, V384, P406, DOI 10.1016/j.jmb.2008.09.018; MURAKAMI A, 1981, J BIOCHEM-TOKYO, V89, P79, DOI 10.1093/oxfordjournals.jbchem.a133205; Murray JW, 2007, ACTA CRYSTALLOGR F, V63, P998, DOI 10.1107/S1744309107050920; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P1795, DOI 10.1016/j.biortech.2010.09.025; Parmar A, 2010, J PHYCOL, V46, P285, DOI 10.1111/j.1529-8817.2009.00798.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh NK, 2012, PROCESS BIOCHEM, V47, P2472, DOI 10.1016/j.procbio.2012.10.009; Singh NK, 2009, BIORESOURCE TECHNOL, V100, P1663, DOI 10.1016/j.biortech.2008.09.021; Sonani RR, 2014, PROCESS BIOCHEM, V49, P1757, DOI 10.1016/j.procbio.2014.06.022; Sonani RR, 2014, AGE, V36, DOI 10.1007/s11357-014-9717-1; Soni B, 2008, BIORESOURCE TECHNOL, V99, P188, DOI 10.1016/j.biortech.2006.11.010; Soni B, 2006, PROCESS BIOCHEM, V41, P2017, DOI 10.1016/j.procbio.2006.04.018; Su HN, 2010, J APPL PHYCOL, V22, P65, DOI 10.1007/s10811-009-9427-8; SWANSON RV, 1990, J MOL BIOL, V214, P787, DOI 10.1016/0022-2836(90)90293-U; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Watanabe M, 2013, PHOTOSYNTH RES, V116, P265, DOI 10.1007/s11120-013-9905-3; Waterbury JB, 1981, PROKARYOTES, P221, DOI DOI 10.1007/978-3-662-13187-9_9; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Work VH, 2012, CURR OPIN BIOTECH, V23, P290, DOI 10.1016/j.copbio.2011.11.022	52	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124580	10.1371/journal.pone.0124580	http://dx.doi.org/10.1371/journal.pone.0124580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923120	Green Published, gold			2022-12-26	WOS:000353711600095
J	van der Geest, KSM; Abdulahad, WH; Horst, G; Lorencetti, PG; Bijzet, J; Arends, S; van der Heiden, M; Buisman, AM; Kroesen, BJ; Brouwer, E; Boots, AMH				van der Geest, Kornelis S. M.; Abdulahad, Wayel H.; Horst, Gerda; Lorencetti, Pedro G.; Bijzet, Johan; Arends, Suzanne; van der Heiden, Marieke; Buisman, Anne-Marie; Kroesen, Bart-Jan; Brouwer, Elisabeth; Boots, Annemieke M. H.			Quantifying Distribution of Flow Cytometric TCR-V beta Usage with Economic Statistics	PLOS ONE			English	Article							T-CELL REPERTOIRE; DIVERSITY; NAIVE; CLONALITY; CD4(+); AGE	Measuring changes of the T cell receptor (TCR) repertoire is important to many fields of medicine. Flow cytometry is a popular technique to study the TCR repertoire, as it quickly provides insight into the TCR-V beta usage among well-defined populations of T cells. However, the interpretation of the flow cytometric data remains difficult, and subtle TCR repertoire changes may go undetected. Here, we introduce a novel means for analyzing the flow cytometric data on TCR-V beta usage. By applying economic statistics, we calculated the Gini-TCR skewing index from the flow cytometric TCR-V beta analysis. The Gini-TCR skewing index, which is a direct measure of TCR-V beta distribution among T cells, allowed us to track subtle changes of the TCR repertoire among distinct populations of T cells. Application of the Gini-TCR skewing index to the flow cytometric TCR-V beta analysis will greatly help to gain better understanding of the TCR repertoire in health and disease.	[van der Geest, Kornelis S. M.; Abdulahad, Wayel H.; Horst, Gerda; Lorencetti, Pedro G.; Bijzet, Johan; Arends, Suzanne; van der Heiden, Marieke; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [van der Heiden, Marieke; Buisman, Anne-Marie] Natl Inst Publ Hlth & Environm, Ctr Immunol Infect Dis & Vaccines, NL-3720 BA Bilthoven, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; Netherlands National Institute for Public Health & the Environment; University of Groningen	van der Geest, KSM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	k.s.m.van.der.geest@umcg.nl	Arends, Suzanne/M-5436-2015; Brouwer, Elisabeth/AAL-9029-2020; Brouwer, Elisabeth/A-3198-2015	Arends, Suzanne/0000-0002-4422-7640; Brouwer, Elisabeth/0000-0002-5652-4423; Brouwer, Elisabeth/0000-0002-5652-4423; /0000-0003-3109-4487; van der Geest, Kornelis/0000-0003-2798-6765	MSD; Foundation 'De Drie Lichten' [19/11 GJF/mk]; Foundation 'Jan Kornelis de Cock' [2012-22]; National Institute of Public Health [SOR230426/01]	MSD; Foundation 'De Drie Lichten'; Foundation 'Jan Kornelis de Cock'; National Institute of Public Health	This study was supported by unrestricted grants from NV Organon (now MSD) to AMHB, Foundation 'De Drie Lichten' (project no. 19/11 GJF/mk) to KvdG, Foundation 'Jan Kornelis de Cock' to KvdG (project no. 2012-22), and by strategic research funding of the National Institute of Public Health (SOR230426/01) to A-MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum PD, 2012, BLOOD, V119, P3469, DOI 10.1182/blood-2011-11-395384; Bellu LG, 2005, INEQUALITY ANAL GINI; Britanova OV, 2014, J IMMUNOL, V192, P2689, DOI 10.4049/jimmunol.1302064; Ceriani L, 2012, J ECON INEQUAL, V10, P421, DOI 10.1007/s10888-011-9188-x; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; GASTWIRT.JL, 1972, REV ECON STAT, V54, P306, DOI 10.2307/1937992; Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Langerak AW, 2001, BLOOD, V98, P165, DOI 10.1182/blood.V98.1.165; Laydon DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003646; Manuel M, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19545; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Thomas PG, 2013, P NATL ACAD SCI USA, V110, P1839, DOI 10.1073/pnas.1222149110; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647	22	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125373	10.1371/journal.pone.0125373	http://dx.doi.org/10.1371/journal.pone.0125373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923356	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600145
J	Mousavi, SJ; Doweidar, MH				Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.			Role of Mechanical Cues in Cell Differentiation and Proliferation: A 3D Numerical Model	PLOS ONE			English	Article							TISSUE DIFFERENTIATION; MATRIX ELASTICITY; STIFFNESS; MIGRATION; STRESS; REGENERATION; RIGIDITY; STIMULI; STRAIN	Cell differentiation, proliferation and migration are essential processes in tissue regeneration. Experimental evidence confirms that cell differentiation or proliferation can be regulated according to the extracellular matrix stiffness. For instance, mesenchymal stem cells (MSCs) can differentiate to neuroblast, chondrocyte or osteoblast within matrices mimicking the stiffness of their native substrate. However, the precise mechanisms by which the substrate stiffness governs cell differentiation or proliferation are not well known. Therefore, a mechano-sensing computational model is here developed to elucidate how substrate stiffness regulates cell differentiation and/or proliferation during cell migration. In agreement with experimental observations, it is assumed that internal deformation of the cell (a mechanical signal) together with the cell maturation state directly coordinates cell differentiation and/or proliferation. Our findings indicate that MSC differentiation to neurogenic, chondrogenic or osteogenic lineage specifications occurs within soft (0.1-1 kPa), intermediate (20-25 kPa) or hard (30-45 kPa) substrates, respectively. These results are consistent with well-known experimental observations. Remarkably, when a MSC differentiate to a compatible phenotype, the average net traction force depends on the substrate stiffness in such a way that it might increase in intermediate and hard substrates but it would reduce in a soft matrix. However, in all cases the average net traction force considerably increases at the instant of cell proliferation because of cell-cell interaction. Moreover cell differentiation and proliferation accelerate with increasing substrate stiffness due to the decrease in the cell maturation time. Thus, the model provides insights to explain the hypothesis that substrate stiffness plays a key role in regulating cell fate during mechanotaxis.	[Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.] Univ Zaragoza, Aragon Inst Engn Res I3A, Grp Struct Mech & Mat Modeling GEMM, Zaragoza, Spain; [Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.] Univ Zaragoza, Sch Engn & Architecture EINA, Dept Mech Engn, Zaragoza, Spain; [Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.] CIBER BBN, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Doweidar, MH (corresponding author), Univ Zaragoza, Aragon Inst Engn Res I3A, Grp Struct Mech & Mat Modeling GEMM, Zaragoza, Spain.	mohamed@unizar.es	Doweidar, Mohamed H./F-2140-2016; Doweidar, Mohamed H./HGF-0661-2022	Doweidar, Mohamed H./0000-0003-0088-7222; 	Spanish Ministry of Economy and Competitiveness (MINECO) [MAT2013-46467-C4-3-R]; Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN)	Spanish Ministry of Economy and Competitiveness (MINECO); Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN)	This work was supported by The Spanish Ministry of Economy and Competitiveness (MINECO), https://sede.micinn.gob.es/, MAT2013-46467-C4-3-R, MHD; and Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), http://www.ciber-bbn.es/es/quienes-somos, MHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1985, J BIOL CHEM, V260, P4492; Allena R, 2013, B MATH BIOL, V75, P288, DOI 10.1007/s11538-012-9806-1; Allena R, 2012, J THEOR BIOL, V306, P15, DOI 10.1016/j.jtbi.2012.03.041; BEAUPRE GS, 1988, J ORTHOP RES, V6, P39, DOI 10.1002/jor.1100060106; Brodland G. Wayne, 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P91; Brown G, 2003, EXP CELL RES, V291, P282, DOI 10.1016/S0014-4827(03)00393-8; Burke DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040737; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Cullinane DM, 2003, J EXP BIOL, V206, P2459, DOI 10.1242/jeb.00453; Delaine-Smith Robin M, 2012, Muscles Ligaments Tendons J, V2, P169; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans ND, 2009, EUR CELLS MATER, V18, P1; Fouliard S, 2009, MATH COMPUT MODEL, V49, P2104, DOI 10.1016/j.mcm.2008.07.003; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Geris L., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P277, DOI 10.1080/10255840310001634412; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gladman SJ, 2010, NEUROSCIENCE, V171, P577, DOI 10.1016/j.neuroscience.2010.07.009; Harrison NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022700; Her GJ, 2013, ACTA BIOMATER, V9, P5170, DOI 10.1016/j.actbio.2012.10.012; Hibbit, 2011, ABAQUS THEORY MANUAL; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037; Mousavi SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122094; Mousavi SJ, 2013, J THEOR BIOL, V329, P64, DOI 10.1016/j.jtbi.2013.03.021; JAMES DW, 1969, EXP CELL RES, V54, P107, DOI 10.1016/0014-4827(69)90299-7; Kang KT, 2011, TISSUE ENG REGEN MED, V8, P359; Kearney EM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979870; Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Lacroix D, 2002, MED BIOL ENG COMPUT, V40, P14, DOI 10.1007/BF02347690; Lee DA, 2011, J CELL BIOCHEM, V112, P1, DOI 10.1002/jcb.22758; Lee YH, 2013, INTEGR BIOL-UK, V5, P1447, DOI 10.1039/c3ib40161h; Li D, 2011, REGEN MED, V6, P229, DOI 10.2217/RME.11.2; Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8; Mousavi SJ, 2014, COMPUT METHOD BIOMEC, V17, P678, DOI 10.1080/10255842.2012.710841; Mousavi SJ, 2013, MOL CELL BIOMECH, V10, P1; Mousavi SJ, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/2/026002; Mousavi SJ, 2014, J PHYS BIOL, V11; OSTER GF, 1983, J EMBRYOL EXP MORPH, V78, P83; Palomares KTS, 2009, J ORTHOP RES, V27, P1123, DOI 10.1002/jor.20863; Palsson E, 2001, FUTURE GENER COMP SY, V17, P835, DOI 10.1016/S0167-739X(00)00062-5; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pauwels F., 1980, BIOMECHANICS LOCOMOT, P375; PIERCE JH, 1990, P NATL ACAD SCI USA, V87, P5613, DOI 10.1073/pnas.87.15.5613; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prokharau PA, 2014, COMPUT METHOD BIOMEC, V17, P1051, DOI 10.1080/10255842.2012.736503; Ramtani S, 2004, J BIOMECH, V37, P1709, DOI 10.1016/j.jbiomech.2004.01.028; Schafer A, 2005, ACTA BIOMATER, V1, P273, DOI 10.1016/j.actbio.2005.02.004; Shi N, 2014, J BIOMED RES, V28, P40, DOI 10.7555/JBR.28.20130130; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stops AJF, 2010, J BIOMECH, V43, P618, DOI 10.1016/j.jbiomech.2009.10.037; Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012; Taylor D L, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 1, P101; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613	65	44	46	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124529	10.1371/journal.pone.0124529	http://dx.doi.org/10.1371/journal.pone.0124529			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933372	gold, Green Submitted, Green Published			2022-12-26	WOS:000353887100048
J	Singh, G; Dal Grande, F; Divakar, PK; Otte, J; Leavitt, SD; Szczepanska, K; Crespo, A; Rico, VJ; Aptroot, A; Caceres, MED; Lumbsch, HT; Schmitt, I				Singh, Garima; Dal Grande, Francesco; Divakar, Pradeep K.; Otte, Juergen; Leavitt, Steven D.; Szczepanska, Katarzyna; Crespo, Ana; Rico, Victor J.; Aptroot, Andre; da Silva Caceres, Marcela Eugenia; Lumbsch, H. Thorsten; Schmitt, Imke			Coalescent-Based Species Delimitation Approach Uncovers High Cryptic Diversity in the Cosmopolitan Lichen-Forming Fungal Genus Protoparmelia (Lecanorales, Ascomycota)	PLOS ONE			English	Article							GENETIC DIVERSITY; PARMELIACEAE LECANORALES; PHYLOGENETIC INFERENCE; PARMELIOID LICHENS; MOLECULAR-DATA; PRIMERS; DNA; IDENTIFICATION; AMPLIFICATION; MORPHOLOGY	Species recognition in lichen-forming fungi has been a challenge because of unsettled species concepts, few taxonomically relevant traits, and limitations of traditionally used morphological and chemical characters for identifying closely related species. Here we analyze species diversity in the cosmopolitan genus Protoparmelia s.l. The similar to 25 described species in this group occur across diverse habitats from the boreal - arctic/alpine to the tropics, but their relationship to each other remains unexplored. In this study, we inferred the phylogeny of 18 species currently assigned to this genus based on 160 specimens and six markers: mtSSU, nuLSU, ITS, RPB1, MCM7, and TSR1. We assessed the circumscription of species-level lineages in Protoparmelia s. str. using two coalescent-based species delimitation methods - BP&P and spedeSTEM. Our results suggest the presence of a tropical and an extra-tropical lineage, and eleven previously unrecognized distinct species-level lineages in Protoparmelia s. str. Several cryptic lineages were discovered as compared to phenotype-based species delimitation. Many of the putative species are supported by geographic evidence.	[Singh, Garima; Schmitt, Imke] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Dept Biol Sci, D-60323 Frankfurt, Germany; [Singh, Garima; Dal Grande, Francesco; Otte, Juergen; Schmitt, Imke] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Divakar, Pradeep K.; Crespo, Ana; Rico, Victor J.] Univ Complutense, Fac Farm, Dept Biol Vegetal 2, E-28040 Madrid, Spain; [Leavitt, Steven D.; Lumbsch, H. Thorsten] Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA; [Szczepanska, Katarzyna] Wroclaw Univ Environm & Life Sci, Dept Bot & Plant Ecol, PL-50363 Wroclaw, Poland; [Aptroot, Andre] Advice Bur Bryol & Lichenol Herbarium, Soest, Netherlands; [da Silva Caceres, Marcela Eugenia] Univ Fed Sergipe, Dept Biociencias, Itabaiana, Sergipe, Brazil	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Complutense University of Madrid; Field Museum of Natural History (Chicago); Wroclaw University of Environmental & Life Sciences; Universidade Federal de Sergipe	Singh, G (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Dept Biol Sci, Gruneburgpl 1, D-60323 Frankfurt, Germany.	garima.singh@senckenberg.de; imke.schmitt@senckenberg.de	Dal Grande, Francesco/K-1914-2016; Singh, Garima/ABF-5659-2021; Rico, Víctor J./AAA-2001-2019; Divakar, Pradeep K/E-5603-2014; Singh, Garima/P-1518-2017; Leavitt, Steven D./AAC-6462-2021; Crespo, Ana/N-6236-2014; Gulliford, Martin/I-8606-2018	Dal Grande, Francesco/0000-0002-1865-6281; Singh, Garima/0000-0003-3753-5431; Divakar, Pradeep K/0000-0002-0300-0124; Singh, Garima/0000-0003-3753-5431; Leavitt, Steven D./0000-0002-5034-9724; Crespo, Ana/0000-0002-5271-0157; , Marcela/0000-0002-5612-1309; Szczepanska, Katarzyna/0000-0002-7752-3024; Gulliford, Martin/0000-0003-1898-9075; Aptroot, Andre/0000-0001-7949-2594; Lumbsch, Thorsten/0000-0003-1512-835X	'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlicho-konomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts; German Academic Exchange Service (DAAD); Ministerio de Ciencia e Innovacion, Spain [CGL2011-25003, CGL2013-42498-P]	'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlicho-konomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by 'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts. Garima Singh was supported by a fellowship from the German Academic Exchange Service (DAAD). P.K.D., V.J.R. and A.C. thanks the Ministerio de Ciencia e Innovacion, Spain for financial support (CGL2011-25003, CGL2013-42498-P).	Agarwal I, 2014, ZOOL SCR, V43, P455, DOI 10.1111/zsc.12062; AHMADJIAN V, 1965, ANNU REV MICROBIOL, V19, P1, DOI 10.1146/annurev.mi.19.100165.000245; Altermann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097556; Aptroot A, 2008, BIODIVERSITY TROPICA, P220; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Arup U, 2007, MYCOLOGIA, V99, P42, DOI 10.3852/mycologia.99.1.42; Baloch E, 2009, MOL ECOL, V18, P2185, DOI 10.1111/j.1365-294X.2009.04183.x; Barbero M, 2006, MYCOTAXON, V97, P299; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; Molina MC, 2011, ORG DIVERS EVOL, V11, P331, DOI 10.1007/s13127-011-0060-4; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2013, BIOL J LINN SOC, V109, P737, DOI 10.1111/bij.12093; Carter BE, 2012, MOL PHYLOGENET EVOL, V63, P891, DOI [10.1016/j.ymPev.2012.03.002, 10.1016/j.ympev.2012.03.002]; Crespo A, 2007, MOL PHYLOGENET EVOL, V44, P812, DOI 10.1016/j.ympev.2006.11.029; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2011, LICHENOLOGIST, V43, P511, DOI 10.1017/S0024282911000570; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Cubero Oscar F., 2002, P381; Dal Grande F, 2014, MOL PHYLOGENET EVOL, V72, P54, DOI 10.1016/j.ympev.2013.12.010; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Del-Prado R, 2013, TAXON, V62, P928, DOI 10.12705/625.22; Divakar PK, EVOLUTION C IN PRESS; Domingos FMCB, 2014, MOL PHYLOGENET EVOL, V80, P113, DOI 10.1016/j.ympev.2014.07.022; Doring H, 2000, LICHENOLOGIST, V32, P200, DOI 10.1006/lich.1999.0250; Drummond A., 2011, GENEIOUS V5 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elbert W, 2012, NAT GEOSCI, V5, P459, DOI 10.1038/ngeo1486; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; ERIKSSON O E, 1989, Systema Ascomycetum, V8, P59; Esslinger T.L., 1989, SYST BOT MONOGR, V28, P1, DOI DOI 10.2307/25027728; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; GALLOWAY DJ, 1992, BIODIVERS CONSERV, V1, P312, DOI 10.1007/BF00693767; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Giarla TC, 2014, MOL PHYLOGENET EVOL, V70, P137, DOI 10.1016/j.ympev.2013.09.019; Grube M, 2000, MYCOL RES, V104, P1284, DOI 10.1017/S0953756200003476; Grube M, 2012, MOL ECOL, V21, P3098, DOI 10.1111/j.1365-294X.2012.05647.x; Hafellner J., 1990, BIBL LICH, V38, P99; Hafellner J., 1984, NOVA HEDWIGIA S, V79, P241; Hale Jr M.E., 1987, SMITHSONIAN CONTR BO, V66, P1, DOI DOI 10.5479/SI.0081024X.66; Harrington RC, 2012, SYST BIOL, V61, P63, DOI 10.1093/sysbio/syr077; Hawksworth DL, 2007, MYCOL RES, V111, P999, DOI 10.1016/j.mycres.2007.10.002; HENSSEN A, 1973, LICHENES EINFUHRUNG, P1; Henssen A, 1995, FLECHTEN FOLLMANN CO; HERTEL H, 1987, Mitteilungen der Botanischen Staatssammlung Muenchen, V23, P377; Hertel H, 1984, NOVA HEDWIGIA S, V79, P399; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kantvilas G, 2010, LICHENOLOGIST, V42, P557, DOI 10.1017/S0024282910000174; Kantvilas G, 2007, LICHENOLOGIST, V39, P135, DOI 10.1017/S0024282907006469; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Leavitt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085240; Leavitt SD, 2011, AM J BOT, V98, P175, DOI 10.3732/ajb.1000230; Lucking R, 2014, P NATL ACAD SCI USA, V111, P11091, DOI 10.1073/pnas.1403517111; Lucking R, 2009, AM J BOT, V96, P1409, DOI 10.3732/ajb.0800258; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch HT, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-257; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miller M.A., 2010, P GAT COMP ENV WORKS; MIYAWAKI H, 1991, Hikobia, V11, P29; Muggia L, 2011, FEMS MICROBIOL ECOL, V75, P255, DOI 10.1111/j.1574-6941.2010.01002.x; Murtagh GJ, 2002, MYCOL RES, V106, P1277, DOI 10.1017/S0953756202006615; Myllys L, 2003, MOL PHYLOGENET EVOL, V27, P58, DOI 10.1016/S1055-7903(02)00398-6; Papong K, 2011, LICHENOLOGIST, V43, P561, DOI 10.1017/S0024282911000284; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Pino-Bodas R, 2011, ORG DIVERS EVOL, V11, P343, DOI 10.1007/s13127-011-0062-2; POELT J, 1991, NOVA HEDWIGIA, V52, P39; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Printzen C, 2010, PROG BOT, V71, P233, DOI 10.1007/978-3-642-02167-1_10; Rambaut A., 2014, TRACER V1 6; Rambaut A, 2009, TREEANNOTATOR; Rambold G, 1989, BIBL LICHENOL, P34; Richardson DHS, 1999, MYCOL RES, V103, P641, DOI 10.1017/S0953756298008259; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan BD, 2004, LICHEN FLORA GREATER, P425; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Singh G, 2013, FUNGAL BIOL-UK, V117, P715, DOI 10.1016/j.funbio.2013.08.001; Sipman H., 1989, ECOSYST WORLD, V14, P303, DOI [10.1016/B978-0-444-42755-7.50001-8, DOI 10.1016/B978-0-444-42755-7.50001-8, DOI 10.1016/8978-0-444-42755-7.50001-8]; Spribille T, 2011, MOL PHYLOGENET EVOL, V59, P603, DOI 10.1016/j.ympev.2011.03.021; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Swafford DL, 2003, PAUP PHYLOGENETIC AN; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; Timdal E, 1990, BIBL LICHENOL, V38, P419; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Welton LJ, 2013, MOL ECOL, V22, P3495, DOI 10.1111/mec.12324; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Zhou SG, 2001, MYCOL RES, V105, P1033, DOI 10.1016/S0953-7562(08)61965-6; Zoller S, 1999, MOL ECOL, V8, P2049, DOI 10.1046/j.1365-294x.1999.00820.x	95	65	69	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124625	10.1371/journal.pone.0124625	http://dx.doi.org/10.1371/journal.pone.0124625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932996	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100052
J	Wintermans, B; Brandt, B; Vandenbroucke-Grauls, C; Budding, A				Wintermans, Bastiaan; Brandt, Bernd; Vandenbroucke-Grauls, Christina; Budding, Andries			TreeSeq, a Fast and Intuitive Tool for Analysis of Whole Genome and Metagenomic Sequence Data	PLOS ONE			English	Article								Next-generation sequencing is not yet commonly used in clinical laboratories because of a lack of simple and intuitive tools. We developed a software tool (TreeSeq) with a quaternary tree search structure for the analysis of sequence data. This permits rapid searches for sequences of interest in large datasets. We used TreeSeq to screen a gut microbiota metagenomic dataset and a whole genome sequencing (WGS) dataset of a strain of Klebsiella pneumoniae for antibiotic resistance genes and compared the results with BLAST and phenotypic resistance determination. TreeSeq was more than thirty times faster than BLAST and accurately detected resistance gene sequences in complex metagenomic data and resistance genes corresponding with the phenotypic resistance pattern of the Klebsiella strain. Resistance genes found by TreeSeq were visualized as a gene coverage heat map, aiding in the interpretation of results. TreeSeq brings analysis of metagenomic and WGS data within reach of clinical diagnostics.	[Wintermans, Bastiaan; Vandenbroucke-Grauls, Christina; Budding, Andries] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Brandt, Bernd] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Brandt, Bernd] Vrije Univ Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Wintermans, B (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.	bb.wintermans@vumc.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Budding, Andries/0000-0001-5128-5411; Brandt, Bernd/0000-0002-1155-1989				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATCC website, ATCC ANT STRAINS; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Chan JZM, 2012, NAT BIOTECHNOL, V30, P1068, DOI 10.1038/nbt.2410; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; TIBCO website, TIBCO SPOTF 6 0; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244	10	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123851	10.1371/journal.pone.0123851	http://dx.doi.org/10.1371/journal.pone.0123851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933115	gold, Green Published			2022-12-26	WOS:000353887100025
J	Lauwerys, BR; Hernandez-Lobato, D; Gramme, P; Ducreux, J; Dessy, A; Focant, I; Ambroise, J; Bearzatto, B; Toukap, AN; Van den Eynde, BJ; Elewaut, D; Gala, JL; Durez, P; Houssiau, FA; Helleputte, T; Dupont, P				Lauwerys, Bernard R.; Hernandez-Lobato, Daniel; Gramme, Pierre; Ducreux, Julie; Dessy, Adrien; Focant, Isabelle; Ambroise, Jerome; Bearzatto, Bertrand; Toukap, Adrien Nzeusseu; Van den Eynde, Benoit J.; Elewaut, Dirk; Gala, Jean-Luc; Durez, Patrick; Houssiau, Frederic A.; Helleputte, Thibault; Dupont, Pierre			Heterogeneity of Synovial Molecular Patterns in Patients with Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; RHEUMATOLOGY/EUROPEAN LEAGUE; UNDIFFERENTIATED ARTHRITIS; AMERICAN-COLLEGE; THERAPY; CRITERIA	Objectives Early diagnosis of rheumatoid arthritis (RA) is an unmet medical need in the field of rheumatology. Previously, we performed high-density transcriptomic studies on synovial biopsies from patients with arthritis, and found that synovial gene expression profiles were significantly different according to the underlying disorder. Here, we wanted to further explore the consistency of the gene expression signals in synovial biopsies of patients with arthritis, using low-density platforms. Methods Low-density assays (cDNA microarray and microfluidics qPCR) were designed, based on the results of the high-density microarray data. Knee synovial biopsies were obtained from patients with RA, spondyloarthropathies (SA) or osteoarthritis (OA) (n = 39), and also from patients with initial undifferentiated arthritis (UA) (n = 49). Results According to high-density microarray data, several molecular pathways are differentially expressed in patients with RA, SA and OA: T and B cell activation, chromatin remodelling, RAS GTPase activation and extracellular matrix regulation. Strikingly, disease activity (DAS28-CRP) has a significant influence on gene expression patterns in RA samples. Using the low-density assays, samples from patients with OA are easily discriminated from RA and SA samples. However, overlapping molecular patterns are found, in particular between RA and SA biopsies. Therefore, prediction of the clinical diagnosis based on gene expression data results in a diagnostic accuracy of 56.8%, which is increased up to 98.6% by the addition of specific clinical symptoms in the prediction algorithm. Similar observations are made in initial UA samples, in which overlapping molecular patterns also impact the accuracy of the diagnostic algorithm. When clinical symptoms are added, the diagnostic accuracy is strongly improved. Conclusions Gene expression signatures are overall different in patients with OA, RA and SA, but overlapping molecular signatures are found in patients with these conditions. Therefore, an accurate diagnosis in patients with UA requires a combination of gene expression and clinical data.	[Lauwerys, Bernard R.; Ducreux, Julie; Focant, Isabelle; Toukap, Adrien Nzeusseu; Durez, Patrick; Houssiau, Frederic A.] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Pathol Rhumatismales, B-1200 Brussels, Belgium; [Lauwerys, Bernard R.; Ducreux, Julie; Focant, Isabelle; Toukap, Adrien Nzeusseu; Durez, Patrick; Houssiau, Frederic A.] Clin Univ St Luc, Dept Rheumatol, B-1200 Brussels, Belgium; [Hernandez-Lobato, Daniel; Dessy, Adrien; Dupont, Pierre] Catholic Univ Louvain, ICTEAM Inst, Machine Learning Grp, B-1348 Louvain La Neuve, Belgium; [Gramme, Pierre; Helleputte, Thibault] DNAlytics, Louvain La Neuve, Belgium; [Ambroise, Jerome; Bearzatto, Bertrand; Gala, Jean-Luc] Catholic Univ Louvain, Inst Rech Expt & Clin, Ctr Technol Mol Appl, B-1200 Brussels, Belgium; [Van den Eynde, Benoit J.] Catholic Univ Louvain, Inst Duve, B-1200 Brussels, Belgium; [Elewaut, Dirk] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Ghent University; Ghent University Hospital	Lauwerys, BR (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Pathol Rhumatismales, B-1200 Brussels, Belgium.	Bernard.Lauwerys@uclouvain.be	Elewaut, Dirk/K-6831-2014	durez, patrick/0000-0002-7156-2356; Elewaut, Dirk/0000-0002-7468-974X	Region Wallonne (BioWin); Fondation Saint-Luc (Cliniques Universitaires Saint-Luc, Brussels, Belgium); UCB grant ("Chaire UCB sur les rhumatismes inflammatoires et systemiques"); DNAlytics	Region Wallonne (BioWin); Fondation Saint-Luc (Cliniques Universitaires Saint-Luc, Brussels, Belgium); UCB grant ("Chaire UCB sur les rhumatismes inflammatoires et systemiques"); DNAlytics	This work was supported by grants from the Region Wallonne (BioWin), and the Fondation Saint-Luc (Cliniques Universitaires Saint-Luc, Brussels, Belgium). JD is funded by a unrestricted UCB grant (" Chaire UCB sur les rhumatismes inflammatoires et systemiques "). BRL is a part-time research fellow (" Clinicien-chercheur ") of the Fonds National de la Recherche Scientifique (Communaute francaise de Belgique). DNAlytics provided support in the form of salaries for authors PG and TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Badot V, 2011, J CELL MOL MED, V15, P2335, DOI 10.1111/j.1582-4934.2010.01228.x; Badot V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2678; Britsemmer K, 2011, ANN RHEUM DIS, V70, P1468, DOI 10.1136/ard.2010.148619; de Hair MJH, 2012, ARTHRITIS RHEUM-US, V64, P389, DOI 10.1002/art.33348; Ducreux J, 2014, ARTHRITIS RHEUMATOL, V66, P15, DOI 10.1002/art.38202; Durbin B, 2003, BIOINFORMATICS, V19, P1360, DOI 10.1093/bioinformatics/btg178; Emery P, 2008, RHEUMATOLOGY, V47, P392, DOI 10.1093/rheumatology/kem257; Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Gutierrez-Roelens I, 2011, ARTHRITIS RHEUM-US, V63, P1246, DOI 10.1002/art.30292; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Machold KP, 2002, J RHEUMATOL, V29, P2278; Mottonen T, 2002, ARTHRITIS RHEUM, V46, P894, DOI 10.1002/art.10135; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P283, DOI 10.1002/art.10092; Quinn MA, 2001, RHEUMATOLOGY, V40, P1211, DOI 10.1093/rheumatology/40.11.1211; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; van Aken J, 2006, ANN RHEUM DIS, V65, P20, DOI 10.1136/ard.2005.038471; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P694, DOI 10.1002/art.27294; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380	20	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122104	10.1371/journal.pone.0122104	http://dx.doi.org/10.1371/journal.pone.0122104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927832	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100007
J	Madina, BR; Kumar, V; Mooers, BHM; Cruz-Reyes, J				Madina, Bhaskara R.; Kumar, Vikas; Mooers, Blaine H. M.; Cruz-Reyes, Jorge			Native Variants of the MRB1 Complex Exhibit Specialized Functions in Kinetoplastid RNA Editing	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; LIFE-CYCLE STAGES; TRYPANOSOMA-BRUCEI; U-DELETION; MESSENGER-RNA; GUIDE RNAS; MITOCHONDRIA; PROTEINS; BINDING; ARCHITECTURE	Adaptation and survival of Trypanosoma brucei requires editing of mitochondrial mRNA by uridylate (U) insertion and deletion. Hundreds of small guide RNAs (gRNAs) direct the mRNA editing at over 3,000 sites. RNA editing is controlled during the life cycle but the regulation of substrate and stage specificity remains unknown. Editing progresses in the 3' to 5' direction along the pre-mRNA in blocks, each targeted by a unique gRNA. A critical editing factor is the mitochondrial RNA binding complex 1 (MRB1) that binds gRNA and transiently interacts with the catalytic RNA editing core complex (RECC). MRB1 is a large and dynamic complex that appears to be comprised of distinct but related subcomplexes (termed here MRBs). MRBs seem to share a 'core' complex of proteins but differ in the composition of the 'variable' proteins. Since some proteins associate transiently the MRBs remain imprecisely defined. MRB1 controls editing by unknown mechanisms, and the functional relevance of the different MRBs is unclear. We previously identified two distinct MRBs, and showed that they carry mRNAs that undergo editing. We proposed that editing takes place in the MRBs because MRBs stably associate with mRNA and gRNA but only transiently interact with RECC, which is RNA free. Here, we identify the first specialized functions in MRBs: 1) 3010-MRB is a major scaffold for RNA editing, and 2) REH2-MRB contains a critical trans-acting RNA helicase (REH2) that affects multiple steps of editing function in 3010-MRB. These trans effects of the REH2 include loading of unedited mRNA and editing in the first block and in subsequent blocks as editing progresses. REH2 binds its own MRB via RNA, and conserved domains in REH2 were critical for REH2 to associate with the RNA and protein components of its MRB. Importantly, REH2 associates with a similar to 30 kDa RNA-binding protein in a novel similar to 15S subcomplex in RNA-depleted mitochondria. We use these new results to update our model of MRB function and organization.	[Madina, Bhaskara R.; Kumar, Vikas; Cruz-Reyes, Jorge] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Texas A&M University System; Texas A&M University College Station; University of Oklahoma System; University of Oklahoma Health Sciences Center	Cruz-Reyes, J (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	cruzrey@tamu.edu	Cruz-Reyes, Jorge/GQP-1338-2022; Mooers, Blaine/S-4383-2017	Mooers, Blaine/0000-0001-8181-8987; Cruz-Reyes, Jorge/0000-0003-0545-1508; Kumar, Vikas/0000-0002-2645-2983	National Science Foundation [NSF1122109]; NIH/National Institute of Allergies and Infectious Diseases [R01 AI088011]; National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103640]; Texas AM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103640] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH/National Institute of Allergies and Infectious Diseases; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Texas AM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant No. NSF1122109 (PI: J. Cruz-Reyes), NIH/National Institute of Allergies and Infectious Diseases R01 AI088011 (PI: Blaine Mooers), and Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103640. The Open Access to Knowledge (OAK) Fund at Texas A&M underwrote the charges for this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatortsev VS, 2008, MOL CELL BIOL, V28, P2437, DOI 10.1128/MCB.01886-07; Ammerman ML, 2012, NUCLEIC ACIDS RES, V40, P5637, DOI 10.1093/nar/gks211; Ammerman ML, 2011, RNA, V17, P865, DOI 10.1261/rna.2446311; Ammerman ML, 2010, RNA, V16, P2239, DOI 10.1261/rna.2285510; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Aphasizheva I, 2014, MOL CELL BIOL, V34, P4329, DOI 10.1128/MCB.01075-14; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; Carnes J, 2007, METHOD ENZYMOL, V424, P25, DOI 10.1016/S0076-6879(07)24002-9; Cifuentes-Rojas C, 2005, NUCLEIC ACIDS RES, V33, P6610, DOI 10.1093/nar/gki943; Cruz-Reyes J, 2002, MOL CELL BIOL, V22, P4652, DOI 10.1128/MCB.22.13.4652-4660.2002; Cruz-Reyes J, 2001, MOL CELL BIOL, V21, P884, DOI 10.1128/MCB.21.3.884-892.2001; Cruz-Reyes J, 2007, METHOD ENZYMOL, V424, P107, DOI 10.1016/S0076-6879(07)24005-4; Cruz-Reyes J, 2013, RNA EDITING: CURRENT RESEARCH AND FUTURE TRENDS, P65; CruzReyes J, 1996, P NATL ACAD SCI USA, V93, P8901, DOI 10.1073/pnas.93.17.8901; Dhote V, 2012, P NATL ACAD SCI USA, V109, pE3150, DOI 10.1073/pnas.1208014109; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Grams J, 2002, J BIOL CHEM, V277, P16952, DOI 10.1074/jbc.M200662200; Hashimi H, 2013, TRENDS PARASITOL, V29, P91, DOI 10.1016/j.pt.2012.11.005; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Kafkova L, 2012, RNA, V18, P1846, DOI 10.1261/rna.033852.112; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koslowsky D., 2013, NUCL ACIDS RES; KOSLOWSKY DJ, 1991, CELL, V67, P537, DOI 10.1016/0092-8674(91)90528-7; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; Kruse E, 2013, BBA-GENE REGUL MECH, V1829, P835, DOI 10.1016/j.bbagrm.2013.04.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madina BR, 2014, RNA, V20, P1142, DOI 10.1261/rna.044495.114; Madina BR, 2011, RNA, V17, P1821, DOI 10.1261/rna.2815911; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Ochsenreiter T, 2007, RNA, V13, P1, DOI 10.1261/rna.232907; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Patel RC, 1996, J BIOL CHEM, V271, P25657, DOI 10.1074/jbc.271.41.25657; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Sacharidou A, 2006, RNA, V12, P1219, DOI 10.1261/rna.2295706; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson L, 2000, P NATL ACAD SCI USA, V97, P6986, DOI 10.1073/pnas.97.13.6986; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123441	10.1371/journal.pone.0123441	http://dx.doi.org/10.1371/journal.pone.0123441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928631	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100017
J	Bonsch, C; Munteanu, M; Rossitto-Borlat, I; Furstenberg, A; Hartley, O				Boensch, Claudia; Munteanu, Mihaela; Rossitto-Borlat, Irene; Fuerstenberg, Alexandre; Hartley, Oliver			Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HIGHLY POTENT; ENTRY INHIBITORS; TRAFFICKING; ARRESTIN; RANTES; INTERNALIZATION; IDENTIFICATION; STIMULATION; INFECTIVITY	G protein-coupled receptors (GPCRs) are desensitized and internalized following activation. They are then subjected to post-endocytic sorting (degradation, slow recycling or fast recycling). The majority of research on post-endocytic sorting has focused on the role of sequence-encoded address structures on receptors. This study focuses on trafficking of CCR5, a GPCR chemokine receptor and the principal entry coreceptor for HIV. Using Chinese Hamster Ovary cells stably expressing CCR5 we show that two different anti-HIV chemokine analogs, PSC-RANTES and 5P14-RANTES, direct receptor trafficking into two distinct subcellular compartments: the trans-Golgi network and the endosome recycling compartment, respectively. Our results indicate that a likely mechanism for ligand-directed sorting of CCR5 involves capacity of the chemokine analogs to elicit the formation of durable complexes of CCR5 and arrestin2 (beta-arrestin-1), with PSC-RANTES eliciting durable association in contrast to 5P14-RANTES, which elicits only transient association.	[Boensch, Claudia; Munteanu, Mihaela; Rossitto-Borlat, Irene; Hartley, Oliver] Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland; [Fuerstenberg, Alexandre] Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland	University of Geneva; University of Geneva	Hartley, O (corresponding author), Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland.	oliver.hartley@unige.ch	Fürstenberg, Alexandre/A-4245-2010; Fürstenberg, Alexandre/ABF-5551-2020	Fürstenberg, Alexandre/0000-0002-6227-3122; 	Swiss National Science Foundation [31_143789]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation (Project 31_143789).	COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Diez LT, 2014, HISTOCHEM CELL BIOL, V142, P69, DOI 10.1007/s00418-014-1206-1; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hartley O, 2005, CURR PROTEIN PEPT SC, V6, P207, DOI 10.2174/1389203054065400; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marie N, 2003, J BIOL CHEM, V278, P22795, DOI 10.1074/jbc.M300084200; MCGRAW TE, 1993, J CELL PHYSIOL, V155, P579, DOI 10.1002/jcp.1041550316; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Schaeuble K, 2012, J CELL SCI, V125, P4463, DOI 10.1242/jcs.097519; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Trkola A, 1998, J VIROL, V72, P396, DOI 10.1128/JVI.72.1.396-404.1998; Truan Z, 2013, J STRUCT BIOL, V184, P329, DOI 10.1016/j.jsb.2013.09.019; Vila-Coro AJ, 1999, J IMMUNOL, V163, P3037; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Zidar David A., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P120; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	41	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125396	10.1371/journal.pone.0125396	http://dx.doi.org/10.1371/journal.pone.0125396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923671	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600148
J	Braga, VAVN; Couto, GK; Lazzarin, MC; Rossoni, LV; Medeiros, A				Braga, Viviane A. V. N.; Couto, Gisele K.; Lazzarin, Mariana C.; Rossoni, Luciana V.; Medeiros, Alessandra			Aerobic Exercise Training Prevents the Onset of Endothelial Dysfunction via Increased Nitric Oxide Bioavailability and Reduced Reactive Oxygen Species in an Experimental Model of Menopause	PLOS ONE			English	Article							OXIDATIVE STRESS; ESTROGEN; OVARIECTOMY; EXPRESSION; MUSCLE; RATS; HYPERTENSION; MICROVESSELS; RELAXATION; DILATION	Objective Previous studies have shown that estrogen deficiency, arising in postmenopause, promotes endothelial dysfunction. This study evaluated the effects of aerobic exercise training on endothelial dependent vasodilation of aorta in ovariectomized rats, specifically investigating the role of nitric oxide (NO) and reactive oxygen species (ROS). Methods Female Wistar rats ovariectomized (OVX - n= 20) or with intact ovary (SHAM - n= 20) remained sedentary (OVX and SHAM) or performed aerobic exercise training on a treadmill 5 times a week for a period of 8 weeks (OVX-TRA and SHAM-TRA). In the thoracic aorta the endothelium-dependent and - independent vasodilation was assessed by acetylcholine (ACh) and sodium nitroprusside (SNP), respectively. Certain aortic rings were incubated with L-NAME to assess the NO modulation on the ACh-induced vasodilation. The fluorescence to dihydroethidium in aortic slices and plasma nitrite/nitrate concentrations were measured to evaluate ROS and NO bioavailability, respectively. Results ACh-induced vasodilation was reduced in OVX rats as compared SHAM (Rmax: SHAM: 86 +/-3.3 vs. OVX: 57+/-3.0%, p<0.01). Training prevented this response in OVX-TRA (Rmax: OVX-TRA: 88+/-2.0%, p<0.01), while did not change it in SHAM-TRA (Rmax: SHAM-TRA: 80+/-2.2%, p<0.01). The L-NAME incubation abolished the differences in ACh-induced relaxation among groups. SNP-induced vasodilation was not different among groups. OVX reduced nitrite/nitrate plasma concentrations and increased ROS in aortic slices, training as effective to restore these parameters to the SHAM levels. Conclusions Exercise training, even in estrogen deficiency conditions, is able to improve endothelial dependent vasodilation in rat aorta via enhanced NO bioavailability and reduced ROS levels.	[Braga, Viviane A. V. N.; Lazzarin, Mariana C.; Medeiros, Alessandra] Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil; [Couto, Gisele K.; Rossoni, Luciana V.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Medeiros, A (corresponding author), Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil.	a.medeiros@unifesp.br	Medeiros, Alessandra/E-8132-2012; Lazzarin, Mariana C/C-7187-2017; Rossoni, Luciana Venturini/AFR-0021-2022; deng, qiongxia/A-3206-2017; Rossoni, Luciana Venturini/C-7226-2012	Medeiros, Alessandra/0000-0002-7962-7185; Lazzarin, Mariana C/0000-0003-2858-5453; Rossoni, Luciana Venturini/0000-0002-0944-9483	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2012/17709-0, 2010/50048-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP# 2012/17709-0 (V.A.V.N.B) and FAPESP# 2010/50048-1 (L.V.R and A.M.). L.V.R. is research fellow at Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; [Anonymous], 2010, REV BRASILEIRA HIPER, V13, P6; [Anonymous], 2013, ARQUIVO BRASILEIRO C, V101, P4; Babaei Parvin, 2010, Menopause Int, V16, P100, DOI 10.1258/mi.2010.010028; Bauersachs J, 1999, CIRCULATION, V100, P292, DOI 10.1161/01.CIR.100.3.292; BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009; Claudio ERG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064806; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Dantas APV, 1999, HYPERTENSION, V34, P914, DOI 10.1161/01.HYP.34.4.914; Davel AP, 2011, BRAZ J MED BIOL RES, V44, P920, DOI [10.1590/S0100-879X2011007500104, 10.1590/S0100-879X2011000900014]; Davel APC, 2006, BRIT J PHARMACOL, V148, P629, DOI 10.1038/sj.bjp.0706749; Dong JH, 2013, KIDNEY INT, V84, P54, DOI 10.1038/ki.2013.12; Dugan SA, 2010, OBESITY, V18, P1260, DOI 10.1038/oby.2009.396; Endlich PW, 2013, PEPTIDES, V47, P29, DOI 10.1016/j.peptides.2013.06.002; Figard H, 2006, APPL PHYSIOL NUTR ME, V31, P621, DOI 10.1139/H06-070; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Camporez JPG, 2011, J PHYSIOL-LONDON, V589, P2585, DOI 10.1113/jphysiol.2011.206078; GAVA NS, 1995, HYPERTENSION, V26, P1129, DOI 10.1161/01.HYP.26.6.1129; Goto C, 2003, CIRCULATION, V108, P530, DOI 10.1161/01.CIR.0000080893.55729.28; Graham DA, 2004, J APPL PHYSIOL, V96, P2088, DOI 10.1152/japplphysiol.01252.2003; Guidry MA, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.03.010; Inoue N, 1996, CIRC RES, V79, P32, DOI 10.1161/01.RES.79.1.32; Irigoyen MC, 2005, HYPERTENSION, V46, P998, DOI 10.1161/01.HYP.0000176238.90688.6b; Ito K, 2006, HYPERTENSION, V48, P651, DOI 10.1161/01.HYP.0000238125.21656.9e; KOLLER A, 1995, CIRC RES, V76, P544, DOI 10.1161/01.RES.76.4.544; Lejskova M, 2012, PHYSIOL RES, V61, P587, DOI 10.33549/physiolres.932313; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; Masson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094927; Maturana MA, 2007, CLINICS, V62, P77, DOI 10.1590/S1807-59322007000100012; McCormick KM, 2004, J MUSCLE RES CELL M, V25, P21, DOI 10.1023/B:JURE.0000021398.78327.39; Melton SA, 2000, APPETITE, V35, P1, DOI 10.1006/appe.2000.0338; Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x; Moreau KL, 2012, J CLIN ENDOCR METAB, V97, P4692, DOI 10.1210/jc.2012-2244; National Research Council Committee for the Update of the Guide for the C Use of Laboratory A, 2011, NATL ACAD COLLECTION; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Park JH, 2008, ACTA PHYSIOL, V193, P47, DOI 10.1111/j.1748-1716.2007.01799.x; Park JK, 2013, J WOMENS HEALTH, V22, P587, DOI 10.1089/jwh.2012.4035; PESCATELLO LS, 1991, CIRCULATION, V83, P1557, DOI 10.1161/01.CIR.83.5.1557; Pierce GL, 2011, CLIN SCI, V120, P13, DOI 10.1042/CS20100174; Pighon A, 2009, CLIMACTERIC, V12, P153, DOI 10.1080/13697130802447074; Roque FR, 2013, BRIT J PHARMACOL, V168, P686, DOI 10.1111/j.1476-5381.2012.02224.x; Veras-Silva AS, 1997, AM J PHYSIOL-HEART C, V273, pH2627, DOI 10.1152/ajpheart.1997.273.6.H2627; Wang D, 2014, HYPERTENSION, V63, P1063, DOI 10.1161/HYPERTENSIONAHA.113.02284; Wassmann S, 2001, CIRCULATION, V103, P435; Widder J, 2003, HYPERTENSION, V42, P991, DOI 10.1161/01.HYP.0000098661.37637.89; Yung LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017437; Zanchi NE, 2006, REV BRAS EDUC FIS ES, V20, p239 a 47	51	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125388	10.1371/journal.pone.0125388	http://dx.doi.org/10.1371/journal.pone.0125388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923465	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600146
J	De Keyser, R; Breuker, CJ; Hails, RS; Dennis, RLH; Shreeve, TG				De Keyser, Rien; Breuker, Casper J.; Hails, Rosemary S.; Dennis, Roger L. H.; Shreeve, Tim G.			Why Small Is Beautiful: Wing Colour Is Free from Thermoregulatory Constraint in the Small Lycaenid Butterfly, Polyommatus icarus	PLOS ONE			English	Article							MATE CHOICE; CLIMATE; PATTERN; DIVERSITY; POSTURE; PIGMENT	We examined the roles of wing melanisation, weight, and basking posture in thermoregulation in Polyommatus Icarus, a phenotypically variable and protandrous member of the diverse Polyommatinae (Lycaenidae). Under controlled experimental conditions, approximating to marginal environmental conditions for activity in the field (=infrequent flight, long duration basking periods), warming rates are maximised with fully open wings and maximum body temperatures are dependent on weight. Variation in wing melanisation within and between sexes has no effect on warming rates; males and females which differ in melanisation had similar warming rates. Posture also affected cooling rates, consistent with cooling being dependent on convective heat loss. We hypothesise that for this small sized butterfly, melanisation has little or no effect on thermoregulation. This may be a factor contributing to the diversity of wing colours in the Polyommatinae. Because of the importance of size for thermoregulation in this small butterfly, requirements for attaining a suitable size to confer thermal stability in adults may also be a factor influencing larval feeding rates, development time and patterns of voltinism. Our findings indicate that commonly accepted views of the importance of melanisation, posture and size to thermoregulation, developed using medium and large sized butterflies, are not necessarily applicable to small sized butterflies.	[De Keyser, Rien; Dennis, Roger L. H.; Shreeve, Tim G.] Oxford Brookes Univ, Fac Hlth & Life Sci, Ctr Ecol Environm & Conservat, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Breuker, Casper J.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Evolutionary Dev Biol Res Grp, Oxford OX3 0BP, England; [Hails, Rosemary S.] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	Oxford Brookes University; Oxford Brookes University; UK Centre for Ecology & Hydrology (UKCEH)	Shreeve, TG (corresponding author), Oxford Brookes Univ, Fac Hlth & Life Sci, Ctr Ecol Environm & Conservat, Dept Biol & Med Sci, Oxford OX3 0BP, England.	tgshreeve@brookes.ac.uk	Hails, Rosemary S/E-9478-2010; Breuker, Casper/N-6582-2013; Breuker, Casper/P-8270-2019	Hails, Rosemary S/0000-0002-6975-1318; Breuker, Casper/0000-0001-7909-1950; Breuker, Casper/0000-0001-7909-1950	Oxford Brookes University; Natural Environment Research Council; Centre for Ecology and Hydrology; NERC [ceh020002] Funding Source: UKRI; Natural Environment Research Council [ceh020002] Funding Source: researchfish	Oxford Brookes University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Centre for Ecology and Hydrology; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	RDK was funded jointly by Oxford Brookes University and the Natural Environment Research Council; Centre for Ecology and Hydrology. The other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint Z, 2004, SCANNING ELECT MICRO, P87; Balint Z, 2012, J R SOC INTERFACE, V9, P1745, DOI 10.1098/rsif.2011.0854; Biro LP, 2003, PHYS REV E, V67, P71; BRUNTON CFA, 1995, P ROY SOC B-BIOL SCI, V260, P199, DOI 10.1098/rspb.1995.0080; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; de Keyser R., 2012, THESIS OXFORD BROOKE; DENNIS RLH, 1989, BIOL J LINN SOC, V38, P323, DOI 10.1111/j.1095-8312.1989.tb01581.x; ELIOT J N, 1973, Bulletin of the British Museum (Natural History) Entomology, V28, P371; Emmet AM, 1982, MOTHS BUTTERFLIES GR, V7, P249; Fordyce JA, 2002, J EVOLUTION BIOL, V15, P871, DOI 10.1046/j.1420-9101.2002.00432.x; Ghiradella H, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P257; HEINRICH B, 1986, PHYSIOL ZOOL, V59, P616, DOI 10.1086/physzool.59.6.30158609; Howe PD, 2007, OECOLOGIA, V153, P857, DOI 10.1007/s00442-007-0782-3; Howe PD, 2004, THESIS OXFORD BROOKE; Ingram AL, 2008, PHILOS T R SOC B, V363, P2465, DOI 10.1098/rstb.2007.2258; Kemp DJ, 2007, P R SOC B, V274, P1043, DOI 10.1098/rspb.2006.0043; Kemp DJ, 2011, ADV STUD BEHAV, V43, P55, DOI 10.1016/B978-0-12-380896-7.00002-2; Kertesz K, 2006, CURR APPL PHYS, V6, P252, DOI 10.1016/j.cap.2005.07.051; KINGSOLVER J G, 1985, Journal of Research on the Lepidoptera, V24, P1; Kingsolver JG, 1996, AM NAT, V147, P296, DOI 10.1086/285852; KINGSOLVER JG, 1982, OECOLOGIA, V53, P27, DOI 10.1007/BF00377132; Klingenberg C, 2008, ANAL ORGANISMAL FORM; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Lyytinen A, 2003, OIKOS, V100, P373, DOI 10.1034/j.1600-0706.2003.11935.x; Morehouse NI, 2010, AM NAT, V176, P768, DOI 10.1086/657043; Nygren GH, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4701; Oliver JC, 2009, P ROY SOC B-BIOL SCI, V276, P2369, DOI 10.1098/rspb.2009.0182; Olofsson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010798; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rasband W.S., 1997, IMAGE J; RUTOWSKI RL, 1985, Z TIERPSYCHOL, V70, P103; Rutowski RL, 2010, FUNCT ECOL, V24, P767, DOI 10.1111/j.1365-2435.2010.01693.x; SHREEVE TG, 1992, BIOL J LINN SOC, V45, P57, DOI 10.1111/j.1095-8312.1992.tb00631.x; Shreeve Tim, 2009, P171; Silberglied R.E., 1984, Symposia of the Royal Entomological Society of London, P207; Talloen W, 2004, EVOLUTION, V58, P360, DOI 10.1111/j.0014-3820.2004.tb01651.x; Van Dyck H, 1998, OECOLOGIA, V114, P326, DOI 10.1007/s004420050454; VanDyck H, 1997, ANIM BEHAV, V53, P39, DOI 10.1006/anbe.1996.0276; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197; Vila R, 2011, P ROY SOC B-BIOL SCI, V278, P2737, DOI 10.1098/rspb.2010.2213; WASSERTHAL LT, 1975, J INSECT PHYSIOL, V21, P1921, DOI 10.1016/0022-1910(75)90224-3; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; Zeuss D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4874	44	16	16	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122623	10.1371/journal.pone.0122623	http://dx.doi.org/10.1371/journal.pone.0122623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923738	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353711600019
J	Shao, MY; Sun, YN; Zhou, SG				Shao, Mingyu; Sun, Yanni; Zhou, Shuigeng			Identifying TF-MiRNA Regulatory Relationships Using Multiple Features	PLOS ONE			English	Article							CHIP-SEQ DATA; GENOME BROWSER DATABASE; CHROMATIN-IMMUNOPRECIPITATION; TRANSCRIPTION FACTOR; MICRORNA GENES; PROFILES; NETWORKS; TOOLS; RNA	MicroRNAs are known to play important roles in the transcriptional and post-transcriptional regulation of gene expression. While intensive research has been conducted to identify miRNAs and their target genes in various genomes, there is only limited knowledge about how microRNAs are regulated. In this study, we construct a pipeline that can infer the regulatory relationships between transcription factors and microRNAs from ChIP-Seq data with high confidence. In particular, after identifying candidate peaks from ChIP-Seq data, we formulate the inference as a PU learning (learning from only positive and unlabeled examples) problem. Multiple features including the statistical significance of the peaks, the location of the peaks, the transcription factor binding site motifs, and the evolutionary conservation are derived from peaks for training and prediction. To further improve the accuracy of our inference, we also apply a mean reciprocal rank (MRR)-based method to the candidate peaks. We apply our pipeline to infer TF-miRNA regulatory relationships in mouse embryonic stem cells. The experimental results show that our approach provides very specific findings of TF-miRNA regulatory relationships.	[Shao, Mingyu; Zhou, Shuigeng] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Shao, Mingyu; Zhou, Shuigeng] Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China; [Shao, Mingyu; Sun, Yanni] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Fudan University; Fudan University; Michigan State University	Sun, YN (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, 428 S Shaw Lane, E Lansing, MI 48824 USA.	yannisun@msu.edu; sgzhou@fudan.edu.cn	SUN, Yanni/AHC-4163-2022; Sun, Yanni/AAZ-7373-2021	SUN, Yanni/0000-0003-1373-8023; 	Fudan University Graduate School, National Natural Science and Foundation of China (NSFC) [61272380]; NSF CAREER [DBI-0953738]; National Natural Science Foundation of China (NSFC) [61272380]	Fudan University Graduate School, National Natural Science and Foundation of China (NSFC); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	MS was supported by the exchange program fund of doctoral student under the Fudan University Graduate School, National Natural Science and Foundation of China (NSFC) under grant no. 61272380. YS was supported by NSF CAREER grant DBI-0953738. SZ was supported by National Natural Science Foundation of China (NSFC) under grant no. 61272380.	Aparicio O, 2005, CURRENT PROTOCOLS MO, P21; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bing L, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P179, DOI 10.1109/icdm.2003.1250918; Bisognin A, 2012, NUCLEIC ACIDS RES, V40, pW13, DOI 10.1093/nar/gks460; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brill E., 2001, TREC; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cerulo L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-228; Chang LW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-84; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Elkan C., 2008, PROC ACM SIGKDD INT, P213, DOI DOI 10.1145/1401890.1401920; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gordon A.H., 2010, FASTX TOOLKIT; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Joachims T, 1999, MACHINE LEARNING, PROCEEDINGS, P200; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Kurubanjerdjit N, 2013, COMPUT BIOL MED, DOI [10.1016/j.compbiomed.2013.08.010, DOI 10.1016/J.C0MPBI0MED.2013.08.010]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liang K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-199; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mendoza MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070153; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mitchell T.M, 2003, MACH LEARN; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Natarajan N., 2011, TR1137 U TEX AUST DE; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Shao M, 2013, BRIEFINGS BIOINFORMA; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Sun GN, 2013, METHODS MOL BIOL, V1038, P193, DOI 10.1007/978-1-62703-514-9_12; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Vapnik V., 2013, NATURE STAT LAERNING; Vega VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005241; Vert J.-P., 2010, ARXIV10100772; Voorhees E.M., 2000, P 2 INT C LANGUAGE R, P77; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125156	10.1371/journal.pone.0125156	http://dx.doi.org/10.1371/journal.pone.0125156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922940	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600130
J	Tseng, ZJ; Flynn, JJ				Tseng, Zhijie Jack; Flynn, John J.			Are Cranial Biomechanical Simulation Data Linked to Known Diets in Extant Taxa? A Method for Applying Diet-Biomechanics Linkage Models to Infer Feeding Capability of Extinct Species	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; ESTIMATED BITING FORCES; PREDATORY BEHAVIOR; BITE FORCE; EVOLUTION; CARNIVORA; SKULL; PERFORMANCE; MAMMALIA; ADAPTATION	Performance of the masticatory system directly influences feeding and survival, so adaptive hypotheses often are proposed to explain craniodental evolution via functional morphology changes. However, the prevalence of "many-to-one" association of cranial forms and functions in vertebrates suggests a complex interplay of ecological and evolutionary histories, resulting in redundant morphology-diet linkages. Here we examine the link between cranial biomechanical properties for taxa with different dietary preferences in crown clade Carnivora, the most diverse clade of carnivorous mammals. We test whether hypercarnivores and generalists can be distinguished based on cranial mechanical simulation models, and how such diet-biomechanics linkages relate to morphology. Comparative finite element and geometric morphometrics analyses document that predicted bite force is positively allometric relative to skull strain energy; this is achieved in part by increased stiffness in larger skull models and shape changes that resist deformation and displacement. Size-standardized strain energy levels do not reflect feeding preferences; instead, caniform models have higher strain energy than feliform models. This caniform-feliform split is reinforced by a sensitivity analysis using published models for six additional taxa. Nevertheless, combined bite force-strain energy curves distinguish hypercarnivorous versus generalist feeders. These findings indicate that the link between cranial biomechanical properties and carnivoran feeding preference can be clearly defined and characterized, despite phylogenetic and allometric effects. Application of this diet-biomechanics linkage model to an analysis of an extinct stem carnivoramorphan and an outgroup creodont species provides biomechanical evidence for the evolution of taxa into distinct hypercarnivorous and generalist feeding styles prior to the appearance of crown carnivoran clades with similar feeding preferences.	[Tseng, Zhijie Jack; Flynn, John J.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Flynn, John J.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH)	Tseng, ZJ (corresponding author), Amer Museum Nat Hist, Div Paleontol, Cent Pk West,79th St, New York, NY 10024 USA.	tsengzhijie@gmail.com			NSF [DEB-1257572]; AMNH Frick Postdoctoral Fellowship	NSF(National Science Foundation (NSF)); AMNH Frick Postdoctoral Fellowship	This research was funded by NSF DEB-1257572 to ZJT and JJF, and an AMNH Frick Postdoctoral Fellowship (to ZJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Arnold SJ, 2003, INTEGR COMP BIOL, V43, P367, DOI 10.1093/icb/43.3.367; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; Chamoli U, 2011, J THEOR BIOL, V283, P217, DOI 10.1016/j.jtbi.2011.05.020; DESSEM D, 1992, J MORPHOL, V213, P275, DOI 10.1002/jmor.1052130211; DESSEM D, 1989, J ANAT, V164, P101; Diaz-Uriarte R, 1998, SYST BIOL, V47, P654, DOI 10.1080/106351598260653; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Ellis JL, 2008, J ANAT, V212, P769, DOI 10.1111/j.1469-7580.2008.00911.x; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Ewer, 1998, CARNIVORES; Figueirido B, 2013, EVOLUTION, V67, P1975, DOI 10.1111/evo.12059; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Flynn John J., 2005, P175; Flynn John J., 1998, P110; FUTUYMA DJ, 1997, EVOLUTIONARY BIOL; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Grosse IR, 2007, ANAT REC, V290, P1069, DOI 10.1002/ar.20568; Hartstone-Rose A, 2012, ANAT REC, V295, P1336, DOI 10.1002/ar.22518; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kolmann MA, 2009, ZOOLOGY, V112, P351, DOI 10.1016/j.zool.2008.11.002; Maddison WP, 2011, MESQUITE MODULAR SYS; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Nowak RM, 1999, WALKERS CARNIVORES W, V313; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Schumacher GH., 1961, FUNKTIONELLE MORPHOL; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2009, J ZOOL, V278, P181, DOI 10.1111/j.1469-7998.2009.00567.x; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; Slater GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013870; Spaulding M, 2012, J SYST PALAEONTOL, V10, P653, DOI 10.1080/14772019.2011.630681; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; Tseng ZJ, 2015, J THEOR BIOL, V365, P112, DOI 10.1016/j.jtbi.2014.10.002; Tseng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065305; Tseng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019171; Tseng ZJ, 2011, BIOL J LINN SOC, V102, P540, DOI 10.1111/j.1095-8312.2010.01602.x; Tseng ZJ, 2010, J MORPHOL, V271, P1386, DOI 10.1002/jmor.10881; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; Turnbull W. D., 1970, Fieldiana (Geol.), V18, P147; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; VanValkenburgh B, 1996, J MAMMAL, V77, P240, DOI 10.2307/1382725; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Wang XM, 1999, B AM MUS NAT HIST, P1; WANG XM, 1994, B AM MUS NAT HIST, P1; WERDELIN L, 1989, PALEOBIOLOGY, V15, P387, DOI 10.1017/S009483730000957X; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; Wesley-Hunt GD, 2005, J SYST PALAEONTOL, V3, P1; Wiley D. F., 2005, P IEEE VIS C, P1; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986	56	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124020	10.1371/journal.pone.0124020	http://dx.doi.org/10.1371/journal.pone.0124020			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923776	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600067
J	Velez-Juarbe, J; Wood, AR; De Gracia, C; Hendy, AJW				Velez-Juarbe, Jorge; Wood, Aaron R.; De Gracia, Carlos; Hendy, Austin J. W.			Evolutionary Patterns among Living and Fossil Kogiid Sperm Whales: Evidence from the Neogene of Central America	PLOS ONE			English	Article							LATE MIOCENE; SEXUAL SELECTION; MARINE MAMMALS; CETACEA; ODONTOCETI; PLIOCENE; BREVICEPS; PHYSETEROIDEA; PANAMA; SKULL	Kogiids are known by two living species, the pygmy and dwarf sperm whale (Kogia breviceps and K. sima). Both are relatively rare, and as their names suggest, they are closely related to the sperm whale, all being characterized by the presence of a spermaceti organ. However, this organ is much reduced in kogiids and may have become functionally different. Here we describe a fossil kogiid from the late Miocene of Panama and we explore the evolutionary history of the group with special attention to this evolutionary reduction. The fossil consists of cranial material from the late Tortonian (similar to 7.5 Ma) Pina facies of the Chagres Formation in Panama. Detailed comparison with other fossil and extant kogiids and the results of a phylogenetic analysis place the Panamanian kogiid, herein named Nanokogia isthmia gen. et sp. nov., as a taxon most closely related to Praekogia cedrosensis from the Messinian (similar to 6 Ma) of Baja California and to Kogia spp. Furthermore our results show that reduction of the spermaceti organ has occurred iteratively in kogiids, once in Thalassocetus antwerpiensis in the early-middle Miocene, and more recently in Kogia spp. Additionally, we estimate the divergence between extant species of Kogia at around the late Pliocene, later than previously predicted by molecular estimates. Finally, comparison of Nanokogia with the coeval Scaphokogia cochlearis from Peru shows that these two species display a greater morphological disparity between them than that observed between the extant members of the group. We hypothesize that this reflects differences in feeding ecologies of the two species, with Nanokogia being more similar to extant Kogia. Nanokogia shows that kogiids have been part of the Neotropical marine mammal communities at least since the late Miocene, and gives us insight into the evolutionary history and origins of one of the rarest groups of living whales.	[Velez-Juarbe, Jorge] Nat Hist Museum Los Angeles Cty, Dept Mammal, Los Angeles, CA 90007 USA; [Velez-Juarbe, Jorge] Calif State Univ Fullerton, Dept Geol Sci, John D Cooper Archaeol & Paleontol Ctr, Fullerton, CA 92634 USA; [Wood, Aaron R.] Iowa State Univ, Dept Geol & Atmospher Sci, Ames, IA USA; [De Gracia, Carlos] Smithsonian Trop Res Inst, Balboa, Panama; [Hendy, Austin J. W.] Nat Hist Museum Los Angeles Cty, Dept Invertebrate Paleontol, Los Angeles, CA USA	California State University System; California State University Fullerton; Iowa State University; Smithsonian Institution; Smithsonian Tropical Research Institute	Velez-Juarbe, J (corresponding author), Nat Hist Museum Los Angeles Cty, Dept Mammal, Los Angeles, CA 90007 USA.	jvelezjuar@nhm.org	Hendy, Austin J/C-1279-2013	Hendy, Austin J/0000-0002-9818-1158; De Gracia, Carlos/0000-0003-0637-3302	National Science Foundation Partnerships for International Research and Education [0966884]; National Science Foundation Earth Sciences Postdoctoral Fellowship [1249920]; Secretaria Nacional de Ciencia, Tecnologia en Innovacion [APY-NI10-016A]; Direct For Biological Sciences [1203222] Funding Source: National Science Foundation	National Science Foundation Partnerships for International Research and Education(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation Earth Sciences Postdoctoral Fellowship; Secretaria Nacional de Ciencia, Tecnologia en Innovacion; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this project was provided by National Science Foundation Partnerships for International Research and Education grant #0966884 to JVJ, ARW, CDG, and AJWH; National Science Foundation Earth Sciences Postdoctoral Fellowship grant #1249920 to JVJ; and Secretaria Nacional de Ciencia, Tecnologia en Innovacion grant #APY-NI10-016A to CDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1905, MEMOIRES MUSEE ROYAL, V3, P1; Barnes L.G., 1973, Contributions Sci, VNo. 247, P1; Barnes L. G., 1984, PALEOBIOS, V42, P1; Barnes Lawrence G., 2008, Natural History Museum of Los Angeles County Science Series, P99; Benham W. B., 1901, Proceedings of the Zoological Society of London, Vii, P107; Bianucci G, 1999, RIV ITAL PALEONTOL S, V105, P445, DOI 10.13130/2039-4942/5385; Bianucci G, 2006, ZOOL J LINN SOC-LOND, V148, P103, DOI 10.1111/j.1096-3642.2006.00228.x; Blainville H. M. de., 1838, ANN FRANCAISES ETRAN, V2, P335; Bloodworth Brian E., 2008, Mammalian Species, P1, DOI 10.1644/819.1; Brisson AD., 1762, LUGDUM BATARORUM APU; Caldwell D.K., 1989, P235; Carrier DR, 2002, J EXP BIOL, V205, P1755; Clarke MR, 2003, J MAR BIOL ASSOC UK, V83, P241, DOI 10.1017/S0025315403007045h; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Collins LS, 1996, GEOLOGY, V24, P687, DOI 10.1130/0091-7613(1996)024<0687:TLMPIS>2.3.CO;2; Cranford TW, 1999, MAR MAMMAL SCI, V15, P1133, DOI 10.1111/j.1748-7692.1999.tb00882.x; Cranford TW, 1996, J MORPHOL, V228, P223; De Gracia C, 2012, GEOL SOC AM ABS, V44, P164; de Muizon C, 1988, TRAVAUX I FRANCAIS E, V42, P1, DOI DOI 10.1179/ACB.2002.068; Dines JP, 2014, EVOLUTION, V68, P3296, DOI 10.1111/evo.12516; Ehret DJ, 2012, PALAEONTOLOGY, V55, P1139, DOI 10.1111/j.1475-4983.2012.01201.x; FIERSTINE HL, 1978, COPEIA, P1; FITCH JE, 1968, J FISH RES BOARD CAN, V25, P2561, DOI 10.1139/f68-227; Fitzgerald Erich M. G., 2005, Memoirs of Museum Victoria, V62, P67; Flower W. H., 1867, T ZOOLOGICAL SOC LON, V6, P87, DOI DOI 10.1111/J.1096-3642.1867.TB00572.X; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Gill T, 1871, AM NAT, V4, P725, DOI DOI 10.1086/270684; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P296; Gray JE, 1846, ZOOLOGY VOYAGE H M 3, V1, P13; Hendy A JW, J GEOL IN PRESS; Huggenberger S., 2014, J MAR BIOL ASS UK; Kernan JD, 1918, B AM MUS NAT HIST, V38, P0231; Lambert O, 2008, CR PALEVOL, V7, P361, DOI 10.1016/j.crpv.2008.06.002; Lambert O, 2013, J VERTEBR PALEONTOL, V33, P709, DOI 10.1080/02724634.2013.743405; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Lambert O, 2008, BULL INST R SC N B-S, V78, P277; Laurito Cesar A., 2011, Revista Geologica de America Central, V44, P153; Lindberg DR, 2007, LETHAIA, V40, P335, DOI 10.1111/j.1502-3931.2007.00032.x; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Lucas SG, 2009, REV GEOL AM CEN, V41, P14; Luo ZX, 1996, J VERTEBR PALEONTOL, V16, P328, DOI 10.1080/02724634.1996.10011320; McAlpine D., 2002, ENCY MARINE MAMMALS, P1007; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Morgan Gary S., 1994, Proceedings of the San Diego Society of Natural History, V29, P239; Owen R., 1866, Transactions of the Zoological Society, Vvi, P17; Perrin WF., 1975, B SCRIPPS I OCEANOGR, V21; PILLERI G, 1987, CETACEA ITALIAN PLIO; Pyenson ND, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3316; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Schulte H.vonW, 1918, B AM MUS NAT HIST, V38, P7; Schulte HV, 1917, B AM MUS NAT HIST, V37, P361; Schwarzhans Werner, 2013, Palaeo Ichthyologica, V13, P83; Staudinger MD, 2014, MAR MAMMAL SCI, V30, P626, DOI 10.1111/mms.12064; Swofford DL, 2002, PAUP V 40B10; Uhen MD, 2010, J S AM EARTH SCI, V30, P167, DOI 10.1016/j.jsames.2010.08.002; Valerio Ana L., 2012, Revista Geologica de America Central, V46, P151; Velez-Juarbe J, 2013, J VERT PAL PROGR ABS, P231; Vigil Dioselina I, 2014, Rev. Geol. Amér. Central, P213; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Whitmore Frank C. Jr, 2008, Virginia Museum of Natural History Special Publication, V14, P181; Willis PM, 1998, CAN FIELD NAT, V112, P114	62	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123909	10.1371/journal.pone.0123909	http://dx.doi.org/10.1371/journal.pone.0123909			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923213	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600060
J	Xu, YY; Evaristo, C; Alegre, ML; Gurbuxani, S; Kee, BL				Xu, Yiying; Evaristo, Cesar; Alegre, Maria-Luisa; Gurbuxani, Sandeep; Kee, Barbara L.			Analysis of Gzmb(Cre) as a Model System for Gene Deletion in the Natural Killer Cell Lineage	PLOS ONE			English	Article							KAPPA-B ACTIVITY; TRANSGENIC MICE; NK CELLS; IN-VIVO; ACTIVATION; MEMORY; CYTOTOXICITY; EXPRESSION; RECEPTOR; NKP46	The analysis of gene function in mature and activated natural killer cells has been hampered by the lack of model systems for Cre-mediated recombination in these cells. Here we have investigated the utility of Gzmb(Cre) for recombination of loxp sequences in these cells predicated on the observation that Gzmb mRNA is highly expressed in mature and activated natural killer cells. Using two different reporter strains we determined that gene function could be investigated in mature natural killer cells after Gzmb(Cre) mediated recombination in vitro in conditions that lead to natural killer cell activation such as in the cytokine combination of interleukin 2 and interleukin 12. We demonstrated the utility of this model by creating Gzmb(Cre); Rosa26(IKKbca) mice in which Cre-mediated recombination resulted in expression of constitutively active IKK beta, which results in activation of the NF kappa B transcription factor. In vivo and in vitro activation of IKK beta in natural killer cells revealed that constitutive activation of this pathway leads to natural killer cell hyper-activation and altered morphology. As a caveat to the use of Gzmb(Cre) we found that this transgene can lead to recombination in all hematopoietic cells the extent of which varies with the particular loxp flanked allele under investigation. We conclude that Gzmb(Cre) can be used under some conditions to investigate gene function in mature and activated natural killer cells.	[Xu, Yiying; Alegre, Maria-Luisa; Kee, Barbara L.] Univ Chicago, Comm Mol Pathogenesis & Mol Med, Chicago, IL 60637 USA; [Evaristo, Cesar; Alegre, Maria-Luisa; Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Gurbuxani, Sandeep; Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Evaristo, Cesar; Alegre, Maria-Luisa] Univ Chicago, Dept Med, Sect Rhuematol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Kee, BL (corresponding author), Univ Chicago, Comm Mol Pathogenesis & Mol Med, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu	Evaristo, Cesar/O-8430-2016	Evaristo, Cesar/0000-0002-2281-1045; Kee, Barbara/0000-0001-7014-1982	National Institute of Allergy and Infectious Diseases [R01 AI106352]; National Institute of Diabetes and Digestive and Diseases [T32 DK007074]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007074] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institute of Allergy and Infectious Diseases (R01 AI106352 to B. L. K.) and a training grant from the National Institute of Diabetes and Digestive and Diseases (T32 DK007074 to Y. X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Cooper MA, 2010, IMMUNOL REV, V235, P297, DOI 10.1111/j.0105-2896.2010.00891.x; Eckelhart E, 2010, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klinger M, 2010, J IMMUNOL, V184, P6170, DOI 10.4049/jimmunol.1000089; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LANIER LL, 1988, J EXP MED, V167, P1572, DOI 10.1084/jem.167.5.1572; Lewis AE, 2013, DEV BIOL, V379, P229, DOI 10.1016/j.ydbio.2013.04.026; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Matthaei KI, 2007, J PHYSIOL-LONDON, V582, P481, DOI 10.1113/jphysiol.2007.134908; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Orange JS, 2002, J CLIN INVEST, V109, P1501, DOI 10.1172/JCI200214858; Pandey R, 2007, J IMMUNOL, V179, P7385, DOI 10.4049/jimmunol.179.11.7385; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Samson SI, 2004, BLOOD, V103, P4573, DOI 10.1182/blood-2003-08-2975; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun JC, EMBO J, V33, P1295; Sun MY, 2014, J COMP NEUROL, V522, P1191, DOI 10.1002/cne.23497; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125211	10.1371/journal.pone.0125211	http://dx.doi.org/10.1371/journal.pone.0125211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923440	gold, Green Submitted, Green Published			2022-12-26	WOS:000353711600134
J	Zuber, Z; Jurecka, A; Rozdzynska-Swiatkowska, A; Migas-Majoch, A; Lembas, A; Kiec-Wilk, B; Tylki-Szymanska, A				Zuber, Zbigniew; Jurecka, Agnieszka; Rozdzynska-Swiatkowska, Agnieszka; Migas-Majoch, Agata; Lembas, Agnieszka; Kiec-Wilk, Beata; Tylki-Szymanska, Anna			Ultrasonographic Features of Hip Joints in Mucopolysaccharidoses Type I and II	PLOS ONE			English	Article							CONVENTIONAL RADIOGRAPHY; DISEASE; BONE; INVOLVEMENT; ARTHRITIS; MECHANISM; VI	Objectives The primary aim of this study was to assess the ultrasonographic features of hip joints in patients with mucopolysaccharidosis (MPS) type I and II in comparison with healthy population. The secondary aims were to correlate these features with clinical measures and to evaluate the utility of ultrasound in the diagnosis of MPS disease. Materials and Methods Sixteen MPS I (n = 3) and II (n = 13) patients were enrolled in the present study and underwent clinical and radiological evaluation, and bilateral high-resolution ultrasonography (US) of hip joints. The distance from the femoral neck to joint capsule (synovial joint space, SJS), joint effusion, synovial hyperthrophy, and local pathological vascularization were evaluated. The results were compared to the healthy population and correlated with clinical and radiological measures. Results 1. There was a difference in US SJS between children with MPS disease and the normative value for healthy population (7mm). Mean values of SJS were 15.81 +/- 4.08 cm (right hip joints) and 15.69 +/- 4.19 cm (left joints). 2. No inflammatory joint abnormalities were detected in MPS patients. 3. There was a clear correlation between US SJS and patients' age and height, while no clear correlation was observed between SJS and disease severity. Conclusions 1. Patients with MPS I and II present specific features in hip joint ultrasonography. 2. The data suggests that ultrasonography might be effective in the evaluation of hip joint involvement in patients with MPS and might present a valuable tool in facilitating the diagnosis and follow up of the disease.	[Zuber, Zbigniew; Migas-Majoch, Agata] St Louis Reg Childrens Hosp, Dept Pediat, Krakow, Poland; [Jurecka, Agnieszka; Tylki-Szymanska, Anna] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, Warsaw, Poland; [Jurecka, Agnieszka] Univ Gdansk, Dept Genet, PL-80952 Gdansk, Poland; [Rozdzynska-Swiatkowska, Agnieszka] Childrens Mem Hlth Inst, Anthropol Lab, Warsaw, Poland; [Lembas, Agnieszka] Childrens Mem Hlth Inst, Dept Radiol, Warsaw, Poland; [Kiec-Wilk, Beata] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland	Children's Memorial Health Institute; Fahrenheit Universities; University of Gdansk; Children's Memorial Health Institute; Children's Memorial Health Institute; Jagiellonian University; Collegium Medicum Jagiellonian University	Jurecka, A (corresponding author), Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, Warsaw, Poland.	ajurecka@gmail.com		Tylki-Szymanska, Anna/0000-0002-8935-1768; Zuber, Zbigniew/0000-0001-9581-0601; Rozdzynska-Swiatkowska, Agnieszka/0000-0001-6936-5989				Backhaus M, 1999, ARTHRITIS RHEUM-US, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO;2-3; Beck M, 2010, J PEDIATR REHAB MED, V3, P39, DOI 10.3233/PRM-2010-0100; Brands MMMG, 2013, MOL GENET METAB, V109, P70, DOI 10.1016/j.ymgme.2013.02.013; Ciechomska Anna, 2005, Reumatologia (Warsaw), V43, P301; Clarke LA, 2009, PEDIATRICS, V123, P229, DOI 10.1542/peds.2007-3847; Coppa GV, 2011, RHEUMATOLOGY, V50, pV1, DOI 10.1093/rheumatology/ker391; D'Agostino MA., 2010, ESSENTIAL APPL MUSCU; Dougados M, 2010, ANN RHEUM DIS, V69, P828, DOI 10.1136/ard.2009.115493; EBERHARDT K, 1995, ANN RHEUM DIS, V54, P45, DOI 10.1136/ard.54.1.45; EICH GF, 1994, PEDIATR RADIOL, V24, P558, DOI 10.1007/BF02012732; Fedrizzi MS, 1997, J RHEUMATOL, V24, P1820; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; Jakubowski W, 2011, STANDARDY BADAN ULTR; Jeka Slawomir, 2009, Reumatologia (Warsaw), V47, P339; Lampe C, 2013, RHEUM DIS CLIN N AM, V39, P431, DOI 10.1016/j.rdc.2013.03.004; Naredo E, 2006, ANN RHEUM DIS, V65, P14, DOI 10.1136/ard.2005.037382; Naredo E, 2009, ANN RHEUM DIS, V68, P1322, DOI 10.1136/ard.2008.090738; Neufeld EF, ONLINE METABOLIC MOL; Oussoren E, 2011, BBA-MOL BASIS DIS, V1812, P1542, DOI 10.1016/j.bbadis.2011.07.013; Pastores GM, 2005, CURR OPIN RHEUMATOL, V17, P70, DOI 10.1097/01.bor.0000147283.40529.13; ROUBICEK M, 1985, AM J MED GENET, V20, P471, DOI 10.1002/ajmg.1320200308; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123792	10.1371/journal.pone.0123792	http://dx.doi.org/10.1371/journal.pone.0123792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922936	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600058
J	Hsieh, JL; Nguyen, TQ; Matte, T; Ito, K				Hsieh, Jennifer L.; Nguyen, Trang Quyen; Matte, Thomas; Ito, Kazuhiko			Drinking Water Turbidity and Emergency Department Visits for Gastrointestinal Illness in New York City, 2002-2009	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; ASSOCIATION; MILWAUKEE; MORTALITY; RAINFALL; OUTBREAK	Background Studies have examined whether there is a relationship between drinking water turbidity and gastrointestinal (GI) illness indicators, and results have varied possibly due to differences in methods and study settings. Objectives As part of a water security improvement project we conducted a retrospective analysis of the relationship between drinking water turbidity and GI illness in New York City (NYC) based on emergency department chief complaint syndromic data that are available in near-real-time. Methods We used a Poisson time-series model to estimate the relationship of turbidity measured at distribution system and source water sites to diarrhea emergency department (ED) visits in NYC during 2002-2009. The analysis assessed age groups and was stratified by season and adjusted for sub-seasonal temporal trends, year-to-year variation, ambient temperature, day-of-week, and holidays. Results Seasonal variation unrelated to turbidity dominated (similar to 90% deviance) the variation of daily diarrhea ED visits, with an additional 0.4% deviance explained with turbidity. Small yet significant multi-day lagged associations were found between NYC turbidity and diarrhea ED visits in the spring only, with approximately 5% excess risk per inter-quartile-range of NYC turbidity peaking at a 6 day lag. This association was strongest among those aged 0-4 years and was explained by the variation in source water turbidity. Conclusions Integrated analysis of turbidity and syndromic surveillance data, as part of overall drinking water surveillance, may be useful for enhanced situational awareness of possible risk factors that can contribute to GI illness. Elucidating the causes of turbidity-GI illness associations including seasonal and regional variations would be necessary to further inform surveillance needs.	[Hsieh, Jennifer L.; Nguyen, Trang Quyen] New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, New York, NY 10013 USA; [Nguyen, Trang Quyen] San Francisco Dept Hlth, Populat Hlth Div, Appl Res Community Hlth Epidemiol & Surveillance, San Francisco, CA USA; [Matte, Thomas; Ito, Kazuhiko] New York City Dept Hlth & Mental Hyg, Bur Environm Surveillance & Policy, New York, NY USA	New York City Department of Health & Mental Hygiene; New York City Department of Health & Mental Hygiene	Hsieh, JL (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, New York, NY 10013 USA.	jhsieh@health.nyc.gov			Environmental Protection Agency Water Security Initiative grant [H1-83380501]	Environmental Protection Agency Water Security Initiative grant	This work was supported by the Environmental Protection Agency Water Security Initiative grant #H1-83380501 (http://water.epa.gov/infrastructure/watersecurity/lawsregs/initiative.cfm). The EPA approved funding for the NYC Water Security Initiative, including funds to conduct a study of water quality and health outcomes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramini J, 2000, Can Commun Dis Rep, V26, P211; Department of Environmental Protection NYC, 2015, DRINK WAT SUPPL QUAL; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gilbert Marie-Line, 2006, Journal of Water and Health, V4, P225, DOI 10.2166/wh.2006.0019; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Hrudey ES, 2008, TURBIDITY MICROBIAL; Hrudey SE, 2002, CAN J PUBLIC HEALTH, V93, P332, DOI 10.1007/BF03404562; Ito K, 2011, ENVIRON HEALTH PERSP, V119, P467, DOI 10.1289/ehp.1002667; Jagai JS, 2012, INT J ENV RES PUB HE, V9, P1771, DOI 10.3390/ijerph9051771; Kistemann T, 2002, APPL ENVIRON MICROB, V68, P2188, DOI 10.1128/AEM.68.5.2188-2197.2002; LeChevallier Mark W., 2003, Journal of Water and Health, V1, P3; Lim G., 2002, INVESTIGATING RELATI; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Mann AG, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-256; Marx MA, 2006, AM J PUBLIC HEALTH, V96, P547, DOI 10.2105/AJPH.2004.061358; Morris RD, 1998, EPIDEMIOLOGY, V9, P264, DOI 10.1097/00001648-199805000-00009; Payment P, 1999, CAN J MICROBIOL, V45, P709, DOI 10.1139/cjm-45-8-709; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1997, EPIDEMIOLOGY, V8, P615, DOI 10.1097/00001648-199710000-00001; SHUMWAY RH, 1988, ENVIRON RES, V45, P224, DOI 10.1016/S0013-9351(88)80049-5; Sitzenfrei R, 2011, WATER SCI TECHNOL, V64, P1885, DOI 10.2166/wst.2011.813; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; Venables WN., 2002, MODERN APPL STAT S 4; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015	25	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125071	10.1371/journal.pone.0125071	http://dx.doi.org/10.1371/journal.pone.0125071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919375	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659400070
J	Obermajer, T; Lipoglavsek, L; Tompa, G; Treven, P; Lorbeg, PM; Matijasic, BB; Rogelj, I				Obermajer, Tanja; Lipoglavsek, Luka; Tompa, Gorazd; Treven, Primoz; Lorbeg, Petra Mohar; Matijasic, Bojana Bogovic; Rogelj, Irena			Colostrum of Healthy Slovenian Mothers: Microbiota Composition and Bacteriocin Gene Prevalence	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; LACTIC-ACID BACTERIA; REAL-TIME PCR; HUMAN-MILK; INTESTINAL MICROBIOTA; BREAST-MILK; TUF GENE; IDENTIFICATION; DIVERSITY; POPULATIONS	Microbial communities inhabiting the breast milk microenvironment are essential in supporting mammary gland health in lactating women and in providing gut-colonizing bacterial 'inoculum' for their infants' gastro-intestinal development. Bacterial DNA was extracted from colostrum samples of 45 healthy Slovenian mothers. Characteristics of the communities in the samples were assessed by polymerase chain reaction (PCR) coupled with denaturing gradient gel electrophoresis (DGGE) and by quantitative real-time PCR (qPCR). PCR screening for the prevalence of bacteriocin genes was performed on DNA of culturable and total colostrum bacteria. DGGE profiling revealed the presence of Staphylococcus and Gemella in most of the samples and exposed 4 clusters based on the abundance of 3 bands: Staphylococcus epidermidis/Gemella, Streptococcus oralis/pneumonia and Streptococcus salivarius. Bacilli represented the largest proportion of the communities. High prevalence in samples at relatively low quantities was confirmed by qPCR for enterobacteria (100%), Clostridia (95.6%), Bacteroides-Prevotella group (62.2%) and bifidobacteria (53.3%). Bacterial quantities (genome equivalents ml(-1)) varied greatly among the samples; Staphylococcus epidermidis and staphylococci varied in the range of 4 logs, streptococci and all bacteria varied in the range of 2 logs, and other researched groups varied in the range of 1 log. The quantity of most bacterial groups was correlated with the amount of all bacteria. The majority of the genus Staphylococcus was represented by the species Staphylococcus epidermidis (on average 61%), and their abundances were linearly correlated. Determinants of salivaricin A, salivaricin B, streptin and cytolysin were found in single samples. This work provides knowledge on the colostrum microbial community composition of healthy lactating Slovenian mothers and reports bacteriocin gene prevalence.	[Obermajer, Tanja; Tompa, Gorazd; Treven, Primoz; Lorbeg, Petra Mohar; Matijasic, Bojana Bogovic; Rogelj, Irena] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Inst Dairy Sci & Probiot, Domzale, Slovenia; [Lipoglavsek, Luka] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia	University of Ljubljana; University of Ljubljana	Obermajer, T (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Inst Dairy Sci & Probiot, Domzale, Slovenia.	tanja.obermajer@bf.uni-lj.si	Matijašić, Bojana Bogovič/ABI-8319-2020; Matijasic, Bojana Bogovic/J-2885-2012; Treven, Primož/AAN-4721-2020	Matijašić, Bojana Bogovič/0000-0003-0666-6981; Treven, Primož/0000-0002-4235-4304	Slovenian Research Agency-ARRS [J4-3606, P4-0097]	Slovenian Research Agency-ARRS(Slovenian Research Agency - Slovenia)	Funding: This work was performed in the frame of the research project "The Role of Human Milk in Development of Breast Fed Child's Intestinal Microbiota." The project was fully supported by Slovenian Research Agency-ARRS (Contract No. J4-3606; P4-0097), https://www.arrs.gov.si/en/agencija/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P1587, DOI 10.1128/AEM.66.4.1587-1594.2000; Cabrera-Rubio R, 2013, AM J CLIN NUTR, V97, P656, DOI 10.3945/ajcn.112.054262; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Chen HC, 2008, J FOOD DRUG ANAL, V16, P44; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Delgado S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-51; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Donangelo C.M., 2003, ENCY FOOD SCI NUTR, Vsecond, P3449, DOI [10.1016/B0-12-227055-X/01356-0, DOI 10.1016/B0-12-227055-X/01356-0]; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Fiedler T, 2013, APPL ENVIRON MICROB, V79, P1265, DOI 10.1128/AEM.03350-12; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Hugon P, 2013, J CLIN MICROBIOL, V51, P3286, DOI 10.1128/JCM.00473-13; Hunt KM, 2012, APPL ENVIRON MICROB, V78, P4763, DOI 10.1128/AEM.00477-12; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jeurink PV, 2013, BENEF MICROBES, V4, P17, DOI 10.3920/BM2012.0040; Jimenez E, 2008, RES MICROBIOL, V159, P595, DOI 10.1016/j.resmic.2008.09.001; Jimenez E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-143; Jost T, 2014, ENVIRON MICROBIOL, V16, P2891, DOI 10.1111/1462-2920.12238; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lakshminarayanan B, 2013, J APPL MICROBIOL, V114, P886, DOI 10.1111/jam.12085; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Maldonado A, 2004, J BACTERIOL, V186, P1556, DOI 10.1128/JB.186.5.1556-1564.2004; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin R, 2007, RES MICROBIOL, V158, P31, DOI 10.1016/j.resmic.2006.11.004; Martin V, 2012, J BACTERIOL, V194, P4466, DOI 10.1128/JB.00896-12; Martineau F, 2001, J CLIN MICROBIOL, V39, P2541, DOI 10.1128/JCM.39.7.2541-2547.2001; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; Matijasic BB, 2014, EUR J NUTR, V53, P1051, DOI 10.1007/s00394-013-0607-6; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Mehanna N. S. H., 2013, Middle East Journal of Scientific Research, V14, P354; Mori Hiroshi, 2014, DNA Res, V21, P217, DOI 10.1093/dnares/dst052; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Ozgun D., 2011, J MED GENET GENOMICS, V3, P46; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Ren DW, 2014, MICROB ECOL, V68, P146, DOI 10.1007/s00248-013-0315-z; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; SELA S, 1989, J BACTERIOL, V171, P581, DOI 10.1128/jb.171.1.581-584.1989; Songjinda P, 2007, BIOSCI BIOTECH BIOCH, V71, P2338, DOI 10.1271/bbb.70154; Trmcic A, 2008, J DAIRY SCI, V91, P4535, DOI 10.3168/jds.2008-1396; Urbaniak C, 2012, WOMENS HEALTH, V8, P385, DOI [10.2217/WHE.12.23, 10.2217/whe.12.23]; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward TL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-116; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744	51	25	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123324	10.1371/journal.pone.0123324	http://dx.doi.org/10.1371/journal.pone.0123324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919457	Green Published, gold			2022-12-26	WOS:000353659400027
J	Guo, Y; Hu, BF; Huang, H; Tsung, A; Gaikwad, NW; Xu, MS; Jiang, MX; Ren, SR; Fan, J; Billiar, TR; Huang, M; Xie, W				Guo, Yan; Hu, Bingfang; Huang, Hai; Tsung, Allan; Gaikwad, Nilesh W.; Xu, Meishu; Jiang, Mengxi; Ren, Songrong; Fan, Jie; Billiar, Timothy R.; Huang, Min; Xie, Wen			Estrogen Sulfotransferase Is an Oxidative Stress-responsive Gene That Gender-specifically Affects Liver Ischemia/Reperfusion Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; REDUCED-SIZE LIVER; NRF2 ACTIVATION; CELL-SURVIVAL; X-RECEPTOR; MICE; 17-BETA-ESTRADIOL; ANTIOXIDANT; MECHANISMS; INHIBITION	Estrogen sulfotransferase (EST) regulates estrogen homeostasis by sulfonating and deactivating estrogens. Liver ischemia and reperfusion (I/R) involves both hypoxia during the ischemic phase and oxidative damage during the reperfusion phase. In this report, we showed that the expression of EST was markedly induced by I/R. Mechanistically, oxidative stress-induced activation of Nrf2 was responsible for the EST induction, which was abolished in Nrf2(-/-) mice. EST is a direct transcriptional target of Nrf2. In female mice, the I/R-responsive induction of EST compromised estrogen activity. EST ablation attenuated I/R injury as a result of decreased estrogen deprivation, whereas this benefit was abolished upon ovariectomy. The effect of EST ablation was sex-specific because the EST-/- males showed heightened I/R injury. Reciprocally, both estrogens and EST regulate the expression and activity of Nrf2. Estrogen deprivation by ovariectomy abolished the I/R-responsive Nrf2 accumulation, whereas the compromised estrogen deprivation in EST-/- mice was associated with increased Nrf2 accumulation. Our results suggested a novel I/R-responsive feedback mechanism to limit the activity of Nrf2 in which Nrf2 induces the expression of EST, which subsequently increases estrogen deactivation and limits the estrogen-responsive activation of Nrf2. Inhibition of EST, at least in females, may represent an effective approach to manage hepatic I/R injury.	[Guo, Yan; Hu, Bingfang; Xu, Meishu; Jiang, Mengxi; Ren, Songrong; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Guo, Yan; Hu, Bingfang; Xu, Meishu; Jiang, Mengxi; Ren, Songrong; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Huang, Hai; Tsung, Allan; Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA; [Xie, Wen] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Guo, Yan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pathol, Shanghai 200025, Peoples R China; [Hu, Bingfang; Huang, Min] Sun Yat Sen Univ, Inst Clin Pharmacol, Guangzhou 510275, Guangdong, Peoples R China; [Gaikwad, Nilesh W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Gaikwad, Nilesh W.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Fan, Jie] Vet Affairs Pittsburgh Healthcare Syst, Surg Res, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shanghai Jiao Tong University; Sun Yat Sen University; University of California System; University of California Davis; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Huang, M (corresponding author), Sun Yat Sen Univ, Inst Clin Pharmacol, Guangzhou 510006, Guangdong, Peoples R China.	huangmin@mail.sysu.edu.cn; wex6@pitt.edu	Xie, Wen/M-1768-2016; Huang, Huang/AAN-5671-2020; Regan, Clinton/E-6250-2012; Huang, Hai/F-4286-2012	Huang, Hai/0000-0001-7430-0119; Guo, Yan/0000-0002-2344-0944; Jiang, Mengxi/0000-0003-4446-984X	National Institutes of Health [HD073070, DK099232, ES023438]; Joseph Koslow Endowed Professorship; Visiting Scholar Foundation of Shanghai Municipal Education Commission; China Scholarship Council [201206380045]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joseph Koslow Endowed Professorship; Visiting Scholar Foundation of Shanghai Municipal Education Commission; China Scholarship Council(China Scholarship Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD073070, DK099232, and ES023438, and by the Joseph Koslow Endowed Professorship (to W. X.).r Supported by the Visiting Scholar Foundation of Shanghai Municipal Education Commission.r Supported by China Scholarship Council Scholarship 201206380045.	Alnouti Y, 2008, J PHARMACOL EXP THER, V324, P612, DOI 10.1124/jpet.107.129650; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Eckhoff DE, 2002, SURGERY, V132, P302, DOI 10.1067/msy.2002.125718; Gao J, 2012, DIABETES, V61, P1543, DOI 10.2337/db11-1152; Gong H, 2008, CANCER RES, V68, P7386, DOI 10.1158/0008-5472.CAN-08-1545; Gong HB, 2007, MOL ENDOCRINOL, V21, P1781, DOI 10.1210/me.2007-0187; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Harada H, 2001, J APPL PHYSIOL, V91, P2816, DOI 10.1152/jappl.2001.91.6.2816; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; James MO, 2010, ENVIRON INT, V36, P942, DOI 10.1016/j.envint.2009.02.004; Jarrar D, 2000, AM J PHYSIOL-HEART C, V279, pH1015, DOI 10.1152/ajpheart.2000.279.3.H1015; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Ke BB, 2013, J HEPATOL, V59, P1200, DOI 10.1016/j.jhep.2013.07.016; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; Kudoh K, 2014, ANN SURG, V260, P118, DOI 10.1097/SLA.0000000000000287; Lee CC, 2000, HEPATO-GASTROENTEROL, V47, P446; Leonard MO, 2006, FASEB J, V20, P2624, DOI 10.1096/fj.06-5097fje; Lin FS, 2012, SHOCK, V37, P183, DOI 10.1097/SHK.0b013e31823f1918; Lin XH, 2011, FREE RADICAL BIO MED, V51, P97, DOI 10.1016/j.freeradbiomed.2011.04.020; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Pasqualini JR, 2009, ANN NY ACAD SCI, V1155, P88, DOI 10.1111/j.1749-6632.2009.04113.x; Penugonda S, 2006, TOXICOL APPL PHARM, V216, P197, DOI 10.1016/j.taap.2006.05.002; Qian YM, 2001, ENDOCRINOLOGY, V142, P5342, DOI 10.1210/en.142.12.5342; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Shen SQ, 2007, J SURG RES, V140, P67, DOI 10.1016/j.jss.2006.10.022; Soljancic A, 2013, AM J PHYSIOL-REG I, V304, pR951, DOI 10.1152/ajpregu.00360.2012; Song WC, 2001, ANN NY ACAD SCI, V948, P43; Staren ED, 2004, AM J SURG, V188, P136, DOI 10.1016/j.amjsurg.2003.12.063; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Sueyoshi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021229; Vilatoba M, 2005, TRANSPL P, V37, P399, DOI 10.1016/j.transproceed.2004.12.053; Wang ZG, 2014, HEPATOLOGY, V59, P1381, DOI 10.1002/hep.26912; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	37	33	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14754	14764		10.1074/jbc.M115.642124	http://dx.doi.org/10.1074/jbc.M115.642124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25922074	Green Published, hybrid			2022-12-26	WOS:000355754600044
J	Li, ZX; Wang, YM; Tang, FB; Zhang, L; Zhang, Y; Ma, JL; Zhou, T; You, WC; Pan, KF				Li, Zhe-Xuan; Wang, Yu-Mei; Tang, Fu-Bing; Zhang, Lian; Zhang, Yang; Ma, Jun-Ling; Zhou, Tong; You, Wei-Cheng; Pan, Kai-Feng			NOD1 and NOD2 Genetic Variants in Association with Risk of Gastric Cancer and Its Precursors in a Chinese Population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; PRECANCEROUS LESIONS; INNATE IMMUNITY; POLYMORPHISMS; SUSCEPTIBILITY; NOD1/CARD4; RECEPTORS; EVOLUTION; APOPTOSIS; DOMAIN	Background Genetic variants of nucleotide-binding oligomerization domain-containing protein (NOD) may influence the outcome of Helicobacter pylori (H. pylori) infection and gastric carcinogenesis. To explore genetic variants of NOD1 and NOD2 in association with gastric cancer (GC) and its precursors, a population-based study was conducted in Linqu County, China. Methods TagSNPs of NOD1 and NOD2 were genotyped by Sequenom MASS array in 132 GCs, and 1,198 subjects with precancerous gastric lesions, and were correlated with evolution of gastric lesions in 766 subjects with follow-up data. Results Among seven tagSNPs, NOD1 rs2709800 and NOD2 rs718226 were associated with gastric lesions. NOD1 rs2709800 TG genotype carriers had a decreased risk of intestinal metaplasia (IM, OR: 0.53; 95% CI: 0.31-0.92), while NOD2 rs718226 G allele (AG/GG) showed increased risks of dysplasia (DYS, OR: 2.96; 95% CI: 1.86-4.71) and GC (OR: 2.35; 95% CI: 1.24-4.46). Moreover, an additive interaction between rs718226 and H. pylori was found in DYS or GC with synergy index of 3.08 (95% CI: 1.38-6.87) or 3.99 (95% CI: 1.55-10.22), respectively. The follow-up data indicated that NOD2 rs2111235 C allele (OR: 0.52; 95% CI: 0.32-0.83) and rs7205423 G allele (OR: 0.56; 95% CI: 0.35-0.89) were associated with decreased risk of progression in H. pylori-infected subjects. Conclusions NOD1 rs2709800, NOD2 rs718226, rs2111235, rs7205423 and interaction between rs718226 and H. pylori infection may be related to risk of gastric lesions.	[Li, Zhe-Xuan; Wang, Yu-Mei; Tang, Fu-Bing; Zhang, Lian; Zhang, Yang; Ma, Jun-Ling; Zhou, Tong; You, Wei-Cheng; Pan, Kai-Feng] Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China	Peking University	You, WC (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, 52 Fu Cheng Rd, Beijing 100142, Peoples R China.	weichengyou@yahoo.com; pankaifeng2002@yahoo.com	Li, Zhe-xuan/E-9182-2017	Li, Zhe-xuan/0000-0003-4023-6432; Pan, Kai-feng/0000-0002-3680-3126	Ministry of Science and Technology, China [2010DFB30310]; National Basic Research Program of China [973 program] [2010CB529303]; National Natural Science Foundation of China [81171989]	Ministry of Science and Technology, China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Basic Research Program of China [973 program](National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Ministry of Science and Technology, China [2010DFB30310], National Basic Research Program of China [973 program 2010CB529303], and National Natural Science Foundation of China [81171989].	Allison CC, 2013, J IMMUNOL, V190, P3706, DOI 10.4049/jimmunol.1200591; Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Angeletti S, 2009, HUM IMMUNOL, V70, P729, DOI 10.1016/j.humimm.2009.04.026; Castano-Rodriguez N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00336; Castano-Rodriguez N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098899; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; CORREA P, 1988, CANCER RES, V48, P3554; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Hnatyszyn A, 2010, EXP MOL PATHOL, V88, P388, DOI 10.1016/j.yexmp.2010.03.003; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim DJ, 2013, EUR J IMMUNOL, V43, P2650, DOI 10.1002/eji.201243281; Kutikhin AG, 2011, HUM IMMUNOL, V72, P955, DOI 10.1016/j.humimm.2011.06.003; Li WQ, 2009, CARCINOGENESIS, V30, P500, DOI 10.1093/carcin/bgp018; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Nikolaou K, 2012, CANCER CELL, V21, P738, DOI 10.1016/j.ccr.2012.04.026; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Rosenstiel P, 2006, CELL MICROBIOL, V8, P1188, DOI 10.1111/j.1462-5822.2006.00701.x; Rugge M, 2000, AM J SURG PATHOL, V24, P167, DOI 10.1097/00000478-200002000-00001; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tsagaratou A, 2010, J IMMUNOL, V185, P2032, DOI 10.4049/jimmunol.0903919; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016; Wang P, 2012, WORLD J GASTROENTERO, V18, P2112, DOI 10.3748/wjg.v18.i17.2112; Wex T, 2008, ANTICANCER RES, V28, P757; Wong BCY, 2012, GUT, V61, P812, DOI 10.1136/gutjnl-2011-300154; Yoshida T, 2014, INT J CANCER, V134, P1445, DOI 10.1002/ijc.28470; You WC, 1999, INT J CANCER, V83, P615, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;615::AID-IJC8&gt;3.0.CO;2-L; You WC, 2000, J NATL CANCER I, V92, P1607, DOI 10.1093/jnci/92.19.1607; YOU WC, 1993, J GASTROEN HEPATOL, V8, P375, DOI 10.1111/j.1440-1746.1993.tb01531.x; YOU WC, 1993, CANCER RES, V53, P1317; You WC, 1998, INT J EPIDEMIOL, V27, P941, DOI 10.1093/ije/27.6.941; You WC, 2006, JNCI-J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Zeng Hong-mei, 2012, Zhonghua Zhong Liu Za Zhi, V34, P525, DOI 10.3760/cma.j.issn.0253-3766.2012.07.011; Zhang L, 1996, CANCER EPIDEM BIOMAR, V5, P627	41	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124949	10.1371/journal.pone.0124949	http://dx.doi.org/10.1371/journal.pone.0124949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933107	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100067
J	Ladwig, N; Franz-Wachtel, M; Hezel, F; Soufi, B; Macek, B; Wohlleben, W; Muth, G				Ladwig, Nils; Franz-Wachtel, Mirita; Hezel, Felix; Soufi, Boumediene; Macek, Boris; Wohlleben, Wolfgang; Muth, Guenther			Control of Morphological Differentiation of Streptomyces coelicolor A3(2) by Phosphorylation of MreC and PBP2	PLOS ONE			English	Article							CELL-DIVISION; SERINE/THREONINE KINASES; ESCHERICHIA-COLI; TEICHOIC-ACIDS; SER/THR KINASE; GROWTH; IDENTIFICATION; PEPTIDOGLYCAN; PROTEINS; PKNA	During morphological differentiation of Streptomyces coelicolor A3(2), the sporogenic aerial hyphae are transformed into a chain of more than fifty spores in a highly coordinated manner. Synthesis of the thickened spore envelope is directed by the Streptomyces spore wall synthesizing complex SSSC which resembles the elongasome of rod-shaped bacteria. The SSSC includes the eukaryotic type serine/threonine protein kinase (eSTPK) PkaI, encoded within a cluster of five independently transcribed eSTPK genes (SCO4775-4779). To understand the role of PkaI in spore wall synthesis, we screened a S. coelicolor genomic library for PkaI interaction partners by bacterial two-hybrid analyses and identified several proteins with a documented role in sporulation. We inactivated pkaI and deleted the complete SCO4775-4779 cluster. Deletion of pkaI alone delayed sporulation and produced some aberrant spores. The five-fold mutant NL.4775-4779 had a more severe defect and produced 18% aberrant spores affected in the integrity of the spore envelope. Moreover, overbalancing phosphorylation activity by expressing a second copy of any of these kinases caused a similar defect. Following co-expression of pkaI with either mreC or pbp2 in E. coli, phosphorylation of MreC and PBP2 was demonstrated and multiple phosphosites were identified by LC-MS/MS. Our data suggest that elaborate protein phosphorylation controls activity of the SSSC to ensure proper sporulation by suppressing premature cross-wall synthesis.	[Ladwig, Nils; Hezel, Felix; Wohlleben, Wolfgang; Muth, Guenther] Univ Tubingen, Interfak Inst Mikrobiol & Infektionsmed Tuebingen, Mikrobiol Biotechnol, D-72076 Tubingen, Germany; [Franz-Wachtel, Mirita; Soufi, Boumediene; Macek, Boris] Univ Tubingen, Interfak Inst Zellbiol, Proteome Ctr Tuebingen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Muth, G (corresponding author), Univ Tubingen, Interfak Inst Mikrobiol & Infektionsmed Tuebingen, Mikrobiol Biotechnol, Morgenstelle 28, D-72076 Tubingen, Germany.	gmuth@biotech.uni-tuebingen.de	Macek, Boris/N-1442-2015	Macek, Boris/0000-0002-1206-2458	Deutsche Forschungsgemeinschaft (DFG) [SFB-766]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), SFB-766.	Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Burger A, 2000, MOL GEN GENET, V263, P1053, DOI 10.1007/s004380050034; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Chandra G, 2014, FEMS MICROBIOL REV, V38, P345, DOI 10.1111/1574-6976.12047; CHIN T, 1966, ARCH BIOCHEM BIOPHYS, V116, P358, DOI 10.1016/0003-9861(66)90042-7; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Conzelmann M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-906; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Del Sol R, 2006, J BACTERIOL, V188, P1540, DOI 10.1128/JB.188.4.1540-1550.2006; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Eccleston M, 2006, J BACTERIOL, V188, P8189, DOI 10.1128/JB.01119-06; Fiuza M, 2008, J BIOL CHEM, V283, P36553, DOI 10.1074/jbc.M807175200; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Fuchino K, 2013, P NATL ACAD SCI USA, V110, pE1889, DOI 10.1073/pnas.1305358110; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Grantcharova N, 2003, MOL MICROBIOL, V47, P645, DOI 10.1046/j.1365-2958.2003.03334.x; Heichlinger A, 2011, J BACTERIOL, V193, P1533, DOI 10.1128/JB.01100-10; Hempel AM, 2008, J BACTERIOL, V190, P7579, DOI 10.1128/JB.00839-08; Holmes NA, 2013, P NATL ACAD SCI USA, V110, pE397, DOI 10.1073/pnas.1210657110; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jakimowicz D, 2012, MOL MICROBIOL, V85, P393, DOI 10.1111/j.1365-2958.2012.08107.x; Jolly L, 1999, EUR J BIOCHEM, V262, P202, DOI 10.1046/j.1432-1327.1999.00373.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2009, MOL MICROBIOL, V73, P719, DOI 10.1111/j.1365-2958.2009.06805.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kleinschnitz EM, 2011, MOL MICROBIOL, V79, P1367, DOI 10.1111/j.1365-2958.2010.07529.x; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; MANILOFF J, 1983, ANNU REV MICROBIOL, V37, P477, DOI 10.1146/annurev.mi.37.100183.002401; Manteca A, 2011, J PROTEOME RES, V10, P5481, DOI 10.1021/pr200762y; Mazza P, 2006, MOL MICROBIOL, V60, P838, DOI 10.1111/j.1365-2958.2006.05134.x; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Noens EEE, 2005, MOL MICROBIOL, V58, P929, DOI 10.1111/j.1365-2958.2005.04883.x; Parker JL, 2010, PROTEOMICS, V10, P2486, DOI 10.1002/pmic.201000090; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Petrickova K, 2003, MICROBIOL-SGM, V149, P1609, DOI 10.1099/mic.0.26275-0; Petrickova K, 2000, BIOCHEM BIOPH RES CO, V279, P942, DOI 10.1006/bbrc.2000.4054; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Ravikumar V, 2014, MOL CELL PROTEOMICS, V13, P1965, DOI 10.1074/mcp.M113.035949; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Shi L, 2004, MICROBIOL-SGM, V150, P2247, DOI 10.1099/mic.0.27057-0; Sigle S, 2015, INT J MED MICROBIOL, V305, P183, DOI 10.1016/j.ijmm.2014.12.014; Soares NC, 2013, J PROTEOME RES, V12, P2611, DOI 10.1021/pr3011843; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Urabe H, 2008, BIOSCI BIOTECH BIOCH, V72, P778, DOI 10.1271/bbb.70658; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Yague P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060665	66	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125425	10.1371/journal.pone.0125425	http://dx.doi.org/10.1371/journal.pone.0125425			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927987	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100089
J	Lundstrom, E; Strand, R; Johansson, L; Bergsten, P; Ahlstrom, H; Kullberg, J				Lundstrom, Elin; Strand, Robin; Johansson, Lars; Bergsten, Peter; Ahlstrom, Hakan; Kullberg, Joel			Magnetic Resonance Imaging Cooling-Reheating Protocol Indicates Decreased Fat Fraction via Lipid Consumption in Suspected Brown Adipose Tissue	PLOS ONE			English	Article							COLD-EXPOSURE; IDENTIFICATION; ADULT; ACTIVATION	Objectives To evaluate whether a water-fat magnetic resonance imaging (MRI) cooling-reheating protocol could be used to detect changes in lipid content and perfusion in the main human brown adipose tissue (BAT) depot after a three-hour long mild cold exposure. Materials and Methods Nine volunteers were investigated with chemical-shift-encoded water-fat MRI at baseline, after a three-hour long cold exposure and after subsequent short reheating. Changes in fat fraction (FF) and R-2*, related to ambient temperature, were quantified within cervical-supraclavicular adipose tissue (considered as suspected BAT, denoted sBAT) after semi-automatic segmentation. In addition, FF and R-2* were quantified fully automatically in subcutaneous adipose tissue (not considered as suspected BAT, denoted SAT) for comparison. By assuming different time scales for the regulation of lipid turnover and perfusion in BAT, the changes were determined as resulting from either altered absolute fat content (lipid-related) or altered absolute water content (perfusion-related). Results sBAT-FF decreased after cold exposure (mean change in percentage points = -1.94 pp, P = 0.021) whereas no change was observed in SAT-FF (mean = 0.23 pp, P = 0.314). sBAT-R-2* tended to increase (mean = 0.65 s(-1), P = 0.051) and SAT-R-2* increased (mean = 0.40 s(-1), P = 0.038) after cold exposure. sBAT-FF remained decreased after reheating (mean = -1.92 pp, P = 0.008, compared to baseline) whereas SAT-FF decreased (mean = -0.79 pp, P = 0.008, compared to after cold exposure). Conclusions The sustained low sBAT-FF after reheating suggests lipid consumption, rather than altered perfusion, as the main cause to the decreased sBAT-FF. The results obtained demonstrate the use of the cooling-reheating protocol for detecting changes in the cervical-supraclavicular fat depot, being the main human brown adipose tissue depot, in terms of lipid content and perfusion.	[Lundstrom, Elin; Strand, Robin; Johansson, Lars; Ahlstrom, Hakan; Kullberg, Joel] Uppsala Univ, Dept Radiol, Uppsala, Sweden; [Strand, Robin] Uppsala Univ, Dept Informat Technol, Uppsala, Sweden; [Bergsten, Peter] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Lundstrom, E (corresponding author), Uppsala Univ, Dept Radiol, Uppsala, Sweden.	elin.lundstrom@radiol.uu.se	Johansson, Lars/AAF-4845-2019; Kullberg, Joel/ABE-3997-2021		Swedish Research Council [2012-2330]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (grant number: 2012-2330; http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Berglund J, 2012, MAGN RESON MED, V67, P1684, DOI 10.1002/mrm.23185; Chen YCI, 2013, J NUCL MED, V54, P1584, DOI 10.2967/jnumed.112.117275; Cinti S, 2006, NUTR METAB CARDIOVAS, V16, P569, DOI 10.1016/j.numecd.2006.07.009; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; HEATON JM, 1972, J ANAT, V112, P35; Holstila M, 2013, METABOLISM, V62, P1189, DOI 10.1016/j.metabol.2013.03.002; Hu HCH, 2014, MAGN RESON IMAGING, V32, P107, DOI 10.1016/j.mri.2013.10.003; Hu HCH, 2013, J MAGN RESON IMAGING, V38, P885, DOI 10.1002/jmri.24053; Hu HH, 2013, AM J ROENTGENOL, V200, P177, DOI 10.2214/AJR.12.8996; Hu HCH, 2012, J MAGN RESON IMAGING, V35, P938, DOI 10.1002/jmri.23531; Hu HH, 2011, J COMPUT ASSIST TOMO, V35, P65, DOI 10.1097/RCT.0b013e3181fc2150; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Muzik O, 2013, J NUCL MED, V54, P523, DOI 10.2967/jnumed.112.111336; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Rasmussen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077907; Reddy NL, 2014, J CLIN ENDOCR METAB, V99, pE117, DOI 10.1210/jc.2013-2036; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; van Rooijen BD, 2013, INVEST RADIOL, V48, P708, DOI 10.1097/RLI.0b013e31829363b8; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	26	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126705	10.1371/journal.pone.0126705	http://dx.doi.org/10.1371/journal.pone.0126705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928226	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100132
J	Mitchell, MW				Mitchell, Matthew W.			A Comparison of Aggregate P-Value Methods and Multivariate Statistics for Self-Contained Tests of Metabolic Pathway Analysis	PLOS ONE			English	Article								For pathway analysis of genomic data, the most common methods involve combining p-values from individual statistical tests. However, there are several multivariate statistical methods that can be used to test whether a pathway has changed. Because of the large number of variables and pathway sizes in genomics data, some of these statistics cannot be computed. However, in metabolomics data, the number of variables and pathway sizes are typically much smaller, making such computations feasible. Of particular interest is being able to detect changes in pathways that may not be detected for the individual variables. We compare the performance of both the p-value methods and multivariate statistics for self-contained tests with an extensive simulation study and a human metabolomics study. Permutation tests, rather than asymptotic results are used to assess the statistical significance of the pathways. Furthermore, both one and two-sided alternatives hypotheses are examined. From the human metabolomic study, many pathways were statistically significant, although the majority of the individual variables in the pathway were not. Overall, the p-value methods perform at least as well as the multivariate statistics for these scenarios.	Metabolon Inc, Durham, NC 27713 USA	Metabolon	Mitchell, MW (corresponding author), Metabolon Inc, Durham, NC 27713 USA.	mmitchell@metabolon.com		Mitchell, Matthew/0000-0002-2681-4091	Metabolon, Inc	Metabolon, Inc	The author received no funding for this work. Metabolon, Inc provided support in the form of salaries for author, Matthew W. Mitchell, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 1932, STAT METHODS RES WOR; Bai ZD, 1996, STAT SINICA, V6, P311; Chongchharoen S., 2012, J MATH STAT, V8, P274; Curran JM, 2003, HOTELLING HOTELLINGS; DEMPSTER AP, 1958, ANN MATH STAT, V29, P995, DOI 10.1214/aoms/1177706437; DEMPSTER AP, 1960, BIOMETRICS, V16, P41, DOI 10.2307/2527954; Evangelou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041018; Evans AM, 2012, J POSTGENOM, V2, P3; Follmann D, 1996, J AM STAT ASSOC, V91, P854, DOI 10.2307/2291680; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; R Core Team, 2014, LANG ENV STAT COMP; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; Sen PK, 1999, J MULTIVARIATE ANAL, V68, P264, DOI 10.1006/jmva.1998.1791; Silvapulle MJ, 1995, J MULTIVARIATE ANAL, V55, P312, DOI 10.1006/jmva.1995.1081; Srivastava MS, 2008, J MULTIVARIATE ANAL, V99, P386, DOI 10.1016/j.jmva.2006.11.002; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	21	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125081	10.1371/journal.pone.0125081	http://dx.doi.org/10.1371/journal.pone.0125081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927705	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100066
J	Qin, L; Wang, MH; Zuo, J; Feng, XY; Liang, XJ; Wu, ZG; Ye, H				Qin, Lu; Wang, Meihuan; Zuo, Jia; Feng, Xiangyang; Liang, Xuejiao; Wu, Zhigeng; Ye, Hong			Cytosolic BolA Plays a Repressive Role in the Tolerance against Excess Iron and MV-Induced Oxidative Stress in Plants	PLOS ONE			English	Article							SULFUR PROTEINS; MONOTHIOL GLUTAREDOXINS; BIOGENESIS; EXPRESSION; IDENTIFICATION; HOMEOSTASIS; MECHANISMS; MORPHOGENE; ATGRXS17; REVEALS	The BolA-like protein is present in all eukaryotes, and it is able to form complex with monothiol glutaredoxin of the same subcellular compartments, suggesting that the BolA-like protein has essential function in eukaryotes, and that the function is associated with its partner glutaredoxin. Some studies have indicated a role for BolA proteins in Fe-S cluster synthesis or in redox homeostasis. However, the physiological function of BolA proteins remains to be elucidated. Here, we report the characterization of an insertion mutant of BolA3 in Arabidopsis. Among the four AtBolA proteins found in Arabidopsis, the AtBolA3 was the only BolA located in the cytosol of plant cells. It was highly expressed in roots. AtBolA3 was able to interact with the cytosolic monothiol glutaredoxin, AtGRXS17. The bola3 mutant did not show any notable phenotype under normal growth condition, but rather grew better than wild type under some stresses. The bola3 mutant was more tolerant to excess iron and the MV-induced oxidative stress than wild type. It displayed no necrosis in leaves, developed longer roots, accumulated more iron and higher Fe-S protein activities in roots. In addition, the mutant possessed a more potent antioxidant defense to scavenge ROS species. Taken together, our data indicated that the cytosolic AtBolA3 has a suppressive role in the tolerance to excess iron and the MV-induced oxidative stress in plants. AtBolA3 seems to be a repressor under some stress conditions.	[Qin, Lu; Wang, Meihuan; Zuo, Jia; Feng, Xiangyang; Liang, Xuejiao; Wu, Zhigeng; Ye, Hong] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Qin, Lu] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan 430062, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Ye, H (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China.	hye@scib.ac.cn			100-Talent Program of Chinese Academy of Sciences; National Basic Research Program of China (973 Program) [2013CB127102]; Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences	100-Talent Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is funded by grants from the 100-Talent Program of Chinese Academy of Sciences, National Basic Research Program of China (973 Program 2013CB127102), Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences.	ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; Cheng NH, 2011, J BIOL CHEM, V286, P20398, DOI 10.1074/jbc.M110.201707; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Couturier J, 2014, MOL PLANT, V7, P187, DOI 10.1093/mp/sst156; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; Fang WC, 2000, PLANT SCI, V158, P71, DOI 10.1016/S0168-9452(00)00307-1; Fukao Y, 2011, PLANT PHYSIOL, V155, P1893, DOI 10.1104/pp.110.169730; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeong J, 2009, TRENDS PLANT SCI, V14, P280, DOI 10.1016/j.tplants.2009.02.006; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Koshiba T, 1996, PLANT PHYSIOL, V110, P781, DOI 10.1104/pp.110.3.781; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; LEE JK, 1994, BIOCHEM BIOPH RES CO, V202, P1113, DOI 10.1006/bbrc.1994.2043; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Nakamura M, 2013, NEW PHYTOL, V199, P925, DOI 10.1111/nph.12350; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Pilon M, 2009, CURR OPIN PLANT BIOL, V12, P347, DOI 10.1016/j.pbi.2009.04.011; Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; Willems P, 2013, ANTIOXID REDOX SIGN, V18, P129, DOI 10.1089/ars.2011.4253; Wu QY, 2012, PLANT BIOTECHNOL J, V10, P945, DOI 10.1111/j.1467-7652.2012.00723.x; Ye H, 2006, J BIOL CHEM, V281, P8958, DOI 10.1074/jbc.M512737200	39	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124887	10.1371/journal.pone.0124887	http://dx.doi.org/10.1371/journal.pone.0124887			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928219	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100052
J	Song, JL; Tang, SH; Liu, X; Gao, YB; Yang, HJ; Lu, P				Song, Jianglong; Tang, Shihuan; Liu, Xi; Gao, Yibo; Yang, Hongjun; Lu, Peng			A Modularity-Based Method Reveals Mixed Modules from Chemical-Gene Heterogeneous Network	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PHARMACOLOGY; MEDICINE; DATABASE	For a multicomponent therapy, molecular network is essential to uncover its specific mode of action from a holistic perspective. The molecular system of a Traditional Chinese Medicine (TCM) formula can be represented by a 2-class heterogeneous network (2-HN), which typically includes chemical similarities, chemical-target interactions and gene interactions. An important premise of uncovering the molecular mechanism is to identify mixed modules from complex chemical-gene heterogeneous network of a TCM formula. We thus proposed a novel method (MixMod) based on mixed modularity to detect accurate mixed modules from 2-HNs. At first, we compared MixMod with Clauset-Newman-Moore algorithm (CNM), Markov Cluster algorithm (MCL), Infomap and Louvain on benchmark 2-HNs with known module structure. Results showed that MixMod was superior to other methods when 2-HNs had promiscuous module structure. Then these methods were tested on a real drug-target network, in which 88 disease clusters were regarded as real modules. MixMod could identify the most accurate mixed modules from the drug-target 2-HN (normalized mutual information 0.62 and classification accuracy 0.4524). In the end, MixMod was applied to the 2-HN of Buchang naoxintong capsule (BNC) and detected 49 mixed modules. By using enrichment analysis, we investigated five mixed modules that contained primary constituents of BNC intestinal absorption liquid. As a matter of fact, the findings of in vitro experiments using BNC intestinal absorption liquid were found to highly accord with previous analysis. Therefore, MixMod is an effective method to detect accurate mixed modules from chemical-gene heterogeneous networks and further uncover the molecular mechanism of multicomponent therapies, especially TCM formulae.	[Song, Jianglong; Liu, Xi; Gao, Yibo; Lu, Peng] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Tang, Shihuan; Yang, Hongjun] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Yang, HJ (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	hongjun0420@vip.sina.com; peng.lu@ia.ac.cn		Tang, Shihuan/0000-0003-0589-4499	National Science Foundation of China [81303152, 81330086, 81203005]; Fundamental Research Funds for the Central public welfare research institutes [ZZ070830]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central public welfare research institutes	This work was supported by National Science Foundation of China (grant nos. 81303152, 81330086, and 81203005) and the Fundamental Research Funds for the Central public welfare research institutes (grant no. ZZ070830).	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Li HY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/495840; Li Jian, 2012, Evid Based Complement Alternat Med, V2012, P149762, DOI 10.1155/2012/149762; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]; Li S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S6; Liang XJ, 2014, MOL BIOSYST, V10, P1014, DOI 10.1039/c3mb70507b; Meila M, 2001, MACH LEARN, V42, P9, DOI 10.1023/A:1007648401407; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Song JL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/731370; van Dongen SM, 2000, GRAPH CLUSTERING BY; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang FB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/802784; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063	38	1	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125585	10.1371/journal.pone.0125585	http://dx.doi.org/10.1371/journal.pone.0125585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927435	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100103
J	Yang, N; Gilman, P; Mirzayans, R; Sun, XJ; Touret, N; Weinfeld, M; Goping, IS				Yang, Ning; Gilman, Paul; Mirzayans, Razmik; Sun, Xuejun; Touret, Nicolas; Weinfeld, Michael; Goping, Ing Swie			Characterization of the Apoptotic Response Induced by the Cyanine Dye D112: A Potentially Selective Anti-Cancer Compound	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY-MEMBERS; CASPASE ACTIVATION; CELL-DEATH; PERMEABILITY TRANSITION; BH3-ONLY PROTEINS; MITOCHONDRIAL; CANCER; BAX; PHAGOCYTOSIS	Chemotherapeutic drugs that are used in anti-cancer treatments often cause the death of both cancerous and noncancerous cells. This non-selective toxicity is the root cause of untoward side effects that limits the effectiveness of therapy. In order to improve chemotherapeutic options for cancer patients, there is a need to identify novel compounds with higher discrimination for cancer cells. In the past, methine dyes that increase the sensitivity of photographic emulsions have been investigated for anti-cancer properties. In the 1970's, Kodak Laboratories initiated a screen of approximately 7000 dye structural variants for selective toxicity. Among these, D112 was identified as a promising compound with elevated toxicity against a colon cancer cell line in comparison to a non-transformed cell line. Despite these results changing industry priorities led to a halt in further studies on D112. We decided to revive investigations on D112 and have further characterized D112-induced cellular toxicity. We identified that in response to D112 treatment, the T-cell leukemia cell line Jurkat showed caspase activation, mitochondrial depolarization, and phosphatidylserine externalization, all of which are hallmarks of apoptosis. Chemical inhibition of caspase enzymatic activity and blockade of the mitochondrial pathway through Bcl-2 expression inhibited D112-induced apoptosis. At lower concentrations, D112 induced growth arrest. To gain insight into the molecular mechanism of D112 induced mitochondrial dysfunction, we analyzed the intracellular localization of D112, and found that D112 associated with mitochondria. Interestingly, in the cell lines that we tested, D112 showed increased toxicity toward transformed versus non-transformed cells. Results from this work identify D112 as a potentially interesting molecule warranting further investigation.	[Yang, Ning; Touret, Nicolas; Goping, Ing Swie] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Gilman, Paul] Eastman Kodak Co Rochester, Res Labs, New York, NY USA; [Mirzayans, Razmik; Sun, Xuejun; Weinfeld, Michael; Goping, Ing Swie] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; Eastman Kodak; University of Alberta	Goping, IS (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	igoping@ualberta.ca			Women's and Children's Health Research Institute; Canadian Breast Cancer Foundation; Eastman Kodak Company	Women's and Children's Health Research Institute; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Eastman Kodak Company	Support was provided by: the Women's and Children's Health Research Institute: [http://www.wchri.org]; Canadian Breast Cancer Foundation: [http://www.cbcf.org/Pages/default.aspx]. Both funders contribute to financial support of this study. Co-author Paul Gilman was employed by Eastman Kodak Company during the course of the study. Eastman Kodak Company provided support in the form of salary for author PG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Borisenko GG, 2003, ARCH BIOCHEM BIOPHYS, V413, P41, DOI 10.1016/S0003-9861(03)00083-3; Brown JM, 1999, CANCER RES, V59, P1391; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Castedo M, 1996, J IMMUNOL, V157, P512; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Gilman P, 2006, USA patent, Patent No. [US20060099712 A1., 20060099712]; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Han J, 2004, LEUKEMIA, V18, P1671, DOI 10.1038/sj.leu.2403496; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Hartman ML, 2012, ANTI-CANCER AGENT ME, V12, P966; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Johnson VL, 2000, J CELL SCI, V113, P2941; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mirzayans R, 2013, INT J MOL SCI, V14, P22409, DOI 10.3390/ijms141122409; Nakamura K, 2002, LIFE SCI, V70, P791, DOI 10.1016/S0024-3205(01)01454-0; Ning Y, 2013, APOPTOSIS; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Society AC, 2014, CANC FACTS FIG 2014; Society CC, 2013, NAT STAT GLANC CAN C; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Takeyama N, 2002, EXP CELL RES, V274, P16, DOI 10.1006/excr.2001.5447; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Wang LX, 2006, ANN THORAC SURG, V81, P1817, DOI 10.1016/j.athoracsur.2005.11.029; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Yasuhara N, 1997, ONCOGENE, V15, P1921, DOI 10.1038/sj.onc.1201370; ZIGMAN S, 1980, SCIENCE, V208, P188, DOI 10.1126/science.7361115	43	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125381	10.1371/journal.pone.0125381	http://dx.doi.org/10.1371/journal.pone.0125381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927702	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100086
J	Zhang, J; Tang, HJ; Deng, RY; Wang, N; Zhang, YQ; Wang, Y; Liu, Y; Li, FY; Wang, X; Zhou, LB				Zhang, Juan; Tang, Hongju; Deng, Ruyuan; Wang, Ning; Zhang, Yuqing; Wang, Yao; Liu, Yun; Li, Fengying; Wang, Xiao; Zhou, Libin			Berberine Suppresses Adipocyte Differentiation via Decreasing CREB Transcriptional Activity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LIPID-ACCUMULATION; AMPK ACTIVATION; 3T3-L1 CELLS; COMPOUND-C; C/EBP-BETA; ADIPOGENESIS; MECHANISM; PREADIPOCYTES; INHIBITION	Berberine, one of the major constituents of Chinese herb Rhizoma coptidis, has been demonstrated to lower blood glucose, blood lipid, and body weight in patients with type 2 diabetes mellitus. The anti-obesity effect of berberine has been attributed to its anti-adipogenic activity. However, the underlying molecular mechanism remains largely unknown. In the present study, we found that berberine significantly suppressed the expressions of CCAAT/enhancer-binding protein (C/EBP)alpha, peroxisome proliferators-activated receptor gamma 2 (PPAR gamma 2), and other adipogenic genes in the process of adipogenesis. Berberine decreased cAMP-response element-binding protein (CREB) phosphorylation and C/EBP beta expression at the early stage of 3T3-L1 preadipocyte differentiation. In addition, CREB phosphorylation and C/EBP beta expression induced by 3-isobutyl-1-methylxanthine (IBMX) and forskolin were also attenuated by berberine. The binding activities of cAMP responsive element (CRE) stimulated by IBMX and forskolin were inhibited by berberine. The binding of phosphorylated CREB to the promoter of C/EBP beta was abrogated by berberine after the induction of preadipocyte differentiation. These results suggest that berberine blocks adipogenesis mainly via suppressing CREB activity, which leads to a decrease in C/EBP beta-triggered transcriptional cascades.	[Zhang, Juan; Tang, Hongju; Deng, Ruyuan; Wang, Ning; Zhang, Yuqing; Wang, Yao; Liu, Yun; Li, Fengying; Wang, Xiao; Zhou, Libin] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med,Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis,Shanghai, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, X (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med,Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis,Shanghai, Shanghai 200030, Peoples R China.	wangxiao1976@hotmail.com; libinzhou99@hotmail.com			National Natural Science Foundation of China [81070652, 81070617, 81170720, 81261120564, 81270910]; Shanghai Municipal Health Bureau [2011-217]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau	This work was funded by grants from the National Natural Science Foundation of China (81070652, 81070617, 81170720, 81261120564, and 81270910) and Shanghai Municipal Health Bureau (2011-217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KH, 2012, BMB REP, V45, P700, DOI 10.5483/BMBRep.2012.45.12.235; Belmonte N, 2001, MOL ENDOCRINOL, V15, P2037, DOI 10.1210/me.15.11.2037; Brusq JM, 2006, J LIPID RES, V47, P1281, DOI 10.1194/jlr.M600020-JLR200; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Fox KE, 2006, J BIOL CHEM, V281, P40341, DOI 10.1074/jbc.M605077200; Gao Y, 2008, BIOL PHARM BULL, V31, P1716, DOI 10.1248/bpb.31.1716; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hu YS, 2010, PHYTOTHER RES, V24, P1831, DOI 10.1002/ptr.3204; Hwang JT, 2007, BIOCHEM BIOPH RES CO, V364, P1002, DOI 10.1016/j.bbrc.2007.10.125; Ikarashi N, 2012, PHYTOTHER RES, V26, P91, DOI 10.1002/ptr.3493; Kim EJ, 2012, J NUTR BIOCHEM, V23, P1552, DOI 10.1016/j.jnutbio.2011.10.008; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lee JW, 2012, J LIPID RES, V53, P1277, DOI 10.1194/jlr.M022897; Lee J, 2012, J BIOL CHEM, V287, P8839, DOI 10.1074/jbc.M111.263434; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Pham TPT, 2011, BIOCHEM BIOPH RES CO, V413, P376, DOI 10.1016/j.bbrc.2011.08.110; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Stephens JM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001436; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Vingtdeux V, 2011, MOL MED, V17, P1022, DOI 10.2119/molmed.2011.00163; Vogel CFA, 2004, J BIOL CHEM, V279, P8886, DOI 10.1074/jbc.M310190200; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493; Zhou LB, 2008, ENDOCRINOLOGY, V149, P4510, DOI 10.1210/en.2007-1752; Zhou LB, 2007, METABOLISM, V56, P405, DOI 10.1016/j.metabol.2006.10.025; Zhou LB, 2011, BBA-MOL BASIS DIS, V1812, P527, DOI 10.1016/j.bbadis.2010.10.001	37	45	47	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125667	10.1371/journal.pone.0125667	http://dx.doi.org/10.1371/journal.pone.0125667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928058	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100110
J	Chiu, CF; Chen, MH; Chang, FH				Chiu, Chun-Fu; Chen, Ming-Hung; Chang, Feng-Hsiang			Carbon Dioxide Concentrations and Temperatures within Tour Buses under Real-Time Traffic Conditions	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; AIR SUPPLY RATE; CO2 CONCENTRATIONS; SLEEP HABITS; RISK; VENTILATION; POPULATION; SYMPTOMS; EXPOSURE; INJURY	This study monitored the carbon dioxide (CO2) concentrations and temperatures of three 43-seat tour buses with high-passenger capacities in a course of a three-day, two-night school excursion. Results showed that both driver zones and passenger zones of the tour buses achieved maximum CO2 concentrations of more than 3000 ppm, and maximum daily average concentrations of 2510.6 and 2646.9 ppm, respectively. The findings confirmed that the CO2 concentrations detected in the tour buses exceeded the indoor air quality standard of Taiwan Environmental Protection Administration (8 hr-CO2: 1000 ppm) and the air quality guideline of Hong Kong Environmental Protection Department (1 hr-CO2: 2500 ppm for Level 1 for buses). Observations also showed that high-capacity tour bus cabins with air conditioning system operating in recirculation mode are severely lacking in air exchange rate, which may negatively impact transportation safety. Moreover, the passenger zones were able to maintain a temperature of between 20 and 25 degrees C during travel, which effectively suppresses the dispersion of volatile organic compounds. Finally, the authors suggest that in the journey, increasing the ventilation frequency of tour bus cabin, which is very beneficial to maintain the travel safety and enhance the quality of travel.	[Chiu, Chun-Fu] Tzu Hui Inst Technol, Dept Tourism Affairs, Pingtung, Taiwan; [Chiu, Chun-Fu] Natl Pingtung Univ Sci & Technol, Dept Trop Agr & Int Cooperat, Pingtung, Taiwan; [Chen, Ming-Hung] Natl Pingtung Univ Sci & Technol, Dept Recreat Sport & Hlth Promot, Pingtung, Taiwan; [Chang, Feng-Hsiang] Tzu Hui Inst Technol, Dept Leisure Recreat & Tourism Management, Pingtung, Taiwan	National Pingtung University Science & Technology; National Pingtung University Science & Technology	Chang, FH (corresponding author), Tzu Hui Inst Technol, Dept Leisure Recreat & Tourism Management, Pingtung, Taiwan.	chang.taiwan@gmail.com			Tzu Hui Institute of Technology Research Program [THIT-103010]	Tzu Hui Institute of Technology Research Program	The authors gratefully acknowledge the financial support of the Tzu Hui Institute of Technology Research Program (Grant No. THIT-103010). They also thank Mr. Wen-Chin Li, engineer of JS Environmental Technology and Energy Saving Co., Ltd., for his assistance in monitoring.	ACGIH (American Conference of Governmental Industrial Hygienists), 2011, TLVS AND BEIS; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 1990, APPL OCCUP ENVIRON H; Chan MY, 2005, INDOOR BUILT ENVIRON, V14, P397, DOI 10.1177/1420326X05057254; Chen YY, 2010, INJURY PREV, V16, P172, DOI 10.1136/ip.2009.021840; Chien YC, 2007, SCI TOTAL ENVIRON, V382, P228, DOI 10.1016/j.scitotenv.2007.04.022; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Consumers' Foundation, 2011, STRENGTH CONTR LENGT; CORNAK J. U. Stefan, 2012, SCI MILITARY, V1, P50; Erdmann CA, 2004, INDOOR AIR, V14, P127, DOI 10.1111/j.1600-0668.2004.00298.x; Federspiel CC, 2004, INDOOR AIR, V14, P41, DOI 10.1111/j.1600-0668.2004.00299.x; Fedoruk MJ, 2003, J EXPO ANAL ENV EPID, V13, P31, DOI 10.1038/sj.jea.7500250; Horne JA, 1996, FALLING ASLEEP WHEEL; Hsu DJ, 2009, ATMOS ENVIRON, V43, P5723, DOI 10.1016/j.atmosenv.2009.08.039; Huang HL, 2009, INDOOR AIR, V19, P234, DOI 10.1111/j.1600-0668.2009.00587.x; Lipsett MJ, 1994, INORGANIC COMPOUNDS, P4621; MacLean AW, 2003, SLEEP MED REV, V7, P507, DOI 10.1016/S1087-0792(03)90004-9; Mathur GD, 2009, SAE INT J PASSEN CAR, V1, P757, DOI 10.4271/2008-01-0829; Milton DK, 2000, INDOOR AIR, V10, P212, DOI 10.1034/j.1600-0668.2000.010004212.x; Mudarri DH, 1997, T AM SOC HEATING REF, V103, P244; OSHA, 2012, SAMPL AN METH CARB D; Park SK, 2009, SAE TECHNICAL PAPER, DOI [10.4271/2009-01-0536, DOI 10.4271/2009-01-0536]; Perez-Chada D, 2005, SLEEP, V28, P1103, DOI 10.1093/sleep/28.9.1103; Persily A.K., 1997, ASHRAE T, V103, P193; Petridou E, 1997, ACCIDENT ANAL PREV, V29, P687, DOI 10.1016/S0001-4575(97)00038-9; Rajhans G, 1983, INDOOR AIR QUALITY C, P160; Rossello J, 2011, ACCIDENT ANAL PREV, V43, P675, DOI 10.1016/j.aap.2010.10.011; Satish U, 2012, ENVIRON HEALTH PERSP, V120, P1671, DOI 10.1289/ehp.1104789; Seo J, 2012, J AUTOMOBILE ENG, V227, P1162; Seppanen OA, 1999, INDOOR AIR, V9, P226, DOI 10.1111/j.1600-0668.1999.00003.x; Shendell DG, 2004, INDOOR AIR, V14, P333, DOI 10.1111/j.1600-0668.2004.00251.x; Taiwan CWB (Taiwan Central Weather Bureau), 2015, OBS DAT QUER SYST; Taiwan EPA (Taiwan Environmental Protection Administration), 2013, METH DET ATM CO2 INF; Taiwan EPA (Taiwan Environmental Protection Administration), 2012, IAQ STAND; Teng MC, 2013, EXPLORATION MAJOR AC; USDOE (U.S. Department of Energy), 2011, MAN FACT AFF MPG; Wargocki P, 2000, INDOOR AIR, V10, P222, DOI 10.1034/j.1600-0668.2000.010004222.x; Yoshida T, 2006, ENVIRON INT, V32, P58, DOI 10.1016/j.envint.2005.04.009; You KW, 2007, J ENVIRON SCI, V19, P1208, DOI 10.1016/S1001-0742(07)60197-1; Zabiegala B, 2006, POL J ENVIRON STUD, V15, P383; Zhang QF, 2010, ATMOS ENVIRON, V44, P253, DOI 10.1016/j.atmosenv.2009.09.044; Zhu SW, 2010, BUILD ENVIRON, V45, P2077, DOI 10.1016/j.buildenv.2010.03.004	43	11	11	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125117	10.1371/journal.pone.0125117	http://dx.doi.org/10.1371/journal.pone.0125117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923722	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600126
J	Pauciullo, A; Erhardt, G				Pauciullo, Alfredo; Erhardt, Georg			Molecular Characterization of the Llamas (Lama glama) Casein Cluster Genes Transcripts (CSN1S1, CSN2, CSN1S2, CSN3) and Regulatory Regions	PLOS ONE			English	Article							BETA-CASEIN; GLUCOCORTICOID-RECEPTOR; POINT MUTATION; PROTEIN; PROMOTER; SEQUENCE; VARIANTS; SITE; POLYMORPHISMS; FIBRINOGEN	In the present paper, we report for the first time the characterization of llama (Lama glama) caseins at transcriptomic and genetic level. A total of 288 casein clones transcripts were analysed from two lactating llamas. The most represented mRNA populations were those correctly assembled (85.07%) and they encoded for mature proteins of 215, 217, 187 and 162 amino acids respectively for the CSN1S1, CSN2, CSN1S2 and CSN3 genes. The exonic subdivision evidenced a structure made of 21, 9, 17 and 6 exons for the alpha s1-, beta-, alpha s2- and kappa-casein genes respectively. Exon skipping and duplication events were evidenced. Two variants A and B were identified in the as1- casein gene as result of the alternative out-splicing of the exon 18. An additional exon coding for a novel esapeptide was found to be cryptic in the kappa-casein gene, whereas one extra exon was found in the as2- casein gene by the comparison with the Camelus dromedaries sequence. A total of 28 putative phosphorylated motifs highlighted a complex heterogeneity and a potential variable degree of post-translational modifications. Ninety-six polymorphic sites were found through the comparison of the lama casein cDNAs with the homologous camel sequences, whereas the first description and characterization of the 5'- and 3'-regulatory regions allowed to identify the main putative consensus sequences involved in the casein genes expression, thus opening the way to new investigations -so far-never achieved in this species.	[Pauciullo, Alfredo] Univ Turin, Dept Agr Forest & Food Sci, Grugliasco, Italy; [Pauciullo, Alfredo; Erhardt, Georg] Univ Giessen, Inst Anim Breeding & Genet, D-35390 Giessen, Germany	University of Turin; Justus Liebig University Giessen	Pauciullo, A (corresponding author), Univ Turin, Dept Agr Forest & Food Sci, Grugliasco, Italy.	alfredo.pauciullo@unito.it	Pauciullo, Alfredo/AAF-7713-2020	Pauciullo, Alfredo/0000-0002-3140-9373	Institute for Animal Breeding and Genetics, Justus-Liebig University of Giessen (Germany); Agricola Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy)	Institute for Animal Breeding and Genetics, Justus-Liebig University of Giessen (Germany); Agricola Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy)	This research was financially supported by the Institute for Animal Breeding and Genetics, Justus-Liebig University of Giessen (Germany) and partially by Agricola Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER LJ, 1992, ANIM GENET, V23, P365, DOI 10.1111/j.1365-2052.1992.tb00159.x; Allain D, 2010, ANIMAL, V4, P1472, DOI 10.1017/S1751731110000029; BOISNARD M, 1991, EUR J BIOCHEM, V201, P633, DOI 10.1111/j.1432-1033.1991.tb16324.x; BONSING J, 1987, J DAIRY RES, V54, P447, DOI 10.1017/S0022029900025632; BOUNIOL C, 1993, GENE, V128, P289, DOI 10.1016/0378-1119(93)90577-P; Caroli A, 2006, J DAIRY SCI, V89, P3178, DOI 10.3168/jds.S0022-0302(06)72592-9; Caroli AM, 2009, J DAIRY SCI, V92, P5335, DOI 10.3168/jds.2009-2461; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Christoffels VM, 1998, MOL CELL BIOL, V18, P6305, DOI 10.1128/MCB.18.11.6305; Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451; Cosenza G, 2008, SMALL RUMINANT RES, V74, P84, DOI 10.1016/j.smallrumres.2007.03.010; Cosenza G, 2009, ANIM GENET, V40, P791, DOI 10.1111/j.1365-2052.2009.01897.x; Cosenza G, 2010, ITAL J ANIM SCI, V9, P206, DOI 10.4081/ijas.2010.e40; FERRANTI P, 1995, J DAIRY RES, V62, P281, DOI 10.1017/S0022029900030983; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Harvatine KJ, 2006, J NUTR, V136, P2468, DOI 10.1093/jn/136.10.2468; Holland JW, 2009, FOOD SCI TECH-INT SE, P107; Inman CK, 2005, MOL CELL BIOL, V25, P3182, DOI 10.1128/MCB.25.8.3182-3193.2005; Jiang Z, 2002, J CELL BIOL, V156, P185, DOI 10.1083/jcb.200106084; JOHNSEN LB, 1995, BIOCHEM J, V309, P237, DOI 10.1042/bj3090237; JOLLES P, 1978, J MOL EVOL, V11, P271, DOI 10.1007/BF01733837; JONES WK, 1985, J BIOL CHEM, V260, P7042; Kappeler S, 1998, J DAIRY RES, V65, P209, DOI 10.1017/S0022029997002847; Kappeler SR, 2003, J DAIRY SCI, V86, P498, DOI 10.3168/jds.S0022-0302(03)73628-5; LEROUX C, 1992, J BIOL CHEM, V267, P6147; Li SS, 2012, J INTEGR AGR, V11, P439, DOI 10.1016/S2095-3119(12)60029-X; Lisson M, 2014, J DAIRY SCI, V97, P1939, DOI 10.3168/jds.2013-7355; MAHE MF, 1982, ANN GENET SEL ANIM, V14, P401, DOI 10.1186/1297-9686-14-4-401; MARTIN P, 1992, BIOCHEM BIOPH RES CO, V183, P750, DOI 10.1016/0006-291X(92)90547-X; Martin P, 2002, REPROD NUTR DEV, V42, P433, DOI 10.1051/rnd:2002036; MENON RS, 1992, GENOMICS, V12, P13, DOI 10.1016/0888-7543(92)90400-M; MENON RS, 1992, MOL BIOL CELL, V3, pA323; MERCIER JC, 1993, J DAIRY SCI, V76, P3079, DOI 10.3168/jds.S0022-0302(93)77647-X; MOHR U, 1994, GENE, V143, P187, DOI 10.1016/0378-1119(94)90095-7; Ottenheijm CAC, 2008, FASEB J, V22, P2912, DOI 10.1096/fj.07-104372; Pauciullo A, 2014, GENE, V547, P159, DOI 10.1016/j.gene.2014.06.055; Pauciullo A, 2013, GENE, V513, P22, DOI 10.1016/j.gene.2012.10.083; PISANO A, 1994, GLYCOBIOLOGY, V4, P837, DOI 10.1093/glycob/4.6.837; Ramunno L, 2004, GENE, V334, P105, DOI 10.1016/j.gene.2004.03.006; Ramunno L, 2005, GENE, V345, P289, DOI 10.1016/j.gene.2004.12.003; Ramunno L, 2001, ANIM GENET, V32, P19, DOI 10.1046/j.1365-2052.2001.00710.x; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Riek A, 2006, J DAIRY SCI, V89, P3484, DOI 10.3168/jds.S0022-0302(06)72387-6; Riek A, 2013, J DAIRY SCI, V96, P1815, DOI 10.3168/jds.2012-6323; Rijnkels M, 2002, J MAMMARY GLAND BIOL, V7, P327, DOI 10.1023/A:1022808918013; Saadaoui B, 2014, ELECTROPHORESIS, V35, P1406, DOI 10.1002/elps.201300383; Schild TA, 1996, THEOR APPL GENET, V93, P887, DOI 10.1007/BF00224090; Shuiep ES, 2013, INT DAIRY J, V28, P88, DOI 10.1016/j.idairyj.2012.09.002; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; Subramaniam N, 2003, BIOCHEM J, V370, P1087, DOI 10.1042/BJ20020471; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Trinks Alexandra, 2012, P79; Wyszomierski SL, 2001, MOL ENDOCRINOL, V15, P228, DOI 10.1210/me.15.2.228; Zhang MQ, 2002, NAT REV GENET, V3, P698, DOI 10.1038/nrg890; Zhao FQ, 2002, BBA-GENE STRUCT EXPR, V1577, P27, DOI 10.1016/S0167-4781(02)00402-5	56	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124963	10.1371/journal.pone.0124963	http://dx.doi.org/10.1371/journal.pone.0124963			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923814	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600116
J	Scott, IM; Pound, N				Scott, Isabel M.; Pound, Nicholas			Menstrual Cycle Phase Does Not Predict Political Conservatism	PLOS ONE			English	Article							DISGUST SENSITIVITY; PSYCHOLOGY; CONCEPTION; SINGLE; WOMEN	Recent authors have reported a relationship between women's fertility status, as indexed by menstrual cycle phase, and conservatism in moral, social and political values. We conducted a survey to test for the existence of a relationship between menstrual cycle day and conservatism. 2213 women reporting regular menstrual cycles provided data about their political views. Of these women, 2208 provided information about their cycle date, 1260 provided additional evidence of reliability in self-reported cycle date, and of these, 750 also indicated an absence of hormonal disruptors such as recent hormonal contraception use, breastfeeding or pregnancy. Cycle day was used to estimate day-specific fertility rate (probability of conception); political conservatism was measured via direct self-report and via responses to the "Moral Foundations" questionnaire. We also recorded relationship status, which has been reported to interact with menstrual cycle phase in determining political preferences. We found no evidence of a relationship between estimated cyclical fertility changes and conservatism, and no evidence of an interaction between relationship status and cyclical fertility in determining political attitudes. Our findings were robust to multiple inclusion/exclusion criteria and to different methods of estimating fertility and measuring conservatism. In summary, the relationship between cycle-linked reproductive parameters and conservatism may be weaker or less reliable than previously thought.	[Scott, Isabel M.; Pound, Nicholas] Brunel Univ London, Div Psychol, Dept Life Sci, Uxbridge UB8 3PH, Middx, England	Brunel University	Scott, IM (corresponding author), Brunel Univ London, Div Psychol, Dept Life Sci, Uxbridge UB8 3PH, Middx, England.	isabel.scott@brunel.ac.uk	Pound, Nicholas/B-5453-2008	Pound, Nicholas/0000-0003-2170-9943	Brunel University	Brunel University	No specific funding was provided for this research. Participant payments were financed by a lecturer start-up fund provided by Brunel University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Durante KM, 2014, PSYCHOL SCI, V25, P1150, DOI 10.1177/0956797614524422; Durante KM, 2013, PSYCHOL SCI, V24, P1007, DOI 10.1177/0956797612466416; Farage MA, 2008, ARCH GYNECOL OBSTET, V278, P299, DOI 10.1007/s00404-008-0708-2; Faraji- Rad A, 2013, J CONSUMER PSYCHOL; Fehring RJ, 2006, JOGNN-J OBST GYN NEO, V35, P376, DOI 10.1111/j.1552-6909.2006.00051.x; Fessler DMT, 2003, EVOL HUM BEHAV, V24, P406, DOI 10.1016/S1090-5138(03)00054-0; Fleischman DS, 2011, HORM BEHAV, V59, P271, DOI 10.1016/j.yhbeh.2010.11.014; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2002, ANN REV SEX RES, V12, P145; Gelman A., 2013, J MANAGE; Gildersleeve K, DO WOMENS MATE PREFE; Gildersleeve K, 2013, SEX ROLES, V69, P516, DOI 10.1007/s11199-013-0273-4; Graham J, 2011, J PERS SOC PSYCHOL; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Guillermo CJ, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-19; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Harris CR, 2014, PSYCHOL SCI, V25, P1147, DOI 10.1177/0956797613520236; Harris CR, 2013, SEX ROLES, V69, P507, DOI 10.1007/s11199-012-0229-0; Inbar Y, 2012, SOC PSYCHOL PERS SCI, V3, P537, DOI 10.1177/1948550611429024; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jones BC, 2008, ARCH SEX BEHAV, V37, P78, DOI 10.1007/s10508-007-9268-y; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Saad G, 2012, J CONSUM PSYCHOL, V22, P102, DOI 10.1016/j.jcps.2011.10.001; Sacher J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00374; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Sommer B., 1992, COGNITION MENSTRUAL, P39, DOI [10.1007/978-1-4613-9148-7_2, DOI 10.1007/978-1-4613-9148-7_2]; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; Tybur JM, 2010, EVOL PSYCHOL-US, V8, P599, DOI 10.1177/147470491000800406; Vitzthum VJ, 2008, ANNU REV ANTHROPOL, V37, P53, DOI 10.1146/annurev.anthro.37.081407.085112; Wegienka G, 2005, J WOMENS HEALTH, V14, P248, DOI 10.1089/jwh.2005.14.248; Wideman L, 2013, SPORTS HEALTH, V5, P143, DOI 10.1177/1941738112469930; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3; Wilcox AJ, 2000, BRIT MED J, V321, P1259, DOI 10.1136/bmj.321.7271.1259; Wood W, 2014, EMOT REV, V6, P229, DOI 10.1177/1754073914523073; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484	39	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0112042	10.1371/journal.pone.0112042	http://dx.doi.org/10.1371/journal.pone.0112042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923332	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600001
J	Simcic, M; Smetko, A; Solkner, J; Seichter, D; Gorjanc, G; Kompan, D; Medugorac, I				Simcic, Mojca; Smetko, Anamarija; Soelkner, Johann; Seichter, Doris; Gorjanc, Gregor; Kompan, Dragomir; Medugorac, Ivica			Recovery of Native Genetic Background in Admixed Populations Using Haplotypes, Phenotypes, and Pedigree Information - Using Cika Cattle as a Case Breed	PLOS ONE			English	Article							MOLECULAR COANCESTRY; CONSERVATION VALUE; DIVERSITY; INFERENCE; MICROSATELLITE; ASSOCIATION; DENSITY; ORIGIN; SHEEP; TREES	The aim of this study was to obtain unbiased estimates of the diversity parameters, the population history, and the degree of admixture in Cika cattle which represents the local admixed breeds at risk of extinction undergoing challenging conservation programs. Genetic analyses were performed on the genome-wide Single Nucleotide Polymorphism(SNP) Illumina Bovine SNP50 array data of 76 Cika animals and 531 animals from 14 reference populations. To obtain unbiased estimates we used short haplotypes spanning four markers instead of single SNPs to avoid an ascertainment bias of the BovineSNP50 array. Genome-wide haplotypes combined with partial pedigree and type trait classification show the potential to improve identification of purebred animals with a low degree of admixture. Phylogenetic analyses demonstrated unique genetic identity of Cika animals. Genetic distance matrix presented by rooted Neighbour-Net suggested long and broad phylogenetic connection between Cika and Pinzgauer. Unsupervised clustering performed by the admixture analysis and two-dimensional presentation of the genetic distances between individuals also suggest Cika is a distinct breed despite being similar in appearance to Pinzgauer. Animals identified as the most purebred could be used as a nucleus for a recovery of the native genetic background in the current admixed population. The results show that local well-adapted strains, which have never been intensively managed and differentiated into specific breeds, exhibit large haplotype diversity. They suggest a conservation and recovery approach that does not rely exclusively on the search for the original native genetic background but rather on the identification and removal of common introgressed haplotypes would be more powerful. Successful implementation of such an approach should be based on combining phenotype, pedigree, and genome-wide haplotype data of the breed of interest and a spectrum of reference breeds which potentially have had direct or indirect historical contribution to the genetic makeup of the breed of interest.	[Simcic, Mojca; Gorjanc, Gregor; Kompan, Dragomir] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia; [Smetko, Anamarija; Soelkner, Johann] Univ Nat Resources & Life Sci Vienna, Dept Sustainable Agr Syst, Div Livestock Sci, Vienna, Austria; [Seichter, Doris] Tierzuchtforsch eV Munchen, Grub, Germany; [Medugorac, Ivica] Univ Munich, Fac Vet Med, Chair Anim Genet & Husb, Munich, Germany	University of Ljubljana; University of Natural Resources & Life Sciences, Vienna; University of Munich	Medugorac, I (corresponding author), Univ Munich, Fac Vet Med, Chair Anim Genet & Husb, Munich, Germany.	ivica.medjugorac@gen.vetmed.uni-muenchen.de	Gorjanc, Gregor/D-3684-2014	Gorjanc, Gregor/0000-0001-8008-2787; Solkner, Johann/0000-0002-1517-5829; Seichter, Doris/0000-0002-0325-1134; Medugorac, Ivica/0000-0002-6891-3039	Program for animal genetic resources conservation - Ministry of Agriculture and the Environment of Slovenia; Slovene human resources development and scholarship fund [11012-45/2012-5]; German Research Foundation (DFG, Bonn, Germany) [ME3404/2-1]; Bavarian State Ministry of Food, Agriculture and Forestry [L/a-7406-917]; Ministry of Science, Education and Sports, Croatia [178-0790466-0398]; Croatian Reproduction Centres	Program for animal genetic resources conservation - Ministry of Agriculture and the Environment of Slovenia; Slovene human resources development and scholarship fund; German Research Foundation (DFG, Bonn, Germany)(German Research Foundation (DFG)); Bavarian State Ministry of Food, Agriculture and Forestry; Ministry of Science, Education and Sports, Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Croatian Reproduction Centres	This research was partly supported by the Program for animal genetic resources conservation financed by Ministry of Agriculture and the Environment of Slovenia. M. Simcic received a scholarship from Slovene human resources development and scholarship fund (Nr. 11012-45/2012-5). Genotyping of RH, FGV, DFV, BBV, OBV and IMB cattle breeds was financially supported by the German Research Foundation (DFG, Bonn, Germany), project ME3404/2-1. Genotyping of the MWF cattle breed was financially supported by the Bavarian State Ministry of Food, Agriculture and Forestry, project L/a-7406-917. Sampling and DNA preparation of HRB, HRI and HRP were supported by the Ministry of Science, Education and Sports, Croatia (Project 178-0790466-0398) as well as Croatian Reproduction Centres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amador C, 2014, EVOL APPL, V7, P227, DOI 10.1111/eva.12113; Amador C, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-13; Amador C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049409; Amador C, 2011, CONSERV GENET, V12, P1565, DOI 10.1007/s10592-011-0255-4; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cinkulov M, 2008, J ANIM BREED GENET, V125, P417, DOI 10.1111/j.1439-0388.2008.00742.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; Decker J. E., 2013, DRYAD DIGIT REPOS, DOI DOI 10.5061/DRYAD.TH092; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Decker JE, 2009, P NATL ACAD SCI USA, V106, P18644, DOI 10.1073/pnas.0904691106; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Falush D, 2003, GENETICS, V164, P1567; FELIUS M, 2007, CATTLE BREEDS ENCY; Ferencakovic M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-42; Fernandez J, 2012, LIVEST SCI, V149, P282, DOI 10.1016/j.livsci.2012.07.019; Frkonja A, 2012, ANIM GENET, V43, P696, DOI 10.1111/j.1365-2052.2012.02345.x; Gandini GC, 2003, J ANIM BREED GENET, V120, P1, DOI 10.1046/j.1439-0388.2003.00365.x; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Gomez-Romano F, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-38; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jeretina J, 2004, 100 LET DELA SELEKCI, P79; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Lohmueller KE, 2009, GENETICS, V182, P217, DOI 10.1534/genetics.108.099275; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Maxa J, 2012, J DAIRY SCI, V95, P5357, DOI 10.3168/jds.2011-4673; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Medugorac I, 2011, ECOL EVOL, V1, P408, DOI 10.1002/ece3.39; Medugorac I, 2009, MOL ECOL, V18, P3394, DOI 10.1111/j.1365-294X.2009.04286.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 1987, MOL EVOLUTIONARY GEN; Neuditschko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048375; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Neto LRP, 2010, ANIM PROD SCI, V50, P792, DOI 10.1071/AN10073; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2018, R LANG ENV STAT COMP; Ramljak J, 2011, J ANIM BREED GENET, V128, P73, DOI 10.1111/j.1439-0388.2010.00905.x; Rothammer S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-908; Sambraus HH, 1999, GEFAHRDETE NUTZTIERR; Simcic M, 2013, J ANIM BREED GENET, V130, P487, DOI 10.1111/jbg.12034; Taberlet P, 2008, MOL ECOL, V17, P275, DOI 10.1111/j.1365-294X.2007.03475.x; Veit-Kensch CE, 2007, GENET SEL EVOL, V39, P447, DOI 10.1051/gse:2007014; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zan Lotric M, 2012, THESIS U LJUBLJANA	55	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123253	10.1371/journal.pone.0123253	http://dx.doi.org/10.1371/journal.pone.0123253			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923207	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600036
J	Wood, L; Martin, K; Christian, H; Nathan, A; Lauritsen, C; Houghton, S; Kawachi, I; McCune, S				Wood, Lisa; Martin, Karen; Christian, Hayley; Nathan, Andrea; Lauritsen, Claire; Houghton, Steve; Kawachi, Ichiro; McCune, Sandra			The Pet Factor - Companion Animals as a Conduit for Getting to Know People, Friendship Formation and Social Support	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HUMAN HEALTH; DOGS; OWNERSHIP; RELIABILITY	Background While companion animals have been previously identified as a direct source of companionship and support to their owners, their role as a catalyst for friendship formation or social support networks among humans has received little attention. This study investigated the indirect role of pets as facilitators for three dimensions of social relatedness; getting to know people, friendship formation and social support networks. Methods A telephone survey of randomly selected residents in four cities, one in Australia (Perth; n = 704) and three in the U.S. (San Diego, n = 690; Portland, n = 634; Nashville, n = 664) was conducted. All participants were asked about getting to know people within their neighborhood. Pet owners were asked additional questions about the type/s of pet/s they owned, whether they had formed friendships as a result of their pet, and if they had received any of four different types of social support from the people they met through their pet. Results Pet owners were significantly more likely to get to know people in their neighborhood than non-pet owners (OR 1.61; 95%CI: 1.30, 1.99). When analyzed by site, this relationship was significant for Perth, San Diego and Nashville. Among pet owners, dog owners in the three U.S. cities (but not Perth) were significantly more likely than owners of other types of pets to regard people whom they met through their pet as a friend (OR 2.59; 95%CI: 1.94, 3.46). Around 40% of pet owners reported receiving one or more types of social support (i.e. emotional, informational, appraisal, instrumental) via people they met through their pet. Conclusion This research suggests companion animals can be a catalyst for several dimensions of human social relationships in neighborhood settings, ranging from incidental social interaction and getting to know people, through to formation of new friendships. For many pet owners, their pets also facilitated relationships from which they derived tangible forms of social support, both of a practical and emotionally supportive nature. Given growing evidence for social isolation as a risk factor for mental health, and, conversely, friendships and social support as protective factors for individual and community well-being, pets may be an important factor in developing healthy neighborhoods.	[Wood, Lisa; Martin, Karen; Lauritsen, Claire] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Christian, Hayley] Univ Western Australia, Ctr Built Environm & Hlth, Crawley, WA, Australia; [Christian, Hayley] Telethon Kids Inst, Perth, WA, Australia; [Nathan, Andrea] Queensland Univ Technol, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia; [Houghton, Steve] Univ Western Australia, Grad Sch Educ, Crawley, WA, Australia; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Cambridge, MA USA; [McCune, Sandra] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England	University of Western Australia; University of Western Australia; Telethon Kids Institute; Queensland University of Technology (QUT); University of Western Australia; Harvard University; Harvard T.H. Chan School of Public Health; Mars; WALTHAM Petcare Science Institute	Wood, L (corresponding author), Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia.	lisa.wood@uwa.edu.au	Wood, Lisa Jane/C-1816-2012; Christian, Hayley/AAU-6163-2020; Martin, Karen/I-2048-2013	Wood, Lisa Jane/0000-0002-9196-8847; Christian, Hayley/0000-0001-8486-5746; Nathan, Andrea/0000-0002-9360-7228; Martin, Karen/0000-0003-2077-0929; Houghton, Stephen/0000-0002-6744-1068	WALTHAM Centre for Pet Nutrition	WALTHAM Centre for Pet Nutrition	This research was funded by a grant from the WALTHAM Centre for Pet Nutrition (a subsidiary of Mars Petcare). The funder had some input into the study design, but did not influence the data analysis or study findings. The interpretation of the results and the content of the manuscript remained the final decision of the authors.	Albery N, 2001, WORLDS GREATEST IDEA; Allen K, 2001, HYPERTENSION, V38, P815, DOI 10.1161/hyp.38.4.815; Allen K, 2002, ANGER HOSTILITY MARR; American Veterinary Association, 2012, 2012 US PET OWN DEM; Animal Health Alliance (Australia) Ltd, 2013, PET OWN AUSTR 2013 S; APPMA, 2011, 2011 2012 NATL PET O; Arambasic L, 2000, STUD PSYCHOL, V42, P135; Australian Bureau of Statistics, 2010, NAT REG PROF PERTH C; Beck AM, 1996, ANNU REV PUBL HEALTH, V17, P247, DOI 10.1146/annurev.pu.17.050196.001335; Brownson RC, 2004, AM J PUBLIC HEALTH, V94, P473, DOI 10.2105/AJPH.94.3.473; Caughy MO, 2003, SOC SCI MED, V57, P227, DOI 10.1016/S0277-9536(02)00342-8; Christian H, 2010, FAM COMMUNITY HEALTH, V33, P44, DOI 10.1097/FCH.0b013e3181c4e208; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Collis G, 2003, COULD ENHANCED UNPUB; Current Results Nexus, 2015, AV ANN TEMP LARG US; Cutt H, 2008, HEALTH PROMOT J AUST, V19, P38; Cutt H, 2008, PREV MED, V46, P120, DOI 10.1016/j.ypmed.2007.08.015; Cutt H, 2008, AM J PUBLIC HEALTH, V98, P66, DOI 10.2105/AJPH.2006.103499; Cutt HE, 2008, J PHYS ACT HEALTH, V5, pS73, DOI 10.1123/jpah.5.s1.s73; Cutt HE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-17; e.Rebublic, 2015, POP DENS US CIT MAP; Edney ATB, 1995, J ROY SOC MED, V88, pP704; Edwards V, 2006, UNDERSTANDING PSYCHO; FRIEDMANN E, 1995, AM J CARDIOL, V76, P1213, DOI 10.1016/S0002-9149(99)80343-9; Headey B, 2008, SOC INDIC RES, V87, P481, DOI 10.1007/s11205-007-9142-2; Headey B, 2007, SOC INDIC RES, V80, P297, DOI 10.1007/s11205-005-5072-z; Hirschauer S, 2005, J THEOR SOC BEHAV, V35, P41, DOI 10.1111/j.0021-8308.2005.00263.x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; House JS, 1981, WORK STRESS SOCIAL S; HUNT SJ, 1992, J SOC PSYCHOL, V132, P245, DOI 10.1080/00224545.1992.9922976; ISRAEL BA, 1985, HEALTH EDUC QUART, V12, P65, DOI 10.1177/109019818501200106; Jofré M. Leonor, 2005, Rev. chil. infectol., V22, P257; Kazdin A.E., 2011, SINGLE CASE RES DESI, V2nd; Knight S, 2008, J AGING HEALTH, V20, P437, DOI 10.1177/0898264308315875; Landolt P., 1996, AM PROSPECT; Leigh A, 2011, DISCONNECTED; Mackay H, 2013, WHAT MAKES US TICK 1; McHarg M., 1995, NATL PEOPLE PETS SUR; McNicholas J, 2000, BRIT J PSYCHOL, V91, P61, DOI 10.1348/000712600161673; McNicholas J., 2006, HDB ANIMAL ASSISTED, P49; Messent P.R., 1983, NEW PERSPECTIVES OUR, P37; Mulcahy C, 2013, REV EVIDENCE PRISON; Newby J, 1997, PACT SURVIVAL HUMANS; Patterson ML, 2002, BASIC APPL SOC PSYCH, V24, P57, DOI 10.1207/S15324834BASP2401_5; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Petcare, 2015, WHAT IS PETS CIT; Podberscek AL, 2000, RELATIONSHIPS PEOPLE; Putnam R.D., 2004, BETTER TOGETHER REST; Qureshi Adnan I, 2009, J Vasc Interv Neurol, V2, P132; ROBINS DM, 1991, J CONTEMP ETHNOGR, V20, P3, DOI 10.1177/089124191020001001; ROGERS J, 1993, J SOC PSYCHOL, V133, P265, DOI 10.1080/00224545.1993.9712145; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Shrapnel B, 2006, CONTRIBUTION PET CAR; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Turner D. C, 1998, COMPANION ANIMALS HU, P3; U. S. Census Bureau, 2012, AM FACT FIND; U.S. Census Bureau, 2010, AM FACT FIND; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Walljasper J., 2007, GREAT NEIGHBORHOOD B; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284; Wood L, 2005, SOC SCI MED, V61, P1159, DOI 10.1016/j.socscimed.2005.01.017; Wood L, 2012, STREETS APART DOES S; Wood L, 2006, THESIS U W AUSTR; Wood LJ, 2007, SOC ANIM, V15, P43, DOI 10.1163/156853007X169333; Wood LL, 2011, NEW DIR HUM-ANIM BON, P51; Young R, 2009, USING SOCIAL NETWORK	66	127	128	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122085	10.1371/journal.pone.0122085	http://dx.doi.org/10.1371/journal.pone.0122085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25924013	Green Published, gold			2022-12-26	WOS:000353711600009
J	Lee, WC				Lee, Wen-Chung			Excess Relative Risk as an Effect Measure in Case-Control Studies of Rare Diseases	PLOS ONE			English	Article							SUFFICIENT CAUSE INTERACTIONS; ATOMIC-BOMB SURVIVORS; CANCER INCIDENCE; MODELS	Epidemiologists often use ratio-type indices (rate ratio, risk ratio and odds ratio) to quantify the association between exposure and disease. By comparison, less attention has been paid to effect measures on a difference scale (excess rate or excess risk). The excess relative risk (ERR) used primarily by radiation epidemiologists is of peculiar interest here, in that it involves both difference and ratio operations. The ERR index (but not the difference-type indices) is estimable in case-control studies. Using the theory of sufficient component cause model, the author shows that when there is no mechanistic interaction (no synergism in the sufficient cause sense) between the exposure under study and the stratifying variable, the ERR index (but not the ratio-type indices) in a rare-disease case-control setting should remain constant across strata and can therefore be regarded as a common effect parameter. By exploiting this homogeneity property, the related attributable fraction indices can also be estimated with greater precision. The author demonstrates the methodology (SAS codes provided) using a case-control dataset, and shows that ERR preserves the logical properties of the ratio-type indices. In light of the many desirable properties of the ERR index, the author advocates its use as an effect measure in case-control studies of rare diseases.	[Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		Lee, Wen-Chung/0000-0003-3171-7672	Ministry of Science and Technology, Taiwan [NSC 102-2628-B-002-036-MY3]; National Taiwan University, Taiwan [NTU-CESRP-102R7622-8]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	Funding: This paper is partly supported by grants from the Ministry of Science and Technology, Taiwan (NSC 102-2628-B-002-036-MY3) and the National Taiwan University, Taiwan (NTU-CESRP-102R7622-8). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	HOGUE CJR, 1983, AM J EPIDEMIOL, V118, P396, DOI 10.1093/oxfordjournals.aje.a113646; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Langholz B, 2010, AM J EPIDEMIOL, V171, P377, DOI 10.1093/aje/kwp403; Lee WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086374; Lee WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067424; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Richardson DB, 2008, AM J EPIDEMIOL, V168, P1333, DOI 10.1093/aje/kwn278; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SHAPIRO S, 1979, LANCET, V1, P743; Suissa S, 1999, AM J EPIDEMIOL, V150, P279; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Vanderweele TJ, 2008, BIOMETRIKA, V95, P49, DOI 10.1093/biomet/asm090; VanderWeele TJ, 2007, EPIDEMIOLOGY, V18, P329, DOI 10.1097/01.ede.0000260218.66432.88; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P6, DOI 10.1097/EDE.0b013e31818f69e7	15	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121141	10.1371/journal.pone.0121141	http://dx.doi.org/10.1371/journal.pone.0121141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919483	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400005
J	Hartmann, M; Parra, LM; Ruschel, A; Lindner, C; Morrison, H; Herrlich, A; Herrlich, P				Hartmann, Monika; Parra, Liseth M.; Ruschel, Anne; Lindner, Christina; Morrison, Helen; Herrlich, Andreas; Herrlich, Peter			Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; GROWTH-FACTOR RECEPTOR; NECROSIS-FACTOR-ALPHA; BREAST-CANCER CELLS; EGF RECEPTOR; TRANSMEMBRANE DOMAIN; SIGNALING PATHWAYS; STRUCTURAL BASIS; CARCINOMA-CELLS; LIGAND RELEASE	Ectodomain shedding of transmembrane precursor proteins generates numerous life-essential molecules, such as epidermal growth factor receptor ligands. This cleavage not only releases the regulatory growth factor, but it is also the required first step for the subsequent processing by gamma-secretase and the release of gene regulatory intracellular fragments. Signaling within the cell modifies the cytoplasmic tails of substrates, a step important in starting the specific and regulated cleavage of a large number of studied substrates. Ectodomain cleavage occurs, however, on the outside of the plasma membrane and is carried out by membrane-bound metalloproteases. How the intracellular domain modification communicates with the ectodomain of the substrate to allow for cleavage to occur is unknown. Here, we show that homodimerization of a cluster-of-differentiation-44 or of pro-neuregulin-1 monomers represents an essential precondition for their regulated ectodomain cleavage. Both substrates are associated with their respective metalloproteases under both basal or cleavage-stimulated conditions. These interactions only turn productive by specific intracellular signal-induced intracellular domain modifications of the substrates, which in turn regulate metalloprotease access to the substrates' ectodomain and cleavage. We propose that substrate intracellular domain modification induces a relative rotation or other positional change of the dimerization partners that allow metalloprotease cleavage in the extracellular space. Our findings fill an important gap in understanding substrate-specific inside-out signal transfer along cleaved transmembrane proteins and suggest that substrate dimerization (homo-or possibly heterodimerization) might represent a general principle in ectodomain shedding.	[Hartmann, Monika; Parra, Liseth M.; Ruschel, Anne; Lindner, Christina; Morrison, Helen; Herrlich, Peter] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Parra, Liseth M.; Herrlich, Andreas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Harvard Inst Med,Renal Div, Boston, MA 02115 USA	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Herrlich, P (corresponding author), Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany.	herrlich@fli-leibniz.de	Morrison, Helen/B-3984-2017; Morrison, Helen/F-9748-2014	Morrison, Helen/0000-0003-4938-1409; Morrison, Helen/0000-0003-4938-1409	National Institutes of Health from NIDDK [R00DK077731]; Ernst- Jung Foundation; German Research Foundation [DFGHE551]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK077731] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Ernst- Jung Foundation; German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R00DK077731 from NIDDK (to A. H.). This work was also supported by our institutions. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the Ernst- Jung Foundation.; Supported by Grant DFGHE551 from the German Research Foundation.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; BAZIL V, 1992, J IMMUNOL, V149, P747; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Dang M, 2013, P NATL ACAD SCI USA, V110, P9776, DOI 10.1073/pnas.1307478110; Dang M, 2011, J BIOL CHEM, V286, P17704, DOI 10.1074/jbc.M110.187823; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hartmann M., 2015, MOL CANCER RES, V13, P1; Hartmann M, 2013, TRENDS BIOCHEM SCI, V38, P111, DOI 10.1016/j.tibs.2012.12.002; Herrlich A, 2008, FASEB J, V22, P4281, DOI 10.1096/fj.08-113852; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Klein T, 2011, J PROTEOME RES, V10, P17, DOI 10.1021/pr100556z; Kosel D, 2010, J CELL SCI, V123, P1320, DOI 10.1242/jcs.057919; Koumangoye RB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-167; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu DC, 1997, J IMMUNOL, V159, P2702; Liu QR, 2004, BIOCHEM J, V377, P171, DOI 10.1042/BJ20030128; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Melis M, 2003, AM J RESP CRIT CARE, V167, P1131, DOI 10.1164/rccm.200207-654OC; Meloty-Kapella L, 2012, DEV CELL, V22, P1299, DOI 10.1016/j.devcel.2012.04.005; Mendelson K, 2010, J BIOL CHEM, V285, P25024, DOI 10.1074/jbc.M110.102566; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Okimoto T, 2001, MOL THER, V4, P232, DOI 10.1006/mthe.2001.0443; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Schulz A, 2010, J NEUROSCI, V30, P10177, DOI 10.1523/JNEUROSCI.0840-10.2010; Schwarz J, 2013, BBA-MOL CELL RES, V1833, P3355, DOI 10.1016/j.bbamcr.2013.10.005; Sleeman JP, 1997, J BIOL CHEM, V272, P31837, DOI 10.1074/jbc.272.50.31837; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Tsukamoto H, 2013, INFLAMM BOWEL DIS, V19, P1365, DOI 10.1097/MIB.0b013e318281f43a; van der Vorst EPC, 2012, ATHEROSCLEROSIS, V224, P302, DOI 10.1016/j.atherosclerosis.2012.04.023; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wild-Bode C, 2006, J BIOL CHEM, V281, P23824, DOI 10.1074/jbc.M601542200; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	72	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17041	17054		10.1074/jbc.M114.610204	http://dx.doi.org/10.1074/jbc.M114.610204			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25925953	hybrid, Green Published			2022-12-26	WOS:000357730900001
J	Ho, WM; Chen, CM; Lee, YS; Chang, KH; Chen, HW; Chen, ST; Chen, YC				Ho, Wei-Min; Chen, Chiung-Mei; Lee, Yun-Shien; Chang, Kuo-Hsuan; Chen, Huei-Wen; Chen, Sien-Tsong; Chen, Yi-Chun			Association of MMP-9 Haplotypes and TIMP-1 Polymorphism with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; DUAL ROLE; MATRIX-METALLOPROTEINASE-9; GENE; DIAGNOSIS; PROTECTS; BLACKS; STROKE; WHITES; RISK	Background Spontaneous deep intracerebral hemorrhage (SDICH) is a devastating stroke subtype. The causes of SDICH are heterogeneous. Matrix metalloproteinase-9 (MMP-9, Gelantinase B) has been shown to relate to stroke and the development of aneurysm and may increase risks of intracerebral hemorrhage. MMP activities are modulated by their endogenous inhibitors, tissue inhibitors of metalloproteinases (TIMPs). We analyzed the genetic variants of MMP-9 and TIMP-1 and SDICH susceptibility. Methods Associations were tested by logistic regression or general linear models with adjusting for multiple covariables. Multiplicative terms between genes were applied to detect the interaction effects on SDICH. Permutation testing of 1,000 replicates was performed for empirical estimates. Results In the group of >= 65 years old (y/o), we found associations of SDICH with rs3787268 (Odds ratio [OR] = 0.48, 95% confidence interval [CI] 0.27 to 0.86, P = 0.01) and haplotype1 (Hap1) (OR = 0.48, 95% CI 0.26 to 0.86, P = 0.014). For TIMP1 gene, rs4898 was associated with SDICH in the elder male group (OR = 0.35, 95% CI 0.15 to 0.81, P = 0.015). In contrast, in the younger male group, there were associations of SDICH with rs2250889 (OR = 0.48, 95% CI 0.27 to 0.84, P = 0.01) and Hap3 (OR = 0.61, 95% CI 0.38 to 0.97, P = 0.04). We found significant genetic interaction between TIMP-1 and MMP-9 in SDICH susceptibility among younger male subjects (P = 0.004). In subjects carrying rs4898 minor allele, carriers with Hap3 had lower SDICH risk than non-carriers (OR = 0.19, 95% CI 0.07 to 0.51, P = 0.001). In addition, this study showed that when young males were exposed to alcohol, Hap3 was a protective factor of SDICH (OR = 0.06, 95% CI 0.01 to 0.27, P = 0.0002). In contrast, when they were exposed to smoke, Hap2 carriers had increased risk of SDICH (OR = 2.45, 95% CI 1.05 to 5.73, P = 0.04). Conclusions This study showed modest to moderate effects of MMP-9 and TIMP-1 polymorphisms on SDICH risks with significant age differences. MMP-9 may interact with alcohol to play a role in the SDICH risk in young men.	[Ho, Wei-Min] Chang Gung Mem Hosp, Dept Neurol, Keelung, Taiwan; [Ho, Wei-Min; Chen, Chiung-Mei; Chang, Kuo-Hsuan; Chen, Huei-Wen; Chen, Sien-Tsong; Chen, Yi-Chun] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chen, Chiung-Mei; Chang, Kuo-Hsuan; Chen, Huei-Wen; Chen, Sien-Tsong; Chen, Yi-Chun] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Lee, Yun-Shien] Chang Gung Mem Hosp, Genom Med Res Core Lab, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Ming Chuan University; Chang Gung Memorial Hospital	Chen, YC (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan.	asd108@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		National Science Council in Taiwan [NSC 101-2314-B-182A-064, 103-2314-B-182A-027]; Chang Gung Memorial Hospital, Taiwan [CMRPG3A0291, CMRPG3C174]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	All funding for this study was provided by the National Science Council in Taiwan (NSC 101-2314-B-182A-064, 103-2314-B-182A-027) and by Chang Gung Memorial Hospital, Taiwan (CMRPG3A0291 and CMRPG3C174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chang JJ, 2014, J STROKE CEREBROVASC, V23, P2498, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.005; Chang KP, 2007, ORAL ONCOL, V43, P345, DOI 10.1016/j.oraloncology.2006.04.006; Chen YC, 2006, CEREBROVASC DIS, V22, P33, DOI 10.1159/000092335; Chen YC, 2009, CLIN CHIM ACTA, V408, P128, DOI 10.1016/j.cca.2009.08.004; Chyatte D, 1997, STROKE, V28, P799, DOI 10.1161/01.STR.28.4.799; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Flaherty ML, 2006, NEUROLOGY, V66, P956, DOI 10.1212/01.wnl.0000218670.19577.4c; Florczak-Rzepka M, 2012, CEREBROVASC DIS, V34, P249, DOI 10.1159/000341686; Gaetani P, 1999, NEUROL RES, V21, P385, DOI 10.1080/01616412.1999.11740948; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Hashimoto T, 2003, STROKE, V34, P925, DOI 10.1161/01.STR.0000061888.71524.DF; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Labovitz DL, 2005, NEUROLOGY, V65, P518, DOI 10.1212/01.wnl.0000172915.71933.00; Lee CHZ, 2007, STROKE, V38, P2563, DOI 10.1161/STROKEAHA.106.481515; Lin HY, 2008, EUR J HUM GENET, V16, P735, DOI 10.1038/sj.ejhg.5202010; Lorente L, 2013, CRIT CARE, V17, DOI 10.1186/cc12739; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Nevzati Edin, 2015, Acta Neurochir Suppl, V120, P141, DOI 10.1007/978-3-319-04981-6_24; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Prevention UCfDCa Health behaviors of adults: United States, 2005, VITAL AND HEALTH STA, V10, P80; Saenger AK, 2010, CLIN CHEM, V56, P21, DOI 10.1373/clinchem.2009.133801; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tada Y, 2014, HYPERTENSION, V63, P1339, DOI 10.1161/HYPERTENSIONAHA.114.03300; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Todor DR, 1998, STROKE, V29, P1580, DOI 10.1161/01.STR.29.8.1580; Wang HX, 2014, INT J NEUROSCI, V124, P61, DOI 10.3109/00207454.2013.823604; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yang J, 2014, J NEUROL SCI, V341, P55, DOI 10.1016/j.jns.2014.03.049; Zhang BP, 1999, CIRCULATION, V99, P1788, DOI 10.1161/01.CIR.99.14.1788; Zheng Y, 2015, STROKE, V46, P485, DOI 10.1161/STROKEAHA.114.006372	38	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125397	10.1371/journal.pone.0125397	http://dx.doi.org/10.1371/journal.pone.0125397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932641	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100106
J	Kosinska, MK; Ludwig, TE; Liebisch, G; Zhang, RY; Siebert, HC; Wilhelm, J; Kaesser, U; Dettmeyer, RB; Klein, H; Ishaque, B; Rickert, M; Schmitz, G; Schmidt, TA; Steinmeyer, J				Kosinska, Marta Krystyna; Ludwig, Taryn E.; Liebisch, Gerhard; Zhang, Ruiyan; Siebert, Hans-Christian; Wilhelm, Jochen; Kaesser, Ulrich; Dettmeyer, Reinhard B.; Klein, Heiko; Ishaque, Bernd; Rickert, Markus; Schmitz, Gerd; Schmidt, Tannin A.; Steinmeyer, Juergen			Articular Joint Lubricants during Osteoarthritis and Rheumatoid Arthritis Display Altered Levels and Molecular Species	PLOS ONE			English	Article							SYNOVIAL-FLUID; BOUNDARY LUBRICATION; HYALURONIC-ACID; PROTEOGLYCAN 4; CARTILAGE; WEIGHT; PHOSPHOLIPASE; EXPRESSION; DISEASE; KNEE	Background Hyaluronic acid (HA), lubricin, and phospholipid species (PLs) contribute independently or together to the boundary lubrication of articular joints that is provided by synovial fluid (SF). Our study is the first reporting quantitative data about the molecular weight (MW) forms of HA, lubricin, and PLs in SF from cohorts of healthy donors, patients with early (eOA)- or late (lOA)-stage osteoarthritis (OA), and patients with active rheumatoid arthritis (RA). Methods We used human SF from unaffected controls, eOA, lOA, and RA. HA and lubricin levels were measured by enzyme-linked immunosorbent assay. PLs was quantified by electrospray ionization tandem mass spectrometry. Fatty acids (FAs) were analyzed by gas chromatography, coupled with mass spectrometry. The MW distribution of HA was determined by agarose gel electrophoresis. Results Compared with control SF, the concentrations of HA and lubricin were lower in OA and RA SF, whereas those of PLs were higher in OA and RA SF. Moreover, the MW distribution of HA shifted toward the lower ranges in OA and RA SF. We noted distinct alterations between cohorts in the relative distribution of PLs and the degree of FA saturation and chain lengths of FAs. Conclusions The levels, composition, and MW distribution of all currently known lubricants in SF-HA, lubricin, PLs-vary with joint disease and stage of OA. Our study is the first delivering a comprehensive view about all joint lubricants during health and widespread joint diseases. Thus, we provide the framework to develop new optimal compounded lubricants to reduce joint destruction.	[Kosinska, Marta Krystyna; Klein, Heiko; Ishaque, Bernd; Rickert, Markus; Steinmeyer, Juergen] Univ Giessen, Dept Orthoped, Orthoped Res Labs, D-35390 Giessen, Germany; [Ludwig, Taryn E.; Schmidt, Tannin A.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Ludwig, Taryn E.; Schmidt, Tannin A.] Univ Calgary, Biomed Engn Grad Program, Calgary, AB T2N 1N4, Canada; [Liebisch, Gerhard; Schmitz, Gerd] Univ Hosp, Dept Clin Chem & Lab Med, Regensburg, Germany; [Zhang, Ruiyan; Siebert, Hans-Christian] RI B NT Res Inst Bioinformat & Nanotechnol, Kiel, Germany; [Zhang, Ruiyan] Univ Kiel, Inst Zool, Ctr Biochem & Mol Biol, Struct Biol, D-24098 Kiel, Germany; [Wilhelm, Jochen] Univ Giessen, Med Clin 2 4, D-35390 Giessen, Germany; [Kaesser, Ulrich] Internist Praxiszentrum Krankenhaus Balser Stiftu, Giessen, Germany; [Dettmeyer, Reinhard B.] Univ Giessen, Inst Forens Med, D-35390 Giessen, Germany	Justus Liebig University Giessen; University of Calgary; University of Calgary; University of Regensburg; University of Kiel; Justus Liebig University Giessen; Justus Liebig University Giessen	Steinmeyer, J (corresponding author), Univ Giessen, Dept Orthoped, Orthoped Res Labs, D-35390 Giessen, Germany.	juergen.steinmeyer@ortho.med.uni-giessen.de	Schmidt, Tannin/AAE-3830-2019; Liebisch, Gerhard/G-6130-2010; Zhang, Ruiyan/HHC-5329-2022; Wilhelm, Jochen/AAX-4302-2021; Rickert, Markus/D-8731-2017	Liebisch, Gerhard/0000-0003-4886-0811; Wilhelm, Jochen/0000-0001-5544-9647; Rickert, Markus/0000-0001-7681-9918; Schmitz, Gerd/0000-0002-1325-1007; Steinmeyer, Juergen/0000-0002-4053-503X	DRB foundation; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Health Solutions; "LipidomicNet" project - Seventh Framework Programme of the European Union [202272]; Alberta Innovates [201400618] Funding Source: researchfish	DRB foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Health Solutions; "LipidomicNet" project - Seventh Framework Programme of the European Union; Alberta Innovates	Supported in part by a grant of the DRB foundation, the Natural Sciences and Engineering Research Council of Canada, and Alberta Innovates Health Solutions, and by the "LipidomicNet" project, funded within the Seventh Framework Programme of the European Union (Grant agreement number 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2010, CURR PHARM DESIGN, V16, P631, DOI 10.2174/138161210790883859; Antonacci JM, 2012, ARTHRITIS RHEUM-US, V64, P2917, DOI 10.1002/art.34520; ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315; Barton KI, 2013, J ORTHOP RES, V31, P1549, DOI 10.1002/jor.22399; Brockmeier SF, 2006, SPORTS MED ARTHROSC, V14, P155, DOI 10.1097/00132585-200609000-00007; Chen Y, 2007, J ORTHOP SURG RES, V2, P14; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; Dunn S, 2009, PATHOBIOLOGY, V76, P322, DOI 10.1159/000245898; Ecker J, 2012, J CHROMATOGR B, V897, P98, DOI 10.1016/j.jchromb.2012.04.015; Elsaid KA, 2007, ARTHRITIS RHEUM, V56, P108, DOI 10.1002/art.22321; Estrella RP, 2010, BIOCHEM J, V429, P359, DOI 10.1042/BJ20100360; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Ghosh P, 2002, SEMIN ARTHRITIS RHEU, V32, P10, DOI 10.1053/sarh.2002.33720; Goldberg VM, 2005, OSTEOARTHR CARTILAGE, V13, P216, DOI 10.1016/j.joca.2004.11.010; Hills BA, 2003, J ARTHROPLASTY, V18, P499, DOI 10.1016/S0883-5403(03)00072-X; Hills BA, 2002, J RHEUMATOL, V29, P200; Hills BA, 1998, BRIT J RHEUMATOL, V37, P137, DOI 10.1093/oxfordjournals.rheumatology.a031463; Hui AY, 2012, WIRES SYST BIOL MED, V4, P15, DOI 10.1002/wsbm.157; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Jay GD, 1999, J RHEUMATOL, V26, P2454; Jay GD, 2000, J RHEUMATOL, V27, P594; Jay GD, 2007, ARTHRITIS RHEUM-US, V56, P3662, DOI 10.1002/art.22974; Kataoka Y, 2013, BIOCHEM BIOPH RES CO, V432, P580, DOI 10.1016/j.bbrc.2013.02.043; Kosinska MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091769; Kosinska MK, 2013, ARTHRITIS RHEUM-US, V65, P2323, DOI 10.1002/art.38053; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Lord MS, 2012, CONNECT TISSUE RES, V53, P132, DOI 10.3109/03008207.2011.614364; Ludwig TE, 2012, ARTHRITIS RHEUM-US, V64, P3963, DOI 10.1002/art.34674; Mirea DA, 2013, TRIBOL INT, V59, P302, DOI 10.1016/j.triboint.2012.06.015; Murano E, 2011, NAT PROD COMMUN, V6, P555; Nitzan DW, 2001, RHEUMATOLOGY, V40, P336, DOI 10.1093/rheumatology/40.3.336; OUTERBRIDGE RE, 1961, J BONE JOINT SURG BR, V43, P752; PasqualiRonchetti I, 1997, J STRUCT BIOL, V120, P1, DOI 10.1006/jsbi.1997.3908; Sarma AV, 2001, J ORTHOP RES, V19, P671, DOI 10.1016/S0736-0266(00)00064-4; Scanzello CR, 2009, OSTEOARTHR CARTILAGE, V17, P1040, DOI 10.1016/j.joca.2009.02.011; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; Schmidt TA, 2009, BBA-GEN SUBJECTS, V1790, P375, DOI 10.1016/j.bbagen.2009.03.016; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; Schwarz IM, 1996, BRIT J RHEUMATOL, V35, P821; Schwarz IM, 1998, BRIT J RHEUMATOL, V37, P21; Sun YL, 2008, J ORTHOP RES, V26, P1225, DOI 10.1002/jor.20624; Temple-Wong MM, 2010, T ORTHOP RES SOC, V56, P340; Trunfio-Sfarghiu AM, 2008, LANGMUIR, V24, P8765, DOI 10.1021/la8005234; Waller KA, 2013, P NATL ACAD SCI USA, V110, P5852, DOI 10.1073/pnas.1219289110	48	95	101	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125192	10.1371/journal.pone.0125192	http://dx.doi.org/10.1371/journal.pone.0125192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933137	Green Published, gold			2022-12-26	WOS:000353887100089
J	Lei, BY; Tan, EL; Chen, SP; Zhuo, L; Li, SL; Ni, D; Wang, TF				Lei, Baiying; Tan, Ee-Leng; Chen, Siping; Zhuo, Liu; Li, Shengli; Ni, Dong; Wang, Tianfu			Automatic Recognition of Fetal Facial Standard Plane in Ultrasound Image via Fisher Vector	PLOS ONE			English	Article							CLASSIFICATION	Acquisition of the standard plane is the prerequisite of biometric measurement and diagnosis during the ultrasound (US) examination. In this paper, a new algorithm is developed for the automatic recognition of the fetal facial standard planes (FFSPs) such as the axial, coronal, and sagittal planes. Specifically, densely sampled root scale invariant feature transform (RootSIFT) features are extracted and then encoded by Fisher vector (FV). The Fisher network with multi-layer design is also developed to extract spatial information to boost the classification performance. Finally, automatic recognition of the FFSPs is implemented by support vector machine (SVM) classifier based on the stochastic dual coordinate ascent (SDCA) algorithm. Experimental results using our dataset demonstrate that the proposed method achieves an accuracy of 93.27% and a mean average precision (mAP) of 99.19% in recognizing different FFSPs. Furthermore, the comparative analyses reveal the superiority of the proposed method based on FV over the traditional methods.	[Lei, Baiying; Chen, Siping; Zhuo, Liu; Ni, Dong; Wang, Tianfu] Shenzhen Univ, Sch Med, Dept Biomed Engn,Guangdong Key Lab Biomed Measure, Natl Reg Key Technol Engn Lab Med Ultrasound, Shenzhen 518060, Guangdong, Peoples R China; [Li, Shengli] Nanfang Med Univ, Affiliated Shenzhen Maternal & Child Healthcare, Dept Ultrasound, Shenzhen, Peoples R China; [Tan, Ee-Leng] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore	Shenzhen University; Southern Medical University - China; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ni, D (corresponding author), Shenzhen Univ, Sch Med, Dept Biomed Engn,Guangdong Key Lab Biomed Measure, Natl Reg Key Technol Engn Lab Med Ultrasound, Nanhai Ave 3688, Shenzhen 518060, Guangdong, Peoples R China.	nidong@szu.edu.cn; tfwang@szu.edu.cn	CHEN, SI/GZL-4800-2022; Lei, Baiying/GRE-9741-2022; Lei, Baiying/AAY-5515-2020	Lei, Baiying/0000-0002-3087-2550; Lei, Baiying/0000-0002-3087-2550; Wang, Tianfu/0000-0002-1248-1214	National Natural Science Foundation of China [61402296, 61101026, 61372006, 81270707, 61427806]; China Postdoctoral Science Foundation [2013M540663, 2014T70824]; National Natural Science Foundation of Guangdong Province [S2013040014448]; 48th Scientific Research Foundation for the Returned Overseas Chinese Scholars, Shenzhen Key Basic Research Project [JCYJ20130329105033277]; Shenzhen-Hong Kong Innovation Circle Funding Program [JSE201109150013A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); 48th Scientific Research Foundation for the Returned Overseas Chinese Scholars, Shenzhen Key Basic Research Project(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Shenzhen-Hong Kong Innovation Circle Funding Program	This work was supported partly by National Natural Science Foundation of China (Nos. 61402296, 61101026, 61372006, 81270707 and 61427806), China Postdoctoral Science Foundation Funded Project (No. 2013M540663 and No. 2014T70824), National Natural Science Foundation of Guangdong Province (No. S2013040014448), 48th Scientific Research Foundation for the Returned Overseas Chinese Scholars, Shenzhen Key Basic Research Project (No. JCYJ20130329105033277), and Shenzhen-Hong Kong Innovation Circle Funding Program (No. JSE201109150013A).	Abuhamad A, 2008, ULTRASOUND OBST GYN, V31, P30, DOI 10.1002/uog.5228; Agarwal D, 2013, I S BIOMED IMAGING, P1368; Arandjelovic R, 2012, PROC CVPR IEEE, P2911, DOI 10.1109/CVPR.2012.6248018; Aschkenasy SV, 2006, ULTRASOUND MED BIOL, V32, P1047, DOI 10.1016/j.ultrasmedbio.2006.03.010; Carneiro G, 2008, IEEE T MED IMAGING, V27, P1342, DOI 10.1109/TMI.2008.928917; Chen B., 2013, IEEE T PATTERN ANAL, V35; Cinbis R., 2013, P INT C COMP VIS; Cuingnet R, 2013, I S BIOMED IMAGING, P768; Gorelick L, 2013, IEEE T MED IMAGING, V32, P1804, DOI 10.1109/TMI.2013.2265334; Guo ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088073; Jegou H, 2012, IEEE T PATTERN ANAL, V34, P1704, DOI 10.1109/TPAMI.2011.235; Jia YQ, 2009, IEEE T NEURAL NETWOR, V20, P729, DOI 10.1109/TNN.2009.2015760; Kumar R, 2009, PROC CVPR IEEE, P723, DOI 10.1109/CVPRW.2009.5206838; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Lei B, 2014, P IEEE INT S BIOM IM; Ni D, 2013, LECT NOTES COMPUT SC, V8198, P203, DOI 10.1007/978-3-642-41083-3_23; Ni D, 2013, I S BIOMED IMAGING, P772; Nie F. P., 2014, P INT C MACH LEARN; Nie FP, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P993; Rahmatullah B, 2012, LECT NOTES COMPUT SC, V7512, P402, DOI 10.1007/978-3-642-33454-2_50; Rahmatullah B, 2011, LECT NOTES COMPUT SC, V7009, P35, DOI 10.1007/978-3-642-24319-6_5; Roy A, 2008, IEEE T INF TECHNOL B, V12, P366, DOI 10.1109/TITB.2007.910352; Sanchez Garcia J. A., 2013, Insecta Mundi, P1; Shalev-Shwartz S, 2013, J MACH LEARN RES, V14, P567; Shalev-Shwartz S, 2011, MATH PROGRAM, V127, P3, DOI 10.1007/s10107-010-0420-4; Shen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082409; Simonyan K., 2013, NEURAL INFORM PROCES, P163; Simonyan K, 2013, P BMVC; Vedaldi A, 2012, IEEE T PATTERN ANAL, V34, P480, DOI 10.1109/TPAMI.2011.153; Wein WG, 2008, MED IMAGE ANAL, V12, P577, DOI 10.1016/j.media.2008.06.006; Wu H, 2013, I S BIOMED IMAGING, P752; Zhang L, 2012, MED PHYS, V39, P5015, DOI 10.1118/1.4736415; Zhou S. K., 2006, P IEEE COMP SOC C CO, V2, P1559, DOI DOI 10.1109/CVPR.2006.146	34	22	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0121838	10.1371/journal.pone.0121838	http://dx.doi.org/10.1371/journal.pone.0121838			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933215	gold, Green Published			2022-12-26	WOS:000353887100005
J	Sanzey, M; Rahim, SAA; Oudin, A; Dirkse, A; Kaoma, T; Vallar, L; Herold-Mende, C; Bjerkvig, R; Golebiewska, A; Niclou, SP				Sanzey, Morgane; Rahim, Siti Aminah Abdul; Oudin, Anais; Dirkse, Anne; Kaoma, Tony; Vallar, Laurent; Herold-Mende, Christel; Bjerkvig, Rolf; Golebiewska, Anna; Niclou, Simone P.			Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma	PLOS ONE			English	Article							LARGE GENE LISTS; STEM-LIKE CELLS; PYRUVATE-KINASE; TUMOR-GROWTH; CANCER; BRAIN; HEXOKINASE; HYPOXIA; NORMALIZATION; MITOCHONDRIA	Major efforts have been put in anti-angiogenic treatment for glioblastoma (GBM), an aggressive and highly vascularized brain tumor with dismal prognosis. However clinical outcome with anti-angiogenic agents has been disappointing and tumors quickly develop escape mechanisms. In preclinical GBM models we have recently shown that bevacizumab, a blocking antibody against vascular endothelial growth factor, induces hypoxia in treated tumors, which is accompanied by increased glycolytic activity and tumor invasiveness. Genomewide transcriptomic analysis of patient derived GBM cells including stem cell lines revealed a strong up-regulation of glycolysis-related genes in response to severe hypoxia. We therefore investigated the importance of glycolytic enzymes in GBM adaptation and survival under hypoxia, both in vitro and in vivo. We found that shRNA-mediated attenuation of glycolytic enzyme expression interfered with GBM growth under normoxic and hypoxic conditions in all cellular models. Using intracranial GBM xenografts we identified seven glycolytic genes whose knockdown led to a dramatic survival benefit in mice. The most drastic effect was observed for PFKP ( PFK1, +21.8%) and PDK1 (+20.9%), followed by PGAM1 and ENO1 (+14.5% each), HK2 (+11.8%), ALDOA (+10.9%) and ENO2 (+7.2%). The increase in mouse survival after genetic interference was confirmed using chemical inhibition of PFK1 with clotrimazole. We thus provide a comprehensive analysis on the importance of the glycolytic pathway for GBM growth in vivo and propose PFK1 and PDK1 as the most promising therapeutic targets to address the metabolic escape mechanisms of GBM.	[Sanzey, Morgane; Rahim, Siti Aminah Abdul; Oudin, Anais; Dirkse, Anne; Bjerkvig, Rolf; Golebiewska, Anna; Niclou, Simone P.] Luxembourg Inst Hlth, Dept Oncol, NorLux Neurooncol Lab, Luxembourg, Luxembourg; [Kaoma, Tony; Vallar, Laurent] Luxembourg Inst Hlth, Genom Res Unit, Luxembourg, Luxembourg; [Herold-Mende, Christel] Heidelberg Univ, Dept Neurosurg, Expt Neurosurg, Heidelberg, Germany; [Bjerkvig, Rolf] Univ Bergen, Dept Biomed, NorLux Neurooncol Lab, Bergen, Norway; [Bjerkvig, Rolf; Niclou, Simone P.] Univ Bergen, Dept Biomed, KG Jebsen Brain Tumour Res Ctr, Bergen, Norway	Luxembourg Institute of Health; Luxembourg Institute of Health; Ruprecht Karls University Heidelberg; University of Bergen; University of Bergen	Niclou, SP (corresponding author), Luxembourg Inst Hlth, Dept Oncol, NorLux Neurooncol Lab, Luxembourg, Luxembourg.	simone.niclou@lih.lu	Golebiewska, Anna/E-1332-2015; Niclou, Simone/P-2304-2018	Golebiewska, Anna/0000-0002-4160-2521; Niclou, Simone/0000-0002-3417-9534; Dirkse, Anne/0000-0003-0778-6651; Vallar, Laurent/0000-0002-4404-1010; Oudin, Anais/0000-0001-5552-9823	Fonds National de la Recherche (FNR) of Luxembourg [ESCAPE 784322 BM]; AFR; Centre de Recherche Public de la Sante (CRP-Sante)	Fonds National de la Recherche (FNR) of Luxembourg(Luxembourg National Research Fund); AFR(Luxembourg National Research Fund); Centre de Recherche Public de la Sante (CRP-Sante)	This work was supported by the Fonds National de la Recherche (FNR) of Luxembourg (ESCAPE 784322 BM to SPN and AFR grant to SAAR) and the Centre de Recherche Public de la Sante (CRP-Sante). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed BY, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chinot OL, 2014, NEW ENGL J MED, V370, P2049, DOI 10.1056/NEJMc1403303; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du JL, 2014, MOL BIOSYST, V10, P2441, DOI 10.1039/c4mb00287c; Fack F, 2014, ACTA NEUROPATHOLOGIC; Ganapathy-Kanniappan S, 2010, CURR PHARM BIOTECHNO, V11, P510, DOI 10.2174/138920110791591427; Gao HS, 2013, J NEUROSURG, V118, P846, DOI 10.3171/2012.9.JNS112134; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Goidts V, 2012, ONCOGENE, V31, P3235, DOI 10.1038/onc.2011.490; Golebiewska A, 2013, BRAIN, V136, P1462, DOI 10.1093/brain/awt025; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kathagen A, 2013, ACTA NEUROPATHOL, V126, P763, DOI 10.1007/s00401-013-1173-y; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kumar K, 2013, J MOL MED, V91, P749, DOI 10.1007/s00109-013-0996-2; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Marcondes MC, 2010, ARCH BIOCHEM BIOPHYS, V497, P62, DOI 10.1016/j.abb.2010.03.013; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Niclou SP, 2008, FASEB J, V22, P3120, DOI 10.1096/fj.08-109611; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Plate KH, 2012, ACTA NEUROPATHOL, V124, P763, DOI 10.1007/s00401-012-1066-5; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Stieber D, 2011, EXPERT OPIN THER TAR, V15, P1227, DOI 10.1517/14728222.2011.588211; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Torsvik A, 2014, CANCER MED-US, V3, P812, DOI 10.1002/cam4.219; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yan T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-524; Zhang XD, 2009, ANTICANCER RES, V29, P1249	45	70	71	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123544	10.1371/journal.pone.0123544	http://dx.doi.org/10.1371/journal.pone.0123544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932951	gold, Green Submitted, Green Published			2022-12-26	WOS:000353887100023
J	Soyka, MB; Holzmann, D; Basinski, TM; Wawrzyniak, M; Bannert, C; Burgler, S; Akkoc, T; Treis, A; Ruckert, B; Akdis, M; Akdis, CA; Eiwegger, T				Soyka, Michael B.; Holzmann, David; Basinski, Tomasz M.; Wawrzyniak, Marcin; Bannert, Christina; Buergler, Simone; Akkoc, Tunc; Treis, Angela; Rueckert, Beate; Akdis, Muebeccel; Akdis, Cezmi A.; Eiwegger, Thomas			The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses	PLOS ONE			English	Article							IMPORTANT RESEARCH QUESTIONS; INNATE LYMPHOID-CELLS; CHRONIC RHINOSINUSITIS; EXPRESSION; INFLAMMATION; ALLERGY; ASTHMA; SUPPRESSION; ENDOTYPES; DIAGNOSIS	Background Chronic rhinosinusitis (CRS) is characterized by epithelial activation and chronic T-cell infiltration in sinonasal mucosa and nasal polyps. IL-33 is a new cytokine of the IL-1 cytokine family that has a pro-inflammatory and Th2 type cytokine induction property. The role of IL-33 in the pathomechanisms of CRS and its interaction with other T cell subsets remain to be fully understood. Methods The main trigger for IL-33 mRNA expression in primary human sinonasal epithelial cells was determined in multiple cytokine and T-cell stimulated cultures. The effects of IL-33 on naive, Th0 and memory T-cells was studied by PCR, ELISA and flow cytometry. Biopsies from sinus tissue were analyzed by PCR and immunofluorescence for the presence of different cytokines and receptors with a special focus on IL-33. Results IL-33 was mainly induced by IFN-gamma in primary sinonasal epithelial cells, and induced a typical CRSwNP Th2 favoring cytokine profile upon co-culture with T-helper cell subsets. IL-33 and its receptor ST2 were highly expressed in the inflamed epithelial tissue of CRS patients. While IL-33 was significantly up-regulated in the epithelium for CRSsNP, its receptor was higher expressed in sinus tissue from CRSwNP. Conclusions production, which could both contribute to a further increase of an established Th2 profile in CRSwNP.The present study delineates the influence of IL-33 in upper airway epithelium and a potential role of IL-33 in chronic inflammation of CRSwNP by enhancing Th2 type cytokine	[Soyka, Michael B.; Basinski, Tomasz M.; Wawrzyniak, Marcin; Buergler, Simone; Akkoc, Tunc; Treis, Angela; Rueckert, Beate; Akdis, Muebeccel; Akdis, Cezmi A.; Eiwegger, Thomas] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Soyka, Michael B.; Holzmann, David] Univ Zurich Hosp, Dept Otorhinolaryngol, CH-8091 Zurich, Switzerland; [Akkoc, Tunc] Marmara Univ, Fac Med, Div Pediat Allergy & Immunol, Istanbul, Turkey; [Treis, Angela; Akdis, Cezmi A.] Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland; [Bannert, Christina; Eiwegger, Thomas] Med Univ Vienna, Dept Pediat, Vienna, Austria	Swiss Institute of Allergy & Asthma Research; University of Zurich; University of Zurich; University Zurich Hospital; Marmara University; Medical University of Vienna	Eiwegger, T (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland.	thomas.eiwegger@meduniwien.ac.at	Wawrzyniak, Marcin/E-5878-2017; Wawrzyniak, Marcin/AAT-9094-2021; Holzmann, David/ABC-7620-2020; Akdis, Cezmi/AAV-4844-2020	Wawrzyniak, Marcin/0000-0002-6911-8010; Akdis, Cezmi/0000-0001-8020-019X; Eiwegger, Thomas/0000-0002-2914-7829; Holzmann, David/0000-0002-8176-8358	Swiss National Science Foundation [320030_140772, 320030_132899]; Muller-Gierok Foundation, Bern; Oesterreichische Nationalbank [13846ONB]; Christine Kuhne-Center for Allergy Research and Education, Davos; Austrian Science Fund Project [F4615-B19, F4605-B19]; European Respiratory Society Fellowship [312]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Muller-Gierok Foundation, Bern; Oesterreichische Nationalbank; Christine Kuhne-Center for Allergy Research and Education, Davos; Austrian Science Fund Project(Austrian Science Fund (FWF)); European Respiratory Society Fellowship	This work was supported by grants from: Swiss National Science Foundation Grants No. 320030_140772, 320030_132899; Muller-Gierok Foundation, Bern; funds from the Oesterreichische Nationalbank (Anniversary Fund, project number 13846ONB); Christine Kuhne-Center for Allergy Research and Education, Davos; and Austrian Science Fund Project, grant numbers F4615-B19, F4605-B19. Tomasz M. Basinski was the recipient of European Respiratory Society Fellowship (Number 312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Baba S, 2014, LARYNGOSCOPE, V124, pE115, DOI 10.1002/lary.24462; Bachert C, 2009, ALLERGY, V64, P520, DOI 10.1111/j.1398-9995.2009.01964.x; Basinski TM, 2009, J ALLERGY CLIN IMMUN, V124, P74, DOI 10.1016/j.jaci.2009.04.019; Blom L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021695; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Bousquet J, 2008, ALLERGY, V63, P842, DOI 10.1111/j.1398-9995.2008.01715.x; Bousquet J, 2009, J ALLERGY CLIN IMMUN, V124, P428, DOI 10.1016/j.jaci.2009.06.027; Burgler S, 2009, J ALLERGY CLIN IMMUN, V123, P588, DOI 10.1016/j.jaci.2008.12.017; Castano R, 2009, AMJ RHINOL ALLERGY, V23, P377, DOI 10.2500/ajra.2009.23.3303; Chan Y, 2009, CURR OPIN OTOLARYNGO, V17, P204, DOI 10.1097/MOO.0b013e32832ac393; Eiwegger T, 2008, CLIN EXP ALLERGY, V38, P1627, DOI 10.1111/j.1365-2222.2008.03080.x; Eiwegger T, 2006, CLIN EXP ALLERGY, V36, P1281, DOI 10.1111/j.1365-2222.2006.02565.x; Eiwegger T, 2011, ALLERGY, V66, P271, DOI 10.1111/j.1398-9995.2010.02475.x; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fux M, 2014, ALLERGY, V69, P216, DOI 10.1111/all.12309; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Klemens JJ, 2006, LARYNGOSCOPE, V116, P1236, DOI 10.1097/01.mlg.0000224526.43698.52; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Li XY, 2010, J ALLERGY CLIN IMMUN, V125, P1061, DOI 10.1016/j.jaci.2010.02.023; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; Marple BF, 2009, POSTGRAD MED, V121, P121, DOI 10.3810/pgm.2009.11.2081; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Meyer N, 2012, J ALLERGY CLIN IMMUN, V129, P964, DOI 10.1016/j.jaci.2011.12.1002; Meyer N, 2010, J ALLERGY CLIN IMMUN, V125, P858, DOI 10.1016/j.jaci.2010.01.016; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Reh DD, 2010, AM J RHINOL ALLERGY, V24, P105, DOI 10.2500/ajra.2010.24.3446; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shan J, 2014, J GASTROENTEROL; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Soyka MB, 2005, AM J RHINOL, V19, P274, DOI 10.1177/194589240501900311; Stevens WW, 2014, J ALLERGY CLIN IMMUN, V133, P1503, DOI 10.1016/j.jaci.2014.03.022; Tiringer K, 2014, EUR RESPIR J, V44, P802, DOI 10.1183/09031936.00046614; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	43	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123163	10.1371/journal.pone.0123163	http://dx.doi.org/10.1371/journal.pone.0123163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932636	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000353887100015
J	Grant, EM; Young, DR; Wu, TT				Grant, Edward M.; Young, Deborah Rohm; Wu, Tong Tong			Predictors for Physical Activity in Adolescent Girls Using Statistical Shrinkage Techniques for Hierarchical Longitudinal Mixed Effects Models	PLOS ONE			English	Article							SCHOOL; MULTILEVEL; BLACK; TRIAL; DEPRESSION; ENJOYMENT; CHILDREN; SCALE	We examined associations among longitudinal, multilevel variables and girls' physical activity to determine the important predictors for physical activity change at different adolescent ages. The Trial of Activity for Adolescent Girls 2 study (Maryland) contributed participants from 8th (2009) to 11th grade (2011) (n=561). Questionnaires were used to obtain demographic, and psychosocial information (individual-and social-level variables); height, weight, and triceps skinfold to assess body composition; interviews and surveys for school-level data; and self-report for neighborhood-level variables. Moderate to vigorous physical activity minutes were assessed from accelerometers. A doubly regularized linear mixed effects model was used for the longitudinal multilevel data to identify the most important covariates for physical activity. Three fixed effects at the individual level and one random effect at the school level were chosen from an initial total of 66 variables, consisting of 47 fixed effects and 19 random effects variables, in additional to the time effect. Self-management strategies, perceived barriers, and social support from friends were the three selected fixed effects, and whether intramural or interscholastic programs were offered in middle school was the selected random effect. Psychosocial factors and friend support, plus a school's physical activity environment, affect adolescent girl's moderate to vigorous physical activity longitudinally.	[Grant, Edward M.; Wu, Tong Tong] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Young, Deborah Rohm] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA	University System of Maryland; University of Maryland College Park; Kaiser Permanente	Young, DR (corresponding author), Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA.	Deborah.r.young@kp.org			National Heart, Lung, and Blood Institute at the National Institutes of Health [R01 HL094572, HL119058]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094572, R01HL119058] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute at the National Institutes of Health (Grants R01 HL094572 and HL119058 to DRY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1986, SOCIAL FDN THOUGHT A; Barr-Anderson DJ, 2008, RES Q EXERCISE SPORT, V79, P18, DOI 10.5641/193250308X13086753542735; Birnbaum AS, 2005, AM J HEALTH BEHAV, V29, P250, DOI 10.5993/AJHB.29.3.6; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; *CDCP, 2000, 2000 CDC GROWTH CHAR; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Duncan SC, 2007, ANN BEHAV MED, V33, P80, DOI 10.1207/s15324796abm3301_9; Elder JP, 2007, HEALTH EDUC RES, V22, P155, DOI 10.1093/her/cyl059; Evenson KR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-28; GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017; Goodman RM, 1997, HLTH BEHAV HLTH ED T; Hearst MO, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-8; Heitzler CD, 2010, AM J HEALTH BEHAV, V34, P593; Kelly EB, 2010, J PHYS ACT HEALTH, V7, P184, DOI 10.1123/jpah.7.2.184; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LANGE N, 1989, J AM STAT ASSOC, V84, P241, DOI 10.2307/2289869; Loftin M, 2007, Int J Body Compos Res, V5, P1; Lytle LA, 2009, ANN BEHAV MED, V38, P124, DOI 10.1007/s12160-009-9127-2; MARSH HW, 1994, J SPORT EXERCISE PSY, V16, P43, DOI 10.1123/jsep.16.1.43; McCambridge TM, 2006, PEDIATRICS, V117, P1834, DOI 10.1542/peds.2006-0472; Mckay CM, 2007, PEDIATRICS, V119, pS84, DOI 10.1542/peds.2006-2089M; MCKENZIE TL, 1992, J TEACH PHYS EDUC, V11, P195, DOI 10.1123/jtpe.11.2.195; Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9; Motl RW, 2000, PREV MED, V31, P584, DOI 10.1006/pmed.2000.0735; Motl RW, 2003, MED SCI SPORT EXER, V35, P128, DOI 10.1097/00005768-200301000-00020; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pate RR, 2009, J ADOLESCENT HEALTH, V44, P275, DOI 10.1016/j.jadohealth.2008.07.003; Patnode CD, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-79; Perry CK, 2012, J PRIM PREV, V33, P111, DOI 10.1007/s10935-012-0270-3; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rushovich BR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-20; Saelens BE, 2000, BEHAV THER, V31, P365, DOI 10.1016/S0005-7894(00)80020-9; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Sallis JF., 1999, PHYS ACTIVITY BEHAV, Vvol. 3; Sallis JF, 2002, PEDIAT EXERC SCI, V2002, P418; Schmitz KH, 2002, PREV MED, V34, P266, DOI 10.1006/pmed.2001.0982; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott MM, 2007, J URBAN HEALTH, V84, P346, DOI 10.1007/s11524-007-9179-1; Skinner BF, 1953, SCI HLTH BEHAV; Stevens J, 2005, CONTEMP CLIN TRIALS, V26, P223, DOI 10.1016/j.cct.2004.12.011; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; Taylor WC, 2002, PEDIAT EXERC SCI, V14, P30; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Wang S, 2010, U MICHIGAN WORKING P; Webber LS, 2008, AM J PREV MED, V34, P173, DOI 10.1016/j.amepre.2007.11.018; Young D, 2014, J PHYS ACT HEALTH, V11, P950, DOI 10.1123/jpah.2012-0192	51	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125431	10.1371/journal.pone.0125431	http://dx.doi.org/10.1371/journal.pone.0125431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25928064	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100090
J	Korkmaz, S; Zararsiz, G; Goksuluk, D				Korkmaz, Selcuk; Zararsiz, Gokmen; Goksuluk, Dincer			MLViS: A Web Tool for Machine Learning-Based Virtual Screening in Early-Phase of Drug Discovery and Development	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CLASSIFICATION; PREDICTION; INHIBITORS; FRAMEWORK; MODEL	Virtual screening is an important step in early-phase of drug discovery process. Since there are thousands of compounds, this step should be both fast and effective in order to distinguish drug-like and nondrug-like molecules. Statistical machine learning methods are widely used in drug discovery studies for classification purpose. Here, we aim to develop a new tool, which can classify molecules as drug-like and nondrug-like based on various machine learning methods, including discriminant, tree-based, kernel-based, ensemble and other algorithms. To construct this tool, first, performances of twenty-three different machine learning algorithms are compared by ten different measures, then, ten best performing algorithms have been selected based on principal component and hierarchical cluster analysis results. Besides classification, this application has also ability to create heat map and dendrogram for visual inspection of the molecules through hierarchical cluster analysis. Moreover, users can connect the PubChem database to download molecular information and to create two-dimensional structures of compounds. This application is freely available through www.biosoft.hacettepe.edu.tr/MLViS/.	[Korkmaz, Selcuk; Zararsiz, Gokmen; Goksuluk, Dincer] Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey	Hacettepe University	Korkmaz, S (corresponding author), Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey.	selcuk.korkmaz@hacettepe.edu.tr	ZARARSIZ, GOKMEN/ABH-7959-2020; GOKSULUK, Dincer/E-9175-2013; Korkmaz, Selçuk/AAU-4677-2020; Zararsız, Gökmen/E-8818-2013	GOKSULUK, Dincer/0000-0002-2752-7668; Korkmaz, Selçuk/0000-0003-4632-6850; Zararsız, Gökmen/0000-0001-5801-1835	Marmara University [FEN-C-DRP-120613-0273]	Marmara University(Marmara University)	This study was supported by the Research Fund of Marmara University [FEN-C-DRP-120613-0273]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo A, 2010, J CHEM INF MODEL, V50, P1012, DOI 10.1021/ci100090p; Agarwal S, 2010, J CHEM INF MODEL, V50, P716, DOI 10.1021/ci9003865; Ajay, 1998, J MED CHEM, V41, P3314, DOI 10.1021/jm970666c; Akbani R, 2004, LECT NOTES COMPUT SC, V3201, P39, DOI 10.1007/978-3-540-30115-8_7; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Byvatov E, 2003, J CHEM INF COMP SCI, V43, P1882, DOI 10.1021/ci0341161; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chawla NV, 2003, LECT NOTES ARTIF INT, V2838, P107, DOI 10.1007/978-3-540-39804-2_12; Chen B, 2007, J COMPUT AID MOL DES, V21, P53, DOI 10.1007/s10822-006-9096-5; Cheng FX, 2011, J CHEM INF MODEL, V51, P996, DOI 10.1021/ci200028n; Ehrman TM, 2007, J CHEM INF MODEL, V47, P264, DOI 10.1021/ci600289v; Estabrooks A, 2004, COMPUT INTELL-US, V20, P18, DOI 10.1111/j.0824-7935.2004.t01-1-00228.x; Fang JS, 2013, J CHEM INF MODEL, V53, P3009, DOI 10.1021/ci400331p; Garcia-Sosa AT, 2012, J CHEM INF MODEL, V52, P2165, DOI 10.1021/ci200587h; Gertrudes JC, 2012, CURR MED CHEM, V19, P4289, DOI 10.2174/092986712802884259; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jorissen RN, 2005, J CHEM INF MODEL, V45, P549, DOI 10.1021/ci049641u; Keiser J, 2011, J ANTIMICROB CHEMOTH, V66, P1791, DOI 10.1093/jac/dkr178; Korkmaz S, 2014, COMPUT METH PROG BIO, V117, P51, DOI 10.1016/j.cmpb.2014.08.009; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Liew CY, 2009, J CHEM INF MODEL, V49, P877, DOI 10.1021/ci800387z; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Miller DW, 2001, J CHEM INF COMP SCI, V41, P168, DOI [10.1021/ci0003348, 10.1021/ci0000348]; Ozturk A, 2008, ERCIYES MED J, V30, P266; Plewczynski D, 2009, COMB CHEM HIGH T SCR, V12, P484, DOI 10.2174/138620709788489000; Pochet N, 2004, BIOINFORMATICS, V20, P3185, DOI 10.1093/bioinformatics/bth383; R Core Team, R LANG ENV STAT COMP; Rathke F, 2011, J CHEM INF MODEL, V51, P83, DOI 10.1021/ci100308f; RStudio Inc, SHIN WEB APPL FRAM R; Sadowski J, 1998, J MED CHEM, V41, P3325, DOI 10.1021/jm9706776; Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559; Sun HM, 2005, J MED CHEM, V48, P4031, DOI 10.1021/jm050180t; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Todorov V, 2009, J STAT SOFTW, V32, P1; Vapnik V.N., 1995, NATURE STAT LEARNING; Warnes G., GPLOTS VARIOUS R PRO; Wassermann AM, 2009, J CHEM INF MODEL, V49, P582, DOI 10.1021/ci800441c; Weidlich IE, 2015, J COMPUT CHEM, V36, P62, DOI 10.1002/jcc.23765; Weston S., CARET CLASSIFICATION; Wildenhain J, 2012, BIOINFORMATICS, V28, P2200, DOI 10.1093/bioinformatics/bts349; Xiao N, RCPI TOOLKIT COMPOUN; Zernov VV, 2003, J CHEM INF COMP SCI, V43, P2048, DOI 10.1021/ci0340916	45	28	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124600	10.1371/journal.pone.0124600	http://dx.doi.org/10.1371/journal.pone.0124600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928885	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100040
J	Yang, XC; Wu, J; Lu, JS; Liu, GY; Di, GH; Chen, CM; Hou, YF; Sun, MH; Yang, WT; Xu, XJ; Zhao, Y; Hu, X; Li, DQ; Cao, ZG; Zhou, XY; Huang, XY; Liu, ZB; Chen, H; Gu, YZ; Chi, YY; Yan, X; Han, QX; Shen, ZZ; Shao, ZM; Hu, Z				Yang, Xiaochen; Wu, Jiong; Lu, Jingsong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Sun, Menghong; Yang, Wentao; Xu, Xiaojing; Zhao, Ying; Hu, Xin; Li, Daqiang; Cao, Zhigang; Zhou, Xiaoyan; Huang, Xiaoyan; Liu, Zhebin; Chen, Huan; Gu, Yanzi; Chi, Yayun; Yan, Xia; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen			Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; REVISED BETHESDA GUIDELINES; GERMLINE MUTATIONS; LYNCH-SYNDROME; MICROSATELLITE INSTABILITY; TP53 MUTATIONS; GASTRIC-CANCER; BRCA2 GENES; FAMILY; SUSCEPTIBILITY	The genetic etiology of hereditary breast cancer has not been fully elucidated. Although germline mutations of high-penetrance genes such as BRCA1/2 are implicated in development of hereditary breast cancers, at least half of all breast cancer families are not linked to these genes. To identify a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population, we performed an analysis of germline mutations in 2,165 coding exons of 152 genes associated with hereditary cancer using next-generation sequencing (NGS) in 99 breast cancer patients from families of cancer patients regardless of cancer types. Forty-two deleterious germline mutations were identified in 21 genes of 34 patients, including 18 (18.2%) BRCA1 or BRCA2 mutations, 3 (3%) TP53 mutations, 5 (5.1%) DNA mismatch repair genemutations, 1 (1%) CDH1 mutation, 6 (6.1%) Fanconi anemia pathway gene mutations, and 9 (9.1%) mutations in other genes. Of seven patients who carried mutations inmore than one gene, 4 were BRCA1/2 mutation carriers, and their average onset age was much younger than patients with only BRCA1/2 mutations. Almost all identified high-penetrance genemutations in those families fulfill the typical phenotypes of hereditary cancer syndromes listed in the National Comprehensive Cancer Network (NCCN) guidelines, except two TP53 and threemismatch repair genemutations. Furthermore, functional studies of MSH3 germline mutations confirmed the association between MSH3 mutation and tumorigenesis, and segregation analysis suggested antagonism between BRCA1 and MSH3. We also identified a lot of low-penetrance gene mutations. Although the clinical significance of those newly identified low-penetrance gene mutations has not been fully appreciated yet, these new findings do provide valuable epidemiological information for the future studies. Together, these findings highlight the importance of genetic testing based on NCCN guidelines and a multi-gene analysis using NGS may be a supplement to traditional genetic counseling.	[Yang, Xiaochen; Wu, Jiong; Lu, Jingsong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Cao, Zhigang; Huang, Xiaoyan; Liu, Zhebin; Yan, Xia; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen] Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Yang, Xiaochen; Wu, Jiong; Lu, Jingsong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Sun, Menghong; Yang, Wentao; Hu, Xin; Li, Daqiang; Cao, Zhigang; Zhou, Xiaoyan; Huang, Xiaoyan; Liu, Zhebin; Chen, Huan; Gu, Yanzi; Chi, Yayun; Yan, Xia; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Sun, Menghong; Chen, Huan; Gu, Yanzi] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Tissue Bank, Shanghai 200433, Peoples R China; [Yang, Wentao; Zhou, Xiaoyan] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Xu, Xiaojing; Zhao, Ying] Natl Engn Ctr Biochip Shanghai, Mol Biol Lab, Shanghai, Peoples R China; [Hu, Xin; Li, Daqiang; Chi, Yayun; Shao, Zhimin] Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Shanghai 200433, Peoples R China; [Zhou, Xiaoyan] Fudan Univ, Inst Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Hu, Z (corresponding author), Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	hzhenhu@yahoo.com		Di, Genhong/0000-0003-1171-7907	Shanghai Committee of Science and Technology Funds [07ZR14025, 08QA14020]	Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee)	This work is supported by the Shanghai Committee of Science and Technology Funds (http://www.stcsm.gov.cn/) grant 07ZR14025 and 08QA14020. ZH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arai H, 2013, INT J CLIN EXP PATHO, V6, P395; Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Borg A, 2000, INT J CANCER, V85, P796; Cai Qi, 2003, Zhonghua Bing Li Xue Za Zhi, V32, P323; Cao AY, 2009, BREAST CANCER RES TR, V114, P457, DOI 10.1007/s10549-008-0036-z; Chompret A, 2001, J MED GENET, V38, P43, DOI 10.1136/jmg.38.1.43; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Debniak T, 2005, J MED GENET, V42, P763, DOI 10.1136/jmg.2005.031476; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Edelmann W, 2000, CANCER RES, V60, P803; Eng C, ANN REV MED, V2, p[52, 371]; FitzGerald MG, 1998, ONCOGENE, V17, P727, DOI 10.1038/sj.onc.1201984; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Hopper JL, 2005, HUM MUTAT, V26, P298, DOI 10.1002/humu.20237; Hucl T, 2007, J GASTROENTEROL, V42, P599, DOI 10.1007/s00535-007-2065-5; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Kwong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043994; Lavie O, 2011, ANN ONCOL, V22, P964, DOI 10.1093/annonc/mdq460; Lee DSC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3172; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li SSL, 1999, HUM GENET, V104, P201, DOI 10.1007/s004390050936; Li WF, 2008, BREAST CANCER RES TR, V110, P99, DOI 10.1007/s10549-007-9708-3; Li XW, 2013, FAM CANCER, V12, P547, DOI 10.1007/s10689-013-9619-x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCuaig JM, 2012, FAM CANCER, V11, P607, DOI 10.1007/s10689-012-9557-z; Mouchawar J, 2010, CANCER RES, V70, P4795, DOI 10.1158/0008-5472.CAN-09-0851; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nielsen M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033217; Pan M, 2011, HUM MUTAT, V32, P1335, DOI 10.1002/humu.21588; Perez-Carbonell L, 2012, GUT, V61, P865, DOI 10.1136/gutjnl-2011-300041; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Sahlin P, 2009, GENE CHROMOSOME CANC, V48, P285, DOI 10.1002/gcc.20637; Schrader KA, 2008, FAM CANCER, V7, P73, DOI 10.1007/s10689-007-9172-6; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tao H, 2004, CARCINOGENESIS, V25, P1859, DOI 10.1093/carcin/bgh206; Thompson ER, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002894; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2001, AM J HUM GENET, V68, P1533, DOI 10.1086/320610; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang ZW, 2009, BREAST CANCER RES TR, V118, P169, DOI 10.1007/s10549-009-0327-z; Wiechec E, 2011, CANCER EPIDEM BIOMAR, V20, P397, DOI 10.1158/1055-9965.EPI-10-0514; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Wu Y, 2001, NAT GENET, V29, P137, DOI 10.1038/ng1001-137; Zhang J, 2012, BREAST CANCER RES TR, V132, P421, DOI 10.1007/s10549-011-1596-x; Zhu ZG, 2004, EJSO-EUR J SURG ONC, V30, P531, DOI 10.1016/j.ejso.2004.03.004	57	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125571	10.1371/journal.pone.0125571	http://dx.doi.org/10.1371/journal.pone.0125571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927356	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100102
J	Dewji, NN; Singer, SJ; Masliah, E; Rockenstein, E; Kim, M; Harber, M; Horwood, T				Dewji, Nazneen N.; Singer, S. Jonathan; Masliah, Eliezer; Rockenstein, Edward; Kim, Mihyun; Harber, Martha; Horwood, Taylor			Peptides of Presenilin-1 Bind the Amyloid Precursor Protein Ectodomain and Offer a Novel and Specific Therapeutic Approach to Reduce beta-Amyloid in Alzheimer's Disease	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; MEMBRANE TOPOLOGY; DOMAIN; SURFACE; APP; ACTIVATION; EXPRESSION; DEPOSITION; RELEASE; PATHWAY	beta-Amyloid (A beta) accumulation in the brain is widely accepted to be critical to the development of Alzheimer's disease (AD). Current efforts at reducing toxic A beta 40 or 42 have largely focused on modulating.-secretase activity to produce shorter, less toxic A beta, while attempting to spare other secretase functions. In this paper we provide data that offer the potential for a new approach for the treatment of AD. The method is based on our previous findings that the production of A beta from the interaction between the beta-amyloid precursor protein (APP) and Presenilin (PS), as part of the gamma-secretase complex, in cell culture is largely inhibited if the entire water-soluble NH2-terminal domain of PS is first added to the culture. Here we demonstrate that two small, non-overlapping water-soluble peptides from the PS-1 NH2-terminal domain can substantially and specifically inhibit the production of total A beta as well as A beta 40 and 42 in vitro and in vivo in the brains of APP transgenic mice. These results suggest that the inhibitory activity of the entire amino terminal domain of PS-1 on A beta production is largely focused in a few smaller sequences within that domain. Using biolayer interferometry and confocal microscopy we provide evidence that peptides effective in reducing A beta give a strong, specific and biologically relevant binding with the purified ectodomain of APP 695. Finally, we demonstrate that the reduction of A beta by the peptides does not affect the catalytic activities of beta- or gamma-secretase, or the level of APP. P4 and P8 are the first reported protein site-specific small peptides to reduce A beta production in model systems of AD. These peptides and their derivatives offer new potential drug candidates for the treatment of AD.	[Dewji, Nazneen N.; Kim, Mihyun] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Masliah, Eliezer; Rockenstein, Edward] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Singer, S. Jonathan] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; [Dewji, Nazneen N.; Singer, S. Jonathan; Kim, Mihyun] Cenna Biosci Inc, La Jolla, CA 92037 USA; [Harber, Martha] Pall Corp, ForteBio, Menlo Pk, CA 94025 USA; [Horwood, Taylor] Univ Calif San Diego, Dept Neurosci Imaging Core, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pall Corporation; University of California System; University of California San Diego	Dewji, NN (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	ndewji@ucsd.edu			National Institutes of Health [5RO1NS055161, 5RO1AG17888, 1R43AG043278, AG18440, AG022074, AG011385, AG03197, NS057096]; Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096, R01NS055161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG011385, R37AG011385, R01AG017888, R37AG018440, R44AG043278, R01AG018440, P01AG022074, R43AG043278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health grants 5RO1NS055161, 5RO1AG17888, 1R43AG043278 and Alzheimer's Drug Discovery Foundation to NND, and National Institutes of Health grants AG18440, AG022074, AG011385, AG03197, NS057096 to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dewji NN, 2006, P NATL ACAD SCI USA, V103, P1540, DOI 10.1073/pnas.0509899103; Dewji NN, 2005, CELL MOL LIFE SCI, V62, P1109, DOI 10.1007/s00018-005-4566-9; Dewji NN, 2004, P NATL ACAD SCI USA, V101, P1057, DOI 10.1073/pnas.0307290101; Dewji NN, 1996, P NATL ACAD SCI USA, V93, P12575, DOI 10.1073/pnas.93.22.12575; Dewji NN, 1997, P NATL ACAD SCI USA, V94, P9926, DOI 10.1073/pnas.94.18.9926; Dewji NN, 1996, SCIENCE, V271, P159, DOI 10.1126/science.271.5246.159; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Keselman HJ, 1998, REV EDUC RES, V68, P350, DOI 10.2307/1170601; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Lehmann S, 1997, J BIOL CHEM, V272, P12047, DOI 10.1074/jbc.272.18.12047; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li XJ, 1996, NEURON, V17, P1015, DOI 10.1016/S0896-6273(00)80231-7; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Lleo A, 2011, CURR TOP MED CHEM, V11, P1513, DOI 10.2174/156802611795861004; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakai T, 1999, J BIOL CHEM, V274, P23647, DOI 10.1074/jbc.274.33.23647; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI, P150; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oh YS, 2005, AM J PHYSIOL-CELL PH, V289, pC576, DOI 10.1152/ajpcell.00636.2004; Pradier L, 1999, NEUROBIOL DIS, V6, P43, DOI 10.1006/nbdi.1998.0212; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; Rich RL, 2009, ANAL BIOCHEM, V386, P194, DOI 10.1016/j.ab.2008.11.021; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schwarzman AL, 1999, P NATL ACAD SCI USA, V96, P7932, DOI 10.1073/pnas.96.14.7932; So Pauline Pl, 2012, Am J Neurodegener Dis, V1, P75; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Verheijen JH, 2006, CLIN CHEM, V52, P1168, DOI 10.1373/clinchem.2006.066720; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Waragai M, 1997, BIOCHEM BIOPH RES CO, V239, P480, DOI 10.1006/bbrc.1997.7488; Weidemann A, 1997, NAT MED, V3, P328, DOI 10.1038/nm0397-328; Zage PE, 2012, PEDIATR BLOOD CANCER, V58, P682, DOI 10.1002/pbc.23202; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	55	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122451	10.1371/journal.pone.0122451	http://dx.doi.org/10.1371/journal.pone.0122451			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923432	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600014
J	Qadeer, E; Fatima, R; Fielding, K; Qazi, F; Moore, D; Khan, MS				Qadeer, Ejaz; Fatima, Razia; Fielding, Katherine; Qazi, Fahad; Moore, David; Khan, Mishal S.			Good Quality Locally Procured Drugs Can Be as Effective as Internationally Quality Assured Drugs in Treating Multi-Drug Resistant Tuberculosis	PLOS ONE			English	Article							ACID-FAST BACILLI; PULMONARY TUBERCULOSIS; CULTURE CONVERSION; PREDICTORS; OUTCOMES; SPUTUM	Background Owing toGiven the high costs of drugs to treat multi-drug resistant tuberculosis (MDR-TB), the Green Light Committee (GLC) initiative enables TB programs to procure quality-assured drugs at reduced prices. Despite price reductions, internationally quality assured (IQA) drugs can be more expensive than locally procured drugs. There is little evidence to inform decision-makers about whether IQA drugs are more effective than local drugs. This is the first study to compare outcomes between MDR-TB patients treated using IQA, and locally procured drugs in the same hospitals during the same time period. Methods/Findings A retrospective cohort study was conducted in three hospitals across Pakistan. Data on baseline characteristics and treatment outcomes during the first six months of treatment were extracted from hospital records of adult culture-positive pulmonary MDR-TB patients starting treatment between January 2011 and June 2012. Two cohorts were defined: patients receiving IQA drugs, and patients receiving locally procured non-IQA drugs. Data were analysed using Kaplan-Meier curves and Cox proportional hazards regression. The primary outcome compared between cohorts was time to culture conversion. Of 231 patients, 90 were in the IQA and 141 in the non-IQA cohorts. Baseline characteristics were similar except for higher frequency of quinolone resistance in the IQA cohort. Overall, 193 patients (84%) culture converted. Culture conversion was not faster in the IQA cohort; the median time was 81 and 68 days in the IQA and non-IQA cohorts, respectively. Unadjusted and adjusted hazard ratios for culture conversion in IQA verses non-IQA cohorts were 0.82 (95%-CI, 0.62-1.10) and 0.95 (95%-CI, 0.66-1.36) respectively. Conclusions Use of good quality, locally procured drugs can be effective in treating MDR-TB, may involve lower costs than using IQA drugs and could strengthen developing country drug quality assurance systems. This may be a suitable alternative in lieu of or whilst awaiting arrival of internationally procured medicines.	[Qadeer, Ejaz; Fatima, Razia] Natl TB Control Program Pakistan, Islamabad, Pakistan; [Fielding, Katherine; Moore, David; Khan, Mishal S.] London Sch Hyg & Trop Med, London WC1, England; [Qazi, Fahad] Res Alliance Advocacy & Dev, Karachi, Pakistan	University of London; London School of Hygiene & Tropical Medicine	Khan, MS (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	mishal.khan@lshtm.ac.uk			Global Fund To Fight AIDS, Tuberculosis and Malaria (GFATM); Medical Research Council [MR/K012126/1] Funding Source: researchfish	Global Fund To Fight AIDS, Tuberculosis and Malaria (GFATM); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by operational research funds made available to the Pakistan National TB Program by the Global Fund To Fight AIDS, Tuberculosis and Malaria (GFATM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Moamary MS, 1999, CHEST, V116, P726, DOI 10.1378/chest.116.3.726; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; [Anonymous], 2013, GLOB TUB REP; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Gupta R, 2000, P M CAMBR US 5 6 JUL; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Lee JS, 2008, J KOREAN MED SCI, V23, P767, DOI 10.3346/jkms.2008.23.5.767; Mpagama SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062034; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; WHO, 2011, NEW GLOB FRAM SUPP E; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744	13	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126099	10.1371/journal.pone.0126099	http://dx.doi.org/10.1371/journal.pone.0126099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923538	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353711600171
J	Wissuwa, M; Kondo, K; Fukuda, T; Mori, A; Rose, MT; Pariasca-Tanaka, J; Kretzschmar, T; Haefele, SM; Rose, TJ				Wissuwa, Matthias; Kondo, Katsuhiko; Fukuda, Takuya; Mori, Asako; Rose, Michael T.; Pariasca-Tanaka, Juan; Kretzschmar, Tobias; Haefele, Stephan M.; Rose, Terry J.			Unmasking Novel Loci for Internal Phosphorus Utilization Efficiency in Rice Germplasm through Genome-Wide Association Analysis	PLOS ONE			English	Article							COMPLEX TRAITS; ORYZA-SATIVA; DEFICIENCY; PLANT; DEPRIVATION; TOLERANCE; SEQUENCE; IMPROVE; CROPS	Depletion of non-renewable rock phosphate reserves and phosphorus (P) fertilizer price increases has renewed interest in breeding P-efficient varieties. Internal P utilization efficiency (PUE) is of prime interest because there has been no progress to date in breeding for high PUE. We characterized the genotypic variation for PUE present within the rice gene pool by using a hydroponic system that assured equal plant P uptake, followed by mapping of loci controlling PUE via Genome-Wide Association Studies (GWAS). Loci associated with PUE were mapped on chromosomes 1, 4, 11 and 12. The highest PUE was associated with a minor indica-specific haplotype on chromosome 1 and a rare aus-specific haplotype on chromosome 11. Comparative variant and expression analysis for genes contained within the chromosome 1 haplotype identified high priority candidate genes. Differences in coding regions and expression patterns between genotypes of contrasting haplotypes, suggested functional alterations for two predicted nucleic acid-interacting proteins that are likely causative for the observed differences in PUE. The loci reported here are the first identified for PUE in any crop that is not confounded by differential P uptake among genotypes. Importantly, modern rice varieties lacked haplotypes associated with superior PUE, and would thus benefit from targeted introgressions of these loci from traditional donors to improve plant growth in phosphorus-limited cropping systems.	[Wissuwa, Matthias; Kondo, Katsuhiko; Fukuda, Takuya; Mori, Asako; Rose, Michael T.; Pariasca-Tanaka, Juan; Rose, Terry J.] Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, Tsukuba, Ibaraki, Japan; [Rose, Michael T.] Monash Univ, Sch Chem, Clayton, Vic, Australia; [Kretzschmar, Tobias] IRRI, Los Banos, Philippines; [Haefele, Stephan M.] ACPFG, Glen Osmond, SA, Australia; [Rose, Terry J.] So Cross Univ, Ctr Plant Sci, Lismore, NSW 2480, Australia	Japan International Research Center for Agricultural Sciences; Monash University; CGIAR; International Rice Research Institute (IRRI); Southern Cross University	Wissuwa, M (corresponding author), Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, Tsukuba, Ibaraki, Japan.	mcwissuwa@gmail.com	Rose, Michael/P-2161-2016; Haefele, Stephan M/E-1256-2017; kretzschmar, tobias/AAH-3739-2021	Rose, Michael/0000-0001-6457-145X; Haefele, Stephan M/0000-0003-0389-8373; kretzschmar, tobias/0000-0002-8227-0746; Wissuwa, Matthias/0000-0003-3505-9398; Rose, Terry/0000-0001-5386-6818	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this work was provided by the Japan Society for the Promotion of Science (JSPS), https://www.jsps.go.jp/english/, in the form of postdoctoral fellowships to TJR and MTR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown RL, 2003, BIOCHEM BIOPH RES CO, V306, P394, DOI 10.1016/S0006-291X(03)00982-3; Calderon-Vazquez C, 2011, PLANT PHYSIOL, V156, P1067, DOI 10.1104/pp.111.174987; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; GOURLEY CJP, 1994, PLANT SOIL, V158, P29, DOI 10.1007/BF00007914; Hammond JP, 2004, ANN BOT-LONDON, V94, P323, DOI 10.1093/aob/mch156; Heuer S, 2009, PLANT BIOTECHNOL J, V7, P456, DOI 10.1111/j.1467-7652.2009.00415.x; Hofmann A, 2000, EMBO J, V19, P6207, DOI 10.1093/emboj/19.22.6207; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kim HJ, 1999, MOL CELL BIOL, V19, P6323; Manske GGB, 2002, EUPHYTICA, V125, P113, DOI 10.1023/A:1015760600750; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Oono Y, 2013, PLANT MOL BIOL, V83, P523, DOI 10.1007/s11103-013-0106-4; Pariasca-Tanaka J, 2009, RICE, V2, P167, DOI 10.1007/s12284-009-9032-0; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Richardson AE, 2011, PLANT SOIL, V349, P121, DOI 10.1007/s11104-011-0950-4; Rose TJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00073; Rose TJ, 2012, ADV AGRON, V116, P185, DOI 10.1016/B978-0-12-394277-7.00005-1; Sharpley AN, 2001, PLANT SOIL, V237, P287, DOI 10.1023/A:1013335814593; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Shenoy VV, 2005, BIOTECHNOL ADV, V23, P501, DOI 10.1016/j.biotechadv.2005.01.004; SIDDIQI MY, 1981, J PLANT NUTR, V4, P289, DOI 10.1080/01904168109362919; Steen I, 1998, PHOSP POTAS, V217, P25; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sulpice R, 2014, PLANT CELL ENVIRON, V37, P1276, DOI 10.1111/pce.12240; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Wang XR, 2010, PLANT SCI, V179, P302, DOI 10.1016/j.plantsci.2010.06.007; Wissuwa M, 1998, THEOR APPL GENET, V97, P777, DOI 10.1007/s001220050955; Wissuwa M, 2009, PLANT SOIL, V321, P409, DOI 10.1007/s11104-008-9693-2; Yoshida S, 1971, INT RICE RES I; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051	35	50	51	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124215	10.1371/journal.pone.0124215	http://dx.doi.org/10.1371/journal.pone.0124215			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923470	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600074
J	Zhang, JJ; O'Reilly, KM; Perry, GLW; Taylor, GA; Dennis, TE				Zhang, Jingjing; O'Reilly, Kathleen M.; Perry, George L. W.; Taylor, Graeme A.; Dennis, Todd E.			Extending the Functionality of Behavioural Change-Point Analysis with k-Means Clustering: A Case Study with the Little Penguin (Eudyptula minor)	PLOS ONE			English	Article							ANIMAL MOVEMENT DATA; FORAGING BEHAVIOR; LARGE HERBIVORES; TELEMETRY DATA; RANDOM-WALKS; MODELS; SPACE; ISLAND; SELECTION; STATES	We present a simple framework for classifying mutually exclusive behavioural states within the geospatial lifelines of animals. This method involves use of three sequentially applied statistical procedures: (1) behavioural change point analysis to partition movement trajectories into discrete bouts of same-state behaviours, based on abrupt changes in the spatiotemporal autocorrelation structure of movement parameters; (2) hierarchical multivariate cluster analysis to determine the number of different behavioural states; and (3) k-means clustering to classify inferred bouts of same-state location observations into behavioural modes. We demonstrate application of the method by analysing synthetic trajectories of known 'artificial behaviours' comprised of different correlated random walks, as well as real foraging trajectories of little penguins (Eudyptula minor) obtained by global-positioning-system telemetry. Our results show that the modelling procedure correctly classified 92.5% of all individual location observations in the synthetic trajectories, demonstrating reasonable ability to successfully discriminate behavioural modes. Most individual little penguins were found to exhibit three unique behavioural states (resting, commuting/active searching, area-restricted foraging), with variation in the timing and locations of observations apparently related to ambient light, bathymetry, and proximity to coastlines and river mouths. Addition of k-means clustering extends the utility of behavioural change point analysis, by providing a simple means through which the behaviours inferred for the location observations comprising individual movement trajectories can be objectively classified.	[Zhang, Jingjing; Perry, George L. W.; Dennis, Todd E.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [O'Reilly, Kathleen M.] Univ Portland, Dept Biol, Portland, OR 97203 USA; [Perry, George L. W.] Univ Auckland, Sch Environm, Auckland 1, New Zealand; [Taylor, Graeme A.] Dept Conservat, Wellington, New Zealand	University of Auckland; University of Portland; University of Auckland	Dennis, TE (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	t.dennis@auckland.ac.nz		Perry, George/0000-0001-9672-9135; Zhang, Jingjing/0000-0001-8809-3405	Fulbright Senior Scholar Award; Center for Biodiversity and Biosecurity, the University of Auckland	Fulbright Senior Scholar Award; Center for Biodiversity and Biosecurity, the University of Auckland	KO was supported by a Fulbright Senior Scholar Award. JZ received a research grant from the Center for Biodiversity and Biosecurity, the University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PJAL, 2010, ZOOLOGIA-CURITIBA, V27, P674, DOI 10.1590/S1984-46702010000500002; Ares JO, 2010, ECOL MODEL, V221, P2323, DOI 10.1016/j.ecolmodel.2010.06.012; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bilmes J. A., 1998, INT COMPUTER SCI I, V4, P126, DOI DOI 10.1080/0042098032000136147; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Bull L, 2000, NEW ZEAL J ZOOL, V27, P291, DOI 10.1080/03014223.2000.9518237; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cannell BL, 1998, IBIS, V140, P467, DOI 10.1111/j.1474-919X.1998.tb04608.x; Chiaradia A., 1999, THESIS U TASMANIA; Dalziel BD, 2010, AM NAT, V175, P762, DOI 10.1086/652521; Dean B, 2012, J R SOC INTERFACE, V10, DOI [10.1098/rsif.2012.0570(78), DOI 10.1098/RSIF.2012.0570(78)]; Dominoni DM, 2014, J ANIM ECOL, V83, P681, DOI 10.1111/1365-2656.12150; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; ERSI, 2013, ARCMAP; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fleming C, 2014, METHODS ECOLOGY EVOL; GALES R, 1990, J ZOOL, V220, P61, DOI 10.1111/j.1469-7998.1990.tb04294.x; Guilford T, 2004, J THEOR BIOL, V227, P25, DOI 10.1016/j.jtbi.2003.07.003; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; Gurarie E, 2013, RCPT D RCPP L PACKAG; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hanks EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022795; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hennig C., 2010, FPC FLEXIBLE PROCEDU, V2, P0; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kinsky F, 1976, SUBSPECIFIC REVISION; KLOMP NI, 1991, EMU, V91, P190, DOI 10.1071/MU9910190; Knell AS, 2012, THEOR ECOL-NETH, V5, P325, DOI 10.1007/s12080-011-0130-4; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; KRZANOWSKI WJ, 1988, BIOMETRICS, V44, P23, DOI 10.2307/2531893; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Maechler M, 2014, CLUSTER CLUSTER ANAL; Marchant S, 1990, HDB AUSTR NZ ANTARCT, V1, p[125, 246]; Mattern T, 2001, THESIS O OTAGO; McClintock BT, 2012, ECOL MONOGR, V82, P335, DOI 10.1890/11-0326.1; Merrill E, 2010, PHILOS T R SOC B, V365, P2279, DOI 10.1098/rstb.2010.0077; Miller LA, 2012, INTEGR COMP BIOL, V52, P553, DOI 10.1093/icb/ics115; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nams VO, 2014, ECOL LETT, V17, P1228, DOI 10.1111/ele.12328; Owen-Smith N, 2012, WILDLIFE RES, V39, P452, DOI 10.1071/WR12062; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; Postlethwaite CM, 2013, J THEOR BIOL, V317, P175, DOI 10.1016/j.jtbi.2012.10.007; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Schwager M, 2007, COMPUT ELECTRON AGR, V56, P46, DOI 10.1016/j.compag.2007.01.002; *STATSOFT I, 2009, STAT DAT AN SOFTW SY; Team R Core, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Tryon R. C., 1939, CLUSTER ANAL; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155; Wilensky U., 1999, NETLOGO; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 1990, FORAGING ECOLOGY BRE, P181	55	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122811	10.1371/journal.pone.0122811	http://dx.doi.org/10.1371/journal.pone.0122811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922935	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600022
J	Abehsera, S; Glazer, L; Tynyakov, J; Plaschkes, I; Chalifa-Caspi, V; Khalaila, I; Aflalo, ED; Sagi, A				Abehsera, Shai; Glazer, Lilah; Tynyakov, Jenny; Plaschkes, Inbar; Chalifa-Caspi, Vered; Khalaila, Isam; Aflalo, Eliahu D.; Sagi, Amir			Binary Gene Expression Patterning of the Molt Cycle: The Case of Chitin Metabolism	PLOS ONE			English	Article							SKELETAL STRUCTURES; CALCIUM-TRANSPORT; GASTROLITH DISK; CRAYFISH; DEPOSITION; ENZYMES; CALCIFICATION; CRUSTACEANS; ANNOTATION; PROTEINS	In crustaceans, like all arthropods, growth is accompanied by a molting cycle. This cycle comprises major physiological events in which mineralized chitinous structures are built and degraded. These events are in turn governed by genes whose patterns of expression are presumably linked to the molting cycle. To study these genes we performed next generation sequencing and constructed a molt-related transcriptomic library from two exoskeletal-forming tissues of the crayfish Cherax quadricarinatus, namely the gastrolith and the mandible cuticle-forming epithelium. To simplify the study of such a complex process as molting, a novel approach, binary patterning of gene expression, was employed. This approach revealed that key genes involved in the synthesis and breakdown of chitin exhibit a molt-related pattern in the gastrolith-forming epithelium. On the other hand, the same genes in the mandible cuticle-forming epithelium showed a molt-independent pattern of expression. Genes related to the metabolism of glucosamine-6-phosphate, a chitin precursor synthesized from simple sugars, showed a molt-related pattern of expression in both tissues. The binary patterning approach unfolds typical patterns of gene expression during the molt cycle of a crustacean. The use of such a simplifying integrative tool for assessing gene patterning seems appropriate for the study of complex biological processes.	[Abehsera, Shai; Glazer, Lilah; Aflalo, Eliahu D.; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Abehsera, Shai; Glazer, Lilah; Tynyakov, Jenny; Plaschkes, Inbar; Chalifa-Caspi, Vered; Aflalo, Eliahu D.; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Khalaila, Isam] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Abehsera, S (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	abehsera@post.bgu.ac.il	khalaila, Isam/F-1498-2012	khalaila, Isam/0000-0003-3250-5778; Chalifa-Caspi, Vered/0000-0001-6030-5816; Sagi, Amir/0000-0002-4229-1059; Aflalo, Eli/0000-0003-1385-2387	Israel Science Foundation [102/09, 613/13]; National Institute for Biotechnology in the Negev	Israel Science Foundation(Israel Science Foundation); National Institute for Biotechnology in the Negev	Funding: This study was supported in part by grants from the Israel Science Foundation (Grant 102/09 and 613/13) (http://www.isf.org.il) and the National Institute for Biotechnology in the Negev (in.bgu.ac.il/en/nibn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BUCHHOLZ F, 1989, POLAR BIOL, V9, P311, DOI 10.1007/BF00287429; Chang ES, 1995, J EXP MAR BIOL ECOL, V193, P1, DOI 10.1016/0022-0981(95)00106-9; COMB DG, 1958, J BIOL CHEM, V232, P807; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Correlo VM, 2005, MACROMOL MATER ENG, V290, P1157, DOI 10.1002/mame.200500163; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dennis JW., 2014, HDB GLYCOSYLTRANSFER, P1481; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drach P, 1939, MUE CYCLE INTERMUE C; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Glazer L, 2013, J EXP BIOL, V216, P1898, DOI 10.1242/jeb.080945; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GWINN JF, 1973, COMP BIOCHEM PHYSIOL, V45, P769, DOI 10.1016/0305-0491(73)90138-7; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hoell IA, 2010, BIOTECHNOL GENET ENG, V27, P331, DOI 10.1080/02648725.2010.10648156; HOHNKE LA, 1971, COMP BIOCHEM PHYSIOL, V40, P757, DOI 10.1016/0305-0491(71)90151-9; HORNUNG DE, 1971, COMP BIOCHEM PHYSIOL, V40, P341, DOI 10.1016/0305-0491(71)90219-7; Huang QS, 2010, FISH SHELLFISH IMMUN, V29, P75, DOI 10.1016/j.fsi.2010.02.014; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kuballa Anna, 2007, Bulletin of Fisheries Research Agency, P53; Lowenstam HA, 1989, BIOMINERALIZATION; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Milewski S, 2002, BBA-PROTEIN STRUCT M, V1597, P173, DOI 10.1016/S0167-4838(02)00318-7; Nagasawa Hiromichi, 2012, Front Biosci (Elite Ed), V4, P711; OBRIEN JJ, 1991, BIOL BULL, V181, P427, DOI 10.2307/1542363; PAHLIC M, 1978, COMP BIOCHEM PHYS B, V60, P281, DOI 10.1016/0305-0491(78)90102-5; Rocha J, 2012, AQUACULTURE, V330, P111, DOI 10.1016/j.aquaculture.2011.12.024; ROER R, 1984, AM ZOOL, V24, P893; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shechter A, 2008, BIOL BULL-US, V214, P122, DOI 10.2307/25066669; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; SKINNER D M, 1985, P43; STEVENSON JR, 1972, AM ZOOL, V12, P373; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TRAVIS DF, 1963, ACTA HISTOCHEM, V15, P251; TRAVIS DF, 1960, BIOL BULL, V118, P137, DOI 10.2307/1539064; UENO M, 1980, J EXP ZOOL, V213, P161, DOI 10.1002/jez.1402130202; UENO M, 1984, HISTOCHEMISTRY, V80, P213, DOI 10.1007/BF00495768; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Yudkovski Y, 2010, COMP BIOCHEM PHYS D, V5, P171, DOI 10.1016/j.cbd.2010.03.010; Zou E, 1999, MAR BIOL, V133, P97, DOI 10.1007/s002270050447	47	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0122602	10.1371/journal.pone.0122602	http://dx.doi.org/10.1371/journal.pone.0122602			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919476	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400016
J	Steck, SE; Arab, L; Zhang, HM; Bensen, JT; Fontham, ETH; Johnson, CS; Mohler, JL; Smith, GJ; Su, JL; Trump, DL; Woloszynska-Read, A				Steck, Susan E.; Arab, Lenore; Zhang, Hongmei; Bensen, Jeannette T.; Fontham, Elizabeth T. H.; Johnson, Candace S.; Mohler, James L.; Smith, Gary J.; Su, Joseph L.; Trump, Donald L.; Woloszynska-Read, Anna			Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP	PLOS ONE			English	Article							SERUM VITAMIN-D; D-BINDING-PROTEIN; UNITED-STATES; RACIAL-DIFFERENCES; SUBSEQUENT RISK; D INSUFFICIENCY; BREAST-CANCER; PREVENTION; 1,25-DIHYDROXYVITAMIN-D; ADULTS	Background African Americans (AAs) have lower circulating 25-hydroxyvitamin D3 [25(OH) D3] concentrations and higher prostate cancer (CaP) aggressiveness than other racial/ethnic groups. The purpose of the current study was to examine the relationship between plasma 25(OH) D3, African ancestry and CaP aggressiveness among AAs and European Americans (EAs). Methods Plasma 25(OH) D3 was measured using LC-MS/MS (Liquid Chromatography Tandem Mass Spectrometry) in 537 AA and 663 EA newly-diagnosed CaP patients from the North Carolina-Louisiana Prostate Cancer Project (PCaP) classified as having either 'high' or 'low' aggressive disease based on clinical stage, Gleason grade and prostate specific antigen at diagnosis. Mean plasma 25(OH) D3 concentrations were compared by proportion of African ancestry. Logistic regression was used to calculate multivariable adjusted odds ratios (OR) and 95% confidence intervals (95% CI) for high aggressive CaP by tertile of plasma 25(OH) D3. Results AAs with highest percent African ancestry (>95%) had the lowest mean plasma 25(OH)D3 concentrations. Overall, plasma 25(OH) D3 was associated positively with aggressiveness among AA men, an association that was modified by calcium intake (ORT3vs.T1: 2.23, 95% CI: 1.26-3.95 among men with low calcium intake, and ORT3vs.T1: 0.19, 95% CI: 0.05-0.70 among men with high calcium intake). Among EAs, the point estimates of the ORs were <1.0 for the upper tertiles with CIs that included the null. Conclusions Among AAs, plasma 25(OH)D3 was associated positively with CaP aggressiveness among men with low calcium intake and inversely among men with high calcium intake. The clinical significance of circulating concentrations of 25(OH)D3 and interactions with calcium intake in the AA population warrants further study.	[Steck, Susan E.] Univ S Carolina, Arnold Sch Publ Hlth, Canc Prevent & Control Program, Ctr Res Nutr & Hlth Dispar,Dept Epidemiol & Biost, Columbia, SC 29208 USA; [Arab, Lenore] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Zhang, Hongmei] Univ Memphis, Memphis, TN 38152 USA; [Bensen, Jeannette T.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Fontham, Elizabeth T. H.] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Johnson, Candace S.; Mohler, James L.; Smith, Gary J.; Trump, Donald L.; Woloszynska-Read, Anna] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Su, Joseph L.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Memphis; University of North Carolina; University of North Carolina Chapel Hill; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Roswell Park Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Woloszynska-Read, A (corresponding author), Roswell Pk Canc Inst, Buffalo, NY 14263 USA.	anna.woloszynska-read@roswellpark.org	Steck, Susan E/G-5736-2013; Facility, Biospecimen Processing/AAC-7837-2022	Steck, Susan E/0000-0002-3201-9537; 	United States Department of Defense [11-1-0568, W81WH11-1-0308PCa]; National Institutes of Health [CA067267, CA137650, CA016056]; NATIONAL CANCER INSTITUTE [R01CA067267, R21CA137650, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	United States Department of Defense 11-1-0568 http://cdmrp.army.mil/default.shtml SES, CSJ; United States Department of Defense W81WH11-1-0308PCa http://cdmrp.army.mil/default.shtml AWR; National Institutes of Health CA067267, CA137650 and CA016056 http://www.nih.gov DLT and CSJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Albanes D, 2011, CANCER EPIDEM BIOMAR, V20, P1850, DOI 10.1158/1055-9965.EPI-11-0403; Amrein K, 2014, J CLIN ENDOCR METAB; [Anonymous], 2011, DIETARY REFERENCE IN; Arab L, 2003, J AM DIET ASSOC, V103, P1008, DOI 10.1016/S0002-8223(03)00474-7; Arab L, 2010, FASEB J, V24, P325322; ARNAUD J, 1993, HUM GENET, V92, P183; Barnett CM, 2010, CANC CAUSES CONTROL; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Brandstedt J, 2012, CANCER CAUSE CONTROL, V23, P1377, DOI 10.1007/s10552-012-9948-3; BRAUN A, 1992, HUM GENET, V89, P401; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P235, DOI 10.1007/BF00051795; Chandler PD, 2014, CANC EPIDEMIOL BIOMA; Chen TC, 2003, TRENDS ENDOCRIN MET, V14, P423, DOI 10.1016/j.tem.2003.09.004; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; CONSTANS J, 1985, AM J PHYS ANTHROPOL, V68, P107, DOI 10.1002/ajpa.1330680110; CORDER EH, 1995, CANCER EPIDEM BIOMAR, V4, P655; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Egan KM, 2008, CANCER CAUSE CONTROL, V19, P527, DOI 10.1007/s10552-008-9115-z; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P2784, DOI 10.1158/1055-9965.EPI-07-0672; Freedman DM, 2013, AM J EPIDEMIOL, V177, P180, DOI 10.1093/aje/kws223; Gann PH, 1996, CANCER EPIDEM BIOMAR, V5, P121; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Gilbert R, 2012, INT J CANCER, V131, P1187, DOI 10.1002/ijc.27327; Gilbert R, 2011, CANCER CAUSE CONTROL, V22, P319, DOI 10.1007/s10552-010-9706-3; Giovannucci E, 2009, ANN EPIDEMIOL, V19, P84, DOI 10.1016/j.annepidem.2007.12.002; Grant WB, 2008, J NATL MED ASSOC, V100, P1040, DOI 10.1016/S0027-9684(15)31441-3; Gupta D, 2009, PROSTATE CANCER P D, V12, P215, DOI 10.1038/pcan.2009.7; Hebert JR, 2009, CANCER-AM CANCER SOC, V115, P2539, DOI 10.1002/cncr.24270; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Jacobs ET, 2004, J STEROID BIOCHEM, V89-90, P533, DOI 10.1016/j.jsbmb.2004.03.063; Johnson CS, 2002, CANCER METAST REV, V21, P147, DOI 10.1023/A:1020836226594; Krishnan AV, 2003, J CELL BIOCHEM, V88, P363, DOI 10.1002/jcb.10334; Kristal AR, 2014, CANCER EPIDEM BIOMAR, V23, P1494, DOI 10.1158/1055-9965.EPI-14-0115; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Moore CE, 2005, J NUTR, V135, P2478, DOI 10.1093/jn/135.10.2478; Moreno J, 2005, J STEROID BIOCHEM, V97, P31, DOI 10.1016/j.jsbmb.2005.06.012; Murphy AB, 2014, CLIN CANCER RES, V20, P2289, DOI 10.1158/1078-0432.CCR-13-3085; Murphy AB, 2012, AM J MENS HEALTH, V6, P420, DOI 10.1177/1557988312437240; Nomura AMY, 1998, CANCER CAUSE CONTROL, V9, P425, DOI 10.1023/A:1008875819232; Ordonez-Mena JM, 2013, CANCER EPIDEM BIOMAR, V22, P905, DOI 10.1158/1055-9965.EPI-12-1332; Park SY, 2010, EUR J CANCER, V46, P932, DOI 10.1016/j.ejca.2009.12.030; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Schenk JM, 2014, CANCER EPIDEM BIOMAR, V23, P1484, DOI 10.1158/1055-9965.EPI-13-1340; Schroeder JC, 2006, PROSTATE, V66, P1162, DOI 10.1002/pros.20449; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Signorello LB, 2010, CANCER EPIDEM BIOMAR, V19, P2325, DOI 10.1158/1055-9965.EPI-10-0482; Sucheston LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030950; Taksler GB, 2013, CANCER-AM CANCER SOC, V119, P3195, DOI 10.1002/cncr.28127; Travis RC, 2009, AM J EPIDEMIOL, V169, P1223, DOI 10.1093/aje/kwp022; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162; Yin L, 2009, CANCER EPIDEMIOL, V33, P435, DOI 10.1016/j.canep.2009.10.014; Zadshir Ashraf, 2005, Ethn Dis, V15, pS5	64	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125151	10.1371/journal.pone.0125151	http://dx.doi.org/10.1371/journal.pone.0125151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919866	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400074
J	Cydzik, M; Abdul-Wahid, A; Park, S; Bourdeau, A; Bowden, K; Prodeus, A; Kollara, A; Brown, TJ; Ringuette, MJ; Gariepy, J				Cydzik, Marzena; Abdul-Wahid, Aws; Park, Soyeon; Bourdeau, Annie; Bowden, Katherine; Prodeus, Aaron; Kollara, Alexandra; Brown, Theodore J.; Ringuette, Maurice J.; Gariepy, Jean			Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis	FASEB JOURNAL			English	Article						HUVECs; signal transduction; surface plasmon resonance	ENDOTHELIAL GROWTH-FACTOR; CALCIUM-BINDING; EXTRACELLULAR-MATRIX; PROCOLLAGEN-I; SPARC; CELLS; BM-40; CALMODULIN; DOMAIN; VASCULOGENESIS	VEGF-A (VEGF) drives angiogenesis through activation of downstream effectors to promote endothelial cell proliferation and migration. Although VEGF binds both VEGF receptor 1 (R1) and receptor 2 (R2), its proangiogenic effects are attributed to R2. Secreted protein, acidic, rich in cysteine (SPARC) is a matricellular glycoprotein thought to inhibit angiogenesis by preventing VEGF from activating R1, but not R2. Because R2 rather than R1 mediates proangiogenic activities of VEGF, the role of human SPARC in angiogenesis was reevaluated. We confirm that association of SPARC with VEGF inhibits VEGF-induced HUVEC adherence, motility, and proliferation in vitro and blocks VEGF-induced blood vessel formation ex vivo. SPARC decreases VEGF-induced phosphorylation of R2 and downstream effectors ERK, Akt, and p38 MAPK as shown by Western blot and/or phosphoflow analysis. Surface plasmon resonance indicates that SPARC binds slowly to VEGF (0.865 +/- 0.023 x 10(4) M-1 s(-1)) with a K-d of 150 nM, forming a stable complex that dissociates slowly (1.26 +/- 0.0033 x 10(-3) s(-1)). Only domain III of SPARC binds VEGF, exhibiting a 15-fold higher affinity than full-length SPARC. These findings support a model whereby SPARC regulates angiogenesis by sequestering VEGF, thus restricting the activation of R2 and the subsequent activation of downstream targets critical for endothelial cell functions-Cydzik, M., Abdul-Wahid, A., Park, S., Bourdeau, A., Bowden, K., Prodeus, A., Kollara, A., Brown, T. J., Ringuette, M. J., Gari ' epy, J. Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis.	[Cydzik, Marzena; Abdul-Wahid, Aws; Bourdeau, Annie; Prodeus, Aaron; Gariepy, Jean] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Cydzik, Marzena; Abdul-Wahid, Aws; Prodeus, Aaron; Gariepy, Jean] Univ Toronto, Dept Med Biophys & Pharmaceut Sci, Toronto, ON M5S 1A1, Canada; [Park, Soyeon; Bowden, Katherine; Ringuette, Maurice J.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 1A1, Canada; [Bourdeau, Annie] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada; [Kollara, Alexandra; Brown, Theodore J.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON M5S 1A1, Canada; [Kollara, Alexandra; Brown, Theodore J.] Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Gariepy, J (corresponding author), Sunnybrook Res Inst, 2075 Bayview Ave,Room M7-434, Toronto, ON M4N 3M5, Canada.	gariepy@sri.utoronto.ca	Brown, Theodore J./E-2192-2013	Brown, Theodore J./0000-0002-3074-4516; Prodeus, Aaron/0000-0002-0719-3891	Canadian Institutes of Health; Natural Sciences and Engineering Research Council of the Canada Collaborative Health Research Program; Canadian Institutes of Health Research [MOP126160, MOP125862]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of the Canada Collaborative Health Research Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Drs. Yutaka Amemiya and Arun Seth, from the Sunnybrook Research Institute Genomics Core Facility, for help with digital reverse transcription-polymerase chain reaction. This study was supported by the Canadian Institutes of Health and the Natural Sciences and Engineering Research Council of the Canada Collaborative Health Research Program (to M.J.R., T.J.B., and J.G.), and by operating grants from the Canadian Institutes of Health Research (MOP126160 to A.B., and MOP125862 to J.G.).	Abdul-Wahid A, 2014, MOL ONCOL, V8, P337, DOI 10.1016/j.molonc.2013.12.002; Abdul-Wahid A, 2012, INT J CANCER, V131, P2839, DOI 10.1002/ijc.27582; ANDERSON WB, 1985, CURR TOP CELL REGUL, V27, P455; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Baratta C.A., 2013, EVOLUTION EXTRACELLU, P191, DOI [10.1007/978-3-642-36002-2_7, DOI 10.1007/978-3-642-36002-2_7]; Bhattacharya Resham, 2008, J Mol Signal, V3, P8, DOI 10.1186/1750-2187-3-8; Bhoopathi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036093; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Cudmore MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1977; DAMJANOVSKI S, 1994, INT J DEV BIOL, V38, P439; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; Ganji PN, 2013, ANGIOGENESIS, V16, P903, DOI 10.1007/s10456-013-9364-7; GOPALAKRISHNA R, 1985, BIOCHIM BIOPHYS ACTA, V844, P265, DOI 10.1016/0167-4889(85)90099-0; Gorantla B, 2013, ANGIOGENESIS, V16, P85, DOI 10.1007/s10456-012-9301-1; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kato Y, 2001, BIOCHEM BIOPH RES CO, V287, P422, DOI 10.1006/bbrc.2001.5622; Kearney JB, 2002, BLOOD, V99, P2397, DOI 10.1182/blood.V99.7.2397; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; LAPORTE DC, 1980, BIOCHEMISTRY-US, V19, P3814, DOI 10.1021/bi00557a025; Margulies David H., 1993, Journal of Molecular Recognition, V6, P59, DOI 10.1002/jmr.300060204; MAURER P, 1992, EUR J BIOCHEM, V205, P233, DOI 10.1111/j.1432-1033.1992.tb16773.x; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; McCluskey AJ, 2007, PROTEIN SCI, V16, P2726, DOI 10.1110/ps.072894407; Nozaki M, 2006, J CLIN INVEST, V116, P422, DOI 10.1172/JCI26316; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; PERETZ D, 1992, BIOCHEM BIOPH RES CO, V182, P1340, DOI 10.1016/0006-291X(92)91880-Y; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Reed MJ, 2005, J CELL PHYSIOL, V204, P800, DOI 10.1002/jcp.20348; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; TERMAN BI, 1994, GROWTH FACTORS, V11, P187, DOI 10.3109/08977199409046916; Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Zhang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044618	43	12	12	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3493	3505		10.1096/fj.15-271775	http://dx.doi.org/10.1096/fj.15-271775			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25921830				2022-12-26	WOS:000358796900035
J	Cha, J; Burnum-Johnson, KE; Bartos, A; Li, YJ; Baker, ES; Tilton, SC; Webb-Robertson, BJM; Piehowski, PD; Monroe, ME; Jegga, AG; Murata, S; Hirota, Y; Dey, SK				Cha, Jeeyeon; Burnum-Johnson, Kristin E.; Bartos, Amanda; Li, Yingju; Baker, Erin S.; Tilton, Susan C.; Webb-Robertson, Bobbie-Jo M.; Piehowski, Paul D.; Monroe, Matthew E.; Jegga, Anil G.; Murata, Shigeo; Hirota, Yasushi; Dey, Sudhansu K.			Muscle Segment Homeobox Genes Direct Embryonic Diapause by Limiting Inflammation in the Uterus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-QUALITY CONTROL; NF-KAPPA-B; UBIQUITIN-PROTEASOME SYSTEM; UTERINE RECEPTIVITY; PROTEOMICS DATA; PEPTIDE IDENTIFICATION; MOLECULAR CHAPERONES; PARKINSONS-DISEASE; SOFTWARE PACKAGE; MOUSE UTERUS	Embryonic diapause is a reproductive strategy widespread in the animal kingdom. This phenomenon is defined by a temporary arrest in blastocyst growth and metabolic activity within a quiescent uterus without implantation until the environmental and maternal milieu become favorable for pregnancy to progress. We found that uterine Msx expression persists during diapause across species; their inactivation in the mouse uterus results in termination of diapause with the development of implantation-like responses ("pseudoimplantation") that ultimately succumbed to resorption. To understand the cause of this failure, we compared proteome profiles between floxed and Msx-deleted uteri. In deleted uteri, several functional networks, including transcription/translation, ubiquitin-proteasome, inflammation, and endoplasmic reticulum stress, were dysregulated. Computational modeling predicted intersection of these pathways on an enhanced inflammatory signature. Further studies showed that this signature was reflected in increased phosphorylated I kappa B levels and nuclear NF kappa B in deleted uteri. This was associated with enhanced proteasome activity and endoplasmic reticulum stress. Interestingly, treatment with anti-inflammatory glucocorticoid (dexamethasone) reduced the inflammatory signature with improvement of the diapause phenotype. These findings highlight an unexpected role of uterine Msx in limiting aberrant inflammatory responses to maintain embryonic diapause.	[Cha, Jeeyeon; Bartos, Amanda; Li, Yingju; Piehowski, Paul D.; Dey, Sudhansu K.] Cincinnati Childrens Hosp, Med Ctr, Div Reprod Sci, Cincinnati, OH 45229 USA; [Jegga, Anil G.] Cincinnati Childrens Hosp, Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Burnum-Johnson, Kristin E.; Baker, Erin S.; Tilton, Susan C.; Webb-Robertson, Bobbie-Jo M.; Monroe, Matthew E.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99354 USA; [Tilton, Susan C.] Oregon State Univ, Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Murata, Shigeo] Univ Tokyo, Lab Prot Metab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Hirota, Yasushi] Univ Tokyo, Dept Obstet & Gynecol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Oregon State University; University of Tokyo; University of Tokyo	Dey, SK (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Reprod Sci, Cincinnati, OH 45229 USA.	sk.dey@cchmc.org	Monroe, Matthew/L-1157-2019; Regan, Clinton/E-6250-2012; Jegga, Anil/H-6140-2011; Hirota, Yasushi/AAD-8713-2020; Murata, Shigeo/A-1426-2010; Baker, Erin S/K-3979-2017; Piehowski, Paul D/AAH-5497-2019; Baker, Erin/AAS-4038-2021; Webb-Robertson, Bobbie-Jo/K-8230-2019; Burnum, Kristin E/B-1308-2011	Jegga, Anil/0000-0002-4881-7752; Hirota, Yasushi/0000-0003-0241-9780; Murata, Shigeo/0000-0002-3177-3503; Baker, Erin S/0000-0001-5246-2213; Piehowski, Paul D/0000-0001-5108-2227; Burnum, Kristin E/0000-0002-2722-4149; Dewar, Amanda/0000-0003-1579-3202; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397	National Institutes of Health [R01ES022190, U01CA184783-01, R01HD068524, P01CA77839]; Laboratory Directed Research and Development Program at the Pacific Northwest National Laboratory [DE-AC05-76RL01830]; Japan Society for the Promotion of Science; Astellas Foundation for Research on Metabolic Disorders; Cell Science Research Foundation; Tokyo Biochemical Research Foundation; Nakatomi Foundation; March of Dimes; National Research Service Award Fellowship of the University of Cincinnati Medical Scientist Training Program [F30AG040858]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068524] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA184783, P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG040858] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratory Directed Research and Development Program at the Pacific Northwest National Laboratory; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Tokyo Biochemical Research Foundation; Nakatomi Foundation; March of Dimes(March of Dimes); National Research Service Award Fellowship of the University of Cincinnati Medical Scientist Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by National Institutes of Health Grants R01ES022190, U01CA184783-01, R01HD068524, and P01CA77839. This work was also supported in part by the Laboratory Directed Research and Development Program at the Pacific Northwest National Laboratory (operated by Battelle for the Department of Energy under Contract DE-AC05-76RL01830), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; grants from the Astellas Foundation for Research on Metabolic Disorders, the Cell Science Research Foundation, the Tokyo Biochemical Research Foundation, and the Nakatomi Foundation (to Y. H.); grants the March of Dimes (to S. K. D.); and National Research Service Award Fellowship F30AG040858 of the University of Cincinnati Medical Scientist Training Program (to J. C.).	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Baker ES, 2007, J AM SOC MASS SPECTR, V18, P1176, DOI 10.1016/j.jasms.2007.03.031; Baker ES, 2014, MOL CELL PROTEOMICS, V13, P1119, DOI 10.1074/mcp.M113.034595; Baker ES, 2010, J PROTEOME RES, V9, P997, DOI 10.1021/pr900888b; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; BIGSBY RM, 1993, J STEROID BIOCHEM, V46, P253, DOI 10.1016/0960-0760(93)90301-C; Burnum KE, 2012, ENDOCRINOLOGY, V153, P4568, DOI 10.1210/en.2012-1335; Cha J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130035; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Das SK, 2000, J BIOL CHEM, V275, P28834, DOI 10.1074/jbc.M003827200; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Horn M, 2014, DEV CELL, V28, P697, DOI 10.1016/j.devcel.2014.01.028; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; JOHNSON DC, 1980, BIOL REPROD, V22, P1136, DOI 10.1093/biolreprod/22.5.1136; Kastle M, 2012, PROG MOL BIOL TRANSL, V109, P113, DOI 10.1016/B978-0-12-397863-9.00004-3; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kawabata T, 2012, J BIOL CHEM, V287, P10289, DOI 10.1074/jbc.M111.319426; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; King AM, 2014, J EXP BIOL, V217, P1719, DOI 10.1242/jeb.100081; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lanigan F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2621; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Matzke MM, 2011, BIOINFORMATICS, V27, P2866, DOI 10.1093/bioinformatics/btr479; MCLAREN A, 1968, J ENDOCRINOL, V42, P453, DOI 10.1677/joe.0.0420453; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Piehowski PD, 2013, PROTEOMICS, V13, P766, DOI 10.1002/pmic.201200096; PSYCHOYOS A, 1973, HDB PHYSL, P187; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Schwartz AL, 1999, ANNU REV MED, V50, P57; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman MY, 2011, ONCOTARGET, V2, P356; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Tranguch S, 2007, J CLIN INVEST, V117, P1824, DOI 10.1172/JCI31622; Vane JR, 1998, INFLAMM RES, V47, pS78; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037647; Wang JQ, 2011, DEV CELL, V21, P575, DOI 10.1016/j.devcel.2011.07.003; Webb-Robertson BJM, 2014, MOL CELL PROTEOMICS, V13, P3639, DOI 10.1074/mcp.M113.030932; Webb-Robertson BJM, 2011, PROTEOMICS, V11, P4736, DOI 10.1002/pmic.201100078; Webb-Robertson BJM, 2010, J PROTEOME RES, V9, P5748, DOI 10.1021/pr1005247; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yang F, 2012, CELL STRESS CHAPERON, V17, P577, DOI 10.1007/s12192-012-0333-7; YOSHINAGA K, 1961, J REPROD FERTIL, V2, P35, DOI 10.1530/jrf.0.0020035; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	72	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15337	15349		10.1074/jbc.M115.655001	http://dx.doi.org/10.1074/jbc.M115.655001			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25931120	Green Published, hybrid			2022-12-26	WOS:000356177300044
J	Zhang, HS; Chen, Y; Fan, L; Xi, QL; Wu, GH; Li, XX; Yuan, TL; He, SQ; Yu, Y; Shao, ML; Liu, Y; Bai, CG; Ling, ZQ; Li, M; Liu, Y; Fang, J				Zhang, Hai-Sheng; Chen, Ying; Fan, Li; Xi, Qiu-Lei; Wu, Guo-Hao; Li, Xiu-Xiu; Yuan, Tang-Long; He, Sheng-Qi; Yu, Yue; Shao, Meng-Le; Liu, Yang; Bai, Chen-Guang; Ling, Zhi-Qiang; Li, Min; Liu, Yong; Fang, Jing			The Endoplasmic Reticulum Stress Sensor IRE1 alpha in Intestinal Epithelial Cells Is Essential for Protecting against Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN; ER STRESS; LIPOPOLYSACCHARIDE; APOPTOSIS; BARRIER; ACTIVATION; MECHANISMS; INDUCTION; DISEASE; DAMAGE	Intestinal epithelial cells (IECs) have critical roles in maintaining homeostasis of intestinal epithelium. Endoplasmic reticulum (ER) stress is implicated in intestinal epithelium homeostasis and inflammatory bowel disease; however, it remains elusive whether IRE1 alpha, a major sensor of ER stress, is directly involved in these processes. We demonstrate here that genetic ablation of Ire1 alpha in IECs leads to spontaneous colitis in mice. Deletion of IRE1 alpha in IECs results in loss of goblet cells and failure of intestinal epithelial barrier function. IRE1 alpha deficiency induces cell apoptosis through induction of CHOP, the pro-apoptotic protein, and sensitizes cells to lipopolysaccharide, an endotoxin from bacteria. IRE1 alpha deficiency confers upon mice higher susceptibility to chemical-induced colitis. These results suggest that IRE1 alpha functions to maintain the intestinal epithelial homeostasis and plays an important role in defending against inflammation bowel diseases.	[Zhang, Hai-Sheng; Chen, Ying; Fan, Li; Li, Xiu-Xiu; Yuan, Tang-Long; He, Sheng-Qi; Yu, Yue; Shao, Meng-Le; Liu, Yang; Liu, Yong; Fang, Jing] Chinese Acad Sci, Lab Food Safety Res, Lab Nutr & Metab, Inst Nutrit Sci, Shanghai 200031, Peoples R China; [Xi, Qiu-Lei; Wu, Guo-Hao; Fang, Jing] Fudan Univ, Sch Med, Dept Surg, Zhongshan Hosp, Shanghai 200030, Peoples R China; [Bai, Chen-Guang] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Ling, Zhi-Qiang] Zhejiang Canc Hosp, Dept Pathol, Zhejiang Canc Res Inst, Hangzhou 310022, Zhejiang, Peoples R China; [Ling, Zhi-Qiang] Zhejiang Canc Ctr, Hangzhou 310022, Zhejiang, Peoples R China; [Fang, Jing] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100021, Peoples R China; [Li, Min] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK 73104 USA	Chinese Academy of Sciences; Fudan University; Naval Medical University; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center	Liu, Y (corresponding author), Chinese Acad Sci, Lab Food Safety Res, Lab Nutr & Metab, Inst Nutrit Sci, Shanghai 200031, Peoples R China.	liuy@sibs.ac.cn; jfang@sibs.ac.cn	Shao, Mengle/AAH-8392-2019	Shao, Mengle/0000-0002-5488-9904; Wu, Guohao/0000-0001-9490-4200	Natural Science Foundation of China [31270829, 31230036, 81321062, 91213306]; Shanghai Ministry of Science and Technology [13JC1406200]; Shanghai Institutes for Biological Sciences [2012CSP003]; Chinese Academy of Sciences/International Partnership Program for Creative Research Teams International Partnership Program for Creative Research Teams; Ministry of Science and Technology (973 Programs) [2012CB524900]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Ministry of Science and Technology; Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences/International Partnership Program for Creative Research Teams International Partnership Program for Creative Research Teams; Ministry of Science and Technology (973 Programs)	This work was supported by Natural Science Foundation of China Grant 31270829, Shanghai Ministry of Science and Technology Grant 13JC1406200, Shanghai Institutes for Biological Sciences Grant 2012CSP003, the Chinese Academy of Sciences/International Partnership Program for Creative Research Teams International Partnership Program for Creative Research Teams (to J. F.), and the Ministry of Science and Technology (973 Programs 2012CB524900) and Natural Science Foundation of China Grants 31230036, 81321062, and 91213306 (to Y. L.).	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Alhusaini S, 2010, BIOCHEM BIOPH RES CO, V397, P472, DOI 10.1016/j.bbrc.2010.05.138; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Braus NA, 2009, CLIN IMMUNOL, V132, P1, DOI 10.1016/j.clim.2009.02.006; Colgan SP, 2013, INFLAMM BOWEL DIS, V19, P2238, DOI 10.1097/MIB.0b013e31828dcaaf; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Dong ML, 2013, BBA-MOL BASIS DIS, V1832, P848, DOI 10.1016/j.bbadis.2013.02.023; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Eri RD, 2011, MUCOSAL IMMUNOL, V4, P354, DOI 10.1038/mi.2010.74; HALL PA, 1994, J CELL SCI, V107, P3569; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Itoh H, 1999, J CLIN INVEST, V104, P1539, DOI 10.1172/JCI6211; Jarry A, 2008, J CLIN INVEST, V118, P1132, DOI 10.1172/JCI32140; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; MORI K, 1993, CELL, V74, P743; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rose WA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00574; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; SETH R, 1991, LANCET, V338, P83, DOI 10.1016/0140-6736(91)90077-3; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tsuru A, 2013, P NATL ACAD SCI USA, V110, P2864, DOI 10.1073/pnas.1212484110; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yue C, 2013, INFLAMM RES, V62, P407, DOI 10.1007/s00011-013-0593-4	47	45	47	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15327	15336		10.1074/jbc.M114.633560	http://dx.doi.org/10.1074/jbc.M114.633560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25925952	Green Published, hybrid			2022-12-26	WOS:000356177300043
J	Chen, JR; Lazarenko, OP; Blackburn, ML; Mercer, KE; Badger, TM; Ronis, MJJ				Chen, Jin-Ran; Lazarenko, Oxana P.; Blackburn, Michael L.; Mercer, Kelly E.; Badger, Thomas M.; Ronis, Martin J. J.			p47(phox)-Nox2-dependent ROS Signaling Inhibits Early Bone Development in Mice but Protects against Skeletal Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE OXYGEN; NADPH OXIDASE; LIFE-SPAN; SENESCENCE PATHWAYS; OXIDATIVE STRESS; DAMAGE THEORY; NOX FAMILY; DIFFERENTIATION; ACTIVATION; CELLS	Bone remodeling is age-dependently regulated and changes dramatically during the course of development. Progressive accumulation of reactive oxygen species (ROS) has been suspected to be the leading cause of many inflammatory and degenerative diseases, as well as an important factor underlying many effects of aging. In contrast, how reduced ROS signaling regulates inflammation and remodeling in bone remains unknown. Here, we utilized a p47(phox) knock-out mouse model, in which an essential cytosolic co-activator of Nox2 is lost, to characterize bone metabolism at 6 weeks and 2 years of age. Compared with their age-matched wild type controls, loss of Nox2 function in p47(phox-/-) mice resulted in age-related switch of bone mass and strength. Differences in bone mass were associated with increased bone formation in 6-week-old p47(phox-/-) mice but decreased in 2-year-old p47(phox-/-) mice. Despite decreases in ROS generation in bone marrow cells and p47(phox)-Nox2 signaling in osteoblastic cells, 2-year-old p47(phox-/-) mice showed increased senescence-associated secretory phenotype in bone compared with their wild type controls. These in vivo findings were mechanistically recapitulated in ex vivo cell culture of primary fetal calvarial cells from p47(phox-/-) mice. These cells showed accelerated cell senescence pathway accompanied by increased inflammation. These data indicate that the observed age-related switch of bone mass in p47(phox)-deficient mice occurs through an increased inflammatory milieu in bone and that p47(phox)-Nox2-dependent physiological ROS signaling suppresses inflammation in aging.	[Chen, Jin-Ran; Lazarenko, Oxana P.; Blackburn, Michael L.; Mercer, Kelly E.; Badger, Thomas M.; Ronis, Martin J. J.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Chen, Jin-Ran; Lazarenko, Oxana P.; Blackburn, Michael L.; Badger, Thomas M.; Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, Slot 512-20B,15 Childrens Way, Little Rock, AR 72202 USA.	chenjinran@uams.edu	Regan, Clinton/E-6250-2012		United States Department of Agriculture/Agricultural Research Service [6251-51000-003]; National Institutes of Health [RO1 AA18282]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018282] Funding Source: NIH RePORTER	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by United States Department of Agriculture/Agricultural Research Service Grant 6251-51000-003 to the Arkansas Children's Nutrition Center, and in part by National Institutes of Health Grant RO1 AA18282.	Almeida Maria, 2012, Bonekey Rep, V1; Arakaki N, 2013, BIOMED RES-TOKYO, V34, P161, DOI 10.2220/biomedres.34.161; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Chen JR, 2008, J PHARMACOL EXP THER, V324, P50, DOI 10.1124/jpet.107.130351; Chen JR, 2014, J BONE MINER RES, V29, P1043, DOI 10.1002/jbmr.2034; Chen JR, 2013, FASEB J, V27, P3514, DOI 10.1096/fj.12-226464; Chen JR, 2011, J PHARMACOL EXP THER, V336, P734, DOI 10.1124/jpet.110.175091; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Chen JR, 2009, J BONE MINER RES, V24, P221, DOI 10.1359/JBMR.081011; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hagenow K, 2009, J IMMUNOL, V183, P874, DOI 10.4049/jimmunol.0900966; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Howcroft TK, 2013, AGING-US, V5, P84, DOI 10.18632/aging.100531; Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x; KEY LL, 1990, BONE, V11, P115, DOI 10.1016/8756-3282(90)90058-7; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Maghzal GJ, 2012, FREE RADICAL BIO MED, V53, P1903, DOI 10.1016/j.freeradbiomed.2012.09.002; Marks DJB, 2009, AM J GASTROENTEROL, V104, P117, DOI 10.1038/ajg.2008.72; Murray TVA, 2013, J BIOL CHEM, V288, P15745, DOI 10.1074/jbc.M112.439844; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Schrenzel J, 1998, NATURE, V392, P734, DOI 10.1038/33725; Tan CY, 2014, ARTERIOSCL THROM VAS, V34, P768, DOI 10.1161/ATVBAHA.113.302847; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang S, 2002, J CELL BIOCHEM, V84, P645, DOI 10.1002/jcb.10074; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Zhang J, 2014, FASEB J, V28, P3134, DOI 10.1096/fj.13-243659; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070438	43	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14692	14704		10.1074/jbc.M114.633461	http://dx.doi.org/10.1074/jbc.M114.633461			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25922068	Green Published, hybrid			2022-12-26	WOS:000355754600039
J	Bortolin, RH; Abreu, BJDA; Ururahy, MAG; de Souza, KSC; Bezerra, JF; Loureiro, MB; da Silva, FS; Marques, DED; Batista, AAD; Oliveira, G; Luchessi, AD; Lima, VMGDM; Miranda, CES; Fook, MVL; Almeida, MD; de Rezende, LA; de Rezende, AA				Bortolin, Raul Hernandes; da Graca Azevedo Abreu, Bento Joao; Galvao Ururahy, Marcela Abbott; Costa de Souza, Karla Simone; Bezerra, Joao Felipe; Loureiro, Melina Bezerra; da Silva, Flavio Santos; da Silva Marques, Dafiny Emanuele; de Sousa Batista, Angelica Amanda; Oliveira, Gisele; Luchessi, Andre Ducati; Duarte Moreira Lima, Valeria Morgiana Gualberto; Saraiva Miranda, Carlos Eduardo; Lia Fook, Marcus Vinicius; Almeida, Maria das Gracas; de Rezende, Luciana Augusto; de Rezende, Adriana Augusto			Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats	PLOS ONE			English	Article							OSTEOBLASTIC MC3T3-E1 CELLS; GENE-EXPRESSION; MINERAL DENSITY; ALKALINE-PHOSPHATASE; MESSENGER-RNA; BIOCHEMICAL MARKERS; GELATINASE-B; STREPTOZOTOCIN; INSULIN; TYPE-1	Several studies have established an association between diabetes and alterations in bone metabolism; however, the underlying mechanism is not well established. Although zinc is recognized as a potential preventive agent against diabetes-induced bone loss, there is no evidence demonstrating its effect in chronic diabetic conditions. This study evaluated the effects of zinc supplementation in a chronic (90 days) type 1 diabetes-induced bone-loss model. Male Wistar rats were distributed in three groups: control, type 1 diabetes mellitus (T1DM), and T1DM plus zinc supplementation (T1DMS). Serum biochemical analysis; tibia histomorphometric, biomechanical, and collagen-content analyses; and femur mRNA expression were evaluated. Relative to T1DM, the zinc-supplemented group showed increased histomorphometric parameters such as TbWi and BAr and decreased TbSp, increased biomechanical parameters (maximum load, stiffness, ultimate strain, and Young's modulus), and increased type I collagen content. Interestingly, similar values for these parameters were observed between the T1DMS and control groups. These results demonstrate the protective effect of zinc on the maintenance of bone strength and flexibility. In addition, downregulation of OPG, COL1A, and MMP-9 genes was observed in T1DMS, and the anabolic effects of zinc were evidenced by increased OC expression and serum ALP activity, both related to osteoblastogenesis, demonstrating a positive effect on bone formation. In contrast, T1DM showed excessive bone loss, observed through reduced histomorphometric and biomechanical parameters, characterizing diabetes-associated bone loss. The bone loss was also observed through upregulation of OPG, COL1A, and MMP-9 genes. In conclusion, zinc showed a positive effect on the maintenance of bone architecture and biomechanical parameters. Indeed, OC upregulation and control of expression of OPG, COL1A, and MMP-9 mRNAs, even in chronic hyperglycemia, support an anabolic and protective effect of zinc under chronic diabetic conditions. Furthermore, these results indicate that zinc supplementation could act as a complementary therapy in chronic T1DM.	[Bortolin, Raul Hernandes; Galvao Ururahy, Marcela Abbott; Costa de Souza, Karla Simone; Bezerra, Joao Felipe; Loureiro, Melina Bezerra; Luchessi, Andre Ducati; Almeida, Maria das Gracas; de Rezende, Adriana Augusto] Univ Fed Rio Grande do Norte, Dept Clin & Toxicol Anal, BR-59072970 Natal, RN, Brazil; [da Graca Azevedo Abreu, Bento Joao; da Silva, Flavio Santos; da Silva Marques, Dafiny Emanuele] Univ Fed Rio Grande do Norte, Dept Morphol, BR-59072970 Natal, RN, Brazil; [Duarte Moreira Lima, Valeria Morgiana Gualberto] State Univ Paraiba, Dept Pharm, Campina Grande, Paraiba, Brazil; [de Sousa Batista, Angelica Amanda; Oliveira, Gisele; de Rezende, Luciana Augusto] Univ Ribeirao Preto, Dept Chem, Ribeirao Preto, SP, Brazil; [Saraiva Miranda, Carlos Eduardo] Univ Ribeirao Preto, Dept Pharm, Ribeirao Preto, SP, Brazil; [Lia Fook, Marcus Vinicius] Univ Fed Campina Grande, Lab Evaluat & Dev Biomat, Campina Grande, Paraiba, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Estadual da Paraiba; Universidade de Ribeirao Preto; Universidade de Ribeirao Preto; Universidade Federal de Campina Grande	de Rezende, AA (corresponding author), Univ Fed Rio Grande do Norte, Dept Clin & Toxicol Anal, BR-59072970 Natal, RN, Brazil.	adrirezende@yahoo.com	Fook, Marcus Vinicius Lia/AAJ-4528-2021; Bortolin, Raul H/O-2277-2016; Fook, Marcus/AAD-2416-2019; Luchessi, André/S-6429-2019; de Souza, Karla Simone Costa/O-9186-2019; Ururahy, Marcela/R-4536-2018; Bezerra, Joao Felipe/AAE-2500-2020; Abreu, Bento J/E-2607-2015; Almeida, Maria das Graças/O-6579-2018; Costa de Souza, Karla Simone/R-3623-2018; Luchessi, André D/E-7019-2012; DE REZENDE, ADRIANA AUGUSTO/L-4170-2018; bezerra, joao/C-8867-2017	Fook, Marcus Vinicius Lia/0000-0002-8566-920X; Luchessi, André/0000-0002-2758-8102; de Souza, Karla Simone Costa/0000-0002-8541-1444; Ururahy, Marcela/0000-0003-0229-9416; Almeida, Maria das Graças/0000-0002-5587-0922; Costa de Souza, Karla Simone/0000-0002-8541-1444; Luchessi, André D/0000-0002-2758-8102; DE REZENDE, ADRIANA AUGUSTO/0000-0003-2452-4047; Bortolin, Raul Hernandes/0000-0003-3424-3281; bezerra, joao/0000-0002-9978-628X; Abreu, Bento Joao/0000-0001-8010-806X	National Council of scientific and technological development [475801/2010]	National Council of scientific and technological development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	BJGAA received financial support by National Council of scientific and technological development (protocol 475801/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-El-Asrar M, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000128; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; ARREOLA F, 1990, ARCH INVEST MED, V21, P195; AUWERX J, 1988, DIABETES, V37, P8, DOI 10.2337/diabetes.37.1.8; Beattie John H., 1992, Nutrition Research Reviews, V5, P167, DOI 10.1079/NRR19920013; Black MJ, 2010, CARDIOVASC PATHOL, V19, P361, DOI 10.1016/j.carpath.2009.07.003; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; Botolin S, 2007, ENDOCRINOLOGY, V148, P198, DOI 10.1210/en.2006-1006; BOUILLON R, 1995, J CLIN ENDOCR METAB, V80, P1194, DOI 10.1210/jc.80.4.1194; Brzoska MM, 2008, CHEM-BIOL INTERACT, V171, P312, DOI 10.1016/j.cbi.2007.11.007; BUYSSCHAERT M, 1992, DIABETES METAB, V18, P32; Cunha JS, 2014, CELL TISSUE RES, V358, P249, DOI 10.1007/s00441-014-1913-x; Dantas Jailson Araujo, 2006, Acta Scientiarum Health Science, V28, P165; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Duarte VMG, 2005, J BONE MINER METAB, V23, P58, DOI 10.1007/s00774-004-0542-y; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Erdal N, 2012, DIABETES RES CLIN PR, V97, P461, DOI 10.1016/j.diabres.2012.03.005; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Fong L, 2009, BONE, V44, P1151, DOI 10.1016/j.bone.2009.02.011; GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Gur A, 2005, CLIN BIOCHEM, V38, P66, DOI 10.1016/j.clinbiochem.2004.10.001; Hadley KB, 2010, J NUTR BIOCHEM, V21, P297, DOI 10.1016/j.jnutbio.2009.01.002; Hamada Y, 2007, BONE, V40, P1408, DOI 10.1016/j.bone.2006.12.057; Hie M, 2011, INT J MOL MED, V28, P455, DOI 10.3892/ijmm.2011.697; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Iitsuka N, 2013, EUR J PHARMACOL, V714, P41, DOI 10.1016/j.ejphar.2013.05.020; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; Korres N, 2013, WORLD J ORTHOP, V4, P124, DOI 10.5312/wjo.v4.i3.124; Kwun IS, 2010, BONE, V46, P732, DOI 10.1016/j.bone.2009.11.003; LEVIN ME, 1976, NEW ENGL J MED, V294, P241, DOI 10.1056/NEJM197601292940502; de Amorim FPLG, 2008, J MOL HISTOL, V39, P401, DOI 10.1007/s10735-008-9178-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZO JA, 1992, MATRIX, V12, P282, DOI 10.1016/S0934-8832(11)80080-6; Loureiro MB, 2014, DIABETES RES CLIN PR, V103, P452, DOI 10.1016/j.diabres.2013.12.018; Marino R. H., 2012, SCI PLENA, V8, P1; Martin LM, 2007, HISTOCHEM CELL BIOL, V128, P125, DOI 10.1007/s00418-007-0308-4; Maser RE, 2008, DIABETES CARE, V31, P2279, DOI 10.2337/dc08-1068; McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573; McCabe LR, 1995, EXP CELL RES, V218, P255; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; MOHTAI M, 1993, J CLIN INVEST, V92, P179, DOI 10.1172/JCI116547; Motyl K, 2009, BIOL PROCED ONLINE, V11, P296, DOI 10.1007/s12575-009-9000-5; Motyl KJ, 2009, J CELL PHYSIOL, V218, P575, DOI 10.1002/jcp.21626; MunozTorres M, 1996, CALCIFIED TISSUE INT, V58, P316; National Research Council, 2011, GUIDE FOR THE CARE A; Nyman JS, 2011, J BONE MINER RES, V26, P1252, DOI 10.1002/jbmr.326; OKADA Y, 1995, LAB INVEST, V72, P311; Ovesen J, 2001, BONE, V29, P565, DOI 10.1016/S8756-3282(01)00616-0; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Prisby RD, 2008, J ENDOCRINOL, V199, P379, DOI 10.1677/JOE-08-0046; Reddy G, 2001, DIABETES RES CLIN PR, V54, P1, DOI 10.1016/S0168-8227(01)00273-X; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Ryz NR, 2009, ANN NUTR METAB, V54, P218, DOI 10.1159/000224627; SEINO Y, 1995, DIABETES METAB REV, V11, P21, DOI 10.1002/dmr.5610110103; Starup-Linde Jakob, 2013, Front Endocrinol (Lausanne), V4, P21, DOI 10.3389/fendo.2013.00021; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Sunar F, 2009, PAK J PHARM SCI, V22, P150; Thrailkill KM, 2005, DIABETES, V54, P2875, DOI 10.2337/diabetes.54.10.2875; Tsuchida T, 2000, CALCIFIED TISSUE INT, V66, P229, DOI 10.1007/PL00005838; Tuominen JT, 1999, DIABETES CARE, V22, P1196, DOI 10.2337/diacare.22.7.1196; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Uchiyama S, 2003, INT J MOL MED, V12, P949; Uchiyama S, 2008, MOL CELL BIOCHEM, V307, P209, DOI 10.1007/s11010-007-9600-9; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; WEINREB M, 1990, J BONE MINER RES, V5, P831; Wittrant Y, 2008, BONE, V42, P1122, DOI 10.1016/j.bone.2008.02.006; Yamaguchi M, 2003, INT J MOL MED, V12, P755; Yamaguchi M, 2008, MOL CELL BIOCHEM, V312, P157, DOI 10.1007/s11010-008-9731-7; Yamaguchi M, 2012, MOL CELL BIOCHEM, V366, P201, DOI 10.1007/s11010-012-1298-7; Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0; Zhang SQ, 2007, J BONE MINER METAB, V25, P293, DOI 10.1007/s00774-007-0759-7; Zhao HB, 1998, CHINESE MED J-PEKING, V111, P551	75	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125349	10.1371/journal.pone.0125349	http://dx.doi.org/10.1371/journal.pone.0125349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933189	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100103
J	Chen, S; Chen, X; Xiu, YL; Sun, KX; Zhao, Y				Chen, Shuo; Chen, Xi; Xiu, Yin-Ling; Sun, Kai-Xuan; Zhao, Yang			Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CANCER-CELLS; PROSTATE-CANCER; EXPRESSION; MMP2; METASTASIS; MECHANISM; MIGRATION; MARKER; GROWTH	Epithelial ovarian cancer (EOC) is the most lethal of the gynecological malignancies. Exploring the molecular mechanisms and major factors of invasion and metastasis could have great significance for the treatment and prognosis of EOC. Studies have demonstrated that microRNA 106b (miR-106b) may be a promising therapeutic target for inhibiting breast cancer bone metastasis, but the role of miR-106b in EOC is largely unknown. In this work, miRNA-106b expression was quantified in various ovarian tissues and tumors. Ovarian carcinoma cell lines were transfected with miR-106b, after which, cell phenotype and expression of relevant molecules was assayed. Dual-luciferase reporter assays and xenograft mouse models were also used to investigate miR-106b and its target gene. MiR-106b mRNA expression was found to be significantly higher in normal ovarian tissues and benign tumors than in ovarian carcinomas and borderline tumors (p<0.01), and was negatively associated with differentiation (Well vs. Por & Mod) and the International Federation of Gynecology and Obstetrics (FIGO) staging (stage I/II vs. stage III/IV) in ovarian carcinoma (p<0.05). MiR-106b transfection reduced cell proliferation; promoted G1 or S arrest and apoptosis (p<0.05); suppressed cell migration and invasion (p<0.05); reduced Ras homolog gene family member C (RhoC), P70 ribosomal S6 kinase (P70S6K), Bcl-xL, Matrix metallopeptidase 2 (MMP2), MMP9 mRNA and protein expression; and induced p53 expression (p<0.05). Dual-luciferase reporter assays indicated that miR-106b directly targets RhoC by binding its 3' UTR. MiR-106b transfection also suppressed tumor development and RhoC expression in vivo in xenograft mouse models. This is the first demonstration that miR-106b may inhibit tumorigenesis and progression of EOC by targeting RhoC. The involvement of miR-106b-mediated RhoC downregulation in EOC aggression may give extended insights into molecular mechanisms underlying cancer aggression. Approaches aimed at overexpressing miR-106b may serve as promising therapeutic strategies for treating EOC patients.	[Chen, Shuo; Chen, Xi; Xiu, Yin-Ling; Sun, Kai-Xuan; Zhao, Yang] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang 110001, Peoples R China	China Medical University	Zhao, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang 110001, Peoples R China.	yida.zhaoyang@163.com		Zhao, Yang/0000-0003-3226-8127; Shuo, Chen/0000-0002-5122-3656	Liaoning Science and Technology Grant [2013021077]; Natural Scientific Foundation of China [81202049, 81472440]	Liaoning Science and Technology Grant; Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	Liaoning Science and Technology Grant (2013021077); the Natural Scientific Foundation of China (81202049, 81472440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2008, BIOMED RES-TOKYO, V29, P155, DOI 10.2220/biomedres.29.155; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boone B, 2009, J CUTAN PATHOL, V36, P629, DOI 10.1111/j.1600-0560.2008.01117.x; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khuu C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00246; Kleer CG, 2006, CLIN CANCER RES, V12, P4485, DOI 10.1158/1078-0432.CCR-06-0376; Lin Ya-Ling, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P23, DOI 10.1016/S2221-1691(11)60063-4; Liu N, 2007, J MOL MED-JMM, V85, P1149, DOI 10.1007/s00109-007-0217-y; Moroz A, 2013, BIOCHEM BIOPH RES CO, V430, P1319, DOI 10.1016/j.bbrc.2012.12.031; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ni XJ, 2014, CANCER SCI, V105, P18, DOI 10.1111/cas.12309; Ogden A, 2013, CANCER METAST REV, V32, P269, DOI 10.1007/s10555-012-9413-5; Park KS, 2011, J GASTROEN HEPATOL, V26, P391, DOI 10.1111/j.1440-1746.2010.06504.x; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Sampath D, 2009, BLOOD, V113, P3744, DOI 10.1182/blood-2008-09-178707; Sanchez-Diaz PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061622; Sotillo E, 2011, PHARMACOL THERAPEUT, V131, P18, DOI 10.1016/j.pharmthera.2011.04.006; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Tang Q, 2014, EUR J PHARMACOL, V741, P97, DOI 10.1016/j.ejphar.2014.07.051; Yoshizaki T, 1999, CLIN EXP METASTAS, V17, P431, DOI 10.1023/A:1006699003525; Zhao Y, 2013, GYNECOL ONCOL, V130, P570, DOI 10.1016/j.ygyno.2013.06.004; Zhao Y, 2010, GYNECOL ONCOL, V116, P563, DOI 10.1016/j.ygyno.2009.11.015	32	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125714	10.1371/journal.pone.0125714	http://dx.doi.org/10.1371/journal.pone.0125714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933027	Green Submitted, gold, Green Published			2022-12-26	WOS:000353887100129
J	Peng, J; Wang, P; Ge, HS; Qu, XQ; Jin, XL				Peng, Jie; Wang, Ping; Ge, Hongshan; Qu, Xianqin; Jin, Xingliang			Effects of Cordycepin on the Microglia-Overactivation-Induced Impairments of Growth and Development of Hippocampal Cultured Neurons	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; PROINFLAMMATORY CYTOKINES; NERVOUS-SYSTEM; CONE FILOPODIA; FACTOR-ALPHA; IN-VIVO; INFLAMMATION; CELLS; BRAIN	Microglial cells are normally activated in response to brain injury or immunological stimuli to protect central nervous system (CNS). However, over-activation of microglia conversely amplifies the inflammatory effects and mediates cellular degeneration, leading to the death of neurons. Recently, cordycepin, an active component found in Cordyceps militarisa known as a rare Chinese caterpillar fungus, has been reported as an effective drug for treating inflammatory diseases and cancer via unclear mechanisms. In this study, we attempted to identify the anti-inflammatory role of cordycepin and its protective effects on the impairments of neural growth and development induced by microglial over-activation. The results indicate that cordycepin could attenuate the lipopolysaccharide (LPS)-induced microglial activation, evidenced by the dramatically reduced release of TNF-alpha and IL-1 beta, as well as the down-regulation of mRNA levels of iNOS and COX-2 after cordycepin treatment. Besides, cordycepin reversed the LPS-induced activation of NF-kappa B pathway, resulting in anti-inflammatory effects. Furthermore, by employing the conditioned medium (CM), we found cordycepin was able to recover the impairments of neural growth and development in the primary hippocampal neurons cultured in LPS-CM, including cell viability, growth cone extension, neurite sprouting and outgrowth as well as spinogenesis. This study expands our knowledge of the anti-inflammatory function of cordycepin and paves the way for the biomedical applications of cordycepin in the therapies of neural injuries.	[Peng, Jie; Wang, Ping] Wuzhong Hosp, Suzhou, Jiangsu, Peoples R China; [Ge, Hongshan; Jin, Xingliang] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Jin, Xingliang] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Sydney Ctr Regenerat & Dev Med, Sydney, NSW 2006, Australia; [Qu, Xianqin] Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia	Wenzhou Medical University; University of Sydney; Kolling Institute of Medical Research; University of Technology Sydney	Qu, XQ (corresponding author), Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia.	xianqin.qu@uts.edu.au; xljin123@163.com			National Natural Science Foundation of China [81471458]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81471458). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Aloisi F, 1999, ADV EXP MED BIOL, V468, P123; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Baugh J A, 2001, Curr Opin Drug Discov Devel, V4, P635; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; Cheng ZY, 2011, EUR J PHARMACOL, V664, P20, DOI 10.1016/j.ejphar.2011.04.052; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; DEITCH AD, 1979, EXP CELL RES, V118, P1, DOI 10.1016/0014-4827(79)90577-9; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Fetler L, 2005, SCIENCE, V309, P392, DOI 10.1126/science.1114852; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; [盖国忠 Gui Guozhong], 2004, [中国新药杂志, Chinese Journal New Drugs], V13, P169; Hung J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003692; Jeong JW, 2010, INT IMMUNOPHARMACOL, V10, P1580, DOI 10.1016/j.intimp.2010.09.011; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McGuire SO, 2001, EXP NEUROL, V169, P219, DOI 10.1006/exnr.2001.7688; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Montine TJ, 2002, J NEUROCHEM, V83, P463, DOI 10.1046/j.1471-4159.2002.01157.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noelker C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-86; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pusic KM, 2014, GLIA, V62, P1176, DOI 10.1002/glia.22672; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; Russo I, 2011, J NEUROCHEM, V116, P947, DOI 10.1111/j.1471-4159.2010.07168.x; Schnieder TP, 2011, BIOL PSYCHIAT, V69, P134, DOI 10.1016/j.biopsych.2010.08.027; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Shin Seulmee, 2009, Immune Netw, V9, P255, DOI 10.4110/in.2009.9.6.255; Shin Seulmee, 2009, Immune Netw, V9, P98, DOI 10.4110/in.2009.9.3.98; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Sugar AM, 1998, ANTIMICROB AGENTS CH, V42, P1424, DOI 10.1128/AAC.42.6.1424; Surh YJ, 2001, J KOREAN MED SCI, V16, pS38, DOI 10.3346/jkms.2001.16.S.S38; Wilkinson K., 2012, INT J ALZHEIMERS DIS, V2012, P489456, DOI [DOI 10.1155/2012/489456, 10.1155/2012/489456]; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Yao LH, 2011, NEUROSCI LETT, V503, P256, DOI 10.1016/j.neulet.2011.08.048; Yun YunHa, 2003, Natural Product Sciences, V9, P291; Zhang DW, 2014, INFLAMMATION, V37, P1044, DOI 10.1007/s10753-014-9827-z	58	24	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125902	10.1371/journal.pone.0125902	http://dx.doi.org/10.1371/journal.pone.0125902			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932642	Green Published, gold, Green Submitted			2022-12-26	WOS:000353887100141
J	Seok, J; Davis, RW; Xiao, WZ				Seok, Junhee; Davis, Ronald W.; Xiao, Wenzhong			A Hybrid Approach of Gene Sets and Single Genes for the Prediction of Survival Risks with Gene Expression Data	PLOS ONE			English	Article							BREAST-CANCER; MOLECULAR CLASSIFICATION; MULTIPLE-MYELOMA; LYMPHOMA; MICROARRAYS; SIGNATURES; PROGNOSIS; DISCOVERY; NETWORKS; DISEASE	Accumulated biological knowledge is often encoded as gene sets, collections of genes associated with similar biological functions or pathways. The use of gene sets in the analyses of high-throughput gene expression data has been intensively studied and applied in clinical research. However, the main interest remains in finding modules of biological knowledge, or corresponding gene sets, significantly associated with disease conditions. Risk prediction from censored survival times using gene sets hasn't been well studied. In this work, we propose a hybrid method that uses both single gene and gene set information together to predict patient survival risks from gene expression profiles. In the proposed method, gene sets provide context-level information that is poorly reflected by single genes. Complementarily, single genes help to supplement incomplete information of gene sets due to our imperfect biomedical knowledge. Through the tests over multiple data sets of cancer and trauma injury, the proposed method showed robust and improved performance compared with the conventional approaches with only single genes or gene sets solely. Additionally, we examined the prediction result in the trauma injury data, and showed that the modules of biological knowledge used in the prediction by the proposed method were highly interpretable in biology. A wide range of survival prediction problems in clinical genomics is expected to benefit from the use of biological knowledge.	[Seok, Junhee] Korea Univ, Sch Elect Engn, Seoul 136713, South Korea; [Davis, Ronald W.; Xiao, Wenzhong] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Xiao, Wenzhong] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Xiao, Wenzhong] Shriners Hosp Children, Boston, MA USA	Korea University; Stanford University; Harvard University; Massachusetts General Hospital	Seok, J (corresponding author), Korea Univ, Sch Elect Engn, Seoul 136713, South Korea.	jseok14@korea.ac.kr; wenzhong.xiao@mgh.harvard.edu		xiao, wenzhong/0000-0003-4944-6380	National Research Foundation of Korea (NRF) - Korea government [NRF-2014R1A1A2A16050527]; Korea University; National Institutes of Health [PO1-HG00205, U54-GM62119, R01-GM101401]; Shriners Research Grant [85500-BOS]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119, R01GM101401] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); Korea University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Research Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2014R1A1A2A16050527) and Korea University grant, as well as grants from the National Institutes of Health (PO1-HG00205, U54-GM62119, R01-GM101401) and Shriners Research Grant (85500-BOS).	Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; COX DR, 1972, J R STAT SOC B, V34, P187; Dairkee SH, 2008, CANCER RES, V68, P2076, DOI 10.1158/0008-5472.CAN-07-6526; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Holec M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S15; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Park PJ, 2002, BIOINFORMATICS, V18, P1576, DOI 10.1093/bioinformatics/18.12.1576; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal MR, 2006, BIOSTATISTICS, V7, P268, DOI 10.1093/biostatistics/kxj006; Seok J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S8; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	35	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0122103	10.1371/journal.pone.0122103	http://dx.doi.org/10.1371/journal.pone.0122103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933378	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100006
J	Simbiri, KO; Smith, NA; Otieno, R; Wohlford, EEM; Daud, II; Odada, SP; Middleton, F; Rochford, R				Simbiri, Kenneth O.; Smith, Nicholas A.; Otieno, Richard; Wohlford, Eric E. M.; Daud, Ibrahim I.; Odada, Sumba P.; Middleton, Frank; Rochford, Rosemary			Epstein-Barr Virus Genetic Variation in Lymphoblastoid Cell Lines Derived from Kenyan Pediatric Population	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; STRAINS; VARIANTS; PROTEIN; IDENTIFICATION; REPLICATION; SEQUENCES; LYMPHOMA; EBNA1; BPLF1	Epstein-Barr virus (EBV) is associated with Burkitt's lymphoma (BL), and in regions of sub-Saharan Africa where endemic BL is common, both the EBV Type 1 (EBV-1) and EBV Type 2 strains (EBV-2) are found. Little is known about genetic variation of EBV strains in areas of sub-Saharan Africa. In the present study, spontaneous lymphoblastoid cell lines (LCLs) were generated from samples obtained from Kenya. Polymerase chain reaction (PCR) amplification of the EBV genome was done using multiple primers and sequenced by next-generation sequencing (NGS). Phylogenetic analyses against the published EBV-1 and EBV-2 strains indicated that one sample, LCL10 was closely related to EBV-2, while the remaining 3 LCL samples were more closely related to EBV-1. Moreover, single nucleotide polymorphism (SNP) analyses showed clustering of LCL variants. We further show by analysis of EBNA-1, BLLF1, BPLF1, and BRRF2 that latent genes are less conserved than lytic genes in these LCLs from a single geographic region. In this study we have shown that NGS is highly useful for deciphering detailed inter and intra-variations in EBV genomes and that within a geographic region different EBV genetic variations can co-exist, the implications of which warrant further investigation. The findings will enhance our understanding of potential pathogenic variants critical to the development and maintenance of EBV-associated malignancies.	[Simbiri, Kenneth O.; Smith, Nicholas A.; Wohlford, Eric E. M.; Rochford, Rosemary] Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Otieno, Richard] Maseno Univ, Maseno, Kenya; [Daud, Ibrahim I.; Odada, Sumba P.] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Middleton, Frank] Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Maseno University; Kenya Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Simbiri, KO (corresponding author), Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	simbirik@upstate.edu		Middleton, Frank/0000-0002-3107-7188	NIH [CA102667]; Alex's Lemonade Stand POST award; NATIONAL CANCER INSTITUTE [R01CA102667] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand POST award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH CA102667 to RR, Alex's Lemonade Stand POST award to RO.	ADLDINGER HK, 1985, VIROLOGY, V141, P221, DOI 10.1016/0042-6822(85)90253-3; AITKEN C, 1994, J GEN VIROL, V75, P95, DOI 10.1099/0022-1317-75-1-95; Lorenzetti MA, 2010, J MED VIROL, V82, P1730, DOI 10.1002/jmv.21871; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Duarte M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053512; Edwards RH, 2004, J VIROL, V78, P868, DOI 10.1128/JVI.78.2.868-881.2004; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; Gorzer I, 2006, VIRUS RES, V118, P105, DOI 10.1016/j.virusres.2005.11.020; Habeshaw G, 1999, J VIROL, V73, P965, DOI 10.1128/JVI.73.2.965-975.1999; Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Kelly BJ, 2009, VIRUS RES, V145, P173, DOI 10.1016/j.virusres.2009.07.007; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Kwok H, 2014, J VIROL, V88, P10662, DOI 10.1128/JVI.01665-14; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; LIN JC, 1993, BLOOD, V81, P3372; Lin Z, 2013, J VIROL, V87, P1172, DOI 10.1128/JVI.02517-12; Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11; Martini M, 2007, J INFECTION, V54, P298, DOI 10.1016/j.jinf.2006.04.015; McGeoch DJ, 2001, PHILOS T ROY SOC B, V356, P421, DOI 10.1098/rstb.2000.0775; McGeoch DJ, 2007, VIROLOGY, V359, P1, DOI 10.1016/j.virol.2006.10.009; MELLINGHOFF I, 1991, VIROLOGY, V185, P922, DOI 10.1016/0042-6822(91)90574-U; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; Paludan C, 2002, J IMMUNOL, V169, P1593, DOI 10.4049/jimmunol.169.3.1593; Piriou E, 2012, J INFECT DIS, V205, P906, DOI 10.1093/infdis/jir872; Saito S, 2013, J VIROL, V87, P4060, DOI 10.1128/JVI.02020-12; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Sawada A, 2011, J GEN VIROL, V92, P1032, DOI 10.1099/vir.0.030023-0; Schmaus S, 2004, VIRUS GENES, V29, P267, DOI 10.1023/B:VIRU.0000036387.39937.9b; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; THORLEYLAWSON DA, 1982, J VIROL, V43, P730, DOI 10.1128/JVI.43.2.730-736.1982; Tsang CW, 2006, J VIROL, V80, P8263, DOI 10.1128/JVI.00400-06; Tzellos S, 2012, PATHOGENS, V1, P156, DOI 10.3390/pathogens1020156; Wang XA, 2010, J GEN VIROL, V91, P2564, DOI 10.1099/vir.0.021881-0; Whitehurst CB, 2012, J VIROL, V86, P8097, DOI 10.1128/JVI.00588-12; Whitehurst CB, 2009, J VIROL, V83, P4345, DOI 10.1128/JVI.02195-08; Yao QY, 1996, J VIROL, V70, P4895, DOI 10.1128/JVI.70.8.4895-4903.1996; Zeng MS, 2005, J VIROL, V79, P15323, DOI 10.1128/JVI.79.24.15323-15330.2005	41	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125420	10.1371/journal.pone.0125420	http://dx.doi.org/10.1371/journal.pone.0125420			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933165	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100110
J	Tiwari, S; Reddy, VB; Bhargava, R; Raman, J				Tiwari, Saumya; Reddy, Vijaya B.; Bhargava, Rohit; Raman, Jaishankar			Computational Chemical Imaging for Cardiovascular Pathology: Chemical Microscopic Imaging Accurately Determines Cardiac Transplant Rejection	PLOS ONE			English	Article							FT-IR SPECTROSCOPY; NEAR-INFRARED SPECTROSCOPY; NEURAL-NETWORK APPROACH; ANALYZED EX-VIVO; RAMAN-SPECTROSCOPY; ENDOMYOCARDIAL BIOPSY; CLUSTER-ANALYSIS; RAT-HEART; DISEASE DIAGNOSIS; VASCULAR WALL	Rejection is a common problem after cardiac transplants leading to significant number of adverse events and deaths, particularly in the first year of transplantation. The gold standard to identify rejection is endomyocardial biopsy. This technique is complex, cumbersome and requires a lot of expertise in the correct interpretation of stained biopsy sections. Traditional histopathology cannot be used actively or quickly during cardiac interventions or surgery. Our objective was to develop a stain-less approach using an emerging technology, Fourier transform infrared (FT-IR) spectroscopic imaging to identify different components of cardiac tissue by their chemical and molecular basis aided by computer recognition, rather than by visual examination using optical microscopy. We studied this technique in assessment of cardiac transplant rejection to evaluate efficacy in an example of complex cardiovascular pathology. We recorded data from human cardiac transplant patients' biopsies, used a Bayesian classification protocol and developed a visualization scheme to observe chemical differences without the need of stains or human supervision. Using receiver operating characteristic curves, we observed probabilities of detection greater than 95% for four out of five histological classes at 10% probability of false alarm at the cellular level while correctly identifying samples with the hallmarks of the immune response in all cases. The efficacy of manual examination can be significantly increased by observing the inherent biochemical changes in tissues, which enables us to achieve greater diagnostic confidence in an automated, label-free manner. We developed a computational pathology system that gives high contrast images and seems superior to traditional staining procedures. This study is a prelude to the development of real time in situ imaging systems, which can assist interventionists and surgeons actively during procedures.	[Tiwari, Saumya] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Bioengn, Urbana, IL 61801 USA; [Reddy, Vijaya B.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Bhargava, Rohit] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Bioengn Chem Mech Sci & Engn Chem & Biomol E, Urbana, IL 61801 USA; [Bhargava, Rohit] Univ Illinois, Univ Illinois, Ctr Canc, Urbana, IL 61801 USA; [Raman, Jaishankar] Rush Univ, Med Ctr, Adv Heart Failure Transplantat & Mech Circulatory, Cardiac Surg, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Urbana-Champaign; Rush University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Rush University	Raman, J (corresponding author), Rush Univ, Med Ctr, Adv Heart Failure Transplantat & Mech Circulatory, Cardiac Surg, 1725 West Harrison St, Chicago, IL 60612 USA.	jairaman2462@gmail.com	Raman, Jaishankar/K-1219-2019; Tiwari, Saumya/AAE-9786-2021	Tiwari, Saumya/0000-0001-5148-6539; Bhargava, Rohit/0000-0001-7360-994X	NIH grant; Rush University internal funds	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rush University internal funds	This work was supported by an NIH grant for instrumentation and Rush University internal funds for conduct of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARETZ HT, 1987, HUM PATHOL, V18, P619; BARAGA JJ, 1991, APPL SPECTROSC, V45, P709, DOI 10.1366/0003702914337047; Bassan P, 2013, ANALYST, V138, P144, DOI 10.1039/c2an36090j; Bhargava R, 2001, ANAL CHEM, V73, P5157, DOI 10.1021/ac010380m; Bhargava R, 2007, ANAL BIOANAL CHEM, V389, P1155, DOI 10.1007/s00216-007-1511-9; Bhargava R, 2006, BBA-BIOMEMBRANES, V1758, P830, DOI 10.1016/j.bbamem.2006.05.007; Birarda G, 2013, BIOMED SPECTROSC IMA, V2, P301, DOI 10.3233/BSI-130057; BURCH GE, 1968, AM J CARDIOL, V21, P261, DOI 10.1016/0002-9149(68)90328-7; Buschman HP, 2000, ANAL CHEM, V72, P3771, DOI 10.1021/ac000298b; Cheheltani R, 2012, NORTHEAST BIOENGIN C, P305, DOI 10.1109/NEBC.2012.6207086; Dritsa V, 2014, IN VIVO, V28, P91; Edwards W D, 1985, Heart Vessels Suppl, V1, P138, DOI 10.1007/BF02072381; Ellis DI, 2006, ANALYST, V131, P875, DOI 10.1039/b602376m; FENOGLIO JJ, 1987, HUM PATHOL, V18, P609, DOI 10.1016/S0046-8177(87)80361-1; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Filik J, 2012, ANALYST, V137, P853, DOI 10.1039/c2an15995c; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Fung MFK, 1996, BIOSPECTROSCOPY, V2, P155, DOI 10.1002/(SICI)1520-6343(1996)2:3<155::AID-BSPY2>3.3.CO;2-F; German MJ, 2006, BIOPHYS J, V90, P3783, DOI 10.1529/biophysj.105.077255; Gough KM, 2003, ANAL BIOCHEM, V316, P232, DOI 10.1016/S0003-2697(03)00039-3; Hahn EA, 1995, EUR HEART J, V16, P162, DOI 10.1093/eurheartj/16.suppl_O.162; Hammond MEH, 2005, J HEART LUNG TRANSPL, V24, P2015, DOI 10.1016/j.healun.2005.08.014; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; Holton SE, 2011, BIOPHYS J, V101, P1513, DOI 10.1016/j.bpj.2011.07.055; JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V; Jastrzebska M, 2006, GEN PHYSIOL BIOPHYS, V25, P231; KODALI DR, 1991, APPL SPECTROSC, V45, P1310, DOI 10.1366/0003702914335878; Kole MR, 2012, ANAL CHEM, V84, P10366, DOI 10.1021/ac302513f; Krafft C, 2005, CYTOM PART A, V64A, P53, DOI 10.1002/cyto.a.20117; Kumar V, 2010, TISSUE RENEWAL REGEN, P79; LANGE LG, 1994, NEW ENGL J MED, V330, P1129; Liu KZ, 1996, BBA-MOL BASIS DIS, V1315, P73, DOI 10.1016/0925-4439(95)00118-2; Mackanos MA, 2010, TRENDS BIOTECHNOL, V28, P317, DOI 10.1016/j.tibtech.2010.04.001; Mackanos MA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3174387; Majzner K, 2013, ANALYST, V138, P7400, DOI 10.1039/c3an00455d; MANOHARAN R, 1993, ATHEROSCLEROSIS, V103, P181, DOI 10.1016/0021-9150(93)90261-R; Martin FL, 2010, NAT PROTOC, V5, P1748, DOI 10.1038/nprot.2010.133; Moreno PR, 2002, CIRCULATION, V105, P923, DOI 10.1161/hc0802.104291; Motz JT, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2190967; Motz JT, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1920247; Nallala J, 2013, CYTOM PART A, V83A, P294, DOI 10.1002/cyto.a.22249; Nasse MJ, 2011, NAT METHODS, V8, P413, DOI [10.1038/NMETH.1585, 10.1038/nmeth.1585]; Parker FS, 1971, APPLICATIONS OF INFR; Patel JK, 2011, SURG-J R COLL SURG E, V9, P160, DOI 10.1016/j.surge.2010.11.023; Petrich W, 2009, ANALYST, V134, P1092, DOI 10.1039/b820923e; Petrich W, 2001, APPL SPECTROSC REV, V36, P181, DOI 10.1081/ASR-100106156; Pounder FN, 2009, PROC SPIE, V7186, DOI 10.1117/12.810122; Reddy RK, 2010, ANALYST, V135, P2818, DOI 10.1039/c0an00350f; Romer TJ, 1998, CIRCULATION, V97, P878, DOI 10.1161/01.CIR.97.9.878; SHANES JG, 1987, CIRCULATION, V75, P401, DOI 10.1161/01.CIR.75.2.401; Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Stone JR, 2012, CARDIOVASC PATHOL, V21, P2, DOI 10.1016/j.carpath.2011.01.001; Toyran N, 2008, FOOD CHEM, V110, P590, DOI 10.1016/j.foodchem.2008.02.044; Toyran N, 2007, SPECTROSC-INT J, V21, P269, DOI 10.1155/2007/269618; Toyran N, 2006, BIOCHEM J, V397, P427, DOI 10.1042/BJ20060171; Wald N, 2015, ANALYST ROYAL SOCIET, DOI [10.1039/c4an02247e, DOI 10.1039/C4AN02247E]; Walker RA, 2006, HISTOPATHOLOGY, V49, P406, DOI 10.1111/j.1365-2559.2006.02514.x; Walsh MJ, 2012, IEEE J SEL TOP QUANT, V18, P1502, DOI 10.1109/JSTQE.2011.2182635; Walsh MJ, 2012, HIGH RESOLUTION MID, V8219, DOI [10.1117/12.909339, DOI 10.1117/12.909339]; Wang L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714030; Wang Q, 2005, VIB SPECTROSC, V38, P217, DOI 10.1016/j.vibspec.2005.02.011; Wei L, 2011, EXP MOL PATHOL, V90, P74, DOI 10.1016/j.yexmp.2010.10.004; Wetzel DL, 2005, VIB SPECTROSC, V38, P53, DOI 10.1016/j.vibspec.2005.02.029; Wood BR, 1998, BIOSPECTROSCOPY, V4, P75, DOI 10.1002/(SICI)1520-6343(1998)4:2<75::AID-BSPY1>3.0.CO;2-R; Wrobel TP, 2012, SPECTROCHIM ACTA A, V96, P940, DOI 10.1016/j.saa.2012.07.103; Wrobel TP, 2011, ANALYST, V136, P5247, DOI 10.1039/c1an15311k; Yeh K, 2015, ANAL CHEM	69	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125183	10.1371/journal.pone.0125183	http://dx.doi.org/10.1371/journal.pone.0125183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932912	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100086
J	de Castro, AI; Ehsani, R; Ploetz, RC; Crane, JH; Buchanon, S				de Castro, Ana I.; Ehsani, Reza; Ploetz, Randy C.; Crane, Jonathan H.; Buchanon, Sherrie			Detection of Laurel Wilt Disease in Avocado Using Low Altitude Aerial Imaging	PLOS ONE			English	Article							AUTOMATED CROP; IMAGERY; REFLECTANCE; IDENTIFICATION; CURCULIONIDAE; COLEOPTERA; SCOLYTINAE; INDEXES; BLIGHT; WEEDS	Laurel wilt is a lethal disease of plants in the Lauraceae plant family, including avocado (Persea americana). This devastating disease has spread rapidly along the southeastern seaboard of the United States and has begun to affect commercial avocado production in Florida. The main objective of this study was to evaluate the potential to discriminate laurel wilt-affected avocado trees using aerial images taken with a modified camera during helicopter surveys at low-altitude in the commercial avocado production area. The ability to distinguish laurel wilt-affected trees from other factors that produce similar external symptoms was also studied. R(mod)GB digital values of healthy trees and laurel wilt-affected trees, as well as fruit stress and vines covering trees were used to calculate several vegetation indices (VIs), band ratios, and VI combinations. These indices were subjected to analysis of variance (ANOVA) and an M-statistic was performed in order to quantify the separability of those classes. Significant differences in spectral values among laurel wilt affected and healthy trees were observed in all vegetation indices calculated, although the best results were achieved with Excess Red (ExR), (Red-Green) and Combination 1 (COMB1) in all locations. B/G showed a very good potential for separate the other factors with symptoms similar to laurel wilt-affected trees, such as fruit stress and vines covering trees, from laurel wilt-affected trees. These consistent results prove the usefulness of using a modified camera (R(mod)GB) to discriminate laurel wilt-affected avocado trees from healthy trees, as well as from other factors that cause the same symptoms and suggest performing the classification in further research. According to our results, ExR and B/G should be utilized to develop an algorithm or decision rules to classify aerial images, since they showed the highest capacity to discriminate laurel wilt-affected trees. This methodology may allow the rapid detection of laurel wilt-affected trees using low altitude aerial images and be a valuable tool in mitigating this important threat to Florida avocado production.	[de Castro, Ana I.; Ehsani, Reza; Buchanon, Sherrie] Univ Florida IFAS, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA; [Ploetz, Randy C.; Crane, Jonathan H.] Univ Florida IFAS, Trop Res & Educ Ctr, Homestead, FL 33031 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ehsani, R (corresponding author), Univ Florida IFAS, Citrus Res & Educ Ctr, 700 Expt Stn Rd, Lake Alfred, FL 33850 USA.	ehsani@ufl.edu	De Castro Megías, Ana Isabel/K-7429-2017	De Castro Megías, Ana Isabel/0000-0002-6699-2204	Florida Department of Agriculture and Consumer Services, USDA Specialty Block Grant [019730]	Florida Department of Agriculture and Consumer Services, USDA Specialty Block Grant	Florida Department of Agriculture and Consumer Services, USDA Specialty Block Grant No. 019730, funded this investigation.	Barton CVM, 2012, PLANT SOIL, V354, P41, DOI 10.1007/s11104-011-1051-0; Calderon R, 2013, REMOTE SENS ENVIRON, V139, P231, DOI 10.1016/j.rse.2013.07.031; Carrillo D, 2014, PLANT PATHOL, V63, P54, DOI 10.1111/ppa.12073; Carrillo D, 2012, FLA ENTOMOL, V95, P573, DOI 10.1653/024.095.0306; Dammer KH, 2011, CROP PROT, V30, P420, DOI 10.1016/j.cropro.2010.12.015; Dreaden TJ, 2014, PLANT DIS, V98, P379, DOI 10.1094/PDIS-07-13-0772-RE; Du Q, 2008, J ENVIRON MANAGE, V86, P14, DOI 10.1016/j.jenvman.2006.11.019; Evans EA, 2010, HORTTECHNOLOGY, V20, P234, DOI 10.21273/HORTTECH.20.1.234; EVERITT JH, 1987, WEED SCI, V35, P427; FAO , 2013, FAOSTAT FAO UN; Fraedrich SW, 2008, PLANT DIS, V92, P215, DOI 10.1094/PDIS-92-2-0215; Garcia-Ruiz F, 2013, COMPUT ELECTRON AGR, V91, P106, DOI 10.1016/j.compag.2012.12.002; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Guerrero JM, 2012, EXPERT SYST APPL, V39, P11149, DOI 10.1016/j.eswa.2012.03.040; Guijarro M, 2011, COMPUT ELECTRON AGR, V75, P75, DOI 10.1016/j.compag.2010.09.013; Hague T, 2006, PRECIS AGRIC, V7, P21, DOI 10.1007/s11119-005-6787-1; HOEFFDING W, 1948, ANN MATH STAT, V19, P293, DOI 10.1214/aoms/1177730196; Inch SA, 2012, FOREST PATHOL, V42, P239, DOI 10.1111/j.1439-0329.2011.00749.x; de Castro AI, 2012, PRECIS AGRIC, V13, P302, DOI 10.1007/s11119-011-9247-0; Kataoka T, 2003, IEEE ASME INT C ADV, P1079, DOI 10.1109/aim.2003.1225492; KAUFMAN YJ, 1994, IEEE T GEOSCI REMOTE, V32, P672, DOI 10.1109/36.297984; Kumar A, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.063542; Lopez-Granados F, 2011, WEED RES, V51, P1, DOI 10.1111/j.1365-3180.2010.00829.x; Mahlein AK, 2010, PRECIS AGRIC, V11, P413, DOI 10.1007/s11119-010-9180-7; Meyer GE, 1998, THE SPIE P, V3543; Meyer GE, 2008, COMPUT ELECTRON AGR, V63, P282, DOI 10.1016/j.compag.2008.03.009; Nebikera S., 2008, P INT ARCH PHOTOGRAM, VVolume XXXVII Part B1, P1193; Neto J.C., 2004, COMBINED STAT SOFT C; Pena-Barragan JM, 2007, WEED RES, V47, P164, DOI 10.1111/j.1365-3180.2007.00553.x; PENUELAS J, 1994, REMOTE SENS ENVIRON, V48, P135, DOI 10.1016/0034-4257(94)90136-8; Ploetz RC, 2012, PLANT PATHOL, V61, P801, DOI 10.1111/j.1365-3059.2011.02564.x; Ploetz RC, 2011, PLANT DIS, V95, P1589, DOI 10.1094/PDIS-08-11-0633; Ploetz R. C., 2011, RECOVERY PLAN LAUREL; Pozdnyakova L, 2002, COMPUT ELECTRON AGR, V37, P57, DOI 10.1016/S0168-1699(02)00119-9; Rabaglia RJ, 2006, ANN ENTOMOL SOC AM, V99, P1034, DOI 10.1603/0013-8746(2006)99[1034:ROAXCC]2.0.CO;2; Raikes C, 1998, PHYTOPATHOLOGY, V88, P446, DOI 10.1094/PHYTO.1998.88.5.446; Ribeiro A, 2005, PRECISION AGRICULTURE 05, P169; Sankaran S, 2012, PLANT DIS, V96, P1683, DOI 10.1094/PDIS-01-12-0030-RE; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Smith AMS, 2007, INT J REMOTE SENS, V28, P2753, DOI 10.1080/01431160600954704; Swain KC, 2010, T ASABE, V53, P21; Torres-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058210; USDA Forest Service, 2014, LAUR WILT DISTR MAP; Usha K, 2013, SCI HORTIC-AMSTERDAM, V153, P71, DOI 10.1016/j.scienta.2013.01.008; WOEBBECKE DM, 1995, T ASAE, V38, P271, DOI 10.13031/2013.27839; Zhang Minghua, 2005, Precision Agriculture, V6, P489, DOI 10.1007/s11119-005-5640-x	46	35	35	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124642	10.1371/journal.pone.0124642	http://dx.doi.org/10.1371/journal.pone.0124642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927209	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100041
J	Flierl, U; Fraccarollo, D; Widder, JD; Micka, J; Neuser, J; Bauersachs, J; Schafer, A				Flierl, Ulrike; Fraccarollo, Daniela; Widder, Julian D.; Micka, Jan; Neuser, Jonas; Bauersachs, Johann; Schaefer, Andreas			The Nitric Oxide Donor Pentaerythritol Tetranitrate Reduces Platelet Activation in Congestive Heart Failure	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; GUANYLYL CYCLASE; HEME OXYGENASE-1; NITRATE THERAPY; IN-VIVO; TOLERANCE; SYNTHASE; INHIBITION; GUIDELINES; INDUCTION	Background Platelet activation associated with endothelial dysfunction and impaired endogenous platelet inhibition is part of the cardiovascular phenotype of congestive heart failure (CHF) and contributes to the increased risk for thromboembolic complications. Pentaerythritol tetranitrate (PETN) has been shown to release nitric oxide without development of nitrate tolerance. We investigated the effect of chronic PETN treatment on platelet activation and aggregation in an experimental CHF model. Methods and Results Chronic ischemic heart failure was induced in male Wistar rats by coronary artery ligation. Starting 7 days thereafter, rats were randomised to placebo or PETN (80 mg/kg twice daily). After 9 weeks, activation of circulating platelets was determined measuring platelet bound fibrinogen, which requires activated glycoprotein IIb/IIIa on the platelet surface. Binding was quantified by flow-cytometry using a FITC-labelled anti-fibrinogen antibody. Platelet-bound fibrinogen was significantly increased in CHF-Placebo (mean fluorescence intensity: Sham 88 +/- 4, CHF-Placebo 104 +/- 6, p<0.05) and reduced following treatment with PETN (89 +/- 7, p<0.05 vs. CHF-Placebo). Maximal and final ADP-induced aggregation was significantly enhanced in CHF-Placebo vs. Sham-operated animals and normalized / decreased following chronic PETN treatment. Moreover, platelet adhesion was significantly reduced (number of adherent platelets: control: 85.6 +/- 5.5, PETN: 40 +/- 3.3; p<0.001) and VASP phosphorylation significantly enhanced following in vitro PETN treatment. Conclusion Chronic NO supplementation using PETN reduces platelet activation in CHF rats. Thus, PETN may constitute a useful approach to prevent thromboembolic complications in CHF.	[Flierl, Ulrike; Fraccarollo, Daniela; Widder, Julian D.; Micka, Jan; Neuser, Jonas; Bauersachs, Johann; Schaefer, Andreas] Hannover Med Sch, Klin Kardiol & Angiol, Hannover, Germany	Hannover Medical School	Schafer, A (corresponding author), Hannover Med Sch, Klin Kardiol & Angiol, Hannover, Germany.	Schaefer.andreas@mh-hannover.de	Schäfer, Andreas/AAQ-9512-2021		Actavis (Munich, Germany); University of Wurzburg	Actavis (Munich, Germany); University of Wurzburg	The study was partially supported by a research grant from Actavis (Munich, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining funding was internal support by the University of Wurzburg, where the research had been performed.	Andrews NP, 2001, J AM COLL CARDIOL, V37, P510, DOI 10.1016/S0735-1097(00)01114-1; Bauersachs J, 2008, PHARMACOL REP, V60, P119; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Chirkov YY, 1999, CIRCULATION, V100, P129, DOI 10.1161/01.CIR.100.2.129; Chung I, 2006, EUR HEART J, V27, P2623, DOI 10.1093/eurheartj/ehl305; Dangel O, 2010, J THROMB HAEMOST, V8, P1343, DOI 10.1111/j.1538-7836.2010.03806.x; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; De Biase L, 2003, THROMB HAEMOSTASIS, V90, P317, DOI 10.1160/TH03-02-0105; de Meirelles LR, 2011, CLIN EXP PHARMACOL P, V38, P705, DOI 10.1111/j.1440-1681.2011.05580.x; Fink B, 1997, J CARDIOVASC PHARM, V30, P831, DOI 10.1097/00005344-199712000-00020; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fraccarollo D, 2008, CIRCULATION, V118, P818, DOI 10.1161/CIRCULATIONAHA.107.717702; Garcia-Souza LF, 2014, INT J BIOCHEM CELL B, V50, P156, DOI 10.1016/j.biocel.2014.02.015; Gibbs CR, 2001, CIRCULATION, V103, P1746, DOI 10.1161/01.CIR.103.13.1746; Gori T, 2009, AM J CARDIOVASC DRUG, V9, P7, DOI 10.2165/00129784-200909010-00002; Holmes AS, 2005, BRIT J CLIN PHARMACO, V60, P355, DOI 10.1111/j.1365-2125.2005.02437.x; Jurt U, 2001, J AM COLL CARDIOL, V38, P854, DOI 10.1016/S0735-1097(01)01414-0; Katz SD, 2005, CIRCULATION, V111, P310, DOI 10.1161/01.CIR.0000153349.77489.CF; Kojda G, 1998, EUR J PHARMACOL, V355, P23, DOI 10.1016/S0014-2999(98)00460-9; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Munzel T, 2013, EUR HEART J, V34, P2666, DOI 10.1093/eurheartj/eht249; Munzel T, 2013, CURR OPIN PHARMACOL, V13, P251, DOI [10.1016/j.coph.2612.12.008, 10.1016/j.coph.2012.12.008]; Munzel T, 2011, CIRCULATION, V123, P2132, DOI 10.1161/CIRCULATIONAHA.110.981407; Munzel T, 2013, EUR HEART J; Peng L, 2004, ANTIOXID REDOX SIGN, V6, P729, DOI 10.1089/1523086041361677; Rutherford E, 2013, EUR HEART J; Schafer A, 2008, CURR VASC PHARMACOL, V6, P52, DOI 10.2174/157016108783331295; Schafer A, 2006, ARTERIOSCL THROM VAS, V26, P2813, DOI 10.1161/01.ATV.0000249407.92147.12; Schafer A, 2010, PHARMACOL RES, V62, P432, DOI 10.1016/j.phrs.2010.06.008; Schafer A, 2009, EUR J HEART FAIL, V11, P336, DOI 10.1093/eurjhf/hfp005; Schafer A, 2004, CIRCULATION, V109, P1819, DOI 10.1161/01.CIR.0000126837.88743.DD; Schnorbus B, 2010, CLIN RES CARDIOL, V99, P115, DOI 10.1007/s00392-009-0096-z; Schuhmacher S, 2010, HYPERTENSION, V55, P897, DOI 10.1161/HYPERTENSIONAHA.109.149542; Wenzel P, 2007, ARTERIOSCL THROM VAS, V27, P1729, DOI 10.1161/ATVBAHA.107.143909	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123621	10.1371/journal.pone.0123621	http://dx.doi.org/10.1371/journal.pone.0123621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928879	gold, Green Published, Green Submitted			2022-12-26	WOS:000353713100020
J	Mishra, D; Harrison, NR; Gonzales, CB; Schilstrom, B; Konradsson-Geuken, A				Mishra, Devesh; Harrison, Nicholas R.; Gonzales, Carolina B.; Schilstrom, Bjorn; Konradsson-Geuken, Asa			Effects of Age and Acute Ethanol on Glutamatergic Neurotransmission in the Medial Prefrontal Cortex of Freely Moving Rats Using Enzyme-Based Microelectrode Amperometry	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NUCLEUS-ACCUMBENS; HIPPOCAMPAL-NEURONS; ADOLESCENT BRAIN; IN-VITRO; PLASTICITY; TRANSMISSION; ELIMINATION; INHIBITION; TRANSIENTS	Ethanol abuse during adolescence may significantly alter development of the prefrontal cortex which continues to undergo structural remodeling into adulthood. Glutamatergic neuro-transmission plays an important role during these brain maturation processes and is modulated by ethanol. In this study, we investigated glutamate dynamics in the medial prefrontal cortex of freely moving rats, using enzyme(based microelectrode amperometry. We analyzed the effects of an intraperitoneal ethanol injection (1 g/kg) on cortical glutamate levels in adolescent and adult rats. Notably, basal glutamate levels decreased with age and these levels were found to be significantly different between postnatal day (PND) 28(38 vs PND 44(55 (p<0.05) and PND 28(38 vs adult animals (p<0.001). We also observed spontaneous glutamate release (transients) throughout the recordings. The frequency of transients (per hour) was significantly higher in adolescent rats (PND 28(38 and PND 44(55) compared to those of adults. In adolescent rats, post(ethanol injection, the frequency of glutamate transients decreased within the first hour (p<0.05), it recovered slowly and in the third hour there was a significant rebound increase of the frequency (p<0.05). Our data demonstrate age(dependent differences in extracellular glutamate levels in the medial prefrontal cortex and suggest that acute ethanol injections have both inhibitory and excitatory effects in adolescent rats. These effects of ethanol on the prefrontal cortex may disturb its maturation and possibly limiting individuals' control over addictive behaviors.	[Mishra, Devesh; Harrison, Nicholas R.; Gonzales, Carolina B.; Schilstrom, Bjorn; Konradsson-Geuken, Asa] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Schilstrom, Bjorn] Gothenburg Univ, Sect Neuropsychiat, Dept Neurosci & Physiol, Gothenburg, Sweden; [Konradsson-Geuken, Asa] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet; University of Gothenburg; Karolinska Institutet	Konradsson-Geuken, A (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	asa.konradsson.geuken@ki.se	Harrison, Nicholas R./V-1200-2019; Mishra, Devesh Rajkumar/AAJ-9060-2021	Harrison, Nicholas R./0000-0003-1929-0266; Bengtsson Gonzales, Carolina/0000-0003-4084-2125	Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (Centralforbundet for alkohol och narkotikaupplysning CAN-SRA); H. Lundbeck A/S: lent us the glutamate recording unit	Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (Centralforbundet for alkohol och narkotikaupplysning CAN-SRA); H. Lundbeck A/S: lent us the glutamate recording unit	Support was provided by: Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (Centralforbundet for alkohol och narkotikaupplysning CAN-SRA) [www.can.se]; H. Lundbeck A/S: lent us the glutamate recording unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adermark L, 2011, NEUROCHEM INT, V58, P693, DOI 10.1016/j.neuint.2011.02.009; Bastrikova N, 2008, P NATL ACAD SCI USA, V105, P3123, DOI 10.1073/pnas.0800027105; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Boyce PJ, 2009, BRAIN RES BULL, V79, P104, DOI 10.1016/j.brainresbull.2009.01.012; Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Day BK, 2006, J NEUROCHEM, V96, P1626, DOI 10.1111/j.1471-4159.2006.03673.x; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Furuta A, 1997, J NEUROSCI, V17, P8363; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Hascup KN, 2011, NEUROPSYCHOPHARMACOL, V36, P1769, DOI 10.1038/npp.2011.60; Hendricson AW, 2003, J PHARMACOL EXP THER, V307, P550, DOI 10.1124/jpet.103.055137; Konradsson-Geuken A, 2010, NEUROSCIENCE, V169, P1848, DOI 10.1016/j.neuroscience.2010.05.052; Konradsson-Geuken A, 2009, SYNAPSE, V63, P1069, DOI 10.1002/syn.20693; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Melendez RI, 2005, ALCOHOL CLIN EXP RES, V29, P326, DOI 10.1097/01.ALC.0000156086.65665.4D; Mishra D, 2013, ADDICT BIOL, V18, P605, DOI 10.1111/j.1369-1600.2011.00350.x; Mitchell KM, 2004, ANAL CHEM, V76, P1098, DOI 10.1021/ac034757v; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; NIE ZG, 1994, J PHARMACOL EXP THER, V271, P1566; Othman T, 2002, NEUROCHEM RES, V27, P289, DOI 10.1023/A:1014955111742; Paxinos G, 2008, RAT BRAIN STEREOTAXI; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; Roberto M, 2004, J NEUROSCI, V24, P1594, DOI 10.1523/JNEUROSCI.5077-03.2004; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rutherford EC, 2007, J NEUROCHEM, V102, P712, DOI 10.1111/j.1471-4159.2007.04596.x; Selim M, 1996, BRAIN RES, V716, P157, DOI 10.1016/0006-8993(95)01385-7; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steffensen SC, 2000, J PHARMACOL EXP THER, V294, P637; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tu Y, 2007, J NEUROSCI, V27, P4765, DOI 10.1523/JNEUROSCI.5378-06.2007; Varlinskaya EI, 2006, ALCOHOL CLIN EXP RES, V30, P1833, DOI 10.1111/j.1530-0277.2006.00220.x; Wassum KM, 2012, J NEUROSCI, V32, P2734, DOI 10.1523/JNEUROSCI.5780-11.2012; Weitlauf C, 2008, ALCOHOL CLIN EXP RES, V32, P690, DOI 10.1111/j.1530-0277.2008.00625.x; White Aaron M, 2005, Recent Dev Alcohol, V17, P161, DOI 10.1007/0-306-48626-1_8	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125567	10.1371/journal.pone.0125567	http://dx.doi.org/10.1371/journal.pone.0125567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927237	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100101
J	Cerino, A; Bremer, CM; Glebe, D; Mondelli, MU				Cerino, Antonella; Bremer, Corinna M.; Glebe, Dieter; Mondelli, Mario U.			A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; IMMUNE GLOBULIN; CELL EPITOPE; VIRUS HBV; VACCINATION; INFECTION	We describe the production and characterization of human monoclonal antibodies (mAb) specific for the major hepatitis B virus (HBV) S protein. The mAbs, two IgG1 kappa and one IgG1 lambda, were secreted by B-cell clones obtained from peripheral blood mononuclear cells (PBMC) of one person convalescent from acute hepatitis B and one vaccinated individual. The former recognized a denaturation-insensitive epitope within the p24 protein whereas the latter recognized a denaturation-sensitive, conformational epitope located within the HBsAg common "a" determinant. This mAb, denominated ADRI-2F3, displayed a very high protective titer of over 43,000 IU/mg mAb and showed an extremely potent neutralizing activity in the in vitro model of HBV infection using primary hepatocytes from Tupaia belangeri as target. Recombinant variable heavy and light domain sequences derived from mAb ADRI-2F3 were cloned into eukaryotic expression vectors and showed identical fine specificity and 1 log(10) higher titer than the original IgG1 lambda. It is envisaged that such mAb will be able to efficiently prevent HBV reinfection after liver transplantation for end-stage chronic HBV infection or infection after needle-stick exposure, providing an unlimited source of valuable protective anti-HBs antibody.	[Cerino, Antonella; Mondelli, Mario U.] Fdn IRCCS Policlin San Matteo, Dept Infect Dis, Res Labs, Pavia, Italy; [Bremer, Corinna M.; Glebe, Dieter] Univ Giessen, German Ctr Infect Res, Natl Reference Ctr Hepatitis B & D Viruses, Inst Med Virol, D-35390 Giessen, Germany; [Mondelli, Mario U.] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; German Center for Infection Research; Justus Liebig University Giessen; University of Pavia	Mondelli, MU (corresponding author), Fdn IRCCS Policlin San Matteo, Dept Infect Dis, Res Labs, Pavia, Italy.	mario.mondelli@unipv.it	Mondelli, Mario U/J-5375-2016	Mondelli, Mario U/0000-0003-1811-3153; Bremer, Corinna Mareen/0000-0003-4811-785X				Allain JP, 2012, BIOLOGICALS, V40, P180, DOI 10.1016/j.biologicals.2011.09.014; Bremer CM, 2011, J HEPATOL, V55, P29, DOI 10.1016/j.jhep.2010.10.019; CERINO A, 1993, J IMMUNOL, V151, P7005; CERINO A, 1991, J IMMUNOL, V147, P2692; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; Eren R, 2000, HEPATOLOGY, V32, P588, DOI 10.1053/jhep.2000.9632; Fox AN, 2012, J HEPATOL, V56, P1189, DOI 10.1016/j.jhep.2011.08.026; Ishigami M, 2014, LIVER TRANSPLANT, V20, P1211, DOI 10.1002/lt.23935; Kim SH, 2008, ANTIVIR RES, V79, P188, DOI 10.1016/j.antiviral.2008.03.006; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; MONDELL MU, 1994, J VIROL, V68, P4829, DOI 10.1128/JVI.68.8.4829-4836.1994; Mondelli Mario U., 1998, V19, P451; Romano L, 2015, HUM VACC IMMUNOTHER, V11, P53, DOI 10.4161/hv.34306; SAMUEL D, 1993, NEW ENGL J MED, V329, P1842, DOI 10.1056/NEJM199312163292503; Schilling R, 2003, J VIROL, V77, P8882, DOI 10.1128/JVI.77.16.8882-8892.2003; Shin YW, 2007, ANTIVIR RES, V75, P113, DOI 10.1016/j.antiviral.2007.01.005; Shouval D, 2000, HEPATOLOGY, V32, P1189, DOI 10.1053/jhep.2000.19789; Tajiri K, 2010, ANTIVIR RES, V87, P40, DOI 10.1016/j.antiviral.2010.04.006; Terrault NA, 1998, HEPATOLOGY, V28, P555, DOI 10.1002/hep.510280237; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; UEDA K, 1991, J VIROL, V65, P3521, DOI 10.1128/JVI.65.7.3521-3529.1991; Walter E, 1996, HEPATOLOGY, V24, P1, DOI 10.1002/hep.510240101; WHO, HEP B WHO FACT SHEET	24	22	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125704	10.1371/journal.pone.0125704	http://dx.doi.org/10.1371/journal.pone.0125704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923526	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600159
J	Lipo, CP; Madsen, ME; Dunnell, RC				Lipo, Carl P.; Madsen, Mark E.; Dunnell, Robert C.			A Theoretically-Sufficient and Computationally-Practical Technique for Deterministic Frequency Seriation	PLOS ONE			English	Article							SIMULTANEOUS CONFIDENCE-INTERVALS; CULTURAL TRANSMISSION; POPULATION-STRUCTURE; MICRO-SERIATION; CHRONOLOGY; SEQUENCE	Frequency seriation played a key role in the formation of archaeology as a discipline due to its ability to generate chronologies. Interest in its utility for exploring issues of contemporary interest beyond chronology, however, has been limited. This limitation is partly due to a lack of quantitative algorithms that can be used to build deterministic seriation solutions. When the number of assemblages becomes greater than just a handful, the resources required for evaluation of possible permutations easily outstrips available computing capacity. On the other hand, probabilistic approaches to creating seriations offer a computationally manageable alternative but rely upon a compressed description of the data to order assemblages. This compression removes the ability to use all of the features of our data to fit to the seriation model, obscuring violations of the model, and thus lessens our ability to understand the degree to which the resulting order is chronological, spatial, or a mixture. Recently, frequency seriation has been reconceived as a general method for studying the structure of cultural transmission through time and across space. The use of an evolution-based framework renews the potential for seriation but also calls for a computationally feasible algorithm that is capable of producing solutions under varying configurations, without manual trial and error fitting. Here, we introduce the Iterative Deterministic Seriation Solution (IDSS) for constructing frequency seriations, an algorithm that dramatically constrains the search for potential valid orders of assemblages. Our initial implementation of IDSS does not solve all the problems of seriation, but begins to moves towards a resolution of a long-standing problem in archaeology while opening up new avenues of research into the study of cultural relatedness. We demonstrate the utility of IDSS using late prehistoric decorated ceramics from the Mississippi River Valley. The results compare favorably to previous analyses but add new details into the structure of cultural transmission of these late prehistoric populations.	[Lipo, Carl P.] Calif State Univ Long Beach, Dept Anthropol, Long Beach, CA 90840 USA; [Lipo, Carl P.] Calif State Univ Long Beach, IIRMES, Long Beach, CA 90840 USA; [Madsen, Mark E.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Dunnell, Robert C.] Mississippi State Univ, Dept Anthropol & Middle Eastern Cultures, Mississippi State, MS 39762 USA	California State University System; California State University Long Beach; California State University System; California State University Long Beach; University of Washington; University of Washington Seattle; Mississippi State University	Lipo, CP (corresponding author), Calif State Univ Long Beach, Dept Anthropol, 1250 Bellflower Blvd, Long Beach, CA 90840 USA.	clipo@csulb.edu	Lipo, Carl/C-9154-2013	Lipo, Carl/0000-0003-4391-3590; Madsen, Mark/0000-0001-9320-8377				Alberti G, 2013, ARCHEOL CALC, V24, P25; Arangala C, 2013, J MATH, V7, P1, DOI [10.2140/involve.2014.7.1, DOI 10.2140/INVOLVE.2014.7.1]; ASCHER M, 1959, AM ANTIQUITY, V25, P212, DOI 10.2307/277440; ASCHER M, 1963, AM ANTHROPOL, V65, P1045, DOI 10.1525/aa.1963.65.5.02a00040; Atkins JE, 1998, SIAM J COMPUT, V28, P297, DOI 10.1137/S0097539795285771; Beals RL, 1945, U CALIFORNIA PUBLICA, V44; Bjorke J. T., 1996, Computers, Environment and Urban Systems, V20, P427, DOI 10.1016/S0198-9715(97)00007-0; Bluhm E, 1951, AM ANTIQUITY, V16, P324, DOI 10.2307/276981; Brainerd GW, 1951, AM ANTIQUITY, V16, P301, DOI 10.2307/276979; Brower J.C., 1985, QUANTITATIVE STRATIG, P95; Buck CE, 2000, J R STAT SOC C-APPL, V49, P423, DOI 10.1111/1467-9876.00203; Buetow KH, 1987, AM J HUM GENET, V49, P423; Cochrane EE, 2010, PHILOS T R SOC B, V365, P3889, DOI 10.1098/rstb.2010.0091; Cochrane GWG, 2003, J ARCHAEOL SCI, V30, P837, DOI 10.1016/S0305-4403(02)00262-5; Collins Henry B., 1937, ARCHAEOLOGY ST LAWRE, V96; Cowgill George L., 1972, MODELS ARCHAEOLOGY, P381; Diestel Reinhard, 2010, GRAPH THEORY; Djindjian F, 1984, TO PATTERN THE PAST, P119; DRENNAN RD, 1976, AM ANTIQUITY, V41, P290, DOI 10.2307/279517; Driver H.E., 1932, U CALIFORNIA PUBLICA, P211; Duff AI, 1996, AM ANTIQUITY, V61, P89, DOI 10.2307/282304; Dunnell R.C., 1971, SYSTEMATICS PREHISTO; DUNNELL RC, 1978, AM ANTIQUITY, V43, P192, DOI 10.2307/279244; DUNNELL RC, 1982, J ANTHROPOL RES, V38, P1; DUNNELL RC, 1970, AM ANTIQUITY, V35, P305, DOI 10.2307/278341; Dunnell RC, 1981, MANEJO DATOS METODOS, P67; Eerkens JW, 2007, J ARCHAEOL RES, V15, P239, DOI 10.1007/s10814-007-9013-z; Eerkens JW, 2005, J ANTHROPOL ARCHAEOL, V24, P316, DOI 10.1016/j.jaa.2005.08.001; Evans C, 1955, BAE B, V160; Flament C., 1963, APPL GRAPH THEORY GR; Ford JA, 1938, AM ANTIQUITY, V3, P260, DOI 10.2307/275264; Ford J. A., 1962, TECHNICAL MANUAL; Ford J. A., 1949, ANTHR PAPERS, V43; Ford JA, 1935, CERAMIC DECORATION S; Gargano ML, 2006, C NUMERANTIUM, V180, P43; Gargano ML, 1996, C NUMERANTIUM, V119, P193; Glaz J, 1999, J STAT PLAN INFER, V82, P251, DOI 10.1016/S0378-3758(99)00047-6; GOODMAN LA, 1965, TECHNOMETRICS, V7, P247, DOI 10.2307/1266673; Halekoh U, 2004, COMPUT STAT DATA AN, V45, P651, DOI 10.1016/S0167-9473(03)00034-3; Halekoh U., 1999, ARCH AG INT CAA97 CO, P107; Harary F., 1969, GRAPH THEORY; Harpole J, 2002, MISSOURI ARCHAEOLOGI, V63, P21; HUBERT L, 1974, BRIT J MATH STAT PSY, V27, P133, DOI 10.1111/j.2044-8317.1974.tb00534.x; Husi P., 2008, J DATA SCI, V6, P135; Kadane JB, 1971, CHRONOLOGICAL ORDERI; KENDALL DG, 1970, PHILOS TR R SOC S-A, V269, P125, DOI 10.1098/rsta.1970.0091; KENDALL DG, 1969, WORLD ARCHAEOL, V1, P68, DOI 10.1080/00438243.1969.9979428; KENDALL DG, 1963, B INT STATIST INST, V40, P657; Kendall DG, 1971, MATH ARCHAEOLOGICAL, P214; Kidder AV, 1917, P NATL ACAD SCI USA, V3, P369, DOI 10.1073/pnas.3.5.369; Kroeber AL, 1919, AM ANTHROPOL, V21, P235, DOI 10.1525/aa.1919.21.3.02a00010; KROEBER AL, 1916, AM MUSEUM NATURAL HI, V18, P1; KUZARA RS, 1966, AM ANTHROPOL, V68, P1442, DOI 10.1525/aa.1966.68.6.02a00050; Laporte G., 1978, J COMPUT APPL MATH, V4, P259, DOI [10.1016/0771-050X(78)90024-4, DOI 10.1016/0771-050X(78)90024-4]; LEBLANC SA, 1975, AM ANTIQUITY, V40, P22, DOI 10.2307/279266; Liiv Innar, 2010, Statistical Analysis and Data Mining, V3, P70, DOI 10.1002/sam.10071; Lipo C., 2001, BRIT ARCHAEOLOGICAL, V918; Lipo C. P., 2001, STYLE FUNCTION CONCE, P91, DOI DOI 10.13140/RG.2.1.1676.2005; Lipo CP, 2006, Mapping Our Ancestors, P89; Lipo Carl P., 2008, CULTURAL TRANSMISSIO, P120; Lipo CP, 1997, J ANTHROPOL ARCHAEOL, V16, P301, DOI 10.1006/jaar.1997.0314; Lipo CP, 2000, THESIS U WASHINGTON; Lyman R.L., 1997, RISE FALL CULTURE HI; Lyman RL, 2006, MAPPING OUR ANCESTORS, P65; Lyman RL., 2006, MEASURING TIME ARTIF; Madsen ME, 2014, COMBINATORIAL STRUCT; Mallios S, 2014, J ANTHROPOL RES, V70, P69, DOI 10.3998/jar.0521004.0070.104; Marquardt W. H., 1978, ADV ARCHAEOLOGICAL M, V1, P257, DOI DOI 10.1016/B978-0-12-003101-6.50014-7; MATTHEWS J, 1963, NATURE, V198, P930, DOI 10.1038/198930a0; Mayer-Oakes WJ, 1955, PREHISTORY UPPER OHI, V34; MCNUTT CH, 1973, AM ANTIQUITY, V38, P45, DOI 10.2307/279310; McNutt CH, 2001, AM ANTHROPOL, V103, P225, DOI 10.1525/aa.2001.103.1.225; MEGGERS Betty, 1957, BUREAU AM ETHNOLOGY, V167; MICHELS JW, 1972, ANNU REV ANTHROPOL, V1, P113, DOI 10.1146/annurev.an.01.100172.000553; MULLER JC, 1983, PROF GEOGR, V35, P196, DOI 10.1111/j.0033-0124.1983.00196.x; NEIMAN FD, 1995, AM ANTIQUITY, V60, P7, DOI 10.2307/282074; Nelson NC, 1916, AM ANTHROPOL, V18, P159, DOI 10.1525/aa.1916.18.2.02a00010; O'Brien MJ, 1998, FORD GROWTH AM ARCHA; O'Brien MJ, 1999, REV ARCHAEOLOGY, V20, P14; O'Brien MJ, 1998, CHANGING PERSPECTIVE, P1; OBrien MJ, 2000, APPL EVOLUTIONARY AR; Peeples MA, 2012, J ARCHAEOL SCI, V39, P2818, DOI 10.1016/j.jas.2012.04.040; PETRIE WMF, 1899, J ANTHR I GREAT BRIT, V29, P295, DOI DOI 10.2307/2843012; Phillips P, 1951, ARCHAEOLOGICAL SURVE, V25; RAFFERTY J, 1994, AM ANTIQUITY, V59, P405, DOI 10.2307/282455; Rafferty J, 2008, SE ARCHAEOLOGY, V27, P253; Robinson WS, 1951, AM ANTIQUITY, V16, P293, DOI 10.2307/276978; Rouse I., 1939, PREHISTORY HAITI STU; Smith CS, 1950, ANTHR PAPERS, V43; Smith K, 2005, SE ARCHAEOLOGY, V26, P49; Spier L, 1917, P NATL ACAD SCI USA, V3, P280, DOI 10.1073/pnas.3.4.280; Spier L, 1917, ANTHROPOL PAP AM MUS, V18, P209; Stein J, 1973, RANDOM HOUSE DICT EN; Teltser P.A., 1995, EVOLUTIONARY ARCHAEO, P51; Usman A, 2003, AFR ARCHAEOL REV, V20, P149, DOI [10.1023/A:1025673401280, DOI 10.1023/A:1025673401280]; VvH Bordaz, 1970, ARCHEOLOGIE CALCULAT, P229; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wikipedia, 2014, SER; Wilkinson EM, 1971, MATH ARCHAEOLOGICAL, P276	99	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124942	10.1371/journal.pone.0124942	http://dx.doi.org/10.1371/journal.pone.0124942			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923765	Green Submitted, gold, Green Published			2022-12-26	WOS:000353711600115
J	Liu, YM; Xu, YY; Fang, F; Zhang, JT; Guo, L; Weng, Z				Liu, Yumeng; Xu, Yunyun; Fang, Fang; Zhang, Jianting; Guo, Liang; Weng, Zhen			Therapeutic Efficacy of Stem Cell-based Therapy in Peripheral Arterial Disease: A Meta-Analysis	PLOS ONE			English	Article							CRITICAL LIMB ISCHEMIA; MARROW MONONUCLEAR-CELL; AUTOLOGOUS TRANSPLANTATION; ANGIOGENESIS; PLACEBO; FOOT	Several cell-based therapies for peripheral arterial disease (PAD) have been studied in multiple clinical trials; however, the outcome of this treatment remains controversial. The aim of this study was to perform a meta-analysis of the clinical trials on stem cell-based therapy after PAD. We searched for clinical trials that investigated the effect of stem cell-based therapy on patients with PAD and were published between January 2000 and October 2014. The outcomes of interest comprised all-cause mortality, amputation rate, ulcer healing, and ankle-brachial index (ABI). In addition, pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to assess the safety and efficacy of the stem cell-based therapies for PAD. Thirteen studies were retrieved from 261 citations for the analysis, and in total, 527 patients (mean age: 64.2 years; median follow up: 6 months) were included in the analysis. After synthesizing data, the meta-analysis showed significant improvement in the amputation rate (OR=0.33, 95% CI=0.22-0.51; P<0.001), ulcer healing (OR=6.11, 95% CI=3.04-12.28; P<0.001), and ABI (SMD=0.65, 95% CI=0.33-0.97; P<0.001) for the stem cell-based therapy group compared with the controls. Moreover, significant improvement in the amputation rate, ulcer healing, and ABI were also found based on the time point and stem cell source. In addition, no significant difference was found in the all-cause mortality (OR=0.80, 95% CI=0.39-1.641; P=0.546) between the stem cell-based therapy and control groups. Therefore, according to the results of our meta-analysis, stem cell-based therapy is safe and shows a beneficial outcome for patients with PAD, especially in the short term.	[Liu, Yumeng; Guo, Liang] Soochow Univ, Affiliated Hosp 1, Dept Radiol, Suzhou, Jiangsu, Peoples R China; [Xu, Yunyun; Fang, Fang] Soochow Univ, Childrens Hosp, Inst Pediat, Suzhou, Jiangsu, Peoples R China; [Zhang, Jianting; Weng, Zhen] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, Key Lab Nanobio Interface, Suzhou, Jiangsu, Peoples R China; [Zhang, Jianting; Weng, Zhen] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, I Lab, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS	Guo, L (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Radiol, Suzhou, Jiangsu, Peoples R China.	guoliangsuda@126.com; zweng2014@sinano.ac.cn			Natural Science Foundation of Jiangsu Providence, China [BK20140388]	Natural Science Foundation of Jiangsu Providence, China	This study was funded by the Natural Science Foundation of Jiangsu Providence, China (Grant No. BK20140388 to ZW).	Behar T, 2013, J Mal Vasc, V38, P22, DOI 10.1016/j.jmv.2012.10.005; Benoit E, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-165; Chen HX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06222; Cobellis G, 2008, BONE MARROW TRANSPL, V42, P667, DOI 10.1038/bmt.2008.228; Diehm C, 2004, ATHEROSCLEROSIS, V172, P95, DOI 10.1016/S0021-9150(03)00204-1; Dubsky M, 2013, DIABETES-METAB RES, V29, P369, DOI 10.1002/dmrr.2399; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fadini GP, 2010, ATHEROSCLEROSIS, V209, P10, DOI 10.1016/j.atherosclerosis.2009.08.033; Gao Wei, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P610; Gupta NK, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0447-2; Gupta PK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-143; Heidrich H, 2004, VASA-J VASCULAR DIS, V33, P63, DOI 10.1024/0301-1526.33.2.63; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Huang PP, 2005, DIABETES CARE, V28, P2155, DOI 10.2337/diacare.28.9.2155; Lasala GP, 2012, J THORAC CARDIOV SUR, V144, P377, DOI 10.1016/j.jtcvs.2011.08.053; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lau JF, 2011, NAT REV CARDIOL, V8, P405, DOI 10.1038/nrcardio.2011.66; Li M, 2013, EXP CLIN TRANSPLANT, V11, P435, DOI 10.6002/ect.2012.0129; Lu DB, 2011, DIABETES RES CLIN PR, V92, P26, DOI 10.1016/j.diabres.2010.12.010; Mohammadzadeh L, 2013, EXP CLIN ENDOCR DIAB, V121, P48, DOI 10.1055/s-0032-1311646; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ozturk A, 2012, J DIABETES COMPLICAT, V26, P29, DOI 10.1016/j.jdiacomp.2011.11.007; Powell RJ, 2011, J VASC SURG, V54, P1032, DOI 10.1016/j.jvs.2011.04.006; Prochazka V, 2010, CELL TRANSPLANT, V19, P1413, DOI 10.3727/096368910X514170; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; Szabo GV, 2013, CYTOTHERAPY, V15, P1245, DOI 10.1016/j.jcyt.2013.05.017; Walter DH, 2011, CIRC-CARDIOVASC INTE, V4, P26, DOI 10.1161/CIRCINTERVENTIONS.110.958348; Wang ZX, 2014, J ATHEROSCLER THROMB, V21, P1183	28	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125032	10.1371/journal.pone.0125032	http://dx.doi.org/10.1371/journal.pone.0125032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923119	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600119
J	Neukam, K; Munteanu, DI; Rivero-Juarez, A; Lutz, T; Fehr, J; Mandorfer, M; Bhagani, S; Lopez-Cortes, LF; Haberl, A; Stoeckle, M; Marquez, M; Scholten, S; de los Santos-Gil, I; Mauss, S; Rivero, A; Collado, A; Delgado, M; Rockstroh, JK; Pineda, JA				Neukam, Karin; Munteanu, Daniela I.; Rivero-Juarez, Antonio; Lutz, Thomas; Fehr, Jan; Mandorfer, Mattias; Bhagani, Sanjay; Lopez-Cortes, Luis F.; Haberl, Annette; Stoeckle, Marcel; Marquez, Manuel; Scholten, Stefan; de los Santos-Gil, Ignacio; Mauss, Stefan; Rivero, Antonio; Collado, Antonio; Delgado, Marcial; Rockstroh, Juergen K.; Pineda, Juan A.			Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; SUSTAINED VIROLOGICAL RESPONSE; INTERFERON PLUS RIBAVIRIN; PEGYLATED INTERFERON; PHASE-2 TRIAL; CIRRHOSIS; FIBROSIS; HIV/HCV; COHORT	Background and Aims Clinical trials of therapy against chronic hepatitis C virus (HCV) infection including boceprevir (BOC) or telaprevir (TVR) plus pegylated interferon and ribavirin (PR) have reported considerably higher response rates than those achieved with PR alone. This study sought to evaluate the efficacy and safety of triple therapy including BOC or TVR in combination with PR in HIV/HCV-coinfected patients under real-life conditions. Methods In a multicentre study conducted in 24 sites throughout five European countries, all HIV/HCV-coinfected patients who initiated a combination of BOC or TVR plus PR and who had at least 60 weeks of follow-up, were analyzed. Sustained virologic response 12 weeks after the scheduled end of therapy date (SVR12) and the rate of discontinuations due to adverse events (AE) were evaluated. Results Of the 159 subjects included, 127 (79.9%) were male, 45 (34.4%) were treatment-naive for PR and 60 (45.4%) showed cirrhosis. SVR12 was observed in 31/46 (67.4%) patients treated with BOC and 69/113 (61.1%) patients treated with TVR. Overall discontinuations due to AE rates were 8.7% for BOC and 8% for TVR. Grade 3 or 4 hematological abnormalities were frequently observed; anemia 7%, thrombocytopenia 17.2% and neutropenia 16.4%. Conclusion The efficacy and safety of triple therapy including BOC or TVR plus PR under real-life conditions of use in the HIV/HCV-coinfected population was similar to what is observed in clinical trials. Hematological side effects are frequent but manageable.	[Neukam, Karin; Pineda, Juan A.] Valme Univ Hosp, Unit Infect Dis & Microbiol, Seville, Spain; [Neukam, Karin; Pineda, Juan A.] Seville Inst Biomed IBiS, Seville, Spain; [Munteanu, Daniela I.; Rockstroh, Juergen K.] Bonn Univ Hosp, Dept Med 1, Bonn, Germany; [Munteanu, Daniela I.] Matei Bals Natl Inst Infect Dis, Bucharest, Romania; [Rivero-Juarez, Antonio; Rivero, Antonio] Reina Sofia Univ Hosp, Maimonides Inst Biomed Invest Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain; [Lutz, Thomas] Infektiologikum Frankfurt, Frankfurt, Germany; [Fehr, Jan] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Mandorfer, Mattias] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Mandorfer, Mattias] Vienna HIV & Liver Study Grp, Vienna, Austria; [Bhagani, Sanjay] Royal Free London NHS Fdn Trust, Dept Infect Dis HIV Med, London, England; [Lopez-Cortes, Luis F.] Virgen del Rocio Univ Hosp, Infect Dis Microbiol & Prevent Med, Seville, Spain; [Lopez-Cortes, Luis F.] Seville Inst Biomed IBiS, Seville, Spain; [Haberl, Annette] Frankfurt Univ Hosp, Dept Med 2, Frankfurt, Germany; [Stoeckle, Marcel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Marquez, Manuel] Virgen de la Victoria Univ Hosp, Infect Dis Unit, Malaga, Spain; [Scholten, Stefan] Praxis Hohenstaufenring, Cologne, Germany; [de los Santos-Gil, Ignacio] La Princesa Univ Hosp, Infect Dis Unit, Madrid, Spain; [Mauss, Stefan] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany; [Collado, Antonio] Torrecardenas Univ Hosp, Infect Dis Unit, Almeria, Spain; [Delgado, Marcial] Carlos Haya Reg Univ Hosp, Infect Dis Unit, Malaga, Spain	Hospital Valme; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Bonn; National Institute for Infectious Diseases "Matei Bals"; University of Zurich; University Zurich Hospital; Medical University of Vienna; University of London; University College London; Royal Free London NHS Foundation Trust; Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Basel; Hospital Virgen de la Victoria; Hospital Carlos Haya	Neukam, K (corresponding author), Valme Univ Hosp, Unit Infect Dis & Microbiol, Seville, Spain.	karin.neukam@gmail.com	Lopez.Cortes, Luis Fernando/W-8323-2019; Pineda, Juan A./AAO-9312-2021; Fehr, Jan S/V-7499-2017; IBIS, VIH/O-8856-2015; Neukam, Karin/D-9415-2018; Rivero-Juarez, Antonio/E-4528-2019; Mandorfer, Mattias/H-7603-2019; Rivero, Antonio/ABE-5294-2020	Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Pineda, Juan A./0000-0002-3751-0296; Fehr, Jan S/0000-0003-1113-9895; Neukam, Karin/0000-0003-3875-1013; Rivero-Juarez, Antonio/0000-0002-5813-6889; Mandorfer, Mattias/0000-0003-2330-0017; Bhagani, Sanjay/0000-0003-2557-4337; Rivero, Antonio/0000-0001-5005-8268; Marquez, Manuel/0000-0002-7901-6966; Rivero Roman, Antonio/0000-0002-8643-4250; De Los Santos Gil, Ignacio/0000-0001-7073-5211	RIS-HEP07 Study Group [RD12/0017/0012]; Ministerio de Sanidad y Servicios Sociales [EC11-304]; Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia [PI-0492-2012]; Swiss National Science Foundation [134277]; Swiss National Science Foundation (SHCS) [688]; Instituto de Salud Carlos III [CP13/00187, Programa-I3SNS]; Fundacion Progreso y Salud of the Junta de Andalucia [RH-0024-2013]	RIS-HEP07 Study Group; Ministerio de Sanidad y Servicios Sociales; Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation (SHCS)(Swiss National Science Foundation (SNSF)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Progreso y Salud of the Junta de Andalucia	This work was supported by the RD12/0017/0012 (RIS-HEP07 Study Group), the Ministerio de Sanidad y Servicios Sociales (grant number EC11-304), the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (grant number PI-0492-2012) and the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant number 134277 and SHCS project number 688). K.N. is the recipient of a Miguel Servet research grant from the Instituto de Salud Carlos III (grant number CP13/00187). D.M. is a participant in the European AIDS Clinical Society Exchange Medical Programme. A.R.-J. is the recipient of a post-doctoral extension grant of the Fundacion Progreso y Salud of the Junta de Andalucia (grant number RH-0024-2013). J.A.P is the recipient of an intensification grant from the Instituto de Salud Carlos III (grant number Programa-I3SNS).	Akiyama Matthew J, 2013, Hawaii J Med Public Health, V72, P6; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Colombo M, 2014, GUT, V63, P1150, DOI 10.1136/gutjnl-2013-305667; Cotte L, 2014, CLIN INFECT DIS, V59, P1768, DOI 10.1093/cid/ciu659; Di Bisceglie A, 2013, PROGRAM AND ABSTRACT; European AIDS Clinical Society, CLINICAL MANAGEMENT; European AIDS Clinical Society (EACS), CLINICAL MANAGEMENT; European Association for the Study of the Liver (EASL), 2014, EASL RECOMMENDATIONS; Gheorghe L, 2014, J GASTROINTEST LIVER, V23, P45; Hare CB, 2013, GLOBAL ANTIVIRAL JOU, V9; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Ioannou GN, 2014, CLIN GASTROENTEROL H, V12, P1371, DOI 10.1016/j.cgh.2013.12.011; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lacombe K, 2013, AIDS, V27, P1356, DOI 10.1097/QAD.0b013e32836138d0; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Mandorfer M, 2015, J INFECT DIS, V211, P729, DOI 10.1093/infdis/jiu516; Martel-Laferriere V, 2013, PROGRAM AND ABSTRACT; Mira JA, 2013, CLIN INFECT DIS, V56, P1646, DOI 10.1093/cid/cit103; Mira JA, 2012, AIDS, V26, P1721, DOI 10.1097/QAD.0b013e3283568884; Montes M, 2013, PROGRAM AND ABSTRACT; Pineda JA, 2007, J ANTIMICROB CHEMOTH, V60, P1347, DOI 10.1093/jac/dkm373; Pineda JA, 2009, CLIN INFECT DIS, V49, P1274, DOI 10.1086/605676; Poizot-Martin I, 2014, PROGRAM AND ABSTRACT; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; U.S. Food and Drug Administration, OLYSIO SIMEPREVIR FO; US Food and Drug Administration, APPROVAL OF SOVALDI; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; Vierling JM, 2014, J HEPATOL, V61, P200, DOI 10.1016/j.jhep.2014.03.022; von Wichmann MA, 2013, PROGRAM AND ABSTRACT; Werner CR, 2014, J VIRAL HEPATITIS, V21, P333, DOI 10.1111/jvh.12145; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zinkernagel AS, 2006, ANTIVIR THER, V11, P131	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125080	10.1371/journal.pone.0125080	http://dx.doi.org/10.1371/journal.pone.0125080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923540	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600123
J	Pollet, T; Cloutier, O; Nozais, C; McKindsey, CW; Archambault, P				Pollet, Thomas; Cloutier, Olivier; Nozais, Christian; McKindsey, Christopher W.; Archambault, Philippe			Metabolic Activity and Functional Diversity Changes in Sediment Prokaryotic Communities Organically Enriched with Mussel Biodeposits	PLOS ONE			English	Article							LEVEL PHYSIOLOGICAL PROFILES; LA-MADELEINE QUEBEC; BIOGEOCHEMICAL FLUXES; NITROGEN DYNAMICS; CULTURE; LAGOON; WATER; CLASSIFICATION; AQUACULTURE; MEIOFAUNA	This experimental microcosm study reports the influence of organic enrichments by mussel biodeposits on the metabolic activity and functional diversity of benthic prokaryotic communities. The different biodeposit enrichment regimes created, which mimicked the quantity of faeces and pseudo-faeces potentially deposited below mussel farms, show a clear stimulatory effect of this organic enrichment on prokaryotic metabolic activity. This effect was detected once a certain level of biodeposition was attained with a tipping point estimated between 3.25 and 10 g day(-1) m(-2). Prokaryotic communities recovered their initial metabolic activity by 11 days after the cessation of biodeposit additions. However, their functional diversity remained greater than prior to the disturbance suggesting that mussel biodeposit enrichment may disturb the functioning and perhaps the role of prokaryotic communities in benthic ecosystems. This manipulative approach provided new information on the influence of mussel biodeposition on benthic prokaryotic communities and dose-response relationships and may support the development of carrying capacity models for bivalve culture.	[Pollet, Thomas; Cloutier, Olivier; Archambault, Philippe] Univ Quebec, Inst Sci de la Mer, Lab Ecol Benth, Rimouski, PQ G5L 3A1, Canada; [Nozais, Christian] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ, Canada; [McKindsey, Christopher W.] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Ocean & Environm Sci Div, Mont Joli, PQ G5H 3Z4, Canada	University of Quebec; University of Quebec; Fisheries & Oceans Canada	Pollet, T (corresponding author), Univ Quebec, Inst Sci de la Mer, Lab Ecol Benth, Rimouski, PQ G5L 3A1, Canada.	thomas.pollet@hotmail.fr	McKindsey, Chris/AAH-6773-2020; Pollet, Thomas/AAZ-2141-2021	McKindsey, Chris/0000-0002-3026-6454	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; Fisheries and Oceans Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fisheries and Oceans Canada	TP was supported by a RAQ-FONCER postdoctoral grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The study was also supported by other funding obtained by PA (NSERC and Fisheries and Oceans Canada) and CN (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brashears MM, 1995, J DAIRY SCI, V78, P2326, DOI 10.3168/jds.S0022-0302(95)76859-X; Callier MD, 2008, AQUACULTURE, V278, P77, DOI 10.1016/j.aquaculture.2008.03.026; Callier MD, 2007, MAR ECOL PROG SER, V348, P103, DOI 10.3354/meps07034; Callier MD, 2006, MAR ECOL PROG SER, V322, P129, DOI 10.3354/meps322129; Callier MD, 2009, MAR POLLUT BULL, V58, P1544, DOI 10.1016/j.marpolbul.2009.05.010; Christensen PB, 2003, AQUACULTURE, V218, P567, DOI 10.1016/S0044-8486(02)00587-2; Crawford CM, 2003, AQUACULTURE, V224, P117, DOI 10.1016/S0044-8486(03)00210-2; Danovaro R, 2004, MAR POLLUT BULL, V49, P325, DOI 10.1016/j.marpolbul.2004.02.038; Danovaro R, 2003, CHEM ECOL, V19, P391, DOI 10.1080/02757540310001596681; FABIANO M, 1994, MAR BIOL, V119, P375, DOI 10.1007/BF00347534; Foschino R, 1996, J DAIRY RES, V63, P295, DOI 10.1017/S0022029900031782; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Gilbert F, 1997, MAR ECOL PROG SER, V151, P143, DOI 10.3354/meps151143; Giles H, 2004, MAR ECOL PROG SER, V282, P205, DOI 10.3354/meps282205; Gillan DC, 2012, SCI TOTAL ENVIRON, V419, P98, DOI 10.1016/j.scitotenv.2011.12.034; Glud RN, 2004, LIMNOL OCEANOGR, V49, P2073, DOI 10.4319/lo.2004.49.6.2073; Gomez E, 2004, APPL SOIL ECOL, V26, P21, DOI 10.1016/j.apsoil.2003.10.007; Grant C, 2012, AQUACULT ENV INTERAC, V2, P117, DOI 10.3354/aei00035; GRENZ C, 1990, HYDROBIOLOGIA, V207, P153, DOI 10.1007/BF00041452; Hargrave BT, 2008, MAR POLLUT BULL, V56, P810, DOI 10.1016/j.marpolbul.2008.02.006; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; Hartstein ND, 2004, MAR ENVIRON RES, V57, P339, DOI 10.1016/j.marenvres.2003.11.003; Kaiser MJ, 1998, J SHELLFISH RES, V17, P59; Kuwae T, 1999, APPL ENVIRON MICROB, V65, P3407; La Rosa T, 2001, ENVIRON POLLUT, V112, P427, DOI 10.1016/S0269-7491(00)00141-X; Lavrentyev PJ, 2000, AQUAT MICROB ECOL, V21, P187, DOI 10.3354/ame021187; Luna GM, 2013, WATER RES, V47, P1156, DOI 10.1016/j.watres.2012.11.036; McKindsey CW, 2006, AQUACULTURE, V261, P451, DOI 10.1016/j.aquaculture.2006.06.044; McKindsey CW, 2011, CAN J ZOOL, V89, P622, DOI [10.1139/Z11-037, 10.1139/z11-037]; McKindsey CW, 2009, AQUACULTURE, V295, P44, DOI 10.1016/j.aquaculture.2009.06.022; Mirto S., 1999, Biologia Marina Mediterranea, V6, P331; Mirto S, 2000, MAR POLLUT BULL, V40, P244, DOI 10.1016/S0025-326X(99)00209-X; Navarro JM, 1997, J EXP MAR BIOL ECOL, V209, P1, DOI 10.1016/0022-0981(96)02681-0; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Piot A, 2014, OIKOS, V123, P203, DOI 10.1111/j.1600-0706.2013.00631.x; Richard M, 2007, CAN J FISH AQUAT SCI, V64, P1491, DOI 10.1139/F07-116; Richard M, 2006, CAN J FISH AQUAT SCI, V63, P1198, DOI 10.1139/F06-030; Robert P, 2013, MAR POLLUT BULL, V66, P92, DOI 10.1016/j.marpolbul.2012.11.003; Sestanovic S., 2005, ACTA ADRIAT, V46, P177; Weise AM, 2009, AQUACULTURE, V288, P239, DOI 10.1016/j.aquaculture.2008.12.001; Zhou Y, 2006, MAR ECOL PROG SER, V317, P127, DOI 10.3354/meps317127	43	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123681	10.1371/journal.pone.0123681	http://dx.doi.org/10.1371/journal.pone.0123681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923715	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600054
J	Rayner, RE; Savill, J; Hafner, LM; Huygens, F				Rayner, Rachael E.; Savill, John; Hafner, Louise M.; Huygens, Flavia			Modified MLVA for Genotyping Queensland Invasive Streptococcus pneumoniae	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; PNEUMOCOCCAL DISEASE; SEROTYPE REPLACEMENT; IDENTIFICATION; DISCOVERY; LOCI	Background Globally, over 800 000 children under five die each year from infectious diseases caused by Streptococcus pneumoniae. To understand genetic relatedness between isolates, study transmission routes, assess the impact of human interventions e.g. vaccines, and determine infection sources, genotyping methods are required. The 'gold standard' genotyping method, Multi-Locus Sequence Typing (MLST), is useful for long-term and global studies. Another genotyping method, Multi-Locus Variable Number of Tandem Repeat Analysis (MLVA), has emerged as a more discriminatory, inexpensive and faster technique; however there is no universally accepted method and it is currently suitable for short-term and localised epidemiology studies. Currently Australia has no national MLST database, nor has it adopted any MLVA method for short-term or localised studies. This study aims to improve S. pneumoniae genotyping methods by modifying the existing MLVA techniques to be more discriminatory, faster, cheaper and technically less demanding than previously published MLVA methods and MLST. Methods Four different MLVA protocols, including a modified method, were applied to 317 isolates of serotyped invasive S. pneumoniae isolated from sterile body sites of Queensland children under 15 years from 2007-2012. MLST was applied to 202 isolates for comparison. Results The modified MLVA4 is significantly more discriminatory than the 'gold standard' MLST method. MLVA4 has similar discrimination compared to other MLVA techniques in this study). The failure to amplify particular loci in previous MLVA methods were minimised in MLVA4. Failure to amplify BOX-13 and Spneu19 were found to be serotype specific. Conclusion We have modified a highly discriminatory MLVA technique for genotyping Queensland invasive S. pneumoniae. MLVA4 has the ability to enhance our understanding of the pneumococcal epidemiology and the changing genetics of the pneumococcus in localised and short-term studies.	[Rayner, Rachael E.; Hafner, Louise M.; Huygens, Flavia] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Rayner, Rachael E.; Hafner, Louise M.; Huygens, Flavia] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Savill, John] Queensland Hlth Forens & Sci Serv, Publ Hlth Microbiol Lab, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland Health	Huygens, F (corresponding author), Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia.	f.huygens@qut.edu.au		Rayner, Rachael E/0000-0002-0659-559X; Huygens, Flavia/0000-0002-2737-2264	Queensland Health Forensic and Scientific Services, Coopers Plains, Australia	Queensland Health Forensic and Scientific Services, Coopers Plains, Australia	This work was supported by the Queensland Health Forensic and Scientific Services, Coopers Plains, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2011, CLIN VACCINE IMMUNOL, V18, P343, DOI 10.1128/CVI.00383-10; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Centers for Disease Control Prevention, 2013, INV PNEUM DIS IPD ST; Croucher NJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-120; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019668; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; HERMANS PWM, 1995, J CLIN MICROBIOL, V33, P1606, DOI 10.1128/JCM.33.6.1606-1612.1995; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jefferies J, 2003, MOL BIOTECHNOL, V24, P303, DOI 10.1385/MB:24:3:303; Johnson DR, 2012, VACCINE, V30, P2206, DOI 10.1016/j.vaccine.2011.12.119; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; Knutsen E, 2006, J BACTERIOL, V188, P8307, DOI 10.1128/JB.00850-06; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13; Koeck JL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-66; Lehmann D, 2010, CLIN INFECT DIS, V50, P1477, DOI 10.1086/652440; Lindstedt BA, 2013, EUROSURVEILLANCE, V18, P7; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Malachowa N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mehr S, 2012, PAEDIATR RESPIR REV, V13, P258, DOI 10.1016/j.prrv.2011.12.001; NNDSS, 2013, DIS NOT RAT QLD 1991; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pichon B, 2010, J CLIN MICROBIOL, V48, P1926, DOI 10.1128/JCM.02054-09; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Sabharwal V, 2013, MICROBES IN IN PRESS; Sanchez-Beato AR, 1998, FEMS MICROBIOL LETT, V164, P207, DOI 10.1016/S0378-1097(98)00206-7; Schouls L, 2012, STREP PNEUM; Selvey C., 2011, INFORM PREVENAR 13 S; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; Statens Serum Institut, 2013, PNEUM ANT; van Cuyck H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-241; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; WALLACE DL, 1983, J AM STAT ASSOC, V78, P569, DOI 10.2307/2288118; Wyres KL, 2013, J INFECT DIS, V207, P439, DOI 10.1093/infdis/jis703; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	43	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0121870	10.1371/journal.pone.0121870	http://dx.doi.org/10.1371/journal.pone.0121870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923909	gold, Green Published, Green Submitted			2022-12-26	WOS:000353711600008
J	Kamiya, K; Sakabe, JI; Yamaguchi, H; Suzuki, T; Yatagai, T; Aoshima, M; Ito, T; Tokura, Y				Kamiya, Koji; Sakabe, Jun-Ichi; Yamaguchi, Hayato; Suzuki, Takahiro; Yatagai, Tsuyoshi; Aoshima, Masahiro; Ito, Taisuke; Tokura, Yoshiki			Gross Cystic Disease Fluid Protein 15 in Stratum Corneum Is a Potential Marker of Decreased Eccrine Sweating for Atopic Dermatitis	PLOS ONE			English	Article							PROLACTIN-INDUCIBLE PROTEIN; SKIN BARRIER FUNCTION; GCDFP-15 EXPRESSION; ANTIMICROBIAL PEPTIDES; CHOLINERGIC URTICARIA	It is well known that eccrine sweating is attenuated in patients with atopic dermatitis (AD). We have reported by using proteome analysis that gross cystic disease fluid protein 15 (GCDFP15), a substance secreted from eccrine sweat glands, is decreased in tape-stripped stratum corneum (SC) samples from AD patients. The aim of this study was to evaluate GCDFP15 production by eccrine glands with SC samples and to assess sweating in AD. SC samples were obtained from 51 healthy control (HC) and 51 AD individuals. Sweat samples were from 18 HC and 12 AD subjects. GCDFP15 was quantified by ELISA. By immunohistochemistry, the expression of GCDFP15 in eccrine glands was examined in normal and AD skin specimens. To identify GCDFP15-producing cells, double immunofluorescence staining for GCDFP15 and S100 protein was performed in frozen sections. To address the mechanism underlying the decreased eccrine sweating in AD patients, we examined the expression of cholinergic receptor M3 (CHRM3), a receptor for acetylcholine-induced sweating, in eccrine sweat glands. The amounts of GCDFP15 in the SC extracts were significantly lower in AD than HC (P < 0.0001). The sweat samples from AD patients also had lower levels of GCDFP15 concentration (P < 0.05). Immunohistochemistry showed positive GCDFP15 staining in the eccrine gland secretory cells and the ductal and acrosyringial lumen in normal skin, but AD lacked clear staining. Immunofluorescence staining revealed that GCDFP15 was co-expressed with S100 protein, suggesting that the clear cell of eccrine glands produces GCDFP15. Finally, we found that the expression of CHRM3 was depressed in AD, suggesting contribution to the low sweating. The SC of AD patients contains a low amount of GCDFP15 due to both low sweating and low GCDFP15 concentration in the sweat. GCDFP15 in SC is a potential marker for dysregulated sweating in AD.	[Kamiya, Koji; Sakabe, Jun-Ichi; Yamaguchi, Hayato; Suzuki, Takahiro; Yatagai, Tsuyoshi; Aoshima, Masahiro; Ito, Taisuke; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine	Kamiya, K (corresponding author), Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan.	m01023kk@jichi.ac.jp		Sakabe, Jun-Ichi/0000-0002-8237-0472				Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Dainichi T, 2014, J DERMATOL SCI, V76, P81, DOI 10.1016/j.jdermsci.2014.08.010; Darb-Esfahani S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-546; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Eishi K, 2002, BRIT J DERMATOL, V147, P683, DOI 10.1046/j.1365-2133.2002.04765.x; Gallo A, 2013, J Genet Syndr Gene Ther, V4, DOI 10.4172/2157-7412.1000140; Gallo RL, 1998, J INVEST DERMATOL, V111, P739, DOI 10.1046/j.1523-1747.1998.00361.x; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Jung M, 2014, J DERMATOL SCI, V76, P231, DOI 10.1016/j.jdermsci.2014.09.004; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kijima A, 2012, ALLERGOL INT, V61, P469, DOI 10.2332/allergolint.12-OA-0429; Kitaba Shun, 2011, Allergology International, V60, P387, DOI 10.2332/allergolint.10-CR-0265; Loos S, 1999, INT J MOL MED, V4, P135; Matsui S, 2014, J INVEST DERMATOL, V134, P326, DOI 10.1038/jid.2013.323; Mori T, 2010, BRIT J DERMATOL, V162, P83, DOI 10.1111/j.1365-2133.2009.09440.x; Murota H, 2015, J DERMATOL SCI, V77, P3, DOI 10.1016/j.jdermsci.2014.08.011; MYAL Y, 1991, MOL CELL ENDOCRINOL, V80, P165, DOI 10.1016/0303-7207(91)90153-J; Nistor A, 2009, ORAL MICROBIOL IMMUN, V24, P510, DOI 10.1111/j.1399-302X.2009.00543.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Priyadarsini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113310; Saga K, 2001, J INVEST DERM SYMP P, V6, P49, DOI 10.1046/j.0022-202x.2001.00005.x; Sakabe J, 2014, J ALLERGY CLIN IMMUN, V134, P957, DOI 10.1016/j.jaci.2014.07.054; Sawada Y, 2014, J INVEST DERMATOL, V134, P276, DOI 10.1038/jid.2013.244; Sawada Y, 2010, J INVEST DERMATOL, V130, P2683, DOI 10.1038/jid.2010.188; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schittek Birgit, 2008, Infectious Disorders - Drug Targets, V8, P135; Schroder JM, 1999, CELL MOL LIFE SCI, V56, P32, DOI 10.1007/s000180050004; Shibasaki Manabu, 2010, Front Biosci (Schol Ed), V2, P685; Striebel JM, 2008, AM J SURG PATHOL, V32, P426, DOI 10.1097/PAS.0b013e318157a5a6; Takahashi A, 2013, ALLERGOL INT, V62, P473, DOI 10.2332/allergolint.13-OA-0547; TOKURA Y, 1986, J CUTAN PATHOL, V13, P102, DOI 10.1111/j.1600-0560.1986.tb01509.x; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Tomar AK, 2012, BIOMARKERS, V17, P545, DOI 10.3109/1354750X.2012.699555; Viacava P, 1998, VIRCHOWS ARCH, V432, P255, DOI 10.1007/s004280050163	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125082	10.1371/journal.pone.0125082	http://dx.doi.org/10.1371/journal.pone.0125082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919462	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659400071
J	Neely, BA; Ferrante, JA; Chaves, JM; Soper, JL; Almeida, JS; Arthur, JM; Gulland, FMD; Janech, MG				Neely, Benjamin A.; Ferrante, Jason A.; Chaves, J. Mauro; Soper, Jennifer L.; Almeida, Jonas S.; Arthur, John M.; Gulland, Frances M. D.; Janech, Michael G.			Proteomic Analysis of Plasma from California Sea Lions (Zalophus californianus) Reveals Apolipoprotein E as a Candidate Biomarker of Chronic Domoic Acid Toxicosis	PLOS ONE			English	Article							TOXICITY; NMDA; GLYCOSYLATION; PATHOLOGY; EPILEPSY; MODEL; MICE	Domoic acid toxicosis (DAT) in California sea lions (Zalophus californianus) is caused by exposure to the marine biotoxin domoic acid and has been linked to massive stranding events and mortality. Diagnosis is based on clinical signs in addition to the presence of domoic acid in body fluids. Chronic DAT further is characterized by reoccurring seizures progressing to status epilepticus. Diagnosis of chronic DAT is often slow and problematic, and minimally invasive tests for DAT have been the focus of numerous recent biomarker studies. The goal of this study was to retrospectively profile plasma proteins in a population of sea lions with chronic DAT and those without DAT using two dimensional gel electrophoresis to discover whether individual, multiple, or combinations of protein and clinical data could be utilized to identify sea lions with DAT. Using a training set of 32 sea lion sera, 20 proteins and their isoforms were identified that were significantly different between the two groups (p<0.05). Interestingly, 11 apolipoprotein E (ApoE) charge forms were decreased in DAT samples, indicating that ApoE charge form distributions may be important in the progression of DAT. In order to develop a classifier of chronic DAT, an independent blinded test set of 20 sea lions, seven with chronic DAT, was used to validate models utilizing ApoE charge forms and eosinophil counts. The resulting support vector machine had high sensitivity (85.7% with 92.3% negative predictive value) and high specificity (92.3% with 85.7% positive predictive value). These results suggest that ApoE and eosinophil counts along with machine learning can perform as a robust and accurate tool to diagnose chronic DAT. Although this analysis is specifically focused on blood biomarkers and routine clinical data, the results demonstrate promise for future studies combining additional variables in multidimensional space to create robust classifiers.	[Neely, Benjamin A.; Ferrante, Jason A.; Chaves, J. Mauro; Arthur, John M.; Janech, Michael G.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Ferrante, Jason A.; Janech, Michael G.] Coll Charleston, Grice Marine Lab, Charleston, SC 29401 USA; [Soper, Jennifer L.; Gulland, Frances M. D.] Marine Mammal Ctr, Sausalito, CA USA; [Almeida, Jonas S.] SUNY Stony Brook, Dept Biomed Informat, Long Isl City, NY USA; [Arthur, John M.; Janech, Michael G.] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC USA	Medical University of South Carolina; College of Charleston; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Janech, MG (corresponding author), Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA.	janechmg@musc.edu	janech, michael/AAA-1011-2019; Almeida, Jonas/C-9093-2009; Chaves, Jose Mauro/GNH-4323-2022; Neely, Benjamin/AGR-8303-2022	Almeida, Jonas/0000-0002-7883-7922; Chaves, Jose Mauro/0000-0001-7416-4356; Ferrante, Jason/0000-0003-3453-4636; Neely, Benjamin/0000-0001-6120-7695; Arthur, John/0000-0003-4342-4762	Office of Naval Research [N00014-08-1-0341]	Office of Naval Research(Office of Naval Research)	Funding: Funding for this work, and for BAN JAF JMC JLS JSA JMA FMDG MGJ, was provided by the Office of Naval Research (N00014-08-1-0341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Berman FW, 2002, BRAIN RES, V924, P20, DOI 10.1016/S0006-8993(01)03221-8; Buckmaster PS, 2014, J COMP NEUROL, V522, P1691, DOI 10.1002/cne.23509; CENDES F, 1995, ANN NEUROL, V37, P123, DOI 10.1002/ana.410370125; Chua CC, 2010, J NEUROCHEM, V112, P1619, DOI 10.1111/j.1471-4159.2010.06586.x; Cook P, 2011, BIOL LETTERS, V7, P536, DOI 10.1098/rsbl.2011.0127; DAVIS RW, 1991, J LIPID RES, V32, P1013; Ferrante JA, 2010, DISCOVERY BLOOD PROT; Funk JA, 2014, J AM SOC NEPHROL, V25, P1187, DOI 10.1681/ASN.2013080836; Fuquay JM, 2012, PHYSIOL BEHAV, V105, P315, DOI 10.1016/j.physbeh.2011.08.013; Goldstein T, 2008, P ROY SOC B-BIOL SCI, V275, P267, DOI 10.1098/rspb.2007.1221; Greig Denise J., 2005, Aquatic Mammals, V31, P11, DOI 10.1578/AM.31.1.2005.11; Gulland FMD, 2002, VET REC, V150, P475; Gulland FMD, 2012, JAVMA-J AM VET MED A, V241, P943, DOI 10.2460/javma.241.7.943; Hampson David R., 1998, Natural Toxins, V6, P153, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<153::AID-NT16>3.0.CO;2-1; Larm JA, 1997, NEUROCHEM INT, V31, P677, DOI 10.1016/S0197-0186(97)00030-2; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Lefebvre KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036213; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Muha N, 2011, TOXICON, V57, P168, DOI 10.1016/j.toxicon.2010.07.018; Neely BA, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-18; Pepe M. S., 2003, STAT EVALUATION MED; PERL TM, 1990, NEW ENGL J MED, V322, P1775, DOI 10.1056/NEJM199006213222504; Pulido OM, 2008, MAR DRUGS, V6, P180, DOI 10.3390/md20080010; Raber J, 2000, J NEUROSCI, V20, P2064; Ramsdell JS, 2014, MAR DRUGS, V12, P1185, DOI 10.3390/md12031185; Ramsey Una P., 1998, Natural Toxins, V6, P137, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<137::AID-NT28>3.3.CO;2-C; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Schwacke LH, 2010, ENVIRON RES, V110, P548, DOI 10.1016/j.envres.2010.05.003; Silvagni PA, 2005, VET PATHOL, V42, P184, DOI 10.1354/vp.42-2-184; Tasker RAR, 2005, AMINO ACIDS, V28, P193, DOI 10.1007/s00726-005-0167-z; Tasker RAR, 1998, NEUROTOXICOLOGY, V19, P593; Thomton JD, 2007, J WILDLIFE DIS, V43, P258, DOI 10.7589/0090-3558-43.2.258; Thorngate FE, 2002, J LIPID RES, V43, P1920, DOI 10.1194/jlr.M200205-JLR200; TRUELOVE J, 1994, B ENVIRON CONTAM TOX, V52, P479; Twiner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017394; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Walz P. M., 1994, Natural Toxins, V2, P271, DOI 10.1002/nt.2620020505; Zabka TS, 2009, VET PATHOL, V46, P105, DOI 10.1354/vp.46-1-105	39	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123295	10.1371/journal.pone.0123295	http://dx.doi.org/10.1371/journal.pone.0123295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919366	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400026
J	Grossman, H; Chuderland, D; Ninio-Many, L; Hasky, N; Kaplan-Kraicer, R; Shalgi, R				Grossman, Hadas; Chuderland, Dana; Ninio-Many, Lihi; Hasky, Noa; Kaplan-Kraicer, Ruth; Shalgi, Ruth			A novel regulatory pathway in granulosa cells, the LH/human chorionic gonadotropin-microRNA-125a-3p-Fyn pathway, is required for ovulation	FASEB JOURNAL			English	Article						ovary; miRNA; Src family kinases; migration	FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; MICRORNA EXPRESSION; OOCYTE COMPLEXES; FYN KINASE; IDENTIFICATION; ACTIVATION; MIGRATION; RECEPTOR; STEROIDOGENESIS	Granulosa cells support the developing oocytes and serve as transducers of the ovulatory stimulus induced by LH surge. Fyn kinase is expressed in granulosa cells, though its role in these cells has not been studied. In human embryonic kidney 293T cells, microRNA (miR)-125a-3p down-regulates Fyn expression, causing a decrease in cells' migratory ability. Our aim was to explore the role of miR-125a-3p and Fyn in granulosa cells toward ovulation, focusing on migration as a possible mechanism. We demonstrate expression of miR-125a-3p and Fyn in mouse mural granulosa cells of preovulatory follicles and miR-125a-3p-induced down-regulation of Fyn expression in a granulosa cell line (rat). Administration of human chorionic gonadotropin (hCG; LH analog) caused a 75% decrease in the in vivo miR-125a-3p: Fyn mRNA ratio, followed by a 2-fold increased migratory ability of mural granulosa cells. In the hCG-treated granulosa cell line, miR-125a-3p expression was decreased, followed by Fyn up-regulation and phosphorylation of focal adhesion kinase and paxillin, enabling cell migration. An in vivo interference with miR-125a-3p: Fyn mRNA ratio in granulosa cells by intrabursal injections of Fyn small interfering RNA or miR-125a-3p mimic caused a 33 or 55% decrease in the number of ovulated oocytes, respectively. These observations reveal a new regulatory pathway in mural granulosa cells under the regulation of LH/hCG. Modulation of cell migration may account for the significance of the LH/hCG-miR-125a-3p-Fyn pathway to ovulation.	[Grossman, Hadas; Chuderland, Dana; Ninio-Many, Lihi; Hasky, Noa; Kaplan-Kraicer, Ruth; Shalgi, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Shalgi, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	shalgir@post.tau.ac.il			Israel Science Foundation [470/14]	Israel Science Foundation(Israel Science Foundation)	The authors are grateful to Professor Ruth Asheri-Padan and Reut Ohana (Tel Aviv University) for their valuable help with the in situ hybridization technique used in this study. This work was partially supported by a grant from the Israel Science Foundation (No. 470/14 to R.S.). H.G. performed this work in partial fulfillment of the requirements for a Ph.D. degree. H.G. developed the concept, designed and carried out the experiments, organized the data, performed the statistical analyses, and wrote the manuscript. D.C. and L.N.-M. participated in the study design and discussed the manuscript. N.H. performed and analyzed the immunohistochemistry assay. R.K.-K. assisted with the intrabursal injections and helped with drafting the manuscript. R.S. conceived the study, participated in its design and coordination, helped draft the manuscript, and supervised the study. All authors read the final manuscript and approved it. The authors declare no conflicts of interest.	Akison LK, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097345; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chuderland D, 2013, HUM REPROD, V28, P1626, DOI 10.1093/humrep/det027; Cohen-Fredarow A, 2014, MOL ENDOCRINOL, V28, P1039, DOI 10.1210/me.2013-1400; Donadeu FX, 2012, J ENDOCRINOL, V215, P323, DOI 10.1530/JOE-12-0252; Duggavathi R, 2009, SCIENCE, V324, P890, DOI 10.1126/science.1174130; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Franz MB, 2013, ARCH GYNECOL OBSTET, V287, P819, DOI 10.1007/s00404-012-2642-6; Hess KA, 1999, BIOL REPROD, V61, P436, DOI 10.1095/biolreprod61.2.436; Huang B, 2013, INT J ONCOL, V42, P1734, DOI 10.3892/ijo.2013.1861; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kawashima I, 2012, ENDOCRINOLOGY, V153, P3949, DOI 10.1210/en.2012-1059; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Leu TH, 2002, ONCOGENE, V21, P6992, DOI 10.1038/sj.onc.1205904; Levi M, 2010, REPRODUCTION, V140, P827, DOI 10.1530/REP-10-0312; Levi M, 2010, CELL CYCLE, V9, P1577, DOI 10.4161/cc.9.8.11299; McGinnis LK, 2011, MOL REPROD DEV, V78, P831, DOI 10.1002/mrd.21326; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mizutani T, 2006, MOL ENDOCRINOL, V20, P619, DOI 10.1210/me.2005-0277; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Ninio-Many L, 2013, J CELL SCI, V126, P2867, DOI 10.1242/jcs.123414; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Puttabyatappa M, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115717; Rolaki A, 2007, AM J PATHOL, V170, P1561, DOI 10.2353/ajpath.2007.060926; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Sang Q, 2013, J CLIN ENDOCR METAB, V98, P3068, DOI 10.1210/jc.2013-1715; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; SUH BS, 1992, J CELL BIOL, V119, P439, DOI 10.1083/jcb.119.2.439; Wayne CM, 2007, MOL ENDOCRINOL, V21, P1940, DOI 10.1210/me.2007-0020; Xu D, 2012, CELL SIGNAL, V24, P282, DOI 10.1016/j.cellsig.2011.09.013; Yao N, 2010, ENDOCRINE, V38, P158, DOI 10.1007/s12020-010-9345-1; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335	39	17	18	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3206	3216		10.1096/fj.14-269449	http://dx.doi.org/10.1096/fj.14-269449			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25921829				2022-12-26	WOS:000358796900010
J	Wang, SH; Cheng, CY; Tang, PC; Chen, CF; Chen, HH; Lee, YP; Huang, SY				Wang, Shih-Han; Cheng, Chuen-Yu; Tang, Pin-Chi; Chen, Chih-Feng; Chen, Hsin-Hsin; Lee, Yen-Pai; Huang, San-Yuan			Acute Heat Stress Induces Differential Gene Expressions in the Testes of a Broiler-Type Strain of Taiwan Country Chickens	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; BARRIER DYNAMICS; CANCER-CELLS; IN-VIVO; PROTEIN; FERTILITY; BLOOD; SPERMATOGENESIS; IDENTIFICATION; HSP60	The expression of testicular genes following acute heat stress has been reported in layer-type roosters, but few similar studies have been conducted on broilers. This study investigated the effect of acute heat stress on the gene expression in the testes of a broiler-type strain of Taiwan country chickens. Roosters were subjected to acute heat stress (38 degrees C) for 4 h, and then exposed to 25 degrees C, with testes collected 0, 2, and 6 h after the cessation of heat stress, using non-heat-stressed roosters as controls (n = 3 roosters per group). The body temperature and respiratory rate increased significantly (p<0.05) during the heat stress. The numbers of apoptotic cells increased 2 h after the acute heat stress (79 +/- 7 vs. 322 +/- 192, control vs. heat stress; p<0.05), which was earlier than the time of increase in layer-type roosters. Based on a chicken 44 K oligo microarray, 163 genes were found to be expressed significantly different in the testes of the heat-stressed chickens from those of the controls, including genes involved in the response to stimulus, protein metabolism, signal transduction, cell adhesion, transcription, and apoptosis. The mRNA expressions of upregulated genes, including HSP25, HSP90AA1, HSPA2, and LPAR2, and of downregulated genes, including CDH5, CTNNA3, EHF, CIRBP, SLA, and NTF3, were confirmed through quantitative real-time polymerase chain reaction (qRT-PCR). Moreover, numerous transcripts in the testes exhibited distinct expressions between the heat-stressed broiler-type and layer-type chickens. We concluded that the transcriptional responses of testes to acute heat stress may differ between the broiler-type and layer-type roosters. Whether the differential expression patterns associate with the heat-tolerance in the strains require a further exploration.	[Wang, Shih-Han; Cheng, Chuen-Yu; Tang, Pin-Chi; Chen, Chih-Feng; Lee, Yen-Pai; Huang, San-Yuan] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Tang, Pin-Chi; Chen, Chih-Feng; Huang, San-Yuan] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Tang, Pin-Chi; Chen, Chih-Feng; Huang, San-Yuan] Natl Chung Hsing Univ, iEGG Ctr, Ctr Integrat & Evolutionary Galliformes Genom, Taichung 40227, Taiwan; [Chen, Hsin-Hsin] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Nanosci & Nanotechnol, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Huang, SY (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.	syhuang@dragon.nchu.edu.tw	Wang, Shih-Han/HGA-7092-2022		National Science Council (NSC) [99-2321-B-005-016-MY3]; Executive Yuan; Ministry of Education, Taiwan, Republic of China	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Executive Yuan; Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This study was supported in part by grants from National Science Council (NSC# 99-2321-B-005-016-MY3), Executive Yuan and the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; BERGMANN M, 1987, INT J ANDROL, V10, P481, DOI 10.1111/j.1365-2605.1987.tb00222.x; Buaas FW, 2009, HUM MOL GENET, V18, P2989, DOI 10.1093/hmg/ddp237; Cai H, 2011, INT J ANDROL, V34, P352, DOI 10.1111/j.1365-2605.2010.01089.x; Chen M, 2008, ENDOCRINOLOGY, V149, P4871, DOI 10.1210/en.2007-1093; Dragone LL, 2006, J IMMUNOL, V176, P335, DOI 10.4049/jimmunol.176.1.335; Ikeda M, 1999, BIOL REPROD, V61, P393, DOI 10.1095/biolreprod61.2.393; Karaca AG, 2002, POULTRY SCI, V81, P1904, DOI 10.1093/ps/81.12.1904; Karaca AG, 2002, BRIT POULTRY SCI, V43, P621, DOI 10.1080/0007166022000004552; Kariya A, 2013, INT J MOL MED, V32, P195, DOI 10.3892/ijmm.2013.1366; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kawakubo T, 2007, CANCER RES, V67, P10869, DOI 10.1158/0008-5472.CAN-07-2048; Kim B, 2013, CELL MOL LIFE SCI, V70, P2623, DOI 10.1007/s00018-012-1165-4; Kim HJ, 2010, J CELL BIOCHEM, V110, P201, DOI 10.1002/jcb.22527; Lee NPY, 2008, OXID MED CELL LONGEV, V1, P25, DOI 10.4161/oxim.1.1.6856; LEE YP, 1990, PROCEEDINGS : THE 5TH AAAP ANIMAL SCIENCE CONGRESS, VOLS 1-3, P349; Lee YP, 2006, TAIWAN COUNTRY CHICK; LI GC, 1985, INT J RADIAT ONCOL, V11, P165, DOI 10.1016/0360-3016(85)90376-1; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Li Y, 2009, J ANDROL, V30, P325, DOI 10.2164/jandrol.108.005934; Lui WY, 2003, ENDOCRINOLOGY, V144, P1139, DOI 10.1210/en.2002-0211; Lui WY, 2001, ENDOCRINOLOGY, V142, P1865, DOI 10.1210/en.142.5.1865; Luo QB, 2014, GENE, V546, P200, DOI 10.1016/j.gene.2014.06.017; MCDANIEL CD, 1995, POULTRY SCI, V74, P1029, DOI 10.3382/ps.0741029; MIEUSSET R, 1992, J REPROD FERTIL, V94, P337, DOI 10.1530/jrf.0.0940337; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; Raymond MN, 2006, ENDOCRINOLOGY, V147, P5873, DOI 10.1210/en.2006-0291; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; SETCHELL BP, 1969, J PHYSIOL-LONDON, V200, P73, DOI 10.1113/jphysiol.1969.sp008682; SKINNER JD, 1966, J APPL PHYSIOL, V21, P1784, DOI 10.1152/jappl.1966.21.6.1784; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; Tabuchi Y, 2003, INT J HYPERTHER, V29, P38; Wang SH, 2013, THERIOGENOLOGY, V79, P374, DOI 10.1016/j.theriogenology.2012.10.010; Wang ZP, 2009, EVOL BIOINFORM, V5, P119; WETTEMANN RP, 1976, J ANIM SCI, V42, P664, DOI 10.2527/jas1976.423664x; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Ye XQ, 2008, BIOL REPROD, V79, P328, DOI 10.1095/biolreprod.108.068783; Yeh CC., 1992, J CHIN SOC ANIM SCI, V21, P57; Zaprjanova S, 2013, EUR J OBSTET GYN R B, V168, P54, DOI 10.1016/j.ejogrb.2012.12.021; Zhang XS, 2005, FRONT BIOSCI-LANDMRK, V10, P3110, DOI 10.2741/1767	46	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125816	10.1371/journal.pone.0125816	http://dx.doi.org/10.1371/journal.pone.0125816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932638	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100134
J	Alagna, A; Vega Fernandez, T; D'Anna, G; Magliola, C; Mazzola, S; Badalamenti, F				Alagna, Adriana; Vega Fernandez, Tomas; D'Anna, Giovanni; Magliola, Carlo; Mazzola, Salvatore; Badalamenti, Fabio			Assessing Posidonia oceanica Seedling Substrate Preference: An Experimental Determination of Seedling Anchorage Success in Rocky vs. Sandy Substrates	PLOS ONE			English	Article							ZOSTERA-MARINA EELGRASS; L. DELILE; SEAGRASS REHABILITATION; GENETIC DIVERSITY; 1ST EVIDENCE; RESTORATION; SURVIVAL; GROWTH; RECRUITMENT; GERMINATION	In the last decades the growing awareness of the ecological importance of seagrass meadows has prompted increasing efforts to protect existing beds and restore degraded habitats. An in-depth knowledge of factors acting as major drivers of propagule settlement and recruitment is required in order to understand patterns of seagrass colonization and recovery and to inform appropriate management and conservation strategies. In this work Posidonia oceanica seedlings were reared for five months in a land-based culture facility under simulated natural hydrodynamic conditions to identify suitable substrates for seedling anchorage. Two main substrate features were investigated: firmness (i.e., sand vs. rock) and complexity (i.e., size of interstitial spaces between rocks). Seedlings were successfully grown in culture tanks, obtaining overall seedling survival of 93%. Anchorage was strongly influenced by substrate firmness and took place only on rocks, where it was as high as 89%. Anchorage occurred through adhesion by sticky root hairs. The minimum force required to dislodge plantlets attached to rocky substrates reached 23.830 N (equivalent to 2.43 kg), which would potentially allow many plantlets to overcome winter storms in the field. The ability of rocky substrates to retain seedlings increased with their complexity. The interstitial spaces between rocks provided appropriate microsites for seedling settlement, as seeds were successfully retained, and a suitable substrate for anchorage was available. In conclusion P. oceanica juveniles showed a clear-cut preference for hard substrates over the sandy one, due to the root system adhesive properties. In particular, firm and complex substrates allowed for propagule early and strong anchorage, enhancing persistence and establishment probabilities. Seedling substrate preference documented here leads to expect a more successful sexual recruitment on hard bottoms compared with soft ones. This feature could have influenced P. oceanica patterns of colonization in past and present time.	[Alagna, Adriana; Vega Fernandez, Tomas; D'Anna, Giovanni; Badalamenti, Fabio] CNR, IAMC, Inst Coastal Marine Environm, Castellammare Del Golfo, TP, Italy; [Magliola, Carlo] Saipem SpA, San Donato Milanese, MI, Italy; [Mazzola, Salvatore] CNR, IAMC, Inst Coastal Marine Environm, Torretta Granitola, TP, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Eni SpA; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Alagna, A (corresponding author), CNR, IAMC, Inst Coastal Marine Environm, Castellammare Del Golfo, TP, Italy.	adriana.alagna@iamc.cnr.it	Fernández, Tomás Vega/AAT-5972-2020; Vega Fernández, Tomás/P-5693-2014; D'Anna, Giovanni/B-7995-2015; BADALAMENTI, FABIO/B-8508-2015	Fernández, Tomás Vega/0000-0002-8788-4253; Vega Fernández, Tomás/0000-0002-8788-4253; D'Anna, Giovanni/0000-0002-8644-8222; Mazzola, Salvatore/0000-0002-4622-8129; BADALAMENTI, FABIO/0000-0002-2395-454X; Alagna, Adriana/0000-0003-1697-0901	Saipem S.p.A.	Saipem S.p.A.	This research was funded by Saipem S.p.A. as part of scientific consultancy provided by the Laboratory of Marine Ecology of CNR-IAMC, Castellammare del Golfo (Tp), Italy. Carlo Magliola (Saipem S.p.A.) contributed to the design of the experiment. The funders as Saipem S.p.A. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Alagna A, 2010, THESIS U SALENTO; Alagna A, 2013, ESTUAR COAST SHELF S, V119, P119, DOI 10.1016/j.ecss.2013.01.009; Badalamenti F, 2015, SCI REP-UK, V5, DOI 10.1038/srep08804; Badalamenti F, 2011, MAR POLLUT BULL, V62, P483, DOI 10.1016/j.marpolbul.2010.12.011; Balestri E, 2008, ESTUAR COAST SHELF S, V76, P634, DOI 10.1016/j.ecss.2007.07.048; Balestri E, 2011, BIOL CONSERV, V144, P1644, DOI 10.1016/j.biocon.2011.02.020; Balestri E, 1998, J EXP MAR BIOL ECOL, V228, P209, DOI 10.1016/S0022-0981(98)00027-6; Balestri E, 1998, AQUAT BOT, V60, P83, DOI 10.1016/S0304-3770(97)00017-X; Balestri E, 2015, ESTUAR COAST SHELF S, V154, P205, DOI 10.1016/j.ecss.2015.01.002; Balestri E, 2012, J APPL ECOL, V49, P1426, DOI 10.1111/j.1365-2664.2012.02197.x; Belzunce M, 2008, BOT MAR, V51, P1, DOI 10.1515/BOT.2008.005; Buia M. C., 2002, BIOL MAR MEDIT, V9, P600; BUIA MC, 1991, AQUAT BOT, V40, P343, DOI 10.1016/0304-3770(91)90080-O; Calvo S, 2006, MAR ECOL-EVOL PERSP, V27, P361, DOI 10.1111/j.1439-0485.2006.00132.x; Clarke S.M., 1989, BIOL SEAGRASSES, P304; Di Carlo G, 2005, MAR BIOL, V147, P1261, DOI 10.1007/s00227-005-0035-0; Almela ED, 2008, AQUAT BOT, V89, P397, DOI 10.1016/j.aquabot.2008.04.012; Gambi M.C., 1996, BIOL MAR MEDITERR, V3, P467; Golden RR, 2010, RESTOR ECOL, V18, P501, DOI 10.1111/j.1526-100X.2010.00691.x; Gonzalez-Correa JM, 2005, J EXP MAR BIOL ECOL, V320, P65, DOI 10.1016/j.jembe.2004.12.032; Infantes E, 2011, LIMNOL OCEANOGR, V56, P2223, DOI 10.4319/lo.2011.56.6.2223; Irving AD, 2010, J APPL ECOL, V47, P1119, DOI 10.1111/j.1365-2664.2010.01852.x; Koch EW, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P193; Lefevre J. R, 1984, 1 INT WORKSH POS OC, V2, P39; Marion SR, 2012, MAR ECOL PROG SER, V448, P197, DOI 10.3354/meps09612; Marion SR, 2010, RESTOR ECOL, V18, P514, DOI 10.1111/j.1526-100X.2010.00692.x; McGlathery KJ, 2012, MAR ECOL PROG SER, V448, P209, DOI 10.3354/meps09574; Olesen B, 2004, ESTUARIES, V27, P770, DOI 10.1007/BF02912039; Piazzi L, 1999, AQUAT BOT, V63, P103, DOI 10.1016/S0304-3770(98)00115-6; Reusch TBH, 2006, ESTUARIES COASTS, V29, P159, DOI 10.1007/BF02784707; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Reynolds LK, 2012, MAR ECOL PROG SER, V448, P223, DOI 10.3354/meps09386; Rivers DO, 2011, J EXP MAR BIOL ECOL, V401, P29, DOI 10.1016/j.jembe.2011.03.005; Sanchez-Lizaso JL, 2009, BOT MAR, V52, P471, DOI 10.1515/BOT.2009.052; Seddon S, 2010, ECOLOGICAL MANAGEMEN, V5, P167; Statton J, 2013, RESTOR ECOL, V21, P250, DOI 10.1111/j.1526-100X.2012.00873.x; Tanner C, 2010, RESTOR ECOL, V18, P538, DOI 10.1111/j.1526-100X.2010.00694.x; Tanner CE, 2010, RESTOR ECOL, V18, P527, DOI 10.1111/j.1526-100X.2010.00693.x; Terrados J, 2013, BOT MAR, V56, P185, DOI 10.1515/bot-2012-0200; Vangeluwe D, 2007, THESIS U LIEGE; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wear RJ, 2010, MAR FRESHWATER RES, V61, P1123, DOI 10.1071/MF09314	43	24	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125321	10.1371/journal.pone.0125321	http://dx.doi.org/10.1371/journal.pone.0125321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928898	Green Submitted, gold, Green Published			2022-12-26	WOS:000353713100080
J	Taddei, C; Gnesotto, R; Forni, S; Bonaccorsi, G; Vannucci, A; Garofalo, G				Taddei, Cristina; Gnesotto, Roberto; Forni, Silvia; Bonaccorsi, Guglielmo; Vannucci, Andrea; Garofalo, Giorgio			Cycling Promotion and Non-Communicable Disease Prevention: Health Impact Assessment and Economic Evaluation of Cycling to Work or School in Florence	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PUBLIC TRANSPORT; BENEFITS; CAR; MORBIDITY; BURDEN; TRAVEL; RISK; VALIDATION; BARCELONA	Objective To estimate the effects of cycling promotion on major non-communicable diseases (NCDs) and costs from the public healthcare payer's perspective. Design Health impact assessment and economic evaluation using a dynamic model over a ten-year period and according to two cycling promotion scenarios. Setting Cycling to work or school in Florence, Italy. Population All individuals aged 15 and older commuting to work or school in Florence. Main outcome measures The primary outcome measures were changes in NCD incidence and healthcare direct costs for the Tuscany Regional Health Service (SST) due to increased cycling. The secondary outcome was change in road traffic accidents. Results Increasing cycling modal share in Florence from 7.5% to about 17% (Scenario 1) or 27% (Scenario 2) could decrease the incidence of type 2 diabetes by 1.2% or 2.5%, and the incidence of acute myocardial infarction (AMI) and stroke by 0.6% or 1.2%. Within 10 years, the number of cases that can be prevented is 280 or 549 for type 2 diabetes, 51 or 100 for AMI, and 51 or 99 for stroke in Scenario 1 or Scenario 2, respectively. Average annual discounted savings for the SST are estimated to amount to (sic)400,804 or (sic)771,201 in Scenario 1 or Scenario 2, respectively. In Florence, due to the high use of vulnerable motorized vehicles (such as scooters, mopeds, and motorcycles), road traffic accidents are expected to decline in both our scenarios. Sensitivity analyses showed that health benefits and savings for the SST are substantial, the most sensitive parameters being the relative risk estimates of NCDs and active commuting. Conclusions Effective policies and programs to promote a modal shift towards cycling among students and workers in Florence will contribute to reducing the NCD burden and helping long-term economic sustainability of the SST.	[Taddei, Cristina] Univ Florence, Specializat Sch Hyg & Prevent Med, Florence, Italy; [Gnesotto, Roberto; Forni, Silvia; Vannucci, Andrea] Reg Hlth Agcy Tuscany, Qual & Equ Unit, Florence, Italy; [Bonaccorsi, Guglielmo] Univ Florence, Dept Clin & Expt Med, Florence, Italy; [Garofalo, Giorgio] Florence Local Hlth Author, Dept Prevent, Florence, Italy	University of Florence; University of Florence	Taddei, C (corresponding author), Univ Florence, Specializat Sch Hyg & Prevent Med, Florence, Italy.	cristina.taddei@yahoo.it	bonaccorsi, guglielmo/AAR-6916-2020	bonaccorsi, guglielmo/0000-0002-5171-4308				Acciai F, 2012, ANNUARIO STAT COMUNE; [Anonymous], 2015, AZ SAN FIR ATT TOSC; [Anonymous], 2013, ARS TOSC REG PAT TOS; Barchielli A, 2012, J EPIDEMIOL COMMUN H, V66, P462, DOI 10.1136/jech.2010.110908; Bartolozzi M, 2012, MOBILITA CICLABILE T; Bauman A., 2008, CYCLING GETTING AUST; Baumann C, 2013, CYCLING LATIN AM CAR; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; BUECHLER R., 2010, SUST J ENV SUST ISSU, P36; Bull F.C., 2004, PHYS INACTIVITY, V1, P729; Capri S, 2005, CURR MED RES OPIN, V21, P913, DOI 10.1185/030079905x46331; City of Copenhagen, 2013, COP CIT CYCL BIC ACC; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Dekoster J., 1999, CYCLING WAY AHEAD TO; Dhondt S, 2013, ENVIRON INT, V51, P45, DOI 10.1016/j.envint.2012.10.005; Elvik R, 2009, ACCIDENT ANAL PREV, V41, P849, DOI 10.1016/j.aap.2009.04.009; Federazione Italiana Amici della Bicicletta Citta in Bici Legambiente, 2012, BICI CITT CITT IT SU; Fries James F, 2011, J Aging Res, V2011, P261702, DOI 10.4061/2011/261702; Fries JF, 2003, ANN INTERN MED, V139, P455, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00015; Gerzeli S, 2005, NEUROL SCI, V26, P72, DOI 10.1007/s10072-005-0439-0; Gini R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-15; Goodman A, 2013, SOC SCI MED, V97, P228, DOI 10.1016/j.socscimed.2013.08.030; Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440; Hoevenaar-Blom MP, 2011, EUR J CARDIOV PREV R, V18, P41, DOI 10.1097/HJR.0b013e32833bfc87; Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Institute for Transportation & Development Policy, 2012, ITDP ANN REP 2012; ISTAT, 2014, 100 STAT CAP PAES CU; ISTAT, 2014, DAT AMB NELL QUAL AM; Istituto Nazionale di Statistica, 2014, 15 CENS GEN POP AB 2; Istituto Nazionale di Statistica, 2013, TAV MORT TOSC 2010, DOI [10.1097/CCM.0b013e318169ed30.Building, DOI 10.1097/CCM.0B013E318169ED30]; Istituto Nazionale di Statistica, 2013, INFL IT 2002 2012; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lindsay G, 2011, AUST NZ J PUBL HEAL, V35, P54, DOI 10.1111/j.1753-6405.2010.00621.x; Mantovani LG, 2011, INT J CARDIOL, V150, P111, DOI 10.1016/j.ijcard.2011.04.030; Marchesini G, 2011, NUTR METAB CARDIOVAS, V21, P339, DOI 10.1016/j.numecd.2009.10.009; Marescotti A, 2009, STUDIO SUI COSTI STI; Midgley P, 2011, 19 SESS COMM SUST DE; New York City Department of Transportation, 2013, MAK SAF STREETS; New York City Department of Transportation, 2013, CYCL CIT UPD NYC CYC; New York City Department of Transportation Division of Traffic Operations, 2011, 2011 NYC COMM CYCL I; OECD, 2013, HLTH GLANC 2013 OECD, DOI [10.1787/health_glance-2013-49-en, DOI 10.1787/HEALTH_GLANCE-2013-49-EN]; Ogilvie D, 2004, BMJ-BRIT MED J, V329, P763, DOI 10.1136/bmj.38216.714560.55; Ogilvie F, 2012, PREV MED, V55, P40, DOI 10.1016/j.ypmed.2012.05.002; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Pucher J, 2010, PREV MED, V50, pS106, DOI 10.1016/j.ypmed.2009.07.028; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Rojas-Rueda D, 2013, PREV MED, V57, P573, DOI 10.1016/j.ypmed.2013.07.021; Rojas-Rueda D, 2012, ENVIRON INT, V49, P100, DOI 10.1016/j.envint.2012.08.009; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Rupprecht S., 2010, PRESTO CYCLING POLIC; Transport for London, 2011, CYCL SAF ACT PLAN EN; Transport for NSW, 2013, SYDN CYCL FUT CYCL E; Valeri E, 2012, GLI INCIDENTI STRADA; Valle Roberto, 2006, Monaldi Arch Chest Dis, V66, P63; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; WHO Regional Office for Europe, 2014, UNL NEW OPP JOBS GRE; WHO Regional Office for Europe, 2014, HLTH EC ASS TOOLS HE; Woodcock J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g425; Woodcock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051462; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; Yang L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5293	66	20	20	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125491	10.1371/journal.pone.0125491	http://dx.doi.org/10.1371/journal.pone.0125491			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0MA	25928421	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100095
J	Wu, LX; Chen, XL; Huang, LS; Tian, J; Ke, F; Xu, JH; Chen, YZ; Zheng, M				Wu, Lixian; Chen, Xianling; Huang, Lisen; Tian, Jue; Ke, Fang; Xu, Jianhua; Chen, Yuanzhong; Zheng, Ming			A Novobiocin Derivative, XN4, Inhibits the Proliferation of Chronic Myeloid Leukemia Cells by Inducing Oxidative DNA Damage	PLOS ONE			English	Article							CLINICAL RESISTANCE; REPAIR FOCI; STRESS; APOPTOSIS; ROS; GAMMA-H2AX; MECHANISM; CHROMATIN; ABSENCE; KINASE	XN4 might induce DNA damage and apoptotic cell death through reactive oxygen species (ROS). The inhibition of proliferation of K562 and K562/G01 cells was measured by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide). The mRNA levels of NADPH oxidase 1-5 (Nox1-5) genes were evaluated by qRT-PCR. The levels of extracellular reactive oxygen species (ROS), DNA damage, apoptosis, and cell cycle progression were examined by flow cytometry (FCM). Protein levels were analyzed by immunoblotting. XN4 significantly inhibited the proliferation of K562 and K562/G01 cells, with IC50 values of 3.75 +/- 0.07 mu M and 2.63 +/- 0.43 mu M, respectively. XN4 significantly increased the levels of Nox4 and Nox5 mRNA, stimulating the generation of intracellular ROS, inducing DNA damage and activating ATM-gamma-H2AX signaling, which increased the number of cells in the S and G2/M phase of the cell cycle. Subsequently, XN4 induced apoptotic cell death by activating caspase-3 and PARP. Moreover, the above effects were all reversed by the ROS scavenger N-acetylcysteine (NAC). Additionally, XN4 can induce apoptosis in progenitor/stem cells isolated from CML patients' bone marrow. In conclusion, XN4-induced DNA damage and cell apoptosis in CML cells is mediated by the generation of ROS.	[Wu, Lixian; Huang, Lisen; Tian, Jue; Xu, Jianhua] Fujian Med Univ, Sch Pharm, Dept Pharmacol, Fuzhou, Peoples R China; [Wu, Lixian; Huang, Lisen; Tian, Jue; Xu, Jianhua] FMU, Inst Mat Med, Fuzhou, Peoples R China; [Wu, Lixian; Huang, Lisen; Tian, Jue; Xu, Jianhua] FMU, Fuijan Key Lab Nat Med Pharmacol, Fuzhou, Peoples R China; [Ke, Fang] FMU, Dept Pharmacochem, Sch Pharm, Fuzhou, Peoples R China; [Chen, Xianling; Chen, Yuanzhong] FMU, Fujian Inst Hematol, Union Hosp, Fuzhou, Peoples R China; [Zheng, Ming] FMU, Sch Basic Med, Dept Anat, Fuzhou, Peoples R China	Fujian Medical University	Wu, LX (corresponding author), Fujian Med Univ, Sch Pharm, Dept Pharmacol, Fuzhou, Peoples R China.	wlx-lisa@126.com; zming_1956@163.com	wu, lisa/ABE-8423-2020	, Fang/0000-0002-5970-2512	National Natural Science Foundation of China [30901824, 81273541]; Natural Science Foundation of Fujian Province of China [2011J06013]; Educational Bureau of Fujian Province of China [JA11101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Educational Bureau of Fujian Province of China	The authors gratefully acknowledge the National Natural Science Foundation of China (30901824, 81273541), the Natural Science Foundation of Fujian Province of China (Outstanding project 2011J06013), and the Educational Bureau of Fujian Province of China (JA11101) support for this project.	Bajrami I, 2014, CANCER RES, V74, P287, DOI 10.1158/0008-5472.CAN-13-2541; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Brem R, 2010, ONCOGENE, V29, P3953, DOI 10.1038/onc.2010.140; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Degtyareva NP, 2013, NUCLEIC ACIDS RES, V41, P8995, DOI 10.1093/nar/gkt671; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ermolaeva MA, 2013, NATURE, V501, P416, DOI 10.1038/nature12452; Floyd SR, 2013, NATURE, V498, P246, DOI 10.1038/nature12147; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hanot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044367; Hu LC, 2013, NATURE, V501, P569, DOI 10.1038/nature12500; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Ko CH, 2005, BIOCHEM PHARMACOL, V69, P913, DOI 10.1016/j.bcp.2004.12.005; Kuo LJ, 2008, IN VIVO, V22, P305; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Lu HF, 2007, ANTICANCER RES, V27, P117; Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065; Mansour WY, 2013, DNA REPAIR, V12, P1134, DOI 10.1016/j.dnarep.2013.10.005; Markus F., 2004, EUROPEAN JOURNAL OF, V40, P1934; Martin OA, 2013, DNA REPAIR, V12, P844, DOI 10.1016/j.dnarep.2013.07.002; Mroz RM, 2008, EUR RESPIR J, V31, P241, DOI 10.1183/09031936.00006707; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070430; Perl A, 2011, J CLIN INVEST, V121, P22, DOI 10.1172/JCI43605; Qi Jing, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P337; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tu WZ, 2013, FEBS LETT, V587, P3437, DOI 10.1016/j.febslet.2013.08.028; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wu LX, 2008, LEUKEMIA, V22, P1402, DOI 10.1038/leu.2008.89; Wu LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018447; Zhao H, 2013, CYTOM PART A, V83, P979, DOI 10.1002/cyto.a.22396	35	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123314	10.1371/journal.pone.0123314	http://dx.doi.org/10.1371/journal.pone.0123314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928540	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100016
J	Xie, XZ; Wang, YY				Xie, Xinzhou; Wang, Yuanyuan			Flow Regulation in Coronary Vascular Tree: A Model Study	PLOS ONE			English	Article							BLOOD-FLOW; THEORETICAL-MODEL; NITRIC-OXIDE; RESPONSES; MICROCIRCULATION; PRESSURE; PERFUSION; MUSCLE; ROLES	Background Coronary blood flow can always be matched to the metabolic demand of the myocardium due to the regulation of vasoactive segments. Myocardial compressive forces play an important role in determining coronary blood flow but its impact on flow regulation is still unknown. The purpose of this study was to develop a coronary specified flow regulation model, which can integrate myocardial compressive forces and other identified regulation factors, to further investigate the coronary blood flow regulation behavior. Method A theoretical coronary flow regulation model including the myogenic, shear-dependent and metabolic responses was developed. Myocardial compressive forces were included in the modified wall tension model. Shear-dependent response was estimated by using the experimental data from coronary circulation. Capillary density and basal oxygen consumption were specified to corresponding to those in coronary circulation. Zero flow pressure was also modeled by using a simplified capillary model. Result Pressure-flow relations predicted by the proposed model are consistent with previous experimental data. The predicted diameter changes in small arteries are in good agreement with experiment observations in adenosine infusion and inhibition of NO synthesis conditions. Results demonstrate that the myocardial compressive forces acting on the vessel wall would extend the auto-regulatory range by decreasing the myogenic tone at the given perfusion pressure. Conclusions Myocardial compressive forces had great impact on coronary auto-regulation effect. The proposed model was proved to be consistent with experiment observations and can be employed to investigate the coronary blood flow regulation effect in physiological and pathophysiological conditions.	[Xie, Xinzhou; Wang, Yuanyuan] Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China; [Wang, Yuanyuan] Key Lab Med Imaging Comp & Comp Assisted Interven, Shanghai, Peoples R China	Fudan University	Wang, YY (corresponding author), Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China.	yywang@fudan.edu.cn	Lv, Yuanjie/AER-0767-2022		National Basic Research Program of China [2015CB755500]; National Natural Science Foundation of China [11474071]; Science and Technology Commission of Shanghai Municipality [13441902800]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Basic Research Program of China (2015CB755500), the National Natural Science Foundation of China (No. 11474071) and the Science and Technology Commission of Shanghai Municipality (No. 13441902800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciero JC, 2008, AM J PHYSIOL-HEART C, V295, pH1562, DOI 10.1152/ajpheart.00261.2008; Carlson BE, 2005, MICROCIRCULATION, V12, P327, DOI 10.1080/10739680590934745; Carlson BE, 2008, AM J PHYSIOL-HEART C, V295, pH1572, DOI 10.1152/ajpheart.00262.2008; CHILIAN WM, 1986, AM J PHYSIOL, V251, pH779, DOI 10.1152/ajpheart.1986.251.4.H779; Chilian WM, 1990, CORONARY CIRCULATION, P173; Cohen KD, 2000, AM J PHYSIOL-HEART C, V278, pH1916, DOI 10.1152/ajpheart.2000.278.6.H1916; Collins DM, 1998, MICROVASC RES, V56, P43, DOI 10.1006/mvre.1998.2076; Cornelissen AJM, 2002, AM J PHYSIOL-HEART C, V282, pH2224, DOI 10.1152/ajpheart.00491.2001; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; FARHI ER, 1991, CIRC RES, V68, P392, DOI 10.1161/01.RES.68.2.392; FELDBERG R, 1995, AM J PHYSIOL-RENAL, V269, pF581, DOI 10.1152/ajprenal.1995.269.4.F581; GONZALEZFERNANDEZ JM, 1994, MATH BIOSCI, V119, P127, DOI 10.1016/0025-5564(94)90074-4; JONES CJH, 1995, CIRCULATION, V91, P1807, DOI 10.1161/01.CIR.91.6.1807; JONES CJH, 1993, ADV EXP MED BIOL, V346, P181; Knaapen P, 2009, BASIC RES CARDIOL, V104, P485, DOI 10.1007/s00395-009-0037-z; KUO L, 1990, AM J PHYSIOL, V259, pH1063, DOI 10.1152/ajpheart.1990.259.4.H1063; KUO L, 1995, CIRCULATION, V92, P518, DOI 10.1161/01.CIR.92.3.518; Liao JC, 1997, AM J PHYSIOL-HEART C, V272, pH1571, DOI 10.1152/ajpheart.1997.272.4.H1571; MAYERS I, 1990, RESP PHYSIOL, V81, P63, DOI 10.1016/0034-5687(90)90070-F; MOSHER P, 1964, CIRC RES, V14, P250, DOI 10.1161/01.RES.14.3.250; Muller JM, 1996, CARDIOVASC RES, V32, P668, DOI 10.1016/0008-6363(96)00111-3; POHL U, 1991, BASIC RES CARDIOL, V86, P97; Secomb T, 2008, MICROCIRCULATION, V15, P765, DOI 10.1080/10739680802350112; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Sircar Sabyasachi, 2008, PRINCIPLES MED PHYSL; Spaan J, 2008, PHILOS T R SOC A, V366, P3137, DOI 10.1098/rsta.2008.0075; Stepp DW, 1999, CIRCULATION, V100, P1555, DOI 10.1161/01.CIR.100.14.1555; Tune JD, 2004, J APPL PHYSIOL, V97, P404, DOI 10.1152/japplphysiol.01345.2003; Westerhof N, 2006, PHYSIOL REV, V86, P1263, DOI 10.1152/physrev.00029.2005; Westerhof N, 2010, SNAPSHOTS OF HEMODYNAMICS: AN AID FOR CLINICAL RESEARCH AND GRADUATE EDUCATION, SECOND EDITION, P45, DOI 10.1007/978-1-4419-6363-5_9	30	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125778	10.1371/journal.pone.0125778	http://dx.doi.org/10.1371/journal.pone.0125778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928718	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100118
J	Yang, L; Chan, KH; Suen, LKP; Chan, KP; Wang, XL; Cao, PH; He, DH; Peiris, JSM; Wong, CM				Yang, Lin; Chan, Kwok Hung; Suen, Lorna K. P.; Chan, King Pan; Wang, Xiling; Cao, Peihua; He, Daihai; Peiris, J. S. Malik; Wong, Chit Ming			Impact of the 2009 H1N1 Pandemic on Age-Specific Epidemic Curves of Other Respiratory Viruses: A Comparison of Pre-Pandemic, Pandemic and Post-Pandemic Periods in a Subtropical City	PLOS ONE			English	Article							INFLUENZA VACCINE EFFECTIVENESS; HONG-KONG; WAVELET ANALYSIS; INFECTIONS; CHILDREN; SYNCHRONY; SEVERITY; A/H1N1	Background The 2009 H1N1 influenza pandemic caused offseason peaks in temperate regions but coincided with the summer epidemic of seasonal influenza and other common respiratory viruses in subtropical Hong Kong. This study was aimed to investigate the impact of the pandemic on age-specific epidemic curves of other respiratory viruses. Methods Weekly laboratory-confirmed cases of influenza A (subtypes seasonal A(H1N1), A(H3N2), pandemic virus A(H1N1) pdm09), influenza B, respiratory syncytial virus (RSV), adenovirus and parainfluenza were obtained from 2004 to 2013. Age-specific epidemic curves of viruses other than A(H1N1) pdm09 were compared between the pre-pandemic (May 2004 - April 2009), pandemic (May 2009 - April 2010) and post-pandemic periods (May 2010 - April 2013). Results There were two peaks of A(H1N1) pdm09 in Hong Kong, the first in September 2009 and the second in February 2011. The infection rate was found highest in young children in both waves, but markedly fewer cases in school children were recorded in the second wave than in the first wave. Positive proportions of viruses other than A(H1N1) pdm09 markedly decreased in all age groups during the first pandemic wave. After the first wave of the pandemic, the positive proportion of A(H3N2) increased, but those of B and RSV remained slightly lower than their pre-pandemic proportions. Changes in seasonal pattern and epidemic peak time were also observed, but inconsistent across virus-age groups. Conclusion Our findings provide some evidence that age distribution, seasonal pattern and peak time of other respiratory viruses have changed since the pandemic. These changes could be the result of immune interference and changing health seeking behavior, but the mechanism behind still needs further investigations.	[Yang, Lin; Suen, Lorna K. P.] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok Hung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chan, King Pan; Wang, Xiling; Cao, Peihua; Wong, Chit Ming] Univ Hong Kong, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China; [He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University; University of Hong Kong	Yang, L (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	l.yang@polyu.edu.hk; hrmrwcm@hku.hk	YANG, Lin/F-9601-2014; Cao, Peihua/GYU-4280-2022; He, Daihai/AAT-8735-2021; Chan, Kwok Hung/ABD-5399-2021; Suen, Lorna KP/F-5077-2014; Peiris, Joseph Sriyal Malik/C-4380-2009	YANG, Lin/0000-0002-5964-3233; Suen, Lorna KP/0000-0002-0126-6674; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; He, Daihai/0000-0003-3253-654X	Health and Medical Research Fund [11100582, 12111232]; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government [AoE/M-12/-06]	Health and Medical Research Fund; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government	This work was supported by the Health and Medical Research Fund (grants 11100582 and 12111232) and the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/-06) of the Hong Kong Special Administrative Region Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borja-Aburto VH, 2012, ARCH MED RES, V43, P563, DOI 10.1016/j.arcmed.2012.09.005; Casalegno JS, 2010, EUROSURVEILLANCE, V15, P5; Centre for Health Protection, 2013, SEAS INFL VACC COV S; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Cowling BJ, 2012, EPIDEMIOLOGY, V23, P930, DOI 10.1097/EDE.0b013e31826b300e; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; Dierig A, 2014, INFLUENZA OTHER RESP, V8, P293, DOI 10.1111/irv.12229; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Horby P, 2012, AM J EPIDEMIOL, V175, P1062, DOI 10.1093/aje/kws121; Lau JTF, 2005, PREV MED, V41, P454, DOI 10.1016/j.ypmed.2004.11.023; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Meningher T, 2014, INFLUENZA OTHER RESP, V8, P422, DOI 10.1111/irv.12249; Monto AS, 2004, PEDIATR INFECT DIS J, V23, pS58, DOI 10.1097/01.inf.0000108193.91607.34; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sundaram ME, 2013, CLIN INFECT DIS, V57, P789, DOI 10.1093/cid/cit379; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yang L, 2012, EUROSURVEILLANCE, V17, P8; Yang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001399; Yang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045807	26	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125447	10.1371/journal.pone.0125447	http://dx.doi.org/10.1371/journal.pone.0125447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928217	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100092
J	Yang, M; Xu, LM; Liu, YL; Yang, PF				Yang, Mei; Xu, Liming; Liu, Yanling; Yang, Pingfang			RNA-Seq Uncovers SNPs and Alternative Splicing Events in Asian Lotus (Nelumbo nucifera)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SACRED LOTUS; MAPPING POPULATION; CAPSICUM-ANNUUM; TRANSCRIPTOME; ARABIDOPSIS; DISCOVERY; LINKAGE; SSR; CONSTRUCTION	RNA-Seq is an efficient way to comprehensively identify single nucleotide polymorphisms (SNPs) and alternative splicing (AS) events from the expressed genes. In this study, we conducted transcriptome sequencing of four Asian lotus (Nelumbo nucifera) cultivars using Illumina HiSeq2000 platform to identify SNPs and AS events in lotus. A total of 505 million pair-end RNA-Seq reads were generated from four cultivars, of which 86% were mapped to the lotus reference genome. Using the four sets of data together, a total of 357,689 putative SNPs were identified with an average density of one SNP per 2.2 kb. These SNPs were located in 1,253 scaffolds and 15,016 expressed genes. A/G and C/T were the two major types of SNPs in the Asian lotus transcriptome. In parallel, a total of 177,540 AS events were detected in the four cultivars and were distributed in 64% of the expressed genes of lotus. The predominant type of AS events was alternative 5' first exon, which accounted for 41.2% of all the observed AS events, and exon skipping only accounted for 4.3% of all AS. Gene Ontology analysis was conducted to analyze the function of the genes containing SNPs and AS events. Validation of selected SNPs and AS events revealed that 74% of SNPs and 80% of AS events were reliable, which indicates that RNA-Seq is an efficient approach to uncover gene-associated SNPs and AS events. A large number of SNPs and AS events identified in our study will facilitate further genetic and functional genomics research in lotus.	[Yang, Mei; Xu, Liming; Yang, Pingfang] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan Bot Garden, Wuhan, Hunan, Peoples R China; [Liu, Yanling] Chinese Acad Sci, Key Lab Aquat Plant & Watershed Ecol, Wuhan Bot Garden, Wuhan, Hunan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Yang, PF (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan Bot Garden, Wuhan, Hunan, Peoples R China.	yangpf@wbgcas.cn	liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; Yang, Mei/AAD-1550-2022		National Natural Science Foundation of China [31200268, 31471899]; Knowledge Innovation Project of Chinese Academy of Sciences [Y455421Z02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This research was financially supported by National Natural Science Foundation of China (31200268 and 31471899) and The Knowledge Innovation Project of Chinese Academy of Sciences (No. Y455421Z02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Beretta S, 2014, J COMPUT BIOL, V21, P16, DOI 10.1089/cmb.2013.0112; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Cadic E, 2013, THEOR APPL GENET, V126, P1337, DOI 10.1007/s00122-013-2056-2; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Duangjit J, 2013, THEOR APPL GENET, V126, P2093, DOI 10.1007/s00122-013-2121-x; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Florea L, 2013, 1000S EXON SKIPPING, V2, P188; Fu J, 2011, J AM SOC HORTIC SCI, V136, P339, DOI 10.21273/JASHS.136.5.339; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li WY, 2014, METHODS, V67, P313, DOI 10.1016/j.ymeth.2014.02.024; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Lu FH, 2011, SCI HORTIC-AMSTERDAM, V129, P38, DOI 10.1016/j.scienta.2011.03.003; Mandel JR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003378; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Nicolai M, 2012, GENET MOL RES, V11, P2295, DOI 10.4238/2012.August.13.3; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Shen YT, 2014, PLANT CELL, V26, P996, DOI 10.1105/tpc.114.122739; Shen-Miller J, 2002, SEED SCI RES, V12, P131, DOI 10.1079/SSR2002112; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VanBuren R, 2013, PLANT OMICS, V6, P311; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Yang M, 2014, ANN APPL BIOL, V165, P73, DOI 10.1111/aab.12119; Yang M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-653; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang D, 2013, EUPHYTICA, V191, P23, DOI 10.1007/s10681-012-0840-8; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-372; Zhang XY, 2011, NEW LOTUS FLOWER CUL, P278; Zou D, 2013, GENOMICS, V102, P57, DOI 10.1016/j.ygeno.2013.02.014	45	22	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125702	10.1371/journal.pone.0125702	http://dx.doi.org/10.1371/journal.pone.0125702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928215	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100112
J	Aguero, J; Ishikawa, K; Fish, KM; Hammoudi, N; Hadri, L; Garcia-Alvarez, A; Ibanez, B; Fuster, V; Hajjar, RJ; Leopold, JA				Aguero, Jaume; Ishikawa, Kiyotake; Fish, Kenneth M.; Hammoudi, Nadjib; Hadri, Lahouaria; Garcia-Alvarez, Ana; Ibanez, Borja; Fuster, Valentin; Hajjar, Roger J.; Leopold, Jane A.			Combination Proximal Pulmonary Artery Coiling and Distal Embolization Induces Chronic Elevations in Pulmonary Artery Pressure in Swine	PLOS ONE			English	Article							HYPERTENSION; MODEL; MORTALITY	Pulmonary hypertension (PH) is associated with aberrant vascular remodeling and right ventricular (RV) dysfunction that contribute to early mortality. Large animal models that recapitulate human PH are essential for mechanistic studies and evaluating novel therapies; however, these models are not readily accessible to the field owing to the need for advanced surgical techniques or hypoxia. In this study, we present a novel swine model that develops cardiopulmonary hemodynamics and structural changes characteristic of chronic PH. This percutaneous model was created in swine (n= 6) by combining distal embolization of dextran beads with selective coiling of the lobar pulmonary arteries (2 procedures per lung over 4 weeks). As controls, findings from this model were compared with those from a standard weekly distal embolization model (n= 6) and sham animals (n= 4). Survival with the combined embolization model was 100%. At 8 weeks after the index procedure, combined embolization procedure animals had increased mean pulmonary artery pressure (mPA) and pulmonary vascular resistance (PVR) compared to the controls with no effect on left heart or systemic pressures. RV remodeling and RV dysfunction were also present with a decrease in the RV ejection fraction, increase in the myocardial performance index, impaired longitudinal function, as well as cardiomyocyte hypertrophy, and interstitial fibrosis, which were not present in the controls. Pulmonary vascular remodeling occurred in both embolization models, although only the combination embolization model had a decrease in pulmonary capacitance. Taken together, these cardiopulmonary hemodynamic and structural findings identify the novel combination embolization swine model as a valuable tool for future studies of chronic PH.	[Aguero, Jaume; Ishikawa, Kiyotake; Fish, Kenneth M.; Hammoudi, Nadjib; Hadri, Lahouaria; Hajjar, Roger J.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [Aguero, Jaume; Garcia-Alvarez, Ana; Ibanez, Borja; Fuster, Valentin] Ctr Nacl Invest Cardiovasc Carlos III CNIC Epidem, Atherothrombosis & Imaging Dept, Madrid, Spain; [Fuster, Valentin] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; [Leopold, Jane A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Aguero, J (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA.	jaimeaguero30@hotmail.com	Ishikawa, Kiyotake/I-6013-2015; Ibáñez, Borja/J-6993-2014; Hadri, Lahouaria/AAP-6415-2020; Aguero, Jaume/I-8582-2016; Alvarez, Ana García/AAB-4999-2021; Fuster, Valentin/H-4319-2015	Ibáñez, Borja/0000-0002-5036-254X; Hadri, Lahouaria/0000-0001-8108-7993; Aguero, Jaume/0000-0001-7416-871X; Alvarez, Ana García/0000-0002-1718-2424; Fuster, Valentin/0000-0002-9043-9986; ishikawa, kiyotake/0000-0002-8287-3483; Hammoudi, Nadjib/0000-0003-2085-8525; FISH, KENNETH/0000-0002-7781-0314	National Institutes of Health [RO1 HL083156, HL093183, HL119046, P20HL100396]; NHLBI Program of Excellence in Nanotechnology Award [HHSN268201000045C]; NIH [R01 105301]; Leducq Foundation; Fundacion Alfonso Martin-Escudero; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL125215, R01HL093183, R01HL083156, R01HL119046, P20HL100396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Program of Excellence in Nanotechnology Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); Fundacion Alfonso Martin-Escudero; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health RO1 HL083156, HL093183, HL119046, P20HL100396 and a NHLBI Program of Excellence in Nanotechnology Award, Contract # HHSN268201000045C (RJH) and NIH R01 105301 (JAL). Part of the work was funded by a Leducq Foundation grant (RJH). JA was supported by the Fundacion Alfonso Martin-Escudero.	Bauer NR, 2007, AM J PHYSIOL-LUNG C, V293, pL580, DOI 10.1152/ajplung.00281.2007; Burrowes K S, 2011, Pulm Circ, V1, P365, DOI 10.4103/2045-8932.87302; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; Garcia-Alvarez A, 2013, J AM COLL CARDIOL, V62, P1621, DOI 10.1016/j.jacc.2013.07.037; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Guihaire J, 2013, EUR HEART J-CARD IMG, V14, P1140, DOI 10.1093/ehjci/jet092; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kim H, 2000, EUR RESPIR J, V15, P640, DOI 10.1034/j.1399-3003.2000.15d04.x; Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054; Mercier O, 2013, PULM CIRC, V3, P908, DOI 10.1086/674757; Pereda D, 2014, J CARDIOVASC TRANSL, V7, P494, DOI 10.1007/s12265-014-9564-6; PERKETT EA, 1991, AM J PATHOL, V139, P1319; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Pohlmann JR, 2012, J SURG RES, V175, P44, DOI 10.1016/j.jss.2011.02.049; Rondelet B, 2003, CIRCULATION, V107, P1329, DOI 10.1161/01.CIR.0000053443.27512.33; Sato H, 2008, ASAIO J, V54, P396, DOI 10.1097/MAT.0b013e31817efa85; SHELUB I, 1984, J APPL PHYSIOL, V56, P810, DOI 10.1152/jappl.1984.56.3.810; SILOVE ED, 1972, CARDIOVASC RES, V6, P36, DOI 10.1093/cvr/6.1.36; Song JK, 2000, J NEUROSURG, V92, P955, DOI 10.3171/jns.2000.92.6.0955; Stenmark KR, 2005, CIRC RES, V97, P95, DOI 10.1161/01.RES.00000175934.68087.29; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Stevens GR, 2012, JACC-CARDIOVASC IMAG, V5, P378, DOI 10.1016/j.jcmg.2011.11.020; Weimann J, 1999, J CRIT CARE, V14, P133, DOI 10.1016/S0883-9441(99)90026-6; Zeng GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078965; Zhou XQ, 2011, J SURG RES, V170, pE11, DOI 10.1016/j.jss.2011.04.030	25	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124526	10.1371/journal.pone.0124526	http://dx.doi.org/10.1371/journal.pone.0124526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923775	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600090
J	Hu, RM; Tan, BH; Tester, DJ; Song, CH; He, Y; Dovat, S; Peterson, BZ; Ackerman, MJ; Makielski, JC				Hu, Rou-Mu; Tan, Bi-Hua; Tester, David J.; Song, Chunhua; He, Yang; Dovat, Sinisa; Peterson, Blaise Z.; Ackerman, Michael J.; Makielski, Jonathan C.			Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis	PLOS ONE			English	Article							CARDIAC SODIUM-CHANNEL; LONG-QT SYNDROME; SUDDEN-INFANT-DEATH; K-ATP CHANNEL; NA+-CHANNEL; TERMINAL DOMAIN; INACTIVATION; BRUGADA; EXPRESSION; PH	Background SCN5A is a susceptibility gene for type 3 long QT syndrome, Brugada syndrome, and sudden infant death syndrome. I-Na dysfunction from mutated SCN5A can depend upon the splice variant background in which it is expressed and also upon environmental factors such as acidosis. S1787N was reported previously as a LQT3-associated mutation and has also been observed in 1 of 295 healthy white controls. Here, we determined the in vitro biophysical phenotype of SCN5A-S1787N in an effort to further assess its possible pathogenicity. Methods and Results We engineered S1787N in the two most common alternatively spliced SCN5A isoforms, the major isoform lacking a glutamine at position 1077 (Q1077del) and the minor isoform containing Q1077, and expressed these two engineered constructs in HEK293 cells for electrophysiological study. Macroscopic voltage-gated I-Na was measured 24 hours after transfection with standard whole-cell patch clamp techniques. We applied intracellular solutions with pH7.4 or pH6.7. S1787N in the Q1077 background had WT-like I-Na including peak I-Na density, activation and inactivation parameters, and late I-Na amplitude in both pH 7.4 and pH 6.7. However, with S1787N in the Q1077del background, the percentages of I-Na late/peak were increased by 2.1 fold in pH 7.4 and by 2.9 fold in pH 6.7 when compared to WT. Conclusion The LQT3-like biophysical phenotype for S1787N depends on both the SCN5A splice variant and on the intracellular pH. These findings provide further evidence that the splice variant and environmental factors affect the molecular phenotype of cardiac SCN5A-encoded sodium channel (Na(v)1.5), has implications for the clinical phenotype, and may provide insight into acidosis-induced arrhythmia mechanisms.	[Hu, Rou-Mu] China Meitan Gen Hosp, Dept Cardiol, Beijing, Peoples R China; [Hu, Rou-Mu; Tan, Bi-Hua; He, Yang; Makielski, Jonathan C.] Univ Wisconsin, Dept Med, Div Cardiovasc Med, Madison, WI 53718 USA; [Tan, Bi-Hua; Song, Chunhua; Dovat, Sinisa; Peterson, Blaise Z.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA USA; [Tan, Bi-Hua; Song, Chunhua; Dovat, Sinisa; Peterson, Blaise Z.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA; [Tester, David J.; Ackerman, Michael J.] Mayo Clin, Dept Med, Rochester, MN USA; [Tester, David J.; Ackerman, Michael J.] Mayo Clin, Dept Pediat, Rochester, MN USA; [Tester, David J.; Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Mayo Clinic; Mayo Clinic; Mayo Clinic	Tan, BH (corresponding author), Univ Wisconsin, Dept Med, Div Cardiovasc Med, Madison, WI 53718 USA.	btan@hmc.psu.edu	song, chunhua/K-7882-2016; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; Dovat, Sinisa/0000-0003-3906-6165; song, chunhua/0000-0002-4081-2543	American Heart Association [0525806Z, 11SDG7470009]; National Heart, Lung, and Blood Institute [HL-71092, HL-42569]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095120, R56HL071092, R01HL071092] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (0525806Z and 11SDG7470009 to B.-H. Tan) and the National Heart, Lung, and Blood Institute (HL-71092 to J. C. Makielski and HL-42569 to M. J. Ackerman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bezzina C, 1999, CIRC RES, V85, P1206; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chandra R, 1998, AM J PHYSIOL-HEART C, V274, pH1643, DOI 10.1152/ajpheart.1998.274.5.H1643; Cheng JD, 2011, PHYSIOL GENOMICS, V43, P461, DOI 10.1152/physiolgenomics.00198.2010; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; EFFROS RM, 1975, J CLIN INVEST, V55, P1100, DOI 10.1172/JCI108011; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Hu RM, 2013, AM J PHYSIOL-HEART C, V304, pH994, DOI 10.1152/ajpheart.00705.2012; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Lowe JS, 2012, CARDIOVASC RES, V95, P300, DOI 10.1093/cvr/cvs160; Makielski JC, 2003, CIRC RES, V93, P821, DOI 10.1161/01.RES.0000096652.14509.96; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Makita N, 2008, J CLIN INVEST, V118, P2219, DOI [10.1172/JCl34057, 10.1172/JCI34057]; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Medeiros-Domingo A, 2010, HEART RHYTHM, V7, P1466, DOI 10.1016/j.hrthm.2010.06.016; Medeiros-Domingo A, 2009, HEART RHYTHM, V6, P1170, DOI 10.1016/j.hrthm.2009.04.034; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Plant LD, 2006, J CLIN INVEST, V116, P430, DOI 10.1172/JCI25618; POOLEWILSON PA, 1975, AM J PHYSIOL, V229, P1305, DOI 10.1152/ajplegacy.1975.229.5.1305; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Tan BH, 2005, HEART RHYTHM, V2, P741, DOI 10.1016/j.hrthm.2005.04.021; Tan BH, 2007, CARDIOVASC RES, V76, P409, DOI 10.1016/j.cardiores.2007.08.006; Tan BH, 2006, AM J PHYSIOL-HEART C, V291, pH1822, DOI 10.1152/ajpheart.00101.2006; Tester DJ, 2011, CIRC-CARDIOVASC GENE, V4, P510, DOI 10.1161/CIRCGENETICS.111.960195; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Wang DW, 2007, CIRCULATION, V115, P368, DOI 10.1161/CIRCULATIONAHA.106.646513; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013300; Wei J, 1999, CIRCULATION, V99, P3165, DOI 10.1161/01.CIR.99.24.3165; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910	43	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124921	10.1371/journal.pone.0124921	http://dx.doi.org/10.1371/journal.pone.0124921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923670	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600112
J	Johnson, J; Borres, MP; Nordvall, L; Lidholm, J; Janson, C; Alving, K; Malinovschi, A				Johnson, Jennifer; Borres, Magnus P.; Nordvall, Lennart; Lidholm, Jonas; Janson, Christer; Alving, Kjell; Malinovschi, Andrei			Perceived Food Hypersensitivity Relates to Poor Asthma Control and Quality of Life in Young Non-Atopic Asthmatics	PLOS ONE			English	Article							GENERAL-POPULATION; IGE SENSITIZATION; NATIONAL-HEALTH; RISK-FACTORS; ALLERGY; CHILDREN; PREVALENCE; SYMPTOMS; MORBIDITY; ADULTS	Background The relationship between perceived food hypersensitivity in asthmatics, food allergen sensitization, asthma control and asthma-related quality of life has not been studied. Objective Our aim was to study the prevalence of perceived food hypersensitivity in a cohort of young asthmatics, its relation to food allergen sensitization, and any correlation to asthma control and asthma-related quality of life. Methods Perceived food hypersensitivity, as well as IgE sensitization to common food allergens, levels of exhaled nitric oxide (FeNO), and blood eosinophil counts (B-Eos) were assessed in 408 subjects (211 women) with asthma, aged (mean +/- SEM) 20.4 +/- 0.3 years. Subjects filled out the Asthma Control Test (ACT) and the Mini Asthma Quality of Life Questionnaire (Mini-AQLQ). Inflammation was assessed by means of FeNO and B-Eos. Results Fifty-three per cent of subjects reported food hypersensitivity. A corresponding food allergen sensitization was found in 68% of these subjects. Non-atopic subjects with perceived food hypersensitivity (n = 31) had lower ACT (19 (15 - 22) vs. 21 (20 - 23), p < 0.001) and Mini-AQLQ - scores (5.3 (4.3 - 6.1) vs. 6.1 (5.5 - 6.5), p < 0.001) than subjects with no food hypersensitivity (n = 190), despite lower levels of FeNO and B-Eos (p < 0.05). Conclusions and Clinical Relevance Food hypersensitivity was commonly reported among young asthmatics. In a majority of cases, a corresponding food allergen sensitization was found. A novel and clinically important finding was that non-atopic subjects with perceived food hypersensitivity were characterized by poorer asthma control and asthma-related quality of life.	[Johnson, Jennifer; Borres, Magnus P.; Nordvall, Lennart; Alving, Kjell] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Borres, Magnus P.; Lidholm, Jonas] Thermo Fisher Sci, Uppsala, Sweden; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci, Clin Physiol, Uppsala, Sweden	Uppsala University; Thermo Fisher Scientific; Uppsala University; Uppsala University	Johnson, J (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	Jennifer.Johnson@kbh.uu.se	Alving, Kjell/M-4579-2014	Alving, Kjell/0000-0003-0784-0443; Lidholm, Jonas/0000-0002-7779-3411	Bror Hjerpstedts Foundation; Uppsala University Hospital; Swedish Heart and Lung Foundation; Swedish Governmental Agency for Innovation Systems (VINNOVA, SAMBIO program) [2007-00084]; Thermo Fisher Scientific	Bror Hjerpstedts Foundation; Uppsala University Hospital; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Governmental Agency for Innovation Systems (VINNOVA, SAMBIO program); Thermo Fisher Scientific	Andrei Malinovschi had research grants/support from Bror Hjerpstedts Foundation, Uppsala University Hospital and Swedish Heart and Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The MIDAS study was financially supported within the framework of an academy/industry collaboration initiated by the Swedish Governmental Agency for Innovation Systems (VINNOVA, SAMBIO program, grant number 2007-00084), where Aerocrine AB and Thermo Fisher Scientific, Immunodiagnostics were partners and co-financed the program. Thermo Fisher Scientific provided support in the form of salaries for authors MPB and JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altman DR, 1996, J ALLERGY CLIN IMMUN, V97, P1247, DOI 10.1016/S0091-6749(96)70192-6; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P912; Axelsson M, 2009, RESP MED, V103, P1033, DOI 10.1016/j.rmed.2009.01.013; Berns SH, 2007, J ASTHMA, V44, P377, DOI 10.1080/02770900701364031; Bjornsson E, 1996, ANN ALLERG ASTHMA IM, V77, P327; Emilsson OI, 2013, EUR RESPIR J, V41, P1347, DOI 10.1183/09031936.00052512; Friedlander JL, 2013, J ALLER CL IMM-PRACT, V1, P479, DOI 10.1016/j.jaip.2013.06.007; Gergen PJ, 2009, J ALLERGY CLIN IMMUN, V124, P447, DOI 10.1016/j.jaci.2009.06.011; Hagmolen of ten Have W, 2005, J ASTHMA, V42, P419; Heijkenskjold-Rentzhog C, 2014, ALLERGY, V69, P1102, DOI 10.1111/all.12430; HIRSCHWEHR R, 1992, J ALLERGY CLIN IMMUN, V90, P927, DOI 10.1016/0091-6749(92)90465-E; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Jyonouchi Harumi, 2008, Inflammation & Allergy Drug Targets, V7, P173, DOI 10.2174/187152808785748119; Keet CA, 2014, ANN ALLERG ASTHMA IM, V112, P222, DOI 10.1016/j.anai.2013.12.007; Kulkarni N, 2012, PEDIAT ALLERG IMM-UK, V23, P28, DOI 10.1111/j.1399-3038.2011.01226.x; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; McGowan EC, 2013, J ALLERGY CLIN IMMUN, V132, P1216, DOI 10.1016/j.jaci.2013.07.018; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Nguyen BP, 1996, ANN ALLERG ASTHMA IM, V77, P209, DOI 10.1016/S1081-1206(10)63257-7; Ostblom E, 2008, ALLERGY, V63, P211, DOI 10.1111/j.1398-9995.2007.01559.x; Ostblom E, 2008, ACTA PAEDIATR, V97, P85, DOI 10.1111/j.1651-2227.2007.00556.x; Osterballe M, 2005, PEDIAT ALLERG IMM-UK, V16, P567, DOI 10.1111/j.1399-3038.2005.00251.x; Patelis A, 2014, ALLERGY, V69, P380, DOI 10.1111/all.12345; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pereira B, 2005, J ALLERGY CLIN IMMUN, V116, P884, DOI 10.1016/j.jaci.2005.05.047; Put C, 1999, EUR RESPIR J, V13, P751, DOI 10.1034/j.1399-3003.1999.13d09.x; Roberts G, 2003, J ALLERGY CLIN IMMUN, V112, P168, DOI 10.1067/mai.2003.1569; Roberts Graham, 2003, Paediatr Respir Rev, V4, P205, DOI 10.1016/S1526-0542(03)00058-7; Roehr CC, 2004, CLIN EXP ALLERGY, V34, P1534, DOI 10.1111/j.1365-2222.2004.02080.x; RUBINFELD AR, 1976, LANCET, V1, P882; Schafer T, 2001, ALLERGY, V56, P1172, DOI 10.1034/j.1398-9995.2001.00196.x; Sicherer SH, 2001, ANN ALLERG ASTHMA IM, V87, P461, DOI 10.1016/S1081-1206(10)62258-2; Simpson AB, 2007, PEDIATR PULM, V42, P489, DOI 10.1002/ppul.20605; Simpson AB, 2010, J PEDIATR-US, V156, P777, DOI 10.1016/j.jpeds.2009.11.080; Sundbom F, 2013, ALLERGY, V68, P213, DOI 10.1111/all.12079; Tariq SM, 2000, PEDIATR ALLERGY IMMU, V11, P162, DOI 10.1034/j.1399-3038.2000.00077.x; Van De Ven MO, 2011, J PSYCHOSOM RES, V71, P166, DOI [10.1016/j.jpsychores.2011.03.002, DOI 10.1016/J.JPSYCHORES.2011.03.002]; Vuorisalo T, 2012, PERSPECT BIOL MED, V55, P163, DOI 10.1353/pbm.2012.0016; Wang JL, 2005, J ALLERGY CLIN IMMUN, V115, P1076, DOI 10.1016/j.jaci.2005.02.014; Wood RA, 2003, PEDIATRICS, V111, P1631; Woods RK, 2001, EUR J CLIN NUTR, V55, P298, DOI 10.1038/sj.ejcn.1601159	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124675	10.1371/journal.pone.0124675	http://dx.doi.org/10.1371/journal.pone.0124675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923451	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600098
J	Maldonado-Aguayo, W; Chavez-Mardones, J; Goncalves, AT; Gallardo-Escarate, C				Maldonado-Aguayo, Waleska; Chavez-Mardones, Jacqueline; Teresa Goncalves, Ana; Gallardo-Escarate, Cristian			Cathepsin Gene Family Reveals Transcriptome Patterns Related to the Infective Stages of the Salmon Louse Caligus rogercresseyi	PLOS ONE			English	Article							CYSTEINE PROTEASE; ASPARTIC PROTEASE; LEPEOPHTHEIRUS-SALMONIS; FASCIOLA-HEPATICA; MOLECULAR-CLONING; FUNCTIONAL-ANALYSIS; HUMAN HEMOGLOBIN; HARD TICK; PROTEINASES; DEGRADATION	Cathepsins are proteases involved in the ability of parasites to overcome and/or modulate host defenses so as to complete their own lifecycle. However, the mechanisms underlying this ability of cathepsins are still poorly understood. One excellent model for identifying and exploring the molecular functions of cathepsins is the marine ectoparasitic copepod Caligus rogercresseyi that currently affects the Chilean salmon industry. Using high-throughput transcriptome sequencing, 56 cathepsin-like sequences were found distributed in five cysteine protease groups (B, F, L, Z, and S) as well as in an aspartic protease group (D). Ontogenic transcriptome analysis evidenced that L cathepsins were the most abundant during the lifecycle, while cathepsins B and K were mostly expressed in the larval stages and adult females, thus suggesting participation in the molting processes and embryonic development, respectively. Interestingly, a variety of cathepsins from groups Z, L, D, B, K, and S were upregulated in the infective stage of copepodid, corroborating the complexity of the processes involved in the parasitic success of this copepod. Putative functional roles of cathepsins were conjectured based on the differential expressions found and on roles previously described in other phylogenetically related species. Moreover, 140 single nucleotide polymorphisms (SNP) were identified in transcripts annotated for cysteine and aspartic proteases located into untranslated regions, or the coding region. This study reports for the first time the presence of cathepsin-like genes and differential expressions throughout a copepod lifecycle. The identification of cathepsins together with functional validations represents a valuable strategy for pinpointing target molecules that could be used in the development of new delousing drugs or vaccines against C. rogercresseyi.	[Maldonado-Aguayo, Waleska; Chavez-Mardones, Jacqueline; Teresa Goncalves, Ana; Gallardo-Escarate, Cristian] Univ Concepcion, Interdisciplinary Ctr Sustainable Aquaculture Res, Lab Biotechnol & Aquat Genom, Concepcion, Chile	Universidad de Concepcion	Gallardo-Escarate, C (corresponding author), Univ Concepcion, Interdisciplinary Ctr Sustainable Aquaculture Res, Lab Biotechnol & Aquat Genom, Concepcion, Chile.	crisgallardo@udec.cl	Gonçalves, Ana Teresa/ABB-3248-2021; Gallardo-Escárate, Cristian/AAE-8980-2022	Gonçalves, Ana Teresa/0000-0002-5443-7182; Gallardo-Escárate, Cristian/0000-0002-7094-6702	FONDAP project [1510027]; CORFO	FONDAP project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); CORFO	This study was funded by FONDAP project 1510027 (CONICYT-Chile) and CORFO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; BILLINGSLEY PF, 1988, INT J INSECT MORPHOL, V17, P295, DOI 10.1016/0020-7322(88)90010-4; Boldbaatar D, 2006, INSECT BIOCHEM MOLEC, V36, P25, DOI 10.1016/j.ibmb.2005.10.003; Bravo S, 2012, AQUACULTURE, V364, P61, DOI 10.1016/j.aquaculture.2012.07.036; Brindley PJ, 2001, MOL BIOCHEM PARASIT, V112, P103, DOI 10.1016/S0166-6851(00)00351-0; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Carmona E, 1996, BIOCHEMISTRY-US, V35, P8149, DOI 10.1021/bi952736s; Cho WL, 1999, J BIOL CHEM, V274, P13311, DOI 10.1074/jbc.274.19.13311; Colbert JD, 2009, EUR J IMMUNOL, V39, P2955, DOI 10.1002/eji.200939650; Connors BM, 2011, BEHAV ECOL, V22, P588, DOI 10.1093/beheco/arr024; Conus S, 2010, SWISS MEDICAL WEEKLY, P1; Cordova M, 2001, MOL BIOCHEM PARASIT, V116, P109, DOI 10.1016/S0166-6851(01)00309-7; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Cunningham E, 2010, AQUACULTURE, V310, P38, DOI 10.1016/j.aquaculture.2010.10.013; Dalton JP, 1996, INFECT IMMUN, V64, P5066, DOI 10.1128/IAI.64.12.5066-5074.1996; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fast MD, 2007, PARASITE IMMUNOL, V29, P179, DOI 10.1111/j.1365-3024.2007.00932.x; Firth KJ, 2000, J PARASITOL, V86, P1199, DOI 10.1645/0022-3395(2000)086[1199:COPITS]2.0.CO;2; Ford L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000377; Gallardo-Escarate C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092239; Ghoneim H, 1995, INT J PARASITOL, V25, P1515, DOI 10.1016/0020-7519(95)00079-8; GOLDBERG DE, 1991, J EXP MED, V173, P961, DOI 10.1084/jem.173.4.961; Gonzalez L, 2003, AQUACULTURE, V220, P101, DOI 10.1016/S0044-8486(02)00512-4; Gui ZZ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-49; Hamilton KA, 2003, INT J PARASITOL, V33, P773, DOI 10.1016/S0020-7519(03)00089-4; Harrop SA, 1996, BIOCHEM BIOPH RES CO, V227, P294, DOI 10.1006/bbrc.1996.1503; Hashmi S, 2002, J BIOL CHEM, V277, P3477, DOI 10.1074/jbc.M106117200; Hashmi S, 2004, J BIOL CHEM, V279, P6035, DOI 10.1074/jbc.M312346200; Helgesen KO, 2014, JOURNAL OF FISH DISE; Jousson O, 2007, FEMS MICROBIOL LETT, V269, P77, DOI 10.1111/j.1574-6968.2006.00611.x; KABATA Z, 1974, J FISH RES BOARD CAN, V31, P1583, DOI 10.1139/f74-199; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kang JM, 2010, MOL BIOCHEM PARASIT, V170, P7, DOI 10.1016/j.molbiopara.2009.11.006; Kelley GO, 2003, EXP PARASITOL, V105, P201, DOI 10.1016/j.exppara.2003.12.004; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li XP, 2013, FISH SHELLFISH IMMUN, V35, P1604, DOI 10.1016/j.fsi.2013.09.004; Liao PY, 2010, BIOCHEM ENG J, V49, P149, DOI 10.1016/j.bej.2009.12.021; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logullo C, 1998, PARASITOLOGY, V116, P525, DOI 10.1017/S0031182098002698; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; Malagon D, 2010, PARASITOL INT, V59, P89, DOI 10.1016/j.parint.2009.11.001; Maldonado-Aguayo W, 2014, MAR GENOM, V15, P55, DOI 10.1016/j.margen.2014.04.006; McCarthy E, 2012, AQUACULTURE, V356, P264, DOI 10.1016/j.aquaculture.2012.05.007; MEDINA M, 1988, ARCH BIOCHEM BIOPHYS, V263, P355, DOI 10.1016/0003-9861(88)90646-7; Mendiola J, 2001, Rev Cubana Med Trop, V53, P145; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Oelckers K, 2014, AQUACULTURE, V420, P126, DOI 10.1016/j.aquaculture.2013.10.016; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Redmond DL, 2006, INT J PARASITOL, V36, P277, DOI 10.1016/j.ijpara.2005.10.011; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rojo L, 2010, MAR BIOTECHNOL, V12, P696, DOI 10.1007/s10126-010-9257-3; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; SAKANARI JA, 1990, J PARASITOL, V76, P625, DOI 10.2307/3282971; Sojka D, 2011, ADV EXP MED BIOL, V712, P177, DOI 10.1007/978-1-4419-8414-2_11; TANG J, 1987, J CELL BIOCHEM, V33, P53, DOI 10.1002/jcb.240330106; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Tveiten H, 2010, J FISH BIOL, V76, P2318, DOI 10.1111/j.1095-8649.2010.02636.x; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Wang J, 2013, J INSECT PHYSIOL, V59, P953, DOI 10.1016/j.jinsphys.2013.07.003; Wang XM, 2008, AQUACULTURE, V282, P41, DOI 10.1016/j.aquaculture.2008.06.014; Williamson AL, 2003, J INFECT DIS, V187, P484, DOI 10.1086/367708; Williamson AL, 2003, TRENDS PARASITOL, V19, P417, DOI 10.1016/S1471-4922(03)00189-2; Yamashima T, 2013, PROG NEUROBIOL, V105, P1, DOI 10.1016/j.pneurobio.2013.02.004	66	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123954	10.1371/journal.pone.0123954	http://dx.doi.org/10.1371/journal.pone.0123954			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923525	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600063
J	Saez-Jimenez, V; Acebes, S; Guallar, V; Martinez, AT; Ruiz-Duenas, FJ				Saez-Jimenez, Veronica; Acebes, Sandra; Guallar, Victor; Martinez, Angel T.; Ruiz-Duenas, Francisco J.			Improving the Oxidative Stability of a High Redox Potential Fungal Peroxidase by Rational Design	PLOS ONE			English	Article							ERYNGII-VERSATILE-PEROXIDASE; SITE-DIRECTED MUTAGENESIS; CYTOCHROME-C PEROXIDASE; HYDROGEN-PEROXIDE; PLEUROTUS-ERYNGII; LIGNIN PEROXIDASE; SUICIDE INACTIVATION; MANGANESE PEROXIDASE; COMPOUND-III; MICROBIAL-DEGRADATION	Ligninolytic peroxidases are enzymes of biotechnological interest due to their ability to oxidize high redox potential aromatic compounds, including the recalcitrant lignin polymer. However, different obstacles prevent their use in industrial and environmental applications, including low stability towards their natural oxidizing-substrate H2O2. In this work, versatile peroxidase was taken as a model ligninolytic peroxidase, its oxidative inactivation by H2O2 was studied and different strategies were evaluated with the aim of improving H2O2 stability. Oxidation of the methionine residues was produced during enzyme inactivation by H2O2 excess. Substitution of these residues, located near the heme cofactor and the catalytic tryptophan, rendered a variant with a 7.8-fold decreased oxidative inactivation rate. A second strategy consisted in mutating two residues (Thr45 and Ile103) near the catalytic distal histidine with the aim of modifying the reactivity of the enzyme with H2O2. The T45A/I103T variant showed a 2.9-fold slower reaction rate with H2O2 and 2.8-fold enhanced oxidative stability. Finally, both strategies were combined in the T45A/I103T/M152F/M262F/M265L variant, whose stability in the presence of H2O2 was improved 11.7-fold. This variant showed an increased half-life, over 30 min compared with 3.4 min of the native enzyme, under an excess of 2000 equivalents of H2O2. Interestingly, the stability improvement achieved was related with slower formation, subsequent stabilization and slower bleaching of the enzyme Compound III, a peroxidase intermediate that is not part of the catalytic cycle and leads to the inactivation of the enzyme.	[Saez-Jimenez, Veronica; Martinez, Angel T.; Ruiz-Duenas, Francisco J.] CSIC, Ctr Invest Biol, Madrid, Spain; [Acebes, Sandra; Guallar, Victor] Barcelona Supercomp Ctr, Inst Biomed Res, Program Computat Biol, Joint Barcelona Supercomp Ctr Ctr Genom Regulat, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS)	Ruiz-Duenas, FJ (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	fjruiz@cib.csic.es	Guallar, Victor/B-1579-2013; Martínez, Angel T/G-7284-2017; Ruiz-Dueñas, Francisco J/L-9837-2015	Guallar, Victor/0000-0002-4580-1114; Martínez, Angel T/0000-0002-1584-2863; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Saez-Jimenez, Veronica/0000-0001-7043-5622; acebes, sandra/0000-0001-8854-654X	Commission of the European Communities through the INDOX project [KBBE-2013-7-613549]; Spanish Ministerio de Economia y Competitividad (MINECO) through the HIPOP project [BIO2011-26694]; Formacion de Personal Investigador, FPI; Ramon y Cajal contract of the Spanish MINECO	Commission of the European Communities through the INDOX project; Spanish Ministerio de Economia y Competitividad (MINECO) through the HIPOP project; Formacion de Personal Investigador, FPI(Spanish Government); Ramon y Cajal contract of the Spanish MINECO	This work was funded by the Commission of the European Communities through the INDOX project (KBBE-2013-7-613549, "Optimized oxidoreductases for medium and large scale industrial biotransformations"), and by the Spanish Ministerio de Economia y Competitividad (MINECO) through the HIPOP project (BIO2011-26694, "Screening and engineering of new high-redoxpotential peroxidases"). VS-J and FJR-D thank the financial support of a research fellowship (Formacion de Personal Investigador, FPI) and a Ramon y Cajal contract of the Spanish MINECO, respectively. The authors have no conflict of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAO MB, 1990, BIOCHIM BIOPHYS ACTA, V1041, P43, DOI 10.1016/0167-4838(90)90120-5; Ayala M, 2008, J MOL MICROB BIOTECH, V15, P172, DOI 10.1159/000121328; Bao X, 2014, ENZYME MICROB TECH, V54, P51, DOI 10.1016/j.enzmictec.2013.10.003; Bao X, 2012, BIOTECHNOL LETT, V34, P1537, DOI 10.1007/s10529-012-0940-5; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; CAI DY, 1989, BIOCHEM BIOPH RES CO, V162, P464, DOI 10.1016/0006-291X(89)92020-2; Casadei CM, 2014, SCIENCE, V345, P193, DOI 10.1126/science.1254398; Cherry JR, 1999, NAT BIOTECHNOL, V17, P379, DOI 10.1038/7939; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Garcia-Ruiz E, 2012, BIOCHEM J, V441, P487, DOI 10.1042/BJ20111199; Gonzalez-Perez D, 2014, ACS CATAL, V4, P3891, DOI 10.1021/cs501218v; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Cuadrado NH, 2011, INT J BIOL MACROMOL, V49, P1078, DOI 10.1016/j.ijbiomac.2011.09.001; Hiner ANP, 2002, J BIOL CHEM, V277, P26879, DOI 10.1074/jbc.M200002200; Hiner ANP, 2000, BIOCHEM J, V348, P321, DOI 10.1042/0264-6021:3480321; Hiner ANP, 2002, J INORG BIOCHEM, V91, P27, DOI 10.1016/S0162-0134(02)00390-2; Houborg K, 2003, ACTA CRYSTALLOGR D, V59, P997, DOI 10.1107/S0907444903006784; KIM K, 1988, BIOCHIM BIOPHYS ACTA, V954, P95, DOI 10.1016/0167-4838(88)90059-3; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; LI D, 1995, APPL ENVIRON MICROB, V61, P341, DOI 10.1128/AEM.61.1.341-345.1995; Marques G, 2010, BIORESOURCE TECHNOL, V101, P5935, DOI 10.1016/j.biortech.2010.02.093; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez AT, 2005, INT MICROBIOL, V8, P195; Miyazaki C, 2001, FEBS LETT, V509, P111, DOI 10.1016/S0014-5793(01)03127-1; Morales M, 2012, J BIOL CHEM, V287, P41053, DOI 10.1074/jbc.M112.405548; Moreira PR, 2007, INT BIODETER BIODEGR, V59, P234, DOI 10.1016/j.ibiod.2006.11.002; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ogola HJO, 2010, APPL MICROBIOL BIOT, V87, P1727, DOI 10.1007/s00253-010-2603-6; Paumann-Page M, 2013, ARCH BIOCHEM BIOPHYS, V539, P51, DOI 10.1016/j.abb.2013.09.004; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Perez-Boada M, 2002, ENZYME MICROB TECH, V30, P518, DOI 10.1016/S0141-0229(02)00008-X; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Ruiz-Duenas FJ, 1999, MOL MICROBIOL, V31, P223, DOI 10.1046/j.1365-2958.1999.01164.x; Ruiz-Duenas FJ, 1999, APPL ENVIRON MICROB, V65, P4458; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Ruiz-Duenas FJ, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P37, DOI 10.1007/978-3-642-12627-7_3; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Salvachua D, 2013, ENZYME MICROB TECH, V52, P303, DOI 10.1016/j.enzmictec.2013.03.010; Sambrook J., 2001, MOL CLONING; Timofeevski SL, 1998, ARCH BIOCHEM BIOPHYS, V356, P287, DOI 10.1006/abbi.1998.0776; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Valderrama B, 2006, FASEB J, V20, P1233, DOI 10.1096/fj.05-4173fje; Villegas JA, 2000, CHEM BIOL, V7, P237, DOI 10.1016/S1074-5521(00)00098-3; VITELLO LB, 1993, BIOCHEMISTRY-US, V32, P9807, DOI 10.1021/bi00088a036; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; WARIISHI H, 1990, J BIOL CHEM, V265, P2070; WARIISHI H, 1989, FEBS LETT, V243, P165, DOI 10.1016/0014-5793(89)80122-X	48	25	25	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124750	10.1371/journal.pone.0124750	http://dx.doi.org/10.1371/journal.pone.0124750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923713	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600102
J	Shimizu, Y; Yoshimoto, J; Toki, S; Takamura, M; Yoshimura, S; Okamoto, Y; Yamawaki, S; Doya, K				Shimizu, Yu; Yoshimoto, Junichiro; Toki, Shigeru; Takamura, Masahiro; Yoshimura, Shinpei; Okamoto, Yasumasa; Yamawaki, Shigeto; Doya, Kenji			Toward Probabilistic Diagnosis and Understanding of Depression Based on Functional MRI Data Analysis with Logistic Group LASSO	PLOS ONE			English	Article							VERBAL FLUENCY; IMAGING BIOMARKERS; CLASSIFICATION; DISEASE; MACHINE; PATTERN; MARKERS; MEMORY	Diagnosis of psychiatric disorders based on brain imaging data is highly desirable in clinical applications. However, a common problem in applying machine learning algorithms is that the number of imaging data dimensions often greatly exceeds the number of available training samples. Furthermore, interpretability of the learned classifier with respect to brain function and anatomy is an important, but non-trivial issue. We propose the use of logistic regression with a least absolute shrinkage and selection operator (LASSO) to capture the most critical input features. In particular, we consider application of group LASSO to select brain areas relevant to diagnosis. An additional advantage of LASSO is its probabilistic output, which allows evaluation of diagnosis certainty. To verify our approach, we obtained semantic and phonological verbal fluency fMRI data from 31 depression patients and 31 control subjects, and compared the performances of group LASSO (gLASSO), and sparse group LASSO (sgLASSO) to those of standard LASSO (sLASSO), Support Vector Machine (SVM), and Random Forest. Over 90% classification accuracy was achieved with gLASSO, sgLASSO, as well as SVM; however, in contrast to SVM, LASSO approaches allow for identification of the most discriminative weights and estimation of prediction reliability. Semantic task data revealed contributions to the classification from left precuneus, left precentral gyrus, left inferior frontal cortex (pars triangularis), and left cerebellum (c rus1). Weights for the phonological task indicated contributions from left inferior frontal operculum, left post central gyrus, left insula, left middle frontal cortex, bilateral middle temporal cortices, bilateral precuneus, left inferior frontal cortex (pars triangularis), and left precentral gyrus. The distribution of normalized odds ratios further showed, that predictions with absolute odds ratios higher than 0.2 could be regarded as certain.	[Shimizu, Yu; Yoshimoto, Junichiro; Doya, Kenji] Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan; [Yoshimoto, Junichiro] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan; [Toki, Shigeru; Takamura, Masahiro; Okamoto, Yasumasa; Yamawaki, Shigeto] Hiroshima Univ, Dept Psychiat & Neurosci, Hiroshima, Japan; [Yoshimura, Shinpei] Otemon Gakuin Univ, Fac Psychol, Ibaraki, Osaka, Japan	Okinawa Institute of Science & Technology Graduate University; Nara Institute of Science & Technology; Hiroshima University	Shimizu, Y (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan.	yu.shimizu@oist.jp	Yoshimoto, Junichiro/ABI-8028-2020; Takamura, Masahiro/AEJ-6059-2022; Shimizu, Yu/G-2906-2015; Yoshimoto, Junichiro/B-5884-2015; Yoshimura, Shinpei/AAG-5540-2019	Yoshimoto, Junichiro/0000-0001-7995-0321; Takamura, Masahiro/0000-0001-9742-152X; Shimizu, Yu/0000-0001-9324-014X; Yoshimoto, Junichiro/0000-0001-7995-0321; Yoshimura, Shinpei/0000-0001-9957-7982; Yoshimura, Shimpei/0000-0001-6756-4829	Grants-in-Aid for Scientific Research [25780413] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Bom de Araujo N, 2011, CLINICS SAO PAULO, V66; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chris R, 2014, MRICRON NIFTI VIEWER; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costafreda SG, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-18; Ebmeier K, 2009, NEUROTOX RES, V10, P1; Fairhall SL, 2010, BIOL PSYCHOL, V85, P499, DOI 10.1016/j.biopsycho.2010.09.002; Fiot JB, 2014, NEUROIMAGE-CLIN, V4, P718, DOI 10.1016/j.nicl.2014.02.002; Forbes EE, 2011, NEUROPSYCHOPHARMACOL, V36, P372, DOI 10.1038/npp.2010.164; Fossati P, 2003, PSYCHIAT RES, V117, P17, DOI 10.1016/S0165-1781(02)00300-1; Friedman J., 2010, TECHNICAL REPORT; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Gooren T, 2013, ACTA NEUROPSYCHIATR, V25; Heath S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-98; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Kipli K, 2013, IJBBB, V3, P444, DOI [10.7763/IJBBB.2013.V3.252, DOI 10.7763/IJBBB.2013.V3.252]; Kipli K, 2013, NEURORADIOLOGY, V55, P567, DOI 10.1007/s00234-013-1139-8; Krug A, 2010, NEUROIMAGE, V49, P1831, DOI 10.1016/j.neuroimage.2009.09.028; Liu J., 2009, SLEP SPARSE LEARNING; Liu MH, 2014, NEUROINFORMATICS, V12, P381, DOI 10.1007/s12021-013-9218-x; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Marquand AF, 2008, NEUROREPORT, V19, P1507, DOI 10.1097/WNR.0b013e328310425e; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Milne AMB, 2012, J PSYCHIATR NEUROSCI, V37, P28, DOI 10.1503/jpn.110004; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Norris MP, 1995, AGING COGNITION, V2, P206, DOI 10.1080/13825589508256598; Nouretdinov I, 2011, NEUROIMAGE, V56, P809, DOI 10.1016/j.neuroimage.2010.05.023; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Palmer SM, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01045; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Tsao S, 2014, P SOC PHOTO-OPT INST; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vapnik V. N., 1998, NATURE STAT LEARNING; Xin B, 2014, AAAI CONF ARTIF INTE, P2163; Zhou JY, 2013, NEUROIMAGE, V78, P233, DOI 10.1016/j.neuroimage.2013.03.073	45	37	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123524	10.1371/journal.pone.0123524	http://dx.doi.org/10.1371/journal.pone.0123524			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932629	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100022
J	Urbinati, G; Ali, HM; Rousseau, Q; Chapuis, H; Desmaele, D; Couvreur, P; Massaad-Massade, L				Urbinati, Giorgia; Ali, Hafiz Muhammad; Rousseau, Quentin; Chapuis, Hubert; Desmaele, Didier; Couvreur, Patrick; Massaad-Massade, Liliane			Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer	PLOS ONE			English	Article							PAPILLARY THYROID-CARCINOMA; SQUALENE NANOPARTICLES; FUSION TRANSCRIPTS; RNA INTERFERENCE; GENE ABERRATIONS; ERG; DELIVERY; CELLS; EXPRESSION; MET	TMPRSS2-ERG junction oncogene is present in more than 50% of patients with prostate cancer and its expression is frequently associated with poor prognosis. Our aim is to achieve gene knockdown by siRNA TMPRSS2-ERG and then to assess the biological consequences of this inhibition. First, we designed siRNAs against the two TMPRSS2-ERG fusion variants (III and IV), most frequently identified in patients' biopsies. Two of the five siRNAs tested were found to efficiently inhibit mRNA of both TMPRSS2-ERG variants and to decrease ERG protein expression. Microarray analysis further confirmed ERG inhibition by both siRNAs TMPRSS2-ERG and revealed one common down-regulated gene, ADRA2A, involved in cell proliferation and migration. The siRNA against TMPRSS2-ERG fusion variant IV showed the highest anti-proliferative effects: Significantly decreased cell viability, increased cleaved caspase-3 and inhibited a cluster of anti-apoptotic proteins. To propose a concrete therapeutic approach, siRNA TMPRSS2-ERG IV was conjugated to squalene, which can self-organize as nanoparticles in water. The nanoparticles of siRNA TMPRSS2-ERG-squalene injected intravenously in SCID mice reduced growth of VCaP xenografted tumours, inhibited oncoprotein expression and partially restored differentiation (decrease in Ki67). In conclusion, this study offers a new prospect of treatment for prostate cancer based on siRNA-squalene nanoparticles targeting TMPRSS2-ERG junction oncogene.	[Urbinati, Giorgia; Ali, Hafiz Muhammad; Rousseau, Quentin; Massaad-Massade, Liliane] Univ Paris 11, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, F-94805 Villejuif, France; [Urbinati, Giorgia; Ali, Hafiz Muhammad; Rousseau, Quentin; Massaad-Massade, Liliane] CNRS Villejuif, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, F-94805 Villejuif, France; [Urbinati, Giorgia; Ali, Hafiz Muhammad; Rousseau, Quentin; Massaad-Massade, Liliane] Gustave Roussy, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, F-94805 Villejuif, France; [Rousseau, Quentin] Ghent Univ Hosp, Lab Expt Canc Res, B-9000 Ghent, Belgium; [Chapuis, Hubert; Desmaele, Didier; Couvreur, Patrick] Univ Paris 11, Fac Pharm, Inst Galien, UMR CNRS 8612, F-92296 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Ghent University; Ghent University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Massaad-Massade, L (corresponding author), Univ Paris 11, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, F-94805 Villejuif, France.	Liliane.MASSADE@gustaveroussy.fr	Ali, HM/AAH-3473-2021; COUVREUR, Patrick/AAY-7568-2020; Desmaële, Didier/X-9435-2019; Massaad, Massaad-Massade or Massade or/O-7226-2017; Patrick, COUVREUR/G-4844-2011	Ali, HM/0000-0001-9266-408X; Massaad, Massaad-Massade or Massade or/0000-0002-9636-4559; Patrick, COUVREUR/0000-0001-7961-5443	Agence Nationale de Recherche (ANR), Program P2N [NANO 00301]	Agence Nationale de Recherche (ANR), Program P2N(French National Research Agency (ANR))	The research leading to these results has received funding from the Agence Nationale de Recherche (ANR), Program P2N, Grant No NANO 00301.	Ali HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095964; Ali HM, 2014, THYROID, V24, P327, DOI 10.1089/thy.2012.0544; Ali HM, 2012, EXPERT REV CLIN PHAR, V5, P403, DOI [10.1586/ECP.12.33, 10.1586/ecp.12.33]; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Fitzpatrick JM, 2014, EUR J CANCER, V50, P1617, DOI 10.1016/j.ejca.2014.03.010; Furlan A, 2011, CELL DEATH DIFFER, V18, P1608, DOI 10.1038/cdd.2011.23; Gilbert-Sirieix M, 2010, THYROID, V20, P1053, DOI 10.1089/thy.2010.0006; Hu XY, 2006, APMIS, V114, P893, DOI 10.1111/j.1600-0463.2006.apm_271.x; Korenchuk S, 2001, IN VIVO, V15, P163; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Leong, 2009, OVER EXPRESSION TRUN; Leus NGJ, 2014, INT J PHARMACEUT, V469, P121, DOI 10.1016/j.ijpharm.2014.04.041; Leus NGJ, 2014, INT J PHARMACEUT, V459, P40, DOI 10.1016/j.ijpharm.2013.11.008; Liu WN, 2007, GENE CHROMOSOME CANC, V46, P972, DOI 10.1002/gcc.20482; Mani RS, 2011, CANCER RES, V71, P5387, DOI 10.1158/0008-5472.CAN-11-0876; Mazaris Evangelos, 2013, Nephrourol Mon, V5, P792, DOI 10.5812/numonthly.9430; Mehra R, 2008, CANCER RES, V68, P3584, DOI 10.1158/0008-5472.CAN-07-6154; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Nam RK, 2007, CANCER BIOL THER, V6, P40, DOI 10.4161/cbt.6.1.3489; Raouane M, 2012, BIOCONJUGATE CHEM, V23, P1091, DOI 10.1021/bc200422w; Raouane M, 2011, J MED CHEM, V54, P4067, DOI 10.1021/jm2000272; Reddy LH, 2009, ADV DRUG DELIVER REV, V61, P1412, DOI 10.1016/j.addr.2009.09.005; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Shao L, 2012, CLIN CANCER RES, V18, P6648, DOI 10.1158/1078-0432.CCR-12-2715; Spencer ES, 2013, PROSTATE, V73, P905, DOI 10.1002/pros.22636; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang LG, 2013, INT J ONCOL, V42, P957, DOI 10.3892/ijo.2013.1767; White NM, 2013, CURR DRUG TARGETS, V14, P450; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu F, 2013, MED HYPOTHESES, V80, P490, DOI 10.1016/j.mehy.2012.12.012	37	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125277	10.1371/journal.pone.0125277	http://dx.doi.org/10.1371/journal.pone.0125277			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933120	Green Submitted, gold, Green Published			2022-12-26	WOS:000353887100095
J	Zou, GY; Zhang, ZT; Walley, J; Gong, WW; Yu, YX; Hu, RY; Yin, J; Yu, M; Wei, XL				Zou, Guanyang; Zhang, Zhitong; Walley, John; Gong, Weiwei; Yu, Yunxian; Hu, Ruying; Yin, Jia; Yu, Min; Wei, Xiaolin			Use of Medications and Lifestyles of Hypertensive Patients with High Risk of Cardiovascular Disease in Rural China	PLOS ONE			English	Article							PRIMARY PREVENTION; BEHAVIORAL-CHANGE; CONTROLLED-TRIAL; DOUBLE-BLIND; FOLLOW-UP; INTERVENTION; PREVALENCE; REDUCTION; AWARENESS; POLYPILL	Background Hypertension, with a global prevalence of 40%, is a risk factor for cardiovascular diseases (CVD). We conducted an exploratory study in Zhejiang China to understand the prevention of CVD among hypertensive patients with a 10 year CVD risk of 20% or higher. We assessed current practices in a rural 'township hospital' (a primary care facility), and compared them with international evidence-based practice. Methods A questionnaire survey was conducted to examine the use of modern drugs (antihypertensive drugs, statins and aspirin) and traditional drugs, compliance to medications and lifestyle among 274 hypertensive patients aged 40-74, with a CVD risk of 20% or higher (using the Asian Equation). Results The majority (72%) were diagnosed with hypertension at township hospitals. Only 15% of study participants used two anti-hypertensive drugs, 0.7% took statin and 2.9% aspirin. Only 2.9% combined two types of modern drugs, while 0.4% combined three types (antihypertensives, statins and aspirin). Herbal compounds, sometimes with internationally rarely recommended drugs such as Reserpine were taken by 44%. Analysis of drug adherence showed that 9.8% had discontinued their drug therapy by themselves. 16% had missed doses and these were on less anti-hypertensive drugs than those who did not (t=-5.217, P=0.003). Of all participants, 28% currently smoked, 39% drank regularly and only 21% exercised frequently. The average salt intake per day was 7.1 (+/- 3.8) g, while the national recommended level is 6g. Conclusion The study revealed outdated and inadequate treatment and health education for hypertensive patients, especially for those who have high risk scores for CVD. There is a need to review the community-based guidelines for hypertension management. Health providers and patients should make a transition from solely treating hypertension, towards prevention of CVD. Health system issues need addressing including improving rural health insurance cover and primary care doctors' capacity to manage chronic disease patients.	[Zou, Guanyang; Zhang, Zhitong] Univ Leeds, COMDIS Hlth Serv Delivery Res Program, China Program, Shenzhen, Peoples R China; [Walley, John] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Gong, Weiwei; Hu, Ruying; Yu, Min] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Yu, Yunxian] Zhejiang Univ, Schoo Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Yin, Jia; Wei, Xiaolin] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	University of Leeds; Zhejiang University; Chinese University of Hong Kong	Wei, XL (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	xiaolinwei@cuhk.edu.hk	Walley, John D/AAY-1375-2021	Walley, John D/0000-0001-7290-0989	COMDIS Health Services Delivery Research Consortium (COMDIS-HSD); Department for International Development of the UK Government (UKAID); Department for International Development (DFID) [201025] Funding Source: researchfish	COMDIS Health Services Delivery Research Consortium (COMDIS-HSD); Department for International Development of the UK Government (UKAID); Department for International Development (DFID)	This study was supported by the COMDIS Health Services Delivery Research Consortium (COMDIS-HSD) hosted by the University of Leeds, UK. COMDIS-HSD is funded by the Department for International Development of the UK Government (UKAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Chang L, 2003, HEALTH PROMOT INT, V18, P219, DOI 10.1093/heapro/dag017; Chung VCH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/426360; Faghanipour S, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/785654; Feng XL, 2014, B WORLD HEALTH ORGAN, V92, P1; Fodor GJ, 2005, J HYPERTENS, V23, P1261, DOI 10.1097/01.hjh.0000170390.07321.ca; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Ministry of Health China, 2009, REPORTS ON THE 2008; National Centre for Cardiovascular Disease, 2010, REPORT ON CARDIOVASC; Okoro RN., 2012, INT J BIOMED SCI, V3, P47; Raju N, 2011, AM J MED, V124, P621, DOI 10.1016/j.amjmed.2011.01.018; Ramli Azuana, 2012, Patient Prefer Adherence, V6, P613, DOI 10.2147/PPA.S34704; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; The Ministry of Health of the People's Republic of China China National Centre for Cardiovascular Diseases, 2010, CHINA NATIONAL GUIDE; The Ministry of Health of the People's Republic of China China National Centre for Cardiovascular Diseases, 2010, NATIONAL GUIDELINE O; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062469; Wang J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/978398; Wei XL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-354; Wei XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054169; World Bank, 2011, TOWARD A HEALTHY AND; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Zhang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070886; Zhou BA, 2010, EDUC GERONTOL, V36, P919, DOI 10.1080/03601271003689514; Zou G, 2014, J PUBLIC HEALTH-UK, V2, P2	31	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124484	10.1371/journal.pone.0124484	http://dx.doi.org/10.1371/journal.pone.0124484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25932640	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100043
J	Appolinario, PP; Medinas, DB; Chaves, AB; Genaro-Mattos, TC; Cussiol, JRR; Netto, LES; Augusto, O; Miyamoto, S				Appolinario, Patricia Postilione; Medinas, Danilo Bilches; Chaves-Filho, Adriano B.; Genaro-Mattos, Thiago C.; Rosa Cussiol, Jose Renato; Soares Netto, Luis Eduardo; Augusto, Ohara; Miyamoto, Sayuri			Oligomerization of Cu,Zn-Superoxide Dismutase (SOD1) by Docosahexaenoic Acid and Its Hydroperoxides In Vitro: Aggregation Dependence on Fatty Acid Unsaturation and Thiols	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; OXIDATIVE MODIFICATION; PROTEIN AGGREGATION; DISULFIDE BOND; MUTATIONS; TRIGGERS; PROTOFIBRILS; CYTOTOXICITY; MODEL	Docosahexaenoic acid (C22:6, n-3, DHA) is a polyunsaturated fatty acid highly enriched in the brain. This fatty acid can be easily oxidized yielding hydroperoxides as primary products. Cu, Zn-Superoxide dismutase (SOD1) aggregation is a common hallmark of Amyotrophic Lateral Sclerosis (ALS) and the molecular mechanisms behind their formation are not completely understood. Here we investigated the effect of DHA and its hydroperoxides (DHAOOH) on human SOD1 oligomerization in vitro. DHA induced the formation of high-molecular-weight (HMW) SOD1 species (>700 kDa). Aggregation was dependent on free thiols and occurred primarily with the protein in its apo-form. SOD1 incubation with DHA was accompanied by changes in protein structure leading to exposure of protein hydrophobic patches and formation of non-amyloid aggregates. Site-directed mutagenesis studies demonstrated that Cys 6 and Cys 111 in wild-type and Cys 6 in ALS-linked G93A mutant are required for aggregation. In contrast, DHAOOH did not induce HMW species formation but promoted abnormal covalent dimerization of apo-SOD1 that was resistant to SDS and thiol reductants. Overall, our data demonstrate that DHA and DHAOOH induce distinct types of apo-SOD1 oligomerization leading to the formation of HMW and low-molecular-weight species, respectively.	[Appolinario, Patricia Postilione; Medinas, Danilo Bilches; Chaves-Filho, Adriano B.; Genaro-Mattos, Thiago C.; Augusto, Ohara; Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Rosa Cussiol, Jose Renato; Soares Netto, Luis Eduardo] Univ Sao Paulo, Inst Biociencias, Dept Biol, BR-01498 Sao Paulo, Brazil; [Medinas, Danilo Bilches] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago, Chile; [Medinas, Danilo Bilches] Univ Chile, Ctr Mol Studies Cell, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago, Chile	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad de Chile; Universidad de Chile	Miyamoto, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	miyamoto@iq.usp.br	Miyamoto, Sayuri/A-2144-2008; Netto, Luis/A-3783-2008; Chaves-Filho, Adriano B/V-5656-2017; Medinas, Danilo/ABA-1182-2021; Cussiol, José Renato/E-5142-2015; Augusto, Ohara/D-3839-2012	Miyamoto, Sayuri/0000-0002-5714-8984; Netto, Luis/0000-0002-4250-9177; Chaves-Filho, Adriano B/0000-0002-2321-6504; Cussiol, José Renato/0000-0001-5909-8215; Augusto, Ohara/0000-0002-7220-4286; Bilches Medinas, Danilo/0000-0002-1822-1974; Genaro-Mattos, Thiago/0000-0001-9377-2285	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [08/57721-0, 10/50891-0, 13/07937-8]; CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico) [573530/2008-4]; PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo) [2011.1.9352.1.8]; FAPESP [09/52702-3]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from: FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: 08/57721-0, 10/50891-0 and 13/07937-8), CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico, 573530/2008-4), and PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo: 2011.1.9352.1.8). The authors are members of INCT Redoxoma (FAPESP/CNPq/CAPES), NAP Redoxoma (PRPUSP), and the CEPID Redoxoma (FAPESP). PPA was recipient of Ph.D. studentship from FAPESP (09/52702-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Antinone SE, 2013, J BIOL CHEM, V288, P21606, DOI 10.1074/jbc.M113.487231; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Bazan NG, ANN REV NUTR, V312011, P321; Benov LT, 1996, FREE RADICAL BIO MED, V21, P117, DOI 10.1016/0891-5849(95)02217-1; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chen XP, 2012, NEUROCHEM RES, V37, P835, DOI 10.1007/s11064-011-0679-8; Choi I, 2011, BBA-MOL BASIS DIS, V1812, P41, DOI 10.1016/j.bbadis.2010.09.003; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Coelho FR, 2014, J BIOL CHEM, V289, P30690, DOI 10.1074/jbc.M114.586370; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; Derogis PBMC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077561; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fu XM, 2005, BIOCHEM BIOPH RES CO, V329, P1087, DOI 10.1016/j.bbrc.2005.01.164; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2011, AMYOTROPHIC LATERAL SCLEROSIS, P335; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Hwang YM, 2010, J BIOL CHEM, V285, P41701, DOI 10.1074/jbc.M110.113696; Johansson AS, 2007, FEBS J, V274, P990, DOI 10.1111/j.1742-4658.2007.05647.x; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kiaei M, 2005, J NEUROCHEM, V93, P403, DOI 10.1111/j.1471-4159.2005.03024.x; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Medinas DB, 2010, FREE RADICAL BIO MED, V49, P1046, DOI 10.1016/j.freeradbiomed.2010.06.018; Medinas DB, 2009, CHEM RES TOXICOL, V22, P639, DOI 10.1021/tx800287m; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Morigaki K, 2007, CURR OPIN COLLOID IN, V12, P75, DOI 10.1016/j.cocis.2007.05.005; Mulligan VK, 2012, J MOL BIOL, V421, P631, DOI 10.1016/j.jmb.2012.04.016; Namani T, 2007, COLLOID SURFACE B, V54, P118, DOI 10.1016/j.colsurfb.2006.05.022; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Orr SK, 2013, J NEUROCHEM, V127, P378, DOI 10.1111/jnc.12392; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shibata N, 2010, ACTA NEUROPATHOL, V119, P345, DOI 10.1007/s00401-009-0636-7; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Tsiroulnikov K, 2009, BBA-PROTEINS PROTEOM, V1794, P506, DOI 10.1016/j.bbapap.2008.12.002; Turell L, 2009, BRAZ J MED BIOL RES, V42, P305, DOI 10.1590/S0100-879X2009000400001; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200; Zhang M, 2009, CHEM-BIOL INTERACT, V180, P131, DOI 10.1016/j.cbi.2009.03.019	57	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125146	10.1371/journal.pone.0125146	http://dx.doi.org/10.1371/journal.pone.0125146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928076	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100070
J	Kim, HJ; Hinchliffe, DJ; Triplett, BA; Chen, ZJ; Stelly, DM; Yeater, KM; Moon, HS; Gilbert, MK; Thyssen, GN; Turley, RB; Fang, DD				Kim, Hee Jin; Hinchliffe, Doug J.; Triplett, Barbara A.; Chen, Z. Jeffrey; Stelly, David M.; Yeater, Kathleen M.; Moon, Hong S.; Gilbert, Matthew K.; Thyssen, Gregory N.; Turley, Rickie B.; Fang, David D.			Phytohormonal Networks Promote Differentiation of Fiber Initials on Pre-Anthesis Cotton Ovules Grown In Vitro and In Planta	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM L.; MYB TRANSCRIPTION FACTOR; GENE-EXPRESSION; CELL-WALL; ALLOTETRAPLOID COTTON; TRICHOME DEVELOPMENT; VACUOLAR INVERTASE; ABSCISIC-ACID; AUXIN; ELONGATION	The number of cotton (Gossypium sp.) ovule epidermal cells differentiating into fiber initials is an important factor affecting cotton yield and fiber quality. Despite extensive efforts in determining the molecular mechanisms regulating fiber initial differentiation, only a few genes responsible for fiber initial differentiation have been discovered. To identify putative genes directly involved in the fiber initiation process, we used a cotton ovule culture technique that controls the timing of fiber initial differentiation by exogenous phytohormone application in combination with comparative expression analyses between wild type and three fiberless mutants. The addition of exogenous auxin and gibberellins to pre-anthesis wild type ovules that did not have visible fiber initials increased the expression of genes affecting auxin, ethylene, ABA and jasmonic acid signaling pathways within 1 h after treatment. Most transcripts expressed differentially by the phytohormone treatment in vitro were also differentially expressed in the ovules of wild type and fiberless mutants that were grown in planta. In addition to MYB25-like, a gene that was previously shown to be associated with the differentiation of fiber initials, several other differentially expressed genes, including auxin/indole-3-acetic acid (AUX/IAA) involved in auxin signaling, ACC oxidase involved in ethylene biosynthesis, and abscisic acid (ABA) 8'-hydroxylase an enzyme that controls the rate of ABA catabolism, were co-regulated in the pre-anthesis ovules of both wild type and fiberless mutants. These results support the hypothesis that phytohormonal signaling networks regulate the temporal expression of genes responsible for differentiation of cotton fiber initials in vitro and in planta.	[Kim, Hee Jin; Hinchliffe, Doug J.; Triplett, Barbara A.; Moon, Hong S.; Gilbert, Matthew K.; Thyssen, Gregory N.; Fang, David D.] USDA ARS, SRRC, Cotton Fiber Biosci Res Unit, New Orleans, LA 70153 USA; [Chen, Z. Jeffrey] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Chen, Z. Jeffrey] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Stelly, David M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Yeater, Kathleen M.] USDA ARS, Plains Area, Ft Collins, CO 80522 USA; [Turley, Rickie B.] USDA ARS, Crop Genet Res Unit, Stoneville, MS 38776 USA	United States Department of Agriculture (USDA); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Kim, HJ (corresponding author), USDA ARS, SRRC, Cotton Fiber Biosci Res Unit, New Orleans, LA 70153 USA.	heejin.kim@ars.usda.gov	Kim, Heejin/HII-8568-2022; FANG, DAVID/AAV-5774-2020; Stelly, David/ABC-7400-2020	FANG, DAVID/0000-0003-0036-5459; Stelly, David/0000-0002-3468-4119; Turley, Rickie/0000-0002-1792-9559	USDA-ARS CRIS Project [6435-21000-016-00D]; NSF [DBI0624077, ISO1025947]; Cotton Incorporated [07-161]; Division Of Integrative Organismal Systems [1025947] Funding Source: National Science Foundation	USDA-ARS CRIS Project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NSF(National Science Foundation (NSF)); Cotton Incorporated(Cotton R&D Corp); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the USDA-ARS CRIS Project #6435-21000-016-00D, NSF DBI0624077 and ISO1025947, and Cotton Incorporated-sponsored project #07-161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; BEASLEY CA, 1973, AM J BOT, V60, P130, DOI 10.2307/2441099; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Deng FL, 2012, PLANT PHYSIOL, V158, P890, DOI 10.1104/pp.111.186742; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gialvalis S., 2001, Journal of Cotton Science, V5, P252; GRAVES DA, 1988, PLANTA, V175, P254, DOI 10.1007/BF00392435; Guan XY, 2008, PHYSIOL PLANTARUM, V134, P174, DOI 10.1111/j.1399-3054.2008.01115.x; Guilfoyle T, 1998, PLANT PHYSIOL, V118, P341, DOI 10.1104/pp.118.2.341; Hadiarto T, 2006, PLANTA, V223, P708, DOI 10.1007/s00425-005-0126-7; Han XY, 2012, GENE, V503, P83, DOI 10.1016/j.gene.2012.03.069; Hao J, 2012, J EXP BOT, V63, P6267, DOI 10.1093/jxb/ers278; Hinchliffe DJ, 2010, THEOR APPL GENET, V120, P1347, DOI 10.1007/s00122-010-1260-6; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Ji XM, 2011, PLANT PHYSIOL, V156, P647, DOI 10.1104/pp.111.176164; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kosmidou-Dimitropoulou K, 1986, COTTON PHYSL, P361; Kunihiro A, 2011, PLANT CELL PHYSIOL, V52, P1315, DOI 10.1093/pcp/pcr076; Lang AG, 1938, J AGRIC RES, V56, P0507; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Leyser O, 2002, ANNU REV PLANT BIOL, V53, P377, DOI 10.1146/annurev.arplant.53.100301.135227; Li CH, 2002, PLANT SCI, V163, P1113, DOI 10.1016/S0168-9452(02)00320-5; Li CQ, 2009, EUPHYTICA, V165, P223, DOI 10.1007/s10681-008-9740-3; Loguercio LL, 1999, MOL GEN GENET, V261, P660; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; Rahman A, 2001, PLANT CELL PHYSIOL, V42, P301, DOI 10.1093/pcp/pce035; Robles LM, 2012, J EXPT BOT; Romano GB, 2011, J COTTON SCI, V15, P61; Ruan YL, 1998, PLANT PHYSIOL, V118, P399, DOI 10.1104/pp.118.2.399; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Ryser U, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P1; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Schiefelbein J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00047; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shimizu Y, 1997, PLANT CELL PHYSIOL, V38, P375, DOI 10.1093/oxfordjournals.pcp.a029178; STEWART JM, 1975, AM J BOT, V62, P723, DOI 10.2307/2442061; Sun Y, 2005, PLANT CELL PHYSIOL, V46, P1384, DOI 10.1093/pcp/pci150; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Turley RB, 2002, J HERED, V93, P359, DOI 10.1093/jhered/93.5.359; Turley RB, 2008, EUPHYTICA, V164, P123, DOI 10.1007/s10681-008-9670-0; Udall JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-81; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wakelyn PJ., 2010, COTTON FIBER CHEM TE; Walford S-A, 2012, PLANT J; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang L, 2014, PLANT J, V78, P686, DOI 10.1111/tpj.12512; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wang MY, 2013, PLANT PHYSIOL, V162, P1669, DOI 10.1104/pp.113.215673; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Wu Y, 2007, PLANTA, V226, P1475, DOI 10.1007/s00425-007-0580-5; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yang ZR, 2014, NEW PHYTOL, V203, P437, DOI 10.1111/nph.12824; Zhang DY, 2007, J INTEGR PLANT BIOL, V49, P1038, DOI 10.1111/j.1672-9072.2007.00454.x; Zhang DY, 2010, J PLANT PHYSIOL, V167, P393, DOI 10.1016/j.jplph.2009.10.005; Zhang HP, 2009, ACTA PHYSIOL PLANT, V31, P979, DOI 10.1007/s11738-009-0313-4; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang TZ, 1991, JIANGSU J AGR SCI, V7, P13	69	51	52	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125046	10.1371/journal.pone.0125046	http://dx.doi.org/10.1371/journal.pone.0125046			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927364	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100062
J	Terrasse, R; Amoroso, A; Vernet, T; Di Guilmi, AM				Terrasse, Remi; Amoroso, Ana; Vernet, Thierry; Di Guilmi, Anne Marie			Streptococcus pneumoniae GAPDH Is Released by Cell Lysis and Interacts with Peptidoglycan	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; ENDOPEPTIDASE O PEPO; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ALPHA-ENOLASE; MOONLIGHTING PROTEINS; SUPEROXIDE-DISMUTASE; HUMAN PLASMINOGEN; ESCHERICHIA-COLI; SURFACE; LISTERIA	Release of conserved cytoplasmic proteins is widely spread among Gram-positive and Gram-negative bacteria. Because these proteins display additional functions when located at the bacterial surface, they have been qualified as moonlighting proteins. The GAPDH is a glycolytic enzyme which plays an important role in the virulence processes of pathogenic microorganisms like bacterial invasion and host immune system modulation. However, GAPDH, like other moonlighting proteins, cannot be secreted through active secretion systems since they do not contain an N-terminal predicted signal peptide. In this work, we investigated the mechanism of GAPDH export and surface retention in Streptococcus pneumoniae, a major human pathogen. We addressed the role of the major autolysin LytA in the delivery process of GAPDH to the cell surface. Pneumococcal lysis is abolished in the Delta lytA mutant strain or when 1% choline chloride is added in the culture media. We showed that these conditions induce a marked reduction in the amount of surface-associated GAPDH. These data suggest that the presence of GAPDH at the surface of pneumococcal cells depends on the LytA-mediated lysis of a fraction of the cell population. Moreover, we demonstrated that pneumococcal GAPDH binds to the bacterial cell wall independently of the presence of the teichoic acids component, supporting peptidoglycan as a ligand to surface GAPDH. Finally, we showed that peptidoglycan-associated GAPDH recruits C1q from human serum but does not activate the complement pathway.	[Terrasse, Remi; Vernet, Thierry; Di Guilmi, Anne Marie] Univ Grenoble Alpes, Inst Biol Struct IBS, F-38044 Grenoble, France; [Terrasse, Remi; Vernet, Thierry; Di Guilmi, Anne Marie] IBS, CNRS UMR5075, F-38044 Grenoble, France; [Terrasse, Remi; Vernet, Thierry; Di Guilmi, Anne Marie] IBS, DSV, CEA, F-38044 Grenoble, France; [Amoroso, Ana] Univ Liege, Ctr Prot Engn, Dept Life Sci, Liege, Belgium	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Liege	Di Guilmi, AM (corresponding author), Univ Grenoble Alpes, Inst Biol Struct IBS, 71 Ave Martyrs, F-38044 Grenoble, France.	anne-marie.di-guilmi@ibs.fr		Di Guilmi, Anne Marie/0000-0001-7335-3470	Agence Nationale de la Recherche grant PiliPath [ANR11BSV800501]	Agence Nationale de la Recherche grant PiliPath(French National Research Agency (ANR))	R.T. was supported by a PhD grant from the Rhone-Alpes region, Cluster Infectiologie. This work was partly supported by Agence Nationale de la Recherche grant PiliPath (ANR11BSV800501).	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Agarwal V, 2014, J BIOL CHEM, V289, P15833, DOI 10.1074/jbc.M113.530212; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Agarwal V, 2012, J IMMUNOL, V189, P3575, DOI 10.4049/jimmunol.1102934; Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Antikainen J, 2007, J BACTERIOL, V189, P4539, DOI 10.1128/JB.00378-07; Archambaud C, 2006, J BIOL CHEM, V281, P31812, DOI 10.1074/jbc.M606249200; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Boel G, 2004, J MOL BIOL, V337, P485, DOI 10.1016/j.jmb.2003.12.082; Boone TJ, 2011, MICROB PATHOGENESIS, V51, P255, DOI 10.1016/j.micpath.2011.06.005; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Carneiro CRW, 2004, MICROBES INFECT, V6, P604, DOI 10.1016/j.micinf.2004.02.003; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; Christie PJ, 2014, BBA-MOL CELL RES, V1843, P1578, DOI 10.1016/j.bbamcr.2013.12.019; Dalbey RE, 2014, BBA-MOL CELL RES, V1843, P1489, DOI 10.1016/j.bbamcr.2013.12.022; Dalia AB, 2011, CELL HOST MICROBE, V10, P486, DOI 10.1016/j.chom.2011.09.009; DWORSCHACK R, 1961, APPL MICROBIOL, V9, P291, DOI 10.1128/AEM.9.4.291-294.1961; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Eldholm V, 2010, MOL MICROBIOL, V76, P905, DOI 10.1111/j.1365-2958.2010.07143.x; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Henderson B, 2014, BIOCH SOC; Henderson B, 2014, BIOCHEM SOC T, V42, P1720, DOI 10.1042/BST20140236; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hernandez S, 2014, NUCLEIC ACIDS RES, V42, pD517, DOI 10.1093/nar/gkt1153; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Jagadeesan B, 2010, MICROBIOL-SGM, V156, P2782, DOI 10.1099/mic.0.036509-0; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jin H, 2011, MBIO, V2, DOI 10.1128/mBio.00068-11; Kainulainen Veera, 2014, Biology (Basel), V3, P178, DOI 10.3390/biology3010178; Kinhikar AG, 2006, MOL MICROBIOL, V60, P999, DOI 10.1111/j.1365-2958.2006.05151.x; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Mani M., 2014, NUCLEIC ACIDS RES, DOI [10.1043/nar/gku954, DOI 10.1043/NAR/GKU954]; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; Mellroth P, 2014, MBIO, V5, DOI 10.1128/mBio.01120-13; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 1997, J EXP MED, V186, P1633, DOI 10.1084/jem.186.10.1633; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pasztor L, 2010, J BIOL CHEM, V285, P36794, DOI 10.1074/jbc.M110.167312; Perez-Dorado I, 2010, NAT STRUCT MOL BIOL, V17, P576, DOI 10.1038/nsmb.1817; Schneewind O, 2014, BBA-MOL CELL RES, V1843, P1687, DOI 10.1016/j.bbamcr.2013.11.009; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Sun XS, 2010, J PROTEOME RES, V9, P275, DOI 10.1021/pr900612v; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Terrasse R, 2012, J BIOL CHEM, V287, P42620, DOI 10.1074/jbc.M112.423731; Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024; WISTOW GJ, 1988, J CELL BIOL, V107, P2729, DOI 10.1083/jcb.107.6.2729; Xia XX, 2008, PROTEOMICS, V8, P2089, DOI 10.1002/pmic.200700826; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11	64	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125377	10.1371/journal.pone.0125377	http://dx.doi.org/10.1371/journal.pone.0125377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927608	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100085
J	Ud-Din, S; Sebastian, A; Giddings, P; Colthurst, J; Whiteside, S; Morris, J; Nuccitelli, R; Pullar, C; Baguneid, M; Bayat, A				Ud-Din, Sara; Sebastian, Anil; Giddings, Pamela; Colthurst, James; Whiteside, Sigrid; Morris, Julie; Nuccitelli, Richard; Pullar, Christine; Baguneid, Mo; Bayat, Ardeshir			Angiogenesis Is Induced and Wound Size Is Reduced by Electrical Stimulation in an Acute Wound Healing Model in Human Skin	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VENOUS LEG ULCERS; HUMAN KERATINOCYTES; BLOOD-FLOW; VEGF; MECHANISMS; EXPRESSION; RECEPTORS; PERMEABILITY; THERAPY	Angiogenesis is critical for wound healing. Insufficient angiogenesis can result in impaired wound healing and chronic wound formation. Electrical stimulation (ES) has been shown to enhance angiogenesis. We previously showed that ES enhanced angiogenesis in acute wounds at one time point (day 14). The aim of this study was to further evaluate the role of ES in affecting angiogenesis during the acute phase of cutaneous wound healing over multiple time points. We compared the angiogenic response to wounding in 40 healthy volunteers (divided into two groups and randomised), treated with ES (post-ES) and compared them to secondary intention wound healing (control). Biopsy time points monitored were days 0, 3, 7, 10, 14. Objective non-invasive measures and H&E analysis were performed in addition to immunohistochemistry (IHC) and Western blotting (WB). Wound volume was significantly reduced on D7, 10 and 14 post-ES (p = 0.003, p = 0.002, p<0.001 respectively), surface area was reduced on days 10 (p = 0.001) and 14 (p<0.001) and wound diameter reduced on days 10 (p = 0.009) and 14 (p = 0.002). Blood flow increased significantly post-ES on D10 (p = 0.002) and 14 (p = 0.001). Angiogenic markers were up-regulated following ES application; protein analysis by IHC showed an increase (p<0.05) in VEGF-A expression by ES treatment on days 7, 10 and 14 (39%, 27% and 35% respectively) and PLGF expression on days 3 and 7 (40% on both days), compared to normal healing. Similarly, WB demonstrated an increase (p<0.05) in PLGF on days 7 and 14 (51% and 35% respectively). WB studies showed a significant increase of 30% (p>0.05) on day 14 in VEGF-A expression post-ES compared to controls. Furthermore, organisation of granulation tissue was improved on day 14 post-ES. This randomised controlled trial has shown that ES enhanced wound healing by reduced wound dimensions and increased VEGF-A and PLGF expression in acute cutaneous wounds, which further substantiates the role of ES in up-regulating angiogenesis as observed over multiple time points. This therapeutic approach may have potential application for clinical management of delayed and chronic wounds.	[Ud-Din, Sara; Sebastian, Anil; Bayat, Ardeshir] Univ Manchester, Plast & Reconstruct Surg Res, Manchester Inst Biotechnol, Manchester, Lancs, England; [Ud-Din, Sara; Baguneid, Mo; Bayat, Ardeshir] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Univ Hosp South Manchester NHS Fdn Trust,Inst Inf, Manchester, Lancs, England; [Giddings, Pamela; Colthurst, James] Oxford Bioelect, Innovat Ctr, Abingdon, Oxon, England; [Whiteside, Sigrid; Morris, Julie] Univ S Manchester Hosp, Med Stat, Manchester M20 8LR, Lancs, England; [Nuccitelli, Richard] BioElectroMed Corp, Burlingame, CA USA; [Pullar, Christine] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester, Leics, England; [Bayat, Ardeshir] Univ Manchester, Inst Inflammat & Repair, Ctr Dermatol Res, Manchester, Lancs, England	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Leicester; University of Manchester	Bayat, A (corresponding author), Univ Manchester, Plast & Reconstruct Surg Res, Manchester Inst Biotechnol, Manchester, Lancs, England.	ardeshir.bayat@manchester.ac.uk		Baguneid, Mohamed/0000-0002-3819-4993; BAYAT, ARDESHIR/0000-0002-4116-6491	Fenzian Ltd.; William Henry Smith of Hambleden	Fenzian Ltd.; William Henry Smith of Hambleden	Partial funding was provided by Fenzian Ltd. Only authors P. Giddings and J. Colthurst are paid as employees of Fenzian Ltd. (URL - www.fenzian.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining funding was a philanthropic donation which was funded by a generous donation from William Henry Smith of Hambleden.	Ardehali B, 2007, PLAST RECONSTR SURG, V119, P556, DOI 10.1097/01.prs.0000252505.52821.76; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Ascher B, 2012, J COSMET LASER THER, V14, P234, DOI 10.3109/14764172.2012.712700; Bai H, 2011, CYTOKINE, V55, P110, DOI 10.1016/j.cyto.2011.03.003; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; BIRCHER A, 1994, CONTACT DERMATITIS, V30, P65, DOI 10.1111/j.1600-0536.1994.tb00565.x; Bloemen MCT, 2011, J AM ACAD DERMATOL, V64, P706, DOI 10.1016/j.jaad.2010.03.006; Bowling FL, 2009, DIABETIC MED, V26, P93, DOI 10.1111/j.1464-5491.2008.02611.x; BROWN LF, 1997, EXS, V79, P233; Carmeliet P, 1999, CURR TOP MICROBIOL, V237, P133; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Clover AJ, 2003, J VASC SURG, V38, P1309, DOI 10.1016/S0741-5214(03)00895-4; Di Peppe SR, 2002, GENE THER, V9, P1271, DOI 10.1038/sj.gt.3301798; Drinkwater SL, 2003, J VASC SURG, V38, P1106, DOI 10.1016/S0741-5214(03)01053-X; Failla CM, 2000, J INVEST DERMATOL, V115, P388, DOI 10.1046/j.1523-1747.2000.00085.x; FEEDAR JA, 1991, PHYS THER, V71, P639, DOI 10.1093/ptj/71.9.639; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOULDS IS, 1983, BRIT J DERMATOL, V109, P515, DOI 10.1111/j.1365-2133.1983.tb07673.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gentzkow GD, 1991, WOUNDS, V3, P158; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; HANG J, 1995, AM J PHYSIOL-HEART C, V269, pH1827, DOI 10.1152/ajpheart.1995.269.5.H1827; Houghton PE, 2003, PHYS THER, V83, P17, DOI 10.1093/ptj/83.1.17; Junger M, 2008, WOUND REPAIR REGEN, V16, P480, DOI 10.1111/j.1524-475X.2008.00393.x; Kanno S, 1999, CIRCULATION, V99, P2682, DOI 10.1161/01.CIR.99.20.2682; Korber Andreas, 2006, J Dtsch Dermatol Ges, V4, P848, DOI 10.1111/j.1610-0387.2006.06113.x; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; McGinnis M E, 1986, Prog Clin Biol Res, V210, P231; Nishimura KY, 1996, J CELL SCI, V109, P199; Nuccitelli R, 2011, WOUND REPAIR REGEN, V19, P645, DOI 10.1111/j.1524-475X.2011.00723.x; Odorisio T, 2006, J DERMATOL SCI, V41, P11, DOI 10.1016/j.jdermsci.2005.08.008; Odorisio T, 2002, J CELL SCI, V115, P2559; Petrofsky J., 2008, Journal of Medical Engineering & Technology, V32, P485, DOI 10.1080/03091900701574407; Pullar CE, 2011, BIOL EFF ELECTROMAGN, P1; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sebastian A, 2015, J INVEST DERMATOL, V135, P1166, DOI 10.1038/jid.2014.502; Sebastian A, 2011, WOUND REPAIR REGEN, V19, P693, DOI 10.1111/j.1524-475X.2011.00736.x; Sebastian A, 2011, EXP DERMATOL, V20, P64, DOI 10.1111/j.1600-0625.2010.01150.x; Suh H, 2009, DIABETES TECHNOL THE, V11, P315, DOI 10.1089/dia.2008.0092; Syeda MM, 2012, AM J PATHOL, V181, P334, DOI 10.1016/j.ajpath.2012.03.012; Ud-Din S, 2012, EXP DERMATOL, V21, P758, DOI 10.1111/exd.12005; Varol AL, 2010, ARCH DERMATOL RES, V302, P383, DOI 10.1007/s00403-010-1043-6	43	79	81	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124502	10.1371/journal.pone.0124502	http://dx.doi.org/10.1371/journal.pone.0124502			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928356	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100034
J	Weiss, JD; Cotterill, FPD; Schliewen, UK				Weiss, Juliane D.; Cotterill, Fenton P. D.; Schliewen, Ulrich K.			Lake Tanganyika-A 'Melting Pot' of Ancient and Young Cichlid Lineages (Teleostei: Cichlidae)?	PLOS ONE			English	Article							SHORT INTERSPERSED ELEMENTS; AFRICAN RIFT SYSTEM; MITOCHONDRIAL PHYLOGENY; ADAPTIVE RADIATION; EXPLOSIVE SPECIATION; EVOLUTIONARY RELATIONSHIPS; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; NUCLEAR SEQUENCES; FISHES	A long history of research focused on the East Africa cichlid radiations (EAR) revealed discrepancies between mtDNA and nuclear phylogenies, suggesting that interspecific hybridisation may have been significant during the radiation of these fishes. The approximately 250 cichlid species of Lake Tanganyika have their roots in a monophyletic African cichlid assemblage, but controversies remain about the precise phylogenetic origin and placement of different lineages and consequently about L. Tanganyika colonization scenarios. 3312 AFLP loci and the mitochondrial ND2 gene were genotyped for 91 species representing almost all major lacustrine and riverine haplotilapiine east African cichlid lineages with a focus on L. Tanganyika endemics. Explicitly testing for the possibility of ancient hybridisation events, a comprehensive phylogenetic network hypothesis is proposed for the origin and diversification of L. Tanganyika cichlids. Inference of discordant phylogenetic signal strongly suggests that the genomes of two endemic L. Tanganyika tribes, Eretmodini and Tropheini, are composed of an ancient mixture of riverine and lacustrine lineages. For the first time a strong monophyly signal of all non-haplochromine mouthbrooding species endemic to L. Tanganyika ("ancient mouthbrooders") was detected. Further, in the genomes of early diverging L. Tanganyika endemics Trematocarini, Bathybatini, Hemibatini and Boulengerochromis genetic components of other lineages belonging to the East African Radiation appear to be present. In combination with recent palaeo-geological results showing that tectonic activity in the L. Tanganyika region resulted in highly dynamic and heterogeneous landscape evolution over the Neogene and Pleistocene, the novel phylogenetic data render a single lacustrine basin as the geographical cradle of the endemic L. Tanganyika cichlid lineages unlikely. Instead a scenario of a pre-rift origin of several independent L. Tanganyika precursor lineages which diversified in ancient rivers and precursor lakes and then amalgamated in the extant L. Tanganyika basin is put forward as an alternative: the 'melting pot Tanganyika' hypothesis.	[Weiss, Juliane D.; Schliewen, Ulrich K.] Bavarian State Collect Zool, Dept Ichthyol, D-81247 Munich, Germany; [Cotterill, Fenton P. D.] Univ Stellenbosch, Dept Bot & Zool, Geoecodynam Res Hub, ZA-7602 Stellenbosch, South Africa	Stellenbosch University	Schliewen, UK (corresponding author), Bavarian State Collect Zool, Dept Ichthyol, Munchhausenstr 21, D-81247 Munich, Germany.	schliewen@zsm.mwn.de			Deutsche Forschungsgemeinschaft DFG [SCHL567/4]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft DFG (www.dfg.de) grant# SCHL567/4 to UKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TRACER V1 6; Anseeuw Dieter, 2012, Int J Evol Biol, V2012, P865603, DOI 10.1155/2012/865603; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; BANISTER KE, 1980, J NAT HIST, V14, P483, DOI 10.1080/00222938000770421; Bauer FU, 2010, INT J EARTH SCI, V99, P1575, DOI 10.1007/s00531-010-0549-7; Brandstatter A, 2005, MOL PHYLOGENET EVOL, V34, P382, DOI 10.1016/j.ympev.2004.10.019; Burgess CF, 1988, TRIASSIC JURASSIC RI, P859; Capart A, 1949, SONDAGES CARTE BATHM, V2; Clabaut C, 2005, J MOL EVOL, V61, P666, DOI 10.1007/s00239-004-0217-2; COHEN AS, 1993, GEOLOGY, V21, P511, DOI 10.1130/0091-7613(1993)021<0511:ETAOFO>2.3.CO;2; Cohen AS, 1997, BASIN RES, V9, P107, DOI 10.1046/j.1365-2117.1997.00038.x; Coulter G.W., 1991, P151; Day JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001730; De Vos Luc, 1998, Ichthyological Exploration of Freshwaters, V9, P371; Dixon CJ, 2009, MOL PHYLOGENET EVOL, V50, P74, DOI 10.1016/j.ympev.2008.10.009; Duftner N, 2005, J MOL EVOL, V60, P277, DOI 10.1007/s00239-004-0017-8; Dunz AR, 2013, MOL PHYLOGENET EVOL, V68, P64, DOI 10.1016/j.ympev.2013.03.015; Dunz AR., 2013, THESIS LUDWIG MAXIMI; Egger B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-137; Farias IP, 1999, J MOL EVOL, V48, P703, DOI 10.1007/PL00006514; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Friedman M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1733; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Genner MJ, 2012, MOL BIOL EVOL, V29, P195, DOI 10.1093/molbev/msr183; Goodier SAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028775; Greenwood P.H., 1980, Bulletin of the British Museum (Natural History) Zoology, V38, P159; Greenwood PH, 1980, BRIT MUSEUM NATURAL, DOI [10.1099/ijs.0.045906-0, DOI 10.1099/IJS.0.045906-0]; Haldemann EG, 1969, GEOLOGICAL PHYSIOGRA, P20; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herder F, 2006, P R SOC B, V273, P2209, DOI 10.1098/rspb.2006.3558; HOOGERHOUD RJC, 1984, NETH J ZOOL, V34, P539, DOI 10.1163/002829684X00281; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; Kirchberger PC, 2014, MOL PHYLOGENET EVOL, V70, P57, DOI 10.1016/j.ympev.2013.09.005; Kirchberger Paul C, 2012, Int J Evol Biol, V2012, P716209, DOI 10.1155/2012/716209; Klett V, 2002, MOL BIOL EVOL, V19, P865, DOI 10.1093/oxfordjournals.molbev.a004144; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Koblmuller S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-7; Koblmuller S, 2007, MOL PHYLOGENET EVOL, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Koblmuller S, 2005, J MOL EVOL, V60, P297, DOI 10.1007/s00239-004-0033-8; Koblmuller S, 2004, J MOL EVOL, V58, P79, DOI 10.1007/s00239-003-2527-1; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Kullander SO, 2011, ICHTHYOL EXPLOR FRES, V22, P355; Lezzar KE, 2002, AAPG BULL, V86, P1027; LINK W, 1995, THEOR APPL GENET, V90, P27, DOI 10.1007/BF00220992; Loh YHE, 2013, MOL BIOL EVOL, V30, P906, DOI 10.1093/molbev/mss326; Macgregor D, 2015, J AFR EARTH SCI, V101, P232, DOI 10.1016/j.jafrearsci.2014.09.016; McMahan CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071162; Meyer BS, 2015, MOL PHYLOGENET EVOL, V83, P56, DOI 10.1016/j.ympev.2014.10.009; Moore JES, 1903, GEOGR J, V21, P682, DOI 10.2307/1775673; Murray AM, 2001, BIOL J LINN SOC, V74, P517, DOI 10.1006/bijl.2001.0599; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Musilova Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065047; Neumann Dirk, 2010, Abc Taxa, V8, P587; Nevado B, 2009, MOL ECOL, V18, P4240, DOI 10.1111/j.1365-294X.2009.04348.x; NISHIDA M, 1991, EXPERIENTIA, V47, P974, DOI 10.1007/BF01929896; Partridge TC., 2010, CENOZOIC MAMMALS AFR, P3, DOI DOI 10.1525/CALIFORNIA/9780520257214.003.0001; POLL M, 1986, Academie Royale de Belgique Memoires de la Classe des Sciences Collection in Octavo, V45, P1; Roller S, 2010, INT J EARTH SCI, V99, P1643, DOI 10.1007/s00531-010-0560-z; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruber L, 2001, MOL ECOL, V10, P1207, DOI 10.1046/j.1365-294X.2001.01259.x; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Salzburger W, 2002, MOL ECOL, V11, P619, DOI 10.1046/j.0962-1083.2001.01438.x; SANDER S, 1989, J AFR EARTH SCI, V8, P323, DOI 10.1016/S0899-5362(89)80031-4; Schelly R, 2006, MOL PHYLOGENET EVOL, V38, P426, DOI 10.1016/j.ympev.2005.04.023; Schliewen Ulrich K., 2004, Frontiers in Zoology, V1, P1; Schliewen Ulrich K., 2003, Ichthyological Exploration of Freshwaters, V14, P61; SCHOLZ CA, 1988, SCIENCE, V240, P1645, DOI 10.1126/science.240.4859.1645; Schwarzer J, 2012, J EVOLUTION BIOL, V25, P138, DOI 10.1111/j.1420-9101.2011.02409.x; Schwarzer J, 2012, P ROY SOC B-BIOL SCI, V279, P4389, DOI 10.1098/rspb.2012.1667; Schwarzer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022380; Schwarzer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-186; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Spiegel C, 2007, GEOLOGY, V35, P427, DOI 10.1130/G23108A.1; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stiassny M.L.J., 1991, CICHLID FISHES BEHAV, P1; STIASSNY MLJ, 1987, J NAT HIST, V21, P1311, DOI 10.1080/00222938700770811; Streelman JT, 1998, MOL BIOL EVOL, V15, P798, DOI 10.1093/oxfordjournals.molbev.a025985; STURMBAUER C, 1994, MOL BIOL EVOL, V11, P691; STURMBAUER C, 1993, MOL BIOL EVOL, V10, P751; Sturmbauer C, 1998, J FISH BIOL, V53, P18; Sturmbauer C, 2003, HYDROBIOLOGIA, V500, P51, DOI 10.1023/A:1024680201436; Sturmbauer C, 2010, MOL PHYLOGENET EVOL, V57, P266, DOI 10.1016/j.ympev.2010.06.018; Sturrock K., 2000, FIELD METHOD, V12, P49, DOI DOI 10.1177/1525822X0001200104; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Takahashi K, 1998, MOL BIOL EVOL, V15, P391, DOI 10.1093/oxfordjournals.molbev.a025936; Takahashi K, 2002, MOL BIOL EVOL, V19, P1303, DOI 10.1093/oxfordjournals.molbev.a004191; Takahashi K, 2001, MOL BIOL EVOL, V18, P2057, DOI 10.1093/oxfordjournals.molbev.a003747; Takahashi R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-195; Takahashi T, 2003, ICHTHYOL RES, V50, P367, DOI 10.1007/s10228-003-0181-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terai Y, 2004, J MOL EVOL, V58, P64, DOI 10.1007/s00239-003-2526-2; Terai Y, 2003, MOL BIOL EVOL, V20, P924, DOI 10.1093/molbev/msg104; Tiercelin JJ, 1991, GEOLOGY TANGANYIKA T, P7; Tukey JW, 1977, READ MA, V231; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Won YJ, 2006, MOL BIOL EVOL, V23, P828, DOI 10.1093/molbev/msj101; Won YJ, 2005, P NATL ACAD SCI USA, V102, P6581, DOI 10.1073/pnas.0502127102	110	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125043	10.1371/journal.pone.0125043	http://dx.doi.org/10.1371/journal.pone.0125043			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928886	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100060
J	Zhong, T; Guo, QL; Zou, WY; Zhu, XY; Song, ZB; Sun, B; He, X; Yang, Y				Zhong, Tao; Guo, Qulian; Zou, Wangyuan; Zhu, Xiaoyan; Song, Zongbin; Sun, Bei; He, Xin; Yang, Yong			Neonatal Isoflurane Exposure Induces Neurocognitive Impairment and Abnormal Hippocampal Histone Acetylation in Mice	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; C-FOS EXPRESSION; DEACETYLASE INHIBITORS; CONTEXTUAL FEAR; MEMORY CONSOLIDATION; ALZHEIMERS-DISEASE; MOUSE MODEL; NEURODEGENERATION; ACTIVATION; BRAIN	Background Neonatal exposure to isoflurane may induce long-term memory impairment in mice. Histone acetylation is an important form of chromatin modification that regulates the transcription of genes required for memory formation. This study investigated whether neonatal isoflurane exposure-induced neurocognitive impairment is related to dysregulated histone acetylation in the hippocampus and whether it can be attenuated by the histone deacetylase (HDAC) inhibitor trichostatin A (TSA). Methods C57BL/6 mice were exposed to 0.75% isoflurane three times (each for 4 h) at postnatal days 7, 8, and 9. Contextual fear conditioning (CFC) was tested at 3 months after anesthesia administration. TSA was intraperitoneally injected 2 h before CFC training. Hippocampal histone acetylation levels were analyzed following CFC training. Levels of the neuronal activation and synaptic plasticity marker c-Fos were investigated at the same time point. Results Mice that were neonatally exposed to isoflurane showed significant memory impairment on CFC testing. These mice also exhibited dysregulated hippocampal H4K12 acetylation and decreased c-Fos expression following CFC training. TSA attenuated isoflurane-induced memory impairment and simultaneously increased histone acetylation and c-Fos levels in the hippocampal cornu ammonis (CA) 1 area 1 h after CFC training. Conclusions Memory impairment induced by repeated neonatal exposure to isoflurane is associated with dysregulated histone H4K12 acetylation in the hippocampus, which probably affects downstream c-Fos gene expression following CFC training. The HDAC inhibitor TSA	[Zhong, Tao; Guo, Qulian; Zou, Wangyuan; Zhu, Xiaoyan; Song, Zongbin; Sun, Bei; He, Xin; Yang, Yong] Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China	Central South University	Yang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	YangYong84327411@gmail.com	Song, Zongbin/GYD-5863-2022	Song, Zongbin/0000-0002-0447-8648; Zhong, Tao/0000-0002-6991-2521	Natural Science Foundation of China [81171053]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (No. 81171053; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Antoine B, 2014, BRAIN STRUCT FUNCT, V219, P415, DOI 10.1007/s00429-013-0505-y; Bekinschtein P, 2010, NEUROTOX RES, V18, P377, DOI 10.1007/s12640-010-9155-5; Bester H, 2000, J COMP NEUROL, V428, P45, DOI 10.1002/1096-9861(20001204)428:1<45::AID-CNE5>3.0.CO;2-A; Bissiere S, 2011, SCIENCE, V331, P87, DOI 10.1126/science.1193785; Bousiges O, 2010, NEUROPSYCHOPHARMACOL, V35, P2521, DOI 10.1038/npp.2010.117; Calfa G, 2012, HIPPOCAMPUS, V22, P1493, DOI 10.1002/hipo.20990; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; da Silva PF, 2012, NEUROSCIENCE, V200, P42, DOI 10.1016/j.neuroscience.2011.10.038; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fabianova K, 2014, BEHAV BRAIN RES, V265, P38, DOI 10.1016/j.bbr.2014.01.023; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fontan-Lozano A, 2008, MOL CELL NEUROSCI, V39, P193, DOI 10.1016/j.mcn.2008.06.009; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Holahan MR, 2004, BEHAV BRAIN RES, V152, P109, DOI 10.1016/j.bbr.2003.09.031; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Itzhak Y, 2012, NEUROBIOL LEARN MEM, V97, P409, DOI 10.1016/j.nlm.2012.03.005; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; KACZMAREK L, 1993, J NEUROSCI RES, V34, P377, DOI 10.1002/jnr.490340402; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Ming Z, 2001, BRAIN RES, V920, P117, DOI 10.1016/S0006-8993(01)03044-X; Misane I, 2013, BEHAV BRAIN RES, V238, P160, DOI 10.1016/j.bbr.2012.10.027; Murphy M, 2004, FRONT BIOSCI-LANDMRK, V9, P40, DOI 10.2741/1203; Neely KE, 2002, BBA-REV CANCER, V1603, P19, DOI 10.1016/S0304-419X(02)00067-7; Olney JW, 2004, TRENDS PHARMACOL SCI, V25, P135, DOI 10.1016/j.tips.2004.01.002; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Peter M, 2012, GENES BRAIN BEHAV, V11, P314, DOI 10.1111/j.1601-183X.2011.00761.x; Petrof I, 2010, BEHAV BRAIN RES, V211, P248, DOI 10.1016/j.bbr.2010.03.045; Radulovic J, 1998, J NEUROSCI, V18, P7452; Rahn EJ, 2013, NEUROBIOL LEARN MEM, V105, P133, DOI 10.1016/j.nlm.2013.06.008; Santin LJ, 2003, PHYSIOL BEHAV, V78, P733, DOI 10.1016/S0031-9384(03)00060-X; Stratmann G, 2010, ANESTHESIOLOGY, V112, P305, DOI 10.1097/ALN.0b013e3181ca33a1; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Zhang L, 2013, MINI-REV MED CHEM, V13, P1999, DOI 10.2174/13895575113136660102; Zhong T, 2014, BRIT J ANAESTH, V113, P634, DOI 10.1093/bja/aeu184	56	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125815	10.1371/journal.pone.0125815	http://dx.doi.org/10.1371/journal.pone.0125815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928815	Green Published, Green Submitted, gold			2022-12-26	WOS:000353713100119
J	Hardman, CA; Ferriday, D; Kyle, L; Rogers, PJ; Brunstrom, JM				Hardman, Charlotte A.; Ferriday, Danielle; Kyle, Lesley; Rogers, Peter J.; Brunstrom, Jeffrey M.			So Many Brands and Varieties to Choose from: Does This Compromise the Control of Food Intake in Humans?	PLOS ONE			English	Article							HIGH-INTENSITY SWEETENERS; CALORIC COMPENSATION; EXPECTED SATIETY; LOSS AVERSION; CHANGES EXPECTATIONS; SELF-REGULATION; PROSPECT-THEORY; PORTION-SIZE; SNACK FOODS; WEIGHT-GAIN	The recent rise in obesity is widely attributed to changes in the dietary environment (e.g., increased availability of energy-dense foods and larger portion sizes). However, a critical feature of our "obesogenic environment" may have been overlooked - the dramatic increase in "dietary variability" (the tendency for specific mass-produced foods to be available in numerous varieties that differ in energy content). In this study we tested the hypothesis that dietary variability compromises the control of food intake in humans. Specifically, we examined the effects of dietary variability in pepperoni pizza on two key outcome variables; i) compensation for calories in pepperoni pizza and ii) expectations about the satiating properties of pepperoni pizza (expected satiation). We reasoned that dietary variability might generate uncertainty about the postingestive effects of a food. An internet-based questionnaire was completed by 199 adults. This revealed substantial variation in exposure to different varieties of pepperoni pizza. In a follow-up study (n=66; 65% female), high pizza variability was associated with i) poorer compensation for calories in pepperoni pizza and ii) lower expected satiation for pepperoni pizza. Furthermore, the effect of uncertainty on caloric compensation was moderated by individual differences in decision making (loss aversion). For the first time, these findings highlight a process by which dietary variability may compromise food-intake control in humans. This is important because it exposes a new feature of Western diets (processed foods in particular) that might contribute to overeating and obesity.	[Hardman, Charlotte A.] Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England; [Ferriday, Danielle; Kyle, Lesley; Rogers, Peter J.; Brunstrom, Jeffrey M.] Univ Bristol, Sch Expt Psychol, Nutr & Behav Unit, Bristol, Avon, England	University of Liverpool; University of Bristol	Brunstrom, JM (corresponding author), Univ Bristol, Sch Expt Psychol, Nutr & Behav Unit, Bristol, Avon, England.	Jeff.Brunstrom@bristol.ac.uk	Brunstrom, Jeffrey M/C-7892-2009; Brunstrom, Jeff/AAS-3433-2021	Brunstrom, Jeffrey M/0000-0003-4657-7799; Brunstrom, Jeff/0000-0003-4657-7799; Ferriday, Dani/0000-0003-2665-0055	Biotechnology and Biological Sciences Research Council (United Kingdom) [BB/I012370/1]; European Union [607310]; BBSRC [BB/I012370/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I012370/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a grant from the Biotechnology and Biological Sciences Research Council (United Kingdom), grant number: BB/I012370/1. JMB and PJR's research is supported by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 607310 (Nudge-it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almiron-Roig E, 2013, NUTR REV, V71, P458, DOI 10.1111/nure.12048; Anderson LR, 2008, J HEALTH ECON, V27, P1260, DOI 10.1016/j.jhealeco.2008.05.011; Barkley-Levenson EE, 2013, DEV COGN NEUROS-NETH, V3, P72, DOI 10.1016/j.dcn.2012.09.007; BIRCH LL, 1986, APPETITE, V7, P323, DOI 10.1016/S0195-6663(86)80001-0; BIRCH LL, 1985, LEARN MOTIV, V16, P341, DOI 10.1016/0023-9690(85)90020-7; Brunstrom JM, 2008, APPETITE, V51, P604, DOI 10.1016/j.appet.2008.04.017; Brunstrom JM, 2007, APPETITE, V49, P268, DOI 10.1016/j.appet.2006.11.007; Brunstrom JM, 2011, P NUTR SOC, V70, P155, DOI 10.1017/S002966511000491X; Brunstrom JM, 2010, APPETITE, V54, P587, DOI 10.1016/j.appet.2010.01.015; Brunstrom JM, 2009, OBESITY, V17, P1884, DOI 10.1038/oby.2009.201; Brunstrom JM, 2009, APPETITE, V52, P108, DOI 10.1016/j.appet.2008.09.002; Brunstrom JM, 2005, PHYSIOL BEHAV, V85, P57, DOI 10.1016/j.physbeh.2005.04.004; Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; Davidson TL, 2005, OBES RES, V13, P537, DOI 10.1038/oby.2005.57; Davidson TL, 2004, INT J OBESITY, V28, P933, DOI 10.1038/sj.ijo.0802660; De Martino B, 2010, P NATL ACAD SCI USA, V107, P3788, DOI 10.1073/pnas.0910230107; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Fay SH, 2011, APPETITE, V56, P284, DOI 10.1016/j.appet.2011.01.006; Gallo A. E., 1997, FoodReview, V20, P33; Hardman CA, 2011, AM J CLIN NUTR, V94, P1196, DOI 10.3945/ajcn.111.016873; HEATHERTON TF, 1988, J ABNORM PSYCHOL, V97, P19, DOI 10.1037/0021-843X.97.1.19; Hinton EC, 2013, APPETITE, V63, P31, DOI 10.1016/j.appet.2012.12.008; JOHNSON SL, 1994, PEDIATRICS, V94, P653; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LOOY H, 1992, PHYSIOL BEHAV, V52, P219, DOI 10.1016/0031-9384(92)90261-Y; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McCrickerd K., 2012, FLAVOUR SCI RECENT D, V1, P20, DOI [DOI 10.1186/2044-7248-1-20, 10.1186/2044-7248-1-20]; Oldham-Cooper RE, 2011, AM J CLIN NUTR, V93, P308, DOI 10.3945/ajcn.110.004580; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Ruel M.T., 2002, IS DIETARY DIVERSITY; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swithers SE, 2006, INT J OBESITY, V30, P1685, DOI 10.1038/sj.ijo.0803329; Swithers SE, 2008, BEHAV NEUROSCI, V122, P161, DOI 10.1037/0735-7044.122.1.161; Swithers SE, 2012, BEHAV BRAIN RES, V233, P1, DOI 10.1016/j.bbr.2012.04.024; Swithers SE, 2011, BEHAV NEUROSCI, V125, P512, DOI 10.1037/a0024404; Swithers SE, 2010, PHYSIOL BEHAV, V100, P55, DOI 10.1016/j.physbeh.2009.12.021; Swithers SE, 2009, BEHAV NEUROSCI, V123, P772, DOI 10.1037/a0016139; Teff KL, 2011, PHYSIOL BEHAV, V103, P44, DOI 10.1016/j.physbeh.2011.01.012; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Van Praag BMS, 2003, RISK AVERSION SUBJEC; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Wilkinson LL, 2012, APPETITE, V59, P933, DOI 10.1016/j.appet.2012.09.007; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; WOODS SC, 1991, PSYCHOL REV, V98, P488, DOI 10.1037/0033-295X.98.4.488; Yeomans MR, 2014, BRIT J NUTR, V111, P1137, DOI 10.1017/S0007114513003474; Yeomans MR, 2011, AM J CLIN NUTR, V94, P1410, DOI 10.3945/ajcn.111.011650; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246	54	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125869	10.1371/journal.pone.0125869	http://dx.doi.org/10.1371/journal.pone.0125869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0LO	25923118	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600167
J	Hong, D; Li, LF; Gao, HC; Wang, X; Li, CC; Luo, Y; Bai, YP; Zhang, GG				Hong, Dan; Li, Ling-Fang; Gao, Hai-Chao; Wang, Xiang; Li, Chuan-Chang; Luo, Ying; Bai, Yong-Ping; Zhang, Guo-Gang			High-Density Lipoprotein Prevents Endoplasmic Reticulum Stress-Induced Downregulation of Liver LOX-1 Expression	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; APOPTOSIS; ER	Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a specific cell-surface receptor for oxidized-low-density lipoprotein (ox-LDL). The impact of high-density lipoprotein (HDL) on endoplasmic reticulum (ER) stress-mediated alteration of the LOX-1 level in hepatocytes remains unclear. We aimed to investigate the impact on LOX-1 expression by tunicamycin (TM)-induced ER stress and to determine the effect of HDL on TM-affected LOX-1 expression in hepatic L02 cells. Overexpression or silencing of related cellular genes was conducted in TM-treated cells. mRNA expression was evaluated using real-time polymerase chain reaction (PCR). Protein expression was analyzed by western blot and immunocytochemistry. Lipid uptake was examined by DiI-ox-LDL, followed by flow cytometric analysis. The results showed that TM induced the upregulation of ER chaperone GRP78, downregulation of LOX-1 expression, and lipid uptake. Knock down of IRE1 or XBP-1 effectively restored LOX-1 expression and improved lipid uptake in TM-treated cells. HDL treatment prevented the negative impact on LOX-1 expression and lipid uptake induced by TM. Additionally, 1-10 mu g/mL HDL significantly reduced the GRP78, IRE1, and XBP-1 expression levels in TM-treated cells. Our findings reveal that HDL could prevent the TM-induced reduction of LOX-1 expression via inhibiting the IRE1/XBP-1 pathway, suggesting a new mechanism for beneficial roles of HDL in improving lipid metabolism.	[Hong, Dan; Li, Ling-Fang; Wang, Xiang; Zhang, Guo-Gang] Cent S Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China; [Gao, Hai-Chao] Chengde Med Coll, Affiliated Hosp, Dept Cardiovasc Med, Chengde, Hebei, Peoples R China; [Li, Chuan-Chang; Luo, Ying; Bai, Yong-Ping] Cent S Univ, Xiangya Hosp, Dept Geriatr Med, Changsha, Hunan, Peoples R China	Central South University; Chengde Medical University; Central South University	Bai, YP (corresponding author), Cent S Univ, Xiangya Hosp, Dept Geriatr Med, Changsha, Hunan, Peoples R China.	baiyongping200613@163.com; xyzgg2006@sina.com	yongping, Bai/HHZ-4785-2022		National Natural Science Foundation of China [81100089, 81170261]; Central South University Doctor's Innovation Project [2013zzts090]; China Postdoctoral Science Foundation [2012M521566]; 973 Program [2014CB542402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central South University Doctor's Innovation Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 973 Program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (No. 81100089 and No. 81170261) and the Central South University Doctor's Innovation Project (No. 2013zzts090). This project was also supported by the China Postdoctoral Science Foundation (No. 2012M521566) and 973 Program (No. 2014CB542402).	Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Assmann G, 2003, ANNU REV MED, V54, P321, DOI 10.1146/annurev.med.54.101601.152409; Chen XP, 2007, VASC PHARMACOL, V47, P1, DOI 10.1016/j.vph.2007.01.004; Cherng YG, 2008, J ORTHOP RES, V26, P1018, DOI 10.1002/jor.20578; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Hong D, 2014, ATHEROSCLEROSIS, V235, P310, DOI 10.1016/j.atherosclerosis.2014.04.028; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Ishiyama J, 2011, J LIPID RES, V52, P299, DOI 10.1194/jlr.m007104; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8; Muller C, 2011, CELL DEATH DIFFER, V18, P817, DOI 10.1038/cdd.2010.149; Muller C, 2011, AUTOPHAGY, V7, P541, DOI 10.4161/auto.7.5.15003; Musso G, 2011, AM J CLIN NUTR, V94, P1033, DOI 10.3945/ajcn.111.015610; Niculescu LS, 2013, BIOCHEM BIOPH RES CO, V434, P173, DOI 10.1016/j.bbrc.2013.03.050; Petremand J, 2012, DIABETES, V61, P1100, DOI 10.2337/db11-1221; Pirillo A, 2012, BIOCHEM BIOPH RES CO, V428, P230, DOI 10.1016/j.bbrc.2012.10.020; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Terpstra V, 2000, ARTERIOSCL THROM VAS, V20, P1860, DOI 10.1161/01.ATV.20.8.1860; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Yan ML, 2011, CARDIOVASC DRUG THER, V25, P469, DOI 10.1007/s10557-011-6335-3; Yoshimoto R, 2011, CARDIOVASC DRUG THER, V25, P379, DOI 10.1007/s10557-011-6324-6; Zhang Q, 2014, J MOL ENDOCRINOL, V53, P281, DOI 10.1530/JME-14-0049	24	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124285	10.1371/journal.pone.0124285	http://dx.doi.org/10.1371/journal.pone.0124285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923692	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600076
J	Ishikawa, S; Okamoto, S; Isogai, K; Akiyama, Y; Yanagihara, N; Yamada, Y				Ishikawa, Shun; Okamoto, Shogo; Isogai, Kaoru; Akiyama, Yasuhiro; Yanagihara, Naomi; Yamada, Yoji			Assessment of Robotic Patient Simulators for Training in Manual Physical Therapy Examination Techniques	PLOS ONE			English	Article							STRETCH REFLEX THRESHOLD; MODIFIED ASHWORTH SCALES; HAPTIC ELBOW SPASTICITY; LEG-ROBOT; RELIABILITY; ACCURACY; CHILDREN; HESS	Robots that simulate patients suffering from joint resistance caused by biomechanical and neural impairments are used to aid the training of physical therapists in manual examination techniques. However, there are few methods for assessing such robots. This article proposes two types of assessment measures based on typical judgments of clinicians. One of the measures involves the evaluation of how well the simulator presents different severities of a specified disease. Experienced clinicians were requested to rate the simulated symptoms in terms of severity, and the consistency of their ratings was used as a performance measure. The other measure involves the evaluation of how well the simulator presents different types of symptoms. In this case, the clinicians were requested to classify the simulated resistances in terms of symptom type, and the average ratios of their answers were used as performance measures. For both types of assessment measures, a higher index implied higher agreement among the experienced clinicians that subjectively assessed the symptoms based on typical symptom features. We applied these two assessment methods to a patient knee robot and achieved positive appraisals. The assessment measures have potential for use in comparing several patient simulators for training physical therapists, rather than as absolute indices for developing a standard.	[Ishikawa, Shun; Okamoto, Shogo; Akiyama, Yasuhiro; Yamada, Yoji] Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Nagoya, Aichi 4648601, Japan; [Isogai, Kaoru] Tokoha Univ, Fac Hlth & Med Sci, Dept Phys Therapy, Hamamatsu, Shizuoka, Japan; [Yanagihara, Naomi] Nagoya Univ, Grad Sch Med, Dept Phys & Occupat Therapy, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Okamoto, S (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Nagoya, Aichi 4648601, Japan.	okamoto-shogo@nagoya-u.jp	Akiyama, Yasuhiro/AAV-6248-2021	Akiyama, Yasuhiro/0000-0002-4169-3734	Naito Science & Engineering Foundation	Naito Science & Engineering Foundation	This work was supported by Naito Science & Engineering Foundation (no grant number), http://www.naitozaidan.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohannon R. W., 1987, PHYS THER, V67, P206; Calota A, 2008, CLIN NEUROPHYSIOL, V119, P2329, DOI 10.1016/j.clinph.2008.07.215; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Fleuren JF, 2009, JOURNAL OF NEUROLOGY, V81, P1; Fujisawa T, 2007, INT C REHAB ROBOT, P48, DOI 10.1109/ICORR.2007.4428405; Grow DI, 2008, SYMPOSIUM ON HAPTICS INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS 2008, PROCEEDINGS, P475; Ishikawa S., 2012, Proceedings of the 2012 IEEE International Conference on Robotics and Biomimetics (ROBIO), P1409, DOI 10.1109/ROBIO.2012.6491166; Ishikawa S, 2013, 2013 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION (SII), P300, DOI 10.1109/SII.2013.6776731; Jobin A, 2000, DEV MED CHILD NEUROL, V42, P531, DOI 10.1017/S0012162200001018; Kaya T, 2011, INT J REHABIL RES, V34, P59, DOI 10.1097/MRR.0b013e32833d6cdf; Kikuchi T, 2010, J INTEL MAT SYST STR, V21, P1523, DOI 10.1177/1045389X10367838; Kikuchi T, 2010, ADV ROBOTICS, V24, P671, DOI 10.1163/016918610X493534; Kim J, 2011, IEEE ENG MED BIO, P8527, DOI 10.1109/IEMBS.2011.6092104; McCrea PH, 2003, J NEUROSCI METH, V128, P121, DOI 10.1016/S0165-0270(03)00169-9; Mehrholz J, 2005, CLIN REHABIL, V19, P751, DOI 10.1191/0269215505cr889oa; Mehrholz J, 2005, CLIN REHABIL, V19, P63, DOI 10.1191/0269215505cr824oa; Morita Y, 2011, P INT WORKSH ROB MOT, P393; Mouri T, 2008, J ROBOT MECHATRON, V20, P280, DOI 10.20965/jrm.2008.p0280; Mutlu A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-44; Okumura H, 2013, PROC SICE ANN CONF, P2272; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Park HS, 2012, IEEE T NEUR SYS REH, V20, P361, DOI 10.1109/TNSRE.2012.2195330; POWERS RK, 1988, ANN NEUROL, V23, P115, DOI 10.1002/ana.410230203; Stebbins GT, 1998, MOVEMENT DISORD, V13, P633, DOI 10.1002/mds.870130404; Takhashi Y., 2011, P IEEE INT C REH ROB, P1; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991; Wakura S, 2006, Patient simulating robot for rehabilitation education and rehabilitation education method, Patent No. [JP2006204832 (A), 2006204832]; Wissel J, 2013, NEUROLOGY, V80, pS13, DOI 10.1212/WNL.0b013e3182762448	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0126392	10.1371/journal.pone.0126392	http://dx.doi.org/10.1371/journal.pone.0126392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923719	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600174
J	Martinez, A; Sese, M; Losa, JH; Robichaud, N; Sonenberg, N; Aasen, T; Cajal, SRY				Martinez, Alba; Sese, Marta; Hernandez Losa, Javier; Robichaud, Nathaniel; Sonenberg, Nahum; Aasen, Trond; Ramon y Cajal, Santiago			Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches	PLOS ONE			English	Article							INITIATION-FACTOR 4E; CAP-BINDING PROTEIN; MAMMARY EPITHELIAL-CELLS; TRANSLATION FACTOR EIF4E; MESSENGER-RNA; BREAST-CANCER; MALIGNANT-TRANSFORMATION; 4E-BINDING PROTEIN-1; FACTOR EIF-4E; SURVIVAL	Phosphorylation of the eukaryotic translation initiation factor eIF4E is associated with malignant progression and poor cancer prognosis. Accordingly, here we have analyzed the association between eIF4E phosphorylation and cellular resistance to oxidative stress, starvation, and DNA-damaging agents in vitro. Using immortalized and cancer cell lines, retroviral expression of a phosphomimetic (S209D) form of eIF4E, but not phospho-dead (S209A) eIF4E or GFP control, significantly increased cellular resistance to stress induced by DNA-damaging agents (cisplatin), starvation (glucose+glutamine withdrawal), and oxidative stress (arsenite). De novo accumulation of eIF4E-containing cytoplasmic bodies colocalizing with the eIF4E-binding protein 4E-T was observed after expression of phosphomimetic S209D, but not S209A or wild-type eIF4E. Increased resistance to cellular stress induced by eIF4E-S209D was lost upon knockdown of endogenous 4E-T or use of an eIF4E-W73A-S209D mutant unable to bind 4E-T. Cancer cells treated with the Mnk1/2 inhibitor CGP57380 to prevent eIF4E phosphorylation and mouse embryonic fibroblasts derived from Mnk1/2 knockout mice were also more sensitive to arsenite and cisplatin treatment. Polysome analysis revealed an 80S peak 2 hours after arsenite treatment in cells over-expressing phosphomimetic eIF4E, indicating translational stalling. Nonetheless, a selective increase was observed in the synthesis of some proteins (cyclin D1, HuR, and Mcl-1). We conclude that phosphorylation of eIF4E confers resistance to various cell stressors and that a direct interaction or regulation of 4E-T by eIF4E is required. Further delineation of this process may identify novel therapeutic avenues for cancer treatment, and these results support the use of modern Mnk1/2 inhibitors in conjunction with standard therapy.	[Martinez, Alba; Sese, Marta; Aasen, Trond; Ramon y Cajal, Santiago] Univ Autonoma Barcelona, VHIR, Hosp Univ Vall Hebron, Mol Pathol, E-08193 Barcelona, Spain; [Hernandez Losa, Javier; Ramon y Cajal, Santiago] Vall Hebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Robichaud, Nathaniel; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ, Canada	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; McGill University	Aasen, T (corresponding author), Univ Autonoma Barcelona, VHIR, Hosp Univ Vall Hebron, Mol Pathol, E-08193 Barcelona, Spain.	trond.aasen@vhir.org; sramon@vhebron.net	Aasen, Trond/B-5279-2013; Ramon y Cajal, Santiago/H-4955-2016; Javier, Hernandez Losa/C-1173-2008; Sese, Marta/AAH-9749-2021	Aasen, Trond/0000-0003-0763-2695; Ramon y Cajal, Santiago/0000-0002-3867-1390; Javier, Hernandez Losa/0000-0003-1526-3201; Sese, Marta/0000-0003-1473-4833; Robichaud, Nathaniel/0000-0002-7653-0767	Fondo de Investigaciones Sanitarias [PI 11/00185, RD09/0076/00066]; Mutua Madrilena [FMMA/2011/11]; Redes Tematicas de Investigacion Cooperativa en Salud [RD06/0020/0104]; Generalitat de Catalunya [2009SGR756]; Instituto de Salud Carlos III [CP10/00624]; European Regional Development Fund (ERDF) [PI13/00763]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Mutua Madrilena; Redes Tematicas de Investigacion Cooperativa en Salud; Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission)	SRC is funded by the following grants: Fondo de Investigaciones Sanitarias (PI 11/00185, RD09/0076/00066), Mutua Madrilena (FMMA/2011/11), Redes Tematicas de Investigacion Cooperativa en Salud (Ref. RD06/0020/0104), and Generalitat de Catalunya (Ref. 2009SGR756). TA is funded by Instituto de Salud Carlos III, grant CP10/00624 and grant PI13/00763 co-financed by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Cargnello M, 2012, MOL CELL BIOL, V32, P4572, DOI 10.1128/MCB.00544-12; Castellvi J, 2006, CANCER-AM CANCER SOC, V107, P1801, DOI 10.1002/cncr.22195; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; Dong K, 2009, BREAST CANCER RES TR, V113, P443, DOI 10.1007/s10549-008-9956-x; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Duncan RF, 2003, BIOCHEM J, V369, P213, DOI 10.1042/BJ20020435; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Fraser CS, 1999, BIOCHEM J, V342, P519, DOI 10.1042/0264-6021:3420519; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Hong DS, 2011, CLIN CANCER RES, V17, P6582, DOI 10.1158/1078-0432.CCR-11-0430; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; KEREKATTE V, 1995, INT J CANCER, V64, P27, DOI 10.1002/ijc.2910640107; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Kubacka D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072761; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; LAZARISKARATZAS A, 1992, GENE DEV, V6, P1631, DOI 10.1101/gad.6.9.1631; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Pons B, 2011, INT J ONCOL, V39, P1337, DOI 10.3892/ijo.2011.1118; Robichaud N, ONCOGENE; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Stead RL, 2013, FEBS LETT, V587, P2623, DOI 10.1016/j.febslet.2013.06.045; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Topisirovic I, 2009, MOL CELL BIOL, V29, P1152, DOI 10.1128/MCB.01532-08; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Volpon L, 2013, BIOCHEM BIOPH RES CO, V434, P614, DOI 10.1016/j.bbrc.2013.03.125; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wheater MJ, 2010, CANCER BIOL THER, V10, P728, DOI 10.4161/cbt.10.7.12965; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Zhou FF, 2011, MED ONCOL, V28, P1302, DOI 10.1007/s12032-010-9630-0	56	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123352	10.1371/journal.pone.0123352	http://dx.doi.org/10.1371/journal.pone.0123352			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923732	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600042
J	Nakanishi, T; Hasegawa, Y; Mimura, R; Wakayama, T; Uetoko, Y; Komori, H; Akanuma, S; Hosoya, K; Tamai, I				Nakanishi, Takeo; Hasegawa, Yoshitaka; Mimura, Reo; Wakayama, Tomohiko; Uetoko, Yuka; Komori, Hisakazu; Akanuma, Shin-ichi; Hosoya, Ken-ichi; Tamai, Ikumi			Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; KINASE C-DELTA; ALVEOLAR MACROPHAGES; CLEARANCE SYSTEM; GENE-EXPRESSION; IN-VIVO; FIBROBLAST; COLLAGEN; CELLS	Prostaglandin (PG) E-2 exhibits an anti-fibrotic effect in the lung in response to inflammatory reactions and is a high-affinity substrate of PG transporter (SLCO2A1). The present study aimed to evaluate the pathophysiological relevance of SLCO2A1 to bleomycin (BLM)-induced pulmonary fibrosis in mice. Immunohistochemical analysis indicated that Slco2a1 protein was expressed in airway and alveolar type I (ATI) and II (ATII) epithelial cells, and electron-microscopic immunohistochemistry further demonstrated cell surface expression of Slco2a1 in ATI cells in wild type (WT) C57BL/6 mice. PGE(2) uptake activity was abrogated in ATI-like cells from Slco2a1-deficient (Slco2a1(-/-)) mice, which was clearly observed in the cells from WT mice. Furthermore, the PGE(2) concentrations in lung tissues were lower in Slco2a1(-/-)than in WT mice. The pathological relevance of SLCO2A1 was further studied in mouse BLM-induced pulmonary fibrosis models. BLM (1 mg/kg) or vehicle (phosphate buffered saline) was intratracheally injected into WT and Slco2a1(-/-)mice, and BLM-induced fibrosis was evaluated on day 14. BLM induced more severe fibrosis in Slco2a1(-/-)than in WT mice, as indicated by thickened interstitial connective tissue and enhanced collagen deposition. PGE2 levels were higher in bronchoalveolar lavage fluid, but lower in lung tissues of Slco2a1(-/-)mice. Transcriptional upregulation of TGF-beta 1 was associated with enhanced gene transcriptions of downstream targets including plasminogen activator inhitor-1. Furthermore, Western blot analysis demonstrated a significant activation of protein kinase C (PKC) delta along with a modest activation of Smad3 in lung from Slco2a1(-/-)mice, suggesting a role of PKC delta associated with TGF-beta signaling in aggravated fibrosis in BLM-treated Slco2a1(-/-)mice. In conclusion, pulmonary PGE2 disposition is largely regulated by SLCO2A1, demonstrating that SLCO2A1 plays a critical role in protecting the lung from BLM-induced fibrosis.	[Nakanishi, Takeo; Hasegawa, Yoshitaka; Mimura, Reo; Uetoko, Yuka; Komori, Hisakazu; Tamai, Ikumi] Kanazawa Univ, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 920, Japan; [Wakayama, Tomohiko] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Akanuma, Shin-ichi; Hosoya, Ken-ichi] Toyama Univ, Dept Pharmaceut, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan	Kanazawa University; Kanazawa University; University of Toyama	Tamai, I (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 920, Japan.	tamai@p.kanazawa-u.ac.jp	Komori, Hisakazu/AAQ-2590-2020; Nakanishi, Takeo/C-3891-2015; TAMAI, Ikumi/D-8412-2015	Nakanishi, Takeo/0000-0002-6561-7138; Komori, Hisakazu/0000-0002-5159-0069	Ono Pharmaceutical Co., Ltd.	Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd)	This study was supported by a grant from Ono Pharmaceutical Co., Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Bao Y, 2002, AM J PHYSIOL-RENAL, V282, pF1103, DOI 10.1152/ajprenal.00152.2001; BAUM BJ, 1980, J BIOL CHEM, V255, P2843; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; Card JW, 2007, AM J RESP CELL MOL, V37, P300, DOI 10.1165/rcmb.2007-0057OC; CASEY ML, 1983, BIOCHEM BIOPH RES CO, V114, P1056, DOI 10.1016/0006-291X(83)90669-1; CHANDLER DB, 1990, CLIN CHEST MED, V11, P21; Chang HY, 2010, CIRCULATION, V121, P529, DOI 10.1161/CIRCULATIONAHA.109.862946; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Chuang PC, 2006, MOL CELL BIOL, V26, P8281, DOI 10.1128/MCB.00941-06; DENHOLM EM, 1990, J LEUKOCYTE BIOL, V48, P519, DOI 10.1002/jlb.48.6.519; Diggle CP, 2012, HUM MUTAT, V33, P1175, DOI 10.1002/humu.22111; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Gonzalez AM, 1996, PEDIATR RES, V39, P375, DOI 10.1203/00006450-199603000-00001; HEMPEL SL, 1994, J BIOL CHEM, V269, P32979; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Ikehata M, 2008, PHARM RES-DORDR, V25, P913, DOI 10.1007/s11095-007-9426-x; Jackson TA, 2001, MOL ENDOCRINOL, V15, P1517, DOI 10.1210/me.15.9.1517; Jimenez SA, 2001, J CLIN INVEST, V108, P1395, DOI 10.1172/JCI200112347; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; KING SL, 1994, J BIOL CHEM, V269, P13156; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Kraft ME, 2010, INVEST OPHTH VIS SCI, V51, P2504, DOI 10.1167/iovs.09-4290; Kucich U, 2000, ARCH BIOCHEM BIOPHYS, V374, P313, DOI 10.1006/abbi.1999.1625; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Lu R, 1996, J CLIN INVEST, V98, P1142, DOI 10.1172/JCI118897; Luzina IG, 2006, AM J RESP CELL MOL, V35, P298, DOI 10.1165/rcmb.2006-0033OC; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Mandery K, 2010, J PHARMACOL EXP THER, V332, P345, DOI 10.1124/jpet.109.154518; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Moore BB, 2005, J IMMUNOL, V174, P5644, DOI 10.4049/jimmunol.174.9.5644; Nakanishi T, 2013, J PHARM SCI-US, V102, P3373, DOI 10.1002/jps.23603; Nakanishi T, 2010, METHODS MOL BIOL, V637, P105, DOI 10.1007/978-1-60761-700-6_5; Nomura T, 2004, MOL PHARMACOL, V65, P973, DOI 10.1124/mol.65.4.973; Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066; OZAKI T, 1987, J APPL PHYSIOL, V62, P219, DOI 10.1152/jappl.1987.62.1.219; PHELPS DS, 1991, EXP LUNG RES, V17, P985, DOI 10.3109/01902149109064330; PIPER PJ, 1970, NATURE, V225, P600, DOI 10.1038/225600a0; Pucci ML, 1999, AM J PHYSIOL-REG I, V277, pR734, DOI 10.1152/ajpregu.1999.277.3.R734; Richards RJ, 1987, LUNG, V165, P3; Sakai Yoshitada, 2001, Kobe Journal of Medical Sciences, V47, P35; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seifert W, 2012, HUM MUTAT, V33, P660, DOI 10.1002/humu.22042; Sheller JR, 2000, J APPL PHYSIOL, V88, P2214, DOI 10.1152/jappl.2000.88.6.2214; Shirasaka Y, 2013, J ENDOCRINOL, V217, P265, DOI 10.1530/JOE-12-0339; Sleijfer S, 2001, CHEST, V120, P617, DOI 10.1378/chest.120.2.617; Tachikawa M, 2012, J PHARMACOL EXP THER, V343, P608, DOI 10.1124/jpet.112.197012; Tachikawa M, 2012, J NEUROCHEM, V123, P750, DOI 10.1111/jnc.12018; Topper JN, 1998, CIRCULATION, V98, P2396, DOI 10.1161/01.CIR.98.22.2396; Wakayama T, 2003, BIOL REPROD, V68, P1755, DOI 10.1095/biolreprod.102.012344; WARDLAW AJ, 1989, J ALLERGY CLIN IMMUN, V84, P19, DOI 10.1016/0091-6749(89)90173-5; Zhou BY, 2007, AM J PHYSIOL-CELL PH, V292, pC1280, DOI 10.1152/ajpcell.00070.2006	58	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123895	10.1371/journal.pone.0123895	http://dx.doi.org/10.1371/journal.pone.0123895			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923111	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600059
J	Posthumus, EE; Koprowski, JL; Steidl, RJ				Posthumus, Erin E.; Koprowski, John L.; Steidl, Robert J.			Red Squirrel Middens Influence Abundance but Not Diversity of Other Vertebrates	PLOS ONE			English	Article							POPULATION; COMMUNITY; HABITAT; PRAIRIE; SITES; BIODIVERSITY; RESPONSES; MAMMALS; MARTEN; PLANT	Some animals modify the environment in ways that can influence the resources available to other species. Because red squirrels (Tamiasciurus hudsonicus) create large piles of conifer-cone debris (middens) in which they store cones, squirrels concentrate resources that might affect biodiversity locally. To determine whether other animals are attracted to midden sites beyond their affinity for the same resources that attract red squirrels, we assessed associations between middens, mammals, and birds at population and community levels. We surveyed 75 middens where residency rates of red squirrels varied during the previous five years; sampling along this residency gradient permitted us to evaluate the influence of resources at middens beyond the influence of a resident squirrel. At each location, we quantified vegetation, landscape structure, abundance of conifer cones, and midden structure, and used capture-recapture, distance sampling, and remote cameras to quantify presence, abundance, and species richness of mammals and birds. Red squirrels and the resources they concentrated at middens influenced mammals and birds at the population scale and to a lesser extent at the community scale. At middens with higher residency rates of red squirrels, richness of medium and large mammals increased markedly and species richness of birds increased slightly. After accounting for local forest characteristics, however, only species richness of medium-to-large mammals was associated with a red squirrel being resident during surveys. In areas where red squirrels were resident during surveys or in areas with greater amounts of resources concentrated by red squirrels, abundances of two of four small mammal species and two of four bird species increased. We conclude that the presence of this ecosystem modifier and the resources it concentrates influence abundance of some mammals and birds, which may have implications for maintaining biodiversity across the wide geographic range inhabited by red squirrels and other larderhoarding animals.	[Posthumus, Erin E.; Koprowski, John L.; Steidl, Robert J.] Univ Arizona, Sch Nat Resources & Environm, Wildlife & Fisheries Sci, Tucson, AZ 85721 USA	University of Arizona	Posthumus, EE (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Wildlife & Fisheries Sci, Tucson, AZ 85721 USA.	eposthum@email.arizona.edu		Koprowski, John/0000-0003-1406-9853	United States Forest Service Rocky Mountain Research Station (University of Arizona) [10-JV-188]; T&E Incorporated's Grants for Conservation Research; American Society of Mammalogists' Grants-in-Aid Program	United States Forest Service Rocky Mountain Research Station (University of Arizona); T&E Incorporated's Grants for Conservation Research; American Society of Mammalogists' Grants-in-Aid Program	This work was supported by the United States Forest Service Rocky Mountain Research Station, #10-JV-188 (University of Arizona; www.fs.fed.us/rmrs); T&E Incorporated's Grants for Conservation Research (www.tandeinc.com); and the American Society of Mammalogists' Grants-in-Aid Program (http://www.mammalsociety.org/committees/grants-aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARANTHUS M, 1994, CAN J FOREST RES, V24, P2157, DOI 10.1139/x94-278; ANDERSON DR, 1983, ECOLOGY, V64, P674, DOI 10.2307/1937188; Azeria ET, 2009, GLOBAL ECOL BIOGEOGR, V18, P333, DOI 10.1111/j.1466-8238.2009.00454.x; BUSKIRK SW, 1984, J WILDLIFE MANAGE, V48, P950, DOI 10.2307/3801445; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CAREY AB, 1995, ECOL APPL, V5, P336, DOI 10.2307/1942026; Cottee-Jones H.E.W., 2012, FRONTIERS BIOGEOGRAP, V4, P117, DOI DOI 10.21425/F54312533; Edelman AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030914; Edelman Andrew J., 2005, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V36, P395; Elphick Chris, 2001, SIBLEY GUIDE BIRD LI; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Fauteux D, 2012, FOREST ECOL MANAG, V266, P194, DOI 10.1016/j.foreco.2011.11.020; FINLEY RB, 1969, MISCELLANEOUS PUBLIC, V51, P233; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fitzpatrick LA, 1993, MOUNT GRAHAM RED SQU; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GURNELL J, 1984, ANIM BEHAV, V32, P1119, DOI 10.1016/S0003-3472(84)80228-6; Gurnell J, 1987, NATURAL HIST SQUIRRE; HART E B, 1992, Mammalian Species, P1, DOI 10.2307/3504238; Hastings KK, 2002, FISH B-NOAA, V100, P51; Hoffmeister D. F., 1986, MAMMALS ARIZONA; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kendall K.C., 1983, BEARS BIOL MANAG, V5, P166, DOI [10.2307/3872534, DOI 10.2307/3872534]; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Koprowski John L., 2008, Endangered Species Research, V4, P227, DOI 10.3354/esr00026; Kotliar NB, 2000, CONSERV BIOL, V14, P1715, DOI 10.1111/j.1523-1739.2000.98384.x; Kotliar NB, 1999, ENVIRON MANAGE, V24, P177, DOI 10.1007/s002679900225; Lee SD, 2004, POL J ECOL, V52, P55; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Mattson DJ, 1997, J APPL ECOL, V34, P926, DOI 10.2307/2405283; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McDiarmid RW, 1996, MEASURING MONITORING, P55; Merrick MJ, 2007, J WILDLIFE MANAGE, V71, P1958, DOI 10.2193/2006-260; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; NAIMAN RJ, 1986, ECOLOGY, V67, P1254, DOI 10.2307/1938681; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patton D. R., 1986, Western Journal of Applied Forestry, V1, P48; Pearson DE, 2001, CAN J ZOOL, V79, P1372, DOI 10.1139/cjz-79-8-1372; PLATT WJ, 1975, ECOL MONOGR, V45, P285, DOI 10.2307/1942425; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Prugh LR, 2012, J ANIM ECOL, V81, P667, DOI 10.1111/j.1365-2656.2011.01930.x; Ralph C.J., 1993, PSWGTR144WWW USDA; Ramsey F. L., 2002, STAT SLEUTH COURSE M; Romero GQ, 2015, BIOL REV, V90, P877, DOI 10.1111/brv.12138; Sanderson H.R., 2009, LAST REFUGE MT GRAHA; Schauffert CA, 2002, SOUTHWEST NAT, V47, P498, DOI 10.2307/3672515; SHERBURNE SS, 1993, AM MIDL NAT, V129, P204, DOI 10.2307/2426449; SMITH AA, 1994, J WILDLIFE MANAGE, V58, P437, DOI 10.2307/3809314; Steele Michael A., 1998, Mammalian Species, V586, P1; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Whitford WG, 2010, J ARID ENVIRON, V74, P1450, DOI 10.1016/j.jaridenv.2010.05.025; Zugmeyer CA, 2009, J MAMMAL, V90, P175, DOI 10.1644/07-MAMM-A-399.1	53	8	8	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123633	10.1371/journal.pone.0123633	http://dx.doi.org/10.1371/journal.pone.0123633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923695	gold, Green Published			2022-12-26	WOS:000353711600053
J	Subramaniam, R; Hillberry, Z; Chen, H; Feng, Y; Fletcher, K; Neuenschwander, P; Shams, H				Subramaniam, Renuka; Hillberry, Zachary; Chen, Han; Feng, Yan; Fletcher, Kalyn; Neuenschwander, Pierre; Shams, Homayoun			Delivery of GM-CSF to Protect against Influenza Pneumonia	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PULMONARY ALVEOLAR PROTEINOSIS; GRANULOCYTE-MACROPHAGE; RHGM-CSF; PEGYLATED INTERFERONS; DENDRITIC CELLS; DEFICIENT MICE; MURINE MODEL; LUNG; RESPONSES	Background Since adaptive immunity is thought to be central to immunity against influenza A virus (IAV) pneumonias, preventive strategies have focused primarily on vaccines. However, vaccine efficacy has been variable, in part because of antigenic shift and drift in circulating influenza viruses. Recent studies have highlighted the importance of innate immunity in protecting against influenza. Methods Granulocyte-macrophage colony stimulating factor (GM-CSF) contributes to maturation of mononuclear phagocytes, enhancing their capacity for phagocytosis and cytokine production. Results Overexpression of granulocyte macrophage-colony stimulating factor (GM-CSF) in the lung of transgenic mice provides remarkable protection against IAV, which depends on alveolar macrophages (AM). In this study, we report that pulmonary delivery of GM-CSF to wild type young and aged mice abrogated mortality from IAV. Conclusion We also demonstrate that protection is species specific and human GM-CSF do not protect the mice nor stimulates mouse immunity. We also show that IAV-induced lung injury is the culprit for side-effects of GM-CSF in treating mice after IAV infection, and introduce a novel strategy to deliver the GM-CSF to and retain it in the alveolar space even after IAV infection.	[Subramaniam, Renuka; Hillberry, Zachary; Chen, Han; Feng, Yan; Fletcher, Kalyn; Shams, Homayoun] Univ Texas Hlth Sci Ctr Tyler, Ctr Pulm & Infect Dis Control, Tyler, TX 75708 USA; [Neuenschwander, Pierre] Univ Texas Hlth Sci Ctr Tyler, Biomed Res, Tyler, TX USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Shams, H (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Ctr Pulm & Infect Dis Control, 11937 US Highway 271, Tyler, TX 75708 USA.	homayoun.shams@uthct.edu			Flight Attendant Medical Research Institute [092015, 123020]	Flight Attendant Medical Research Institute	The authors have no additional financial interests. This work was in part supported by grants to H. Shams from the Flight Attendant Medical Research Institute (092015-Clinical Innovator Award and 123020-Clinical Innovator Award). H. Shams is the inventor of two pending patents filed by the Board of Regents, The University of Texas System, for use of GM-CSF to prevent influenza and its secondary bacterial pneumonia.	Aghemo A, 2010, NAT REV GASTRO HEPAT, V7, P485, DOI 10.1038/nrgastro.2010.101; CANTRELL MA, 1985, P NATL ACAD SCI USA, V82, P6250, DOI 10.1073/pnas.82.18.6250; Cates EC, 2003, J ALLERGY CLIN IMMUN, V111, P1076, DOI 10.1067/mai.2003.1460; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Craxi A, 2003, ANTIVIR RES, V60, P87, DOI 10.1016/j.antiviral.2003.08.015; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; DIEDERICHS K, 1991, SCIENCE, V254, P1779, DOI 10.1126/science.1837174; Frasca D, 2014, CURR OPIN IMMUNOL, V29, P112, DOI 10.1016/j.coi.2014.05.008; Frasca D, 2010, VACCINE, V28, P8077, DOI 10.1016/j.vaccine.2010.10.023; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Guo JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034681; Herold S, 2014, AM J RESP CRIT CARE, V189, P609, DOI 10.1164/rccm.201311-2041LE; Hofer M, 2005, PHYSIOL RES, V54, P207, DOI 10.33549/physiolres.930606; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Huang H, 2010, CYTOKINE, V51, P151, DOI 10.1016/j.cyto.2010.04.001; Huffman JA, 1996, J CLIN INVEST, V97, P649, DOI 10.1172/JCI118461; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; KAUSHANSKY K, 1988, J CLIN INVEST, V81, P92, DOI 10.1172/JCI113316; KAUSHANSKY K, 1989, P NATL ACAD SCI USA, V86, P1213, DOI 10.1073/pnas.86.4.1213; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu WM, 2011, HUM VACCINES, V7, P94, DOI 10.4161/hv.7.0.14568; McClure B, 2001, BLOOD, V98, P3165, DOI 10.1182/blood.V98.10.3165; METCALF D, 1986, BLOOD, V67, P257; MIYATAKE S, 1985, EMBO J, V4, P2561, DOI 10.1002/j.1460-2075.1985.tb03971.x; Nishijima I, 1997, HUMAN GRANULOCYTE MA; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; Paine R, 2012, CRIT CARE MED, V40, P90, DOI 10.1097/CCM.0b013e31822d7bf0; Reed JA, 1999, AM J PHYSIOL-LUNG C, V276, pL556, DOI 10.1152/ajplung.1999.276.4.L556; Reed JAH, 1997, AM J PHYSIOL-LUNG C, V273, pL715, DOI 10.1152/ajplung.1997.273.4.L715; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; SHANAFELT AB, 1989, P NATL ACAD SCI USA, V86, P4872, DOI 10.1073/pnas.86.13.4872; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Su YC, 2008, J IMMUNOL, V180, P2600, DOI 10.4049/jimmunol.180.4.2600; Subramaniam R, 2014, J INFECT DIS, V209, P1827, DOI 10.1093/infdis/jit830; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Tazawa R, 2005, AM J RESP CRIT CARE, V171, P1142, DOI 10.1164/rccm.200406-716OC; Tazawa R, 2014, CHEST, V145, P729, DOI 10.1378/chest.13-0603; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Trilla A, 2008, CLIN INFECT DIS, V47, P668, DOI 10.1086/590567; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139; Xue RY, 2012, TRANSGENIC RES, V21, P101, DOI 10.1007/s11248-011-9513-y; Yamashita N, 2002, CELL IMMUNOL, V219, P92, DOI 10.1016/S0008-8749(02)00565-8; Yu CH, 2011, BIOL RES NURS, V13, P32, DOI 10.1177/1099800410378160; Zhang YZ, 2006, EUR J PHARM SCI, V28, P212, DOI 10.1016/j.ejps.2006.02.014	46	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124593	10.1371/journal.pone.0124593	http://dx.doi.org/10.1371/journal.pone.0124593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923215	Green Published, gold, Green Submitted			2022-12-26	WOS:000353711600096
J	Tsukahara, K; Sawada, H; Kohno, Y; Matsuura, T; Mori, IC; Terao, T; Ioki, M; Tamaoki, M				Tsukahara, Keita; Sawada, Hiroko; Kohno, Yoshihisa; Matsuura, Takakazu; Mori, Izumi C.; Terao, Tomio; Ioki, Motohide; Tamaoki, Masanori			Ozone-Induced Rice Grain Yield Loss Is Triggered via a Change in Panicle Morphology That Is Controlled by ABERRANT PANICLE ORGANIZATION 1 Gene	PLOS ONE			English	Article							SPIKELET DEVELOPMENT; QUANTITATIVE TRAITS; ABSCISIC-ACID; STRESS; QTL; DISSECTION; MECHANISMS; TOLERANCE; CULTIVARS; RESPONSES	Rice grain yield is predicted to decrease in the future because of an increase in tropospheric ozone concentration. However, the underlying mechanisms are unclear. Here, we investigated the responses to ozone of two rice (Oryza Sativa L.) cultivars, Sasanishiki and Habataki. Sasanishiki showed ozone-induced leaf injury, but no grain yield loss. By contrast, Habataki showed grain yield loss with minimal leaf injury. A QTL associated with grain yield loss caused by ozone was identified in Sasanishiki/Habataki chromosome segment substitution lines and included the ABERRANT PANICLE ORGANIZATION 1 (APO1) gene. The Habataki allele of the APO1 locus in a near-isogenic line also resulted in grain yield loss upon ozone exposure, suggesting APO1 involvement in ozone-induced yield loss. Only a few differences in the APO1 amino acid sequences were detected between the cultivars, but the APO1 transcript level was oppositely regulated by ozone exposure: i.e., it increased in Sasanishiki and decreased in Habataki. Interestingly, the levels of some phytohormones (jasmonic acid, jasmonoyl-L-isoleucine, and abscisic acid) known to be involved in attenuation of ozone-induced leaf injury tended to decrease in Sasanishiki but to increase in Habataki upon ozone exposure. These data indicate that ozone-induced grain yield loss in Habataki is caused by a reduction in the APO1 transcript level through an increase in the levels of phytohormones that reduce leaf damage.	[Tsukahara, Keita; Sawada, Hiroko; Ioki, Motohide; Tamaoki, Masanori] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst, Tsukuba, Ibaraki 3058506, Japan; [Tsukahara, Keita; Tamaoki, Masanori] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Kohno, Yoshihisa] Cent Res Inst Elect Power Ind, Abiko, Chiba 2701194, Japan; [Matsuura, Takakazu; Mori, Izumi C.] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan; [Terao, Tomio] Natl Agr & Food Res Org, NARO Agr Res Ctr, Hokuriku Res Ctr, Crop Dev Div, Joetsu, Niigata 9430193, Japan	National Institute for Environmental Studies - Japan; University of Tsukuba; Central Research Institute of Electric Power Industry - Japan; Okayama University; National Agriculture & Food Research Organization - Japan	Tamaoki, M (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst, Tsukuba, Ibaraki 3058506, Japan.	mtamaoki@nies.go.jp		Sawada, Hiroko/0000-0002-3232-710X; Mori, Izumi/0000-0002-2235-0779	Global Environment Research Fund of the Ministry of the Environment, Japan [A-0806]; Japan Advanced Plant Science Network	Global Environment Research Fund of the Ministry of the Environment, Japan; Japan Advanced Plant Science Network	This work was supported by the Global Environment Research Fund (A-0806) of the Ministry of the Environment, Japan to YK and MT (http://www.env.go.jp/policy/kenkyu/suishin/english/index.html), and by the Japan Advanced Plant Science Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2010, ENVIRON POLLUT, V158, P2970, DOI 10.1016/j.envpol.2010.05.026; Ando T, 2008, THEOR APPL GENET, V116, P881, DOI 10.1007/s00122-008-0722-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashmore M, 2006, NEW PHYTOL, V170, P201, DOI 10.1111/j.1469-8137.2006.01709.x; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cai Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4476; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Frei M, 2008, J EXP BOT, V59, P3741, DOI 10.1093/jxb/ern222; GUPTA AS, 1991, PLANT PHYSIOL, V96, P650, DOI 10.1104/pp.96.2.650; Haldane JBS, 1919, J GENET, V8, P299; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hoeberichts FA, 2003, BIOESSAYS, V25, P47, DOI 10.1002/bies.10175; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iehisa JCM, 2014, J PLANT PHYSIOL, V171, P25, DOI 10.1016/j.jplph.2013.10.001; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ikeda K, 2007, PLANT J, V51, P1030, DOI 10.1111/j.1365-313X.2007.03200.x; KANGASJARVI J, 1994, PLANT CELL ENVIRON, V17, P783, DOI 10.1111/j.1365-3040.1994.tb00173.x; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim EH, 2009, PLANT SIGNAL BEHAV, V4, P348, DOI 10.4161/psb.4.4.8199; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; KRUPA SV, 1988, ENVIRON POLLUT, V50, P101, DOI 10.1016/0269-7491(88)90187-X; Laloi C, 2004, CURR OPIN PLANT BIOL, V7, P323, DOI 10.1016/j.pbi.2004.03.005; LANDER ES, 1989, GENETICS, V121, P185; Lin DI, 2001, PLANT GROWTH REGUL, V35, P295, DOI 10.1023/A:1014427505353; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pell EJ, 1997, PHYSIOL PLANTARUM, V100, P264, DOI 10.1034/j.1399-3054.1997.1000207.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rao MV, 2001, PLANTA, V213, P682, DOI 10.1007/s004250100618; Sandermann H, 1998, TRENDS PLANT SCI, V3, P47, DOI 10.1016/S1360-1385(97)01162-X; Sawada H, 2009, PLANT BIOLOGY, V11, P70, DOI 10.1111/j.1438-8677.2009.00233.x; Sharma YK, 1997, FREE RADICAL BIO MED, V23, P480, DOI 10.1016/S0891-5849(97)00108-1; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spartz AK, 2008, GENE DEV, V22, P2139, DOI 10.1101/gad.1693208; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; Tsukahara K, 2013, ENVIRON EXP BOT, V88, P100, DOI 10.1016/j.envexpbot.2011.12.012; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang JC, 2004, PLANT CELL ENVIRON, V27, P1055, DOI 10.1111/j.1365-3040.2004.01210.x	43	27	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123308	10.1371/journal.pone.0123308	http://dx.doi.org/10.1371/journal.pone.0123308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923431	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600038
J	Banga, S; Coursen, JD; Portugal, S; Tran, TM; Hancox, L; Ongoiba, A; Traore, B; Doumbo, OK; Huang, CY; Harty, JT; Crompton, PD				Banga, Simran; Coursen, Jill D.; Portugal, Silvia; Tran, Tuan M.; Hancox, Lisa; Ongoiba, Aissata; Traore, Boubacar; Doumbo, Ogobara K.; Huang, Chiung-Yu; Harty, John T.; Crompton, Peter D.			Impact of Acute Malaria on Pre-Existing Antibodies to Viral and Vaccine Antigens in Mice and Humans	PLOS ONE			English	Article							MEMORY B-CELLS; PLASMODIUM-FALCIPARUM; CHILDREN; ACTIVATION; RESPONSES; DURATION; IMMUNITY	Vaccine-induced immunity depends on long-lived plasma cells (LLPCs) that maintain antibody levels. A recent mouse study showed that Plasmodium chaubaudi infection reduced pre-existing influenza-specific antibodies-raising concerns that malaria may compromise pre-existing vaccine responses. We extended these findings to P. yoelii infection, observing decreases in antibodies to model antigens in inbred mice and to influenza in outbred mice, associated with LLPC depletion and increased susceptibility to influenza rechallenge. We investigated the implications of these findings in Malian children by measuring vaccine-specific IgG (tetanus, measles, hepatitis B) before and after the malaria-free 6-month dry season, 10 days after the first malaria episode of the malaria season, and after the subsequent dry season. On average, vaccine-specific IgG did not decrease following acute malaria. However, in some children malaria was associated with an accelerated decline in vaccine-specific IgG, underscoring the need to further investigate the impact of malaria on pre-existing vaccine-specific antibodies.	[Banga, Simran; Hancox, Lisa; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Coursen, Jill D.; Portugal, Silvia; Tran, Tuan M.; Crompton, Peter D.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Ongoiba, Aissata; Traore, Boubacar; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Mali Int Ctr Excellence Res, Bamako, Mali; [Huang, Chiung-Yu] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Biostat & Bioinformat, Baltimore, MD USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Science & Technology of Bamako; Johns Hopkins University; Johns Hopkins Medicine; University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu; pcrompton@niaid.nih.gov	Banga, Simran/L-8806-2013; Crompton, Peter/N-1130-2016; Tran, Tuan M./H-9439-2019	Tran, Tuan M./0000-0002-1928-861X; Hancox, Lisa/0000-0003-1940-2619; Harty, John/0000-0001-7266-2802; Portugal, Silvia/0000-0003-4567-9101	National Institutes of Health (NIH) [AI085515, AI095178, AI100527]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085515, R01AI100527, R01AI095178, ZIAAI001155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Malaria work in the JTH laboratory is supported by National Institutes of Health (NIH) grants (AI085515, AI095178, AI100527). The PDC laboratory and study in Mali is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Amanna IJ, 2012, HUM IMMUNOL, V73, P1082, DOI 10.1016/j.humimm.2012.07.328; Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BIN D, 1991, B WORLD HEALTH ORGAN, V69, P415; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Centers for Disease C Prevention. Global routine vaccination coverage, 2011, MMWR-MORBID MORTAL W, V61, P883; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Donati D, 2006, J IMMUNOL, V177, P3035, DOI 10.4049/jimmunol.177.5.3035; GREENWOOD BM, 1972, LANCET, V1, P169; Hepatitis B, 2009, WKLY EPIDEMIOL REC, V84, P405; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; KEJA K, 1988, World Health Statistics Quarterly, V41, P59; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Minta D K, 2012, Bull Soc Pathol Exot, V105, P58, DOI 10.1007/s13149-011-0204-y; Nduati E, 2011, J INFECT DIS, V204, P962, DOI 10.1093/infdis/jir438; Ng DHL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003843; Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Rogers NJ, 2000, INFECT IMMUN, V68, P3455, DOI 10.1128/IAI.68.6.3455-3462.2000; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tetanus vaccine, 2006, HLTH SECTION SECRETA, V81, P198; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, IMM SUMM, P106; Wolters K. L., 1942, ZEITSCHR HYG U INJEKTIONSKRANKH, V124, P326, DOI 10.1007/BF02178438	35	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125090	10.1371/journal.pone.0125090	http://dx.doi.org/10.1371/journal.pone.0125090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919588	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400072
J	Chen, PL; Li, YC; Toback, FG				Chen, Peili; Li, Yan Chun; Toback, F. Gary			AMP-18 Targets p21 to Maintain Epithelial Homeostasis	PLOS ONE			English	Article							SODIUM-INDUCED COLITIS; INFLAMMATORY-BOWEL-DISEASE; CELL-CYCLE INHIBITORS; VITAMIN-D-RECEPTOR; BARRIER FUNCTION; TNF-ALPHA; INTESTINAL BARRIER; CROHNS-DISEASE; APOPTOSIS; PROLIFERATION	Dysregulated homeostasis of epithelial cells resulting in disruption of mucosal barrier function is an important pathogenic mechanism in inflammatory bowel diseases (IBD). We have characterized a novel gastric protein, Antrum Mucosal Protein (AMP)-18, that has pleiotropic properties; it is mitogenic, anti-apoptotic and can stimulate formation of tight junctions. A 21-mer synthetic peptide derived from AMP-18 exhibits the same biological functions as the full-length protein and is an effective therapeutic agent in mouse models of IBD. In this study we set out to characterize therapeutic mechanisms and identify molecular targets by which AMP-18 maintains and restores disrupted epithelial homeostasis in cultured intestinal epithelial cells and a mouse model of IBD. Tumor necrosis factor (TNF)-alpha, a pro-inflammatory cytokine known to mediate gastrointestinal (GI) mucosal injury in IBD, was used to induce intestinal epithelial cell injury, and study the effects of AMP-18 on apoptosis and the cell cycle. An apoptosis array used to search for targets of AMP-18 in cells exposed to TNF-alpha identified the cyclin-dependent kinase inhibitor p21(WAF1/CIP1). Treatment with AMP-18 blunted increases in p21 expression and apoptosis, while reversing disturbed cell cycle kinetics induced by TNF-alpha. AMP-18 appears to act through PI3K/AKT pathways to increase p21 phosphorylation, thereby reducing its nuclear accumulation to overcome the antiproliferative effects of TNF-alpha. In vitamin D receptor-deficient mice with TNBS-induced IBD, the observed increase in p21 expression in colonic epithelial cells was suppressed by treatment with AMP peptide. The results indicate that AMP-18 can maintain and/or restore the homeostatic balance between proliferation and apoptosis in intestinal epithelial cells to protect and repair mucosal barrier homeostasis and function, suggesting a therapeutic role in IBD.	[Chen, Peili; Li, Yan Chun; Toback, F. Gary] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Chen, PL (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	pchen@medicine.bsd.uchicago.edu; gtoback@medicine.bsd.uchicago.edu			National Cancer Institute [CA 176032]; CA 180087; NATIONAL CANCER INSTITUTE [R01CA180087, R21CA176032] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CA 180087; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the National Cancer Institute: CA 176032 to F. G. Toback; CA 180087 to YC Li (www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2000, GASTROENTEROLOGY, V119, P1524, DOI 10.1053/gast.2000.20232; Arai N, 1999, MODERN PATHOL, V12, P604; Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Butzner JD, 1996, GUT, V38, P568, DOI 10.1136/gut.38.4.568; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chen PL, 2012, INFLAMM BOWEL DIS, V18, P1749, DOI 10.1002/ibd.22886; Chen PL, 2011, ORAL ONCOL, V47, P831, DOI 10.1016/j.oraloncology.2011.06.012; Chen Y, 2012, BIOINFORMATICS, V28, P1, DOI 10.1093/bioinformatics/btr619; COOPER HS, 1993, LAB INVEST, V69, P238; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Edelblum KL, 2006, INFLAMM BOWEL DIS, V12, P413, DOI 10.1097/01.MIB.0000217334.30689.3e; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Ghanem L, 2005, LEUKEMIA RES, V29, P1315, DOI 10.1016/j.leukres.2005.03.018; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Goretsky T, 2012, AM J PATHOL, V181, P1306, DOI 10.1016/j.ajpath.2012.06.016; HALL PA, 1994, J CELL SCI, V107, P3569; Ioachim EE, 2004, INT J COLORECTAL DIS, V19, P325, DOI 10.1007/s00384-003-0571-3; Iwamoto M, 1996, J PATHOL, V180, P152; Joo YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004562; Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liu SX, 2003, DRUG RESIST UPDATE, V6, P183, DOI 10.1016/S1368-7646(03)00044-X; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Manapov F, 2005, GUT, V54, P814, DOI 10.1136/gut.2003.036491; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marini M, 2003, P NATL ACAD SCI USA, V100, P8366, DOI 10.1073/pnas.1432897100; Martin TE, 2003, AM J PHYSIOL-GASTR L, V285, pG332, DOI 10.1152/ajpgi.00453.2002; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Miller JP, 2007, CELL CYCLE, V6, P2932, DOI 10.4161/cc.6.23.5042; Pavelic SK, 2008, CANCER GENE THER, V15, P576, DOI 10.1038/cgt.2008.28; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sipos F, 2005, DIS COLON RECTUM, V48, P775, DOI 10.1007/s10350-004-0831-5; Strater J, 1997, GASTROENTEROLOGY, V113, P160, DOI 10.1016/S0016-5085(97)70091-X; Toback FG, 2003, AM J PHYSIOL-GASTR L, V285, pG344, DOI 10.1152/ajpgi.00455.2002; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walsh-Reitz MM, 2005, AM J PHYSIOL-GASTR L, V289, pG163, DOI 10.1152/ajpgi.00013.2005; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Wu XY, 2012, INT J RADIAT ONCOL, V83, pE409, DOI 10.1016/j.ijrobp.2012.01.006; Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yoon JH, 2013, J CELL BIOCHEM, V114, P1800, DOI 10.1002/jcb.24524; Yoon JH, 2011, J CANCER RES CLIN, V137, P1697, DOI 10.1007/s00432-011-1051-8; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	62	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125490	10.1371/journal.pone.0125490	http://dx.doi.org/10.1371/journal.pone.0125490			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919700	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400085
J	Luo, XY; Fan, Y; Park, IW; He, JJ				Luo, Xiaoyu; Fan, Yan; Park, In-Woo; He, Johnny J.			Exosomes Are Unlikely Involved in Intercellular Nef Transfer	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; HEPATITIS-C VIRUS; CD4(+) T-CELLS; HIV-1 NEF; DOWN-REGULATION; IN-VITRO; TUNNELING NANOTUBES; ACCESSORY PROTEINS; INFECTED-CELLS; IMMUNODEFICIENCY	HIV-1 Nef is an important pathogenic factor for HIV/AIDS pathogenesis. Several recent studies including ours have demonstrated that Nef can be transferred to neighboring cells and alters the function of these cells. However, how the intercellular Nef transfer occurs is in dispute. In the current study, we attempted to address this important issue using several complementary strategies, a panel of exosomal markers, and human CD4+ T lymphocyte cell line Jurkat and a commonly used cell line 293T. First, we showed that Nef was transferred from Nef-expressing or HIV-infected Jurkat to naive Jurkat and other non-Jurkat cells and that the transfer required the membrane targeting function of Nef and was cell density-dependent. Then, we showed that Nef transfer was cell-cell contact-dependent, as exposure to culture supernatants or exosomes from HIV-infected Jurkat or Nef-expressing Jurkat and 293T led to little Nef detection in the target cells Jurkat. Thirdly, we demonstrated that Nef was only detected to be associated with HIV virions but not with acetylcholinesterase (AChE+) exosomes from HIV-infected Jurkat and not in the exosomes from Nef-expressing Jurkat. In comparison, when it was over-expressed in 293T, Nef was detected in detergent-insoluble AChE+/CD81(low)/TSG101(low) exosomes, but not in detergent-soluble AChE-/CD81(high)/TSG101(high) exosomes. Lastly, microscopic imaging showed no significant Nef detection in exosomal vesicle-like structures in and out 293T. Taken together, these results show that exosomes are unlikely involved in intercellular Nef transfer. In addition, this study reveals existence of two types of exosomes: AChE+/CD81(low)/TSG101(low) exosomes and AChE-/CD81(high)/TSG101(high) exosomes.	[Luo, Xiaoyu; Fan, Yan; Park, In-Woo; He, Johnny J.] Univ N Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	He, JJ (corresponding author), Univ N Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	johnny.he@unthsc.edu	Fan, Yan/F-5107-2018	Luo, Xiaoyu/0000-0001-6059-0434	National Institutes of Health [NIH/NINDS R01NS065785, NIH/NIMH R01MH092673]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NIH/NINDS R01NS065785 and NIH/NIMH R01MH092673 (to JJH) from National Institutes of Health.	Ahmed KA, 2008, CELL MOL IMMUNOL, V5, P261, DOI 10.1038/cmi.2008.32; Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; AMEISEN JC, 1989, AIDS RES HUM RETROV, V5, P279, DOI 10.1089/aid.1989.5.279; Arenaccio C, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-46; Aucher A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/907371; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Campbell Tamika D, 2008, Ethn Dis, V18, pS2; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Caumartin J, 2006, TRANSPL IMMUNOL, V17, P20, DOI 10.1016/j.trim.2006.09.032; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Choi DS, 2014, MASS SPECTROMETRY RE; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Cocucci E, 2011, CURR BIOL, V21, pR940, DOI 10.1016/j.cub.2011.10.011; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Costin JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-100; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Das SR, 2005, INDIAN J MED RES, V121, P315; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; de Carvalho JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113691; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fackler OT, 1996, VIRUS RES, V46, P105, DOI 10.1016/S0168-1702(96)01389-5; Foster JL, 2007, ADV PHARMACOL, V55, P389, DOI 10.1016/S1054-3589(07)55011-8; Fritzsching B, 2002, J IMMUNOL, V169, P5531, DOI 10.4049/jimmunol.169.10.5531; Fujii Y, 1996, J GEN VIROL, V77, P2943, DOI 10.1099/0022-1317-77-12-2943; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Green LA, 2009, J BIOL CHEM, V284, P13363, DOI 10.1074/jbc.M806631200; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Gulizia RJ, 1997, J VIROL, V71, P4161, DOI 10.1128/JVI.71.5.4161-4164.1997; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; James CO, 2004, J VIROL, V78, P3099, DOI 10.1128/JVI.78.6.3099-3109.2004; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; KAMINCHIK J, 1994, AIDS RES HUM RETROV, V10, P1003, DOI 10.1089/aid.1994.10.1003; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Khan IH, 1998, J VIROL, V72, P5820, DOI 10.1128/JVI.72.7.5820-5830.1998; Kimura S, 2012, EXP CELL RES, V318, P1699, DOI 10.1016/j.yexcr.2012.05.013; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Krogstad Paul, 2003, Semin Pediatr Infect Dis, V14, P258, DOI 10.1053/j.spid.2003.09.007; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liu Y, 2002, J BIOL CHEM, V277, P23854, DOI 10.1074/jbc.M200773200; Liu ZQ, 2014, BIOCHEM BIOPH RES CO, V455, P218, DOI 10.1016/j.bbrc.2014.10.146; Liu ZQ, 2013, J VIROL, V87, P8545, DOI 10.1128/JVI.01062-13; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mignot G, 2006, J CELL MOL MED, V10, P376, DOI 10.1111/j.1582-4934.2006.tb00406.x; Morita D, 2011, J IMMUNOL, V187, P608, DOI 10.4049/jimmunol.1101216; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Ohno Hiroshi, 2010, Commun Integr Biol, V3, P231; OVOD V, 1992, AIDS, V6, P25, DOI 10.1097/00002030-199201000-00003; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; Park IW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099545; Park IW, 2013, ARCH VIROL, V158, P845, DOI 10.1007/s00705-012-1560-z; Park IW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-234; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Puigdomenech I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-89; Qi ML, 2008, VIROLOGY, V373, P287, DOI 10.1016/j.virol.2007.12.001; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Shelton MN, 2012, J VIROL, V86, P406, DOI 10.1128/JVI.05720-11; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Sierra S, 2005, J CLIN VIROL, V34, P233, DOI 10.1016/j.jcv.2005.09.004; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Szilluweit R, 2009, BIOPHYS J, V96, P3242, DOI 10.1016/j.bpj.2008.12.3947; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; Welker R, 1996, VIROLOGY, V219, P228, DOI 10.1006/viro.1996.0240; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; ZAZOPOULOS E, 1993, J VIROL, V67, P1676, DOI 10.1128/JVI.67.3.1676-1680.1993	93	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124436	10.1371/journal.pone.0124436	http://dx.doi.org/10.1371/journal.pone.0124436			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919665	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400051
J	Oganesyan, V; Peng, L; Woods, RM; Wu, HR; Dall'Acqua, WF				Oganesyan, Vaheh; Peng, Li; Woods, Robert M.; Wu, Herren; Dall'Acqua, William F.			Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I INTERFERON-RECEPTOR; ALPHA-RECEPTOR; BINDING-SITE; MUTATIONAL ANALYSIS; LIGAND-BINDING; CYTOKINES; RESIDUES; CHAIN; BETA	We report the three-dimensional structure of human interferon alpha-2A (IFN-alpha 2A) bound to the Fab fragment of a therapeutic monoclonal antibody (sifalimumab; IgG1/kappa). The structure of the corresponding complex was solved at a resolution of 3.0 angstrom using molecular replacement and constitutes the first reported structure of a human type I IFN bound to a therapeutic antibody. This study revealed the major contribution made by the first complementarity-determining region in each of sifalimumab light and heavy chains. These data also provided the molecular basis for sifalimumab mechanism of action. We propose that its interferon-neutralizing properties are the result of direct competition for IFN-alpha 2A binding to the IFN receptor subunit 1 (IFNAR1) and do not involve inhibiting IFN-alpha 2A binding to the IFN receptor subunit 2 (IFNAR2).	[Oganesyan, Vaheh; Peng, Li; Woods, Robert M.; Wu, Herren; Dall'Acqua, William F.] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune	Oganesyan, V (corresponding author), MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	oganesyanv@medimmune.com; dallacquaw@medimmune.com			AstraZeneca	AstraZeneca(AstraZeneca)	This work was supported by AstraZeneca. All authors are full-time employees of MedImmune LLC (Gaithersburg, MD).	Alsharifi M, 2008, IMMUNOL CELL BIOL, V86, P239, DOI 10.1038/sj.icb.7100159; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cajean-Feroldi C, 2004, BIOCHEMISTRY-US, V43, P12498, DOI 10.1021/bi049111r; Chill JH, 2002, BIOCHEMISTRY-US, V41, P3575, DOI 10.1021/bi011778f; Chuntharapai A, 1999, J IMMUNOL, V163, P766; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Foster GR, 1998, J VIRAL HEPATITIS, V5, P143, DOI 10.1046/j.1365-2893.1998.00103.x; Gavutis M, 2005, BIOPHYS J, V88, P4289, DOI 10.1529/biophysj.104.055855; Ghasriani H, 2013, J BIOL CHEM, V288, P247, DOI 10.1074/jbc.M112.413252; GRESSER I, 1976, J EXP MED, V144, P1305, DOI 10.1084/jem.144.5.1305; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Isaacs A., 1957, J INTERFERON RES, P429; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabat EA, 1991, SEQUENCES PROTEINS I; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813; Klaus W, 1997, J MOL BIOL, V274, P661, DOI 10.1006/jmbi.1997.1396; Kumaran J, 2007, FASEB J, V21, P3288, DOI 10.1096/fj.07-8585com; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewerenz M, 1998, J MOL BIOL, V282, P585, DOI 10.1006/jmbi.1998.2026; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; Oganesyan V, 2009, ACTA CRYSTALLOGR F, V65, P14, DOI 10.1107/S1744309108037925; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouyang SY, 2012, J MOL MED, V90, P837, DOI 10.1007/s00109-012-0866-3; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pan MJ, 2008, BIOCHEMISTRY-US, V47, P12018, DOI 10.1021/bi801588g; Peng L, 2015, MABS-AUSTIN, V7, P428, DOI 10.1080/19420862.2015.1007810; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Quadt-Akabayov SR, 2006, PROTEIN SCI, V15, P2656, DOI 10.1110/ps.062283006; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Selmi C, 2006, CURR OPIN INVEST DR, V7, P451; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	45	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14979	14985		10.1074/jbc.M115.652156	http://dx.doi.org/10.1074/jbc.M115.652156			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25925951	hybrid, Green Published			2022-12-26	WOS:000356177300015
J	Holand, H; Jensen, H; Tufto, J; Parn, H; Saether, BE; Ringsby, TH				Holand, Hakon; Jensen, Henrik; Tufto, Jarle; Parn, Henrik; Saether, Bernt-Erik; Ringsby, Thor Harald			Endoparasite Infection Has Both Short- and Long-Term Negative Effects on Reproductive Success of Female House Sparrows, as Revealed by Faecal Parasitic Egg Counts	PLOS ONE			English	Article							PASSER-DOMESTICUS; GAPEWORM SYNGAMUS; SPATIAL VARIATION; RED DEER; POPULATION; METAPOPULATION; SURVIVAL; HOST; CONSEQUENCES; DEMOGRAPHY	Parasites have the potential to severely reduce host reproductive success. However, the effects of endoparasites on reproductive success have not received the same amount of attention as the effects of parasites on host survival. We investigated the relationship between an avian endoparasite (gapeworm, Syngamus trachea) and both current and future reproductive success of female house sparrows (Passer domesticus) in a population on the coast of Helgeland, northern Norway. We found that the proportion of eggs in a nest that failed to develop into fledglings increased as the faecal parasitic egg count of the mothers increased. We also found that juvenile females with high numbers of parasitic eggs in their faeces had lower lifetime reproductive success as adults. However, we did not find a relationship between maternal parasite infection and clutch size or recruitment rate of offspring. To our knowledge this is the first study to find a relationship between reproductive success of an avian host and faecal egg count of an endoparasite. The present study indicates that infection by an endoparasite may be associated with lower individual reproductive success in both the short-term and long-term in a wild population of hosts.	[Holand, Hakon; Jensen, Henrik; Parn, Henrik; Saether, Bernt-Erik; Ringsby, Thor Harald] Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Dept Biol, NO-7491 Trondheim, Norway; [Tufto, Jarle] Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Dept Math, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Holand, H (corresponding author), Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Dept Biol, NO-7491 Trondheim, Norway.	hakon.holand@ntnu.no	Jensen, Henrik/B-5085-2011	Jensen, Henrik/0000-0001-7804-1564	Norwegian Research Council [204303, 221956]; Norwegian University of Science and Technology	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian University of Science and Technology	This study was funded by the Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906) (grants no. 204303 and 221956) and the Norwegian University of Science and Technology (www.ntnu.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, EVOLUTION, V40, P574, DOI 10.1111/j.1558-5646.1986.tb00508.x; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Anderson TR, 2006, BIOLOGY OF THE UBIQU, Vi-xi, P1; Atkinson CT, 2008, PARASITIC DISEASES O, Vi-xi, P1; Audige L, 1999, ANIM REPROD SCI, V55, P239, DOI 10.1016/S0378-4320(99)00018-4; BARUS V, 1966, Helminthologia (Bratislava), V7, P103; BARUS V, 1966, Folia Parasitologica (Ceske Budejovice), V13, P274; Bonds MH, 2006, AM NAT, V168, P281, DOI 10.1086/506922; Brown CR, 1995, P ROY SOC B-BIOL SCI, V262, P313, DOI 10.1098/rspb.1995.0211; Burnham K. P., 2002, MODEL SELECTION AND; Campbell JW, 1935, J ANIM ECOL, V4, P208, DOI 10.2307/1010; Clapham PA, 1934, P R SOC LOND B-CONTA, V115, P18, DOI 10.1098/rspb.1934.0027; Fitze PS, 2004, ECOLOGY, V85, P2018, DOI 10.1890/03-0138; Hall SR, 2007, INTEGR COMP BIOL, V47, P295, DOI 10.1093/icb/icm057; Holand H, 2014, J AVIAN BIOL, V45, P365, DOI 10.1111/jav.00354; Holand H, 2013, PARASITOLOGY, V140, P1275, DOI 10.1017/S0031182013000735; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Hudson PJ, 2002, THE ECOLOGY OF WILDL, Vi-xii, P1; Husby A, 2006, J ANIM ECOL, V75, P1128, DOI 10.1111/j.1365-2656.2006.01132.x; Jensen H, 2004, J ANIM ECOL, V73, P599, DOI 10.1111/j.0021-8790.2004.00837.x; Jensen H, 2008, EVOLUTION, V62, P1275, DOI 10.1111/j.1558-5646.2008.00395.x; Mageroy JH, 2011, PARASITOLOGY, V138, P1910, DOI 10.1017/S0031182011001302; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Nager RG, 2006, ARDEA, V94, P323; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Owen JP, 2010, TRENDS PARASITOL, V26, P530, DOI 10.1016/j.pt.2010.06.005; Patterson JEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055779; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Poulin R., 2007, EVOL ECOL, V2; R Core Team, 2013, R A LANGUAGE AND ENV, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Redpath SM, 2006, ECOL LETT, V9, P410, DOI 10.1111/j.1461-0248.2006.00895.x; Reed TE, 2008, SCIENCE, V321, P1681, DOI 10.1126/science.1159466; Ringsby TH, 2002, ECOLOGY, V83, P561, DOI 10.1890/0012-9658(2002)083[0561:ASDOAH]2.0.CO;2; Ringsby TH, 1999, OIKOS, V85, P419, DOI 10.2307/3546691; Ringsby TH, 2009, J ORNITHOL, V150, P469, DOI 10.1007/s10336-008-0365-z; Saether BE, 1999, J ANIM ECOL, V68, P628, DOI 10.1046/j.1365-2656.1999.00314.x; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Wilson K, 2002, THE ECOLOGY OF WILDL; WISSLER K, 1975, Journal of Wildlife Diseases, V11, P245	44	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125773	10.1371/journal.pone.0125773	http://dx.doi.org/10.1371/journal.pone.0125773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933371	gold, Green Submitted, Green Published			2022-12-26	WOS:000353887100132
J	Mansouri, A; Sarayani, A; Ashouri, A; Sherafatmand, M; Hadjibabaie, M; Gholami, K				Mansouri, Ava; Sarayani, Amir; Ashouri, Asieh; Sherafatmand, Mona; Hadjibabaie, Molouk; Gholami, Kheirollah			Is 'Self-Medication' a Useful Term to Retrieve Related Publications in the Literature? A Systematic Exploration of Related Terms	PLOS ONE			English	Article							THE-COUNTER DRUGS; COMMUNITY PHARMACIES; CLARIFICATION; TERMINOLOGY; MEDICINES; ILLNESSES; SAFETY; ADULTS; PAPER; CARE	Background Self-Medication (SM), i.e. using medications to treat oneself, is a major concern for health researchers and policy makers. The terms "self medication" or "self-medication" (SM terms) have been used to explain various concepts while several terms have also been employed to define this practice. Hence, retrieving relevant publications would require exhaustive literature screening. So, we assessed the current situation of SM terms in the literature to improve the relevancy of search outcomes. Methods In this Systematic exploration, SM terms were searched in the 6 following databases and publisher's portals till April 2012: Web of Science, Scopus, PubMed, Google scholar, ScienceDirect, and Wiley. A simple search query was used to include only publications with SM terms. We used Relative-Risk (RR) to estimate the probability of SM terms use in related compared to unrelated publications. Sensitivity and specificity of SM terms as keywords in search query were also calculated. Relevant terms to SM practice were extracted and their Likelihood Ratio positive and negative (LR+/-) were calculated to assess their effect on the probability of search outcomes relevancy in addition to previous search queries. We also evaluated the content of unrelated publications. All mentioned steps were performed in title (TI) and title or abstract (TIAB) of publications. Results 1999 related and 1917 unrelated publications were found. SM terms RR was 4.5 in TI and 2.1 in TIAB. SM terms sensitivity and specificity respectively were 55.4% and 87.7% in TI and 84.0% and 59.5% in TIAB. "OTC" and "Over-The-Counter Medication", with LR+ 16.78 and 16.30 respectively, provided the most conclusive increase in the probability of the relevancy of publications. The most common unrelated SM themes were self-medication hypothesis, drug abuse and Zoopharmacognosy. Conclusions Due to relatively low specificity or sensitivity of SM terms, relevant terms should be employed in search queries and clear definitions of SM applications should be applied to improve the relevancy of publications.	[Mansouri, Ava; Sarayani, Amir; Ashouri, Asieh; Hadjibabaie, Molouk; Gholami, Kheirollah] Univ Tehran Med Sci, Res Ctr Rat Use Drugs, Tehran, Iran; [Ashouri, Asieh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Sherafatmand, Mona; Hadjibabaie, Molouk; Gholami, Kheirollah] Univ Tehran Med Sci, Fac Pharm, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Hadjibabaie, M (corresponding author), Univ Tehran Med Sci, Res Ctr Rat Use Drugs, Tehran, Iran.	hajibaba@tums.ac.ir	Ashouri, Asieh/H-3630-2018	Ashouri, Asieh/0000-0002-3791-8451; Sarayani, Amir/0000-0003-2790-9938	Tehran University of Medical Sciences (TUMS) [18373-156-02-91]	Tehran University of Medical Sciences (TUMS)(Tehran University of Medical Sciences)	This work was supported by Tehran University of Medical Sciences (TUMS) (Grant number: 18373-156-02-91). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasdy D, 2011, ARCH PHARM PRACT, V2, P95; Aronson JK, 2005, DRUG SAFETY, V28, P851, DOI 10.2165/00002018-200528100-00003; Blenkinsopp A, 1996, BRIT MED J, V312, P629; Brata C, 2013, RES SOC ADMIN PHARM, V9, P370, DOI 10.1016/j.sapharm.2012.08.001; Cavaco AM, 2012, RES SOC ADMIN PHARM, V8, P87, DOI 10.1016/j.sapharm.2011.07.004; Du Y, 2009, BRIT J CLIN PHARMACO, V68, P599, DOI 10.1111/j.1365-2125.2009.03477.x; Elliott Rohan A, 2009, BMC Geriatr, V9, P27, DOI 10.1186/1471-2318-9-27; Ferner RE, 2006, DRUG SAFETY, V29, P1011, DOI 10.2165/00002018-200629110-00001; Fried PW, 2001, J THORAC CARDIOV SUR, V121, pS3, DOI 10.1067/mtc.2001.114493; Gambescia Stephen F, 2013, Educ Health (Abingdon), V26, P122, DOI 10.4103/1357-6283.120706; Geissler PW, 2000, SOC SCI MED, V50, P1771, DOI 10.1016/S0277-9536(99)00428-1; Godfrey CM, 2011, JBI DATABASE SYSTEMA, V8, P1351; Goh LY, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-42; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Hall DH, 2007, J PSYCHOACTIVE DRUGS, V39, P151, DOI 10.1080/02791072.2007.10399873; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Hughes CM, 2001, DRUG SAFETY, V24, P1027, DOI 10.2165/00002018-200124140-00002; Hughes GF, 1999, PHARM WORLD SCI, V21, P251, DOI 10.1023/A:1008788726842; Jamali HR, 2011, SCIENTOMETRICS, V88, P653, DOI 10.1007/s11192-011-0412-z; Jenkins Michelle, 2004, Health Info Libr J, V21, P148, DOI 10.1111/j.1471-1842.2004.00511.x; Kaizer F, 2010, J REHABIL MED, V42, P239, DOI 10.2340/16501977-0523; Landers TF, 2010, J AM ACAD NURSE PRAC, V22, P488, DOI 10.1111/j.1745-7599.2010.00539.x; Lawrence S, 1999, INT TECHN SERV 1999; Lefebvre C, 2011, COCHRANE COLLABORATI; Masic Izet, 2011, Acta Inform Med, V19, P68, DOI 10.5455/aim.2011.19.68-79; McKenna L, 2006, J ADV NURS, V56, P636, DOI 10.1111/j.1365-2648.2006.04037.x; Montgomery AJ, 2011, OCCUP MED-OXFORD, V61, P490, DOI 10.1093/occmed/kqr098; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Ryan A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-96; Sallam S. A., 2009, Eastern Mediterranean Health Journal, V15, P683; Sanz F, 2000, AM J HEALTH-SYST PH, V57, P1601, DOI 10.1093/ajhp/57.17.1601; Schroeder K, 2009, EVID BASED CHILD HLT, V4, P65; Segarra R, 2011, EUR ARCH PSY CLIN N, V261, P241, DOI 10.1007/s00406-010-0146-6; Setiati Siti, 2007, Acta Med Indones, V39, P50; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Wertheimer AI, 2008, PHARM WORLD SCI, V30, P309, DOI 10.1007/s11096-007-9187-y; Wimpenny P., 2010, JBI LIB SYST REV, V8, P405, DOI [10.11124/jbisrir-2010-123, DOI 10.11124/JBISRIR-2010-123]	37	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125093	10.1371/journal.pone.0125093	http://dx.doi.org/10.1371/journal.pone.0125093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH2XA	25932634	Green Published, Green Submitted, gold			2022-12-26	WOS:000353887100078
J	Sulzgruber, P; Koller, L; Reiberger, T; El-Hamid, F; Forster, S; Rothgerber, DJ; Goliasch, G; Wojta, J; Niessner, A				Sulzgruber, Patrick; Koller, Lorenz; Reiberger, Thomas; El-Hamid, Feras; Forster, Stefan; Rothgerber, David-Jonas; Goliasch, Georg; Wojta, Johann; Niessner, Alexander			Butyrylcholinesterase Predicts Cardiac Mortality in Young Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ARTERY-DISEASE; RISK-FACTORS; COLLABORATION; GUIDELINES; SURVIVAL	Background The incidence of acute coronary syndrome (ACS) in young people (<= 65 years) is continuously rising. While prognostic factors in ACS are well-investigated less attention has been paid to their age-dependent prognostic value and their particular relevance in younger patients. The aim of our study was to assess the age-dependent prognostic impact of butyrylcholinesterase (BChE). Methods Retrospective cohort study including 624 patients with ACS. Patients were stratified by age into equal groups (n = 208) corresponding to "young patients" (45-64 years), "middle-aged patients" (65-84 years) and "old patients" (85-100 years). Cox regression hazard analysis was used to assess the influence of BChE on survival. Results After a mean follow-up time of 4.0 (interquartile range [IQR] 2.0-6.4) years, 154 patients (24.7%) died due to a cardiac cause. In the overall cohort, BChE was indirectly associated with cardiac mortality-free survival (adjusted hazard ratio (HR): 0.70 (95% confidence interval [CI] 0.53-0.93, p = 0.01). The primary-analysis of BChE by age strata showed the strongest effect in the age group 45-64 years with an adjusted HR per 1-SD of 0.28 (95% CI 0.12-0.64, p = 0.003), a weaker association with mortality in middle aged (65-84 years: adjusted HR per 1-SD 0.66 [95% CI: 0.41-1.06], p = 0.087), and no association in older patients (85-100 years: adjusted HR per 1-SD 0.89 [95% CI: 0.58-1.38], p = 0.613). Conclusion BChE is a strong predictor for cardiac mortality specifically in younger patients with ACS aged between 45 and 64 years. No significant association of BChE with cardiac-mortality was detected in other age classes.	[Sulzgruber, Patrick; Koller, Lorenz; El-Hamid, Feras; Forster, Stefan; Rothgerber, David-Jonas; Goliasch, Georg; Wojta, Johann; Niessner, Alexander] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria; [Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Reiberger, Thomas] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA; [Reiberger, Thomas] Harvard Univ, Sch Med, Boston, MA USA	Medical University of Vienna; Medical University of Vienna; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Niessner, A (corresponding author), Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria.	alexander.niessner@meduniwien.ac.at	Wojta, Johann/AAC-8433-2020; Reiberger, Thomas/H-7613-2019	Wojta, Johann/0000-0002-1282-9276; Reiberger, Thomas/0000-0002-4590-3583; Goliasch, Georg/0000-0002-6219-6104; Sulzgruber, Patrick/0000-0001-5146-0099	Verein zur Forderung der Forschung - ATVB (Vienna, Austria)	Verein zur Forderung der Forschung - ATVB (Vienna, Austria)	The authors received funding from Verein zur Forderung der Forschung - ATVB (Vienna, Austria) to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara VM, 2002, SCAND J CLIN LAB INV, V62, P399, DOI 10.1080/00365510260296564; Alexander KP, 2007, CIRCULATION, V115, P2549, DOI 10.1161/CIRCULATIONAHA.107.182615; [Anonymous], 2000, EUR HEART J, V21, P1502; BARBASH GI, 1995, EUR HEART J, V16, P313; Basoor Abhijeet, 2011, Am Heart Hosp J, V9, pE37; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Calderon-Margalit R, 2006, CLIN CHEM, V52, P845, DOI 10.1373/clinchem.2005.059857; Distelmaier K, 2014, CRIT CARE, V18, DOI 10.1186/cc13711; Fuhrmann V, 2010, WIEN KLIN WOCHENSCHR, V122, P129, DOI 10.1007/s00508-010-1357-6; Goliasch G, 2013, EUR J CLIN INVEST, V43, P332, DOI 10.1111/eci.12049; Goliasch G, 2012, CLIN CHEM, V58, P1055, DOI 10.1373/clinchem.2011.175984; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Johnson G, 2012, NEUROCHEM INT, V61, P783, DOI 10.1016/j.neuint.2012.06.016; MAGARIAN EO, 1987, J CLIN PHARMACOL, V27, P819, DOI 10.1002/j.1552-4604.1987.tb03004.x; Mandorfer M, 2014, J VIRAL HEPATITIS, V21, P33, DOI 10.1111/jvh.12118; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397	17	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123948	10.1371/journal.pone.0123948	http://dx.doi.org/10.1371/journal.pone.0123948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933219	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100026
J	Ramalho, FS; Malaquias, JB; Lira, ACS; Oliveira, FQ; Zanuncio, JC; Fernandes, FS				Ramalho, Francisco S.; Malaquias, Jose B.; Lira, Aline C. S.; Oliveira, Flavia Q.; Zanuncio, Jose C.; Fernandes, Francisco S.			Temperature-Dependent Fecundity and Life Table of the Fennel Aphid Hyadaphis foeniculi (Passerini) (Hemiptera: Aphididae)	PLOS ONE			English	Article							PERSICAE SULZER HOMOPTERA; GOSSYPII GLOVER; POPULATION PARAMETERS; NASONOVIA-RIBISNIGRI; ASHMEAD HYMENOPTERA; AULACORTHUM-SOLANI; DEVELOPMENTAL RATE; REPRODUCTION; GROWTH; BRACONIDAE	Hyadaphis foeniculi (Passerini) (Hemiptera: Aphididae) is a cosmopolitan species and the main pest of fennel in northeastern Brazil. Understanding the relationship between temperature variations and the population growth rates of H. foeniculi is essential to predict the population dynamics of this aphid in the fennel crop. The aim of this study was to measure the effect of constant temperature on the adult prereproductive period and the life table fertility parameters (infinitesimal increase ratio (r(m)), gross reproduction rate (GRR), net reproduction rate (R-0), finite increase ratio (lambda), generation time (GT), the time required for the population to double in the number of individuals (DT), and the reproduction value (RVx)) of the fennel pest H. foeniculi. The values of lx (survival of nymphs at age x) increased as the temperature rose from 15 to 28 degrees C and fell at 30 degrees C, whereas mx (number of nymphs produced by each nymph of age x) increased from 15 to 25 degrees C and fell at 28 and 30 degrees C. The net reproduction rates (R-0) of populations of H. foeniculi increased with temperature and ranged from 1.9 at 15 degrees C to 12.23 at 28 degrees C for each generation. The highest population increase occurred with the apterous aphids at 28 degrees C. The rate of population increase per unit time (r(m)) (day) ranged from 0.0033 (15 degrees C) to 0.1995 (28 degrees C). The highest values of r(m) were recorded at temperatures of 28 degrees C and 30 degrees C. The rm values were a good fit to the models tested, with R-2 > 0.91 and R-adj(2) > 0.88. The models tested (Davidson, Sharpe and DeMichele modified by Schoolfield et al., Logan et al., Lamb, and Briere et al.) were very good fits for the rm values observed, with R-2 > 0.91 and R-adj(2) > 0.88. The only exception was the Davidson model. Of the parameters studied, the reproductive capacity was higher in the apterous aphids, with the unique exception of daily fecundity at 28 degrees C, which was higher in the alate aphids of H. foeniculi. Parameters relating to the age-specific fertility table for H. foeniculi were heavily influenced by temperature, with the highest biotic potential and population growth capacity found at 34 degrees C. Therefore, the results obtained in this study could be of practical significance for predicting outbreaks of fennel aphids and improving the management of this aphid in fennel crops.	[Ramalho, Francisco S.; Malaquias, Jose B.; Lira, Aline C. S.; Fernandes, Francisco S.] Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil; [Oliveira, Flavia Q.] Univ Estadual Paulista Jaboticabal, Sao Paulo, Brazil; [Zanuncio, Jose C.] Univ Fed Vicosa, Vicosa, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Universidade Federal de Vicosa	Ramalho, FS (corresponding author), Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil.	ramalhohvv@globo.com	Malaquias, José Bruno B/I-1945-2015; FS, Ramalho/AAC-8058-2019; Lira, Aline/C-2354-2017; Fernandes, Francisco/E-4608-2016	Malaquias, José Bruno B/0000-0003-3937-9575; Lira, Aline/0000-0002-8592-2068; Fernandes, Francisco/0000-0002-0592-2536	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This project was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Aprotosoaie AC, 2010, FARMACIA, V58, P46; Bale JS, 2007, APHIDS AS CROP PESTS, P287, DOI 10.1079/9780851998190.0287; Bernardi D, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.2801; Briere JF, 1998, ENVIRON ENTOMOL, V27, P94, DOI 10.1093/ee/27.1.94; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chakravarty N. V. K., 2004, Journal of Agrometeorology, V6, P215; Chattopadhyay C, 2005, CROP PROT, V24, P1042, DOI 10.1016/j.cropro.2005.02.010; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; Cividanes Francisco J., 2003, Neotrop. entomol., V32, P413, DOI 10.1590/S1519-566X2003000300005; Cividanes Francisco J., 2003, Bragantia, V62, P61, DOI 10.1590/S0006-87052003000100008; Cividanes FJ, 2012, PESQUI AGROPECU BRAS, V47, P505, DOI 10.1590/S0100-204X2012000400005; COFFELT MA, 1989, ENVIRON ENTOMOL, V18, P46, DOI 10.1093/ee/18.1.46; Davidson J., 1942, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V20, P233, DOI 10.1038/icb.1942.39; Davidson J, 1944, J ANIM ECOL, V13, P26, DOI 10.2307/1326; DAY RK, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P323; De Conti BF, 2010, REV BRAS ENTOMOL, V54, P654, DOI 10.1590/S0085-56262010000400018; Diaz BM, 2005, ENVIRON ENTOMOL, V34, P527, DOI 10.1603/0046-225X-34.3.527; DIXON AFG, 1971, OECOLOGIA, V8, P179, DOI 10.1007/BF00345812; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; Fernandes FS, 2013, FLA ENTOMOL, V96, P92, DOI 10.1653/024.096.0112; Ferreira RG, 2004, PESQUI AGROPECU BRAS, V39, P1265, DOI 10.1590/S0100-204X2004001200015; GODOY KARLLA B., 2002, Neotrop. entomol., V31, P41, DOI 10.1590/S1519-566X2002000100006; HUTCHISON WD, 1984, ENVIRON ENTOMOL, V13, P1173, DOI 10.1093/ee/13.5.1173; KEULS M., 1952, Euphytica, V1, P112, DOI 10.1007/BF01908269; Krebs CJ, 1994, ECOLOGY EXPT ANAL DI; Kuo MH, 2006, APPL ENTOMOL ZOOL, V41, P171, DOI 10.1303/aez.2006.171; La Rossa FR, 2013, NEOTROP ENTOMOL, V42, P634, DOI 10.1007/s13744-013-0166-9; LAMB RJ, 1992, ENVIRON ENTOMOL, V21, P10, DOI 10.1093/ee/21.1.10; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lotka AJ, 1907, AM J SCI, V24, P199; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Malaquias JB, 2015, PEST MANAG SCI, V71, P744, DOI 10.1002/ps.3845; Malaquias JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100983; Malaquias JB, 2010, TURK J AGRIC FOR, V34, P235, DOI 10.3906/tar-0811-18; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Mehrparvar M, 2007, EUR J ENTOMOL, V104, P631, DOI 10.14411/eje.2007.078; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; NOWIERSKI RM, 1983, ENVIRON ENTOMOL, V12, P680, DOI 10.1093/ee/12.3.680; Opender Koul, 2008, Biopesticides International, V4, P63; Price PW., 1997, INSECT ECOLOGY, V3rd edn; RABASSE JM, 1999, DEV PLANT PATHOL, V14, P235; Ramalho FS, 2012, J ECON ENTOMOL, V105, P113, DOI 10.1603/EC11219; Ramalho FS, 2011, AN ACAD BRAS CIENC, V83, P1021, DOI 10.1590/S0001-37652011005000026; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Sanchez JA, 2007, J ECON ENTOMOL, V100, P123, DOI 10.1603/0022-0493(2007)100[123:TAMSFA]2.0.CO;2; SAS Institute, 2006, SAS STAT US GUID; Satar S, 2008, J PLANT DIS PROTECT, V115, P69, DOI 10.1007/BF03356241; Satar S., 1998, Turkiye Entomoloji Dergisi, V22, P187; Satar S, 2005, J PEST SCI, V78, P133, DOI 10.1007/s10340-005-0082-9; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Takalloozadeh Hadji Mohammad, 2010, Middle-East Journal of Scientific Research, V6, P25; Vasicek A, 2002, PESQUI AGROPECU BRAS, V37, P407, DOI 10.1590/S0100-204X2002000300023; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Wilson L. T., 1983, California Agriculture, V37, P4; Zamani AA, 2006, J APPL ENTOMOL, V130, P453, DOI 10.1111/j.1439-0418.2006.01088.x	58	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0122490	10.1371/journal.pone.0122490	http://dx.doi.org/10.1371/journal.pone.0122490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927991	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100009
J	Castaneda-Alvarez, NP; de Haan, S; Juarez, H; Khoury, CK; Achicanoy, HA; Sosa, CC; Bernau, V; Salas, A; Heider, B; Simon, R; Maxted, N; Spooner, DM				Castaneda-Alvarez, Nora P.; de Haan, Stef; Juarez, Henry; Khoury, Colin K.; Achicanoy, Harold A.; Sosa, Chrystian C.; Bernau, Vivian; Salas, Alberto; Heider, Bettina; Simon, Reinhard; Maxted, Nigel; Spooner, David M.			Ex Situ Conservation Priorities for the Wild Relatives of Potato (Solanum L. Section Petota)	PLOS ONE			English	Article							GLOBODERA-PALLIDA STONE; LATE BLIGHT RESISTANCE; TUBER-BEARING SOLANUM; SOMATIC HYBRIDS; CULTIVATED POTATO; PHYTOPHTHORA-INFESTANS; RALSTONIA-SOLANACEARUM; SPECIES DISTRIBUTIONS; ORTHOLOG SEQUENCES; GENETIC-RESOURCES	Crop wild relatives have a long history of use in potato breeding, particularly for pest and disease resistance, and are expected to be increasingly used in the search for tolerance to biotic and abiotic stresses. Their current and future use in crop improvement depends on their availability in ex situ germplasm collections. As these plants are impacted in the wild by habitat destruction and climate change, actions to ensure their conservation ex situ become ever more urgent. We analyzed the state of ex situ conservation of 73 of the closest wild relatives of potato (Solanum section Petota) with the aim of establishing priorities for further collecting to fill important gaps in germplasm collections. A total of 32 species (43.8%), were assigned high priority for further collecting due to severe gaps in their ex situ collections. Such gaps are most pronounced in the geographic center of diversity of the wild relatives in Peru. A total of 20 and 18 species were assessed as medium and low priority for further collecting, respectively, with only three species determined to be sufficiently represented currently. Priorities for further collecting include: (i) species completely lacking representation in germplasm collections; (ii) other high priority taxa, with geographic emphasis on the center of species diversity; (iii) medium priority species. Such collecting efforts combined with further emphasis on improving ex situ conservation technologies and methods, performing genotypic and phenotypic characterization of wild relative diversity, monitoring wild populations in situ, and making conserved wild relatives and their associated data accessible to the global research community, represent key steps in ensuring the long-term availability of the wild genetic resources of this important crop.	[Castaneda-Alvarez, Nora P.; Khoury, Colin K.; Achicanoy, Harold A.; Sosa, Chrystian C.; Bernau, Vivian] CIAT, Decis & Policy Anal Program, Cali, Colombia; [Castaneda-Alvarez, Nora P.; Maxted, Nigel] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [de Haan, Stef; Juarez, Henry; Salas, Alberto; Heider, Bettina] CIP, Global Program Genet Resources, Lima, Peru; [Khoury, Colin K.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands; [Simon, Reinhard] CIP, Integrated IT & Computat Res Unit, Lima, Peru; [Spooner, David M.] Univ Wisconsin, USDA ARS, Dept Hort, Vegetable Crop Res Unit, Madison, WI 53706 USA	Alliance; International Center for Tropical Agriculture - CIAT; University of Birmingham; CGIAR; International Potato Center (CIP); Wageningen University & Research; CGIAR; International Potato Center (CIP); United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Castaneda-Alvarez, NP (corresponding author), CIAT, Decis & Policy Anal Program, Cali, Colombia.	n.p.castaneda@cgiar.org	Álvarez, Nora Patricia Castañeda/I-8026-2015; Arango, Chrystian Camilo Sosa/N-3989-2019; Juarez, Henry/AFN-7756-2022; Sosa, Chrystian Camilo/I-6787-2016; Khoury, Colin K./AAA-1864-2020	Álvarez, Nora Patricia Castañeda/0000-0003-1827-4782; Arango, Chrystian Camilo Sosa/0000-0002-3734-3248; Juarez, Henry/0000-0002-8535-7089; Sosa, Chrystian Camilo/0000-0002-3734-3248; Khoury, Colin K./0000-0001-7893-5744; Simon, Reinhard/0000-0002-4608-9077; Heider, Bettina/0000-0002-9792-8512; Bernau, Vivian/0000-0002-2393-8101	Government of Norway; aforementioned initiative; CGIAR Research Program on Roots, Tubers and Bananas; CGIAR Research Program on Climate Change, Agriculture, and Food Security in Cali, Colombia; ARS [ARS-0424614] Funding Source: Federal RePORTER	Government of Norway; aforementioned initiative; CGIAR Research Program on Roots, Tubers and Bananas; CGIAR Research Program on Climate Change, Agriculture, and Food Security in Cali, Colombia; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was undertaken as part of the initiative "Adapting Agriculture to Climate Change: Conserving, Protecting and Preparing Crop Wild Relatives," which is supported by the Government of Norway. The project is managed by the Global Crop Diversity Trust with the Millennium Seed Bank of the Royal Botanic Gardens, Kew UK and implemented in partnership with national and international genebanks and plant breeding institutes around the world. For further information, go to the project website: http://www.cwrdiversity.org/. Funding was provided by the aforementioned initiative; the CGIAR Research Program on Roots, Tubers and Bananas; and the CGIAR Research Program on Climate Change, Agriculture, and Food Security in Cali, Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames M, 2010, TAXON, V59, P1091, DOI 10.1002/tax.594009; Azurdia C, 2011, ATLAS GUATEMALTECO D; Bivand R, 2014, RGDAL BINDINGS FOR T; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Bradshaw JE, 2005, EUPHYTICA, V146, P9, DOI 10.1007/s10681-005-3881-4; Bradshaw JE., 2006, POTATO RES, V49, P49, DOI [10.1007/s11540-006-9002-5, DOI 10.1007/S11540-006-9002-5]; Cadima X, 2014, J NAT CONSERV, V22, P113, DOI 10.1016/j.jnc.2013.09.007; Cai DY, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-70; Camadro E.L, 2014, BAG, J. basic appl. genet., V25, P41; Camadro EL, 2004, THEOR APPL GENET, V109, P1369, DOI 10.1007/s00122-004-1753-2; Camadro EL, 2012, BOTANY, V90, P1065, DOI 10.1139/b2012-090; CARDI T, 1993, THEOR APPL GENET, V87, P193, DOI 10.1007/BF00223764; Carputo D., 1996, Journal of Genetics and Breeding, V50, P221; Carputo D, 1997, AM POTATO J, V74, P161, DOI 10.1007/BF02851595; delRio AH, 1997, THEOR APPL GENET, V95, P191, DOI 10.1007/s001220050547; delRio AH, 1997, THEOR APPL GENET, V95, P199, DOI 10.1007/s001220050548; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Estrada N, 1991, SOLANACEAE III TAXON; ESTRADA RN, 1980, AM POTATO J, V57, P609, DOI 10.1007/BF02854131; Fajardo D, 2011, SYST BOT, V36, P163, DOI 10.1600/036364411X553252; Frost KE, 2006, EUPHYTICA, V149, P281, DOI 10.1007/s10681-005-9076-1; Gonzalez M, 2013, AGROCIENCIA-URUGUAY, V17, P45; Guarino L, 2011, NAT CLIM CHANGE, V1, P374, DOI 10.1038/nclimate1272; Hanneman RE, 1999, POTATO RES, V42, P283, DOI 10.1007/BF02357859; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Hawkes J. G., 1979, Broadening the genetic base of crops. Proceedings of the conference, Wageningen, Netherlands, 3-7 July 1978, P19; Hawkes JG, 2000, THE EX SITU CONSERVA; Hijmans R.J., 2014, DISMO SPECIES DISTRI; Hijmans R. J., 2014, R PACKAGE VERSION; Hijmans RJ, 2003, EUPHYTICA, V130, P47, DOI 10.1023/A:1022344327669; Hijmans RJ, 2001, AM J BOT, V88, P2101, DOI 10.2307/3558435; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2000, CONSERV BIOL, V14, P1755, DOI [10.1046/j.1523-1739.2000.98543.x, 10.1111/j.1523-1739.2000.98543.x]; Hijmans RJ, 2002, ATLAS OF WILD POTATO, P143; Hijmans RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P485, DOI 10.1111/j.1466-8238.2007.00308.x; Hodgkin T., 2008, P535, DOI 10.1079/9781845930998.0535; Iriondo JM, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P72, DOI 10.1079/9781845938512.0072; Jansky SH, 2013, CROP SCI, V53, P746, DOI 10.2135/cropsci2012.11.0627; Jansky SH, 2006, CROP SCI, V46, P2561, DOI 10.2135/cropsci2005.12.0461; Jansky SH, 2011, AM J POTATO RES, V88, P218, DOI 10.1007/s12230-011-9186-3; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Jo KR, 2011, THEOR APPL GENET, V123, P1331, DOI 10.1007/s00122-011-1670-0; Jones JDG, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0087, 10.1098/rstb.2013.008]; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kraak A., 1992, Industrial Crops and Products, V1, P107, DOI 10.1016/0926-6690(92)90007-I; Laferriere LT, 1999, THEOR APPL GENET, V98, P1272, DOI 10.1007/s001220051193; Lewin-Koh N, 2014, MAPTOOLS TOOLS FOR R; Lindqvist-Kreuze H, 2010, MOL PLANT PATHOL, V11, P513, DOI [10.1111/J.1364-3703.2010.00622.X, 10.1111/j.1364-3703.2010.00622.x]; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu ZY, 2009, AM J POTATO RES, V86, P476, DOI 10.1007/s12230-009-9103-1; Luthra S. K., 2009, Potato Journal (Shimla), V36, P115; MATTHEIJ WM, 1992, THEOR APPL GENET, V83, P459, DOI 10.1007/BF00226534; Maxted N, 2012, BOCCONEA, V24, P115, DOI DOI 10.7320/B0CC25.005); Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; MENDOZA H A, 1974, Hortscience, V9, P328; Naess SK, 2000, THEOR APPL GENET, V101, P697, DOI 10.1007/s001220051533; Narancio R, 2013, EUR J PLANT PATHOL, V136, P823, DOI 10.1007/s10658-013-0210-y; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Ochoa C, 1999, LAS PAPAS DE SUDAMER, P1036; Ochoa C., 1990, THE POTATOES OF SOUT; Ochoa C, 2003, LAS PAPAS DEL PERU B; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ovchinnikova A, 2011, BOT J LINN SOC, V165, P107, DOI 10.1111/j.1095-8339.2010.01107.x; Pavek JJ, 2001, AM J POTATO RES, V78, P433, DOI 10.1007/BF02896375; Pebesma E.J., 2005, R NEWS, V5, P9; Pelletier Y, 2007, AM J POTATO RES, V84, P143, DOI 10.1007/BF02987137; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Team, 2014, R A LANGUAGE AND ENV, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Ramirez-Villegas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013497; Rodriguez F, BMC EVOL BIOL; Ross H., 1979, Broadening the genetic base of crops. Proceedings of the conference, Wageningen, Netherlands, 3-7 July 1978, P237; Ross H, 1986, FORTSCHRITTE DER PFL, V13; RUDORF W., 1958, EUROPEAN POTATO JOUR, V1, P10; Santini M, 2000, AM J POTATO RES, V77, P211, DOI 10.1007/BF02855788; Shan F, 2005, THEOR APPL GENET, V110, P381, DOI 10.1007/s00122-004-1849-8; Simon R, 2011, SYST BOT, V36, P1062, DOI 10.1600/036364411X605065; Simon R, 2010, INVAS PLANT SCI MANA, V3, P286, DOI 10.1614/IPSM-D-09-00043.1; Smyda P, 2013, PLANT CELL REP, V32, P1231, DOI 10.1007/s00299-013-1422-5; Spooner DM, 2014, BOT REV, V80, P283, DOI 10.1007/s12229-014-9146-y; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Spooner DM, 2001, AM J POTATO RES, V78, P237, DOI 10.1007/BF02875691; Stevenson W, 2001, COMPENDIUM OF POTATO; Storlie C., 2014, SDMTOOLS SPECIES DIS; Suarez SI, 2009, J NEMATOL, V41, P5; Thieme R, 2008, THEOR APPL GENET, V116, P691, DOI 10.1007/s00122-007-0702-2; Tucci M, 1996, POTATO RES, V39, P345, DOI 10.1007/BF02357938; UHRIG H, 1981, Z PFLANZENZUCHT, V86, P148; Uitdewillgen J, 2013, PLOS ONE, V8, P1; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; Vice-ministry for the environment biodiversity and climate change (VMABCC), 2009, RED BOOK OF CROP WIL, P340; Villamon FG, 2005, THEOR APPL GENET, V111, P1201, DOI 10.1007/s00122-005-0053-9; Vincent H, 2013, BIOL CONSERV, V167, P265, DOI 10.1016/j.biocon.2013.08.011; Wale SJ, 2008, DISEASES PESTS AND D; Wang Fang, 2011, Molecular Plant Breeding, V2011, P04; Wang MX, 2008, HEREDITY, V101, P527, DOI 10.1038/hdy.2008.61; WATANABE KN, 1995, GENOME, V38, P27, DOI 10.1139/g95-004; WATANABE KN, 1994, THEOR APPL GENET, V88, P135, DOI 10.1007/BF00225888; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiersema JH, 2012, ACTA HORTIC, V948, P285, DOI 10.17660/ActaHortic.2012.948.33	99	38	43	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0122599	10.1371/journal.pone.0122599	http://dx.doi.org/10.1371/journal.pone.0122599			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923711	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600018
J	Gay, MS; Li, Y; Xiong, FX; Lin, T; Zhang, LB				Gay, Maresha S.; Li, Yong; Xiong, Fuxia; Lin, Thant; Zhang, Lubo			Dexamethasone Treatment of Newborn Rats Decreases Cardiomyocyte Endowment in the Developing Heart through Epigenetic Modifications	PLOS ONE			English	Article							CELL-CYCLE CONTROL; GLUCOCORTICOID-RECEPTOR; DNA METHYLATION; CARDIAC MYOCYTES; VENTRICULAR MYOCYTES; MYOCARDIAL-CELLS; HYPERTROPHY; GROWTH; TRANSITION; MATURATION	The potential adverse effect of synthetic glucocorticoid, dexamethasone therapy on the developing heart remains unknown. The present study investigated the effects of dexamethasone on cardiomyocyte proliferation and binucleation in the developing heart of newborn rats and evaluated DNA methylation as a potential mechanism. Dexamethasone was administered intraperitoneally in a three day tapered dose on postnatal day 1 (P1), 2 and 3 to rat pups in the absence or presence of a glucocorticoid receptor antagonist Ru486, given 30 minutes prior to dexamethasone. Cardiomyocytes from P4, P7 or P14 animals were analyzed for proliferation, binucleation and cell number. Dexamethasone treatment significantly increased the percentage of binucleated cardiomyocytes in the hearts of P4 pups, decreased myocyte proliferation in P4 and P7 pups, reduced cardiomyocyte number and increased the heart to body weight ratio in P14 pups. Ru486 abrogated the effects of dexamethasone. In addition, 5-aza-2'-deoxycytidine (5-AZA) blocked the effects of dexamethasone on binucleation in P4 animals and proliferation at P7, leading to recovered cardiomyocyte number in P14 hearts. 5-AZA alone promoted cardiomyocyte proliferation at P7 and resulted in a higher number of cardiomyocytes in P14 hearts. Dexamethasone significantly decreased cyclin D2, but not p27 expression in P4 hearts. 5-AZA inhibited global DNA methylation and blocked dexamethasone-mediated down-regulation of cyclin D2 in the heart of P4 pups. The findings suggest that dexamethasone acting on glucocorticoid receptors inhibits proliferation and stimulates premature terminal differentiation of cardiomyocytes in the developing heart via increased DNA methylation in a gene specific manner.	[Gay, Maresha S.; Li, Yong; Xiong, Fuxia; Zhang, Lubo] Dept Basic Sci, Div Pharmacol, Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [Lin, Thant] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA	Loma Linda University	Zhang, LB (corresponding author), Dept Basic Sci, Div Pharmacol, Ctr Perinatal Biol, Loma Linda, CA 92350 USA.	lzhang@llu.edu		Zhang, Lubo/0000-0002-9386-8938	NIH [HL118861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH HL118861.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bal MP, 2008, J APPL PHYSIOL, V104, P446, DOI 10.1152/japplphysiol.00951.2007; Bal MP, 2009, PEDIATR RES, V66, P74, DOI 10.1203/PDR.0b013e3181a283a0; Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; Brooks G, 1997, J MOL CELL CARDIOL, V29, P2261, DOI 10.1006/jmcc.1997.0471; Brown SE, 2007, EPIGENETICS-US, V2, P54, DOI 10.4161/epi.2.1.3880; CAPASSO JM, 1992, CIRC RES, V71, P1379, DOI 10.1161/01.RES.71.6.1379; Chang KH, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-18; CLUBB FJ, 1984, LAB INVEST, V50, P571; Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD; Crochemore C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0577com; Crudo A, 2013, ENDOCRINOLOGY, V154, P4170, DOI 10.1210/en.2013-1484; Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160; De Vries WB, 2002, PEDIATR RES, V52, P900, DOI 10.1203/01.PDR.0000036281.74804.27; Garland JS, 1999, PEDIATRICS, V104, P91, DOI 10.1542/peds.104.1.91; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Giraud GD, 2006, ENDOCRINOLOGY, V147, P3643, DOI 10.1210/en.2006-0061; GOYA L, 1993, MOL ENDOCRINOL, V7, P1121, DOI 10.1210/me.7.9.1121; Grange T, 2001, ONCOGENE, V20, P3028, DOI 10.1038/sj.onc.1204327; Horky M, 1997, PHYSIOL RES, V46, P233; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jobe AH, 2010, PEDIATR NEONATOL, V51, P7, DOI 10.1016/S1875-9572(10)60003-4; Kamphuis PJGH, 2007, PEDIATR RES, V61, P72, DOI 10.1203/01.pdr.0000249980.95264.dd; Kim MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093407; Kou CYC, 2010, BIOCHEM BIOPH RES CO, V400, P278, DOI 10.1016/j.bbrc.2010.08.064; LaMear NS, 1997, BIOL NEONATE, V72, P175; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037030; Lister K, 2006, CARDIOVASC RES, V70, P555, DOI 10.1016/j.cardiores.2006.02.010; Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X; MCGILL CJ, 1995, CARDIOVASC RES, V30, P557, DOI 10.1016/S0008-6363(95)00113-1; Nagai T, 2001, J MOL CELL CARDIOL, V33, P1769, DOI 10.1006/jmcc.2001.1449; Oakley RH, 2013, P NATL ACAD SCI USA, V110, P17035, DOI 10.1073/pnas.1302546110; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Paradis AN, 2014, DRUG DISCOV TODAY, V19, P602, DOI 10.1016/j.drudis.2013.10.019; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Poolman RA, 1998, J MOL CELL CARDIOL, V30, P2121, DOI 10.1006/jmcc.1998.0808; Porrello ER, 2010, NEONATOLOGY, V97, P257, DOI 10.1159/000253757; Qin Xue CD, 2012, CARDIOVASC RES, V89, P300; Rog-Zielinska EA, 2013, HUM MOL GENET, V22, P3269, DOI 10.1093/hmg/ddt182; Rudolph AM, 1999, PEDIATR RES, V46, P141, DOI 10.1203/00006450-199908000-00002; Sato A, 1996, AM J PHYSIOL-ENDOC M, V271, pE827, DOI 10.1152/ajpendo.1996.271.5.E827; Sharma D, 2013, MOL ENDOCRINOL, V27, P1142, DOI 10.1210/me.2013-1079; Smith E, 2000, J BIOL CHEM, V275, P19992, DOI 10.1074/jbc.M001758200; Torres A, 1997, PEDIATR RES, V42, P139, DOI 10.1203/00006450-199708000-00001; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; WERNER JC, 1992, J PEDIATR-US, V120, P286, DOI 10.1016/S0022-3476(05)80446-9; Whitehurst RM, 1999, J MOL CELL CARDIOL, V31, P1551, DOI 10.1006/jmcc.1999.0990; Xiao YJ, 2000, J PHARMACOL EXP THER, V292, P8	50	30	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125033	10.1371/journal.pone.0125033	http://dx.doi.org/10.1371/journal.pone.0125033			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923220	Green Submitted, gold, Green Published			2022-12-26	WOS:000353711600120
J	Ma, J; Guo, CY; Guo, CW; Sun, Y; Liao, T; Beattie, U; Lopez, FJ; Chen, DF; Lashkari, K				Ma, Jie; Guo, Chenying; Guo, Caiwei; Sun, Yu; Liao, Tiffany; Beattie, Ursula; Lopez, Francisco J.; Chen, Dong Feng; Lashkari, Kameran			Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival	PLOS ONE			English	Article							GROWTH-FACTOR-I; PLURIPOTENT STEM-CELLS; NECROSIS-FACTOR-ALPHA; MOUSE MODEL; TRANSGENIC MICE; POSTNATAL-DEVELOPMENT; INTRAOCULAR-PRESSURE; VENTRICULAR MYOCYTES; BINDING PROTEIN-2; INSULIN-RECEPTOR	We have previously characterized human neuronal progenitor cells (hNP) that can adopt a retinal ganglion cell (RGC)-like morphology within the RGC and nerve fiber layers of the retina. In an effort to determine whether hNPs could be used a candidate cells for targeted delivery of neurotrophic factors (NTFs), we evaluated whether hNPs transfected with an vector that expresses IGF-1 in the form of a fusion protein with tdTomato (TD), would increase RGC survival in vitro and confer neuroprotective effects in a mouse model of glaucoma. RGCs co-cultured with hNP(IGF-TD) cells displayed enhanced survival, and increased neurite extension and branching as compared to hNP(TD) or untransfected hNP cells. Application of various IGF-1 signaling blockers or IGF-1 receptor antagonists abrogated these effects. In vivo, using a model of glaucoma we showed that IOP elevation led to reductions in retinal RGC count. In this model, evaluation of retinal flatmounts and optic nerve cross sections indicated that only hNP(IGF-TD) cells effectively reduced RGC death and showed a trend to improve optic nerve axonal loss. RT-PCR analysis of retina lysates over time showed that the neurotrophic effects of IGF-1 were also attributed to down-regulation of inflammatory and to some extent, angiogenic pathways. This study shows that neuronal progenitor cells that hone into the RGC and nerve fiber layers may be used as vehicles for local production and delivery of a desired NTF. Transplantation of hNP(IGF-TD) cells improves RGC survival in vitro and protects against RGC loss in a rodent model of glaucoma. Our findings have provided experimental evidence and form the basis for applying cell-based strategies for local delivery of NTFs into the retina. Application of cell-based delivery may be extended to other disease conditions beyond glaucoma.	[Ma, Jie; Guo, Chenying; Guo, Caiwei; Sun, Yu; Liao, Tiffany; Beattie, Ursula; Chen, Dong Feng; Lashkari, Kameran] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA 02114 USA; [Lopez, Francisco J.] GlaxoSmithKline, Ophthalmol DPU RD Alternat Discovery & Dev, King Of Prussia, PA 19406 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; GlaxoSmithKline	Lashkari, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA 02114 USA.	kameran_lashkari@meei.harvard.edu	Chen, Dong/AAJ-2444-2020	Chen, Dong/0000-0001-6283-8843; Beattie, Ursula/0000-0002-7131-3712; Guo, Caiwei/0000-0002-9975-9732; Lashkari, Kameran/0000-0003-3855-0246	Canary Charitable Foundation, New York, NY	Canary Charitable Foundation, New York, NY	This work was funded from an unrestricted grant from Canary Charitable Foundation, New York, NY to KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BATCHELOR DC, 1995, J MOL ENDOCRINOL, V15, P105, DOI 10.1677/jme.0.0150105; BEHRINGER RR, 1990, ENDOCRINOLOGY, V127, P1033, DOI 10.1210/endo-127-3-1033; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; BIENZLE D, 1994, P NATL ACAD SCI USA, V91, P350, DOI 10.1073/pnas.91.1.350; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Boyd ZS, 2003, INVEST OPHTH VIS SCI, V44, P5206, DOI 10.1167/iovs.03-0534; Burren CP, 1996, INVEST OPHTH VIS SCI, V37, P1459; Chen GC, 2012, CELL TRANSPLANT, V21, P2621, DOI 10.3727/096368912X647153; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Dana M Reza, 2006, Semin Ophthalmol, V21, P19, DOI 10.1080/08820530500509358; Danias J, 1996, CURRENT EYE RES, V9, P379; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; EPSTEIN RJ, 1987, CORNEA, V6, P250, DOI 10.1097/00003226-198706040-00004; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Galvan V, 2003, J BIOL CHEM, V278, P13325, DOI 10.1074/jbc.M211398200; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; GRANT M, 1986, DIABETES, V35, P416, DOI 10.2337/diabetes.35.4.416; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Heck S, 1999, J BIOL CHEM, V274, P9828, DOI 10.1074/jbc.274.14.9828; Hintz KK, 2002, DIABETES RES CLIN PR, V55, P89, DOI 10.1016/S0168-8227(01)00323-0; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; Kwon J, 2009, CANCER RES, V69, P1350, DOI 10.1158/0008-5472.CAN-08-1328; Laron Z, 1999, BIODRUGS, V11, P55, DOI 10.2165/00063030-199911010-00006; Lenkowski JR, 2014, PROG RETIN EYE RES, V40, P94, DOI 10.1016/j.preteyeres.2013.12.007; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu XJ, 2001, J BIOL CHEM, V276, P32419, DOI 10.1074/jbc.C100299200; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082061; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109305; Mead B, 2013, INVEST OPHTH VIS SCI, V54, P7544, DOI 10.1167/iovs.13-13045; MEYERSCHWICKERATH R, 1993, J CLIN INVEST, V92, P2620, DOI 10.1172/JCI116877; O'Driscoll C, 2006, EXP EYE RES, V83, P1482, DOI 10.1016/j.exer.2006.08.007; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Pearson RA, 2014, BIOTECHNOL ADV, V32, P485, DOI 10.1016/j.biotechadv.2014.01.001; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Ren J, 2003, CARDIOVASC RES, V57, P738, DOI 10.1016/S0008-6363(02)00788-5; Ruecker O, 2008, MOL GENET GENOMICS, V280, P153, DOI 10.1007/s00438-008-0352-3; Seigel G, 2000, MOL VIS, V6, P157; Smith LEH, 1997, SCIENCE, V276, P1706, DOI 10.1126/science.276.5319.1706; Suzuki K, 2004, CIRCULATION, V110, pII219, DOI 10.1161/01.CIR.0000138388.55416.06; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Venters HD, 2000, ANN NY ACAD SCI, V917, P210; WHITE MF, 1988, J BIOL CHEM, V263, P2969; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; XU LC, 1995, P NATL ACAD SCI USA, V92, P4372, DOI 10.1073/pnas.92.10.4372; Yang Q, 2012, INVEST OPHTH VIS SCI, V53, P3733, DOI 10.1167/iovs.12-9814; Ye P, 1997, ENDOCRINOLOGY, V138, P5466, DOI 10.1210/en.138.12.5466; YE P, 1995, J NEUROSCI, V15, P7344; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200	71	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125695	10.1371/journal.pone.0125695	http://dx.doi.org/10.1371/journal.pone.0125695			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923430	Green Submitted, Green Published, gold			2022-12-26	WOS:000353711600158
J	Mumford, JA; Poline, JB; Poldrack, RA				Mumford, Jeanette A.; Poline, Jean-Baptiste; Poldrack, Russell A.			Orthogonalization of Regressors in fMRI Models	PLOS ONE			English	Article								The occurrence of collinearity in fMRI-based GLMs (general linear models) may reduce power or produce unreliable parameter estimates. It is commonly believed that orthogonalizing collinear regressors in the model will solve this problem, and some software packages apply automatic orthogonalization. However, the effects of orthogonalization on the interpretation of the resulting parameter estimates is widely unappreciated or misunderstood. Here we discuss the nature and causes of collinearity in fMRI models, with a focus on the appropriate uses of orthogonalization. Special attention is given to how the two popular fMRI data analysis software packages, SPM and FSL, handle orthogonalization, and pitfalls that may be encountered in their usage. Strategies are discussed for reducing collinearity in fMRI designs and addressing their effects when they occur.	[Mumford, Jeanette A.] Univ Wisconsin, Waisman Ctr, Ctr Investigating Hlth Minds, Madison, WI 53705 USA; [Poline, Jean-Baptiste] Univ Calif Berkeley, Brain Imaging Ctr, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; Stanford University	Mumford, JA (corresponding author), Univ Wisconsin, Waisman Ctr, Ctr Investigating Hlth Minds, Madison, WI 53705 USA.	jeanette.mumford@gmail.com		Poldrack, Russell/0000-0001-6755-0259				Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Mumford JA, 2006, IEEE ENG MED BIOL, V25, P42, DOI 10.1109/MEMB.2006.1607668; Neter J, APPL LINEAR STAT MOD; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pernet CR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00001; Poline J, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P126, DOI 10.1016/B978-012372560-8/50009-7	7	141	142	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0126255	10.1371/journal.pone.0126255	http://dx.doi.org/10.1371/journal.pone.0126255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919488	gold, Green Published			2022-12-26	WOS:000353659400093
J	Williamson, RC; Cowell, CAM; Reville, T; Roper, JA; Rendall, TCS; Bass, MD				Williamson, Rosalind C.; Cowell, Christopher A. M.; Reville, Thomas; Roper, James A.; Rendall, Thomas C. S.; Bass, Mark D.			Coronin-1C Protein and Caveolin Protein Provide Constitutive and Inducible Mechanisms of Rac1 Protein Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolin; endocytosis; fibroblast; fibronectin; migration; Rac (Rac GTPase); trafficking; coronin-1c; syndecan-4	RESONANCE ENERGY-TRANSFER; WOUND REPAIR; DIRECTIONAL MIGRATION; EXTRACELLULAR-MATRIX; CELL-ADHESION; RHO-GTPASES; ACTIVATION; FIBRONECTIN; MEMBRANE; CDC42	Background: Directional migration requires removal of Rac1 from the back of the cell. Results: Coronin-1C and caveolin provide parallel pathways for constitutive recycling or fibronectin-inducible degradation of Rac1. Discussion: Redundant trafficking pathways facilitate polarity while migrating, and responsiveness to chemotactic gradients while stationary. Significance: Maintenance of polarized migration, when the chemotactic gradient has dissipated, is essential for wound healing over a period of days. Sustained directional fibroblast migration requires both polarized activation of the protrusive signal, Rac1, and redistribution of inactive Rac1 from the rear of the cell so that it can be redistributed or degraded. In this work, we determine how alternative endocytic mechanisms dictate the fate of Rac1 in response to the extracellular matrix environment. We discover that both coronin-1C and caveolin retrieve Rac1 from similar locations at the rear and sides of the cell. We find that coronin-1C-mediated extraction, which is responsible for Rac1 recycling, is a constitutive process that maintains Rac1 protein levels within the cell. In the absence of coronin-1C, the effect of caveolin-mediated endocytosis, which targets Rac1 for proteasomal degradation, becomes apparent. Unlike constitutive coronin-1C-mediated trafficking, caveolin-mediated Rac1 endocytosis is induced by engagement of the fibronectin receptor syndecan-4. Such an inducible endocytic/degradation mechanism would predict that, in the presence of fibronectin, caveolin defines regions of the cell that are resistant to Rac1 activation but, in the absence of fibronectin leaves more of the membrane susceptible to Rac1 activation and protrusion. Indeed, we demonstrate that fibronectin-stimulated activation of Rac1 is accelerated in the absence of caveolin and that, when caveolin is knocked down, polarization of active Rac1 is lost in FRET experiments and culminates in shunting migration in a fibrous fibronectin matrix. Although the concept of polarized Rac1 activity in response to chemoattractants has always been apparent, our understanding of the balance between recycling and degradation explains how polarity can be maintained when the chemotactic gradient has faded.	[Williamson, Rosalind C.; Cowell, Christopher A. M.; Reville, Thomas; Roper, James A.; Bass, Mark D.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Rendall, Thomas C. S.] Univ Bristol, Dept Engn, Bristol BS8 1TD, Avon, England; [Bass, Mark D.] Univ Sheffield, Dept Biomed Sci, Ctr Membrane Interact & Dynam, Sheffield S10 2TN, S Yorkshire, England	University of Bristol; University of Bristol; University of Sheffield	Bass, MD (corresponding author), Univ Bristol, Sch Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	mark.bass@sheffield.ac.uk		Roper, James/0000-0002-8910-6033; Bass, Mark/0000-0002-8854-9705; Rendall, Thomas/0000-0001-8930-4307	Wellcome Trust [088419]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant 088419 (to M. D. B.).	Barrientos S, 2014, WOUND REPAIR REGEN, V22, P569, DOI 10.1111/wrr.12205; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bass MD, 2011, DEV CELL, V21, P681, DOI 10.1016/j.devcel.2011.08.007; Bridgewater RE, 2012, J CELL SCI, V125, P3695, DOI 10.1242/jcs.095810; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hassanain HH, 2005, SURGERY, V137, P92, DOI 10.1016/j.surg.2004.06.012; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kwon AH, 2007, EXP BIOL MED, V232, P935; Liu SX, 2009, AM J PATHOL, V174, P1847, DOI 10.2353/ajpath.2009.080779; Lynch EA, 2006, MOL BIOL CELL, V17, P2236, DOI 10.1091/mbc.E05-08-0779; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; MAKAREM R, 1994, J BIOL CHEM, V269, P4005; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Ojeda V, 2014, MOL CELL BIOL, V34, P3388, DOI 10.1128/MCB.00347-14; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Prieto-Sanchez RM, 2006, ONCOGENE, V25, P2961, DOI 10.1038/sj.onc.1209333; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Razani B, 2001, J BIOL CHEM, V276, P38121; Rosentreter A, 2007, EXP CELL RES, V313, P878, DOI 10.1016/j.yexcr.2006.12.015; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Spoerl Z, 2002, J BIOL CHEM, V277, P48858, DOI 10.1074/jbc.M205136200; Visvikis O, 2008, FEBS J, V275, P386, DOI 10.1111/j.1742-4658.2007.06209.x; Wang ZG, 2013, ONCOL REP, V29, P1066, DOI 10.3892/or.2012.2216; Williamson RC, 2014, J CELL SCI, V127, P4292, DOI 10.1242/jcs.154864; Xavier Charks-Paer, 2008, V48, P98, DOI 10.1007/978-0-387-09595-0_9	37	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15437	15449		10.1074/jbc.M115.640367	http://dx.doi.org/10.1074/jbc.M115.640367			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25925950	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000356527400011
J	Banu, S; Rahman, MT; Uddin, MKM; Khatun, R; Khan, MSR; Rahman, MM; Uddin, SI; Ahmed, T; Heffelfinger, JD				Banu, Sayera; Rahman, Md. Toufiq; Uddin, Mohammad Khaja Mafij; Khatun, Razia; Khan, Md. Siddiqur Rahman; Rahman, Md. Mojibur; Uddin, Syed Iftekhar; Ahmed, Tahmeed; Heffelfinger, James D.			Effect of Active Case Finding on Prevalence and Transmission of Pulmonary Tuberculosis in Dhaka Central Jail, Bangladesh	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; PRISON; STRAIN	Background Understanding tuberculosis (TB) transmission dynamics is essential for establishing effective TB control strategies in settings where the burden and risk of transmission are high. The objectives of this study were to evaluate the effect of active screening on controlling TB transmission and also to characterize Mycobacterium tuberculosis strains for investigating transmission dynamics in a correctional setting. Methods The study was carried out in Dhaka Central Jail (DCJ), from October 2005 to February 2010. An active case finding strategy for pulmonary TB was established both at the entry point to the prison and inside the prison. Three sputum specimens were collected from all pulmonary TB suspects and subjected to smear microscopy, culture, and drug susceptibility testing as well as genotyping which included deletion analysis, spoligotyping and analysis of mycobacterial interspersed repetitive units (MIRU). Results A total of 60,585 inmates were screened during the study period. We found 466 inmates with pulmonary TB of whom 357 (77%) had positive smear microscopy results and 109 (23%) had negative smear microscopy results but had positive results on culture. The number of pulmonary TB cases declined significantly, from 49 cases during the first quarter to 8 cases in the final quarter of the study period (p=0.001). Deletion analysis identified all isolates as M. tuberculosis and further identified 229 (70%) strains as 'modern' and 100 (30%) strains as 'ancestral'. Analysis of MIRU showed that 347 strains (85%) exhibited unique patterns, whereas 61 strains (15%) clustered into 22 groups. The largest cluster comprised eight strains of the Beijing M. tuberculosis type. The rate of recent transmission was estimated to be 9.6%. Conclusions Implementation of active screening for TB was associated with a decline in TB cases in DCJ. Implementation of active screening in prison settings might substantially reduce the national burden of TB in Bangladesh.	[Banu, Sayera; Rahman, Md. Toufiq; Uddin, Mohammad Khaja Mafij; Khatun, Razia; Khan, Md. Siddiqur Rahman; Ahmed, Tahmeed; Heffelfinger, James D.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Rahman, Md. Mojibur] Directorate Gen Hlth Serv, Natl TB Control Program, Dhaka, Bangladesh; [Uddin, Syed Iftekhar] Directorate Prisons, Dhaka, Bangladesh; [Heffelfinger, James D.] US Ctr Dis Control & Prevent, Global Dis Detect Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA	Banu, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	sbanu@icddrb.org	Rahman Khan, Mohammad Siddiqur/J-3025-2018	Rahman Khan, Mohammad Siddiqur/0000-0003-2479-6405; Banu, Sayera/0000-0002-5121-1962	Government of the People's Republic of Bangladesh (GoB);  [GR-00410]	Government of the People's Republic of Bangladesh (GoB); 	This research protocol was funded by Government of the People's Republic of Bangladesh (GoB). The grant number was GR-00410 and SB received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES H, 1970, AM REV RESPIR DIS, V101, P706; [Anonymous], 1901, PRISONS RULES LOCAL, P4; Bangladesh Go, 2013, NAT GUID OP MAN TUB; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Banu S, 2012, INT J TUBERC LUNG D, V16, P319, DOI 10.5588/ijtld.11.0426; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Banu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040545; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Brudey K, 2004, J CLIN MICROBIOL, V42, P3046, DOI 10.1128/JCM.42.7.3046-3051.2004; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; CHEVRELDELLAGI D, 1993, J CLIN MICROBIOL, V31, P2446, DOI 10.1128/JCM.31.9.2446-2450.1993; Dara M, 2009, GUIDELINES CONTROL T; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KING L, 1977, JAMA-J AM MED ASSOC, V237, P791, DOI 10.1001/jama.237.8.791; Kononets A S, 2004, Probl Tuberk Bolezn Legk, P18; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mihret A, 2013, AFR HEALTH SCI, V12, P339; Niveau G, 2006, PUBLIC HEALTH, V120, P33, DOI 10.1016/j.puhe.2005.03.017; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Reyes H, 1997, BRIT MED J, V315, P1447, DOI 10.1136/bmj.315.7120.1447; Reyes H, 2007, INT J PRISON HEALTH, V3, P43, DOI 10.1080/17449200601149148; SKOLER DL, 1975, J INT LAW ECON, V10, P453; STEAD WW, 1978, JAMA-J AM MED ASSOC, V240, P2544, DOI 10.1001/jama.240.23.2544; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Trebucq A, 1999, LANCET, V353, P2244, DOI 10.1016/S0140-6736(05)76293-0; Tuberculosis Coalition for Technical Assistance and the International Committee of the Red Cross, 2009, GUID CONTR TUB PRIS; Uddin Mohammad Khaja Mafij, 2013, BMC Res Notes, V6, P291, DOI 10.1186/1756-0500-6-291; VALWAY SE, 1994, AM J EPIDEMIOL, V140, P113, DOI 10.1093/oxfordjournals.aje.a117222; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; WHO, 2014, JOINT MON MISS BANGL	32	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124976	10.1371/journal.pone.0124976	http://dx.doi.org/10.1371/journal.pone.0124976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933377	gold, Green Submitted, Green Published			2022-12-26	WOS:000353887100069
J	Forn, M; Diez-Villanueva, A; Merlos-Suarez, A; Munoz, M; Lois, S; Carrio, E; Jorda, M; Bigas, A; Batlle, E; Peinado, MA				Forn, Marta; Diez-Villanueva, Anna; Merlos-Suarez, Anna; Munoz, Mar; Lois, Sergi; Carrio, Elvira; Jorda, Mireia; Bigas, Anna; Batlle, Eduard; Peinado, Miguel A.			Overlapping DNA Methylation Dynamics in Mouse Intestinal Cell Differentiation and Early Stages of Malignant Progression	PLOS ONE			English	Article							CPG ISLAND METHYLATION; STEM-CELLS; COLORECTAL-CANCER; HUMAN COLON; IN-VITRO; CHROMOSOMAL INSTABILITY; GENE-EXPRESSION; HYPOMETHYLATION; GENOME; METHYLOME	Mouse models of intestinal crypt cell differentiation and tumorigenesis have been used to characterize the molecular mechanisms underlying both processes. DNA methylation is a key epigenetic mark and plays an important role in cell identity and differentiation programs and cancer. To get insights into the dynamics of cell differentiation and malignant transformation we have compared the DNA methylation profiles along the mouse small intestine crypt and early stages of tumorigenesis. Genome-scale analysis of DNA methylation together with microarray gene expression have been applied to compare intestinal crypt stem cells (EphB2(high)), differentiated cells (EphB2(negative)), Apc(Min/+) adenomas and the corresponding non-tumor adjacent tissue, together with small and large intestine samples and the colon cancer cell line CT26. Compared with late stages, small intestine crypt differentiation and early stages of tumorigenesis display few and relatively small changes in DNA methylation. Hypermethylated loci are largely shared by the two processes and affect the proximities of promoter and enhancer regions, with enrichment in genes associated with the intestinal stem cell signature and the PRC2 complex. The hypermethylation is progressive, with minute levels in differentiated cells, as compared with intestinal stem cells, and reaching full methylation in advanced stages. Hypomethylation shows different signatures in differentiation and cancer and is already present in the non-tumor tissue adjacent to the adenomas in Apc(Min/+) mice, but at lower levels than advanced cancers. This study provides a reference framework to decipher the mechanisms driving mouse intestinal tumorigenesis and also the human counterpart.	[Forn, Marta; Diez-Villanueva, Anna; Munoz, Mar; Lois, Sergi; Carrio, Elvira; Jorda, Mireia; Peinado, Miguel A.] IMPPC, Badalona 08916, Barcelona, Spain; [Merlos-Suarez, Anna; Batlle, Eduard] IRB Barcelona, Barcelona 08028, Spain; [Bigas, Anna] Inst Hosp Mar Invest Med IMIM, Barcelona 08003, Spain; [Batlle, Eduard] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); ICREA	Peinado, MA (corresponding author), IMPPC, Badalona 08916, Barcelona, Spain.	map@imppc.org	Forn, Marta/R-2808-2016; Bigas, Anna/A-7457-2014; Jordà, Mireia/Z-4519-2019; Peinado, Miguel A./A-5591-2008; Carrio Gaspar, Elvira/R-3371-2018; Batlle, Eduard/K-8080-2014	Forn, Marta/0000-0002-0230-0141; Peinado, Miguel A./0000-0002-4090-793X; Carrio Gaspar, Elvira/0000-0002-0435-3423; Batlle, Eduard/0000-0003-2422-0326; Bigas, Anna/0000-0003-4801-6899; Jorda, Mireia/0000-0003-3709-1850	Ministerio de Economia y Competitividad [PTC2011-1091, SAF2011/23638]; ERC; ICREA Funding Source: Custom	Ministerio de Economia y Competitividad(Spanish Government); ERC(European Research Council (ERC)European Commission); ICREA(ICREA)	MF and EC were supported by respective FPI fellowships from the Ministerio de Economia y Competitividad. AMS held an AECC postdoctoral fellowship. AD-V was supported in part by a contract PTC2011-1091 from Ministerio de Economia y Competitividad. This work was supported by grants from the Ministerio de Economia y Competitividad (SAF2011/23638) to MAP; and an ERC grant to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barrera V, 2012, NUCLEIC ACIDS RES, V40, P11490, DOI 10.1093/nar/gks928; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Carrio E, 2015, STEM CELLS IN PRESS; Chandra Sruti, 2014, Biology (Basel), V3, P426, DOI 10.3390/biology3020426; Clark SJ, 2007, HUM MOL GENET, V16, pR88, DOI 10.1093/hmg/ddm051; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Cortese R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026002; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Forn M, 2013, MOL ONCOL, V7, P1129, DOI 10.1016/j.molonc.2013.08.008; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Frigola J, 2005, ONCOGENE, V24, P7320, DOI 10.1038/sj.onc.1208883; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Frigola J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e28; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Graham TA, 2011, GASTROENTEROLOGY, V140, P1241, DOI 10.1053/j.gastro.2010.12.036; Grimm C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003250; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JPJ, 2001, CANCER RES, V61, P3573; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Javierre BM, 2011, MOL CANCER RES, V9, P1139, DOI 10.1158/1541-7786.MCR-10-0515; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jorda M, 2010, MUTAT RES-FUND MOL M, V693, P84, DOI 10.1016/j.mrfmmm.2010.06.010; Jorda Mireia, 2009, V507, P107, DOI 10.1007/978-1-59745-522-0_9; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kaaij LTJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r50; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mallona I, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-11; Mayor R, 2009, BRIT J CANCER, V100, P1534, DOI 10.1038/sj.bjc.6605045; McCabe MT, 2009, CANCER RES, V69, P282, DOI 10.1158/0008-5472.CAN-08-3274; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; Muto Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-466; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ong CT, 2012, EMBO REP, V13, P423, DOI 10.1038/embor.2012.52; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Paz MF, 2003, HUM MOL GENET, V12, P2209, DOI 10.1093/hmg/ddg226; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Sadikovic B, 2004, BREAST CANCER RES, V6, pR329, DOI 10.1186/bcr799; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Yamada Y, 2007, CANCER SCI, V98, P6, DOI 10.1111/j.1349-7006.2006.00348.x; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	84	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123263	10.1371/journal.pone.0123263	http://dx.doi.org/10.1371/journal.pone.0123263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933092	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100018
J	Hu, HB; Zhu, XY; Joshi, S; Lu, L; Xia, CQ; Patel, JM				Hu, Hanbo; Zhu, Xiaoyan; Joshi, Sunil; Lu, Li; Xia, Chang-Qing; Patel, Jawaharlal M.			Thioredoxin Priming Prolongs Lung Allograft Survival by Promoting Immune Tolerance	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; IMMATURE DENDRITIC CELLS; CD4(+) T-CELLS; REJECTION; TRANSPLANTATION; INDUCTION; ACTIVATION; EXPRESSION; THERAPY; MICE	Tolerance to allograft antigen is the major challenge and final goal of transplant medicine. Our previous study demonstrated that thioredoxin-1 (Trx) priming of donor lung significantly protected allogeneic lung graft. To determine whether Trx priming of donor lung inhibits allograft rejection, extends allograft survival and induces immune tolerance, orthotopic left lung transplantation was performed from Lewis to Sprague-Dawley rats without immunosuppression. Donor lungs were primed with Trx at 4 degrees C for 4 hr prior to transplantation. After up to 37 days post-transplantation, allograft lung morphology, recipient T cell and humoral alloantigen-specific immune responses were examined. We found that Trx-primed lungs exhibited much reduced acute rejection and associated lung injuries resulting in loss of graft functional area at 5-37 days post-transplant in contrast to the control groups. CD4(+) T cells from the recipients with Trx-primed grafts responded to the stimulation of dendritic cells (DCs) of donor origin, in contrast to DCs from the third party, with significantly reduced proliferation. Consistent with above findings, we observed that CD4(+)Foxp3(+) regulatory T cells in spleen cells from the recipients with Trx-primed grafts were significantly increased compared to controls, and CD4(+) T cells from the recipients with Trx-primed grafts produced much higher levels of immunosuppressive cytokine, IL-10 when stimulated with allogeneic donor DCs. In addition, humoral immune tolerance was also induced as there was no significant increase levels of serum antibodies against donor antigens in Trx-lung recipients when re-challenged with allogeneic donor antigens. Our results demonstrate that one-time Trx-priming of donor lung grafts prior to transplantation significantly prolongs the survival of the grafts through inducing or promoting cellular and humoral alloantigen-specific immune tolerance, which might be associated with the induction of immunosuppressive regulatory T cells.	[Hu, Hanbo; Zhu, Xiaoyan; Patel, Jawaharlal M.] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32608 USA; [Joshi, Sunil; Lu, Li; Xia, Chang-Qing] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32608 USA; [Lu, Li; Patel, Jawaharlal M.] North Florida South Georgia Vet Hlth Syst, Res Serv, Gainesville, FL 32608 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Xia, CQ (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32608 USA.	xia@pathology.ufl.edu; Pateljm@medicine.ufl.edu		Joshi, Sunil/0000-0001-8230-980X	Department of Medicine's Gatorade [00100966]; Research Service of the VHS	Department of Medicine's Gatorade; Research Service of the VHS	This study was supported by the Department of Medicine's Gatorade funding project #00100966 and the Research Service of the VHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfi G, 2012, MOL THER, V20, P1778, DOI 10.1038/mt.2012.71; Bhorade SM, 2010, TRANSPLANTATION, V90, P540, DOI 10.1097/TP.0b013e3181e8dabe; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bozulic LD, 2011, TRANSPLANTATION, V91, P908, DOI 10.1097/TP.0b013e31820fafb4; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1104, DOI 10.1016/j.healun.2010.08.004; Fan HM, 2009, INT J CLIN EXP MED, V2, P212; Glantzounis GK, 2006, CURR PHARM DESIGN, V12, P2891, DOI 10.2174/138161206777947641; Gregori S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00030; Hattori I, 2004, ANTIOXID REDOX SIGN, V6, P81, DOI 10.1089/152308604771978372; Hirayama S, 2013, AM J TRANSPLANT, V13, P1586, DOI 10.1111/ajt.12230; Hu HB, 2008, J HEART LUNG TRANSPL, V27, P1142, DOI 10.1016/j.healun.2008.07.006; Jeon SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002714; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; Lemaitre PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070236; Mauiyyedi S, 2001, J AM SOC NEPHROL, V12, P574, DOI 10.1681/ASN.V123574; McManigle W, 2013, SEMIN RESP CRIT CARE, V34, P320, DOI 10.1055/s-0033-1348471; Nakamura T, 2005, ANTIOXID REDOX SIGN, V7, P60, DOI 10.1089/ars.2005.7.60; Regateiro FS, 2012, J IMMUNOL, V189, P3947, DOI 10.4049/jimmunol.1200449; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shibuki H, 1998, INVEST OPHTH VIS SCI, V39, P1470; Shibuki H, 2000, INVEST OPHTH VIS SCI, V41, P3607; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Tolar J, 2014, EXP DERMATOL, V23, P97, DOI 10.1111/exd.12227; Xia CQ, 2005, TRANSFUSION, V45, P181, DOI 10.1111/j.1537-2995.2004.04137.x; Yoon IH, 2008, TRANSPLANTATION, V86, P1352, DOI 10.1097/TP.0b013e31818aa43c; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; Zhi L, 2012, J IMMUNOL, V189, P1639, DOI 10.4049/jimmunol.1200528; Zhou F, 2013, IMMUNOL RES, V56, P1, DOI 10.1007/s12026-012-8382-7	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0124705	10.1371/journal.pone.0124705	http://dx.doi.org/10.1371/journal.pone.0124705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933390	Green Submitted, Green Published, gold			2022-12-26	WOS:000353887100056
J	Lorente, L; Martin, MM; Abreu-Gonzalez, P; Ramos, L; Argueso, M; Sole-Violan, J; Riano-Ruiz, M; Jimenez, A				Lorente, Leonardo; Martin, Maria M.; Abreu-Gonzalez, Pedro; Ramos, Luis; Argueso, Monica; Sole-Violan, Jordi; Riano-Ruiz, Marta; Jimenez, Alejandro			Serum Malondialdehyde Levels in Patients with Malignant Middle Cerebral Artery Infarction Are Associated with Mortality	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MITIGATES OXIDATIVE DAMAGE; LIPID-PEROXIDATION; ANTIOXIDANT SUPPLEMENTATION; COMPENSATORY REACTIONS; PLASMA; CAPACITY; OUTCOMES; DISEASE; STRESS	Objective Malondialdehyde (MDA) is an end-product formed during lipid peroxidation, due to degradation of cellular membrane phospholipids. MDA is released into extracellular space and finally into the blood; it has been used as an effective biomarker of lipid oxidation. High circulating levels of MDA have been previously described in patients with ischemic stoke than in controls, and an association between circulating MDA levels and neurological functional outcome in patients with ischemic stoke. However, an association between serum MDA levels and mortality in patients with ischemic stroke has not been previously reported, and that was the objective of this study. Methods Observational, prospective and multicenter study performed in six Intensive Care Units. We included patients with severe malignant middle cerebral artery infarction (MMCAI) defined as Glasgow Coma Scale (GCS) lower than 9. We measured serum MDA levels in 50 patients with severe MMCAI at the time of diagnosis and in 100 healthy subjects. Mortality at 30 days was the end point of the study. Results We found that patients with severe MMCAI showed higher serum MDA levels than healthy subjects (p < 0.001). We found higher serum MDA levels (p < 0.001) in non-surviving MMCAI patients (n = 26) than in survivors (n = 24). The area under the curve for prediction of 30-day mortality for serum MDA levels was 0.77 (95% CI = 0.63-0.88; p < 0.001). Serum MDA levels >2.27 nmol/mL were associated with 30-day mortality (OR = 7.23; 95% CI = 1.84-28.73; p=0.005) controlling for GCS and age on multiple binomial logistic regression analysis. Conclusions To our knowledge, this is the first study showing that serum malondialdehyde levels in patients with MMCAI are associated with early mortality.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Med, Dept Phisiol, E-38207 San Cristobal la Laguna, Santa Cruz De T, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain; [Argueso, Monica] Univ Valencia, Hosp Clin, Intens Care Unit, Valencia, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CIBERES, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Riano-Ruiz, Marta] Univ Insular Materno Infantil, Complejo Hosp, Serv Bioquim Clin, Las Palmas Gran Canaria, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna, Santa Cruz De T, Spain	Universidad de la Laguna; Universidad de la Laguna; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universidad de la Laguna	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife, Spain.	lorentemartin@msn.com	Martín, María/HDL-9512-2022; Abreu-Gonzalez, Pedro/AAC-7790-2020	Abreu-Gonzalez, Pedro/0000-0002-7553-1784; Argueso, Monica/0000-0001-5917-1056	Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain)	Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain)	Fundings from Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Alferova VV, 2011, ZH NEVROL PSIKHIATR, V111, P36; Alferova VV, 2010, ZH NEVROL PSIKHIATR, V110, P36; Bir LS, 2006, TOHOKU J EXP MED, V208, P33, DOI 10.1620/tjem.208.33; Bolokadze N, 2004, CLIN HEMORHEOL MICRO, V30, P99; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chen Jian-hua, 2003, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V15, P232; Correa MD, 2008, BIOMED PHARMACOTHER, V62, P317, DOI 10.1016/j.biopha.2007.10.002; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; FRANCESCO V, 1985, STROKE, V16, P14, DOI 10.1161/01.STR.16.1.14; IMRE SG, 1994, STROKE, V25, P2416, DOI 10.1161/01.STR.25.12.2416; Katzan IL, 2014, STROKE, V45, P918, DOI 10.1161/01.str.0000441948.35804.77; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Lorente L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053741; Ozkul A, 2007, J CLIN NEUROSCI, V14, P1062, DOI 10.1016/j.jocn.2006.11.008; Polidori MC, 2002, FREE RADICAL RES, V36, P265, DOI 10.1080/10715760290019273; SANTOS MT, 1980, J CLIN PATHOL, V33, P973, DOI 10.1136/jcp.33.10.973; Silina EV, 2011, ZH NEVROL PSIKHIATR, V111, P36; TEASDALE G, 1974, LANCET, V2, P81; Thanoon Imad A-J, 2012, Sultan Qaboos Univ Med J, V12, P197; Ullegaddi R, 2005, EUR J CLIN NUTR, V59, P1367, DOI 10.1038/sj.ejcn.1602248; Ullegaddi R, 2004, CLIN SCI, V107, P477, DOI 10.1042/CS20040134; Ullegaddi R, 2006, JPEN-PARENTER ENTER, V30, P108, DOI 10.1177/0148607106030002108; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Yang TH, 2004, CLIN BIOCHEM, V37, P494, DOI 10.1016/j.clinbiochem.2004.02.006; Yavorskaya VA, 2000, ZH NEVROPATOL PSIKH, V100, P48; Zhang JL, 1994, CHUNG KUO CHUNG HIS, V14, P478	29	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0125893	10.1371/journal.pone.0125893	http://dx.doi.org/10.1371/journal.pone.0125893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933254	gold, Green Published, Green Submitted			2022-12-26	WOS:000353887100139
J	Yamaguchi, Y; Li, ZQ; Zhu, XF; Liu, CC; Zhang, DW; Dou, XM				Yamaguchi, Yoshinori; Li, Zhenqing; Zhu, Xifang; Liu, Chenchen; Zhang, Dawei; Dou, Xiaoming			Polyethylene Oxide (PEO) and Polyethylene Glycol (PEG) Polymer Sieving Matrix for RNA Capillary Electrophoresis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; POLY(ETHYLENE OXIDE); DNA SEPARATION; NUCLEIC-ACIDS; BEHAVIOR; DYNAMICS; TEMPERATURE; MORPHOLOGY; FRAGMENTS; SIZE	The selection of sieving polymer for RNA fragments separation by capillary electrophoresis is imperative. We investigated the separation of RNA fragments ranged from 100 to 10,000 nt in polyethylene glycol (PEG) and polyethylene oxide (PEO) solutions with different molecular weight and different concentration. We found that the separation performance of the small RNA fragments (<1000 nt) was improved with the increase of polymer concentration, whereas the separation performance for the large ones (>4000 nt) deteriorated in PEG/PEO solutions when the concentration was above 1.0%/0.6%, respectively. By double logarithmic plot of mobility and RNA fragment size, we revealed three migration regimes for RNA in PEG (300-500k) and PEO (4,000k). Moreover, we calculated the smallest resolvable nucleotide length (N-min) from the resolution length analysis.	[Li, Zhenqing; Liu, Chenchen; Zhang, Dawei] E China Univ Sci & Technol, Grad Sch Sci, IPBM, Shanghai 200237, Peoples R China; [Yamaguchi, Yoshinori; Dou, Xiaoming] Univ Shanghai Sci & Technol, Engn Res Ctr Opt Instrument & Syst, Shanghai Key Lab Modern Opt Syst, Minist Educ, Shanghai 200093, Peoples R China; [Yamaguchi, Yoshinori] Osaka Univ, Grad Sch Engn, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Zhu, Xifang] Changzhou Inst Technol, Coll Photoelect Engn, Changzhou 213002, Peoples R China	East China University of Science & Technology; University of Shanghai for Science & Technology; Osaka University; Changzhou Institute of Technology	Li, ZQ (corresponding author), E China Univ Sci & Technol, Grad Sch Sci, IPBM, 130 Meilong Rd, Shanghai 200237, Peoples R China.	zhenqingli@163.com; xiaomingdou@yeah.net	Zhang, Dawei/K-4719-2018	li, zhenqing/0000-0001-9060-7305; Liu, Chenchen/0000-0001-9148-8029	JSPS, Japan [25600049]; National Natural Science Foundation of China [21205078, 61378060]; Research Fund for the Doctoral Program of Higher Education of China [20123120110002]; Innovation Fund Project for Graduate Student of Shanghai, China [JWCXSL1401]	JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Innovation Fund Project for Graduate Student of Shanghai, China	This project was partly supported by Grant-in-Aid for Scientific Research (Houga) (No. 25600049 (Y.Y.)), JSPS, Japan. The authors also gratefully acknowledge support from National Natural Science Foundation of China (No. 21205078 and No. 61378060), Research Fund for the Doctoral Program of Higher Education of China (No. 20123120110002), and the Innovation Fund Project for Graduate Student of Shanghai (No. JWCXSL1401), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2011, ANAL CHEM, V83, P1350, DOI 10.1021/ac102671n; Balijepalli S, 1996, MACROMOLECULES, V29, P6601, DOI 10.1021/ma960678s; BARRON AE, 1993, J CHROMATOGR A, V652, P3, DOI 10.1016/0021-9673(93)80639-P; Bernard Tinland AP, 1997, MACROMOLECULES, V30, P5763; BIEZE TWN, 1994, MACROMOLECULES, V27, P1355, DOI 10.1021/ma00084a013; Briscoe B, 1996, MACROMOLECULES, V29, P6208, DOI 10.1021/ma960667z; CHEN JH, 1995, J POLYM SCI POL PHYS, V33, P1851, DOI 10.1002/polb.1995.090331301; CHENG SZD, 1991, J POLYM SCI POL PHYS, V29, P311, DOI 10.1002/polb.1991.090290306; Guttman A, 1996, NATURE, V380, P461, DOI 10.1038/380461a0; Heller C, 2001, ELECTROPHORESIS, V22, P629, DOI 10.1002/1522-2683(200102)22:4<629::AID-ELPS629>3.0.CO;2-S; HJERTEN S, 1985, J CHROMATOGR, V347, P191, DOI 10.1016/S0021-9673(01)95485-8; Kan CW, 2003, ELECTROPHORESIS, V24, P55, DOI 10.1002/elps.200390031; KARGER BL, 1989, NATURE, V339, P641, DOI 10.1038/339641a0; Kim Y, 1997, J CHROMATOGR A, V781, P315, DOI 10.1016/S0021-9673(97)00472-X; Kim YS, 1997, ELECTROPHORESIS, V18, P2901, DOI 10.1002/elps.1150181530; Li Q, 2010, ANAL CHEM, V82, P5260, DOI 10.1021/ac100669z; Li ZQ, 2014, ANALYST, V139, P6113, DOI 10.1039/c4an01649a; Li ZQ, 2014, ANAL METHODS-UK, V6, P2473, DOI 10.1039/c3ay41965g; Li ZQ, 2014, J CHROMATOGR A, V1331, P100, DOI 10.1016/j.chroma.2014.01.021; Li ZQ, 2012, J CHROMATOGR A, V1229, P274, DOI 10.1016/j.chroma.2012.01.056; Li ZQ, 2011, ANAL BIOANAL CHEM, V401, P1661, DOI 10.1007/s00216-011-5228-4; Li ZQ, 2010, ELECTROPHORESIS, V31, P3531, DOI 10.1002/elps.201000175; Li ZQ, 2010, J SEP SCI, V33, P2811, DOI 10.1002/jssc.201000188; Lines JA, 2014, BIOCHEM BIOPH RES CO, V443, P308, DOI 10.1016/j.bbrc.2013.11.095; Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k; Masubuchi Y, 1996, ELECTROPHORESIS, V17, P1065, DOI 10.1002/elps.1150170615; Merdas A, 1996, J PHYS CHEM-US, V100, P15180, DOI 10.1021/jp960628p; Mitchelson KR, 2004, CAPILLARY ELECTROPHO; OANA H, 1994, MACROMOLECULES, V27, P6061, DOI 10.1021/ma00099a019; SHI XL, 1995, ANAL CHEM, V67, P3219, DOI 10.1021/ac00114a018; SLATER GW, 1993, ELECTROPHORESIS, V14, P1, DOI 10.1002/elps.1150140102; Slater GW, 2001, METH MOL B, V162, P27; Slater GW, 2000, ELECTROPHORESIS, V21, P3873, DOI 10.1002/1522-2683(200012)21:18<3873::AID-ELPS3873>3.3.CO;2-#; Sumitomo K, 2009, ELECTROPHORESIS, V30, P3607, DOI 10.1002/elps.200900255; Sumitomo K, 2009, ELECTROPHORESIS, V30, P1538, DOI 10.1002/elps.200800457; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Todorov TI, 2003, ANAL CHEM, V75, P1837, DOI 10.1021/ac026325a; Todorov TI, 2002, ELECTROPHORESIS, V23, P1033, DOI 10.1002/1522-2683(200204)23:7/8<1033::AID-ELPS1033>3.0.CO;2-7; VIOVY JL, 1993, ELECTROPHORESIS, V14, P322, DOI 10.1002/elps.1150140155; Yamaguchi Y, 2004, ELECTROPHORESIS, V25, P999, DOI 10.1002/elps.200305783; Yu ZQ, 2013, J AM CHEM SOC, V135, P2883, DOI 10.1021/ja311090e; Yu ZQ, 2010, ANAL BIOCHEM, V397, P197, DOI 10.1016/j.ab.2009.10.030	42	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2015	10	5							e0123406	10.1371/journal.pone.0123406	http://dx.doi.org/10.1371/journal.pone.0123406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XA	25933347	Green Submitted, gold, Green Published			2022-12-26	WOS:000353887100020
J	Brand, B; Hadlich, F; Brandt, B; Schauer, N; Graunke, KL; Langbein, J; Repsilber, D; Ponsuksili, S; Schwerin, M				Brand, Bodo; Hadlich, Frieder; Brandt, Bettina; Schauer, Nicolas; Graunke, Katharina L.; Langbein, Jan; Repsilber, Dirk; Ponsuksili, Siriluk; Schwerin, Manfred			Temperament Type Specific Metabolite Profiles of the Prefrontal Cortex and Serum in Cattle	PLOS ONE			English	Article							OXIDATIVE STRESS; 5-ALPHA-REDUCED GLUCOCORTICOIDS; N-ACYLETHANOLAMINES; MILK-PRODUCTION; FLIGHT SPEED; ALLOPREGNANOLONE; BRAIN; CONSISTENCY; FEAR; IDENTIFICATION	In the past decade the number of studies investigating temperament in farm animals has increased greatly because temperament has been shown not only to affect handling but also reproduction, health and economically important production traits. However, molecular pathways underlying temperament and molecular pathways linking temperament to production traits, health and reproduction have yet to be studied in full detail. Here we report the results of metabolite profiling of the prefrontal cortex and serum of cattle with distinct temperament types that were performed to further explore their molecular divergence in the response to the slaughter procedure and to identify new targets for further research of cattle temperament. By performing an untargeted comprehensive metabolite profiling, 627 and 1097 metabolite features comprising 235 and 328 metabolites could be detected in the prefrontal cortex and serum, respectively. In total, 54 prefrontal cortex and 51 serum metabolite features were indicated to have a high relevance in the classification of temperament types by a sparse partial least square discriminant analysis. A clear discrimination between fearful/neophobic-alert, interested-stressed, subdued/uninterested-calm and outgoing/neophilic-alert temperament types could be observed based on the abundance of the identified relevant prefrontal cortex and serum metabolites. Metabolites with high relevance in the classification of temperament types revealed that the main differences between temperament types in the response to the slaughter procedure were related to the abundance of glycerophospholipids, fatty acyls and sterol lipids. Differences in the abundance of metabolites related to C21 steroid metabolism and oxidative stress indicated that the differences in the metabolite profiles of the four extreme temperament types could be the result of a temperament type specific regulation of molecular pathways that are known to be involved in the stress and fear response.	[Brand, Bodo; Hadlich, Frieder; Brandt, Bettina; Ponsuksili, Siriluk; Schwerin, Manfred] Leibniz Inst Farm Anim Biol, Inst Genome Biol, Dummerstorf, Germany; [Schauer, Nicolas] Metabol Discoveries GmbH, Golm, Germany; [Graunke, Katharina L.; Langbein, Jan] Leibniz Inst Farm Anim Biol, Inst Behav Physiol, Dummerstorf, Germany; [Schwerin, Manfred] Univ Rostock, Inst Farm Anim Res & Technol, D-18055 Rostock, Germany; [Repsilber, Dirk] Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Rostock; Forschungsinstitut fur Nutztierbiologie (FBN)	Schwerin, M (corresponding author), Leibniz Inst Farm Anim Biol, Inst Genome Biol, Dummerstorf, Germany.	schwerin@fbn-dummerstorf.de	Langbein, Jan/AFO-8965-2022	Langbein, Jan/0000-0002-1170-5431	German Federal Ministry of Education and Research (BMBF) [0315535, 0315536A, 0315536G]; Metabolomic Discoveries GmbH	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Metabolomic Discoveries GmbH	This work is part of the project "PHENOMICS - a system biological approach of genotype-phenotype-distinction in the context of farm animal performance, health and welfare in cattle and pig" (0315535 (BBt), 0315536A and 0315536G (KLG)) (http://www.phaenomics.auf.uni-rostock.de/enhome.html) funded by the German Federal Ministry of Education and Research (BMBF). Metabolomic Discoveries GmbH provided support in the form of salary for author NS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	Adamczyk K, 2013, LIVEST SCI, V154, P1, DOI 10.1016/j.livsci.2013.01.016; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Backstrom T, 2013, PROG NEUROBIOL, V113, DOI [10.1016/j.pneurobio.2013.09.003, DOI 10.1016/J.PNEUROBIO.2013.09.003]; Bernardi F, 1998, EUR J ENDOCRINOL, V138, P316, DOI 10.1530/eje.0.1380316; Bicikova M, 2013, J STEROID BIOCHEM, V133, P77, DOI 10.1016/j.jsbmb.2012.08.009; Black TE, 2013, J ANIM SCI, V91, P2254, DOI [10.2527/jas.2012-5242, 10.2527/jas2012-5242]; Boissy A, 2005, LIVEST PROD SCI, V93, P23, DOI 10.1016/j.livprodsci.2004.11.003; Bolten EE, 2008, ANN REPORTS COMPUTAT, V4; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; BROWN GK, 1987, J INHERIT METAB DIS, V10, P367, DOI 10.1007/BF01799979; Burdick N. C., 2011, International Journal of Zoology, V2011, P373197, DOI 10.1155/2011/373197; Burdick NC, 2009, J ANIM SCI, V87, P3202, DOI 10.2527/jas.2009-1931; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Coombes SV, 2014, MEAT SCI, V98, P815, DOI 10.1016/j.meatsci.2014.06.029; Curley KO, 2006, J ANIM SCI, V84, P3100, DOI 10.2527/jas.2006-055; Degn M, 2007, J NEUROCHEM, V103, P1907, DOI 10.1111/j.1471-4159.2007.04892.x; Dejean S, MIXOMICS OMICS DATA; Exton J H, 1979, Monogr Endocrinol, V12, P535; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; Ferguson DM, 2008, MEAT SCI, V80, P12, DOI 10.1016/j.meatsci.2008.05.004; Filiou MD, 2014, J PSYCHIATR RES, V58, P115, DOI 10.1016/j.jpsychires.2014.07.019; FORDYCE G, 1988, AUST J EXP AGR, V28, P689, DOI 10.1071/EA9880683; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Grandin T, 1997, J ANIM SCI, V75, P249; Graunke KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074579; Gruber SL, 2010, J ANIM SCI, V88, P1148, DOI 10.2527/jas.2009-2183; Gutierrez-Gil B, 2008, J HERED, V99, P629, DOI 10.1093/jhered/esn060; Hammon HM, 2010, J DAIRY SCI, V93, P3007, DOI 10.3168/jds.2009-2931; Hanna LLH, 2014, LIVEST SCI, V161, P17, DOI 10.1016/j.livsci.2013.12.012; HANSEN HS, 1995, BBA-LIPID LIPID MET, V1258, P303, DOI 10.1016/0005-2760(95)00134-X; Hansen HS, 1998, BIOCHEM PHARMACOL, V55, P719, DOI 10.1016/S0006-2952(97)00396-1; Hastie T., 2009, UNSUPERVISED LEARNIN; Hemsworth PH, 2000, J ANIM SCI, V78, P2821; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Hiendleder S, 2003, J HERED, V94, P496, DOI 10.1093/jhered/esg090; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jiang P., 2014, PSYCHOPHARMACOLOGY, P1; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Khisti RT, 2000, PHARMACOL BIOCHEM BE, V67, P137, DOI 10.1016/S0091-3057(00)00300-2; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Kramer M, 2014, J DAIRY SCI, V97, P1774, DOI 10.3168/jds.2013-7054; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Kuhn C, 2002, ARCH TIERZUCHT, V45, P317; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lu YR, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-123; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Makkar SR, 2010, NEUROPSYCHOPHARMACOL, V35, P1625, DOI 10.1038/npp.2010.53; MCCORMICK DA, 1989, J NEUROPHYSIOL, V62, P1018, DOI 10.1152/jn.1989.62.5.1018; McEwen BS, 2000, NEUROCHEM RES, V25, P1219, DOI 10.1023/A:1007687911139; McInnes KJ, 2004, J BIOL CHEM, V279, P22908, DOI 10.1074/jbc.M402822200; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Muller R, 2006, APPL ANIM BEHAV SCI, V99, P193, DOI 10.1016/j.applanim.2005.05.012; Munhoz CD, 2008, BRAZ J MED BIOL RES, V41, P1037, DOI 10.1590/S0100-879X2008001200001; Nixon M, 2012, J ENDOCRINOL, V212, P111, DOI 10.1530/JOE-11-0318; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Pinna G, 2005, P NATL ACAD SCI USA, V102, P2135, DOI 10.1073/pnas.0409643102; R Development Core Team, R LANG ENV STAT COMP; Raymond D, 2014, BASIC NEUROCHEMISTRY; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sanchez NCB, 2014, J ANIM PHYSIOL AN N, V98, P178, DOI 10.1111/jpn.12074; Sarro EC, 2014, NEUROSCIENCE, V258, P147, DOI 10.1016/j.neuroscience.2013.10.064; Schmutz SM, 2001, J HERED, V92, P290, DOI 10.1093/jhered/92.3.290; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Schulz D, 2013, INT J NEUROPSYCHOPH, V16, P199, DOI 10.1017/S1461145711001994; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smaga I, 2012, PROG NEURO-PSYCHOPH, V39, P280, DOI 10.1016/j.pnpbp.2012.06.018; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sripada RK, 2013, BIOL PSYCHIAT, V73, P1045, DOI 10.1016/j.biopsych.2012.12.008; Sutherland MA, 2012, PHYSIOL BEHAV, V107, P329, DOI 10.1016/j.physbeh.2012.07.013; Terlouw EMC, 2008, ANIMAL, V2, P1501, DOI 10.1017/S1751731108002723; Terlouw EMC, 2012, ANIM WELFARE, V21, P43, DOI 10.7120/096272812X13353700593482; Van Reenen CG, 2005, PHYSIOL BEHAV, V85, P557, DOI 10.1016/j.physbeh.2005.06.015; Van Reenen CG, 2013, APPL ANIM BEHAV SCI, V147, P55, DOI 10.1016/j.applanim.2013.04.020; Vervoort LMT, 1997, BIOCHEM PHARMACOL, V54, P871, DOI 10.1016/S0006-2952(97)00254-2; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wood PL, 2014, NEUROPSYCHOPHARMACOL, V39, P24, DOI 10.1038/npp.2013.167; Yang C, 2011, BRIT J PHARMACOL, V164, P1661, DOI 10.1111/j.1476-5381.2011.01465.x; Zaidi SMKR, 2004, CLIN CHIM ACTA, V340, P229, DOI 10.1016/j.cccn.2003.11.003; Zhang J, 2013, NEUROSCI LETT, V545, P132, DOI 10.1016/j.neulet.2013.04.035	88	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125044	10.1371/journal.pone.0125044	http://dx.doi.org/10.1371/journal.pone.0125044			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927228	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100061
J	Khakshour, S; Beischlag, TV; Sparrey, C; Park, EJ				Khakshour, Samaneh; Beischlag, Timothy V.; Sparrey, Carolyn; Park, Edward J.			Probing Mechanical Properties of Jurkat Cells under the Effect of ART Using Oscillating Optical Tweezers	PLOS ONE			English	Article							CARCINOMA; APOPTOSIS; TARGETS	Acute lymphoid leukemia is a common type of blood cancer and chemotherapy is the initial treatment of choice. Quantifying the effect of a chemotherapeutic drug at the cellular level plays an important role in the process of the treatment. In this study, an oscillating optical tweezer was employed to characterize the frequency-dependent mechanical properties of Jurkat cells exposed to the chemotherapeutic agent, artesunate (ART). A motion equation for a bead bound to a cell was applied to describe the mechanical characteristics of the cell cytoskeleton. By comparing between the modeling results and experimental results from the optical tweezer, the stiffness and viscosity of the Jurkat cells before and after the ART treatment were obtained. The results demonstrate a weak power-law dependency of cell stiffness with frequency. Furthermore, the stiffness and viscosity were increased after the treatment. Therefore, the cytoskeleton cell stiffness as the well as power-law coefficient can provide a useful insight into the chemo-mechanical relationship of drug treated cancer cells and may serve as another tool for evaluating therapeutic performance quantitatively.	[Khakshour, Samaneh; Sparrey, Carolyn; Park, Edward J.] Simon Fraser Univ, Fac Sci Appl, Sch Mechatron Syst Engn, Surrey, BC, Canada; [Beischlag, Timothy V.; Park, Edward J.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Park, EJ (corresponding author), Simon Fraser Univ, Fac Sci Appl, Sch Mechatron Syst Engn, Surrey, BC, Canada.	ed_park@sfu.ca		Sparrey, Carolyn/0000-0002-5524-4577	Natural Sciences and Engineering Research Council of Canada [RGPIN/298219-2012]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca/) under Grant RGPIN/298219-2012 (PI: EJP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; Baek JH, 2007, AS S PREC ENG NAN; Cai P, 2013, BIOPHYS J, V105, P1093, DOI 10.1016/j.bpj.2013.07.035; Cai XF, 2009, SCANNING, V31, P83, DOI 10.1002/sca.20144; Efferth T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000693; Fabry B, 2003, PHYS REV E, V68, P1, DOI [10.1103/PhysRevE.68.041914, DOI 10.1103/PhysRevE.68.041914]; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Goldmann WH, 1996, EXP CELL RES, V226, P234, DOI 10.1006/excr.1996.0223; Grzanka A, 2003, BIOCHEM PHARMACOL, V66, P1611, DOI 10.1016/S0006-2952(03)00532-X; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Knudsen PB, 2014, LEUKEMIA, V28, P1289, DOI 10.1038/leu.2013.360; Kollmannsberger P, 2011, SOFT MATTER, V7, P3127, DOI 10.1039/c0sm00833h; Lam WA, 2007, BLOOD, V109, P3505, DOI 10.1182/blood-2006-08-043570; Levee M, 1996, AM J PHYSIOL, V271, P1982; Li LN, 2007, INT J CANCER, V121, P1360, DOI 10.1002/ijc.22804; Maksym GN, 2000, J APPL PHYSIOL, V89, P1619, DOI 10.1152/jappl.2000.89.4.1619; Marin-Esteban V, 2010, J IMMUNOTHER, V33, P364, DOI 10.1097/CJI.0b013e3181cd1094; Miyoshi H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.120223; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Puig-de-Morales M, 2001, J APPL PHYSIOL, V91, P1152, DOI 10.1152/jappl.2001.91.3.1152; Purves WK, 1994, LIFE SCI BIOL; SHROFF SG, 1995, AM J PHYSIOL-CELL PH, V269, pC286, DOI 10.1152/ajpcell.1995.269.1.C286; Stehn JR, 2013, CANCER RES, V73, P5169, DOI 10.1158/0008-5472.CAN-12-4501; Wuang SC, 2011, CELL MOL BIOENG, V4, P466, DOI 10.1007/s12195-011-0163-1; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0126548	10.1371/journal.pone.0126548	http://dx.doi.org/10.1371/journal.pone.0126548			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928073	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100130
J	Kolby, JE; Ramirez, SD; Berger, L; Richards-Hrdlicka, KL; Jocque, M; Skerratt, LF				Kolby, Jonathan E.; Ramirez, Sara D.; Berger, Lee; Richards-Hrdlicka, Kathryn L.; Jocque, Merlijn; Skerratt, Lee F.			Terrestrial Dispersal and Potential Environmental Transmission of the Amphibian Chytrid Fungus (Batrachochytrium dendrobatidis)	PLOS ONE			English	Article							NATIONAL-PARK; CHYTRIDIOMYCOSIS; PATHOGEN; DISEASE; INFECTION; DECLINES; HISTORY; POPULATION; PREVALENCE; ABUNDANCE	Dispersal and exposure to amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd) is not confined to the aquatic habitat, but little is known about pathways that facilitate exposure to wild terrestrial amphibians that do not typically enter bodies of water. We explored the possible spread of Bd from an aquatic reservoir to terrestrial substrates by the emergence of recently metamorphosed infected amphibians and potential deposition of Bd-positive residue on riparian vegetation in Cusuco National Park, Honduras (CNP). Amphibians and their respective leaf perches were both sampled for Bd presence and the pathogen was detected on 76.1% (35/46) of leaves where a Bd-positive frog had rested. Although the viability of Bd detected on these leaves cannot be discerned from our quantitative PCR results, the cool air temperature, closed canopy, and high humidity of this cloud forest environment in CNP is expected to encourage pathogen persistence. High prevalence of infection (88.5%) detected in the recently metamorphosed amphibians and frequent shedding of Bd-positive residue on foliage demonstrates a pathway of Bd dispersal between aquatic and terrestrial habitats. This pathway provides the opportunity for environmental transmission of Bd among and between amphibian species without direct physical contact or exposure to an aquatic habitat.	[Kolby, Jonathan E.; Berger, Lee; Skerratt, Lee F.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia; [Kolby, Jonathan E.; Ramirez, Sara D.; Jocque, Merlijn] Operat Wallacea, Old Bolingbroke PE23 4EX, Lincs, England; [Ramirez, Sara D.] Ramapo Coll, Sustainabil Studies Program, Mahwah, NJ USA; [Richards-Hrdlicka, Kathryn L.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Jocque, Merlijn] Royal Belgian Inst Nat Sci, B-1000 Brussels, Belgium	James Cook University; Ramapo College New Jersey (RCNJ); Yale University; Royal Belgian Institute of Natural Sciences	Kolby, JE (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia.	jonathan.kolby@my.jcu.edu.au	Kolby, Jonathan/GWV-5557-2022; Kolby, Jonathan/GWZ-3092-2022	Skerratt, Lee/0000-0003-3471-7512; Berger, Lee/0000-0001-9227-5439	Operation Wallacea	Operation Wallacea	Operation Wallacea provided support in the form of salaries for authors Jonathan E. Kolby, Sara D. Ramirez and Merlijn Jocque but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Becker CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048205; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burrowes PA, 2008, HERPETOTROPICOS, V4, P51; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Caruso NM, 2013, DIVERS DISTRIB, V19, P38, DOI 10.1111/j.1472-4642.2012.00938.x; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Chestnut T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106790; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Cummer Michelle R., 2005, Herpetological Review, V36, P248; Daszak P, 2004, HERPETOL J, V14, P201; DiRenzo GV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093356; Doherty-Bone TM, 2013, DIS AQUAT ORGAN, V102, P187, DOI 10.3354/dao02557; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fiers F, 2013, ZOOTAXA, V3630, P270, DOI 10.11646/zootaxa.3630.2.4; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Garmyn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035038; Gilbert M, 2012, ECOHEALTH, V9, P386, DOI 10.1007/s10393-013-0817-7; Gower DJ, 2013, ECOHEALTH, V10, P173, DOI 10.1007/s10393-013-0831-9; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jocque M, 2013, J CRUSTACEAN BIOL, V33, P451, DOI 10.1163/1937240X-00002161; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090750; Kolby Jonathan E., 2009, Herpetological Review, V40, P307; Kolby JE, 2010, DIS AQUAT ORGAN, V92, P245, DOI 10.3354/dao02055; Kolby Jonathan E., 2009, Herpetological Review, V40, P282; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Langhammer PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077630; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; McCracken Shawn, 2009, Herpetological Review, V40, P190; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Piovia-Scott J, 2011, BIOL CONSERV, V144, P2913, DOI 10.1016/j.biocon.2011.08.008; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Puschendorf R, 2006, ECOHEALTH, V3, P178, DOI 10.1007/s10393-006-0026-8; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Richards-Hrdlicka KL, 2013, DIS AQUAT ORGAN, V102, P169, DOI 10.3354/dao02552; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Rowley Jodi J. L., 2007, Herpetological Review, V38, P308; Russell DM, 2010, DIS AQUAT ORGAN, V92, P223, DOI 10.3354/dao02286; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Speare R, 2004, AUST VET J, V82, P300, DOI 10.1111/j.1751-0813.2004.tb12710.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Weinstein SB, 2009, COPEIA, P653, DOI 10.1643/CH-08-180; WILSON L. D., 2003, AMPHIB REPTILE CONSE, V3, P6; Wimsatt J, 2014, ZOO BIOL, V33, P577, DOI 10.1002/zoo.21154	58	44	45	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0125386	10.1371/journal.pone.0125386	http://dx.doi.org/10.1371/journal.pone.0125386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25927835	gold, Green Published, Green Accepted			2022-12-26	WOS:000353713100087
J	Lezzerini, M; van de Ven, K; Veerman, M; Brul, S; Budovskaya, YV				Lezzerini, Marco; van de Ven, Koen; Veerman, Martijn; Brul, Stanley; Budovskaya, Yelena V.			Specific RNA Interference in Caenorhabditis elegans by Ingested dsRNA Expressed in Bacillus subtilis	PLOS ONE			English	Article							LIFE-SPAN; GENE-EXPRESSION; ESCHERICHIA-COLI; RESISTANCE; LONGEVITY; HEALTHSPAN; LIPOFUSCIN; PROTEINS; BACTERIA; RECEPTOR	In nematodes, genome-wide RNAi-screening has been widely used as a rapid and efficient method to identify genes involved in the aging processes. By far the easiest way of inducing RNA interference (RNAi) in Caenorhabditis elegans is by feeding Escherichia coli that expresses specific double stranded RNA (dsRNA) to knockdown translation of targeted mRNAs. However, it has been shown that E. coli is mildly pathogenic to C. elegans and this pathogenicity might influence aging and the accuracy of the RNAi-screening during aging may as well be affected. Here, we describe a novel system that utilizes the non-pathogenic bacterium Bacillus subtilis, to express dsRNA and therefore eliminates the effects of bacterial pathogenicity from the genetic analysis of aging.	[Lezzerini, Marco; van de Ven, Koen; Veerman, Martijn; Brul, Stanley; Budovskaya, Yelena V.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands	University of Amsterdam	Budovskaya, YV (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	y.budovskaya@uva.nl		van de Ven, Koen/0000-0001-7549-5683	MacGillavry fellowship	MacGillavry fellowship	This research was funded my MacGillavry fellowship awarded to Yelena Budovskaya at the University of Amsterdam, Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; BRENNER S, 1974, GENETICS, V77, P71; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; DAVIS BO, 1982, BIOCHEMISTRY-US, V21, P4089, DOI 10.1021/bi00260a027; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2000, GENETICS, V154, P1597; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Herskovitz MA, 2000, MOL MICROBIOL, V38, P1027, DOI 10.1046/j.1365-2958.2000.02185.x; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Iwasa H, 2010, AGING CELL, V9, P490, DOI 10.1111/j.1474-9726.2010.00575.x; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laaberki MH, 2008, J BACTERIOL, V190, P6197, DOI 10.1128/JB.00623-08; Laaberki MH, 2008, SYMBIOSIS, V46, P95; LAWLESS JF, 1982, MODELS METHODS LIFET; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; McGee MD, 2011, AGING CELL, V10, P699, DOI 10.1111/j.1474-9726.2011.00713.x; Montalvo-Katz S, 2013, INFECT IMMUN, V81, P514, DOI 10.1128/IAI.00653-12; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Quisel JD, 2001, J BACTERIOL, V183, P6573, DOI 10.1128/JB.183.22.6573-6578.2001; Sanchez-Blanco A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002047; Smith ED, 2008, GENOME RES, V18, P564, DOI 10.1101/gr.074724.107; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Van Nostrand EL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003325; YANSURA DG, 1984, P NATL ACAD SCI-BIOL, V81, P439, DOI 10.1073/pnas.81.2.439	47	6	7	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0124508	10.1371/journal.pone.0124508	http://dx.doi.org/10.1371/journal.pone.0124508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928543	Green Submitted, Green Published, gold			2022-12-26	WOS:000353713100036
J	Moreira, A; Pereira, SS; Costa, M; Morais, T; Pinto, A; Fernandes, R; Monteiro, MP				Moreira, Angela; Pereira, Sofia S.; Costa, Madalena; Morais, Tiago; Pinto, Ana; Fernandes, Ruben; Monteiro, Mariana P.			Adipocyte Secreted Factors Enhance Aggressiveness of Prostate Carcinoma Cells	PLOS ONE			English	Article							PERIPROSTATIC ADIPOSE-TISSUE; CANCER-CELLS; OBESITY; DIFFERENTIATION; PROLIFERATION; PROMOTE; CULTURE; GROWTH; PHENOTYPE	Obesity has been associated with increased incidence and risk of mortality of prostate cancer. One of the proposed mechanisms underlying this risk association is the change in adipokines expression that could promote the development and progression of the prostate tumor cells. The main goal of this study was to evaluate the effect of preadipocyte and adipocyte secretome in the proliferation, migration and invasion of androgen independent prostate carcinoma cells (RM1) and to assess cell proliferation in the presence of the adiposity signals leptin and insulin. RM1 cells were co-cultured in with preadipocytes, adipocytes or cultured in their respective conditioned medium. Cell proliferation was assessed by flow cytometry and XTT viability test. Cell migration was evaluated using a wound healing injury assay of RM1 cells cultured with conditioned media. Cellular invasion of RM1 cells co-cultured with adipocytes and preadipocytes was assessed using matrigel membranes. Preadipocyte conditioned medium was associated with a small increase in RM1 proliferation, while adipocytes conditioned media significantly increased RM1 cell proliferation (p<0.01). Adipocytes also significantly increased the RM1 cells proliferation in co-culture (p <0.01). Cell migration was higher in RM1 cells cultured with preadipocyte and adipocyte conditioned medium. RM1 cell invasion was significantly increased after co-culture with preadipocytes and adipocytes (p <0.05). Insulin also increased significantly the cell proliferation in contrast to leptin, which showed no effect. In conclusion, prostate carcinoma cells seem to be influenced by factors secreted by adipocytes that are able to increase their ability to proliferate, migrate and invade.	[Moreira, Angela; Pereira, Sofia S.; Costa, Madalena; Morais, Tiago; Pinto, Ana; Monteiro, Mariana P.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Unit Multidisciplinary Res Biomed UMIB, Dept Anat, P-4100 Porto, Portugal; [Fernandes, Ruben] Inst Politecn Porto, Escola Super Tecnol Saude Porto, Ciencias Quim & Biomol, Vila Nova De Gaia, Portugal; [Fernandes, Ruben] Inst Politecn Porto, Escola Super Tecnol Saude Porto, Ctr Invest Saude & Ambiente, Vila Nova De Gaia, Portugal	Universidade do Porto; Polytechnic Institute of Porto; Polytechnic Institute of Porto	Monteiro, MP (corresponding author), Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Unit Multidisciplinary Res Biomed UMIB, Dept Anat, Rua Campo Alegre 823, P-4100 Porto, Portugal.	mpmonteiro@icbas.up.pt	Pereira, Sofia S/D-9006-2017; Monteiro, Mariana P./AFP-7479-2022; Fernandes, Ruben/L-5753-2013	Pereira, Sofia S/0000-0001-6947-4560; Monteiro, Mariana P./0000-0002-0662-1831; Fernandes, Ruben/0000-0001-8933-3984; Pinto, Ana/0000-0001-8860-7090; Moreira, Angela Marisa/0000-0001-9660-0200; Santos, Madalena/0000-0002-1101-3515; Morais, Tiago/0000-0003-4905-706X	Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal [Fcomp-01-0124-FEDER-015893]; Sociedade Portuguesa de Endocrinologia Diabetes e Metabolismo (SPEDM)	Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal(Portuguese Foundation for Science and Technology); Sociedade Portuguesa de Endocrinologia Diabetes e Metabolismo (SPEDM)	This study was supported by grants Fcomp-01-0124-FEDER-015893 of the Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal to The Unit for Multidisciplinary Research in Biomedicine (UMIB) and by a research grant from the Sociedade Portuguesa de Endocrinologia Diabetes e Metabolismo (SPEDM) to Angela Moreira. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sacca PA, 2012, CELL PHYSIOL BIOCHEM, V30, P113, DOI 10.1159/000339051; Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; Asmar R, 2013, PROSTATE CANCER P D, V16, P61, DOI 10.1038/pcan.2012.32; BALEY PA, 1995, J STEROID BIOCHEM, V52, P403, DOI 10.1016/0960-0760(95)00001-G; Bray F, 2010, EUR J CANCER, V46, P3040, DOI 10.1016/j.ejca.2010.09.013; Cheetham PJ, 2013, PROSTATE CANC COMPRE, P355; Cheung Wai W, 2012, ISRN Endocrinol, V2012, P536905, DOI 10.5402/2012/536905; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Donohoe CL, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-12; Forte V, 2012, CARDIORENAL MED, V2, P143, DOI 10.1159/000337314; Fowke JH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-23; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gunter JH, 2012, ADVANCES IN UROLOGY, V2012, P11; Hefetz-Sela S, 2013, PHARMACOL THERAPEUT, V138, P197, DOI 10.1016/j.pharmthera.2013.01.008; Heidegger I, 2012, ENDOCRINOLOGY, V153, P4633, DOI 10.1210/en.2012-1348; Hoda MR, 2012, J ONCOL, V2012, DOI 10.1155/2012/280386; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Kanasaki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197636; Kaneko A, 2010, INT J UROL, V17, P369, DOI 10.1111/j.1442-2042.2010.02472.x; Koochekpour S, 2011, IRAN RED CRESCENT ME, V13, P80; Leitzmann Michael F, 2012, Clin Epidemiol, V4, P1, DOI 10.2147/CLEP.S16747; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Manvar AM, 2013, PROSTATE CANC COMPRE, P285; Mistry T, 2007, EUR UROL, V52, P46, DOI 10.1016/j.eururo.2007.03.054; Moreira A, 2014, INT J CLIN EXP PATHO, V7, P348; Nieman KM, 2013, BIOCH BIOPHYS ACTA; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Onuma M, 2003, J BIOL CHEM, V278, P42660, DOI 10.1074/jbc.M304984200; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Paz G, 2011, FRONT BIOSCI-LANDMRK, V16, P1634, DOI 10.2741/3810; Philippou Anastassios, 2013, Front Endocrinol (Lausanne), V4, P31, DOI 10.3389/fendo.2013.00031; Price RS, 2012, PROSTATE CANCER P D, V15, P135, DOI 10.1038/pcan.2011.54; Prieto-Hontoria PL, 2011, BBA-BIOENERGETICS, V1807, P664, DOI 10.1016/j.bbabio.2010.11.004; Ribeiro AM, 2012, PATHOL ONCOL RES, V18, P499, DOI 10.1007/s12253-011-9473-9; Ribeiro AM, 2010, INT J EXP PATHOL, V91, P374, DOI 10.1111/j.1365-2613.2010.00726.x; Ribeiro R, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-32; Ribeiro RJT, 2012, CELL PHYSIOL BIOCHEM, V29, P233, DOI 10.1159/000337604; Sayeed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076513; Shafi AA, 2013, PHARMACOL THERAPEUT, V140, P223, DOI 10.1016/j.pharmthera.2013.07.003; Tan JX, 2011, INT J DEV BIOL, V55, P851, DOI 10.1387/ijdb.113365jt; Tokuda Y, 2003, BJU INT, V91, P716, DOI 10.1046/j.1464-410X.2003.04218.x; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Verma Mukesh, 2011, Cancers (Basel), V3, P3773, DOI 10.3390/cancers3043773; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005	44	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2015	10	4							e0123217	10.1371/journal.pone.0123217	http://dx.doi.org/10.1371/journal.pone.0123217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0MA	25928422	Green Published, gold, Green Submitted			2022-12-26	WOS:000353713100015
J	Browne, JL; van Nievelt, SW; Srofenyoh, EK; Grobbee, DE; Klipstein-Grobusch, K				Browne, Joyce L.; van Nievelt, Sabine W.; Srofenyoh, Emmanuel K.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin			Criteria-Based Audit of Quality of Care to Women with Severe Pre-Eclampsia and Eclampsia in a Referral Hospital in Accra, Ghana	PLOS ONE			English	Article							MISS; MANAGEMENT	Objectives Severe pre-eclampsia and eclampsia are one of the major causes of maternal mortality globally. Reducing maternal morbidity and mortality demands optimizing quality of care. Criteria-based audits are a tool to define, assess and improve quality of care. The aim of this study was to determine applicability of a criteria-based audit to assess quality of care delivered to women with severe hypertensive disorders in pregnancy, and to assess adherence to protocols and quality of care provided at a regional hospital in Accra, Ghana. Methods Checklists for management of severe preeclampsia, hypertensive emergency and eclampsia were developed in an audit cycle based on nine existing key clinical care protocols. Fifty cases were audited to assess quality of care, defined as adherence to protocols. Analysis was stratified for complicated cases, defined as (imminent) eclampsia, perinatal mortality and/or one or more WHO maternal near miss C-criteria. Results Mean adherence to the nine protocols ranged from 15-85%. Protocols for 'plan for delivery' and 'magnesium sulphate administration' were best adhered to (85%), followed by adherence to protocols for 'eclampsia' (64%), 'severe pre-eclampsia at admission' (60%), 'severe pre-eclampsia ward follow-up' (53%) and 'hypertensive emergency' (53%). Protocols for monitoring were least adhered to (15%). No difference was observed for severe disease. Increased awareness, protocol-based training of staff, and clear task assignment were identified as contributors to better adherence. Conclusion A criteria-based audit is an effective tool to determine quality of care, identify gaps in standard of care, and allow for monitoring and evaluation in a health facility, ultimately resulting in improved quality of care provided and reduced maternal morbidity and mortality. In our audit, good adherence was observed for plan for delivery and treatment with magnesium sulphate. Substandard adherence to a number of protocols was identified, and points towards opportunities for targeted improvement strategies.	[Browne, Joyce L.; van Nievelt, Sabine W.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Srofenyoh, Emmanuel K.] Ghana Hlth Serv, Ridge Reg Hosp, Greater Accra Region, Accra, Ghana; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Div Epidemiol & Biostat, Johannesburg, South Africa	Utrecht University; Utrecht University Medical Center; Ghana Health Service; University of Witwatersrand	Browne, JL (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.	J.L.Browne@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889				Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Andersgaard AB, 2006, ACTA OBSTET GYN SCAN, V85, P929, DOI 10.1080/00016340600607149; [Anonymous], ACC PROGR HLTH REL M; [Anonymous], 2012, UN SYSTEM TASK TEAM; Baldwin KJ, 2001, HYPERTENS PREGNANCY, V20, P257, DOI 10.1081/PRG-100107828; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Crombie I K, 1993, Qual Health Care, V2, P47, DOI 10.1136/qshc.2.1.47; De Brouwere V., 2013, CONDUCT MATERNAL DEA; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Edson W, 2007, INT J GYNECOL OBSTET, V97, P209, DOI 10.1016/j.ijgo.2007.02.018; Engmann C, 2010, INT ANESTHESIOL CLIN, V48, P109, DOI 10.1097/AIA.0b013e3181dd4f13; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Gao Y, 2010, INT J GYNECOL OBSTET, V110, P181, DOI 10.1016/j.ijgo.2010.05.001; Ghana Ministry of Health, 2010, STAND TREATM GUID; Hunyinbo K I, 2008, Afr J Reprod Health, V12, P59; IBM Corp, 2011, IBM SPSS STAT WIND V; Jabir M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-11; Kidanto HL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-134; Lauritsen J, COMPREHENSIVE TOOL V; Liabsuetrakul T, 2008, INT J GYNECOL OBSTET, V103, P166, DOI 10.1016/j.ijgo.2008.06.016; Lori JR, 2012, MIDWIFERY, V28, P67, DOI 10.1016/j.midw.2010.12.001; Nelissen EJT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-141; Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001; Penney G, 2011, SCOTTISH CONFIDENTIA; Pirkle CM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-118; Safe Motherhood Services, 2007, GHAN NAT SAF MOTH SE; Srofenyoh E, 2012, INT J GYNECOL OBSTET, V116, P17, DOI 10.1016/j.ijgo.2011.08.010; Talungchit P, 2013, INT J GYNECOLOGY OBS; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; van den Akker T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054805; Wagaarachchi PT, 2001, INT J GYNECOL OBSTET, V74, P119, DOI 10.1016/S0020-7292(01)00427-1; Weeks AD, 2005, INT J GYNECOL OBSTET, V91, P292, DOI 10.1016/j.ijgo.2005.07.022; WHO UNICEF, 2013, TRENDS MAT MORT 1990; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2011, WHO REC PREV TREATM; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	37	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0125749	10.1371/journal.pone.0125749	http://dx.doi.org/10.1371/journal.pone.0125749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923663	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600160
J	Gao, F; Wang, JY; Wei, SJ; Li, ZL; Wang, N; Li, HY; Feng, JC; Li, HJ; Zhou, YJ; Zhang, FX				Gao, Fei; Wang, Jianyue; Wei, Shanjun; Li, Zhanglei; Wang, Ning; Li, Huayun; Feng, Jinchao; Li, Hongjie; Zhou, Yijun; Zhang, Feixiong			Transcriptomic Analysis of Drought Stress Responses in Ammopiptanthus mongolicus Leaves Using the RNA-Seq Technique	PLOS ONE			English	Article							ZIP CLASS-I; GENE; EXPRESSION; LEGUMINOSAE; ACCLIMATION; PROTEINS; PLANTS; CHINA; LEAF; TOOL	Ammopiptanthus mongolicus (Maxim. Ex Kom.) Cheng f., a relic tree of the Tertiary period, plays a critical role in maintaining desert ecosystems in the Mid-Asia region. Genome-scale gene expression profiling studies will provide deep insight into the molecular mechanism underlying the drought tolerance of A. mongolicus. In the present study, we investigated the transcriptional changes induced by drought treatment in A. mongolicus leaves by establishing a comprehensive transcriptome database and then performing a Digital Gene Expression (DGE) analysis using Solexa sequencing technology. A comprehensive transcriptome database was obtained by assembling the Illumina unigenes with expressed sequence tags (EST) available publicly, and other high throughput sequencing data. To analyze the dynamic and complicated gene regulation network during PEG6000-induced drought treatment in leaves of A. mongolicus, a time-course gene expression analysis was performed using tag-based DGE technology, which identified 437, 1,247 and 802 differentially expressed transcripts in 1, 24 and 72 h drought stress libraries, respectively. GO and KEGG analyses revealed hormone signal transduction and phenylpropanoid biosynthesis were enriched during drought treatment. A batch of drought-regulated transcription factor transcripts were identified, including the subsets of HD-ZIP, bZIP, WRKY, AP2/ERF and bHLH family members, which may play roles in drought response in A. mongolicus. The sequence collection assembled in the present study represents one of the most comprehensive transcriptome databases for A. mongolicus currently. The differentially expressed transcripts identified in our study provide a good start for identifying the key genes in stress response and performing functional analysis to reveal their roles in stress adaptation in planta.	[Gao, Fei; Wei, Shanjun; Li, Zhanglei; Wang, Ning; Li, Huayun; Feng, Jinchao; Zhou, Yijun] Minzu Univ China, Coll Life & Environm Sci, Beijing 100081, Peoples R China; [Wang, Jianyue; Zhang, Feixiong] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Li, Hongjie] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China	Minzu University of China; Capital Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhou, YJ (corresponding author), Minzu Univ China, Coll Life & Environm Sci, Beijing 100081, Peoples R China.	queenzhou@263.net; fxzhang@hotmail.com	Gao, Fei/I-5768-2019	Gao, Fei/0000-0003-3600-4970	National Natural Science Foundation of China [31370356, 31100507]; Ministry of Education of China [B08044, MUC985, YLDX01013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (31370356 and 31100507), the Ministry of Education of China through 111 and 985 projects (B08044, MUC985, YLDX01013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chen JH, 2011, PLANT GROWTH REGUL, V63, P259, DOI 10.1007/s10725-010-9523-4; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Deikman J, 2012, CURR OPIN BIOTECH, V23, P243, DOI 10.1016/j.copbio.2011.11.003; Derelle R, 2007, EVOL DEV, V9, P212, DOI 10.1111/j.1525-142X.2007.00153.x; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Gao C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-570; Ge XJ, 2005, ANN BOT-LONDON, V95, P843, DOI 10.1093/aob/mci089; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; Hussain SS, 2011, BIOTECHNOL PROGR, V27, P297, DOI 10.1002/btpr.514; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; LIU J-Q, 1982, Acta Botanica Sinica, V24, P568; Liu MQ, 2006, DNA SEQUENCE, V17, P342, DOI 10.1080/10425170600908484; Liu RL, 2010, PLANT GROWTH REGUL, V60, P163, DOI 10.1007/s10725-009-9432-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Song J, 2013, GENE, V513, P118, DOI 10.1016/j.gene.2012.10.058; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Valdes AE, 2012, PLANT MOL BIOL, V80, P405, DOI 10.1007/s11103-012-9956-4; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang W, 2007, BOT STUD, V48, P55; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841; Wei Q, 2012, PLANT CELL TISS ORG, V110, P359, DOI 10.1007/s11240-012-0157-2; Wei Q, 2011, PLANT CELL TISS ORG, V105, P309, DOI 10.1007/s11240-010-9869-3; Wei Q, 2012, PLANT CELL TISS ORG, V110, P299, DOI 10.1007/s11240-012-0151-8; Yan Shun, 2000, Acta Micropalaeontologica Sinica, V17, P165; Yang XP, 2004, QUATERN INT, V118, P69, DOI 10.1016/S1040-6182(03)00131-9; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081096	51	39	46	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0124382	10.1371/journal.pone.0124382	http://dx.doi.org/10.1371/journal.pone.0124382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25923822	Green Published, Green Submitted, gold			2022-12-26	WOS:000353711600080
J	Tian, LX; Pan, YX; Metzner, W; Zhang, JS; Zhang, BF				Tian, Lan-Xiang; Pan, Yong-Xin; Metzner, Walter; Zhang, Jin-Shuo; Zhang, Bing-Fang			Bats Respond to Very Weak Magnetic Fields	PLOS ONE			English	Article							MOUSE-EARED BAT; BIOGENIC MAGNETITE; MAGNETORECEPTION; ORIENTATION; NAVIGATION; INTENSITY; ALIGNMENT; ANIMALS; COMPASS; REVERSALS	How animals, including mammals, can respond to and utilize the direction and intensity of the Earth's magnetic field for orientation and navigation is contentious. In this study, we experimentally tested whether the Chinese Noctule, Nyctalus plancyi (Vespertilionidae) can sense magnetic field strengths that were even lower than those of the present-day geomagnetic field. Such field strengths occurred during geomagnetic excursions or polarity reversals and thus may have played an important role in the evolution of a magnetic sense. We found that in a present-day local geomagnetic field, the bats showed a clear preference for positioning themselves at the magnetic north. As the field intensity decreased to only 1/5th of the natural intensity (i.e., 10 mu T; the lowest field strength tested here), the bats still responded by positioning themselves at the magnetic north. When the field polarity was artificially reversed, the bats still preferred the new magnetic north, even at the lowest field strength tested (10 mu T), despite the fact that the artificial field orientation was opposite to the natural geomagnetic field (P<0.05). Hence, N. plancyi is able to detect the direction of a magnetic field even at 1/5th of the present-day field strength. This high sensitivity to magnetic fields may explain how magnetic orientation could have evolved in bats even as the Earth's magnetic field strength varied and the polarity reversed tens of times over the past fifty million years.	[Tian, Lan-Xiang; Pan, Yong-Xin; Zhang, Bing-Fang] Chinese Acad Sci, Inst Geol & Geophys, Biogeomagnetism Grp, PGL,Key Lab Earth & Planetary Phys, Beijing, Peoples R China; [Tian, Lan-Xiang; Pan, Yong-Xin; Zhang, Bing-Fang] Chinese Acad Sci, France China Biomineralizat & Nanostruct Lab, Beijing, Peoples R China; [Metzner, Walter] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Zhang, Jin-Shuo] Chinese Acad Sci, Inst Zool, Natl Zool Museum, Beijing, Peoples R China; [Zhang, Bing-Fang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Pan, YX (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Biogeomagnetism Grp, PGL,Key Lab Earth & Planetary Phys, Beijing, Peoples R China.	yxpan@mail.iggcas.ac.cn	Pan, Yongxin/B-4302-2008	Pan, Yongxin/0000-0002-4227-3061	Chinese Academy of Sciences Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation; CAS [KZCX2-YW-T10]; National Natural Science Foundation of China [41374074, 41330104]	Chinese Academy of Sciences Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation; CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Chinese Academy of Sciences Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation, the CAS project (KZCX2-YW-T10) and National Natural Science Foundation of China grants (41374074, 41330104).	Altringham JD, 1996, BATS BIOL BEHAV; Begall S, 2011, J COMP PHYSIOL A, V197, P1127, DOI 10.1007/s00359-011-0674-1; Begall S, 2008, P NATL ACAD SCI USA, V105, P13451, DOI 10.1073/pnas.0803650105; Begall S, 2013, MAMM BIOL, V78, P10, DOI 10.1016/j.mambio.2012.05.005; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Boles LC, 2003, NATURE, V421, P60, DOI 10.1038/nature01226; Cai SH, 2014, EARTH PLANET SC LETT, V392, P217, DOI 10.1016/j.epsl.2014.02.030; Cain SD, 2005, INTEGR COMP BIOL, V45, P539, DOI 10.1093/icb/45.3.539; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Channell JET, 2009, EARTH PLANET SC LETT, V283, P14, DOI 10.1016/j.epsl.2009.03.012; Davila AF, 2005, BIOPHYS J, V89, P56, DOI 10.1529/biophysj.104.049346; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Finlay CC, 2010, GEOPHYS J INT, V183, P1216, DOI 10.1111/j.1365-246X.2010.04804.x; FIRESTER AH, 1966, REV SCI INSTRUM, V37, P1264, DOI 10.1063/1.1720478; Greif S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5488; Gubbins D, 1999, GEOPHYS J INT, V137, pF1, DOI 10.1046/j.1365-246x.1999.00810.x; Hart V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-80; Holland RA, 2006, NATURE, V444, P702, DOI 10.1038/444702b; Holland RA, 2010, P NATL ACAD SCI USA, V107, P6941, DOI 10.1073/pnas.0912477107; Holland RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001676; Juarez MT, 1998, NATURE, V394, P878, DOI 10.1038/29746; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; Li T T, 2004, TRIAXIAL SQUARE HELM; Lohmann KJ, 2012, CURR OPIN NEUROBIOL, V22, P336, DOI 10.1016/j.conb.2011.11.005; MANN S, 1988, J EXP BIOL, V140, P35; Merlin C, 2012, CURR OPIN NEUROBIOL, V22, P353, DOI 10.1016/j.conb.2011.11.009; Mora CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072869; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Oliveriusova L, 2012, J EXP BIOL, V215, P3649, DOI 10.1242/jeb.069625; Olson P, 2014, EARTH PLANET SC LETT, V388, P9, DOI 10.1016/j.epsl.2013.11.038; Putman NF, 2011, CURR BIOL, V21, P463, DOI 10.1016/j.cub.2011.01.057; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Shi Hongyan, 2001, Acta Theriologica Sinica, V21, P210; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tian LX, 2010, BIOELECTROMAGNETICS, V31, P499, DOI 10.1002/bem.20590; Vacha M, 2006, J EXP BIOL, V209, P3882, DOI 10.1242/jeb.02456; Valet JP, 2005, NATURE, V435, P802, DOI 10.1038/nature03674; VALET JP, 1993, NATURE, V366, P234, DOI 10.1038/366234a0; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wang YN, 2007, P R SOC B, V274, P2901, DOI 10.1098/rspb.2007.0904; Wegner RE, 2006, J EXP BIOL, V209, P4747, DOI 10.1242/jeb.02573; Wiltschko R, 2013, J COMP PHYSIOL A, V199, P89, DOI 10.1007/s00359-012-0769-3; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Winklhofer M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0853; Zhu RX, 2000, J GEOPHYS RES-SOL EA, V105, P8305, DOI 10.1029/1999JB900448	47	8	9	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2015	10	4							e0123205	10.1371/journal.pone.0123205	http://dx.doi.org/10.1371/journal.pone.0123205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0LO	25922944	Green Submitted, gold, Green Published			2022-12-26	WOS:000353711600034
J	Tan, HL; Xie, QJ; Xiang, XOE; Li, JQ; Zheng, SN; Xu, XY; Guo, HL; Ye, WX				Tan, Helin; Xie, Qingjun; Xiang, Xiaoe; Li, Jianqiao; Zheng, Suning; Xu, Xinying; Guo, Haolun; Ye, Wenxue			Dynamic Metabolic Profiles and Tissue-Specific Source Effects on the Metabolome of Developing Seeds of Brassica napus	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; OIL CONTENT; LIPID-METABOLISM; GENE-EXPRESSION; ACETYL-COENZYME; PHOTOSYNTHESIS; ACCUMULATION; CANOLA; CARBOXYLASE; WRINKLED1	Canola (Brassica napus) is one of several important oil-producing crops, and the physiological processes, enzymes, and genes involved in oil synthesis in canola seeds have been well characterized. However, relatively little is known about the dynamic metabolic changes that occur during oil accumulation in seeds, as well as the mechanistic origins of metabolic changes. To explore the metabolic changes that occur during oil accumulation, we isolated metabolites from both seed and silique wall and identified and characterized them by using gas chromatography coupled with mass spectrometry (GC-MS). The results showed that a total of 443 metabolites were identified from four developmental stages. Dozens of these metabolites were differentially expressed during seed ripening, including 20 known to be involved in seed development. To investigate the contribution of tissue-specific carbon sources to the biosynthesis of these metabolites, we examined the metabolic changes of silique walls and seeds under three treatments: leaf-detachment (Ld), phloem-peeling (Pe), and selective silique darkening (Sd). Our study demonstrated that the oil content was independent of leaf photosynthesis and phloem transport during oil accumulation, but required the metabolic influx from the silique wall. Notably, Sd treatment resulted in seed senescence, which eventually led to a severe reduction of the oil content. Sd treatment also caused a significant accumulation of fatty acids (FA), organic acids and amino acids. Furthermore, an unexpected accumulation of sugar derivatives and organic acid was observed in the Pe- and Sd-treated seeds. Consistent with this, the expression of a subset of genes involved in FA metabolism, sugar and oil storage was significantly altered in Pe and Sd treated seeds. Taken together, our studies suggest the metabolite profiles of canola seeds dynamically varied during the course of oil accumulation, which may provide a new insight into the mechanisms of the oil accumulation at the metabolite level.	[Tan, Helin; Li, Jianqiao; Xu, Xinying; Guo, Haolun; Ye, Wenxue] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Xie, Qingjun] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China; [Xiang, Xiaoe] Nanjing Agr Univ, Anim Sci Natl Teaching Demonstrat Ctr, Nanjing 210095, Jiangsu, Peoples R China; [Zheng, Suning] Chinese Acad Agr Sci, Supervis & Testing Ctr Vegetable Qual, Inst Vegetables & Flowers, Minist Agr, Beijing 100081, Peoples R China	Nanjing Agricultural University; South China Agricultural University; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Tan, HL (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	hltan@njau.edu.cn	Xie, Qingjun/A-4199-2017	Xie, Qingjun/0000-0002-6372-3260	Natural Science Foundation of Jiangsu province [BK2012767]; Fundamental Research Funds for the Central Universities [KYZ201301]	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by the Natural Science Foundation of Jiangsu province (BK2012767), the Fundamental Research Funds for the Central Universities (KYZ201301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokanthan PS, 1997, PHYSIOL PLANTARUM, V101, P353, DOI 10.1034/j.1399-3054.1997.1010215.x; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Baud S, 2009, PLANT J, V60, P933, DOI 10.1111/j.1365-313X.2009.04011.x; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Bennett EJ, 2011, NEW PHYTOL, V190, P838, DOI 10.1111/j.1469-8137.2011.03714.x; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; BROWSE J, 1985, PLANTA, V166, P74, DOI 10.1007/BF00397388; Clauss K, 2011, PLANT PHYSIOL, V155, P1127, DOI 10.1104/pp.110.169821; de Sousa CAF, 2003, ENVIRON EXP BOT, V50, P1, DOI 10.1016/S0098-8472(02)00108-9; Ding WH, 2003, RAPID COMMUN MASS SP, V17, P56, DOI 10.1002/rcm.819; Eastmond P, 1996, J EXP BOT, V47, P1763, DOI 10.1093/jxb/47.11.1763; Fritschi FB, 2007, PHOTOSYNTHETICA, V45, P92, DOI 10.1007/s11099-007-0014-4; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; Hill LM, 2003, PLANT PHYSIOL, V131, P228, DOI 10.1104/pp.010868; Hsieh R J, 1989, Adv Food Nutr Res, V33, P233, DOI 10.1016/S1043-4526(08)60129-1; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; HUANG LS, 1990, PHYTOCHEMISTRY, V29, P1441, DOI 10.1016/0031-9422(90)80097-Z; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Jessica P., 2010, THESIS U MANITOBA; Jiang JJ, 2013, J INTEGR PLANT BIOL, V55, P537, DOI 10.1111/jipb.12039; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; LEWIS GJ, 1994, AUST J EXP AGR, V34, P93, DOI 10.1071/EA9940093; Maeo K, 2009, PLANT J, V60, P476, DOI 10.1111/j.1365-313X.2009.03967.x; Masaki T, 2005, PLANT CELL PHYSIOL, V46, P547, DOI 10.1093/pcp/pci072; Millar AA, 2000, TRENDS PLANT SCI, V5, P95, DOI 10.1016/S1360-1385(00)01566-1; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Napier JA, 2014, CURR OPIN PLANT BIOL, V19, P68, DOI 10.1016/j.pbi.2014.04.001; Nesi N, 2008, CR BIOL, V331, P763, DOI 10.1016/j.crvi.2008.07.018; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; PECHAN PA, 1985, J EXP BOT, V36, P458, DOI 10.1093/jxb/36.3.458; Porterfield DM, 1999, CAN J BOT, V77, P1439, DOI 10.1139/cjb-77-10-1439; Puthur JT, 2013, J PLANT PHYSIOL, V170, P1131, DOI 10.1016/j.jplph.2013.04.011; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; SHORROSH BS, 1995, PLANT PHYSIOL, V108, P805, DOI 10.1104/pp.108.2.805; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; SINGAL HR, 1987, PLANT PHYSIOL, V83, P1043, DOI 10.1104/pp.83.4.1043; SLABAS AR, 1992, PLANT MOL BIOL, V19, P169, DOI 10.1007/BF00015613; Tan HL, 2011, PLANT PHYSIOL, V156, P1577, DOI 10.1104/pp.111.175000; Ting JTL, 1996, PLANTA, V199, P158, DOI 10.1007/BF00196892; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; TZEN JTC, 1992, J BIOL CHEM, V267, P15626; Vigeolas H, 2003, PLANT PHYSIOL, V133, P2048, DOI 10.1104/pp.103.031963; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; Watanabe M, 2013, PLANT PHYSIOL, V162, P1290, DOI 10.1104/pp.113.217380; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Wu XL, 2014, J INTEGR PLANT BIOL, V56, P582, DOI 10.1111/jipb.12158; Yu CY, 2013, J APPL GENET, V54, P135, DOI 10.1007/s13353-012-0132-y; Zou JT, 1997, PLANT CELL, V9, P909, DOI 10.1105/tpc.9.6.909	52	27	30	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124794	10.1371/journal.pone.0124794	http://dx.doi.org/10.1371/journal.pone.0124794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919591	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400062
J	Bachmann, D; Gockele, A; Ravenek, JM; Roscher, C; Strecker, T; Weigelt, A; Buchmann, N				Bachmann, Doerte; Gockele, Annette; Ravenek, Janneke M.; Roscher, Christiane; Strecker, Tanja; Weigelt, Alexandra; Buchmann, Nina			No Evidence of Complementary Water Use along a Plant Species Richness Gradient in Temperate Experimental Grasslands	PLOS ONE			English	Article							DIVERSITY-PRODUCTIVITY RELATIONSHIPS; BIODIVERSITY EXPERIMENTS; ECOSYSTEM PROCESSES; CURRENT KNOWLEDGE; STABLE ISOTOPES; COMMUNITIES; DEPTH; NITROGEN; PATTERNS; SPACE	Niche complementarity in resource use has been proposed as a key mechanism to explain the positive effects of increasing plant species richness on ecosystem processes, in particular on primary productivity. Since hardly any information is available for niche complementarity in water use, we tested the effects of plant diversity on spatial and temporal complementarity in water uptake in experimental grasslands by using stable water isotopes. We hypothesized that water uptake from deeper soil depths increases in more diverse compared to low diverse plant species mixtures. We labeled soil water in 8 cm (with O-18) and 28 cm depth (with H-2) three times during the 2011 growing season in 40 temperate grassland communities of varying species richness (2, 4, 8 and 16 species) and functional group number and composition (legumes, grasses, tall herbs, small herbs). Stable isotope analyses of xylem and soil water allowed identifying the preferential depth of water uptake. Higher enrichment in 18O of xylem water than in H-2 suggested that the main water uptake was in the upper soil layer. Furthermore, our results revealed no differences in root water uptake among communities with different species richness, different number of functional groups or with time. Thus, our results do not support the hypothesis of increased complementarity in water use in more diverse than in less diverse communities of temperate grassland species.	[Bachmann, Doerte; Buchmann, Nina] ETH, Inst Agr Sci, Zurich, Switzerland; [Gockele, Annette] Univ Freiburg, Fac Biol, Dept Geobot, D-79106 Freiburg, Germany; [Ravenek, Janneke M.] Radboud Univ Nijmegen, Dept Expt Plant Ecol, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Roscher, Christiane] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Strecker, Tanja] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Weigelt, Alexandra] Univ Leipzig, Dept Special Bot & Funct Biodivers, Inst Biol, D-04109 Leipzig, Germany; [Weigelt, Alexandra] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; Radboud University Nijmegen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen; Leipzig University	Bachmann, D (corresponding author), ETH, Inst Agr Sci, Zurich, Switzerland.	doerte.bachmann@usys.ethz.ch	Buchmann, Nina/E-6095-2011	Buchmann, Nina/0000-0003-0826-2980; Bachmann, Dorte/0000-0003-2171-3838; Segura, Diego Fernando/0000-0003-2927-9028; Fernandez, Patricia C./0000-0002-4360-6761; Juarez, Maria Laura/0000-0002-4563-5080; Vera, Maria Teresa/0000-0002-1446-6042; Ruiz, Maria Josefina/0000-0003-0773-2629	Swiss National Science Foundation [315230E-131194]; German Science Foundation [FOR 456/1451]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Science Foundation(German Research Foundation (DFG))	This study was financially supported by the Swiss National Science Foundation (315230E-131194, www.snf.ch) and the German Science Foundation (FOR 456/1451, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2013, OECOLOGIA, V173, P223, DOI 10.1007/s00442-012-2589-0; ALLISON GB, 1983, EFFECT CLIMATE VEGET, P105; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnard RL, 2006, RAPID COMMUN MASS SP, V20, P3799, DOI 10.1002/rcm.2778; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BERENDSE F, 1982, OECOLOGIA, V53, P50, DOI 10.1007/BF00377135; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bessler H, 2012, PLANT SOIL, V358, P301, DOI 10.1007/s11104-012-1181-z; Caldeira MC, 2001, ECOL LETT, V4, P439, DOI 10.1046/j.1461-0248.2001.00238.x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Clark I., 1997, ENV ISOTOPES HYDROLO; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Dodd MB, 1998, OECOLOGIA, V117, P504, DOI 10.1007/s004420050686; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; EHLERINGER JR, 1991, OECOLOGIA, V88, P430, DOI 10.1007/BF00317589; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Fischer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098987; GORDON DR, 1992, AM J BOT, V79, P967, DOI 10.2307/2444905; Grieu P, 2001, PLANT SOIL, V230, P197, DOI 10.1023/A:1010363532118; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hoekstra NJ, 2014, BIOGEOSCIENCES DISCU, V11, P4151, DOI DOI 10.5194/BGD-11-4151-2014; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Moreno-Gutierrez C, 2012, NEW PHYTOL, V196, P489, DOI 10.1111/j.1469-8137.2012.04276.x; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Muller-Westermeier G, 2000, BERICHTE DTSCH WETTE, V213; Nippert JB, 2007, OIKOS, V116, P1017, DOI [10.1111/j.2007.0030-1299.15630.x, 10.1111/j.0030-1299.2007.15630.x]; Oelmann Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003869; Ogle K, 2004, ECOLOGY, V85, P1967, DOI 10.1890/03-0346; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Verheyen K, 2008, OECOLOGIA, V156, P351, DOI 10.1007/s00442-008-0998-x; Volaire F, 2014, EUR J AGRON, V52, P81, DOI 10.1016/j.eja.2013.10.002; von Felten S, 2008, J PLANT ECOL, V1, P33, DOI 10.1093/jpe/rtm006; von Felten S, 2009, ECOLOGY, V90, P1389, DOI 10.1890/08-0802.1; Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C; WHITE JWC, 1985, GEOCHIM COSMOCHIM AC, V49, P237, DOI 10.1016/0016-7037(85)90207-8	57	54	57	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2015	10	1							e0116367	10.1371/journal.pone.0116367	http://dx.doi.org/10.1371/journal.pone.0116367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0ID	25923584	Green Submitted, Green Published, gold			2022-12-26	WOS:000347928300011
